"","pmid","doi","title","abstract","year","month","day","jabbrv","journal","keywords","lastname","firstname","address","email"
"1","34227767","","COVID-19 Immunity to Vaccination in India.",NA,"2021","07","09","J Assoc Physicians India","The Journal of the Association of Physicians of India","COVID-19; Humans; India; SARS-CoV-2; Vaccination","Joshi","Shashank R","Dean, Indian College of Physicians, Mumbai, Maharashtra",NA
"2","34227752","10.3947/ic.2021.0013","Radiologically Suspected Organizing Pneumonia in a Patient Recovering from COVID-19: A Case Report.","We report a case of coronavirus disease 2019 (COVID-19)-associated radiologically suspected organizing pneumonia with repeated negative Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) polymerase chain reaction (PCR) results from nasopharyngeal swab and sputum samples, but positive result from bronchoalveolar lavage fluid. Performing SARS-CoV-2 RT-PCR in upper respiratory tract samples only could fail to detect COVID-19-associated pneumonia, and SARS-CoV-2 could be an etiology of rad","2021","07","06","Infect Chemother","Infection &amp; chemotherapy","Bronchoalveolar lavage; COVID-19; Organizing pneumonia; Polymerase chain reaction; SARS-CoV-2","Seo","Hyeonji","Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea",NA
"3","34227752","10.3947/ic.2021.0013","Radiologically Suspected Organizing Pneumonia in a Patient Recovering from COVID-19: A Case Report.","We report a case of coronavirus disease 2019 (COVID-19)-associated radiologically suspected organizing pneumonia with repeated negative Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) polymerase chain reaction (PCR) results from nasopharyngeal swab and sputum samples, but positive result from bronchoalveolar lavage fluid. Performing SARS-CoV-2 RT-PCR in upper respiratory tract samples only could fail to detect COVID-19-associated pneumonia, and SARS-CoV-2 could be an etiology of rad","2021","07","06","Infect Chemother","Infection &amp; chemotherapy","Bronchoalveolar lavage; COVID-19; Organizing pneumonia; Polymerase chain reaction; SARS-CoV-2","Jung","Jiwon","Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea",NA
"4","34227752","10.3947/ic.2021.0013","Radiologically Suspected Organizing Pneumonia in a Patient Recovering from COVID-19: A Case Report.","We report a case of coronavirus disease 2019 (COVID-19)-associated radiologically suspected organizing pneumonia with repeated negative Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) polymerase chain reaction (PCR) results from nasopharyngeal swab and sputum samples, but positive result from bronchoalveolar lavage fluid. Performing SARS-CoV-2 RT-PCR in upper respiratory tract samples only could fail to detect COVID-19-associated pneumonia, and SARS-CoV-2 could be an etiology of rad","2021","07","06","Infect Chemother","Infection &amp; chemotherapy","Bronchoalveolar lavage; COVID-19; Organizing pneumonia; Polymerase chain reaction; SARS-CoV-2","Kim","Min Jae","Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea",NA
"5","34227752","10.3947/ic.2021.0013","Radiologically Suspected Organizing Pneumonia in a Patient Recovering from COVID-19: A Case Report.","We report a case of coronavirus disease 2019 (COVID-19)-associated radiologically suspected organizing pneumonia with repeated negative Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) polymerase chain reaction (PCR) results from nasopharyngeal swab and sputum samples, but positive result from bronchoalveolar lavage fluid. Performing SARS-CoV-2 RT-PCR in upper respiratory tract samples only could fail to detect COVID-19-associated pneumonia, and SARS-CoV-2 could be an etiology of rad","2021","07","06","Infect Chemother","Infection &amp; chemotherapy","Bronchoalveolar lavage; COVID-19; Organizing pneumonia; Polymerase chain reaction; SARS-CoV-2","Jang","Se Jin","Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea",NA
"6","34227752","10.3947/ic.2021.0013","Radiologically Suspected Organizing Pneumonia in a Patient Recovering from COVID-19: A Case Report.","We report a case of coronavirus disease 2019 (COVID-19)-associated radiologically suspected organizing pneumonia with repeated negative Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) polymerase chain reaction (PCR) results from nasopharyngeal swab and sputum samples, but positive result from bronchoalveolar lavage fluid. Performing SARS-CoV-2 RT-PCR in upper respiratory tract samples only could fail to detect COVID-19-associated pneumonia, and SARS-CoV-2 could be an etiology of rad","2021","07","06","Infect Chemother","Infection &amp; chemotherapy","Bronchoalveolar lavage; COVID-19; Organizing pneumonia; Polymerase chain reaction; SARS-CoV-2","Kim","Sung Han","Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. kimsunghanmd@hotmail","kimsunghanmd@hotmail.com"
"7","34227749","10.1002/nop2.970","Working in a Dutch nursing home during the COVID-19 pandemic: Experiences and lessons learned.","To gain insight into how direct care staff in Dutch nursing homes experienced work during the COVID-19 pandemic. A qualitative study consisting of semi-structured, face-to-face focus groups was conducted using ""the active dialogue approach"". Participants (n = 29) were care staff from four care teams at Dutch nursing homes. Teams were selected based on the number of COVID-19 infections amongst residents. Data were analysed with conventional content analysis. Themes emerging from the data were the","2021","07","06","Nurs Open","Nursing open","dementia; long-term care; management; nursing staff; relationship-centred care","Rutten","Johanna E R","Department of Health Services Research, Maastricht University, Care and Public Health Research Institute, Maastricht, The Netherlands",NA
"8","34227749","10.1002/nop2.970","Working in a Dutch nursing home during the COVID-19 pandemic: Experiences and lessons learned.","To gain insight into how direct care staff in Dutch nursing homes experienced work during the COVID-19 pandemic. A qualitative study consisting of semi-structured, face-to-face focus groups was conducted using ""the active dialogue approach"". Participants (n = 29) were care staff from four care teams at Dutch nursing homes. Teams were selected based on the number of COVID-19 infections amongst residents. Data were analysed with conventional content analysis. Themes emerging from the data were the","2021","07","06","Nurs Open","Nursing open","dementia; long-term care; management; nursing staff; relationship-centred care","Backhaus","Ramona","Department of Health Services Research, Maastricht University, Care and Public Health Research Institute, Maastricht, The Netherlands",NA
"9","34227749","10.1002/nop2.970","Working in a Dutch nursing home during the COVID-19 pandemic: Experiences and lessons learned.","To gain insight into how direct care staff in Dutch nursing homes experienced work during the COVID-19 pandemic. A qualitative study consisting of semi-structured, face-to-face focus groups was conducted using ""the active dialogue approach"". Participants (n = 29) were care staff from four care teams at Dutch nursing homes. Teams were selected based on the number of COVID-19 infections amongst residents. Data were analysed with conventional content analysis. Themes emerging from the data were the","2021","07","06","Nurs Open","Nursing open","dementia; long-term care; management; nursing staff; relationship-centred care","Ph Hamers","Jan","Department of Health Services Research, Maastricht University, Care and Public Health Research Institute, Maastricht, The Netherlands",NA
"10","34227749","10.1002/nop2.970","Working in a Dutch nursing home during the COVID-19 pandemic: Experiences and lessons learned.","To gain insight into how direct care staff in Dutch nursing homes experienced work during the COVID-19 pandemic. A qualitative study consisting of semi-structured, face-to-face focus groups was conducted using ""the active dialogue approach"". Participants (n = 29) were care staff from four care teams at Dutch nursing homes. Teams were selected based on the number of COVID-19 infections amongst residents. Data were analysed with conventional content analysis. Themes emerging from the data were the","2021","07","06","Nurs Open","Nursing open","dementia; long-term care; management; nursing staff; relationship-centred care","Verbeek","Hilde","Department of Health Services Research, Maastricht University, Care and Public Health Research Institute, Maastricht, The Netherlands",NA
"11","34227739","10.1002/iub.2519","Homeostatic control of redox status and health.","Research on oxidants and electrophiles has shifted from focusing on damage to biomolecules to the more fine-grained physiological arena. Redox transitions as excursions from a steady-state redox set point are continually ongoing in maintenance of redox balance. Current excitement on these topics results from the fact that recent research provided mechanistic insight, which gives rise to more concrete and differentiated questions. This Commentary focuses on redox eustress and the feedback restora","2021","07","06","IUBMB Life","IUBMB life","COVID-19; hormesis; oxidative eustress; parahormesis; redox biology; steady state","Sies","Helmut","Institute for Biochemistry and Molecular Biology I, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany",NA
"12","34227739","10.1002/iub.2519","Homeostatic control of redox status and health.","Research on oxidants and electrophiles has shifted from focusing on damage to biomolecules to the more fine-grained physiological arena. Redox transitions as excursions from a steady-state redox set point are continually ongoing in maintenance of redox balance. Current excitement on these topics results from the fact that recent research provided mechanistic insight, which gives rise to more concrete and differentiated questions. This Commentary focuses on redox eustress and the feedback restora","2021","07","06","IUBMB Life","IUBMB life","COVID-19; hormesis; oxidative eustress; parahormesis; redox biology; steady state","Ursini","Fulvio","Department of Molecular Medicine, University of Padova, Padova, Italy",NA
"13","34227728","10.1111/hex.13284","'They're getting a taste of our world': A qualitative study of people with multiple sclerosis' experiences of accessing health care during the COVID-19 pandemic in the Australian Capital Territory.","People with multiple sclerosis (MS), who are often immunocompromised, require complex care and engage with a variety of health-care providers to manage their health. To elucidate people with MS' experiences of accessing health care during the COVID-19 pandemic in Australia. A qualitative study involving semi-structured interviews and thematic analysis. Eight adults with a clinical diagnosis of MS participated in telephone or video call interviews between June and July 2020. Participants were awa","2021","07","06","Health Expect","Health expectations : an international journal of public participation in health care and health policy","multiple sclerosis; pandemic; patient experience; qualitative; risk assessment; telehealth","Parkinson","Anne","Department of Health Services, Research and Policy, Australian National University, Canberra, ACT, Australia",NA
"14","34227728","10.1111/hex.13284","'They're getting a taste of our world': A qualitative study of people with multiple sclerosis' experiences of accessing health care during the COVID-19 pandemic in the Australian Capital Territory.","People with multiple sclerosis (MS), who are often immunocompromised, require complex care and engage with a variety of health-care providers to manage their health. To elucidate people with MS' experiences of accessing health care during the COVID-19 pandemic in Australia. A qualitative study involving semi-structured interviews and thematic analysis. Eight adults with a clinical diagnosis of MS participated in telephone or video call interviews between June and July 2020. Participants were awa","2021","07","06","Health Expect","Health expectations : an international journal of public participation in health care and health policy","multiple sclerosis; pandemic; patient experience; qualitative; risk assessment; telehealth","Drew","Janet","Department of Health Services, Research and Policy, Australian National University, Canberra, ACT, Australia",NA
"15","34227728","10.1111/hex.13284","'They're getting a taste of our world': A qualitative study of people with multiple sclerosis' experiences of accessing health care during the COVID-19 pandemic in the Australian Capital Territory.","People with multiple sclerosis (MS), who are often immunocompromised, require complex care and engage with a variety of health-care providers to manage their health. To elucidate people with MS' experiences of accessing health care during the COVID-19 pandemic in Australia. A qualitative study involving semi-structured interviews and thematic analysis. Eight adults with a clinical diagnosis of MS participated in telephone or video call interviews between June and July 2020. Participants were awa","2021","07","06","Health Expect","Health expectations : an international journal of public participation in health care and health policy","multiple sclerosis; pandemic; patient experience; qualitative; risk assessment; telehealth","Hall Dykgraaf","Sally","Medical School, Australian National University, Canberra, ACT, Australia",NA
"16","34227728","10.1111/hex.13284","'They're getting a taste of our world': A qualitative study of people with multiple sclerosis' experiences of accessing health care during the COVID-19 pandemic in the Australian Capital Territory.","People with multiple sclerosis (MS), who are often immunocompromised, require complex care and engage with a variety of health-care providers to manage their health. To elucidate people with MS' experiences of accessing health care during the COVID-19 pandemic in Australia. A qualitative study involving semi-structured interviews and thematic analysis. Eight adults with a clinical diagnosis of MS participated in telephone or video call interviews between June and July 2020. Participants were awa","2021","07","06","Health Expect","Health expectations : an international journal of public participation in health care and health policy","multiple sclerosis; pandemic; patient experience; qualitative; risk assessment; telehealth","Fanning","Vanessa","Department of Health Services, Research and Policy, Australian National University, Canberra, ACT, Australia",NA
"17","34227728","10.1111/hex.13284","'They're getting a taste of our world': A qualitative study of people with multiple sclerosis' experiences of accessing health care during the COVID-19 pandemic in the Australian Capital Territory.","People with multiple sclerosis (MS), who are often immunocompromised, require complex care and engage with a variety of health-care providers to manage their health. To elucidate people with MS' experiences of accessing health care during the COVID-19 pandemic in Australia. A qualitative study involving semi-structured interviews and thematic analysis. Eight adults with a clinical diagnosis of MS participated in telephone or video call interviews between June and July 2020. Participants were awa","2021","07","06","Health Expect","Health expectations : an international journal of public participation in health care and health policy","multiple sclerosis; pandemic; patient experience; qualitative; risk assessment; telehealth","Chisholm","Katrina","Department of Health Services, Research and Policy, Australian National University, Canberra, ACT, Australia",NA
"18","34227728","10.1111/hex.13284","'They're getting a taste of our world': A qualitative study of people with multiple sclerosis' experiences of accessing health care during the COVID-19 pandemic in the Australian Capital Territory.","People with multiple sclerosis (MS), who are often immunocompromised, require complex care and engage with a variety of health-care providers to manage their health. To elucidate people with MS' experiences of accessing health care during the COVID-19 pandemic in Australia. A qualitative study involving semi-structured interviews and thematic analysis. Eight adults with a clinical diagnosis of MS participated in telephone or video call interviews between June and July 2020. Participants were awa","2021","07","06","Health Expect","Health expectations : an international journal of public participation in health care and health policy","multiple sclerosis; pandemic; patient experience; qualitative; risk assessment; telehealth","Elisha","Mark","Department of Health Services, Research and Policy, Australian National University, Canberra, ACT, Australia",NA
"19","34227728","10.1111/hex.13284","'They're getting a taste of our world': A qualitative study of people with multiple sclerosis' experiences of accessing health care during the COVID-19 pandemic in the Australian Capital Territory.","People with multiple sclerosis (MS), who are often immunocompromised, require complex care and engage with a variety of health-care providers to manage their health. To elucidate people with MS' experiences of accessing health care during the COVID-19 pandemic in Australia. A qualitative study involving semi-structured interviews and thematic analysis. Eight adults with a clinical diagnosis of MS participated in telephone or video call interviews between June and July 2020. Participants were awa","2021","07","06","Health Expect","Health expectations : an international journal of public participation in health care and health policy","multiple sclerosis; pandemic; patient experience; qualitative; risk assessment; telehealth","Lueck","Christian","Medical School, Australian National University, Canberra, ACT, Australia",NA
"20","34227728","10.1111/hex.13284","'They're getting a taste of our world': A qualitative study of people with multiple sclerosis' experiences of accessing health care during the COVID-19 pandemic in the Australian Capital Territory.","People with multiple sclerosis (MS), who are often immunocompromised, require complex care and engage with a variety of health-care providers to manage their health. To elucidate people with MS' experiences of accessing health care during the COVID-19 pandemic in Australia. A qualitative study involving semi-structured interviews and thematic analysis. Eight adults with a clinical diagnosis of MS participated in telephone or video call interviews between June and July 2020. Participants were awa","2021","07","06","Health Expect","Health expectations : an international journal of public participation in health care and health policy","multiple sclerosis; pandemic; patient experience; qualitative; risk assessment; telehealth","Phillips","Christine","Medical School, Australian National University, Canberra, ACT, Australia",NA
"21","34227728","10.1111/hex.13284","'They're getting a taste of our world': A qualitative study of people with multiple sclerosis' experiences of accessing health care during the COVID-19 pandemic in the Australian Capital Territory.","People with multiple sclerosis (MS), who are often immunocompromised, require complex care and engage with a variety of health-care providers to manage their health. To elucidate people with MS' experiences of accessing health care during the COVID-19 pandemic in Australia. A qualitative study involving semi-structured interviews and thematic analysis. Eight adults with a clinical diagnosis of MS participated in telephone or video call interviews between June and July 2020. Participants were awa","2021","07","06","Health Expect","Health expectations : an international journal of public participation in health care and health policy","multiple sclerosis; pandemic; patient experience; qualitative; risk assessment; telehealth","Desborough","Jane","Department of Health Services, Research and Policy, Australian National University, Canberra, ACT, Australia",NA
"22","34227718","10.1111/imj.15441","Utilization of telehealth for outpatient diabetes management during COVID-19 pandemic: how did the patients fare?","During the coronavirus disease 2019 (COVID-19) pandemic, many outpatient services at public hospitals, including diabetes services, had adopted telehealth appointments for their clinic patients. There was concern that patients' glycaemic control may worsen during the pandemic. We conducted a retrospective review of patients with diabetes managed by telehealth consultations over 5 months at two metropolitan hospitals in Sydney. Their attendance rate, glycaemic control and unplanned admissions to ","2021","07","06","Intern Med J","Internal medicine journal","COVID-19; Diabetes mellitus; glycaemic control; outpatient service; telehealth","Wong","Vincent W","Diabetes and Endocrine Service, Liverpool Hospital, Liverpool, New South Wales",NA
"23","34227718","10.1111/imj.15441","Utilization of telehealth for outpatient diabetes management during COVID-19 pandemic: how did the patients fare?","During the coronavirus disease 2019 (COVID-19) pandemic, many outpatient services at public hospitals, including diabetes services, had adopted telehealth appointments for their clinic patients. There was concern that patients' glycaemic control may worsen during the pandemic. We conducted a retrospective review of patients with diabetes managed by telehealth consultations over 5 months at two metropolitan hospitals in Sydney. Their attendance rate, glycaemic control and unplanned admissions to ","2021","07","06","Intern Med J","Internal medicine journal","COVID-19; Diabetes mellitus; glycaemic control; outpatient service; telehealth","Wang","Alexandra","Diabetes and Endocrine Service, Liverpool Hospital, Liverpool, New South Wales",NA
"24","34227718","10.1111/imj.15441","Utilization of telehealth for outpatient diabetes management during COVID-19 pandemic: how did the patients fare?","During the coronavirus disease 2019 (COVID-19) pandemic, many outpatient services at public hospitals, including diabetes services, had adopted telehealth appointments for their clinic patients. There was concern that patients' glycaemic control may worsen during the pandemic. We conducted a retrospective review of patients with diabetes managed by telehealth consultations over 5 months at two metropolitan hospitals in Sydney. Their attendance rate, glycaemic control and unplanned admissions to ","2021","07","06","Intern Med J","Internal medicine journal","COVID-19; Diabetes mellitus; glycaemic control; outpatient service; telehealth","Manoharan","Manimegalai","Diabetes and Endocrine Service, Liverpool Hospital, Liverpool, New South Wales",NA
"25","34227713","10.1111/imj.15444","Telehealth in Australian cardiology: Insight into factors predicting the use of telephone versus video during the COVID-19 pandemic.","The use of telehealth has increased dramatically in Australia in 2020 as a pragmatic response to the COVID-19 pandemic, however differences between telehealth modalities have not been established. To identify characteristics contributing to choosing telephone (TP) versus video-consultation (VC) and assess patient outcomes between telehealth modalities. We conducted an observational study of cardiology outpatients at a tertiary hospital with appointments from 17 March 2020 to 12 August 2020. Demo","2021","07","06","Intern Med J","Internal medicine journal","COVID-19; Telemedicine; ambulatory care; cardiology; telehealth","Rowe BBiomed","Stephanie J","Department of Cardiology, St Vincent's Hospital Melbourne, 41 Victoria Parade, Fitzroy, Vic, 3065",NA
"26","34227713","10.1111/imj.15444","Telehealth in Australian cardiology: Insight into factors predicting the use of telephone versus video during the COVID-19 pandemic.","The use of telehealth has increased dramatically in Australia in 2020 as a pragmatic response to the COVID-19 pandemic, however differences between telehealth modalities have not been established. To identify characteristics contributing to choosing telephone (TP) versus video-consultation (VC) and assess patient outcomes between telehealth modalities. We conducted an observational study of cardiology outpatients at a tertiary hospital with appointments from 17 March 2020 to 12 August 2020. Demo","2021","07","06","Intern Med J","Internal medicine journal","COVID-19; Telemedicine; ambulatory care; cardiology; telehealth","Paratz","Elizabeth D","Department of Cardiology, St Vincent's Hospital Melbourne, 41 Victoria Parade, Fitzroy, Vic, 3065",NA
"27","34227713","10.1111/imj.15444","Telehealth in Australian cardiology: Insight into factors predicting the use of telephone versus video during the COVID-19 pandemic.","The use of telehealth has increased dramatically in Australia in 2020 as a pragmatic response to the COVID-19 pandemic, however differences between telehealth modalities have not been established. To identify characteristics contributing to choosing telephone (TP) versus video-consultation (VC) and assess patient outcomes between telehealth modalities. We conducted an observational study of cardiology outpatients at a tertiary hospital with appointments from 17 March 2020 to 12 August 2020. Demo","2021","07","06","Intern Med J","Internal medicine journal","COVID-19; Telemedicine; ambulatory care; cardiology; telehealth","Fahy","Louise","Department of Cardiology, St Vincent's Hospital Melbourne, 41 Victoria Parade, Fitzroy, Vic, 3065",NA
"28","34227713","10.1111/imj.15444","Telehealth in Australian cardiology: Insight into factors predicting the use of telephone versus video during the COVID-19 pandemic.","The use of telehealth has increased dramatically in Australia in 2020 as a pragmatic response to the COVID-19 pandemic, however differences between telehealth modalities have not been established. To identify characteristics contributing to choosing telephone (TP) versus video-consultation (VC) and assess patient outcomes between telehealth modalities. We conducted an observational study of cardiology outpatients at a tertiary hospital with appointments from 17 March 2020 to 12 August 2020. Demo","2021","07","06","Intern Med J","Internal medicine journal","COVID-19; Telemedicine; ambulatory care; cardiology; telehealth","Prior","David L","Department of Cardiology, St Vincent's Hospital Melbourne, 41 Victoria Parade, Fitzroy, Vic, 3065",NA
"29","34227713","10.1111/imj.15444","Telehealth in Australian cardiology: Insight into factors predicting the use of telephone versus video during the COVID-19 pandemic.","The use of telehealth has increased dramatically in Australia in 2020 as a pragmatic response to the COVID-19 pandemic, however differences between telehealth modalities have not been established. To identify characteristics contributing to choosing telephone (TP) versus video-consultation (VC) and assess patient outcomes between telehealth modalities. We conducted an observational study of cardiology outpatients at a tertiary hospital with appointments from 17 March 2020 to 12 August 2020. Demo","2021","07","06","Intern Med J","Internal medicine journal","COVID-19; Telemedicine; ambulatory care; cardiology; telehealth","MacIsaac","Andrew I","Department of Cardiology, St Vincent's Hospital Melbourne, 41 Victoria Parade, Fitzroy, Vic, 3065",NA
"30","34227711","10.1111/ped.14742","Multisystem inflammatory syndrome in children: A single-center experience.","This case series aims to evaluate the presenting symptoms, laboratory data, systemic findings, and response to early treatment in patients who were followed up with the diagnosis of multisystemic inflammatory syndrome associated with novel coronavirus disease 2019 (COVID-19). The presentation, laboratory findings, and responses to treatment of patients hospitalized and diagnosed with multisystemic inflammatory syndrome were evaluated retrospectively. A total of 32 patients were included in the s","2021","07","06","Pediatr Int","Pediatrics international : official journal of the Japan Pediatric Society","COVID 19; multisystem inflammatory syndrome; pediatrics","Türe","Mehmet","Department of Pediatric Cardiology, Dicle University Hospital, Diyarbakir, Turkey",NA
"31","34227711","10.1111/ped.14742","Multisystem inflammatory syndrome in children: A single-center experience.","This case series aims to evaluate the presenting symptoms, laboratory data, systemic findings, and response to early treatment in patients who were followed up with the diagnosis of multisystemic inflammatory syndrome associated with novel coronavirus disease 2019 (COVID-19). The presentation, laboratory findings, and responses to treatment of patients hospitalized and diagnosed with multisystemic inflammatory syndrome were evaluated retrospectively. A total of 32 patients were included in the s","2021","07","06","Pediatr Int","Pediatrics international : official journal of the Japan Pediatric Society","COVID 19; multisystem inflammatory syndrome; pediatrics","Kan","Ahmet","Department of Pediatric allergy and immunology, Dicle University Hospital, Diyarbakir, Turkey",NA
"32","34227711","10.1111/ped.14742","Multisystem inflammatory syndrome in children: A single-center experience.","This case series aims to evaluate the presenting symptoms, laboratory data, systemic findings, and response to early treatment in patients who were followed up with the diagnosis of multisystemic inflammatory syndrome associated with novel coronavirus disease 2019 (COVID-19). The presentation, laboratory findings, and responses to treatment of patients hospitalized and diagnosed with multisystemic inflammatory syndrome were evaluated retrospectively. A total of 32 patients were included in the s","2021","07","06","Pediatr Int","Pediatrics international : official journal of the Japan Pediatric Society","COVID 19; multisystem inflammatory syndrome; pediatrics","Akin","Alper","Department of Pediatric Cardiology, Dicle University Hospital, Diyarbakir, Turkey",NA
"33","34227711","10.1111/ped.14742","Multisystem inflammatory syndrome in children: A single-center experience.","This case series aims to evaluate the presenting symptoms, laboratory data, systemic findings, and response to early treatment in patients who were followed up with the diagnosis of multisystemic inflammatory syndrome associated with novel coronavirus disease 2019 (COVID-19). The presentation, laboratory findings, and responses to treatment of patients hospitalized and diagnosed with multisystemic inflammatory syndrome were evaluated retrospectively. A total of 32 patients were included in the s","2021","07","06","Pediatr Int","Pediatrics international : official journal of the Japan Pediatric Society","COVID 19; multisystem inflammatory syndrome; pediatrics","Yilmaz","Kamil","Department of Pediatrics, Dicle University Medical Faculty, Diyarbakir, Turkey",NA
"34","34227711","10.1111/ped.14742","Multisystem inflammatory syndrome in children: A single-center experience.","This case series aims to evaluate the presenting symptoms, laboratory data, systemic findings, and response to early treatment in patients who were followed up with the diagnosis of multisystemic inflammatory syndrome associated with novel coronavirus disease 2019 (COVID-19). The presentation, laboratory findings, and responses to treatment of patients hospitalized and diagnosed with multisystemic inflammatory syndrome were evaluated retrospectively. A total of 32 patients were included in the s","2021","07","06","Pediatr Int","Pediatrics international : official journal of the Japan Pediatric Society","COVID 19; multisystem inflammatory syndrome; pediatrics","Sen","Velat","Department of Pediatrics, Dicle University Medical Faculty, Diyarbakir, Turkey",NA
"35","34227699","10.1111/jocs.15780","Cardiac transplantation as surgical treatment for cardiac sarcoidosis.",NA,"2021","07","06","J Card Surg","Journal of cardiac surgery","Covid-19; echo; sepsis","Ghodsizad","Ali","Department of Surgery, Division Thoracic Transplantation and MCS, Miami Transplant Institute, University of Miami, Miami, Florida, USA",NA
"36","34227689","10.1111/trf.16572","The safety of COVID-19 convalescent plasma donation: A multi-institutional donor hemovigilance study.","Although the safety and therapeutic efficacy of COVID-19 convalescent plasma (CCP) has been extensively evaluated, the safety of CCP donation has not been explored in a multi-institutional context. Nine blood collection organizations (BCOs) participated in a multi-institutional donor hemovigilance effort to assess the safety of CCP donation. Donor adverse events (DAEs) were defined according to the Standard for Surveillance of Complications Related to Blood Donation, and severity was assessed us","2021","07","06","Transfusion","Transfusion","CCP; COVID-19; adverse events; convalescent plasma; donor hemovigilance","Cho","Joseph H","Medical Sciences Institute, Versiti, Milwaukee, Wisconsin, USA",NA
"37","34227689","10.1111/trf.16572","The safety of COVID-19 convalescent plasma donation: A multi-institutional donor hemovigilance study.","Although the safety and therapeutic efficacy of COVID-19 convalescent plasma (CCP) has been extensively evaluated, the safety of CCP donation has not been explored in a multi-institutional context. Nine blood collection organizations (BCOs) participated in a multi-institutional donor hemovigilance effort to assess the safety of CCP donation. Donor adverse events (DAEs) were defined according to the Standard for Surveillance of Complications Related to Blood Donation, and severity was assessed us","2021","07","06","Transfusion","Transfusion","CCP; COVID-19; adverse events; convalescent plasma; donor hemovigilance","Rajbhandary","Srijana","Department of Research, AABB, Bethesda, Maryland, USA",NA
"38","34227689","10.1111/trf.16572","The safety of COVID-19 convalescent plasma donation: A multi-institutional donor hemovigilance study.","Although the safety and therapeutic efficacy of COVID-19 convalescent plasma (CCP) has been extensively evaluated, the safety of CCP donation has not been explored in a multi-institutional context. Nine blood collection organizations (BCOs) participated in a multi-institutional donor hemovigilance effort to assess the safety of CCP donation. Donor adverse events (DAEs) were defined according to the Standard for Surveillance of Complications Related to Blood Donation, and severity was assessed us","2021","07","06","Transfusion","Transfusion","CCP; COVID-19; adverse events; convalescent plasma; donor hemovigilance","van Buren","Nancy L","Innovative Blood Resources, Division of New York Blood Center, St. Paul, Minnesota, USA",NA
"39","34227689","10.1111/trf.16572","The safety of COVID-19 convalescent plasma donation: A multi-institutional donor hemovigilance study.","Although the safety and therapeutic efficacy of COVID-19 convalescent plasma (CCP) has been extensively evaluated, the safety of CCP donation has not been explored in a multi-institutional context. Nine blood collection organizations (BCOs) participated in a multi-institutional donor hemovigilance effort to assess the safety of CCP donation. Donor adverse events (DAEs) were defined according to the Standard for Surveillance of Complications Related to Blood Donation, and severity was assessed us","2021","07","06","Transfusion","Transfusion","CCP; COVID-19; adverse events; convalescent plasma; donor hemovigilance","Fung","Mark K","Department of Pathology and Laboratory Medicine, The University of Vermont Health Network, Burlington, Vermont, USA",NA
"40","34227689","10.1111/trf.16572","The safety of COVID-19 convalescent plasma donation: A multi-institutional donor hemovigilance study.","Although the safety and therapeutic efficacy of COVID-19 convalescent plasma (CCP) has been extensively evaluated, the safety of CCP donation has not been explored in a multi-institutional context. Nine blood collection organizations (BCOs) participated in a multi-institutional donor hemovigilance effort to assess the safety of CCP donation. Donor adverse events (DAEs) were defined according to the Standard for Surveillance of Complications Related to Blood Donation, and severity was assessed us","2021","07","06","Transfusion","Transfusion","CCP; COVID-19; adverse events; convalescent plasma; donor hemovigilance","Al-Ghafry","Maha","New York Blood Center, New York, New York, USA",NA
"41","34227689","10.1111/trf.16572","The safety of COVID-19 convalescent plasma donation: A multi-institutional donor hemovigilance study.","Although the safety and therapeutic efficacy of COVID-19 convalescent plasma (CCP) has been extensively evaluated, the safety of CCP donation has not been explored in a multi-institutional context. Nine blood collection organizations (BCOs) participated in a multi-institutional donor hemovigilance effort to assess the safety of CCP donation. Donor adverse events (DAEs) were defined according to the Standard for Surveillance of Complications Related to Blood Donation, and severity was assessed us","2021","07","06","Transfusion","Transfusion","CCP; COVID-19; adverse events; convalescent plasma; donor hemovigilance","Fridey","Joy L","American Red Cross Blood Services, Southern California Region, Pomona, California, USA",NA
"42","34227689","10.1111/trf.16572","The safety of COVID-19 convalescent plasma donation: A multi-institutional donor hemovigilance study.","Although the safety and therapeutic efficacy of COVID-19 convalescent plasma (CCP) has been extensively evaluated, the safety of CCP donation has not been explored in a multi-institutional context. Nine blood collection organizations (BCOs) participated in a multi-institutional donor hemovigilance effort to assess the safety of CCP donation. Donor adverse events (DAEs) were defined according to the Standard for Surveillance of Complications Related to Blood Donation, and severity was assessed us","2021","07","06","Transfusion","Transfusion","CCP; COVID-19; adverse events; convalescent plasma; donor hemovigilance","Dy","Beth A","American Red Cross Biomedical Services, Washington, District of Columbia, USA",NA
"43","34227689","10.1111/trf.16572","The safety of COVID-19 convalescent plasma donation: A multi-institutional donor hemovigilance study.","Although the safety and therapeutic efficacy of COVID-19 convalescent plasma (CCP) has been extensively evaluated, the safety of CCP donation has not been explored in a multi-institutional context. Nine blood collection organizations (BCOs) participated in a multi-institutional donor hemovigilance effort to assess the safety of CCP donation. Donor adverse events (DAEs) were defined according to the Standard for Surveillance of Complications Related to Blood Donation, and severity was assessed us","2021","07","06","Transfusion","Transfusion","CCP; COVID-19; adverse events; convalescent plasma; donor hemovigilance","Ziman","Alyssa","Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California, USA",NA
"44","34227689","10.1111/trf.16572","The safety of COVID-19 convalescent plasma donation: A multi-institutional donor hemovigilance study.","Although the safety and therapeutic efficacy of COVID-19 convalescent plasma (CCP) has been extensively evaluated, the safety of CCP donation has not been explored in a multi-institutional context. Nine blood collection organizations (BCOs) participated in a multi-institutional donor hemovigilance effort to assess the safety of CCP donation. Donor adverse events (DAEs) were defined according to the Standard for Surveillance of Complications Related to Blood Donation, and severity was assessed us","2021","07","06","Transfusion","Transfusion","CCP; COVID-19; adverse events; convalescent plasma; donor hemovigilance","Schreiber","George B","Plasma Protein Therapeutics Association, Annapolis, Maryland, USA",NA
"45","34227689","10.1111/trf.16572","The safety of COVID-19 convalescent plasma donation: A multi-institutional donor hemovigilance study.","Although the safety and therapeutic efficacy of COVID-19 convalescent plasma (CCP) has been extensively evaluated, the safety of CCP donation has not been explored in a multi-institutional context. Nine blood collection organizations (BCOs) participated in a multi-institutional donor hemovigilance effort to assess the safety of CCP donation. Donor adverse events (DAEs) were defined according to the Standard for Surveillance of Complications Related to Blood Donation, and severity was assessed us","2021","07","06","Transfusion","Transfusion","CCP; COVID-19; adverse events; convalescent plasma; donor hemovigilance","Gammon","Richard R","Scientific, Medical, Technical Direction, OneBlood, Orlando, Florida, USA",NA
"46","34227689","10.1111/trf.16572","The safety of COVID-19 convalescent plasma donation: A multi-institutional donor hemovigilance study.","Although the safety and therapeutic efficacy of COVID-19 convalescent plasma (CCP) has been extensively evaluated, the safety of CCP donation has not been explored in a multi-institutional context. Nine blood collection organizations (BCOs) participated in a multi-institutional donor hemovigilance effort to assess the safety of CCP donation. Donor adverse events (DAEs) were defined according to the Standard for Surveillance of Complications Related to Blood Donation, and severity was assessed us","2021","07","06","Transfusion","Transfusion","CCP; COVID-19; adverse events; convalescent plasma; donor hemovigilance","Reik","Rita","Scientific, Medical, Technical Direction, OneBlood, Orlando, Florida, USA",NA
"47","34227689","10.1111/trf.16572","The safety of COVID-19 convalescent plasma donation: A multi-institutional donor hemovigilance study.","Although the safety and therapeutic efficacy of COVID-19 convalescent plasma (CCP) has been extensively evaluated, the safety of CCP donation has not been explored in a multi-institutional context. Nine blood collection organizations (BCOs) participated in a multi-institutional donor hemovigilance effort to assess the safety of CCP donation. Donor adverse events (DAEs) were defined according to the Standard for Surveillance of Complications Related to Blood Donation, and severity was assessed us","2021","07","06","Transfusion","Transfusion","CCP; COVID-19; adverse events; convalescent plasma; donor hemovigilance","Stubbs","James R","Division of Transfusion Medicine, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA",NA
"48","34227689","10.1111/trf.16572","The safety of COVID-19 convalescent plasma donation: A multi-institutional donor hemovigilance study.","Although the safety and therapeutic efficacy of COVID-19 convalescent plasma (CCP) has been extensively evaluated, the safety of CCP donation has not been explored in a multi-institutional context. Nine blood collection organizations (BCOs) participated in a multi-institutional donor hemovigilance effort to assess the safety of CCP donation. Donor adverse events (DAEs) were defined according to the Standard for Surveillance of Complications Related to Blood Donation, and severity was assessed us","2021","07","06","Transfusion","Transfusion","CCP; COVID-19; adverse events; convalescent plasma; donor hemovigilance","van Buskirk","Camille M","Division of Transfusion Medicine, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA",NA
"49","34227689","10.1111/trf.16572","The safety of COVID-19 convalescent plasma donation: A multi-institutional donor hemovigilance study.","Although the safety and therapeutic efficacy of COVID-19 convalescent plasma (CCP) has been extensively evaluated, the safety of CCP donation has not been explored in a multi-institutional context. Nine blood collection organizations (BCOs) participated in a multi-institutional donor hemovigilance effort to assess the safety of CCP donation. Donor adverse events (DAEs) were defined according to the Standard for Surveillance of Complications Related to Blood Donation, and severity was assessed us","2021","07","06","Transfusion","Transfusion","CCP; COVID-19; adverse events; convalescent plasma; donor hemovigilance","Kamel","Hany","Vitalant, Scottsdale, Arizona, USA",NA
"50","34227689","10.1111/trf.16572","The safety of COVID-19 convalescent plasma donation: A multi-institutional donor hemovigilance study.","Although the safety and therapeutic efficacy of COVID-19 convalescent plasma (CCP) has been extensively evaluated, the safety of CCP donation has not been explored in a multi-institutional context. Nine blood collection organizations (BCOs) participated in a multi-institutional donor hemovigilance effort to assess the safety of CCP donation. Donor adverse events (DAEs) were defined according to the Standard for Surveillance of Complications Related to Blood Donation, and severity was assessed us","2021","07","06","Transfusion","Transfusion","CCP; COVID-19; adverse events; convalescent plasma; donor hemovigilance","Townsend","Mary J","Vitalant, Scottsdale, Arizona, USA",NA
"51","34227689","10.1111/trf.16572","The safety of COVID-19 convalescent plasma donation: A multi-institutional donor hemovigilance study.","Although the safety and therapeutic efficacy of COVID-19 convalescent plasma (CCP) has been extensively evaluated, the safety of CCP donation has not been explored in a multi-institutional context. Nine blood collection organizations (BCOs) participated in a multi-institutional donor hemovigilance effort to assess the safety of CCP donation. Donor adverse events (DAEs) were defined according to the Standard for Surveillance of Complications Related to Blood Donation, and severity was assessed us","2021","07","06","Transfusion","Transfusion","CCP; COVID-19; adverse events; convalescent plasma; donor hemovigilance","Zeller","Michelle P","Canadian Blood Services, Ottawa, Ontario, Canada",NA
"52","34227689","10.1111/trf.16572","The safety of COVID-19 convalescent plasma donation: A multi-institutional donor hemovigilance study.","Although the safety and therapeutic efficacy of COVID-19 convalescent plasma (CCP) has been extensively evaluated, the safety of CCP donation has not been explored in a multi-institutional context. Nine blood collection organizations (BCOs) participated in a multi-institutional donor hemovigilance effort to assess the safety of CCP donation. Donor adverse events (DAEs) were defined according to the Standard for Surveillance of Complications Related to Blood Donation, and severity was assessed us","2021","07","06","Transfusion","Transfusion","CCP; COVID-19; adverse events; convalescent plasma; donor hemovigilance","Gottschall","Jerome L","Medical Sciences Institute, Versiti, Milwaukee, Wisconsin, USA",NA
"53","34227661","10.1093/pubmed/fdab277","Global health governance and disaster recovery for rebel returnees during COVID-19.","This article highlights the need for governing some gradual ruptures from the past to achieve a sense of new normalcy in public health. The rebel returnees during the pandemic form a case of a vulnerable group who triply experience disasters: from the pandemic and natural disasters to terrorism. Global health governance carries on the management of past problems attaining their maturation and faces new ones for disaster recovery.","2021","07","06","J Public Health (Oxf)","Journal of public health (Oxford, England)","COVID-19; disaster recovery; global health governance; rebel returnees","Kahambing","Jan Gresil","Social Science Unit, Leyte Normal University, Tacloban City, Philippines Paterno Street, Tacloban City 6500, Philippines",NA
"54","34227658","10.1093/bjs/znab208","Paving the road to recovery: the colorectal surgery ERAS pathway during the COVID-19 pandemic.",NA,"2021","07","06","Br J Surg","The British journal of surgery",NA,"Goodmaker","C J G","Department of Colorectal Surgery, Salford Royal Hospital, Stott Lane, Salford, M6 8HD, UK",NA
"55","34227658","10.1093/bjs/znab208","Paving the road to recovery: the colorectal surgery ERAS pathway during the COVID-19 pandemic.",NA,"2021","07","06","Br J Surg","The British journal of surgery",NA,"Kopczynska","M","Department of Colorectal Surgery, Salford Royal Hospital, Stott Lane, Salford, M6 8HD, UK",NA
"56","34227658","10.1093/bjs/znab208","Paving the road to recovery: the colorectal surgery ERAS pathway during the COVID-19 pandemic.",NA,"2021","07","06","Br J Surg","The British journal of surgery",NA,"Meskell","R","Department of Colorectal Surgery, Salford Royal Hospital, Stott Lane, Salford, M6 8HD, UK",NA
"57","34227658","10.1093/bjs/znab208","Paving the road to recovery: the colorectal surgery ERAS pathway during the COVID-19 pandemic.",NA,"2021","07","06","Br J Surg","The British journal of surgery",NA,"Slade","D","Department of Colorectal Surgery, Salford Royal Hospital, Stott Lane, Salford, M6 8HD, UK",NA
"59","34227650","10.1093/bjs/znab178","Exploring Koch's postulate for SARS-CoV-2-induced acute pancreatitis: is it all about the ACE?",NA,"2021","07","06","Br J Surg","The British journal of surgery",NA,"Pandanaboyana","S","Hepatopancreatobiliary and Transplant Unit, Freeman Hospital, Newcastle upon Tyne, UK",NA
"60","34227618","10.1097/MCG.0000000000001508","Comments on the ""WGO Guidance for the Care of Patients With COVID-19 and Liver Disease"".",NA,"2021","07","08","J Clin Gastroenterol","Journal of clinical gastroenterology","COVID-19; Digestive System Diseases; Humans; Liver Diseases; SARS-CoV-2","Li","Zhe","Liver Cirrhosis Study Group, Department of Gastroenterology, General Hospital of Northern Theater Command, Shenyang China",NA
"61","34227618","10.1097/MCG.0000000000001508","Comments on the ""WGO Guidance for the Care of Patients With COVID-19 and Liver Disease"".",NA,"2021","07","08","J Clin Gastroenterol","Journal of clinical gastroenterology","COVID-19; Digestive System Diseases; Humans; Liver Diseases; SARS-CoV-2","Wu","Yanyan","Liver Cirrhosis Study Group, Department of Gastroenterology, General Hospital of Northern Theater Command, Shenyang China",NA
"62","34227618","10.1097/MCG.0000000000001508","Comments on the ""WGO Guidance for the Care of Patients With COVID-19 and Liver Disease"".",NA,"2021","07","08","J Clin Gastroenterol","Journal of clinical gastroenterology","COVID-19; Digestive System Diseases; Humans; Liver Diseases; SARS-CoV-2","Qi","Xingshun","Liver Cirrhosis Study Group, Department of Gastroenterology, General Hospital of Northern Theater Command, Shenyang China",NA
"63","34227581","10.1097/QCO.0000000000000734","The front-line during the coronavirus disease 2019 pandemic: healthcare personnel.","An estimated four to 11% of reported coronavirus disease 2019 (COVID-19) cases occurs in healthcare personnel (HCP). HCP are at high risk of acquiring and transmitting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) given their close contact with individuals with recognized and unrecognized COVID-19. We summarize the literature to date describing the epidemiology, identifying risk factors associated with COVID-19, and analyzing clinical characteristics and outcomes of SARS-CoV-2 inf","2021","07","22","Curr Opin Infect Dis","Current opinion in infectious diseases","COVID-19; Health Personnel; Humans; Infectious Disease Transmission, Patient-to-Professional; Occupational Exposure; Pandemics; Public Health Surveillance; Risk Factors; SARS-CoV-2; Seroepidemiologic Studies","Kang","Minji","Division of Infectious Diseases and Geographic Medicine, Department of Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA",NA
"64","34227581","10.1097/QCO.0000000000000734","The front-line during the coronavirus disease 2019 pandemic: healthcare personnel.","An estimated four to 11% of reported coronavirus disease 2019 (COVID-19) cases occurs in healthcare personnel (HCP). HCP are at high risk of acquiring and transmitting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) given their close contact with individuals with recognized and unrecognized COVID-19. We summarize the literature to date describing the epidemiology, identifying risk factors associated with COVID-19, and analyzing clinical characteristics and outcomes of SARS-CoV-2 inf","2021","07","22","Curr Opin Infect Dis","Current opinion in infectious diseases","COVID-19; Health Personnel; Humans; Infectious Disease Transmission, Patient-to-Professional; Occupational Exposure; Pandemics; Public Health Surveillance; Risk Factors; SARS-CoV-2; Seroepidemiologic Studies","Perl","Trish M","Division of Infectious Diseases and Geographic Medicine, Department of Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA",NA
"65","34227577","10.1097/MOL.0000000000000765","Cholesterol 25-hydroxylase expression following immune activation in response to SARS-CoV-2 infection.",NA,"2021","07","14","Curr Opin Lipidol","Current opinion in lipidology","COVID-19; Gene Expression Regulation, Enzymologic; Humans; Immunity, Innate; Lipid Metabolism; Lipids; SARS-CoV-2; Steroid Hydroxylases","Davidson","Jillian","Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, UK",NA
"66","34227577","10.1097/MOL.0000000000000765","Cholesterol 25-hydroxylase expression following immune activation in response to SARS-CoV-2 infection.",NA,"2021","07","14","Curr Opin Lipidol","Current opinion in lipidology","COVID-19; Gene Expression Regulation, Enzymologic; Humans; Immunity, Innate; Lipid Metabolism; Lipids; SARS-CoV-2; Steroid Hydroxylases","Rotondo","Dino","Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, UK",NA
"67","34227468","10.7554/eLife.64188","Mendelian randomization analysis provides causality of smoking on the expression of ACE2, a putative SARS-CoV-2 receptor.","To understand a causal role of modifiable lifestyle factors in angiotensin-converting enzyme 2 (ACE2) expression (a putative severe acute respiratory syndrome coronavirus 2 [SARS-CoV-2] receptor) across 44 human tissues/organs, and in coronavirus disease 2019 (COVID-19) susceptibility and severity, we conducted a phenome-wide two-sample Mendelian randomization (MR) study. More than 500 genetic variants were used as instrumental variables to predict smoking and alcohol consumption. Inverse-varian","2021","07","22","Elife","eLife","ACE2 expression; COVID-19 related adverse outcomes; alcohol consumption; epidemiology; global health; human; mendelian randomization; smoking intensity; smoking status; Adipose Tissue; Alcohol Drinking; Angiotensin-Converting Enzyme 2; Brain; COVID-19; Causality; Colon; Gene Expression Regulation; Humans; Liver; Mendelian Randomization Analysis; Polymorphism, Single Nucleotide; SARS-CoV-2; Thyroid Gland; Tobacco Smoking","Liu","Hui","Biomedical Research Center, Zhejiang Provincial Key Laboratory of Laparoscopic Technology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China",NA
"68","34227468","10.7554/eLife.64188","Mendelian randomization analysis provides causality of smoking on the expression of ACE2, a putative SARS-CoV-2 receptor.","To understand a causal role of modifiable lifestyle factors in angiotensin-converting enzyme 2 (ACE2) expression (a putative severe acute respiratory syndrome coronavirus 2 [SARS-CoV-2] receptor) across 44 human tissues/organs, and in coronavirus disease 2019 (COVID-19) susceptibility and severity, we conducted a phenome-wide two-sample Mendelian randomization (MR) study. More than 500 genetic variants were used as instrumental variables to predict smoking and alcohol consumption. Inverse-varian","2021","07","22","Elife","eLife","ACE2 expression; COVID-19 related adverse outcomes; alcohol consumption; epidemiology; global health; human; mendelian randomization; smoking intensity; smoking status; Adipose Tissue; Alcohol Drinking; Angiotensin-Converting Enzyme 2; Brain; COVID-19; Causality; Colon; Gene Expression Regulation; Humans; Liver; Mendelian Randomization Analysis; Polymorphism, Single Nucleotide; SARS-CoV-2; Thyroid Gland; Tobacco Smoking","Xin","Junyi","Department of Environmental Genomics, Jiangsu Key Laboratory of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, School of Public Health, Nanjing Medical University, Nanjing, China",NA
"69","34227468","10.7554/eLife.64188","Mendelian randomization analysis provides causality of smoking on the expression of ACE2, a putative SARS-CoV-2 receptor.","To understand a causal role of modifiable lifestyle factors in angiotensin-converting enzyme 2 (ACE2) expression (a putative severe acute respiratory syndrome coronavirus 2 [SARS-CoV-2] receptor) across 44 human tissues/organs, and in coronavirus disease 2019 (COVID-19) susceptibility and severity, we conducted a phenome-wide two-sample Mendelian randomization (MR) study. More than 500 genetic variants were used as instrumental variables to predict smoking and alcohol consumption. Inverse-varian","2021","07","22","Elife","eLife","ACE2 expression; COVID-19 related adverse outcomes; alcohol consumption; epidemiology; global health; human; mendelian randomization; smoking intensity; smoking status; Adipose Tissue; Alcohol Drinking; Angiotensin-Converting Enzyme 2; Brain; COVID-19; Causality; Colon; Gene Expression Regulation; Humans; Liver; Mendelian Randomization Analysis; Polymorphism, Single Nucleotide; SARS-CoV-2; Thyroid Gland; Tobacco Smoking","Cai","Sheng","Institute of Drug Metabolism and Pharmaceutical Analysis, Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, Zhejiang University, Hangzhou, China",NA
"70","34227468","10.7554/eLife.64188","Mendelian randomization analysis provides causality of smoking on the expression of ACE2, a putative SARS-CoV-2 receptor.","To understand a causal role of modifiable lifestyle factors in angiotensin-converting enzyme 2 (ACE2) expression (a putative severe acute respiratory syndrome coronavirus 2 [SARS-CoV-2] receptor) across 44 human tissues/organs, and in coronavirus disease 2019 (COVID-19) susceptibility and severity, we conducted a phenome-wide two-sample Mendelian randomization (MR) study. More than 500 genetic variants were used as instrumental variables to predict smoking and alcohol consumption. Inverse-varian","2021","07","22","Elife","eLife","ACE2 expression; COVID-19 related adverse outcomes; alcohol consumption; epidemiology; global health; human; mendelian randomization; smoking intensity; smoking status; Adipose Tissue; Alcohol Drinking; Angiotensin-Converting Enzyme 2; Brain; COVID-19; Causality; Colon; Gene Expression Regulation; Humans; Liver; Mendelian Randomization Analysis; Polymorphism, Single Nucleotide; SARS-CoV-2; Thyroid Gland; Tobacco Smoking","Jiang","Xia","Department of Clinical Neuroscience, Center for Molecular Medicine, Karolinska Institute, Stockholm, Sweden",NA
"71","34227439","10.1080/17476348.2021.1951708","Clinico-pathological features in fatal Covid-19 Infection: A Preliminary Experience of a Tertiary Care Centre in North India using Post-Mortem Minimally Invasive Tissue Sampling.","Covid-19 pandemic started in December 2019. Histopathological studies are critical in better understanding of the disease. Minimally invasive biopsy techniques provide a suitableMethods:This was a single-centre observational study conducted at JPNTC AIIMS. 37 patients who died of Covid-19 were enrolled. Post-mortem percutaneous biopsies were taken from lung, heart, liver, kidney and stained with haematoxylin and eosin. Immunohistochemistry was performed using CD61 and CD163. SARS-CoV-2 virus was","2021","07","06","Expert Rev Respir Med","Expert review of respiratory medicine","Covid-19; Diffuse alveolar damage (DAD); Histopathology; Immunohistochemistry; India; Minimally invasive tissue sampling (MITS)","Ray","Animesh","Department of Medicine, AIIMS, New Delhi",NA
"72","34227439","10.1080/17476348.2021.1951708","Clinico-pathological features in fatal Covid-19 Infection: A Preliminary Experience of a Tertiary Care Centre in North India using Post-Mortem Minimally Invasive Tissue Sampling.","Covid-19 pandemic started in December 2019. Histopathological studies are critical in better understanding of the disease. Minimally invasive biopsy techniques provide a suitableMethods:This was a single-centre observational study conducted at JPNTC AIIMS. 37 patients who died of Covid-19 were enrolled. Post-mortem percutaneous biopsies were taken from lung, heart, liver, kidney and stained with haematoxylin and eosin. Immunohistochemistry was performed using CD61 and CD163. SARS-CoV-2 virus was","2021","07","06","Expert Rev Respir Med","Expert review of respiratory medicine","Covid-19; Diffuse alveolar damage (DAD); Histopathology; Immunohistochemistry; India; Minimally invasive tissue sampling (MITS)","Jain","Deepali","Department of Pathology, AIIMS, New Delhi",NA
"73","34227439","10.1080/17476348.2021.1951708","Clinico-pathological features in fatal Covid-19 Infection: A Preliminary Experience of a Tertiary Care Centre in North India using Post-Mortem Minimally Invasive Tissue Sampling.","Covid-19 pandemic started in December 2019. Histopathological studies are critical in better understanding of the disease. Minimally invasive biopsy techniques provide a suitableMethods:This was a single-centre observational study conducted at JPNTC AIIMS. 37 patients who died of Covid-19 were enrolled. Post-mortem percutaneous biopsies were taken from lung, heart, liver, kidney and stained with haematoxylin and eosin. Immunohistochemistry was performed using CD61 and CD163. SARS-CoV-2 virus was","2021","07","06","Expert Rev Respir Med","Expert review of respiratory medicine","Covid-19; Diffuse alveolar damage (DAD); Histopathology; Immunohistochemistry; India; Minimally invasive tissue sampling (MITS)","Goel","Ayush","Department of Medicine, AIIMS, New Delhi",NA
"74","34227439","10.1080/17476348.2021.1951708","Clinico-pathological features in fatal Covid-19 Infection: A Preliminary Experience of a Tertiary Care Centre in North India using Post-Mortem Minimally Invasive Tissue Sampling.","Covid-19 pandemic started in December 2019. Histopathological studies are critical in better understanding of the disease. Minimally invasive biopsy techniques provide a suitableMethods:This was a single-centre observational study conducted at JPNTC AIIMS. 37 patients who died of Covid-19 were enrolled. Post-mortem percutaneous biopsies were taken from lung, heart, liver, kidney and stained with haematoxylin and eosin. Immunohistochemistry was performed using CD61 and CD163. SARS-CoV-2 virus was","2021","07","06","Expert Rev Respir Med","Expert review of respiratory medicine","Covid-19; Diffuse alveolar damage (DAD); Histopathology; Immunohistochemistry; India; Minimally invasive tissue sampling (MITS)","Agarwal","Shubham","Department of Medicine, AIIMS, New Delhi",NA
"75","34227439","10.1080/17476348.2021.1951708","Clinico-pathological features in fatal Covid-19 Infection: A Preliminary Experience of a Tertiary Care Centre in North India using Post-Mortem Minimally Invasive Tissue Sampling.","Covid-19 pandemic started in December 2019. Histopathological studies are critical in better understanding of the disease. Minimally invasive biopsy techniques provide a suitableMethods:This was a single-centre observational study conducted at JPNTC AIIMS. 37 patients who died of Covid-19 were enrolled. Post-mortem percutaneous biopsies were taken from lung, heart, liver, kidney and stained with haematoxylin and eosin. Immunohistochemistry was performed using CD61 and CD163. SARS-CoV-2 virus was","2021","07","06","Expert Rev Respir Med","Expert review of respiratory medicine","Covid-19; Diffuse alveolar damage (DAD); Histopathology; Immunohistochemistry; India; Minimally invasive tissue sampling (MITS)","Swaroop","Shekhar","Department of Medicine, AIIMS, New Delhi",NA
"76","34227439","10.1080/17476348.2021.1951708","Clinico-pathological features in fatal Covid-19 Infection: A Preliminary Experience of a Tertiary Care Centre in North India using Post-Mortem Minimally Invasive Tissue Sampling.","Covid-19 pandemic started in December 2019. Histopathological studies are critical in better understanding of the disease. Minimally invasive biopsy techniques provide a suitableMethods:This was a single-centre observational study conducted at JPNTC AIIMS. 37 patients who died of Covid-19 were enrolled. Post-mortem percutaneous biopsies were taken from lung, heart, liver, kidney and stained with haematoxylin and eosin. Immunohistochemistry was performed using CD61 and CD163. SARS-CoV-2 virus was","2021","07","06","Expert Rev Respir Med","Expert review of respiratory medicine","Covid-19; Diffuse alveolar damage (DAD); Histopathology; Immunohistochemistry; India; Minimally invasive tissue sampling (MITS)","Das","Prasenjit","Department of Pathology, AIIMS, New Delhi",NA
"77","34227439","10.1080/17476348.2021.1951708","Clinico-pathological features in fatal Covid-19 Infection: A Preliminary Experience of a Tertiary Care Centre in North India using Post-Mortem Minimally Invasive Tissue Sampling.","Covid-19 pandemic started in December 2019. Histopathological studies are critical in better understanding of the disease. Minimally invasive biopsy techniques provide a suitableMethods:This was a single-centre observational study conducted at JPNTC AIIMS. 37 patients who died of Covid-19 were enrolled. Post-mortem percutaneous biopsies were taken from lung, heart, liver, kidney and stained with haematoxylin and eosin. Immunohistochemistry was performed using CD61 and CD163. SARS-CoV-2 virus was","2021","07","06","Expert Rev Respir Med","Expert review of respiratory medicine","Covid-19; Diffuse alveolar damage (DAD); Histopathology; Immunohistochemistry; India; Minimally invasive tissue sampling (MITS)","Arava","Sudheer Kumar","Department of Pathology, AIIMS, New Delhi",NA
"78","34227439","10.1080/17476348.2021.1951708","Clinico-pathological features in fatal Covid-19 Infection: A Preliminary Experience of a Tertiary Care Centre in North India using Post-Mortem Minimally Invasive Tissue Sampling.","Covid-19 pandemic started in December 2019. Histopathological studies are critical in better understanding of the disease. Minimally invasive biopsy techniques provide a suitableMethods:This was a single-centre observational study conducted at JPNTC AIIMS. 37 patients who died of Covid-19 were enrolled. Post-mortem percutaneous biopsies were taken from lung, heart, liver, kidney and stained with haematoxylin and eosin. Immunohistochemistry was performed using CD61 and CD163. SARS-CoV-2 virus was","2021","07","06","Expert Rev Respir Med","Expert review of respiratory medicine","Covid-19; Diffuse alveolar damage (DAD); Histopathology; Immunohistochemistry; India; Minimally invasive tissue sampling (MITS)","Mridha","Asit Ranjan","Department of Pathology, AIIMS, New Delhi",NA
"79","34227439","10.1080/17476348.2021.1951708","Clinico-pathological features in fatal Covid-19 Infection: A Preliminary Experience of a Tertiary Care Centre in North India using Post-Mortem Minimally Invasive Tissue Sampling.","Covid-19 pandemic started in December 2019. Histopathological studies are critical in better understanding of the disease. Minimally invasive biopsy techniques provide a suitableMethods:This was a single-centre observational study conducted at JPNTC AIIMS. 37 patients who died of Covid-19 were enrolled. Post-mortem percutaneous biopsies were taken from lung, heart, liver, kidney and stained with haematoxylin and eosin. Immunohistochemistry was performed using CD61 and CD163. SARS-CoV-2 virus was","2021","07","06","Expert Rev Respir Med","Expert review of respiratory medicine","Covid-19; Diffuse alveolar damage (DAD); Histopathology; Immunohistochemistry; India; Minimally invasive tissue sampling (MITS)","Nambirajan","Aruna","Department of Pathology, AIIMS, New Delhi",NA
"80","34227439","10.1080/17476348.2021.1951708","Clinico-pathological features in fatal Covid-19 Infection: A Preliminary Experience of a Tertiary Care Centre in North India using Post-Mortem Minimally Invasive Tissue Sampling.","Covid-19 pandemic started in December 2019. Histopathological studies are critical in better understanding of the disease. Minimally invasive biopsy techniques provide a suitableMethods:This was a single-centre observational study conducted at JPNTC AIIMS. 37 patients who died of Covid-19 were enrolled. Post-mortem percutaneous biopsies were taken from lung, heart, liver, kidney and stained with haematoxylin and eosin. Immunohistochemistry was performed using CD61 and CD163. SARS-CoV-2 virus was","2021","07","06","Expert Rev Respir Med","Expert review of respiratory medicine","Covid-19; Diffuse alveolar damage (DAD); Histopathology; Immunohistochemistry; India; Minimally invasive tissue sampling (MITS)","Singh","Geetika","Department of Pathology, AIIMS, New Delhi",NA
"81","34227439","10.1080/17476348.2021.1951708","Clinico-pathological features in fatal Covid-19 Infection: A Preliminary Experience of a Tertiary Care Centre in North India using Post-Mortem Minimally Invasive Tissue Sampling.","Covid-19 pandemic started in December 2019. Histopathological studies are critical in better understanding of the disease. Minimally invasive biopsy techniques provide a suitableMethods:This was a single-centre observational study conducted at JPNTC AIIMS. 37 patients who died of Covid-19 were enrolled. Post-mortem percutaneous biopsies were taken from lung, heart, liver, kidney and stained with haematoxylin and eosin. Immunohistochemistry was performed using CD61 and CD163. SARS-CoV-2 virus was","2021","07","06","Expert Rev Respir Med","Expert review of respiratory medicine","Covid-19; Diffuse alveolar damage (DAD); Histopathology; Immunohistochemistry; India; Minimally invasive tissue sampling (MITS)","Arulselvi","S","Department of Laboratory Medicine, JPNATC, AIIMS, New Delhi",NA
"82","34227439","10.1080/17476348.2021.1951708","Clinico-pathological features in fatal Covid-19 Infection: A Preliminary Experience of a Tertiary Care Centre in North India using Post-Mortem Minimally Invasive Tissue Sampling.","Covid-19 pandemic started in December 2019. Histopathological studies are critical in better understanding of the disease. Minimally invasive biopsy techniques provide a suitableMethods:This was a single-centre observational study conducted at JPNTC AIIMS. 37 patients who died of Covid-19 were enrolled. Post-mortem percutaneous biopsies were taken from lung, heart, liver, kidney and stained with haematoxylin and eosin. Immunohistochemistry was performed using CD61 and CD163. SARS-CoV-2 virus was","2021","07","06","Expert Rev Respir Med","Expert review of respiratory medicine","Covid-19; Diffuse alveolar damage (DAD); Histopathology; Immunohistochemistry; India; Minimally invasive tissue sampling (MITS)","Mathur","Purva","Department of Laboratory Medicine, JPNATC, AIIMS, New Delhi",NA
"83","34227439","10.1080/17476348.2021.1951708","Clinico-pathological features in fatal Covid-19 Infection: A Preliminary Experience of a Tertiary Care Centre in North India using Post-Mortem Minimally Invasive Tissue Sampling.","Covid-19 pandemic started in December 2019. Histopathological studies are critical in better understanding of the disease. Minimally invasive biopsy techniques provide a suitableMethods:This was a single-centre observational study conducted at JPNTC AIIMS. 37 patients who died of Covid-19 were enrolled. Post-mortem percutaneous biopsies were taken from lung, heart, liver, kidney and stained with haematoxylin and eosin. Immunohistochemistry was performed using CD61 and CD163. SARS-CoV-2 virus was","2021","07","06","Expert Rev Respir Med","Expert review of respiratory medicine","Covid-19; Diffuse alveolar damage (DAD); Histopathology; Immunohistochemistry; India; Minimally invasive tissue sampling (MITS)","Kumar","Sanchit","Department of Medicine, AIIMS, New Delhi",NA
"84","34227439","10.1080/17476348.2021.1951708","Clinico-pathological features in fatal Covid-19 Infection: A Preliminary Experience of a Tertiary Care Centre in North India using Post-Mortem Minimally Invasive Tissue Sampling.","Covid-19 pandemic started in December 2019. Histopathological studies are critical in better understanding of the disease. Minimally invasive biopsy techniques provide a suitableMethods:This was a single-centre observational study conducted at JPNTC AIIMS. 37 patients who died of Covid-19 were enrolled. Post-mortem percutaneous biopsies were taken from lung, heart, liver, kidney and stained with haematoxylin and eosin. Immunohistochemistry was performed using CD61 and CD163. SARS-CoV-2 virus was","2021","07","06","Expert Rev Respir Med","Expert review of respiratory medicine","Covid-19; Diffuse alveolar damage (DAD); Histopathology; Immunohistochemistry; India; Minimally invasive tissue sampling (MITS)","Sahni","Shubham","Department of Medicine, AIIMS, New Delhi",NA
"85","34227439","10.1080/17476348.2021.1951708","Clinico-pathological features in fatal Covid-19 Infection: A Preliminary Experience of a Tertiary Care Centre in North India using Post-Mortem Minimally Invasive Tissue Sampling.","Covid-19 pandemic started in December 2019. Histopathological studies are critical in better understanding of the disease. Minimally invasive biopsy techniques provide a suitableMethods:This was a single-centre observational study conducted at JPNTC AIIMS. 37 patients who died of Covid-19 were enrolled. Post-mortem percutaneous biopsies were taken from lung, heart, liver, kidney and stained with haematoxylin and eosin. Immunohistochemistry was performed using CD61 and CD163. SARS-CoV-2 virus was","2021","07","06","Expert Rev Respir Med","Expert review of respiratory medicine","Covid-19; Diffuse alveolar damage (DAD); Histopathology; Immunohistochemistry; India; Minimally invasive tissue sampling (MITS)","Nehra","Jagbir","Department of Medicine, AIIMS, New Delhi",NA
"86","34227439","10.1080/17476348.2021.1951708","Clinico-pathological features in fatal Covid-19 Infection: A Preliminary Experience of a Tertiary Care Centre in North India using Post-Mortem Minimally Invasive Tissue Sampling.","Covid-19 pandemic started in December 2019. Histopathological studies are critical in better understanding of the disease. Minimally invasive biopsy techniques provide a suitableMethods:This was a single-centre observational study conducted at JPNTC AIIMS. 37 patients who died of Covid-19 were enrolled. Post-mortem percutaneous biopsies were taken from lung, heart, liver, kidney and stained with haematoxylin and eosin. Immunohistochemistry was performed using CD61 and CD163. SARS-CoV-2 virus was","2021","07","06","Expert Rev Respir Med","Expert review of respiratory medicine","Covid-19; Diffuse alveolar damage (DAD); Histopathology; Immunohistochemistry; India; Minimally invasive tissue sampling (MITS)","Nazneen","Department of Medicine, AIIMS, New Delhi","Department of Medicine, AIIMS, New Delhi","34227439"
"87","34227439","10.1080/17476348.2021.1951708","Clinico-pathological features in fatal Covid-19 Infection: A Preliminary Experience of a Tertiary Care Centre in North India using Post-Mortem Minimally Invasive Tissue Sampling.","Covid-19 pandemic started in December 2019. Histopathological studies are critical in better understanding of the disease. Minimally invasive biopsy techniques provide a suitableMethods:This was a single-centre observational study conducted at JPNTC AIIMS. 37 patients who died of Covid-19 were enrolled. Post-mortem percutaneous biopsies were taken from lung, heart, liver, kidney and stained with haematoxylin and eosin. Immunohistochemistry was performed using CD61 and CD163. SARS-CoV-2 virus was","2021","07","06","Expert Rev Respir Med","Expert review of respiratory medicine","Covid-19; Diffuse alveolar damage (DAD); Histopathology; Immunohistochemistry; India; Minimally invasive tissue sampling (MITS)","Bm","Mouna","Department of Medicine, AIIMS, New Delhi",NA
"88","34227439","10.1080/17476348.2021.1951708","Clinico-pathological features in fatal Covid-19 Infection: A Preliminary Experience of a Tertiary Care Centre in North India using Post-Mortem Minimally Invasive Tissue Sampling.","Covid-19 pandemic started in December 2019. Histopathological studies are critical in better understanding of the disease. Minimally invasive biopsy techniques provide a suitableMethods:This was a single-centre observational study conducted at JPNTC AIIMS. 37 patients who died of Covid-19 were enrolled. Post-mortem percutaneous biopsies were taken from lung, heart, liver, kidney and stained with haematoxylin and eosin. Immunohistochemistry was performed using CD61 and CD163. SARS-CoV-2 virus was","2021","07","06","Expert Rev Respir Med","Expert review of respiratory medicine","Covid-19; Diffuse alveolar damage (DAD); Histopathology; Immunohistochemistry; India; Minimally invasive tissue sampling (MITS)","Rastogi","Neha","Department of Medicine, AIIMS, New Delhi",NA
"89","34227439","10.1080/17476348.2021.1951708","Clinico-pathological features in fatal Covid-19 Infection: A Preliminary Experience of a Tertiary Care Centre in North India using Post-Mortem Minimally Invasive Tissue Sampling.","Covid-19 pandemic started in December 2019. Histopathological studies are critical in better understanding of the disease. Minimally invasive biopsy techniques provide a suitableMethods:This was a single-centre observational study conducted at JPNTC AIIMS. 37 patients who died of Covid-19 were enrolled. Post-mortem percutaneous biopsies were taken from lung, heart, liver, kidney and stained with haematoxylin and eosin. Immunohistochemistry was performed using CD61 and CD163. SARS-CoV-2 virus was","2021","07","06","Expert Rev Respir Med","Expert review of respiratory medicine","Covid-19; Diffuse alveolar damage (DAD); Histopathology; Immunohistochemistry; India; Minimally invasive tissue sampling (MITS)","Mahato","Sandeep","Department of Medicine, AIIMS, New Delhi",NA
"90","34227439","10.1080/17476348.2021.1951708","Clinico-pathological features in fatal Covid-19 Infection: A Preliminary Experience of a Tertiary Care Centre in North India using Post-Mortem Minimally Invasive Tissue Sampling.","Covid-19 pandemic started in December 2019. Histopathological studies are critical in better understanding of the disease. Minimally invasive biopsy techniques provide a suitableMethods:This was a single-centre observational study conducted at JPNTC AIIMS. 37 patients who died of Covid-19 were enrolled. Post-mortem percutaneous biopsies were taken from lung, heart, liver, kidney and stained with haematoxylin and eosin. Immunohistochemistry was performed using CD61 and CD163. SARS-CoV-2 virus was","2021","07","06","Expert Rev Respir Med","Expert review of respiratory medicine","Covid-19; Diffuse alveolar damage (DAD); Histopathology; Immunohistochemistry; India; Minimally invasive tissue sampling (MITS)","Gupta","Chaavi","Department of Medicine, AIIMS, New Delhi",NA
"91","34227439","10.1080/17476348.2021.1951708","Clinico-pathological features in fatal Covid-19 Infection: A Preliminary Experience of a Tertiary Care Centre in North India using Post-Mortem Minimally Invasive Tissue Sampling.","Covid-19 pandemic started in December 2019. Histopathological studies are critical in better understanding of the disease. Minimally invasive biopsy techniques provide a suitableMethods:This was a single-centre observational study conducted at JPNTC AIIMS. 37 patients who died of Covid-19 were enrolled. Post-mortem percutaneous biopsies were taken from lung, heart, liver, kidney and stained with haematoxylin and eosin. Immunohistochemistry was performed using CD61 and CD163. SARS-CoV-2 virus was","2021","07","06","Expert Rev Respir Med","Expert review of respiratory medicine","Covid-19; Diffuse alveolar damage (DAD); Histopathology; Immunohistochemistry; India; Minimally invasive tissue sampling (MITS)","Bharadhan","S","Department of Medicine, AIIMS, New Delhi",NA
"92","34227439","10.1080/17476348.2021.1951708","Clinico-pathological features in fatal Covid-19 Infection: A Preliminary Experience of a Tertiary Care Centre in North India using Post-Mortem Minimally Invasive Tissue Sampling.","Covid-19 pandemic started in December 2019. Histopathological studies are critical in better understanding of the disease. Minimally invasive biopsy techniques provide a suitableMethods:This was a single-centre observational study conducted at JPNTC AIIMS. 37 patients who died of Covid-19 were enrolled. Post-mortem percutaneous biopsies were taken from lung, heart, liver, kidney and stained with haematoxylin and eosin. Immunohistochemistry was performed using CD61 and CD163. SARS-CoV-2 virus was","2021","07","06","Expert Rev Respir Med","Expert review of respiratory medicine","Covid-19; Diffuse alveolar damage (DAD); Histopathology; Immunohistochemistry; India; Minimally invasive tissue sampling (MITS)","Dhital","Gaurav","Department of Medicine, AIIMS, New Delhi",NA
"93","34227439","10.1080/17476348.2021.1951708","Clinico-pathological features in fatal Covid-19 Infection: A Preliminary Experience of a Tertiary Care Centre in North India using Post-Mortem Minimally Invasive Tissue Sampling.","Covid-19 pandemic started in December 2019. Histopathological studies are critical in better understanding of the disease. Minimally invasive biopsy techniques provide a suitableMethods:This was a single-centre observational study conducted at JPNTC AIIMS. 37 patients who died of Covid-19 were enrolled. Post-mortem percutaneous biopsies were taken from lung, heart, liver, kidney and stained with haematoxylin and eosin. Immunohistochemistry was performed using CD61 and CD163. SARS-CoV-2 virus was","2021","07","06","Expert Rev Respir Med","Expert review of respiratory medicine","Covid-19; Diffuse alveolar damage (DAD); Histopathology; Immunohistochemistry; India; Minimally invasive tissue sampling (MITS)","Goel","Pawan","Department of Medicine, AIIMS, New Delhi",NA
"94","34227439","10.1080/17476348.2021.1951708","Clinico-pathological features in fatal Covid-19 Infection: A Preliminary Experience of a Tertiary Care Centre in North India using Post-Mortem Minimally Invasive Tissue Sampling.","Covid-19 pandemic started in December 2019. Histopathological studies are critical in better understanding of the disease. Minimally invasive biopsy techniques provide a suitableMethods:This was a single-centre observational study conducted at JPNTC AIIMS. 37 patients who died of Covid-19 were enrolled. Post-mortem percutaneous biopsies were taken from lung, heart, liver, kidney and stained with haematoxylin and eosin. Immunohistochemistry was performed using CD61 and CD163. SARS-CoV-2 virus was","2021","07","06","Expert Rev Respir Med","Expert review of respiratory medicine","Covid-19; Diffuse alveolar damage (DAD); Histopathology; Immunohistochemistry; India; Minimally invasive tissue sampling (MITS)","Pandey","Praful","Department of Medicine, AIIMS, New Delhi",NA
"95","34227439","10.1080/17476348.2021.1951708","Clinico-pathological features in fatal Covid-19 Infection: A Preliminary Experience of a Tertiary Care Centre in North India using Post-Mortem Minimally Invasive Tissue Sampling.","Covid-19 pandemic started in December 2019. Histopathological studies are critical in better understanding of the disease. Minimally invasive biopsy techniques provide a suitableMethods:This was a single-centre observational study conducted at JPNTC AIIMS. 37 patients who died of Covid-19 were enrolled. Post-mortem percutaneous biopsies were taken from lung, heart, liver, kidney and stained with haematoxylin and eosin. Immunohistochemistry was performed using CD61 and CD163. SARS-CoV-2 virus was","2021","07","06","Expert Rev Respir Med","Expert review of respiratory medicine","Covid-19; Diffuse alveolar damage (DAD); Histopathology; Immunohistochemistry; India; Minimally invasive tissue sampling (MITS)","Kn","Santosh","Department of Medicine, AIIMS, New Delhi",NA
"96","34227439","10.1080/17476348.2021.1951708","Clinico-pathological features in fatal Covid-19 Infection: A Preliminary Experience of a Tertiary Care Centre in North India using Post-Mortem Minimally Invasive Tissue Sampling.","Covid-19 pandemic started in December 2019. Histopathological studies are critical in better understanding of the disease. Minimally invasive biopsy techniques provide a suitableMethods:This was a single-centre observational study conducted at JPNTC AIIMS. 37 patients who died of Covid-19 were enrolled. Post-mortem percutaneous biopsies were taken from lung, heart, liver, kidney and stained with haematoxylin and eosin. Immunohistochemistry was performed using CD61 and CD163. SARS-CoV-2 virus was","2021","07","06","Expert Rev Respir Med","Expert review of respiratory medicine","Covid-19; Diffuse alveolar damage (DAD); Histopathology; Immunohistochemistry; India; Minimally invasive tissue sampling (MITS)","Chaudhary","Shitij","Department of Medicine, AIIMS, New Delhi",NA
"97","34227439","10.1080/17476348.2021.1951708","Clinico-pathological features in fatal Covid-19 Infection: A Preliminary Experience of a Tertiary Care Centre in North India using Post-Mortem Minimally Invasive Tissue Sampling.","Covid-19 pandemic started in December 2019. Histopathological studies are critical in better understanding of the disease. Minimally invasive biopsy techniques provide a suitableMethods:This was a single-centre observational study conducted at JPNTC AIIMS. 37 patients who died of Covid-19 were enrolled. Post-mortem percutaneous biopsies were taken from lung, heart, liver, kidney and stained with haematoxylin and eosin. Immunohistochemistry was performed using CD61 and CD163. SARS-CoV-2 virus was","2021","07","06","Expert Rev Respir Med","Expert review of respiratory medicine","Covid-19; Diffuse alveolar damage (DAD); Histopathology; Immunohistochemistry; India; Minimally invasive tissue sampling (MITS)","Keri","Vishakh C","Department of Medicine, AIIMS, New Delhi",NA
"98","34227439","10.1080/17476348.2021.1951708","Clinico-pathological features in fatal Covid-19 Infection: A Preliminary Experience of a Tertiary Care Centre in North India using Post-Mortem Minimally Invasive Tissue Sampling.","Covid-19 pandemic started in December 2019. Histopathological studies are critical in better understanding of the disease. Minimally invasive biopsy techniques provide a suitableMethods:This was a single-centre observational study conducted at JPNTC AIIMS. 37 patients who died of Covid-19 were enrolled. Post-mortem percutaneous biopsies were taken from lung, heart, liver, kidney and stained with haematoxylin and eosin. Immunohistochemistry was performed using CD61 and CD163. SARS-CoV-2 virus was","2021","07","06","Expert Rev Respir Med","Expert review of respiratory medicine","Covid-19; Diffuse alveolar damage (DAD); Histopathology; Immunohistochemistry; India; Minimally invasive tissue sampling (MITS)","Chauhan","Vishal Singh","Department of Medicine, AIIMS, New Delhi",NA
"99","34227439","10.1080/17476348.2021.1951708","Clinico-pathological features in fatal Covid-19 Infection: A Preliminary Experience of a Tertiary Care Centre in North India using Post-Mortem Minimally Invasive Tissue Sampling.","Covid-19 pandemic started in December 2019. Histopathological studies are critical in better understanding of the disease. Minimally invasive biopsy techniques provide a suitableMethods:This was a single-centre observational study conducted at JPNTC AIIMS. 37 patients who died of Covid-19 were enrolled. Post-mortem percutaneous biopsies were taken from lung, heart, liver, kidney and stained with haematoxylin and eosin. Immunohistochemistry was performed using CD61 and CD163. SARS-CoV-2 virus was","2021","07","06","Expert Rev Respir Med","Expert review of respiratory medicine","Covid-19; Diffuse alveolar damage (DAD); Histopathology; Immunohistochemistry; India; Minimally invasive tissue sampling (MITS)","Mahishi","Niranjan","Department of Medicine, AIIMS, New Delhi",NA
"100","34227439","10.1080/17476348.2021.1951708","Clinico-pathological features in fatal Covid-19 Infection: A Preliminary Experience of a Tertiary Care Centre in North India using Post-Mortem Minimally Invasive Tissue Sampling.","Covid-19 pandemic started in December 2019. Histopathological studies are critical in better understanding of the disease. Minimally invasive biopsy techniques provide a suitableMethods:This was a single-centre observational study conducted at JPNTC AIIMS. 37 patients who died of Covid-19 were enrolled. Post-mortem percutaneous biopsies were taken from lung, heart, liver, kidney and stained with haematoxylin and eosin. Immunohistochemistry was performed using CD61 and CD163. SARS-CoV-2 virus was","2021","07","06","Expert Rev Respir Med","Expert review of respiratory medicine","Covid-19; Diffuse alveolar damage (DAD); Histopathology; Immunohistochemistry; India; Minimally invasive tissue sampling (MITS)","Shahi","Anand","Department of Medicine, AIIMS, New Delhi",NA
"101","34227439","10.1080/17476348.2021.1951708","Clinico-pathological features in fatal Covid-19 Infection: A Preliminary Experience of a Tertiary Care Centre in North India using Post-Mortem Minimally Invasive Tissue Sampling.","Covid-19 pandemic started in December 2019. Histopathological studies are critical in better understanding of the disease. Minimally invasive biopsy techniques provide a suitableMethods:This was a single-centre observational study conducted at JPNTC AIIMS. 37 patients who died of Covid-19 were enrolled. Post-mortem percutaneous biopsies were taken from lung, heart, liver, kidney and stained with haematoxylin and eosin. Immunohistochemistry was performed using CD61 and CD163. SARS-CoV-2 virus was","2021","07","06","Expert Rev Respir Med","Expert review of respiratory medicine","Covid-19; Diffuse alveolar damage (DAD); Histopathology; Immunohistochemistry; India; Minimally invasive tissue sampling (MITS)","R","Ragu","Department of Medicine, AIIMS, New Delhi",NA
"102","34227439","10.1080/17476348.2021.1951708","Clinico-pathological features in fatal Covid-19 Infection: A Preliminary Experience of a Tertiary Care Centre in North India using Post-Mortem Minimally Invasive Tissue Sampling.","Covid-19 pandemic started in December 2019. Histopathological studies are critical in better understanding of the disease. Minimally invasive biopsy techniques provide a suitableMethods:This was a single-centre observational study conducted at JPNTC AIIMS. 37 patients who died of Covid-19 were enrolled. Post-mortem percutaneous biopsies were taken from lung, heart, liver, kidney and stained with haematoxylin and eosin. Immunohistochemistry was performed using CD61 and CD163. SARS-CoV-2 virus was","2021","07","06","Expert Rev Respir Med","Expert review of respiratory medicine","Covid-19; Diffuse alveolar damage (DAD); Histopathology; Immunohistochemistry; India; Minimally invasive tissue sampling (MITS)","Gupta","Baidnath K","Department of Medicine, AIIMS, New Delhi",NA
"103","34227439","10.1080/17476348.2021.1951708","Clinico-pathological features in fatal Covid-19 Infection: A Preliminary Experience of a Tertiary Care Centre in North India using Post-Mortem Minimally Invasive Tissue Sampling.","Covid-19 pandemic started in December 2019. Histopathological studies are critical in better understanding of the disease. Minimally invasive biopsy techniques provide a suitableMethods:This was a single-centre observational study conducted at JPNTC AIIMS. 37 patients who died of Covid-19 were enrolled. Post-mortem percutaneous biopsies were taken from lung, heart, liver, kidney and stained with haematoxylin and eosin. Immunohistochemistry was performed using CD61 and CD163. SARS-CoV-2 virus was","2021","07","06","Expert Rev Respir Med","Expert review of respiratory medicine","Covid-19; Diffuse alveolar damage (DAD); Histopathology; Immunohistochemistry; India; Minimally invasive tissue sampling (MITS)","Aggarwal","Richa","Department of Anesthesia &amp",NA
"104","34227439","10.1080/17476348.2021.1951708","Clinico-pathological features in fatal Covid-19 Infection: A Preliminary Experience of a Tertiary Care Centre in North India using Post-Mortem Minimally Invasive Tissue Sampling.","Covid-19 pandemic started in December 2019. Histopathological studies are critical in better understanding of the disease. Minimally invasive biopsy techniques provide a suitableMethods:This was a single-centre observational study conducted at JPNTC AIIMS. 37 patients who died of Covid-19 were enrolled. Post-mortem percutaneous biopsies were taken from lung, heart, liver, kidney and stained with haematoxylin and eosin. Immunohistochemistry was performed using CD61 and CD163. SARS-CoV-2 virus was","2021","07","06","Expert Rev Respir Med","Expert review of respiratory medicine","Covid-19; Diffuse alveolar damage (DAD); Histopathology; Immunohistochemistry; India; Minimally invasive tissue sampling (MITS)","Soni","Kapil Dev","Department of Anesthesia &amp",NA
"105","34227439","10.1080/17476348.2021.1951708","Clinico-pathological features in fatal Covid-19 Infection: A Preliminary Experience of a Tertiary Care Centre in North India using Post-Mortem Minimally Invasive Tissue Sampling.","Covid-19 pandemic started in December 2019. Histopathological studies are critical in better understanding of the disease. Minimally invasive biopsy techniques provide a suitableMethods:This was a single-centre observational study conducted at JPNTC AIIMS. 37 patients who died of Covid-19 were enrolled. Post-mortem percutaneous biopsies were taken from lung, heart, liver, kidney and stained with haematoxylin and eosin. Immunohistochemistry was performed using CD61 and CD163. SARS-CoV-2 virus was","2021","07","06","Expert Rev Respir Med","Expert review of respiratory medicine","Covid-19; Diffuse alveolar damage (DAD); Histopathology; Immunohistochemistry; India; Minimally invasive tissue sampling (MITS)","Nischal","Neeraj","Department of Medicine, AIIMS, New Delhi",NA
"106","34227439","10.1080/17476348.2021.1951708","Clinico-pathological features in fatal Covid-19 Infection: A Preliminary Experience of a Tertiary Care Centre in North India using Post-Mortem Minimally Invasive Tissue Sampling.","Covid-19 pandemic started in December 2019. Histopathological studies are critical in better understanding of the disease. Minimally invasive biopsy techniques provide a suitableMethods:This was a single-centre observational study conducted at JPNTC AIIMS. 37 patients who died of Covid-19 were enrolled. Post-mortem percutaneous biopsies were taken from lung, heart, liver, kidney and stained with haematoxylin and eosin. Immunohistochemistry was performed using CD61 and CD163. SARS-CoV-2 virus was","2021","07","06","Expert Rev Respir Med","Expert review of respiratory medicine","Covid-19; Diffuse alveolar damage (DAD); Histopathology; Immunohistochemistry; India; Minimally invasive tissue sampling (MITS)","Soneja","Manish","Department of Medicine, AIIMS, New Delhi",NA
"107","34227439","10.1080/17476348.2021.1951708","Clinico-pathological features in fatal Covid-19 Infection: A Preliminary Experience of a Tertiary Care Centre in North India using Post-Mortem Minimally Invasive Tissue Sampling.","Covid-19 pandemic started in December 2019. Histopathological studies are critical in better understanding of the disease. Minimally invasive biopsy techniques provide a suitableMethods:This was a single-centre observational study conducted at JPNTC AIIMS. 37 patients who died of Covid-19 were enrolled. Post-mortem percutaneous biopsies were taken from lung, heart, liver, kidney and stained with haematoxylin and eosin. Immunohistochemistry was performed using CD61 and CD163. SARS-CoV-2 virus was","2021","07","06","Expert Rev Respir Med","Expert review of respiratory medicine","Covid-19; Diffuse alveolar damage (DAD); Histopathology; Immunohistochemistry; India; Minimally invasive tissue sampling (MITS)","Lalwani","Sanjeev","Division of Forensic Pathology and Molecular Laboratory, JPNATC, AIIMS, New Delhi",NA
"108","34227439","10.1080/17476348.2021.1951708","Clinico-pathological features in fatal Covid-19 Infection: A Preliminary Experience of a Tertiary Care Centre in North India using Post-Mortem Minimally Invasive Tissue Sampling.","Covid-19 pandemic started in December 2019. Histopathological studies are critical in better understanding of the disease. Minimally invasive biopsy techniques provide a suitableMethods:This was a single-centre observational study conducted at JPNTC AIIMS. 37 patients who died of Covid-19 were enrolled. Post-mortem percutaneous biopsies were taken from lung, heart, liver, kidney and stained with haematoxylin and eosin. Immunohistochemistry was performed using CD61 and CD163. SARS-CoV-2 virus was","2021","07","06","Expert Rev Respir Med","Expert review of respiratory medicine","Covid-19; Diffuse alveolar damage (DAD); Histopathology; Immunohistochemistry; India; Minimally invasive tissue sampling (MITS)","Sarkar","Chitra","Department of Pathology, AIIMS, New Delhi",NA
"109","34227439","10.1080/17476348.2021.1951708","Clinico-pathological features in fatal Covid-19 Infection: A Preliminary Experience of a Tertiary Care Centre in North India using Post-Mortem Minimally Invasive Tissue Sampling.","Covid-19 pandemic started in December 2019. Histopathological studies are critical in better understanding of the disease. Minimally invasive biopsy techniques provide a suitableMethods:This was a single-centre observational study conducted at JPNTC AIIMS. 37 patients who died of Covid-19 were enrolled. Post-mortem percutaneous biopsies were taken from lung, heart, liver, kidney and stained with haematoxylin and eosin. Immunohistochemistry was performed using CD61 and CD163. SARS-CoV-2 virus was","2021","07","06","Expert Rev Respir Med","Expert review of respiratory medicine","Covid-19; Diffuse alveolar damage (DAD); Histopathology; Immunohistochemistry; India; Minimally invasive tissue sampling (MITS)","Guleria","Randeep","Director, AIIMS, New Delhi",NA
"110","34227439","10.1080/17476348.2021.1951708","Clinico-pathological features in fatal Covid-19 Infection: A Preliminary Experience of a Tertiary Care Centre in North India using Post-Mortem Minimally Invasive Tissue Sampling.","Covid-19 pandemic started in December 2019. Histopathological studies are critical in better understanding of the disease. Minimally invasive biopsy techniques provide a suitableMethods:This was a single-centre observational study conducted at JPNTC AIIMS. 37 patients who died of Covid-19 were enrolled. Post-mortem percutaneous biopsies were taken from lung, heart, liver, kidney and stained with haematoxylin and eosin. Immunohistochemistry was performed using CD61 and CD163. SARS-CoV-2 virus was","2021","07","06","Expert Rev Respir Med","Expert review of respiratory medicine","Covid-19; Diffuse alveolar damage (DAD); Histopathology; Immunohistochemistry; India; Minimally invasive tissue sampling (MITS)","Wig","Naveet","Department of Medicine, AIIMS, New Delhi",NA
"111","34227439","10.1080/17476348.2021.1951708","Clinico-pathological features in fatal Covid-19 Infection: A Preliminary Experience of a Tertiary Care Centre in North India using Post-Mortem Minimally Invasive Tissue Sampling.","Covid-19 pandemic started in December 2019. Histopathological studies are critical in better understanding of the disease. Minimally invasive biopsy techniques provide a suitableMethods:This was a single-centre observational study conducted at JPNTC AIIMS. 37 patients who died of Covid-19 were enrolled. Post-mortem percutaneous biopsies were taken from lung, heart, liver, kidney and stained with haematoxylin and eosin. Immunohistochemistry was performed using CD61 and CD163. SARS-CoV-2 virus was","2021","07","06","Expert Rev Respir Med","Expert review of respiratory medicine","Covid-19; Diffuse alveolar damage (DAD); Histopathology; Immunohistochemistry; India; Minimally invasive tissue sampling (MITS)","Trikha","Anjan","Department of Anaesthesiology, Critical Care and Pain Medicine, JPNATC, AIIMS, New Delhi",NA
"112","34227364","10.3724/SP.J.1123.2021.03022","[Applications of separation technology in novel coronavirus research, epidemic prevention and detection].","The novel coronavirus disease 2019 (COVID-19) outbreak has brought to light unprecedented challenges to global public health security. Researchers have devoted their efforts to in-depth research on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to bring the epidemic under control as rapidly as possible. Among the many areas of burgeoning SARS-CoV-2 related research, various analytical technologies have been applied to the advancement of virus detection, and development of vaccines ","2021","07","06","Se Pu","Se pu = Chinese journal of chromatography","affinity chromatography (AC); centrifugation; electrophoresis; liquid chromatography (LC); magnetic bead separation; micro/nano-separation; separation technology; severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); size exclusion chromatography (SEC)","Li","Linsen","School of Life Science, Beijing Institute of Technology, ""Molecular Medicine and Biological Diagnosis"" Key Laboratory of Ministry of Industry and Information Technology, Beijing 100081, China",NA
"113","34227364","10.3724/SP.J.1123.2021.03022","[Applications of separation technology in novel coronavirus research, epidemic prevention and detection].","The novel coronavirus disease 2019 (COVID-19) outbreak has brought to light unprecedented challenges to global public health security. Researchers have devoted their efforts to in-depth research on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to bring the epidemic under control as rapidly as possible. Among the many areas of burgeoning SARS-CoV-2 related research, various analytical technologies have been applied to the advancement of virus detection, and development of vaccines ","2021","07","06","Se Pu","Se pu = Chinese journal of chromatography","affinity chromatography (AC); centrifugation; electrophoresis; liquid chromatography (LC); magnetic bead separation; micro/nano-separation; separation technology; severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); size exclusion chromatography (SEC)","Zhu","Chao","School of Life Science, Beijing Institute of Technology, ""Molecular Medicine and Biological Diagnosis"" Key Laboratory of Ministry of Industry and Information Technology, Beijing 100081, China",NA
"114","34227364","10.3724/SP.J.1123.2021.03022","[Applications of separation technology in novel coronavirus research, epidemic prevention and detection].","The novel coronavirus disease 2019 (COVID-19) outbreak has brought to light unprecedented challenges to global public health security. Researchers have devoted their efforts to in-depth research on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to bring the epidemic under control as rapidly as possible. Among the many areas of burgeoning SARS-CoV-2 related research, various analytical technologies have been applied to the advancement of virus detection, and development of vaccines ","2021","07","06","Se Pu","Se pu = Chinese journal of chromatography","affinity chromatography (AC); centrifugation; electrophoresis; liquid chromatography (LC); magnetic bead separation; micro/nano-separation; separation technology; severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); size exclusion chromatography (SEC)","Zhao","Xinying","Beijing Polytechnic, Beijing 100176, China",NA
"115","34227364","10.3724/SP.J.1123.2021.03022","[Applications of separation technology in novel coronavirus research, epidemic prevention and detection].","The novel coronavirus disease 2019 (COVID-19) outbreak has brought to light unprecedented challenges to global public health security. Researchers have devoted their efforts to in-depth research on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to bring the epidemic under control as rapidly as possible. Among the many areas of burgeoning SARS-CoV-2 related research, various analytical technologies have been applied to the advancement of virus detection, and development of vaccines ","2021","07","06","Se Pu","Se pu = Chinese journal of chromatography","affinity chromatography (AC); centrifugation; electrophoresis; liquid chromatography (LC); magnetic bead separation; micro/nano-separation; separation technology; severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); size exclusion chromatography (SEC)","Qu","Feng","School of Life Science, Beijing Institute of Technology, ""Molecular Medicine and Biological Diagnosis"" Key Laboratory of Ministry of Industry and Information Technology, Beijing 100081, China",NA
"116","34227264","10.3346/jkms.2021.36.e188","Lessons from Cadaver Dissection during the COVID-19 Pandemic.","The rapid increase of the coronavirus disease 2019 pandemic from mid-February 2020 has led the anatomy department of the Korea University College of Medicine to cease the dissection laboratory. However, the hands-on anatomy laboratory experience is paramount to maximizing learning outcomes. In this paper, we share the experiences and lessons learned through the face-to-face cadaveric dissection experience during this disruptive situation. To minimize infection risks, the following strategies wer","2021","07","15","J Korean Med Sci","Journal of Korean medical science","COVID-19; COVID-19 Symptom Screening; Dissection Laboratory Operational Strategy; Personal Protective Equipment; Anatomy; COVID-19; Cadaver; Dissection; Education, Distance; Humans; Personal Protective Equipment; Republic of Korea; SARS-CoV-2; Schools, Medical; Students, Medical","Kim","Dasom","Department of Anatomy, College of Medicine, Korea University, Seoul, Korea",NA
"117","34227264","10.3346/jkms.2021.36.e188","Lessons from Cadaver Dissection during the COVID-19 Pandemic.","The rapid increase of the coronavirus disease 2019 pandemic from mid-February 2020 has led the anatomy department of the Korea University College of Medicine to cease the dissection laboratory. However, the hands-on anatomy laboratory experience is paramount to maximizing learning outcomes. In this paper, we share the experiences and lessons learned through the face-to-face cadaveric dissection experience during this disruptive situation. To minimize infection risks, the following strategies wer","2021","07","15","J Korean Med Sci","Journal of Korean medical science","COVID-19; COVID-19 Symptom Screening; Dissection Laboratory Operational Strategy; Personal Protective Equipment; Anatomy; COVID-19; Cadaver; Dissection; Education, Distance; Humans; Personal Protective Equipment; Republic of Korea; SARS-CoV-2; Schools, Medical; Students, Medical","Yoo","Hyeijung","Department of Anatomy, College of Medicine, Korea University, Seoul, Korea",NA
"118","34227264","10.3346/jkms.2021.36.e188","Lessons from Cadaver Dissection during the COVID-19 Pandemic.","The rapid increase of the coronavirus disease 2019 pandemic from mid-February 2020 has led the anatomy department of the Korea University College of Medicine to cease the dissection laboratory. However, the hands-on anatomy laboratory experience is paramount to maximizing learning outcomes. In this paper, we share the experiences and lessons learned through the face-to-face cadaveric dissection experience during this disruptive situation. To minimize infection risks, the following strategies wer","2021","07","15","J Korean Med Sci","Journal of Korean medical science","COVID-19; COVID-19 Symptom Screening; Dissection Laboratory Operational Strategy; Personal Protective Equipment; Anatomy; COVID-19; Cadaver; Dissection; Education, Distance; Humans; Personal Protective Equipment; Republic of Korea; SARS-CoV-2; Schools, Medical; Students, Medical","Lee","Young Mee","Department of Medical Education, College of Medicine, Korea University, Seoul, Korea. ymleehj@korea.ac","ymleehj@korea.ac.kr"
"119","34227264","10.3346/jkms.2021.36.e188","Lessons from Cadaver Dissection during the COVID-19 Pandemic.","The rapid increase of the coronavirus disease 2019 pandemic from mid-February 2020 has led the anatomy department of the Korea University College of Medicine to cease the dissection laboratory. However, the hands-on anatomy laboratory experience is paramount to maximizing learning outcomes. In this paper, we share the experiences and lessons learned through the face-to-face cadaveric dissection experience during this disruptive situation. To minimize infection risks, the following strategies wer","2021","07","15","J Korean Med Sci","Journal of Korean medical science","COVID-19; COVID-19 Symptom Screening; Dissection Laboratory Operational Strategy; Personal Protective Equipment; Anatomy; COVID-19; Cadaver; Dissection; Education, Distance; Humans; Personal Protective Equipment; Republic of Korea; SARS-CoV-2; Schools, Medical; Students, Medical","Rhyu","Im Joo","Department of Anatomy, College of Medicine, Korea University, Seoul, Korea","irhyu@korea.ac.kr"
"120","34227230","10.1111/jth.15423","Anti-PF4 testing for vaccine-induced immune thrombocytopenia and thrombosis and heparin induced thrombocytopenia: Results from a UK National External Quality Assessment Scheme exercise April 2021.","Vaccine-induced immune thrombocytopenia and thrombosis (VITT) following the administration of the AstraZeneca (AZ) ChAdOx1 nCOV-19 vaccine has recently been reported. The associated clinical and laboratory features have included thrombosis at unusual sites, thrombocytopenia, and raised D-dimers with positivity for IgG anti-platelet factor 4 (PF4) antibodies. A UK National External Quality Control Assessment Scheme external quality control exercise was carried out by distributing liquid and lyoph","2021","07","06","J Thromb Haemost","Journal of thrombosis and haemostasis : JTH","COVID-19; heparin; thrombocytopenia; thrombosis; vaccine-induced","Reilly-Stitt","Christopher","UK NEQAS (Blood Coagulation), Sheffield, UK",NA
"121","34227230","10.1111/jth.15423","Anti-PF4 testing for vaccine-induced immune thrombocytopenia and thrombosis and heparin induced thrombocytopenia: Results from a UK National External Quality Assessment Scheme exercise April 2021.","Vaccine-induced immune thrombocytopenia and thrombosis (VITT) following the administration of the AstraZeneca (AZ) ChAdOx1 nCOV-19 vaccine has recently been reported. The associated clinical and laboratory features have included thrombosis at unusual sites, thrombocytopenia, and raised D-dimers with positivity for IgG anti-platelet factor 4 (PF4) antibodies. A UK National External Quality Control Assessment Scheme external quality control exercise was carried out by distributing liquid and lyoph","2021","07","06","J Thromb Haemost","Journal of thrombosis and haemostasis : JTH","COVID-19; heparin; thrombocytopenia; thrombosis; vaccine-induced","Kitchen","Steve","UK NEQAS (Blood Coagulation), Sheffield, UK",NA
"122","34227230","10.1111/jth.15423","Anti-PF4 testing for vaccine-induced immune thrombocytopenia and thrombosis and heparin induced thrombocytopenia: Results from a UK National External Quality Assessment Scheme exercise April 2021.","Vaccine-induced immune thrombocytopenia and thrombosis (VITT) following the administration of the AstraZeneca (AZ) ChAdOx1 nCOV-19 vaccine has recently been reported. The associated clinical and laboratory features have included thrombosis at unusual sites, thrombocytopenia, and raised D-dimers with positivity for IgG anti-platelet factor 4 (PF4) antibodies. A UK National External Quality Control Assessment Scheme external quality control exercise was carried out by distributing liquid and lyoph","2021","07","06","J Thromb Haemost","Journal of thrombosis and haemostasis : JTH","COVID-19; heparin; thrombocytopenia; thrombosis; vaccine-induced","Jennings","Ian","UK NEQAS (Blood Coagulation), Sheffield, UK",NA
"123","34227230","10.1111/jth.15423","Anti-PF4 testing for vaccine-induced immune thrombocytopenia and thrombosis and heparin induced thrombocytopenia: Results from a UK National External Quality Assessment Scheme exercise April 2021.","Vaccine-induced immune thrombocytopenia and thrombosis (VITT) following the administration of the AstraZeneca (AZ) ChAdOx1 nCOV-19 vaccine has recently been reported. The associated clinical and laboratory features have included thrombosis at unusual sites, thrombocytopenia, and raised D-dimers with positivity for IgG anti-platelet factor 4 (PF4) antibodies. A UK National External Quality Control Assessment Scheme external quality control exercise was carried out by distributing liquid and lyoph","2021","07","06","J Thromb Haemost","Journal of thrombosis and haemostasis : JTH","COVID-19; heparin; thrombocytopenia; thrombosis; vaccine-induced","Horner","Kevin","Sheffield Haemophilia and Thrombosis Centre, Royal Hallamshire Hospital, Sheffield, UK",NA
"124","34227230","10.1111/jth.15423","Anti-PF4 testing for vaccine-induced immune thrombocytopenia and thrombosis and heparin induced thrombocytopenia: Results from a UK National External Quality Assessment Scheme exercise April 2021.","Vaccine-induced immune thrombocytopenia and thrombosis (VITT) following the administration of the AstraZeneca (AZ) ChAdOx1 nCOV-19 vaccine has recently been reported. The associated clinical and laboratory features have included thrombosis at unusual sites, thrombocytopenia, and raised D-dimers with positivity for IgG anti-platelet factor 4 (PF4) antibodies. A UK National External Quality Control Assessment Scheme external quality control exercise was carried out by distributing liquid and lyoph","2021","07","06","J Thromb Haemost","Journal of thrombosis and haemostasis : JTH","COVID-19; heparin; thrombocytopenia; thrombosis; vaccine-induced","Jones","Robert","Sheffield Haemophilia and Thrombosis Centre, Royal Hallamshire Hospital, Sheffield, UK",NA
"125","34227230","10.1111/jth.15423","Anti-PF4 testing for vaccine-induced immune thrombocytopenia and thrombosis and heparin induced thrombocytopenia: Results from a UK National External Quality Assessment Scheme exercise April 2021.","Vaccine-induced immune thrombocytopenia and thrombosis (VITT) following the administration of the AstraZeneca (AZ) ChAdOx1 nCOV-19 vaccine has recently been reported. The associated clinical and laboratory features have included thrombosis at unusual sites, thrombocytopenia, and raised D-dimers with positivity for IgG anti-platelet factor 4 (PF4) antibodies. A UK National External Quality Control Assessment Scheme external quality control exercise was carried out by distributing liquid and lyoph","2021","07","06","J Thromb Haemost","Journal of thrombosis and haemostasis : JTH","COVID-19; heparin; thrombocytopenia; thrombosis; vaccine-induced","Makris","Mike","Sheffield Haemophilia and Thrombosis Centre, Royal Hallamshire Hospital, Sheffield, UK",NA
"126","34227230","10.1111/jth.15423","Anti-PF4 testing for vaccine-induced immune thrombocytopenia and thrombosis and heparin induced thrombocytopenia: Results from a UK National External Quality Assessment Scheme exercise April 2021.","Vaccine-induced immune thrombocytopenia and thrombosis (VITT) following the administration of the AstraZeneca (AZ) ChAdOx1 nCOV-19 vaccine has recently been reported. The associated clinical and laboratory features have included thrombosis at unusual sites, thrombocytopenia, and raised D-dimers with positivity for IgG anti-platelet factor 4 (PF4) antibodies. A UK National External Quality Control Assessment Scheme external quality control exercise was carried out by distributing liquid and lyoph","2021","07","06","J Thromb Haemost","Journal of thrombosis and haemostasis : JTH","COVID-19; heparin; thrombocytopenia; thrombosis; vaccine-induced","Walker","Isobel D","UK NEQAS (Blood Coagulation), Sheffield, UK",NA
"127","34227197","10.1111/tid.13683","A case report of successful kidney transplantation from a deceased donor with terminal COVID-19-related lung damage: Ongoing dilemma between discarding and accepting organs in COVID-19 era!",NA,"2021","07","12","Transpl Infect Dis","Transplant infectious disease : an official journal of the Transplantation Society",NA,"Meshram","Hari Shankar","Department of Nephrology and Transplantation, IKDRC-ITS, Ahmedabad, Gujarat, India",NA
"128","34227197","10.1111/tid.13683","A case report of successful kidney transplantation from a deceased donor with terminal COVID-19-related lung damage: Ongoing dilemma between discarding and accepting organs in COVID-19 era!",NA,"2021","07","12","Transpl Infect Dis","Transplant infectious disease : an official journal of the Transplantation Society",NA,"Kute","Vivek B","Department of Nephrology and Transplantation, IKDRC-ITS, Ahmedabad, Gujarat, India",NA
"129","34227197","10.1111/tid.13683","A case report of successful kidney transplantation from a deceased donor with terminal COVID-19-related lung damage: Ongoing dilemma between discarding and accepting organs in COVID-19 era!",NA,"2021","07","12","Transpl Infect Dis","Transplant infectious disease : an official journal of the Transplantation Society",NA,"Patel","Himanshu","Department of Nephrology and Transplantation, IKDRC-ITS, Ahmedabad, Gujarat, India",NA
"130","34227197","10.1111/tid.13683","A case report of successful kidney transplantation from a deceased donor with terminal COVID-19-related lung damage: Ongoing dilemma between discarding and accepting organs in COVID-19 era!",NA,"2021","07","12","Transpl Infect Dis","Transplant infectious disease : an official journal of the Transplantation Society",NA,"Desai","Sudeep","Department of Nephrology and Transplantation, IKDRC-ITS, Ahmedabad, Gujarat, India",NA
"131","34227197","10.1111/tid.13683","A case report of successful kidney transplantation from a deceased donor with terminal COVID-19-related lung damage: Ongoing dilemma between discarding and accepting organs in COVID-19 era!",NA,"2021","07","12","Transpl Infect Dis","Transplant infectious disease : an official journal of the Transplantation Society",NA,"Chauhan","Sanshriti","Department of Nephrology and Transplantation, IKDRC-ITS, Ahmedabad, Gujarat, India",NA
"132","34227197","10.1111/tid.13683","A case report of successful kidney transplantation from a deceased donor with terminal COVID-19-related lung damage: Ongoing dilemma between discarding and accepting organs in COVID-19 era!",NA,"2021","07","12","Transpl Infect Dis","Transplant infectious disease : an official journal of the Transplantation Society",NA,"Dave","Ruchir B","Department of Nephrology and Transplantation, IKDRC-ITS, Ahmedabad, Gujarat, India",NA
"133","34227196","10.1111/ijcp.14599","Clinical Frailty Score vs Hospital Frailty Risk Score for predicting mortality and other adverse outcome in hospitalised patients with COVID-19: Spanish case series.","Frailty can be used as a predictor of adverse outcomes in people with coronavirus disease 2019 (COVID-19). The aim of the study was to analyse the prognostic value of two different frailty scores in patients hospitalised for COVID-19. This retrospective cohort study included adult (=18 years) inpatients with COVID-19 and took place from 3 March to 2 May 2020. Patients were categorised by Clinical Frailty Score (CFS) and Hospital Frailty Risk Score (HFRS). The primary outcome was in-hospital mort","2021","07","16","Int J Clin Pract","International journal of clinical practice",NA,"Ramos-Rincon","Jose-Manuel","Internal Medicine Department, Alicante General University Hospital-Alicante Institute of Sanitary and Biomedical Research (ISABIAL), Alicante, Spain",NA
"134","34227196","10.1111/ijcp.14599","Clinical Frailty Score vs Hospital Frailty Risk Score for predicting mortality and other adverse outcome in hospitalised patients with COVID-19: Spanish case series.","Frailty can be used as a predictor of adverse outcomes in people with coronavirus disease 2019 (COVID-19). The aim of the study was to analyse the prognostic value of two different frailty scores in patients hospitalised for COVID-19. This retrospective cohort study included adult (=18 years) inpatients with COVID-19 and took place from 3 March to 2 May 2020. Patients were categorised by Clinical Frailty Score (CFS) and Hospital Frailty Risk Score (HFRS). The primary outcome was in-hospital mort","2021","07","16","Int J Clin Pract","International journal of clinical practice",NA,"Moreno-Perez","Oscar","Clinical Medicine Department, Miguel Hernández University, Elche, Spain",NA
"135","34227196","10.1111/ijcp.14599","Clinical Frailty Score vs Hospital Frailty Risk Score for predicting mortality and other adverse outcome in hospitalised patients with COVID-19: Spanish case series.","Frailty can be used as a predictor of adverse outcomes in people with coronavirus disease 2019 (COVID-19). The aim of the study was to analyse the prognostic value of two different frailty scores in patients hospitalised for COVID-19. This retrospective cohort study included adult (=18 years) inpatients with COVID-19 and took place from 3 March to 2 May 2020. Patients were categorised by Clinical Frailty Score (CFS) and Hospital Frailty Risk Score (HFRS). The primary outcome was in-hospital mort","2021","07","16","Int J Clin Pract","International journal of clinical practice",NA,"Pinargote-Celorio","Hector","Infectious Diseases Unit, Alicante General University Hospital-Alicante Institute of Sanitary and Biomedical Research (ISABIAL), Alicante, Spain",NA
"136","34227196","10.1111/ijcp.14599","Clinical Frailty Score vs Hospital Frailty Risk Score for predicting mortality and other adverse outcome in hospitalised patients with COVID-19: Spanish case series.","Frailty can be used as a predictor of adverse outcomes in people with coronavirus disease 2019 (COVID-19). The aim of the study was to analyse the prognostic value of two different frailty scores in patients hospitalised for COVID-19. This retrospective cohort study included adult (=18 years) inpatients with COVID-19 and took place from 3 March to 2 May 2020. Patients were categorised by Clinical Frailty Score (CFS) and Hospital Frailty Risk Score (HFRS). The primary outcome was in-hospital mort","2021","07","16","Int J Clin Pract","International journal of clinical practice",NA,"Leon-Ramirez","Jose-Manuel","Pneumology Department, Alicante General University Hospital-Alicante Institute of Health and Biomedical Research (ISABIAL), Alicante, Spain",NA
"137","34227196","10.1111/ijcp.14599","Clinical Frailty Score vs Hospital Frailty Risk Score for predicting mortality and other adverse outcome in hospitalised patients with COVID-19: Spanish case series.","Frailty can be used as a predictor of adverse outcomes in people with coronavirus disease 2019 (COVID-19). The aim of the study was to analyse the prognostic value of two different frailty scores in patients hospitalised for COVID-19. This retrospective cohort study included adult (=18 years) inpatients with COVID-19 and took place from 3 March to 2 May 2020. Patients were categorised by Clinical Frailty Score (CFS) and Hospital Frailty Risk Score (HFRS). The primary outcome was in-hospital mort","2021","07","16","Int J Clin Pract","International journal of clinical practice",NA,"Andres","Mariano","Clinical Medicine Department, Miguel Hernández University, Elche, Spain",NA
"138","34227196","10.1111/ijcp.14599","Clinical Frailty Score vs Hospital Frailty Risk Score for predicting mortality and other adverse outcome in hospitalised patients with COVID-19: Spanish case series.","Frailty can be used as a predictor of adverse outcomes in people with coronavirus disease 2019 (COVID-19). The aim of the study was to analyse the prognostic value of two different frailty scores in patients hospitalised for COVID-19. This retrospective cohort study included adult (=18 years) inpatients with COVID-19 and took place from 3 March to 2 May 2020. Patients were categorised by Clinical Frailty Score (CFS) and Hospital Frailty Risk Score (HFRS). The primary outcome was in-hospital mort","2021","07","16","Int J Clin Pract","International journal of clinical practice",NA,"Reus","Sergio","Clinical Medicine Department, Miguel Hernández University, Elche, Spain",NA
"139","34227196","10.1111/ijcp.14599","Clinical Frailty Score vs Hospital Frailty Risk Score for predicting mortality and other adverse outcome in hospitalised patients with COVID-19: Spanish case series.","Frailty can be used as a predictor of adverse outcomes in people with coronavirus disease 2019 (COVID-19). The aim of the study was to analyse the prognostic value of two different frailty scores in patients hospitalised for COVID-19. This retrospective cohort study included adult (=18 years) inpatients with COVID-19 and took place from 3 March to 2 May 2020. Patients were categorised by Clinical Frailty Score (CFS) and Hospital Frailty Risk Score (HFRS). The primary outcome was in-hospital mort","2021","07","16","Int J Clin Pract","International journal of clinical practice",NA,"Herrera-García","Cristian","Internal Medicine Department, Alicante General University Hospital-Alicante Institute of Sanitary and Biomedical Research (ISABIAL), Alicante, Spain",NA
"140","34227196","10.1111/ijcp.14599","Clinical Frailty Score vs Hospital Frailty Risk Score for predicting mortality and other adverse outcome in hospitalised patients with COVID-19: Spanish case series.","Frailty can be used as a predictor of adverse outcomes in people with coronavirus disease 2019 (COVID-19). The aim of the study was to analyse the prognostic value of two different frailty scores in patients hospitalised for COVID-19. This retrospective cohort study included adult (=18 years) inpatients with COVID-19 and took place from 3 March to 2 May 2020. Patients were categorised by Clinical Frailty Score (CFS) and Hospital Frailty Risk Score (HFRS). The primary outcome was in-hospital mort","2021","07","16","Int J Clin Pract","International journal of clinical practice",NA,"Martí-Pastor","Ana","Internal Medicine Department, Alicante General University Hospital-Alicante Institute of Sanitary and Biomedical Research (ISABIAL), Alicante, Spain",NA
"141","34227196","10.1111/ijcp.14599","Clinical Frailty Score vs Hospital Frailty Risk Score for predicting mortality and other adverse outcome in hospitalised patients with COVID-19: Spanish case series.","Frailty can be used as a predictor of adverse outcomes in people with coronavirus disease 2019 (COVID-19). The aim of the study was to analyse the prognostic value of two different frailty scores in patients hospitalised for COVID-19. This retrospective cohort study included adult (=18 years) inpatients with COVID-19 and took place from 3 March to 2 May 2020. Patients were categorised by Clinical Frailty Score (CFS) and Hospital Frailty Risk Score (HFRS). The primary outcome was in-hospital mort","2021","07","16","Int J Clin Pract","International journal of clinical practice",NA,"Boix","Vicente","Clinical Medicine Department, Miguel Hernández University, Elche, Spain",NA
"142","34227196","10.1111/ijcp.14599","Clinical Frailty Score vs Hospital Frailty Risk Score for predicting mortality and other adverse outcome in hospitalised patients with COVID-19: Spanish case series.","Frailty can be used as a predictor of adverse outcomes in people with coronavirus disease 2019 (COVID-19). The aim of the study was to analyse the prognostic value of two different frailty scores in patients hospitalised for COVID-19. This retrospective cohort study included adult (=18 years) inpatients with COVID-19 and took place from 3 March to 2 May 2020. Patients were categorised by Clinical Frailty Score (CFS) and Hospital Frailty Risk Score (HFRS). The primary outcome was in-hospital mort","2021","07","16","Int J Clin Pract","International journal of clinical practice",NA,"Gil","Joan","Pneumology Department, Alicante General University Hospital-Alicante Institute of Health and Biomedical Research (ISABIAL), Alicante, Spain",NA
"143","34227196","10.1111/ijcp.14599","Clinical Frailty Score vs Hospital Frailty Risk Score for predicting mortality and other adverse outcome in hospitalised patients with COVID-19: Spanish case series.","Frailty can be used as a predictor of adverse outcomes in people with coronavirus disease 2019 (COVID-19). The aim of the study was to analyse the prognostic value of two different frailty scores in patients hospitalised for COVID-19. This retrospective cohort study included adult (=18 years) inpatients with COVID-19 and took place from 3 March to 2 May 2020. Patients were categorised by Clinical Frailty Score (CFS) and Hospital Frailty Risk Score (HFRS). The primary outcome was in-hospital mort","2021","07","16","Int J Clin Pract","International journal of clinical practice",NA,"Sanchez-Martinez","Rosario","Internal Medicine Department, Alicante General University Hospital-Alicante Institute of Sanitary and Biomedical Research (ISABIAL), Alicante, Spain",NA
"144","34227196","10.1111/ijcp.14599","Clinical Frailty Score vs Hospital Frailty Risk Score for predicting mortality and other adverse outcome in hospitalised patients with COVID-19: Spanish case series.","Frailty can be used as a predictor of adverse outcomes in people with coronavirus disease 2019 (COVID-19). The aim of the study was to analyse the prognostic value of two different frailty scores in patients hospitalised for COVID-19. This retrospective cohort study included adult (=18 years) inpatients with COVID-19 and took place from 3 March to 2 May 2020. Patients were categorised by Clinical Frailty Score (CFS) and Hospital Frailty Risk Score (HFRS). The primary outcome was in-hospital mort","2021","07","16","Int J Clin Pract","International journal of clinical practice",NA,"Merino","Esperanza","Infectious Diseases Unit, Alicante General University Hospital-Alicante Institute of Sanitary and Biomedical Research (ISABIAL), Alicante, Spain",NA
"145","34227179","10.1111/jocn.15951","COVID-19 vaccination intention in the first year of the pandemic: A systematic review.","To synthesise evidence regarding vaccination intention, identify factors contributing to vaccine hesitancy among healthcare professionals and the general populations globally. As COVID-19 vaccine becomes available worldwide, attention is being directed to community vaccine uptake, to achieve population-wide immunity. A number of factors have been reported to influence vaccine intention. Following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, a system","2021","07","06","J Clin Nurs","Journal of clinical nursing","COVID-19; coronavirus; vaccination; vaccine acceptance; vaccine hesitancy; vaccine uptake","Al-Amer","Rasmieh","Nursing School, Isra University of Jordan, Amman, Jordan",NA
"146","34227179","10.1111/jocn.15951","COVID-19 vaccination intention in the first year of the pandemic: A systematic review.","To synthesise evidence regarding vaccination intention, identify factors contributing to vaccine hesitancy among healthcare professionals and the general populations globally. As COVID-19 vaccine becomes available worldwide, attention is being directed to community vaccine uptake, to achieve population-wide immunity. A number of factors have been reported to influence vaccine intention. Following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, a system","2021","07","06","J Clin Nurs","Journal of clinical nursing","COVID-19; coronavirus; vaccination; vaccine acceptance; vaccine hesitancy; vaccine uptake","Maneze","Della","Western Sydney University, School of Nursing and Midwifery, Penrith, NSW, Australia",NA
"147","34227179","10.1111/jocn.15951","COVID-19 vaccination intention in the first year of the pandemic: A systematic review.","To synthesise evidence regarding vaccination intention, identify factors contributing to vaccine hesitancy among healthcare professionals and the general populations globally. As COVID-19 vaccine becomes available worldwide, attention is being directed to community vaccine uptake, to achieve population-wide immunity. A number of factors have been reported to influence vaccine intention. Following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, a system","2021","07","06","J Clin Nurs","Journal of clinical nursing","COVID-19; coronavirus; vaccination; vaccine acceptance; vaccine hesitancy; vaccine uptake","Everett","Bronwyn","Western Sydney University, School of Nursing and Midwifery, Penrith, NSW, Australia",NA
"148","34227179","10.1111/jocn.15951","COVID-19 vaccination intention in the first year of the pandemic: A systematic review.","To synthesise evidence regarding vaccination intention, identify factors contributing to vaccine hesitancy among healthcare professionals and the general populations globally. As COVID-19 vaccine becomes available worldwide, attention is being directed to community vaccine uptake, to achieve population-wide immunity. A number of factors have been reported to influence vaccine intention. Following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, a system","2021","07","06","J Clin Nurs","Journal of clinical nursing","COVID-19; coronavirus; vaccination; vaccine acceptance; vaccine hesitancy; vaccine uptake","Montayre","Jed","Western Sydney University, School of Nursing and Midwifery, Penrith, NSW, Australia",NA
"149","34227179","10.1111/jocn.15951","COVID-19 vaccination intention in the first year of the pandemic: A systematic review.","To synthesise evidence regarding vaccination intention, identify factors contributing to vaccine hesitancy among healthcare professionals and the general populations globally. As COVID-19 vaccine becomes available worldwide, attention is being directed to community vaccine uptake, to achieve population-wide immunity. A number of factors have been reported to influence vaccine intention. Following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, a system","2021","07","06","J Clin Nurs","Journal of clinical nursing","COVID-19; coronavirus; vaccination; vaccine acceptance; vaccine hesitancy; vaccine uptake","Villarosa","Amy R","Western Sydney University, School of Nursing and Midwifery, Penrith, NSW, Australia",NA
"150","34227179","10.1111/jocn.15951","COVID-19 vaccination intention in the first year of the pandemic: A systematic review.","To synthesise evidence regarding vaccination intention, identify factors contributing to vaccine hesitancy among healthcare professionals and the general populations globally. As COVID-19 vaccine becomes available worldwide, attention is being directed to community vaccine uptake, to achieve population-wide immunity. A number of factors have been reported to influence vaccine intention. Following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, a system","2021","07","06","J Clin Nurs","Journal of clinical nursing","COVID-19; coronavirus; vaccination; vaccine acceptance; vaccine hesitancy; vaccine uptake","Dwekat","Entisar","Nursing School, Isra University of Jordan, Amman, Jordan",NA
"151","34227179","10.1111/jocn.15951","COVID-19 vaccination intention in the first year of the pandemic: A systematic review.","To synthesise evidence regarding vaccination intention, identify factors contributing to vaccine hesitancy among healthcare professionals and the general populations globally. As COVID-19 vaccine becomes available worldwide, attention is being directed to community vaccine uptake, to achieve population-wide immunity. A number of factors have been reported to influence vaccine intention. Following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, a system","2021","07","06","J Clin Nurs","Journal of clinical nursing","COVID-19; coronavirus; vaccination; vaccine acceptance; vaccine hesitancy; vaccine uptake","Salamonson","Yenna","Western Sydney University, School of Nursing and Midwifery, Penrith, NSW, Australia",NA
"152","34227154","10.1002/bmc.5212","Accelerated Stability Study of the Ester Prodrug Remdesivir; Recently FDA Approved Covid-19 Antiviral Using RP-HPLC with Fluorimetric and Diode Array Detection.","Remdesivir is the first antiviral drug, approved by the Food and Drug Administration, to treat SARS-CoV-2. Remdesivir is a relatively new chemical entity, ""ester prodrug"", with no reported stability profile. Due to the urge of its use and thus, fast production, it is important to develop a stability-indicating method for its assay. Chromatographic separation was carried on C18 (250 x 4.6 mm, 5 µm) column with dual detection; Diode-array at 240 nm and fluorescence at <U+03BB>ex/em 245/390 nm. Isocratic ","2021","07","06","Biomed Chromatogr","Biomedical chromatography : BMC","Covid-19; Degradation hypothesis; Remdesivir; Stability-indicating HPLC; validation","Hamdy","Mohamed M A","Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Pharos University in Alexandria, Alexandria, Egypt",NA
"153","34227154","10.1002/bmc.5212","Accelerated Stability Study of the Ester Prodrug Remdesivir; Recently FDA Approved Covid-19 Antiviral Using RP-HPLC with Fluorimetric and Diode Array Detection.","Remdesivir is the first antiviral drug, approved by the Food and Drug Administration, to treat SARS-CoV-2. Remdesivir is a relatively new chemical entity, ""ester prodrug"", with no reported stability profile. Due to the urge of its use and thus, fast production, it is important to develop a stability-indicating method for its assay. Chromatographic separation was carried on C18 (250 x 4.6 mm, 5 µm) column with dual detection; Diode-array at 240 nm and fluorescence at <U+03BB>ex/em 245/390 nm. Isocratic ","2021","07","06","Biomed Chromatogr","Biomedical chromatography : BMC","Covid-19; Degradation hypothesis; Remdesivir; Stability-indicating HPLC; validation","Abdel Moneim","Mona M","Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Pharos University in Alexandria, Alexandria, Egypt",NA
"154","34227154","10.1002/bmc.5212","Accelerated Stability Study of the Ester Prodrug Remdesivir; Recently FDA Approved Covid-19 Antiviral Using RP-HPLC with Fluorimetric and Diode Array Detection.","Remdesivir is the first antiviral drug, approved by the Food and Drug Administration, to treat SARS-CoV-2. Remdesivir is a relatively new chemical entity, ""ester prodrug"", with no reported stability profile. Due to the urge of its use and thus, fast production, it is important to develop a stability-indicating method for its assay. Chromatographic separation was carried on C18 (250 x 4.6 mm, 5 µm) column with dual detection; Diode-array at 240 nm and fluorescence at <U+03BB>ex/em 245/390 nm. Isocratic ","2021","07","06","Biomed Chromatogr","Biomedical chromatography : BMC","Covid-19; Degradation hypothesis; Remdesivir; Stability-indicating HPLC; validation","Kamal","Miranda F","Department of Pharmaceutical Analytical Chemistry, Faculty of Pharmacy, Damanhour University, Beheira, Egypt",NA
"155","34227136","10.1002/nur.22167","COVID-19 and the impact on rural and black church Congregants: Results of the C-M-C project.","The COVID-19 pandemic has had devastating effects on Black and rural populations with a mortality rate among Blacks three times that of Whites and both rural and Black populations experiencing limited access to COVID-19 resources. The primary purpose of this study was to explore the health, financial, and psychological impact of COVID-19 among rural White Appalachian and Black nonrural central Kentucky church congregants. Secondarily we sought to examine the association between sociodemographics","2021","07","06","Res Nurs Health","Research in nursing &amp; health","COVID-19; Health Belief Model; Theory of Planned Behavior; health equity","Williams","Lovoria B","Department of Nursing Instruction, College of Nursing, University of Kentucky, Lexington, Kentucky, USA",NA
"156","34227136","10.1002/nur.22167","COVID-19 and the impact on rural and black church Congregants: Results of the C-M-C project.","The COVID-19 pandemic has had devastating effects on Black and rural populations with a mortality rate among Blacks three times that of Whites and both rural and Black populations experiencing limited access to COVID-19 resources. The primary purpose of this study was to explore the health, financial, and psychological impact of COVID-19 among rural White Appalachian and Black nonrural central Kentucky church congregants. Secondarily we sought to examine the association between sociodemographics","2021","07","06","Res Nurs Health","Research in nursing &amp; health","COVID-19; Health Belief Model; Theory of Planned Behavior; health equity","Fernander","Anita F","Department of Behavioral Science, College of Medicine, University of Kentucky, Lexington, Kentucky, USA",NA
"157","34227136","10.1002/nur.22167","COVID-19 and the impact on rural and black church Congregants: Results of the C-M-C project.","The COVID-19 pandemic has had devastating effects on Black and rural populations with a mortality rate among Blacks three times that of Whites and both rural and Black populations experiencing limited access to COVID-19 resources. The primary purpose of this study was to explore the health, financial, and psychological impact of COVID-19 among rural White Appalachian and Black nonrural central Kentucky church congregants. Secondarily we sought to examine the association between sociodemographics","2021","07","06","Res Nurs Health","Research in nursing &amp; health","COVID-19; Health Belief Model; Theory of Planned Behavior; health equity","Azam","Tofial","Department of Biostatistics, University of Kentucky, Lexington, Kentucky, USA",NA
"158","34227136","10.1002/nur.22167","COVID-19 and the impact on rural and black church Congregants: Results of the C-M-C project.","The COVID-19 pandemic has had devastating effects on Black and rural populations with a mortality rate among Blacks three times that of Whites and both rural and Black populations experiencing limited access to COVID-19 resources. The primary purpose of this study was to explore the health, financial, and psychological impact of COVID-19 among rural White Appalachian and Black nonrural central Kentucky church congregants. Secondarily we sought to examine the association between sociodemographics","2021","07","06","Res Nurs Health","Research in nursing &amp; health","COVID-19; Health Belief Model; Theory of Planned Behavior; health equity","Gomez","Maria L","Department of Nursing Instruction, College of Nursing, University of Kentucky, Lexington, Kentucky, USA",NA
"159","34227136","10.1002/nur.22167","COVID-19 and the impact on rural and black church Congregants: Results of the C-M-C project.","The COVID-19 pandemic has had devastating effects on Black and rural populations with a mortality rate among Blacks three times that of Whites and both rural and Black populations experiencing limited access to COVID-19 resources. The primary purpose of this study was to explore the health, financial, and psychological impact of COVID-19 among rural White Appalachian and Black nonrural central Kentucky church congregants. Secondarily we sought to examine the association between sociodemographics","2021","07","06","Res Nurs Health","Research in nursing &amp; health","COVID-19; Health Belief Model; Theory of Planned Behavior; health equity","Kang","JungHee","Department of Nursing Instruction, College of Nursing, University of Kentucky, Lexington, Kentucky, USA",NA
"160","34227136","10.1002/nur.22167","COVID-19 and the impact on rural and black church Congregants: Results of the C-M-C project.","The COVID-19 pandemic has had devastating effects on Black and rural populations with a mortality rate among Blacks three times that of Whites and both rural and Black populations experiencing limited access to COVID-19 resources. The primary purpose of this study was to explore the health, financial, and psychological impact of COVID-19 among rural White Appalachian and Black nonrural central Kentucky church congregants. Secondarily we sought to examine the association between sociodemographics","2021","07","06","Res Nurs Health","Research in nursing &amp; health","COVID-19; Health Belief Model; Theory of Planned Behavior; health equity","Moody","Cassidy L","College of Medicine, University of Kentucky, Lexington, Kentucky, USA",NA
"161","34227136","10.1002/nur.22167","COVID-19 and the impact on rural and black church Congregants: Results of the C-M-C project.","The COVID-19 pandemic has had devastating effects on Black and rural populations with a mortality rate among Blacks three times that of Whites and both rural and Black populations experiencing limited access to COVID-19 resources. The primary purpose of this study was to explore the health, financial, and psychological impact of COVID-19 among rural White Appalachian and Black nonrural central Kentucky church congregants. Secondarily we sought to examine the association between sociodemographics","2021","07","06","Res Nurs Health","Research in nursing &amp; health","COVID-19; Health Belief Model; Theory of Planned Behavior; health equity","Bowman","Hannah","Department of Nursing Instruction, College of Nursing, University of Kentucky, Lexington, Kentucky, USA",NA
"162","34227136","10.1002/nur.22167","COVID-19 and the impact on rural and black church Congregants: Results of the C-M-C project.","The COVID-19 pandemic has had devastating effects on Black and rural populations with a mortality rate among Blacks three times that of Whites and both rural and Black populations experiencing limited access to COVID-19 resources. The primary purpose of this study was to explore the health, financial, and psychological impact of COVID-19 among rural White Appalachian and Black nonrural central Kentucky church congregants. Secondarily we sought to examine the association between sociodemographics","2021","07","06","Res Nurs Health","Research in nursing &amp; health","COVID-19; Health Belief Model; Theory of Planned Behavior; health equity","E Schoenberg","Nancy","Department of Behavioral Science, College of Medicine, University of Kentucky, Lexington, Kentucky, USA",NA
"163","34227132","10.1111/jan.14944","Did rest breaks help with acute fatigue among nursing staff on 12-h shifts during the COVID-19 pandemic? A cross-sectional study.","This study aimed to explore whether 30-min rest breaks were as effective at lowering acute fatigue among 12-h shift hospital nursing staff who cared for patients with COVID-19 as among those who did not. The study was cross-sectional in design. Data from the SAFE-CARE study collected online between May and June 2020 were used. A subsample (N = 338) comprised of nursing staff who reported working 12-h shifts, and providing direct patient care in hospitals was used in this study. Data on socio-dem","2021","07","06","J Adv Nurs","Journal of advanced nursing","COVID-19; breaks; fatigue; nurses; recovery; rest","Sagherian","Knar","College of Nursing, The University of Tennessee Knoxville, Knoxville, TN, USA",NA
"164","34227132","10.1111/jan.14944","Did rest breaks help with acute fatigue among nursing staff on 12-h shifts during the COVID-19 pandemic? A cross-sectional study.","This study aimed to explore whether 30-min rest breaks were as effective at lowering acute fatigue among 12-h shift hospital nursing staff who cared for patients with COVID-19 as among those who did not. The study was cross-sectional in design. Data from the SAFE-CARE study collected online between May and June 2020 were used. A subsample (N = 338) comprised of nursing staff who reported working 12-h shifts, and providing direct patient care in hospitals was used in this study. Data on socio-dem","2021","07","06","J Adv Nurs","Journal of advanced nursing","COVID-19; breaks; fatigue; nurses; recovery; rest","McNeely","Clea A","College of Nursing, The University of Tennessee Knoxville, Knoxville, TN, USA",NA
"165","34227132","10.1111/jan.14944","Did rest breaks help with acute fatigue among nursing staff on 12-h shifts during the COVID-19 pandemic? A cross-sectional study.","This study aimed to explore whether 30-min rest breaks were as effective at lowering acute fatigue among 12-h shift hospital nursing staff who cared for patients with COVID-19 as among those who did not. The study was cross-sectional in design. Data from the SAFE-CARE study collected online between May and June 2020 were used. A subsample (N = 338) comprised of nursing staff who reported working 12-h shifts, and providing direct patient care in hospitals was used in this study. Data on socio-dem","2021","07","06","J Adv Nurs","Journal of advanced nursing","COVID-19; breaks; fatigue; nurses; recovery; rest","Steege","Linsey M","School of Nursing, University of Wisconsin-Madison, Madison, WI, USA",NA
"166","34227123","10.1111/nuf.12625","Patient safety time for federally mandated registered nurse to patient ratios.","COVID-19 highlighted the role registered nurses (RNs) have in our healthcare system. The shortage of equipment plus an overwhelming demand for nursing care placed significant stress on nurses. The physical and emotional toll of caring for COVID patients and not having an adequate number of nurses in many cases placed many nurses in harm's way. Despite some healthcare systems reporting significant profits during COVID, few nurses benefited financially. ICU nurses found themselves assigned to thre","2021","07","06","Nurs Forum","Nursing forum","improved outcomes; patient ratio; quality of care; registered nurses","Anders","Robert L","School of Nursing, The University of Texas at El Paso Ringgold standard institution, Delta, Texas, USA",NA
"167","34227110","10.1111/trf.16581","Upper age limits for convalescent plasma donation and treatment of COVID-19 patients: A further marker of ageism.",NA,"2021","07","06","Transfusion","Transfusion",NA,"Fedecostante","Massimiliano","Geriatria, Accettazione geriatrica e Centro di ricerca per l'invecchiamento, IRCCS INRCA, Ancona, Italy",NA
"168","34227110","10.1111/trf.16581","Upper age limits for convalescent plasma donation and treatment of COVID-19 patients: A further marker of ageism.",NA,"2021","07","06","Transfusion","Transfusion",NA,"O'Neill","Desmond","Centre for Ageing, Neuroscience and the Humanities, Trinity College Dublin, Trinity Centre for Health Sciences, Tallaght University Hospital, Dublin, Ireland",NA
"169","34227110","10.1111/trf.16581","Upper age limits for convalescent plasma donation and treatment of COVID-19 patients: A further marker of ageism.",NA,"2021","07","06","Transfusion","Transfusion",NA,"Pierri","Francesca","Dipartimento di Economia, Università di Perugia, Perugia, Italy",NA
"170","34227110","10.1111/trf.16581","Upper age limits for convalescent plasma donation and treatment of COVID-19 patients: A further marker of ageism.",NA,"2021","07","06","Transfusion","Transfusion",NA,"Carrieri","Barbara","Geriatria, Accettazione geriatrica e Centro di ricerca per l'invecchiamento, IRCCS INRCA, Ancona, Italy",NA
"171","34227110","10.1111/trf.16581","Upper age limits for convalescent plasma donation and treatment of COVID-19 patients: A further marker of ageism.",NA,"2021","07","06","Transfusion","Transfusion",NA,"Lattanzio","Fabrizia","Scientific Direction, IRCCS INRCA, Ancona, Italy",NA
"172","34227110","10.1111/trf.16581","Upper age limits for convalescent plasma donation and treatment of COVID-19 patients: A further marker of ageism.",NA,"2021","07","06","Transfusion","Transfusion",NA,"Cherubini","Antonio","Geriatria, Accettazione geriatrica e Centro di ricerca per l'invecchiamento, IRCCS INRCA, Ancona, Italy",NA
"173","34227102","10.1002/ijgo.13816","Prioritizing pregnant women for COVID-19 vaccination.","Despite emerging evidence on safety and efficacy, most countries do not offer COVID-19 vaccines to pregnant women even though they are at higher risk of complications from COVID-19. We performed a web search of COVID-19 vaccination policies for pregnant women under two categories: countries bearing a high burden of COVID-19 cases and countries with a high burden of maternal and under-five mortality. Of the top 20 countries affected by COVID-19, 11 allow vaccination of pregnant women, of which tw","2021","07","19","Int J Gynaecol Obstet","International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics","COVID-19; dual burden of disease; maternal mortality; pregnancy; under-five mortality; vaccination","Sarwal","Yamini","Department of Obstetrics and Gynaecology, Vardhman Mahavir Medical College &amp",NA
"174","34227102","10.1002/ijgo.13816","Prioritizing pregnant women for COVID-19 vaccination.","Despite emerging evidence on safety and efficacy, most countries do not offer COVID-19 vaccines to pregnant women even though they are at higher risk of complications from COVID-19. We performed a web search of COVID-19 vaccination policies for pregnant women under two categories: countries bearing a high burden of COVID-19 cases and countries with a high burden of maternal and under-five mortality. Of the top 20 countries affected by COVID-19, 11 allow vaccination of pregnant women, of which tw","2021","07","19","Int J Gynaecol Obstet","International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics","COVID-19; dual burden of disease; maternal mortality; pregnancy; under-five mortality; vaccination","Sarwal","Tanvi","Independent Researcher, New Delhi, India",NA
"175","34227102","10.1002/ijgo.13816","Prioritizing pregnant women for COVID-19 vaccination.","Despite emerging evidence on safety and efficacy, most countries do not offer COVID-19 vaccines to pregnant women even though they are at higher risk of complications from COVID-19. We performed a web search of COVID-19 vaccination policies for pregnant women under two categories: countries bearing a high burden of COVID-19 cases and countries with a high burden of maternal and under-five mortality. Of the top 20 countries affected by COVID-19, 11 allow vaccination of pregnant women, of which tw","2021","07","19","Int J Gynaecol Obstet","International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics","COVID-19; dual burden of disease; maternal mortality; pregnancy; under-five mortality; vaccination","Sarwal","Rakesh","National Institution for Transforming India, New Delhi, India",NA
"176","34227099","10.1111/famp.12693","Divorced and separated parents during the COVID-19 pandemic.","The COVID-19 pandemic has caused significant stress for individuals, couples, and families. Divorced and separated couples with children face unique stresses amid the pandemic. This mixed-methods study explored these challenges among 296 divorced and separated parents: namely 204 women formerly partnered with men, 34 men formerly partnered with women, and 58 women formerly partnered with women, who were surveyed during Summer/Fall of 2020. Participants described legal, financial, and coparenting","2021","07","06","Fam Process","Family process","COVID-19; COVID-19 pandemic; cocrianza; coparenting; divorce; divorcio; estrés; padres; pandemia; parents; stress; <U+5171><U+540C><U+517B><U+80B2>; <U+538B><U+529B>; <U+7236><U+6BCD>; <U+79BB><U+5A5A>","Goldberg","Abbie E","Department of Psychology, Clark University, Worcester, MA, USA",NA
"177","34227099","10.1111/famp.12693","Divorced and separated parents during the COVID-19 pandemic.","The COVID-19 pandemic has caused significant stress for individuals, couples, and families. Divorced and separated couples with children face unique stresses amid the pandemic. This mixed-methods study explored these challenges among 296 divorced and separated parents: namely 204 women formerly partnered with men, 34 men formerly partnered with women, and 58 women formerly partnered with women, who were surveyed during Summer/Fall of 2020. Participants described legal, financial, and coparenting","2021","07","06","Fam Process","Family process","COVID-19; COVID-19 pandemic; cocrianza; coparenting; divorce; divorcio; estrés; padres; pandemia; parents; stress; <U+5171><U+540C><U+517B><U+80B2>; <U+538B><U+529B>; <U+7236><U+6BCD>; <U+79BB><U+5A5A>","Allen","Katherine R","Human Development and Family Science, Virginia Tech, Blacksburg, VA, USA",NA
"178","34227099","10.1111/famp.12693","Divorced and separated parents during the COVID-19 pandemic.","The COVID-19 pandemic has caused significant stress for individuals, couples, and families. Divorced and separated couples with children face unique stresses amid the pandemic. This mixed-methods study explored these challenges among 296 divorced and separated parents: namely 204 women formerly partnered with men, 34 men formerly partnered with women, and 58 women formerly partnered with women, who were surveyed during Summer/Fall of 2020. Participants described legal, financial, and coparenting","2021","07","06","Fam Process","Family process","COVID-19; COVID-19 pandemic; cocrianza; coparenting; divorce; divorcio; estrés; padres; pandemia; parents; stress; <U+5171><U+540C><U+517B><U+80B2>; <U+538B><U+529B>; <U+7236><U+6BCD>; <U+79BB><U+5A5A>","Smith","JuliAnna Z","Amherst, MA, USA",NA
"179","34227097","10.1111/bjh.17693","Experts' views on COVID-19 vaccination and the impact of the pandemic on patients with Gaucher disease.",NA,"2021","07","06","Br J Haematol","British journal of haematology",NA,"Hamiel","Uri","Genetics Institute and Genomics Center, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel",NA
"180","34227097","10.1111/bjh.17693","Experts' views on COVID-19 vaccination and the impact of the pandemic on patients with Gaucher disease.",NA,"2021","07","06","Br J Haematol","British journal of haematology",NA,"Kurolap","Alina","Genetics Institute and Genomics Center, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel",NA
"181","34227097","10.1111/bjh.17693","Experts' views on COVID-19 vaccination and the impact of the pandemic on patients with Gaucher disease.",NA,"2021","07","06","Br J Haematol","British journal of haematology",NA,"Cohen","Ian J","Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel",NA
"182","34227097","10.1111/bjh.17693","Experts' views on COVID-19 vaccination and the impact of the pandemic on patients with Gaucher disease.",NA,"2021","07","06","Br J Haematol","British journal of haematology",NA,"Ruhrman-Shahar","Noa","Recanati Genetics Institute, Rabin Medical Center, Petah Tikva, Israel",NA
"183","34227097","10.1111/bjh.17693","Experts' views on COVID-19 vaccination and the impact of the pandemic on patients with Gaucher disease.",NA,"2021","07","06","Br J Haematol","British journal of haematology",NA,"Hershkovitz","Tova","The Genetics Institute, Rambam Health Care Campus, Haifa, Israel",NA
"184","34227097","10.1111/bjh.17693","Experts' views on COVID-19 vaccination and the impact of the pandemic on patients with Gaucher disease.",NA,"2021","07","06","Br J Haematol","British journal of haematology",NA,"Niederau","Claus","Medical Pracitice Oberhausen, Oberhausen, Germany",NA
"185","34227097","10.1111/bjh.17693","Experts' views on COVID-19 vaccination and the impact of the pandemic on patients with Gaucher disease.",NA,"2021","07","06","Br J Haematol","British journal of haematology",NA,"Zimran","Ari","Gaucher Unit, Shaare Zedek Medical Centre, Jerusalem, Israel",NA
"186","34227097","10.1111/bjh.17693","Experts' views on COVID-19 vaccination and the impact of the pandemic on patients with Gaucher disease.",NA,"2021","07","06","Br J Haematol","British journal of haematology",NA,"Revel-Vilk","Shoshana","Gaucher Unit, Shaare Zedek Medical Centre, Jerusalem, Israel",NA
"187","34227097","10.1111/bjh.17693","Experts' views on COVID-19 vaccination and the impact of the pandemic on patients with Gaucher disease.",NA,"2021","07","06","Br J Haematol","British journal of haematology",NA,"Istaiti","Majdolen","Gaucher Unit, Shaare Zedek Medical Centre, Jerusalem, Israel",NA
"188","34227097","10.1111/bjh.17693","Experts' views on COVID-19 vaccination and the impact of the pandemic on patients with Gaucher disease.",NA,"2021","07","06","Br J Haematol","British journal of haematology",NA,"Cappellini","Maria Domenica","Department of Medicine and Medical Specialities, Fondazione IRCSS Cà Granda, Milan, Italy",NA
"189","34227097","10.1111/bjh.17693","Experts' views on COVID-19 vaccination and the impact of the pandemic on patients with Gaucher disease.",NA,"2021","07","06","Br J Haematol","British journal of haematology",NA,"Baris Feldman","Hagit","Genetics Institute and Genomics Center, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel",NA
"190","34227081","10.26355/eurrev_202106_26156","Umbilical Cord-derived Mesenchymal Stem Cells modulate TNF and soluble TNF Receptor 2 (sTNFR2) in COVID-19 ARDS patients.","We aimed at explaining the mechanism of therapeutic effect of Umbilical Cord Mesenchymal Stem Cells (UC-MSC) in subjects with COVID-19 Acute Respiratory Distress Syndrome (ARDS). Patients with COVID-19 ARDS present with a hyperinflammatory response characterized by high levels of circulating pro-inflammatory mediators, including tumor necrosis factor a and ß (TNFa and TNFß). Inflammatory functions of these TNFs can be inhibited by soluble TNF Receptor 2 (sTNFR2). In patients with COVID-19 ARDS, ","2021","07","14","Eur Rev Med Pharmacol Sci","European review for medical and pharmacological sciences","Biomarkers; COVID-19; Double-Blind Method; Humans; Lymphotoxin-alpha; Mesenchymal Stem Cell Transplantation; Receptors, Tumor Necrosis Factor, Type II; Respiratory Distress Syndrome; Tumor Necrosis Factor-alpha; Umbilical Cord","Kouroupis","D","Department of Orthopedics, UHealth Sports Medicine Institute, University of Miami Miller School of Medicine, Miami, FL, USA. ricordi@miami","ricordi@miami.edu"
"191","34227081","10.26355/eurrev_202106_26156","Umbilical Cord-derived Mesenchymal Stem Cells modulate TNF and soluble TNF Receptor 2 (sTNFR2) in COVID-19 ARDS patients.","We aimed at explaining the mechanism of therapeutic effect of Umbilical Cord Mesenchymal Stem Cells (UC-MSC) in subjects with COVID-19 Acute Respiratory Distress Syndrome (ARDS). Patients with COVID-19 ARDS present with a hyperinflammatory response characterized by high levels of circulating pro-inflammatory mediators, including tumor necrosis factor a and ß (TNFa and TNFß). Inflammatory functions of these TNFs can be inhibited by soluble TNF Receptor 2 (sTNFR2). In patients with COVID-19 ARDS, ","2021","07","14","Eur Rev Med Pharmacol Sci","European review for medical and pharmacological sciences","Biomarkers; COVID-19; Double-Blind Method; Humans; Lymphotoxin-alpha; Mesenchymal Stem Cell Transplantation; Receptors, Tumor Necrosis Factor, Type II; Respiratory Distress Syndrome; Tumor Necrosis Factor-alpha; Umbilical Cord","Lanzoni","G","Department of Orthopedics, UHealth Sports Medicine Institute, University of Miami Miller School of Medicine, Miami, FL, USA. ricordi@miami",NA
"192","34227081","10.26355/eurrev_202106_26156","Umbilical Cord-derived Mesenchymal Stem Cells modulate TNF and soluble TNF Receptor 2 (sTNFR2) in COVID-19 ARDS patients.","We aimed at explaining the mechanism of therapeutic effect of Umbilical Cord Mesenchymal Stem Cells (UC-MSC) in subjects with COVID-19 Acute Respiratory Distress Syndrome (ARDS). Patients with COVID-19 ARDS present with a hyperinflammatory response characterized by high levels of circulating pro-inflammatory mediators, including tumor necrosis factor a and ß (TNFa and TNFß). Inflammatory functions of these TNFs can be inhibited by soluble TNF Receptor 2 (sTNFR2). In patients with COVID-19 ARDS, ","2021","07","14","Eur Rev Med Pharmacol Sci","European review for medical and pharmacological sciences","Biomarkers; COVID-19; Double-Blind Method; Humans; Lymphotoxin-alpha; Mesenchymal Stem Cell Transplantation; Receptors, Tumor Necrosis Factor, Type II; Respiratory Distress Syndrome; Tumor Necrosis Factor-alpha; Umbilical Cord","Linetsky","E","Department of Orthopedics, UHealth Sports Medicine Institute, University of Miami Miller School of Medicine, Miami, FL, USA. ricordi@miami",NA
"193","34227081","10.26355/eurrev_202106_26156","Umbilical Cord-derived Mesenchymal Stem Cells modulate TNF and soluble TNF Receptor 2 (sTNFR2) in COVID-19 ARDS patients.","We aimed at explaining the mechanism of therapeutic effect of Umbilical Cord Mesenchymal Stem Cells (UC-MSC) in subjects with COVID-19 Acute Respiratory Distress Syndrome (ARDS). Patients with COVID-19 ARDS present with a hyperinflammatory response characterized by high levels of circulating pro-inflammatory mediators, including tumor necrosis factor a and ß (TNFa and TNFß). Inflammatory functions of these TNFs can be inhibited by soluble TNF Receptor 2 (sTNFR2). In patients with COVID-19 ARDS, ","2021","07","14","Eur Rev Med Pharmacol Sci","European review for medical and pharmacological sciences","Biomarkers; COVID-19; Double-Blind Method; Humans; Lymphotoxin-alpha; Mesenchymal Stem Cell Transplantation; Receptors, Tumor Necrosis Factor, Type II; Respiratory Distress Syndrome; Tumor Necrosis Factor-alpha; Umbilical Cord","Messinger Cayetano","S","Department of Orthopedics, UHealth Sports Medicine Institute, University of Miami Miller School of Medicine, Miami, FL, USA. ricordi@miami",NA
"194","34227081","10.26355/eurrev_202106_26156","Umbilical Cord-derived Mesenchymal Stem Cells modulate TNF and soluble TNF Receptor 2 (sTNFR2) in COVID-19 ARDS patients.","We aimed at explaining the mechanism of therapeutic effect of Umbilical Cord Mesenchymal Stem Cells (UC-MSC) in subjects with COVID-19 Acute Respiratory Distress Syndrome (ARDS). Patients with COVID-19 ARDS present with a hyperinflammatory response characterized by high levels of circulating pro-inflammatory mediators, including tumor necrosis factor a and ß (TNFa and TNFß). Inflammatory functions of these TNFs can be inhibited by soluble TNF Receptor 2 (sTNFR2). In patients with COVID-19 ARDS, ","2021","07","14","Eur Rev Med Pharmacol Sci","European review for medical and pharmacological sciences","Biomarkers; COVID-19; Double-Blind Method; Humans; Lymphotoxin-alpha; Mesenchymal Stem Cell Transplantation; Receptors, Tumor Necrosis Factor, Type II; Respiratory Distress Syndrome; Tumor Necrosis Factor-alpha; Umbilical Cord","Wishnek Metalonis","S","Department of Orthopedics, UHealth Sports Medicine Institute, University of Miami Miller School of Medicine, Miami, FL, USA. ricordi@miami",NA
"195","34227081","10.26355/eurrev_202106_26156","Umbilical Cord-derived Mesenchymal Stem Cells modulate TNF and soluble TNF Receptor 2 (sTNFR2) in COVID-19 ARDS patients.","We aimed at explaining the mechanism of therapeutic effect of Umbilical Cord Mesenchymal Stem Cells (UC-MSC) in subjects with COVID-19 Acute Respiratory Distress Syndrome (ARDS). Patients with COVID-19 ARDS present with a hyperinflammatory response characterized by high levels of circulating pro-inflammatory mediators, including tumor necrosis factor a and ß (TNFa and TNFß). Inflammatory functions of these TNFs can be inhibited by soluble TNF Receptor 2 (sTNFR2). In patients with COVID-19 ARDS, ","2021","07","14","Eur Rev Med Pharmacol Sci","European review for medical and pharmacological sciences","Biomarkers; COVID-19; Double-Blind Method; Humans; Lymphotoxin-alpha; Mesenchymal Stem Cell Transplantation; Receptors, Tumor Necrosis Factor, Type II; Respiratory Distress Syndrome; Tumor Necrosis Factor-alpha; Umbilical Cord","Leñero","C","Department of Orthopedics, UHealth Sports Medicine Institute, University of Miami Miller School of Medicine, Miami, FL, USA. ricordi@miami",NA
"196","34227081","10.26355/eurrev_202106_26156","Umbilical Cord-derived Mesenchymal Stem Cells modulate TNF and soluble TNF Receptor 2 (sTNFR2) in COVID-19 ARDS patients.","We aimed at explaining the mechanism of therapeutic effect of Umbilical Cord Mesenchymal Stem Cells (UC-MSC) in subjects with COVID-19 Acute Respiratory Distress Syndrome (ARDS). Patients with COVID-19 ARDS present with a hyperinflammatory response characterized by high levels of circulating pro-inflammatory mediators, including tumor necrosis factor a and ß (TNFa and TNFß). Inflammatory functions of these TNFs can be inhibited by soluble TNF Receptor 2 (sTNFR2). In patients with COVID-19 ARDS, ","2021","07","14","Eur Rev Med Pharmacol Sci","European review for medical and pharmacological sciences","Biomarkers; COVID-19; Double-Blind Method; Humans; Lymphotoxin-alpha; Mesenchymal Stem Cell Transplantation; Receptors, Tumor Necrosis Factor, Type II; Respiratory Distress Syndrome; Tumor Necrosis Factor-alpha; Umbilical Cord","Stone","L D","Department of Orthopedics, UHealth Sports Medicine Institute, University of Miami Miller School of Medicine, Miami, FL, USA. ricordi@miami",NA
"197","34227081","10.26355/eurrev_202106_26156","Umbilical Cord-derived Mesenchymal Stem Cells modulate TNF and soluble TNF Receptor 2 (sTNFR2) in COVID-19 ARDS patients.","We aimed at explaining the mechanism of therapeutic effect of Umbilical Cord Mesenchymal Stem Cells (UC-MSC) in subjects with COVID-19 Acute Respiratory Distress Syndrome (ARDS). Patients with COVID-19 ARDS present with a hyperinflammatory response characterized by high levels of circulating pro-inflammatory mediators, including tumor necrosis factor a and ß (TNFa and TNFß). Inflammatory functions of these TNFs can be inhibited by soluble TNF Receptor 2 (sTNFR2). In patients with COVID-19 ARDS, ","2021","07","14","Eur Rev Med Pharmacol Sci","European review for medical and pharmacological sciences","Biomarkers; COVID-19; Double-Blind Method; Humans; Lymphotoxin-alpha; Mesenchymal Stem Cell Transplantation; Receptors, Tumor Necrosis Factor, Type II; Respiratory Distress Syndrome; Tumor Necrosis Factor-alpha; Umbilical Cord","Ruiz","P","Department of Orthopedics, UHealth Sports Medicine Institute, University of Miami Miller School of Medicine, Miami, FL, USA. ricordi@miami",NA
"198","34227081","10.26355/eurrev_202106_26156","Umbilical Cord-derived Mesenchymal Stem Cells modulate TNF and soluble TNF Receptor 2 (sTNFR2) in COVID-19 ARDS patients.","We aimed at explaining the mechanism of therapeutic effect of Umbilical Cord Mesenchymal Stem Cells (UC-MSC) in subjects with COVID-19 Acute Respiratory Distress Syndrome (ARDS). Patients with COVID-19 ARDS present with a hyperinflammatory response characterized by high levels of circulating pro-inflammatory mediators, including tumor necrosis factor a and ß (TNFa and TNFß). Inflammatory functions of these TNFs can be inhibited by soluble TNF Receptor 2 (sTNFR2). In patients with COVID-19 ARDS, ","2021","07","14","Eur Rev Med Pharmacol Sci","European review for medical and pharmacological sciences","Biomarkers; COVID-19; Double-Blind Method; Humans; Lymphotoxin-alpha; Mesenchymal Stem Cell Transplantation; Receptors, Tumor Necrosis Factor, Type II; Respiratory Distress Syndrome; Tumor Necrosis Factor-alpha; Umbilical Cord","Correa","D","Department of Orthopedics, UHealth Sports Medicine Institute, University of Miami Miller School of Medicine, Miami, FL, USA. ricordi@miami",NA
"199","34227081","10.26355/eurrev_202106_26156","Umbilical Cord-derived Mesenchymal Stem Cells modulate TNF and soluble TNF Receptor 2 (sTNFR2) in COVID-19 ARDS patients.","We aimed at explaining the mechanism of therapeutic effect of Umbilical Cord Mesenchymal Stem Cells (UC-MSC) in subjects with COVID-19 Acute Respiratory Distress Syndrome (ARDS). Patients with COVID-19 ARDS present with a hyperinflammatory response characterized by high levels of circulating pro-inflammatory mediators, including tumor necrosis factor a and ß (TNFa and TNFß). Inflammatory functions of these TNFs can be inhibited by soluble TNF Receptor 2 (sTNFR2). In patients with COVID-19 ARDS, ","2021","07","14","Eur Rev Med Pharmacol Sci","European review for medical and pharmacological sciences","Biomarkers; COVID-19; Double-Blind Method; Humans; Lymphotoxin-alpha; Mesenchymal Stem Cell Transplantation; Receptors, Tumor Necrosis Factor, Type II; Respiratory Distress Syndrome; Tumor Necrosis Factor-alpha; Umbilical Cord","Ricordi","C","Department of Orthopedics, UHealth Sports Medicine Institute, University of Miami Miller School of Medicine, Miami, FL, USA. ricordi@miami",NA
"200","34227080","10.26355/eurrev_202106_26155","Changes in undergraduate medical education due to COVID-19: a systematic review.","This study aims to provide medical educators with insights into the current status and prospects of undergraduate medical education, which has been affected by the COVID-19 pandemic. We conducted a database search of PubMed, Embase, and ERIC and identified articles on COVID-19-related undergraduate medical education. We independently reviewed titles and abstracts and extracted data on the geographic location of the study, area of specialty, phase in medical school (preclinical year, clerkship ye","2021","07","14","Eur Rev Med Pharmacol Sci","European review for medical and pharmacological sciences","COVID-19; Curriculum; Education, Distance; Education, Medical, Undergraduate; Humans; Students, Medical","Lee","I R","Department of Medical Education, Yonsei University College of Medicine, Seoul, Republic of Korea. shinji@yuhs","shinji@yuhs.ac"
"201","34227080","10.26355/eurrev_202106_26155","Changes in undergraduate medical education due to COVID-19: a systematic review.","This study aims to provide medical educators with insights into the current status and prospects of undergraduate medical education, which has been affected by the COVID-19 pandemic. We conducted a database search of PubMed, Embase, and ERIC and identified articles on COVID-19-related undergraduate medical education. We independently reviewed titles and abstracts and extracted data on the geographic location of the study, area of specialty, phase in medical school (preclinical year, clerkship ye","2021","07","14","Eur Rev Med Pharmacol Sci","European review for medical and pharmacological sciences","COVID-19; Curriculum; Education, Distance; Education, Medical, Undergraduate; Humans; Students, Medical","Kim","H W","Department of Medical Education, Yonsei University College of Medicine, Seoul, Republic of Korea. shinji@yuhs",NA
"202","34227080","10.26355/eurrev_202106_26155","Changes in undergraduate medical education due to COVID-19: a systematic review.","This study aims to provide medical educators with insights into the current status and prospects of undergraduate medical education, which has been affected by the COVID-19 pandemic. We conducted a database search of PubMed, Embase, and ERIC and identified articles on COVID-19-related undergraduate medical education. We independently reviewed titles and abstracts and extracted data on the geographic location of the study, area of specialty, phase in medical school (preclinical year, clerkship ye","2021","07","14","Eur Rev Med Pharmacol Sci","European review for medical and pharmacological sciences","COVID-19; Curriculum; Education, Distance; Education, Medical, Undergraduate; Humans; Students, Medical","Lee","Y","Department of Medical Education, Yonsei University College of Medicine, Seoul, Republic of Korea. shinji@yuhs",NA
"203","34227080","10.26355/eurrev_202106_26155","Changes in undergraduate medical education due to COVID-19: a systematic review.","This study aims to provide medical educators with insights into the current status and prospects of undergraduate medical education, which has been affected by the COVID-19 pandemic. We conducted a database search of PubMed, Embase, and ERIC and identified articles on COVID-19-related undergraduate medical education. We independently reviewed titles and abstracts and extracted data on the geographic location of the study, area of specialty, phase in medical school (preclinical year, clerkship ye","2021","07","14","Eur Rev Med Pharmacol Sci","European review for medical and pharmacological sciences","COVID-19; Curriculum; Education, Distance; Education, Medical, Undergraduate; Humans; Students, Medical","Koyanagi","A","Department of Medical Education, Yonsei University College of Medicine, Seoul, Republic of Korea. shinji@yuhs",NA
"204","34227080","10.26355/eurrev_202106_26155","Changes in undergraduate medical education due to COVID-19: a systematic review.","This study aims to provide medical educators with insights into the current status and prospects of undergraduate medical education, which has been affected by the COVID-19 pandemic. We conducted a database search of PubMed, Embase, and ERIC and identified articles on COVID-19-related undergraduate medical education. We independently reviewed titles and abstracts and extracted data on the geographic location of the study, area of specialty, phase in medical school (preclinical year, clerkship ye","2021","07","14","Eur Rev Med Pharmacol Sci","European review for medical and pharmacological sciences","COVID-19; Curriculum; Education, Distance; Education, Medical, Undergraduate; Humans; Students, Medical","Jacob","L","Department of Medical Education, Yonsei University College of Medicine, Seoul, Republic of Korea. shinji@yuhs",NA
"205","34227080","10.26355/eurrev_202106_26155","Changes in undergraduate medical education due to COVID-19: a systematic review.","This study aims to provide medical educators with insights into the current status and prospects of undergraduate medical education, which has been affected by the COVID-19 pandemic. We conducted a database search of PubMed, Embase, and ERIC and identified articles on COVID-19-related undergraduate medical education. We independently reviewed titles and abstracts and extracted data on the geographic location of the study, area of specialty, phase in medical school (preclinical year, clerkship ye","2021","07","14","Eur Rev Med Pharmacol Sci","European review for medical and pharmacological sciences","COVID-19; Curriculum; Education, Distance; Education, Medical, Undergraduate; Humans; Students, Medical","An","S","Department of Medical Education, Yonsei University College of Medicine, Seoul, Republic of Korea. shinji@yuhs",NA
"206","34227080","10.26355/eurrev_202106_26155","Changes in undergraduate medical education due to COVID-19: a systematic review.","This study aims to provide medical educators with insights into the current status and prospects of undergraduate medical education, which has been affected by the COVID-19 pandemic. We conducted a database search of PubMed, Embase, and ERIC and identified articles on COVID-19-related undergraduate medical education. We independently reviewed titles and abstracts and extracted data on the geographic location of the study, area of specialty, phase in medical school (preclinical year, clerkship ye","2021","07","14","Eur Rev Med Pharmacol Sci","European review for medical and pharmacological sciences","COVID-19; Curriculum; Education, Distance; Education, Medical, Undergraduate; Humans; Students, Medical","Shin","J I","Department of Medical Education, Yonsei University College of Medicine, Seoul, Republic of Korea. shinji@yuhs",NA
"207","34227080","10.26355/eurrev_202106_26155","Changes in undergraduate medical education due to COVID-19: a systematic review.","This study aims to provide medical educators with insights into the current status and prospects of undergraduate medical education, which has been affected by the COVID-19 pandemic. We conducted a database search of PubMed, Embase, and ERIC and identified articles on COVID-19-related undergraduate medical education. We independently reviewed titles and abstracts and extracted data on the geographic location of the study, area of specialty, phase in medical school (preclinical year, clerkship ye","2021","07","14","Eur Rev Med Pharmacol Sci","European review for medical and pharmacological sciences","COVID-19; Curriculum; Education, Distance; Education, Medical, Undergraduate; Humans; Students, Medical","Smith","L","Department of Medical Education, Yonsei University College of Medicine, Seoul, Republic of Korea. shinji@yuhs",NA
"208","34227079","10.26355/eurrev_202106_26154","Post COVID syndrome: a new challenge for medicine.","The huge concern raised by SARS-CoV2 pandemic about public health management and social impact is still under debate, particularly because COVID-19 may affect infected people much longer than expected from a typical air-borne viral disease. The scientific community is actually wondering about the etiopathogenesis and clinical development of this ""post-COVID"" complex symptomatology, very close to symptoms typically observed in chronic fatigue syndrome, so recently named as ""post-acute sequelae of","2021","07","14","Eur Rev Med Pharmacol Sci","European review for medical and pharmacological sciences","COVID-19; Fatigue Syndrome, Chronic; Humans; SARS-CoV-2; Syndrome","Tirelli","U","Tirelli Medical Group, Pordenone (PN), Italy. salvatore.chirumbolo@univr","salvatore.chirumbolo@univr.it"
"209","34227079","10.26355/eurrev_202106_26154","Post COVID syndrome: a new challenge for medicine.","The huge concern raised by SARS-CoV2 pandemic about public health management and social impact is still under debate, particularly because COVID-19 may affect infected people much longer than expected from a typical air-borne viral disease. The scientific community is actually wondering about the etiopathogenesis and clinical development of this ""post-COVID"" complex symptomatology, very close to symptoms typically observed in chronic fatigue syndrome, so recently named as ""post-acute sequelae of","2021","07","14","Eur Rev Med Pharmacol Sci","European review for medical and pharmacological sciences","COVID-19; Fatigue Syndrome, Chronic; Humans; SARS-CoV-2; Syndrome","Taibi","R","Tirelli Medical Group, Pordenone (PN), Italy. salvatore.chirumbolo@univr",NA
"210","34227079","10.26355/eurrev_202106_26154","Post COVID syndrome: a new challenge for medicine.","The huge concern raised by SARS-CoV2 pandemic about public health management and social impact is still under debate, particularly because COVID-19 may affect infected people much longer than expected from a typical air-borne viral disease. The scientific community is actually wondering about the etiopathogenesis and clinical development of this ""post-COVID"" complex symptomatology, very close to symptoms typically observed in chronic fatigue syndrome, so recently named as ""post-acute sequelae of","2021","07","14","Eur Rev Med Pharmacol Sci","European review for medical and pharmacological sciences","COVID-19; Fatigue Syndrome, Chronic; Humans; SARS-CoV-2; Syndrome","Chirumbolo","S","Tirelli Medical Group, Pordenone (PN), Italy. salvatore.chirumbolo@univr",NA
"211","34227078","10.26355/eurrev_202106_26153","Side effects after COVID-19 vaccinations among residents of Poland.","Side effects of vaccines are common, but people react differently to different vaccines. Manufacturers provide lists of the side effects of their products. Adverse reactions are proof of the effectiveness of vaccines and that the immune system is responding. In this study, we compare the side effects of the AstraZeneca and Pfizer vaccines. Our survey results show that the side effects of the first dose of the AstraZeneca vaccine are more common than after the first and second doses of the Pfizer","2021","07","14","Eur Rev Med Pharmacol Sci","European review for medical and pharmacological sciences","Adult; Aged; Aged, 80 and over; COVID-19; COVID-19 Vaccines; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Middle Aged; Poland; Surveys and Questionnaires; Vaccination; Young Adult","Andrzejczak-Grzadko","S","Faculty of Biological Science, Department of Biotechnology, University of Zielona Góra, Zielona Góra, Poland. s.andrzejczak-grzadko@wnb.uz.zgora","grzadko@wnb.uz.zgora.pl"
"212","34227078","10.26355/eurrev_202106_26153","Side effects after COVID-19 vaccinations among residents of Poland.","Side effects of vaccines are common, but people react differently to different vaccines. Manufacturers provide lists of the side effects of their products. Adverse reactions are proof of the effectiveness of vaccines and that the immune system is responding. In this study, we compare the side effects of the AstraZeneca and Pfizer vaccines. Our survey results show that the side effects of the first dose of the AstraZeneca vaccine are more common than after the first and second doses of the Pfizer","2021","07","14","Eur Rev Med Pharmacol Sci","European review for medical and pharmacological sciences","Adult; Aged; Aged, 80 and over; COVID-19; COVID-19 Vaccines; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Middle Aged; Poland; Surveys and Questionnaires; Vaccination; Young Adult","Czudy","Z","Faculty of Biological Science, Department of Biotechnology, University of Zielona Góra, Zielona Góra, Poland. s.andrzejczak-grzadko@wnb.uz.zgora",NA
"213","34227078","10.26355/eurrev_202106_26153","Side effects after COVID-19 vaccinations among residents of Poland.","Side effects of vaccines are common, but people react differently to different vaccines. Manufacturers provide lists of the side effects of their products. Adverse reactions are proof of the effectiveness of vaccines and that the immune system is responding. In this study, we compare the side effects of the AstraZeneca and Pfizer vaccines. Our survey results show that the side effects of the first dose of the AstraZeneca vaccine are more common than after the first and second doses of the Pfizer","2021","07","14","Eur Rev Med Pharmacol Sci","European review for medical and pharmacological sciences","Adult; Aged; Aged, 80 and over; COVID-19; COVID-19 Vaccines; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Middle Aged; Poland; Surveys and Questionnaires; Vaccination; Young Adult","Donderska","M","Faculty of Biological Science, Department of Biotechnology, University of Zielona Góra, Zielona Góra, Poland. s.andrzejczak-grzadko@wnb.uz.zgora",NA
"214","34227077","10.26355/eurrev_202106_26152","Early spontaneous pneumothorax, pneumomediastinum and pneumorrhachis in an adolescent with SARS-CoV-2 infection.","We report a case of spontaneous pneumomediastinum, pneumothorax, emphysema subcutaneous and pneumorrhachis, occurring in an adolescent resulting positive to SARS-CoV-2 nasopharyngeal swab. At the admission in Emergency Department, the child presented with left cervical and sternal pain, without respiratory symptoms. Radiological studies showed sizeable pneumomediastinum, bilateral apical pneumothorax, massive emphysema subcutaneous and pneumorrhachis. Patients' clinical conditions stood stable d","2021","07","14","Eur Rev Med Pharmacol Sci","European review for medical and pharmacological sciences","Adolescent; COVID-19; Humans; Male; Mediastinal Emphysema; Pneumorrhachis; Pneumothorax","Buonsenso","D","Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario A. Gemelli, Rome, Italy. danilobuonsenso@gmail","danilobuonsenso@gmail.com"
"215","34227077","10.26355/eurrev_202106_26152","Early spontaneous pneumothorax, pneumomediastinum and pneumorrhachis in an adolescent with SARS-CoV-2 infection.","We report a case of spontaneous pneumomediastinum, pneumothorax, emphysema subcutaneous and pneumorrhachis, occurring in an adolescent resulting positive to SARS-CoV-2 nasopharyngeal swab. At the admission in Emergency Department, the child presented with left cervical and sternal pain, without respiratory symptoms. Radiological studies showed sizeable pneumomediastinum, bilateral apical pneumothorax, massive emphysema subcutaneous and pneumorrhachis. Patients' clinical conditions stood stable d","2021","07","14","Eur Rev Med Pharmacol Sci","European review for medical and pharmacological sciences","Adolescent; COVID-19; Humans; Male; Mediastinal Emphysema; Pneumorrhachis; Pneumothorax","Gatto","A","Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario A. Gemelli, Rome, Italy. danilobuonsenso@gmail",NA
"216","34227077","10.26355/eurrev_202106_26152","Early spontaneous pneumothorax, pneumomediastinum and pneumorrhachis in an adolescent with SARS-CoV-2 infection.","We report a case of spontaneous pneumomediastinum, pneumothorax, emphysema subcutaneous and pneumorrhachis, occurring in an adolescent resulting positive to SARS-CoV-2 nasopharyngeal swab. At the admission in Emergency Department, the child presented with left cervical and sternal pain, without respiratory symptoms. Radiological studies showed sizeable pneumomediastinum, bilateral apical pneumothorax, massive emphysema subcutaneous and pneumorrhachis. Patients' clinical conditions stood stable d","2021","07","14","Eur Rev Med Pharmacol Sci","European review for medical and pharmacological sciences","Adolescent; COVID-19; Humans; Male; Mediastinal Emphysema; Pneumorrhachis; Pneumothorax","Graglia","B","Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario A. Gemelli, Rome, Italy. danilobuonsenso@gmail",NA
"217","34227077","10.26355/eurrev_202106_26152","Early spontaneous pneumothorax, pneumomediastinum and pneumorrhachis in an adolescent with SARS-CoV-2 infection.","We report a case of spontaneous pneumomediastinum, pneumothorax, emphysema subcutaneous and pneumorrhachis, occurring in an adolescent resulting positive to SARS-CoV-2 nasopharyngeal swab. At the admission in Emergency Department, the child presented with left cervical and sternal pain, without respiratory symptoms. Radiological studies showed sizeable pneumomediastinum, bilateral apical pneumothorax, massive emphysema subcutaneous and pneumorrhachis. Patients' clinical conditions stood stable d","2021","07","14","Eur Rev Med Pharmacol Sci","European review for medical and pharmacological sciences","Adolescent; COVID-19; Humans; Male; Mediastinal Emphysema; Pneumorrhachis; Pneumothorax","Rivetti","S","Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario A. Gemelli, Rome, Italy. danilobuonsenso@gmail",NA
"218","34227077","10.26355/eurrev_202106_26152","Early spontaneous pneumothorax, pneumomediastinum and pneumorrhachis in an adolescent with SARS-CoV-2 infection.","We report a case of spontaneous pneumomediastinum, pneumothorax, emphysema subcutaneous and pneumorrhachis, occurring in an adolescent resulting positive to SARS-CoV-2 nasopharyngeal swab. At the admission in Emergency Department, the child presented with left cervical and sternal pain, without respiratory symptoms. Radiological studies showed sizeable pneumomediastinum, bilateral apical pneumothorax, massive emphysema subcutaneous and pneumorrhachis. Patients' clinical conditions stood stable d","2021","07","14","Eur Rev Med Pharmacol Sci","European review for medical and pharmacological sciences","Adolescent; COVID-19; Humans; Male; Mediastinal Emphysema; Pneumorrhachis; Pneumothorax","Ferretti","S","Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario A. Gemelli, Rome, Italy. danilobuonsenso@gmail",NA
"219","34227077","10.26355/eurrev_202106_26152","Early spontaneous pneumothorax, pneumomediastinum and pneumorrhachis in an adolescent with SARS-CoV-2 infection.","We report a case of spontaneous pneumomediastinum, pneumothorax, emphysema subcutaneous and pneumorrhachis, occurring in an adolescent resulting positive to SARS-CoV-2 nasopharyngeal swab. At the admission in Emergency Department, the child presented with left cervical and sternal pain, without respiratory symptoms. Radiological studies showed sizeable pneumomediastinum, bilateral apical pneumothorax, massive emphysema subcutaneous and pneumorrhachis. Patients' clinical conditions stood stable d","2021","07","14","Eur Rev Med Pharmacol Sci","European review for medical and pharmacological sciences","Adolescent; COVID-19; Humans; Male; Mediastinal Emphysema; Pneumorrhachis; Pneumothorax","Paradiso","F V","Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario A. Gemelli, Rome, Italy. danilobuonsenso@gmail",NA
"220","34227077","10.26355/eurrev_202106_26152","Early spontaneous pneumothorax, pneumomediastinum and pneumorrhachis in an adolescent with SARS-CoV-2 infection.","We report a case of spontaneous pneumomediastinum, pneumothorax, emphysema subcutaneous and pneumorrhachis, occurring in an adolescent resulting positive to SARS-CoV-2 nasopharyngeal swab. At the admission in Emergency Department, the child presented with left cervical and sternal pain, without respiratory symptoms. Radiological studies showed sizeable pneumomediastinum, bilateral apical pneumothorax, massive emphysema subcutaneous and pneumorrhachis. Patients' clinical conditions stood stable d","2021","07","14","Eur Rev Med Pharmacol Sci","European review for medical and pharmacological sciences","Adolescent; COVID-19; Humans; Male; Mediastinal Emphysema; Pneumorrhachis; Pneumothorax","Chiaretti","A","Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario A. Gemelli, Rome, Italy. danilobuonsenso@gmail",NA
"221","34227076","10.26355/eurrev_202106_26151","Evolving biothreat of variant SARS-CoV-2 - molecular properties, virulence and epidemiology.","SARS-CoV-2 are enveloped RNA viruses that belong to the family Coronaviridae of genus Beta coronavirus, responsible for the COVID-19 pandemic. The mutation rate is high among RNA viruses and in particular, coronavirus replication is error prone with an estimated mutation rate of 4x10-4 nucleotide substitutions per site per year. Variants of SARS-CoV-2 have been reported from various countries like United Kingdom, South Africa, Denmark, Brazil and India. These variants evolved due to mutations in","2021","07","14","Eur Rev Med Pharmacol Sci","European review for medical and pharmacological sciences","COVID-19; Humans; India; Mutation; Protein Structure, Secondary; SARS-CoV-2; United Kingdom; Virulence","Kannan","S","School of Medicine, The Maldives National University Male, Maldives. Kannan.subbaram@mnu.edu","Kannan.subbaram@mnu.edu.mv"
"222","34227076","10.26355/eurrev_202106_26151","Evolving biothreat of variant SARS-CoV-2 - molecular properties, virulence and epidemiology.","SARS-CoV-2 are enveloped RNA viruses that belong to the family Coronaviridae of genus Beta coronavirus, responsible for the COVID-19 pandemic. The mutation rate is high among RNA viruses and in particular, coronavirus replication is error prone with an estimated mutation rate of 4x10-4 nucleotide substitutions per site per year. Variants of SARS-CoV-2 have been reported from various countries like United Kingdom, South Africa, Denmark, Brazil and India. These variants evolved due to mutations in","2021","07","14","Eur Rev Med Pharmacol Sci","European review for medical and pharmacological sciences","COVID-19; Humans; India; Mutation; Protein Structure, Secondary; SARS-CoV-2; United Kingdom; Virulence","Shaik Syed Ali","P","School of Medicine, The Maldives National University Male, Maldives. Kannan.subbaram@mnu.edu",NA
"223","34227076","10.26355/eurrev_202106_26151","Evolving biothreat of variant SARS-CoV-2 - molecular properties, virulence and epidemiology.","SARS-CoV-2 are enveloped RNA viruses that belong to the family Coronaviridae of genus Beta coronavirus, responsible for the COVID-19 pandemic. The mutation rate is high among RNA viruses and in particular, coronavirus replication is error prone with an estimated mutation rate of 4x10-4 nucleotide substitutions per site per year. Variants of SARS-CoV-2 have been reported from various countries like United Kingdom, South Africa, Denmark, Brazil and India. These variants evolved due to mutations in","2021","07","14","Eur Rev Med Pharmacol Sci","European review for medical and pharmacological sciences","COVID-19; Humans; India; Mutation; Protein Structure, Secondary; SARS-CoV-2; United Kingdom; Virulence","Sheeza","A","School of Medicine, The Maldives National University Male, Maldives. Kannan.subbaram@mnu.edu",NA
"224","34227075","10.26355/eurrev_202106_26150","COVID-19 in celiac disease: a multicentric retrospective cohort study.","Celiac disease (CD) is an autoimmune disorder, characterized by increased susceptibility to bacterial and viral infections. Therefore, the CD patients could be exposed to an increased risk of contracting SARS-CoV-2, a virus for which the WHO declared a pandemic status in March 2020. This study aims to investigate the incidence of SARS-CoV-2 infection in CD patients, to assess the impact of CD on the risk of contracting this virus. This retrospective multicentric cohort study evaluated 542 celiac","2021","07","14","Eur Rev Med Pharmacol Sci","European review for medical and pharmacological sciences","COVID-19; COVID-19 Testing; Celiac Disease; Cohort Studies; Diet, Gluten-Free; Humans; Italy; Retrospective Studies","Gasbarrini","G","Institute of Internal Medicine and Gastroenterology, Fondazione Policlinico Universitario. tommasodionisi@libero","tommasodionisi@libero.it"
"225","34227075","10.26355/eurrev_202106_26150","COVID-19 in celiac disease: a multicentric retrospective cohort study.","Celiac disease (CD) is an autoimmune disorder, characterized by increased susceptibility to bacterial and viral infections. Therefore, the CD patients could be exposed to an increased risk of contracting SARS-CoV-2, a virus for which the WHO declared a pandemic status in March 2020. This study aims to investigate the incidence of SARS-CoV-2 infection in CD patients, to assess the impact of CD on the risk of contracting this virus. This retrospective multicentric cohort study evaluated 542 celiac","2021","07","14","Eur Rev Med Pharmacol Sci","European review for medical and pharmacological sciences","COVID-19; COVID-19 Testing; Celiac Disease; Cohort Studies; Diet, Gluten-Free; Humans; Italy; Retrospective Studies","Dionisi","T","Institute of Internal Medicine and Gastroenterology, Fondazione Policlinico Universitario. tommasodionisi@libero",NA
"226","34227075","10.26355/eurrev_202106_26150","COVID-19 in celiac disease: a multicentric retrospective cohort study.","Celiac disease (CD) is an autoimmune disorder, characterized by increased susceptibility to bacterial and viral infections. Therefore, the CD patients could be exposed to an increased risk of contracting SARS-CoV-2, a virus for which the WHO declared a pandemic status in March 2020. This study aims to investigate the incidence of SARS-CoV-2 infection in CD patients, to assess the impact of CD on the risk of contracting this virus. This retrospective multicentric cohort study evaluated 542 celiac","2021","07","14","Eur Rev Med Pharmacol Sci","European review for medical and pharmacological sciences","COVID-19; COVID-19 Testing; Celiac Disease; Cohort Studies; Diet, Gluten-Free; Humans; Italy; Retrospective Studies","Corazza","G R","Institute of Internal Medicine and Gastroenterology, Fondazione Policlinico Universitario. tommasodionisi@libero",NA
"227","34227075","10.26355/eurrev_202106_26150","COVID-19 in celiac disease: a multicentric retrospective cohort study.","Celiac disease (CD) is an autoimmune disorder, characterized by increased susceptibility to bacterial and viral infections. Therefore, the CD patients could be exposed to an increased risk of contracting SARS-CoV-2, a virus for which the WHO declared a pandemic status in March 2020. This study aims to investigate the incidence of SARS-CoV-2 infection in CD patients, to assess the impact of CD on the risk of contracting this virus. This retrospective multicentric cohort study evaluated 542 celiac","2021","07","14","Eur Rev Med Pharmacol Sci","European review for medical and pharmacological sciences","COVID-19; COVID-19 Testing; Celiac Disease; Cohort Studies; Diet, Gluten-Free; Humans; Italy; Retrospective Studies","Aronico","N","Institute of Internal Medicine and Gastroenterology, Fondazione Policlinico Universitario. tommasodionisi@libero",NA
"228","34227075","10.26355/eurrev_202106_26150","COVID-19 in celiac disease: a multicentric retrospective cohort study.","Celiac disease (CD) is an autoimmune disorder, characterized by increased susceptibility to bacterial and viral infections. Therefore, the CD patients could be exposed to an increased risk of contracting SARS-CoV-2, a virus for which the WHO declared a pandemic status in March 2020. This study aims to investigate the incidence of SARS-CoV-2 infection in CD patients, to assess the impact of CD on the risk of contracting this virus. This retrospective multicentric cohort study evaluated 542 celiac","2021","07","14","Eur Rev Med Pharmacol Sci","European review for medical and pharmacological sciences","COVID-19; COVID-19 Testing; Celiac Disease; Cohort Studies; Diet, Gluten-Free; Humans; Italy; Retrospective Studies","Cammarota","G","Institute of Internal Medicine and Gastroenterology, Fondazione Policlinico Universitario. tommasodionisi@libero",NA
"229","34227075","10.26355/eurrev_202106_26150","COVID-19 in celiac disease: a multicentric retrospective cohort study.","Celiac disease (CD) is an autoimmune disorder, characterized by increased susceptibility to bacterial and viral infections. Therefore, the CD patients could be exposed to an increased risk of contracting SARS-CoV-2, a virus for which the WHO declared a pandemic status in March 2020. This study aims to investigate the incidence of SARS-CoV-2 infection in CD patients, to assess the impact of CD on the risk of contracting this virus. This retrospective multicentric cohort study evaluated 542 celiac","2021","07","14","Eur Rev Med Pharmacol Sci","European review for medical and pharmacological sciences","COVID-19; COVID-19 Testing; Celiac Disease; Cohort Studies; Diet, Gluten-Free; Humans; Italy; Retrospective Studies","Ianiro","G","Institute of Internal Medicine and Gastroenterology, Fondazione Policlinico Universitario. tommasodionisi@libero",NA
"230","34227075","10.26355/eurrev_202106_26150","COVID-19 in celiac disease: a multicentric retrospective cohort study.","Celiac disease (CD) is an autoimmune disorder, characterized by increased susceptibility to bacterial and viral infections. Therefore, the CD patients could be exposed to an increased risk of contracting SARS-CoV-2, a virus for which the WHO declared a pandemic status in March 2020. This study aims to investigate the incidence of SARS-CoV-2 infection in CD patients, to assess the impact of CD on the risk of contracting this virus. This retrospective multicentric cohort study evaluated 542 celiac","2021","07","14","Eur Rev Med Pharmacol Sci","European review for medical and pharmacological sciences","COVID-19; COVID-19 Testing; Celiac Disease; Cohort Studies; Diet, Gluten-Free; Humans; Italy; Retrospective Studies","De Vitis","I","Institute of Internal Medicine and Gastroenterology, Fondazione Policlinico Universitario. tommasodionisi@libero",NA
"231","34227075","10.26355/eurrev_202106_26150","COVID-19 in celiac disease: a multicentric retrospective cohort study.","Celiac disease (CD) is an autoimmune disorder, characterized by increased susceptibility to bacterial and viral infections. Therefore, the CD patients could be exposed to an increased risk of contracting SARS-CoV-2, a virus for which the WHO declared a pandemic status in March 2020. This study aims to investigate the incidence of SARS-CoV-2 infection in CD patients, to assess the impact of CD on the risk of contracting this virus. This retrospective multicentric cohort study evaluated 542 celiac","2021","07","14","Eur Rev Med Pharmacol Sci","European review for medical and pharmacological sciences","COVID-19; COVID-19 Testing; Celiac Disease; Cohort Studies; Diet, Gluten-Free; Humans; Italy; Retrospective Studies","Candelli","M","Institute of Internal Medicine and Gastroenterology, Fondazione Policlinico Universitario. tommasodionisi@libero",NA
"232","34227075","10.26355/eurrev_202106_26150","COVID-19 in celiac disease: a multicentric retrospective cohort study.","Celiac disease (CD) is an autoimmune disorder, characterized by increased susceptibility to bacterial and viral infections. Therefore, the CD patients could be exposed to an increased risk of contracting SARS-CoV-2, a virus for which the WHO declared a pandemic status in March 2020. This study aims to investigate the incidence of SARS-CoV-2 infection in CD patients, to assess the impact of CD on the risk of contracting this virus. This retrospective multicentric cohort study evaluated 542 celiac","2021","07","14","Eur Rev Med Pharmacol Sci","European review for medical and pharmacological sciences","COVID-19; COVID-19 Testing; Celiac Disease; Cohort Studies; Diet, Gluten-Free; Humans; Italy; Retrospective Studies","Mancarella","F A","Institute of Internal Medicine and Gastroenterology, Fondazione Policlinico Universitario. tommasodionisi@libero",NA
"233","34227075","10.26355/eurrev_202106_26150","COVID-19 in celiac disease: a multicentric retrospective cohort study.","Celiac disease (CD) is an autoimmune disorder, characterized by increased susceptibility to bacterial and viral infections. Therefore, the CD patients could be exposed to an increased risk of contracting SARS-CoV-2, a virus for which the WHO declared a pandemic status in March 2020. This study aims to investigate the incidence of SARS-CoV-2 infection in CD patients, to assess the impact of CD on the risk of contracting this virus. This retrospective multicentric cohort study evaluated 542 celiac","2021","07","14","Eur Rev Med Pharmacol Sci","European review for medical and pharmacological sciences","COVID-19; COVID-19 Testing; Celiac Disease; Cohort Studies; Diet, Gluten-Free; Humans; Italy; Retrospective Studies","Simeoni","S","Institute of Internal Medicine and Gastroenterology, Fondazione Policlinico Universitario. tommasodionisi@libero",NA
"234","34227075","10.26355/eurrev_202106_26150","COVID-19 in celiac disease: a multicentric retrospective cohort study.","Celiac disease (CD) is an autoimmune disorder, characterized by increased susceptibility to bacterial and viral infections. Therefore, the CD patients could be exposed to an increased risk of contracting SARS-CoV-2, a virus for which the WHO declared a pandemic status in March 2020. This study aims to investigate the incidence of SARS-CoV-2 infection in CD patients, to assess the impact of CD on the risk of contracting this virus. This retrospective multicentric cohort study evaluated 542 celiac","2021","07","14","Eur Rev Med Pharmacol Sci","European review for medical and pharmacological sciences","COVID-19; COVID-19 Testing; Celiac Disease; Cohort Studies; Diet, Gluten-Free; Humans; Italy; Retrospective Studies","Addolorato","G","Institute of Internal Medicine and Gastroenterology, Fondazione Policlinico Universitario. tommasodionisi@libero",NA
"235","34227075","10.26355/eurrev_202106_26150","COVID-19 in celiac disease: a multicentric retrospective cohort study.","Celiac disease (CD) is an autoimmune disorder, characterized by increased susceptibility to bacterial and viral infections. Therefore, the CD patients could be exposed to an increased risk of contracting SARS-CoV-2, a virus for which the WHO declared a pandemic status in March 2020. This study aims to investigate the incidence of SARS-CoV-2 infection in CD patients, to assess the impact of CD on the risk of contracting this virus. This retrospective multicentric cohort study evaluated 542 celiac","2021","07","14","Eur Rev Med Pharmacol Sci","European review for medical and pharmacological sciences","COVID-19; COVID-19 Testing; Celiac Disease; Cohort Studies; Diet, Gluten-Free; Humans; Italy; Retrospective Studies","Bonvicini","F","Institute of Internal Medicine and Gastroenterology, Fondazione Policlinico Universitario. tommasodionisi@libero",NA
"236","34227034","10.1007/s11845-021-02710-3","Assessment of COVID-19-related meta-analysis reporting quality.","Meta-analysis of high-quality primary articles represents the top-quality evidence in medical literature. In this project, our aim was to assess the number and quality of COVID-related meta-analysis published since the beginning of the COVID-19 pandemic. The search included the period from January 1, 2020, when the beginning of primary articles on COVID-19, till October 31, 2020. We screened a total of 793 studies. We excluded non-meta-analytic non-COVID-19-related studies. We obtained different","2021","07","08","Ir J Med Sci","Irish journal of medical science","AMSTAR; COVID-19; Coronavirus; Meta-analysis; Quality","Al-Ryalat","Nosaiba","Department of Radiology, The University of Jordan, Amman, 11942, Jordan",NA
"237","34227034","10.1007/s11845-021-02710-3","Assessment of COVID-19-related meta-analysis reporting quality.","Meta-analysis of high-quality primary articles represents the top-quality evidence in medical literature. In this project, our aim was to assess the number and quality of COVID-related meta-analysis published since the beginning of the COVID-19 pandemic. The search included the period from January 1, 2020, when the beginning of primary articles on COVID-19, till October 31, 2020. We screened a total of 793 studies. We excluded non-meta-analytic non-COVID-19-related studies. We obtained different","2021","07","08","Ir J Med Sci","Irish journal of medical science","AMSTAR; COVID-19; Coronavirus; Meta-analysis; Quality","Al-Rashdan","Omar","Department of Oral and Maxillofacial Surgery, Royal Jordanian Medical Services, Amman, Jordan",NA
"238","34227034","10.1007/s11845-021-02710-3","Assessment of COVID-19-related meta-analysis reporting quality.","Meta-analysis of high-quality primary articles represents the top-quality evidence in medical literature. In this project, our aim was to assess the number and quality of COVID-related meta-analysis published since the beginning of the COVID-19 pandemic. The search included the period from January 1, 2020, when the beginning of primary articles on COVID-19, till October 31, 2020. We screened a total of 793 studies. We excluded non-meta-analytic non-COVID-19-related studies. We obtained different","2021","07","08","Ir J Med Sci","Irish journal of medical science","AMSTAR; COVID-19; Coronavirus; Meta-analysis; Quality","Alaaraj","Bayan","Department of Pediatrics, The University of Jordan, Amman, 11942, Jordan",NA
"239","34227034","10.1007/s11845-021-02710-3","Assessment of COVID-19-related meta-analysis reporting quality.","Meta-analysis of high-quality primary articles represents the top-quality evidence in medical literature. In this project, our aim was to assess the number and quality of COVID-related meta-analysis published since the beginning of the COVID-19 pandemic. The search included the period from January 1, 2020, when the beginning of primary articles on COVID-19, till October 31, 2020. We screened a total of 793 studies. We excluded non-meta-analytic non-COVID-19-related studies. We obtained different","2021","07","08","Ir J Med Sci","Irish journal of medical science","AMSTAR; COVID-19; Coronavirus; Meta-analysis; Quality","Toubasi","Ahmad A","School of Medicine, The University of Jordan, Amman, 11942, Jordan",NA
"240","34227034","10.1007/s11845-021-02710-3","Assessment of COVID-19-related meta-analysis reporting quality.","Meta-analysis of high-quality primary articles represents the top-quality evidence in medical literature. In this project, our aim was to assess the number and quality of COVID-related meta-analysis published since the beginning of the COVID-19 pandemic. The search included the period from January 1, 2020, when the beginning of primary articles on COVID-19, till October 31, 2020. We screened a total of 793 studies. We excluded non-meta-analytic non-COVID-19-related studies. We obtained different","2021","07","08","Ir J Med Sci","Irish journal of medical science","AMSTAR; COVID-19; Coronavirus; Meta-analysis; Quality","Alsghaireen","Hadil","School of Medicine, The University of Jordan, Amman, 11942, Jordan",NA
"241","34227034","10.1007/s11845-021-02710-3","Assessment of COVID-19-related meta-analysis reporting quality.","Meta-analysis of high-quality primary articles represents the top-quality evidence in medical literature. In this project, our aim was to assess the number and quality of COVID-related meta-analysis published since the beginning of the COVID-19 pandemic. The search included the period from January 1, 2020, when the beginning of primary articles on COVID-19, till October 31, 2020. We screened a total of 793 studies. We excluded non-meta-analytic non-COVID-19-related studies. We obtained different","2021","07","08","Ir J Med Sci","Irish journal of medical science","AMSTAR; COVID-19; Coronavirus; Meta-analysis; Quality","Yaseen","Abeer","Department of Internal Medicine, The University of Jordan, Amman, 11942, Jordan",NA
"242","34227034","10.1007/s11845-021-02710-3","Assessment of COVID-19-related meta-analysis reporting quality.","Meta-analysis of high-quality primary articles represents the top-quality evidence in medical literature. In this project, our aim was to assess the number and quality of COVID-related meta-analysis published since the beginning of the COVID-19 pandemic. The search included the period from January 1, 2020, when the beginning of primary articles on COVID-19, till October 31, 2020. We screened a total of 793 studies. We excluded non-meta-analytic non-COVID-19-related studies. We obtained different","2021","07","08","Ir J Med Sci","Irish journal of medical science","AMSTAR; COVID-19; Coronavirus; Meta-analysis; Quality","Mesmar","Ahmad","Department of Internal Medicine, The University of Jordan, Amman, 11942, Jordan",NA
"243","34227034","10.1007/s11845-021-02710-3","Assessment of COVID-19-related meta-analysis reporting quality.","Meta-analysis of high-quality primary articles represents the top-quality evidence in medical literature. In this project, our aim was to assess the number and quality of COVID-related meta-analysis published since the beginning of the COVID-19 pandemic. The search included the period from January 1, 2020, when the beginning of primary articles on COVID-19, till October 31, 2020. We screened a total of 793 studies. We excluded non-meta-analytic non-COVID-19-related studies. We obtained different","2021","07","08","Ir J Med Sci","Irish journal of medical science","AMSTAR; COVID-19; Coronavirus; Meta-analysis; Quality","AlRyalat","Saif Aldeen","Department of Special Surgery, The University of Jordan, Amman, 11942, Jordan. s.alryalat@ju.edu","s.alryalat@ju.edu.jo"
"244","34227016","10.1007/s11255-021-02926-3","Risk factors for infection and mortality among hemodialysis patients during COVID-19 pandemic.","The aim of this study was to evaluate risk factors for COVID-19 infection and mortality and to document if any relation exists between 25 (OH) Vitamin D and COVID-19 infection. This retrospective study evaluated 151 HD patients. Patients infected with COVID-19 were compared to patients without the infection. Risk factors for intensive care unit (ICU) stay and mortality were analyzed. Deceased infected patients were also compared to patients who died due to other causes. The mean age of all HD pa","2021","07","08","Int Urol Nephrol","International urology and nephrology","COVID-19; Hemodialysis; Mortality; Vitamin D","Can","Özgür","Medical Doctor, Department of Nephrology, Bitlis Tatvan State Hospital, Bitlis, Turkey. canozgur62@hotmail","canozgur62@hotmail.com"
"245","34227016","10.1007/s11255-021-02926-3","Risk factors for infection and mortality among hemodialysis patients during COVID-19 pandemic.","The aim of this study was to evaluate risk factors for COVID-19 infection and mortality and to document if any relation exists between 25 (OH) Vitamin D and COVID-19 infection. This retrospective study evaluated 151 HD patients. Patients infected with COVID-19 were compared to patients without the infection. Risk factors for intensive care unit (ICU) stay and mortality were analyzed. Deceased infected patients were also compared to patients who died due to other causes. The mean age of all HD pa","2021","07","08","Int Urol Nephrol","International urology and nephrology","COVID-19; Hemodialysis; Mortality; Vitamin D","Bilek","Gunal","Department of Business Administration, Izmir Democracy University, Izmir, Turkey",NA
"246","34227016","10.1007/s11255-021-02926-3","Risk factors for infection and mortality among hemodialysis patients during COVID-19 pandemic.","The aim of this study was to evaluate risk factors for COVID-19 infection and mortality and to document if any relation exists between 25 (OH) Vitamin D and COVID-19 infection. This retrospective study evaluated 151 HD patients. Patients infected with COVID-19 were compared to patients without the infection. Risk factors for intensive care unit (ICU) stay and mortality were analyzed. Deceased infected patients were also compared to patients who died due to other causes. The mean age of all HD pa","2021","07","08","Int Urol Nephrol","International urology and nephrology","COVID-19; Hemodialysis; Mortality; Vitamin D","Sahan","Sibel","Dialysis Technician, Bitlis Tatvan State Hospital, Bitlis, Turkey",NA
"247","34227006","10.1007/s11356-021-15275-6","Socio-economic and corporate factors and COVID-19 pandemic: a wake-up call.","The novel coronavirus 2019 (COVID-19) emerges from the Chinese city Wuhan and its spread to the rest of the world, primarily affected economies and their businesses, leading to a global depression. The explanatory and cross-sectional regression approach assesses the impact of COVID-19 cases on healthcare expenditures, logistics performance index, carbon damages, and corporate social responsibility in a panel of 77 countries. The results show that COVID-19 cases substantially increase healthcare ","2021","07","08","Environ Sci Pollut Res Int","Environmental science and pollution research international","COVID-19 cases; Carbon damages; Corporate social responsibility; Cross-sectional regression; Healthcare expenditures; Logistics activities","Anser","Muhammad Khalid","School of Public Administration, Xi'an University of Architecture and Technology, Xi'an, 710000, China",NA
"248","34227006","10.1007/s11356-021-15275-6","Socio-economic and corporate factors and COVID-19 pandemic: a wake-up call.","The novel coronavirus 2019 (COVID-19) emerges from the Chinese city Wuhan and its spread to the rest of the world, primarily affected economies and their businesses, leading to a global depression. The explanatory and cross-sectional regression approach assesses the impact of COVID-19 cases on healthcare expenditures, logistics performance index, carbon damages, and corporate social responsibility in a panel of 77 countries. The results show that COVID-19 cases substantially increase healthcare ","2021","07","08","Environ Sci Pollut Res Int","Environmental science and pollution research international","COVID-19 cases; Carbon damages; Corporate social responsibility; Cross-sectional regression; Healthcare expenditures; Logistics activities","Yousaf","Sheikh Usman","Hailey College of Banking and Finance, University of the Punjab, Lahore, Pakistan",NA
"249","34227006","10.1007/s11356-021-15275-6","Socio-economic and corporate factors and COVID-19 pandemic: a wake-up call.","The novel coronavirus 2019 (COVID-19) emerges from the Chinese city Wuhan and its spread to the rest of the world, primarily affected economies and their businesses, leading to a global depression. The explanatory and cross-sectional regression approach assesses the impact of COVID-19 cases on healthcare expenditures, logistics performance index, carbon damages, and corporate social responsibility in a panel of 77 countries. The results show that COVID-19 cases substantially increase healthcare ","2021","07","08","Environ Sci Pollut Res Int","Environmental science and pollution research international","COVID-19 cases; Carbon damages; Corporate social responsibility; Cross-sectional regression; Healthcare expenditures; Logistics activities","Hyder","Shabir","Department of Management Sciences, COMSATS University Islamabad, Attock Campus, Attock, Pakistan",NA
"250","34227006","10.1007/s11356-021-15275-6","Socio-economic and corporate factors and COVID-19 pandemic: a wake-up call.","The novel coronavirus 2019 (COVID-19) emerges from the Chinese city Wuhan and its spread to the rest of the world, primarily affected economies and their businesses, leading to a global depression. The explanatory and cross-sectional regression approach assesses the impact of COVID-19 cases on healthcare expenditures, logistics performance index, carbon damages, and corporate social responsibility in a panel of 77 countries. The results show that COVID-19 cases substantially increase healthcare ","2021","07","08","Environ Sci Pollut Res Int","Environmental science and pollution research international","COVID-19 cases; Carbon damages; Corporate social responsibility; Cross-sectional regression; Healthcare expenditures; Logistics activities","Nassani","Abdelmohsen A","Department of Management, College of Business Administration, King Saud University, P.O. Box 71115, Riyadh, 11587, Saudi Arabia",NA
"251","34227006","10.1007/s11356-021-15275-6","Socio-economic and corporate factors and COVID-19 pandemic: a wake-up call.","The novel coronavirus 2019 (COVID-19) emerges from the Chinese city Wuhan and its spread to the rest of the world, primarily affected economies and their businesses, leading to a global depression. The explanatory and cross-sectional regression approach assesses the impact of COVID-19 cases on healthcare expenditures, logistics performance index, carbon damages, and corporate social responsibility in a panel of 77 countries. The results show that COVID-19 cases substantially increase healthcare ","2021","07","08","Environ Sci Pollut Res Int","Environmental science and pollution research international","COVID-19 cases; Carbon damages; Corporate social responsibility; Cross-sectional regression; Healthcare expenditures; Logistics activities","Zaman","Khalid","Department of Economics, University of Haripur, Haripur Khyber Pakhtunkhwa, Pakistan. khalid_zaman786@yahoo","zaman786@yahoo.com"
"252","34227006","10.1007/s11356-021-15275-6","Socio-economic and corporate factors and COVID-19 pandemic: a wake-up call.","The novel coronavirus 2019 (COVID-19) emerges from the Chinese city Wuhan and its spread to the rest of the world, primarily affected economies and their businesses, leading to a global depression. The explanatory and cross-sectional regression approach assesses the impact of COVID-19 cases on healthcare expenditures, logistics performance index, carbon damages, and corporate social responsibility in a panel of 77 countries. The results show that COVID-19 cases substantially increase healthcare ","2021","07","08","Environ Sci Pollut Res Int","Environmental science and pollution research international","COVID-19 cases; Carbon damages; Corporate social responsibility; Cross-sectional regression; Healthcare expenditures; Logistics activities","Abro","Muhammad Moinuddin Qazi","Department of Management, College of Business Administration, King Saud University, P.O. Box 71115, Riyadh, 11587, Saudi Arabia",NA
"253","34226979","10.1007/s11883-021-00952-1","Highlights from Studies Presented at the Virtual American College of Cardiology Scientific Sessions 2021: Staying Updated with the Latest Advancements in Prevention.","This review highlights late-breaking science presented at the Virtual American College of Cardiology Scientific Sessions 2021 that demonstrated advancements in preventative cardiology and introduced novel therapeutic modalities for the management of chronic kidney disease, heart failure, and COVID-19. The studies reviewed include clinical trials that assessed the use of dapagliflozin in patients with respiratory failure due to COVID-19 (DARE-19 trial); evinacumab for patients with severe hypertr","2021","07","21","Curr Atheroscler Rep","Current atherosclerosis reports","Aspirin; Dapagliflozin; Evinacumab; Omega-3 fatty acid; Rehabilitation; Severe hypertriglyceridemia","Jain","Vardhmaan","Department of Internal Medicine, Cleveland Clinic, Cleveland, OH, USA",NA
"254","34226979","10.1007/s11883-021-00952-1","Highlights from Studies Presented at the Virtual American College of Cardiology Scientific Sessions 2021: Staying Updated with the Latest Advancements in Prevention.","This review highlights late-breaking science presented at the Virtual American College of Cardiology Scientific Sessions 2021 that demonstrated advancements in preventative cardiology and introduced novel therapeutic modalities for the management of chronic kidney disease, heart failure, and COVID-19. The studies reviewed include clinical trials that assessed the use of dapagliflozin in patients with respiratory failure due to COVID-19 (DARE-19 trial); evinacumab for patients with severe hypertr","2021","07","21","Curr Atheroscler Rep","Current atherosclerosis reports","Aspirin; Dapagliflozin; Evinacumab; Omega-3 fatty acid; Rehabilitation; Severe hypertriglyceridemia","Al Rifai","Mahmoud","Section of Cardiology Department of Medicine, Baylor College of Medicine, Houston, TX, USA",NA
"255","34226979","10.1007/s11883-021-00952-1","Highlights from Studies Presented at the Virtual American College of Cardiology Scientific Sessions 2021: Staying Updated with the Latest Advancements in Prevention.","This review highlights late-breaking science presented at the Virtual American College of Cardiology Scientific Sessions 2021 that demonstrated advancements in preventative cardiology and introduced novel therapeutic modalities for the management of chronic kidney disease, heart failure, and COVID-19. The studies reviewed include clinical trials that assessed the use of dapagliflozin in patients with respiratory failure due to COVID-19 (DARE-19 trial); evinacumab for patients with severe hypertr","2021","07","21","Curr Atheroscler Rep","Current atherosclerosis reports","Aspirin; Dapagliflozin; Evinacumab; Omega-3 fatty acid; Rehabilitation; Severe hypertriglyceridemia","Mahtta","Dhruv","Section of Cardiology Department of Medicine, Baylor College of Medicine, Houston, TX, USA",NA
"256","34226979","10.1007/s11883-021-00952-1","Highlights from Studies Presented at the Virtual American College of Cardiology Scientific Sessions 2021: Staying Updated with the Latest Advancements in Prevention.","This review highlights late-breaking science presented at the Virtual American College of Cardiology Scientific Sessions 2021 that demonstrated advancements in preventative cardiology and introduced novel therapeutic modalities for the management of chronic kidney disease, heart failure, and COVID-19. The studies reviewed include clinical trials that assessed the use of dapagliflozin in patients with respiratory failure due to COVID-19 (DARE-19 trial); evinacumab for patients with severe hypertr","2021","07","21","Curr Atheroscler Rep","Current atherosclerosis reports","Aspirin; Dapagliflozin; Evinacumab; Omega-3 fatty acid; Rehabilitation; Severe hypertriglyceridemia","Liu","Jing","Section of Cardiology Department of Medicine, Baylor College of Medicine, Houston, TX, USA",NA
"257","34226979","10.1007/s11883-021-00952-1","Highlights from Studies Presented at the Virtual American College of Cardiology Scientific Sessions 2021: Staying Updated with the Latest Advancements in Prevention.","This review highlights late-breaking science presented at the Virtual American College of Cardiology Scientific Sessions 2021 that demonstrated advancements in preventative cardiology and introduced novel therapeutic modalities for the management of chronic kidney disease, heart failure, and COVID-19. The studies reviewed include clinical trials that assessed the use of dapagliflozin in patients with respiratory failure due to COVID-19 (DARE-19 trial); evinacumab for patients with severe hypertr","2021","07","21","Curr Atheroscler Rep","Current atherosclerosis reports","Aspirin; Dapagliflozin; Evinacumab; Omega-3 fatty acid; Rehabilitation; Severe hypertriglyceridemia","Hussain","Aliza","Section of Cardiology Department of Medicine, Baylor College of Medicine, Houston, TX, USA",NA
"258","34226979","10.1007/s11883-021-00952-1","Highlights from Studies Presented at the Virtual American College of Cardiology Scientific Sessions 2021: Staying Updated with the Latest Advancements in Prevention.","This review highlights late-breaking science presented at the Virtual American College of Cardiology Scientific Sessions 2021 that demonstrated advancements in preventative cardiology and introduced novel therapeutic modalities for the management of chronic kidney disease, heart failure, and COVID-19. The studies reviewed include clinical trials that assessed the use of dapagliflozin in patients with respiratory failure due to COVID-19 (DARE-19 trial); evinacumab for patients with severe hypertr","2021","07","21","Curr Atheroscler Rep","Current atherosclerosis reports","Aspirin; Dapagliflozin; Evinacumab; Omega-3 fatty acid; Rehabilitation; Severe hypertriglyceridemia","Virani","Salim S","Section of Cardiology Department of Medicine, Baylor College of Medicine, Houston, TX, USA. virani@bcm","virani@bcm.edu"
"259","34226969","10.1007/s00383-021-04958-3","Preoperative screening for COVID-19 is required in low-risk pediatric patients under the urgent surgical condition.",NA,"2021","07","08","Pediatr Surg Int","Pediatric surgery international",NA,"Moon","Suk Bae","Department of Surgery, Kangwon National University School of Medicine, Chuncheon, 24341, South Korea. sukbae75.moon@gmail","sukbae75.moon@gmail.com"
"260","34226904","10.1002/jha2.167","Mild anemia as a single independent predictor of mortality in patients with COVID-19.","The coronavirus disease 2019 (COVID-19) caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has led to an unprecedented international health crisis. COVID-19 clinical presentations cover a wide range from asymptomatic to severe illness and death. Given the limited therapeutic resources and unexpected clinical features of the disease, readily accessible predictive biomarkers are urgently needed to improve patient care and management. We asked the degree to which anemia may infl","2021","07","07","EJHaem","EJHaem","COVID-19; RBC; anemia; haemoglobin; mortality; prognosis","Tremblay","Douglas","Department of Medicine Division of Hematology Oncology Icahn School of Medicine at Mount Sinai New York New York USA",NA
"261","34226904","10.1002/jha2.167","Mild anemia as a single independent predictor of mortality in patients with COVID-19.","The coronavirus disease 2019 (COVID-19) caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has led to an unprecedented international health crisis. COVID-19 clinical presentations cover a wide range from asymptomatic to severe illness and death. Given the limited therapeutic resources and unexpected clinical features of the disease, readily accessible predictive biomarkers are urgently needed to improve patient care and management. We asked the degree to which anemia may infl","2021","07","07","EJHaem","EJHaem","COVID-19; RBC; anemia; haemoglobin; mortality; prognosis","Rapp","Joseph L","Institute for Translational Epidemiology Icahn School of Medicine at Mount Sinai New York New York USA",NA
"262","34226904","10.1002/jha2.167","Mild anemia as a single independent predictor of mortality in patients with COVID-19.","The coronavirus disease 2019 (COVID-19) caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has led to an unprecedented international health crisis. COVID-19 clinical presentations cover a wide range from asymptomatic to severe illness and death. Given the limited therapeutic resources and unexpected clinical features of the disease, readily accessible predictive biomarkers are urgently needed to improve patient care and management. We asked the degree to which anemia may infl","2021","07","07","EJHaem","EJHaem","COVID-19; RBC; anemia; haemoglobin; mortality; prognosis","Alpert","Naomi","Institute for Translational Epidemiology Icahn School of Medicine at Mount Sinai New York New York USA",NA
"263","34226904","10.1002/jha2.167","Mild anemia as a single independent predictor of mortality in patients with COVID-19.","The coronavirus disease 2019 (COVID-19) caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has led to an unprecedented international health crisis. COVID-19 clinical presentations cover a wide range from asymptomatic to severe illness and death. Given the limited therapeutic resources and unexpected clinical features of the disease, readily accessible predictive biomarkers are urgently needed to improve patient care and management. We asked the degree to which anemia may infl","2021","07","07","EJHaem","EJHaem","COVID-19; RBC; anemia; haemoglobin; mortality; prognosis","Lieberman-Cribbin","Wil","Institute for Translational Epidemiology Icahn School of Medicine at Mount Sinai New York New York USA",NA
"264","34226904","10.1002/jha2.167","Mild anemia as a single independent predictor of mortality in patients with COVID-19.","The coronavirus disease 2019 (COVID-19) caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has led to an unprecedented international health crisis. COVID-19 clinical presentations cover a wide range from asymptomatic to severe illness and death. Given the limited therapeutic resources and unexpected clinical features of the disease, readily accessible predictive biomarkers are urgently needed to improve patient care and management. We asked the degree to which anemia may infl","2021","07","07","EJHaem","EJHaem","COVID-19; RBC; anemia; haemoglobin; mortality; prognosis","Mascarenhas","John","Department of Medicine Division of Hematology Oncology Icahn School of Medicine at Mount Sinai New York New York USA",NA
"265","34226904","10.1002/jha2.167","Mild anemia as a single independent predictor of mortality in patients with COVID-19.","The coronavirus disease 2019 (COVID-19) caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has led to an unprecedented international health crisis. COVID-19 clinical presentations cover a wide range from asymptomatic to severe illness and death. Given the limited therapeutic resources and unexpected clinical features of the disease, readily accessible predictive biomarkers are urgently needed to improve patient care and management. We asked the degree to which anemia may infl","2021","07","07","EJHaem","EJHaem","COVID-19; RBC; anemia; haemoglobin; mortality; prognosis","Taioli","Emanuela","Institute for Translational Epidemiology Icahn School of Medicine at Mount Sinai New York New York USA",NA
"266","34226904","10.1002/jha2.167","Mild anemia as a single independent predictor of mortality in patients with COVID-19.","The coronavirus disease 2019 (COVID-19) caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has led to an unprecedented international health crisis. COVID-19 clinical presentations cover a wide range from asymptomatic to severe illness and death. Given the limited therapeutic resources and unexpected clinical features of the disease, readily accessible predictive biomarkers are urgently needed to improve patient care and management. We asked the degree to which anemia may infl","2021","07","07","EJHaem","EJHaem","COVID-19; RBC; anemia; haemoglobin; mortality; prognosis","Ghaffari","Saghi","Tisch Cancer Institute Icahn School of Medicine at Mount Sinai New York New York USA",NA
"267","34226903","10.1002/jha2.242","Safety and immunogenicity of a first dose of SARS-CoV-2 mRNA vaccine in allogeneic hematopoietic stem-cells recipients.","This was a monocentric prospective study testing the efficacy and safety of a first injection of BNT162b2 (Pfizer-BioNTech) in 112 Allo-HSCT patients. Antibody response to SARS-CoV-2 spike protein receptor-binding domain was tested at the time of the second injection (Roche Elecsys). The study also included a non-randomized control arm of 26 healthy controls. This study shows that a first dose of SARS-CoV-2 messenger RNA vaccine is safe and provides a 55% rate of seroconversion in allotransplant","2021","07","07","EJHaem","EJHaem",NA,"Chevallier","Patrice","Department of Hematology Nantes University Hospital Nantes France",NA
"268","34226903","10.1002/jha2.242","Safety and immunogenicity of a first dose of SARS-CoV-2 mRNA vaccine in allogeneic hematopoietic stem-cells recipients.","This was a monocentric prospective study testing the efficacy and safety of a first injection of BNT162b2 (Pfizer-BioNTech) in 112 Allo-HSCT patients. Antibody response to SARS-CoV-2 spike protein receptor-binding domain was tested at the time of the second injection (Roche Elecsys). The study also included a non-randomized control arm of 26 healthy controls. This study shows that a first dose of SARS-CoV-2 messenger RNA vaccine is safe and provides a 55% rate of seroconversion in allotransplant","2021","07","07","EJHaem","EJHaem",NA,"Coste-Burel","Marianne","Department of Virology Nantes University Hospital Nantes France",NA
"269","34226903","10.1002/jha2.242","Safety and immunogenicity of a first dose of SARS-CoV-2 mRNA vaccine in allogeneic hematopoietic stem-cells recipients.","This was a monocentric prospective study testing the efficacy and safety of a first injection of BNT162b2 (Pfizer-BioNTech) in 112 Allo-HSCT patients. Antibody response to SARS-CoV-2 spike protein receptor-binding domain was tested at the time of the second injection (Roche Elecsys). The study also included a non-randomized control arm of 26 healthy controls. This study shows that a first dose of SARS-CoV-2 messenger RNA vaccine is safe and provides a 55% rate of seroconversion in allotransplant","2021","07","07","EJHaem","EJHaem",NA,"Le Bourgeois","Amandine","Department of Hematology Nantes University Hospital Nantes France",NA
"270","34226903","10.1002/jha2.242","Safety and immunogenicity of a first dose of SARS-CoV-2 mRNA vaccine in allogeneic hematopoietic stem-cells recipients.","This was a monocentric prospective study testing the efficacy and safety of a first injection of BNT162b2 (Pfizer-BioNTech) in 112 Allo-HSCT patients. Antibody response to SARS-CoV-2 spike protein receptor-binding domain was tested at the time of the second injection (Roche Elecsys). The study also included a non-randomized control arm of 26 healthy controls. This study shows that a first dose of SARS-CoV-2 messenger RNA vaccine is safe and provides a 55% rate of seroconversion in allotransplant","2021","07","07","EJHaem","EJHaem",NA,"Peterlin","Pierre","Department of Hematology Nantes University Hospital Nantes France",NA
"271","34226903","10.1002/jha2.242","Safety and immunogenicity of a first dose of SARS-CoV-2 mRNA vaccine in allogeneic hematopoietic stem-cells recipients.","This was a monocentric prospective study testing the efficacy and safety of a first injection of BNT162b2 (Pfizer-BioNTech) in 112 Allo-HSCT patients. Antibody response to SARS-CoV-2 spike protein receptor-binding domain was tested at the time of the second injection (Roche Elecsys). The study also included a non-randomized control arm of 26 healthy controls. This study shows that a first dose of SARS-CoV-2 messenger RNA vaccine is safe and provides a 55% rate of seroconversion in allotransplant","2021","07","07","EJHaem","EJHaem",NA,"Garnier","Alice","Department of Hematology Nantes University Hospital Nantes France",NA
"272","34226903","10.1002/jha2.242","Safety and immunogenicity of a first dose of SARS-CoV-2 mRNA vaccine in allogeneic hematopoietic stem-cells recipients.","This was a monocentric prospective study testing the efficacy and safety of a first injection of BNT162b2 (Pfizer-BioNTech) in 112 Allo-HSCT patients. Antibody response to SARS-CoV-2 spike protein receptor-binding domain was tested at the time of the second injection (Roche Elecsys). The study also included a non-randomized control arm of 26 healthy controls. This study shows that a first dose of SARS-CoV-2 messenger RNA vaccine is safe and provides a 55% rate of seroconversion in allotransplant","2021","07","07","EJHaem","EJHaem",NA,"Béné","Marie C","INSERM UMR1232 CRCINA IRS-UN University of Nantes Nantes France",NA
"273","34226903","10.1002/jha2.242","Safety and immunogenicity of a first dose of SARS-CoV-2 mRNA vaccine in allogeneic hematopoietic stem-cells recipients.","This was a monocentric prospective study testing the efficacy and safety of a first injection of BNT162b2 (Pfizer-BioNTech) in 112 Allo-HSCT patients. Antibody response to SARS-CoV-2 spike protein receptor-binding domain was tested at the time of the second injection (Roche Elecsys). The study also included a non-randomized control arm of 26 healthy controls. This study shows that a first dose of SARS-CoV-2 messenger RNA vaccine is safe and provides a 55% rate of seroconversion in allotransplant","2021","07","07","EJHaem","EJHaem",NA,"Imbert","Berthe-Marie","Department of Virology Nantes University Hospital Nantes France",NA
"274","34226903","10.1002/jha2.242","Safety and immunogenicity of a first dose of SARS-CoV-2 mRNA vaccine in allogeneic hematopoietic stem-cells recipients.","This was a monocentric prospective study testing the efficacy and safety of a first injection of BNT162b2 (Pfizer-BioNTech) in 112 Allo-HSCT patients. Antibody response to SARS-CoV-2 spike protein receptor-binding domain was tested at the time of the second injection (Roche Elecsys). The study also included a non-randomized control arm of 26 healthy controls. This study shows that a first dose of SARS-CoV-2 messenger RNA vaccine is safe and provides a 55% rate of seroconversion in allotransplant","2021","07","07","EJHaem","EJHaem",NA,"Drumel","Thomas","Department of Virology Nantes University Hospital Nantes France",NA
"275","34226903","10.1002/jha2.242","Safety and immunogenicity of a first dose of SARS-CoV-2 mRNA vaccine in allogeneic hematopoietic stem-cells recipients.","This was a monocentric prospective study testing the efficacy and safety of a first injection of BNT162b2 (Pfizer-BioNTech) in 112 Allo-HSCT patients. Antibody response to SARS-CoV-2 spike protein receptor-binding domain was tested at the time of the second injection (Roche Elecsys). The study also included a non-randomized control arm of 26 healthy controls. This study shows that a first dose of SARS-CoV-2 messenger RNA vaccine is safe and provides a 55% rate of seroconversion in allotransplant","2021","07","07","EJHaem","EJHaem",NA,"Le Gouill","Steven","Department of Hematology Nantes University Hospital Nantes France",NA
"276","34226903","10.1002/jha2.242","Safety and immunogenicity of a first dose of SARS-CoV-2 mRNA vaccine in allogeneic hematopoietic stem-cells recipients.","This was a monocentric prospective study testing the efficacy and safety of a first injection of BNT162b2 (Pfizer-BioNTech) in 112 Allo-HSCT patients. Antibody response to SARS-CoV-2 spike protein receptor-binding domain was tested at the time of the second injection (Roche Elecsys). The study also included a non-randomized control arm of 26 healthy controls. This study shows that a first dose of SARS-CoV-2 messenger RNA vaccine is safe and provides a 55% rate of seroconversion in allotransplant","2021","07","07","EJHaem","EJHaem",NA,"Moreau","Philippe","Department of Hematology Nantes University Hospital Nantes France",NA
"277","34226903","10.1002/jha2.242","Safety and immunogenicity of a first dose of SARS-CoV-2 mRNA vaccine in allogeneic hematopoietic stem-cells recipients.","This was a monocentric prospective study testing the efficacy and safety of a first injection of BNT162b2 (Pfizer-BioNTech) in 112 Allo-HSCT patients. Antibody response to SARS-CoV-2 spike protein receptor-binding domain was tested at the time of the second injection (Roche Elecsys). The study also included a non-randomized control arm of 26 healthy controls. This study shows that a first dose of SARS-CoV-2 messenger RNA vaccine is safe and provides a 55% rate of seroconversion in allotransplant","2021","07","07","EJHaem","EJHaem",NA,"Mahe","Beatrice","Department of Hematology Nantes University Hospital Nantes France",NA
"278","34226903","10.1002/jha2.242","Safety and immunogenicity of a first dose of SARS-CoV-2 mRNA vaccine in allogeneic hematopoietic stem-cells recipients.","This was a monocentric prospective study testing the efficacy and safety of a first injection of BNT162b2 (Pfizer-BioNTech) in 112 Allo-HSCT patients. Antibody response to SARS-CoV-2 spike protein receptor-binding domain was tested at the time of the second injection (Roche Elecsys). The study also included a non-randomized control arm of 26 healthy controls. This study shows that a first dose of SARS-CoV-2 messenger RNA vaccine is safe and provides a 55% rate of seroconversion in allotransplant","2021","07","07","EJHaem","EJHaem",NA,"Dubruille","Viviane","Department of Hematology Nantes University Hospital Nantes France",NA
"279","34226903","10.1002/jha2.242","Safety and immunogenicity of a first dose of SARS-CoV-2 mRNA vaccine in allogeneic hematopoietic stem-cells recipients.","This was a monocentric prospective study testing the efficacy and safety of a first injection of BNT162b2 (Pfizer-BioNTech) in 112 Allo-HSCT patients. Antibody response to SARS-CoV-2 spike protein receptor-binding domain was tested at the time of the second injection (Roche Elecsys). The study also included a non-randomized control arm of 26 healthy controls. This study shows that a first dose of SARS-CoV-2 messenger RNA vaccine is safe and provides a 55% rate of seroconversion in allotransplant","2021","07","07","EJHaem","EJHaem",NA,"Blin","Nicolas","Department of Hematology Nantes University Hospital Nantes France",NA
"280","34226903","10.1002/jha2.242","Safety and immunogenicity of a first dose of SARS-CoV-2 mRNA vaccine in allogeneic hematopoietic stem-cells recipients.","This was a monocentric prospective study testing the efficacy and safety of a first injection of BNT162b2 (Pfizer-BioNTech) in 112 Allo-HSCT patients. Antibody response to SARS-CoV-2 spike protein receptor-binding domain was tested at the time of the second injection (Roche Elecsys). The study also included a non-randomized control arm of 26 healthy controls. This study shows that a first dose of SARS-CoV-2 messenger RNA vaccine is safe and provides a 55% rate of seroconversion in allotransplant","2021","07","07","EJHaem","EJHaem",NA,"Lok","Anne","Department of Hematology Nantes University Hospital Nantes France",NA
"281","34226903","10.1002/jha2.242","Safety and immunogenicity of a first dose of SARS-CoV-2 mRNA vaccine in allogeneic hematopoietic stem-cells recipients.","This was a monocentric prospective study testing the efficacy and safety of a first injection of BNT162b2 (Pfizer-BioNTech) in 112 Allo-HSCT patients. Antibody response to SARS-CoV-2 spike protein receptor-binding domain was tested at the time of the second injection (Roche Elecsys). The study also included a non-randomized control arm of 26 healthy controls. This study shows that a first dose of SARS-CoV-2 messenger RNA vaccine is safe and provides a 55% rate of seroconversion in allotransplant","2021","07","07","EJHaem","EJHaem",NA,"Touzeau","Cyrille","Department of Hematology Nantes University Hospital Nantes France",NA
"282","34226903","10.1002/jha2.242","Safety and immunogenicity of a first dose of SARS-CoV-2 mRNA vaccine in allogeneic hematopoietic stem-cells recipients.","This was a monocentric prospective study testing the efficacy and safety of a first injection of BNT162b2 (Pfizer-BioNTech) in 112 Allo-HSCT patients. Antibody response to SARS-CoV-2 spike protein receptor-binding domain was tested at the time of the second injection (Roche Elecsys). The study also included a non-randomized control arm of 26 healthy controls. This study shows that a first dose of SARS-CoV-2 messenger RNA vaccine is safe and provides a 55% rate of seroconversion in allotransplant","2021","07","07","EJHaem","EJHaem",NA,"Gastinne","Thomas","Department of Hematology Nantes University Hospital Nantes France",NA
"283","34226903","10.1002/jha2.242","Safety and immunogenicity of a first dose of SARS-CoV-2 mRNA vaccine in allogeneic hematopoietic stem-cells recipients.","This was a monocentric prospective study testing the efficacy and safety of a first injection of BNT162b2 (Pfizer-BioNTech) in 112 Allo-HSCT patients. Antibody response to SARS-CoV-2 spike protein receptor-binding domain was tested at the time of the second injection (Roche Elecsys). The study also included a non-randomized control arm of 26 healthy controls. This study shows that a first dose of SARS-CoV-2 messenger RNA vaccine is safe and provides a 55% rate of seroconversion in allotransplant","2021","07","07","EJHaem","EJHaem",NA,"Jullien","Maxime","Department of Hematology Nantes University Hospital Nantes France",NA
"284","34226903","10.1002/jha2.242","Safety and immunogenicity of a first dose of SARS-CoV-2 mRNA vaccine in allogeneic hematopoietic stem-cells recipients.","This was a monocentric prospective study testing the efficacy and safety of a first injection of BNT162b2 (Pfizer-BioNTech) in 112 Allo-HSCT patients. Antibody response to SARS-CoV-2 spike protein receptor-binding domain was tested at the time of the second injection (Roche Elecsys). The study also included a non-randomized control arm of 26 healthy controls. This study shows that a first dose of SARS-CoV-2 messenger RNA vaccine is safe and provides a 55% rate of seroconversion in allotransplant","2021","07","07","EJHaem","EJHaem",NA,"Vanthygem","Sophie","Department of Hematology Nantes University Hospital Nantes France",NA
"285","34226903","10.1002/jha2.242","Safety and immunogenicity of a first dose of SARS-CoV-2 mRNA vaccine in allogeneic hematopoietic stem-cells recipients.","This was a monocentric prospective study testing the efficacy and safety of a first injection of BNT162b2 (Pfizer-BioNTech) in 112 Allo-HSCT patients. Antibody response to SARS-CoV-2 spike protein receptor-binding domain was tested at the time of the second injection (Roche Elecsys). The study also included a non-randomized control arm of 26 healthy controls. This study shows that a first dose of SARS-CoV-2 messenger RNA vaccine is safe and provides a 55% rate of seroconversion in allotransplant","2021","07","07","EJHaem","EJHaem",NA,"Guillaume","Thierry","Department of Hematology Nantes University Hospital Nantes France",NA
"286","34226902","10.1002/jha2.220","Models of care for chronic myeloid leukemia patients during the COVID-19 pandemic in the United Kingdom: Changes in patient attitudes to remote consultations and future implications.","The ongoing COVID-19 pandemic has presented numerous challenges to the provision of patient care within hematology. We undertook a questionnaire-based study investigating the experiences and opinions of patients with chronic myeloid leukemia (CML) in the UK in relation to the different models of follow-up care received during the pandemic. One hundred fifty-four patients completed the online questionnaire. Only 19% of patients had experienced remote clinics prior to the pandemic compared with 91","2021","07","07","EJHaem","EJHaem",NA,"Duncan","Nicholas","Queen Elizabeth Hospital and University of Birmingham Birmingham UK",NA
"287","34226902","10.1002/jha2.220","Models of care for chronic myeloid leukemia patients during the COVID-19 pandemic in the United Kingdom: Changes in patient attitudes to remote consultations and future implications.","The ongoing COVID-19 pandemic has presented numerous challenges to the provision of patient care within hematology. We undertook a questionnaire-based study investigating the experiences and opinions of patients with chronic myeloid leukemia (CML) in the UK in relation to the different models of follow-up care received during the pandemic. One hundred fifty-four patients completed the online questionnaire. Only 19% of patients had experienced remote clinics prior to the pandemic compared with 91","2021","07","07","EJHaem","EJHaem",NA,"Deekes","Nigel","Patient representative",NA
"288","34226902","10.1002/jha2.220","Models of care for chronic myeloid leukemia patients during the COVID-19 pandemic in the United Kingdom: Changes in patient attitudes to remote consultations and future implications.","The ongoing COVID-19 pandemic has presented numerous challenges to the provision of patient care within hematology. We undertook a questionnaire-based study investigating the experiences and opinions of patients with chronic myeloid leukemia (CML) in the UK in relation to the different models of follow-up care received during the pandemic. One hundred fifty-four patients completed the online questionnaire. Only 19% of patients had experienced remote clinics prior to the pandemic compared with 91","2021","07","07","EJHaem","EJHaem",NA,"FitzGerald","David","Patient representative",NA
"289","34226902","10.1002/jha2.220","Models of care for chronic myeloid leukemia patients during the COVID-19 pandemic in the United Kingdom: Changes in patient attitudes to remote consultations and future implications.","The ongoing COVID-19 pandemic has presented numerous challenges to the provision of patient care within hematology. We undertook a questionnaire-based study investigating the experiences and opinions of patients with chronic myeloid leukemia (CML) in the UK in relation to the different models of follow-up care received during the pandemic. One hundred fifty-four patients completed the online questionnaire. Only 19% of patients had experienced remote clinics prior to the pandemic compared with 91","2021","07","07","EJHaem","EJHaem",NA,"Ng","Tin Wai Terry","School of Pharmacy University College London London UK",NA
"290","34226902","10.1002/jha2.220","Models of care for chronic myeloid leukemia patients during the COVID-19 pandemic in the United Kingdom: Changes in patient attitudes to remote consultations and future implications.","The ongoing COVID-19 pandemic has presented numerous challenges to the provision of patient care within hematology. We undertook a questionnaire-based study investigating the experiences and opinions of patients with chronic myeloid leukemia (CML) in the UK in relation to the different models of follow-up care received during the pandemic. One hundred fifty-four patients completed the online questionnaire. Only 19% of patients had experienced remote clinics prior to the pandemic compared with 91","2021","07","07","EJHaem","EJHaem",NA,"Raghavan","Manoj","Queen Elizabeth Hospital and University of Birmingham Birmingham UK",NA
"291","34226901","10.1002/jha2.195","In-hospital mortality in SARS-CoV-2 stratified by hemoglobin levels: A retrospective study.","This study is to estimate in-hospital mortality in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) patients stratified by hemoglobin (Hb) level. Patients were stratified according to hemoglobin level into two groups, that is, Hb &lt;100 g/L and Hb &gt;100 g/L. A total of 6931 patients were included. Of these, 6377 (92%) patients had hemoglobin levels &gt;100 g/L. The mean age was 44 ± 17 years, and 66% of the patients were males. The median length of overall hospital stay was 13 day","2021","07","07","EJHaem","EJHaem","COVID-19; SARS-CoV-2; anemia; hemoglobin; in-hospital mortality","Al-Jarallah","Mohammed","Department of Cardiology, Sabah Al Ahmed Cardiac Centre Al Amiri Hospital, Kuwait Kuwait",NA
"292","34226901","10.1002/jha2.195","In-hospital mortality in SARS-CoV-2 stratified by hemoglobin levels: A retrospective study.","This study is to estimate in-hospital mortality in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) patients stratified by hemoglobin (Hb) level. Patients were stratified according to hemoglobin level into two groups, that is, Hb &lt;100 g/L and Hb &gt;100 g/L. A total of 6931 patients were included. Of these, 6377 (92%) patients had hemoglobin levels &gt;100 g/L. The mean age was 44 ± 17 years, and 66% of the patients were males. The median length of overall hospital stay was 13 day","2021","07","07","EJHaem","EJHaem","COVID-19; SARS-CoV-2; anemia; hemoglobin; in-hospital mortality","Rajan","Rajesh","Department of Cardiology, Sabah Al Ahmed Cardiac Centre Al Amiri Hospital, Kuwait Kuwait",NA
"293","34226901","10.1002/jha2.195","In-hospital mortality in SARS-CoV-2 stratified by hemoglobin levels: A retrospective study.","This study is to estimate in-hospital mortality in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) patients stratified by hemoglobin (Hb) level. Patients were stratified according to hemoglobin level into two groups, that is, Hb &lt;100 g/L and Hb &gt;100 g/L. A total of 6931 patients were included. Of these, 6377 (92%) patients had hemoglobin levels &gt;100 g/L. The mean age was 44 ± 17 years, and 66% of the patients were males. The median length of overall hospital stay was 13 day","2021","07","07","EJHaem","EJHaem","COVID-19; SARS-CoV-2; anemia; hemoglobin; in-hospital mortality","Saber","Ahmad Al","Department of Mathematics and Statistics University of Strathclyde Glasgow UK",NA
"294","34226901","10.1002/jha2.195","In-hospital mortality in SARS-CoV-2 stratified by hemoglobin levels: A retrospective study.","This study is to estimate in-hospital mortality in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) patients stratified by hemoglobin (Hb) level. Patients were stratified according to hemoglobin level into two groups, that is, Hb &lt;100 g/L and Hb &gt;100 g/L. A total of 6931 patients were included. Of these, 6377 (92%) patients had hemoglobin levels &gt;100 g/L. The mean age was 44 ± 17 years, and 66% of the patients were males. The median length of overall hospital stay was 13 day","2021","07","07","EJHaem","EJHaem","COVID-19; SARS-CoV-2; anemia; hemoglobin; in-hospital mortality","Pan","Jiazhu","Department of Mathematics and Statistics University of Strathclyde Glasgow UK",NA
"295","34226901","10.1002/jha2.195","In-hospital mortality in SARS-CoV-2 stratified by hemoglobin levels: A retrospective study.","This study is to estimate in-hospital mortality in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) patients stratified by hemoglobin (Hb) level. Patients were stratified according to hemoglobin level into two groups, that is, Hb &lt;100 g/L and Hb &gt;100 g/L. A total of 6931 patients were included. Of these, 6377 (92%) patients had hemoglobin levels &gt;100 g/L. The mean age was 44 ± 17 years, and 66% of the patients were males. The median length of overall hospital stay was 13 day","2021","07","07","EJHaem","EJHaem","COVID-19; SARS-CoV-2; anemia; hemoglobin; in-hospital mortality","Al-Sultan","Ahmad T","Department of Community Medicine and Behavioural Sciences, College of Medicine Kuwait University Kuwait City Kuwait",NA
"296","34226901","10.1002/jha2.195","In-hospital mortality in SARS-CoV-2 stratified by hemoglobin levels: A retrospective study.","This study is to estimate in-hospital mortality in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) patients stratified by hemoglobin (Hb) level. Patients were stratified according to hemoglobin level into two groups, that is, Hb &lt;100 g/L and Hb &gt;100 g/L. A total of 6931 patients were included. Of these, 6377 (92%) patients had hemoglobin levels &gt;100 g/L. The mean age was 44 ± 17 years, and 66% of the patients were males. The median length of overall hospital stay was 13 day","2021","07","07","EJHaem","EJHaem","COVID-19; SARS-CoV-2; anemia; hemoglobin; in-hospital mortality","Abdelnaby","Hassan","Department of Endemic and Infectious diseases, Faculty of Medicine, Suez Canal University, Ismailia, Egypt. Department of Internal Medicine, Division of gastroenterology, Al Sabah Hospital Ministry of Health, Shuwaikh Medical Area Kuwait",NA
"297","34226901","10.1002/jha2.195","In-hospital mortality in SARS-CoV-2 stratified by hemoglobin levels: A retrospective study.","This study is to estimate in-hospital mortality in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) patients stratified by hemoglobin (Hb) level. Patients were stratified according to hemoglobin level into two groups, that is, Hb &lt;100 g/L and Hb &gt;100 g/L. A total of 6931 patients were included. Of these, 6377 (92%) patients had hemoglobin levels &gt;100 g/L. The mean age was 44 ± 17 years, and 66% of the patients were males. The median length of overall hospital stay was 13 day","2021","07","07","EJHaem","EJHaem","COVID-19; SARS-CoV-2; anemia; hemoglobin; in-hospital mortality","Alroomi","Moudhi","Department of Infectious Diseases, Infectious Diseases Hospital Ministry of Health, Shuwaikh Medical Area Kuwait",NA
"298","34226901","10.1002/jha2.195","In-hospital mortality in SARS-CoV-2 stratified by hemoglobin levels: A retrospective study.","This study is to estimate in-hospital mortality in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) patients stratified by hemoglobin (Hb) level. Patients were stratified according to hemoglobin level into two groups, that is, Hb &lt;100 g/L and Hb &gt;100 g/L. A total of 6931 patients were included. Of these, 6377 (92%) patients had hemoglobin levels &gt;100 g/L. The mean age was 44 ± 17 years, and 66% of the patients were males. The median length of overall hospital stay was 13 day","2021","07","07","EJHaem","EJHaem","COVID-19; SARS-CoV-2; anemia; hemoglobin; in-hospital mortality","Dashti","Raja","Department of Cardiology, Sabah Al Ahmed Cardiac Centre Al Amiri Hospital, Kuwait Kuwait",NA
"299","34226901","10.1002/jha2.195","In-hospital mortality in SARS-CoV-2 stratified by hemoglobin levels: A retrospective study.","This study is to estimate in-hospital mortality in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) patients stratified by hemoglobin (Hb) level. Patients were stratified according to hemoglobin level into two groups, that is, Hb &lt;100 g/L and Hb &gt;100 g/L. A total of 6931 patients were included. Of these, 6377 (92%) patients had hemoglobin levels &gt;100 g/L. The mean age was 44 ± 17 years, and 66% of the patients were males. The median length of overall hospital stay was 13 day","2021","07","07","EJHaem","EJHaem","COVID-19; SARS-CoV-2; anemia; hemoglobin; in-hospital mortality","Aboelhassan","Wael","Department of Internal Medicine, Division of gastroenterology, Jaber Al Ahmed Hospital Ministry of Health, South Surra Kuwait",NA
"300","34226901","10.1002/jha2.195","In-hospital mortality in SARS-CoV-2 stratified by hemoglobin levels: A retrospective study.","This study is to estimate in-hospital mortality in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) patients stratified by hemoglobin (Hb) level. Patients were stratified according to hemoglobin level into two groups, that is, Hb &lt;100 g/L and Hb &gt;100 g/L. A total of 6931 patients were included. Of these, 6377 (92%) patients had hemoglobin levels &gt;100 g/L. The mean age was 44 ± 17 years, and 66% of the patients were males. The median length of overall hospital stay was 13 day","2021","07","07","EJHaem","EJHaem","COVID-19; SARS-CoV-2; anemia; hemoglobin; in-hospital mortality","Almutairi","Farah","Department of medicine, Farwaniya Hospital Ministry of Health Farwaniya Kuwait",NA
"301","34226901","10.1002/jha2.195","In-hospital mortality in SARS-CoV-2 stratified by hemoglobin levels: A retrospective study.","This study is to estimate in-hospital mortality in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) patients stratified by hemoglobin (Hb) level. Patients were stratified according to hemoglobin level into two groups, that is, Hb &lt;100 g/L and Hb &gt;100 g/L. A total of 6931 patients were included. Of these, 6377 (92%) patients had hemoglobin levels &gt;100 g/L. The mean age was 44 ± 17 years, and 66% of the patients were males. The median length of overall hospital stay was 13 day","2021","07","07","EJHaem","EJHaem","COVID-19; SARS-CoV-2; anemia; hemoglobin; in-hospital mortality","Abdullah","Mohammed","Department of Infectious Diseases, Infectious Diseases Hospital Ministry of Health, Shuwaikh Medical Area Kuwait",NA
"302","34226901","10.1002/jha2.195","In-hospital mortality in SARS-CoV-2 stratified by hemoglobin levels: A retrospective study.","This study is to estimate in-hospital mortality in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) patients stratified by hemoglobin (Hb) level. Patients were stratified according to hemoglobin level into two groups, that is, Hb &lt;100 g/L and Hb &gt;100 g/L. A total of 6931 patients were included. Of these, 6377 (92%) patients had hemoglobin levels &gt;100 g/L. The mean age was 44 ± 17 years, and 66% of the patients were males. The median length of overall hospital stay was 13 day","2021","07","07","EJHaem","EJHaem","COVID-19; SARS-CoV-2; anemia; hemoglobin; in-hospital mortality","Alotaibi","Naser","Department of Medicine, Al Adan Hospital Ministry of Health, Hadiya Kuwait",NA
"303","34226901","10.1002/jha2.195","In-hospital mortality in SARS-CoV-2 stratified by hemoglobin levels: A retrospective study.","This study is to estimate in-hospital mortality in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) patients stratified by hemoglobin (Hb) level. Patients were stratified according to hemoglobin level into two groups, that is, Hb &lt;100 g/L and Hb &gt;100 g/L. A total of 6931 patients were included. Of these, 6377 (92%) patients had hemoglobin levels &gt;100 g/L. The mean age was 44 ± 17 years, and 66% of the patients were males. The median length of overall hospital stay was 13 day","2021","07","07","EJHaem","EJHaem","COVID-19; SARS-CoV-2; anemia; hemoglobin; in-hospital mortality","Saleh","Mohammad Al","Department of medicine, Farwaniya Hospital Ministry of Health Farwaniya Kuwait",NA
"304","34226901","10.1002/jha2.195","In-hospital mortality in SARS-CoV-2 stratified by hemoglobin levels: A retrospective study.","This study is to estimate in-hospital mortality in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) patients stratified by hemoglobin (Hb) level. Patients were stratified according to hemoglobin level into two groups, that is, Hb &lt;100 g/L and Hb &gt;100 g/L. A total of 6931 patients were included. Of these, 6377 (92%) patients had hemoglobin levels &gt;100 g/L. The mean age was 44 ± 17 years, and 66% of the patients were males. The median length of overall hospital stay was 13 day","2021","07","07","EJHaem","EJHaem","COVID-19; SARS-CoV-2; anemia; hemoglobin; in-hospital mortality","AlNasrallah","Noor","Department of Medicine, Al Adan Hospital Ministry of Health, Hadiya Kuwait",NA
"305","34226901","10.1002/jha2.195","In-hospital mortality in SARS-CoV-2 stratified by hemoglobin levels: A retrospective study.","This study is to estimate in-hospital mortality in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) patients stratified by hemoglobin (Hb) level. Patients were stratified according to hemoglobin level into two groups, that is, Hb &lt;100 g/L and Hb &gt;100 g/L. A total of 6931 patients were included. Of these, 6377 (92%) patients had hemoglobin levels &gt;100 g/L. The mean age was 44 ± 17 years, and 66% of the patients were males. The median length of overall hospital stay was 13 day","2021","07","07","EJHaem","EJHaem","COVID-19; SARS-CoV-2; anemia; hemoglobin; in-hospital mortality","Al-Bader","Bader","Department of medicine, Farwaniya Hospital Ministry of Health Farwaniya Kuwait",NA
"306","34226901","10.1002/jha2.195","In-hospital mortality in SARS-CoV-2 stratified by hemoglobin levels: A retrospective study.","This study is to estimate in-hospital mortality in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) patients stratified by hemoglobin (Hb) level. Patients were stratified according to hemoglobin level into two groups, that is, Hb &lt;100 g/L and Hb &gt;100 g/L. A total of 6931 patients were included. Of these, 6377 (92%) patients had hemoglobin levels &gt;100 g/L. The mean age was 44 ± 17 years, and 66% of the patients were males. The median length of overall hospital stay was 13 day","2021","07","07","EJHaem","EJHaem","COVID-19; SARS-CoV-2; anemia; hemoglobin; in-hospital mortality","Malhas","Haya","Department of Emergency Medicine, Mubarak Al-Kabeer Hospital Ministry of Health Jabriya Kuwait",NA
"307","34226901","10.1002/jha2.195","In-hospital mortality in SARS-CoV-2 stratified by hemoglobin levels: A retrospective study.","This study is to estimate in-hospital mortality in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) patients stratified by hemoglobin (Hb) level. Patients were stratified according to hemoglobin level into two groups, that is, Hb &lt;100 g/L and Hb &gt;100 g/L. A total of 6931 patients were included. Of these, 6377 (92%) patients had hemoglobin levels &gt;100 g/L. The mean age was 44 ± 17 years, and 66% of the patients were males. The median length of overall hospital stay was 13 day","2021","07","07","EJHaem","EJHaem","COVID-19; SARS-CoV-2; anemia; hemoglobin; in-hospital mortality","Ramadhan","Maryam","Department of Obstetric and Gynecology, Maternity Hospital Ministry of Health Sabah Area, Shuwaikh Medical Area Kuwait",NA
"308","34226901","10.1002/jha2.195","In-hospital mortality in SARS-CoV-2 stratified by hemoglobin levels: A retrospective study.","This study is to estimate in-hospital mortality in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) patients stratified by hemoglobin (Hb) level. Patients were stratified according to hemoglobin level into two groups, that is, Hb &lt;100 g/L and Hb &gt;100 g/L. A total of 6931 patients were included. Of these, 6377 (92%) patients had hemoglobin levels &gt;100 g/L. The mean age was 44 ± 17 years, and 66% of the patients were males. The median length of overall hospital stay was 13 day","2021","07","07","EJHaem","EJHaem","COVID-19; SARS-CoV-2; anemia; hemoglobin; in-hospital mortality","Hamza","Mahdy","Department of Medical Imaging, Al Adan Hospital Ministry of Health, Hadiya Kuwait",NA
"309","34226901","10.1002/jha2.195","In-hospital mortality in SARS-CoV-2 stratified by hemoglobin levels: A retrospective study.","This study is to estimate in-hospital mortality in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) patients stratified by hemoglobin (Hb) level. Patients were stratified according to hemoglobin level into two groups, that is, Hb &lt;100 g/L and Hb &gt;100 g/L. A total of 6931 patients were included. Of these, 6377 (92%) patients had hemoglobin levels &gt;100 g/L. The mean age was 44 ± 17 years, and 66% of the patients were males. The median length of overall hospital stay was 13 day","2021","07","07","EJHaem","EJHaem","COVID-19; SARS-CoV-2; anemia; hemoglobin; in-hospital mortality","Zhanna","Kobalava D","Department of Internal Medicine with the Subspecialty of Cardiology and Functional Diagnostics Named after V.S. Moiseev, Institute of Medicine Peoples' Friendship University of Russia (RUDN University) Moscow Russian Federation",NA
"310","34226900","10.1002/jha2.228","Lessons learnt from COVID-19 coagulopathy.","The coronavirus disease 2019 (COVID-19) pandemic has already left an indelible mark in human lives. Despite the havoc it created, this pandemic also saw significant advances in the management of an infectious disease wherein worldwide collaborative efforts from health care professionals have been unprecedented. One of the commonest complications recognised early in the pandemic is the development of coagulopathy. In this review, the lessons learnt from COVID-19 coagulopathy are summarised with s","2021","07","07","EJHaem","EJHaem","COVID-19; D-dimer; coagulopathy; fibrinogen; platelets; thrombocytopenia","Thachil","Jecko","Department of Haematology Manchester University Hospitals Manchester UK",NA
"311","34226899","10.1002/jha2.219","Acquired thrombotic thrombocytopenic purpura with possible association with AstraZeneca-Oxford COVID-19 vaccine.","Acquired thrombotic thrombocytopenic purpura is characterized by the microvascular aggregation of platelets and microangiopathic hemolytic anemia causing ischemia of multiple organs including the brain mainly and less likely the kidney and the heart. The disease is caused by severe reduction in the activity of ADAMTS 13 due to presence of inhibitory antibodies.","2021","07","07","EJHaem","EJHaem","TTP; covid-19; thrombocytopenia; vaccines","Al-Ahmad","Mona","Microbiology Department Faculty of Medicine Kuwait University Kuwait Kuwait",NA
"312","34226899","10.1002/jha2.219","Acquired thrombotic thrombocytopenic purpura with possible association with AstraZeneca-Oxford COVID-19 vaccine.","Acquired thrombotic thrombocytopenic purpura is characterized by the microvascular aggregation of platelets and microangiopathic hemolytic anemia causing ischemia of multiple organs including the brain mainly and less likely the kidney and the heart. The disease is caused by severe reduction in the activity of ADAMTS 13 due to presence of inhibitory antibodies.","2021","07","07","EJHaem","EJHaem","TTP; covid-19; thrombocytopenia; vaccines","Al-Rasheed","Mona","Hematology Unit Department of Medicine Al Adnan Hospital Ministry of Health Kuwait",NA
"313","34226899","10.1002/jha2.219","Acquired thrombotic thrombocytopenic purpura with possible association with AstraZeneca-Oxford COVID-19 vaccine.","Acquired thrombotic thrombocytopenic purpura is characterized by the microvascular aggregation of platelets and microangiopathic hemolytic anemia causing ischemia of multiple organs including the brain mainly and less likely the kidney and the heart. The disease is caused by severe reduction in the activity of ADAMTS 13 due to presence of inhibitory antibodies.","2021","07","07","EJHaem","EJHaem","TTP; covid-19; thrombocytopenia; vaccines","Shalaby","Neveen Abo Bakr","Hematology Unit Department of Medicine Al Adnan Hospital Ministry of Health Kuwait",NA
"314","34226898","10.1002/jha2.197","Green bodies: Inclusions in a critically ill COVID-19 patient.",NA,"2021","07","06","EJHaem","EJHaem",NA,"Chaliori","Ioulia","Hematology Laboratory General Hospital of Athens ""G. Gennimatas,"" Athens Greece",NA
"315","34226898","10.1002/jha2.197","Green bodies: Inclusions in a critically ill COVID-19 patient.",NA,"2021","07","06","EJHaem","EJHaem",NA,"Tsagarakis","Nikolaos J","Hematology Laboratory General Hospital of Athens ""G. Gennimatas,"" Athens Greece",NA
"316","34226898","10.1002/jha2.197","Green bodies: Inclusions in a critically ill COVID-19 patient.",NA,"2021","07","06","EJHaem","EJHaem",NA,"Chaniotaki","Sofia","Hematology Laboratory General Hospital of Athens ""G. Gennimatas,"" Athens Greece",NA
"317","34226898","10.1002/jha2.197","Green bodies: Inclusions in a critically ill COVID-19 patient.",NA,"2021","07","06","EJHaem","EJHaem",NA,"Androutsos","Georgios","Hematology Laboratory General Hospital of Athens ""G. Gennimatas,"" Athens Greece",NA
"318","34226898","10.1002/jha2.197","Green bodies: Inclusions in a critically ill COVID-19 patient.",NA,"2021","07","06","EJHaem","EJHaem",NA,"Liakopoulos","Dimitrios","Hematology Laboratory General Hospital of Athens ""G. Gennimatas,"" Athens Greece",NA
"319","34226898","10.1002/jha2.197","Green bodies: Inclusions in a critically ill COVID-19 patient.",NA,"2021","07","06","EJHaem","EJHaem",NA,"Kritikou-Griva","Elpiniki","Hematology Laboratory General Hospital of Athens ""G. Gennimatas,"" Athens Greece",NA
"320","34226897","10.1002/jha2.201","Persistent immune thrombocytopaenic purpura associated with SARS-CoV-2 infection.",NA,"2021","07","07","EJHaem","EJHaem",NA,"Furukawa","Yoshiki","Department of Hematology, Juntendo University School of Medicine Tokyo Japan",NA
"321","34226897","10.1002/jha2.201","Persistent immune thrombocytopaenic purpura associated with SARS-CoV-2 infection.",NA,"2021","07","07","EJHaem","EJHaem",NA,"Ando","Miki","Department of Hematology, Juntendo University School of Medicine Tokyo Japan",NA
"322","34226897","10.1002/jha2.201","Persistent immune thrombocytopaenic purpura associated with SARS-CoV-2 infection.",NA,"2021","07","07","EJHaem","EJHaem",NA,"Azusawa","Yoko","Department of Transfusion Medicine and Stem Cell Regulation, Juntendo University School of Medicine Tokyo Japan",NA
"323","34226897","10.1002/jha2.201","Persistent immune thrombocytopaenic purpura associated with SARS-CoV-2 infection.",NA,"2021","07","07","EJHaem","EJHaem",NA,"Kinoshita","Shintaro","Department of Hematology, Juntendo University School of Medicine Tokyo Japan",NA
"324","34226897","10.1002/jha2.201","Persistent immune thrombocytopaenic purpura associated with SARS-CoV-2 infection.",NA,"2021","07","07","EJHaem","EJHaem",NA,"Harada","Sakiko","Department of Hematology, Juntendo University School of Medicine Tokyo Japan",NA
"325","34226897","10.1002/jha2.201","Persistent immune thrombocytopaenic purpura associated with SARS-CoV-2 infection.",NA,"2021","07","07","EJHaem","EJHaem",NA,"Ochiai","Tomonori","Department of Hematology, Juntendo University School of Medicine Tokyo Japan",NA
"326","34226897","10.1002/jha2.201","Persistent immune thrombocytopaenic purpura associated with SARS-CoV-2 infection.",NA,"2021","07","07","EJHaem","EJHaem",NA,"Honda","Tadahiro","Department of Hematology, Juntendo University School of Medicine Tokyo Japan",NA
"327","34226897","10.1002/jha2.201","Persistent immune thrombocytopaenic purpura associated with SARS-CoV-2 infection.",NA,"2021","07","07","EJHaem","EJHaem",NA,"Sugimoto","Kazuya","Department of Hematology, Juntendo University School of Medicine Tokyo Japan",NA
"328","34226897","10.1002/jha2.201","Persistent immune thrombocytopaenic purpura associated with SARS-CoV-2 infection.",NA,"2021","07","07","EJHaem","EJHaem",NA,"Tabe","Yoko","Department of Next Generation Hematological Laboratory Medicine Juntendo University School of Medicine Tokyo Japan",NA
"329","34226897","10.1002/jha2.201","Persistent immune thrombocytopaenic purpura associated with SARS-CoV-2 infection.",NA,"2021","07","07","EJHaem","EJHaem",NA,"Komatsu","Norio","Department of Hematology, Juntendo University School of Medicine Tokyo Japan",NA
"330","34226897","10.1002/jha2.201","Persistent immune thrombocytopaenic purpura associated with SARS-CoV-2 infection.",NA,"2021","07","07","EJHaem","EJHaem",NA,"Ando","Jun","Department of Hematology, Juntendo University School of Medicine Tokyo Japan",NA
"331","34226896","10.1002/jha2.239","COVID-19-associated pseudothrombocytopenia.",NA,"2021","07","07","EJHaem","EJHaem",NA,"Van Dijck","Ruben","Department of Haematology Erasmus MC University Medical Center Rotterdam Rotterdam The Netherlands",NA
"332","34226896","10.1002/jha2.239","COVID-19-associated pseudothrombocytopenia.",NA,"2021","07","07","EJHaem","EJHaem",NA,"Lauw","Mandy N","Department of Haematology Erasmus MC University Medical Center Rotterdam Rotterdam The Netherlands",NA
"333","34226896","10.1002/jha2.239","COVID-19-associated pseudothrombocytopenia.",NA,"2021","07","07","EJHaem","EJHaem",NA,"Swinkels","Maurice","Department of Haematology Erasmus MC University Medical Center Rotterdam Rotterdam The Netherlands",NA
"334","34226896","10.1002/jha2.239","COVID-19-associated pseudothrombocytopenia.",NA,"2021","07","07","EJHaem","EJHaem",NA,"Russcher","Henk","Department of Clinical Chemistry Erasmus MC University Medical Center Rotterdam Rotterdam The Netherlands",NA
"335","34226896","10.1002/jha2.239","COVID-19-associated pseudothrombocytopenia.",NA,"2021","07","07","EJHaem","EJHaem",NA,"Jansen","A J Gerard","Department of Haematology Erasmus MC University Medical Center Rotterdam Rotterdam The Netherlands",NA
"336","34226895","10.1002/mco2.72","A bivalent recombinant vaccine targeting the S1 protein induces neutralizing antibodies against both SARS-CoV-2 variants and wild-type of the virus.","The emerging variants of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) in pandemic call for the urgent development of universal corona virus disease 2019 (COVID-19) vaccines which could be effective for both wild-type SARS-CoV-2 and mutant strains. In the current study, we formulated protein subunit vaccines with AS03 adjuvant and recombinant proteins of S1 subunit of SARS-CoV-2 (S1-WT) and S1 variant (K417N, E484K, N501Y, and D614G) subunit (S1-Mut), and immunized transgenic mice","2021","07","21","MedComm (Beijing)","MedComm","SARS-CoV-2; bivalent vaccine; recombinant protein; variant","He","Cai","Laboratory of Aging Research and Cancer Drug Target State Key Laboratory of Biotherapy and Cancer Center, National Clinical Research Center for Geriatrics West China Hospital, Sichuan University Chengdu China",NA
"337","34226895","10.1002/mco2.72","A bivalent recombinant vaccine targeting the S1 protein induces neutralizing antibodies against both SARS-CoV-2 variants and wild-type of the virus.","The emerging variants of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) in pandemic call for the urgent development of universal corona virus disease 2019 (COVID-19) vaccines which could be effective for both wild-type SARS-CoV-2 and mutant strains. In the current study, we formulated protein subunit vaccines with AS03 adjuvant and recombinant proteins of S1 subunit of SARS-CoV-2 (S1-WT) and S1 variant (K417N, E484K, N501Y, and D614G) subunit (S1-Mut), and immunized transgenic mice","2021","07","21","MedComm (Beijing)","MedComm","SARS-CoV-2; bivalent vaccine; recombinant protein; variant","Yang","Jingyun","Laboratory of Aging Research and Cancer Drug Target State Key Laboratory of Biotherapy and Cancer Center, National Clinical Research Center for Geriatrics West China Hospital, Sichuan University Chengdu China",NA
"338","34226895","10.1002/mco2.72","A bivalent recombinant vaccine targeting the S1 protein induces neutralizing antibodies against both SARS-CoV-2 variants and wild-type of the virus.","The emerging variants of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) in pandemic call for the urgent development of universal corona virus disease 2019 (COVID-19) vaccines which could be effective for both wild-type SARS-CoV-2 and mutant strains. In the current study, we formulated protein subunit vaccines with AS03 adjuvant and recombinant proteins of S1 subunit of SARS-CoV-2 (S1-WT) and S1 variant (K417N, E484K, N501Y, and D614G) subunit (S1-Mut), and immunized transgenic mice","2021","07","21","MedComm (Beijing)","MedComm","SARS-CoV-2; bivalent vaccine; recombinant protein; variant","He","Xuemei","Laboratory of Aging Research and Cancer Drug Target State Key Laboratory of Biotherapy and Cancer Center, National Clinical Research Center for Geriatrics West China Hospital, Sichuan University Chengdu China",NA
"339","34226895","10.1002/mco2.72","A bivalent recombinant vaccine targeting the S1 protein induces neutralizing antibodies against both SARS-CoV-2 variants and wild-type of the virus.","The emerging variants of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) in pandemic call for the urgent development of universal corona virus disease 2019 (COVID-19) vaccines which could be effective for both wild-type SARS-CoV-2 and mutant strains. In the current study, we formulated protein subunit vaccines with AS03 adjuvant and recombinant proteins of S1 subunit of SARS-CoV-2 (S1-WT) and S1 variant (K417N, E484K, N501Y, and D614G) subunit (S1-Mut), and immunized transgenic mice","2021","07","21","MedComm (Beijing)","MedComm","SARS-CoV-2; bivalent vaccine; recombinant protein; variant","Hong","Weiqi","Laboratory of Aging Research and Cancer Drug Target State Key Laboratory of Biotherapy and Cancer Center, National Clinical Research Center for Geriatrics West China Hospital, Sichuan University Chengdu China",NA
"340","34226895","10.1002/mco2.72","A bivalent recombinant vaccine targeting the S1 protein induces neutralizing antibodies against both SARS-CoV-2 variants and wild-type of the virus.","The emerging variants of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) in pandemic call for the urgent development of universal corona virus disease 2019 (COVID-19) vaccines which could be effective for both wild-type SARS-CoV-2 and mutant strains. In the current study, we formulated protein subunit vaccines with AS03 adjuvant and recombinant proteins of S1 subunit of SARS-CoV-2 (S1-WT) and S1 variant (K417N, E484K, N501Y, and D614G) subunit (S1-Mut), and immunized transgenic mice","2021","07","21","MedComm (Beijing)","MedComm","SARS-CoV-2; bivalent vaccine; recombinant protein; variant","Lei","Hong","Laboratory of Aging Research and Cancer Drug Target State Key Laboratory of Biotherapy and Cancer Center, National Clinical Research Center for Geriatrics West China Hospital, Sichuan University Chengdu China",NA
"341","34226895","10.1002/mco2.72","A bivalent recombinant vaccine targeting the S1 protein induces neutralizing antibodies against both SARS-CoV-2 variants and wild-type of the virus.","The emerging variants of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) in pandemic call for the urgent development of universal corona virus disease 2019 (COVID-19) vaccines which could be effective for both wild-type SARS-CoV-2 and mutant strains. In the current study, we formulated protein subunit vaccines with AS03 adjuvant and recombinant proteins of S1 subunit of SARS-CoV-2 (S1-WT) and S1 variant (K417N, E484K, N501Y, and D614G) subunit (S1-Mut), and immunized transgenic mice","2021","07","21","MedComm (Beijing)","MedComm","SARS-CoV-2; bivalent vaccine; recombinant protein; variant","Chen","Zimin","Laboratory of Aging Research and Cancer Drug Target State Key Laboratory of Biotherapy and Cancer Center, National Clinical Research Center for Geriatrics West China Hospital, Sichuan University Chengdu China",NA
"342","34226895","10.1002/mco2.72","A bivalent recombinant vaccine targeting the S1 protein induces neutralizing antibodies against both SARS-CoV-2 variants and wild-type of the virus.","The emerging variants of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) in pandemic call for the urgent development of universal corona virus disease 2019 (COVID-19) vaccines which could be effective for both wild-type SARS-CoV-2 and mutant strains. In the current study, we formulated protein subunit vaccines with AS03 adjuvant and recombinant proteins of S1 subunit of SARS-CoV-2 (S1-WT) and S1 variant (K417N, E484K, N501Y, and D614G) subunit (S1-Mut), and immunized transgenic mice","2021","07","21","MedComm (Beijing)","MedComm","SARS-CoV-2; bivalent vaccine; recombinant protein; variant","Shen","Guobo","Laboratory of Aging Research and Cancer Drug Target State Key Laboratory of Biotherapy and Cancer Center, National Clinical Research Center for Geriatrics West China Hospital, Sichuan University Chengdu China",NA
"343","34226895","10.1002/mco2.72","A bivalent recombinant vaccine targeting the S1 protein induces neutralizing antibodies against both SARS-CoV-2 variants and wild-type of the virus.","The emerging variants of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) in pandemic call for the urgent development of universal corona virus disease 2019 (COVID-19) vaccines which could be effective for both wild-type SARS-CoV-2 and mutant strains. In the current study, we formulated protein subunit vaccines with AS03 adjuvant and recombinant proteins of S1 subunit of SARS-CoV-2 (S1-WT) and S1 variant (K417N, E484K, N501Y, and D614G) subunit (S1-Mut), and immunized transgenic mice","2021","07","21","MedComm (Beijing)","MedComm","SARS-CoV-2; bivalent vaccine; recombinant protein; variant","Yang","Li","Laboratory of Aging Research and Cancer Drug Target State Key Laboratory of Biotherapy and Cancer Center, National Clinical Research Center for Geriatrics West China Hospital, Sichuan University Chengdu China",NA
"344","34226895","10.1002/mco2.72","A bivalent recombinant vaccine targeting the S1 protein induces neutralizing antibodies against both SARS-CoV-2 variants and wild-type of the virus.","The emerging variants of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) in pandemic call for the urgent development of universal corona virus disease 2019 (COVID-19) vaccines which could be effective for both wild-type SARS-CoV-2 and mutant strains. In the current study, we formulated protein subunit vaccines with AS03 adjuvant and recombinant proteins of S1 subunit of SARS-CoV-2 (S1-WT) and S1 variant (K417N, E484K, N501Y, and D614G) subunit (S1-Mut), and immunized transgenic mice","2021","07","21","MedComm (Beijing)","MedComm","SARS-CoV-2; bivalent vaccine; recombinant protein; variant","Li","Jiong","Laboratory of Aging Research and Cancer Drug Target State Key Laboratory of Biotherapy and Cancer Center, National Clinical Research Center for Geriatrics West China Hospital, Sichuan University Chengdu China",NA
"345","34226895","10.1002/mco2.72","A bivalent recombinant vaccine targeting the S1 protein induces neutralizing antibodies against both SARS-CoV-2 variants and wild-type of the virus.","The emerging variants of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) in pandemic call for the urgent development of universal corona virus disease 2019 (COVID-19) vaccines which could be effective for both wild-type SARS-CoV-2 and mutant strains. In the current study, we formulated protein subunit vaccines with AS03 adjuvant and recombinant proteins of S1 subunit of SARS-CoV-2 (S1-WT) and S1 variant (K417N, E484K, N501Y, and D614G) subunit (S1-Mut), and immunized transgenic mice","2021","07","21","MedComm (Beijing)","MedComm","SARS-CoV-2; bivalent vaccine; recombinant protein; variant","Wang","Zhenling","Laboratory of Aging Research and Cancer Drug Target State Key Laboratory of Biotherapy and Cancer Center, National Clinical Research Center for Geriatrics West China Hospital, Sichuan University Chengdu China",NA
"346","34226895","10.1002/mco2.72","A bivalent recombinant vaccine targeting the S1 protein induces neutralizing antibodies against both SARS-CoV-2 variants and wild-type of the virus.","The emerging variants of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) in pandemic call for the urgent development of universal corona virus disease 2019 (COVID-19) vaccines which could be effective for both wild-type SARS-CoV-2 and mutant strains. In the current study, we formulated protein subunit vaccines with AS03 adjuvant and recombinant proteins of S1 subunit of SARS-CoV-2 (S1-WT) and S1 variant (K417N, E484K, N501Y, and D614G) subunit (S1-Mut), and immunized transgenic mice","2021","07","21","MedComm (Beijing)","MedComm","SARS-CoV-2; bivalent vaccine; recombinant protein; variant","Song","Xiangrong","Laboratory of Aging Research and Cancer Drug Target State Key Laboratory of Biotherapy and Cancer Center, National Clinical Research Center for Geriatrics West China Hospital, Sichuan University Chengdu China",NA
"347","34226895","10.1002/mco2.72","A bivalent recombinant vaccine targeting the S1 protein induces neutralizing antibodies against both SARS-CoV-2 variants and wild-type of the virus.","The emerging variants of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) in pandemic call for the urgent development of universal corona virus disease 2019 (COVID-19) vaccines which could be effective for both wild-type SARS-CoV-2 and mutant strains. In the current study, we formulated protein subunit vaccines with AS03 adjuvant and recombinant proteins of S1 subunit of SARS-CoV-2 (S1-WT) and S1 variant (K417N, E484K, N501Y, and D614G) subunit (S1-Mut), and immunized transgenic mice","2021","07","21","MedComm (Beijing)","MedComm","SARS-CoV-2; bivalent vaccine; recombinant protein; variant","Wang","Wei","Laboratory of Aging Research and Cancer Drug Target State Key Laboratory of Biotherapy and Cancer Center, National Clinical Research Center for Geriatrics West China Hospital, Sichuan University Chengdu China",NA
"348","34226895","10.1002/mco2.72","A bivalent recombinant vaccine targeting the S1 protein induces neutralizing antibodies against both SARS-CoV-2 variants and wild-type of the virus.","The emerging variants of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) in pandemic call for the urgent development of universal corona virus disease 2019 (COVID-19) vaccines which could be effective for both wild-type SARS-CoV-2 and mutant strains. In the current study, we formulated protein subunit vaccines with AS03 adjuvant and recombinant proteins of S1 subunit of SARS-CoV-2 (S1-WT) and S1 variant (K417N, E484K, N501Y, and D614G) subunit (S1-Mut), and immunized transgenic mice","2021","07","21","MedComm (Beijing)","MedComm","SARS-CoV-2; bivalent vaccine; recombinant protein; variant","Lu","Guangwen","Laboratory of Aging Research and Cancer Drug Target State Key Laboratory of Biotherapy and Cancer Center, National Clinical Research Center for Geriatrics West China Hospital, Sichuan University Chengdu China",NA
"349","34226895","10.1002/mco2.72","A bivalent recombinant vaccine targeting the S1 protein induces neutralizing antibodies against both SARS-CoV-2 variants and wild-type of the virus.","The emerging variants of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) in pandemic call for the urgent development of universal corona virus disease 2019 (COVID-19) vaccines which could be effective for both wild-type SARS-CoV-2 and mutant strains. In the current study, we formulated protein subunit vaccines with AS03 adjuvant and recombinant proteins of S1 subunit of SARS-CoV-2 (S1-WT) and S1 variant (K417N, E484K, N501Y, and D614G) subunit (S1-Mut), and immunized transgenic mice","2021","07","21","MedComm (Beijing)","MedComm","SARS-CoV-2; bivalent vaccine; recombinant protein; variant","Wei","Xiawei","Laboratory of Aging Research and Cancer Drug Target State Key Laboratory of Biotherapy and Cancer Center, National Clinical Research Center for Geriatrics West China Hospital, Sichuan University Chengdu China",NA
"350","34226894","10.1016/j.lanepe.2021.100152","The impact of COVID-19 on primary care in Europe.",NA,"2021","07","20","Lancet Reg Health Eur","The Lancet regional health. Europe",NA,"Mughal","Dr F","School of Medicine, Keele University, Keele, UK",NA
"351","34226894","10.1016/j.lanepe.2021.100152","The impact of COVID-19 on primary care in Europe.",NA,"2021","07","20","Lancet Reg Health Eur","The Lancet regional health. Europe",NA,"Mallen","C D","School of Medicine, Keele University, Keele, UK",NA
"352","34226894","10.1016/j.lanepe.2021.100152","The impact of COVID-19 on primary care in Europe.",NA,"2021","07","20","Lancet Reg Health Eur","The Lancet regional health. Europe",NA,"McKee","M","Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, London, UK",NA
"353","34226893","10.1016/S2666-5247(21)00143-9","Comparative performance of SARS-CoV-2 lateral flow antigen tests and association with detection of infectious virus in clinical specimens: a single-centre laboratory evaluation study.","Lateral flow devices (LFDs) for rapid antigen testing are set to become a cornerstone of SARS-CoV-2 mass community testing, although their reduced sensitivity compared with PCR has raised questions of how well they identify infectious cases. Understanding their capabilities and limitations is, therefore, essential for successful implementation. We evaluated six commercial LFDs and assessed their correlation with infectious virus culture and PCR cycle threshold (Ct) values. In a single-centre, la","2021","07","07","Lancet Microbe","The Lancet. Microbe",NA,"Pickering","Suzanne","Department of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, London, UK",NA
"354","34226893","10.1016/S2666-5247(21)00143-9","Comparative performance of SARS-CoV-2 lateral flow antigen tests and association with detection of infectious virus in clinical specimens: a single-centre laboratory evaluation study.","Lateral flow devices (LFDs) for rapid antigen testing are set to become a cornerstone of SARS-CoV-2 mass community testing, although their reduced sensitivity compared with PCR has raised questions of how well they identify infectious cases. Understanding their capabilities and limitations is, therefore, essential for successful implementation. We evaluated six commercial LFDs and assessed their correlation with infectious virus culture and PCR cycle threshold (Ct) values. In a single-centre, la","2021","07","07","Lancet Microbe","The Lancet. Microbe",NA,"Batra","Rahul","Centre for Clinical Infection and Diagnostics Research, Department of Infectious Diseases, Guy's and St Thomas' NHS Foundation Trust, London, UK",NA
"355","34226893","10.1016/S2666-5247(21)00143-9","Comparative performance of SARS-CoV-2 lateral flow antigen tests and association with detection of infectious virus in clinical specimens: a single-centre laboratory evaluation study.","Lateral flow devices (LFDs) for rapid antigen testing are set to become a cornerstone of SARS-CoV-2 mass community testing, although their reduced sensitivity compared with PCR has raised questions of how well they identify infectious cases. Understanding their capabilities and limitations is, therefore, essential for successful implementation. We evaluated six commercial LFDs and assessed their correlation with infectious virus culture and PCR cycle threshold (Ct) values. In a single-centre, la","2021","07","07","Lancet Microbe","The Lancet. Microbe",NA,"Merrick","Blair","Centre for Clinical Infection and Diagnostics Research, Department of Infectious Diseases, Guy's and St Thomas' NHS Foundation Trust, London, UK",NA
"356","34226893","10.1016/S2666-5247(21)00143-9","Comparative performance of SARS-CoV-2 lateral flow antigen tests and association with detection of infectious virus in clinical specimens: a single-centre laboratory evaluation study.","Lateral flow devices (LFDs) for rapid antigen testing are set to become a cornerstone of SARS-CoV-2 mass community testing, although their reduced sensitivity compared with PCR has raised questions of how well they identify infectious cases. Understanding their capabilities and limitations is, therefore, essential for successful implementation. We evaluated six commercial LFDs and assessed their correlation with infectious virus culture and PCR cycle threshold (Ct) values. In a single-centre, la","2021","07","07","Lancet Microbe","The Lancet. Microbe",NA,"Snell","Luke B","Centre for Clinical Infection and Diagnostics Research, Department of Infectious Diseases, Guy's and St Thomas' NHS Foundation Trust, London, UK",NA
"357","34226893","10.1016/S2666-5247(21)00143-9","Comparative performance of SARS-CoV-2 lateral flow antigen tests and association with detection of infectious virus in clinical specimens: a single-centre laboratory evaluation study.","Lateral flow devices (LFDs) for rapid antigen testing are set to become a cornerstone of SARS-CoV-2 mass community testing, although their reduced sensitivity compared with PCR has raised questions of how well they identify infectious cases. Understanding their capabilities and limitations is, therefore, essential for successful implementation. We evaluated six commercial LFDs and assessed their correlation with infectious virus culture and PCR cycle threshold (Ct) values. In a single-centre, la","2021","07","07","Lancet Microbe","The Lancet. Microbe",NA,"Nebbia","Gaia","Centre for Clinical Infection and Diagnostics Research, Department of Infectious Diseases, Guy's and St Thomas' NHS Foundation Trust, London, UK",NA
"358","34226893","10.1016/S2666-5247(21)00143-9","Comparative performance of SARS-CoV-2 lateral flow antigen tests and association with detection of infectious virus in clinical specimens: a single-centre laboratory evaluation study.","Lateral flow devices (LFDs) for rapid antigen testing are set to become a cornerstone of SARS-CoV-2 mass community testing, although their reduced sensitivity compared with PCR has raised questions of how well they identify infectious cases. Understanding their capabilities and limitations is, therefore, essential for successful implementation. We evaluated six commercial LFDs and assessed their correlation with infectious virus culture and PCR cycle threshold (Ct) values. In a single-centre, la","2021","07","07","Lancet Microbe","The Lancet. Microbe",NA,"Douthwaite","Sam","Centre for Clinical Infection and Diagnostics Research, Department of Infectious Diseases, Guy's and St Thomas' NHS Foundation Trust, London, UK",NA
"359","34226893","10.1016/S2666-5247(21)00143-9","Comparative performance of SARS-CoV-2 lateral flow antigen tests and association with detection of infectious virus in clinical specimens: a single-centre laboratory evaluation study.","Lateral flow devices (LFDs) for rapid antigen testing are set to become a cornerstone of SARS-CoV-2 mass community testing, although their reduced sensitivity compared with PCR has raised questions of how well they identify infectious cases. Understanding their capabilities and limitations is, therefore, essential for successful implementation. We evaluated six commercial LFDs and assessed their correlation with infectious virus culture and PCR cycle threshold (Ct) values. In a single-centre, la","2021","07","07","Lancet Microbe","The Lancet. Microbe",NA,"Reid","Fiona","School of Population Health and Environmental Sciences, King's College London, London, UK",NA
"360","34226893","10.1016/S2666-5247(21)00143-9","Comparative performance of SARS-CoV-2 lateral flow antigen tests and association with detection of infectious virus in clinical specimens: a single-centre laboratory evaluation study.","Lateral flow devices (LFDs) for rapid antigen testing are set to become a cornerstone of SARS-CoV-2 mass community testing, although their reduced sensitivity compared with PCR has raised questions of how well they identify infectious cases. Understanding their capabilities and limitations is, therefore, essential for successful implementation. We evaluated six commercial LFDs and assessed their correlation with infectious virus culture and PCR cycle threshold (Ct) values. In a single-centre, la","2021","07","07","Lancet Microbe","The Lancet. Microbe",NA,"Patel","Amita","Centre for Clinical Infection and Diagnostics Research, Department of Infectious Diseases, Guy's and St Thomas' NHS Foundation Trust, London, UK",NA
"361","34226893","10.1016/S2666-5247(21)00143-9","Comparative performance of SARS-CoV-2 lateral flow antigen tests and association with detection of infectious virus in clinical specimens: a single-centre laboratory evaluation study.","Lateral flow devices (LFDs) for rapid antigen testing are set to become a cornerstone of SARS-CoV-2 mass community testing, although their reduced sensitivity compared with PCR has raised questions of how well they identify infectious cases. Understanding their capabilities and limitations is, therefore, essential for successful implementation. We evaluated six commercial LFDs and assessed their correlation with infectious virus culture and PCR cycle threshold (Ct) values. In a single-centre, la","2021","07","07","Lancet Microbe","The Lancet. Microbe",NA,"Kia Ik","Mark Tan","Centre for Clinical Infection and Diagnostics Research, Department of Infectious Diseases, Guy's and St Thomas' NHS Foundation Trust, London, UK",NA
"362","34226893","10.1016/S2666-5247(21)00143-9","Comparative performance of SARS-CoV-2 lateral flow antigen tests and association with detection of infectious virus in clinical specimens: a single-centre laboratory evaluation study.","Lateral flow devices (LFDs) for rapid antigen testing are set to become a cornerstone of SARS-CoV-2 mass community testing, although their reduced sensitivity compared with PCR has raised questions of how well they identify infectious cases. Understanding their capabilities and limitations is, therefore, essential for successful implementation. We evaluated six commercial LFDs and assessed their correlation with infectious virus culture and PCR cycle threshold (Ct) values. In a single-centre, la","2021","07","07","Lancet Microbe","The Lancet. Microbe",NA,"Patel","Bindi","Centre for Clinical Infection and Diagnostics Research, Department of Infectious Diseases, Guy's and St Thomas' NHS Foundation Trust, London, UK",NA
"363","34226893","10.1016/S2666-5247(21)00143-9","Comparative performance of SARS-CoV-2 lateral flow antigen tests and association with detection of infectious virus in clinical specimens: a single-centre laboratory evaluation study.","Lateral flow devices (LFDs) for rapid antigen testing are set to become a cornerstone of SARS-CoV-2 mass community testing, although their reduced sensitivity compared with PCR has raised questions of how well they identify infectious cases. Understanding their capabilities and limitations is, therefore, essential for successful implementation. We evaluated six commercial LFDs and assessed their correlation with infectious virus culture and PCR cycle threshold (Ct) values. In a single-centre, la","2021","07","07","Lancet Microbe","The Lancet. Microbe",NA,"Charalampous","Themoula","Centre for Clinical Infection and Diagnostics Research, Department of Infectious Diseases, Guy's and St Thomas' NHS Foundation Trust, London, UK",NA
"364","34226893","10.1016/S2666-5247(21)00143-9","Comparative performance of SARS-CoV-2 lateral flow antigen tests and association with detection of infectious virus in clinical specimens: a single-centre laboratory evaluation study.","Lateral flow devices (LFDs) for rapid antigen testing are set to become a cornerstone of SARS-CoV-2 mass community testing, although their reduced sensitivity compared with PCR has raised questions of how well they identify infectious cases. Understanding their capabilities and limitations is, therefore, essential for successful implementation. We evaluated six commercial LFDs and assessed their correlation with infectious virus culture and PCR cycle threshold (Ct) values. In a single-centre, la","2021","07","07","Lancet Microbe","The Lancet. Microbe",NA,"Alcolea-Medina","Adela","Centre for Clinical Infection and Diagnostics Research, Department of Infectious Diseases, Guy's and St Thomas' NHS Foundation Trust, London, UK",NA
"365","34226893","10.1016/S2666-5247(21)00143-9","Comparative performance of SARS-CoV-2 lateral flow antigen tests and association with detection of infectious virus in clinical specimens: a single-centre laboratory evaluation study.","Lateral flow devices (LFDs) for rapid antigen testing are set to become a cornerstone of SARS-CoV-2 mass community testing, although their reduced sensitivity compared with PCR has raised questions of how well they identify infectious cases. Understanding their capabilities and limitations is, therefore, essential for successful implementation. We evaluated six commercial LFDs and assessed their correlation with infectious virus culture and PCR cycle threshold (Ct) values. In a single-centre, la","2021","07","07","Lancet Microbe","The Lancet. Microbe",NA,"Lista","Maria Jose","Department of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, London, UK",NA
"366","34226893","10.1016/S2666-5247(21)00143-9","Comparative performance of SARS-CoV-2 lateral flow antigen tests and association with detection of infectious virus in clinical specimens: a single-centre laboratory evaluation study.","Lateral flow devices (LFDs) for rapid antigen testing are set to become a cornerstone of SARS-CoV-2 mass community testing, although their reduced sensitivity compared with PCR has raised questions of how well they identify infectious cases. Understanding their capabilities and limitations is, therefore, essential for successful implementation. We evaluated six commercial LFDs and assessed their correlation with infectious virus culture and PCR cycle threshold (Ct) values. In a single-centre, la","2021","07","07","Lancet Microbe","The Lancet. Microbe",NA,"Cliff","Penelope R","Viapath Group, Guy's and St Thomas' NHS Foundation Trust, London, UK",NA
"367","34226893","10.1016/S2666-5247(21)00143-9","Comparative performance of SARS-CoV-2 lateral flow antigen tests and association with detection of infectious virus in clinical specimens: a single-centre laboratory evaluation study.","Lateral flow devices (LFDs) for rapid antigen testing are set to become a cornerstone of SARS-CoV-2 mass community testing, although their reduced sensitivity compared with PCR has raised questions of how well they identify infectious cases. Understanding their capabilities and limitations is, therefore, essential for successful implementation. We evaluated six commercial LFDs and assessed their correlation with infectious virus culture and PCR cycle threshold (Ct) values. In a single-centre, la","2021","07","07","Lancet Microbe","The Lancet. Microbe",NA,"Cunningham","Emma","Viapath Group, Guy's and St Thomas' NHS Foundation Trust, London, UK",NA
"368","34226893","10.1016/S2666-5247(21)00143-9","Comparative performance of SARS-CoV-2 lateral flow antigen tests and association with detection of infectious virus in clinical specimens: a single-centre laboratory evaluation study.","Lateral flow devices (LFDs) for rapid antigen testing are set to become a cornerstone of SARS-CoV-2 mass community testing, although their reduced sensitivity compared with PCR has raised questions of how well they identify infectious cases. Understanding their capabilities and limitations is, therefore, essential for successful implementation. We evaluated six commercial LFDs and assessed their correlation with infectious virus culture and PCR cycle threshold (Ct) values. In a single-centre, la","2021","07","07","Lancet Microbe","The Lancet. Microbe",NA,"Mullen","Jane","Viapath Group, Guy's and St Thomas' NHS Foundation Trust, London, UK",NA
"369","34226893","10.1016/S2666-5247(21)00143-9","Comparative performance of SARS-CoV-2 lateral flow antigen tests and association with detection of infectious virus in clinical specimens: a single-centre laboratory evaluation study.","Lateral flow devices (LFDs) for rapid antigen testing are set to become a cornerstone of SARS-CoV-2 mass community testing, although their reduced sensitivity compared with PCR has raised questions of how well they identify infectious cases. Understanding their capabilities and limitations is, therefore, essential for successful implementation. We evaluated six commercial LFDs and assessed their correlation with infectious virus culture and PCR cycle threshold (Ct) values. In a single-centre, la","2021","07","07","Lancet Microbe","The Lancet. Microbe",NA,"Doores","Katie J","Department of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, London, UK",NA
"370","34226893","10.1016/S2666-5247(21)00143-9","Comparative performance of SARS-CoV-2 lateral flow antigen tests and association with detection of infectious virus in clinical specimens: a single-centre laboratory evaluation study.","Lateral flow devices (LFDs) for rapid antigen testing are set to become a cornerstone of SARS-CoV-2 mass community testing, although their reduced sensitivity compared with PCR has raised questions of how well they identify infectious cases. Understanding their capabilities and limitations is, therefore, essential for successful implementation. We evaluated six commercial LFDs and assessed their correlation with infectious virus culture and PCR cycle threshold (Ct) values. In a single-centre, la","2021","07","07","Lancet Microbe","The Lancet. Microbe",NA,"Edgeworth","Jonathan D","Department of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, London, UK",NA
"371","34226893","10.1016/S2666-5247(21)00143-9","Comparative performance of SARS-CoV-2 lateral flow antigen tests and association with detection of infectious virus in clinical specimens: a single-centre laboratory evaluation study.","Lateral flow devices (LFDs) for rapid antigen testing are set to become a cornerstone of SARS-CoV-2 mass community testing, although their reduced sensitivity compared with PCR has raised questions of how well they identify infectious cases. Understanding their capabilities and limitations is, therefore, essential for successful implementation. We evaluated six commercial LFDs and assessed their correlation with infectious virus culture and PCR cycle threshold (Ct) values. In a single-centre, la","2021","07","07","Lancet Microbe","The Lancet. Microbe",NA,"Malim","Michael H","Department of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, London, UK",NA
"372","34226893","10.1016/S2666-5247(21)00143-9","Comparative performance of SARS-CoV-2 lateral flow antigen tests and association with detection of infectious virus in clinical specimens: a single-centre laboratory evaluation study.","Lateral flow devices (LFDs) for rapid antigen testing are set to become a cornerstone of SARS-CoV-2 mass community testing, although their reduced sensitivity compared with PCR has raised questions of how well they identify infectious cases. Understanding their capabilities and limitations is, therefore, essential for successful implementation. We evaluated six commercial LFDs and assessed their correlation with infectious virus culture and PCR cycle threshold (Ct) values. In a single-centre, la","2021","07","07","Lancet Microbe","The Lancet. Microbe",NA,"Neil","Stuart J D","Department of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, London, UK",NA
"373","34226893","10.1016/S2666-5247(21)00143-9","Comparative performance of SARS-CoV-2 lateral flow antigen tests and association with detection of infectious virus in clinical specimens: a single-centre laboratory evaluation study.","Lateral flow devices (LFDs) for rapid antigen testing are set to become a cornerstone of SARS-CoV-2 mass community testing, although their reduced sensitivity compared with PCR has raised questions of how well they identify infectious cases. Understanding their capabilities and limitations is, therefore, essential for successful implementation. We evaluated six commercial LFDs and assessed their correlation with infectious virus culture and PCR cycle threshold (Ct) values. In a single-centre, la","2021","07","07","Lancet Microbe","The Lancet. Microbe",NA,"Galão","Rui Pedro","Department of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, London, UK",NA
"374","34226892","10.1016/j.bbih.2021.100289","COVID-19 vaccination hesitancy in students and trainees of healthcare professions: A global assessment and call for action.",NA,"2021","07","12","Brain Behav Immun Health","Brain, behavior, &amp; immunity - health","COVID; COVID-19; Coronavirus; Dental; Health; Healthcare; Medical; Nursing; Student; Trainee; Vaccination; Vaccine","Mustapha","Toheeb","Department of Public Health Sciences, New Mexico State University, Las Cruces, NM, 88003, USA",NA
"375","34226892","10.1016/j.bbih.2021.100289","COVID-19 vaccination hesitancy in students and trainees of healthcare professions: A global assessment and call for action.",NA,"2021","07","12","Brain Behav Immun Health","Brain, behavior, &amp; immunity - health","COVID; COVID-19; Coronavirus; Dental; Health; Healthcare; Medical; Nursing; Student; Trainee; Vaccination; Vaccine","Khubchandani","Jagdish","Department of Public Health Sciences, New Mexico State University, Las Cruces, NM, 88003, USA",NA
"376","34226892","10.1016/j.bbih.2021.100289","COVID-19 vaccination hesitancy in students and trainees of healthcare professions: A global assessment and call for action.",NA,"2021","07","12","Brain Behav Immun Health","Brain, behavior, &amp; immunity - health","COVID; COVID-19; Coronavirus; Dental; Health; Healthcare; Medical; Nursing; Student; Trainee; Vaccination; Vaccine","Biswas","Nirbachita","Department of Public Health Sciences, New Mexico State University, Las Cruces, NM, 88003, USA",NA
"377","34226890","10.1016/j.trip.2021.100423","Commuting before and after COVID-19.","Major life events like COVID-19 have the potential to change how people think about and use transport systems. The COVID-19 pandemic has created an extended period of disruption in peoples' lives and could result in long-term changes towards travel attitudes, and use of transport services. There has previously been little research available on changes towards travel attitudes and use of domestic travel as a result of pandemics. To investigate the changes in attitudes to travel resulting from COV","2021","07","12","Transp Res Interdiscip Perspect","Transportation research interdisciplinary perspectives","Air travel; Pandemic; Public transport; Transport system; Transport use; Travel attitude; Travel intentions","Thomas","Francene M F","Transport Research Group, University of Waikato, New Zealand",NA
"378","34226890","10.1016/j.trip.2021.100423","Commuting before and after COVID-19.","Major life events like COVID-19 have the potential to change how people think about and use transport systems. The COVID-19 pandemic has created an extended period of disruption in peoples' lives and could result in long-term changes towards travel attitudes, and use of transport services. There has previously been little research available on changes towards travel attitudes and use of domestic travel as a result of pandemics. To investigate the changes in attitudes to travel resulting from COV","2021","07","12","Transp Res Interdiscip Perspect","Transportation research interdisciplinary perspectives","Air travel; Pandemic; Public transport; Transport system; Transport use; Travel attitude; Travel intentions","Charlton","Samuel G","Transport Research Group, University of Waikato, New Zealand",NA
"379","34226890","10.1016/j.trip.2021.100423","Commuting before and after COVID-19.","Major life events like COVID-19 have the potential to change how people think about and use transport systems. The COVID-19 pandemic has created an extended period of disruption in peoples' lives and could result in long-term changes towards travel attitudes, and use of transport services. There has previously been little research available on changes towards travel attitudes and use of domestic travel as a result of pandemics. To investigate the changes in attitudes to travel resulting from COV","2021","07","12","Transp Res Interdiscip Perspect","Transportation research interdisciplinary perspectives","Air travel; Pandemic; Public transport; Transport system; Transport use; Travel attitude; Travel intentions","Lewis","Ioni","Centre for Accident Research and Road Safety-Queensland, Queensland University of Technology, Australia",NA
"380","34226890","10.1016/j.trip.2021.100423","Commuting before and after COVID-19.","Major life events like COVID-19 have the potential to change how people think about and use transport systems. The COVID-19 pandemic has created an extended period of disruption in peoples' lives and could result in long-term changes towards travel attitudes, and use of transport services. There has previously been little research available on changes towards travel attitudes and use of domestic travel as a result of pandemics. To investigate the changes in attitudes to travel resulting from COV","2021","07","12","Transp Res Interdiscip Perspect","Transportation research interdisciplinary perspectives","Air travel; Pandemic; Public transport; Transport system; Transport use; Travel attitude; Travel intentions","Nandavar","Sonali","Centre for Accident Research and Road Safety-Queensland, Queensland University of Technology, Australia",NA
"381","34226889","10.1016/j.biteb.2021.100756","Repurposing proteases: An <i>in-silico</i> analysis of the binding potential of extracellular fungal proteases with selected viral proteins.","Proteases have long been the target of many drugs, but their potential as therapeutic agents is a well-known, but under-explored area. Due to the heightened threat from new and emerging infectious agents, it is worthwhile to tap into the vast microbial protease resource to identify potential therapeutics. By docking proteases of the fungus Penicillium janthinellum NCIM 1366 with the proteins encoded by the SARS-CoV-2 virus, the enzymes that have the potential to bind with, and thereby deg","2021","07","14","Bioresour Technol Rep","Bioresource technology reports","Antiviral; COVID; Fungal; Penicillium; Protease; Therapeutic","Christopher","Meera","Biofuels and Biorefineries Section, Microbial Processes and Technology Division, CSIR- National Institute for Interdisciplinary Science and Technology, Industrial Estate P.O., Pappanamcode, Thiruvananthapuram 695019, Kerala, India",NA
"382","34226889","10.1016/j.biteb.2021.100756","Repurposing proteases: An <i>in-silico</i> analysis of the binding potential of extracellular fungal proteases with selected viral proteins.","Proteases have long been the target of many drugs, but their potential as therapeutic agents is a well-known, but under-explored area. Due to the heightened threat from new and emerging infectious agents, it is worthwhile to tap into the vast microbial protease resource to identify potential therapeutics. By docking proteases of the fungus Penicillium janthinellum NCIM 1366 with the proteins encoded by the SARS-CoV-2 virus, the enzymes that have the potential to bind with, and thereby deg","2021","07","14","Bioresour Technol Rep","Bioresource technology reports","Antiviral; COVID; Fungal; Penicillium; Protease; Therapeutic","Kooloth-Valappil","Prajeesh","Biofuels and Biorefineries Section, Microbial Processes and Technology Division, CSIR- National Institute for Interdisciplinary Science and Technology, Industrial Estate P.O., Pappanamcode, Thiruvananthapuram 695019, Kerala, India",NA
"383","34226889","10.1016/j.biteb.2021.100756","Repurposing proteases: An <i>in-silico</i> analysis of the binding potential of extracellular fungal proteases with selected viral proteins.","Proteases have long been the target of many drugs, but their potential as therapeutic agents is a well-known, but under-explored area. Due to the heightened threat from new and emerging infectious agents, it is worthwhile to tap into the vast microbial protease resource to identify potential therapeutics. By docking proteases of the fungus Penicillium janthinellum NCIM 1366 with the proteins encoded by the SARS-CoV-2 virus, the enzymes that have the potential to bind with, and thereby deg","2021","07","14","Bioresour Technol Rep","Bioresource technology reports","Antiviral; COVID; Fungal; Penicillium; Protease; Therapeutic","Sreeja-Raju","Athiraraj","Biofuels and Biorefineries Section, Microbial Processes and Technology Division, CSIR- National Institute for Interdisciplinary Science and Technology, Industrial Estate P.O., Pappanamcode, Thiruvananthapuram 695019, Kerala, India",NA
"384","34226889","10.1016/j.biteb.2021.100756","Repurposing proteases: An <i>in-silico</i> analysis of the binding potential of extracellular fungal proteases with selected viral proteins.","Proteases have long been the target of many drugs, but their potential as therapeutic agents is a well-known, but under-explored area. Due to the heightened threat from new and emerging infectious agents, it is worthwhile to tap into the vast microbial protease resource to identify potential therapeutics. By docking proteases of the fungus Penicillium janthinellum NCIM 1366 with the proteins encoded by the SARS-CoV-2 virus, the enzymes that have the potential to bind with, and thereby deg","2021","07","14","Bioresour Technol Rep","Bioresource technology reports","Antiviral; COVID; Fungal; Penicillium; Protease; Therapeutic","Sukumaran","Rajeev K","Biofuels and Biorefineries Section, Microbial Processes and Technology Division, CSIR- National Institute for Interdisciplinary Science and Technology, Industrial Estate P.O., Pappanamcode, Thiruvananthapuram 695019, Kerala, India",NA
"385","34226888","10.1016/j.jobb.2021.06.001","China's COVID-19 vaccine approved for WHO emergency use listing.",NA,"2021","07","12","J Biosaf Biosecur","Journal of biosafety and biosecurity",NA,NA,NA,NA,NA
"386","34226887","10.1002/jac5.1469","Drive-up INR testing and phone-based consultations service during COVID-19 pandemic in a pharmacist-lead anticoagulation clinic in Qatar: Monitoring, clinical, resource utilization, and patient- oriented outcomes.","Coronavirus disease 2019 (COVID-19) pandemic has resulted in unprecedented pressure on healthcare systems and led to widespread utilization of telemedicine or telehealth services. Combined with teleclinics, using drive-up fingerstick International normalized ratio (INR) testing was recommended to decrease exposure risk of anticoagulation patients. To evaluate the impact of transitioning from clinic-based anticoagulation management services to drive-up and phone-based services during COVID-19 pan","2021","07","07","J Am Coll Clin Pharm","Journal of the American College of Clinical Pharmacy : JACCP","COVID-19; anticoagulation; telehealth","Alhmoud","Eman N","Al Wakra Hospital Hamad Medical Corporation Doha Qatar",NA
"387","34226887","10.1002/jac5.1469","Drive-up INR testing and phone-based consultations service during COVID-19 pandemic in a pharmacist-lead anticoagulation clinic in Qatar: Monitoring, clinical, resource utilization, and patient- oriented outcomes.","Coronavirus disease 2019 (COVID-19) pandemic has resulted in unprecedented pressure on healthcare systems and led to widespread utilization of telemedicine or telehealth services. Combined with teleclinics, using drive-up fingerstick International normalized ratio (INR) testing was recommended to decrease exposure risk of anticoagulation patients. To evaluate the impact of transitioning from clinic-based anticoagulation management services to drive-up and phone-based services during COVID-19 pan","2021","07","07","J Am Coll Clin Pharm","Journal of the American College of Clinical Pharmacy : JACCP","COVID-19; anticoagulation; telehealth","Abd El Samad","Osama Badry","Al Wakra Hospital Hamad Medical Corporation Doha Qatar",NA
"388","34226887","10.1002/jac5.1469","Drive-up INR testing and phone-based consultations service during COVID-19 pandemic in a pharmacist-lead anticoagulation clinic in Qatar: Monitoring, clinical, resource utilization, and patient- oriented outcomes.","Coronavirus disease 2019 (COVID-19) pandemic has resulted in unprecedented pressure on healthcare systems and led to widespread utilization of telemedicine or telehealth services. Combined with teleclinics, using drive-up fingerstick International normalized ratio (INR) testing was recommended to decrease exposure risk of anticoagulation patients. To evaluate the impact of transitioning from clinic-based anticoagulation management services to drive-up and phone-based services during COVID-19 pan","2021","07","07","J Am Coll Clin Pharm","Journal of the American College of Clinical Pharmacy : JACCP","COVID-19; anticoagulation; telehealth","Elewa","Hazem","College of Pharmacy, QU Health Qatar University Doha- Qatar",NA
"389","34226887","10.1002/jac5.1469","Drive-up INR testing and phone-based consultations service during COVID-19 pandemic in a pharmacist-lead anticoagulation clinic in Qatar: Monitoring, clinical, resource utilization, and patient- oriented outcomes.","Coronavirus disease 2019 (COVID-19) pandemic has resulted in unprecedented pressure on healthcare systems and led to widespread utilization of telemedicine or telehealth services. Combined with teleclinics, using drive-up fingerstick International normalized ratio (INR) testing was recommended to decrease exposure risk of anticoagulation patients. To evaluate the impact of transitioning from clinic-based anticoagulation management services to drive-up and phone-based services during COVID-19 pan","2021","07","07","J Am Coll Clin Pharm","Journal of the American College of Clinical Pharmacy : JACCP","COVID-19; anticoagulation; telehealth","Alkhozondar","Ola","Al Wakra Hospital Hamad Medical Corporation Doha Qatar",NA
"390","34226887","10.1002/jac5.1469","Drive-up INR testing and phone-based consultations service during COVID-19 pandemic in a pharmacist-lead anticoagulation clinic in Qatar: Monitoring, clinical, resource utilization, and patient- oriented outcomes.","Coronavirus disease 2019 (COVID-19) pandemic has resulted in unprecedented pressure on healthcare systems and led to widespread utilization of telemedicine or telehealth services. Combined with teleclinics, using drive-up fingerstick International normalized ratio (INR) testing was recommended to decrease exposure risk of anticoagulation patients. To evaluate the impact of transitioning from clinic-based anticoagulation management services to drive-up and phone-based services during COVID-19 pan","2021","07","07","J Am Coll Clin Pharm","Journal of the American College of Clinical Pharmacy : JACCP","COVID-19; anticoagulation; telehealth","Soaly","Ezeldin","Al Wakra Hospital Hamad Medical Corporation Doha Qatar",NA
"391","34226887","10.1002/jac5.1469","Drive-up INR testing and phone-based consultations service during COVID-19 pandemic in a pharmacist-lead anticoagulation clinic in Qatar: Monitoring, clinical, resource utilization, and patient- oriented outcomes.","Coronavirus disease 2019 (COVID-19) pandemic has resulted in unprecedented pressure on healthcare systems and led to widespread utilization of telemedicine or telehealth services. Combined with teleclinics, using drive-up fingerstick International normalized ratio (INR) testing was recommended to decrease exposure risk of anticoagulation patients. To evaluate the impact of transitioning from clinic-based anticoagulation management services to drive-up and phone-based services during COVID-19 pan","2021","07","07","J Am Coll Clin Pharm","Journal of the American College of Clinical Pharmacy : JACCP","COVID-19; anticoagulation; telehealth","El Anany","Rasha","Al Wakra Hospital Hamad Medical Corporation Doha Qatar",NA
"392","34226886","10.1002/jac5.1445","Changes to summative skills-based assessments within the Big Ten Academic Alliance Performance-Based Assessment Collaborative (BTAA-PBAC) due to COVID-19.","In Spring 2020 many academic institutions transitioned to remote learning in response to the developing COVID-19 pandemic. These changes affected skills-based training, as schools of pharmacy were forced to transition traditionally in-person assessments to a remote setting. The purpose of this article is to describe the experience of pharmacy skills lab coordinators when transitioning summative skills-based assessments (SSBA). A web-based survey instrument administered through Qualtrics<sup>XM</","2021","07","07","J Am Coll Clin Pharm","Journal of the American College of Clinical Pharmacy : JACCP","COVID-19; United States; clinical; competence; pharmacy; schools; students","Nolan","Mary","Purdue University College of Pharmacy West Lafayette Indiana USA",NA
"393","34226886","10.1002/jac5.1445","Changes to summative skills-based assessments within the Big Ten Academic Alliance Performance-Based Assessment Collaborative (BTAA-PBAC) due to COVID-19.","In Spring 2020 many academic institutions transitioned to remote learning in response to the developing COVID-19 pandemic. These changes affected skills-based training, as schools of pharmacy were forced to transition traditionally in-person assessments to a remote setting. The purpose of this article is to describe the experience of pharmacy skills lab coordinators when transitioning summative skills-based assessments (SSBA). A web-based survey instrument administered through Qualtrics<sup>XM</","2021","07","07","J Am Coll Clin Pharm","Journal of the American College of Clinical Pharmacy : JACCP","COVID-19; United States; clinical; competence; pharmacy; schools; students","Maes","Marina","University of Wisconsin-Madison School of Pharmacy Madison Wisconsin USA",NA
"394","34226886","10.1002/jac5.1445","Changes to summative skills-based assessments within the Big Ten Academic Alliance Performance-Based Assessment Collaborative (BTAA-PBAC) due to COVID-19.","In Spring 2020 many academic institutions transitioned to remote learning in response to the developing COVID-19 pandemic. These changes affected skills-based training, as schools of pharmacy were forced to transition traditionally in-person assessments to a remote setting. The purpose of this article is to describe the experience of pharmacy skills lab coordinators when transitioning summative skills-based assessments (SSBA). A web-based survey instrument administered through Qualtrics<sup>XM</","2021","07","07","J Am Coll Clin Pharm","Journal of the American College of Clinical Pharmacy : JACCP","COVID-19; United States; clinical; competence; pharmacy; schools; students","Tran","Deanna","University of Maryland School of Pharmacy Baltimore Maryland USA",NA
"395","34226886","10.1002/jac5.1445","Changes to summative skills-based assessments within the Big Ten Academic Alliance Performance-Based Assessment Collaborative (BTAA-PBAC) due to COVID-19.","In Spring 2020 many academic institutions transitioned to remote learning in response to the developing COVID-19 pandemic. These changes affected skills-based training, as schools of pharmacy were forced to transition traditionally in-person assessments to a remote setting. The purpose of this article is to describe the experience of pharmacy skills lab coordinators when transitioning summative skills-based assessments (SSBA). A web-based survey instrument administered through Qualtrics<sup>XM</","2021","07","07","J Am Coll Clin Pharm","Journal of the American College of Clinical Pharmacy : JACCP","COVID-19; United States; clinical; competence; pharmacy; schools; students","Driscoll","Tara","University of Illinois Chicago College of Pharmacy Chicago Illinois USA",NA
"396","34226886","10.1002/jac5.1445","Changes to summative skills-based assessments within the Big Ten Academic Alliance Performance-Based Assessment Collaborative (BTAA-PBAC) due to COVID-19.","In Spring 2020 many academic institutions transitioned to remote learning in response to the developing COVID-19 pandemic. These changes affected skills-based training, as schools of pharmacy were forced to transition traditionally in-person assessments to a remote setting. The purpose of this article is to describe the experience of pharmacy skills lab coordinators when transitioning summative skills-based assessments (SSBA). A web-based survey instrument administered through Qualtrics<sup>XM</","2021","07","07","J Am Coll Clin Pharm","Journal of the American College of Clinical Pharmacy : JACCP","COVID-19; United States; clinical; competence; pharmacy; schools; students","Knockel","Laura","The University of Iowa College of Pharmacy Iowa City Iowa USA",NA
"397","34226886","10.1002/jac5.1445","Changes to summative skills-based assessments within the Big Ten Academic Alliance Performance-Based Assessment Collaborative (BTAA-PBAC) due to COVID-19.","In Spring 2020 many academic institutions transitioned to remote learning in response to the developing COVID-19 pandemic. These changes affected skills-based training, as schools of pharmacy were forced to transition traditionally in-person assessments to a remote setting. The purpose of this article is to describe the experience of pharmacy skills lab coordinators when transitioning summative skills-based assessments (SSBA). A web-based survey instrument administered through Qualtrics<sup>XM</","2021","07","07","J Am Coll Clin Pharm","Journal of the American College of Clinical Pharmacy : JACCP","COVID-19; United States; clinical; competence; pharmacy; schools; students","Van Hooser","Jared","University of Minnesota College of Pharmacy Duluth Minnesota USA",NA
"398","34226886","10.1002/jac5.1445","Changes to summative skills-based assessments within the Big Ten Academic Alliance Performance-Based Assessment Collaborative (BTAA-PBAC) due to COVID-19.","In Spring 2020 many academic institutions transitioned to remote learning in response to the developing COVID-19 pandemic. These changes affected skills-based training, as schools of pharmacy were forced to transition traditionally in-person assessments to a remote setting. The purpose of this article is to describe the experience of pharmacy skills lab coordinators when transitioning summative skills-based assessments (SSBA). A web-based survey instrument administered through Qualtrics<sup>XM</","2021","07","07","J Am Coll Clin Pharm","Journal of the American College of Clinical Pharmacy : JACCP","COVID-19; United States; clinical; competence; pharmacy; schools; students","Dula","Colleen","The Ohio State University College of Pharmacy Columbus Ohio USA",NA
"399","34226886","10.1002/jac5.1445","Changes to summative skills-based assessments within the Big Ten Academic Alliance Performance-Based Assessment Collaborative (BTAA-PBAC) due to COVID-19.","In Spring 2020 many academic institutions transitioned to remote learning in response to the developing COVID-19 pandemic. These changes affected skills-based training, as schools of pharmacy were forced to transition traditionally in-person assessments to a remote setting. The purpose of this article is to describe the experience of pharmacy skills lab coordinators when transitioning summative skills-based assessments (SSBA). A web-based survey instrument administered through Qualtrics<sup>XM</","2021","07","07","J Am Coll Clin Pharm","Journal of the American College of Clinical Pharmacy : JACCP","COVID-19; United States; clinical; competence; pharmacy; schools; students","Cook","Kristen","University of Nebraska Medical Center College of Pharmacy Omaha Nebraska USA",NA
"400","34226886","10.1002/jac5.1445","Changes to summative skills-based assessments within the Big Ten Academic Alliance Performance-Based Assessment Collaborative (BTAA-PBAC) due to COVID-19.","In Spring 2020 many academic institutions transitioned to remote learning in response to the developing COVID-19 pandemic. These changes affected skills-based training, as schools of pharmacy were forced to transition traditionally in-person assessments to a remote setting. The purpose of this article is to describe the experience of pharmacy skills lab coordinators when transitioning summative skills-based assessments (SSBA). A web-based survey instrument administered through Qualtrics<sup>XM</","2021","07","07","J Am Coll Clin Pharm","Journal of the American College of Clinical Pharmacy : JACCP","COVID-19; United States; clinical; competence; pharmacy; schools; students","Stoa","Morgan","University of Minnesota College of Pharmacy Duluth Minnesota USA",NA
"401","34226886","10.1002/jac5.1445","Changes to summative skills-based assessments within the Big Ten Academic Alliance Performance-Based Assessment Collaborative (BTAA-PBAC) due to COVID-19.","In Spring 2020 many academic institutions transitioned to remote learning in response to the developing COVID-19 pandemic. These changes affected skills-based training, as schools of pharmacy were forced to transition traditionally in-person assessments to a remote setting. The purpose of this article is to describe the experience of pharmacy skills lab coordinators when transitioning summative skills-based assessments (SSBA). A web-based survey instrument administered through Qualtrics<sup>XM</","2021","07","07","J Am Coll Clin Pharm","Journal of the American College of Clinical Pharmacy : JACCP","COVID-19; United States; clinical; competence; pharmacy; schools; students","Ives","Amy","University of Maryland School of Pharmacy Baltimore Maryland USA",NA
"402","34226886","10.1002/jac5.1445","Changes to summative skills-based assessments within the Big Ten Academic Alliance Performance-Based Assessment Collaborative (BTAA-PBAC) due to COVID-19.","In Spring 2020 many academic institutions transitioned to remote learning in response to the developing COVID-19 pandemic. These changes affected skills-based training, as schools of pharmacy were forced to transition traditionally in-person assessments to a remote setting. The purpose of this article is to describe the experience of pharmacy skills lab coordinators when transitioning summative skills-based assessments (SSBA). A web-based survey instrument administered through Qualtrics<sup>XM</","2021","07","07","J Am Coll Clin Pharm","Journal of the American College of Clinical Pharmacy : JACCP","COVID-19; United States; clinical; competence; pharmacy; schools; students","Volino","Lucio","Rutgers University Ernest Mario School of Pharmacy Piscataway New Jersey USA",NA
"403","34226886","10.1002/jac5.1445","Changes to summative skills-based assessments within the Big Ten Academic Alliance Performance-Based Assessment Collaborative (BTAA-PBAC) due to COVID-19.","In Spring 2020 many academic institutions transitioned to remote learning in response to the developing COVID-19 pandemic. These changes affected skills-based training, as schools of pharmacy were forced to transition traditionally in-person assessments to a remote setting. The purpose of this article is to describe the experience of pharmacy skills lab coordinators when transitioning summative skills-based assessments (SSBA). A web-based survey instrument administered through Qualtrics<sup>XM</","2021","07","07","J Am Coll Clin Pharm","Journal of the American College of Clinical Pharmacy : JACCP","COVID-19; United States; clinical; competence; pharmacy; schools; students","Rupnow","Nichole","University of Minnesota College of Pharmacy Duluth Minnesota USA",NA
"404","34226886","10.1002/jac5.1445","Changes to summative skills-based assessments within the Big Ten Academic Alliance Performance-Based Assessment Collaborative (BTAA-PBAC) due to COVID-19.","In Spring 2020 many academic institutions transitioned to remote learning in response to the developing COVID-19 pandemic. These changes affected skills-based training, as schools of pharmacy were forced to transition traditionally in-person assessments to a remote setting. The purpose of this article is to describe the experience of pharmacy skills lab coordinators when transitioning summative skills-based assessments (SSBA). A web-based survey instrument administered through Qualtrics<sup>XM</","2021","07","07","J Am Coll Clin Pharm","Journal of the American College of Clinical Pharmacy : JACCP","COVID-19; United States; clinical; competence; pharmacy; schools; students","Parbuoni","Kristine","University of Maryland School of Pharmacy Baltimore Maryland USA",NA
"405","34226886","10.1002/jac5.1445","Changes to summative skills-based assessments within the Big Ten Academic Alliance Performance-Based Assessment Collaborative (BTAA-PBAC) due to COVID-19.","In Spring 2020 many academic institutions transitioned to remote learning in response to the developing COVID-19 pandemic. These changes affected skills-based training, as schools of pharmacy were forced to transition traditionally in-person assessments to a remote setting. The purpose of this article is to describe the experience of pharmacy skills lab coordinators when transitioning summative skills-based assessments (SSBA). A web-based survey instrument administered through Qualtrics<sup>XM</","2021","07","07","J Am Coll Clin Pharm","Journal of the American College of Clinical Pharmacy : JACCP","COVID-19; United States; clinical; competence; pharmacy; schools; students","Woodyard","Jamie L","Purdue University College of Pharmacy West Lafayette Indiana USA",NA
"406","34226885","10.1002/jac5.1470","Implementation of warfarin to direct oral anticoagulant conversion initiative in pharmacist-run anticoagulation clinics during COVID-19 pandemic.","Due to community transmission of coronavirus disease 2019 (COVID-19), social distancing and stay-at-home orders were implemented statewide in an effort to limit the spread of disease. This posed unique challenges for patients on medications requiring close and continued monitoring by clinic staff, such as anticoagulation clinics. Thus, innovative measures were implemented at Cleveland Clinic Health System (CCHS) to maintain the health and care of ambulatory patients. An initiative to evaluate pa","2021","07","07","J Am Coll Clin Pharm","Journal of the American College of Clinical Pharmacy : JACCP","COVID-19; DOAC; ambulatory care; anticoagulation; pharmacy services; warfarin","Kish","Katie","Department of Pharmacy Cleveland Clinic - Main Campus Cleveland Ohio USA",NA
"407","34226885","10.1002/jac5.1470","Implementation of warfarin to direct oral anticoagulant conversion initiative in pharmacist-run anticoagulation clinics during COVID-19 pandemic.","Due to community transmission of coronavirus disease 2019 (COVID-19), social distancing and stay-at-home orders were implemented statewide in an effort to limit the spread of disease. This posed unique challenges for patients on medications requiring close and continued monitoring by clinic staff, such as anticoagulation clinics. Thus, innovative measures were implemented at Cleveland Clinic Health System (CCHS) to maintain the health and care of ambulatory patients. An initiative to evaluate pa","2021","07","07","J Am Coll Clin Pharm","Journal of the American College of Clinical Pharmacy : JACCP","COVID-19; DOAC; ambulatory care; anticoagulation; pharmacy services; warfarin","Lekic","Sanela","Department of Pharmacy Cleveland Clinic - Beachwood Beachwood Ohio USA",NA
"408","34226884","10.1016/j.mayocpiqo.2021.06.006","Physician Satisfaction with Telemedicine during the COVID-19 Pandemic: The Mayo Clinic Florida Experience.","To evaluate physician perceptions and attitudes toward telemedicine use at a tertiary care academic institution in Northeast Florida during the COVID-19 pandemic. An anonymous 38-question cross-sectional survey was developed using Qualtrics and emailed to all staff physicians from all specialty disciplines at the Mayo Clinic Florida. The survey was open from August 17, 2020 through September 1, 2020. Collected data included general demographics and employment information, attitude and experience","2021","07","06","Mayo Clin Proc Innov Qual Outcomes","Mayo Clinic proceedings. Innovations, quality &amp; outcomes","COVID-19, Coronavirus Disease 2019; FTE, Full Time Equivalent; HIPAA, Health Insurance Portability and Accountability Act; NHS, National Health Service; TAM2, Technology Acceptance Model 2; UTAUT, Unified Theory of Acceptance and Use of Technology","Malouff","Timothy D","Department of Radiation Oncology, Mayo Clinic, Jacksonville, FL, USA",NA
"409","34226884","10.1016/j.mayocpiqo.2021.06.006","Physician Satisfaction with Telemedicine during the COVID-19 Pandemic: The Mayo Clinic Florida Experience.","To evaluate physician perceptions and attitudes toward telemedicine use at a tertiary care academic institution in Northeast Florida during the COVID-19 pandemic. An anonymous 38-question cross-sectional survey was developed using Qualtrics and emailed to all staff physicians from all specialty disciplines at the Mayo Clinic Florida. The survey was open from August 17, 2020 through September 1, 2020. Collected data included general demographics and employment information, attitude and experience","2021","07","06","Mayo Clin Proc Innov Qual Outcomes","Mayo Clinic proceedings. Innovations, quality &amp; outcomes","COVID-19, Coronavirus Disease 2019; FTE, Full Time Equivalent; HIPAA, Health Insurance Portability and Accountability Act; NHS, National Health Service; TAM2, Technology Acceptance Model 2; UTAUT, Unified Theory of Acceptance and Use of Technology","TerKonda","Sarvam P","Division of Plastic Surgery, Mayo Clinic, Jacksonville, FL, USA",NA
"410","34226884","10.1016/j.mayocpiqo.2021.06.006","Physician Satisfaction with Telemedicine during the COVID-19 Pandemic: The Mayo Clinic Florida Experience.","To evaluate physician perceptions and attitudes toward telemedicine use at a tertiary care academic institution in Northeast Florida during the COVID-19 pandemic. An anonymous 38-question cross-sectional survey was developed using Qualtrics and emailed to all staff physicians from all specialty disciplines at the Mayo Clinic Florida. The survey was open from August 17, 2020 through September 1, 2020. Collected data included general demographics and employment information, attitude and experience","2021","07","06","Mayo Clin Proc Innov Qual Outcomes","Mayo Clinic proceedings. Innovations, quality &amp; outcomes","COVID-19, Coronavirus Disease 2019; FTE, Full Time Equivalent; HIPAA, Health Insurance Portability and Accountability Act; NHS, National Health Service; TAM2, Technology Acceptance Model 2; UTAUT, Unified Theory of Acceptance and Use of Technology","Knight","Dacre","Division of General Internal Medicine, Mayo Clinic, Jacksonville, FL, USA",NA
"411","34226884","10.1016/j.mayocpiqo.2021.06.006","Physician Satisfaction with Telemedicine during the COVID-19 Pandemic: The Mayo Clinic Florida Experience.","To evaluate physician perceptions and attitudes toward telemedicine use at a tertiary care academic institution in Northeast Florida during the COVID-19 pandemic. An anonymous 38-question cross-sectional survey was developed using Qualtrics and emailed to all staff physicians from all specialty disciplines at the Mayo Clinic Florida. The survey was open from August 17, 2020 through September 1, 2020. Collected data included general demographics and employment information, attitude and experience","2021","07","06","Mayo Clin Proc Innov Qual Outcomes","Mayo Clinic proceedings. Innovations, quality &amp; outcomes","COVID-19, Coronavirus Disease 2019; FTE, Full Time Equivalent; HIPAA, Health Insurance Portability and Accountability Act; NHS, National Health Service; TAM2, Technology Acceptance Model 2; UTAUT, Unified Theory of Acceptance and Use of Technology","Abu Dabrh","Abd Moain","Division of General Internal Medicine, Mayo Clinic, Jacksonville, FL, USA",NA
"412","34226884","10.1016/j.mayocpiqo.2021.06.006","Physician Satisfaction with Telemedicine during the COVID-19 Pandemic: The Mayo Clinic Florida Experience.","To evaluate physician perceptions and attitudes toward telemedicine use at a tertiary care academic institution in Northeast Florida during the COVID-19 pandemic. An anonymous 38-question cross-sectional survey was developed using Qualtrics and emailed to all staff physicians from all specialty disciplines at the Mayo Clinic Florida. The survey was open from August 17, 2020 through September 1, 2020. Collected data included general demographics and employment information, attitude and experience","2021","07","06","Mayo Clin Proc Innov Qual Outcomes","Mayo Clinic proceedings. Innovations, quality &amp; outcomes","COVID-19, Coronavirus Disease 2019; FTE, Full Time Equivalent; HIPAA, Health Insurance Portability and Accountability Act; NHS, National Health Service; TAM2, Technology Acceptance Model 2; UTAUT, Unified Theory of Acceptance and Use of Technology","Perlman","Adam I","Division of General Internal Medicine, Mayo Clinic, Jacksonville, FL, USA",NA
"413","34226884","10.1016/j.mayocpiqo.2021.06.006","Physician Satisfaction with Telemedicine during the COVID-19 Pandemic: The Mayo Clinic Florida Experience.","To evaluate physician perceptions and attitudes toward telemedicine use at a tertiary care academic institution in Northeast Florida during the COVID-19 pandemic. An anonymous 38-question cross-sectional survey was developed using Qualtrics and emailed to all staff physicians from all specialty disciplines at the Mayo Clinic Florida. The survey was open from August 17, 2020 through September 1, 2020. Collected data included general demographics and employment information, attitude and experience","2021","07","06","Mayo Clin Proc Innov Qual Outcomes","Mayo Clinic proceedings. Innovations, quality &amp; outcomes","COVID-19, Coronavirus Disease 2019; FTE, Full Time Equivalent; HIPAA, Health Insurance Portability and Accountability Act; NHS, National Health Service; TAM2, Technology Acceptance Model 2; UTAUT, Unified Theory of Acceptance and Use of Technology","Munipalli","Bala","Division of General Internal Medicine, Mayo Clinic, Jacksonville, FL, USA",NA
"414","34226884","10.1016/j.mayocpiqo.2021.06.006","Physician Satisfaction with Telemedicine during the COVID-19 Pandemic: The Mayo Clinic Florida Experience.","To evaluate physician perceptions and attitudes toward telemedicine use at a tertiary care academic institution in Northeast Florida during the COVID-19 pandemic. An anonymous 38-question cross-sectional survey was developed using Qualtrics and emailed to all staff physicians from all specialty disciplines at the Mayo Clinic Florida. The survey was open from August 17, 2020 through September 1, 2020. Collected data included general demographics and employment information, attitude and experience","2021","07","06","Mayo Clin Proc Innov Qual Outcomes","Mayo Clinic proceedings. Innovations, quality &amp; outcomes","COVID-19, Coronavirus Disease 2019; FTE, Full Time Equivalent; HIPAA, Health Insurance Portability and Accountability Act; NHS, National Health Service; TAM2, Technology Acceptance Model 2; UTAUT, Unified Theory of Acceptance and Use of Technology","Dudenkov","Daniel V","Division of General Internal Medicine, Mayo Clinic, Jacksonville, FL, USA",NA
"415","34226884","10.1016/j.mayocpiqo.2021.06.006","Physician Satisfaction with Telemedicine during the COVID-19 Pandemic: The Mayo Clinic Florida Experience.","To evaluate physician perceptions and attitudes toward telemedicine use at a tertiary care academic institution in Northeast Florida during the COVID-19 pandemic. An anonymous 38-question cross-sectional survey was developed using Qualtrics and emailed to all staff physicians from all specialty disciplines at the Mayo Clinic Florida. The survey was open from August 17, 2020 through September 1, 2020. Collected data included general demographics and employment information, attitude and experience","2021","07","06","Mayo Clin Proc Innov Qual Outcomes","Mayo Clinic proceedings. Innovations, quality &amp; outcomes","COVID-19, Coronavirus Disease 2019; FTE, Full Time Equivalent; HIPAA, Health Insurance Portability and Accountability Act; NHS, National Health Service; TAM2, Technology Acceptance Model 2; UTAUT, Unified Theory of Acceptance and Use of Technology","Heckman","Michael G","Division of Biomedical Sciences and Informatics, Mayo Clinic, Jacksonville, FL",NA
"416","34226884","10.1016/j.mayocpiqo.2021.06.006","Physician Satisfaction with Telemedicine during the COVID-19 Pandemic: The Mayo Clinic Florida Experience.","To evaluate physician perceptions and attitudes toward telemedicine use at a tertiary care academic institution in Northeast Florida during the COVID-19 pandemic. An anonymous 38-question cross-sectional survey was developed using Qualtrics and emailed to all staff physicians from all specialty disciplines at the Mayo Clinic Florida. The survey was open from August 17, 2020 through September 1, 2020. Collected data included general demographics and employment information, attitude and experience","2021","07","06","Mayo Clin Proc Innov Qual Outcomes","Mayo Clinic proceedings. Innovations, quality &amp; outcomes","COVID-19, Coronavirus Disease 2019; FTE, Full Time Equivalent; HIPAA, Health Insurance Portability and Accountability Act; NHS, National Health Service; TAM2, Technology Acceptance Model 2; UTAUT, Unified Theory of Acceptance and Use of Technology","White","Launia J","Division of Biomedical Sciences and Informatics, Mayo Clinic, Jacksonville, FL",NA
"417","34226884","10.1016/j.mayocpiqo.2021.06.006","Physician Satisfaction with Telemedicine during the COVID-19 Pandemic: The Mayo Clinic Florida Experience.","To evaluate physician perceptions and attitudes toward telemedicine use at a tertiary care academic institution in Northeast Florida during the COVID-19 pandemic. An anonymous 38-question cross-sectional survey was developed using Qualtrics and emailed to all staff physicians from all specialty disciplines at the Mayo Clinic Florida. The survey was open from August 17, 2020 through September 1, 2020. Collected data included general demographics and employment information, attitude and experience","2021","07","06","Mayo Clin Proc Innov Qual Outcomes","Mayo Clinic proceedings. Innovations, quality &amp; outcomes","COVID-19, Coronavirus Disease 2019; FTE, Full Time Equivalent; HIPAA, Health Insurance Portability and Accountability Act; NHS, National Health Service; TAM2, Technology Acceptance Model 2; UTAUT, Unified Theory of Acceptance and Use of Technology","Wert","Katey M","Department of Radiation Oncology, Mayo Clinic, Jacksonville, FL, USA",NA
"418","34226884","10.1016/j.mayocpiqo.2021.06.006","Physician Satisfaction with Telemedicine during the COVID-19 Pandemic: The Mayo Clinic Florida Experience.","To evaluate physician perceptions and attitudes toward telemedicine use at a tertiary care academic institution in Northeast Florida during the COVID-19 pandemic. An anonymous 38-question cross-sectional survey was developed using Qualtrics and emailed to all staff physicians from all specialty disciplines at the Mayo Clinic Florida. The survey was open from August 17, 2020 through September 1, 2020. Collected data included general demographics and employment information, attitude and experience","2021","07","06","Mayo Clin Proc Innov Qual Outcomes","Mayo Clinic proceedings. Innovations, quality &amp; outcomes","COVID-19, Coronavirus Disease 2019; FTE, Full Time Equivalent; HIPAA, Health Insurance Portability and Accountability Act; NHS, National Health Service; TAM2, Technology Acceptance Model 2; UTAUT, Unified Theory of Acceptance and Use of Technology","Pascual","Jorge M","Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Jacksonville, FL, USA",NA
"419","34226884","10.1016/j.mayocpiqo.2021.06.006","Physician Satisfaction with Telemedicine during the COVID-19 Pandemic: The Mayo Clinic Florida Experience.","To evaluate physician perceptions and attitudes toward telemedicine use at a tertiary care academic institution in Northeast Florida during the COVID-19 pandemic. An anonymous 38-question cross-sectional survey was developed using Qualtrics and emailed to all staff physicians from all specialty disciplines at the Mayo Clinic Florida. The survey was open from August 17, 2020 through September 1, 2020. Collected data included general demographics and employment information, attitude and experience","2021","07","06","Mayo Clin Proc Innov Qual Outcomes","Mayo Clinic proceedings. Innovations, quality &amp; outcomes","COVID-19, Coronavirus Disease 2019; FTE, Full Time Equivalent; HIPAA, Health Insurance Portability and Accountability Act; NHS, National Health Service; TAM2, Technology Acceptance Model 2; UTAUT, Unified Theory of Acceptance and Use of Technology","Rivera","Fernando A","Division of General Internal Medicine, Mayo Clinic, Jacksonville, FL, USA",NA
"420","34226884","10.1016/j.mayocpiqo.2021.06.006","Physician Satisfaction with Telemedicine during the COVID-19 Pandemic: The Mayo Clinic Florida Experience.","To evaluate physician perceptions and attitudes toward telemedicine use at a tertiary care academic institution in Northeast Florida during the COVID-19 pandemic. An anonymous 38-question cross-sectional survey was developed using Qualtrics and emailed to all staff physicians from all specialty disciplines at the Mayo Clinic Florida. The survey was open from August 17, 2020 through September 1, 2020. Collected data included general demographics and employment information, attitude and experience","2021","07","06","Mayo Clin Proc Innov Qual Outcomes","Mayo Clinic proceedings. Innovations, quality &amp; outcomes","COVID-19, Coronavirus Disease 2019; FTE, Full Time Equivalent; HIPAA, Health Insurance Portability and Accountability Act; NHS, National Health Service; TAM2, Technology Acceptance Model 2; UTAUT, Unified Theory of Acceptance and Use of Technology","Shoaei","Michelle M","Administrative Operations, Mayo Clinic, Jacksonville, FL USA",NA
"421","34226884","10.1016/j.mayocpiqo.2021.06.006","Physician Satisfaction with Telemedicine during the COVID-19 Pandemic: The Mayo Clinic Florida Experience.","To evaluate physician perceptions and attitudes toward telemedicine use at a tertiary care academic institution in Northeast Florida during the COVID-19 pandemic. An anonymous 38-question cross-sectional survey was developed using Qualtrics and emailed to all staff physicians from all specialty disciplines at the Mayo Clinic Florida. The survey was open from August 17, 2020 through September 1, 2020. Collected data included general demographics and employment information, attitude and experience","2021","07","06","Mayo Clin Proc Innov Qual Outcomes","Mayo Clinic proceedings. Innovations, quality &amp; outcomes","COVID-19, Coronavirus Disease 2019; FTE, Full Time Equivalent; HIPAA, Health Insurance Portability and Accountability Act; NHS, National Health Service; TAM2, Technology Acceptance Model 2; UTAUT, Unified Theory of Acceptance and Use of Technology","Leak","Michelle A","Administrative Operations, Mayo Clinic, Jacksonville, FL USA",NA
"422","34226884","10.1016/j.mayocpiqo.2021.06.006","Physician Satisfaction with Telemedicine during the COVID-19 Pandemic: The Mayo Clinic Florida Experience.","To evaluate physician perceptions and attitudes toward telemedicine use at a tertiary care academic institution in Northeast Florida during the COVID-19 pandemic. An anonymous 38-question cross-sectional survey was developed using Qualtrics and emailed to all staff physicians from all specialty disciplines at the Mayo Clinic Florida. The survey was open from August 17, 2020 through September 1, 2020. Collected data included general demographics and employment information, attitude and experience","2021","07","06","Mayo Clin Proc Innov Qual Outcomes","Mayo Clinic proceedings. Innovations, quality &amp; outcomes","COVID-19, Coronavirus Disease 2019; FTE, Full Time Equivalent; HIPAA, Health Insurance Portability and Accountability Act; NHS, National Health Service; TAM2, Technology Acceptance Model 2; UTAUT, Unified Theory of Acceptance and Use of Technology","Harrell","Anna C","Department of Radiation Oncology, Mayo Clinic, Jacksonville, FL, USA",NA
"423","34226884","10.1016/j.mayocpiqo.2021.06.006","Physician Satisfaction with Telemedicine during the COVID-19 Pandemic: The Mayo Clinic Florida Experience.","To evaluate physician perceptions and attitudes toward telemedicine use at a tertiary care academic institution in Northeast Florida during the COVID-19 pandemic. An anonymous 38-question cross-sectional survey was developed using Qualtrics and emailed to all staff physicians from all specialty disciplines at the Mayo Clinic Florida. The survey was open from August 17, 2020 through September 1, 2020. Collected data included general demographics and employment information, attitude and experience","2021","07","06","Mayo Clin Proc Innov Qual Outcomes","Mayo Clinic proceedings. Innovations, quality &amp; outcomes","COVID-19, Coronavirus Disease 2019; FTE, Full Time Equivalent; HIPAA, Health Insurance Portability and Accountability Act; NHS, National Health Service; TAM2, Technology Acceptance Model 2; UTAUT, Unified Theory of Acceptance and Use of Technology","Trifiletti","Daniel M","Department of Radiation Oncology, Mayo Clinic, Jacksonville, FL, USA",NA
"424","34226884","10.1016/j.mayocpiqo.2021.06.006","Physician Satisfaction with Telemedicine during the COVID-19 Pandemic: The Mayo Clinic Florida Experience.","To evaluate physician perceptions and attitudes toward telemedicine use at a tertiary care academic institution in Northeast Florida during the COVID-19 pandemic. An anonymous 38-question cross-sectional survey was developed using Qualtrics and emailed to all staff physicians from all specialty disciplines at the Mayo Clinic Florida. The survey was open from August 17, 2020 through September 1, 2020. Collected data included general demographics and employment information, attitude and experience","2021","07","06","Mayo Clin Proc Innov Qual Outcomes","Mayo Clinic proceedings. Innovations, quality &amp; outcomes","COVID-19, Coronavirus Disease 2019; FTE, Full Time Equivalent; HIPAA, Health Insurance Portability and Accountability Act; NHS, National Health Service; TAM2, Technology Acceptance Model 2; UTAUT, Unified Theory of Acceptance and Use of Technology","Buskirk","Steven J","Department of Radiation Oncology, Mayo Clinic, Jacksonville, FL, USA",NA
"425","34226883","10.1136/gpsych-2021-100565","Isolation and mental health: challenges and experiences from China.",NA,"2021","07","07","Gen Psychiatr","General psychiatry","COVID-19; mental health; social Isolation","Wang","Xing","Clinical Research Center, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China",NA
"426","34226883","10.1136/gpsych-2021-100565","Isolation and mental health: challenges and experiences from China.",NA,"2021","07","07","Gen Psychiatr","General psychiatry","COVID-19; mental health; social Isolation","Chen","Jun","Clinical Research Center, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China",NA
"427","34226882","10.1016/j.heliyon.2021.e07416","Prediction model for the spread of the COVID-19 outbreak in the global environment.","COVID-19 has long become a worldwide pandemic. It is responsible for the death of over two million people and posed an economic recession. This paper studies the spread pattern of COVID-19, aiming to establish a prediction model for this event. We harness Data Mining and Machine Learning methodologies to train regression models to predict the number of confirmed cases in a spatial-temporal space. We introduce an innovative concept - the Center of Infection Mass (CoIM) - adapted from the field of","2021","07","07","Heliyon","Heliyon","COVID-19; Data mining; Decision support systems; Machine learning; Prediction methods","Hirschprung","Ron S","Department of Industrial Engineering and Management, Ariel University, Israel",NA
"428","34226882","10.1016/j.heliyon.2021.e07416","Prediction model for the spread of the COVID-19 outbreak in the global environment.","COVID-19 has long become a worldwide pandemic. It is responsible for the death of over two million people and posed an economic recession. This paper studies the spread pattern of COVID-19, aiming to establish a prediction model for this event. We harness Data Mining and Machine Learning methodologies to train regression models to predict the number of confirmed cases in a spatial-temporal space. We introduce an innovative concept - the Center of Infection Mass (CoIM) - adapted from the field of","2021","07","07","Heliyon","Heliyon","COVID-19; Data mining; Decision support systems; Machine learning; Prediction methods","Hajaj","Chen","Department of Industrial Engineering and Management, Ariel University, Israel",NA
"429","34226881","10.1016/j.heliyon.2021.e07443","Use of local perforator flaps for closure of a thoraco-omphalopagus conjoined twin defect after separation during the COVID-19 pandemic.","Conjoined twins are a rare medical phenomenon that poses unique challenges for surgeons. Separation of conjoined twins involves multidisciplinary teamwork, complex medical management and surgical planning, and multi-stage operations and often still has a high mortality and morbidity rate. In the times of the COVID-19 pandemic, separation of conjoined twins pose even greater challenges. Aiming for the best outcome possible, while minimizing the risk of COVID transmission and ensuring the safety o","2021","07","12","Heliyon","Heliyon","COVID-19; Case report; Negative pressure wound therapy; Perforator flaps; Thoraco-omphalopagus conjoined twins","Putri","Nandita Melati","Division of Plastic, Reconstructive, and Aesthetic Surgery, Department of Surgery, Dr. Cipto Mangunkusumo Hospital, Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia",NA
"430","34226881","10.1016/j.heliyon.2021.e07443","Use of local perforator flaps for closure of a thoraco-omphalopagus conjoined twin defect after separation during the COVID-19 pandemic.","Conjoined twins are a rare medical phenomenon that poses unique challenges for surgeons. Separation of conjoined twins involves multidisciplinary teamwork, complex medical management and surgical planning, and multi-stage operations and often still has a high mortality and morbidity rate. In the times of the COVID-19 pandemic, separation of conjoined twins pose even greater challenges. Aiming for the best outcome possible, while minimizing the risk of COVID transmission and ensuring the safety o","2021","07","12","Heliyon","Heliyon","COVID-19; Case report; Negative pressure wound therapy; Perforator flaps; Thoraco-omphalopagus conjoined twins","Kreshanti","Prasetyanugraheni","Division of Plastic, Reconstructive, and Aesthetic Surgery, Department of Surgery, Dr. Cipto Mangunkusumo Hospital, Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia",NA
"431","34226881","10.1016/j.heliyon.2021.e07443","Use of local perforator flaps for closure of a thoraco-omphalopagus conjoined twin defect after separation during the COVID-19 pandemic.","Conjoined twins are a rare medical phenomenon that poses unique challenges for surgeons. Separation of conjoined twins involves multidisciplinary teamwork, complex medical management and surgical planning, and multi-stage operations and often still has a high mortality and morbidity rate. In the times of the COVID-19 pandemic, separation of conjoined twins pose even greater challenges. Aiming for the best outcome possible, while minimizing the risk of COVID transmission and ensuring the safety o","2021","07","12","Heliyon","Heliyon","COVID-19; Case report; Negative pressure wound therapy; Perforator flaps; Thoraco-omphalopagus conjoined twins","Aulia","Indri","Division of Plastic, Reconstructive, and Aesthetic Surgery, Department of Surgery, Dr. Cipto Mangunkusumo Hospital, Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia",NA
"432","34226881","10.1016/j.heliyon.2021.e07443","Use of local perforator flaps for closure of a thoraco-omphalopagus conjoined twin defect after separation during the COVID-19 pandemic.","Conjoined twins are a rare medical phenomenon that poses unique challenges for surgeons. Separation of conjoined twins involves multidisciplinary teamwork, complex medical management and surgical planning, and multi-stage operations and often still has a high mortality and morbidity rate. In the times of the COVID-19 pandemic, separation of conjoined twins pose even greater challenges. Aiming for the best outcome possible, while minimizing the risk of COVID transmission and ensuring the safety o","2021","07","12","Heliyon","Heliyon","COVID-19; Case report; Negative pressure wound therapy; Perforator flaps; Thoraco-omphalopagus conjoined twins","Syarif","Akhmad Noviandi","Division of Plastic, Reconstructive, and Aesthetic Surgery, Department of Surgery, Dr. Cipto Mangunkusumo Hospital, Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia",NA
"433","34226881","10.1016/j.heliyon.2021.e07443","Use of local perforator flaps for closure of a thoraco-omphalopagus conjoined twin defect after separation during the COVID-19 pandemic.","Conjoined twins are a rare medical phenomenon that poses unique challenges for surgeons. Separation of conjoined twins involves multidisciplinary teamwork, complex medical management and surgical planning, and multi-stage operations and often still has a high mortality and morbidity rate. In the times of the COVID-19 pandemic, separation of conjoined twins pose even greater challenges. Aiming for the best outcome possible, while minimizing the risk of COVID transmission and ensuring the safety o","2021","07","12","Heliyon","Heliyon","COVID-19; Case report; Negative pressure wound therapy; Perforator flaps; Thoraco-omphalopagus conjoined twins","Tunjung","Narottama","Division of Plastic, Reconstructive, and Aesthetic Surgery, Department of Surgery, Dr. Cipto Mangunkusumo Hospital, Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia",NA
"434","34226881","10.1016/j.heliyon.2021.e07443","Use of local perforator flaps for closure of a thoraco-omphalopagus conjoined twin defect after separation during the COVID-19 pandemic.","Conjoined twins are a rare medical phenomenon that poses unique challenges for surgeons. Separation of conjoined twins involves multidisciplinary teamwork, complex medical management and surgical planning, and multi-stage operations and often still has a high mortality and morbidity rate. In the times of the COVID-19 pandemic, separation of conjoined twins pose even greater challenges. Aiming for the best outcome possible, while minimizing the risk of COVID transmission and ensuring the safety o","2021","07","12","Heliyon","Heliyon","COVID-19; Case report; Negative pressure wound therapy; Perforator flaps; Thoraco-omphalopagus conjoined twins","Sukasah","Chaula Luthfia","Division of Plastic, Reconstructive, and Aesthetic Surgery, Department of Surgery, Dr. Cipto Mangunkusumo Hospital, Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia",NA
"435","34226880","10.1016/j.ctro.2021.06.002","A multi-centre survey reveals variations in the standard treatments and treatment modifications for head and neck cancer patients during Covid-19 pandemic.","The onset of the COVID-19 pandemic necessitated rapid changes to the practice of head and neck oncology in UK. There was a delay between the onset of the pandemic and the release of guidelines from cancer societies and networks, leading to a variable response of individual centres. This survey was conducted to assess the pre-Covid-19 pandemic standard of practice for head and neck oncology patients and the treatment modifications introduced during the first wave of the pandemic in UK. The UK Nat","2021","07","20","Clin Transl Radiat Oncol","Clinical and translational radiation oncology","COVID-19 pandemic; Chemotherapy; Feeding tube; Head and neck cancers; Immunotherapy; Radiotherapy; SARS-CoV-2; Survey; Treatment modifications","Vasiliadou","Ifigenia","Guy's and St. Thomas NHS Foundation Trust, London, United Kingdom",NA
"436","34226880","10.1016/j.ctro.2021.06.002","A multi-centre survey reveals variations in the standard treatments and treatment modifications for head and neck cancer patients during Covid-19 pandemic.","The onset of the COVID-19 pandemic necessitated rapid changes to the practice of head and neck oncology in UK. There was a delay between the onset of the pandemic and the release of guidelines from cancer societies and networks, leading to a variable response of individual centres. This survey was conducted to assess the pre-Covid-19 pandemic standard of practice for head and neck oncology patients and the treatment modifications introduced during the first wave of the pandemic in UK. The UK Nat","2021","07","20","Clin Transl Radiat Oncol","Clinical and translational radiation oncology","COVID-19 pandemic; Chemotherapy; Feeding tube; Head and neck cancers; Immunotherapy; Radiotherapy; SARS-CoV-2; Survey; Treatment modifications","Noble","David","Edinburgh Cancer Centre, Edinburgh, United Kingdom",NA
"437","34226880","10.1016/j.ctro.2021.06.002","A multi-centre survey reveals variations in the standard treatments and treatment modifications for head and neck cancer patients during Covid-19 pandemic.","The onset of the COVID-19 pandemic necessitated rapid changes to the practice of head and neck oncology in UK. There was a delay between the onset of the pandemic and the release of guidelines from cancer societies and networks, leading to a variable response of individual centres. This survey was conducted to assess the pre-Covid-19 pandemic standard of practice for head and neck oncology patients and the treatment modifications introduced during the first wave of the pandemic in UK. The UK Nat","2021","07","20","Clin Transl Radiat Oncol","Clinical and translational radiation oncology","COVID-19 pandemic; Chemotherapy; Feeding tube; Head and neck cancers; Immunotherapy; Radiotherapy; SARS-CoV-2; Survey; Treatment modifications","Hartley","Andrew","Queen Elizabeth Hospital Birmingham, Birmingham, United Kingdom",NA
"438","34226880","10.1016/j.ctro.2021.06.002","A multi-centre survey reveals variations in the standard treatments and treatment modifications for head and neck cancer patients during Covid-19 pandemic.","The onset of the COVID-19 pandemic necessitated rapid changes to the practice of head and neck oncology in UK. There was a delay between the onset of the pandemic and the release of guidelines from cancer societies and networks, leading to a variable response of individual centres. This survey was conducted to assess the pre-Covid-19 pandemic standard of practice for head and neck oncology patients and the treatment modifications introduced during the first wave of the pandemic in UK. The UK Nat","2021","07","20","Clin Transl Radiat Oncol","Clinical and translational radiation oncology","COVID-19 pandemic; Chemotherapy; Feeding tube; Head and neck cancers; Immunotherapy; Radiotherapy; SARS-CoV-2; Survey; Treatment modifications","Moleron","Rafael","Aberdeen Royal Infirmary, Aberdeen, United Kingdom",NA
"439","34226880","10.1016/j.ctro.2021.06.002","A multi-centre survey reveals variations in the standard treatments and treatment modifications for head and neck cancer patients during Covid-19 pandemic.","The onset of the COVID-19 pandemic necessitated rapid changes to the practice of head and neck oncology in UK. There was a delay between the onset of the pandemic and the release of guidelines from cancer societies and networks, leading to a variable response of individual centres. This survey was conducted to assess the pre-Covid-19 pandemic standard of practice for head and neck oncology patients and the treatment modifications introduced during the first wave of the pandemic in UK. The UK Nat","2021","07","20","Clin Transl Radiat Oncol","Clinical and translational radiation oncology","COVID-19 pandemic; Chemotherapy; Feeding tube; Head and neck cancers; Immunotherapy; Radiotherapy; SARS-CoV-2; Survey; Treatment modifications","Sanghera","Paul","Queen Elizabeth Hospital Birmingham, Birmingham, United Kingdom",NA
"440","34226880","10.1016/j.ctro.2021.06.002","A multi-centre survey reveals variations in the standard treatments and treatment modifications for head and neck cancer patients during Covid-19 pandemic.","The onset of the COVID-19 pandemic necessitated rapid changes to the practice of head and neck oncology in UK. There was a delay between the onset of the pandemic and the release of guidelines from cancer societies and networks, leading to a variable response of individual centres. This survey was conducted to assess the pre-Covid-19 pandemic standard of practice for head and neck oncology patients and the treatment modifications introduced during the first wave of the pandemic in UK. The UK Nat","2021","07","20","Clin Transl Radiat Oncol","Clinical and translational radiation oncology","COVID-19 pandemic; Chemotherapy; Feeding tube; Head and neck cancers; Immunotherapy; Radiotherapy; SARS-CoV-2; Survey; Treatment modifications","Urbano","Teresa Guerrero","Guy's and St. Thomas NHS Foundation Trust, London, United Kingdom",NA
"441","34226880","10.1016/j.ctro.2021.06.002","A multi-centre survey reveals variations in the standard treatments and treatment modifications for head and neck cancer patients during Covid-19 pandemic.","The onset of the COVID-19 pandemic necessitated rapid changes to the practice of head and neck oncology in UK. There was a delay between the onset of the pandemic and the release of guidelines from cancer societies and networks, leading to a variable response of individual centres. This survey was conducted to assess the pre-Covid-19 pandemic standard of practice for head and neck oncology patients and the treatment modifications introduced during the first wave of the pandemic in UK. The UK Nat","2021","07","20","Clin Transl Radiat Oncol","Clinical and translational radiation oncology","COVID-19 pandemic; Chemotherapy; Feeding tube; Head and neck cancers; Immunotherapy; Radiotherapy; SARS-CoV-2; Survey; Treatment modifications","Schipani","Stefano","Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom",NA
"442","34226880","10.1016/j.ctro.2021.06.002","A multi-centre survey reveals variations in the standard treatments and treatment modifications for head and neck cancer patients during Covid-19 pandemic.","The onset of the COVID-19 pandemic necessitated rapid changes to the practice of head and neck oncology in UK. There was a delay between the onset of the pandemic and the release of guidelines from cancer societies and networks, leading to a variable response of individual centres. This survey was conducted to assess the pre-Covid-19 pandemic standard of practice for head and neck oncology patients and the treatment modifications introduced during the first wave of the pandemic in UK. The UK Nat","2021","07","20","Clin Transl Radiat Oncol","Clinical and translational radiation oncology","COVID-19 pandemic; Chemotherapy; Feeding tube; Head and neck cancers; Immunotherapy; Radiotherapy; SARS-CoV-2; Survey; Treatment modifications","Gujral","Dorothy","Imperial College Healthcare NHS Trust, London, United Kingdom",NA
"443","34226880","10.1016/j.ctro.2021.06.002","A multi-centre survey reveals variations in the standard treatments and treatment modifications for head and neck cancer patients during Covid-19 pandemic.","The onset of the COVID-19 pandemic necessitated rapid changes to the practice of head and neck oncology in UK. There was a delay between the onset of the pandemic and the release of guidelines from cancer societies and networks, leading to a variable response of individual centres. This survey was conducted to assess the pre-Covid-19 pandemic standard of practice for head and neck oncology patients and the treatment modifications introduced during the first wave of the pandemic in UK. The UK Nat","2021","07","20","Clin Transl Radiat Oncol","Clinical and translational radiation oncology","COVID-19 pandemic; Chemotherapy; Feeding tube; Head and neck cancers; Immunotherapy; Radiotherapy; SARS-CoV-2; Survey; Treatment modifications","Foran","Bernie","Weston Park Cancer Centre, Sheffield, United Kingdom",NA
"444","34226880","10.1016/j.ctro.2021.06.002","A multi-centre survey reveals variations in the standard treatments and treatment modifications for head and neck cancer patients during Covid-19 pandemic.","The onset of the COVID-19 pandemic necessitated rapid changes to the practice of head and neck oncology in UK. There was a delay between the onset of the pandemic and the release of guidelines from cancer societies and networks, leading to a variable response of individual centres. This survey was conducted to assess the pre-Covid-19 pandemic standard of practice for head and neck oncology patients and the treatment modifications introduced during the first wave of the pandemic in UK. The UK Nat","2021","07","20","Clin Transl Radiat Oncol","Clinical and translational radiation oncology","COVID-19 pandemic; Chemotherapy; Feeding tube; Head and neck cancers; Immunotherapy; Radiotherapy; SARS-CoV-2; Survey; Treatment modifications","Bhide","Shree","Royal Marsden NHS Foundation Trust, London and Sutton, United Kingdom",NA
"445","34226880","10.1016/j.ctro.2021.06.002","A multi-centre survey reveals variations in the standard treatments and treatment modifications for head and neck cancer patients during Covid-19 pandemic.","The onset of the COVID-19 pandemic necessitated rapid changes to the practice of head and neck oncology in UK. There was a delay between the onset of the pandemic and the release of guidelines from cancer societies and networks, leading to a variable response of individual centres. This survey was conducted to assess the pre-Covid-19 pandemic standard of practice for head and neck oncology patients and the treatment modifications introduced during the first wave of the pandemic in UK. The UK Nat","2021","07","20","Clin Transl Radiat Oncol","Clinical and translational radiation oncology","COVID-19 pandemic; Chemotherapy; Feeding tube; Head and neck cancers; Immunotherapy; Radiotherapy; SARS-CoV-2; Survey; Treatment modifications","Haridass","Anoop","Clatterbridge Cancer Centre, Liverpool, United Kingdom",NA
"446","34226880","10.1016/j.ctro.2021.06.002","A multi-centre survey reveals variations in the standard treatments and treatment modifications for head and neck cancer patients during Covid-19 pandemic.","The onset of the COVID-19 pandemic necessitated rapid changes to the practice of head and neck oncology in UK. There was a delay between the onset of the pandemic and the release of guidelines from cancer societies and networks, leading to a variable response of individual centres. This survey was conducted to assess the pre-Covid-19 pandemic standard of practice for head and neck oncology patients and the treatment modifications introduced during the first wave of the pandemic in UK. The UK Nat","2021","07","20","Clin Transl Radiat Oncol","Clinical and translational radiation oncology","COVID-19 pandemic; Chemotherapy; Feeding tube; Head and neck cancers; Immunotherapy; Radiotherapy; SARS-CoV-2; Survey; Treatment modifications","Nathan","Kannon","Kent Oncology Centre, Maidstone and Canterbury, United Kingdom",NA
"447","34226880","10.1016/j.ctro.2021.06.002","A multi-centre survey reveals variations in the standard treatments and treatment modifications for head and neck cancer patients during Covid-19 pandemic.","The onset of the COVID-19 pandemic necessitated rapid changes to the practice of head and neck oncology in UK. There was a delay between the onset of the pandemic and the release of guidelines from cancer societies and networks, leading to a variable response of individual centres. This survey was conducted to assess the pre-Covid-19 pandemic standard of practice for head and neck oncology patients and the treatment modifications introduced during the first wave of the pandemic in UK. The UK Nat","2021","07","20","Clin Transl Radiat Oncol","Clinical and translational radiation oncology","COVID-19 pandemic; Chemotherapy; Feeding tube; Head and neck cancers; Immunotherapy; Radiotherapy; SARS-CoV-2; Survey; Treatment modifications","Michaelidou","Andriana","Kent Oncology Centre, Maidstone and Canterbury, United Kingdom",NA
"448","34226880","10.1016/j.ctro.2021.06.002","A multi-centre survey reveals variations in the standard treatments and treatment modifications for head and neck cancer patients during Covid-19 pandemic.","The onset of the COVID-19 pandemic necessitated rapid changes to the practice of head and neck oncology in UK. There was a delay between the onset of the pandemic and the release of guidelines from cancer societies and networks, leading to a variable response of individual centres. This survey was conducted to assess the pre-Covid-19 pandemic standard of practice for head and neck oncology patients and the treatment modifications introduced during the first wave of the pandemic in UK. The UK Nat","2021","07","20","Clin Transl Radiat Oncol","Clinical and translational radiation oncology","COVID-19 pandemic; Chemotherapy; Feeding tube; Head and neck cancers; Immunotherapy; Radiotherapy; SARS-CoV-2; Survey; Treatment modifications","Sen","Mehmet","Leeds Cancer Centre, Leeds, United Kingdom",NA
"449","34226880","10.1016/j.ctro.2021.06.002","A multi-centre survey reveals variations in the standard treatments and treatment modifications for head and neck cancer patients during Covid-19 pandemic.","The onset of the COVID-19 pandemic necessitated rapid changes to the practice of head and neck oncology in UK. There was a delay between the onset of the pandemic and the release of guidelines from cancer societies and networks, leading to a variable response of individual centres. This survey was conducted to assess the pre-Covid-19 pandemic standard of practice for head and neck oncology patients and the treatment modifications introduced during the first wave of the pandemic in UK. The UK Nat","2021","07","20","Clin Transl Radiat Oncol","Clinical and translational radiation oncology","COVID-19 pandemic; Chemotherapy; Feeding tube; Head and neck cancers; Immunotherapy; Radiotherapy; SARS-CoV-2; Survey; Treatment modifications","Geropantas","Konstantinos","Nortfolk and Norwich University Hospital, Norwich, United Kingdom",NA
"450","34226880","10.1016/j.ctro.2021.06.002","A multi-centre survey reveals variations in the standard treatments and treatment modifications for head and neck cancer patients during Covid-19 pandemic.","The onset of the COVID-19 pandemic necessitated rapid changes to the practice of head and neck oncology in UK. There was a delay between the onset of the pandemic and the release of guidelines from cancer societies and networks, leading to a variable response of individual centres. This survey was conducted to assess the pre-Covid-19 pandemic standard of practice for head and neck oncology patients and the treatment modifications introduced during the first wave of the pandemic in UK. The UK Nat","2021","07","20","Clin Transl Radiat Oncol","Clinical and translational radiation oncology","COVID-19 pandemic; Chemotherapy; Feeding tube; Head and neck cancers; Immunotherapy; Radiotherapy; SARS-CoV-2; Survey; Treatment modifications","Joseph","Mano","The Royal Wolverhampton NHS Trust, Wolverhampton, United Kingdom",NA
"451","34226880","10.1016/j.ctro.2021.06.002","A multi-centre survey reveals variations in the standard treatments and treatment modifications for head and neck cancer patients during Covid-19 pandemic.","The onset of the COVID-19 pandemic necessitated rapid changes to the practice of head and neck oncology in UK. There was a delay between the onset of the pandemic and the release of guidelines from cancer societies and networks, leading to a variable response of individual centres. This survey was conducted to assess the pre-Covid-19 pandemic standard of practice for head and neck oncology patients and the treatment modifications introduced during the first wave of the pandemic in UK. The UK Nat","2021","07","20","Clin Transl Radiat Oncol","Clinical and translational radiation oncology","COVID-19 pandemic; Chemotherapy; Feeding tube; Head and neck cancers; Immunotherapy; Radiotherapy; SARS-CoV-2; Survey; Treatment modifications","O'Toole","Lorcan","Castle Hill Hospital, Cottingham, United Kingdom",NA
"452","34226880","10.1016/j.ctro.2021.06.002","A multi-centre survey reveals variations in the standard treatments and treatment modifications for head and neck cancer patients during Covid-19 pandemic.","The onset of the COVID-19 pandemic necessitated rapid changes to the practice of head and neck oncology in UK. There was a delay between the onset of the pandemic and the release of guidelines from cancer societies and networks, leading to a variable response of individual centres. This survey was conducted to assess the pre-Covid-19 pandemic standard of practice for head and neck oncology patients and the treatment modifications introduced during the first wave of the pandemic in UK. The UK Nat","2021","07","20","Clin Transl Radiat Oncol","Clinical and translational radiation oncology","COVID-19 pandemic; Chemotherapy; Feeding tube; Head and neck cancers; Immunotherapy; Radiotherapy; SARS-CoV-2; Survey; Treatment modifications","Griffin","Matthew","Nottingham University Hospitals, Nottingham, United Kingdom",NA
"453","34226880","10.1016/j.ctro.2021.06.002","A multi-centre survey reveals variations in the standard treatments and treatment modifications for head and neck cancer patients during Covid-19 pandemic.","The onset of the COVID-19 pandemic necessitated rapid changes to the practice of head and neck oncology in UK. There was a delay between the onset of the pandemic and the release of guidelines from cancer societies and networks, leading to a variable response of individual centres. This survey was conducted to assess the pre-Covid-19 pandemic standard of practice for head and neck oncology patients and the treatment modifications introduced during the first wave of the pandemic in UK. The UK Nat","2021","07","20","Clin Transl Radiat Oncol","Clinical and translational radiation oncology","COVID-19 pandemic; Chemotherapy; Feeding tube; Head and neck cancers; Immunotherapy; Radiotherapy; SARS-CoV-2; Survey; Treatment modifications","Pettit","Laura","Lingen Davie Cancer Centre, Shrewsbury, United Kingdom",NA
"454","34226880","10.1016/j.ctro.2021.06.002","A multi-centre survey reveals variations in the standard treatments and treatment modifications for head and neck cancer patients during Covid-19 pandemic.","The onset of the COVID-19 pandemic necessitated rapid changes to the practice of head and neck oncology in UK. There was a delay between the onset of the pandemic and the release of guidelines from cancer societies and networks, leading to a variable response of individual centres. This survey was conducted to assess the pre-Covid-19 pandemic standard of practice for head and neck oncology patients and the treatment modifications introduced during the first wave of the pandemic in UK. The UK Nat","2021","07","20","Clin Transl Radiat Oncol","Clinical and translational radiation oncology","COVID-19 pandemic; Chemotherapy; Feeding tube; Head and neck cancers; Immunotherapy; Radiotherapy; SARS-CoV-2; Survey; Treatment modifications","Chambers","Jonathan","Torbay Hospital, Torquay, United Kingdom",NA
"455","34226880","10.1016/j.ctro.2021.06.002","A multi-centre survey reveals variations in the standard treatments and treatment modifications for head and neck cancer patients during Covid-19 pandemic.","The onset of the COVID-19 pandemic necessitated rapid changes to the practice of head and neck oncology in UK. There was a delay between the onset of the pandemic and the release of guidelines from cancer societies and networks, leading to a variable response of individual centres. This survey was conducted to assess the pre-Covid-19 pandemic standard of practice for head and neck oncology patients and the treatment modifications introduced during the first wave of the pandemic in UK. The UK Nat","2021","07","20","Clin Transl Radiat Oncol","Clinical and translational radiation oncology","COVID-19 pandemic; Chemotherapy; Feeding tube; Head and neck cancers; Immunotherapy; Radiotherapy; SARS-CoV-2; Survey; Treatment modifications","Jankowska","Petra","Musgrove Park Hospital, Taunton, United Kingdom",NA
"456","34226880","10.1016/j.ctro.2021.06.002","A multi-centre survey reveals variations in the standard treatments and treatment modifications for head and neck cancer patients during Covid-19 pandemic.","The onset of the COVID-19 pandemic necessitated rapid changes to the practice of head and neck oncology in UK. There was a delay between the onset of the pandemic and the release of guidelines from cancer societies and networks, leading to a variable response of individual centres. This survey was conducted to assess the pre-Covid-19 pandemic standard of practice for head and neck oncology patients and the treatment modifications introduced during the first wave of the pandemic in UK. The UK Nat","2021","07","20","Clin Transl Radiat Oncol","Clinical and translational radiation oncology","COVID-19 pandemic; Chemotherapy; Feeding tube; Head and neck cancers; Immunotherapy; Radiotherapy; SARS-CoV-2; Survey; Treatment modifications","De Winton","Emma","Royal United Hospital, Bath, United Kingdom",NA
"457","34226880","10.1016/j.ctro.2021.06.002","A multi-centre survey reveals variations in the standard treatments and treatment modifications for head and neck cancer patients during Covid-19 pandemic.","The onset of the COVID-19 pandemic necessitated rapid changes to the practice of head and neck oncology in UK. There was a delay between the onset of the pandemic and the release of guidelines from cancer societies and networks, leading to a variable response of individual centres. This survey was conducted to assess the pre-Covid-19 pandemic standard of practice for head and neck oncology patients and the treatment modifications introduced during the first wave of the pandemic in UK. The UK Nat","2021","07","20","Clin Transl Radiat Oncol","Clinical and translational radiation oncology","COVID-19 pandemic; Chemotherapy; Feeding tube; Head and neck cancers; Immunotherapy; Radiotherapy; SARS-CoV-2; Survey; Treatment modifications","Goranova","Rebecca","Derriford Hospital, Plymouth, United Kingdom",NA
"458","34226880","10.1016/j.ctro.2021.06.002","A multi-centre survey reveals variations in the standard treatments and treatment modifications for head and neck cancer patients during Covid-19 pandemic.","The onset of the COVID-19 pandemic necessitated rapid changes to the practice of head and neck oncology in UK. There was a delay between the onset of the pandemic and the release of guidelines from cancer societies and networks, leading to a variable response of individual centres. This survey was conducted to assess the pre-Covid-19 pandemic standard of practice for head and neck oncology patients and the treatment modifications introduced during the first wave of the pandemic in UK. The UK Nat","2021","07","20","Clin Transl Radiat Oncol","Clinical and translational radiation oncology","COVID-19 pandemic; Chemotherapy; Feeding tube; Head and neck cancers; Immunotherapy; Radiotherapy; SARS-CoV-2; Survey; Treatment modifications","Singh","Niveditha","Northampton General Hospital, Northampton, United Kingdom",NA
"459","34226880","10.1016/j.ctro.2021.06.002","A multi-centre survey reveals variations in the standard treatments and treatment modifications for head and neck cancer patients during Covid-19 pandemic.","The onset of the COVID-19 pandemic necessitated rapid changes to the practice of head and neck oncology in UK. There was a delay between the onset of the pandemic and the release of guidelines from cancer societies and networks, leading to a variable response of individual centres. This survey was conducted to assess the pre-Covid-19 pandemic standard of practice for head and neck oncology patients and the treatment modifications introduced during the first wave of the pandemic in UK. The UK Nat","2021","07","20","Clin Transl Radiat Oncol","Clinical and translational radiation oncology","COVID-19 pandemic; Chemotherapy; Feeding tube; Head and neck cancers; Immunotherapy; Radiotherapy; SARS-CoV-2; Survey; Treatment modifications","Shah","Ketan","Oxford University Hospitals, Oxford, United Kingdom",NA
"460","34226880","10.1016/j.ctro.2021.06.002","A multi-centre survey reveals variations in the standard treatments and treatment modifications for head and neck cancer patients during Covid-19 pandemic.","The onset of the COVID-19 pandemic necessitated rapid changes to the practice of head and neck oncology in UK. There was a delay between the onset of the pandemic and the release of guidelines from cancer societies and networks, leading to a variable response of individual centres. This survey was conducted to assess the pre-Covid-19 pandemic standard of practice for head and neck oncology patients and the treatment modifications introduced during the first wave of the pandemic in UK. The UK Nat","2021","07","20","Clin Transl Radiat Oncol","Clinical and translational radiation oncology","COVID-19 pandemic; Chemotherapy; Feeding tube; Head and neck cancers; Immunotherapy; Radiotherapy; SARS-CoV-2; Survey; Treatment modifications","Kong Conceptualisation","Anthony","Guy's and St. Thomas NHS Foundation Trust, London, United Kingdom",NA
"461","34226878","10.1186/s41231-021-00090-5","Does Covera-19 know 'when to hold 'em or 'when to fold 'em? A translational thought experiment.","The function of proteins depends on their structure. The structural integrity of proteins is dynamic and depends on interacting nearby neighboring moieties that influence their properties and induce folding and structural changes. The conformational changes induced by these nearby neighbors in the micro-environmental milieu at that moment are guided by chemical or electrical bonding attractions. There are few literature references that describe the potential for environmental milieu changes to d","2021","07","07","Transl Med Commun","Translational medicine communications",NA,"Griffin","Gerald Dieter","Adjunct Faculty, School of Pharmacy &amp",NA
"462","34226877","10.1016/j.medcle.2021.01.011","Application of validated severity scores for pneumonia caused by SARS-CoV-2.","Compare the accuracy of PSI, CURB-65, MuLBSTA and COVID-GRAM prognostic scores to predict mortality, the need for invasive mechanical ventilation (IMV) in patients with pneumonia caused by SARS-CoV-2 and assess the coexistence of bacterial respiratory tract infection during admission. Retrospective observational study that included hospitalized adults with pneumonia caused by SARS-CoV-2 from 15/03 to 15/05/2020. We excluded immunocompromised patients, nursing home residents and those admitted in","2021","07","14","Med Clin (Engl Ed)","Medicina clinica (English ed.)","COVID-19; Coronavirus; Penumonia; Severity scores","Esteban Ronda","Violeta","Servicio de Neumología, Hospital General Universitario de Alicante, Alicante, Spain",NA
"463","34226877","10.1016/j.medcle.2021.01.011","Application of validated severity scores for pneumonia caused by SARS-CoV-2.","Compare the accuracy of PSI, CURB-65, MuLBSTA and COVID-GRAM prognostic scores to predict mortality, the need for invasive mechanical ventilation (IMV) in patients with pneumonia caused by SARS-CoV-2 and assess the coexistence of bacterial respiratory tract infection during admission. Retrospective observational study that included hospitalized adults with pneumonia caused by SARS-CoV-2 from 15/03 to 15/05/2020. We excluded immunocompromised patients, nursing home residents and those admitted in","2021","07","14","Med Clin (Engl Ed)","Medicina clinica (English ed.)","COVID-19; Coronavirus; Penumonia; Severity scores","Ruiz Alcaraz","Sandra","Servicio de Neumología, Hospital General Universitario de Alicante, Alicante, Spain",NA
"464","34226877","10.1016/j.medcle.2021.01.011","Application of validated severity scores for pneumonia caused by SARS-CoV-2.","Compare the accuracy of PSI, CURB-65, MuLBSTA and COVID-GRAM prognostic scores to predict mortality, the need for invasive mechanical ventilation (IMV) in patients with pneumonia caused by SARS-CoV-2 and assess the coexistence of bacterial respiratory tract infection during admission. Retrospective observational study that included hospitalized adults with pneumonia caused by SARS-CoV-2 from 15/03 to 15/05/2020. We excluded immunocompromised patients, nursing home residents and those admitted in","2021","07","14","Med Clin (Engl Ed)","Medicina clinica (English ed.)","COVID-19; Coronavirus; Penumonia; Severity scores","Ruiz Torregrosa","Paloma","Servicio de Neumología, Hospital General Universitario de Alicante, Alicante, Spain",NA
"465","34226877","10.1016/j.medcle.2021.01.011","Application of validated severity scores for pneumonia caused by SARS-CoV-2.","Compare the accuracy of PSI, CURB-65, MuLBSTA and COVID-GRAM prognostic scores to predict mortality, the need for invasive mechanical ventilation (IMV) in patients with pneumonia caused by SARS-CoV-2 and assess the coexistence of bacterial respiratory tract infection during admission. Retrospective observational study that included hospitalized adults with pneumonia caused by SARS-CoV-2 from 15/03 to 15/05/2020. We excluded immunocompromised patients, nursing home residents and those admitted in","2021","07","14","Med Clin (Engl Ed)","Medicina clinica (English ed.)","COVID-19; Coronavirus; Penumonia; Severity scores","Giménez Suau","Mario","Servicio de Neumología, Hospital General Universitario de Alicante, Alicante, Spain",NA
"466","34226877","10.1016/j.medcle.2021.01.011","Application of validated severity scores for pneumonia caused by SARS-CoV-2.","Compare the accuracy of PSI, CURB-65, MuLBSTA and COVID-GRAM prognostic scores to predict mortality, the need for invasive mechanical ventilation (IMV) in patients with pneumonia caused by SARS-CoV-2 and assess the coexistence of bacterial respiratory tract infection during admission. Retrospective observational study that included hospitalized adults with pneumonia caused by SARS-CoV-2 from 15/03 to 15/05/2020. We excluded immunocompromised patients, nursing home residents and those admitted in","2021","07","14","Med Clin (Engl Ed)","Medicina clinica (English ed.)","COVID-19; Coronavirus; Penumonia; Severity scores","Nofuentes Pérez","Ester","Servicio de Neumología, Hospital General Universitario de Alicante, Alicante, Spain",NA
"467","34226877","10.1016/j.medcle.2021.01.011","Application of validated severity scores for pneumonia caused by SARS-CoV-2.","Compare the accuracy of PSI, CURB-65, MuLBSTA and COVID-GRAM prognostic scores to predict mortality, the need for invasive mechanical ventilation (IMV) in patients with pneumonia caused by SARS-CoV-2 and assess the coexistence of bacterial respiratory tract infection during admission. Retrospective observational study that included hospitalized adults with pneumonia caused by SARS-CoV-2 from 15/03 to 15/05/2020. We excluded immunocompromised patients, nursing home residents and those admitted in","2021","07","14","Med Clin (Engl Ed)","Medicina clinica (English ed.)","COVID-19; Coronavirus; Penumonia; Severity scores","León Ramírez","José Manuel","Servicio de Neumología, Hospital General Universitario de Alicante, Alicante, Spain",NA
"468","34226877","10.1016/j.medcle.2021.01.011","Application of validated severity scores for pneumonia caused by SARS-CoV-2.","Compare the accuracy of PSI, CURB-65, MuLBSTA and COVID-GRAM prognostic scores to predict mortality, the need for invasive mechanical ventilation (IMV) in patients with pneumonia caused by SARS-CoV-2 and assess the coexistence of bacterial respiratory tract infection during admission. Retrospective observational study that included hospitalized adults with pneumonia caused by SARS-CoV-2 from 15/03 to 15/05/2020. We excluded immunocompromised patients, nursing home residents and those admitted in","2021","07","14","Med Clin (Engl Ed)","Medicina clinica (English ed.)","COVID-19; Coronavirus; Penumonia; Severity scores","Andrés","Mariano","Servicio de Reumatología, Hospital General Universitario de Alicante, Alicante, Spain",NA
"469","34226877","10.1016/j.medcle.2021.01.011","Application of validated severity scores for pneumonia caused by SARS-CoV-2.","Compare the accuracy of PSI, CURB-65, MuLBSTA and COVID-GRAM prognostic scores to predict mortality, the need for invasive mechanical ventilation (IMV) in patients with pneumonia caused by SARS-CoV-2 and assess the coexistence of bacterial respiratory tract infection during admission. Retrospective observational study that included hospitalized adults with pneumonia caused by SARS-CoV-2 from 15/03 to 15/05/2020. We excluded immunocompromised patients, nursing home residents and those admitted in","2021","07","14","Med Clin (Engl Ed)","Medicina clinica (English ed.)","COVID-19; Coronavirus; Penumonia; Severity scores","Moreno-Pérez","Óscar","Servicio de Endocrinología y Nutrición, Hospital General Universitario de Alicante, Alicante, Spain",NA
"470","34226877","10.1016/j.medcle.2021.01.011","Application of validated severity scores for pneumonia caused by SARS-CoV-2.","Compare the accuracy of PSI, CURB-65, MuLBSTA and COVID-GRAM prognostic scores to predict mortality, the need for invasive mechanical ventilation (IMV) in patients with pneumonia caused by SARS-CoV-2 and assess the coexistence of bacterial respiratory tract infection during admission. Retrospective observational study that included hospitalized adults with pneumonia caused by SARS-CoV-2 from 15/03 to 15/05/2020. We excluded immunocompromised patients, nursing home residents and those admitted in","2021","07","14","Med Clin (Engl Ed)","Medicina clinica (English ed.)","COVID-19; Coronavirus; Penumonia; Severity scores","Candela Blanes","Alfredo","Servicio de Neumología, Hospital General Universitario de Alicante, Alicante, Spain",NA
"471","34226877","10.1016/j.medcle.2021.01.011","Application of validated severity scores for pneumonia caused by SARS-CoV-2.","Compare the accuracy of PSI, CURB-65, MuLBSTA and COVID-GRAM prognostic scores to predict mortality, the need for invasive mechanical ventilation (IMV) in patients with pneumonia caused by SARS-CoV-2 and assess the coexistence of bacterial respiratory tract infection during admission. Retrospective observational study that included hospitalized adults with pneumonia caused by SARS-CoV-2 from 15/03 to 15/05/2020. We excluded immunocompromised patients, nursing home residents and those admitted in","2021","07","14","Med Clin (Engl Ed)","Medicina clinica (English ed.)","COVID-19; Coronavirus; Penumonia; Severity scores","Gil Carbonell","Joan","Servicio de Neumología, Hospital General Universitario de Alicante, Alicante, Spain",NA
"472","34226877","10.1016/j.medcle.2021.01.011","Application of validated severity scores for pneumonia caused by SARS-CoV-2.","Compare the accuracy of PSI, CURB-65, MuLBSTA and COVID-GRAM prognostic scores to predict mortality, the need for invasive mechanical ventilation (IMV) in patients with pneumonia caused by SARS-CoV-2 and assess the coexistence of bacterial respiratory tract infection during admission. Retrospective observational study that included hospitalized adults with pneumonia caused by SARS-CoV-2 from 15/03 to 15/05/2020. We excluded immunocompromised patients, nursing home residents and those admitted in","2021","07","14","Med Clin (Engl Ed)","Medicina clinica (English ed.)","COVID-19; Coronavirus; Penumonia; Severity scores","Merino de Lucas","Esperanza","Unidad de Enfermedades Infecciosas, Hospital General Universitario de Alicante, Alicante, Spain",NA
"473","34226876","10.1002/lio2.591","Safety practices for in-office laryngology procedures during clinical reintroduction amidst COVID-19.","Describe safety practices for performing in-office laryngology procedures during clinical re-introduction amidst the coronavirus disease 2019 (COVID-19) pandemic. An anonymous survey in Qualtrics was created to evaluate demographics, preprocedure testing, practice settings, anesthesia, and personal protective equipment (PPE) use for five procedure categories (non-mucosal-traversing injections, mucosal-traversing injections, endoscopy without suction, endoscopy with suction/mucosal intervention v","2021","07","07","Laryngoscope Investig Otolaryngol","Laryngoscope investigative otolaryngology","COVID-19; coronavirus; laryngoscopy; otolaryngology; personal protective equipment","Calcagno","Haley","The Indiana University School of Medicine and the Department of Otolaryngology-Head and Neck Surgery, Indiana University Indianapolis Indiana USA",NA
"474","34226876","10.1002/lio2.591","Safety practices for in-office laryngology procedures during clinical reintroduction amidst COVID-19.","Describe safety practices for performing in-office laryngology procedures during clinical re-introduction amidst the coronavirus disease 2019 (COVID-19) pandemic. An anonymous survey in Qualtrics was created to evaluate demographics, preprocedure testing, practice settings, anesthesia, and personal protective equipment (PPE) use for five procedure categories (non-mucosal-traversing injections, mucosal-traversing injections, endoscopy without suction, endoscopy with suction/mucosal intervention v","2021","07","07","Laryngoscope Investig Otolaryngol","Laryngoscope investigative otolaryngology","COVID-19; coronavirus; laryngoscopy; otolaryngology; personal protective equipment","Anthony","Benjamin P","The Indiana University School of Medicine and the Department of Otolaryngology-Head and Neck Surgery, Indiana University Indianapolis Indiana USA",NA
"475","34226876","10.1002/lio2.591","Safety practices for in-office laryngology procedures during clinical reintroduction amidst COVID-19.","Describe safety practices for performing in-office laryngology procedures during clinical re-introduction amidst the coronavirus disease 2019 (COVID-19) pandemic. An anonymous survey in Qualtrics was created to evaluate demographics, preprocedure testing, practice settings, anesthesia, and personal protective equipment (PPE) use for five procedure categories (non-mucosal-traversing injections, mucosal-traversing injections, endoscopy without suction, endoscopy with suction/mucosal intervention v","2021","07","07","Laryngoscope Investig Otolaryngol","Laryngoscope investigative otolaryngology","COVID-19; coronavirus; laryngoscopy; otolaryngology; personal protective equipment","Halum","Stacey L","The Indiana University School of Medicine and the Department of Otolaryngology-Head and Neck Surgery, Indiana University Indianapolis Indiana USA",NA
"476","34226876","10.1002/lio2.591","Safety practices for in-office laryngology procedures during clinical reintroduction amidst COVID-19.","Describe safety practices for performing in-office laryngology procedures during clinical re-introduction amidst the coronavirus disease 2019 (COVID-19) pandemic. An anonymous survey in Qualtrics was created to evaluate demographics, preprocedure testing, practice settings, anesthesia, and personal protective equipment (PPE) use for five procedure categories (non-mucosal-traversing injections, mucosal-traversing injections, endoscopy without suction, endoscopy with suction/mucosal intervention v","2021","07","07","Laryngoscope Investig Otolaryngol","Laryngoscope investigative otolaryngology","COVID-19; coronavirus; laryngoscopy; otolaryngology; personal protective equipment","Parker","Noah P","The Indiana University School of Medicine and the Department of Otolaryngology-Head and Neck Surgery, Indiana University Indianapolis Indiana USA",NA
"477","34226872","10.1007/s40819-021-01086-3","Fractional Model and Numerical Algorithms for Predicting COVID-19 with Isolation and Quarantine Strategies.","In December 2019, a new outbreak in Wuhan, China has attracted world-wide attention, the virus then spread rapidly in most countries of the world, the objective of this paper is to investigate the mathematical modelling and dynamics of a novel coronavirus (COVID-19) with Caputo-Fabrizio fractional derivative in the presence of quarantine and isolation strategies. The existence and uniqueness of the solutions for the fractional model is proved using fixed point iterations, the fractional model ar","2021","07","07","Int J Appl Comput Math","International journal of applied and computational mathematics","COVID-19; Caputo-Fabrizio derivative; Fractional AdamsBashforth method; Fractional differential equations; SEIR epidemic model","Alla Hamou","Abdelouahed","Laboratory of Mathematical Analysis and Applications, Faculty of Sciences Dhar Al Mahraz, Sidi Mohamed Ben Abdellah University, B.P. 1796, 30000 Fez, Morocco",NA
"478","34226872","10.1007/s40819-021-01086-3","Fractional Model and Numerical Algorithms for Predicting COVID-19 with Isolation and Quarantine Strategies.","In December 2019, a new outbreak in Wuhan, China has attracted world-wide attention, the virus then spread rapidly in most countries of the world, the objective of this paper is to investigate the mathematical modelling and dynamics of a novel coronavirus (COVID-19) with Caputo-Fabrizio fractional derivative in the presence of quarantine and isolation strategies. The existence and uniqueness of the solutions for the fractional model is proved using fixed point iterations, the fractional model ar","2021","07","07","Int J Appl Comput Math","International journal of applied and computational mathematics","COVID-19; Caputo-Fabrizio derivative; Fractional AdamsBashforth method; Fractional differential equations; SEIR epidemic model","Azroul","Elhoussine","Laboratory of Mathematical Analysis and Applications, Faculty of Sciences Dhar Al Mahraz, Sidi Mohamed Ben Abdellah University, B.P. 1796, 30000 Fez, Morocco",NA
"479","34226872","10.1007/s40819-021-01086-3","Fractional Model and Numerical Algorithms for Predicting COVID-19 with Isolation and Quarantine Strategies.","In December 2019, a new outbreak in Wuhan, China has attracted world-wide attention, the virus then spread rapidly in most countries of the world, the objective of this paper is to investigate the mathematical modelling and dynamics of a novel coronavirus (COVID-19) with Caputo-Fabrizio fractional derivative in the presence of quarantine and isolation strategies. The existence and uniqueness of the solutions for the fractional model is proved using fixed point iterations, the fractional model ar","2021","07","07","Int J Appl Comput Math","International journal of applied and computational mathematics","COVID-19; Caputo-Fabrizio derivative; Fractional AdamsBashforth method; Fractional differential equations; SEIR epidemic model","Lamrani Alaoui","Abdelilah","Laboratory of Mathematical Analysis and Applications, Faculty of Sciences Dhar Al Mahraz, Sidi Mohamed Ben Abdellah University, B.P. 1796, 30000 Fez, Morocco",NA
"480","34226871","10.1007/s13337-021-00717-z","Target-based drug discovery, ADMET profiling and bioactivity studies of antibiotics as potential inhibitors of SARS-CoV-2 main protease (M<sup>pro</sup>).","A recent outbreak of a new strain of Coronavirus (SARS-CoV-2) has become a global health burden, which has resulted in deaths. No proven drug has been found to effectively cure this fast-spreading infection, hence the need to explore old drugs with the known profile in tackling this pandemic. A computer-aided drug design approach involving virtual screening was used to obtain the binding scores and inhibiting efficiencies of previously known antibiotics against SARS-CoV-2 main protease (M<sup>pr","2021","07","07","Virusdisease","Virusdisease","ADMET profiling; Antibiotics; COVID-19; Molecular docking; SARS-CoV-2 main protease (Mpro)","Abdul-Hammed","Misbaudeen","Department of Pure and Applied Chemistry, Ladoke Akintola University of Technology, P.M.B. 4000, Ogbomoso, Nigeria",NA
"481","34226871","10.1007/s13337-021-00717-z","Target-based drug discovery, ADMET profiling and bioactivity studies of antibiotics as potential inhibitors of SARS-CoV-2 main protease (M<sup>pro</sup>).","A recent outbreak of a new strain of Coronavirus (SARS-CoV-2) has become a global health burden, which has resulted in deaths. No proven drug has been found to effectively cure this fast-spreading infection, hence the need to explore old drugs with the known profile in tackling this pandemic. A computer-aided drug design approach involving virtual screening was used to obtain the binding scores and inhibiting efficiencies of previously known antibiotics against SARS-CoV-2 main protease (M<sup>pr","2021","07","07","Virusdisease","Virusdisease","ADMET profiling; Antibiotics; COVID-19; Molecular docking; SARS-CoV-2 main protease (Mpro)","Adedotun","Ibrahim Olaide","Department of Pure and Applied Chemistry, Ladoke Akintola University of Technology, P.M.B. 4000, Ogbomoso, Nigeria",NA
"482","34226871","10.1007/s13337-021-00717-z","Target-based drug discovery, ADMET profiling and bioactivity studies of antibiotics as potential inhibitors of SARS-CoV-2 main protease (M<sup>pro</sup>).","A recent outbreak of a new strain of Coronavirus (SARS-CoV-2) has become a global health burden, which has resulted in deaths. No proven drug has been found to effectively cure this fast-spreading infection, hence the need to explore old drugs with the known profile in tackling this pandemic. A computer-aided drug design approach involving virtual screening was used to obtain the binding scores and inhibiting efficiencies of previously known antibiotics against SARS-CoV-2 main protease (M<sup>pr","2021","07","07","Virusdisease","Virusdisease","ADMET profiling; Antibiotics; COVID-19; Molecular docking; SARS-CoV-2 main protease (Mpro)","Falade","Victoria Adeola","Department of Pure and Applied Chemistry, Ladoke Akintola University of Technology, P.M.B. 4000, Ogbomoso, Nigeria",NA
"483","34226871","10.1007/s13337-021-00717-z","Target-based drug discovery, ADMET profiling and bioactivity studies of antibiotics as potential inhibitors of SARS-CoV-2 main protease (M<sup>pro</sup>).","A recent outbreak of a new strain of Coronavirus (SARS-CoV-2) has become a global health burden, which has resulted in deaths. No proven drug has been found to effectively cure this fast-spreading infection, hence the need to explore old drugs with the known profile in tackling this pandemic. A computer-aided drug design approach involving virtual screening was used to obtain the binding scores and inhibiting efficiencies of previously known antibiotics against SARS-CoV-2 main protease (M<sup>pr","2021","07","07","Virusdisease","Virusdisease","ADMET profiling; Antibiotics; COVID-19; Molecular docking; SARS-CoV-2 main protease (Mpro)","Adepoju","Adewusi John","Department of Pure and Applied Chemistry, Ladoke Akintola University of Technology, P.M.B. 4000, Ogbomoso, Nigeria",NA
"484","34226871","10.1007/s13337-021-00717-z","Target-based drug discovery, ADMET profiling and bioactivity studies of antibiotics as potential inhibitors of SARS-CoV-2 main protease (M<sup>pro</sup>).","A recent outbreak of a new strain of Coronavirus (SARS-CoV-2) has become a global health burden, which has resulted in deaths. No proven drug has been found to effectively cure this fast-spreading infection, hence the need to explore old drugs with the known profile in tackling this pandemic. A computer-aided drug design approach involving virtual screening was used to obtain the binding scores and inhibiting efficiencies of previously known antibiotics against SARS-CoV-2 main protease (M<sup>pr","2021","07","07","Virusdisease","Virusdisease","ADMET profiling; Antibiotics; COVID-19; Molecular docking; SARS-CoV-2 main protease (Mpro)","Olasupo","Sabitu Babatunde","National Agency for Food and Drug Administration and Control (NAFDAC), Abuja, Nigeria",NA
"485","34226871","10.1007/s13337-021-00717-z","Target-based drug discovery, ADMET profiling and bioactivity studies of antibiotics as potential inhibitors of SARS-CoV-2 main protease (M<sup>pro</sup>).","A recent outbreak of a new strain of Coronavirus (SARS-CoV-2) has become a global health burden, which has resulted in deaths. No proven drug has been found to effectively cure this fast-spreading infection, hence the need to explore old drugs with the known profile in tackling this pandemic. A computer-aided drug design approach involving virtual screening was used to obtain the binding scores and inhibiting efficiencies of previously known antibiotics against SARS-CoV-2 main protease (M<sup>pr","2021","07","07","Virusdisease","Virusdisease","ADMET profiling; Antibiotics; COVID-19; Molecular docking; SARS-CoV-2 main protease (Mpro)","Akinboade","Modinat Wuraola","Department of Biochemistry, Ladoke Akintola University of Technology, P.M.B. 4000, Ogbomoso, Nigeria",NA
"486","34226870","10.1002/mdc3.13231","Outcome of Hospitalized Parkinson's Disease Patients with and without COVID-19.","The Parkinson's disease (PD) patient population, with an already reduced life expectancy, is rendered particularly vulnerable by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). We determined the risk factors that increase the risk of death in patients with Parkinson's disease who are infected by SARS-CoV-2. Patients with a diagnosis of PD admitted to Montefiore Hospital (Bronx, New York) and tested for SARS-CoV-2 were identified. Retrospective review of electronic medical recor","2021","07","07","Mov Disord Clin Pract","Movement disorders clinical practice","Parkinson's disease; SARS-CoV-2; ethnicity; mortality; socioeconomic","Parihar","Raminder","Saul R. Korey Department of Neurology Albert Einstein College of Medicine Bronx New York USA",NA
"487","34226870","10.1002/mdc3.13231","Outcome of Hospitalized Parkinson's Disease Patients with and without COVID-19.","The Parkinson's disease (PD) patient population, with an already reduced life expectancy, is rendered particularly vulnerable by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). We determined the risk factors that increase the risk of death in patients with Parkinson's disease who are infected by SARS-CoV-2. Patients with a diagnosis of PD admitted to Montefiore Hospital (Bronx, New York) and tested for SARS-CoV-2 were identified. Retrospective review of electronic medical recor","2021","07","07","Mov Disord Clin Pract","Movement disorders clinical practice","Parkinson's disease; SARS-CoV-2; ethnicity; mortality; socioeconomic","Ferastraoaru","Victor","Saul R. Korey Department of Neurology Albert Einstein College of Medicine Bronx New York USA",NA
"488","34226870","10.1002/mdc3.13231","Outcome of Hospitalized Parkinson's Disease Patients with and without COVID-19.","The Parkinson's disease (PD) patient population, with an already reduced life expectancy, is rendered particularly vulnerable by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). We determined the risk factors that increase the risk of death in patients with Parkinson's disease who are infected by SARS-CoV-2. Patients with a diagnosis of PD admitted to Montefiore Hospital (Bronx, New York) and tested for SARS-CoV-2 were identified. Retrospective review of electronic medical recor","2021","07","07","Mov Disord Clin Pract","Movement disorders clinical practice","Parkinson's disease; SARS-CoV-2; ethnicity; mortality; socioeconomic","Galanopoulou","Aristea S","Saul R. Korey Department of Neurology Albert Einstein College of Medicine Bronx New York USA",NA
"489","34226870","10.1002/mdc3.13231","Outcome of Hospitalized Parkinson's Disease Patients with and without COVID-19.","The Parkinson's disease (PD) patient population, with an already reduced life expectancy, is rendered particularly vulnerable by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). We determined the risk factors that increase the risk of death in patients with Parkinson's disease who are infected by SARS-CoV-2. Patients with a diagnosis of PD admitted to Montefiore Hospital (Bronx, New York) and tested for SARS-CoV-2 were identified. Retrospective review of electronic medical recor","2021","07","07","Mov Disord Clin Pract","Movement disorders clinical practice","Parkinson's disease; SARS-CoV-2; ethnicity; mortality; socioeconomic","Geyer","Howard L","Saul R. Korey Department of Neurology Albert Einstein College of Medicine Bronx New York USA",NA
"490","34226870","10.1002/mdc3.13231","Outcome of Hospitalized Parkinson's Disease Patients with and without COVID-19.","The Parkinson's disease (PD) patient population, with an already reduced life expectancy, is rendered particularly vulnerable by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). We determined the risk factors that increase the risk of death in patients with Parkinson's disease who are infected by SARS-CoV-2. Patients with a diagnosis of PD admitted to Montefiore Hospital (Bronx, New York) and tested for SARS-CoV-2 were identified. Retrospective review of electronic medical recor","2021","07","07","Mov Disord Clin Pract","Movement disorders clinical practice","Parkinson's disease; SARS-CoV-2; ethnicity; mortality; socioeconomic","Kaufman","David M","Saul R. Korey Department of Neurology Albert Einstein College of Medicine Bronx New York USA",NA
"491","34226869","10.1093/ofid/ofab236","Trends in Antibiotic Use in United States Hospitals During the Coronavirus Disease 2019 Pandemic.","We described antibiotic use among inpatients with coronavirus disease 2019 (COVID-19). Most COVID-19 inpatients received antibiotic therapy. We also described hospital-wide antibiotic use during 2020 compared with 2019, stratified by hospital COVID-19 burden. Although total antibiotic use decreased between years, certain antibiotic use increased with higher COVID-19 burden.","2021","07","07","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; antibiotic use; antimicrobial stewardship; epidemiology","Rose","Ashley N","Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA",NA
"492","34226869","10.1093/ofid/ofab236","Trends in Antibiotic Use in United States Hospitals During the Coronavirus Disease 2019 Pandemic.","We described antibiotic use among inpatients with coronavirus disease 2019 (COVID-19). Most COVID-19 inpatients received antibiotic therapy. We also described hospital-wide antibiotic use during 2020 compared with 2019, stratified by hospital COVID-19 burden. Although total antibiotic use decreased between years, certain antibiotic use increased with higher COVID-19 burden.","2021","07","07","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; antibiotic use; antimicrobial stewardship; epidemiology","Baggs","James","Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA",NA
"493","34226869","10.1093/ofid/ofab236","Trends in Antibiotic Use in United States Hospitals During the Coronavirus Disease 2019 Pandemic.","We described antibiotic use among inpatients with coronavirus disease 2019 (COVID-19). Most COVID-19 inpatients received antibiotic therapy. We also described hospital-wide antibiotic use during 2020 compared with 2019, stratified by hospital COVID-19 burden. Although total antibiotic use decreased between years, certain antibiotic use increased with higher COVID-19 burden.","2021","07","07","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; antibiotic use; antimicrobial stewardship; epidemiology","Wolford","Hannah","Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA",NA
"494","34226869","10.1093/ofid/ofab236","Trends in Antibiotic Use in United States Hospitals During the Coronavirus Disease 2019 Pandemic.","We described antibiotic use among inpatients with coronavirus disease 2019 (COVID-19). Most COVID-19 inpatients received antibiotic therapy. We also described hospital-wide antibiotic use during 2020 compared with 2019, stratified by hospital COVID-19 burden. Although total antibiotic use decreased between years, certain antibiotic use increased with higher COVID-19 burden.","2021","07","07","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; antibiotic use; antimicrobial stewardship; epidemiology","Neuhauser","Melinda M","Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA",NA
"495","34226869","10.1093/ofid/ofab236","Trends in Antibiotic Use in United States Hospitals During the Coronavirus Disease 2019 Pandemic.","We described antibiotic use among inpatients with coronavirus disease 2019 (COVID-19). Most COVID-19 inpatients received antibiotic therapy. We also described hospital-wide antibiotic use during 2020 compared with 2019, stratified by hospital COVID-19 burden. Although total antibiotic use decreased between years, certain antibiotic use increased with higher COVID-19 burden.","2021","07","07","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; antibiotic use; antimicrobial stewardship; epidemiology","Srinivasan","Arjun","Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA",NA
"496","34226869","10.1093/ofid/ofab236","Trends in Antibiotic Use in United States Hospitals During the Coronavirus Disease 2019 Pandemic.","We described antibiotic use among inpatients with coronavirus disease 2019 (COVID-19). Most COVID-19 inpatients received antibiotic therapy. We also described hospital-wide antibiotic use during 2020 compared with 2019, stratified by hospital COVID-19 burden. Although total antibiotic use decreased between years, certain antibiotic use increased with higher COVID-19 burden.","2021","07","07","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; antibiotic use; antimicrobial stewardship; epidemiology","Gundlapalli","Adi V","CDC COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA",NA
"497","34226869","10.1093/ofid/ofab236","Trends in Antibiotic Use in United States Hospitals During the Coronavirus Disease 2019 Pandemic.","We described antibiotic use among inpatients with coronavirus disease 2019 (COVID-19). Most COVID-19 inpatients received antibiotic therapy. We also described hospital-wide antibiotic use during 2020 compared with 2019, stratified by hospital COVID-19 burden. Although total antibiotic use decreased between years, certain antibiotic use increased with higher COVID-19 burden.","2021","07","07","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; antibiotic use; antimicrobial stewardship; epidemiology","Reddy","Sujan","Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA",NA
"498","34226869","10.1093/ofid/ofab236","Trends in Antibiotic Use in United States Hospitals During the Coronavirus Disease 2019 Pandemic.","We described antibiotic use among inpatients with coronavirus disease 2019 (COVID-19). Most COVID-19 inpatients received antibiotic therapy. We also described hospital-wide antibiotic use during 2020 compared with 2019, stratified by hospital COVID-19 burden. Although total antibiotic use decreased between years, certain antibiotic use increased with higher COVID-19 burden.","2021","07","07","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; antibiotic use; antimicrobial stewardship; epidemiology","Kompaniyets","Lyudmyla","CDC COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA",NA
"499","34226869","10.1093/ofid/ofab236","Trends in Antibiotic Use in United States Hospitals During the Coronavirus Disease 2019 Pandemic.","We described antibiotic use among inpatients with coronavirus disease 2019 (COVID-19). Most COVID-19 inpatients received antibiotic therapy. We also described hospital-wide antibiotic use during 2020 compared with 2019, stratified by hospital COVID-19 burden. Although total antibiotic use decreased between years, certain antibiotic use increased with higher COVID-19 burden.","2021","07","07","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; antibiotic use; antimicrobial stewardship; epidemiology","Pennington","Audrey F","CDC COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA",NA
"500","34226869","10.1093/ofid/ofab236","Trends in Antibiotic Use in United States Hospitals During the Coronavirus Disease 2019 Pandemic.","We described antibiotic use among inpatients with coronavirus disease 2019 (COVID-19). Most COVID-19 inpatients received antibiotic therapy. We also described hospital-wide antibiotic use during 2020 compared with 2019, stratified by hospital COVID-19 burden. Although total antibiotic use decreased between years, certain antibiotic use increased with higher COVID-19 burden.","2021","07","07","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; antibiotic use; antimicrobial stewardship; epidemiology","Grigg","Cheri","Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA",NA
"501","34226869","10.1093/ofid/ofab236","Trends in Antibiotic Use in United States Hospitals During the Coronavirus Disease 2019 Pandemic.","We described antibiotic use among inpatients with coronavirus disease 2019 (COVID-19). Most COVID-19 inpatients received antibiotic therapy. We also described hospital-wide antibiotic use during 2020 compared with 2019, stratified by hospital COVID-19 burden. Although total antibiotic use decreased between years, certain antibiotic use increased with higher COVID-19 burden.","2021","07","07","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; antibiotic use; antimicrobial stewardship; epidemiology","Kabbani","Sarah","Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA",NA
"502","34226867","10.1007/s12070-021-02709-3","Screening for Olfactory Dysfunction in COVID-19 Patients Using Quick Smell Identification Test.","To determine the prevalence of OD in the confirmed case with COVID-19 among our population using quick smell identification test (Q-SIT) as screening tool. Cross- sectional study carried out in Qatif area-Saudi Arabia among adult hospitalized patient with confirm COVID-19 during the period between May and July, 2020. All adults confirmed COVID-19 patients were interviewed for history of current disease and associated symptoms as well as performing Q-SIT. Participants who had history of olfactory","2021","07","07","Indian J Otolaryngol Head Neck Surg","Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India","COVID-19; Odor; Olfaction disorders; Prevalence; Smell test","Albaharna","Hussain Abdullali","Qatif Central Hospital, Dhahran Jubail Branch Rd, Al Iskan, Qatif, 23654 Saudi Arabia",NA
"503","34226867","10.1007/s12070-021-02709-3","Screening for Olfactory Dysfunction in COVID-19 Patients Using Quick Smell Identification Test.","To determine the prevalence of OD in the confirmed case with COVID-19 among our population using quick smell identification test (Q-SIT) as screening tool. Cross- sectional study carried out in Qatif area-Saudi Arabia among adult hospitalized patient with confirm COVID-19 during the period between May and July, 2020. All adults confirmed COVID-19 patients were interviewed for history of current disease and associated symptoms as well as performing Q-SIT. Participants who had history of olfactory","2021","07","07","Indian J Otolaryngol Head Neck Surg","Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India","COVID-19; Odor; Olfaction disorders; Prevalence; Smell test","Alhajjaj","Alya Hassan","Qatif Central Hospital, Dhahran Jubail Branch Rd, Al Iskan, Qatif, 23654 Saudi Arabia",NA
"504","34226867","10.1007/s12070-021-02709-3","Screening for Olfactory Dysfunction in COVID-19 Patients Using Quick Smell Identification Test.","To determine the prevalence of OD in the confirmed case with COVID-19 among our population using quick smell identification test (Q-SIT) as screening tool. Cross- sectional study carried out in Qatif area-Saudi Arabia among adult hospitalized patient with confirm COVID-19 during the period between May and July, 2020. All adults confirmed COVID-19 patients were interviewed for history of current disease and associated symptoms as well as performing Q-SIT. Participants who had history of olfactory","2021","07","07","Indian J Otolaryngol Head Neck Surg","Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India","COVID-19; Odor; Olfaction disorders; Prevalence; Smell test","Al Shabeb","Hussain Ali","Qatif Central Hospital, Dhahran Jubail Branch Rd, Al Iskan, Qatif, 23654 Saudi Arabia",NA
"505","34226867","10.1007/s12070-021-02709-3","Screening for Olfactory Dysfunction in COVID-19 Patients Using Quick Smell Identification Test.","To determine the prevalence of OD in the confirmed case with COVID-19 among our population using quick smell identification test (Q-SIT) as screening tool. Cross- sectional study carried out in Qatif area-Saudi Arabia among adult hospitalized patient with confirm COVID-19 during the period between May and July, 2020. All adults confirmed COVID-19 patients were interviewed for history of current disease and associated symptoms as well as performing Q-SIT. Participants who had history of olfactory","2021","07","07","Indian J Otolaryngol Head Neck Surg","Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India","COVID-19; Odor; Olfaction disorders; Prevalence; Smell test","Alghanim","Dhuha Abdulaziz","Qatif Central Hospital, Dhahran Jubail Branch Rd, Al Iskan, Qatif, 23654 Saudi Arabia",NA
"506","34226867","10.1007/s12070-021-02709-3","Screening for Olfactory Dysfunction in COVID-19 Patients Using Quick Smell Identification Test.","To determine the prevalence of OD in the confirmed case with COVID-19 among our population using quick smell identification test (Q-SIT) as screening tool. Cross- sectional study carried out in Qatif area-Saudi Arabia among adult hospitalized patient with confirm COVID-19 during the period between May and July, 2020. All adults confirmed COVID-19 patients were interviewed for history of current disease and associated symptoms as well as performing Q-SIT. Participants who had history of olfactory","2021","07","07","Indian J Otolaryngol Head Neck Surg","Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India","COVID-19; Odor; Olfaction disorders; Prevalence; Smell test","Alkhabbaz","Fatimah Lateef","Qatif Central Hospital, Dhahran Jubail Branch Rd, Al Iskan, Qatif, 23654 Saudi Arabia",NA
"507","34226867","10.1007/s12070-021-02709-3","Screening for Olfactory Dysfunction in COVID-19 Patients Using Quick Smell Identification Test.","To determine the prevalence of OD in the confirmed case with COVID-19 among our population using quick smell identification test (Q-SIT) as screening tool. Cross- sectional study carried out in Qatif area-Saudi Arabia among adult hospitalized patient with confirm COVID-19 during the period between May and July, 2020. All adults confirmed COVID-19 patients were interviewed for history of current disease and associated symptoms as well as performing Q-SIT. Participants who had history of olfactory","2021","07","07","Indian J Otolaryngol Head Neck Surg","Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India","COVID-19; Odor; Olfaction disorders; Prevalence; Smell test","AlJishi","Jumana Mansour","Qatif Central Hospital, Dhahran Jubail Branch Rd, Al Iskan, Qatif, 23654 Saudi Arabia",NA
"508","34226865","10.1016/j.mex.2021.101433","Viral transport media for COVID-19 testing.","Precautionary measures of physical isolation, social distancing, and masks have all aided in controlling the spread of COVID-19. However, detection of the virus is crucial to implement isolation of infected individuals. This paper presents the innovative repurposing of lab materials, workspace, and personnel in response to the COVID-19-induced shutdown and consequential shortage of commercially made virus transport media (VTM). This method for VTM production highlights the ability of standard re","2021","07","07","MethodsX","MethodsX","COVID-19; Pandemic; Supply chain; Viral transport media","Mears","Matthew J","Davis Heart and Lung Research Institute, Wexner Medical Center, The Ohio State University, Columbus, OH USA",NA
"509","34226865","10.1016/j.mex.2021.101433","Viral transport media for COVID-19 testing.","Precautionary measures of physical isolation, social distancing, and masks have all aided in controlling the spread of COVID-19. However, detection of the virus is crucial to implement isolation of infected individuals. This paper presents the innovative repurposing of lab materials, workspace, and personnel in response to the COVID-19-induced shutdown and consequential shortage of commercially made virus transport media (VTM). This method for VTM production highlights the ability of standard re","2021","07","07","MethodsX","MethodsX","COVID-19; Pandemic; Supply chain; Viral transport media","Wallace","Michael J","Davis Heart and Lung Research Institute, Wexner Medical Center, The Ohio State University, Columbus, OH USA",NA
"510","34226865","10.1016/j.mex.2021.101433","Viral transport media for COVID-19 testing.","Precautionary measures of physical isolation, social distancing, and masks have all aided in controlling the spread of COVID-19. However, detection of the virus is crucial to implement isolation of infected individuals. This paper presents the innovative repurposing of lab materials, workspace, and personnel in response to the COVID-19-induced shutdown and consequential shortage of commercially made virus transport media (VTM). This method for VTM production highlights the ability of standard re","2021","07","07","MethodsX","MethodsX","COVID-19; Pandemic; Supply chain; Viral transport media","Yount","Jacob S","College of Medicine, Department of Microbial Infection and Immunity, The Ohio State University, Columbus, OH USA",NA
"511","34226865","10.1016/j.mex.2021.101433","Viral transport media for COVID-19 testing.","Precautionary measures of physical isolation, social distancing, and masks have all aided in controlling the spread of COVID-19. However, detection of the virus is crucial to implement isolation of infected individuals. This paper presents the innovative repurposing of lab materials, workspace, and personnel in response to the COVID-19-induced shutdown and consequential shortage of commercially made virus transport media (VTM). This method for VTM production highlights the ability of standard re","2021","07","07","MethodsX","MethodsX","COVID-19; Pandemic; Supply chain; Viral transport media","Fowler","Lorri A","Davis Heart and Lung Research Institute, Wexner Medical Center, The Ohio State University, Columbus, OH USA",NA
"512","34226865","10.1016/j.mex.2021.101433","Viral transport media for COVID-19 testing.","Precautionary measures of physical isolation, social distancing, and masks have all aided in controlling the spread of COVID-19. However, detection of the virus is crucial to implement isolation of infected individuals. This paper presents the innovative repurposing of lab materials, workspace, and personnel in response to the COVID-19-induced shutdown and consequential shortage of commercially made virus transport media (VTM). This method for VTM production highlights the ability of standard re","2021","07","07","MethodsX","MethodsX","COVID-19; Pandemic; Supply chain; Viral transport media","Jones","Penny S","Davis Heart and Lung Research Institute, Wexner Medical Center, The Ohio State University, Columbus, OH USA",NA
"513","34226865","10.1016/j.mex.2021.101433","Viral transport media for COVID-19 testing.","Precautionary measures of physical isolation, social distancing, and masks have all aided in controlling the spread of COVID-19. However, detection of the virus is crucial to implement isolation of infected individuals. This paper presents the innovative repurposing of lab materials, workspace, and personnel in response to the COVID-19-induced shutdown and consequential shortage of commercially made virus transport media (VTM). This method for VTM production highlights the ability of standard re","2021","07","07","MethodsX","MethodsX","COVID-19; Pandemic; Supply chain; Viral transport media","Mohler","Peter J","Davis Heart and Lung Research Institute, Wexner Medical Center, The Ohio State University, Columbus, OH USA",NA
"514","34226865","10.1016/j.mex.2021.101433","Viral transport media for COVID-19 testing.","Precautionary measures of physical isolation, social distancing, and masks have all aided in controlling the spread of COVID-19. However, detection of the virus is crucial to implement isolation of infected individuals. This paper presents the innovative repurposing of lab materials, workspace, and personnel in response to the COVID-19-induced shutdown and consequential shortage of commercially made virus transport media (VTM). This method for VTM production highlights the ability of standard re","2021","07","07","MethodsX","MethodsX","COVID-19; Pandemic; Supply chain; Viral transport media","Wold","Loren E","Davis Heart and Lung Research Institute, Wexner Medical Center, The Ohio State University, Columbus, OH USA",NA
"515","34226864","10.1016/j.uclim.2021.100903","Influences of weather-related parameters on the spread of Covid-19 pandemic - The scenario of Bangladesh.","Weather parameters such as temperature, humidity, air quality index and wind speed are the important factors influencing the infectious diseases like Covid-19. Therefore, this study aims to discuss and analyse the relation between weather parameters and the spread of Coronavirus disease (Covid-19) from the perspective of Bangladesh. Correlation among weather parameters and infection and death rate were established using several graphical plots and wind rose diagrams, Kendall and Spearman correla","2021","07","16","Urban Clim","Urban climate","Bangladesh; Covid-19; Humidity; Temperature; Weather parameters; Wind speed","Arefin","Md Arman","Department of Mechanical Engineering, Rajshahi University of Engineering &amp",NA
"516","34226864","10.1016/j.uclim.2021.100903","Influences of weather-related parameters on the spread of Covid-19 pandemic - The scenario of Bangladesh.","Weather parameters such as temperature, humidity, air quality index and wind speed are the important factors influencing the infectious diseases like Covid-19. Therefore, this study aims to discuss and analyse the relation between weather parameters and the spread of Coronavirus disease (Covid-19) from the perspective of Bangladesh. Correlation among weather parameters and infection and death rate were established using several graphical plots and wind rose diagrams, Kendall and Spearman correla","2021","07","16","Urban Clim","Urban climate","Bangladesh; Covid-19; Humidity; Temperature; Weather parameters; Wind speed","Nabi","Md Nurun","School of Engineering and Technology, Central Queensland University, WA 6000, Australia",NA
"517","34226864","10.1016/j.uclim.2021.100903","Influences of weather-related parameters on the spread of Covid-19 pandemic - The scenario of Bangladesh.","Weather parameters such as temperature, humidity, air quality index and wind speed are the important factors influencing the infectious diseases like Covid-19. Therefore, this study aims to discuss and analyse the relation between weather parameters and the spread of Coronavirus disease (Covid-19) from the perspective of Bangladesh. Correlation among weather parameters and infection and death rate were established using several graphical plots and wind rose diagrams, Kendall and Spearman correla","2021","07","16","Urban Clim","Urban climate","Bangladesh; Covid-19; Humidity; Temperature; Weather parameters; Wind speed","Islam","Mohammad Towhidul","Department of Mechanical Engineering, Rajshahi University of Engineering &amp",NA
"518","34226864","10.1016/j.uclim.2021.100903","Influences of weather-related parameters on the spread of Covid-19 pandemic - The scenario of Bangladesh.","Weather parameters such as temperature, humidity, air quality index and wind speed are the important factors influencing the infectious diseases like Covid-19. Therefore, this study aims to discuss and analyse the relation between weather parameters and the spread of Coronavirus disease (Covid-19) from the perspective of Bangladesh. Correlation among weather parameters and infection and death rate were established using several graphical plots and wind rose diagrams, Kendall and Spearman correla","2021","07","16","Urban Clim","Urban climate","Bangladesh; Covid-19; Humidity; Temperature; Weather parameters; Wind speed","Islam","Md Shamiul","Department of Mechanical Engineering, Rajshahi University of Engineering &amp",NA
"519","34226863","10.1016/j.hlpt.2021.100542","A Biased Analysis of the Swedish Management of Covid-19.",NA,"2021","07","07","Health Policy Technol","Health policy and technology",NA,"Nilson","Finn","Karlstad University, Centre for Societal Risk Research, Sweden",NA
"520","34226862","10.1002/sono.12263","The initial impact of COVID-19 on Australasian Sonographers Part 1: Changes in scan numbers and sonographer work hours.","COVID-19 has seen a series of lockdowns and suspension on non-urgent elective surgeries. Subsequently, there was a drop in the number of diagnostic imaging services billed in April, May, 2020. A survey was undertaken from March to June 2020 to determine the initial impact of COVID-19 on Australasian Sonographers. This article, the first in a 3-part series presents and discusses the results of this survey pertaining to changes in the number of scans performed, and changes in the working hours of ","2021","07","07","Sonography","Sonography","Australasian; COVID-19; impact; scan-numbers; sonographers; workhours","Childs","Jessie","Allied Health and Human Performance University of South Australia Adelaide Australia",NA
"521","34226862","10.1002/sono.12263","The initial impact of COVID-19 on Australasian Sonographers Part 1: Changes in scan numbers and sonographer work hours.","COVID-19 has seen a series of lockdowns and suspension on non-urgent elective surgeries. Subsequently, there was a drop in the number of diagnostic imaging services billed in April, May, 2020. A survey was undertaken from March to June 2020 to determine the initial impact of COVID-19 on Australasian Sonographers. This article, the first in a 3-part series presents and discusses the results of this survey pertaining to changes in the number of scans performed, and changes in the working hours of ","2021","07","07","Sonography","Sonography","Australasian; COVID-19; impact; scan-numbers; sonographers; workhours","Lamb","Kathryn","Allied Health and Human Performance University of South Australia Adelaide Australia",NA
"522","34226862","10.1002/sono.12263","The initial impact of COVID-19 on Australasian Sonographers Part 1: Changes in scan numbers and sonographer work hours.","COVID-19 has seen a series of lockdowns and suspension on non-urgent elective surgeries. Subsequently, there was a drop in the number of diagnostic imaging services billed in April, May, 2020. A survey was undertaken from March to June 2020 to determine the initial impact of COVID-19 on Australasian Sonographers. This article, the first in a 3-part series presents and discusses the results of this survey pertaining to changes in the number of scans performed, and changes in the working hours of ","2021","07","07","Sonography","Sonography","Australasian; COVID-19; impact; scan-numbers; sonographers; workhours","Osborne","Brooke","Allied Health and Human Performance University of South Australia Adelaide Australia",NA
"523","34226862","10.1002/sono.12263","The initial impact of COVID-19 on Australasian Sonographers Part 1: Changes in scan numbers and sonographer work hours.","COVID-19 has seen a series of lockdowns and suspension on non-urgent elective surgeries. Subsequently, there was a drop in the number of diagnostic imaging services billed in April, May, 2020. A survey was undertaken from March to June 2020 to determine the initial impact of COVID-19 on Australasian Sonographers. This article, the first in a 3-part series presents and discusses the results of this survey pertaining to changes in the number of scans performed, and changes in the working hours of ","2021","07","07","Sonography","Sonography","Australasian; COVID-19; impact; scan-numbers; sonographers; workhours","Maranna","Sandhya","Allied Health and Human Performance University of South Australia Adelaide Australia",NA
"524","34226862","10.1002/sono.12263","The initial impact of COVID-19 on Australasian Sonographers Part 1: Changes in scan numbers and sonographer work hours.","COVID-19 has seen a series of lockdowns and suspension on non-urgent elective surgeries. Subsequently, there was a drop in the number of diagnostic imaging services billed in April, May, 2020. A survey was undertaken from March to June 2020 to determine the initial impact of COVID-19 on Australasian Sonographers. This article, the first in a 3-part series presents and discusses the results of this survey pertaining to changes in the number of scans performed, and changes in the working hours of ","2021","07","07","Sonography","Sonography","Australasian; COVID-19; impact; scan-numbers; sonographers; workhours","Esterman","Adrian","Nursing, University of South Australia Adelaide Australia",NA
"525","34226861","10.1186/s40163-021-00151-y","Crime and COVID-19: effect of changes in routine activities in Mexico City.","This study aimed to determine whether crime patterns in Mexico City changed due to the COVID-19 pandemic, and to test whether any changes observed were associated with the disruption of routine activities, as measured by changes in public transport passenger numbers. The first objective was assessed by comparing the observed incidence of crime after the COVID-19 pandemic was detected in the country with that expected based on ARIMA forecasts based on the pre-pandemic trends. The second objective","2021","07","07","Crime Sci","Crime science","ARIMA; COVID-19; Crime incidence; Mexico City","Estévez-Soto","Patricio R","UCL Department of Security and Crime Science, UCL Jill Dando Institute of Security and Crime Science, 35 Tavistock Sq, London, WC1H 9EZ UK",NA
"526","34226860","10.1186/s40163-021-00147-8","The U-shaped crime recovery during COVID-19: evidence from national crime rates in Mexico.","The existing empirical evidence suggests a reduction in aggregate crime as a consequence of the COVID-19 lockdown. However, what happens when lockdown measures are relaxed? This paper considers how the COVID-19 pandemic affects crime rates throughout Mexico when the stay-at-home orders end. We use national crime data from Mexico's National Public Security System, which reports municipality-level rates on assault &amp; battery, theft &amp; property crime, fraud, drug crimes &amp; extortion","2021","07","07","Crime Sci","Crime science","COVID-19; Crime; Lockdown; Mexico; Pandemic","Balmori de la Miyar","Jose Roberto","Business and Economics School, Universidad Anahuac Mexico, Av. Universidad Anáhuac 46, 52786 Huixquilucan, Mexico",NA
"527","34226860","10.1186/s40163-021-00147-8","The U-shaped crime recovery during COVID-19: evidence from national crime rates in Mexico.","The existing empirical evidence suggests a reduction in aggregate crime as a consequence of the COVID-19 lockdown. However, what happens when lockdown measures are relaxed? This paper considers how the COVID-19 pandemic affects crime rates throughout Mexico when the stay-at-home orders end. We use national crime data from Mexico's National Public Security System, which reports municipality-level rates on assault &amp; battery, theft &amp; property crime, fraud, drug crimes &amp; extortion","2021","07","07","Crime Sci","Crime science","COVID-19; Crime; Lockdown; Mexico; Pandemic","Hoehn-Velasco","Lauren","Andrew Young School of Policy Studies, Georgia State University, Atlanta, USA",NA
"528","34226860","10.1186/s40163-021-00147-8","The U-shaped crime recovery during COVID-19: evidence from national crime rates in Mexico.","The existing empirical evidence suggests a reduction in aggregate crime as a consequence of the COVID-19 lockdown. However, what happens when lockdown measures are relaxed? This paper considers how the COVID-19 pandemic affects crime rates throughout Mexico when the stay-at-home orders end. We use national crime data from Mexico's National Public Security System, which reports municipality-level rates on assault &amp; battery, theft &amp; property crime, fraud, drug crimes &amp; extortion","2021","07","07","Crime Sci","Crime science","COVID-19; Crime; Lockdown; Mexico; Pandemic","Silverio-Murillo","Adan","School of Government, Tecnologico de Monterrey, Mexico City, Mexico",NA
"529","34226858","10.1002/jgf2.452","Primary care physicians' narratives on COVID-19 responses in Japan: Professional roles evoked under a pandemic.","Within the vague system of primary care and COVID-19 infection control in Japan, we explored how primary care (PC) physicians exhibited adaptive performance in their institutions and communities to cope with the COVID-19 pandemic from January to May 2020. Narrative analysis conducted by a team of medical professionals and anthropologists. We purposefully selected 10 PC physicians in community-based hospitals and clinics and conducted a total of 17 individual and group interviews. The verbatim tr","2021","07","07","J Gen Fam Med","Journal of general and family medicine","COVID-19; Japan; adaptive performance; contextual performance; infectious disease; primary care; qualitative research","Haruta","Junji","Medical Education Center School of Medicine Keio University Tokyo Japan",NA
"530","34226858","10.1002/jgf2.452","Primary care physicians' narratives on COVID-19 responses in Japan: Professional roles evoked under a pandemic.","Within the vague system of primary care and COVID-19 infection control in Japan, we explored how primary care (PC) physicians exhibited adaptive performance in their institutions and communities to cope with the COVID-19 pandemic from January to May 2020. Narrative analysis conducted by a team of medical professionals and anthropologists. We purposefully selected 10 PC physicians in community-based hospitals and clinics and conducted a total of 17 individual and group interviews. The verbatim tr","2021","07","07","J Gen Fam Med","Journal of general and family medicine","COVID-19; Japan; adaptive performance; contextual performance; infectious disease; primary care; qualitative research","Horiguchi","Sachiko","Undergraduate Program Temple University Japan Tokyo Japan",NA
"531","34226858","10.1002/jgf2.452","Primary care physicians' narratives on COVID-19 responses in Japan: Professional roles evoked under a pandemic.","Within the vague system of primary care and COVID-19 infection control in Japan, we explored how primary care (PC) physicians exhibited adaptive performance in their institutions and communities to cope with the COVID-19 pandemic from January to May 2020. Narrative analysis conducted by a team of medical professionals and anthropologists. We purposefully selected 10 PC physicians in community-based hospitals and clinics and conducted a total of 17 individual and group interviews. The verbatim tr","2021","07","07","J Gen Fam Med","Journal of general and family medicine","COVID-19; Japan; adaptive performance; contextual performance; infectious disease; primary care; qualitative research","Miyachi","Junichiro","Azai-higashi Clinic Hokkaido Centre for Family Medicine Nagahama Japan",NA
"532","34226858","10.1002/jgf2.452","Primary care physicians' narratives on COVID-19 responses in Japan: Professional roles evoked under a pandemic.","Within the vague system of primary care and COVID-19 infection control in Japan, we explored how primary care (PC) physicians exhibited adaptive performance in their institutions and communities to cope with the COVID-19 pandemic from January to May 2020. Narrative analysis conducted by a team of medical professionals and anthropologists. We purposefully selected 10 PC physicians in community-based hospitals and clinics and conducted a total of 17 individual and group interviews. The verbatim tr","2021","07","07","J Gen Fam Med","Journal of general and family medicine","COVID-19; Japan; adaptive performance; contextual performance; infectious disease; primary care; qualitative research","Teruyama","Junko","Faculty of Library, Information and Media Science University of Tsukuba Tsukuba Japan",NA
"533","34226858","10.1002/jgf2.452","Primary care physicians' narratives on COVID-19 responses in Japan: Professional roles evoked under a pandemic.","Within the vague system of primary care and COVID-19 infection control in Japan, we explored how primary care (PC) physicians exhibited adaptive performance in their institutions and communities to cope with the COVID-19 pandemic from January to May 2020. Narrative analysis conducted by a team of medical professionals and anthropologists. We purposefully selected 10 PC physicians in community-based hospitals and clinics and conducted a total of 17 individual and group interviews. The verbatim tr","2021","07","07","J Gen Fam Med","Journal of general and family medicine","COVID-19; Japan; adaptive performance; contextual performance; infectious disease; primary care; qualitative research","Kimura","Shuhei","Faculty of Humanities and Social Sciences University of Tsukuba Tsukuba Japan",NA
"534","34226858","10.1002/jgf2.452","Primary care physicians' narratives on COVID-19 responses in Japan: Professional roles evoked under a pandemic.","Within the vague system of primary care and COVID-19 infection control in Japan, we explored how primary care (PC) physicians exhibited adaptive performance in their institutions and communities to cope with the COVID-19 pandemic from January to May 2020. Narrative analysis conducted by a team of medical professionals and anthropologists. We purposefully selected 10 PC physicians in community-based hospitals and clinics and conducted a total of 17 individual and group interviews. The verbatim tr","2021","07","07","J Gen Fam Med","Journal of general and family medicine","COVID-19; Japan; adaptive performance; contextual performance; infectious disease; primary care; qualitative research","Iida","Junko","Faculty of Health and Welfare Kawasaki University of Medical Welfare Kurashiki Japan",NA
"535","34226858","10.1002/jgf2.452","Primary care physicians' narratives on COVID-19 responses in Japan: Professional roles evoked under a pandemic.","Within the vague system of primary care and COVID-19 infection control in Japan, we explored how primary care (PC) physicians exhibited adaptive performance in their institutions and communities to cope with the COVID-19 pandemic from January to May 2020. Narrative analysis conducted by a team of medical professionals and anthropologists. We purposefully selected 10 PC physicians in community-based hospitals and clinics and conducted a total of 17 individual and group interviews. The verbatim tr","2021","07","07","J Gen Fam Med","Journal of general and family medicine","COVID-19; Japan; adaptive performance; contextual performance; infectious disease; primary care; qualitative research","Ozone","Sachiko","Faculty of Humanities and Social Sciences University of Tsukuba Tsukuba Japan",NA
"536","34226858","10.1002/jgf2.452","Primary care physicians' narratives on COVID-19 responses in Japan: Professional roles evoked under a pandemic.","Within the vague system of primary care and COVID-19 infection control in Japan, we explored how primary care (PC) physicians exhibited adaptive performance in their institutions and communities to cope with the COVID-19 pandemic from January to May 2020. Narrative analysis conducted by a team of medical professionals and anthropologists. We purposefully selected 10 PC physicians in community-based hospitals and clinics and conducted a total of 17 individual and group interviews. The verbatim tr","2021","07","07","J Gen Fam Med","Journal of general and family medicine","COVID-19; Japan; adaptive performance; contextual performance; infectious disease; primary care; qualitative research","Goto","Ryohei","Department of General Medicine and Primary Care Faculty of Medicine University of Tsukuba Tsukuba Japan",NA
"537","34226858","10.1002/jgf2.452","Primary care physicians' narratives on COVID-19 responses in Japan: Professional roles evoked under a pandemic.","Within the vague system of primary care and COVID-19 infection control in Japan, we explored how primary care (PC) physicians exhibited adaptive performance in their institutions and communities to cope with the COVID-19 pandemic from January to May 2020. Narrative analysis conducted by a team of medical professionals and anthropologists. We purposefully selected 10 PC physicians in community-based hospitals and clinics and conducted a total of 17 individual and group interviews. The verbatim tr","2021","07","07","J Gen Fam Med","Journal of general and family medicine","COVID-19; Japan; adaptive performance; contextual performance; infectious disease; primary care; qualitative research","Kaneko","Makoto","Department of Health Data Science, Graduate School of Data Science Yokohama City University Yokohama Japan",NA
"538","34226858","10.1002/jgf2.452","Primary care physicians' narratives on COVID-19 responses in Japan: Professional roles evoked under a pandemic.","Within the vague system of primary care and COVID-19 infection control in Japan, we explored how primary care (PC) physicians exhibited adaptive performance in their institutions and communities to cope with the COVID-19 pandemic from January to May 2020. Narrative analysis conducted by a team of medical professionals and anthropologists. We purposefully selected 10 PC physicians in community-based hospitals and clinics and conducted a total of 17 individual and group interviews. The verbatim tr","2021","07","07","J Gen Fam Med","Journal of general and family medicine","COVID-19; Japan; adaptive performance; contextual performance; infectious disease; primary care; qualitative research","Hama","Yusuke","Tokyo Junior College of Transportation Tokyo Japan",NA
"539","34226857","10.1002/jgf2.462","Changes in influenza vaccination coverage associated during the COVID-19 pandemic in Japan.","Changes in influenza vaccination coverage during the COVID-19 pandemic in Japan were limited. Not only changes in individual behavior and the threat of disease, but also vaccine dissemination policy based on system-based interventions, including behavioral economic approaches, is desirable.","2021","07","07","J Gen Fam Med","Journal of general and family medicine","COVID-19; barriers to the vaccination; influenza vaccine","Watanabe","Dan","Department of General Medicine Showa University Hospital Tokyo Japan",NA
"540","34226857","10.1002/jgf2.462","Changes in influenza vaccination coverage associated during the COVID-19 pandemic in Japan.","Changes in influenza vaccination coverage during the COVID-19 pandemic in Japan were limited. Not only changes in individual behavior and the threat of disease, but also vaccine dissemination policy based on system-based interventions, including behavioral economic approaches, is desirable.","2021","07","07","J Gen Fam Med","Journal of general and family medicine","COVID-19; barriers to the vaccination; influenza vaccine","Harada","Taku","Department of General Medicine Showa University Hospital Tokyo Japan",NA
"541","34226857","10.1002/jgf2.462","Changes in influenza vaccination coverage associated during the COVID-19 pandemic in Japan.","Changes in influenza vaccination coverage during the COVID-19 pandemic in Japan were limited. Not only changes in individual behavior and the threat of disease, but also vaccine dissemination policy based on system-based interventions, including behavioral economic approaches, is desirable.","2021","07","07","J Gen Fam Med","Journal of general and family medicine","COVID-19; barriers to the vaccination; influenza vaccine","Hiroshige","Juichi","Department of General Medicine Showa University Hospital Tokyo Japan",NA
"542","34226856","10.1002/wmh3.435","Death by political party: The relationship between COVID-19 deaths and political party affiliation in the United States.","This study explored social factors that are associated with the US deaths caused by COVID-19 after the declaration of economic reopening on May 1, 2020 by President Donald Trump. We seek to understand how county-level support for Trump interacted with social distancing policies to impact COVID-19 death rates. Overall, controlling for several potential confounders, counties with higher levels of Trump support do not necessarily experience greater mortality rates due to COVID-19. The predicted wee","2021","07","07","World Med Health Policy","World medical &amp; health policy","COVID-19; health policies; political affiliation; social distancing activities","Gao","Jingjing","Department of Public Policy University of North Carolina at Charlotte Charlotte North Carolina USA",NA
"543","34226856","10.1002/wmh3.435","Death by political party: The relationship between COVID-19 deaths and political party affiliation in the United States.","This study explored social factors that are associated with the US deaths caused by COVID-19 after the declaration of economic reopening on May 1, 2020 by President Donald Trump. We seek to understand how county-level support for Trump interacted with social distancing policies to impact COVID-19 death rates. Overall, controlling for several potential confounders, counties with higher levels of Trump support do not necessarily experience greater mortality rates due to COVID-19. The predicted wee","2021","07","07","World Med Health Policy","World medical &amp; health policy","COVID-19; health policies; political affiliation; social distancing activities","Radford","Benjamin J","Department of Political Science and Public Administration University of North Carolina at Charlotte Charlotte North Carolina USA",NA
"544","34226855","10.1002/wmh3.445","The COVID-19 pandemic: Stay Home policy and exposure to risks of infection among Nigerians.","The global threat which continues to accompany SARS-CoV-2 has led to a global response which adopts lockdown and stays home policy as means of curtailing its spread. This study investigates compliance with the Stay Home policy and exposure to COVID-19 in Nigeria. A survey was conducted from April 4 to May 8, 2020 using a cross-sectional mixed-methods approach to elicit responses from 879 participants across six geopolitical zones of Nigeria. Descriptive, <U+03C7> <sup>2</sup>, and multiple regre","2021","07","07","World Med Health Policy","World medical &amp; health policy","COVID-19; Nigeria; stay at home","Akeju","David O","Department of Sociology University of Lagos Lagos Nigeria",NA
"545","34226855","10.1002/wmh3.445","The COVID-19 pandemic: Stay Home policy and exposure to risks of infection among Nigerians.","The global threat which continues to accompany SARS-CoV-2 has led to a global response which adopts lockdown and stays home policy as means of curtailing its spread. This study investigates compliance with the Stay Home policy and exposure to COVID-19 in Nigeria. A survey was conducted from April 4 to May 8, 2020 using a cross-sectional mixed-methods approach to elicit responses from 879 participants across six geopolitical zones of Nigeria. Descriptive, <U+03C7> <sup>2</sup>, and multiple regre","2021","07","07","World Med Health Policy","World medical &amp; health policy","COVID-19; Nigeria; stay at home","Adejoh","Samuel O","Department of Social Work University of Lagos Lagos Nigeria",NA
"546","34226855","10.1002/wmh3.445","The COVID-19 pandemic: Stay Home policy and exposure to risks of infection among Nigerians.","The global threat which continues to accompany SARS-CoV-2 has led to a global response which adopts lockdown and stays home policy as means of curtailing its spread. This study investigates compliance with the Stay Home policy and exposure to COVID-19 in Nigeria. A survey was conducted from April 4 to May 8, 2020 using a cross-sectional mixed-methods approach to elicit responses from 879 participants across six geopolitical zones of Nigeria. Descriptive, <U+03C7> <sup>2</sup>, and multiple regre","2021","07","07","World Med Health Policy","World medical &amp; health policy","COVID-19; Nigeria; stay at home","Fakunmoju","Ayoola J","Department of Sociology University of Ibadan Ibadan Nigeria",NA
"547","34226855","10.1002/wmh3.445","The COVID-19 pandemic: Stay Home policy and exposure to risks of infection among Nigerians.","The global threat which continues to accompany SARS-CoV-2 has led to a global response which adopts lockdown and stays home policy as means of curtailing its spread. This study investigates compliance with the Stay Home policy and exposure to COVID-19 in Nigeria. A survey was conducted from April 4 to May 8, 2020 using a cross-sectional mixed-methods approach to elicit responses from 879 participants across six geopolitical zones of Nigeria. Descriptive, <U+03C7> <sup>2</sup>, and multiple regre","2021","07","07","World Med Health Policy","World medical &amp; health policy","COVID-19; Nigeria; stay at home","Allsop","Matthew J","Academic Unit of Palliative Care, Leeds Institute of Health Sciences University of Leeds Leeds UK",NA
"548","34226855","10.1002/wmh3.445","The COVID-19 pandemic: Stay Home policy and exposure to risks of infection among Nigerians.","The global threat which continues to accompany SARS-CoV-2 has led to a global response which adopts lockdown and stays home policy as means of curtailing its spread. This study investigates compliance with the Stay Home policy and exposure to COVID-19 in Nigeria. A survey was conducted from April 4 to May 8, 2020 using a cross-sectional mixed-methods approach to elicit responses from 879 participants across six geopolitical zones of Nigeria. Descriptive, <U+03C7> <sup>2</sup>, and multiple regre","2021","07","07","World Med Health Policy","World medical &amp; health policy","COVID-19; Nigeria; stay at home","Ebenso","Bassey","Nuffield Centre for International Health and Development, Leeds Institute of Health Sciences University of Leeds Leeds UK",NA
"549","34226855","10.1002/wmh3.445","The COVID-19 pandemic: Stay Home policy and exposure to risks of infection among Nigerians.","The global threat which continues to accompany SARS-CoV-2 has led to a global response which adopts lockdown and stays home policy as means of curtailing its spread. This study investigates compliance with the Stay Home policy and exposure to COVID-19 in Nigeria. A survey was conducted from April 4 to May 8, 2020 using a cross-sectional mixed-methods approach to elicit responses from 879 participants across six geopolitical zones of Nigeria. Descriptive, <U+03C7> <sup>2</sup>, and multiple regre","2021","07","07","World Med Health Policy","World medical &amp; health policy","COVID-19; Nigeria; stay at home","Tade","Titilayo","Department of Medical Social Services Lagos University Teaching Hospital Lagos Nigeria",NA
"550","34226855","10.1002/wmh3.445","The COVID-19 pandemic: Stay Home policy and exposure to risks of infection among Nigerians.","The global threat which continues to accompany SARS-CoV-2 has led to a global response which adopts lockdown and stays home policy as means of curtailing its spread. This study investigates compliance with the Stay Home policy and exposure to COVID-19 in Nigeria. A survey was conducted from April 4 to May 8, 2020 using a cross-sectional mixed-methods approach to elicit responses from 879 participants across six geopolitical zones of Nigeria. Descriptive, <U+03C7> <sup>2</sup>, and multiple regre","2021","07","07","World Med Health Policy","World medical &amp; health policy","COVID-19; Nigeria; stay at home","Okusanya","Babasola O","Department of Obstetrics and Gynaecology, College of Medicine University of Lagos Lagos Nigeria",NA
"551","34226854","10.1002/wmh3.449","Sweden's coronavirus strategy: The Public Health Agency and the sites of controversy.","In contrast to the vast majority of Western countries, Sweden left large segments of the society open instead of imposing a lockdown to combat the spread of the coronavirus. As a result, the Swedish COVID-19 measures, largely devised by its expert agency on health, garnered widespread international attention. Despite the global interest in the corona strategy of the Public Health Agency of Sweden (PHAS), there are currently no systematic studies on their COVID-19 policy. The present investigatio","2021","07","07","World Med Health Policy","World medical &amp; health policy","COVID-19; Sweden; controversy; facemasks; pandemic; public health agency; risk; testing; the elderly; voluntarism","Pashakhanlou","Arash Heydarian","Department of Military Studies Swedish Defence University Stockholm Sweden",NA
"552","34226853","10.1002/wmh3.436","How are healthcare provider systems preparing for health emergency situations?","Natural disasters, disease outbreaks, famine, and human conflict have strained communities everywhere over the course of human existence. However, modern changes in climate, human mobility, and other factors have increased the global community's vulnerability to widespread emergencies. We are in the midst of a disruptive health event, with the COVID-19 pandemic testing our health provider systems globally. This study presents a qualitative analysis of published literature, obtained systematicall","2021","07","07","World Med Health Policy","World medical &amp; health policy","disaster; emergency; preparation","DeVita","Timothy","Department of Internal Medicine Yale University School of Medicine New Haven Connecticut USA",NA
"553","34226853","10.1002/wmh3.436","How are healthcare provider systems preparing for health emergency situations?","Natural disasters, disease outbreaks, famine, and human conflict have strained communities everywhere over the course of human existence. However, modern changes in climate, human mobility, and other factors have increased the global community's vulnerability to widespread emergencies. We are in the midst of a disruptive health event, with the COVID-19 pandemic testing our health provider systems globally. This study presents a qualitative analysis of published literature, obtained systematicall","2021","07","07","World Med Health Policy","World medical &amp; health policy","disaster; emergency; preparation","Brett-Major","David","Department of Epidemiology, College of Public Health University of Nebraska Medical Center Omaha Nebraska USA",NA
"554","34226853","10.1002/wmh3.436","How are healthcare provider systems preparing for health emergency situations?","Natural disasters, disease outbreaks, famine, and human conflict have strained communities everywhere over the course of human existence. However, modern changes in climate, human mobility, and other factors have increased the global community's vulnerability to widespread emergencies. We are in the midst of a disruptive health event, with the COVID-19 pandemic testing our health provider systems globally. This study presents a qualitative analysis of published literature, obtained systematicall","2021","07","07","World Med Health Policy","World medical &amp; health policy","disaster; emergency; preparation","Katz","Rebecca","Center for Global Health Science and Security Georgetown University School of Medicine Washington District of Columbia USA",NA
"555","34226852","10.1002/wmh3.412","The Impact of United Kingdom and Malaysia's Inherent Health Systems on Their COVID-19 Responses: A Comparison of Containment Strategies.","In March 2020, the outbreak of COVID-19 was officially declared a global pandemic by the World Health Organization. Given the novelty of the virus, and hence, lack of official guidance on effective containment strategies, individual countries opted for different containment approaches ranging from herd immunity to strict lockdown. The opposing strategies followed by the United Kingdom and its former colony, Malaysia, stand exemplary for this. Real-time polymerase chain reaction was implemented f","2021","07","07","World Med Health Policy","World medical &amp; health policy","COVID-19; community spread; inherent health system; pandemic response; public health","Allaham","Shereen",NA,NA
"556","34226852","10.1002/wmh3.412","The Impact of United Kingdom and Malaysia's Inherent Health Systems on Their COVID-19 Responses: A Comparison of Containment Strategies.","In March 2020, the outbreak of COVID-19 was officially declared a global pandemic by the World Health Organization. Given the novelty of the virus, and hence, lack of official guidance on effective containment strategies, individual countries opted for different containment approaches ranging from herd immunity to strict lockdown. The opposing strategies followed by the United Kingdom and its former colony, Malaysia, stand exemplary for this. Real-time polymerase chain reaction was implemented f","2021","07","07","World Med Health Policy","World medical &amp; health policy","COVID-19; community spread; inherent health system; pandemic response; public health","Demel","Isabel-Cathérine",NA,NA
"557","34226852","10.1002/wmh3.412","The Impact of United Kingdom and Malaysia's Inherent Health Systems on Their COVID-19 Responses: A Comparison of Containment Strategies.","In March 2020, the outbreak of COVID-19 was officially declared a global pandemic by the World Health Organization. Given the novelty of the virus, and hence, lack of official guidance on effective containment strategies, individual countries opted for different containment approaches ranging from herd immunity to strict lockdown. The opposing strategies followed by the United Kingdom and its former colony, Malaysia, stand exemplary for this. Real-time polymerase chain reaction was implemented f","2021","07","07","World Med Health Policy","World medical &amp; health policy","COVID-19; community spread; inherent health system; pandemic response; public health","Nur","Intesar",NA,NA
"558","34226852","10.1002/wmh3.412","The Impact of United Kingdom and Malaysia's Inherent Health Systems on Their COVID-19 Responses: A Comparison of Containment Strategies.","In March 2020, the outbreak of COVID-19 was officially declared a global pandemic by the World Health Organization. Given the novelty of the virus, and hence, lack of official guidance on effective containment strategies, individual countries opted for different containment approaches ranging from herd immunity to strict lockdown. The opposing strategies followed by the United Kingdom and its former colony, Malaysia, stand exemplary for this. Real-time polymerase chain reaction was implemented f","2021","07","07","World Med Health Policy","World medical &amp; health policy","COVID-19; community spread; inherent health system; pandemic response; public health","Abu Salim","Faizul Nizam",NA,NA
"559","34226852","10.1002/wmh3.412","The Impact of United Kingdom and Malaysia's Inherent Health Systems on Their COVID-19 Responses: A Comparison of Containment Strategies.","In March 2020, the outbreak of COVID-19 was officially declared a global pandemic by the World Health Organization. Given the novelty of the virus, and hence, lack of official guidance on effective containment strategies, individual countries opted for different containment approaches ranging from herd immunity to strict lockdown. The opposing strategies followed by the United Kingdom and its former colony, Malaysia, stand exemplary for this. Real-time polymerase chain reaction was implemented f","2021","07","07","World Med Health Policy","World medical &amp; health policy","COVID-19; community spread; inherent health system; pandemic response; public health","Manikam","Logan",NA,NA
"560","34226851","10.1002/wmh3.444","Identifying factors associated with the issuance of coronavirus-related stay-at-home orders in the Middle East and North Africa Region.","The COVID-19 pandemic has not spared the Middle East and North Africa (MENA) Region. MENA is one of the most politically, socially, and economically heterogeneous regions in the world, a characteristic reflected in its governments' responses to COVID-19. About two-thirds of these governments issued coronavirus-related stay-at-home orders (SAHOs), one of the most effective tools public health officials have for slowing the spread of infectious diseases. While SAHOs are very effective in terms of ","2021","07","07","World Med Health Policy","World medical &amp; health policy","COVID-19; MENA; coronavirus; lockdowns; pandemic; policy diffusion; public health; stay-at-home orders","Murray","Gregg R","Augusta University Augusta Georgia USA",NA
"561","34226851","10.1002/wmh3.444","Identifying factors associated with the issuance of coronavirus-related stay-at-home orders in the Middle East and North Africa Region.","The COVID-19 pandemic has not spared the Middle East and North Africa (MENA) Region. MENA is one of the most politically, socially, and economically heterogeneous regions in the world, a characteristic reflected in its governments' responses to COVID-19. About two-thirds of these governments issued coronavirus-related stay-at-home orders (SAHOs), one of the most effective tools public health officials have for slowing the spread of infectious diseases. While SAHOs are very effective in terms of ","2021","07","07","World Med Health Policy","World medical &amp; health policy","COVID-19; MENA; coronavirus; lockdowns; pandemic; policy diffusion; public health; stay-at-home orders","Jilani-Hyler","Nadia","Augusta University Augusta Georgia USA",NA
"562","34226850","10.1038/s41578-021-00346-4","Artificially intelligent nanopore for rapid SARS-CoV-2 testing.",NA,"2021","07","07","Nat Rev Mater","Nature reviews. Materials","Infectious-disease diagnostics; Nanopores; SARS-CoV-2; Viral infection","Horejs","Christine","Nature Reviews Materials, http://www.nature.com/natrevmats/",NA
"563","34226849","10.1002/osp4.534","Obesity and its implications on cerebral circulation and intracranial compliance in severe COVID-19.","Multiple factors have been identified as causes of intracranial compliance impairment (ICCI) among patients with obesity. On the other hand, obesity has been linked with worst outcomes in COVID-19. Thus, the hypothesis of severe acute respiratory syndrome (SARS) conducing to cerebral hemodynamic disorders (CHD) able to worsen ICCI and play an additional role on prognosis determination for COVID-19 among obese patients becomes suitable. 50 cases of SARS by COVID-19 were evaluated, for the presenc","2021","07","07","Obes Sci Pract","Obesity science &amp; practice","COVID-19; cerebral hemodynamics; intracranial compliance; obesity; severe acute respiratory syndrome","Brasil","Sérgio","Universidade de São Paulo Brazil",NA
"564","34226849","10.1002/osp4.534","Obesity and its implications on cerebral circulation and intracranial compliance in severe COVID-19.","Multiple factors have been identified as causes of intracranial compliance impairment (ICCI) among patients with obesity. On the other hand, obesity has been linked with worst outcomes in COVID-19. Thus, the hypothesis of severe acute respiratory syndrome (SARS) conducing to cerebral hemodynamic disorders (CHD) able to worsen ICCI and play an additional role on prognosis determination for COVID-19 among obese patients becomes suitable. 50 cases of SARS by COVID-19 were evaluated, for the presenc","2021","07","07","Obes Sci Pract","Obesity science &amp; practice","COVID-19; cerebral hemodynamics; intracranial compliance; obesity; severe acute respiratory syndrome","Renck","Alessandra Covallero","Universidade de São Paulo Brazil",NA
"565","34226849","10.1002/osp4.534","Obesity and its implications on cerebral circulation and intracranial compliance in severe COVID-19.","Multiple factors have been identified as causes of intracranial compliance impairment (ICCI) among patients with obesity. On the other hand, obesity has been linked with worst outcomes in COVID-19. Thus, the hypothesis of severe acute respiratory syndrome (SARS) conducing to cerebral hemodynamic disorders (CHD) able to worsen ICCI and play an additional role on prognosis determination for COVID-19 among obese patients becomes suitable. 50 cases of SARS by COVID-19 were evaluated, for the presenc","2021","07","07","Obes Sci Pract","Obesity science &amp; practice","COVID-19; cerebral hemodynamics; intracranial compliance; obesity; severe acute respiratory syndrome","Taccone","Fabio Silvio","Universitè Libre de Bruxelles Belgium",NA
"566","34226849","10.1002/osp4.534","Obesity and its implications on cerebral circulation and intracranial compliance in severe COVID-19.","Multiple factors have been identified as causes of intracranial compliance impairment (ICCI) among patients with obesity. On the other hand, obesity has been linked with worst outcomes in COVID-19. Thus, the hypothesis of severe acute respiratory syndrome (SARS) conducing to cerebral hemodynamic disorders (CHD) able to worsen ICCI and play an additional role on prognosis determination for COVID-19 among obese patients becomes suitable. 50 cases of SARS by COVID-19 were evaluated, for the presenc","2021","07","07","Obes Sci Pract","Obesity science &amp; practice","COVID-19; cerebral hemodynamics; intracranial compliance; obesity; severe acute respiratory syndrome","Fontoura Solla","Davi Jorge","Universidade de São Paulo Brazil",NA
"567","34226849","10.1002/osp4.534","Obesity and its implications on cerebral circulation and intracranial compliance in severe COVID-19.","Multiple factors have been identified as causes of intracranial compliance impairment (ICCI) among patients with obesity. On the other hand, obesity has been linked with worst outcomes in COVID-19. Thus, the hypothesis of severe acute respiratory syndrome (SARS) conducing to cerebral hemodynamic disorders (CHD) able to worsen ICCI and play an additional role on prognosis determination for COVID-19 among obese patients becomes suitable. 50 cases of SARS by COVID-19 were evaluated, for the presenc","2021","07","07","Obes Sci Pract","Obesity science &amp; practice","COVID-19; cerebral hemodynamics; intracranial compliance; obesity; severe acute respiratory syndrome","Tomazini","Bruno Martins","Universidade de São Paulo Brazil",NA
"568","34226849","10.1002/osp4.534","Obesity and its implications on cerebral circulation and intracranial compliance in severe COVID-19.","Multiple factors have been identified as causes of intracranial compliance impairment (ICCI) among patients with obesity. On the other hand, obesity has been linked with worst outcomes in COVID-19. Thus, the hypothesis of severe acute respiratory syndrome (SARS) conducing to cerebral hemodynamic disorders (CHD) able to worsen ICCI and play an additional role on prognosis determination for COVID-19 among obese patients becomes suitable. 50 cases of SARS by COVID-19 were evaluated, for the presenc","2021","07","07","Obes Sci Pract","Obesity science &amp; practice","COVID-19; cerebral hemodynamics; intracranial compliance; obesity; severe acute respiratory syndrome","Wayhs","Sâmia Yasin","Universidade de São Paulo Brazil",NA
"569","34226849","10.1002/osp4.534","Obesity and its implications on cerebral circulation and intracranial compliance in severe COVID-19.","Multiple factors have been identified as causes of intracranial compliance impairment (ICCI) among patients with obesity. On the other hand, obesity has been linked with worst outcomes in COVID-19. Thus, the hypothesis of severe acute respiratory syndrome (SARS) conducing to cerebral hemodynamic disorders (CHD) able to worsen ICCI and play an additional role on prognosis determination for COVID-19 among obese patients becomes suitable. 50 cases of SARS by COVID-19 were evaluated, for the presenc","2021","07","07","Obes Sci Pract","Obesity science &amp; practice","COVID-19; cerebral hemodynamics; intracranial compliance; obesity; severe acute respiratory syndrome","Fonseca","Sérgio","Universidade de São Paulo Brazil",NA
"570","34226849","10.1002/osp4.534","Obesity and its implications on cerebral circulation and intracranial compliance in severe COVID-19.","Multiple factors have been identified as causes of intracranial compliance impairment (ICCI) among patients with obesity. On the other hand, obesity has been linked with worst outcomes in COVID-19. Thus, the hypothesis of severe acute respiratory syndrome (SARS) conducing to cerebral hemodynamic disorders (CHD) able to worsen ICCI and play an additional role on prognosis determination for COVID-19 among obese patients becomes suitable. 50 cases of SARS by COVID-19 were evaluated, for the presenc","2021","07","07","Obes Sci Pract","Obesity science &amp; practice","COVID-19; cerebral hemodynamics; intracranial compliance; obesity; severe acute respiratory syndrome","Bassi","Estevão","Universidade de São Paulo Brazil",NA
"571","34226849","10.1002/osp4.534","Obesity and its implications on cerebral circulation and intracranial compliance in severe COVID-19.","Multiple factors have been identified as causes of intracranial compliance impairment (ICCI) among patients with obesity. On the other hand, obesity has been linked with worst outcomes in COVID-19. Thus, the hypothesis of severe acute respiratory syndrome (SARS) conducing to cerebral hemodynamic disorders (CHD) able to worsen ICCI and play an additional role on prognosis determination for COVID-19 among obese patients becomes suitable. 50 cases of SARS by COVID-19 were evaluated, for the presenc","2021","07","07","Obes Sci Pract","Obesity science &amp; practice","COVID-19; cerebral hemodynamics; intracranial compliance; obesity; severe acute respiratory syndrome","Lucena","Bruno","Universidade de São Paulo Brazil",NA
"572","34226849","10.1002/osp4.534","Obesity and its implications on cerebral circulation and intracranial compliance in severe COVID-19.","Multiple factors have been identified as causes of intracranial compliance impairment (ICCI) among patients with obesity. On the other hand, obesity has been linked with worst outcomes in COVID-19. Thus, the hypothesis of severe acute respiratory syndrome (SARS) conducing to cerebral hemodynamic disorders (CHD) able to worsen ICCI and play an additional role on prognosis determination for COVID-19 among obese patients becomes suitable. 50 cases of SARS by COVID-19 were evaluated, for the presenc","2021","07","07","Obes Sci Pract","Obesity science &amp; practice","COVID-19; cerebral hemodynamics; intracranial compliance; obesity; severe acute respiratory syndrome","De Carvalho Nogueira","Ricardo","Universidade de São Paulo Brazil",NA
"573","34226849","10.1002/osp4.534","Obesity and its implications on cerebral circulation and intracranial compliance in severe COVID-19.","Multiple factors have been identified as causes of intracranial compliance impairment (ICCI) among patients with obesity. On the other hand, obesity has been linked with worst outcomes in COVID-19. Thus, the hypothesis of severe acute respiratory syndrome (SARS) conducing to cerebral hemodynamic disorders (CHD) able to worsen ICCI and play an additional role on prognosis determination for COVID-19 among obese patients becomes suitable. 50 cases of SARS by COVID-19 were evaluated, for the presenc","2021","07","07","Obes Sci Pract","Obesity science &amp; practice","COVID-19; cerebral hemodynamics; intracranial compliance; obesity; severe acute respiratory syndrome","Paiva","Wellingson","Universidade de São Paulo Brazil",NA
"574","34226849","10.1002/osp4.534","Obesity and its implications on cerebral circulation and intracranial compliance in severe COVID-19.","Multiple factors have been identified as causes of intracranial compliance impairment (ICCI) among patients with obesity. On the other hand, obesity has been linked with worst outcomes in COVID-19. Thus, the hypothesis of severe acute respiratory syndrome (SARS) conducing to cerebral hemodynamic disorders (CHD) able to worsen ICCI and play an additional role on prognosis determination for COVID-19 among obese patients becomes suitable. 50 cases of SARS by COVID-19 were evaluated, for the presenc","2021","07","07","Obes Sci Pract","Obesity science &amp; practice","COVID-19; cerebral hemodynamics; intracranial compliance; obesity; severe acute respiratory syndrome","Teixeira","Manoel Jacobsen","Universidade de São Paulo Brazil",NA
"575","34226849","10.1002/osp4.534","Obesity and its implications on cerebral circulation and intracranial compliance in severe COVID-19.","Multiple factors have been identified as causes of intracranial compliance impairment (ICCI) among patients with obesity. On the other hand, obesity has been linked with worst outcomes in COVID-19. Thus, the hypothesis of severe acute respiratory syndrome (SARS) conducing to cerebral hemodynamic disorders (CHD) able to worsen ICCI and play an additional role on prognosis determination for COVID-19 among obese patients becomes suitable. 50 cases of SARS by COVID-19 were evaluated, for the presenc","2021","07","07","Obes Sci Pract","Obesity science &amp; practice","COVID-19; cerebral hemodynamics; intracranial compliance; obesity; severe acute respiratory syndrome","Frade Costa","Elaine Maria","Universidade de São Paulo Brazil",NA
"576","34226849","10.1002/osp4.534","Obesity and its implications on cerebral circulation and intracranial compliance in severe COVID-19.","Multiple factors have been identified as causes of intracranial compliance impairment (ICCI) among patients with obesity. On the other hand, obesity has been linked with worst outcomes in COVID-19. Thus, the hypothesis of severe acute respiratory syndrome (SARS) conducing to cerebral hemodynamic disorders (CHD) able to worsen ICCI and play an additional role on prognosis determination for COVID-19 among obese patients becomes suitable. 50 cases of SARS by COVID-19 were evaluated, for the presenc","2021","07","07","Obes Sci Pract","Obesity science &amp; practice","COVID-19; cerebral hemodynamics; intracranial compliance; obesity; severe acute respiratory syndrome","Sá Malbouisson","Luiz Marcelo","Universidade de São Paulo Brazil",NA
"577","34226848","10.1017/gmh.2021.24","Prevalence and correlates of depressive symptoms among Rohingya (forcibly displaced Myanmar nationals or FDMNs) older adults in Bangladesh amid the COVID-19 pandemic.","Depression is globally a crucial communal psychiatric disorder, which is more common in older adults. The situation is considerably worse among millions of older (forcibly displaced Myanmar nationals or FDMNs) Rohingya adults, and the coronavirus disease-2019 (COVID-19) pandemic may exacerbate the already existing precarious situation. The present study investigated depressive symptoms and their associated factors in older adult Rohingya FDMNs in Cox Bazar, Bangladesh, during the COVID-19 pandem","2021","07","07","Glob Ment Health (Camb)","Global mental health (Cambridge, England)","COVID-19; GDS-15; Rohingya; depressive symptoms; forcibly displaced Myanmar nationals","Mistry","Sabuj Kanti","ARCED Foundation, 13/1 Pallabi, Mirpur-12, Dhaka, Bangladesh",NA
"578","34226848","10.1017/gmh.2021.24","Prevalence and correlates of depressive symptoms among Rohingya (forcibly displaced Myanmar nationals or FDMNs) older adults in Bangladesh amid the COVID-19 pandemic.","Depression is globally a crucial communal psychiatric disorder, which is more common in older adults. The situation is considerably worse among millions of older (forcibly displaced Myanmar nationals or FDMNs) Rohingya adults, and the coronavirus disease-2019 (COVID-19) pandemic may exacerbate the already existing precarious situation. The present study investigated depressive symptoms and their associated factors in older adult Rohingya FDMNs in Cox Bazar, Bangladesh, during the COVID-19 pandem","2021","07","07","Glob Ment Health (Camb)","Global mental health (Cambridge, England)","COVID-19; GDS-15; Rohingya; depressive symptoms; forcibly displaced Myanmar nationals","Ali","A R M Mehrab","ARCED Foundation, 13/1 Pallabi, Mirpur-12, Dhaka, Bangladesh",NA
"579","34226848","10.1017/gmh.2021.24","Prevalence and correlates of depressive symptoms among Rohingya (forcibly displaced Myanmar nationals or FDMNs) older adults in Bangladesh amid the COVID-19 pandemic.","Depression is globally a crucial communal psychiatric disorder, which is more common in older adults. The situation is considerably worse among millions of older (forcibly displaced Myanmar nationals or FDMNs) Rohingya adults, and the coronavirus disease-2019 (COVID-19) pandemic may exacerbate the already existing precarious situation. The present study investigated depressive symptoms and their associated factors in older adult Rohingya FDMNs in Cox Bazar, Bangladesh, during the COVID-19 pandem","2021","07","07","Glob Ment Health (Camb)","Global mental health (Cambridge, England)","COVID-19; GDS-15; Rohingya; depressive symptoms; forcibly displaced Myanmar nationals","Irfan","Nafis Md","Institute of Nutrition and Food Science, University of Dhaka, Dhaka 1000, Bangladesh",NA
"580","34226848","10.1017/gmh.2021.24","Prevalence and correlates of depressive symptoms among Rohingya (forcibly displaced Myanmar nationals or FDMNs) older adults in Bangladesh amid the COVID-19 pandemic.","Depression is globally a crucial communal psychiatric disorder, which is more common in older adults. The situation is considerably worse among millions of older (forcibly displaced Myanmar nationals or FDMNs) Rohingya adults, and the coronavirus disease-2019 (COVID-19) pandemic may exacerbate the already existing precarious situation. The present study investigated depressive symptoms and their associated factors in older adult Rohingya FDMNs in Cox Bazar, Bangladesh, during the COVID-19 pandem","2021","07","07","Glob Ment Health (Camb)","Global mental health (Cambridge, England)","COVID-19; GDS-15; Rohingya; depressive symptoms; forcibly displaced Myanmar nationals","Yadav","Uday Narayan","Centre for Primary Health Care and Equity, University of New South Wales, Sydney, Australia",NA
"581","34226848","10.1017/gmh.2021.24","Prevalence and correlates of depressive symptoms among Rohingya (forcibly displaced Myanmar nationals or FDMNs) older adults in Bangladesh amid the COVID-19 pandemic.","Depression is globally a crucial communal psychiatric disorder, which is more common in older adults. The situation is considerably worse among millions of older (forcibly displaced Myanmar nationals or FDMNs) Rohingya adults, and the coronavirus disease-2019 (COVID-19) pandemic may exacerbate the already existing precarious situation. The present study investigated depressive symptoms and their associated factors in older adult Rohingya FDMNs in Cox Bazar, Bangladesh, during the COVID-19 pandem","2021","07","07","Glob Ment Health (Camb)","Global mental health (Cambridge, England)","COVID-19; GDS-15; Rohingya; depressive symptoms; forcibly displaced Myanmar nationals","Siddique","Rumana Ferdousi","Department of Psychology, University of Dhaka, Dhaka 1000, Bangladesh",NA
"582","34226848","10.1017/gmh.2021.24","Prevalence and correlates of depressive symptoms among Rohingya (forcibly displaced Myanmar nationals or FDMNs) older adults in Bangladesh amid the COVID-19 pandemic.","Depression is globally a crucial communal psychiatric disorder, which is more common in older adults. The situation is considerably worse among millions of older (forcibly displaced Myanmar nationals or FDMNs) Rohingya adults, and the coronavirus disease-2019 (COVID-19) pandemic may exacerbate the already existing precarious situation. The present study investigated depressive symptoms and their associated factors in older adult Rohingya FDMNs in Cox Bazar, Bangladesh, during the COVID-19 pandem","2021","07","07","Glob Ment Health (Camb)","Global mental health (Cambridge, England)","COVID-19; GDS-15; Rohingya; depressive symptoms; forcibly displaced Myanmar nationals","Peprah","Prince","Centre for Primary Health Care and Equity, University of New South Wales, Sydney, Australia",NA
"583","34226848","10.1017/gmh.2021.24","Prevalence and correlates of depressive symptoms among Rohingya (forcibly displaced Myanmar nationals or FDMNs) older adults in Bangladesh amid the COVID-19 pandemic.","Depression is globally a crucial communal psychiatric disorder, which is more common in older adults. The situation is considerably worse among millions of older (forcibly displaced Myanmar nationals or FDMNs) Rohingya adults, and the coronavirus disease-2019 (COVID-19) pandemic may exacerbate the already existing precarious situation. The present study investigated depressive symptoms and their associated factors in older adult Rohingya FDMNs in Cox Bazar, Bangladesh, during the COVID-19 pandem","2021","07","07","Glob Ment Health (Camb)","Global mental health (Cambridge, England)","COVID-19; GDS-15; Rohingya; depressive symptoms; forcibly displaced Myanmar nationals","Reza","Sompa","Society for Health Extension and Development (SHED), Cox's Bazar, Bangladesh",NA
"584","34226848","10.1017/gmh.2021.24","Prevalence and correlates of depressive symptoms among Rohingya (forcibly displaced Myanmar nationals or FDMNs) older adults in Bangladesh amid the COVID-19 pandemic.","Depression is globally a crucial communal psychiatric disorder, which is more common in older adults. The situation is considerably worse among millions of older (forcibly displaced Myanmar nationals or FDMNs) Rohingya adults, and the coronavirus disease-2019 (COVID-19) pandemic may exacerbate the already existing precarious situation. The present study investigated depressive symptoms and their associated factors in older adult Rohingya FDMNs in Cox Bazar, Bangladesh, during the COVID-19 pandem","2021","07","07","Glob Ment Health (Camb)","Global mental health (Cambridge, England)","COVID-19; GDS-15; Rohingya; depressive symptoms; forcibly displaced Myanmar nationals","Rahman","Ziaur","Society for Health Extension and Development (SHED), Cox's Bazar, Bangladesh",NA
"585","34226848","10.1017/gmh.2021.24","Prevalence and correlates of depressive symptoms among Rohingya (forcibly displaced Myanmar nationals or FDMNs) older adults in Bangladesh amid the COVID-19 pandemic.","Depression is globally a crucial communal psychiatric disorder, which is more common in older adults. The situation is considerably worse among millions of older (forcibly displaced Myanmar nationals or FDMNs) Rohingya adults, and the coronavirus disease-2019 (COVID-19) pandemic may exacerbate the already existing precarious situation. The present study investigated depressive symptoms and their associated factors in older adult Rohingya FDMNs in Cox Bazar, Bangladesh, during the COVID-19 pandem","2021","07","07","Glob Ment Health (Camb)","Global mental health (Cambridge, England)","COVID-19; GDS-15; Rohingya; depressive symptoms; forcibly displaced Myanmar nationals","Casanelia","Lisa","Torrens University, Melbourne, Australia",NA
"586","34226848","10.1017/gmh.2021.24","Prevalence and correlates of depressive symptoms among Rohingya (forcibly displaced Myanmar nationals or FDMNs) older adults in Bangladesh amid the COVID-19 pandemic.","Depression is globally a crucial communal psychiatric disorder, which is more common in older adults. The situation is considerably worse among millions of older (forcibly displaced Myanmar nationals or FDMNs) Rohingya adults, and the coronavirus disease-2019 (COVID-19) pandemic may exacerbate the already existing precarious situation. The present study investigated depressive symptoms and their associated factors in older adult Rohingya FDMNs in Cox Bazar, Bangladesh, during the COVID-19 pandem","2021","07","07","Glob Ment Health (Camb)","Global mental health (Cambridge, England)","COVID-19; GDS-15; Rohingya; depressive symptoms; forcibly displaced Myanmar nationals","O'Callaghan","Cathy","Centre for Primary Health Care and Equity, University of New South Wales, Sydney, Australia",NA
"587","34226847","10.1016/j.nmni.2021.100910","Bacterial Co-infection among COVID-19 patient groups: an update Systematic review and Meta-analysis.","The pandemic of SARS COV-2 raised the attention toward bacterial coinfection and their role in COVID-19 disease. This study aims to systematically review and identify the pooled prevalence of the bacterial coinfection in the related articles. A comprehensive search was conducted in international databases, including Medline, Scopus, Web of Science, and Embase, to identify the articles on the prevalence of Bacterial coinfections in COIVD-19 patients from December 1, 2019, until December 30, 2020.","2021","07","06","New Microbes New Infect","New microbes and new infections","COVID-19; Coronavirus; Meta-analysis; coinfection; systematics review","Soltani","Saber","Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran",NA
"588","34226847","10.1016/j.nmni.2021.100910","Bacterial Co-infection among COVID-19 patient groups: an update Systematic review and Meta-analysis.","The pandemic of SARS COV-2 raised the attention toward bacterial coinfection and their role in COVID-19 disease. This study aims to systematically review and identify the pooled prevalence of the bacterial coinfection in the related articles. A comprehensive search was conducted in international databases, including Medline, Scopus, Web of Science, and Embase, to identify the articles on the prevalence of Bacterial coinfections in COIVD-19 patients from December 1, 2019, until December 30, 2020.","2021","07","06","New Microbes New Infect","New microbes and new infections","COVID-19; Coronavirus; Meta-analysis; coinfection; systematics review","Faramarzi","Samireh","Razi Vaccine and Serum Research Institute, Agricultural Research, Education and Extension Organization (AREEO), Karaj, Iran",NA
"589","34226847","10.1016/j.nmni.2021.100910","Bacterial Co-infection among COVID-19 patient groups: an update Systematic review and Meta-analysis.","The pandemic of SARS COV-2 raised the attention toward bacterial coinfection and their role in COVID-19 disease. This study aims to systematically review and identify the pooled prevalence of the bacterial coinfection in the related articles. A comprehensive search was conducted in international databases, including Medline, Scopus, Web of Science, and Embase, to identify the articles on the prevalence of Bacterial coinfections in COIVD-19 patients from December 1, 2019, until December 30, 2020.","2021","07","06","New Microbes New Infect","New microbes and new infections","COVID-19; Coronavirus; Meta-analysis; coinfection; systematics review","Zandi","Milad","Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran",NA
"590","34226847","10.1016/j.nmni.2021.100910","Bacterial Co-infection among COVID-19 patient groups: an update Systematic review and Meta-analysis.","The pandemic of SARS COV-2 raised the attention toward bacterial coinfection and their role in COVID-19 disease. This study aims to systematically review and identify the pooled prevalence of the bacterial coinfection in the related articles. A comprehensive search was conducted in international databases, including Medline, Scopus, Web of Science, and Embase, to identify the articles on the prevalence of Bacterial coinfections in COIVD-19 patients from December 1, 2019, until December 30, 2020.","2021","07","06","New Microbes New Infect","New microbes and new infections","COVID-19; Coronavirus; Meta-analysis; coinfection; systematics review","Shahbahrami","Ramin","Research Center for Clinical Virology, Tehran University of Medical Sciences, Tehran, Iran",NA
"591","34226847","10.1016/j.nmni.2021.100910","Bacterial Co-infection among COVID-19 patient groups: an update Systematic review and Meta-analysis.","The pandemic of SARS COV-2 raised the attention toward bacterial coinfection and their role in COVID-19 disease. This study aims to systematically review and identify the pooled prevalence of the bacterial coinfection in the related articles. A comprehensive search was conducted in international databases, including Medline, Scopus, Web of Science, and Embase, to identify the articles on the prevalence of Bacterial coinfections in COIVD-19 patients from December 1, 2019, until December 30, 2020.","2021","07","06","New Microbes New Infect","New microbes and new infections","COVID-19; Coronavirus; Meta-analysis; coinfection; systematics review","Jafarpour","Ali","Research Center for Clinical Virology, Tehran University of Medical Sciences, Tehran, Iran",NA
"592","34226847","10.1016/j.nmni.2021.100910","Bacterial Co-infection among COVID-19 patient groups: an update Systematic review and Meta-analysis.","The pandemic of SARS COV-2 raised the attention toward bacterial coinfection and their role in COVID-19 disease. This study aims to systematically review and identify the pooled prevalence of the bacterial coinfection in the related articles. A comprehensive search was conducted in international databases, including Medline, Scopus, Web of Science, and Embase, to identify the articles on the prevalence of Bacterial coinfections in COIVD-19 patients from December 1, 2019, until December 30, 2020.","2021","07","06","New Microbes New Infect","New microbes and new infections","COVID-19; Coronavirus; Meta-analysis; coinfection; systematics review","Rezayat","Sara Akhavan","Department of Management &amp",NA
"593","34226847","10.1016/j.nmni.2021.100910","Bacterial Co-infection among COVID-19 patient groups: an update Systematic review and Meta-analysis.","The pandemic of SARS COV-2 raised the attention toward bacterial coinfection and their role in COVID-19 disease. This study aims to systematically review and identify the pooled prevalence of the bacterial coinfection in the related articles. A comprehensive search was conducted in international databases, including Medline, Scopus, Web of Science, and Embase, to identify the articles on the prevalence of Bacterial coinfections in COIVD-19 patients from December 1, 2019, until December 30, 2020.","2021","07","06","New Microbes New Infect","New microbes and new infections","COVID-19; Coronavirus; Meta-analysis; coinfection; systematics review","Pakzad","Iraj","Full Professor of Medical Microbiology, Department of Microbiology, School of Medicine, Ilam University Medical Sciences, Ilam, Iran",NA
"594","34226847","10.1016/j.nmni.2021.100910","Bacterial Co-infection among COVID-19 patient groups: an update Systematic review and Meta-analysis.","The pandemic of SARS COV-2 raised the attention toward bacterial coinfection and their role in COVID-19 disease. This study aims to systematically review and identify the pooled prevalence of the bacterial coinfection in the related articles. A comprehensive search was conducted in international databases, including Medline, Scopus, Web of Science, and Embase, to identify the articles on the prevalence of Bacterial coinfections in COIVD-19 patients from December 1, 2019, until December 30, 2020.","2021","07","06","New Microbes New Infect","New microbes and new infections","COVID-19; Coronavirus; Meta-analysis; coinfection; systematics review","Abdi","Fatemeh","School of Nursing and Midwifery, Alborz University of Medical Sciences, Karaj, Iran",NA
"595","34226847","10.1016/j.nmni.2021.100910","Bacterial Co-infection among COVID-19 patient groups: an update Systematic review and Meta-analysis.","The pandemic of SARS COV-2 raised the attention toward bacterial coinfection and their role in COVID-19 disease. This study aims to systematically review and identify the pooled prevalence of the bacterial coinfection in the related articles. A comprehensive search was conducted in international databases, including Medline, Scopus, Web of Science, and Embase, to identify the articles on the prevalence of Bacterial coinfections in COIVD-19 patients from December 1, 2019, until December 30, 2020.","2021","07","06","New Microbes New Infect","New microbes and new infections","COVID-19; Coronavirus; Meta-analysis; coinfection; systematics review","Malekifar","Pooneh","Department of Epidemiology, School of Public Health, Tehran University Medical Sciences, Tehran, Iran",NA
"596","34226847","10.1016/j.nmni.2021.100910","Bacterial Co-infection among COVID-19 patient groups: an update Systematic review and Meta-analysis.","The pandemic of SARS COV-2 raised the attention toward bacterial coinfection and their role in COVID-19 disease. This study aims to systematically review and identify the pooled prevalence of the bacterial coinfection in the related articles. A comprehensive search was conducted in international databases, including Medline, Scopus, Web of Science, and Embase, to identify the articles on the prevalence of Bacterial coinfections in COIVD-19 patients from December 1, 2019, until December 30, 2020.","2021","07","06","New Microbes New Infect","New microbes and new infections","COVID-19; Coronavirus; Meta-analysis; coinfection; systematics review","Pakzad","Reza","Department of Epidemiology, Faculty of Health, Ilam University Medical Sciences, Ilam, Iran",NA
"597","34226846","10.1002/rhc3.12225","Dancing with death. A historical perspective on coping with Covid-19.","In this paper, we address the question on how societies coped with pandemic crises, how they tried to control or adapt to the disease, or even managed to overcome the death trap in history. On the basis of historical research, we describe how societies in the western world accommodated to or exited hardship and restrictive measures over the course of the last four centuries. In particular, we are interested in how historically embedded citizens' resources were directed towards living with and to","2021","07","07","Risk Hazards Crisis Public Policy","Risk, hazards &amp; crisis in public policy","history of crisis management; pandemics; social adaptation","de Graaf","Beatrice","Faculty of Arts Utrecht University The Netherlands",NA
"598","34226846","10.1002/rhc3.12225","Dancing with death. A historical perspective on coping with Covid-19.","In this paper, we address the question on how societies coped with pandemic crises, how they tried to control or adapt to the disease, or even managed to overcome the death trap in history. On the basis of historical research, we describe how societies in the western world accommodated to or exited hardship and restrictive measures over the course of the last four centuries. In particular, we are interested in how historically embedded citizens' resources were directed towards living with and to","2021","07","07","Risk Hazards Crisis Public Policy","Risk, hazards &amp; crisis in public policy","history of crisis management; pandemics; social adaptation","Jensen","Lotte","Faculty of Arts Radboud University Nijmegen The Netherlands",NA
"599","34226846","10.1002/rhc3.12225","Dancing with death. A historical perspective on coping with Covid-19.","In this paper, we address the question on how societies coped with pandemic crises, how they tried to control or adapt to the disease, or even managed to overcome the death trap in history. On the basis of historical research, we describe how societies in the western world accommodated to or exited hardship and restrictive measures over the course of the last four centuries. In particular, we are interested in how historically embedded citizens' resources were directed towards living with and to","2021","07","07","Risk Hazards Crisis Public Policy","Risk, hazards &amp; crisis in public policy","history of crisis management; pandemics; social adaptation","Knoeff","Rina","Faculty of Arts University of Groningen Groningen The Netherlands",NA
"600","34226846","10.1002/rhc3.12225","Dancing with death. A historical perspective on coping with Covid-19.","In this paper, we address the question on how societies coped with pandemic crises, how they tried to control or adapt to the disease, or even managed to overcome the death trap in history. On the basis of historical research, we describe how societies in the western world accommodated to or exited hardship and restrictive measures over the course of the last four centuries. In particular, we are interested in how historically embedded citizens' resources were directed towards living with and to","2021","07","07","Risk Hazards Crisis Public Policy","Risk, hazards &amp; crisis in public policy","history of crisis management; pandemics; social adaptation","Santing","Catrien","Faculty of Arts University of Groningen Groningen The Netherlands",NA
"601","34226845","10.1002/rhc3.12230","Assessing the effects of calculated inaction on national responses to the COVID-19 crisis.","How does calculated inaction affect subsequent responses to the COVID-19 crisis? We argue that when governments employ calculated inaction during crises, they are more likely to manipulate the technical (scientific) aspects of national responses and highlight symbolic politics, each in the name of projecting power and strengthening the regime's governing authority. Using theoretical insight from McConnell and 't Hart's policy inaction typology, we investigate sense-making and crisis response nar","2021","07","07","Risk Hazards Crisis Public Policy","Risk, hazards &amp; crisis in public policy","COVID-19 national responses; calculated inaction; sense- and meaning-making","Zahariadis","Nikolaos","Department of International Studies Rhodes College Memphis Tennessee USA",NA
"602","34226845","10.1002/rhc3.12230","Assessing the effects of calculated inaction on national responses to the COVID-19 crisis.","How does calculated inaction affect subsequent responses to the COVID-19 crisis? We argue that when governments employ calculated inaction during crises, they are more likely to manipulate the technical (scientific) aspects of national responses and highlight symbolic politics, each in the name of projecting power and strengthening the regime's governing authority. Using theoretical insight from McConnell and 't Hart's policy inaction typology, we investigate sense-making and crisis response nar","2021","07","07","Risk Hazards Crisis Public Policy","Risk, hazards &amp; crisis in public policy","COVID-19 national responses; calculated inaction; sense- and meaning-making","Ceccoli","Stephen","Department of International Studies Rhodes College Memphis Tennessee USA",NA
"603","34226845","10.1002/rhc3.12230","Assessing the effects of calculated inaction on national responses to the COVID-19 crisis.","How does calculated inaction affect subsequent responses to the COVID-19 crisis? We argue that when governments employ calculated inaction during crises, they are more likely to manipulate the technical (scientific) aspects of national responses and highlight symbolic politics, each in the name of projecting power and strengthening the regime's governing authority. Using theoretical insight from McConnell and 't Hart's policy inaction typology, we investigate sense-making and crisis response nar","2021","07","07","Risk Hazards Crisis Public Policy","Risk, hazards &amp; crisis in public policy","COVID-19 national responses; calculated inaction; sense- and meaning-making","Petridou","Evangelia","Department of International Studies, Risk and Crisis Research Center Mid Sweden University Östersund Sweden",NA
"604","34226844","10.1002/rhc3.12219","Trust in experts, not trust in national leadership, leads to greater uptake of recommended actions during the COVID-19 pandemic.","Evidence suggests that people vary in their desire to undertake protective actions during a health emergency, and that trust in authorities may influence decision making. We sought to examine how the trust in health experts and trust in White House leadership during the COVID-19 pandemic impacts individuals' decisions to adopt recommended protective actions such as mask-wearing. A mediation analysis was conducted using cross-sectional U.S. survey data collected between March 27 and 30, 2020, to ","2021","07","07","Risk Hazards Crisis Public Policy","Risk, hazards &amp; crisis in public policy","risk communication; risk perception","Ahluwalia","Sangeeta C","Department of Behavioral and Policy Sciences RAND Corporation Santa Monica California USA",NA
"605","34226844","10.1002/rhc3.12219","Trust in experts, not trust in national leadership, leads to greater uptake of recommended actions during the COVID-19 pandemic.","Evidence suggests that people vary in their desire to undertake protective actions during a health emergency, and that trust in authorities may influence decision making. We sought to examine how the trust in health experts and trust in White House leadership during the COVID-19 pandemic impacts individuals' decisions to adopt recommended protective actions such as mask-wearing. A mediation analysis was conducted using cross-sectional U.S. survey data collected between March 27 and 30, 2020, to ","2021","07","07","Risk Hazards Crisis Public Policy","Risk, hazards &amp; crisis in public policy","risk communication; risk perception","Edelen","Maria O","Department of Behavioral and Policy Sciences RAND Corporation Santa Monica California USA",NA
"606","34226844","10.1002/rhc3.12219","Trust in experts, not trust in national leadership, leads to greater uptake of recommended actions during the COVID-19 pandemic.","Evidence suggests that people vary in their desire to undertake protective actions during a health emergency, and that trust in authorities may influence decision making. We sought to examine how the trust in health experts and trust in White House leadership during the COVID-19 pandemic impacts individuals' decisions to adopt recommended protective actions such as mask-wearing. A mediation analysis was conducted using cross-sectional U.S. survey data collected between March 27 and 30, 2020, to ","2021","07","07","Risk Hazards Crisis Public Policy","Risk, hazards &amp; crisis in public policy","risk communication; risk perception","Qureshi","Nabeel","RAND Pardee Graduate School RAND Corporation Santa Monica California USA",NA
"607","34226844","10.1002/rhc3.12219","Trust in experts, not trust in national leadership, leads to greater uptake of recommended actions during the COVID-19 pandemic.","Evidence suggests that people vary in their desire to undertake protective actions during a health emergency, and that trust in authorities may influence decision making. We sought to examine how the trust in health experts and trust in White House leadership during the COVID-19 pandemic impacts individuals' decisions to adopt recommended protective actions such as mask-wearing. A mediation analysis was conducted using cross-sectional U.S. survey data collected between March 27 and 30, 2020, to ","2021","07","07","Risk Hazards Crisis Public Policy","Risk, hazards &amp; crisis in public policy","risk communication; risk perception","Etchegaray","Jason M","Department of Behavioral and Policy Sciences RAND Corporation Santa Monica California USA",NA
"608","34226843","10.1007/s11482-021-09957-z","Access to Epidemic Information and Life Satisfaction under the Period of COVID-19: the Mediating Role of Perceived Stress and the Moderating Role of Friendship Quality.","The present study mainly focused on college students amidst the COVID-19 outbreak and aimed to develop and examine a moderated mediation model between access to epidemic information and life satisfaction. Friendship quality as a moderator, and perceived stress as a mediator. A sample of 1032 college students participated in this study and completed questionnaires regarding access to epidemic information, perceived stress, friendship quality, and life satisfaction. Findings indicated that 1) acce","2021","07","07","Appl Res Qual Life","Applied research in quality of life","Access to epidemic information; COVID-19; Friendship quality; Life satisfaction; Perceived stress","Ye","Baojuan","Center of Mental Health Education and Research, School of Psychology, Jiangxi Normal University, 99 Ziyang Aven ue, Nanchang, 330022 China",NA
"609","34226843","10.1007/s11482-021-09957-z","Access to Epidemic Information and Life Satisfaction under the Period of COVID-19: the Mediating Role of Perceived Stress and the Moderating Role of Friendship Quality.","The present study mainly focused on college students amidst the COVID-19 outbreak and aimed to develop and examine a moderated mediation model between access to epidemic information and life satisfaction. Friendship quality as a moderator, and perceived stress as a mediator. A sample of 1032 college students participated in this study and completed questionnaires regarding access to epidemic information, perceived stress, friendship quality, and life satisfaction. Findings indicated that 1) acce","2021","07","07","Appl Res Qual Life","Applied research in quality of life","Access to epidemic information; COVID-19; Friendship quality; Life satisfaction; Perceived stress","Hu","Jing","Center of Mental Health Education and Research, School of Psychology, Jiangxi Normal University, 99 Ziyang Aven ue, Nanchang, 330022 China",NA
"610","34226843","10.1007/s11482-021-09957-z","Access to Epidemic Information and Life Satisfaction under the Period of COVID-19: the Mediating Role of Perceived Stress and the Moderating Role of Friendship Quality.","The present study mainly focused on college students amidst the COVID-19 outbreak and aimed to develop and examine a moderated mediation model between access to epidemic information and life satisfaction. Friendship quality as a moderator, and perceived stress as a mediator. A sample of 1032 college students participated in this study and completed questionnaires regarding access to epidemic information, perceived stress, friendship quality, and life satisfaction. Findings indicated that 1) acce","2021","07","07","Appl Res Qual Life","Applied research in quality of life","Access to epidemic information; COVID-19; Friendship quality; Life satisfaction; Perceived stress","Xiao","Gensen","University High School, 4771 Campus Dr, Irvine, CA 92612 USA",NA
"611","34226843","10.1007/s11482-021-09957-z","Access to Epidemic Information and Life Satisfaction under the Period of COVID-19: the Mediating Role of Perceived Stress and the Moderating Role of Friendship Quality.","The present study mainly focused on college students amidst the COVID-19 outbreak and aimed to develop and examine a moderated mediation model between access to epidemic information and life satisfaction. Friendship quality as a moderator, and perceived stress as a mediator. A sample of 1032 college students participated in this study and completed questionnaires regarding access to epidemic information, perceived stress, friendship quality, and life satisfaction. Findings indicated that 1) acce","2021","07","07","Appl Res Qual Life","Applied research in quality of life","Access to epidemic information; COVID-19; Friendship quality; Life satisfaction; Perceived stress","Zhang","Yanzhen","Department of Psychology, University of California, Riverside, Riverside, CA, 900 University Ave, Riverside, CA 92521 USA",NA
"612","34226843","10.1007/s11482-021-09957-z","Access to Epidemic Information and Life Satisfaction under the Period of COVID-19: the Mediating Role of Perceived Stress and the Moderating Role of Friendship Quality.","The present study mainly focused on college students amidst the COVID-19 outbreak and aimed to develop and examine a moderated mediation model between access to epidemic information and life satisfaction. Friendship quality as a moderator, and perceived stress as a mediator. A sample of 1032 college students participated in this study and completed questionnaires regarding access to epidemic information, perceived stress, friendship quality, and life satisfaction. Findings indicated that 1) acce","2021","07","07","Appl Res Qual Life","Applied research in quality of life","Access to epidemic information; COVID-19; Friendship quality; Life satisfaction; Perceived stress","Liu","Mingfan","Center of Mental Health Education and Research, School of Psychology, Jiangxi Normal University, 99 Ziyang Aven ue, Nanchang, 330022 China",NA
"613","34226843","10.1007/s11482-021-09957-z","Access to Epidemic Information and Life Satisfaction under the Period of COVID-19: the Mediating Role of Perceived Stress and the Moderating Role of Friendship Quality.","The present study mainly focused on college students amidst the COVID-19 outbreak and aimed to develop and examine a moderated mediation model between access to epidemic information and life satisfaction. Friendship quality as a moderator, and perceived stress as a mediator. A sample of 1032 college students participated in this study and completed questionnaires regarding access to epidemic information, perceived stress, friendship quality, and life satisfaction. Findings indicated that 1) acce","2021","07","07","Appl Res Qual Life","Applied research in quality of life","Access to epidemic information; COVID-19; Friendship quality; Life satisfaction; Perceived stress","Wang","Xinqiang","Center of Mental Health Education and Research, School of Psychology, Jiangxi Normal University, 99 Ziyang Aven ue, Nanchang, 330022 China",NA
"614","34226843","10.1007/s11482-021-09957-z","Access to Epidemic Information and Life Satisfaction under the Period of COVID-19: the Mediating Role of Perceived Stress and the Moderating Role of Friendship Quality.","The present study mainly focused on college students amidst the COVID-19 outbreak and aimed to develop and examine a moderated mediation model between access to epidemic information and life satisfaction. Friendship quality as a moderator, and perceived stress as a mediator. A sample of 1032 college students participated in this study and completed questionnaires regarding access to epidemic information, perceived stress, friendship quality, and life satisfaction. Findings indicated that 1) acce","2021","07","07","Appl Res Qual Life","Applied research in quality of life","Access to epidemic information; COVID-19; Friendship quality; Life satisfaction; Perceived stress","Yang","Qiang","School of Education, Jiangxi Normal University, 99 Ziyang Avenue, Nanchang, 330022 China",NA
"615","34226843","10.1007/s11482-021-09957-z","Access to Epidemic Information and Life Satisfaction under the Period of COVID-19: the Mediating Role of Perceived Stress and the Moderating Role of Friendship Quality.","The present study mainly focused on college students amidst the COVID-19 outbreak and aimed to develop and examine a moderated mediation model between access to epidemic information and life satisfaction. Friendship quality as a moderator, and perceived stress as a mediator. A sample of 1032 college students participated in this study and completed questionnaires regarding access to epidemic information, perceived stress, friendship quality, and life satisfaction. Findings indicated that 1) acce","2021","07","07","Appl Res Qual Life","Applied research in quality of life","Access to epidemic information; COVID-19; Friendship quality; Life satisfaction; Perceived stress","Xia","Fei","School of Education, Jiangxi Normal University, 99 Ziyang Avenue, Nanchang, 330022 China",NA
"616","34226838","10.1111/ors.12636","Two sides of the same coin in COVID-19: Dental aerosol and medical aerosol.",NA,"2021","07","07","Oral Surg","Oral surgery",NA,"Shetty","Sameep S","Manipal College of Dental Sciences, Manipal Academy of Higher Education, A Constituent of MAHE Mangalore India",NA
"617","34226838","10.1111/ors.12636","Two sides of the same coin in COVID-19: Dental aerosol and medical aerosol.",NA,"2021","07","07","Oral Surg","Oral surgery",NA,"de Arruda","José Alcides Almeida","Department of Oral Surgery, Pathology and Clinical Dentistry, School of Dentistry Universidade Federal de Minas Gerais Belo Horizonte, Minas Gerais Brazil",NA
"618","34226838","10.1111/ors.12636","Two sides of the same coin in COVID-19: Dental aerosol and medical aerosol.",NA,"2021","07","07","Oral Surg","Oral surgery",NA,"Silva","Tarcília Aparecida","Department of Oral Surgery, Pathology and Clinical Dentistry, School of Dentistry Universidade Federal de Minas Gerais Belo Horizonte, Minas Gerais Brazil",NA
"619","34226838","10.1111/ors.12636","Two sides of the same coin in COVID-19: Dental aerosol and medical aerosol.",NA,"2021","07","07","Oral Surg","Oral surgery",NA,"Singh","Rica","Manipal College of Dental Sciences, Manipal Academy of Higher Education, A Constituent of MAHE Mangalore India",NA
"620","34226837","10.1111/ors.12642","Remote oral imaging diagnosis using an ultrahigh-definition video microscope in the COVID-19 era.",NA,"2021","07","07","Oral Surg","Oral surgery",NA,"Kawana","Hiromasa","Department of Oral and Maxillofacial Implantology Kanagawa Dental University Yokosuka Japan",NA
"621","34226837","10.1111/ors.12642","Remote oral imaging diagnosis using an ultrahigh-definition video microscope in the COVID-19 era.",NA,"2021","07","07","Oral Surg","Oral surgery",NA,"Asoda","Seiji","Division of Oral and Maxillofacial Surgery Department of Oral and Maxillofacial Surgery Keio University School of Medicine Tokyo Japan",NA
"622","34226837","10.1111/ors.12642","Remote oral imaging diagnosis using an ultrahigh-definition video microscope in the COVID-19 era.",NA,"2021","07","07","Oral Surg","Oral surgery",NA,"Kobayashi","Eiji","Department of Kidney Regenerative Medicine The Jikei University School of Medicine Tokyo Japan",NA
"623","34226836","10.1049/ipr2.12249","A multi-class COVID-19 segmentation network with pyramid attention and edge loss in CT images.","At the end of 2019, a novel coronavirus COVID-19 broke out. Due to its high contagiousness, more than 74 million people have been infected worldwide. Automatic segmentation of the COVID-19 lesion area in CT images is an effective auxiliary medical technology which can quantitatively diagnose and judge the severity of the disease. In this paper, a multi-class COVID-19 CT image segmentation network is proposed, which includes a pyramid attention module to extract multi-scale contextual attention i","2021","07","07","IET Image Process","IET image processing",NA,"Yu","Fuli","School of Information Science and Engineering East China University of Science and Technology Shanghai 200237 People's Republic of China",NA
"624","34226836","10.1049/ipr2.12249","A multi-class COVID-19 segmentation network with pyramid attention and edge loss in CT images.","At the end of 2019, a novel coronavirus COVID-19 broke out. Due to its high contagiousness, more than 74 million people have been infected worldwide. Automatic segmentation of the COVID-19 lesion area in CT images is an effective auxiliary medical technology which can quantitatively diagnose and judge the severity of the disease. In this paper, a multi-class COVID-19 CT image segmentation network is proposed, which includes a pyramid attention module to extract multi-scale contextual attention i","2021","07","07","IET Image Process","IET image processing",NA,"Zhu","Yu","School of Information Science and Engineering East China University of Science and Technology Shanghai 200237 People's Republic of China",NA
"625","34226836","10.1049/ipr2.12249","A multi-class COVID-19 segmentation network with pyramid attention and edge loss in CT images.","At the end of 2019, a novel coronavirus COVID-19 broke out. Due to its high contagiousness, more than 74 million people have been infected worldwide. Automatic segmentation of the COVID-19 lesion area in CT images is an effective auxiliary medical technology which can quantitatively diagnose and judge the severity of the disease. In this paper, a multi-class COVID-19 CT image segmentation network is proposed, which includes a pyramid attention module to extract multi-scale contextual attention i","2021","07","07","IET Image Process","IET image processing",NA,"Qin","Xiangxiang","School of Information Science and Engineering East China University of Science and Technology Shanghai 200237 People's Republic of China",NA
"626","34226836","10.1049/ipr2.12249","A multi-class COVID-19 segmentation network with pyramid attention and edge loss in CT images.","At the end of 2019, a novel coronavirus COVID-19 broke out. Due to its high contagiousness, more than 74 million people have been infected worldwide. Automatic segmentation of the COVID-19 lesion area in CT images is an effective auxiliary medical technology which can quantitatively diagnose and judge the severity of the disease. In this paper, a multi-class COVID-19 CT image segmentation network is proposed, which includes a pyramid attention module to extract multi-scale contextual attention i","2021","07","07","IET Image Process","IET image processing",NA,"Xin","Ying","Department of Endocrine and Metabolic Diseases The Affiliated Hospital of Qingdao University Qingdao 266003 People's Republic of China",NA
"627","34226836","10.1049/ipr2.12249","A multi-class COVID-19 segmentation network with pyramid attention and edge loss in CT images.","At the end of 2019, a novel coronavirus COVID-19 broke out. Due to its high contagiousness, more than 74 million people have been infected worldwide. Automatic segmentation of the COVID-19 lesion area in CT images is an effective auxiliary medical technology which can quantitatively diagnose and judge the severity of the disease. In this paper, a multi-class COVID-19 CT image segmentation network is proposed, which includes a pyramid attention module to extract multi-scale contextual attention i","2021","07","07","IET Image Process","IET image processing",NA,"Yang","Dawei","Department of Pulmonary Medicine Zhongshan Hospital Fudan University Shanghai 200032 People's Republic of China",NA
"628","34226836","10.1049/ipr2.12249","A multi-class COVID-19 segmentation network with pyramid attention and edge loss in CT images.","At the end of 2019, a novel coronavirus COVID-19 broke out. Due to its high contagiousness, more than 74 million people have been infected worldwide. Automatic segmentation of the COVID-19 lesion area in CT images is an effective auxiliary medical technology which can quantitatively diagnose and judge the severity of the disease. In this paper, a multi-class COVID-19 CT image segmentation network is proposed, which includes a pyramid attention module to extract multi-scale contextual attention i","2021","07","07","IET Image Process","IET image processing",NA,"Xu","Tao","Department of Pulmonary and Critical Care Medicine The Affiliated Hospital of Qingdao University Qingdao Shandong 266000 People's Republic of China",NA
"629","34226835","10.1111/voxs.12639","A prospective study on COVID-19 convalescent plasma donor (CCP) recruitment strategies in a resource constrained blood centre.","The COVID-19 pandemic has spread across 87 million people with more than 1·8 million deaths in the world. As there is no definite treatment modality, the use of convalescent plasma has become increasingly popular worldwide. This study aimed to identify an appropriate strategy of donor recruitment and to evaluate the appropriateness of pre-set plasma donation guidelines. In this prospective study conducted from May to September 2020, the donors were recruited under the following two circumstances","2021","07","07","ISBT Sci Ser","ISBT science series","convalescent plasma; donor recruitment; plasmapheresis","Biswas","Durba","Department of Immunohematology and Blood Transfusion Medical College and Hospital Kolkata India",NA
"630","34226835","10.1111/voxs.12639","A prospective study on COVID-19 convalescent plasma donor (CCP) recruitment strategies in a resource constrained blood centre.","The COVID-19 pandemic has spread across 87 million people with more than 1·8 million deaths in the world. As there is no definite treatment modality, the use of convalescent plasma has become increasingly popular worldwide. This study aimed to identify an appropriate strategy of donor recruitment and to evaluate the appropriateness of pre-set plasma donation guidelines. In this prospective study conducted from May to September 2020, the donors were recruited under the following two circumstances","2021","07","07","ISBT Sci Ser","ISBT science series","convalescent plasma; donor recruitment; plasmapheresis","Maiti","Chikam","Department of Immunohematology and Blood Transfusion Medical College and Hospital Kolkata India",NA
"631","34226835","10.1111/voxs.12639","A prospective study on COVID-19 convalescent plasma donor (CCP) recruitment strategies in a resource constrained blood centre.","The COVID-19 pandemic has spread across 87 million people with more than 1·8 million deaths in the world. As there is no definite treatment modality, the use of convalescent plasma has become increasingly popular worldwide. This study aimed to identify an appropriate strategy of donor recruitment and to evaluate the appropriateness of pre-set plasma donation guidelines. In this prospective study conducted from May to September 2020, the donors were recruited under the following two circumstances","2021","07","07","ISBT Sci Ser","ISBT science series","convalescent plasma; donor recruitment; plasmapheresis","Talukder","Biplabendu","Department of Immunohematology and Blood Transfusion Medical College and Hospital Kolkata India",NA
"632","34226835","10.1111/voxs.12639","A prospective study on COVID-19 convalescent plasma donor (CCP) recruitment strategies in a resource constrained blood centre.","The COVID-19 pandemic has spread across 87 million people with more than 1·8 million deaths in the world. As there is no definite treatment modality, the use of convalescent plasma has become increasingly popular worldwide. This study aimed to identify an appropriate strategy of donor recruitment and to evaluate the appropriateness of pre-set plasma donation guidelines. In this prospective study conducted from May to September 2020, the donors were recruited under the following two circumstances","2021","07","07","ISBT Sci Ser","ISBT science series","convalescent plasma; donor recruitment; plasmapheresis","Azharuddin","Md","Department of Immunohematology and Blood Transfusion Medical College and Hospital Kolkata India",NA
"633","34226835","10.1111/voxs.12639","A prospective study on COVID-19 convalescent plasma donor (CCP) recruitment strategies in a resource constrained blood centre.","The COVID-19 pandemic has spread across 87 million people with more than 1·8 million deaths in the world. As there is no definite treatment modality, the use of convalescent plasma has become increasingly popular worldwide. This study aimed to identify an appropriate strategy of donor recruitment and to evaluate the appropriateness of pre-set plasma donation guidelines. In this prospective study conducted from May to September 2020, the donors were recruited under the following two circumstances","2021","07","07","ISBT Sci Ser","ISBT science series","convalescent plasma; donor recruitment; plasmapheresis","Saha","Sayantan","Department of Immunohematology and Blood Transfusion Medical College and Hospital Kolkata India",NA
"634","34226835","10.1111/voxs.12639","A prospective study on COVID-19 convalescent plasma donor (CCP) recruitment strategies in a resource constrained blood centre.","The COVID-19 pandemic has spread across 87 million people with more than 1·8 million deaths in the world. As there is no definite treatment modality, the use of convalescent plasma has become increasingly popular worldwide. This study aimed to identify an appropriate strategy of donor recruitment and to evaluate the appropriateness of pre-set plasma donation guidelines. In this prospective study conducted from May to September 2020, the donors were recruited under the following two circumstances","2021","07","07","ISBT Sci Ser","ISBT science series","convalescent plasma; donor recruitment; plasmapheresis","Pandey","Sumita","Department of Immunohematology and Blood Transfusion Medical College and Hospital Kolkata India",NA
"635","34226835","10.1111/voxs.12639","A prospective study on COVID-19 convalescent plasma donor (CCP) recruitment strategies in a resource constrained blood centre.","The COVID-19 pandemic has spread across 87 million people with more than 1·8 million deaths in the world. As there is no definite treatment modality, the use of convalescent plasma has become increasingly popular worldwide. This study aimed to identify an appropriate strategy of donor recruitment and to evaluate the appropriateness of pre-set plasma donation guidelines. In this prospective study conducted from May to September 2020, the donors were recruited under the following two circumstances","2021","07","07","ISBT Sci Ser","ISBT science series","convalescent plasma; donor recruitment; plasmapheresis","Das","Arijit","Department of Immunohematology and Blood Transfusion Medical College and Hospital Kolkata India",NA
"636","34226835","10.1111/voxs.12639","A prospective study on COVID-19 convalescent plasma donor (CCP) recruitment strategies in a resource constrained blood centre.","The COVID-19 pandemic has spread across 87 million people with more than 1·8 million deaths in the world. As there is no definite treatment modality, the use of convalescent plasma has become increasingly popular worldwide. This study aimed to identify an appropriate strategy of donor recruitment and to evaluate the appropriateness of pre-set plasma donation guidelines. In this prospective study conducted from May to September 2020, the donors were recruited under the following two circumstances","2021","07","07","ISBT Sci Ser","ISBT science series","convalescent plasma; donor recruitment; plasmapheresis","Adhikari","Setu Das","Department of Immunohematology and Blood Transfusion Medical College and Hospital Kolkata India",NA
"637","34226835","10.1111/voxs.12639","A prospective study on COVID-19 convalescent plasma donor (CCP) recruitment strategies in a resource constrained blood centre.","The COVID-19 pandemic has spread across 87 million people with more than 1·8 million deaths in the world. As there is no definite treatment modality, the use of convalescent plasma has become increasingly popular worldwide. This study aimed to identify an appropriate strategy of donor recruitment and to evaluate the appropriateness of pre-set plasma donation guidelines. In this prospective study conducted from May to September 2020, the donors were recruited under the following two circumstances","2021","07","07","ISBT Sci Ser","ISBT science series","convalescent plasma; donor recruitment; plasmapheresis","Ray","Yogiraj","Department of Medicine I.D&amp",NA
"638","34226835","10.1111/voxs.12639","A prospective study on COVID-19 convalescent plasma donor (CCP) recruitment strategies in a resource constrained blood centre.","The COVID-19 pandemic has spread across 87 million people with more than 1·8 million deaths in the world. As there is no definite treatment modality, the use of convalescent plasma has become increasingly popular worldwide. This study aimed to identify an appropriate strategy of donor recruitment and to evaluate the appropriateness of pre-set plasma donation guidelines. In this prospective study conducted from May to September 2020, the donors were recruited under the following two circumstances","2021","07","07","ISBT Sci Ser","ISBT science series","convalescent plasma; donor recruitment; plasmapheresis","Sarkar","Biswanath S","Department of Medicine I.D&amp",NA
"639","34226835","10.1111/voxs.12639","A prospective study on COVID-19 convalescent plasma donor (CCP) recruitment strategies in a resource constrained blood centre.","The COVID-19 pandemic has spread across 87 million people with more than 1·8 million deaths in the world. As there is no definite treatment modality, the use of convalescent plasma has become increasingly popular worldwide. This study aimed to identify an appropriate strategy of donor recruitment and to evaluate the appropriateness of pre-set plasma donation guidelines. In this prospective study conducted from May to September 2020, the donors were recruited under the following two circumstances","2021","07","07","ISBT Sci Ser","ISBT science series","convalescent plasma; donor recruitment; plasmapheresis","Paul","Sekhar R","Department of Medicine I.D&amp",NA
"640","34226835","10.1111/voxs.12639","A prospective study on COVID-19 convalescent plasma donor (CCP) recruitment strategies in a resource constrained blood centre.","The COVID-19 pandemic has spread across 87 million people with more than 1·8 million deaths in the world. As there is no definite treatment modality, the use of convalescent plasma has become increasingly popular worldwide. This study aimed to identify an appropriate strategy of donor recruitment and to evaluate the appropriateness of pre-set plasma donation guidelines. In this prospective study conducted from May to September 2020, the donors were recruited under the following two circumstances","2021","07","07","ISBT Sci Ser","ISBT science series","convalescent plasma; donor recruitment; plasmapheresis","Saha","Bibhuti","Department of Tropical Medicine Calcutta School of Tropical Medicine Kolkata India",NA
"641","34226835","10.1111/voxs.12639","A prospective study on COVID-19 convalescent plasma donor (CCP) recruitment strategies in a resource constrained blood centre.","The COVID-19 pandemic has spread across 87 million people with more than 1·8 million deaths in the world. As there is no definite treatment modality, the use of convalescent plasma has become increasingly popular worldwide. This study aimed to identify an appropriate strategy of donor recruitment and to evaluate the appropriateness of pre-set plasma donation guidelines. In this prospective study conducted from May to September 2020, the donors were recruited under the following two circumstances","2021","07","07","ISBT Sci Ser","ISBT science series","convalescent plasma; donor recruitment; plasmapheresis","Paul","Sandip","CSIR-Indian Institute of Chemical Biology Kolkata India",NA
"642","34226835","10.1111/voxs.12639","A prospective study on COVID-19 convalescent plasma donor (CCP) recruitment strategies in a resource constrained blood centre.","The COVID-19 pandemic has spread across 87 million people with more than 1·8 million deaths in the world. As there is no definite treatment modality, the use of convalescent plasma has become increasingly popular worldwide. This study aimed to identify an appropriate strategy of donor recruitment and to evaluate the appropriateness of pre-set plasma donation guidelines. In this prospective study conducted from May to September 2020, the donors were recruited under the following two circumstances","2021","07","07","ISBT Sci Ser","ISBT science series","convalescent plasma; donor recruitment; plasmapheresis","Chatterjee","Shilpak","Department of Immunohematology and Blood Transfusion Medical College and Hospital Kolkata India",NA
"643","34226835","10.1111/voxs.12639","A prospective study on COVID-19 convalescent plasma donor (CCP) recruitment strategies in a resource constrained blood centre.","The COVID-19 pandemic has spread across 87 million people with more than 1·8 million deaths in the world. As there is no definite treatment modality, the use of convalescent plasma has become increasingly popular worldwide. This study aimed to identify an appropriate strategy of donor recruitment and to evaluate the appropriateness of pre-set plasma donation guidelines. In this prospective study conducted from May to September 2020, the donors were recruited under the following two circumstances","2021","07","07","ISBT Sci Ser","ISBT science series","convalescent plasma; donor recruitment; plasmapheresis","Ganguly","Dipyaman","CSIR-Indian Institute of Chemical Biology Kolkata India",NA
"644","34226835","10.1111/voxs.12639","A prospective study on COVID-19 convalescent plasma donor (CCP) recruitment strategies in a resource constrained blood centre.","The COVID-19 pandemic has spread across 87 million people with more than 1·8 million deaths in the world. As there is no definite treatment modality, the use of convalescent plasma has become increasingly popular worldwide. This study aimed to identify an appropriate strategy of donor recruitment and to evaluate the appropriateness of pre-set plasma donation guidelines. In this prospective study conducted from May to September 2020, the donors were recruited under the following two circumstances","2021","07","07","ISBT Sci Ser","ISBT science series","convalescent plasma; donor recruitment; plasmapheresis","Bhattacharya","Prasun","Department of Immunohematology and Blood Transfusion Medical College and Hospital Kolkata India",NA
"645","34226834","10.1111/rego.12413","Perspectives in the study of the political economy of COVID-19 vaccine regulation.","Vaccines against SARS-CoV-2 continue to be developed at an astonishingly quick speed and the early ones, like Pfizer and Moderna, have been shown to be more effective than many public health scientists had dared to hope. As COVID-19 vaccine research continues to progress, the world's eyes are turning toward medicine regulators. COVID-19 vaccines need to be authorized for use in each country in which the pharmaceutical industry intends to commercialize its product. This results in a patchwork of ","2021","07","07","Regul Gov","Regulation &amp; governance","COVID-19; comparative politics; pharmaceutical regulation; political economy","da Fonseca","Elize M","Sao Paulo School of Business Administration Getulio Vargas Foundation Sao Paulo Brazil",NA
"646","34226834","10.1111/rego.12413","Perspectives in the study of the political economy of COVID-19 vaccine regulation.","Vaccines against SARS-CoV-2 continue to be developed at an astonishingly quick speed and the early ones, like Pfizer and Moderna, have been shown to be more effective than many public health scientists had dared to hope. As COVID-19 vaccine research continues to progress, the world's eyes are turning toward medicine regulators. COVID-19 vaccines need to be authorized for use in each country in which the pharmaceutical industry intends to commercialize its product. This results in a patchwork of ","2021","07","07","Regul Gov","Regulation &amp; governance","COVID-19; comparative politics; pharmaceutical regulation; political economy","Jarman","Holly","School of Public Health University of Michigan Ann Arbor MI USA",NA
"647","34226834","10.1111/rego.12413","Perspectives in the study of the political economy of COVID-19 vaccine regulation.","Vaccines against SARS-CoV-2 continue to be developed at an astonishingly quick speed and the early ones, like Pfizer and Moderna, have been shown to be more effective than many public health scientists had dared to hope. As COVID-19 vaccine research continues to progress, the world's eyes are turning toward medicine regulators. COVID-19 vaccines need to be authorized for use in each country in which the pharmaceutical industry intends to commercialize its product. This results in a patchwork of ","2021","07","07","Regul Gov","Regulation &amp; governance","COVID-19; comparative politics; pharmaceutical regulation; political economy","King","Elizabeth J","School of Public Health University of Michigan Ann Arbor MI USA",NA
"648","34226834","10.1111/rego.12413","Perspectives in the study of the political economy of COVID-19 vaccine regulation.","Vaccines against SARS-CoV-2 continue to be developed at an astonishingly quick speed and the early ones, like Pfizer and Moderna, have been shown to be more effective than many public health scientists had dared to hope. As COVID-19 vaccine research continues to progress, the world's eyes are turning toward medicine regulators. COVID-19 vaccines need to be authorized for use in each country in which the pharmaceutical industry intends to commercialize its product. This results in a patchwork of ","2021","07","07","Regul Gov","Regulation &amp; governance","COVID-19; comparative politics; pharmaceutical regulation; political economy","Greer","Scott L","School of Public Health University of Michigan Ann Arbor MI USA",NA
"649","34226833","10.1111/wej.12737","COVID-19 and the UK water sector: Exploring organizational responses through a resilience framework.","The unprecedented scale and impact of the COVID-19 pandemic have required organizations to adapt all facets of their operations. The impact on the UK water sector extends beyond engineering and treatment processes, with social, economic and environmental consequences. Semi-structured interviews were conducted with executives from 10 UK water companies to investigate the organizational response to the pandemic, and how their response impacted operational delivery. The Safe and SuRe framework was ","2021","07","07","Water Environ J","Water and environment journal : the journal","COVID-19; Safe and SuRe; organisational response; resilience; water sector","Lawson","Elizabeth","Centre for Water Systems University of Exeter Exeter UK",NA
"650","34226833","10.1111/wej.12737","COVID-19 and the UK water sector: Exploring organizational responses through a resilience framework.","The unprecedented scale and impact of the COVID-19 pandemic have required organizations to adapt all facets of their operations. The impact on the UK water sector extends beyond engineering and treatment processes, with social, economic and environmental consequences. Semi-structured interviews were conducted with executives from 10 UK water companies to investigate the organizational response to the pandemic, and how their response impacted operational delivery. The Safe and SuRe framework was ","2021","07","07","Water Environ J","Water and environment journal : the journal","COVID-19; Safe and SuRe; organisational response; resilience; water sector","Bunney","Sarah","Department of Mathematics Imperial College London London UK",NA
"651","34226833","10.1111/wej.12737","COVID-19 and the UK water sector: Exploring organizational responses through a resilience framework.","The unprecedented scale and impact of the COVID-19 pandemic have required organizations to adapt all facets of their operations. The impact on the UK water sector extends beyond engineering and treatment processes, with social, economic and environmental consequences. Semi-structured interviews were conducted with executives from 10 UK water companies to investigate the organizational response to the pandemic, and how their response impacted operational delivery. The Safe and SuRe framework was ","2021","07","07","Water Environ J","Water and environment journal : the journal","COVID-19; Safe and SuRe; organisational response; resilience; water sector","Cotterill","Sarah","School of Civil Engineering University College Dublin Dublin Ireland",NA
"652","34226833","10.1111/wej.12737","COVID-19 and the UK water sector: Exploring organizational responses through a resilience framework.","The unprecedented scale and impact of the COVID-19 pandemic have required organizations to adapt all facets of their operations. The impact on the UK water sector extends beyond engineering and treatment processes, with social, economic and environmental consequences. Semi-structured interviews were conducted with executives from 10 UK water companies to investigate the organizational response to the pandemic, and how their response impacted operational delivery. The Safe and SuRe framework was ","2021","07","07","Water Environ J","Water and environment journal : the journal","COVID-19; Safe and SuRe; organisational response; resilience; water sector","Farmani","Raziyeh","Centre for Water Systems University of Exeter Exeter UK",NA
"653","34226833","10.1111/wej.12737","COVID-19 and the UK water sector: Exploring organizational responses through a resilience framework.","The unprecedented scale and impact of the COVID-19 pandemic have required organizations to adapt all facets of their operations. The impact on the UK water sector extends beyond engineering and treatment processes, with social, economic and environmental consequences. Semi-structured interviews were conducted with executives from 10 UK water companies to investigate the organizational response to the pandemic, and how their response impacted operational delivery. The Safe and SuRe framework was ","2021","07","07","Water Environ J","Water and environment journal : the journal","COVID-19; Safe and SuRe; organisational response; resilience; water sector","Melville-Shreeve","Peter","Centre for Water Systems University of Exeter Exeter UK",NA
"654","34226833","10.1111/wej.12737","COVID-19 and the UK water sector: Exploring organizational responses through a resilience framework.","The unprecedented scale and impact of the COVID-19 pandemic have required organizations to adapt all facets of their operations. The impact on the UK water sector extends beyond engineering and treatment processes, with social, economic and environmental consequences. Semi-structured interviews were conducted with executives from 10 UK water companies to investigate the organizational response to the pandemic, and how their response impacted operational delivery. The Safe and SuRe framework was ","2021","07","07","Water Environ J","Water and environment journal : the journal","COVID-19; Safe and SuRe; organisational response; resilience; water sector","Butler","David","Centre for Water Systems University of Exeter Exeter UK",NA
"655","34226832","10.1016/j.bspc.2021.102920","X-ray and CT-scan-based automated detection and classification of covid-19 using convolutional neural networks (CNN).","Covid-19 (Coronavirus Disease-2019) is the most recent coronavirus-related disease that has been announced as a pandemic by the World Health Organization (WHO). Furthermore, it has brought the whole planet to a halt as a result of the worldwide introduction of lockdown and killed millions of people. While this virus has a low fatality rate, the problem is that it is highly infectious, and as a result, it has infected a large number of people, putting a strain on the healthcare system, hence, Cov","2021","07","12","Biomed Signal Process Control","Biomedical signal processing and control","Accuracy; CNN; Deep learning; Precision; ROC; Recall","Thakur","Samritika","Department of Electronics and Communication, National Institute of Technology, Hamirpur, India",NA
"656","34226832","10.1016/j.bspc.2021.102920","X-ray and CT-scan-based automated detection and classification of covid-19 using convolutional neural networks (CNN).","Covid-19 (Coronavirus Disease-2019) is the most recent coronavirus-related disease that has been announced as a pandemic by the World Health Organization (WHO). Furthermore, it has brought the whole planet to a halt as a result of the worldwide introduction of lockdown and killed millions of people. While this virus has a low fatality rate, the problem is that it is highly infectious, and as a result, it has infected a large number of people, putting a strain on the healthcare system, hence, Cov","2021","07","12","Biomed Signal Process Control","Biomedical signal processing and control","Accuracy; CNN; Deep learning; Precision; ROC; Recall","Kumar","Aman","Department of Electronics and Communication, National Institute of Technology, Hamirpur, India",NA
"657","34226830","10.1111/jppi.12382","The Experiences of Carers of Adults With Intellectual Disabilities During the First COVID-19 Lockdown Period.","The recent COVID-19 pandemic led to widespread international restrictions, severely impacting on health and social care services. For many individuals with an intellectual disability (ID) this meant reduced access to services and support for them and their carers. The aim of this study was to gain insight into the ways parents of adults with ID coped during the first 2020 lockdown period. Eight parents of adults with ID were interviewed. The recordings of these interviews were subjected to a the","2021","07","07","J Policy Pract Intellect Disabil","Journal of policy and practice in intellectual disabilities","COVID-19; carers; intellectual disability; lockdown; parents","Patel","Varsha","Birmingham Community Healthcare NHS Foundation Trust Unit 3 Priestley Wharf, Holt Street Birmingham B7 4BN UK",NA
"658","34226830","10.1111/jppi.12382","The Experiences of Carers of Adults With Intellectual Disabilities During the First COVID-19 Lockdown Period.","The recent COVID-19 pandemic led to widespread international restrictions, severely impacting on health and social care services. For many individuals with an intellectual disability (ID) this meant reduced access to services and support for them and their carers. The aim of this study was to gain insight into the ways parents of adults with ID coped during the first 2020 lockdown period. Eight parents of adults with ID were interviewed. The recordings of these interviews were subjected to a the","2021","07","07","J Policy Pract Intellect Disabil","Journal of policy and practice in intellectual disabilities","COVID-19; carers; intellectual disability; lockdown; parents","Perez-Olivas","Gisela","Hertfordshire Partnership University NHS Foundation Trust 99 Waverley Road, St Albans Hertfordshire AL3 5TQ UK",NA
"659","34226830","10.1111/jppi.12382","The Experiences of Carers of Adults With Intellectual Disabilities During the First COVID-19 Lockdown Period.","The recent COVID-19 pandemic led to widespread international restrictions, severely impacting on health and social care services. For many individuals with an intellectual disability (ID) this meant reduced access to services and support for them and their carers. The aim of this study was to gain insight into the ways parents of adults with ID coped during the first 2020 lockdown period. Eight parents of adults with ID were interviewed. The recordings of these interviews were subjected to a the","2021","07","07","J Policy Pract Intellect Disabil","Journal of policy and practice in intellectual disabilities","COVID-19; carers; intellectual disability; lockdown; parents","Kroese","Biza Stenfert","University of Birmingham, School of Psychology Edgbaston Birmingham B15 2TT UK",NA
"660","34226830","10.1111/jppi.12382","The Experiences of Carers of Adults With Intellectual Disabilities During the First COVID-19 Lockdown Period.","The recent COVID-19 pandemic led to widespread international restrictions, severely impacting on health and social care services. For many individuals with an intellectual disability (ID) this meant reduced access to services and support for them and their carers. The aim of this study was to gain insight into the ways parents of adults with ID coped during the first 2020 lockdown period. Eight parents of adults with ID were interviewed. The recordings of these interviews were subjected to a the","2021","07","07","J Policy Pract Intellect Disabil","Journal of policy and practice in intellectual disabilities","COVID-19; carers; intellectual disability; lockdown; parents","Rogers","Gemma","Kent and Medway NHS and Social Care Partnership Trust, The Tarentfort Centre Bow Arrow Lane, Dartford Kent DA2 6PB UK",NA
"661","34226830","10.1111/jppi.12382","The Experiences of Carers of Adults With Intellectual Disabilities During the First COVID-19 Lockdown Period.","The recent COVID-19 pandemic led to widespread international restrictions, severely impacting on health and social care services. For many individuals with an intellectual disability (ID) this meant reduced access to services and support for them and their carers. The aim of this study was to gain insight into the ways parents of adults with ID coped during the first 2020 lockdown period. Eight parents of adults with ID were interviewed. The recordings of these interviews were subjected to a the","2021","07","07","J Policy Pract Intellect Disabil","Journal of policy and practice in intellectual disabilities","COVID-19; carers; intellectual disability; lockdown; parents","Rose","John","University of Birmingham, School of Psychology Edgbaston Birmingham B15 2TT UK",NA
"662","34226830","10.1111/jppi.12382","The Experiences of Carers of Adults With Intellectual Disabilities During the First COVID-19 Lockdown Period.","The recent COVID-19 pandemic led to widespread international restrictions, severely impacting on health and social care services. For many individuals with an intellectual disability (ID) this meant reduced access to services and support for them and their carers. The aim of this study was to gain insight into the ways parents of adults with ID coped during the first 2020 lockdown period. Eight parents of adults with ID were interviewed. The recordings of these interviews were subjected to a the","2021","07","07","J Policy Pract Intellect Disabil","Journal of policy and practice in intellectual disabilities","COVID-19; carers; intellectual disability; lockdown; parents","Murphy","Glynis","University of Kent Tizard Centre, Cornwallis North East Canterbury Kent CT2 7NF UK",NA
"663","34226830","10.1111/jppi.12382","The Experiences of Carers of Adults With Intellectual Disabilities During the First COVID-19 Lockdown Period.","The recent COVID-19 pandemic led to widespread international restrictions, severely impacting on health and social care services. For many individuals with an intellectual disability (ID) this meant reduced access to services and support for them and their carers. The aim of this study was to gain insight into the ways parents of adults with ID coped during the first 2020 lockdown period. Eight parents of adults with ID were interviewed. The recordings of these interviews were subjected to a the","2021","07","07","J Policy Pract Intellect Disabil","Journal of policy and practice in intellectual disabilities","COVID-19; carers; intellectual disability; lockdown; parents","Cooper","Vivien","Challenging Behaviour Foundation, The Old Courthouse New Road Avenue, Chatham Kent ME4 6BE UK",NA
"664","34226830","10.1111/jppi.12382","The Experiences of Carers of Adults With Intellectual Disabilities During the First COVID-19 Lockdown Period.","The recent COVID-19 pandemic led to widespread international restrictions, severely impacting on health and social care services. For many individuals with an intellectual disability (ID) this meant reduced access to services and support for them and their carers. The aim of this study was to gain insight into the ways parents of adults with ID coped during the first 2020 lockdown period. Eight parents of adults with ID were interviewed. The recordings of these interviews were subjected to a the","2021","07","07","J Policy Pract Intellect Disabil","Journal of policy and practice in intellectual disabilities","COVID-19; carers; intellectual disability; lockdown; parents","Langdon","Peter E","Centre for Educational Development, Appraisal and Research University of Warwick Coventry CV4 7AL UK",NA
"665","34226830","10.1111/jppi.12382","The Experiences of Carers of Adults With Intellectual Disabilities During the First COVID-19 Lockdown Period.","The recent COVID-19 pandemic led to widespread international restrictions, severely impacting on health and social care services. For many individuals with an intellectual disability (ID) this meant reduced access to services and support for them and their carers. The aim of this study was to gain insight into the ways parents of adults with ID coped during the first 2020 lockdown period. Eight parents of adults with ID were interviewed. The recordings of these interviews were subjected to a the","2021","07","07","J Policy Pract Intellect Disabil","Journal of policy and practice in intellectual disabilities","COVID-19; carers; intellectual disability; lockdown; parents","Hiles","Steve","Swansea Trials Unit, Clinical Research Facility, Institute of Life Science, Swansea University Swansea SA2 8PP UK",NA
"666","34226830","10.1111/jppi.12382","The Experiences of Carers of Adults With Intellectual Disabilities During the First COVID-19 Lockdown Period.","The recent COVID-19 pandemic led to widespread international restrictions, severely impacting on health and social care services. For many individuals with an intellectual disability (ID) this meant reduced access to services and support for them and their carers. The aim of this study was to gain insight into the ways parents of adults with ID coped during the first 2020 lockdown period. Eight parents of adults with ID were interviewed. The recordings of these interviews were subjected to a the","2021","07","07","J Policy Pract Intellect Disabil","Journal of policy and practice in intellectual disabilities","COVID-19; carers; intellectual disability; lockdown; parents","Clifford","Clair","Birmingham Community Healthcare NHS Foundation Trust Unit 3 Priestley Wharf, Holt Street Birmingham B7 4BN UK",NA
"667","34226830","10.1111/jppi.12382","The Experiences of Carers of Adults With Intellectual Disabilities During the First COVID-19 Lockdown Period.","The recent COVID-19 pandemic led to widespread international restrictions, severely impacting on health and social care services. For many individuals with an intellectual disability (ID) this meant reduced access to services and support for them and their carers. The aim of this study was to gain insight into the ways parents of adults with ID coped during the first 2020 lockdown period. Eight parents of adults with ID were interviewed. The recordings of these interviews were subjected to a the","2021","07","07","J Policy Pract Intellect Disabil","Journal of policy and practice in intellectual disabilities","COVID-19; carers; intellectual disability; lockdown; parents","Willner","Paul","Swansea Trials Unit, Clinical Research Facility, Institute of Life Science, Swansea University Swansea SA2 8PP UK",NA
"668","34226828","10.1007/s13762-021-03505-w","Transboundary sources dominated PM<sub>2.5</sub> in Thimphu, Bhutan.","This study estimates the potential source regions contributing to PM2.5 in the capital city of Thimphu, Bhutan, during the years 2018-2020 using the ground-based data, followed by the HYSPLIT back trajectory analysis. The average PM2.5 concentration in the entire study period was 32.47 µg/m<sup>3</sup> which is three times of the World Health Organization recommended limit of 10 µg/m<sup>3</sup>. Less than half of the days in pre-monsoon (43.47%) and post-monsoon (46.41%), ","2021","07","07","Int J Environ Sci Technol (Tehran)","International journal of environmental science and technology : IJEST","Bhutan; HYSPLIT; PM2.5; Source regions; Transboundary sources","Sharma","S","Department of Civil Engineering, Indian Institute of Technology Delhi, Hauz Khas, New Delhi, 110016 India",NA
"669","34226828","10.1007/s13762-021-03505-w","Transboundary sources dominated PM<sub>2.5</sub> in Thimphu, Bhutan.","This study estimates the potential source regions contributing to PM2.5 in the capital city of Thimphu, Bhutan, during the years 2018-2020 using the ground-based data, followed by the HYSPLIT back trajectory analysis. The average PM2.5 concentration in the entire study period was 32.47 µg/m<sup>3</sup> which is three times of the World Health Organization recommended limit of 10 µg/m<sup>3</sup>. Less than half of the days in pre-monsoon (43.47%) and post-monsoon (46.41%), ","2021","07","07","Int J Environ Sci Technol (Tehran)","International journal of environmental science and technology : IJEST","Bhutan; HYSPLIT; PM2.5; Source regions; Transboundary sources","Sharma","R","Department of Civil Engineering, Indian Institute of Technology Delhi, Hauz Khas, New Delhi, 110016 India",NA
"670","34226828","10.1007/s13762-021-03505-w","Transboundary sources dominated PM<sub>2.5</sub> in Thimphu, Bhutan.","This study estimates the potential source regions contributing to PM2.5 in the capital city of Thimphu, Bhutan, during the years 2018-2020 using the ground-based data, followed by the HYSPLIT back trajectory analysis. The average PM2.5 concentration in the entire study period was 32.47 µg/m<sup>3</sup> which is three times of the World Health Organization recommended limit of 10 µg/m<sup>3</sup>. Less than half of the days in pre-monsoon (43.47%) and post-monsoon (46.41%), ","2021","07","07","Int J Environ Sci Technol (Tehran)","International journal of environmental science and technology : IJEST","Bhutan; HYSPLIT; PM2.5; Source regions; Transboundary sources","Sahu","S K","State Key Joint Laboratory of Environmental Simulation and Pollution Control, School of Environment, Tsinghua University, Beijing, 100084 China",NA
"671","34226828","10.1007/s13762-021-03505-w","Transboundary sources dominated PM<sub>2.5</sub> in Thimphu, Bhutan.","This study estimates the potential source regions contributing to PM2.5 in the capital city of Thimphu, Bhutan, during the years 2018-2020 using the ground-based data, followed by the HYSPLIT back trajectory analysis. The average PM2.5 concentration in the entire study period was 32.47 µg/m<sup>3</sup> which is three times of the World Health Organization recommended limit of 10 µg/m<sup>3</sup>. Less than half of the days in pre-monsoon (43.47%) and post-monsoon (46.41%), ","2021","07","07","Int J Environ Sci Technol (Tehran)","International journal of environmental science and technology : IJEST","Bhutan; HYSPLIT; PM2.5; Source regions; Transboundary sources","Kota","S H","Department of Civil Engineering, Indian Institute of Technology Delhi, Hauz Khas, New Delhi, 110016 India",NA
"672","34226825","10.3389/fendo.2021.694083","Testosterone Deficiency Is a Risk Factor for Severe COVID-19.","Male sex is related to increased COVID-19 severity and fatality although confirmed infections are similarly distributed between men and women. The aim of this retrospective analysis was to investigate the impact of sex hormones on disease progression and immune activation in men with COVID-19. We studied for effects of sex hormones on disease severity and immune activation in 377 patients (230 men, 147 women) with PCR-confirmed SARS-CoV-2 infections hospitalized at the Innsbruck University Hospi","2021","07","12","Front Endocrinol (Lausanne)","Frontiers in endocrinology","COVID-19; SARS-CoV-2; disease severity; estradiol; inflammation; outcome; testosterone; Aged; COVID-19; Female; Humans; Male; Middle Aged; Retrospective Studies; Risk Factors; Severity of Illness Index; Testosterone","Lanser","Lukas","Department of Internal Medicine II, Innsbruck Medical University, Innsbruck, Austria",NA
"673","34226825","10.3389/fendo.2021.694083","Testosterone Deficiency Is a Risk Factor for Severe COVID-19.","Male sex is related to increased COVID-19 severity and fatality although confirmed infections are similarly distributed between men and women. The aim of this retrospective analysis was to investigate the impact of sex hormones on disease progression and immune activation in men with COVID-19. We studied for effects of sex hormones on disease severity and immune activation in 377 patients (230 men, 147 women) with PCR-confirmed SARS-CoV-2 infections hospitalized at the Innsbruck University Hospi","2021","07","12","Front Endocrinol (Lausanne)","Frontiers in endocrinology","COVID-19; SARS-CoV-2; disease severity; estradiol; inflammation; outcome; testosterone; Aged; COVID-19; Female; Humans; Male; Middle Aged; Retrospective Studies; Risk Factors; Severity of Illness Index; Testosterone","Burkert","Francesco Robert","Department of Internal Medicine II, Innsbruck Medical University, Innsbruck, Austria",NA
"674","34226825","10.3389/fendo.2021.694083","Testosterone Deficiency Is a Risk Factor for Severe COVID-19.","Male sex is related to increased COVID-19 severity and fatality although confirmed infections are similarly distributed between men and women. The aim of this retrospective analysis was to investigate the impact of sex hormones on disease progression and immune activation in men with COVID-19. We studied for effects of sex hormones on disease severity and immune activation in 377 patients (230 men, 147 women) with PCR-confirmed SARS-CoV-2 infections hospitalized at the Innsbruck University Hospi","2021","07","12","Front Endocrinol (Lausanne)","Frontiers in endocrinology","COVID-19; SARS-CoV-2; disease severity; estradiol; inflammation; outcome; testosterone; Aged; COVID-19; Female; Humans; Male; Middle Aged; Retrospective Studies; Risk Factors; Severity of Illness Index; Testosterone","Thommes","Lis","Department of Internal Medicine II, Innsbruck Medical University, Innsbruck, Austria",NA
"675","34226825","10.3389/fendo.2021.694083","Testosterone Deficiency Is a Risk Factor for Severe COVID-19.","Male sex is related to increased COVID-19 severity and fatality although confirmed infections are similarly distributed between men and women. The aim of this retrospective analysis was to investigate the impact of sex hormones on disease progression and immune activation in men with COVID-19. We studied for effects of sex hormones on disease severity and immune activation in 377 patients (230 men, 147 women) with PCR-confirmed SARS-CoV-2 infections hospitalized at the Innsbruck University Hospi","2021","07","12","Front Endocrinol (Lausanne)","Frontiers in endocrinology","COVID-19; SARS-CoV-2; disease severity; estradiol; inflammation; outcome; testosterone; Aged; COVID-19; Female; Humans; Male; Middle Aged; Retrospective Studies; Risk Factors; Severity of Illness Index; Testosterone","Egger","Alexander","Central Institute for Medical and Chemical Laboratory Diagnosis, Innsbruck University Hospital, Innsbruck, Austria",NA
"676","34226825","10.3389/fendo.2021.694083","Testosterone Deficiency Is a Risk Factor for Severe COVID-19.","Male sex is related to increased COVID-19 severity and fatality although confirmed infections are similarly distributed between men and women. The aim of this retrospective analysis was to investigate the impact of sex hormones on disease progression and immune activation in men with COVID-19. We studied for effects of sex hormones on disease severity and immune activation in 377 patients (230 men, 147 women) with PCR-confirmed SARS-CoV-2 infections hospitalized at the Innsbruck University Hospi","2021","07","12","Front Endocrinol (Lausanne)","Frontiers in endocrinology","COVID-19; SARS-CoV-2; disease severity; estradiol; inflammation; outcome; testosterone; Aged; COVID-19; Female; Humans; Male; Middle Aged; Retrospective Studies; Risk Factors; Severity of Illness Index; Testosterone","Hoermann","Gregor","Central Institute for Medical and Chemical Laboratory Diagnosis, Innsbruck University Hospital, Innsbruck, Austria",NA
"677","34226825","10.3389/fendo.2021.694083","Testosterone Deficiency Is a Risk Factor for Severe COVID-19.","Male sex is related to increased COVID-19 severity and fatality although confirmed infections are similarly distributed between men and women. The aim of this retrospective analysis was to investigate the impact of sex hormones on disease progression and immune activation in men with COVID-19. We studied for effects of sex hormones on disease severity and immune activation in 377 patients (230 men, 147 women) with PCR-confirmed SARS-CoV-2 infections hospitalized at the Innsbruck University Hospi","2021","07","12","Front Endocrinol (Lausanne)","Frontiers in endocrinology","COVID-19; SARS-CoV-2; disease severity; estradiol; inflammation; outcome; testosterone; Aged; COVID-19; Female; Humans; Male; Middle Aged; Retrospective Studies; Risk Factors; Severity of Illness Index; Testosterone","Kaser","Susanne","Department of Internal Medicine I, Innsbruck Medical University, Innsbruck, Austria",NA
"678","34226825","10.3389/fendo.2021.694083","Testosterone Deficiency Is a Risk Factor for Severe COVID-19.","Male sex is related to increased COVID-19 severity and fatality although confirmed infections are similarly distributed between men and women. The aim of this retrospective analysis was to investigate the impact of sex hormones on disease progression and immune activation in men with COVID-19. We studied for effects of sex hormones on disease severity and immune activation in 377 patients (230 men, 147 women) with PCR-confirmed SARS-CoV-2 infections hospitalized at the Innsbruck University Hospi","2021","07","12","Front Endocrinol (Lausanne)","Frontiers in endocrinology","COVID-19; SARS-CoV-2; disease severity; estradiol; inflammation; outcome; testosterone; Aged; COVID-19; Female; Humans; Male; Middle Aged; Retrospective Studies; Risk Factors; Severity of Illness Index; Testosterone","Pinggera","Germar Michael","Department of Urology, Innsbruck Medical University, Innsbruck, Austria",NA
"679","34226825","10.3389/fendo.2021.694083","Testosterone Deficiency Is a Risk Factor for Severe COVID-19.","Male sex is related to increased COVID-19 severity and fatality although confirmed infections are similarly distributed between men and women. The aim of this retrospective analysis was to investigate the impact of sex hormones on disease progression and immune activation in men with COVID-19. We studied for effects of sex hormones on disease severity and immune activation in 377 patients (230 men, 147 women) with PCR-confirmed SARS-CoV-2 infections hospitalized at the Innsbruck University Hospi","2021","07","12","Front Endocrinol (Lausanne)","Frontiers in endocrinology","COVID-19; SARS-CoV-2; disease severity; estradiol; inflammation; outcome; testosterone; Aged; COVID-19; Female; Humans; Male; Middle Aged; Retrospective Studies; Risk Factors; Severity of Illness Index; Testosterone","Anliker","Markus","Central Institute for Medical and Chemical Laboratory Diagnosis, Innsbruck University Hospital, Innsbruck, Austria",NA
"680","34226825","10.3389/fendo.2021.694083","Testosterone Deficiency Is a Risk Factor for Severe COVID-19.","Male sex is related to increased COVID-19 severity and fatality although confirmed infections are similarly distributed between men and women. The aim of this retrospective analysis was to investigate the impact of sex hormones on disease progression and immune activation in men with COVID-19. We studied for effects of sex hormones on disease severity and immune activation in 377 patients (230 men, 147 women) with PCR-confirmed SARS-CoV-2 infections hospitalized at the Innsbruck University Hospi","2021","07","12","Front Endocrinol (Lausanne)","Frontiers in endocrinology","COVID-19; SARS-CoV-2; disease severity; estradiol; inflammation; outcome; testosterone; Aged; COVID-19; Female; Humans; Male; Middle Aged; Retrospective Studies; Risk Factors; Severity of Illness Index; Testosterone","Griesmacher","Andrea","Central Institute for Medical and Chemical Laboratory Diagnosis, Innsbruck University Hospital, Innsbruck, Austria",NA
"681","34226825","10.3389/fendo.2021.694083","Testosterone Deficiency Is a Risk Factor for Severe COVID-19.","Male sex is related to increased COVID-19 severity and fatality although confirmed infections are similarly distributed between men and women. The aim of this retrospective analysis was to investigate the impact of sex hormones on disease progression and immune activation in men with COVID-19. We studied for effects of sex hormones on disease severity and immune activation in 377 patients (230 men, 147 women) with PCR-confirmed SARS-CoV-2 infections hospitalized at the Innsbruck University Hospi","2021","07","12","Front Endocrinol (Lausanne)","Frontiers in endocrinology","COVID-19; SARS-CoV-2; disease severity; estradiol; inflammation; outcome; testosterone; Aged; COVID-19; Female; Humans; Male; Middle Aged; Retrospective Studies; Risk Factors; Severity of Illness Index; Testosterone","Weiss","Günter","Department of Internal Medicine II, Innsbruck Medical University, Innsbruck, Austria",NA
"682","34226825","10.3389/fendo.2021.694083","Testosterone Deficiency Is a Risk Factor for Severe COVID-19.","Male sex is related to increased COVID-19 severity and fatality although confirmed infections are similarly distributed between men and women. The aim of this retrospective analysis was to investigate the impact of sex hormones on disease progression and immune activation in men with COVID-19. We studied for effects of sex hormones on disease severity and immune activation in 377 patients (230 men, 147 women) with PCR-confirmed SARS-CoV-2 infections hospitalized at the Innsbruck University Hospi","2021","07","12","Front Endocrinol (Lausanne)","Frontiers in endocrinology","COVID-19; SARS-CoV-2; disease severity; estradiol; inflammation; outcome; testosterone; Aged; COVID-19; Female; Humans; Male; Middle Aged; Retrospective Studies; Risk Factors; Severity of Illness Index; Testosterone","Bellmann-Weiler","Rosa","Department of Internal Medicine II, Innsbruck Medical University, Innsbruck, Austria",NA
"683","34226821","10.1016/j.asoc.2021.107653","Evaluation of government strategies against COVID-19 pandemic using q-rung orthopair fuzzy TOPSIS method.","The COVID-19 outbreak, which emerged in China and continues to spread rapidly all over the world, has brought with it increasing numbers of cases and deaths. Governments have suffered serious damage and losses not only in the field of health but also in many other fields. This has directed governments to adopt and implement various strategies in their communities. However, only a few countries succeed partially from the strategies implemented while other countries have failed. In this context, i","2021","07","07","Appl Soft Comput","Applied soft computing","COVID-19; MCDM; Q-rung orthopair fuzzy sets; Strategy selection; TOPSIS","Alkan","Nursah","Istanbul Technical University, Industrial Engineering Department, 34367 Macka, Istanbul, Turkey",NA
"684","34226821","10.1016/j.asoc.2021.107653","Evaluation of government strategies against COVID-19 pandemic using q-rung orthopair fuzzy TOPSIS method.","The COVID-19 outbreak, which emerged in China and continues to spread rapidly all over the world, has brought with it increasing numbers of cases and deaths. Governments have suffered serious damage and losses not only in the field of health but also in many other fields. This has directed governments to adopt and implement various strategies in their communities. However, only a few countries succeed partially from the strategies implemented while other countries have failed. In this context, i","2021","07","07","Appl Soft Comput","Applied soft computing","COVID-19; MCDM; Q-rung orthopair fuzzy sets; Strategy selection; TOPSIS","Kahraman","Cengiz","Istanbul Technical University, Industrial Engineering Department, 34367 Macka, Istanbul, Turkey",NA
"685","34226820","10.1002/rra.3820","Role of digital technology in freshwater biodiversity monitoring through citizen science during COVID-19 pandemic.","Citizen Science plays a vital role in monitoring biodiversity. However, it has been challenging for scientists to interact with citizens involved in biodiversity monitoring during the COVID-19 pandemic. In such circumstances, digital technology can serve as a tool for biodiversity monitoring through the cooperation between citizens and scientists. Trained volunteers can share ecological data, photographs, and videos of the species, and disturbances within ecosystems, due to anthropological activ","2021","07","07","River Res Appl","River research and applications","COVID-19; citizen science; digital technology; freshwater biodiversity monitoring","Dwivedi","Arvind Kumar","Department of Habitat Ecology Wildlife Institute of India Dehradun Uttarakhand India",NA
"686","34226818","10.1007/s10639-021-10598-w","When school bells last rung: New Jersey schools and the reaction to COVID-19.","This study was an examination of the immediate effects of remote learning during the COVID-19 shutdown in New Jersey during Spring 2020. This mixed methods study relied on survey data capturing the experiences, difficulties, and successes of 708 New Jersey public school educators during the first few weeks of the school closures. These educators were teachers, administrators, school librarians, and other school personnel. The disruptions of COVID-19 will leave indelible changes on education in N","2021","07","07","Educ Inf Technol (Dordr)","Education and information technologies","COVID; Digital divide; New Jersey","Shamburg","Christopher","Educational Technology Department, New Jersey City University, Jersey City, NJ USA",NA
"687","34226818","10.1007/s10639-021-10598-w","When school bells last rung: New Jersey schools and the reaction to COVID-19.","This study was an examination of the immediate effects of remote learning during the COVID-19 shutdown in New Jersey during Spring 2020. This mixed methods study relied on survey data capturing the experiences, difficulties, and successes of 708 New Jersey public school educators during the first few weeks of the school closures. These educators were teachers, administrators, school librarians, and other school personnel. The disruptions of COVID-19 will leave indelible changes on education in N","2021","07","07","Educ Inf Technol (Dordr)","Education and information technologies","COVID; Digital divide; New Jersey","Amerman","Tracy","Educational Technology Department, New Jersey City University, Jersey City, NJ USA",NA
"688","34226818","10.1007/s10639-021-10598-w","When school bells last rung: New Jersey schools and the reaction to COVID-19.","This study was an examination of the immediate effects of remote learning during the COVID-19 shutdown in New Jersey during Spring 2020. This mixed methods study relied on survey data capturing the experiences, difficulties, and successes of 708 New Jersey public school educators during the first few weeks of the school closures. These educators were teachers, administrators, school librarians, and other school personnel. The disruptions of COVID-19 will leave indelible changes on education in N","2021","07","07","Educ Inf Technol (Dordr)","Education and information technologies","COVID; Digital divide; New Jersey","Zieger","Laura","Educational Technology Department, New Jersey City University, Jersey City, NJ USA",NA
"689","34226818","10.1007/s10639-021-10598-w","When school bells last rung: New Jersey schools and the reaction to COVID-19.","This study was an examination of the immediate effects of remote learning during the COVID-19 shutdown in New Jersey during Spring 2020. This mixed methods study relied on survey data capturing the experiences, difficulties, and successes of 708 New Jersey public school educators during the first few weeks of the school closures. These educators were teachers, administrators, school librarians, and other school personnel. The disruptions of COVID-19 will leave indelible changes on education in N","2021","07","07","Educ Inf Technol (Dordr)","Education and information technologies","COVID; Digital divide; New Jersey","Bahna","Samantha","Educational Technology Department, New Jersey City University, Jersey City, NJ USA",NA
"690","34226817","10.1007/s10639-021-10592-2","Students academic and social concerns during COVID-19 pandemic.","Due to the COVID-19 pandemic, Higher Education Institutions (HEI) replaced regular face-to-face teaching with online teaching and learning. However, the shift caused several academic and social concerns for students, such as lack of academic support, lack of adequate resources to support online teaching, lack of socialization, stress, anxiety, and lack of motivation in attending classes. This research evaluates the impact of HEIs support, faculty support, and resources available on the academic ","2021","07","07","Educ Inf Technol (Dordr)","Education and information technologies","Academic concerns; social concerns; COVID-19 pandemic; support; Resources","Al-Maskari","Azzah","University of Technology and Applied Colleges- Ibra, Ibra, Oman",NA
"691","34226817","10.1007/s10639-021-10592-2","Students academic and social concerns during COVID-19 pandemic.","Due to the COVID-19 pandemic, Higher Education Institutions (HEI) replaced regular face-to-face teaching with online teaching and learning. However, the shift caused several academic and social concerns for students, such as lack of academic support, lack of adequate resources to support online teaching, lack of socialization, stress, anxiety, and lack of motivation in attending classes. This research evaluates the impact of HEIs support, faculty support, and resources available on the academic ","2021","07","07","Educ Inf Technol (Dordr)","Education and information technologies","Academic concerns; social concerns; COVID-19 pandemic; support; Resources","Al-Riyami","Thurayya","University of Technology and Applied Colleges- Ibra, Ibra, Oman",NA
"692","34226817","10.1007/s10639-021-10592-2","Students academic and social concerns during COVID-19 pandemic.","Due to the COVID-19 pandemic, Higher Education Institutions (HEI) replaced regular face-to-face teaching with online teaching and learning. However, the shift caused several academic and social concerns for students, such as lack of academic support, lack of adequate resources to support online teaching, lack of socialization, stress, anxiety, and lack of motivation in attending classes. This research evaluates the impact of HEIs support, faculty support, and resources available on the academic ","2021","07","07","Educ Inf Technol (Dordr)","Education and information technologies","Academic concerns; social concerns; COVID-19 pandemic; support; Resources","Kunjumuhammed","Siraj K","Modern College of Business and Sciences, Muscat, Oman",NA
"693","34226816","10.1111/nana.12749","Pandemics and citizen perceptions about their country: Did COVID-19 increase national pride in South Korea?","Exogenous shocks such as pandemics have a profound influence on how citizens think about their country. We explore how the successful handling of COVID-19 shaped South Korean citizens' perception of their country. Empirically, we compare data from surveys conducted in August 2019 and April 2020. Using regression on matched samples, we find a significant increase in general national pride. More importantly, we find an increase in positive assessments of their country in domains directly related t","2021","07","07","Nations Natl","Nations and nationalism","South Korea; civic awareness; international leadership; national pride; pandemics","Lim","Sijeong","Division of International Studies Korea University Seoul South Korea",NA
"694","34226816","10.1111/nana.12749","Pandemics and citizen perceptions about their country: Did COVID-19 increase national pride in South Korea?","Exogenous shocks such as pandemics have a profound influence on how citizens think about their country. We explore how the successful handling of COVID-19 shaped South Korean citizens' perception of their country. Empirically, we compare data from surveys conducted in August 2019 and April 2020. Using regression on matched samples, we find a significant increase in general national pride. More importantly, we find an increase in positive assessments of their country in domains directly related t","2021","07","07","Nations Natl","Nations and nationalism","South Korea; civic awareness; international leadership; national pride; pandemics","Prakash","Aseem","Department of Political Science University of Washington Seattle Washington USA",NA
"695","34226815","10.1007/s11831-021-09613-7","Risk Assessment of Infection by Airborne Droplets and Aerosols at Different Levels of Cardiovascular Activity.","Since end of 2019 the COVID-19 pandemic, caused by the SARS-CoV-2 virus, is threatening humanity. Despite the fact that various scientists across the globe try to shed a light on this new respiratory disease, it is not yet fully understood. Unlike many studies on the geographical spread of the pandemic, including the study of external transmission routes, this work focuses on droplet and aerosol transport and their deposition inside the human airways. For this purpose, a digital replica of the h","2021","07","07","Arch Comput Methods Eng","Archives of computational methods in engineering : state of the art reviews",NA,"Wedel","Jana","Institute of Applied Mechanics, University of Erlangen-Nuremberg, Erlangen, Germany",NA
"696","34226815","10.1007/s11831-021-09613-7","Risk Assessment of Infection by Airborne Droplets and Aerosols at Different Levels of Cardiovascular Activity.","Since end of 2019 the COVID-19 pandemic, caused by the SARS-CoV-2 virus, is threatening humanity. Despite the fact that various scientists across the globe try to shed a light on this new respiratory disease, it is not yet fully understood. Unlike many studies on the geographical spread of the pandemic, including the study of external transmission routes, this work focuses on droplet and aerosol transport and their deposition inside the human airways. For this purpose, a digital replica of the h","2021","07","07","Arch Comput Methods Eng","Archives of computational methods in engineering : state of the art reviews",NA,"Steinmann","Paul","Institute of Applied Mechanics, University of Erlangen-Nuremberg, Erlangen, Germany",NA
"697","34226815","10.1007/s11831-021-09613-7","Risk Assessment of Infection by Airborne Droplets and Aerosols at Different Levels of Cardiovascular Activity.","Since end of 2019 the COVID-19 pandemic, caused by the SARS-CoV-2 virus, is threatening humanity. Despite the fact that various scientists across the globe try to shed a light on this new respiratory disease, it is not yet fully understood. Unlike many studies on the geographical spread of the pandemic, including the study of external transmission routes, this work focuses on droplet and aerosol transport and their deposition inside the human airways. For this purpose, a digital replica of the h","2021","07","07","Arch Comput Methods Eng","Archives of computational methods in engineering : state of the art reviews",NA,"trakl","Mitja","Faculty of Mechanical Engineering, University of Maribor, Maribor, Slovenia",NA
"698","34226815","10.1007/s11831-021-09613-7","Risk Assessment of Infection by Airborne Droplets and Aerosols at Different Levels of Cardiovascular Activity.","Since end of 2019 the COVID-19 pandemic, caused by the SARS-CoV-2 virus, is threatening humanity. Despite the fact that various scientists across the globe try to shed a light on this new respiratory disease, it is not yet fully understood. Unlike many studies on the geographical spread of the pandemic, including the study of external transmission routes, this work focuses on droplet and aerosol transport and their deposition inside the human airways. For this purpose, a digital replica of the h","2021","07","07","Arch Comput Methods Eng","Archives of computational methods in engineering : state of the art reviews",NA,"Hriberek","Matja","Faculty of Mechanical Engineering, University of Maribor, Maribor, Slovenia",NA
"699","34226815","10.1007/s11831-021-09613-7","Risk Assessment of Infection by Airborne Droplets and Aerosols at Different Levels of Cardiovascular Activity.","Since end of 2019 the COVID-19 pandemic, caused by the SARS-CoV-2 virus, is threatening humanity. Despite the fact that various scientists across the globe try to shed a light on this new respiratory disease, it is not yet fully understood. Unlike many studies on the geographical spread of the pandemic, including the study of external transmission routes, this work focuses on droplet and aerosol transport and their deposition inside the human airways. For this purpose, a digital replica of the h","2021","07","07","Arch Comput Methods Eng","Archives of computational methods in engineering : state of the art reviews",NA,"Ravnik","Jure","Faculty of Mechanical Engineering, University of Maribor, Maribor, Slovenia",NA
"700","34226813","10.1007/s12119-021-09890-1","""It Strengthened My Core Relationships, and Filtered Out the Rest:"" Intimacy Communication During COVID-19.","Informed by scripting theories and Relational Dialectics Theory, this qualitative study used interviews, focus groups, and friendship pods conducted during the summer of 2020 in the COVID-19 pandemic to explore how 29 cisgender women and gender minorities made sense of, communicated about, and maintained their intimate relationships during COVID-19. Findings reveal a discourse of scripted intimacy reflecting normative relational patterns such as the heterosexual life script and the discourse of ","2021","07","07","Sex Cult","Sexuality &amp; culture","Dialectics; Intimate relationships; Scripts; Sexual activity; Sexuality","Rubinsky","Valerie","University of Maine at Augusta, Augusta, ME USA",NA
"701","34226813","10.1007/s12119-021-09890-1","""It Strengthened My Core Relationships, and Filtered Out the Rest:"" Intimacy Communication During COVID-19.","Informed by scripting theories and Relational Dialectics Theory, this qualitative study used interviews, focus groups, and friendship pods conducted during the summer of 2020 in the COVID-19 pandemic to explore how 29 cisgender women and gender minorities made sense of, communicated about, and maintained their intimate relationships during COVID-19. Findings reveal a discourse of scripted intimacy reflecting normative relational patterns such as the heterosexual life script and the discourse of ","2021","07","07","Sex Cult","Sexuality &amp; culture","Dialectics; Intimate relationships; Scripts; Sexual activity; Sexuality","Cooke-Jackson","Angela","California State University, Los Angeles 5151 State University Dr, Los Angeles, CA, 90032 USA",NA
"702","34226813","10.1007/s12119-021-09890-1","""It Strengthened My Core Relationships, and Filtered Out the Rest:"" Intimacy Communication During COVID-19.","Informed by scripting theories and Relational Dialectics Theory, this qualitative study used interviews, focus groups, and friendship pods conducted during the summer of 2020 in the COVID-19 pandemic to explore how 29 cisgender women and gender minorities made sense of, communicated about, and maintained their intimate relationships during COVID-19. Findings reveal a discourse of scripted intimacy reflecting normative relational patterns such as the heterosexual life script and the discourse of ","2021","07","07","Sex Cult","Sexuality &amp; culture","Dialectics; Intimate relationships; Scripts; Sexual activity; Sexuality","McMahon","Taylor","Emerson College, Boston ME 104 Boylston St, Boston, MA 02116 USA",NA
"703","34226813","10.1007/s12119-021-09890-1","""It Strengthened My Core Relationships, and Filtered Out the Rest:"" Intimacy Communication During COVID-19.","Informed by scripting theories and Relational Dialectics Theory, this qualitative study used interviews, focus groups, and friendship pods conducted during the summer of 2020 in the COVID-19 pandemic to explore how 29 cisgender women and gender minorities made sense of, communicated about, and maintained their intimate relationships during COVID-19. Findings reveal a discourse of scripted intimacy reflecting normative relational patterns such as the heterosexual life script and the discourse of ","2021","07","07","Sex Cult","Sexuality &amp; culture","Dialectics; Intimate relationships; Scripts; Sexual activity; Sexuality","Roldán","Monica","California State University, Los Angeles 5151 State University Dr, Los Angeles, CA, 90032 USA",NA
"704","34226813","10.1007/s12119-021-09890-1","""It Strengthened My Core Relationships, and Filtered Out the Rest:"" Intimacy Communication During COVID-19.","Informed by scripting theories and Relational Dialectics Theory, this qualitative study used interviews, focus groups, and friendship pods conducted during the summer of 2020 in the COVID-19 pandemic to explore how 29 cisgender women and gender minorities made sense of, communicated about, and maintained their intimate relationships during COVID-19. Findings reveal a discourse of scripted intimacy reflecting normative relational patterns such as the heterosexual life script and the discourse of ","2021","07","07","Sex Cult","Sexuality &amp; culture","Dialectics; Intimate relationships; Scripts; Sexual activity; Sexuality","Aragón","Ashley","University of Maryland College Park, MD, 20742 USA",NA
"705","34226812","10.1002/jcpy.1257","COVID-19 is Feminine: Grammatical Gender Influences Danger Perceptions and Precautionary Behavioral Intentions by Activating Gender Stereotypes.","Gendered languages assign masculine and feminine grammatical gender to all nouns, including nonhuman entities. In French and Spanish, the name of the disease resulting from the virus (COVID-19) is grammatically feminine, whereas the virus that causes the disease (coronavirus) is masculine. In this research, we test whether the grammatical gender mark affects judgments. In a series of experiments with French and Spanish speakers, we show that grammatical gender affects virus-related judgments con","2021","07","06","J Consum Psychol","Journal of consumer psychology : the official journal of the Society for Consumer Psychology","COVID-19; cross-cultural research; gender; gendered language; linguistics; risk perceptions; stereotypes","Mecit","Alican","SKEMA Business School 5 Quai Marcel Dassault 92150 Suresnes France",NA
"706","34226812","10.1002/jcpy.1257","COVID-19 is Feminine: Grammatical Gender Influences Danger Perceptions and Precautionary Behavioral Intentions by Activating Gender Stereotypes.","Gendered languages assign masculine and feminine grammatical gender to all nouns, including nonhuman entities. In French and Spanish, the name of the disease resulting from the virus (COVID-19) is grammatically feminine, whereas the virus that causes the disease (coronavirus) is masculine. In this research, we test whether the grammatical gender mark affects judgments. In a series of experiments with French and Spanish speakers, we show that grammatical gender affects virus-related judgments con","2021","07","06","J Consum Psychol","Journal of consumer psychology : the official journal of the Society for Consumer Psychology","COVID-19; cross-cultural research; gender; gendered language; linguistics; risk perceptions; stereotypes","Shrum","L J","HEC Paris 1 Rue de la Libération 78351 Jouy-en-Josas France",NA
"707","34226812","10.1002/jcpy.1257","COVID-19 is Feminine: Grammatical Gender Influences Danger Perceptions and Precautionary Behavioral Intentions by Activating Gender Stereotypes.","Gendered languages assign masculine and feminine grammatical gender to all nouns, including nonhuman entities. In French and Spanish, the name of the disease resulting from the virus (COVID-19) is grammatically feminine, whereas the virus that causes the disease (coronavirus) is masculine. In this research, we test whether the grammatical gender mark affects judgments. In a series of experiments with French and Spanish speakers, we show that grammatical gender affects virus-related judgments con","2021","07","06","J Consum Psychol","Journal of consumer psychology : the official journal of the Society for Consumer Psychology","COVID-19; cross-cultural research; gender; gendered language; linguistics; risk perceptions; stereotypes","Lowrey","Tina M","HEC Paris 1 Rue de la Libération 78351 Jouy-en-Josas France",NA
"708","34226811","10.1111/pirs.12615","Modeling the spread of COVID-19 in New York City.","This paper proposes an ensemble predictor for the weekly increase in the number of confirmed COVID-19 cases in the city of New York at zip code level. Within a Bayesian model averaging framework, the baseline is a Poisson regression for count data. The set of covariates includes autoregressive terms, spatial effects, and demographic and socioeconomic variables. Our results for the second wave of the coronavirus pandemic show that these regressors are more significant to predict the number of new","2021","07","07","Pap Reg Sci","Papers in regional science : the journal of the Regional Science Association International","Bayesian model averaging; COVID-19; Poisson regression; prediction models; spatial effects","Olmo","Jose","Departamento de Análisis Económico Universidad de Zaragoza Spain",NA
"709","34226811","10.1111/pirs.12615","Modeling the spread of COVID-19 in New York City.","This paper proposes an ensemble predictor for the weekly increase in the number of confirmed COVID-19 cases in the city of New York at zip code level. Within a Bayesian model averaging framework, the baseline is a Poisson regression for count data. The set of covariates includes autoregressive terms, spatial effects, and demographic and socioeconomic variables. Our results for the second wave of the coronavirus pandemic show that these regressors are more significant to predict the number of new","2021","07","07","Pap Reg Sci","Papers in regional science : the journal of the Regional Science Association International","Bayesian model averaging; COVID-19; Poisson regression; prediction models; spatial effects","Sanso-Navarro","Marcos","Departamento de Análisis Económico Universidad de Zaragoza Spain",NA
"710","34226805","10.1016/j.jaim.2021.06.009","Repurposing Siddha mercurial drug for mild to moderate COVID-19 - Case series and exploration of its chemical profile.","Vajra kandi maathirai (VKM) is a mercury based traditional Siddha drug used to treat various types of fevers and inflammatory diseases. We report our experience of using VKM successfully to treat 5 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infected patients and its chemical profile. A family with 5 members age ranges between 13 to 77, both male and females, one with preexisting renal impairment, SARS CoV-2 positive with mild to moderate category were treated with VKM along wit","2021","07","07","J Ayurveda Integr Med","Journal of Ayurveda and integrative medicine","Ayurveda; COVID-19; SARS-CoV-2; Siddha; Traditional Medicine; mercury","Shiva","Saravana","Agara Superspeciality Siddha Clinic, Saraswathy Nagar, Thirumullaivayal, Chennai - 62, India",NA
"711","34226805","10.1016/j.jaim.2021.06.009","Repurposing Siddha mercurial drug for mild to moderate COVID-19 - Case series and exploration of its chemical profile.","Vajra kandi maathirai (VKM) is a mercury based traditional Siddha drug used to treat various types of fevers and inflammatory diseases. We report our experience of using VKM successfully to treat 5 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infected patients and its chemical profile. A family with 5 members age ranges between 13 to 77, both male and females, one with preexisting renal impairment, SARS CoV-2 positive with mild to moderate category were treated with VKM along wit","2021","07","07","J Ayurveda Integr Med","Journal of Ayurveda and integrative medicine","Ayurveda; COVID-19; SARS-CoV-2; Siddha; Traditional Medicine; mercury","Mari","Shanmugam","Arut Jothi Siddha Clinic, Redhills, Chennai - 6000052, India",NA
"712","34226805","10.1016/j.jaim.2021.06.009","Repurposing Siddha mercurial drug for mild to moderate COVID-19 - Case series and exploration of its chemical profile.","Vajra kandi maathirai (VKM) is a mercury based traditional Siddha drug used to treat various types of fevers and inflammatory diseases. We report our experience of using VKM successfully to treat 5 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infected patients and its chemical profile. A family with 5 members age ranges between 13 to 77, both male and females, one with preexisting renal impairment, SARS CoV-2 positive with mild to moderate category were treated with VKM along wit","2021","07","07","J Ayurveda Integr Med","Journal of Ayurveda and integrative medicine","Ayurveda; COVID-19; SARS-CoV-2; Siddha; Traditional Medicine; mercury","Amuthan","Arul","Melaka Manipal Medical College, Manipal Academy of Higher Education, India - 56104",NA
"713","34226805","10.1016/j.jaim.2021.06.009","Repurposing Siddha mercurial drug for mild to moderate COVID-19 - Case series and exploration of its chemical profile.","Vajra kandi maathirai (VKM) is a mercury based traditional Siddha drug used to treat various types of fevers and inflammatory diseases. We report our experience of using VKM successfully to treat 5 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infected patients and its chemical profile. A family with 5 members age ranges between 13 to 77, both male and females, one with preexisting renal impairment, SARS CoV-2 positive with mild to moderate category were treated with VKM along wit","2021","07","07","J Ayurveda Integr Med","Journal of Ayurveda and integrative medicine","Ayurveda; COVID-19; SARS-CoV-2; Siddha; Traditional Medicine; mercury","Shanmugam","Ramalingam","Arut Jothi Siddha Clinic, Thanjavur, Tamil Nadu - 661305, India",NA
"714","34226804","10.1016/j.jceh.2021.06.020","Rescue devascularization in COVID-19 induced early shunt thrombosis after emergency proximal spleno-renal shunt for extrahepatic portal vein obstruction.",NA,"2021","07","22","J Clin Exp Hepatol","Journal of clinical and experimental hepatology","Devascularisation surgery; EHPVO","Nayak","Hemanta Kumar","Department of Gastroenterology, All India Institute of Medical Sciences, Bhubaneswar, India",NA
"715","34226804","10.1016/j.jceh.2021.06.020","Rescue devascularization in COVID-19 induced early shunt thrombosis after emergency proximal spleno-renal shunt for extrahepatic portal vein obstruction.",NA,"2021","07","22","J Clin Exp Hepatol","Journal of clinical and experimental hepatology","Devascularisation surgery; EHPVO","Pattnaik","Bramhadatta","Department of Surgical Gastroenterology, All India Institute of Medical Sciences, Bhubaneswar, India",NA
"716","34226804","10.1016/j.jceh.2021.06.020","Rescue devascularization in COVID-19 induced early shunt thrombosis after emergency proximal spleno-renal shunt for extrahepatic portal vein obstruction.",NA,"2021","07","22","J Clin Exp Hepatol","Journal of clinical and experimental hepatology","Devascularisation surgery; EHPVO","Mohakud","Sudipta","Department of Radiodiagnosis, All India Institute of Medical Sciences, Bhubaneswar, India",NA
"717","34226804","10.1016/j.jceh.2021.06.020","Rescue devascularization in COVID-19 induced early shunt thrombosis after emergency proximal spleno-renal shunt for extrahepatic portal vein obstruction.",NA,"2021","07","22","J Clin Exp Hepatol","Journal of clinical and experimental hepatology","Devascularisation surgery; EHPVO","Mitra","Jayanta Kumar","Department of Anaesthesiology and Critical Care Medicine, All India Institute of Medical Sciences, Bhubaneswar, India",NA
"718","34226804","10.1016/j.jceh.2021.06.020","Rescue devascularization in COVID-19 induced early shunt thrombosis after emergency proximal spleno-renal shunt for extrahepatic portal vein obstruction.",NA,"2021","07","22","J Clin Exp Hepatol","Journal of clinical and experimental hepatology","Devascularisation surgery; EHPVO","Krishna","Edla Vamshi","Department of Surgical Gastroenterology, All India Institute of Medical Sciences, Bhubaneswar, India",NA
"719","34226804","10.1016/j.jceh.2021.06.020","Rescue devascularization in COVID-19 induced early shunt thrombosis after emergency proximal spleno-renal shunt for extrahepatic portal vein obstruction.",NA,"2021","07","22","J Clin Exp Hepatol","Journal of clinical and experimental hepatology","Devascularisation surgery; EHPVO","Sethi","Shivam","Department of Gastroenterology, All India Institute of Medical Sciences, Bhubaneswar, India",NA
"720","34226804","10.1016/j.jceh.2021.06.020","Rescue devascularization in COVID-19 induced early shunt thrombosis after emergency proximal spleno-renal shunt for extrahepatic portal vein obstruction.",NA,"2021","07","22","J Clin Exp Hepatol","Journal of clinical and experimental hepatology","Devascularisation surgery; EHPVO","Samal","Subash Chandra","Department of Gastroenterology, All India Institute of Medical Sciences, Bhubaneswar, India",NA
"721","34226802","10.1111/itor.12986","Modeling of Covid-19 trade measures on essential products: a multiproduct, multicountry spatial price equilibrium framework.","In this paper, we develop a unified variational inequality framework in the context of spatial price network equilibrium problems that handles multiple products with multiple demand and supply markets in multiple countries as well as multiple transportation routes. The model incorporates a plethora of distinct trade measures, which is particularly important in the pandemic, as PPEs and other essential products are in high demand, but short in supply globally. In the model, product flows as well ","2021","07","07","Int Trans Oper Res","International transactions in operational research : a journal of The International Federation of Operational Research Societies","Covid-19; essential supplies; networks; spatial price equilibrium; trade measures","Nagurney","Anna","Department of Operations and Information Management Isenberg School of Management University of Massachusetts Amherst Amherst MA USA",NA
"722","34226802","10.1111/itor.12986","Modeling of Covid-19 trade measures on essential products: a multiproduct, multicountry spatial price equilibrium framework.","In this paper, we develop a unified variational inequality framework in the context of spatial price network equilibrium problems that handles multiple products with multiple demand and supply markets in multiple countries as well as multiple transportation routes. The model incorporates a plethora of distinct trade measures, which is particularly important in the pandemic, as PPEs and other essential products are in high demand, but short in supply globally. In the model, product flows as well ","2021","07","07","Int Trans Oper Res","International transactions in operational research : a journal of The International Federation of Operational Research Societies","Covid-19; essential supplies; networks; spatial price equilibrium; trade measures","Salarpour","Mojtaba","Department of Operations and Information Management Isenberg School of Management University of Massachusetts Amherst Amherst MA USA",NA
"723","34226802","10.1111/itor.12986","Modeling of Covid-19 trade measures on essential products: a multiproduct, multicountry spatial price equilibrium framework.","In this paper, we develop a unified variational inequality framework in the context of spatial price network equilibrium problems that handles multiple products with multiple demand and supply markets in multiple countries as well as multiple transportation routes. The model incorporates a plethora of distinct trade measures, which is particularly important in the pandemic, as PPEs and other essential products are in high demand, but short in supply globally. In the model, product flows as well ","2021","07","07","Int Trans Oper Res","International transactions in operational research : a journal of The International Federation of Operational Research Societies","Covid-19; essential supplies; networks; spatial price equilibrium; trade measures","Dong","June","Department of Marketing and Management School of Business State University of New York Oswego NY USA",NA
"724","34226801","10.1016/j.psep.2021.06.040","A critical review on environmental presence of pharmaceutical drugs tested for the covid-19 treatment.","On March 11, 2020, the World Health Organization (WHO) declared COVID-19 a pandemic. The outbreak caused a worldwide impact, becoming a health threat to the general population and its professionals. To date, there are no specific antiviral treatments or vaccines for the COVID-19 infection, however, some drugs are being clinically tested. The use of these drugs on large scale raises great concern about their imminent environmental risk, since the elimination of these compounds by feces and urine ","2021","07","07","Process Saf Environ Prot","Process safety and environmental protection : transactions of the Institution of Chemical Engineers, Part B","Emerging micropollutants; Environmental pollution; Medicaments; Pandemic; SARS-CoV-2","Nippes","Ramiro Picoli","State University of Maringa, Department of Chemical Engineering, Maringa, 87020-900, Parana, Brazil",NA
"725","34226801","10.1016/j.psep.2021.06.040","A critical review on environmental presence of pharmaceutical drugs tested for the covid-19 treatment.","On March 11, 2020, the World Health Organization (WHO) declared COVID-19 a pandemic. The outbreak caused a worldwide impact, becoming a health threat to the general population and its professionals. To date, there are no specific antiviral treatments or vaccines for the COVID-19 infection, however, some drugs are being clinically tested. The use of these drugs on large scale raises great concern about their imminent environmental risk, since the elimination of these compounds by feces and urine ","2021","07","07","Process Saf Environ Prot","Process safety and environmental protection : transactions of the Institution of Chemical Engineers, Part B","Emerging micropollutants; Environmental pollution; Medicaments; Pandemic; SARS-CoV-2","Macruz","Paula Derksen","State University of Maringa, Department of Chemical Engineering, Maringa, 87020-900, Parana, Brazil",NA
"726","34226801","10.1016/j.psep.2021.06.040","A critical review on environmental presence of pharmaceutical drugs tested for the covid-19 treatment.","On March 11, 2020, the World Health Organization (WHO) declared COVID-19 a pandemic. The outbreak caused a worldwide impact, becoming a health threat to the general population and its professionals. To date, there are no specific antiviral treatments or vaccines for the COVID-19 infection, however, some drugs are being clinically tested. The use of these drugs on large scale raises great concern about their imminent environmental risk, since the elimination of these compounds by feces and urine ","2021","07","07","Process Saf Environ Prot","Process safety and environmental protection : transactions of the Institution of Chemical Engineers, Part B","Emerging micropollutants; Environmental pollution; Medicaments; Pandemic; SARS-CoV-2","da Silva","Gabriela Nascimento","State University of Maringa, Department of Chemical Engineering, Maringa, 87020-900, Parana, Brazil",NA
"727","34226801","10.1016/j.psep.2021.06.040","A critical review on environmental presence of pharmaceutical drugs tested for the covid-19 treatment.","On March 11, 2020, the World Health Organization (WHO) declared COVID-19 a pandemic. The outbreak caused a worldwide impact, becoming a health threat to the general population and its professionals. To date, there are no specific antiviral treatments or vaccines for the COVID-19 infection, however, some drugs are being clinically tested. The use of these drugs on large scale raises great concern about their imminent environmental risk, since the elimination of these compounds by feces and urine ","2021","07","07","Process Saf Environ Prot","Process safety and environmental protection : transactions of the Institution of Chemical Engineers, Part B","Emerging micropollutants; Environmental pollution; Medicaments; Pandemic; SARS-CoV-2","Neves Olsen Scaliante","Mara Heloisa","State University of Maringa, Department of Chemical Engineering, Maringa, 87020-900, Parana, Brazil",NA
"728","34226800","10.1002/leap.1403","Is rapid scientific publication also high quality? Bibliometric analysis of highly disseminated COVID-19 research papers.","The impact of COVID-19 has underlined the need for reliable information to guide clinical practice and policy. This urgency has to be balanced against disruption to journal handling capacity and the continued need to ensure scientific rigour. We examined the reporting quality of highly disseminated COVID-19 research papers using a bibliometric analysis examining reporting quality and risk of bias (RoB) amongst 250 top scoring Altmetric Attention Score (AAS) COVID-19 research papers between Janua","2021","07","07","Learn Publ","Learned publishing : journal of the Association of Learned and Professional Society Publishers","COVID-19; altmetrics; coronavirus Infections; pandemics; publication impact; quality","Khatter","Amandeep","School of Population Health and Environmental Sciences King's College London London UK",NA
"729","34226800","10.1002/leap.1403","Is rapid scientific publication also high quality? Bibliometric analysis of highly disseminated COVID-19 research papers.","The impact of COVID-19 has underlined the need for reliable information to guide clinical practice and policy. This urgency has to be balanced against disruption to journal handling capacity and the continued need to ensure scientific rigour. We examined the reporting quality of highly disseminated COVID-19 research papers using a bibliometric analysis examining reporting quality and risk of bias (RoB) amongst 250 top scoring Altmetric Attention Score (AAS) COVID-19 research papers between Janua","2021","07","07","Learn Publ","Learned publishing : journal of the Association of Learned and Professional Society Publishers","COVID-19; altmetrics; coronavirus Infections; pandemics; publication impact; quality","Naughton","Michael","School of Population Health and Environmental Sciences King's College London London UK",NA
"730","34226800","10.1002/leap.1403","Is rapid scientific publication also high quality? Bibliometric analysis of highly disseminated COVID-19 research papers.","The impact of COVID-19 has underlined the need for reliable information to guide clinical practice and policy. This urgency has to be balanced against disruption to journal handling capacity and the continued need to ensure scientific rigour. We examined the reporting quality of highly disseminated COVID-19 research papers using a bibliometric analysis examining reporting quality and risk of bias (RoB) amongst 250 top scoring Altmetric Attention Score (AAS) COVID-19 research papers between Janua","2021","07","07","Learn Publ","Learned publishing : journal of the Association of Learned and Professional Society Publishers","COVID-19; altmetrics; coronavirus Infections; pandemics; publication impact; quality","Dambha-Miller","Hajira","School of Primary Care Population Sciences and Medical Education (PPM) University of Southampton UK",NA
"731","34226800","10.1002/leap.1403","Is rapid scientific publication also high quality? Bibliometric analysis of highly disseminated COVID-19 research papers.","The impact of COVID-19 has underlined the need for reliable information to guide clinical practice and policy. This urgency has to be balanced against disruption to journal handling capacity and the continued need to ensure scientific rigour. We examined the reporting quality of highly disseminated COVID-19 research papers using a bibliometric analysis examining reporting quality and risk of bias (RoB) amongst 250 top scoring Altmetric Attention Score (AAS) COVID-19 research papers between Janua","2021","07","07","Learn Publ","Learned publishing : journal of the Association of Learned and Professional Society Publishers","COVID-19; altmetrics; coronavirus Infections; pandemics; publication impact; quality","Redmond","Patrick","School of Population Health and Environmental Sciences King's College London London UK",NA
"732","34226798","10.1007/s00717-021-00493-7","Retinal detachment during COVID-19 era: a review of challenges and solutions.","Since the beginning of the Coronavirus disease 2019 (COVID-19) pandemic, there have been obstacles in the proper diagnosis and management of many diseases. We evaluated the changes in retinal detachment (RD) presentation and surgery during the COVID-19 pandemic and propose solutions to minimize the detrimental effects of lockdown on RD diagnosis. PubMed, Embase, Scopus, Web of Science, and Google Scholar were searched for relevant articles with the keywords ""Retinal detachment"" AND ""Coronavirus ","2021","07","07","Spektrum Augenheilkd","Spektrum der Augenheilkunde : Zeitschrift der Osterreichischen Ophthalmologischen Gesellschaft, OOG","Delayed diagnosis; Macula-on; Presentation; Telemedicine; Vitrectomy","Roshanshad","Amirhossein","Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran",NA
"733","34226798","10.1007/s00717-021-00493-7","Retinal detachment during COVID-19 era: a review of challenges and solutions.","Since the beginning of the Coronavirus disease 2019 (COVID-19) pandemic, there have been obstacles in the proper diagnosis and management of many diseases. We evaluated the changes in retinal detachment (RD) presentation and surgery during the COVID-19 pandemic and propose solutions to minimize the detrimental effects of lockdown on RD diagnosis. PubMed, Embase, Scopus, Web of Science, and Google Scholar were searched for relevant articles with the keywords ""Retinal detachment"" AND ""Coronavirus ","2021","07","07","Spektrum Augenheilkd","Spektrum der Augenheilkunde : Zeitschrift der Osterreichischen Ophthalmologischen Gesellschaft, OOG","Delayed diagnosis; Macula-on; Presentation; Telemedicine; Vitrectomy","Binder","Susanne","Department of Ophthalmology, Sigmund Freud University, Vienna, Austria",NA
"734","34226795","10.1002/ima.22611","COVSeg-NET: A deep convolution neural network for COVID-19 lung CT image segmentation.","COVID-19 is a new type of respiratory infectious disease that poses a serious threat to the survival of human beings all over the world. Using artificial intelligence technology to analyze lung images of COVID-19 patients can achieve rapid and effective detection. This study proposes a COVSeg-NET model that can accurately segment ground glass opaque lesions in COVID-19 lung CT images. The COVSeg-NET model is based on the fully convolutional neural network model structure, which mainly includes c","2021","07","07","Int J Imaging Syst Technol","International journal of imaging systems and technology","COVID-19; convolution neural network; image segmentation; lung CT image","Zhang","XiaoQing","Taizhou Institute of Science and Technology, Nanjing University of Science and Technology No.8, Meilan East Road Taizhou China",NA
"735","34226795","10.1002/ima.22611","COVSeg-NET: A deep convolution neural network for COVID-19 lung CT image segmentation.","COVID-19 is a new type of respiratory infectious disease that poses a serious threat to the survival of human beings all over the world. Using artificial intelligence technology to analyze lung images of COVID-19 patients can achieve rapid and effective detection. This study proposes a COVSeg-NET model that can accurately segment ground glass opaque lesions in COVID-19 lung CT images. The COVSeg-NET model is based on the fully convolutional neural network model structure, which mainly includes c","2021","07","07","Int J Imaging Syst Technol","International journal of imaging systems and technology","COVID-19; convolution neural network; image segmentation; lung CT image","Wang","GuangYu","College of Information Science and Technology, Donghua University Shanghai China",NA
"736","34226795","10.1002/ima.22611","COVSeg-NET: A deep convolution neural network for COVID-19 lung CT image segmentation.","COVID-19 is a new type of respiratory infectious disease that poses a serious threat to the survival of human beings all over the world. Using artificial intelligence technology to analyze lung images of COVID-19 patients can achieve rapid and effective detection. This study proposes a COVSeg-NET model that can accurately segment ground glass opaque lesions in COVID-19 lung CT images. The COVSeg-NET model is based on the fully convolutional neural network model structure, which mainly includes c","2021","07","07","Int J Imaging Syst Technol","International journal of imaging systems and technology","COVID-19; convolution neural network; image segmentation; lung CT image","Zhao","Shu-Guang","College of Information Science and Technology, Donghua University Shanghai China",NA
"737","34226794","10.1007/s10896-021-00300-6","Survivors' Experiences of Intimate Partner Violence and Shelter Utilization During COVID-19.","This paper examines the effects of COVID-19 on service-engaged female survivors of IPV and makes recommendations for service providers based on these survivors' voices. The researchers adopted an exploratory, descriptive, and qualitative approach to inquiry due to the novelty of the research questions during the early days of the COVID-19 in March 2020. Semi-structured interviews with service-engaged survivors were analyzed using inductive and deductive coding processes. Two categories arose fro","2021","07","07","J Fam Violence","Journal of family violence","COVID-19; Domestic violence; Intimate partner violence; Qualitative","Ravi","Kristen E","The University of Tennessee-Knoxville, 1618 Cumberland Ave, Knoxville, TN 37996 USA",NA
"738","34226794","10.1007/s10896-021-00300-6","Survivors' Experiences of Intimate Partner Violence and Shelter Utilization During COVID-19.","This paper examines the effects of COVID-19 on service-engaged female survivors of IPV and makes recommendations for service providers based on these survivors' voices. The researchers adopted an exploratory, descriptive, and qualitative approach to inquiry due to the novelty of the research questions during the early days of the COVID-19 in March 2020. Semi-structured interviews with service-engaged survivors were analyzed using inductive and deductive coding processes. Two categories arose fro","2021","07","07","J Fam Violence","Journal of family violence","COVID-19; Domestic violence; Intimate partner violence; Qualitative","Rai","Abha","Loyola University Chicago, Chicago, IL USA",NA
"739","34226794","10.1007/s10896-021-00300-6","Survivors' Experiences of Intimate Partner Violence and Shelter Utilization During COVID-19.","This paper examines the effects of COVID-19 on service-engaged female survivors of IPV and makes recommendations for service providers based on these survivors' voices. The researchers adopted an exploratory, descriptive, and qualitative approach to inquiry due to the novelty of the research questions during the early days of the COVID-19 in March 2020. Semi-structured interviews with service-engaged survivors were analyzed using inductive and deductive coding processes. Two categories arose fro","2021","07","07","J Fam Violence","Journal of family violence","COVID-19; Domestic violence; Intimate partner violence; Qualitative","Schrag","Rachel Voth","University of Texas At Arlington, Arlington, TX USA",NA
"740","34226792","10.1111/twec.13157","COVID-19 and tourism: What can we learn from the past?","The impact of the COVID-19 crisis on tourism flows is without precedent in terms of speed and severity. In this paper, we try to infer a possible future scenario for the tourism sector, evaluating the medium-term effects of past pandemics on tourist arrivals. We find that pandemics lead to a persistent decline in tourist arrivals, with the effects being larger in developing and emerging countries. Interestingly, the effects are heterogeneous across countries and episodes, and depend on several e","2021","07","07","World Econ","The World economy","COVID-19; health systems; international arrivals; pandemics; tourism; uncertainty","Aronica","Martina","Department of Economics, Business and Statistics (SEAS) University of Palermo Palermo Italy",NA
"741","34226792","10.1111/twec.13157","COVID-19 and tourism: What can we learn from the past?","The impact of the COVID-19 crisis on tourism flows is without precedent in terms of speed and severity. In this paper, we try to infer a possible future scenario for the tourism sector, evaluating the medium-term effects of past pandemics on tourist arrivals. We find that pandemics lead to a persistent decline in tourist arrivals, with the effects being larger in developing and emerging countries. Interestingly, the effects are heterogeneous across countries and episodes, and depend on several e","2021","07","07","World Econ","The World economy","COVID-19; health systems; international arrivals; pandemics; tourism; uncertainty","Pizzuto","Pietro","Department of Economics, Business and Statistics (SEAS) University of Palermo Palermo Italy",NA
"742","34226792","10.1111/twec.13157","COVID-19 and tourism: What can we learn from the past?","The impact of the COVID-19 crisis on tourism flows is without precedent in terms of speed and severity. In this paper, we try to infer a possible future scenario for the tourism sector, evaluating the medium-term effects of past pandemics on tourist arrivals. We find that pandemics lead to a persistent decline in tourist arrivals, with the effects being larger in developing and emerging countries. Interestingly, the effects are heterogeneous across countries and episodes, and depend on several e","2021","07","07","World Econ","The World economy","COVID-19; health systems; international arrivals; pandemics; tourism; uncertainty","Sciortino","Caterina","Department of Economics, Business and Statistics (SEAS) University of Palermo Palermo Italy",NA
"743","34226791","10.1111/twec.13134","How COVID-19 travels in- and outside of value chains and then affects the stock market: Evidence from China.","The organisation of value chains within and between firms and even countries is an important reason for domestic as well as international travel. Hence, value chains create interdependencies which have to do with economic but also personal interactions between firms and places. The latter means value chains are a springboard for shocks-positive or negative-to travel and other related outcomes. This paper sheds light on how input-output relations in China as one human-interaction-intensive activi","2021","07","07","World Econ","The World economy","COVID-19; stock market; value chains","Egger","Peter H","ETH Zurich, CEPR, and CESifo Zurich Switzerland",NA
"744","34226791","10.1111/twec.13134","How COVID-19 travels in- and outside of value chains and then affects the stock market: Evidence from China.","The organisation of value chains within and between firms and even countries is an important reason for domestic as well as international travel. Hence, value chains create interdependencies which have to do with economic but also personal interactions between firms and places. The latter means value chains are a springboard for shocks-positive or negative-to travel and other related outcomes. This paper sheds light on how input-output relations in China as one human-interaction-intensive activi","2021","07","07","World Econ","The World economy","COVID-19; stock market; value chains","Zhu","Jiaqing","Guangdong University of Foreign Studies Southern China Institute of Fortune Management Research, and Institute of Financial Openness and Asset Management Guangzhou China",NA
"745","34226790","10.1111/twec.13156","Demand and Supply Exposure through Global Value Chains: Euro-Mediterranean Countries during COVID.","This paper tries to examine how the COVID-19 shock affects different countries through their regional integration and their exposure to Global Value Chains (GVCs). Using input-output tables (EORA 2016), our contribution is threefold. First, building on Pahl et al. (2021), we conceptually revise the approaches to analyse input-output relationships. We underline the difference between the bilateral flow of value added and trade and distinguish between the producers and consumers of value-added. Se","2021","07","06","World Econ","The World economy","COVID-19; Global Value Chains; Regional Integration","Ayadi","Rym","CASS Business School and EMEA",NA
"746","34226790","10.1111/twec.13156","Demand and Supply Exposure through Global Value Chains: Euro-Mediterranean Countries during COVID.","This paper tries to examine how the COVID-19 shock affects different countries through their regional integration and their exposure to Global Value Chains (GVCs). Using input-output tables (EORA 2016), our contribution is threefold. First, building on Pahl et al. (2021), we conceptually revise the approaches to analyse input-output relationships. We underline the difference between the bilateral flow of value added and trade and distinguish between the producers and consumers of value-added. Se","2021","07","06","World Econ","The World economy","COVID-19; Global Value Chains; Regional Integration","Giovannetti","Giorgia","University of Firenze &amp",NA
"747","34226790","10.1111/twec.13156","Demand and Supply Exposure through Global Value Chains: Euro-Mediterranean Countries during COVID.","This paper tries to examine how the COVID-19 shock affects different countries through their regional integration and their exposure to Global Value Chains (GVCs). Using input-output tables (EORA 2016), our contribution is threefold. First, building on Pahl et al. (2021), we conceptually revise the approaches to analyse input-output relationships. We underline the difference between the bilateral flow of value added and trade and distinguish between the producers and consumers of value-added. Se","2021","07","06","World Econ","The World economy","COVID-19; Global Value Chains; Regional Integration","Marvasi","Enrico","University of Firenze &amp",NA
"748","34226790","10.1111/twec.13156","Demand and Supply Exposure through Global Value Chains: Euro-Mediterranean Countries during COVID.","This paper tries to examine how the COVID-19 shock affects different countries through their regional integration and their exposure to Global Value Chains (GVCs). Using input-output tables (EORA 2016), our contribution is threefold. First, building on Pahl et al. (2021), we conceptually revise the approaches to analyse input-output relationships. We underline the difference between the bilateral flow of value added and trade and distinguish between the producers and consumers of value-added. Se","2021","07","06","World Econ","The World economy","COVID-19; Global Value Chains; Regional Integration","Vannelli","Giulio","University of Trento and PSE",NA
"749","34226790","10.1111/twec.13156","Demand and Supply Exposure through Global Value Chains: Euro-Mediterranean Countries during COVID.","This paper tries to examine how the COVID-19 shock affects different countries through their regional integration and their exposure to Global Value Chains (GVCs). Using input-output tables (EORA 2016), our contribution is threefold. First, building on Pahl et al. (2021), we conceptually revise the approaches to analyse input-output relationships. We underline the difference between the bilateral flow of value added and trade and distinguish between the producers and consumers of value-added. Se","2021","07","06","World Econ","The World economy","COVID-19; Global Value Chains; Regional Integration","Zaki","Chahir","Cairo University and ERF",NA
"750","34226789","10.1016/j.energy.2021.121315","Energy, environmental, economic and social equity (4E) pressures of COVID-19 vaccination mismanagement: A global perspective.","Vaccination now offers a way to resolve the COVID-19 pandemic. However, it is critical to recognise the full energy, environmental, economic and social equity (4E) impacts of the vaccination life cycle. The full 4E impacts include the design and trials, order management, material preparation, manufacturing, cold chain logistics, low-temperature storage, crowd management and end-of-life waste management. A life cycle perspective is necessary for sustainable vaccination management because a prolon","2021","07","12","Energy (Oxf)","Energy (Oxford, England)","COVID-19; Cold chain logistics; Energy-environment-economy-equity; Sustainable management; Vaccination; Vaccines","Jiang","Peng","Department of Industrial Engineering and Engineering Management, Business School, Sichuan University, Chengdu, 610064, China",NA
"751","34226789","10.1016/j.energy.2021.121315","Energy, environmental, economic and social equity (4E) pressures of COVID-19 vaccination mismanagement: A global perspective.","Vaccination now offers a way to resolve the COVID-19 pandemic. However, it is critical to recognise the full energy, environmental, economic and social equity (4E) impacts of the vaccination life cycle. The full 4E impacts include the design and trials, order management, material preparation, manufacturing, cold chain logistics, low-temperature storage, crowd management and end-of-life waste management. A life cycle perspective is necessary for sustainable vaccination management because a prolon","2021","07","12","Energy (Oxf)","Energy (Oxford, England)","COVID-19; Cold chain logistics; Energy-environment-economy-equity; Sustainable management; Vaccination; Vaccines","Kleme","Jirí Jaromír","Sustainable Process Integration Laboratory - SPIL, NETME Centre, Faculty of Mechanical Engineering, Brno University of Technology- VUT Brno, Technická 2896/2, 616 69, Brno, Czech Republic",NA
"752","34226789","10.1016/j.energy.2021.121315","Energy, environmental, economic and social equity (4E) pressures of COVID-19 vaccination mismanagement: A global perspective.","Vaccination now offers a way to resolve the COVID-19 pandemic. However, it is critical to recognise the full energy, environmental, economic and social equity (4E) impacts of the vaccination life cycle. The full 4E impacts include the design and trials, order management, material preparation, manufacturing, cold chain logistics, low-temperature storage, crowd management and end-of-life waste management. A life cycle perspective is necessary for sustainable vaccination management because a prolon","2021","07","12","Energy (Oxf)","Energy (Oxford, England)","COVID-19; Cold chain logistics; Energy-environment-economy-equity; Sustainable management; Vaccination; Vaccines","Fan","Yee Van","Sustainable Process Integration Laboratory - SPIL, NETME Centre, Faculty of Mechanical Engineering, Brno University of Technology- VUT Brno, Technická 2896/2, 616 69, Brno, Czech Republic",NA
"753","34226789","10.1016/j.energy.2021.121315","Energy, environmental, economic and social equity (4E) pressures of COVID-19 vaccination mismanagement: A global perspective.","Vaccination now offers a way to resolve the COVID-19 pandemic. However, it is critical to recognise the full energy, environmental, economic and social equity (4E) impacts of the vaccination life cycle. The full 4E impacts include the design and trials, order management, material preparation, manufacturing, cold chain logistics, low-temperature storage, crowd management and end-of-life waste management. A life cycle perspective is necessary for sustainable vaccination management because a prolon","2021","07","12","Energy (Oxf)","Energy (Oxford, England)","COVID-19; Cold chain logistics; Energy-environment-economy-equity; Sustainable management; Vaccination; Vaccines","Fu","Xiuju","Department of Systems Science, Institute of High Performance Computing (IHPC), Agency for Science, Technology and Research (A*STAR), Singapore, 138632, Singapore",NA
"754","34226789","10.1016/j.energy.2021.121315","Energy, environmental, economic and social equity (4E) pressures of COVID-19 vaccination mismanagement: A global perspective.","Vaccination now offers a way to resolve the COVID-19 pandemic. However, it is critical to recognise the full energy, environmental, economic and social equity (4E) impacts of the vaccination life cycle. The full 4E impacts include the design and trials, order management, material preparation, manufacturing, cold chain logistics, low-temperature storage, crowd management and end-of-life waste management. A life cycle perspective is necessary for sustainable vaccination management because a prolon","2021","07","12","Energy (Oxf)","Energy (Oxford, England)","COVID-19; Cold chain logistics; Energy-environment-economy-equity; Sustainable management; Vaccination; Vaccines","Tan","Raymond R","Chemical Engineering Department, De La Salle University, 2401 Taft Avenue, 0922, Manila, Philippines",NA
"755","34226789","10.1016/j.energy.2021.121315","Energy, environmental, economic and social equity (4E) pressures of COVID-19 vaccination mismanagement: A global perspective.","Vaccination now offers a way to resolve the COVID-19 pandemic. However, it is critical to recognise the full energy, environmental, economic and social equity (4E) impacts of the vaccination life cycle. The full 4E impacts include the design and trials, order management, material preparation, manufacturing, cold chain logistics, low-temperature storage, crowd management and end-of-life waste management. A life cycle perspective is necessary for sustainable vaccination management because a prolon","2021","07","12","Energy (Oxf)","Energy (Oxford, England)","COVID-19; Cold chain logistics; Energy-environment-economy-equity; Sustainable management; Vaccination; Vaccines","You","Siming","James Watt School of Engineering, University of Glasgow, Glasgow, G12 8QQ, United Kingdom",NA
"756","34226789","10.1016/j.energy.2021.121315","Energy, environmental, economic and social equity (4E) pressures of COVID-19 vaccination mismanagement: A global perspective.","Vaccination now offers a way to resolve the COVID-19 pandemic. However, it is critical to recognise the full energy, environmental, economic and social equity (4E) impacts of the vaccination life cycle. The full 4E impacts include the design and trials, order management, material preparation, manufacturing, cold chain logistics, low-temperature storage, crowd management and end-of-life waste management. A life cycle perspective is necessary for sustainable vaccination management because a prolon","2021","07","12","Energy (Oxf)","Energy (Oxford, England)","COVID-19; Cold chain logistics; Energy-environment-economy-equity; Sustainable management; Vaccination; Vaccines","Foley","Aoife M","Civil, Structural, and Environmental Engineering, Trinity College Dublin, The University of Dublin, Ireland",NA
"757","34226787","10.1111/obes.12442","Covid-19 Control and the Economy: Test, Test, Test.","Hard lockdowns have left policymakers to face the ethical dilemma of choosing between saving lives and saving the economy. However, massive testing could have helped to respond more effectively to Covid-19 crisis. In this paper, we study the trade-off between infection control, lockdown and testing. The aim is to understand how these policies can be effectively combined to contain Covid-19 without damaging the economy. An extended SIR epidemic model is developed to identify the set of testing an","2021","07","07","Oxf Bull Econ Stat","Oxford bulletin of economics and statistics",NA,"Taamouti","Abderrahim","Department of Economics and Finance Durham University Business School Mill Hill Lane Durham DH1 3LB UK",NA
"758","34226784","10.1111/jcal.12569","Online engagement during COVID-19: Role of agency on collaborative learning orientation and learning expectations.","During the COVID-19 outbreak, students had to cope with succeeding in video-conferencing classes susceptible to technical problems like choppy audio, frozen screens and poor Internet connection, leading to interrupted delivery of facial expressions and eye-contact. For these reasons, agentic engagement during video-conferencing became critical for successful learning outcomes. This study explores the mediating effect agentic engagement has on collaborative language learning orientations (CLLO) w","2021","07","07","J Comput Assist Learn","Journal of computer assisted learning","EFL; agentic engagement; collaborative learning; computer-mediated communication; learning expectations","Almusharraf","Norah Mansour","Applied Linguistics Department, College of Humanities Prince Sultan University Riyadh Saudi Arabia",NA
"759","34226784","10.1111/jcal.12569","Online engagement during COVID-19: Role of agency on collaborative learning orientation and learning expectations.","During the COVID-19 outbreak, students had to cope with succeeding in video-conferencing classes susceptible to technical problems like choppy audio, frozen screens and poor Internet connection, leading to interrupted delivery of facial expressions and eye-contact. For these reasons, agentic engagement during video-conferencing became critical for successful learning outcomes. This study explores the mediating effect agentic engagement has on collaborative language learning orientations (CLLO) w","2021","07","07","J Comput Assist Learn","Journal of computer assisted learning","EFL; agentic engagement; collaborative learning; computer-mediated communication; learning expectations","Bailey","Daniel","English Language and Literature Department Konkuk University Chungju South Korea",NA
"760","34226782","10.1016/j.sajb.2021.06.033","Docking-based virtual screening and identification of potential COVID-19 main protease inhibitors from brown algae.","COVID-19 (SARS-CoV-2) is a viral disease that causes acute respiratory syndrome, which has increased the morbidity and mortality rate throughout the world. World Health Organization has declared this COVID-19 outbreak as pandemic and classified health emergency throughout the world. In the recent past, outbreaks of SARS and MERS have shown the interspecies transmission potential of coronaviruses and limitations of already prescribed drugs to overcome this global public health issue. Therefore, t","2021","07","10","S Afr J Bot","South African journal of botany : official journal of the South African Association of Botanists = Suid-Afrikaanse tydskrif vir plantkunde : amptelike tydskrif van die Suid-Afrikaanse Genootskap van Plantkundiges","Covid-19; docking-based VS; seaweed; structure-based virtual screening","Rauf","Abdur","Department of Chemistry, University of Swabi, Anbar-23561, K.P.K, Pakistan",NA
"761","34226782","10.1016/j.sajb.2021.06.033","Docking-based virtual screening and identification of potential COVID-19 main protease inhibitors from brown algae.","COVID-19 (SARS-CoV-2) is a viral disease that causes acute respiratory syndrome, which has increased the morbidity and mortality rate throughout the world. World Health Organization has declared this COVID-19 outbreak as pandemic and classified health emergency throughout the world. In the recent past, outbreaks of SARS and MERS have shown the interspecies transmission potential of coronaviruses and limitations of already prescribed drugs to overcome this global public health issue. Therefore, t","2021","07","10","S Afr J Bot","South African journal of botany : official journal of the South African Association of Botanists = Suid-Afrikaanse tydskrif vir plantkunde : amptelike tydskrif van die Suid-Afrikaanse Genootskap van Plantkundiges","Covid-19; docking-based VS; seaweed; structure-based virtual screening","Rashid","Umer","Department of Chemistry, COMSATS University Islamabad, Abbottabad Campus 22060, Pakistan",NA
"762","34226782","10.1016/j.sajb.2021.06.033","Docking-based virtual screening and identification of potential COVID-19 main protease inhibitors from brown algae.","COVID-19 (SARS-CoV-2) is a viral disease that causes acute respiratory syndrome, which has increased the morbidity and mortality rate throughout the world. World Health Organization has declared this COVID-19 outbreak as pandemic and classified health emergency throughout the world. In the recent past, outbreaks of SARS and MERS have shown the interspecies transmission potential of coronaviruses and limitations of already prescribed drugs to overcome this global public health issue. Therefore, t","2021","07","10","S Afr J Bot","South African journal of botany : official journal of the South African Association of Botanists = Suid-Afrikaanse tydskrif vir plantkunde : amptelike tydskrif van die Suid-Afrikaanse Genootskap van Plantkundiges","Covid-19; docking-based VS; seaweed; structure-based virtual screening","Khalil","Anees Ahmed","University Institute of Diet and Nutritional Sciences, Faculty of Allied Health Sciences, The University of Lahore-Pakistan",NA
"763","34226782","10.1016/j.sajb.2021.06.033","Docking-based virtual screening and identification of potential COVID-19 main protease inhibitors from brown algae.","COVID-19 (SARS-CoV-2) is a viral disease that causes acute respiratory syndrome, which has increased the morbidity and mortality rate throughout the world. World Health Organization has declared this COVID-19 outbreak as pandemic and classified health emergency throughout the world. In the recent past, outbreaks of SARS and MERS have shown the interspecies transmission potential of coronaviruses and limitations of already prescribed drugs to overcome this global public health issue. Therefore, t","2021","07","10","S Afr J Bot","South African journal of botany : official journal of the South African Association of Botanists = Suid-Afrikaanse tydskrif vir plantkunde : amptelike tydskrif van die Suid-Afrikaanse Genootskap van Plantkundiges","Covid-19; docking-based VS; seaweed; structure-based virtual screening","Khan","Shahid Ali","Department of Chemistry, University of Swabi, Anbar-23561, K.P.K, Pakistan",NA
"764","34226782","10.1016/j.sajb.2021.06.033","Docking-based virtual screening and identification of potential COVID-19 main protease inhibitors from brown algae.","COVID-19 (SARS-CoV-2) is a viral disease that causes acute respiratory syndrome, which has increased the morbidity and mortality rate throughout the world. World Health Organization has declared this COVID-19 outbreak as pandemic and classified health emergency throughout the world. In the recent past, outbreaks of SARS and MERS have shown the interspecies transmission potential of coronaviruses and limitations of already prescribed drugs to overcome this global public health issue. Therefore, t","2021","07","10","S Afr J Bot","South African journal of botany : official journal of the South African Association of Botanists = Suid-Afrikaanse tydskrif vir plantkunde : amptelike tydskrif van die Suid-Afrikaanse Genootskap van Plantkundiges","Covid-19; docking-based VS; seaweed; structure-based virtual screening","Anwar","Sirajudheen","Pharmacology and Toxicology department, College of Pharmacy, Hail University, 81451 Saudi Arabia",NA
"765","34226782","10.1016/j.sajb.2021.06.033","Docking-based virtual screening and identification of potential COVID-19 main protease inhibitors from brown algae.","COVID-19 (SARS-CoV-2) is a viral disease that causes acute respiratory syndrome, which has increased the morbidity and mortality rate throughout the world. World Health Organization has declared this COVID-19 outbreak as pandemic and classified health emergency throughout the world. In the recent past, outbreaks of SARS and MERS have shown the interspecies transmission potential of coronaviruses and limitations of already prescribed drugs to overcome this global public health issue. Therefore, t","2021","07","10","S Afr J Bot","South African journal of botany : official journal of the South African Association of Botanists = Suid-Afrikaanse tydskrif vir plantkunde : amptelike tydskrif van die Suid-Afrikaanse Genootskap van Plantkundiges","Covid-19; docking-based VS; seaweed; structure-based virtual screening","Alafnan","Ahmed","Pharmacology and Toxicology department, College of Pharmacy, Hail University, 81451 Saudi Arabia",NA
"766","34226782","10.1016/j.sajb.2021.06.033","Docking-based virtual screening and identification of potential COVID-19 main protease inhibitors from brown algae.","COVID-19 (SARS-CoV-2) is a viral disease that causes acute respiratory syndrome, which has increased the morbidity and mortality rate throughout the world. World Health Organization has declared this COVID-19 outbreak as pandemic and classified health emergency throughout the world. In the recent past, outbreaks of SARS and MERS have shown the interspecies transmission potential of coronaviruses and limitations of already prescribed drugs to overcome this global public health issue. Therefore, t","2021","07","10","S Afr J Bot","South African journal of botany : official journal of the South African Association of Botanists = Suid-Afrikaanse tydskrif vir plantkunde : amptelike tydskrif van die Suid-Afrikaanse Genootskap van Plantkundiges","Covid-19; docking-based VS; seaweed; structure-based virtual screening","Alamri","Abdulhakeem","Department of Clinical Laboratory Sciences, College of Applied Medical Science, Taif University, P. O. Box 11099, Taif, 21944, Saudi Arabia",NA
"767","34226782","10.1016/j.sajb.2021.06.033","Docking-based virtual screening and identification of potential COVID-19 main protease inhibitors from brown algae.","COVID-19 (SARS-CoV-2) is a viral disease that causes acute respiratory syndrome, which has increased the morbidity and mortality rate throughout the world. World Health Organization has declared this COVID-19 outbreak as pandemic and classified health emergency throughout the world. In the recent past, outbreaks of SARS and MERS have shown the interspecies transmission potential of coronaviruses and limitations of already prescribed drugs to overcome this global public health issue. Therefore, t","2021","07","10","S Afr J Bot","South African journal of botany : official journal of the South African Association of Botanists = Suid-Afrikaanse tydskrif vir plantkunde : amptelike tydskrif van die Suid-Afrikaanse Genootskap van Plantkundiges","Covid-19; docking-based VS; seaweed; structure-based virtual screening","Rengasamy","Kannan Rr","Green Biotechnologies Research Centre of Excellence, University of Limpopo, Private Bag X1106, Polokwane, Sovenga 0727, South Africa",NA
"768","34226781","10.1007/s10479-021-04107-y","A structured literature review on the interplay between emerging technologies and COVID-19 - insights and directions to operations fields.","In recent years, emerging technologies have gained popularity and being implemented in different fields. Thus, critical leading-edge technologies such as artificial intelligence and other related technologies (blockchain, simulation, 3d printing, etc.) are transforming the operations and other traditional fields and proving their value in fighting against unprecedented COVID-19 pandemic outbreaks. However, due to this relation's novelty, little is known about the interplay between emerging techn","2021","07","07","Ann Oper Res","Annals of operations research","Artificial intelligence; COVID-19; Emerging technologies; Structured literature review","Queiroz","Maciel M","Postgraduate Program in Business Administration, Paulista University-UNIP, Dr. Bacelar Street 1212, Sao Paulo, 04026-002 Brazil",NA
"769","34226781","10.1007/s10479-021-04107-y","A structured literature review on the interplay between emerging technologies and COVID-19 - insights and directions to operations fields.","In recent years, emerging technologies have gained popularity and being implemented in different fields. Thus, critical leading-edge technologies such as artificial intelligence and other related technologies (blockchain, simulation, 3d printing, etc.) are transforming the operations and other traditional fields and proving their value in fighting against unprecedented COVID-19 pandemic outbreaks. However, due to this relation's novelty, little is known about the interplay between emerging techn","2021","07","07","Ann Oper Res","Annals of operations research","Artificial intelligence; COVID-19; Emerging technologies; Structured literature review","Fosso Wamba","Samuel","Information, Operations and Management Sciences, TBS Business School, 1 Place Alphonse Jourdain, 31068 Toulouse, France",NA
"770","34226779","10.1002/mma.7286","Generalized form of fractional order COVID-19 model with Mittag-Leffler kernel.","An important advantage of fractional derivatives is that we can formulate models describing much better systems with memory effects. Fractional operators with different memory are related to the different type of relaxation process of the nonlocal dynamical systems. Therefore, we investigate the COVID-19 model with the fractional derivatives in this paper. We apply very effective numerical methods to obtain the numerical results. We also use the Sumudu transform to get the solutions of the model","2021","07","07","Math Methods Appl Sci","Mathematical methods in the applied sciences","COVID-19; MittagLeffler kernel; Sumudu transform; numerical methods","Aslam","Muhammad","Department of Chemistry and Materials Science, Northwest University Key Laboratory of Synthetic and Natural Functional Molecule Chemistry of Ministry of Education Xi'an P.R China",NA
"771","34226779","10.1002/mma.7286","Generalized form of fractional order COVID-19 model with Mittag-Leffler kernel.","An important advantage of fractional derivatives is that we can formulate models describing much better systems with memory effects. Fractional operators with different memory are related to the different type of relaxation process of the nonlocal dynamical systems. Therefore, we investigate the COVID-19 model with the fractional derivatives in this paper. We apply very effective numerical methods to obtain the numerical results. We also use the Sumudu transform to get the solutions of the model","2021","07","07","Math Methods Appl Sci","Mathematical methods in the applied sciences","COVID-19; MittagLeffler kernel; Sumudu transform; numerical methods","Farman","Muhammad","Department of Mathematics and statistics University of Lahore Lahore Pakistan",NA
"772","34226779","10.1002/mma.7286","Generalized form of fractional order COVID-19 model with Mittag-Leffler kernel.","An important advantage of fractional derivatives is that we can formulate models describing much better systems with memory effects. Fractional operators with different memory are related to the different type of relaxation process of the nonlocal dynamical systems. Therefore, we investigate the COVID-19 model with the fractional derivatives in this paper. We apply very effective numerical methods to obtain the numerical results. We also use the Sumudu transform to get the solutions of the model","2021","07","07","Math Methods Appl Sci","Mathematical methods in the applied sciences","COVID-19; MittagLeffler kernel; Sumudu transform; numerical methods","Akgül","Ali","Department of Mathematics Art and Science Faculty, Siirt University Siirt Turkey",NA
"773","34226779","10.1002/mma.7286","Generalized form of fractional order COVID-19 model with Mittag-Leffler kernel.","An important advantage of fractional derivatives is that we can formulate models describing much better systems with memory effects. Fractional operators with different memory are related to the different type of relaxation process of the nonlocal dynamical systems. Therefore, we investigate the COVID-19 model with the fractional derivatives in this paper. We apply very effective numerical methods to obtain the numerical results. We also use the Sumudu transform to get the solutions of the model","2021","07","07","Math Methods Appl Sci","Mathematical methods in the applied sciences","COVID-19; MittagLeffler kernel; Sumudu transform; numerical methods","Ahmad","Aqeel","Department of Mathematics and statistics University of Lahore Lahore Pakistan",NA
"774","34226779","10.1002/mma.7286","Generalized form of fractional order COVID-19 model with Mittag-Leffler kernel.","An important advantage of fractional derivatives is that we can formulate models describing much better systems with memory effects. Fractional operators with different memory are related to the different type of relaxation process of the nonlocal dynamical systems. Therefore, we investigate the COVID-19 model with the fractional derivatives in this paper. We apply very effective numerical methods to obtain the numerical results. We also use the Sumudu transform to get the solutions of the model","2021","07","07","Math Methods Appl Sci","Mathematical methods in the applied sciences","COVID-19; MittagLeffler kernel; Sumudu transform; numerical methods","Sun","Meng","Department of Chemistry and Materials Science Key Laboratory and Natural Functional Molecule Chemistry of Ministry of Education, Northwest University Xi'an China",NA
"775","34226778","10.1002/mma.7481","Analysis of transmission dynamics of COVID-19 via closed-form solutions of a susceptible-infectious-quarantined-diseased model with a quarantine-adjusted incidence function.","We analyze the disease control and prevention strategies in a susceptible-infectious-quarantined-diseased (SIQD) model with a quarantine-adjusted incidence function. We have established the closed-form solutions for all the variables of SIQD model with a quarantine-adjusted incidence function provided <mml:math xmlns:mml=""http://www.w3.org/1998/Math/MathML""><mml:mi>ß</mml:mi> <mml:mo><U+2260></mml:mo> <mml:mi><U+03B3></mml:mi> <mml:mo>+</mml:mo> <mml:mi>a</mml:mi></mml:math> by utilizing the classical techniq","2021","07","07","Math Methods Appl Sci","Mathematical methods in the applied sciences","dynamical systems in biology; exact solutions","Naz","Rehana","Department of Mathematics and Statistical Sciences Lahore School of Economics Lahore Pakistan",NA
"776","34226778","10.1002/mma.7481","Analysis of transmission dynamics of COVID-19 via closed-form solutions of a susceptible-infectious-quarantined-diseased model with a quarantine-adjusted incidence function.","We analyze the disease control and prevention strategies in a susceptible-infectious-quarantined-diseased (SIQD) model with a quarantine-adjusted incidence function. We have established the closed-form solutions for all the variables of SIQD model with a quarantine-adjusted incidence function provided <mml:math xmlns:mml=""http://www.w3.org/1998/Math/MathML""><mml:mi>ß</mml:mi> <mml:mo><U+2260></mml:mo> <mml:mi><U+03B3></mml:mi> <mml:mo>+</mml:mo> <mml:mi>a</mml:mi></mml:math> by utilizing the classical techniq","2021","07","07","Math Methods Appl Sci","Mathematical methods in the applied sciences","dynamical systems in biology; exact solutions","Al-Raeei","Marwan","Faculty of Sciences Damascus University Damascus Syrian Arab Republic",NA
"777","34226777","10.1002/mma.7500","Improving the performance of deep learning models using statistical features: The case study of COVID-19 forecasting.","COVID-19 pandemic has affected all aspects of people's lives and disrupted the economy. Forecasting the number of cases infected with this virus can help authorities make accurate decisions on the interventions that must be implemented to control the pandemic. Investigation of the studies on COVID-19 forecasting indicates that various techniques such as statistical, mathematical, and machine and deep learning have been utilized. Although deep learning models have shown promising results in this ","2021","07","07","Math Methods Appl Sci","Mathematical methods in the applied sciences","COVID-19 pandemic; deep learning; hybrid methods; statistical features","Abbasimehr","Hossein","Faculty of Information Technology and Computer Engineering Azarbaijan Shahid Madani University Tabriz Iran",NA
"778","34226777","10.1002/mma.7500","Improving the performance of deep learning models using statistical features: The case study of COVID-19 forecasting.","COVID-19 pandemic has affected all aspects of people's lives and disrupted the economy. Forecasting the number of cases infected with this virus can help authorities make accurate decisions on the interventions that must be implemented to control the pandemic. Investigation of the studies on COVID-19 forecasting indicates that various techniques such as statistical, mathematical, and machine and deep learning have been utilized. Although deep learning models have shown promising results in this ","2021","07","07","Math Methods Appl Sci","Mathematical methods in the applied sciences","COVID-19 pandemic; deep learning; hybrid methods; statistical features","Paki","Reza","Faculty of Information Technology and Computer Engineering Azarbaijan Shahid Madani University Tabriz Iran",NA
"779","34226777","10.1002/mma.7500","Improving the performance of deep learning models using statistical features: The case study of COVID-19 forecasting.","COVID-19 pandemic has affected all aspects of people's lives and disrupted the economy. Forecasting the number of cases infected with this virus can help authorities make accurate decisions on the interventions that must be implemented to control the pandemic. Investigation of the studies on COVID-19 forecasting indicates that various techniques such as statistical, mathematical, and machine and deep learning have been utilized. Although deep learning models have shown promising results in this ","2021","07","07","Math Methods Appl Sci","Mathematical methods in the applied sciences","COVID-19 pandemic; deep learning; hybrid methods; statistical features","Bahrini","Aram","Department of Engineering Systems and Environment University of Virginia Charlottesville Virginia USA",NA
"780","34226776","10.1111/pops.12752","War Against COVID-19: How Is National Identification Linked With the Adoption of Disease-Preventive Behaviors in China and the United States?","Fighting the COVID-19 pandemic requires large numbers of citizens to adopt disease-preventive practices. We contend that national identification can mobilize and motivate people to engage in preventive behaviors to protect the collective, which in return would heighten national identification further. To test these reciprocal links, we conducted studies in two countries with diverse national tactics toward curbing the pandemic: (1) a two-wave longitudinal survey in China (Study 1, N = 120","2021","07","07","Polit Psychol","Political psychology","COVID-19; disease prevention; disease-preventive behavior; national discourse; national identification; pandemic; social identity approach","Chan","Hoi-Wing","The Chinese University of Hong Kong",NA
"781","34226776","10.1111/pops.12752","War Against COVID-19: How Is National Identification Linked With the Adoption of Disease-Preventive Behaviors in China and the United States?","Fighting the COVID-19 pandemic requires large numbers of citizens to adopt disease-preventive practices. We contend that national identification can mobilize and motivate people to engage in preventive behaviors to protect the collective, which in return would heighten national identification further. To test these reciprocal links, we conducted studies in two countries with diverse national tactics toward curbing the pandemic: (1) a two-wave longitudinal survey in China (Study 1, N = 120","2021","07","07","Polit Psychol","Political psychology","COVID-19; disease prevention; disease-preventive behavior; national discourse; national identification; pandemic; social identity approach","Wang","Xue","The Chinese University of Hong Kong",NA
"782","34226776","10.1111/pops.12752","War Against COVID-19: How Is National Identification Linked With the Adoption of Disease-Preventive Behaviors in China and the United States?","Fighting the COVID-19 pandemic requires large numbers of citizens to adopt disease-preventive practices. We contend that national identification can mobilize and motivate people to engage in preventive behaviors to protect the collective, which in return would heighten national identification further. To test these reciprocal links, we conducted studies in two countries with diverse national tactics toward curbing the pandemic: (1) a two-wave longitudinal survey in China (Study 1, N = 120","2021","07","07","Polit Psychol","Political psychology","COVID-19; disease prevention; disease-preventive behavior; national discourse; national identification; pandemic; social identity approach","Zuo","Shi-Jiang","Beijing Normal University",NA
"783","34226776","10.1111/pops.12752","War Against COVID-19: How Is National Identification Linked With the Adoption of Disease-Preventive Behaviors in China and the United States?","Fighting the COVID-19 pandemic requires large numbers of citizens to adopt disease-preventive practices. We contend that national identification can mobilize and motivate people to engage in preventive behaviors to protect the collective, which in return would heighten national identification further. To test these reciprocal links, we conducted studies in two countries with diverse national tactics toward curbing the pandemic: (1) a two-wave longitudinal survey in China (Study 1, N = 120","2021","07","07","Polit Psychol","Political psychology","COVID-19; disease prevention; disease-preventive behavior; national discourse; national identification; pandemic; social identity approach","Chiu","Connie Pui-Yee","The Chinese University of Hong Kong",NA
"784","34226776","10.1111/pops.12752","War Against COVID-19: How Is National Identification Linked With the Adoption of Disease-Preventive Behaviors in China and the United States?","Fighting the COVID-19 pandemic requires large numbers of citizens to adopt disease-preventive practices. We contend that national identification can mobilize and motivate people to engage in preventive behaviors to protect the collective, which in return would heighten national identification further. To test these reciprocal links, we conducted studies in two countries with diverse national tactics toward curbing the pandemic: (1) a two-wave longitudinal survey in China (Study 1, N = 120","2021","07","07","Polit Psychol","Political psychology","COVID-19; disease prevention; disease-preventive behavior; national discourse; national identification; pandemic; social identity approach","Liu","Li","Beijing Normal University",NA
"785","34226776","10.1111/pops.12752","War Against COVID-19: How Is National Identification Linked With the Adoption of Disease-Preventive Behaviors in China and the United States?","Fighting the COVID-19 pandemic requires large numbers of citizens to adopt disease-preventive practices. We contend that national identification can mobilize and motivate people to engage in preventive behaviors to protect the collective, which in return would heighten national identification further. To test these reciprocal links, we conducted studies in two countries with diverse national tactics toward curbing the pandemic: (1) a two-wave longitudinal survey in China (Study 1, N = 120","2021","07","07","Polit Psychol","Political psychology","COVID-19; disease prevention; disease-preventive behavior; national discourse; national identification; pandemic; social identity approach","Yiu","Daphne W","The University of Oklahoma",NA
"786","34226776","10.1111/pops.12752","War Against COVID-19: How Is National Identification Linked With the Adoption of Disease-Preventive Behaviors in China and the United States?","Fighting the COVID-19 pandemic requires large numbers of citizens to adopt disease-preventive practices. We contend that national identification can mobilize and motivate people to engage in preventive behaviors to protect the collective, which in return would heighten national identification further. To test these reciprocal links, we conducted studies in two countries with diverse national tactics toward curbing the pandemic: (1) a two-wave longitudinal survey in China (Study 1, N = 120","2021","07","07","Polit Psychol","Political psychology","COVID-19; disease prevention; disease-preventive behavior; national discourse; national identification; pandemic; social identity approach","Hong","Ying-Yi","The Chinese University of Hong Kong",NA
"787","34226775","10.1111/pops.12740","Examining the Left-Right Divide Through the Lens of a Global Crisis: Ideological Differences and Their Implications for Responses to the COVID-19 Pandemic.","The COVID-19 disease pandemic is one of the most pressing global health issues of our time. Nevertheless, responses to the pandemic exhibit a stark ideological divide, with political conservatives (versus liberals/progressives) expressing less concern about the virus and less behavioral compliance with efforts to combat it. Drawing from decades of research on the psychological underpinnings of ideology, in four studies (total N = 4441) we examine the factors that contribute to the ideolog","2021","07","07","Polit Psychol","Political psychology","COVID-19; ideology; individual differences; politics","Ruisch","Benjamin Coe","The Ohio State University",NA
"788","34226775","10.1111/pops.12740","Examining the Left-Right Divide Through the Lens of a Global Crisis: Ideological Differences and Their Implications for Responses to the COVID-19 Pandemic.","The COVID-19 disease pandemic is one of the most pressing global health issues of our time. Nevertheless, responses to the pandemic exhibit a stark ideological divide, with political conservatives (versus liberals/progressives) expressing less concern about the virus and less behavioral compliance with efforts to combat it. Drawing from decades of research on the psychological underpinnings of ideology, in four studies (total N = 4441) we examine the factors that contribute to the ideolog","2021","07","07","Polit Psychol","Political psychology","COVID-19; ideology; individual differences; politics","Moore","Courtney","The Ohio State University",NA
"789","34226775","10.1111/pops.12740","Examining the Left-Right Divide Through the Lens of a Global Crisis: Ideological Differences and Their Implications for Responses to the COVID-19 Pandemic.","The COVID-19 disease pandemic is one of the most pressing global health issues of our time. Nevertheless, responses to the pandemic exhibit a stark ideological divide, with political conservatives (versus liberals/progressives) expressing less concern about the virus and less behavioral compliance with efforts to combat it. Drawing from decades of research on the psychological underpinnings of ideology, in four studies (total N = 4441) we examine the factors that contribute to the ideolog","2021","07","07","Polit Psychol","Political psychology","COVID-19; ideology; individual differences; politics","Granados Samayoa","Javier","The Ohio State University",NA
"790","34226775","10.1111/pops.12740","Examining the Left-Right Divide Through the Lens of a Global Crisis: Ideological Differences and Their Implications for Responses to the COVID-19 Pandemic.","The COVID-19 disease pandemic is one of the most pressing global health issues of our time. Nevertheless, responses to the pandemic exhibit a stark ideological divide, with political conservatives (versus liberals/progressives) expressing less concern about the virus and less behavioral compliance with efforts to combat it. Drawing from decades of research on the psychological underpinnings of ideology, in four studies (total N = 4441) we examine the factors that contribute to the ideolog","2021","07","07","Polit Psychol","Political psychology","COVID-19; ideology; individual differences; politics","Boggs","Shelby","The Ohio State University",NA
"791","34226775","10.1111/pops.12740","Examining the Left-Right Divide Through the Lens of a Global Crisis: Ideological Differences and Their Implications for Responses to the COVID-19 Pandemic.","The COVID-19 disease pandemic is one of the most pressing global health issues of our time. Nevertheless, responses to the pandemic exhibit a stark ideological divide, with political conservatives (versus liberals/progressives) expressing less concern about the virus and less behavioral compliance with efforts to combat it. Drawing from decades of research on the psychological underpinnings of ideology, in four studies (total N = 4441) we examine the factors that contribute to the ideolog","2021","07","07","Polit Psychol","Political psychology","COVID-19; ideology; individual differences; politics","Ladanyi","Jesse","The Ohio State University",NA
"792","34226775","10.1111/pops.12740","Examining the Left-Right Divide Through the Lens of a Global Crisis: Ideological Differences and Their Implications for Responses to the COVID-19 Pandemic.","The COVID-19 disease pandemic is one of the most pressing global health issues of our time. Nevertheless, responses to the pandemic exhibit a stark ideological divide, with political conservatives (versus liberals/progressives) expressing less concern about the virus and less behavioral compliance with efforts to combat it. Drawing from decades of research on the psychological underpinnings of ideology, in four studies (total N = 4441) we examine the factors that contribute to the ideolog","2021","07","07","Polit Psychol","Political psychology","COVID-19; ideology; individual differences; politics","Fazio","Russell","The Ohio State University",NA
"793","34226774","10.1002/oca.2748","Analysis of COVID-19 and comorbidity co-infection model with optimal control.","In this work, we develop and analyze a mathematical model for the dynamics of COVID-19 with re-infection in order to assess the impact of prior comorbidity (specifically, diabetes mellitus) on COVID-19 complications. The model is simulated using data relevant to the dynamics of the diseases in Lagos, Nigeria, making predictions for the attainment of peak periods in the presence or absence of comorbidity. The model is shown to undergo the phenomenon of backward bifurcation caused by the pa","2021","07","07","Optim Control Appl Methods","Optimal control applications &amp; methods","COVID-19; comorbidity; data-fitting; optimal control; reinfection","Omame","Andrew","Department of Mathematics Federal University of Technology Owerri Owerri Nigeria",NA
"794","34226774","10.1002/oca.2748","Analysis of COVID-19 and comorbidity co-infection model with optimal control.","In this work, we develop and analyze a mathematical model for the dynamics of COVID-19 with re-infection in order to assess the impact of prior comorbidity (specifically, diabetes mellitus) on COVID-19 complications. The model is simulated using data relevant to the dynamics of the diseases in Lagos, Nigeria, making predictions for the attainment of peak periods in the presence or absence of comorbidity. The model is shown to undergo the phenomenon of backward bifurcation caused by the pa","2021","07","07","Optim Control Appl Methods","Optimal control applications &amp; methods","COVID-19; comorbidity; data-fitting; optimal control; reinfection","Sene","Ndolane","Laboratoire Lmdan, Département de Mathématiques de la Décision, Facultédes Sciences Economiques et Gestion Université Cheikh Anta Diop de Dakar Dakar Fann Senegal",NA
"795","34226774","10.1002/oca.2748","Analysis of COVID-19 and comorbidity co-infection model with optimal control.","In this work, we develop and analyze a mathematical model for the dynamics of COVID-19 with re-infection in order to assess the impact of prior comorbidity (specifically, diabetes mellitus) on COVID-19 complications. The model is simulated using data relevant to the dynamics of the diseases in Lagos, Nigeria, making predictions for the attainment of peak periods in the presence or absence of comorbidity. The model is shown to undergo the phenomenon of backward bifurcation caused by the pa","2021","07","07","Optim Control Appl Methods","Optimal control applications &amp; methods","COVID-19; comorbidity; data-fitting; optimal control; reinfection","Nometa","Ikenna","Department of Mathematics University of Hawaii Manoa Honolulu Hawaii USA",NA
"796","34226774","10.1002/oca.2748","Analysis of COVID-19 and comorbidity co-infection model with optimal control.","In this work, we develop and analyze a mathematical model for the dynamics of COVID-19 with re-infection in order to assess the impact of prior comorbidity (specifically, diabetes mellitus) on COVID-19 complications. The model is simulated using data relevant to the dynamics of the diseases in Lagos, Nigeria, making predictions for the attainment of peak periods in the presence or absence of comorbidity. The model is shown to undergo the phenomenon of backward bifurcation caused by the pa","2021","07","07","Optim Control Appl Methods","Optimal control applications &amp; methods","COVID-19; comorbidity; data-fitting; optimal control; reinfection","Nwakanma","Cosmas I","Networked Systems Lab, IT Covergence Engineering, School of Electronic Engineering Kumoh National Institute of Technology Gumi Korea",NA
"797","34226774","10.1002/oca.2748","Analysis of COVID-19 and comorbidity co-infection model with optimal control.","In this work, we develop and analyze a mathematical model for the dynamics of COVID-19 with re-infection in order to assess the impact of prior comorbidity (specifically, diabetes mellitus) on COVID-19 complications. The model is simulated using data relevant to the dynamics of the diseases in Lagos, Nigeria, making predictions for the attainment of peak periods in the presence or absence of comorbidity. The model is shown to undergo the phenomenon of backward bifurcation caused by the pa","2021","07","07","Optim Control Appl Methods","Optimal control applications &amp; methods","COVID-19; comorbidity; data-fitting; optimal control; reinfection","Nwafor","Emmanuel U","Department of Mathematics Federal University of Technology Owerri Owerri Nigeria",NA
"798","34226774","10.1002/oca.2748","Analysis of COVID-19 and comorbidity co-infection model with optimal control.","In this work, we develop and analyze a mathematical model for the dynamics of COVID-19 with re-infection in order to assess the impact of prior comorbidity (specifically, diabetes mellitus) on COVID-19 complications. The model is simulated using data relevant to the dynamics of the diseases in Lagos, Nigeria, making predictions for the attainment of peak periods in the presence or absence of comorbidity. The model is shown to undergo the phenomenon of backward bifurcation caused by the pa","2021","07","07","Optim Control Appl Methods","Optimal control applications &amp; methods","COVID-19; comorbidity; data-fitting; optimal control; reinfection","Iheonu","Nneka O","Department of Mathematics Federal University of Technology Owerri Owerri Nigeria",NA
"799","34226774","10.1002/oca.2748","Analysis of COVID-19 and comorbidity co-infection model with optimal control.","In this work, we develop and analyze a mathematical model for the dynamics of COVID-19 with re-infection in order to assess the impact of prior comorbidity (specifically, diabetes mellitus) on COVID-19 complications. The model is simulated using data relevant to the dynamics of the diseases in Lagos, Nigeria, making predictions for the attainment of peak periods in the presence or absence of comorbidity. The model is shown to undergo the phenomenon of backward bifurcation caused by the pa","2021","07","07","Optim Control Appl Methods","Optimal control applications &amp; methods","COVID-19; comorbidity; data-fitting; optimal control; reinfection","Okuonghae","Daniel","Department of Mathematics University of Benin Benin City Nigeria",NA
"800","34226773","10.1111/stan.12251","Change-point analysis through INAR process with application to some COVID-19 data.","In this article, we consider the problem of change-point analysis for the count time series data through an integer-valued autoregressive process of order 1 (INAR(1)) with time-varying covariates. These types of features we observe in many real-life scenarios especially in the COVID-19 data sets where the number of active cases over time starts falling and then again increases. In order to capture those features, we use Poisson INAR(1) process with a time-varying smoothing covariate. By using su","2021","07","06","Stat Neerl","Statistica Neerlandica","Active cases; COVID-19; Change-point; INAR(1) process; Poisson distribution; Smoothing function; Time-varying covariates","Chattopadhyay","Subhankar","Applied Statistics Unit Indian Statistical Institute Kolkata India",NA
"801","34226773","10.1111/stan.12251","Change-point analysis through INAR process with application to some COVID-19 data.","In this article, we consider the problem of change-point analysis for the count time series data through an integer-valued autoregressive process of order 1 (INAR(1)) with time-varying covariates. These types of features we observe in many real-life scenarios especially in the COVID-19 data sets where the number of active cases over time starts falling and then again increases. In order to capture those features, we use Poisson INAR(1) process with a time-varying smoothing covariate. By using su","2021","07","06","Stat Neerl","Statistica Neerlandica","Active cases; COVID-19; Change-point; INAR(1) process; Poisson distribution; Smoothing function; Time-varying covariates","Maiti","Raju","Economic Research Unit Indian Statistical Institute Kolkata India",NA
"802","34226773","10.1111/stan.12251","Change-point analysis through INAR process with application to some COVID-19 data.","In this article, we consider the problem of change-point analysis for the count time series data through an integer-valued autoregressive process of order 1 (INAR(1)) with time-varying covariates. These types of features we observe in many real-life scenarios especially in the COVID-19 data sets where the number of active cases over time starts falling and then again increases. In order to capture those features, we use Poisson INAR(1) process with a time-varying smoothing covariate. By using su","2021","07","06","Stat Neerl","Statistica Neerlandica","Active cases; COVID-19; Change-point; INAR(1) process; Poisson distribution; Smoothing function; Time-varying covariates","Das","Samarjit","Economic Research Unit Indian Statistical Institute Kolkata India",NA
"803","34226773","10.1111/stan.12251","Change-point analysis through INAR process with application to some COVID-19 data.","In this article, we consider the problem of change-point analysis for the count time series data through an integer-valued autoregressive process of order 1 (INAR(1)) with time-varying covariates. These types of features we observe in many real-life scenarios especially in the COVID-19 data sets where the number of active cases over time starts falling and then again increases. In order to capture those features, we use Poisson INAR(1) process with a time-varying smoothing covariate. By using su","2021","07","06","Stat Neerl","Statistica Neerlandica","Active cases; COVID-19; Change-point; INAR(1) process; Poisson distribution; Smoothing function; Time-varying covariates","Biswas","Atanu","Applied Statistics Unit Indian Statistical Institute Kolkata India",NA
"804","34226772","10.1111/ssqu.12977","Who Trusts the WHO? Heuristics and Americans' Trust in the World Health Organization During the COVID-19 Pandemic.","Why do some Americans trust the World Health Organization (WHO) during the COVID-19 pandemic, but others do not? To date, there has been no examination of trust in the WHO. Yet the global nature of the pandemic necessitates expanding our scholarship to international health organizations. We test the effects of partisanship, ideology, the cooperative internationalist foreign policy orientation, and nationalism on trust in the WHO and subsequently examine how this trust relates to preventive healt","2021","07","07","Soc Sci Q","Social science quarterly",NA,"Bayram","A Burcu","University of Arkansas",NA
"805","34226772","10.1111/ssqu.12977","Who Trusts the WHO? Heuristics and Americans' Trust in the World Health Organization During the COVID-19 Pandemic.","Why do some Americans trust the World Health Organization (WHO) during the COVID-19 pandemic, but others do not? To date, there has been no examination of trust in the WHO. Yet the global nature of the pandemic necessitates expanding our scholarship to international health organizations. We test the effects of partisanship, ideology, the cooperative internationalist foreign policy orientation, and nationalism on trust in the WHO and subsequently examine how this trust relates to preventive healt","2021","07","07","Soc Sci Q","Social science quarterly",NA,"Shields","Todd","University of Arkansas",NA
"806","34226771","10.1111/ssqu.12989","COVID-19 and Motivated Reasoning: The Influence of Knowledge on COVID-Related Policy and Health Behavior.","The spread of misinformation about COVID-19 severely influences the governments' ability to address the COVID-19 pandemic. This study explores the predictors of accurate beliefs about COVID-19 and its influence on COVID-related policy and behavior. Data from an original survey collected by Lucid in July 2020 are used. Ordinary Least Squares regression (OLS) is used to predict accurate beliefs about COVID-19. Ordered logistic regression models are estimated to examine the relationship between COV","2021","07","07","Soc Sci Q","Social science quarterly",NA,"Sylvester","Steven M","Utah Valley University",NA
"807","34226770","10.1111/ssqu.12992","Did Covid-19 Kill Trump Politically? The Pandemic and Voting in the 2020 Presidential Election.","This article investigates the impact of public reactions to the Covid-19 panemic on voting for former President Donald Trump in the 2020 American presidential election. The impact of the pandemic on voting is assessed by multivariate statistical analyses of representative national survey data gathered before and after the 2020 presidential election. Analyses show that voters reacted very negatively to Trump's handling of the pandemic. Controlling for several other relevant factors, these reactio","2021","07","06","Soc Sci Q","Social science quarterly",NA,"Clarke","Harold","University of Texas at Dallas",NA
"808","34226770","10.1111/ssqu.12992","Did Covid-19 Kill Trump Politically? The Pandemic and Voting in the 2020 Presidential Election.","This article investigates the impact of public reactions to the Covid-19 panemic on voting for former President Donald Trump in the 2020 American presidential election. The impact of the pandemic on voting is assessed by multivariate statistical analyses of representative national survey data gathered before and after the 2020 presidential election. Analyses show that voters reacted very negatively to Trump's handling of the pandemic. Controlling for several other relevant factors, these reactio","2021","07","06","Soc Sci Q","Social science quarterly",NA,"Stewart","Marianne C","University of Texas at Dallas",NA
"809","34226770","10.1111/ssqu.12992","Did Covid-19 Kill Trump Politically? The Pandemic and Voting in the 2020 Presidential Election.","This article investigates the impact of public reactions to the Covid-19 panemic on voting for former President Donald Trump in the 2020 American presidential election. The impact of the pandemic on voting is assessed by multivariate statistical analyses of representative national survey data gathered before and after the 2020 presidential election. Analyses show that voters reacted very negatively to Trump's handling of the pandemic. Controlling for several other relevant factors, these reactio","2021","07","06","Soc Sci Q","Social science quarterly",NA,"Ho","Karl","University of Texas at Dallas",NA
"810","34226769","10.1111/ssqu.12988","The Effect of Social Distancing on the Early Spread of the Novel Coronavirus.","This article quantifies the effect of individual social distancing on the spread of the novel coronavirus. To do so, we use data on time spent by individuals on activities that would potentially expose them to crowds from the American Time Use Survey linked with state-level data on positive tests from the COVID Tracking Project. We estimate count data specifications of observed COVID-19 infections at the state level as a function of control demographic variables, and a measure of social distance","2021","07","07","Soc Sci Q","Social science quarterly",NA,"Price","Gregory","University of New Orleans College of Business Administration",NA
"811","34226769","10.1111/ssqu.12988","The Effect of Social Distancing on the Early Spread of the Novel Coronavirus.","This article quantifies the effect of individual social distancing on the spread of the novel coronavirus. To do so, we use data on time spent by individuals on activities that would potentially expose them to crowds from the American Time Use Survey linked with state-level data on positive tests from the COVID Tracking Project. We estimate count data specifications of observed COVID-19 infections at the state level as a function of control demographic variables, and a measure of social distance","2021","07","07","Soc Sci Q","Social science quarterly",NA,"van Holm","Eric","University of New Orleans College of Liberal Arts",NA
"812","34226768","10.1002/spe.2983","NovidChain: Blockchain-based privacy-preserving platform for COVID-19 test/vaccine certificates.","The COVID-19 pandemic has emerged as a highly transmissible disease which has caused a disastrous impact worldwide by adversely affecting the global economy, health, and human lives. This sudden explosion and uncontrolled worldwide spread of COVID-19 has revealed the limitations of existing healthcare systems regarding handling public health emergencies. As governments seek to effectively re-establish their economies, open workplaces, ensure safe travels and progressively return to normal life, ","2021","07","07","Softw Pract Exp","Software: practice &amp; experience","Blockchain; COVID-19 pandemic; GDPR; KYC; W3C verifiable credentials; digital health certificate; privacy self-sovereignty","Abid","Amal","ReDCAD, National Engineering School of Sfax University of Sfax Sfax Tunisia",NA
"813","34226768","10.1002/spe.2983","NovidChain: Blockchain-based privacy-preserving platform for COVID-19 test/vaccine certificates.","The COVID-19 pandemic has emerged as a highly transmissible disease which has caused a disastrous impact worldwide by adversely affecting the global economy, health, and human lives. This sudden explosion and uncontrolled worldwide spread of COVID-19 has revealed the limitations of existing healthcare systems regarding handling public health emergencies. As governments seek to effectively re-establish their economies, open workplaces, ensure safe travels and progressively return to normal life, ","2021","07","07","Softw Pract Exp","Software: practice &amp; experience","Blockchain; COVID-19 pandemic; GDPR; KYC; W3C verifiable credentials; digital health certificate; privacy self-sovereignty","Cheikhrouhou","Saoussen","ReDCAD, National Engineering School of Sfax University of Sfax Sfax Tunisia",NA
"814","34226768","10.1002/spe.2983","NovidChain: Blockchain-based privacy-preserving platform for COVID-19 test/vaccine certificates.","The COVID-19 pandemic has emerged as a highly transmissible disease which has caused a disastrous impact worldwide by adversely affecting the global economy, health, and human lives. This sudden explosion and uncontrolled worldwide spread of COVID-19 has revealed the limitations of existing healthcare systems regarding handling public health emergencies. As governments seek to effectively re-establish their economies, open workplaces, ensure safe travels and progressively return to normal life, ","2021","07","07","Softw Pract Exp","Software: practice &amp; experience","Blockchain; COVID-19 pandemic; GDPR; KYC; W3C verifiable credentials; digital health certificate; privacy self-sovereignty","Kallel","Slim","ReDCAD, National Engineering School of Sfax University of Sfax Sfax Tunisia",NA
"815","34226768","10.1002/spe.2983","NovidChain: Blockchain-based privacy-preserving platform for COVID-19 test/vaccine certificates.","The COVID-19 pandemic has emerged as a highly transmissible disease which has caused a disastrous impact worldwide by adversely affecting the global economy, health, and human lives. This sudden explosion and uncontrolled worldwide spread of COVID-19 has revealed the limitations of existing healthcare systems regarding handling public health emergencies. As governments seek to effectively re-establish their economies, open workplaces, ensure safe travels and progressively return to normal life, ","2021","07","07","Softw Pract Exp","Software: practice &amp; experience","Blockchain; COVID-19 pandemic; GDPR; KYC; W3C verifiable credentials; digital health certificate; privacy self-sovereignty","Jmaiel","Mohamed","ReDCAD, National Engineering School of Sfax University of Sfax Sfax Tunisia",NA
"816","34226767","10.1111/puar.13394","The Effect of Health and Economic Costs on Governments' Policy Responses to COVID-19 Crisis under Incomplete Information.","The COVID-19 pandemic has become an unprecedented health, economic, and social crisis. The present study has built a theoretical model and used it to develop an empirical strategy, analyzing the drivers of policy-response agility during the outbreak. Our empirical results show that national policy responses were delayed, both by government expectations of the healthcare system capacity and by expectations that any hard measures used to manage the crisis would entail severe economic costs. With d","2021","07","07","Public Adm Rev","Public administration review",NA,"Bel","Germà","Universitat de Barcelona",NA
"817","34226767","10.1111/puar.13394","The Effect of Health and Economic Costs on Governments' Policy Responses to COVID-19 Crisis under Incomplete Information.","The COVID-19 pandemic has become an unprecedented health, economic, and social crisis. The present study has built a theoretical model and used it to develop an empirical strategy, analyzing the drivers of policy-response agility during the outbreak. Our empirical results show that national policy responses were delayed, both by government expectations of the healthcare system capacity and by expectations that any hard measures used to manage the crisis would entail severe economic costs. With d","2021","07","07","Public Adm Rev","Public administration review",NA,"Gasulla","Óscar","Universitat de Barcelona",NA
"818","34226767","10.1111/puar.13394","The Effect of Health and Economic Costs on Governments' Policy Responses to COVID-19 Crisis under Incomplete Information.","The COVID-19 pandemic has become an unprecedented health, economic, and social crisis. The present study has built a theoretical model and used it to develop an empirical strategy, analyzing the drivers of policy-response agility during the outbreak. Our empirical results show that national policy responses were delayed, both by government expectations of the healthcare system capacity and by expectations that any hard measures used to manage the crisis would entail severe economic costs. With d","2021","07","07","Public Adm Rev","Public administration review",NA,"Mazaira-Font","Ferran A","Universitat de Barcelona",NA
"819","34226766","10.1111/padm.12745","Working through the fog of a pandemic: Street-level policy entrepreneurship in times of crises.","Imposing significant challenges for both street-level implementation and policy (re)design, crises alter the environment for street-level policy entrepreneurship (SLPE), wherein street-level bureaucrats engage in policy formulation processes to secure future policy outcomes. Nevertheless, like street-level implementation in general, SLPE is studied during ordinary times but rarely during crises. Focusing on community-health workers in Brazil during the Covid-19 crisis uncovered a defensive motiv","2021","07","07","Public Adm","Public administration",NA,"Gofen","Anat","School of Public Policy and Government Hebrew University of Jerusalem Jerusalem Israel",NA
"820","34226766","10.1111/padm.12745","Working through the fog of a pandemic: Street-level policy entrepreneurship in times of crises.","Imposing significant challenges for both street-level implementation and policy (re)design, crises alter the environment for street-level policy entrepreneurship (SLPE), wherein street-level bureaucrats engage in policy formulation processes to secure future policy outcomes. Nevertheless, like street-level implementation in general, SLPE is studied during ordinary times but rarely during crises. Focusing on community-health workers in Brazil during the Covid-19 crisis uncovered a defensive motiv","2021","07","07","Public Adm","Public administration",NA,"Lotta","Gabriela","Public Administration Department Fundação Getulio Vargas Sao Paulo Brazil",NA
"821","34226766","10.1111/padm.12745","Working through the fog of a pandemic: Street-level policy entrepreneurship in times of crises.","Imposing significant challenges for both street-level implementation and policy (re)design, crises alter the environment for street-level policy entrepreneurship (SLPE), wherein street-level bureaucrats engage in policy formulation processes to secure future policy outcomes. Nevertheless, like street-level implementation in general, SLPE is studied during ordinary times but rarely during crises. Focusing on community-health workers in Brazil during the Covid-19 crisis uncovered a defensive motiv","2021","07","07","Public Adm","Public administration",NA,"Marchesini da Costa","Marcelo","Insper Sao Paulo Brazil",NA
"822","34226764","10.1111/meca.12334","Unmasking the demand for masks: Analytics of mandating coronavirus masks.","This paper analytically examines the demand for surgical masks following the recent health precautions due to coronavirus. Using a simple linear demand curve and alternatively examining the impacts of requirements that mandate (a) the wearing of masks by frontline workers; (b) suggested but not required masking by the whole public; and (c) compulsory masking by the whole public. The impacts of the different scenarios on the price elasticity of demand are determined along with the slope (or the r","2021","07","07","Metroeconomica","Metroeconomica","COVID-19; consumer surplus; coronavirus; demand analysis; demand complementarity; elasticity; health; market equilibrium; regulation","Goel","Rajeev K","Department of Economics Illinois State University Normal IL USA",NA
"823","34226764","10.1111/meca.12334","Unmasking the demand for masks: Analytics of mandating coronavirus masks.","This paper analytically examines the demand for surgical masks following the recent health precautions due to coronavirus. Using a simple linear demand curve and alternatively examining the impacts of requirements that mandate (a) the wearing of masks by frontline workers; (b) suggested but not required masking by the whole public; and (c) compulsory masking by the whole public. The impacts of the different scenarios on the price elasticity of demand are determined along with the slope (or the r","2021","07","07","Metroeconomica","Metroeconomica","COVID-19; consumer surplus; coronavirus; demand analysis; demand complementarity; elasticity; health; market equilibrium; regulation","Haruna","Shoji","Department of Economics Okayama University Okayama Japan",NA
"824","34226763","10.1111/meca.12338","A simple macro-model of COVID-19 with special reference to India.","Motivated by the prevailing severe situation in India, we extend the SIR(S) model of infectious diseases to incorporate demand dynamics and its interaction with COVID-19 spread. We argue that, on one hand, the spread of COVID-19 creates panic among consumers and firms and negatively affects economic activity. On the other hand, economic activity intensifies the spread of the infection. Initially assuming that recovered individuals do not develop antibodies and become susceptible again, we captur","2021","07","06","Metroeconomica","Metroeconomica","COVID-19; animal spirits; consumer confidence; effective demand; fiscal policy; public health","Parui","Pintu","Jawaharlal Nehru University",NA
"825","34226762","10.1111/josi.12443","Bidirectional legal socialization and the boundaries of law: The case of enclave communities' compliance with COVID-19 regulations.","COVID-19 has challenged people worldwide to comply with strict lock-downs and meticulous healthcare instructions. Can states harness enclave communities to comply with the law in such crucial times, even when compliance conflicts with communal sources of authority? We investigated this question through the case of Israeli ultra-Orthodox schools compliance with COVID-19 regulations. Drawing on semi-structured interviews with school principals, documents and media sources, and a field survey, we f","2021","07","07","J Soc Issues","The Journal of social issues","COVID-19; bounded authority; enclave communities; enforcement; law and policy; law and religion; legal socialization; reciprocity; ultra-orthodox community","Barak-Corren","Netta","School of Law Hebrew University of Jerusalem Mt. Scopus Jerusalem Israel",NA
"826","34226762","10.1111/josi.12443","Bidirectional legal socialization and the boundaries of law: The case of enclave communities' compliance with COVID-19 regulations.","COVID-19 has challenged people worldwide to comply with strict lock-downs and meticulous healthcare instructions. Can states harness enclave communities to comply with the law in such crucial times, even when compliance conflicts with communal sources of authority? We investigated this question through the case of Israeli ultra-Orthodox schools compliance with COVID-19 regulations. Drawing on semi-structured interviews with school principals, documents and media sources, and a field survey, we f","2021","07","07","J Soc Issues","The Journal of social issues","COVID-19; bounded authority; enclave communities; enforcement; law and policy; law and religion; legal socialization; reciprocity; ultra-orthodox community","Perry-Hazan","Lotem","Department of Leadership and Policy in Education, Faculty of Education University of Haifa Haifa Israel",NA
"827","34226761","10.1111/jori.12344","Did COVID-19 change life insurance offerings?","The profitability of life insurance offerings is contingent on accurate projections and pricing of mortality risk. The COVID-19 pandemic created significant uncertainty, with dire mortality predictions from early forecasts resulting in widespread government intervention and greater individual precaution that reduced the projected death toll. We analyze how life insurance companies changed pricing and offerings in response to COVID-19 using monthly data on term life insurance policies from Compul","2021","07","07","J Risk Insur","The Journal of risk and insurance","2019 novel coronavirus; COVID-19; SARS-CoV-2; severe acute respiratory syndrome 2; term life insurance","Harris","Timothy F","Department of Economics Illinois State University Normal Illinois USA",NA
"828","34226761","10.1111/jori.12344","Did COVID-19 change life insurance offerings?","The profitability of life insurance offerings is contingent on accurate projections and pricing of mortality risk. The COVID-19 pandemic created significant uncertainty, with dire mortality predictions from early forecasts resulting in widespread government intervention and greater individual precaution that reduced the projected death toll. We analyze how life insurance companies changed pricing and offerings in response to COVID-19 using monthly data on term life insurance policies from Compul","2021","07","07","J Risk Insur","The Journal of risk and insurance","2019 novel coronavirus; COVID-19; SARS-CoV-2; severe acute respiratory syndrome 2; term life insurance","Yelowitz","Aaron","Department of Economics, Gatton College of Business and Economics University of Kentucky Lexington Kentucky USA",NA
"829","34226761","10.1111/jori.12344","Did COVID-19 change life insurance offerings?","The profitability of life insurance offerings is contingent on accurate projections and pricing of mortality risk. The COVID-19 pandemic created significant uncertainty, with dire mortality predictions from early forecasts resulting in widespread government intervention and greater individual precaution that reduced the projected death toll. We analyze how life insurance companies changed pricing and offerings in response to COVID-19 using monthly data on term life insurance policies from Compul","2021","07","07","J Risk Insur","The Journal of risk and insurance","2019 novel coronavirus; COVID-19; SARS-CoV-2; severe acute respiratory syndrome 2; term life insurance","Courtemanche","Charles","Department of Economics, Gatton College of Business and Economics University of Kentucky Lexington Kentucky USA",NA
"830","34226760","10.1111/jors.12541","Institutions and the uneven geography of the first wave of the COVID-19 pandemic.","This paper examines the uneven geography of COVID-19-related excess mortality during the first wave of the pandemic in Europe, before assessing the factors behind the geographical differences in impact. The analysis of 206 regions across 23 European countries reveals a distinct COVID-19 geography. Excess deaths were concentrated in a limited number of regions-expected deaths exceeded 20% in just 16 regions-with more than 40% of the regions considered experiencing no excess mortality during the f","2021","07","07","J Reg Sci","Journal of regional science","COVID-19; Europe; institutions; pandemic; regions","Rodríguez-Pose","Andrés","Cañada Blanch Centre, Department of Geography and Environment London School of Economics London UK",NA
"831","34226760","10.1111/jors.12541","Institutions and the uneven geography of the first wave of the COVID-19 pandemic.","This paper examines the uneven geography of COVID-19-related excess mortality during the first wave of the pandemic in Europe, before assessing the factors behind the geographical differences in impact. The analysis of 206 regions across 23 European countries reveals a distinct COVID-19 geography. Excess deaths were concentrated in a limited number of regions-expected deaths exceeded 20% in just 16 regions-with more than 40% of the regions considered experiencing no excess mortality during the f","2021","07","07","J Reg Sci","Journal of regional science","COVID-19; Europe; institutions; pandemic; regions","Burlina","Chiara","Social Sciences Gran Sasso Science Institute L'Aquila Italy",NA
"832","34226759","10.1111/jors.12539","Learning from deregulation: The asymmetric impact of lockdown and reopening on risky behavior during COVID-19.","During the coronavirus disease 2019 (COVID-19) pandemic, states issued and then rescinded stay-at-home orders that restricted mobility. We develop a model of learning by deregulation, which predicts that lifting stay-at-home orders can signal that going out has become safer. Using restaurant activity data, we find that the implementation of stay-at-home orders initially had a limited impact, but that activity rose quickly after states' reopenings. The results suggest that consumers inferred from","2021","07","07","J Reg Sci","Journal of regional science","COVID-19; coronavirus; mobility; public health measures","Glaeser","Edward L","Department of Economics Harvard University Cambridge Massachusetts USA",NA
"833","34226759","10.1111/jors.12539","Learning from deregulation: The asymmetric impact of lockdown and reopening on risky behavior during COVID-19.","During the coronavirus disease 2019 (COVID-19) pandemic, states issued and then rescinded stay-at-home orders that restricted mobility. We develop a model of learning by deregulation, which predicts that lifting stay-at-home orders can signal that going out has become safer. Using restaurant activity data, we find that the implementation of stay-at-home orders initially had a limited impact, but that activity rose quickly after states' reopenings. The results suggest that consumers inferred from","2021","07","07","J Reg Sci","Journal of regional science","COVID-19; coronavirus; mobility; public health measures","Jin","Ginger Z","NBER Cambridge Massachusetts USA",NA
"834","34226759","10.1111/jors.12539","Learning from deregulation: The asymmetric impact of lockdown and reopening on risky behavior during COVID-19.","During the coronavirus disease 2019 (COVID-19) pandemic, states issued and then rescinded stay-at-home orders that restricted mobility. We develop a model of learning by deregulation, which predicts that lifting stay-at-home orders can signal that going out has become safer. Using restaurant activity data, we find that the implementation of stay-at-home orders initially had a limited impact, but that activity rose quickly after states' reopenings. The results suggest that consumers inferred from","2021","07","07","J Reg Sci","Journal of regional science","COVID-19; coronavirus; mobility; public health measures","Leyden","Benjamin T","Dyson School of Applied Economics and Management Cornell University Ithaca New York USA",NA
"835","34226759","10.1111/jors.12539","Learning from deregulation: The asymmetric impact of lockdown and reopening on risky behavior during COVID-19.","During the coronavirus disease 2019 (COVID-19) pandemic, states issued and then rescinded stay-at-home orders that restricted mobility. We develop a model of learning by deregulation, which predicts that lifting stay-at-home orders can signal that going out has become safer. Using restaurant activity data, we find that the implementation of stay-at-home orders initially had a limited impact, but that activity rose quickly after states' reopenings. The results suggest that consumers inferred from","2021","07","07","J Reg Sci","Journal of regional science","COVID-19; coronavirus; mobility; public health measures","Luca","Michael","NBER Cambridge Massachusetts USA",NA
"836","34226758","10.1111/jors.12540","Welfare costs of COVID-19: Evidence from US counties.","Using daily US county-level data on consumption, employment, mobility, and the coronavirus disease 2019 (COVID-19) cases, this paper investigates the welfare costs of COVID-19. The investigation is achieved by using implications of a model, where there is a trade-off between consumption and COVID-19 cases that are both determined by the optimal mobility decision of individuals. The empirical results show evidence for about 11% of an average (across days) reduction of welfare during the sample pe","2021","07","07","J Reg Sci","Journal of regional science","COVID-19; US counties; coronavirus; welfare","Yilmazkuday","Hakan","Department of Economics Florida International University Miami Florida USA",NA
"837","34226757","10.1111/jors.12542","Regional growth and disparities in a post-COVID Europe: A new normality scenario.","This paper addresses the important question ""Which European areas will be able to better react to the crisis induced by COVID-19 and how regional disparities will look like?"" To provide an answer, a ""new normality"" scenario is built, comprising the structural changes likely to take place in the aftermath of the COVID pandemic. To develop such scenario, two intermediate steps are necessary, in both cases relying on the use of the latest generation of the MAcroeconomic, Sectoral, Social, Territori","2021","07","07","J Reg Sci","Journal of regional science","regional disparities; regional growth forecasting models; short- and long-run regional effects of COVID-19","Capello","Roberta","Politecnico di Milano ABC Department Milan (MI) Italy",NA
"838","34226757","10.1111/jors.12542","Regional growth and disparities in a post-COVID Europe: A new normality scenario.","This paper addresses the important question ""Which European areas will be able to better react to the crisis induced by COVID-19 and how regional disparities will look like?"" To provide an answer, a ""new normality"" scenario is built, comprising the structural changes likely to take place in the aftermath of the COVID pandemic. To develop such scenario, two intermediate steps are necessary, in both cases relying on the use of the latest generation of the MAcroeconomic, Sectoral, Social, Territori","2021","07","07","J Reg Sci","Journal of regional science","regional disparities; regional growth forecasting models; short- and long-run regional effects of COVID-19","Caragliu","Andrea","Politecnico di Milano ABC Department Milan (MI) Italy",NA
"839","34226756","10.1111/sapm.12393","Optimal quarantine-related strategies for COVID-19 control models.","At the time when this paper was written, quarantine-related strategies (from full lockdown to some relaxed preventive measures) were the only available measure to control coronavirus disease 2019 (COVID-19) epidemic. However, long-term quarantine and especially full lockdown is an extremely expensive measure. To explore the possibility of controlling and suppressing the COVID-19 epidemic at the lowest possible cost, we apply optimal control theory. In this paper, we create two controlled Suscept","2021","07","07","Stud Appl Math","Studies in applied mathematics (Cambridge, Mass.)","COVID-19; Pontryagin maximum principle; SEIR epidemics model; nonlinear control system","Grigorieva","Ellina V","Department of Mathematics and Computer Sciences Texas Woman's University Denton Texas USA",NA
"840","34226756","10.1111/sapm.12393","Optimal quarantine-related strategies for COVID-19 control models.","At the time when this paper was written, quarantine-related strategies (from full lockdown to some relaxed preventive measures) were the only available measure to control coronavirus disease 2019 (COVID-19) epidemic. However, long-term quarantine and especially full lockdown is an extremely expensive measure. To explore the possibility of controlling and suppressing the COVID-19 epidemic at the lowest possible cost, we apply optimal control theory. In this paper, we create two controlled Suscept","2021","07","07","Stud Appl Math","Studies in applied mathematics (Cambridge, Mass.)","COVID-19; Pontryagin maximum principle; SEIR epidemics model; nonlinear control system","Khailov","Evgenii N","Faculty of Computational Mathematics and Cybernetics Lomonosov Moscow State University Moscow Russia",NA
"841","34226756","10.1111/sapm.12393","Optimal quarantine-related strategies for COVID-19 control models.","At the time when this paper was written, quarantine-related strategies (from full lockdown to some relaxed preventive measures) were the only available measure to control coronavirus disease 2019 (COVID-19) epidemic. However, long-term quarantine and especially full lockdown is an extremely expensive measure. To explore the possibility of controlling and suppressing the COVID-19 epidemic at the lowest possible cost, we apply optimal control theory. In this paper, we create two controlled Suscept","2021","07","07","Stud Appl Math","Studies in applied mathematics (Cambridge, Mass.)","COVID-19; Pontryagin maximum principle; SEIR epidemics model; nonlinear control system","Korobeinikov","Andrei","School of Mathematics and Information Science Shaanxi Normal University Xi'an China",NA
"842","34226755","10.1016/j.jesp.2021.104186","Faith and science mindsets as predictors of COVID-19 concern: A three-wave longitudinal study.","The COVID-19 pandemic allowed for a naturalistic, longitudinal investigation of the relationship between faith and science mindsets and concern about COVID-19. Our goal was to examine two possible directional relationships: (Model 1) COVID-19 concern <U+2794> disease avoidance and self-protection motivations <U+2794> science and faith mindsets versus (Model 2) science and faith mindsets <U+2794> COVID-19 concern. We surveyed 858 Mechanical Turk workers in three waves of a study conducted in March, April, and June 20","2021","07","07","J Exp Soc Psychol","Journal of experimental social psychology","COVID-19; Longitudinal; Religion; Science; Social motivations","Johnson","Kathryn A","Arizona State University, USA",NA
"843","34226755","10.1016/j.jesp.2021.104186","Faith and science mindsets as predictors of COVID-19 concern: A three-wave longitudinal study.","The COVID-19 pandemic allowed for a naturalistic, longitudinal investigation of the relationship between faith and science mindsets and concern about COVID-19. Our goal was to examine two possible directional relationships: (Model 1) COVID-19 concern <U+2794> disease avoidance and self-protection motivations <U+2794> science and faith mindsets versus (Model 2) science and faith mindsets <U+2794> COVID-19 concern. We surveyed 858 Mechanical Turk workers in three waves of a study conducted in March, April, and June 20","2021","07","07","J Exp Soc Psychol","Journal of experimental social psychology","COVID-19; Longitudinal; Religion; Science; Social motivations","Baraldi","Amanda N","Oklahoma State University, USA",NA
"844","34226755","10.1016/j.jesp.2021.104186","Faith and science mindsets as predictors of COVID-19 concern: A three-wave longitudinal study.","The COVID-19 pandemic allowed for a naturalistic, longitudinal investigation of the relationship between faith and science mindsets and concern about COVID-19. Our goal was to examine two possible directional relationships: (Model 1) COVID-19 concern <U+2794> disease avoidance and self-protection motivations <U+2794> science and faith mindsets versus (Model 2) science and faith mindsets <U+2794> COVID-19 concern. We surveyed 858 Mechanical Turk workers in three waves of a study conducted in March, April, and June 20","2021","07","07","J Exp Soc Psychol","Journal of experimental social psychology","COVID-19; Longitudinal; Religion; Science; Social motivations","Moon","Jordan W","Arizona State University, USA",NA
"845","34226755","10.1016/j.jesp.2021.104186","Faith and science mindsets as predictors of COVID-19 concern: A three-wave longitudinal study.","The COVID-19 pandemic allowed for a naturalistic, longitudinal investigation of the relationship between faith and science mindsets and concern about COVID-19. Our goal was to examine two possible directional relationships: (Model 1) COVID-19 concern <U+2794> disease avoidance and self-protection motivations <U+2794> science and faith mindsets versus (Model 2) science and faith mindsets <U+2794> COVID-19 concern. We surveyed 858 Mechanical Turk workers in three waves of a study conducted in March, April, and June 20","2021","07","07","J Exp Soc Psychol","Journal of experimental social psychology","COVID-19; Longitudinal; Religion; Science; Social motivations","Okun","Morris A","Arizona State University, USA",NA
"846","34226755","10.1016/j.jesp.2021.104186","Faith and science mindsets as predictors of COVID-19 concern: A three-wave longitudinal study.","The COVID-19 pandemic allowed for a naturalistic, longitudinal investigation of the relationship between faith and science mindsets and concern about COVID-19. Our goal was to examine two possible directional relationships: (Model 1) COVID-19 concern <U+2794> disease avoidance and self-protection motivations <U+2794> science and faith mindsets versus (Model 2) science and faith mindsets <U+2794> COVID-19 concern. We surveyed 858 Mechanical Turk workers in three waves of a study conducted in March, April, and June 20","2021","07","07","J Exp Soc Psychol","Journal of experimental social psychology","COVID-19; Longitudinal; Religion; Science; Social motivations","Cohen","Adam B","Arizona State University, USA",NA
"847","34226753","10.1111/joca.12381","""The greedy I that gives""-The paradox of egocentrism and altruism: Terror management and system justification perspectives on the interrelationship between mortality salience and charitable donations amid the COVID-19 pandemic.","Why do people give and help others in face of their own mortality salience? The existential struggle with the awareness of death impacts the gamut of human cognition, emotion, and behavior. This multi-method research (SN = 1,219) explains the psychosocial impact of COVID-19-related mortality salience on altruism. Drawing from terror management theory, two studies tested death-thought accessibility, mortality salience, and anxiety buffer hypotheses. Study 1 (cross-sectional survey), using ","2021","07","07","J Consum Aff","The Journal of consumer affairs","COVID-19 pandemic; charitable donations; consumer well-being; mortality salience; system justification theory; terror management theory","Jin","S Venus","NU-Q Communication Department Northwestern University in Qatar Education City Doha Qatar",NA
"848","34226753","10.1111/joca.12381","""The greedy I that gives""-The paradox of egocentrism and altruism: Terror management and system justification perspectives on the interrelationship between mortality salience and charitable donations amid the COVID-19 pandemic.","Why do people give and help others in face of their own mortality salience? The existential struggle with the awareness of death impacts the gamut of human cognition, emotion, and behavior. This multi-method research (SN = 1,219) explains the psychosocial impact of COVID-19-related mortality salience on altruism. Drawing from terror management theory, two studies tested death-thought accessibility, mortality salience, and anxiety buffer hypotheses. Study 1 (cross-sectional survey), using ","2021","07","07","J Consum Aff","The Journal of consumer affairs","COVID-19 pandemic; charitable donations; consumer well-being; mortality salience; system justification theory; terror management theory","Ryu","Ehri","Department of Psychology Boston College Chestnut Hill Massachusetts USA",NA
"849","34226752","10.1111/joca.12375","Web workouts and consumer well-being: The role of digital-physical activity during the UK COVID-19 lockdown.","By using three areas of well-being, psychological, physical, and social this study aims to explore the perceptions of consumers engaging in digital-physical platforms and communities during the UK COVID-19 lockdown and the impact such participation had on their well-being. Ninety people were recruited via an online study, all were using online workouts, and self-selected to participate. The use of virtual ethnography gave further insight into the functions of these platforms and their role in so","2021","07","07","J Consum Aff","The Journal of consumer affairs","digital-physical activity; online communities; well-being","Cronshaw","Sue","Liverpool John Moores University Liverpool United Kingdom",NA
"850","34226738","10.1038/s41591-021-01439-x","Choosing Wisely for COVID-19: ten evidence-based recommendations for patients and physicians.",NA,"2021","07","06","Nat Med","Nature medicine",NA,"Pramesh","C S","Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India. prameshcs@tmc.gov","prameshcs@tmc.gov.in"
"851","34226738","10.1038/s41591-021-01439-x","Choosing Wisely for COVID-19: ten evidence-based recommendations for patients and physicians.",NA,"2021","07","06","Nat Med","Nature medicine",NA,"Babu","Giridhara R","Lifecourse Epidemiology, Indian Institute of Public Health, Public Health Foundation of India, Bengaluru, India",NA
"852","34226738","10.1038/s41591-021-01439-x","Choosing Wisely for COVID-19: ten evidence-based recommendations for patients and physicians.",NA,"2021","07","06","Nat Med","Nature medicine",NA,"Basu","Joyeeta","Doctors Hub, New Delhi, India",NA
"853","34226738","10.1038/s41591-021-01439-x","Choosing Wisely for COVID-19: ten evidence-based recommendations for patients and physicians.",NA,"2021","07","06","Nat Med","Nature medicine",NA,"Bhushan","Indu","Department of International Health, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA",NA
"854","34226738","10.1038/s41591-021-01439-x","Choosing Wisely for COVID-19: ten evidence-based recommendations for patients and physicians.",NA,"2021","07","06","Nat Med","Nature medicine",NA,"Booth","Christopher M","Department of Cancer Care and Epidemiology, Queen's University Cancer Research Institute, Kingston, Canada",NA
"855","34226738","10.1038/s41591-021-01439-x","Choosing Wisely for COVID-19: ten evidence-based recommendations for patients and physicians.",NA,"2021","07","06","Nat Med","Nature medicine",NA,"Chinnaswamy","Girish","Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India",NA
"856","34226738","10.1038/s41591-021-01439-x","Choosing Wisely for COVID-19: ten evidence-based recommendations for patients and physicians.",NA,"2021","07","06","Nat Med","Nature medicine",NA,"Guleria","Randeep","All India Institute of Medical Sciences, New Delhi, India",NA
"857","34226738","10.1038/s41591-021-01439-x","Choosing Wisely for COVID-19: ten evidence-based recommendations for patients and physicians.",NA,"2021","07","06","Nat Med","Nature medicine",NA,"Kalantri","S P","Mahatma Gandhi Institute of Medical Sciences, Sevagram, India",NA
"858","34226738","10.1038/s41591-021-01439-x","Choosing Wisely for COVID-19: ten evidence-based recommendations for patients and physicians.",NA,"2021","07","06","Nat Med","Nature medicine",NA,"Kang","Gagandeep","Christian Medical College, Vellore, India",NA
"859","34226738","10.1038/s41591-021-01439-x","Choosing Wisely for COVID-19: ten evidence-based recommendations for patients and physicians.",NA,"2021","07","06","Nat Med","Nature medicine",NA,"Mohan","Pavitra","Basic Healthcare Services, Udaipur, India",NA
"860","34226738","10.1038/s41591-021-01439-x","Choosing Wisely for COVID-19: ten evidence-based recommendations for patients and physicians.",NA,"2021","07","06","Nat Med","Nature medicine",NA,"Mor","Nachiket","The Banyan Academy of Leadership in Mental Health, Kovalam, India",NA
"861","34226738","10.1038/s41591-021-01439-x","Choosing Wisely for COVID-19: ten evidence-based recommendations for patients and physicians.",NA,"2021","07","06","Nat Med","Nature medicine",NA,"Pai","Madhukar","Department of Epidemiology and Biostatistics, McGill University, Montreal, Canada",NA
"862","34226738","10.1038/s41591-021-01439-x","Choosing Wisely for COVID-19: ten evidence-based recommendations for patients and physicians.",NA,"2021","07","06","Nat Med","Nature medicine",NA,"Prakash","Manu","Department of Bioengineering &amp",NA
"863","34226738","10.1038/s41591-021-01439-x","Choosing Wisely for COVID-19: ten evidence-based recommendations for patients and physicians.",NA,"2021","07","06","Nat Med","Nature medicine",NA,"Rupali","Priscilla","Christian Medical College, Vellore, India",NA
"864","34226738","10.1038/s41591-021-01439-x","Choosing Wisely for COVID-19: ten evidence-based recommendations for patients and physicians.",NA,"2021","07","06","Nat Med","Nature medicine",NA,"Sampathkumar","Priya","Division of Infectious Diseases, Department of Medicine, Mayo Clinic, Rochester, NY, USA",NA
"865","34226738","10.1038/s41591-021-01439-x","Choosing Wisely for COVID-19: ten evidence-based recommendations for patients and physicians.",NA,"2021","07","06","Nat Med","Nature medicine",NA,"Sengar","Manju","Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India",NA
"866","34226738","10.1038/s41591-021-01439-x","Choosing Wisely for COVID-19: ten evidence-based recommendations for patients and physicians.",NA,"2021","07","06","Nat Med","Nature medicine",NA,"Sullivan","Richard","Institute of Cancer Policy, King's College London, &amp",NA
"867","34226738","10.1038/s41591-021-01439-x","Choosing Wisely for COVID-19: ten evidence-based recommendations for patients and physicians.",NA,"2021","07","06","Nat Med","Nature medicine",NA,"Ranganathan","Priya","Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India",NA
"868","34226735","10.1038/s41591-021-01440-4","Fractionation of COVID-19 vaccine doses could extend limited supplies and reduce mortality.",NA,"2021","07","06","Nat Med","Nature medicine",NA,"Cowling","Benjamin J","World Health Organization Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, Hong Kong, China. bcowling@hku","bcowling@hku.hk"
"869","34226735","10.1038/s41591-021-01440-4","Fractionation of COVID-19 vaccine doses could extend limited supplies and reduce mortality.",NA,"2021","07","06","Nat Med","Nature medicine",NA,"Lim","Wey Wen","World Health Organization Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, Hong Kong, China",NA
"870","34226735","10.1038/s41591-021-01440-4","Fractionation of COVID-19 vaccine doses could extend limited supplies and reduce mortality.",NA,"2021","07","06","Nat Med","Nature medicine",NA,"Cobey","Sarah","Department of Ecology and Evolution, University of Chicago, Chicago, IL, USA",NA
"871","34226718","10.1038/s41581-021-00452-0","Pathophysiology of COVID-19-associated acute kidney injury.","Although respiratory failure and hypoxaemia are the main manifestations of COVID-19, kidney involvement is also common. Available evidence supports a number of potential pathophysiological pathways through which acute kidney injury (AKI) can develop in the context of SARS-CoV-2 infection. Histopathological findings have highlighted both similarities and differences between AKI in patients with COVID-19 and in those with AKI in non-COVID-related sepsis. Acute tubular injury is common, although it","2021","07","08","Nat Rev Nephrol","Nature reviews. Nephrology",NA,"Legrand","Matthieu","Department of Anesthesia and Perioperative Care, Division of Critical Care Medicine, University of California, San Francisco, CA, USA. matthieu.legrand@ucsf","matthieu.legrand@ucsf.edu"
"872","34226718","10.1038/s41581-021-00452-0","Pathophysiology of COVID-19-associated acute kidney injury.","Although respiratory failure and hypoxaemia are the main manifestations of COVID-19, kidney involvement is also common. Available evidence supports a number of potential pathophysiological pathways through which acute kidney injury (AKI) can develop in the context of SARS-CoV-2 infection. Histopathological findings have highlighted both similarities and differences between AKI in patients with COVID-19 and in those with AKI in non-COVID-related sepsis. Acute tubular injury is common, although it","2021","07","08","Nat Rev Nephrol","Nature reviews. Nephrology",NA,"Bell","Samira","Division of Population Health and Genomics, School of Medicine, University of Dundee, Dundee, UK",NA
"873","34226718","10.1038/s41581-021-00452-0","Pathophysiology of COVID-19-associated acute kidney injury.","Although respiratory failure and hypoxaemia are the main manifestations of COVID-19, kidney involvement is also common. Available evidence supports a number of potential pathophysiological pathways through which acute kidney injury (AKI) can develop in the context of SARS-CoV-2 infection. Histopathological findings have highlighted both similarities and differences between AKI in patients with COVID-19 and in those with AKI in non-COVID-related sepsis. Acute tubular injury is common, although it","2021","07","08","Nat Rev Nephrol","Nature reviews. Nephrology",NA,"Forni","Lui","Intensive Care Unit, Royal Surrey Hospital NHS Foundation Trust, Surrey, UK",NA
"874","34226718","10.1038/s41581-021-00452-0","Pathophysiology of COVID-19-associated acute kidney injury.","Although respiratory failure and hypoxaemia are the main manifestations of COVID-19, kidney involvement is also common. Available evidence supports a number of potential pathophysiological pathways through which acute kidney injury (AKI) can develop in the context of SARS-CoV-2 infection. Histopathological findings have highlighted both similarities and differences between AKI in patients with COVID-19 and in those with AKI in non-COVID-related sepsis. Acute tubular injury is common, although it","2021","07","08","Nat Rev Nephrol","Nature reviews. Nephrology",NA,"Joannidis","Michael","Division of Intensive Care and Emergency Medicine, Medical University of Innsbruck, Innsbruck, Austria",NA
"875","34226718","10.1038/s41581-021-00452-0","Pathophysiology of COVID-19-associated acute kidney injury.","Although respiratory failure and hypoxaemia are the main manifestations of COVID-19, kidney involvement is also common. Available evidence supports a number of potential pathophysiological pathways through which acute kidney injury (AKI) can develop in the context of SARS-CoV-2 infection. Histopathological findings have highlighted both similarities and differences between AKI in patients with COVID-19 and in those with AKI in non-COVID-related sepsis. Acute tubular injury is common, although it","2021","07","08","Nat Rev Nephrol","Nature reviews. Nephrology",NA,"Koyner","Jay L","Divisions of Nephrology, Departments of Medicine, University of Chicago, Chicago, IL, USA",NA
"876","34226718","10.1038/s41581-021-00452-0","Pathophysiology of COVID-19-associated acute kidney injury.","Although respiratory failure and hypoxaemia are the main manifestations of COVID-19, kidney involvement is also common. Available evidence supports a number of potential pathophysiological pathways through which acute kidney injury (AKI) can develop in the context of SARS-CoV-2 infection. Histopathological findings have highlighted both similarities and differences between AKI in patients with COVID-19 and in those with AKI in non-COVID-related sepsis. Acute tubular injury is common, although it","2021","07","08","Nat Rev Nephrol","Nature reviews. Nephrology",NA,"Liu","Kathleen","Divisions of Nephrology and Critical Care Medicine, Departments of Medicine and Anesthesia, University of San Francisco, San Francisco, CA, USA",NA
"877","34226718","10.1038/s41581-021-00452-0","Pathophysiology of COVID-19-associated acute kidney injury.","Although respiratory failure and hypoxaemia are the main manifestations of COVID-19, kidney involvement is also common. Available evidence supports a number of potential pathophysiological pathways through which acute kidney injury (AKI) can develop in the context of SARS-CoV-2 infection. Histopathological findings have highlighted both similarities and differences between AKI in patients with COVID-19 and in those with AKI in non-COVID-related sepsis. Acute tubular injury is common, although it","2021","07","08","Nat Rev Nephrol","Nature reviews. Nephrology",NA,"Cantaluppi","Vincenzo","Nephrology and Kidney Transplantation Unit, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy",NA
"878","34226667","10.1038/s41409-021-01379-7","SARS-CoV-2 respiratory screening of asymptomatic stem cell donors on day of collection; to test or not to test. UK Aligned Stem Cell Donor Registry.",NA,"2021","07","08","Bone Marrow Transplant","Bone marrow transplantation",NA,"Pryce","Angharad","Anthony Nolan, London, UK. Angharad.pryce@anthonynolan","Angharad.pryce@anthonynolan.org"
"879","34226667","10.1038/s41409-021-01379-7","SARS-CoV-2 respiratory screening of asymptomatic stem cell donors on day of collection; to test or not to test. UK Aligned Stem Cell Donor Registry.",NA,"2021","07","08","Bone Marrow Transplant","Bone marrow transplantation",NA,"Mir","Farheen","Anthony Nolan, London, UK",NA
"880","34226667","10.1038/s41409-021-01379-7","SARS-CoV-2 respiratory screening of asymptomatic stem cell donors on day of collection; to test or not to test. UK Aligned Stem Cell Donor Registry.",NA,"2021","07","08","Bone Marrow Transplant","Bone marrow transplantation",NA,"Ushiro-Lumb","Ines","British Bone Marrow Registry, NHS Blood and Transplant, Bristol, UK",NA
"881","34226667","10.1038/s41409-021-01379-7","SARS-CoV-2 respiratory screening of asymptomatic stem cell donors on day of collection; to test or not to test. UK Aligned Stem Cell Donor Registry.",NA,"2021","07","08","Bone Marrow Transplant","Bone marrow transplantation",NA,"Drypen","Roman","DKMS UK, London, UK",NA
"882","34226667","10.1038/s41409-021-01379-7","SARS-CoV-2 respiratory screening of asymptomatic stem cell donors on day of collection; to test or not to test. UK Aligned Stem Cell Donor Registry.",NA,"2021","07","08","Bone Marrow Transplant","Bone marrow transplantation",NA,"Moss","Ellie","DKMS UK, London, UK",NA
"883","34226667","10.1038/s41409-021-01379-7","SARS-CoV-2 respiratory screening of asymptomatic stem cell donors on day of collection; to test or not to test. UK Aligned Stem Cell Donor Registry.",NA,"2021","07","08","Bone Marrow Transplant","Bone marrow transplantation",NA,"Kelly","Helen","DKMS UK, London, UK",NA
"884","34226667","10.1038/s41409-021-01379-7","SARS-CoV-2 respiratory screening of asymptomatic stem cell donors on day of collection; to test or not to test. UK Aligned Stem Cell Donor Registry.",NA,"2021","07","08","Bone Marrow Transplant","Bone marrow transplantation",NA,"O'Leary","Ann","Anthony Nolan, London, UK",NA
"885","34226667","10.1038/s41409-021-01379-7","SARS-CoV-2 respiratory screening of asymptomatic stem cell donors on day of collection; to test or not to test. UK Aligned Stem Cell Donor Registry.",NA,"2021","07","08","Bone Marrow Transplant","Bone marrow transplantation",NA,"Pawson","Rachel","British Bone Marrow Registry, NHS Blood and Transplant, Bristol, UK",NA
"886","34226667","10.1038/s41409-021-01379-7","SARS-CoV-2 respiratory screening of asymptomatic stem cell donors on day of collection; to test or not to test. UK Aligned Stem Cell Donor Registry.",NA,"2021","07","08","Bone Marrow Transplant","Bone marrow transplantation",NA,"Danby","Robert","Anthony Nolan, London, UK",NA
"887","34226649","10.1038/s41598-021-93388-1","A unifying nonlinear probabilistic epidemic model in space and time.","Covid-19 epidemic dramatically relaunched the importance of mathematical modelling in supporting governments decisions to slow down the disease propagation. On the other hand, it remains a challenging task for mathematical modelling. The interplay between different models could be a key element in the modelling strategies. Here we propose a continuous space-time non-linear probabilistic model from which we can derive many of the existing models both deterministic and stochastic as for example SI","2021","07","15","Sci Rep","Scientific reports","Algorithms; COVID-19; Computer Simulation; Humans; Models, Biological; Models, Statistical; Models, Theoretical; SARS-CoV-2; Stochastic Processes","Beneduci","Roberto","Department of Physics, University of Calabria, Rende, CS, 87036, Italy. roberto.beneduci@unical","roberto.beneduci@unical.it"
"888","34226649","10.1038/s41598-021-93388-1","A unifying nonlinear probabilistic epidemic model in space and time.","Covid-19 epidemic dramatically relaunched the importance of mathematical modelling in supporting governments decisions to slow down the disease propagation. On the other hand, it remains a challenging task for mathematical modelling. The interplay between different models could be a key element in the modelling strategies. Here we propose a continuous space-time non-linear probabilistic model from which we can derive many of the existing models both deterministic and stochastic as for example SI","2021","07","15","Sci Rep","Scientific reports","Algorithms; COVID-19; Computer Simulation; Humans; Models, Biological; Models, Statistical; Models, Theoretical; SARS-CoV-2; Stochastic Processes","Bilotta","Eleonora","Department of Physics, University of Calabria, Rende, CS, 87036, Italy",NA
"889","34226649","10.1038/s41598-021-93388-1","A unifying nonlinear probabilistic epidemic model in space and time.","Covid-19 epidemic dramatically relaunched the importance of mathematical modelling in supporting governments decisions to slow down the disease propagation. On the other hand, it remains a challenging task for mathematical modelling. The interplay between different models could be a key element in the modelling strategies. Here we propose a continuous space-time non-linear probabilistic model from which we can derive many of the existing models both deterministic and stochastic as for example SI","2021","07","15","Sci Rep","Scientific reports","Algorithms; COVID-19; Computer Simulation; Humans; Models, Biological; Models, Statistical; Models, Theoretical; SARS-CoV-2; Stochastic Processes","Pantano","Pietro","Department of Physics, University of Calabria, Rende, CS, 87036, Italy",NA
"890","34226648","10.1038/s41372-021-01136-0","Leveraging the Massachusetts perinatal quality collaborative to address the COVID-19 pandemic among diverse populations.","We leveraged the Massachusetts perinatal quality collaborative (PQC) to address the COVID-19 pandemic. Our goals were to: (1) implement perinatal practices thought to reduce mother-to-infant SARS-CoV-2 transmission while limiting disruption of health-promoting practices and (2) do so without inequities attributable to race/ethnicity, language status, and social vulnerability. Main outcomes were cesarean and preterm delivery, rooming-in, and breastfeeding. We examined changes over time overall an","2021","07","08","J Perinatol","Journal of perinatology : official journal of the California Perinatal Association",NA,"Sullivan","Katherine","Department of Pediatrics, UMass Memorial Health Center, UMass Memorial Medical School, Worcester, MA, USA. Katherine.Sullivan@umassmemorial","Katherine.Sullivan@umassmemorial.org"
"891","34226648","10.1038/s41372-021-01136-0","Leveraging the Massachusetts perinatal quality collaborative to address the COVID-19 pandemic among diverse populations.","We leveraged the Massachusetts perinatal quality collaborative (PQC) to address the COVID-19 pandemic. Our goals were to: (1) implement perinatal practices thought to reduce mother-to-infant SARS-CoV-2 transmission while limiting disruption of health-promoting practices and (2) do so without inequities attributable to race/ethnicity, language status, and social vulnerability. Main outcomes were cesarean and preterm delivery, rooming-in, and breastfeeding. We examined changes over time overall an","2021","07","08","J Perinatol","Journal of perinatology : official journal of the California Perinatal Association",NA,"Belfort","Mandy B","Department of Pediatric Newborn Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA",NA
"892","34226648","10.1038/s41372-021-01136-0","Leveraging the Massachusetts perinatal quality collaborative to address the COVID-19 pandemic among diverse populations.","We leveraged the Massachusetts perinatal quality collaborative (PQC) to address the COVID-19 pandemic. Our goals were to: (1) implement perinatal practices thought to reduce mother-to-infant SARS-CoV-2 transmission while limiting disruption of health-promoting practices and (2) do so without inequities attributable to race/ethnicity, language status, and social vulnerability. Main outcomes were cesarean and preterm delivery, rooming-in, and breastfeeding. We examined changes over time overall an","2021","07","08","J Perinatol","Journal of perinatology : official journal of the California Perinatal Association",NA,"Melvin","Patrice","Center for Applied Pediatric Quality Analytics, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA",NA
"893","34226648","10.1038/s41372-021-01136-0","Leveraging the Massachusetts perinatal quality collaborative to address the COVID-19 pandemic among diverse populations.","We leveraged the Massachusetts perinatal quality collaborative (PQC) to address the COVID-19 pandemic. Our goals were to: (1) implement perinatal practices thought to reduce mother-to-infant SARS-CoV-2 transmission while limiting disruption of health-promoting practices and (2) do so without inequities attributable to race/ethnicity, language status, and social vulnerability. Main outcomes were cesarean and preterm delivery, rooming-in, and breastfeeding. We examined changes over time overall an","2021","07","08","J Perinatol","Journal of perinatology : official journal of the California Perinatal Association",NA,"Angelidou","Asimenia","Department of Neonatology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA",NA
"894","34226648","10.1038/s41372-021-01136-0","Leveraging the Massachusetts perinatal quality collaborative to address the COVID-19 pandemic among diverse populations.","We leveraged the Massachusetts perinatal quality collaborative (PQC) to address the COVID-19 pandemic. Our goals were to: (1) implement perinatal practices thought to reduce mother-to-infant SARS-CoV-2 transmission while limiting disruption of health-promoting practices and (2) do so without inequities attributable to race/ethnicity, language status, and social vulnerability. Main outcomes were cesarean and preterm delivery, rooming-in, and breastfeeding. We examined changes over time overall an","2021","07","08","J Perinatol","Journal of perinatology : official journal of the California Perinatal Association",NA,"Peaceman","Aviel","Department of Pediatrics, Boston Medical Center, Boston University School of Medicine, Boston, MA, USA",NA
"895","34226648","10.1038/s41372-021-01136-0","Leveraging the Massachusetts perinatal quality collaborative to address the COVID-19 pandemic among diverse populations.","We leveraged the Massachusetts perinatal quality collaborative (PQC) to address the COVID-19 pandemic. Our goals were to: (1) implement perinatal practices thought to reduce mother-to-infant SARS-CoV-2 transmission while limiting disruption of health-promoting practices and (2) do so without inequities attributable to race/ethnicity, language status, and social vulnerability. Main outcomes were cesarean and preterm delivery, rooming-in, and breastfeeding. We examined changes over time overall an","2021","07","08","J Perinatol","Journal of perinatology : official journal of the California Perinatal Association",NA,"Shui","Jessica E","Department of Pediatrics, Division of Neonatology and Newborn Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA",NA
"896","34226648","10.1038/s41372-021-01136-0","Leveraging the Massachusetts perinatal quality collaborative to address the COVID-19 pandemic among diverse populations.","We leveraged the Massachusetts perinatal quality collaborative (PQC) to address the COVID-19 pandemic. Our goals were to: (1) implement perinatal practices thought to reduce mother-to-infant SARS-CoV-2 transmission while limiting disruption of health-promoting practices and (2) do so without inequities attributable to race/ethnicity, language status, and social vulnerability. Main outcomes were cesarean and preterm delivery, rooming-in, and breastfeeding. We examined changes over time overall an","2021","07","08","J Perinatol","Journal of perinatology : official journal of the California Perinatal Association",NA,"Vaidya","Ruben","Department of Pediatrics, University of Massachusetts Medical Center-Baystate, Springfield, MA, USA",NA
"897","34226648","10.1038/s41372-021-01136-0","Leveraging the Massachusetts perinatal quality collaborative to address the COVID-19 pandemic among diverse populations.","We leveraged the Massachusetts perinatal quality collaborative (PQC) to address the COVID-19 pandemic. Our goals were to: (1) implement perinatal practices thought to reduce mother-to-infant SARS-CoV-2 transmission while limiting disruption of health-promoting practices and (2) do so without inequities attributable to race/ethnicity, language status, and social vulnerability. Main outcomes were cesarean and preterm delivery, rooming-in, and breastfeeding. We examined changes over time overall an","2021","07","08","J Perinatol","Journal of perinatology : official journal of the California Perinatal Association",NA,"Singh","Rachana","Department of Pediatrics, University of Massachusetts Medical Center-Baystate, Springfield, MA, USA",NA
"898","34226648","10.1038/s41372-021-01136-0","Leveraging the Massachusetts perinatal quality collaborative to address the COVID-19 pandemic among diverse populations.","We leveraged the Massachusetts perinatal quality collaborative (PQC) to address the COVID-19 pandemic. Our goals were to: (1) implement perinatal practices thought to reduce mother-to-infant SARS-CoV-2 transmission while limiting disruption of health-promoting practices and (2) do so without inequities attributable to race/ethnicity, language status, and social vulnerability. Main outcomes were cesarean and preterm delivery, rooming-in, and breastfeeding. We examined changes over time overall an","2021","07","08","J Perinatol","Journal of perinatology : official journal of the California Perinatal Association",NA,"Bartolome","Ruby","Department of Pediatrics, Boston Medical Center, Boston University School of Medicine, Boston, MA, USA",NA
"899","34226648","10.1038/s41372-021-01136-0","Leveraging the Massachusetts perinatal quality collaborative to address the COVID-19 pandemic among diverse populations.","We leveraged the Massachusetts perinatal quality collaborative (PQC) to address the COVID-19 pandemic. Our goals were to: (1) implement perinatal practices thought to reduce mother-to-infant SARS-CoV-2 transmission while limiting disruption of health-promoting practices and (2) do so without inequities attributable to race/ethnicity, language status, and social vulnerability. Main outcomes were cesarean and preterm delivery, rooming-in, and breastfeeding. We examined changes over time overall an","2021","07","08","J Perinatol","Journal of perinatology : official journal of the California Perinatal Association",NA,"Patrizi","Silvia","Department of Pediatric Newborn Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA",NA
"900","34226648","10.1038/s41372-021-01136-0","Leveraging the Massachusetts perinatal quality collaborative to address the COVID-19 pandemic among diverse populations.","We leveraged the Massachusetts perinatal quality collaborative (PQC) to address the COVID-19 pandemic. Our goals were to: (1) implement perinatal practices thought to reduce mother-to-infant SARS-CoV-2 transmission while limiting disruption of health-promoting practices and (2) do so without inequities attributable to race/ethnicity, language status, and social vulnerability. Main outcomes were cesarean and preterm delivery, rooming-in, and breastfeeding. We examined changes over time overall an","2021","07","08","J Perinatol","Journal of perinatology : official journal of the California Perinatal Association",NA,"Chaudhary","Neha","Department of Neonatology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA",NA
"901","34226648","10.1038/s41372-021-01136-0","Leveraging the Massachusetts perinatal quality collaborative to address the COVID-19 pandemic among diverse populations.","We leveraged the Massachusetts perinatal quality collaborative (PQC) to address the COVID-19 pandemic. Our goals were to: (1) implement perinatal practices thought to reduce mother-to-infant SARS-CoV-2 transmission while limiting disruption of health-promoting practices and (2) do so without inequities attributable to race/ethnicity, language status, and social vulnerability. Main outcomes were cesarean and preterm delivery, rooming-in, and breastfeeding. We examined changes over time overall an","2021","07","08","J Perinatol","Journal of perinatology : official journal of the California Perinatal Association",NA,"Goldfarb","Ilona Telefus","Deparatment of Obstetrics and Gynecology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA",NA
"902","34226648","10.1038/s41372-021-01136-0","Leveraging the Massachusetts perinatal quality collaborative to address the COVID-19 pandemic among diverse populations.","We leveraged the Massachusetts perinatal quality collaborative (PQC) to address the COVID-19 pandemic. Our goals were to: (1) implement perinatal practices thought to reduce mother-to-infant SARS-CoV-2 transmission while limiting disruption of health-promoting practices and (2) do so without inequities attributable to race/ethnicity, language status, and social vulnerability. Main outcomes were cesarean and preterm delivery, rooming-in, and breastfeeding. We examined changes over time overall an","2021","07","08","J Perinatol","Journal of perinatology : official journal of the California Perinatal Association",NA,"Culic","Ivana","Department of Neonatology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA",NA
"903","34226648","10.1038/s41372-021-01136-0","Leveraging the Massachusetts perinatal quality collaborative to address the COVID-19 pandemic among diverse populations.","We leveraged the Massachusetts perinatal quality collaborative (PQC) to address the COVID-19 pandemic. Our goals were to: (1) implement perinatal practices thought to reduce mother-to-infant SARS-CoV-2 transmission while limiting disruption of health-promoting practices and (2) do so without inequities attributable to race/ethnicity, language status, and social vulnerability. Main outcomes were cesarean and preterm delivery, rooming-in, and breastfeeding. We examined changes over time overall an","2021","07","08","J Perinatol","Journal of perinatology : official journal of the California Perinatal Association",NA,"Yanni","Diana","Department of Neonatology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA",NA
"904","34226648","10.1038/s41372-021-01136-0","Leveraging the Massachusetts perinatal quality collaborative to address the COVID-19 pandemic among diverse populations.","We leveraged the Massachusetts perinatal quality collaborative (PQC) to address the COVID-19 pandemic. Our goals were to: (1) implement perinatal practices thought to reduce mother-to-infant SARS-CoV-2 transmission while limiting disruption of health-promoting practices and (2) do so without inequities attributable to race/ethnicity, language status, and social vulnerability. Main outcomes were cesarean and preterm delivery, rooming-in, and breastfeeding. We examined changes over time overall an","2021","07","08","J Perinatol","Journal of perinatology : official journal of the California Perinatal Association",NA,"Gupta","Munish","Department of Neonatology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA",NA
"905","34226648","10.1038/s41372-021-01136-0","Leveraging the Massachusetts perinatal quality collaborative to address the COVID-19 pandemic among diverse populations.","We leveraged the Massachusetts perinatal quality collaborative (PQC) to address the COVID-19 pandemic. Our goals were to: (1) implement perinatal practices thought to reduce mother-to-infant SARS-CoV-2 transmission while limiting disruption of health-promoting practices and (2) do so without inequities attributable to race/ethnicity, language status, and social vulnerability. Main outcomes were cesarean and preterm delivery, rooming-in, and breastfeeding. We examined changes over time overall an","2021","07","08","J Perinatol","Journal of perinatology : official journal of the California Perinatal Association",NA,"Hudak","Mark","Department of Pediatrics, University of Florida Health, University of Florida College of Medicine, Jacksonville, FL, USA",NA
"906","34226648","10.1038/s41372-021-01136-0","Leveraging the Massachusetts perinatal quality collaborative to address the COVID-19 pandemic among diverse populations.","We leveraged the Massachusetts perinatal quality collaborative (PQC) to address the COVID-19 pandemic. Our goals were to: (1) implement perinatal practices thought to reduce mother-to-infant SARS-CoV-2 transmission while limiting disruption of health-promoting practices and (2) do so without inequities attributable to race/ethnicity, language status, and social vulnerability. Main outcomes were cesarean and preterm delivery, rooming-in, and breastfeeding. We examined changes over time overall an","2021","07","08","J Perinatol","Journal of perinatology : official journal of the California Perinatal Association",NA,"Parker","Margaret G","Department of Pediatrics, Boston Medical Center, Boston University School of Medicine, Boston, MA, USA",NA
"907","34226646","10.1038/s41598-021-93366-7","Critical fluctuations in epidemic models explain COVID-19 post-lockdown dynamics.","As the COVID-19 pandemic progressed, research on mathematical modeling became imperative and very influential to understand the epidemiological dynamics of disease spreading. The momentary reproduction ratio r(t) of an epidemic is used as a public health guiding tool to evaluate the course of the epidemic, with the evolution of r(t) being the reasoning behind tightening and relaxing control measures over time. Here we investigate critical fluctuations around the epidemiological threshold, resemb","2021","07","15","Sci Rep","Scientific reports","Basic Reproduction Number; COVID-19; Communicable Disease Control; Computer Simulation; Epidemics; Humans; Models, Biological; Models, Theoretical; Public Health; SARS-CoV-2","Aguiar","Maíra","Basque Center for Applied Mathematics (BCAM), Alameda Mazarredo, 14, 48009, Bilbao, Spain. maguiar@bcamath","maguiar@bcamath.org"
"908","34226646","10.1038/s41598-021-93366-7","Critical fluctuations in epidemic models explain COVID-19 post-lockdown dynamics.","As the COVID-19 pandemic progressed, research on mathematical modeling became imperative and very influential to understand the epidemiological dynamics of disease spreading. The momentary reproduction ratio r(t) of an epidemic is used as a public health guiding tool to evaluate the course of the epidemic, with the evolution of r(t) being the reasoning behind tightening and relaxing control measures over time. Here we investigate critical fluctuations around the epidemiological threshold, resemb","2021","07","15","Sci Rep","Scientific reports","Basic Reproduction Number; COVID-19; Communicable Disease Control; Computer Simulation; Epidemics; Humans; Models, Biological; Models, Theoretical; Public Health; SARS-CoV-2","Van-Dierdonck","Joseba Bidaurrazaga","Public Health, Basque Health Department, Rekalde Zumarkalea 39A, 48008, Bilbao, Spain",NA
"909","34226646","10.1038/s41598-021-93366-7","Critical fluctuations in epidemic models explain COVID-19 post-lockdown dynamics.","As the COVID-19 pandemic progressed, research on mathematical modeling became imperative and very influential to understand the epidemiological dynamics of disease spreading. The momentary reproduction ratio r(t) of an epidemic is used as a public health guiding tool to evaluate the course of the epidemic, with the evolution of r(t) being the reasoning behind tightening and relaxing control measures over time. Here we investigate critical fluctuations around the epidemiological threshold, resemb","2021","07","15","Sci Rep","Scientific reports","Basic Reproduction Number; COVID-19; Communicable Disease Control; Computer Simulation; Epidemics; Humans; Models, Biological; Models, Theoretical; Public Health; SARS-CoV-2","Mar","Javier","Osakidetza Basque Health Service, Debagoiena Integrated Healthcare Organisation, Research Unit, Arrasate-Mondragón, Guipúzcoa, Spain",NA
"910","34226646","10.1038/s41598-021-93366-7","Critical fluctuations in epidemic models explain COVID-19 post-lockdown dynamics.","As the COVID-19 pandemic progressed, research on mathematical modeling became imperative and very influential to understand the epidemiological dynamics of disease spreading. The momentary reproduction ratio r(t) of an epidemic is used as a public health guiding tool to evaluate the course of the epidemic, with the evolution of r(t) being the reasoning behind tightening and relaxing control measures over time. Here we investigate critical fluctuations around the epidemiological threshold, resemb","2021","07","15","Sci Rep","Scientific reports","Basic Reproduction Number; COVID-19; Communicable Disease Control; Computer Simulation; Epidemics; Humans; Models, Biological; Models, Theoretical; Public Health; SARS-CoV-2","Cusimano","Nicole","Basque Center for Applied Mathematics (BCAM), Alameda Mazarredo, 14, 48009, Bilbao, Spain",NA
"911","34226646","10.1038/s41598-021-93366-7","Critical fluctuations in epidemic models explain COVID-19 post-lockdown dynamics.","As the COVID-19 pandemic progressed, research on mathematical modeling became imperative and very influential to understand the epidemiological dynamics of disease spreading. The momentary reproduction ratio r(t) of an epidemic is used as a public health guiding tool to evaluate the course of the epidemic, with the evolution of r(t) being the reasoning behind tightening and relaxing control measures over time. Here we investigate critical fluctuations around the epidemiological threshold, resemb","2021","07","15","Sci Rep","Scientific reports","Basic Reproduction Number; COVID-19; Communicable Disease Control; Computer Simulation; Epidemics; Humans; Models, Biological; Models, Theoretical; Public Health; SARS-CoV-2","Knopoff","Damián","Basque Center for Applied Mathematics (BCAM), Alameda Mazarredo, 14, 48009, Bilbao, Spain",NA
"912","34226646","10.1038/s41598-021-93366-7","Critical fluctuations in epidemic models explain COVID-19 post-lockdown dynamics.","As the COVID-19 pandemic progressed, research on mathematical modeling became imperative and very influential to understand the epidemiological dynamics of disease spreading. The momentary reproduction ratio r(t) of an epidemic is used as a public health guiding tool to evaluate the course of the epidemic, with the evolution of r(t) being the reasoning behind tightening and relaxing control measures over time. Here we investigate critical fluctuations around the epidemiological threshold, resemb","2021","07","15","Sci Rep","Scientific reports","Basic Reproduction Number; COVID-19; Communicable Disease Control; Computer Simulation; Epidemics; Humans; Models, Biological; Models, Theoretical; Public Health; SARS-CoV-2","Anam","Vizda","Basque Center for Applied Mathematics (BCAM), Alameda Mazarredo, 14, 48009, Bilbao, Spain",NA
"913","34226646","10.1038/s41598-021-93366-7","Critical fluctuations in epidemic models explain COVID-19 post-lockdown dynamics.","As the COVID-19 pandemic progressed, research on mathematical modeling became imperative and very influential to understand the epidemiological dynamics of disease spreading. The momentary reproduction ratio r(t) of an epidemic is used as a public health guiding tool to evaluate the course of the epidemic, with the evolution of r(t) being the reasoning behind tightening and relaxing control measures over time. Here we investigate critical fluctuations around the epidemiological threshold, resemb","2021","07","15","Sci Rep","Scientific reports","Basic Reproduction Number; COVID-19; Communicable Disease Control; Computer Simulation; Epidemics; Humans; Models, Biological; Models, Theoretical; Public Health; SARS-CoV-2","Stollenwerk","Nico","Basque Center for Applied Mathematics (BCAM), Alameda Mazarredo, 14, 48009, Bilbao, Spain",NA
"914","34226623","10.1038/s41598-021-93231-7","UVC disinfects SARS-CoV-2 by induction of viral genome damage without apparent effects on viral morphology and proteins.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been a pandemic threat worldwide and causes severe health and economic burdens. Contaminated environments, such as personal items and room surfaces, are considered to have virus transmission potential. Ultraviolet C (UVC) light has demonstrated germicidal ability and removes environmental contamination. UVC has inactivated SARS-CoV-2; however, the underlying mechanisms are not clear. It was confirmed here that UVC 253.7 nm, with a ","2021","07","15","Sci Rep","Scientific reports","Animals; COVID-19; Chlorocebus aethiops; Disinfection; Genome, Viral; Nucleocapsid Proteins; RNA, Viral; SARS-CoV-2; Ultraviolet Rays; Vero Cells; Virus Inactivation","Lo","Chieh-Wen","Laboratory of Global Infectious Diseases Control Science, Graduate School of Agricultural and Life Sciences, the University of Tokyo, 1-1-1 Yayoi, Bunkyo-ku, Tokyo, 113-8657, Japan",NA
"915","34226623","10.1038/s41598-021-93231-7","UVC disinfects SARS-CoV-2 by induction of viral genome damage without apparent effects on viral morphology and proteins.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been a pandemic threat worldwide and causes severe health and economic burdens. Contaminated environments, such as personal items and room surfaces, are considered to have virus transmission potential. Ultraviolet C (UVC) light has demonstrated germicidal ability and removes environmental contamination. UVC has inactivated SARS-CoV-2; however, the underlying mechanisms are not clear. It was confirmed here that UVC 253.7 nm, with a ","2021","07","15","Sci Rep","Scientific reports","Animals; COVID-19; Chlorocebus aethiops; Disinfection; Genome, Viral; Nucleocapsid Proteins; RNA, Viral; SARS-CoV-2; Ultraviolet Rays; Vero Cells; Virus Inactivation","Matsuura","Ryosuke","Laboratory of Global Infectious Diseases Control Science, Graduate School of Agricultural and Life Sciences, the University of Tokyo, 1-1-1 Yayoi, Bunkyo-ku, Tokyo, 113-8657, Japan",NA
"916","34226623","10.1038/s41598-021-93231-7","UVC disinfects SARS-CoV-2 by induction of viral genome damage without apparent effects on viral morphology and proteins.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been a pandemic threat worldwide and causes severe health and economic burdens. Contaminated environments, such as personal items and room surfaces, are considered to have virus transmission potential. Ultraviolet C (UVC) light has demonstrated germicidal ability and removes environmental contamination. UVC has inactivated SARS-CoV-2; however, the underlying mechanisms are not clear. It was confirmed here that UVC 253.7 nm, with a ","2021","07","15","Sci Rep","Scientific reports","Animals; COVID-19; Chlorocebus aethiops; Disinfection; Genome, Viral; Nucleocapsid Proteins; RNA, Viral; SARS-CoV-2; Ultraviolet Rays; Vero Cells; Virus Inactivation","Iimura","Kazuki","Division of Hematology and Rheumatology, Department of Medicine, Nihon University School of Medicine, 30-1 Oyaguchi, Kami-Cho, Itabashi, Tokyo, 173-8610, Japan",NA
"917","34226623","10.1038/s41598-021-93231-7","UVC disinfects SARS-CoV-2 by induction of viral genome damage without apparent effects on viral morphology and proteins.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been a pandemic threat worldwide and causes severe health and economic burdens. Contaminated environments, such as personal items and room surfaces, are considered to have virus transmission potential. Ultraviolet C (UVC) light has demonstrated germicidal ability and removes environmental contamination. UVC has inactivated SARS-CoV-2; however, the underlying mechanisms are not clear. It was confirmed here that UVC 253.7 nm, with a ","2021","07","15","Sci Rep","Scientific reports","Animals; COVID-19; Chlorocebus aethiops; Disinfection; Genome, Viral; Nucleocapsid Proteins; RNA, Viral; SARS-CoV-2; Ultraviolet Rays; Vero Cells; Virus Inactivation","Wada","Satoshi","Division of Hematology and Rheumatology, Department of Medicine, Nihon University School of Medicine, 30-1 Oyaguchi, Kami-Cho, Itabashi, Tokyo, 173-8610, Japan",NA
"918","34226623","10.1038/s41598-021-93231-7","UVC disinfects SARS-CoV-2 by induction of viral genome damage without apparent effects on viral morphology and proteins.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been a pandemic threat worldwide and causes severe health and economic burdens. Contaminated environments, such as personal items and room surfaces, are considered to have virus transmission potential. Ultraviolet C (UVC) light has demonstrated germicidal ability and removes environmental contamination. UVC has inactivated SARS-CoV-2; however, the underlying mechanisms are not clear. It was confirmed here that UVC 253.7 nm, with a ","2021","07","15","Sci Rep","Scientific reports","Animals; COVID-19; Chlorocebus aethiops; Disinfection; Genome, Viral; Nucleocapsid Proteins; RNA, Viral; SARS-CoV-2; Ultraviolet Rays; Vero Cells; Virus Inactivation","Shinjo","Atsushi","Photonics Control Technology Team, RIKEN Center for Advanced Photonics, 2-1 Hirosawa, Wako, Saitama, 351-0198, Japan",NA
"919","34226623","10.1038/s41598-021-93231-7","UVC disinfects SARS-CoV-2 by induction of viral genome damage without apparent effects on viral morphology and proteins.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been a pandemic threat worldwide and causes severe health and economic burdens. Contaminated environments, such as personal items and room surfaces, are considered to have virus transmission potential. Ultraviolet C (UVC) light has demonstrated germicidal ability and removes environmental contamination. UVC has inactivated SARS-CoV-2; however, the underlying mechanisms are not clear. It was confirmed here that UVC 253.7 nm, with a ","2021","07","15","Sci Rep","Scientific reports","Animals; COVID-19; Chlorocebus aethiops; Disinfection; Genome, Viral; Nucleocapsid Proteins; RNA, Viral; SARS-CoV-2; Ultraviolet Rays; Vero Cells; Virus Inactivation","Benno","Yoshimi","Benno Laboratory, Baton Zone Program, RIKEN Cluster for Science, Technology and Innovation Hub, 2-1 Hirosawa, Wako, Saitama, 351-0198, Japan",NA
"920","34226623","10.1038/s41598-021-93231-7","UVC disinfects SARS-CoV-2 by induction of viral genome damage without apparent effects on viral morphology and proteins.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been a pandemic threat worldwide and causes severe health and economic burdens. Contaminated environments, such as personal items and room surfaces, are considered to have virus transmission potential. Ultraviolet C (UVC) light has demonstrated germicidal ability and removes environmental contamination. UVC has inactivated SARS-CoV-2; however, the underlying mechanisms are not clear. It was confirmed here that UVC 253.7 nm, with a ","2021","07","15","Sci Rep","Scientific reports","Animals; COVID-19; Chlorocebus aethiops; Disinfection; Genome, Viral; Nucleocapsid Proteins; RNA, Viral; SARS-CoV-2; Ultraviolet Rays; Vero Cells; Virus Inactivation","Nakagawa","Masaru","Division of Hematology and Rheumatology, Department of Medicine, Nihon University School of Medicine, 30-1 Oyaguchi, Kami-Cho, Itabashi, Tokyo, 173-8610, Japan",NA
"921","34226623","10.1038/s41598-021-93231-7","UVC disinfects SARS-CoV-2 by induction of viral genome damage without apparent effects on viral morphology and proteins.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been a pandemic threat worldwide and causes severe health and economic burdens. Contaminated environments, such as personal items and room surfaces, are considered to have virus transmission potential. Ultraviolet C (UVC) light has demonstrated germicidal ability and removes environmental contamination. UVC has inactivated SARS-CoV-2; however, the underlying mechanisms are not clear. It was confirmed here that UVC 253.7 nm, with a ","2021","07","15","Sci Rep","Scientific reports","Animals; COVID-19; Chlorocebus aethiops; Disinfection; Genome, Viral; Nucleocapsid Proteins; RNA, Viral; SARS-CoV-2; Ultraviolet Rays; Vero Cells; Virus Inactivation","Takei","Masami","Division of Hematology and Rheumatology, Department of Medicine, Nihon University School of Medicine, 30-1 Oyaguchi, Kami-Cho, Itabashi, Tokyo, 173-8610, Japan",NA
"922","34226623","10.1038/s41598-021-93231-7","UVC disinfects SARS-CoV-2 by induction of viral genome damage without apparent effects on viral morphology and proteins.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been a pandemic threat worldwide and causes severe health and economic burdens. Contaminated environments, such as personal items and room surfaces, are considered to have virus transmission potential. Ultraviolet C (UVC) light has demonstrated germicidal ability and removes environmental contamination. UVC has inactivated SARS-CoV-2; however, the underlying mechanisms are not clear. It was confirmed here that UVC 253.7 nm, with a ","2021","07","15","Sci Rep","Scientific reports","Animals; COVID-19; Chlorocebus aethiops; Disinfection; Genome, Viral; Nucleocapsid Proteins; RNA, Viral; SARS-CoV-2; Ultraviolet Rays; Vero Cells; Virus Inactivation","Aida","Yoko","Laboratory of Global Infectious Diseases Control Science, Graduate School of Agricultural and Life Sciences, the University of Tokyo, 1-1-1 Yayoi, Bunkyo-ku, Tokyo, 113-8657, Japan. aida@riken","aida@riken.jp"
"923","34226622","10.1038/s41598-021-93260-2","Understanding protection from SARS-CoV-2 using metabolomics.","The COVID-19 pandemic is still raging in most countries. Although the recent mass vaccination campaign has opened a new chapter in the battle against SARS-CoV-2, the world is still far from herd immunity. There is an urgent need to identify healthy people at high risk of contracting COVID-19, as well as supplements and nutraceuticals that can reduce the risk of infection or mitigate symptoms. In the present study, a metabolic phenotype that could protect individuals from SARS-CoV-2 infection or ","2021","07","15","Sci Rep","Scientific reports","Antiviral Agents; COVID-19; Disease Outbreaks; Health Personnel; Humans; Immunity, Herd; Italy; Metabolomics; SARS-CoV-2","Barberis","Elettra","Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy",NA
"924","34226622","10.1038/s41598-021-93260-2","Understanding protection from SARS-CoV-2 using metabolomics.","The COVID-19 pandemic is still raging in most countries. Although the recent mass vaccination campaign has opened a new chapter in the battle against SARS-CoV-2, the world is still far from herd immunity. There is an urgent need to identify healthy people at high risk of contracting COVID-19, as well as supplements and nutraceuticals that can reduce the risk of infection or mitigate symptoms. In the present study, a metabolic phenotype that could protect individuals from SARS-CoV-2 infection or ","2021","07","15","Sci Rep","Scientific reports","Antiviral Agents; COVID-19; Disease Outbreaks; Health Personnel; Humans; Immunity, Herd; Italy; Metabolomics; SARS-CoV-2","Amede","Elia","Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy",NA
"925","34226622","10.1038/s41598-021-93260-2","Understanding protection from SARS-CoV-2 using metabolomics.","The COVID-19 pandemic is still raging in most countries. Although the recent mass vaccination campaign has opened a new chapter in the battle against SARS-CoV-2, the world is still far from herd immunity. There is an urgent need to identify healthy people at high risk of contracting COVID-19, as well as supplements and nutraceuticals that can reduce the risk of infection or mitigate symptoms. In the present study, a metabolic phenotype that could protect individuals from SARS-CoV-2 infection or ","2021","07","15","Sci Rep","Scientific reports","Antiviral Agents; COVID-19; Disease Outbreaks; Health Personnel; Humans; Immunity, Herd; Italy; Metabolomics; SARS-CoV-2","Tavecchia","Matteo","Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy",NA
"926","34226622","10.1038/s41598-021-93260-2","Understanding protection from SARS-CoV-2 using metabolomics.","The COVID-19 pandemic is still raging in most countries. Although the recent mass vaccination campaign has opened a new chapter in the battle against SARS-CoV-2, the world is still far from herd immunity. There is an urgent need to identify healthy people at high risk of contracting COVID-19, as well as supplements and nutraceuticals that can reduce the risk of infection or mitigate symptoms. In the present study, a metabolic phenotype that could protect individuals from SARS-CoV-2 infection or ","2021","07","15","Sci Rep","Scientific reports","Antiviral Agents; COVID-19; Disease Outbreaks; Health Personnel; Humans; Immunity, Herd; Italy; Metabolomics; SARS-CoV-2","Marengo","Emilio","Center for Translational Research on Autoimmune and Allergic Diseases, University of Piemonte Orientale, Novara, Italy",NA
"927","34226622","10.1038/s41598-021-93260-2","Understanding protection from SARS-CoV-2 using metabolomics.","The COVID-19 pandemic is still raging in most countries. Although the recent mass vaccination campaign has opened a new chapter in the battle against SARS-CoV-2, the world is still far from herd immunity. There is an urgent need to identify healthy people at high risk of contracting COVID-19, as well as supplements and nutraceuticals that can reduce the risk of infection or mitigate symptoms. In the present study, a metabolic phenotype that could protect individuals from SARS-CoV-2 infection or ","2021","07","15","Sci Rep","Scientific reports","Antiviral Agents; COVID-19; Disease Outbreaks; Health Personnel; Humans; Immunity, Herd; Italy; Metabolomics; SARS-CoV-2","Cittone","Micol G","Internal and Emergency Medicine Departments, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy",NA
"928","34226622","10.1038/s41598-021-93260-2","Understanding protection from SARS-CoV-2 using metabolomics.","The COVID-19 pandemic is still raging in most countries. Although the recent mass vaccination campaign has opened a new chapter in the battle against SARS-CoV-2, the world is still far from herd immunity. There is an urgent need to identify healthy people at high risk of contracting COVID-19, as well as supplements and nutraceuticals that can reduce the risk of infection or mitigate symptoms. In the present study, a metabolic phenotype that could protect individuals from SARS-CoV-2 infection or ","2021","07","15","Sci Rep","Scientific reports","Antiviral Agents; COVID-19; Disease Outbreaks; Health Personnel; Humans; Immunity, Herd; Italy; Metabolomics; SARS-CoV-2","Rizzi","Eleonora","Internal and Emergency Medicine Departments, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy",NA
"929","34226622","10.1038/s41598-021-93260-2","Understanding protection from SARS-CoV-2 using metabolomics.","The COVID-19 pandemic is still raging in most countries. Although the recent mass vaccination campaign has opened a new chapter in the battle against SARS-CoV-2, the world is still far from herd immunity. There is an urgent need to identify healthy people at high risk of contracting COVID-19, as well as supplements and nutraceuticals that can reduce the risk of infection or mitigate symptoms. In the present study, a metabolic phenotype that could protect individuals from SARS-CoV-2 infection or ","2021","07","15","Sci Rep","Scientific reports","Antiviral Agents; COVID-19; Disease Outbreaks; Health Personnel; Humans; Immunity, Herd; Italy; Metabolomics; SARS-CoV-2","Pedrinelli","Anita R","Internal and Emergency Medicine Departments, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy",NA
"930","34226622","10.1038/s41598-021-93260-2","Understanding protection from SARS-CoV-2 using metabolomics.","The COVID-19 pandemic is still raging in most countries. Although the recent mass vaccination campaign has opened a new chapter in the battle against SARS-CoV-2, the world is still far from herd immunity. There is an urgent need to identify healthy people at high risk of contracting COVID-19, as well as supplements and nutraceuticals that can reduce the risk of infection or mitigate symptoms. In the present study, a metabolic phenotype that could protect individuals from SARS-CoV-2 infection or ","2021","07","15","Sci Rep","Scientific reports","Antiviral Agents; COVID-19; Disease Outbreaks; Health Personnel; Humans; Immunity, Herd; Italy; Metabolomics; SARS-CoV-2","Tonello","Stelvio","Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy",NA
"931","34226622","10.1038/s41598-021-93260-2","Understanding protection from SARS-CoV-2 using metabolomics.","The COVID-19 pandemic is still raging in most countries. Although the recent mass vaccination campaign has opened a new chapter in the battle against SARS-CoV-2, the world is still far from herd immunity. There is an urgent need to identify healthy people at high risk of contracting COVID-19, as well as supplements and nutraceuticals that can reduce the risk of infection or mitigate symptoms. In the present study, a metabolic phenotype that could protect individuals from SARS-CoV-2 infection or ","2021","07","15","Sci Rep","Scientific reports","Antiviral Agents; COVID-19; Disease Outbreaks; Health Personnel; Humans; Immunity, Herd; Italy; Metabolomics; SARS-CoV-2","Minisini","Rosalba","Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy",NA
"932","34226622","10.1038/s41598-021-93260-2","Understanding protection from SARS-CoV-2 using metabolomics.","The COVID-19 pandemic is still raging in most countries. Although the recent mass vaccination campaign has opened a new chapter in the battle against SARS-CoV-2, the world is still far from herd immunity. There is an urgent need to identify healthy people at high risk of contracting COVID-19, as well as supplements and nutraceuticals that can reduce the risk of infection or mitigate symptoms. In the present study, a metabolic phenotype that could protect individuals from SARS-CoV-2 infection or ","2021","07","15","Sci Rep","Scientific reports","Antiviral Agents; COVID-19; Disease Outbreaks; Health Personnel; Humans; Immunity, Herd; Italy; Metabolomics; SARS-CoV-2","Pirisi","Mario","Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy",NA
"933","34226622","10.1038/s41598-021-93260-2","Understanding protection from SARS-CoV-2 using metabolomics.","The COVID-19 pandemic is still raging in most countries. Although the recent mass vaccination campaign has opened a new chapter in the battle against SARS-CoV-2, the world is still far from herd immunity. There is an urgent need to identify healthy people at high risk of contracting COVID-19, as well as supplements and nutraceuticals that can reduce the risk of infection or mitigate symptoms. In the present study, a metabolic phenotype that could protect individuals from SARS-CoV-2 infection or ","2021","07","15","Sci Rep","Scientific reports","Antiviral Agents; COVID-19; Disease Outbreaks; Health Personnel; Humans; Immunity, Herd; Italy; Metabolomics; SARS-CoV-2","Manfredi","Marcello","Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy. marcello.manfredi@uniupo","marcello.manfredi@uniupo.it"
"934","34226622","10.1038/s41598-021-93260-2","Understanding protection from SARS-CoV-2 using metabolomics.","The COVID-19 pandemic is still raging in most countries. Although the recent mass vaccination campaign has opened a new chapter in the battle against SARS-CoV-2, the world is still far from herd immunity. There is an urgent need to identify healthy people at high risk of contracting COVID-19, as well as supplements and nutraceuticals that can reduce the risk of infection or mitigate symptoms. In the present study, a metabolic phenotype that could protect individuals from SARS-CoV-2 infection or ","2021","07","15","Sci Rep","Scientific reports","Antiviral Agents; COVID-19; Disease Outbreaks; Health Personnel; Humans; Immunity, Herd; Italy; Metabolomics; SARS-CoV-2","Sainaghi","Pier Paolo","Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy",NA
"935","34226597","10.1038/s41598-021-93191-y","Eight months follow-up study on pulmonary function, lung radiographic, and related physiological characteristics in COVID-19 survivors.","To describe the long-term health outcomes of patients with COVID-19 and investigate the potential risk factors. Clinical data during hospitalization and at a mean (SD) day of 249 (15) days after discharge from 40 survivors with confirmed COVID-19 (including 25 severe cases) were collected and analyzed retrospectively. At follow-up, severe cases had higher incidences of persistent symptoms, DLCO impairment, and higher abnormal CT score as compared with mild cases. CT score at follow-up was positi","2021","07","15","Sci Rep","Scientific reports","Adult; Aged; COVID-19; Follow-Up Studies; Humans; Lung; Male; Middle Aged; Respiration Disorders; Respiratory Physiological Phenomena; Retrospective Studies; SARS-CoV-2; Survivors","Zhang","Shengding","Department of Respiratory and Critical Care MedicineTongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China",NA
"936","34226597","10.1038/s41598-021-93191-y","Eight months follow-up study on pulmonary function, lung radiographic, and related physiological characteristics in COVID-19 survivors.","To describe the long-term health outcomes of patients with COVID-19 and investigate the potential risk factors. Clinical data during hospitalization and at a mean (SD) day of 249 (15) days after discharge from 40 survivors with confirmed COVID-19 (including 25 severe cases) were collected and analyzed retrospectively. At follow-up, severe cases had higher incidences of persistent symptoms, DLCO impairment, and higher abnormal CT score as compared with mild cases. CT score at follow-up was positi","2021","07","15","Sci Rep","Scientific reports","Adult; Aged; COVID-19; Follow-Up Studies; Humans; Lung; Male; Middle Aged; Respiration Disorders; Respiratory Physiological Phenomena; Retrospective Studies; SARS-CoV-2; Survivors","Bai","Wenxue","Department of Respiratory and Critical Care MedicineTongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China",NA
"937","34226597","10.1038/s41598-021-93191-y","Eight months follow-up study on pulmonary function, lung radiographic, and related physiological characteristics in COVID-19 survivors.","To describe the long-term health outcomes of patients with COVID-19 and investigate the potential risk factors. Clinical data during hospitalization and at a mean (SD) day of 249 (15) days after discharge from 40 survivors with confirmed COVID-19 (including 25 severe cases) were collected and analyzed retrospectively. At follow-up, severe cases had higher incidences of persistent symptoms, DLCO impairment, and higher abnormal CT score as compared with mild cases. CT score at follow-up was positi","2021","07","15","Sci Rep","Scientific reports","Adult; Aged; COVID-19; Follow-Up Studies; Humans; Lung; Male; Middle Aged; Respiration Disorders; Respiratory Physiological Phenomena; Retrospective Studies; SARS-CoV-2; Survivors","Yue","Junqing","Department of Respiratory and Critical Care MedicineTongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China",NA
"938","34226597","10.1038/s41598-021-93191-y","Eight months follow-up study on pulmonary function, lung radiographic, and related physiological characteristics in COVID-19 survivors.","To describe the long-term health outcomes of patients with COVID-19 and investigate the potential risk factors. Clinical data during hospitalization and at a mean (SD) day of 249 (15) days after discharge from 40 survivors with confirmed COVID-19 (including 25 severe cases) were collected and analyzed retrospectively. At follow-up, severe cases had higher incidences of persistent symptoms, DLCO impairment, and higher abnormal CT score as compared with mild cases. CT score at follow-up was positi","2021","07","15","Sci Rep","Scientific reports","Adult; Aged; COVID-19; Follow-Up Studies; Humans; Lung; Male; Middle Aged; Respiration Disorders; Respiratory Physiological Phenomena; Retrospective Studies; SARS-CoV-2; Survivors","Qin","Lu","Department of Respiratory and Critical Care MedicineTongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China",NA
"939","34226597","10.1038/s41598-021-93191-y","Eight months follow-up study on pulmonary function, lung radiographic, and related physiological characteristics in COVID-19 survivors.","To describe the long-term health outcomes of patients with COVID-19 and investigate the potential risk factors. Clinical data during hospitalization and at a mean (SD) day of 249 (15) days after discharge from 40 survivors with confirmed COVID-19 (including 25 severe cases) were collected and analyzed retrospectively. At follow-up, severe cases had higher incidences of persistent symptoms, DLCO impairment, and higher abnormal CT score as compared with mild cases. CT score at follow-up was positi","2021","07","15","Sci Rep","Scientific reports","Adult; Aged; COVID-19; Follow-Up Studies; Humans; Lung; Male; Middle Aged; Respiration Disorders; Respiratory Physiological Phenomena; Retrospective Studies; SARS-CoV-2; Survivors","Zhang","Cong","Department of Respiratory and Critical Care MedicineTongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China",NA
"940","34226597","10.1038/s41598-021-93191-y","Eight months follow-up study on pulmonary function, lung radiographic, and related physiological characteristics in COVID-19 survivors.","To describe the long-term health outcomes of patients with COVID-19 and investigate the potential risk factors. Clinical data during hospitalization and at a mean (SD) day of 249 (15) days after discharge from 40 survivors with confirmed COVID-19 (including 25 severe cases) were collected and analyzed retrospectively. At follow-up, severe cases had higher incidences of persistent symptoms, DLCO impairment, and higher abnormal CT score as compared with mild cases. CT score at follow-up was positi","2021","07","15","Sci Rep","Scientific reports","Adult; Aged; COVID-19; Follow-Up Studies; Humans; Lung; Male; Middle Aged; Respiration Disorders; Respiratory Physiological Phenomena; Retrospective Studies; SARS-CoV-2; Survivors","Xu","Shuyun","Department of Respiratory and Critical Care MedicineTongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China",NA
"941","34226597","10.1038/s41598-021-93191-y","Eight months follow-up study on pulmonary function, lung radiographic, and related physiological characteristics in COVID-19 survivors.","To describe the long-term health outcomes of patients with COVID-19 and investigate the potential risk factors. Clinical data during hospitalization and at a mean (SD) day of 249 (15) days after discharge from 40 survivors with confirmed COVID-19 (including 25 severe cases) were collected and analyzed retrospectively. At follow-up, severe cases had higher incidences of persistent symptoms, DLCO impairment, and higher abnormal CT score as compared with mild cases. CT score at follow-up was positi","2021","07","15","Sci Rep","Scientific reports","Adult; Aged; COVID-19; Follow-Up Studies; Humans; Lung; Male; Middle Aged; Respiration Disorders; Respiratory Physiological Phenomena; Retrospective Studies; SARS-CoV-2; Survivors","Liu","Xiansheng","Department of Respiratory and Critical Care MedicineTongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China",NA
"942","34226597","10.1038/s41598-021-93191-y","Eight months follow-up study on pulmonary function, lung radiographic, and related physiological characteristics in COVID-19 survivors.","To describe the long-term health outcomes of patients with COVID-19 and investigate the potential risk factors. Clinical data during hospitalization and at a mean (SD) day of 249 (15) days after discharge from 40 survivors with confirmed COVID-19 (including 25 severe cases) were collected and analyzed retrospectively. At follow-up, severe cases had higher incidences of persistent symptoms, DLCO impairment, and higher abnormal CT score as compared with mild cases. CT score at follow-up was positi","2021","07","15","Sci Rep","Scientific reports","Adult; Aged; COVID-19; Follow-Up Studies; Humans; Lung; Male; Middle Aged; Respiration Disorders; Respiratory Physiological Phenomena; Retrospective Studies; SARS-CoV-2; Survivors","Ni","Wang","Department of Respiratory and Critical Care MedicineTongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China. niwang@tjh.tjmu.edu","niwang@tjh.tjmu.edu.cn"
"943","34226597","10.1038/s41598-021-93191-y","Eight months follow-up study on pulmonary function, lung radiographic, and related physiological characteristics in COVID-19 survivors.","To describe the long-term health outcomes of patients with COVID-19 and investigate the potential risk factors. Clinical data during hospitalization and at a mean (SD) day of 249 (15) days after discharge from 40 survivors with confirmed COVID-19 (including 25 severe cases) were collected and analyzed retrospectively. At follow-up, severe cases had higher incidences of persistent symptoms, DLCO impairment, and higher abnormal CT score as compared with mild cases. CT score at follow-up was positi","2021","07","15","Sci Rep","Scientific reports","Adult; Aged; COVID-19; Follow-Up Studies; Humans; Lung; Male; Middle Aged; Respiration Disorders; Respiratory Physiological Phenomena; Retrospective Studies; SARS-CoV-2; Survivors","Xie","Min","Department of Respiratory and Critical Care MedicineTongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China. xie_m@126",NA
"944","34226584","10.1038/s41598-021-91365-2","Accurate long-range forecasting of COVID-19 mortality in the USA.","The need for improved models that can accurately predict COVID-19 dynamics is vital to managing the pandemic and its consequences. We use machine learning techniques to design an adaptive learner that, based on epidemiological data available at any given time, produces a model that accurately forecasts the number of reported COVID-19 deaths and cases in the United States, up to 10 weeks into the future with a mean absolute percentage error of 9%. In addition to being the most accurate long-range","2021","07","15","Sci Rep","Scientific reports","COVID-19; Communicable Diseases; Forecasting; Humans; Machine Learning; Models, Statistical; SARS-CoV-2; United States","Ramazi","Pouria","Department of Mathematics and Statistics, Brock University, St. Catharines, ON, L2S 3A1, Canada. pramazi@brocku","pramazi@brocku.ca"
"945","34226584","10.1038/s41598-021-91365-2","Accurate long-range forecasting of COVID-19 mortality in the USA.","The need for improved models that can accurately predict COVID-19 dynamics is vital to managing the pandemic and its consequences. We use machine learning techniques to design an adaptive learner that, based on epidemiological data available at any given time, produces a model that accurately forecasts the number of reported COVID-19 deaths and cases in the United States, up to 10 weeks into the future with a mean absolute percentage error of 9%. In addition to being the most accurate long-range","2021","07","15","Sci Rep","Scientific reports","COVID-19; Communicable Diseases; Forecasting; Humans; Machine Learning; Models, Statistical; SARS-CoV-2; United States","Haratian","Arezoo","Department of Electrical and Computer Engineering, Isfahan University of Technology, 84156-83111, Isfahan, Iran",NA
"946","34226584","10.1038/s41598-021-91365-2","Accurate long-range forecasting of COVID-19 mortality in the USA.","The need for improved models that can accurately predict COVID-19 dynamics is vital to managing the pandemic and its consequences. We use machine learning techniques to design an adaptive learner that, based on epidemiological data available at any given time, produces a model that accurately forecasts the number of reported COVID-19 deaths and cases in the United States, up to 10 weeks into the future with a mean absolute percentage error of 9%. In addition to being the most accurate long-range","2021","07","15","Sci Rep","Scientific reports","COVID-19; Communicable Diseases; Forecasting; Humans; Machine Learning; Models, Statistical; SARS-CoV-2; United States","Meghdadi","Maryam","Department of Electrical and Computer Engineering, Isfahan University of Technology, 84156-83111, Isfahan, Iran",NA
"947","34226584","10.1038/s41598-021-91365-2","Accurate long-range forecasting of COVID-19 mortality in the USA.","The need for improved models that can accurately predict COVID-19 dynamics is vital to managing the pandemic and its consequences. We use machine learning techniques to design an adaptive learner that, based on epidemiological data available at any given time, produces a model that accurately forecasts the number of reported COVID-19 deaths and cases in the United States, up to 10 weeks into the future with a mean absolute percentage error of 9%. In addition to being the most accurate long-range","2021","07","15","Sci Rep","Scientific reports","COVID-19; Communicable Diseases; Forecasting; Humans; Machine Learning; Models, Statistical; SARS-CoV-2; United States","Mari Oriyad","Arash","Department of Electrical and Computer Engineering, Isfahan University of Technology, 84156-83111, Isfahan, Iran",NA
"948","34226584","10.1038/s41598-021-91365-2","Accurate long-range forecasting of COVID-19 mortality in the USA.","The need for improved models that can accurately predict COVID-19 dynamics is vital to managing the pandemic and its consequences. We use machine learning techniques to design an adaptive learner that, based on epidemiological data available at any given time, produces a model that accurately forecasts the number of reported COVID-19 deaths and cases in the United States, up to 10 weeks into the future with a mean absolute percentage error of 9%. In addition to being the most accurate long-range","2021","07","15","Sci Rep","Scientific reports","COVID-19; Communicable Diseases; Forecasting; Humans; Machine Learning; Models, Statistical; SARS-CoV-2; United States","Lewis","Mark A","Department of Mathematical and Statistical Sciences, University of Alberta, Edmonton, AB, T6G 2G1, Canada",NA
"949","34226584","10.1038/s41598-021-91365-2","Accurate long-range forecasting of COVID-19 mortality in the USA.","The need for improved models that can accurately predict COVID-19 dynamics is vital to managing the pandemic and its consequences. We use machine learning techniques to design an adaptive learner that, based on epidemiological data available at any given time, produces a model that accurately forecasts the number of reported COVID-19 deaths and cases in the United States, up to 10 weeks into the future with a mean absolute percentage error of 9%. In addition to being the most accurate long-range","2021","07","15","Sci Rep","Scientific reports","COVID-19; Communicable Diseases; Forecasting; Humans; Machine Learning; Models, Statistical; SARS-CoV-2; United States","Maleki","Zeinab","Department of Electrical and Computer Engineering, Isfahan University of Technology, 84156-83111, Isfahan, Iran",NA
"950","34226584","10.1038/s41598-021-91365-2","Accurate long-range forecasting of COVID-19 mortality in the USA.","The need for improved models that can accurately predict COVID-19 dynamics is vital to managing the pandemic and its consequences. We use machine learning techniques to design an adaptive learner that, based on epidemiological data available at any given time, produces a model that accurately forecasts the number of reported COVID-19 deaths and cases in the United States, up to 10 weeks into the future with a mean absolute percentage error of 9%. In addition to being the most accurate long-range","2021","07","15","Sci Rep","Scientific reports","COVID-19; Communicable Diseases; Forecasting; Humans; Machine Learning; Models, Statistical; SARS-CoV-2; United States","Vega","Roberto","Department of Computing Science, University of Alberta, Edmonton, AB, T6G 2E8, Canada",NA
"951","34226584","10.1038/s41598-021-91365-2","Accurate long-range forecasting of COVID-19 mortality in the USA.","The need for improved models that can accurately predict COVID-19 dynamics is vital to managing the pandemic and its consequences. We use machine learning techniques to design an adaptive learner that, based on epidemiological data available at any given time, produces a model that accurately forecasts the number of reported COVID-19 deaths and cases in the United States, up to 10 weeks into the future with a mean absolute percentage error of 9%. In addition to being the most accurate long-range","2021","07","15","Sci Rep","Scientific reports","COVID-19; Communicable Diseases; Forecasting; Humans; Machine Learning; Models, Statistical; SARS-CoV-2; United States","Wang","Hao","Department of Mathematical and Statistical Sciences, University of Alberta, Edmonton, AB, T6G 2G1, Canada",NA
"952","34226584","10.1038/s41598-021-91365-2","Accurate long-range forecasting of COVID-19 mortality in the USA.","The need for improved models that can accurately predict COVID-19 dynamics is vital to managing the pandemic and its consequences. We use machine learning techniques to design an adaptive learner that, based on epidemiological data available at any given time, produces a model that accurately forecasts the number of reported COVID-19 deaths and cases in the United States, up to 10 weeks into the future with a mean absolute percentage error of 9%. In addition to being the most accurate long-range","2021","07","15","Sci Rep","Scientific reports","COVID-19; Communicable Diseases; Forecasting; Humans; Machine Learning; Models, Statistical; SARS-CoV-2; United States","Wishart","David S","Department of Biological Sciences, University of Alberta, Edmonton, AB, T6G 2E9, Canada",NA
"953","34226584","10.1038/s41598-021-91365-2","Accurate long-range forecasting of COVID-19 mortality in the USA.","The need for improved models that can accurately predict COVID-19 dynamics is vital to managing the pandemic and its consequences. We use machine learning techniques to design an adaptive learner that, based on epidemiological data available at any given time, produces a model that accurately forecasts the number of reported COVID-19 deaths and cases in the United States, up to 10 weeks into the future with a mean absolute percentage error of 9%. In addition to being the most accurate long-range","2021","07","15","Sci Rep","Scientific reports","COVID-19; Communicable Diseases; Forecasting; Humans; Machine Learning; Models, Statistical; SARS-CoV-2; United States","Greiner","Russell","Department of Computing Science, University of Alberta, Edmonton, AB, T6G 2E8, Canada",NA
"954","34226537","10.1038/s41467-021-24360-w","Monocyte-driven atypical cytokine storm and aberrant neutrophil activation as key mediators of COVID-19 disease severity.","Epidemiological and clinical reports indicate that SARS-CoV-2 virulence hinges upon the triggering of an aberrant host immune response, more so than on direct virus-induced cellular damage. To elucidate the immunopathology underlying COVID-19 severity, we perform cytokine and multiplex immune profiling in COVID-19 patients. We show that hypercytokinemia in COVID-19 differs from the interferon-gamma-driven cytokine storm in macrophage activation syndrome, and is more pronounced in critical versus","2021","07","13","Nat Commun","Nature communications","Aged; Antigen-Presenting Cells; COVID-19; Case-Control Studies; Cytokine Release Syndrome; Cytokines; Extracellular Traps; Female; Histocompatibility Antigens Class II; Humans; Immunophenotyping; Male; Middle Aged; Monocytes; Neutrophil Activation; SARS-CoV-2; Severity of Illness Index","Vanderbeke","L","Laboratory of Clinical Bacteriology and Mycology, Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium",NA
"955","34226537","10.1038/s41467-021-24360-w","Monocyte-driven atypical cytokine storm and aberrant neutrophil activation as key mediators of COVID-19 disease severity.","Epidemiological and clinical reports indicate that SARS-CoV-2 virulence hinges upon the triggering of an aberrant host immune response, more so than on direct virus-induced cellular damage. To elucidate the immunopathology underlying COVID-19 severity, we perform cytokine and multiplex immune profiling in COVID-19 patients. We show that hypercytokinemia in COVID-19 differs from the interferon-gamma-driven cytokine storm in macrophage activation syndrome, and is more pronounced in critical versus","2021","07","13","Nat Commun","Nature communications","Aged; Antigen-Presenting Cells; COVID-19; Case-Control Studies; Cytokine Release Syndrome; Cytokines; Extracellular Traps; Female; Histocompatibility Antigens Class II; Humans; Immunophenotyping; Male; Middle Aged; Monocytes; Neutrophil Activation; SARS-CoV-2; Severity of Illness Index","Van Mol","P","Laboratory of Translational Genetics, Department of Human Genetics, VIB-KU Leuven, Leuven, Belgium",NA
"956","34226537","10.1038/s41467-021-24360-w","Monocyte-driven atypical cytokine storm and aberrant neutrophil activation as key mediators of COVID-19 disease severity.","Epidemiological and clinical reports indicate that SARS-CoV-2 virulence hinges upon the triggering of an aberrant host immune response, more so than on direct virus-induced cellular damage. To elucidate the immunopathology underlying COVID-19 severity, we perform cytokine and multiplex immune profiling in COVID-19 patients. We show that hypercytokinemia in COVID-19 differs from the interferon-gamma-driven cytokine storm in macrophage activation syndrome, and is more pronounced in critical versus","2021","07","13","Nat Commun","Nature communications","Aged; Antigen-Presenting Cells; COVID-19; Case-Control Studies; Cytokine Release Syndrome; Cytokines; Extracellular Traps; Female; Histocompatibility Antigens Class II; Humans; Immunophenotyping; Male; Middle Aged; Monocytes; Neutrophil Activation; SARS-CoV-2; Severity of Illness Index","Van Herck","Y","Laboratory of Experimental Oncology, Department of Oncology, KU Leuven, Leuven, Belgium",NA
"957","34226537","10.1038/s41467-021-24360-w","Monocyte-driven atypical cytokine storm and aberrant neutrophil activation as key mediators of COVID-19 disease severity.","Epidemiological and clinical reports indicate that SARS-CoV-2 virulence hinges upon the triggering of an aberrant host immune response, more so than on direct virus-induced cellular damage. To elucidate the immunopathology underlying COVID-19 severity, we perform cytokine and multiplex immune profiling in COVID-19 patients. We show that hypercytokinemia in COVID-19 differs from the interferon-gamma-driven cytokine storm in macrophage activation syndrome, and is more pronounced in critical versus","2021","07","13","Nat Commun","Nature communications","Aged; Antigen-Presenting Cells; COVID-19; Case-Control Studies; Cytokine Release Syndrome; Cytokines; Extracellular Traps; Female; Histocompatibility Antigens Class II; Humans; Immunophenotyping; Male; Middle Aged; Monocytes; Neutrophil Activation; SARS-CoV-2; Severity of Illness Index","De Smet","F","Laboratory for Precision Cancer Medicine, Translational Cell and Tissue Research, Department of Imaging &amp",NA
"958","34226537","10.1038/s41467-021-24360-w","Monocyte-driven atypical cytokine storm and aberrant neutrophil activation as key mediators of COVID-19 disease severity.","Epidemiological and clinical reports indicate that SARS-CoV-2 virulence hinges upon the triggering of an aberrant host immune response, more so than on direct virus-induced cellular damage. To elucidate the immunopathology underlying COVID-19 severity, we perform cytokine and multiplex immune profiling in COVID-19 patients. We show that hypercytokinemia in COVID-19 differs from the interferon-gamma-driven cytokine storm in macrophage activation syndrome, and is more pronounced in critical versus","2021","07","13","Nat Commun","Nature communications","Aged; Antigen-Presenting Cells; COVID-19; Case-Control Studies; Cytokine Release Syndrome; Cytokines; Extracellular Traps; Female; Histocompatibility Antigens Class II; Humans; Immunophenotyping; Male; Middle Aged; Monocytes; Neutrophil Activation; SARS-CoV-2; Severity of Illness Index","Humblet-Baron","S","Adaptive Immunology, Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium",NA
"959","34226537","10.1038/s41467-021-24360-w","Monocyte-driven atypical cytokine storm and aberrant neutrophil activation as key mediators of COVID-19 disease severity.","Epidemiological and clinical reports indicate that SARS-CoV-2 virulence hinges upon the triggering of an aberrant host immune response, more so than on direct virus-induced cellular damage. To elucidate the immunopathology underlying COVID-19 severity, we perform cytokine and multiplex immune profiling in COVID-19 patients. We show that hypercytokinemia in COVID-19 differs from the interferon-gamma-driven cytokine storm in macrophage activation syndrome, and is more pronounced in critical versus","2021","07","13","Nat Commun","Nature communications","Aged; Antigen-Presenting Cells; COVID-19; Case-Control Studies; Cytokine Release Syndrome; Cytokines; Extracellular Traps; Female; Histocompatibility Antigens Class II; Humans; Immunophenotyping; Male; Middle Aged; Monocytes; Neutrophil Activation; SARS-CoV-2; Severity of Illness Index","Martinod","K","Centre for Molecular and Vascular Biology, Department of Cardiovascular Sciences, KU Leuven, Leuven, Belgium",NA
"960","34226537","10.1038/s41467-021-24360-w","Monocyte-driven atypical cytokine storm and aberrant neutrophil activation as key mediators of COVID-19 disease severity.","Epidemiological and clinical reports indicate that SARS-CoV-2 virulence hinges upon the triggering of an aberrant host immune response, more so than on direct virus-induced cellular damage. To elucidate the immunopathology underlying COVID-19 severity, we perform cytokine and multiplex immune profiling in COVID-19 patients. We show that hypercytokinemia in COVID-19 differs from the interferon-gamma-driven cytokine storm in macrophage activation syndrome, and is more pronounced in critical versus","2021","07","13","Nat Commun","Nature communications","Aged; Antigen-Presenting Cells; COVID-19; Case-Control Studies; Cytokine Release Syndrome; Cytokines; Extracellular Traps; Female; Histocompatibility Antigens Class II; Humans; Immunophenotyping; Male; Middle Aged; Monocytes; Neutrophil Activation; SARS-CoV-2; Severity of Illness Index","Antoranz","A","Laboratory for Precision Cancer Medicine, Translational Cell and Tissue Research, Department of Imaging &amp",NA
"961","34226537","10.1038/s41467-021-24360-w","Monocyte-driven atypical cytokine storm and aberrant neutrophil activation as key mediators of COVID-19 disease severity.","Epidemiological and clinical reports indicate that SARS-CoV-2 virulence hinges upon the triggering of an aberrant host immune response, more so than on direct virus-induced cellular damage. To elucidate the immunopathology underlying COVID-19 severity, we perform cytokine and multiplex immune profiling in COVID-19 patients. We show that hypercytokinemia in COVID-19 differs from the interferon-gamma-driven cytokine storm in macrophage activation syndrome, and is more pronounced in critical versus","2021","07","13","Nat Commun","Nature communications","Aged; Antigen-Presenting Cells; COVID-19; Case-Control Studies; Cytokine Release Syndrome; Cytokines; Extracellular Traps; Female; Histocompatibility Antigens Class II; Humans; Immunophenotyping; Male; Middle Aged; Monocytes; Neutrophil Activation; SARS-CoV-2; Severity of Illness Index","Arijs","I","Laboratory of Translational Genetics, Department of Human Genetics, VIB-KU Leuven, Leuven, Belgium",NA
"962","34226537","10.1038/s41467-021-24360-w","Monocyte-driven atypical cytokine storm and aberrant neutrophil activation as key mediators of COVID-19 disease severity.","Epidemiological and clinical reports indicate that SARS-CoV-2 virulence hinges upon the triggering of an aberrant host immune response, more so than on direct virus-induced cellular damage. To elucidate the immunopathology underlying COVID-19 severity, we perform cytokine and multiplex immune profiling in COVID-19 patients. We show that hypercytokinemia in COVID-19 differs from the interferon-gamma-driven cytokine storm in macrophage activation syndrome, and is more pronounced in critical versus","2021","07","13","Nat Commun","Nature communications","Aged; Antigen-Presenting Cells; COVID-19; Case-Control Studies; Cytokine Release Syndrome; Cytokines; Extracellular Traps; Female; Histocompatibility Antigens Class II; Humans; Immunophenotyping; Male; Middle Aged; Monocytes; Neutrophil Activation; SARS-CoV-2; Severity of Illness Index","Boeckx","B","Laboratory of Translational Genetics, Department of Human Genetics, VIB-KU Leuven, Leuven, Belgium",NA
"963","34226537","10.1038/s41467-021-24360-w","Monocyte-driven atypical cytokine storm and aberrant neutrophil activation as key mediators of COVID-19 disease severity.","Epidemiological and clinical reports indicate that SARS-CoV-2 virulence hinges upon the triggering of an aberrant host immune response, more so than on direct virus-induced cellular damage. To elucidate the immunopathology underlying COVID-19 severity, we perform cytokine and multiplex immune profiling in COVID-19 patients. We show that hypercytokinemia in COVID-19 differs from the interferon-gamma-driven cytokine storm in macrophage activation syndrome, and is more pronounced in critical versus","2021","07","13","Nat Commun","Nature communications","Aged; Antigen-Presenting Cells; COVID-19; Case-Control Studies; Cytokine Release Syndrome; Cytokines; Extracellular Traps; Female; Histocompatibility Antigens Class II; Humans; Immunophenotyping; Male; Middle Aged; Monocytes; Neutrophil Activation; SARS-CoV-2; Severity of Illness Index","Bosisio","F M","Translational Cell &amp",NA
"964","34226537","10.1038/s41467-021-24360-w","Monocyte-driven atypical cytokine storm and aberrant neutrophil activation as key mediators of COVID-19 disease severity.","Epidemiological and clinical reports indicate that SARS-CoV-2 virulence hinges upon the triggering of an aberrant host immune response, more so than on direct virus-induced cellular damage. To elucidate the immunopathology underlying COVID-19 severity, we perform cytokine and multiplex immune profiling in COVID-19 patients. We show that hypercytokinemia in COVID-19 differs from the interferon-gamma-driven cytokine storm in macrophage activation syndrome, and is more pronounced in critical versus","2021","07","13","Nat Commun","Nature communications","Aged; Antigen-Presenting Cells; COVID-19; Case-Control Studies; Cytokine Release Syndrome; Cytokines; Extracellular Traps; Female; Histocompatibility Antigens Class II; Humans; Immunophenotyping; Male; Middle Aged; Monocytes; Neutrophil Activation; SARS-CoV-2; Severity of Illness Index","Casaer","M","Laboratory of Intensive Care Medicine, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium",NA
"965","34226537","10.1038/s41467-021-24360-w","Monocyte-driven atypical cytokine storm and aberrant neutrophil activation as key mediators of COVID-19 disease severity.","Epidemiological and clinical reports indicate that SARS-CoV-2 virulence hinges upon the triggering of an aberrant host immune response, more so than on direct virus-induced cellular damage. To elucidate the immunopathology underlying COVID-19 severity, we perform cytokine and multiplex immune profiling in COVID-19 patients. We show that hypercytokinemia in COVID-19 differs from the interferon-gamma-driven cytokine storm in macrophage activation syndrome, and is more pronounced in critical versus","2021","07","13","Nat Commun","Nature communications","Aged; Antigen-Presenting Cells; COVID-19; Case-Control Studies; Cytokine Release Syndrome; Cytokines; Extracellular Traps; Female; Histocompatibility Antigens Class II; Humans; Immunophenotyping; Male; Middle Aged; Monocytes; Neutrophil Activation; SARS-CoV-2; Severity of Illness Index","Dauwe","D","Laboratory of Intensive Care Medicine, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium",NA
"966","34226537","10.1038/s41467-021-24360-w","Monocyte-driven atypical cytokine storm and aberrant neutrophil activation as key mediators of COVID-19 disease severity.","Epidemiological and clinical reports indicate that SARS-CoV-2 virulence hinges upon the triggering of an aberrant host immune response, more so than on direct virus-induced cellular damage. To elucidate the immunopathology underlying COVID-19 severity, we perform cytokine and multiplex immune profiling in COVID-19 patients. We show that hypercytokinemia in COVID-19 differs from the interferon-gamma-driven cytokine storm in macrophage activation syndrome, and is more pronounced in critical versus","2021","07","13","Nat Commun","Nature communications","Aged; Antigen-Presenting Cells; COVID-19; Case-Control Studies; Cytokine Release Syndrome; Cytokines; Extracellular Traps; Female; Histocompatibility Antigens Class II; Humans; Immunophenotyping; Male; Middle Aged; Monocytes; Neutrophil Activation; SARS-CoV-2; Severity of Illness Index","De Wever","W","Radiology, Department of Imaging &amp",NA
"967","34226537","10.1038/s41467-021-24360-w","Monocyte-driven atypical cytokine storm and aberrant neutrophil activation as key mediators of COVID-19 disease severity.","Epidemiological and clinical reports indicate that SARS-CoV-2 virulence hinges upon the triggering of an aberrant host immune response, more so than on direct virus-induced cellular damage. To elucidate the immunopathology underlying COVID-19 severity, we perform cytokine and multiplex immune profiling in COVID-19 patients. We show that hypercytokinemia in COVID-19 differs from the interferon-gamma-driven cytokine storm in macrophage activation syndrome, and is more pronounced in critical versus","2021","07","13","Nat Commun","Nature communications","Aged; Antigen-Presenting Cells; COVID-19; Case-Control Studies; Cytokine Release Syndrome; Cytokines; Extracellular Traps; Female; Histocompatibility Antigens Class II; Humans; Immunophenotyping; Male; Middle Aged; Monocytes; Neutrophil Activation; SARS-CoV-2; Severity of Illness Index","Dooms","C","Laboratory of Respiratory Diseases and Thoracic Surgery (BREATHE), Department of Chronic Diseases and Metabolism, KU Leuven, Leuven, Belgium",NA
"968","34226537","10.1038/s41467-021-24360-w","Monocyte-driven atypical cytokine storm and aberrant neutrophil activation as key mediators of COVID-19 disease severity.","Epidemiological and clinical reports indicate that SARS-CoV-2 virulence hinges upon the triggering of an aberrant host immune response, more so than on direct virus-induced cellular damage. To elucidate the immunopathology underlying COVID-19 severity, we perform cytokine and multiplex immune profiling in COVID-19 patients. We show that hypercytokinemia in COVID-19 differs from the interferon-gamma-driven cytokine storm in macrophage activation syndrome, and is more pronounced in critical versus","2021","07","13","Nat Commun","Nature communications","Aged; Antigen-Presenting Cells; COVID-19; Case-Control Studies; Cytokine Release Syndrome; Cytokines; Extracellular Traps; Female; Histocompatibility Antigens Class II; Humans; Immunophenotyping; Male; Middle Aged; Monocytes; Neutrophil Activation; SARS-CoV-2; Severity of Illness Index","Dreesen","E","Clinical Pharmacology and Pharmacotherapy, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium",NA
"969","34226537","10.1038/s41467-021-24360-w","Monocyte-driven atypical cytokine storm and aberrant neutrophil activation as key mediators of COVID-19 disease severity.","Epidemiological and clinical reports indicate that SARS-CoV-2 virulence hinges upon the triggering of an aberrant host immune response, more so than on direct virus-induced cellular damage. To elucidate the immunopathology underlying COVID-19 severity, we perform cytokine and multiplex immune profiling in COVID-19 patients. We show that hypercytokinemia in COVID-19 differs from the interferon-gamma-driven cytokine storm in macrophage activation syndrome, and is more pronounced in critical versus","2021","07","13","Nat Commun","Nature communications","Aged; Antigen-Presenting Cells; COVID-19; Case-Control Studies; Cytokine Release Syndrome; Cytokines; Extracellular Traps; Female; Histocompatibility Antigens Class II; Humans; Immunophenotyping; Male; Middle Aged; Monocytes; Neutrophil Activation; SARS-CoV-2; Severity of Illness Index","Emmaneel","A","Department of Applied Mathematics, Computer Science and Statistics, VIB-UGent Center for Inflammation Research, VIB-UGent, Gent, Belgium",NA
"970","34226537","10.1038/s41467-021-24360-w","Monocyte-driven atypical cytokine storm and aberrant neutrophil activation as key mediators of COVID-19 disease severity.","Epidemiological and clinical reports indicate that SARS-CoV-2 virulence hinges upon the triggering of an aberrant host immune response, more so than on direct virus-induced cellular damage. To elucidate the immunopathology underlying COVID-19 severity, we perform cytokine and multiplex immune profiling in COVID-19 patients. We show that hypercytokinemia in COVID-19 differs from the interferon-gamma-driven cytokine storm in macrophage activation syndrome, and is more pronounced in critical versus","2021","07","13","Nat Commun","Nature communications","Aged; Antigen-Presenting Cells; COVID-19; Case-Control Studies; Cytokine Release Syndrome; Cytokines; Extracellular Traps; Female; Histocompatibility Antigens Class II; Humans; Immunophenotyping; Male; Middle Aged; Monocytes; Neutrophil Activation; SARS-CoV-2; Severity of Illness Index","Filtjens","J","Laboratory of Immunobiology, Department of Microbiology, Immunology and Transplantation, Rega Institute, KU Leuven, Leuven, Belgium",NA
"971","34226537","10.1038/s41467-021-24360-w","Monocyte-driven atypical cytokine storm and aberrant neutrophil activation as key mediators of COVID-19 disease severity.","Epidemiological and clinical reports indicate that SARS-CoV-2 virulence hinges upon the triggering of an aberrant host immune response, more so than on direct virus-induced cellular damage. To elucidate the immunopathology underlying COVID-19 severity, we perform cytokine and multiplex immune profiling in COVID-19 patients. We show that hypercytokinemia in COVID-19 differs from the interferon-gamma-driven cytokine storm in macrophage activation syndrome, and is more pronounced in critical versus","2021","07","13","Nat Commun","Nature communications","Aged; Antigen-Presenting Cells; COVID-19; Case-Control Studies; Cytokine Release Syndrome; Cytokines; Extracellular Traps; Female; Histocompatibility Antigens Class II; Humans; Immunophenotyping; Male; Middle Aged; Monocytes; Neutrophil Activation; SARS-CoV-2; Severity of Illness Index","Gouwy","M","Laboratory of Molecular Immunology, Department of Microbiology, Immunology and Transplantation, Rega Institute, KU Leuven, Leuven, Belgium",NA
"972","34226537","10.1038/s41467-021-24360-w","Monocyte-driven atypical cytokine storm and aberrant neutrophil activation as key mediators of COVID-19 disease severity.","Epidemiological and clinical reports indicate that SARS-CoV-2 virulence hinges upon the triggering of an aberrant host immune response, more so than on direct virus-induced cellular damage. To elucidate the immunopathology underlying COVID-19 severity, we perform cytokine and multiplex immune profiling in COVID-19 patients. We show that hypercytokinemia in COVID-19 differs from the interferon-gamma-driven cytokine storm in macrophage activation syndrome, and is more pronounced in critical versus","2021","07","13","Nat Commun","Nature communications","Aged; Antigen-Presenting Cells; COVID-19; Case-Control Studies; Cytokine Release Syndrome; Cytokines; Extracellular Traps; Female; Histocompatibility Antigens Class II; Humans; Immunophenotyping; Male; Middle Aged; Monocytes; Neutrophil Activation; SARS-CoV-2; Severity of Illness Index","Gunst","J","Laboratory of Intensive Care Medicine, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium",NA
"973","34226537","10.1038/s41467-021-24360-w","Monocyte-driven atypical cytokine storm and aberrant neutrophil activation as key mediators of COVID-19 disease severity.","Epidemiological and clinical reports indicate that SARS-CoV-2 virulence hinges upon the triggering of an aberrant host immune response, more so than on direct virus-induced cellular damage. To elucidate the immunopathology underlying COVID-19 severity, we perform cytokine and multiplex immune profiling in COVID-19 patients. We show that hypercytokinemia in COVID-19 differs from the interferon-gamma-driven cytokine storm in macrophage activation syndrome, and is more pronounced in critical versus","2021","07","13","Nat Commun","Nature communications","Aged; Antigen-Presenting Cells; COVID-19; Case-Control Studies; Cytokine Release Syndrome; Cytokines; Extracellular Traps; Female; Histocompatibility Antigens Class II; Humans; Immunophenotyping; Male; Middle Aged; Monocytes; Neutrophil Activation; SARS-CoV-2; Severity of Illness Index","Hermans","G","Laboratory of Intensive Care Medicine, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium",NA
"974","34226537","10.1038/s41467-021-24360-w","Monocyte-driven atypical cytokine storm and aberrant neutrophil activation as key mediators of COVID-19 disease severity.","Epidemiological and clinical reports indicate that SARS-CoV-2 virulence hinges upon the triggering of an aberrant host immune response, more so than on direct virus-induced cellular damage. To elucidate the immunopathology underlying COVID-19 severity, we perform cytokine and multiplex immune profiling in COVID-19 patients. We show that hypercytokinemia in COVID-19 differs from the interferon-gamma-driven cytokine storm in macrophage activation syndrome, and is more pronounced in critical versus","2021","07","13","Nat Commun","Nature communications","Aged; Antigen-Presenting Cells; COVID-19; Case-Control Studies; Cytokine Release Syndrome; Cytokines; Extracellular Traps; Female; Histocompatibility Antigens Class II; Humans; Immunophenotyping; Male; Middle Aged; Monocytes; Neutrophil Activation; SARS-CoV-2; Severity of Illness Index","Jansen","S","Laboratory of Virology and Chemotherapy, Department of Microbiology, Immunology and Transplantation, Rega Institute, KU Leuven, B Leuven, Belgium",NA
"975","34226537","10.1038/s41467-021-24360-w","Monocyte-driven atypical cytokine storm and aberrant neutrophil activation as key mediators of COVID-19 disease severity.","Epidemiological and clinical reports indicate that SARS-CoV-2 virulence hinges upon the triggering of an aberrant host immune response, more so than on direct virus-induced cellular damage. To elucidate the immunopathology underlying COVID-19 severity, we perform cytokine and multiplex immune profiling in COVID-19 patients. We show that hypercytokinemia in COVID-19 differs from the interferon-gamma-driven cytokine storm in macrophage activation syndrome, and is more pronounced in critical versus","2021","07","13","Nat Commun","Nature communications","Aged; Antigen-Presenting Cells; COVID-19; Case-Control Studies; Cytokine Release Syndrome; Cytokines; Extracellular Traps; Female; Histocompatibility Antigens Class II; Humans; Immunophenotyping; Male; Middle Aged; Monocytes; Neutrophil Activation; SARS-CoV-2; Severity of Illness Index","Lagrou","K","Laboratory of Clinical Bacteriology and Mycology, Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium",NA
"976","34226537","10.1038/s41467-021-24360-w","Monocyte-driven atypical cytokine storm and aberrant neutrophil activation as key mediators of COVID-19 disease severity.","Epidemiological and clinical reports indicate that SARS-CoV-2 virulence hinges upon the triggering of an aberrant host immune response, more so than on direct virus-induced cellular damage. To elucidate the immunopathology underlying COVID-19 severity, we perform cytokine and multiplex immune profiling in COVID-19 patients. We show that hypercytokinemia in COVID-19 differs from the interferon-gamma-driven cytokine storm in macrophage activation syndrome, and is more pronounced in critical versus","2021","07","13","Nat Commun","Nature communications","Aged; Antigen-Presenting Cells; COVID-19; Case-Control Studies; Cytokine Release Syndrome; Cytokines; Extracellular Traps; Female; Histocompatibility Antigens Class II; Humans; Immunophenotyping; Male; Middle Aged; Monocytes; Neutrophil Activation; SARS-CoV-2; Severity of Illness Index","Liston","A","Laboratory of Lymphocyte Signalling and Development, The Babraham Institute, Babraham Research Campus, Cambridge, UK",NA
"977","34226537","10.1038/s41467-021-24360-w","Monocyte-driven atypical cytokine storm and aberrant neutrophil activation as key mediators of COVID-19 disease severity.","Epidemiological and clinical reports indicate that SARS-CoV-2 virulence hinges upon the triggering of an aberrant host immune response, more so than on direct virus-induced cellular damage. To elucidate the immunopathology underlying COVID-19 severity, we perform cytokine and multiplex immune profiling in COVID-19 patients. We show that hypercytokinemia in COVID-19 differs from the interferon-gamma-driven cytokine storm in macrophage activation syndrome, and is more pronounced in critical versus","2021","07","13","Nat Commun","Nature communications","Aged; Antigen-Presenting Cells; COVID-19; Case-Control Studies; Cytokine Release Syndrome; Cytokines; Extracellular Traps; Female; Histocompatibility Antigens Class II; Humans; Immunophenotyping; Male; Middle Aged; Monocytes; Neutrophil Activation; SARS-CoV-2; Severity of Illness Index","Lorent","N","Department of Pneumology, University Hospitals Leuven, Leuven, Belgium",NA
"978","34226537","10.1038/s41467-021-24360-w","Monocyte-driven atypical cytokine storm and aberrant neutrophil activation as key mediators of COVID-19 disease severity.","Epidemiological and clinical reports indicate that SARS-CoV-2 virulence hinges upon the triggering of an aberrant host immune response, more so than on direct virus-induced cellular damage. To elucidate the immunopathology underlying COVID-19 severity, we perform cytokine and multiplex immune profiling in COVID-19 patients. We show that hypercytokinemia in COVID-19 differs from the interferon-gamma-driven cytokine storm in macrophage activation syndrome, and is more pronounced in critical versus","2021","07","13","Nat Commun","Nature communications","Aged; Antigen-Presenting Cells; COVID-19; Case-Control Studies; Cytokine Release Syndrome; Cytokines; Extracellular Traps; Female; Histocompatibility Antigens Class II; Humans; Immunophenotyping; Male; Middle Aged; Monocytes; Neutrophil Activation; SARS-CoV-2; Severity of Illness Index","Meersseman","P","Laboratory for Clinical Infectious and Inflammatory Disorders, Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium",NA
"979","34226537","10.1038/s41467-021-24360-w","Monocyte-driven atypical cytokine storm and aberrant neutrophil activation as key mediators of COVID-19 disease severity.","Epidemiological and clinical reports indicate that SARS-CoV-2 virulence hinges upon the triggering of an aberrant host immune response, more so than on direct virus-induced cellular damage. To elucidate the immunopathology underlying COVID-19 severity, we perform cytokine and multiplex immune profiling in COVID-19 patients. We show that hypercytokinemia in COVID-19 differs from the interferon-gamma-driven cytokine storm in macrophage activation syndrome, and is more pronounced in critical versus","2021","07","13","Nat Commun","Nature communications","Aged; Antigen-Presenting Cells; COVID-19; Case-Control Studies; Cytokine Release Syndrome; Cytokines; Extracellular Traps; Female; Histocompatibility Antigens Class II; Humans; Immunophenotyping; Male; Middle Aged; Monocytes; Neutrophil Activation; SARS-CoV-2; Severity of Illness Index","Mercier","T","Laboratory of Clinical Bacteriology and Mycology, Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium",NA
"980","34226537","10.1038/s41467-021-24360-w","Monocyte-driven atypical cytokine storm and aberrant neutrophil activation as key mediators of COVID-19 disease severity.","Epidemiological and clinical reports indicate that SARS-CoV-2 virulence hinges upon the triggering of an aberrant host immune response, more so than on direct virus-induced cellular damage. To elucidate the immunopathology underlying COVID-19 severity, we perform cytokine and multiplex immune profiling in COVID-19 patients. We show that hypercytokinemia in COVID-19 differs from the interferon-gamma-driven cytokine storm in macrophage activation syndrome, and is more pronounced in critical versus","2021","07","13","Nat Commun","Nature communications","Aged; Antigen-Presenting Cells; COVID-19; Case-Control Studies; Cytokine Release Syndrome; Cytokines; Extracellular Traps; Female; Histocompatibility Antigens Class II; Humans; Immunophenotyping; Male; Middle Aged; Monocytes; Neutrophil Activation; SARS-CoV-2; Severity of Illness Index","Neyts","J","Laboratory of Virology and Chemotherapy, Department of Microbiology, Immunology and Transplantation, Rega Institute, KU Leuven, B Leuven, Belgium",NA
"981","34226537","10.1038/s41467-021-24360-w","Monocyte-driven atypical cytokine storm and aberrant neutrophil activation as key mediators of COVID-19 disease severity.","Epidemiological and clinical reports indicate that SARS-CoV-2 virulence hinges upon the triggering of an aberrant host immune response, more so than on direct virus-induced cellular damage. To elucidate the immunopathology underlying COVID-19 severity, we perform cytokine and multiplex immune profiling in COVID-19 patients. We show that hypercytokinemia in COVID-19 differs from the interferon-gamma-driven cytokine storm in macrophage activation syndrome, and is more pronounced in critical versus","2021","07","13","Nat Commun","Nature communications","Aged; Antigen-Presenting Cells; COVID-19; Case-Control Studies; Cytokine Release Syndrome; Cytokines; Extracellular Traps; Female; Histocompatibility Antigens Class II; Humans; Immunophenotyping; Male; Middle Aged; Monocytes; Neutrophil Activation; SARS-CoV-2; Severity of Illness Index","Odent","J","Department of Internal Medicine, University Hospitals Leuven, Leuven, Belgium",NA
"982","34226537","10.1038/s41467-021-24360-w","Monocyte-driven atypical cytokine storm and aberrant neutrophil activation as key mediators of COVID-19 disease severity.","Epidemiological and clinical reports indicate that SARS-CoV-2 virulence hinges upon the triggering of an aberrant host immune response, more so than on direct virus-induced cellular damage. To elucidate the immunopathology underlying COVID-19 severity, we perform cytokine and multiplex immune profiling in COVID-19 patients. We show that hypercytokinemia in COVID-19 differs from the interferon-gamma-driven cytokine storm in macrophage activation syndrome, and is more pronounced in critical versus","2021","07","13","Nat Commun","Nature communications","Aged; Antigen-Presenting Cells; COVID-19; Case-Control Studies; Cytokine Release Syndrome; Cytokines; Extracellular Traps; Female; Histocompatibility Antigens Class II; Humans; Immunophenotyping; Male; Middle Aged; Monocytes; Neutrophil Activation; SARS-CoV-2; Severity of Illness Index","Panovska","D","Laboratory for Precision Cancer Medicine, Translational Cell and Tissue Research, Department of Imaging &amp",NA
"983","34226537","10.1038/s41467-021-24360-w","Monocyte-driven atypical cytokine storm and aberrant neutrophil activation as key mediators of COVID-19 disease severity.","Epidemiological and clinical reports indicate that SARS-CoV-2 virulence hinges upon the triggering of an aberrant host immune response, more so than on direct virus-induced cellular damage. To elucidate the immunopathology underlying COVID-19 severity, we perform cytokine and multiplex immune profiling in COVID-19 patients. We show that hypercytokinemia in COVID-19 differs from the interferon-gamma-driven cytokine storm in macrophage activation syndrome, and is more pronounced in critical versus","2021","07","13","Nat Commun","Nature communications","Aged; Antigen-Presenting Cells; COVID-19; Case-Control Studies; Cytokine Release Syndrome; Cytokines; Extracellular Traps; Female; Histocompatibility Antigens Class II; Humans; Immunophenotyping; Male; Middle Aged; Monocytes; Neutrophil Activation; SARS-CoV-2; Severity of Illness Index","Penttila","P A","KU Leuven Flow &amp",NA
"984","34226537","10.1038/s41467-021-24360-w","Monocyte-driven atypical cytokine storm and aberrant neutrophil activation as key mediators of COVID-19 disease severity.","Epidemiological and clinical reports indicate that SARS-CoV-2 virulence hinges upon the triggering of an aberrant host immune response, more so than on direct virus-induced cellular damage. To elucidate the immunopathology underlying COVID-19 severity, we perform cytokine and multiplex immune profiling in COVID-19 patients. We show that hypercytokinemia in COVID-19 differs from the interferon-gamma-driven cytokine storm in macrophage activation syndrome, and is more pronounced in critical versus","2021","07","13","Nat Commun","Nature communications","Aged; Antigen-Presenting Cells; COVID-19; Case-Control Studies; Cytokine Release Syndrome; Cytokines; Extracellular Traps; Female; Histocompatibility Antigens Class II; Humans; Immunophenotyping; Male; Middle Aged; Monocytes; Neutrophil Activation; SARS-CoV-2; Severity of Illness Index","Pollet","E","Department of Internal Medicine, University Hospitals Leuven, Leuven, Belgium",NA
"985","34226537","10.1038/s41467-021-24360-w","Monocyte-driven atypical cytokine storm and aberrant neutrophil activation as key mediators of COVID-19 disease severity.","Epidemiological and clinical reports indicate that SARS-CoV-2 virulence hinges upon the triggering of an aberrant host immune response, more so than on direct virus-induced cellular damage. To elucidate the immunopathology underlying COVID-19 severity, we perform cytokine and multiplex immune profiling in COVID-19 patients. We show that hypercytokinemia in COVID-19 differs from the interferon-gamma-driven cytokine storm in macrophage activation syndrome, and is more pronounced in critical versus","2021","07","13","Nat Commun","Nature communications","Aged; Antigen-Presenting Cells; COVID-19; Case-Control Studies; Cytokine Release Syndrome; Cytokines; Extracellular Traps; Female; Histocompatibility Antigens Class II; Humans; Immunophenotyping; Male; Middle Aged; Monocytes; Neutrophil Activation; SARS-CoV-2; Severity of Illness Index","Proost","P","Laboratory of Molecular Immunology, Department of Microbiology, Immunology and Transplantation, Rega Institute, KU Leuven, Leuven, Belgium",NA
"986","34226537","10.1038/s41467-021-24360-w","Monocyte-driven atypical cytokine storm and aberrant neutrophil activation as key mediators of COVID-19 disease severity.","Epidemiological and clinical reports indicate that SARS-CoV-2 virulence hinges upon the triggering of an aberrant host immune response, more so than on direct virus-induced cellular damage. To elucidate the immunopathology underlying COVID-19 severity, we perform cytokine and multiplex immune profiling in COVID-19 patients. We show that hypercytokinemia in COVID-19 differs from the interferon-gamma-driven cytokine storm in macrophage activation syndrome, and is more pronounced in critical versus","2021","07","13","Nat Commun","Nature communications","Aged; Antigen-Presenting Cells; COVID-19; Case-Control Studies; Cytokine Release Syndrome; Cytokines; Extracellular Traps; Female; Histocompatibility Antigens Class II; Humans; Immunophenotyping; Male; Middle Aged; Monocytes; Neutrophil Activation; SARS-CoV-2; Severity of Illness Index","Qian","J","Laboratory of Translational Genetics, Department of Human Genetics, VIB-KU Leuven, Leuven, Belgium",NA
"987","34226537","10.1038/s41467-021-24360-w","Monocyte-driven atypical cytokine storm and aberrant neutrophil activation as key mediators of COVID-19 disease severity.","Epidemiological and clinical reports indicate that SARS-CoV-2 virulence hinges upon the triggering of an aberrant host immune response, more so than on direct virus-induced cellular damage. To elucidate the immunopathology underlying COVID-19 severity, we perform cytokine and multiplex immune profiling in COVID-19 patients. We show that hypercytokinemia in COVID-19 differs from the interferon-gamma-driven cytokine storm in macrophage activation syndrome, and is more pronounced in critical versus","2021","07","13","Nat Commun","Nature communications","Aged; Antigen-Presenting Cells; COVID-19; Case-Control Studies; Cytokine Release Syndrome; Cytokines; Extracellular Traps; Female; Histocompatibility Antigens Class II; Humans; Immunophenotyping; Male; Middle Aged; Monocytes; Neutrophil Activation; SARS-CoV-2; Severity of Illness Index","Quintelier","K","Department of Applied Mathematics, Computer Science and Statistics, VIB-UGent Center for Inflammation Research, VIB-UGent, Gent, Belgium",NA
"988","34226537","10.1038/s41467-021-24360-w","Monocyte-driven atypical cytokine storm and aberrant neutrophil activation as key mediators of COVID-19 disease severity.","Epidemiological and clinical reports indicate that SARS-CoV-2 virulence hinges upon the triggering of an aberrant host immune response, more so than on direct virus-induced cellular damage. To elucidate the immunopathology underlying COVID-19 severity, we perform cytokine and multiplex immune profiling in COVID-19 patients. We show that hypercytokinemia in COVID-19 differs from the interferon-gamma-driven cytokine storm in macrophage activation syndrome, and is more pronounced in critical versus","2021","07","13","Nat Commun","Nature communications","Aged; Antigen-Presenting Cells; COVID-19; Case-Control Studies; Cytokine Release Syndrome; Cytokines; Extracellular Traps; Female; Histocompatibility Antigens Class II; Humans; Immunophenotyping; Male; Middle Aged; Monocytes; Neutrophil Activation; SARS-CoV-2; Severity of Illness Index","Raes","J","Laboratory of Molecular Bacteriology (Rega Institute), Department of Microbiology, Immunology and Transplantation, KU Leuven, and VIB Center for Microbiology, Leuven, Belgium",NA
"989","34226537","10.1038/s41467-021-24360-w","Monocyte-driven atypical cytokine storm and aberrant neutrophil activation as key mediators of COVID-19 disease severity.","Epidemiological and clinical reports indicate that SARS-CoV-2 virulence hinges upon the triggering of an aberrant host immune response, more so than on direct virus-induced cellular damage. To elucidate the immunopathology underlying COVID-19 severity, we perform cytokine and multiplex immune profiling in COVID-19 patients. We show that hypercytokinemia in COVID-19 differs from the interferon-gamma-driven cytokine storm in macrophage activation syndrome, and is more pronounced in critical versus","2021","07","13","Nat Commun","Nature communications","Aged; Antigen-Presenting Cells; COVID-19; Case-Control Studies; Cytokine Release Syndrome; Cytokines; Extracellular Traps; Female; Histocompatibility Antigens Class II; Humans; Immunophenotyping; Male; Middle Aged; Monocytes; Neutrophil Activation; SARS-CoV-2; Severity of Illness Index","Rex","S","Anesthesiology and Algology, Department of Cardiovascular Sciences, KU Leuven, Leuven, Belgium",NA
"990","34226537","10.1038/s41467-021-24360-w","Monocyte-driven atypical cytokine storm and aberrant neutrophil activation as key mediators of COVID-19 disease severity.","Epidemiological and clinical reports indicate that SARS-CoV-2 virulence hinges upon the triggering of an aberrant host immune response, more so than on direct virus-induced cellular damage. To elucidate the immunopathology underlying COVID-19 severity, we perform cytokine and multiplex immune profiling in COVID-19 patients. We show that hypercytokinemia in COVID-19 differs from the interferon-gamma-driven cytokine storm in macrophage activation syndrome, and is more pronounced in critical versus","2021","07","13","Nat Commun","Nature communications","Aged; Antigen-Presenting Cells; COVID-19; Case-Control Studies; Cytokine Release Syndrome; Cytokines; Extracellular Traps; Female; Histocompatibility Antigens Class II; Humans; Immunophenotyping; Male; Middle Aged; Monocytes; Neutrophil Activation; SARS-CoV-2; Severity of Illness Index","Saeys","Y","Department of Applied Mathematics, Computer Science and Statistics, VIB-UGent Center for Inflammation Research, VIB-UGent, Gent, Belgium",NA
"991","34226537","10.1038/s41467-021-24360-w","Monocyte-driven atypical cytokine storm and aberrant neutrophil activation as key mediators of COVID-19 disease severity.","Epidemiological and clinical reports indicate that SARS-CoV-2 virulence hinges upon the triggering of an aberrant host immune response, more so than on direct virus-induced cellular damage. To elucidate the immunopathology underlying COVID-19 severity, we perform cytokine and multiplex immune profiling in COVID-19 patients. We show that hypercytokinemia in COVID-19 differs from the interferon-gamma-driven cytokine storm in macrophage activation syndrome, and is more pronounced in critical versus","2021","07","13","Nat Commun","Nature communications","Aged; Antigen-Presenting Cells; COVID-19; Case-Control Studies; Cytokine Release Syndrome; Cytokines; Extracellular Traps; Female; Histocompatibility Antigens Class II; Humans; Immunophenotyping; Male; Middle Aged; Monocytes; Neutrophil Activation; SARS-CoV-2; Severity of Illness Index","Sprooten","J","Laboratory for Cell Stress &amp",NA
"992","34226537","10.1038/s41467-021-24360-w","Monocyte-driven atypical cytokine storm and aberrant neutrophil activation as key mediators of COVID-19 disease severity.","Epidemiological and clinical reports indicate that SARS-CoV-2 virulence hinges upon the triggering of an aberrant host immune response, more so than on direct virus-induced cellular damage. To elucidate the immunopathology underlying COVID-19 severity, we perform cytokine and multiplex immune profiling in COVID-19 patients. We show that hypercytokinemia in COVID-19 differs from the interferon-gamma-driven cytokine storm in macrophage activation syndrome, and is more pronounced in critical versus","2021","07","13","Nat Commun","Nature communications","Aged; Antigen-Presenting Cells; COVID-19; Case-Control Studies; Cytokine Release Syndrome; Cytokines; Extracellular Traps; Female; Histocompatibility Antigens Class II; Humans; Immunophenotyping; Male; Middle Aged; Monocytes; Neutrophil Activation; SARS-CoV-2; Severity of Illness Index","Tejpar","S","Molecular Digestive Oncology, Department of Oncology, KU Leuven, Leuven, Belgium",NA
"993","34226537","10.1038/s41467-021-24360-w","Monocyte-driven atypical cytokine storm and aberrant neutrophil activation as key mediators of COVID-19 disease severity.","Epidemiological and clinical reports indicate that SARS-CoV-2 virulence hinges upon the triggering of an aberrant host immune response, more so than on direct virus-induced cellular damage. To elucidate the immunopathology underlying COVID-19 severity, we perform cytokine and multiplex immune profiling in COVID-19 patients. We show that hypercytokinemia in COVID-19 differs from the interferon-gamma-driven cytokine storm in macrophage activation syndrome, and is more pronounced in critical versus","2021","07","13","Nat Commun","Nature communications","Aged; Antigen-Presenting Cells; COVID-19; Case-Control Studies; Cytokine Release Syndrome; Cytokines; Extracellular Traps; Female; Histocompatibility Antigens Class II; Humans; Immunophenotyping; Male; Middle Aged; Monocytes; Neutrophil Activation; SARS-CoV-2; Severity of Illness Index","Testelmans","D","Laboratory of Respiratory Diseases and Thoracic Surgery (BREATHE), Department of Chronic Diseases and Metabolism, KU Leuven, Leuven, Belgium",NA
"994","34226537","10.1038/s41467-021-24360-w","Monocyte-driven atypical cytokine storm and aberrant neutrophil activation as key mediators of COVID-19 disease severity.","Epidemiological and clinical reports indicate that SARS-CoV-2 virulence hinges upon the triggering of an aberrant host immune response, more so than on direct virus-induced cellular damage. To elucidate the immunopathology underlying COVID-19 severity, we perform cytokine and multiplex immune profiling in COVID-19 patients. We show that hypercytokinemia in COVID-19 differs from the interferon-gamma-driven cytokine storm in macrophage activation syndrome, and is more pronounced in critical versus","2021","07","13","Nat Commun","Nature communications","Aged; Antigen-Presenting Cells; COVID-19; Case-Control Studies; Cytokine Release Syndrome; Cytokines; Extracellular Traps; Female; Histocompatibility Antigens Class II; Humans; Immunophenotyping; Male; Middle Aged; Monocytes; Neutrophil Activation; SARS-CoV-2; Severity of Illness Index","Thevissen","K","Centre of Microbial and Plant Genetics, Department of Microbial and Molecular Systems (M2S), KU Leuven, Leuven, Belgium",NA
"995","34226537","10.1038/s41467-021-24360-w","Monocyte-driven atypical cytokine storm and aberrant neutrophil activation as key mediators of COVID-19 disease severity.","Epidemiological and clinical reports indicate that SARS-CoV-2 virulence hinges upon the triggering of an aberrant host immune response, more so than on direct virus-induced cellular damage. To elucidate the immunopathology underlying COVID-19 severity, we perform cytokine and multiplex immune profiling in COVID-19 patients. We show that hypercytokinemia in COVID-19 differs from the interferon-gamma-driven cytokine storm in macrophage activation syndrome, and is more pronounced in critical versus","2021","07","13","Nat Commun","Nature communications","Aged; Antigen-Presenting Cells; COVID-19; Case-Control Studies; Cytokine Release Syndrome; Cytokines; Extracellular Traps; Female; Histocompatibility Antigens Class II; Humans; Immunophenotyping; Male; Middle Aged; Monocytes; Neutrophil Activation; SARS-CoV-2; Severity of Illness Index","Van Buyten","T","Laboratory of Virology and Chemotherapy, Department of Microbiology, Immunology and Transplantation, Rega Institute, KU Leuven, B Leuven, Belgium",NA
"996","34226537","10.1038/s41467-021-24360-w","Monocyte-driven atypical cytokine storm and aberrant neutrophil activation as key mediators of COVID-19 disease severity.","Epidemiological and clinical reports indicate that SARS-CoV-2 virulence hinges upon the triggering of an aberrant host immune response, more so than on direct virus-induced cellular damage. To elucidate the immunopathology underlying COVID-19 severity, we perform cytokine and multiplex immune profiling in COVID-19 patients. We show that hypercytokinemia in COVID-19 differs from the interferon-gamma-driven cytokine storm in macrophage activation syndrome, and is more pronounced in critical versus","2021","07","13","Nat Commun","Nature communications","Aged; Antigen-Presenting Cells; COVID-19; Case-Control Studies; Cytokine Release Syndrome; Cytokines; Extracellular Traps; Female; Histocompatibility Antigens Class II; Humans; Immunophenotyping; Male; Middle Aged; Monocytes; Neutrophil Activation; SARS-CoV-2; Severity of Illness Index","Vandenhaute","J","Laboratory of Immunobiology, Department of Microbiology, Immunology and Transplantation, Rega Institute, KU Leuven, Leuven, Belgium",NA
"997","34226537","10.1038/s41467-021-24360-w","Monocyte-driven atypical cytokine storm and aberrant neutrophil activation as key mediators of COVID-19 disease severity.","Epidemiological and clinical reports indicate that SARS-CoV-2 virulence hinges upon the triggering of an aberrant host immune response, more so than on direct virus-induced cellular damage. To elucidate the immunopathology underlying COVID-19 severity, we perform cytokine and multiplex immune profiling in COVID-19 patients. We show that hypercytokinemia in COVID-19 differs from the interferon-gamma-driven cytokine storm in macrophage activation syndrome, and is more pronounced in critical versus","2021","07","13","Nat Commun","Nature communications","Aged; Antigen-Presenting Cells; COVID-19; Case-Control Studies; Cytokine Release Syndrome; Cytokines; Extracellular Traps; Female; Histocompatibility Antigens Class II; Humans; Immunophenotyping; Male; Middle Aged; Monocytes; Neutrophil Activation; SARS-CoV-2; Severity of Illness Index","Van Gassen","S","Department of Applied Mathematics, Computer Science and Statistics, VIB-UGent Center for Inflammation Research, VIB-UGent, Gent, Belgium",NA
"998","34226537","10.1038/s41467-021-24360-w","Monocyte-driven atypical cytokine storm and aberrant neutrophil activation as key mediators of COVID-19 disease severity.","Epidemiological and clinical reports indicate that SARS-CoV-2 virulence hinges upon the triggering of an aberrant host immune response, more so than on direct virus-induced cellular damage. To elucidate the immunopathology underlying COVID-19 severity, we perform cytokine and multiplex immune profiling in COVID-19 patients. We show that hypercytokinemia in COVID-19 differs from the interferon-gamma-driven cytokine storm in macrophage activation syndrome, and is more pronounced in critical versus","2021","07","13","Nat Commun","Nature communications","Aged; Antigen-Presenting Cells; COVID-19; Case-Control Studies; Cytokine Release Syndrome; Cytokines; Extracellular Traps; Female; Histocompatibility Antigens Class II; Humans; Immunophenotyping; Male; Middle Aged; Monocytes; Neutrophil Activation; SARS-CoV-2; Severity of Illness Index","Velásquez Pereira","L C","Centre for Molecular and Vascular Biology, Department of Cardiovascular Sciences, KU Leuven, Leuven, Belgium",NA
"999","34226537","10.1038/s41467-021-24360-w","Monocyte-driven atypical cytokine storm and aberrant neutrophil activation as key mediators of COVID-19 disease severity.","Epidemiological and clinical reports indicate that SARS-CoV-2 virulence hinges upon the triggering of an aberrant host immune response, more so than on direct virus-induced cellular damage. To elucidate the immunopathology underlying COVID-19 severity, we perform cytokine and multiplex immune profiling in COVID-19 patients. We show that hypercytokinemia in COVID-19 differs from the interferon-gamma-driven cytokine storm in macrophage activation syndrome, and is more pronounced in critical versus","2021","07","13","Nat Commun","Nature communications","Aged; Antigen-Presenting Cells; COVID-19; Case-Control Studies; Cytokine Release Syndrome; Cytokines; Extracellular Traps; Female; Histocompatibility Antigens Class II; Humans; Immunophenotyping; Male; Middle Aged; Monocytes; Neutrophil Activation; SARS-CoV-2; Severity of Illness Index","Vos","R","Laboratory of Respiratory Diseases and Thoracic Surgery (BREATHE), Department of Chronic Diseases and Metabolism, KU Leuven, Leuven, Belgium",NA
"1000","34226537","10.1038/s41467-021-24360-w","Monocyte-driven atypical cytokine storm and aberrant neutrophil activation as key mediators of COVID-19 disease severity.","Epidemiological and clinical reports indicate that SARS-CoV-2 virulence hinges upon the triggering of an aberrant host immune response, more so than on direct virus-induced cellular damage. To elucidate the immunopathology underlying COVID-19 severity, we perform cytokine and multiplex immune profiling in COVID-19 patients. We show that hypercytokinemia in COVID-19 differs from the interferon-gamma-driven cytokine storm in macrophage activation syndrome, and is more pronounced in critical versus","2021","07","13","Nat Commun","Nature communications","Aged; Antigen-Presenting Cells; COVID-19; Case-Control Studies; Cytokine Release Syndrome; Cytokines; Extracellular Traps; Female; Histocompatibility Antigens Class II; Humans; Immunophenotyping; Male; Middle Aged; Monocytes; Neutrophil Activation; SARS-CoV-2; Severity of Illness Index","Weynand","B","Translational Cell &amp",NA
"1001","34226537","10.1038/s41467-021-24360-w","Monocyte-driven atypical cytokine storm and aberrant neutrophil activation as key mediators of COVID-19 disease severity.","Epidemiological and clinical reports indicate that SARS-CoV-2 virulence hinges upon the triggering of an aberrant host immune response, more so than on direct virus-induced cellular damage. To elucidate the immunopathology underlying COVID-19 severity, we perform cytokine and multiplex immune profiling in COVID-19 patients. We show that hypercytokinemia in COVID-19 differs from the interferon-gamma-driven cytokine storm in macrophage activation syndrome, and is more pronounced in critical versus","2021","07","13","Nat Commun","Nature communications","Aged; Antigen-Presenting Cells; COVID-19; Case-Control Studies; Cytokine Release Syndrome; Cytokines; Extracellular Traps; Female; Histocompatibility Antigens Class II; Humans; Immunophenotyping; Male; Middle Aged; Monocytes; Neutrophil Activation; SARS-CoV-2; Severity of Illness Index","Wilmer","A","Laboratory for Clinical Infectious and Inflammatory Disorders, Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium",NA
"1002","34226537","10.1038/s41467-021-24360-w","Monocyte-driven atypical cytokine storm and aberrant neutrophil activation as key mediators of COVID-19 disease severity.","Epidemiological and clinical reports indicate that SARS-CoV-2 virulence hinges upon the triggering of an aberrant host immune response, more so than on direct virus-induced cellular damage. To elucidate the immunopathology underlying COVID-19 severity, we perform cytokine and multiplex immune profiling in COVID-19 patients. We show that hypercytokinemia in COVID-19 differs from the interferon-gamma-driven cytokine storm in macrophage activation syndrome, and is more pronounced in critical versus","2021","07","13","Nat Commun","Nature communications","Aged; Antigen-Presenting Cells; COVID-19; Case-Control Studies; Cytokine Release Syndrome; Cytokines; Extracellular Traps; Female; Histocompatibility Antigens Class II; Humans; Immunophenotyping; Male; Middle Aged; Monocytes; Neutrophil Activation; SARS-CoV-2; Severity of Illness Index","Yserbyt","J","Laboratory of Respiratory Diseases and Thoracic Surgery (BREATHE), Department of Chronic Diseases and Metabolism, KU Leuven, Leuven, Belgium",NA
"1003","34226537","10.1038/s41467-021-24360-w","Monocyte-driven atypical cytokine storm and aberrant neutrophil activation as key mediators of COVID-19 disease severity.","Epidemiological and clinical reports indicate that SARS-CoV-2 virulence hinges upon the triggering of an aberrant host immune response, more so than on direct virus-induced cellular damage. To elucidate the immunopathology underlying COVID-19 severity, we perform cytokine and multiplex immune profiling in COVID-19 patients. We show that hypercytokinemia in COVID-19 differs from the interferon-gamma-driven cytokine storm in macrophage activation syndrome, and is more pronounced in critical versus","2021","07","13","Nat Commun","Nature communications","Aged; Antigen-Presenting Cells; COVID-19; Case-Control Studies; Cytokine Release Syndrome; Cytokines; Extracellular Traps; Female; Histocompatibility Antigens Class II; Humans; Immunophenotyping; Male; Middle Aged; Monocytes; Neutrophil Activation; SARS-CoV-2; Severity of Illness Index","Garg","A D","Laboratory for Cell Stress &amp",NA
"1004","34226537","10.1038/s41467-021-24360-w","Monocyte-driven atypical cytokine storm and aberrant neutrophil activation as key mediators of COVID-19 disease severity.","Epidemiological and clinical reports indicate that SARS-CoV-2 virulence hinges upon the triggering of an aberrant host immune response, more so than on direct virus-induced cellular damage. To elucidate the immunopathology underlying COVID-19 severity, we perform cytokine and multiplex immune profiling in COVID-19 patients. We show that hypercytokinemia in COVID-19 differs from the interferon-gamma-driven cytokine storm in macrophage activation syndrome, and is more pronounced in critical versus","2021","07","13","Nat Commun","Nature communications","Aged; Antigen-Presenting Cells; COVID-19; Case-Control Studies; Cytokine Release Syndrome; Cytokines; Extracellular Traps; Female; Histocompatibility Antigens Class II; Humans; Immunophenotyping; Male; Middle Aged; Monocytes; Neutrophil Activation; SARS-CoV-2; Severity of Illness Index","Matthys","P","Laboratory of Immunobiology, Department of Microbiology, Immunology and Transplantation, Rega Institute, KU Leuven, Leuven, Belgium",NA
"1005","34226537","10.1038/s41467-021-24360-w","Monocyte-driven atypical cytokine storm and aberrant neutrophil activation as key mediators of COVID-19 disease severity.","Epidemiological and clinical reports indicate that SARS-CoV-2 virulence hinges upon the triggering of an aberrant host immune response, more so than on direct virus-induced cellular damage. To elucidate the immunopathology underlying COVID-19 severity, we perform cytokine and multiplex immune profiling in COVID-19 patients. We show that hypercytokinemia in COVID-19 differs from the interferon-gamma-driven cytokine storm in macrophage activation syndrome, and is more pronounced in critical versus","2021","07","13","Nat Commun","Nature communications","Aged; Antigen-Presenting Cells; COVID-19; Case-Control Studies; Cytokine Release Syndrome; Cytokines; Extracellular Traps; Female; Histocompatibility Antigens Class II; Humans; Immunophenotyping; Male; Middle Aged; Monocytes; Neutrophil Activation; SARS-CoV-2; Severity of Illness Index","Wouters","C","Adaptive Immunology, Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium",NA
"1006","34226537","10.1038/s41467-021-24360-w","Monocyte-driven atypical cytokine storm and aberrant neutrophil activation as key mediators of COVID-19 disease severity.","Epidemiological and clinical reports indicate that SARS-CoV-2 virulence hinges upon the triggering of an aberrant host immune response, more so than on direct virus-induced cellular damage. To elucidate the immunopathology underlying COVID-19 severity, we perform cytokine and multiplex immune profiling in COVID-19 patients. We show that hypercytokinemia in COVID-19 differs from the interferon-gamma-driven cytokine storm in macrophage activation syndrome, and is more pronounced in critical versus","2021","07","13","Nat Commun","Nature communications","Aged; Antigen-Presenting Cells; COVID-19; Case-Control Studies; Cytokine Release Syndrome; Cytokines; Extracellular Traps; Female; Histocompatibility Antigens Class II; Humans; Immunophenotyping; Male; Middle Aged; Monocytes; Neutrophil Activation; SARS-CoV-2; Severity of Illness Index","Lambrechts","D","Laboratory of Translational Genetics, Department of Human Genetics, VIB-KU Leuven, Leuven, Belgium",NA
"1007","34226537","10.1038/s41467-021-24360-w","Monocyte-driven atypical cytokine storm and aberrant neutrophil activation as key mediators of COVID-19 disease severity.","Epidemiological and clinical reports indicate that SARS-CoV-2 virulence hinges upon the triggering of an aberrant host immune response, more so than on direct virus-induced cellular damage. To elucidate the immunopathology underlying COVID-19 severity, we perform cytokine and multiplex immune profiling in COVID-19 patients. We show that hypercytokinemia in COVID-19 differs from the interferon-gamma-driven cytokine storm in macrophage activation syndrome, and is more pronounced in critical versus","2021","07","13","Nat Commun","Nature communications","Aged; Antigen-Presenting Cells; COVID-19; Case-Control Studies; Cytokine Release Syndrome; Cytokines; Extracellular Traps; Female; Histocompatibility Antigens Class II; Humans; Immunophenotyping; Male; Middle Aged; Monocytes; Neutrophil Activation; SARS-CoV-2; Severity of Illness Index","Wauters","E","Laboratory of Respiratory Diseases and Thoracic Surgery (BREATHE), Department of Chronic Diseases and Metabolism, KU Leuven, Leuven, Belgium. els.wauters@kuleuven","els.wauters@kuleuven.be"
"1008","34226537","10.1038/s41467-021-24360-w","Monocyte-driven atypical cytokine storm and aberrant neutrophil activation as key mediators of COVID-19 disease severity.","Epidemiological and clinical reports indicate that SARS-CoV-2 virulence hinges upon the triggering of an aberrant host immune response, more so than on direct virus-induced cellular damage. To elucidate the immunopathology underlying COVID-19 severity, we perform cytokine and multiplex immune profiling in COVID-19 patients. We show that hypercytokinemia in COVID-19 differs from the interferon-gamma-driven cytokine storm in macrophage activation syndrome, and is more pronounced in critical versus","2021","07","13","Nat Commun","Nature communications","Aged; Antigen-Presenting Cells; COVID-19; Case-Control Studies; Cytokine Release Syndrome; Cytokines; Extracellular Traps; Female; Histocompatibility Antigens Class II; Humans; Immunophenotyping; Male; Middle Aged; Monocytes; Neutrophil Activation; SARS-CoV-2; Severity of Illness Index","Wauters","J","Laboratory for Clinical Infectious and Inflammatory Disorders, Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium",NA
"1009","34226530","10.1038/s41421-021-00289-8","A virus-derived microRNA-like small RNA serves as a serum biomarker to prioritize the COVID-19 patients at high risk of developing severe disease.",NA,"2021","07","24","Cell Discov","Cell discovery",NA,"Fu","Zheng","Nanjing Drum Tower Hospital Center of Molecular Diagnostic and Therapy, Chinese Academy of Medical Sciences Research Unit of Extracellular RNA, State Key Laboratory of Pharmaceutical Biotechnology, Jiangsu Engineering Research Center for MicroRNA Biology and Biotechnology, NJU Advanced Institute of Life Sciences (NAILS), Chemistry and Biomedicine Innovation Center, Institute of Artificial Intelligence Biomedicine, School of Life Sciences, Nanjing University, Nanjing, Jiangsu, China",NA
"1010","34226530","10.1038/s41421-021-00289-8","A virus-derived microRNA-like small RNA serves as a serum biomarker to prioritize the COVID-19 patients at high risk of developing severe disease.",NA,"2021","07","24","Cell Discov","Cell discovery",NA,"Wang","Jian","Department of Clinical Laboratory, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China",NA
"1011","34226530","10.1038/s41421-021-00289-8","A virus-derived microRNA-like small RNA serves as a serum biomarker to prioritize the COVID-19 patients at high risk of developing severe disease.",NA,"2021","07","24","Cell Discov","Cell discovery",NA,"Wang","Zheng","Department of Gastrointestinal Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China",NA
"1012","34226530","10.1038/s41421-021-00289-8","A virus-derived microRNA-like small RNA serves as a serum biomarker to prioritize the COVID-19 patients at high risk of developing severe disease.",NA,"2021","07","24","Cell Discov","Cell discovery",NA,"Sun","Ying","Nanjing Drum Tower Hospital Center of Molecular Diagnostic and Therapy, Chinese Academy of Medical Sciences Research Unit of Extracellular RNA, State Key Laboratory of Pharmaceutical Biotechnology, Jiangsu Engineering Research Center for MicroRNA Biology and Biotechnology, NJU Advanced Institute of Life Sciences (NAILS), Chemistry and Biomedicine Innovation Center, Institute of Artificial Intelligence Biomedicine, School of Life Sciences, Nanjing University, Nanjing, Jiangsu, China",NA
"1013","34226530","10.1038/s41421-021-00289-8","A virus-derived microRNA-like small RNA serves as a serum biomarker to prioritize the COVID-19 patients at high risk of developing severe disease.",NA,"2021","07","24","Cell Discov","Cell discovery",NA,"Wu","Jian","COVID-19 Research Center, Institute of Laboratory Medicine, Jinling Hospital, Nanjing University School of Medicine, Nanjing, Jiangsu, China",NA
"1014","34226530","10.1038/s41421-021-00289-8","A virus-derived microRNA-like small RNA serves as a serum biomarker to prioritize the COVID-19 patients at high risk of developing severe disease.",NA,"2021","07","24","Cell Discov","Cell discovery",NA,"Zhang","Yongchen","Department of Laboratory Medicine, The Second Hospital of Nanjing, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China",NA
"1015","34226530","10.1038/s41421-021-00289-8","A virus-derived microRNA-like small RNA serves as a serum biomarker to prioritize the COVID-19 patients at high risk of developing severe disease.",NA,"2021","07","24","Cell Discov","Cell discovery",NA,"Liu","Xingxiang","Huai'an Fourth Hospital, Huai'an, Jiangsu, China",NA
"1016","34226530","10.1038/s41421-021-00289-8","A virus-derived microRNA-like small RNA serves as a serum biomarker to prioritize the COVID-19 patients at high risk of developing severe disease.",NA,"2021","07","24","Cell Discov","Cell discovery",NA,"Zhou","Zhen","Nanjing Drum Tower Hospital Center of Molecular Diagnostic and Therapy, Chinese Academy of Medical Sciences Research Unit of Extracellular RNA, State Key Laboratory of Pharmaceutical Biotechnology, Jiangsu Engineering Research Center for MicroRNA Biology and Biotechnology, NJU Advanced Institute of Life Sciences (NAILS), Chemistry and Biomedicine Innovation Center, Institute of Artificial Intelligence Biomedicine, School of Life Sciences, Nanjing University, Nanjing, Jiangsu, China",NA
"1017","34226530","10.1038/s41421-021-00289-8","A virus-derived microRNA-like small RNA serves as a serum biomarker to prioritize the COVID-19 patients at high risk of developing severe disease.",NA,"2021","07","24","Cell Discov","Cell discovery",NA,"Zhou","Likun","Nanjing Drum Tower Hospital Center of Molecular Diagnostic and Therapy, Chinese Academy of Medical Sciences Research Unit of Extracellular RNA, State Key Laboratory of Pharmaceutical Biotechnology, Jiangsu Engineering Research Center for MicroRNA Biology and Biotechnology, NJU Advanced Institute of Life Sciences (NAILS), Chemistry and Biomedicine Innovation Center, Institute of Artificial Intelligence Biomedicine, School of Life Sciences, Nanjing University, Nanjing, Jiangsu, China",NA
"1018","34226530","10.1038/s41421-021-00289-8","A virus-derived microRNA-like small RNA serves as a serum biomarker to prioritize the COVID-19 patients at high risk of developing severe disease.",NA,"2021","07","24","Cell Discov","Cell discovery",NA,"Zhang","Chen-Yu","Nanjing Drum Tower Hospital Center of Molecular Diagnostic and Therapy, Chinese Academy of Medical Sciences Research Unit of Extracellular RNA, State Key Laboratory of Pharmaceutical Biotechnology, Jiangsu Engineering Research Center for MicroRNA Biology and Biotechnology, NJU Advanced Institute of Life Sciences (NAILS), Chemistry and Biomedicine Innovation Center, Institute of Artificial Intelligence Biomedicine, School of Life Sciences, Nanjing University, Nanjing, Jiangsu, China. cyzhang@nju.edu","cyzhang@nju.edu.cn"
"1019","34226530","10.1038/s41421-021-00289-8","A virus-derived microRNA-like small RNA serves as a serum biomarker to prioritize the COVID-19 patients at high risk of developing severe disease.",NA,"2021","07","24","Cell Discov","Cell discovery",NA,"Yi","Yongxiang","Department of Laboratory Medicine, The Second Hospital of Nanjing, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China. ian0216@126","ian0216@126.com"
"1020","34226530","10.1038/s41421-021-00289-8","A virus-derived microRNA-like small RNA serves as a serum biomarker to prioritize the COVID-19 patients at high risk of developing severe disease.",NA,"2021","07","24","Cell Discov","Cell discovery",NA,"Xia","Xinyi","COVID-19 Research Center, Institute of Laboratory Medicine, Jinling Hospital, Nanjing University School of Medicine, Nanjing, Jiangsu, China. xiaxynju@nju.edu","xiaxynju@nju.edu.cn"
"1021","34226530","10.1038/s41421-021-00289-8","A virus-derived microRNA-like small RNA serves as a serum biomarker to prioritize the COVID-19 patients at high risk of developing severe disease.",NA,"2021","07","24","Cell Discov","Cell discovery",NA,"Wang","Lin","Department of Clinical Laboratory, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China. wang@hust.edu","wang@hust.edu.cn"
"1022","34226530","10.1038/s41421-021-00289-8","A virus-derived microRNA-like small RNA serves as a serum biomarker to prioritize the COVID-19 patients at high risk of developing severe disease.",NA,"2021","07","24","Cell Discov","Cell discovery",NA,"Chen","Xi","Nanjing Drum Tower Hospital Center of Molecular Diagnostic and Therapy, Chinese Academy of Medical Sciences Research Unit of Extracellular RNA, State Key Laboratory of Pharmaceutical Biotechnology, Jiangsu Engineering Research Center for MicroRNA Biology and Biotechnology, NJU Advanced Institute of Life Sciences (NAILS), Chemistry and Biomedicine Innovation Center, Institute of Artificial Intelligence Biomedicine, School of Life Sciences, Nanjing University, Nanjing, Jiangsu, China. xichen@nju.edu","xichen@nju.edu.cn"
"1023","34226510","10.1038/s41398-021-01503-7","Possible posttraumatic stress disorder in Chinese frontline healthcare workers who survived COVID-19 6 months after the COVID-19 outbreak: prevalence, correlates, and symptoms.","Suffering from COVID-19 and witnessing the suffering and deaths of patients with COVID-19 may place frontline healthcare workers (HCWs) at particularly high risk for posttraumatic stress disorder (PTSD); however, few data are available on the clinical characteristics of PTSD among frontline HCWs who survived COVID-19 (""surviving HCWs"" hereafter). The present study examined the prevalence, correlates, and clinical symptoms of possible PTSD in surviving HCWs 6 months after the COVID-19 outbreak in","2021","07","09","Transl Psychiatry","Translational psychiatry","COVID-19; China; Disease Outbreaks; Health Personnel; Humans; Prevalence; SARS-CoV-2; Stress Disorders, Post-Traumatic","Xiong","Li-Juan","Department of Nosocomial Infection Management, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, Hubei, China",NA
"1024","34226510","10.1038/s41398-021-01503-7","Possible posttraumatic stress disorder in Chinese frontline healthcare workers who survived COVID-19 6 months after the COVID-19 outbreak: prevalence, correlates, and symptoms.","Suffering from COVID-19 and witnessing the suffering and deaths of patients with COVID-19 may place frontline healthcare workers (HCWs) at particularly high risk for posttraumatic stress disorder (PTSD); however, few data are available on the clinical characteristics of PTSD among frontline HCWs who survived COVID-19 (""surviving HCWs"" hereafter). The present study examined the prevalence, correlates, and clinical symptoms of possible PTSD in surviving HCWs 6 months after the COVID-19 outbreak in","2021","07","09","Transl Psychiatry","Translational psychiatry","COVID-19; China; Disease Outbreaks; Health Personnel; Humans; Prevalence; SARS-CoV-2; Stress Disorders, Post-Traumatic","Zhong","Bao-Liang","Affiliated Wuhan Mental Health Center, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, 430012, Hubei province, China",NA
"1025","34226510","10.1038/s41398-021-01503-7","Possible posttraumatic stress disorder in Chinese frontline healthcare workers who survived COVID-19 6 months after the COVID-19 outbreak: prevalence, correlates, and symptoms.","Suffering from COVID-19 and witnessing the suffering and deaths of patients with COVID-19 may place frontline healthcare workers (HCWs) at particularly high risk for posttraumatic stress disorder (PTSD); however, few data are available on the clinical characteristics of PTSD among frontline HCWs who survived COVID-19 (""surviving HCWs"" hereafter). The present study examined the prevalence, correlates, and clinical symptoms of possible PTSD in surviving HCWs 6 months after the COVID-19 outbreak in","2021","07","09","Transl Psychiatry","Translational psychiatry","COVID-19; China; Disease Outbreaks; Health Personnel; Humans; Prevalence; SARS-CoV-2; Stress Disorders, Post-Traumatic","Cao","Xiong-Jing","Department of Nosocomial Infection Management, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, Hubei, China",NA
"1026","34226510","10.1038/s41398-021-01503-7","Possible posttraumatic stress disorder in Chinese frontline healthcare workers who survived COVID-19 6 months after the COVID-19 outbreak: prevalence, correlates, and symptoms.","Suffering from COVID-19 and witnessing the suffering and deaths of patients with COVID-19 may place frontline healthcare workers (HCWs) at particularly high risk for posttraumatic stress disorder (PTSD); however, few data are available on the clinical characteristics of PTSD among frontline HCWs who survived COVID-19 (""surviving HCWs"" hereafter). The present study examined the prevalence, correlates, and clinical symptoms of possible PTSD in surviving HCWs 6 months after the COVID-19 outbreak in","2021","07","09","Transl Psychiatry","Translational psychiatry","COVID-19; China; Disease Outbreaks; Health Personnel; Humans; Prevalence; SARS-CoV-2; Stress Disorders, Post-Traumatic","Xiong","Huang-Guo","Department of Nosocomial Infection Management, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, Hubei, China",NA
"1027","34226510","10.1038/s41398-021-01503-7","Possible posttraumatic stress disorder in Chinese frontline healthcare workers who survived COVID-19 6 months after the COVID-19 outbreak: prevalence, correlates, and symptoms.","Suffering from COVID-19 and witnessing the suffering and deaths of patients with COVID-19 may place frontline healthcare workers (HCWs) at particularly high risk for posttraumatic stress disorder (PTSD); however, few data are available on the clinical characteristics of PTSD among frontline HCWs who survived COVID-19 (""surviving HCWs"" hereafter). The present study examined the prevalence, correlates, and clinical symptoms of possible PTSD in surviving HCWs 6 months after the COVID-19 outbreak in","2021","07","09","Transl Psychiatry","Translational psychiatry","COVID-19; China; Disease Outbreaks; Health Personnel; Humans; Prevalence; SARS-CoV-2; Stress Disorders, Post-Traumatic","Huang","Ming","State Key Laboratory of Component-Based Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, 301617, China",NA
"1028","34226510","10.1038/s41398-021-01503-7","Possible posttraumatic stress disorder in Chinese frontline healthcare workers who survived COVID-19 6 months after the COVID-19 outbreak: prevalence, correlates, and symptoms.","Suffering from COVID-19 and witnessing the suffering and deaths of patients with COVID-19 may place frontline healthcare workers (HCWs) at particularly high risk for posttraumatic stress disorder (PTSD); however, few data are available on the clinical characteristics of PTSD among frontline HCWs who survived COVID-19 (""surviving HCWs"" hereafter). The present study examined the prevalence, correlates, and clinical symptoms of possible PTSD in surviving HCWs 6 months after the COVID-19 outbreak in","2021","07","09","Transl Psychiatry","Translational psychiatry","COVID-19; China; Disease Outbreaks; Health Personnel; Humans; Prevalence; SARS-CoV-2; Stress Disorders, Post-Traumatic","Ding","Jing","Research Center for Psychological and Health Sciences, China University of Geosciences, Wuhan, 430074, Hubei province, China",NA
"1029","34226510","10.1038/s41398-021-01503-7","Possible posttraumatic stress disorder in Chinese frontline healthcare workers who survived COVID-19 6 months after the COVID-19 outbreak: prevalence, correlates, and symptoms.","Suffering from COVID-19 and witnessing the suffering and deaths of patients with COVID-19 may place frontline healthcare workers (HCWs) at particularly high risk for posttraumatic stress disorder (PTSD); however, few data are available on the clinical characteristics of PTSD among frontline HCWs who survived COVID-19 (""surviving HCWs"" hereafter). The present study examined the prevalence, correlates, and clinical symptoms of possible PTSD in surviving HCWs 6 months after the COVID-19 outbreak in","2021","07","09","Transl Psychiatry","Translational psychiatry","COVID-19; China; Disease Outbreaks; Health Personnel; Humans; Prevalence; SARS-CoV-2; Stress Disorders, Post-Traumatic","Li","Wen-Tian","Affiliated Wuhan Mental Health Center, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, 430012, Hubei province, China",NA
"1030","34226510","10.1038/s41398-021-01503-7","Possible posttraumatic stress disorder in Chinese frontline healthcare workers who survived COVID-19 6 months after the COVID-19 outbreak: prevalence, correlates, and symptoms.","Suffering from COVID-19 and witnessing the suffering and deaths of patients with COVID-19 may place frontline healthcare workers (HCWs) at particularly high risk for posttraumatic stress disorder (PTSD); however, few data are available on the clinical characteristics of PTSD among frontline HCWs who survived COVID-19 (""surviving HCWs"" hereafter). The present study examined the prevalence, correlates, and clinical symptoms of possible PTSD in surviving HCWs 6 months after the COVID-19 outbreak in","2021","07","09","Transl Psychiatry","Translational psychiatry","COVID-19; China; Disease Outbreaks; Health Personnel; Humans; Prevalence; SARS-CoV-2; Stress Disorders, Post-Traumatic","Tong","Jun","Affiliated Wuhan Mental Health Center, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, 430012, Hubei province, China. junetong@vip.sina","junetong@vip.sina.com"
"1031","34226510","10.1038/s41398-021-01503-7","Possible posttraumatic stress disorder in Chinese frontline healthcare workers who survived COVID-19 6 months after the COVID-19 outbreak: prevalence, correlates, and symptoms.","Suffering from COVID-19 and witnessing the suffering and deaths of patients with COVID-19 may place frontline healthcare workers (HCWs) at particularly high risk for posttraumatic stress disorder (PTSD); however, few data are available on the clinical characteristics of PTSD among frontline HCWs who survived COVID-19 (""surviving HCWs"" hereafter). The present study examined the prevalence, correlates, and clinical symptoms of possible PTSD in surviving HCWs 6 months after the COVID-19 outbreak in","2021","07","09","Transl Psychiatry","Translational psychiatry","COVID-19; China; Disease Outbreaks; Health Personnel; Humans; Prevalence; SARS-CoV-2; Stress Disorders, Post-Traumatic","Shen","He-Yong","Institute of Analytical Psychology, City University of Macau, Macau, China. shenheyong@cityu","shenheyong@cityu.mo"
"1032","34226510","10.1038/s41398-021-01503-7","Possible posttraumatic stress disorder in Chinese frontline healthcare workers who survived COVID-19 6 months after the COVID-19 outbreak: prevalence, correlates, and symptoms.","Suffering from COVID-19 and witnessing the suffering and deaths of patients with COVID-19 may place frontline healthcare workers (HCWs) at particularly high risk for posttraumatic stress disorder (PTSD); however, few data are available on the clinical characteristics of PTSD among frontline HCWs who survived COVID-19 (""surviving HCWs"" hereafter). The present study examined the prevalence, correlates, and clinical symptoms of possible PTSD in surviving HCWs 6 months after the COVID-19 outbreak in","2021","07","09","Transl Psychiatry","Translational psychiatry","COVID-19; China; Disease Outbreaks; Health Personnel; Humans; Prevalence; SARS-CoV-2; Stress Disorders, Post-Traumatic","Xia","Jia-Hong","Department of Cardiovascular Surgery, Union Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, Hubei, China. jiahong.xia@hust.edu","jiahong.xia@hust.edu.cn"
"1033","34226510","10.1038/s41398-021-01503-7","Possible posttraumatic stress disorder in Chinese frontline healthcare workers who survived COVID-19 6 months after the COVID-19 outbreak: prevalence, correlates, and symptoms.","Suffering from COVID-19 and witnessing the suffering and deaths of patients with COVID-19 may place frontline healthcare workers (HCWs) at particularly high risk for posttraumatic stress disorder (PTSD); however, few data are available on the clinical characteristics of PTSD among frontline HCWs who survived COVID-19 (""surviving HCWs"" hereafter). The present study examined the prevalence, correlates, and clinical symptoms of possible PTSD in surviving HCWs 6 months after the COVID-19 outbreak in","2021","07","09","Transl Psychiatry","Translational psychiatry","COVID-19; China; Disease Outbreaks; Health Personnel; Humans; Prevalence; SARS-CoV-2; Stress Disorders, Post-Traumatic","Hu","Yu","Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, Hubei, China. dr_huyu@126","huyu@126.com"
"1034","34226505","10.1038/s41420-021-00541-w","H-Ras gene takes part to the host immune response to COVID-19.","Ras gene family members play a relevant role in cancer, especially when they are mutated. However, they may play additional roles in other conditions beside cancer. We performed gene expression analysis using the NanoString PanCancer IO 360 panel in the peripheral blood mononuclear cell (PBMC) of six COVID-19 patients and we found that H-Ras gene was significantly upregulated, while both K-Ras and N-Ras genes were downregulated. In particular, H-Ras gene upregulation was more evident in COVID-19","2021","07","09","Cell Death Discov","Cell death discovery",NA,"Sciacchitano","Salvatore","Department of Clinical and Molecular Medicine, Sapienza University of Rome, via di Grottarossa 1035-1039, 00189, Rome, Italy",NA
"1035","34226505","10.1038/s41420-021-00541-w","H-Ras gene takes part to the host immune response to COVID-19.","Ras gene family members play a relevant role in cancer, especially when they are mutated. However, they may play additional roles in other conditions beside cancer. We performed gene expression analysis using the NanoString PanCancer IO 360 panel in the peripheral blood mononuclear cell (PBMC) of six COVID-19 patients and we found that H-Ras gene was significantly upregulated, while both K-Ras and N-Ras genes were downregulated. In particular, H-Ras gene upregulation was more evident in COVID-19","2021","07","09","Cell Death Discov","Cell death discovery",NA,"Sacconi","Andrea","UOSD Clinical Trial Center, Biostatistics and Bioinformatics, IRCCS Regina Elena National Cancer Institute, Rome, Italy",NA
"1036","34226505","10.1038/s41420-021-00541-w","H-Ras gene takes part to the host immune response to COVID-19.","Ras gene family members play a relevant role in cancer, especially when they are mutated. However, they may play additional roles in other conditions beside cancer. We performed gene expression analysis using the NanoString PanCancer IO 360 panel in the peripheral blood mononuclear cell (PBMC) of six COVID-19 patients and we found that H-Ras gene was significantly upregulated, while both K-Ras and N-Ras genes were downregulated. In particular, H-Ras gene upregulation was more evident in COVID-19","2021","07","09","Cell Death Discov","Cell death discovery",NA,"De Vitis","Claudia","Department of Clinical and Molecular Medicine, Sapienza University of Rome, via di Grottarossa 1035-1039, 00189, Rome, Italy",NA
"1037","34226505","10.1038/s41420-021-00541-w","H-Ras gene takes part to the host immune response to COVID-19.","Ras gene family members play a relevant role in cancer, especially when they are mutated. However, they may play additional roles in other conditions beside cancer. We performed gene expression analysis using the NanoString PanCancer IO 360 panel in the peripheral blood mononuclear cell (PBMC) of six COVID-19 patients and we found that H-Ras gene was significantly upregulated, while both K-Ras and N-Ras genes were downregulated. In particular, H-Ras gene upregulation was more evident in COVID-19","2021","07","09","Cell Death Discov","Cell death discovery",NA,"Blandino","Giovanni","UOSD Clinical Trial Center, Biostatistics and Bioinformatics, IRCCS Regina Elena National Cancer Institute, Rome, Italy",NA
"1038","34226505","10.1038/s41420-021-00541-w","H-Ras gene takes part to the host immune response to COVID-19.","Ras gene family members play a relevant role in cancer, especially when they are mutated. However, they may play additional roles in other conditions beside cancer. We performed gene expression analysis using the NanoString PanCancer IO 360 panel in the peripheral blood mononuclear cell (PBMC) of six COVID-19 patients and we found that H-Ras gene was significantly upregulated, while both K-Ras and N-Ras genes were downregulated. In particular, H-Ras gene upregulation was more evident in COVID-19","2021","07","09","Cell Death Discov","Cell death discovery",NA,"Piaggio","Giulia","UOSD SAFU, Department of Research, Diagnosis and Innovative Technologies, IRCCS-Regina Elena National Cancer Institute, Roma, Italy",NA
"1039","34226505","10.1038/s41420-021-00541-w","H-Ras gene takes part to the host immune response to COVID-19.","Ras gene family members play a relevant role in cancer, especially when they are mutated. However, they may play additional roles in other conditions beside cancer. We performed gene expression analysis using the NanoString PanCancer IO 360 panel in the peripheral blood mononuclear cell (PBMC) of six COVID-19 patients and we found that H-Ras gene was significantly upregulated, while both K-Ras and N-Ras genes were downregulated. In particular, H-Ras gene upregulation was more evident in COVID-19","2021","07","09","Cell Death Discov","Cell death discovery",NA,"Salvati","Valentina","UOSD SAFU, Department of Research, Diagnosis and Innovative Technologies, IRCCS-Regina Elena National Cancer Institute, Roma, Italy",NA
"1040","34226505","10.1038/s41420-021-00541-w","H-Ras gene takes part to the host immune response to COVID-19.","Ras gene family members play a relevant role in cancer, especially when they are mutated. However, they may play additional roles in other conditions beside cancer. We performed gene expression analysis using the NanoString PanCancer IO 360 panel in the peripheral blood mononuclear cell (PBMC) of six COVID-19 patients and we found that H-Ras gene was significantly upregulated, while both K-Ras and N-Ras genes were downregulated. In particular, H-Ras gene upregulation was more evident in COVID-19","2021","07","09","Cell Death Discov","Cell death discovery",NA,"Napoli","Christian","Department of Medical Surgical Sciences and Translational Medicine, Sapienza University of Rome, via di Grottarossa 1035/1039, 00189, Rome, Italy",NA
"1041","34226505","10.1038/s41420-021-00541-w","H-Ras gene takes part to the host immune response to COVID-19.","Ras gene family members play a relevant role in cancer, especially when they are mutated. However, they may play additional roles in other conditions beside cancer. We performed gene expression analysis using the NanoString PanCancer IO 360 panel in the peripheral blood mononuclear cell (PBMC) of six COVID-19 patients and we found that H-Ras gene was significantly upregulated, while both K-Ras and N-Ras genes were downregulated. In particular, H-Ras gene upregulation was more evident in COVID-19","2021","07","09","Cell Death Discov","Cell death discovery",NA,"Marchetti","Paolo","Department of Clinical and Molecular Medicine, Sapienza University of Rome, via di Grottarossa 1035-1039, 00189, Rome, Italy",NA
"1042","34226505","10.1038/s41420-021-00541-w","H-Ras gene takes part to the host immune response to COVID-19.","Ras gene family members play a relevant role in cancer, especially when they are mutated. However, they may play additional roles in other conditions beside cancer. We performed gene expression analysis using the NanoString PanCancer IO 360 panel in the peripheral blood mononuclear cell (PBMC) of six COVID-19 patients and we found that H-Ras gene was significantly upregulated, while both K-Ras and N-Ras genes were downregulated. In particular, H-Ras gene upregulation was more evident in COVID-19","2021","07","09","Cell Death Discov","Cell death discovery",NA,"Taurelli","Beatrice Salimbeni","Medical Oncology Sant'Andrea Hospital, University La Sapienza, via di Grottarossa 1035-1039, 00189, Rome, Italy",NA
"1043","34226505","10.1038/s41420-021-00541-w","H-Ras gene takes part to the host immune response to COVID-19.","Ras gene family members play a relevant role in cancer, especially when they are mutated. However, they may play additional roles in other conditions beside cancer. We performed gene expression analysis using the NanoString PanCancer IO 360 panel in the peripheral blood mononuclear cell (PBMC) of six COVID-19 patients and we found that H-Ras gene was significantly upregulated, while both K-Ras and N-Ras genes were downregulated. In particular, H-Ras gene upregulation was more evident in COVID-19","2021","07","09","Cell Death Discov","Cell death discovery",NA,"Coluzzi","Flaminia","Unit of Anesthesia, Intensive Care and Pain Medicine, Sant'Andrea University Hospital, Rome, Italy",NA
"1044","34226505","10.1038/s41420-021-00541-w","H-Ras gene takes part to the host immune response to COVID-19.","Ras gene family members play a relevant role in cancer, especially when they are mutated. However, they may play additional roles in other conditions beside cancer. We performed gene expression analysis using the NanoString PanCancer IO 360 panel in the peripheral blood mononuclear cell (PBMC) of six COVID-19 patients and we found that H-Ras gene was significantly upregulated, while both K-Ras and N-Ras genes were downregulated. In particular, H-Ras gene upregulation was more evident in COVID-19","2021","07","09","Cell Death Discov","Cell death discovery",NA,"Rocco","Monica","Unit of Anesthesia, Intensive Care and Pain Medicine, Sant'Andrea University Hospital, Rome, Italy",NA
"1045","34226505","10.1038/s41420-021-00541-w","H-Ras gene takes part to the host immune response to COVID-19.","Ras gene family members play a relevant role in cancer, especially when they are mutated. However, they may play additional roles in other conditions beside cancer. We performed gene expression analysis using the NanoString PanCancer IO 360 panel in the peripheral blood mononuclear cell (PBMC) of six COVID-19 patients and we found that H-Ras gene was significantly upregulated, while both K-Ras and N-Ras genes were downregulated. In particular, H-Ras gene upregulation was more evident in COVID-19","2021","07","09","Cell Death Discov","Cell death discovery",NA,"Vecchione","Andrea","Department of Clinical and Molecular Medicine, Sapienza University of Rome, via di Grottarossa 1035-1039, 00189, Rome, Italy",NA
"1046","34226505","10.1038/s41420-021-00541-w","H-Ras gene takes part to the host immune response to COVID-19.","Ras gene family members play a relevant role in cancer, especially when they are mutated. However, they may play additional roles in other conditions beside cancer. We performed gene expression analysis using the NanoString PanCancer IO 360 panel in the peripheral blood mononuclear cell (PBMC) of six COVID-19 patients and we found that H-Ras gene was significantly upregulated, while both K-Ras and N-Ras genes were downregulated. In particular, H-Ras gene upregulation was more evident in COVID-19","2021","07","09","Cell Death Discov","Cell death discovery",NA,"Anibaldi","Paolo","Medical Direction Sant'Andrea Hospital, University La Sapienza, 00189, Rome, Italy",NA
"1047","34226505","10.1038/s41420-021-00541-w","H-Ras gene takes part to the host immune response to COVID-19.","Ras gene family members play a relevant role in cancer, especially when they are mutated. However, they may play additional roles in other conditions beside cancer. We performed gene expression analysis using the NanoString PanCancer IO 360 panel in the peripheral blood mononuclear cell (PBMC) of six COVID-19 patients and we found that H-Ras gene was significantly upregulated, while both K-Ras and N-Ras genes were downregulated. In particular, H-Ras gene upregulation was more evident in COVID-19","2021","07","09","Cell Death Discov","Cell death discovery",NA,"Marcolongo","Adriano","General Direction Sant'Andrea Hospital, University La Sapienza, 00189, Rome, Italy",NA
"1048","34226505","10.1038/s41420-021-00541-w","H-Ras gene takes part to the host immune response to COVID-19.","Ras gene family members play a relevant role in cancer, especially when they are mutated. However, they may play additional roles in other conditions beside cancer. We performed gene expression analysis using the NanoString PanCancer IO 360 panel in the peripheral blood mononuclear cell (PBMC) of six COVID-19 patients and we found that H-Ras gene was significantly upregulated, while both K-Ras and N-Ras genes were downregulated. In particular, H-Ras gene upregulation was more evident in COVID-19","2021","07","09","Cell Death Discov","Cell death discovery",NA,"Ciliberto","Gennaro","Scientific Directorate, IRCSS Regina Elena National Cancer Institute, 00144, Rome, Italy",NA
"1049","34226505","10.1038/s41420-021-00541-w","H-Ras gene takes part to the host immune response to COVID-19.","Ras gene family members play a relevant role in cancer, especially when they are mutated. However, they may play additional roles in other conditions beside cancer. We performed gene expression analysis using the NanoString PanCancer IO 360 panel in the peripheral blood mononuclear cell (PBMC) of six COVID-19 patients and we found that H-Ras gene was significantly upregulated, while both K-Ras and N-Ras genes were downregulated. In particular, H-Ras gene upregulation was more evident in COVID-19","2021","07","09","Cell Death Discov","Cell death discovery",NA,"Mancini","Rita","Department of Clinical and Molecular Medicine, Sapienza University of Rome, via di Grottarossa 1035-1039, 00189, Rome, Italy",NA
"1050","34226505","10.1038/s41420-021-00541-w","H-Ras gene takes part to the host immune response to COVID-19.","Ras gene family members play a relevant role in cancer, especially when they are mutated. However, they may play additional roles in other conditions beside cancer. We performed gene expression analysis using the NanoString PanCancer IO 360 panel in the peripheral blood mononuclear cell (PBMC) of six COVID-19 patients and we found that H-Ras gene was significantly upregulated, while both K-Ras and N-Ras genes were downregulated. In particular, H-Ras gene upregulation was more evident in COVID-19","2021","07","09","Cell Death Discov","Cell death discovery",NA,"Capalbo","Carlo","Medical Oncology Sant'Andrea Hospital, University La Sapienza, via di Grottarossa 1035-1039, 00189, Rome, Italy. carlo.capalbo@uniroma1","carlo.capalbo@uniroma1.it"
"1051","34226483","","Mucormycosis, The Deadly New Worry to COVID-19 Pandemic.","Recently, mucormycosis, extremely rare fungal infections are emerging as a matter of concern in COVID-19. The saprophytic fungi of Mucorales species cause the disease, Mucormycosis, only in immunocompromised hosts. Clinical presentation of mucormycosis is related to the underlying conditions; rhino-cerebral disease is the most common form, especially in patients with diabetes mellitus; pulmonary, cutaneous, or gastrointestinal infections can also occur. Severe COVID-19 itself is a life-threateni","2021","07","07","Mymensingh Med J","Mymensingh medical journal : MMJ","Antifungal Agents; COVID-19; Debridement; Humans; Mucormycosis; Pandemics; SARS-CoV-2","Kamrul-Hasan","A B","Dr ABM Kamrul Hasan, Assistant Professor &amp","rangassmc@gmail.com"
"1052","34226483","","Mucormycosis, The Deadly New Worry to COVID-19 Pandemic.","Recently, mucormycosis, extremely rare fungal infections are emerging as a matter of concern in COVID-19. The saprophytic fungi of Mucorales species cause the disease, Mucormycosis, only in immunocompromised hosts. Clinical presentation of mucormycosis is related to the underlying conditions; rhino-cerebral disease is the most common form, especially in patients with diabetes mellitus; pulmonary, cutaneous, or gastrointestinal infections can also occur. Severe COVID-19 itself is a life-threateni","2021","07","07","Mymensingh Med J","Mymensingh medical journal : MMJ","Antifungal Agents; COVID-19; Debridement; Humans; Mucormycosis; Pandemics; SARS-CoV-2","Selim","S","Dr ABM Kamrul Hasan, Assistant Professor &amp",NA
"1053","34226472","","Vaccination against COVID-19 in Bangladesh: Perception and Attitude of Healthcare Workers in COVID-dedicated Hospitals.","Healthcare professionals are the crucial and influencing source of information for vaccines and their communication among patients and communities that can accelerate successful vaccination in a country. This cross-sectional study was one of the first and foremost ones in Bangladesh to observe the basic perception and attitudes towards vaccination against COVID-19 among the healthcare workers (HCWs) - doctors, interns, nurses, ward boys, cleaners, and medical technologists of major COVID-dedicat","2021","07","07","Mymensingh Med J","Mymensingh medical journal : MMJ","Adult; Attitude; Bangladesh; COVID-19; COVID-19 Vaccines; Child; Cross-Sectional Studies; Female; Health Personnel; Hospitals; Humans; Male; Middle Aged; Perception; SARS-CoV-2; Surveys and Questionnaires; Vaccination","Nasir","M","Professor Morshed Nasir, Professor and Head of Pharmacology, Holy Family Red Crescent Medical College (HFRCMC), Dhaka, Bangladesh","morshed@hfrcmc.edu.bd"
"1054","34226472","","Vaccination against COVID-19 in Bangladesh: Perception and Attitude of Healthcare Workers in COVID-dedicated Hospitals.","Healthcare professionals are the crucial and influencing source of information for vaccines and their communication among patients and communities that can accelerate successful vaccination in a country. This cross-sectional study was one of the first and foremost ones in Bangladesh to observe the basic perception and attitudes towards vaccination against COVID-19 among the healthcare workers (HCWs) - doctors, interns, nurses, ward boys, cleaners, and medical technologists of major COVID-dedicat","2021","07","07","Mymensingh Med J","Mymensingh medical journal : MMJ","Adult; Attitude; Bangladesh; COVID-19; COVID-19 Vaccines; Child; Cross-Sectional Studies; Female; Health Personnel; Hospitals; Humans; Male; Middle Aged; Perception; SARS-CoV-2; Surveys and Questionnaires; Vaccination","Perveen","R A","Professor Morshed Nasir, Professor and Head of Pharmacology, Holy Family Red Crescent Medical College (HFRCMC), Dhaka, Bangladesh",NA
"1055","34226472","","Vaccination against COVID-19 in Bangladesh: Perception and Attitude of Healthcare Workers in COVID-dedicated Hospitals.","Healthcare professionals are the crucial and influencing source of information for vaccines and their communication among patients and communities that can accelerate successful vaccination in a country. This cross-sectional study was one of the first and foremost ones in Bangladesh to observe the basic perception and attitudes towards vaccination against COVID-19 among the healthcare workers (HCWs) - doctors, interns, nurses, ward boys, cleaners, and medical technologists of major COVID-dedicat","2021","07","07","Mymensingh Med J","Mymensingh medical journal : MMJ","Adult; Attitude; Bangladesh; COVID-19; COVID-19 Vaccines; Child; Cross-Sectional Studies; Female; Health Personnel; Hospitals; Humans; Male; Middle Aged; Perception; SARS-CoV-2; Surveys and Questionnaires; Vaccination","Saha","S K","Professor Morshed Nasir, Professor and Head of Pharmacology, Holy Family Red Crescent Medical College (HFRCMC), Dhaka, Bangladesh",NA
"1056","34226472","","Vaccination against COVID-19 in Bangladesh: Perception and Attitude of Healthcare Workers in COVID-dedicated Hospitals.","Healthcare professionals are the crucial and influencing source of information for vaccines and their communication among patients and communities that can accelerate successful vaccination in a country. This cross-sectional study was one of the first and foremost ones in Bangladesh to observe the basic perception and attitudes towards vaccination against COVID-19 among the healthcare workers (HCWs) - doctors, interns, nurses, ward boys, cleaners, and medical technologists of major COVID-dedicat","2021","07","07","Mymensingh Med J","Mymensingh medical journal : MMJ","Adult; Attitude; Bangladesh; COVID-19; COVID-19 Vaccines; Child; Cross-Sectional Studies; Female; Health Personnel; Hospitals; Humans; Male; Middle Aged; Perception; SARS-CoV-2; Surveys and Questionnaires; Vaccination","Nessa","A","Professor Morshed Nasir, Professor and Head of Pharmacology, Holy Family Red Crescent Medical College (HFRCMC), Dhaka, Bangladesh",NA
"1057","34226472","","Vaccination against COVID-19 in Bangladesh: Perception and Attitude of Healthcare Workers in COVID-dedicated Hospitals.","Healthcare professionals are the crucial and influencing source of information for vaccines and their communication among patients and communities that can accelerate successful vaccination in a country. This cross-sectional study was one of the first and foremost ones in Bangladesh to observe the basic perception and attitudes towards vaccination against COVID-19 among the healthcare workers (HCWs) - doctors, interns, nurses, ward boys, cleaners, and medical technologists of major COVID-dedicat","2021","07","07","Mymensingh Med J","Mymensingh medical journal : MMJ","Adult; Attitude; Bangladesh; COVID-19; COVID-19 Vaccines; Child; Cross-Sectional Studies; Female; Health Personnel; Hospitals; Humans; Male; Middle Aged; Perception; SARS-CoV-2; Surveys and Questionnaires; Vaccination","Zaman","A","Professor Morshed Nasir, Professor and Head of Pharmacology, Holy Family Red Crescent Medical College (HFRCMC), Dhaka, Bangladesh",NA
"1058","34226472","","Vaccination against COVID-19 in Bangladesh: Perception and Attitude of Healthcare Workers in COVID-dedicated Hospitals.","Healthcare professionals are the crucial and influencing source of information for vaccines and their communication among patients and communities that can accelerate successful vaccination in a country. This cross-sectional study was one of the first and foremost ones in Bangladesh to observe the basic perception and attitudes towards vaccination against COVID-19 among the healthcare workers (HCWs) - doctors, interns, nurses, ward boys, cleaners, and medical technologists of major COVID-dedicat","2021","07","07","Mymensingh Med J","Mymensingh medical journal : MMJ","Adult; Attitude; Bangladesh; COVID-19; COVID-19 Vaccines; Child; Cross-Sectional Studies; Female; Health Personnel; Hospitals; Humans; Male; Middle Aged; Perception; SARS-CoV-2; Surveys and Questionnaires; Vaccination","Nazneen","R","Professor Morshed Nasir, Professor and Head of Pharmacology, Holy Family Red Crescent Medical College (HFRCMC), Dhaka, Bangladesh",NA
"1059","34226472","","Vaccination against COVID-19 in Bangladesh: Perception and Attitude of Healthcare Workers in COVID-dedicated Hospitals.","Healthcare professionals are the crucial and influencing source of information for vaccines and their communication among patients and communities that can accelerate successful vaccination in a country. This cross-sectional study was one of the first and foremost ones in Bangladesh to observe the basic perception and attitudes towards vaccination against COVID-19 among the healthcare workers (HCWs) - doctors, interns, nurses, ward boys, cleaners, and medical technologists of major COVID-dedicat","2021","07","07","Mymensingh Med J","Mymensingh medical journal : MMJ","Adult; Attitude; Bangladesh; COVID-19; COVID-19 Vaccines; Child; Cross-Sectional Studies; Female; Health Personnel; Hospitals; Humans; Male; Middle Aged; Perception; SARS-CoV-2; Surveys and Questionnaires; Vaccination","Ferdous","J","Professor Morshed Nasir, Professor and Head of Pharmacology, Holy Family Red Crescent Medical College (HFRCMC), Dhaka, Bangladesh",NA
"1060","34226472","","Vaccination against COVID-19 in Bangladesh: Perception and Attitude of Healthcare Workers in COVID-dedicated Hospitals.","Healthcare professionals are the crucial and influencing source of information for vaccines and their communication among patients and communities that can accelerate successful vaccination in a country. This cross-sectional study was one of the first and foremost ones in Bangladesh to observe the basic perception and attitudes towards vaccination against COVID-19 among the healthcare workers (HCWs) - doctors, interns, nurses, ward boys, cleaners, and medical technologists of major COVID-dedicat","2021","07","07","Mymensingh Med J","Mymensingh medical journal : MMJ","Adult; Attitude; Bangladesh; COVID-19; COVID-19 Vaccines; Child; Cross-Sectional Studies; Female; Health Personnel; Hospitals; Humans; Male; Middle Aged; Perception; SARS-CoV-2; Surveys and Questionnaires; Vaccination","Farha","N","Professor Morshed Nasir, Professor and Head of Pharmacology, Holy Family Red Crescent Medical College (HFRCMC), Dhaka, Bangladesh",NA
"1061","34226472","","Vaccination against COVID-19 in Bangladesh: Perception and Attitude of Healthcare Workers in COVID-dedicated Hospitals.","Healthcare professionals are the crucial and influencing source of information for vaccines and their communication among patients and communities that can accelerate successful vaccination in a country. This cross-sectional study was one of the first and foremost ones in Bangladesh to observe the basic perception and attitudes towards vaccination against COVID-19 among the healthcare workers (HCWs) - doctors, interns, nurses, ward boys, cleaners, and medical technologists of major COVID-dedicat","2021","07","07","Mymensingh Med J","Mymensingh medical journal : MMJ","Adult; Attitude; Bangladesh; COVID-19; COVID-19 Vaccines; Child; Cross-Sectional Studies; Female; Health Personnel; Hospitals; Humans; Male; Middle Aged; Perception; SARS-CoV-2; Surveys and Questionnaires; Vaccination","Majumder","T K","Professor Morshed Nasir, Professor and Head of Pharmacology, Holy Family Red Crescent Medical College (HFRCMC), Dhaka, Bangladesh",NA
"1062","34226472","","Vaccination against COVID-19 in Bangladesh: Perception and Attitude of Healthcare Workers in COVID-dedicated Hospitals.","Healthcare professionals are the crucial and influencing source of information for vaccines and their communication among patients and communities that can accelerate successful vaccination in a country. This cross-sectional study was one of the first and foremost ones in Bangladesh to observe the basic perception and attitudes towards vaccination against COVID-19 among the healthcare workers (HCWs) - doctors, interns, nurses, ward boys, cleaners, and medical technologists of major COVID-dedicat","2021","07","07","Mymensingh Med J","Mymensingh medical journal : MMJ","Adult; Attitude; Bangladesh; COVID-19; COVID-19 Vaccines; Child; Cross-Sectional Studies; Female; Health Personnel; Hospitals; Humans; Male; Middle Aged; Perception; SARS-CoV-2; Surveys and Questionnaires; Vaccination","Hossain","M J","Professor Morshed Nasir, Professor and Head of Pharmacology, Holy Family Red Crescent Medical College (HFRCMC), Dhaka, Bangladesh",NA
"1063","34226472","","Vaccination against COVID-19 in Bangladesh: Perception and Attitude of Healthcare Workers in COVID-dedicated Hospitals.","Healthcare professionals are the crucial and influencing source of information for vaccines and their communication among patients and communities that can accelerate successful vaccination in a country. This cross-sectional study was one of the first and foremost ones in Bangladesh to observe the basic perception and attitudes towards vaccination against COVID-19 among the healthcare workers (HCWs) - doctors, interns, nurses, ward boys, cleaners, and medical technologists of major COVID-dedicat","2021","07","07","Mymensingh Med J","Mymensingh medical journal : MMJ","Adult; Attitude; Bangladesh; COVID-19; COVID-19 Vaccines; Child; Cross-Sectional Studies; Female; Health Personnel; Hospitals; Humans; Male; Middle Aged; Perception; SARS-CoV-2; Surveys and Questionnaires; Vaccination","Parvin","S","Professor Morshed Nasir, Professor and Head of Pharmacology, Holy Family Red Crescent Medical College (HFRCMC), Dhaka, Bangladesh",NA
"1064","34226472","","Vaccination against COVID-19 in Bangladesh: Perception and Attitude of Healthcare Workers in COVID-dedicated Hospitals.","Healthcare professionals are the crucial and influencing source of information for vaccines and their communication among patients and communities that can accelerate successful vaccination in a country. This cross-sectional study was one of the first and foremost ones in Bangladesh to observe the basic perception and attitudes towards vaccination against COVID-19 among the healthcare workers (HCWs) - doctors, interns, nurses, ward boys, cleaners, and medical technologists of major COVID-dedicat","2021","07","07","Mymensingh Med J","Mymensingh medical journal : MMJ","Adult; Attitude; Bangladesh; COVID-19; COVID-19 Vaccines; Child; Cross-Sectional Studies; Female; Health Personnel; Hospitals; Humans; Male; Middle Aged; Perception; SARS-CoV-2; Surveys and Questionnaires; Vaccination","Chowdhury","M R","Professor Morshed Nasir, Professor and Head of Pharmacology, Holy Family Red Crescent Medical College (HFRCMC), Dhaka, Bangladesh",NA
"1065","34226472","","Vaccination against COVID-19 in Bangladesh: Perception and Attitude of Healthcare Workers in COVID-dedicated Hospitals.","Healthcare professionals are the crucial and influencing source of information for vaccines and their communication among patients and communities that can accelerate successful vaccination in a country. This cross-sectional study was one of the first and foremost ones in Bangladesh to observe the basic perception and attitudes towards vaccination against COVID-19 among the healthcare workers (HCWs) - doctors, interns, nurses, ward boys, cleaners, and medical technologists of major COVID-dedicat","2021","07","07","Mymensingh Med J","Mymensingh medical journal : MMJ","Adult; Attitude; Bangladesh; COVID-19; COVID-19 Vaccines; Child; Cross-Sectional Studies; Female; Health Personnel; Hospitals; Humans; Male; Middle Aged; Perception; SARS-CoV-2; Surveys and Questionnaires; Vaccination","Begum","H","Professor Morshed Nasir, Professor and Head of Pharmacology, Holy Family Red Crescent Medical College (HFRCMC), Dhaka, Bangladesh",NA
"1066","34226472","","Vaccination against COVID-19 in Bangladesh: Perception and Attitude of Healthcare Workers in COVID-dedicated Hospitals.","Healthcare professionals are the crucial and influencing source of information for vaccines and their communication among patients and communities that can accelerate successful vaccination in a country. This cross-sectional study was one of the first and foremost ones in Bangladesh to observe the basic perception and attitudes towards vaccination against COVID-19 among the healthcare workers (HCWs) - doctors, interns, nurses, ward boys, cleaners, and medical technologists of major COVID-dedicat","2021","07","07","Mymensingh Med J","Mymensingh medical journal : MMJ","Adult; Attitude; Bangladesh; COVID-19; COVID-19 Vaccines; Child; Cross-Sectional Studies; Female; Health Personnel; Hospitals; Humans; Male; Middle Aged; Perception; SARS-CoV-2; Surveys and Questionnaires; Vaccination","Ahmed","F","Professor Morshed Nasir, Professor and Head of Pharmacology, Holy Family Red Crescent Medical College (HFRCMC), Dhaka, Bangladesh",NA
"1067","34226470","","Socio-demographic Profile of COVID-19 Patients and Difficulties Faced by Them while Testing RT-PCR: A Multi-center Cross-sectional Study.","This study was aimed to find out the socio-demographic profiles as well as difficulties of Reverse transcription polymerase chain reaction (RT-PCR) testing faced by Coronavirus Disease 2019 (COVID-19) patients. This cross-sectional study was conducted from 10th August to 7th September 2020. Data were collected by telephone interview using a pre-designed questionnaire after taking verbal consent from the participants. Out of 281 COVID-19 patients, 279 were diagnosed by RT-PCR; 10.3% were asymptom","2021","07","07","Mymensingh Med J","Mymensingh medical journal : MMJ","COVID-19; COVID-19 Testing; Cross-Sectional Studies; Demography; Humans; Male; Reverse Transcriptase Polymerase Chain Reaction; SARS-CoV-2","Mahbub-Uz-Zaman","K","Dr Khandker Mahbub-Uz-Zaman, Assistant Registrar, Sheikh Russel Gastroliver Institute and Hospital (SRGIH), Mohakhali, Dhaka, Bangladesh","mahbub.bsmmu.13@gmail.com"
"1068","34226470","","Socio-demographic Profile of COVID-19 Patients and Difficulties Faced by Them while Testing RT-PCR: A Multi-center Cross-sectional Study.","This study was aimed to find out the socio-demographic profiles as well as difficulties of Reverse transcription polymerase chain reaction (RT-PCR) testing faced by Coronavirus Disease 2019 (COVID-19) patients. This cross-sectional study was conducted from 10th August to 7th September 2020. Data were collected by telephone interview using a pre-designed questionnaire after taking verbal consent from the participants. Out of 281 COVID-19 patients, 279 were diagnosed by RT-PCR; 10.3% were asymptom","2021","07","07","Mymensingh Med J","Mymensingh medical journal : MMJ","COVID-19; COVID-19 Testing; Cross-Sectional Studies; Demography; Humans; Male; Reverse Transcriptase Polymerase Chain Reaction; SARS-CoV-2","Debnath","D","Dr Khandker Mahbub-Uz-Zaman, Assistant Registrar, Sheikh Russel Gastroliver Institute and Hospital (SRGIH), Mohakhali, Dhaka, Bangladesh",NA
"1069","34226470","","Socio-demographic Profile of COVID-19 Patients and Difficulties Faced by Them while Testing RT-PCR: A Multi-center Cross-sectional Study.","This study was aimed to find out the socio-demographic profiles as well as difficulties of Reverse transcription polymerase chain reaction (RT-PCR) testing faced by Coronavirus Disease 2019 (COVID-19) patients. This cross-sectional study was conducted from 10th August to 7th September 2020. Data were collected by telephone interview using a pre-designed questionnaire after taking verbal consent from the participants. Out of 281 COVID-19 patients, 279 were diagnosed by RT-PCR; 10.3% were asymptom","2021","07","07","Mymensingh Med J","Mymensingh medical journal : MMJ","COVID-19; COVID-19 Testing; Cross-Sectional Studies; Demography; Humans; Male; Reverse Transcriptase Polymerase Chain Reaction; SARS-CoV-2","Khalil","M M","Dr Khandker Mahbub-Uz-Zaman, Assistant Registrar, Sheikh Russel Gastroliver Institute and Hospital (SRGIH), Mohakhali, Dhaka, Bangladesh",NA
"1070","34226470","","Socio-demographic Profile of COVID-19 Patients and Difficulties Faced by Them while Testing RT-PCR: A Multi-center Cross-sectional Study.","This study was aimed to find out the socio-demographic profiles as well as difficulties of Reverse transcription polymerase chain reaction (RT-PCR) testing faced by Coronavirus Disease 2019 (COVID-19) patients. This cross-sectional study was conducted from 10th August to 7th September 2020. Data were collected by telephone interview using a pre-designed questionnaire after taking verbal consent from the participants. Out of 281 COVID-19 patients, 279 were diagnosed by RT-PCR; 10.3% were asymptom","2021","07","07","Mymensingh Med J","Mymensingh medical journal : MMJ","COVID-19; COVID-19 Testing; Cross-Sectional Studies; Demography; Humans; Male; Reverse Transcriptase Polymerase Chain Reaction; SARS-CoV-2","Tahmid","M S","Dr Khandker Mahbub-Uz-Zaman, Assistant Registrar, Sheikh Russel Gastroliver Institute and Hospital (SRGIH), Mohakhali, Dhaka, Bangladesh",NA
"1071","34226470","","Socio-demographic Profile of COVID-19 Patients and Difficulties Faced by Them while Testing RT-PCR: A Multi-center Cross-sectional Study.","This study was aimed to find out the socio-demographic profiles as well as difficulties of Reverse transcription polymerase chain reaction (RT-PCR) testing faced by Coronavirus Disease 2019 (COVID-19) patients. This cross-sectional study was conducted from 10th August to 7th September 2020. Data were collected by telephone interview using a pre-designed questionnaire after taking verbal consent from the participants. Out of 281 COVID-19 patients, 279 were diagnosed by RT-PCR; 10.3% were asymptom","2021","07","07","Mymensingh Med J","Mymensingh medical journal : MMJ","COVID-19; COVID-19 Testing; Cross-Sectional Studies; Demography; Humans; Male; Reverse Transcriptase Polymerase Chain Reaction; SARS-CoV-2","Monir","S","Dr Khandker Mahbub-Uz-Zaman, Assistant Registrar, Sheikh Russel Gastroliver Institute and Hospital (SRGIH), Mohakhali, Dhaka, Bangladesh",NA
"1072","34226470","","Socio-demographic Profile of COVID-19 Patients and Difficulties Faced by Them while Testing RT-PCR: A Multi-center Cross-sectional Study.","This study was aimed to find out the socio-demographic profiles as well as difficulties of Reverse transcription polymerase chain reaction (RT-PCR) testing faced by Coronavirus Disease 2019 (COVID-19) patients. This cross-sectional study was conducted from 10th August to 7th September 2020. Data were collected by telephone interview using a pre-designed questionnaire after taking verbal consent from the participants. Out of 281 COVID-19 patients, 279 were diagnosed by RT-PCR; 10.3% were asymptom","2021","07","07","Mymensingh Med J","Mymensingh medical journal : MMJ","COVID-19; COVID-19 Testing; Cross-Sectional Studies; Demography; Humans; Male; Reverse Transcriptase Polymerase Chain Reaction; SARS-CoV-2","Munmun","S T","Dr Khandker Mahbub-Uz-Zaman, Assistant Registrar, Sheikh Russel Gastroliver Institute and Hospital (SRGIH), Mohakhali, Dhaka, Bangladesh",NA
"1073","34226470","","Socio-demographic Profile of COVID-19 Patients and Difficulties Faced by Them while Testing RT-PCR: A Multi-center Cross-sectional Study.","This study was aimed to find out the socio-demographic profiles as well as difficulties of Reverse transcription polymerase chain reaction (RT-PCR) testing faced by Coronavirus Disease 2019 (COVID-19) patients. This cross-sectional study was conducted from 10th August to 7th September 2020. Data were collected by telephone interview using a pre-designed questionnaire after taking verbal consent from the participants. Out of 281 COVID-19 patients, 279 were diagnosed by RT-PCR; 10.3% were asymptom","2021","07","07","Mymensingh Med J","Mymensingh medical journal : MMJ","COVID-19; COVID-19 Testing; Cross-Sectional Studies; Demography; Humans; Male; Reverse Transcriptase Polymerase Chain Reaction; SARS-CoV-2","Jannat","T","Dr Khandker Mahbub-Uz-Zaman, Assistant Registrar, Sheikh Russel Gastroliver Institute and Hospital (SRGIH), Mohakhali, Dhaka, Bangladesh",NA
"1074","34226470","","Socio-demographic Profile of COVID-19 Patients and Difficulties Faced by Them while Testing RT-PCR: A Multi-center Cross-sectional Study.","This study was aimed to find out the socio-demographic profiles as well as difficulties of Reverse transcription polymerase chain reaction (RT-PCR) testing faced by Coronavirus Disease 2019 (COVID-19) patients. This cross-sectional study was conducted from 10th August to 7th September 2020. Data were collected by telephone interview using a pre-designed questionnaire after taking verbal consent from the participants. Out of 281 COVID-19 patients, 279 were diagnosed by RT-PCR; 10.3% were asymptom","2021","07","07","Mymensingh Med J","Mymensingh medical journal : MMJ","COVID-19; COVID-19 Testing; Cross-Sectional Studies; Demography; Humans; Male; Reverse Transcriptase Polymerase Chain Reaction; SARS-CoV-2","Samaruk","R","Dr Khandker Mahbub-Uz-Zaman, Assistant Registrar, Sheikh Russel Gastroliver Institute and Hospital (SRGIH), Mohakhali, Dhaka, Bangladesh",NA
"1075","34226470","","Socio-demographic Profile of COVID-19 Patients and Difficulties Faced by Them while Testing RT-PCR: A Multi-center Cross-sectional Study.","This study was aimed to find out the socio-demographic profiles as well as difficulties of Reverse transcription polymerase chain reaction (RT-PCR) testing faced by Coronavirus Disease 2019 (COVID-19) patients. This cross-sectional study was conducted from 10th August to 7th September 2020. Data were collected by telephone interview using a pre-designed questionnaire after taking verbal consent from the participants. Out of 281 COVID-19 patients, 279 were diagnosed by RT-PCR; 10.3% were asymptom","2021","07","07","Mymensingh Med J","Mymensingh medical journal : MMJ","COVID-19; COVID-19 Testing; Cross-Sectional Studies; Demography; Humans; Male; Reverse Transcriptase Polymerase Chain Reaction; SARS-CoV-2","Sharmi","T Z","Dr Khandker Mahbub-Uz-Zaman, Assistant Registrar, Sheikh Russel Gastroliver Institute and Hospital (SRGIH), Mohakhali, Dhaka, Bangladesh",NA
"1076","34226470","","Socio-demographic Profile of COVID-19 Patients and Difficulties Faced by Them while Testing RT-PCR: A Multi-center Cross-sectional Study.","This study was aimed to find out the socio-demographic profiles as well as difficulties of Reverse transcription polymerase chain reaction (RT-PCR) testing faced by Coronavirus Disease 2019 (COVID-19) patients. This cross-sectional study was conducted from 10th August to 7th September 2020. Data were collected by telephone interview using a pre-designed questionnaire after taking verbal consent from the participants. Out of 281 COVID-19 patients, 279 were diagnosed by RT-PCR; 10.3% were asymptom","2021","07","07","Mymensingh Med J","Mymensingh medical journal : MMJ","COVID-19; COVID-19 Testing; Cross-Sectional Studies; Demography; Humans; Male; Reverse Transcriptase Polymerase Chain Reaction; SARS-CoV-2","Debnath","D","Dr Khandker Mahbub-Uz-Zaman, Assistant Registrar, Sheikh Russel Gastroliver Institute and Hospital (SRGIH), Mohakhali, Dhaka, Bangladesh",NA
"1077","34226470","","Socio-demographic Profile of COVID-19 Patients and Difficulties Faced by Them while Testing RT-PCR: A Multi-center Cross-sectional Study.","This study was aimed to find out the socio-demographic profiles as well as difficulties of Reverse transcription polymerase chain reaction (RT-PCR) testing faced by Coronavirus Disease 2019 (COVID-19) patients. This cross-sectional study was conducted from 10th August to 7th September 2020. Data were collected by telephone interview using a pre-designed questionnaire after taking verbal consent from the participants. Out of 281 COVID-19 patients, 279 were diagnosed by RT-PCR; 10.3% were asymptom","2021","07","07","Mymensingh Med J","Mymensingh medical journal : MMJ","COVID-19; COVID-19 Testing; Cross-Sectional Studies; Demography; Humans; Male; Reverse Transcriptase Polymerase Chain Reaction; SARS-CoV-2","Dey","S","Dr Khandker Mahbub-Uz-Zaman, Assistant Registrar, Sheikh Russel Gastroliver Institute and Hospital (SRGIH), Mohakhali, Dhaka, Bangladesh",NA
"1078","34226470","","Socio-demographic Profile of COVID-19 Patients and Difficulties Faced by Them while Testing RT-PCR: A Multi-center Cross-sectional Study.","This study was aimed to find out the socio-demographic profiles as well as difficulties of Reverse transcription polymerase chain reaction (RT-PCR) testing faced by Coronavirus Disease 2019 (COVID-19) patients. This cross-sectional study was conducted from 10th August to 7th September 2020. Data were collected by telephone interview using a pre-designed questionnaire after taking verbal consent from the participants. Out of 281 COVID-19 patients, 279 were diagnosed by RT-PCR; 10.3% were asymptom","2021","07","07","Mymensingh Med J","Mymensingh medical journal : MMJ","COVID-19; COVID-19 Testing; Cross-Sectional Studies; Demography; Humans; Male; Reverse Transcriptase Polymerase Chain Reaction; SARS-CoV-2","Ahmed","M","Dr Khandker Mahbub-Uz-Zaman, Assistant Registrar, Sheikh Russel Gastroliver Institute and Hospital (SRGIH), Mohakhali, Dhaka, Bangladesh",NA
"1079","34226470","","Socio-demographic Profile of COVID-19 Patients and Difficulties Faced by Them while Testing RT-PCR: A Multi-center Cross-sectional Study.","This study was aimed to find out the socio-demographic profiles as well as difficulties of Reverse transcription polymerase chain reaction (RT-PCR) testing faced by Coronavirus Disease 2019 (COVID-19) patients. This cross-sectional study was conducted from 10th August to 7th September 2020. Data were collected by telephone interview using a pre-designed questionnaire after taking verbal consent from the participants. Out of 281 COVID-19 patients, 279 were diagnosed by RT-PCR; 10.3% were asymptom","2021","07","07","Mymensingh Med J","Mymensingh medical journal : MMJ","COVID-19; COVID-19 Testing; Cross-Sectional Studies; Demography; Humans; Male; Reverse Transcriptase Polymerase Chain Reaction; SARS-CoV-2","Ahmad","F","Dr Khandker Mahbub-Uz-Zaman, Assistant Registrar, Sheikh Russel Gastroliver Institute and Hospital (SRGIH), Mohakhali, Dhaka, Bangladesh",NA
"1080","34226470","","Socio-demographic Profile of COVID-19 Patients and Difficulties Faced by Them while Testing RT-PCR: A Multi-center Cross-sectional Study.","This study was aimed to find out the socio-demographic profiles as well as difficulties of Reverse transcription polymerase chain reaction (RT-PCR) testing faced by Coronavirus Disease 2019 (COVID-19) patients. This cross-sectional study was conducted from 10th August to 7th September 2020. Data were collected by telephone interview using a pre-designed questionnaire after taking verbal consent from the participants. Out of 281 COVID-19 patients, 279 were diagnosed by RT-PCR; 10.3% were asymptom","2021","07","07","Mymensingh Med J","Mymensingh medical journal : MMJ","COVID-19; COVID-19 Testing; Cross-Sectional Studies; Demography; Humans; Male; Reverse Transcriptase Polymerase Chain Reaction; SARS-CoV-2","Debnath","C R","Dr Khandker Mahbub-Uz-Zaman, Assistant Registrar, Sheikh Russel Gastroliver Institute and Hospital (SRGIH), Mohakhali, Dhaka, Bangladesh",NA
"1081","34226467","","Clinical Presentation, Management and In-Hospital Outcome of COVID-19 among Non-Healthcare Personnel and Healthcare Personnel in a Tertiary Cardiac Care Hospital.","The huge numbers of non-healthcare personnel (non-HCP) who get infected by corona virus disease 2019 (COVID-19) not only paralyze health care systems but also put health care personnel (HCP) at potential risk globally. Objective of the study was to compare the Healthcare personnel (HCP) and non-HCP COVID-19 cases. This prospective observational study was carried out in National Heart Foundation Hospital and Research Institute of Bangladesh from March 08, 2020 to July 20, 2020. During this study ","2021","07","07","Mymensingh Med J","Mymensingh medical journal : MMJ","Adult; Aged; Bangladesh; COVID-19; Delivery of Health Care; Female; Hospitals; Humans; Male; Middle Aged; SARS-CoV-2","Malik","F","Professor Fazila-Tun-Nesa Malik, Professor, Department of Cardiology, National Heart Foundation Hospital &amp","fazilamalik@yahoo.com"
"1082","34226467","","Clinical Presentation, Management and In-Hospital Outcome of COVID-19 among Non-Healthcare Personnel and Healthcare Personnel in a Tertiary Cardiac Care Hospital.","The huge numbers of non-healthcare personnel (non-HCP) who get infected by corona virus disease 2019 (COVID-19) not only paralyze health care systems but also put health care personnel (HCP) at potential risk globally. Objective of the study was to compare the Healthcare personnel (HCP) and non-HCP COVID-19 cases. This prospective observational study was carried out in National Heart Foundation Hospital and Research Institute of Bangladesh from March 08, 2020 to July 20, 2020. During this study ","2021","07","07","Mymensingh Med J","Mymensingh medical journal : MMJ","Adult; Aged; Bangladesh; COVID-19; Delivery of Health Care; Female; Hospitals; Humans; Male; Middle Aged; SARS-CoV-2","Kalimuddin","M","Professor Fazila-Tun-Nesa Malik, Professor, Department of Cardiology, National Heart Foundation Hospital &amp",NA
"1083","34226467","","Clinical Presentation, Management and In-Hospital Outcome of COVID-19 among Non-Healthcare Personnel and Healthcare Personnel in a Tertiary Cardiac Care Hospital.","The huge numbers of non-healthcare personnel (non-HCP) who get infected by corona virus disease 2019 (COVID-19) not only paralyze health care systems but also put health care personnel (HCP) at potential risk globally. Objective of the study was to compare the Healthcare personnel (HCP) and non-HCP COVID-19 cases. This prospective observational study was carried out in National Heart Foundation Hospital and Research Institute of Bangladesh from March 08, 2020 to July 20, 2020. During this study ","2021","07","07","Mymensingh Med J","Mymensingh medical journal : MMJ","Adult; Aged; Bangladesh; COVID-19; Delivery of Health Care; Female; Hospitals; Humans; Male; Middle Aged; SARS-CoV-2","Ishraquzzaman","M","Professor Fazila-Tun-Nesa Malik, Professor, Department of Cardiology, National Heart Foundation Hospital &amp",NA
"1084","34226467","","Clinical Presentation, Management and In-Hospital Outcome of COVID-19 among Non-Healthcare Personnel and Healthcare Personnel in a Tertiary Cardiac Care Hospital.","The huge numbers of non-healthcare personnel (non-HCP) who get infected by corona virus disease 2019 (COVID-19) not only paralyze health care systems but also put health care personnel (HCP) at potential risk globally. Objective of the study was to compare the Healthcare personnel (HCP) and non-HCP COVID-19 cases. This prospective observational study was carried out in National Heart Foundation Hospital and Research Institute of Bangladesh from March 08, 2020 to July 20, 2020. During this study ","2021","07","07","Mymensingh Med J","Mymensingh medical journal : MMJ","Adult; Aged; Bangladesh; COVID-19; Delivery of Health Care; Female; Hospitals; Humans; Male; Middle Aged; SARS-CoV-2","Mamun","M A","Professor Fazila-Tun-Nesa Malik, Professor, Department of Cardiology, National Heart Foundation Hospital &amp",NA
"1085","34226467","","Clinical Presentation, Management and In-Hospital Outcome of COVID-19 among Non-Healthcare Personnel and Healthcare Personnel in a Tertiary Cardiac Care Hospital.","The huge numbers of non-healthcare personnel (non-HCP) who get infected by corona virus disease 2019 (COVID-19) not only paralyze health care systems but also put health care personnel (HCP) at potential risk globally. Objective of the study was to compare the Healthcare personnel (HCP) and non-HCP COVID-19 cases. This prospective observational study was carried out in National Heart Foundation Hospital and Research Institute of Bangladesh from March 08, 2020 to July 20, 2020. During this study ","2021","07","07","Mymensingh Med J","Mymensingh medical journal : MMJ","Adult; Aged; Bangladesh; COVID-19; Delivery of Health Care; Female; Hospitals; Humans; Male; Middle Aged; SARS-CoV-2","Chowdhury","M S","Professor Fazila-Tun-Nesa Malik, Professor, Department of Cardiology, National Heart Foundation Hospital &amp",NA
"1086","34226467","","Clinical Presentation, Management and In-Hospital Outcome of COVID-19 among Non-Healthcare Personnel and Healthcare Personnel in a Tertiary Cardiac Care Hospital.","The huge numbers of non-healthcare personnel (non-HCP) who get infected by corona virus disease 2019 (COVID-19) not only paralyze health care systems but also put health care personnel (HCP) at potential risk globally. Objective of the study was to compare the Healthcare personnel (HCP) and non-HCP COVID-19 cases. This prospective observational study was carried out in National Heart Foundation Hospital and Research Institute of Bangladesh from March 08, 2020 to July 20, 2020. During this study ","2021","07","07","Mymensingh Med J","Mymensingh medical journal : MMJ","Adult; Aged; Bangladesh; COVID-19; Delivery of Health Care; Female; Hospitals; Humans; Male; Middle Aged; SARS-CoV-2","Dutta","A","Professor Fazila-Tun-Nesa Malik, Professor, Department of Cardiology, National Heart Foundation Hospital &amp",NA
"1087","34226467","","Clinical Presentation, Management and In-Hospital Outcome of COVID-19 among Non-Healthcare Personnel and Healthcare Personnel in a Tertiary Cardiac Care Hospital.","The huge numbers of non-healthcare personnel (non-HCP) who get infected by corona virus disease 2019 (COVID-19) not only paralyze health care systems but also put health care personnel (HCP) at potential risk globally. Objective of the study was to compare the Healthcare personnel (HCP) and non-HCP COVID-19 cases. This prospective observational study was carried out in National Heart Foundation Hospital and Research Institute of Bangladesh from March 08, 2020 to July 20, 2020. During this study ","2021","07","07","Mymensingh Med J","Mymensingh medical journal : MMJ","Adult; Aged; Bangladesh; COVID-19; Delivery of Health Care; Female; Hospitals; Humans; Male; Middle Aged; SARS-CoV-2","Rahman","M H","Professor Fazila-Tun-Nesa Malik, Professor, Department of Cardiology, National Heart Foundation Hospital &amp",NA
"1088","34226467","","Clinical Presentation, Management and In-Hospital Outcome of COVID-19 among Non-Healthcare Personnel and Healthcare Personnel in a Tertiary Cardiac Care Hospital.","The huge numbers of non-healthcare personnel (non-HCP) who get infected by corona virus disease 2019 (COVID-19) not only paralyze health care systems but also put health care personnel (HCP) at potential risk globally. Objective of the study was to compare the Healthcare personnel (HCP) and non-HCP COVID-19 cases. This prospective observational study was carried out in National Heart Foundation Hospital and Research Institute of Bangladesh from March 08, 2020 to July 20, 2020. During this study ","2021","07","07","Mymensingh Med J","Mymensingh medical journal : MMJ","Adult; Aged; Bangladesh; COVID-19; Delivery of Health Care; Female; Hospitals; Humans; Male; Middle Aged; SARS-CoV-2","Kanungo","S","Professor Fazila-Tun-Nesa Malik, Professor, Department of Cardiology, National Heart Foundation Hospital &amp",NA
"1089","34226467","","Clinical Presentation, Management and In-Hospital Outcome of COVID-19 among Non-Healthcare Personnel and Healthcare Personnel in a Tertiary Cardiac Care Hospital.","The huge numbers of non-healthcare personnel (non-HCP) who get infected by corona virus disease 2019 (COVID-19) not only paralyze health care systems but also put health care personnel (HCP) at potential risk globally. Objective of the study was to compare the Healthcare personnel (HCP) and non-HCP COVID-19 cases. This prospective observational study was carried out in National Heart Foundation Hospital and Research Institute of Bangladesh from March 08, 2020 to July 20, 2020. During this study ","2021","07","07","Mymensingh Med J","Mymensingh medical journal : MMJ","Adult; Aged; Bangladesh; COVID-19; Delivery of Health Care; Female; Hospitals; Humans; Male; Middle Aged; SARS-CoV-2","Laila","N","Professor Fazila-Tun-Nesa Malik, Professor, Department of Cardiology, National Heart Foundation Hospital &amp",NA
"1090","34226467","","Clinical Presentation, Management and In-Hospital Outcome of COVID-19 among Non-Healthcare Personnel and Healthcare Personnel in a Tertiary Cardiac Care Hospital.","The huge numbers of non-healthcare personnel (non-HCP) who get infected by corona virus disease 2019 (COVID-19) not only paralyze health care systems but also put health care personnel (HCP) at potential risk globally. Objective of the study was to compare the Healthcare personnel (HCP) and non-HCP COVID-19 cases. This prospective observational study was carried out in National Heart Foundation Hospital and Research Institute of Bangladesh from March 08, 2020 to July 20, 2020. During this study ","2021","07","07","Mymensingh Med J","Mymensingh medical journal : MMJ","Adult; Aged; Bangladesh; COVID-19; Delivery of Health Care; Female; Hospitals; Humans; Male; Middle Aged; SARS-CoV-2","Choudhury","S R","Professor Fazila-Tun-Nesa Malik, Professor, Department of Cardiology, National Heart Foundation Hospital &amp",NA
"1091","34226453","","Clinical Features of Covid-19 Infection: a Study of SARS-CoV-2 Positive Patients from Mymensingh Region, in Bangladesh.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread to almost every country on the globe and it is considered by World Health Organization as a pandemic. SARS-CoV-2 causes the Coronavirus disease 2019 (COVID-19). Many of country are reporting the symptomatic characteristics of their cases to give better observations into the various clinical presentations of SARS-CoV-2 infection. However, the symptomatic literature is limited in Bangladesh. The aim of the study is to analyze ","2021","07","07","Mymensingh Med J","Mymensingh medical journal : MMJ","Bangladesh; COVID-19; Female; Humans; Male; Pandemics; Real-Time Polymerase Chain Reaction; SARS-CoV-2","Barman","T K","Dr Tridip Kanti Barman, Assistant Professor, Department of Medicine, Mymensingh Medical College (MMC), Mymensingh, Bangladesh",NA
"1092","34226453","","Clinical Features of Covid-19 Infection: a Study of SARS-CoV-2 Positive Patients from Mymensingh Region, in Bangladesh.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread to almost every country on the globe and it is considered by World Health Organization as a pandemic. SARS-CoV-2 causes the Coronavirus disease 2019 (COVID-19). Many of country are reporting the symptomatic characteristics of their cases to give better observations into the various clinical presentations of SARS-CoV-2 infection. However, the symptomatic literature is limited in Bangladesh. The aim of the study is to analyze ","2021","07","07","Mymensingh Med J","Mymensingh medical journal : MMJ","Bangladesh; COVID-19; Female; Humans; Male; Pandemics; Real-Time Polymerase Chain Reaction; SARS-CoV-2","Roy","S","Dr Tridip Kanti Barman, Assistant Professor, Department of Medicine, Mymensingh Medical College (MMC), Mymensingh, Bangladesh",NA
"1093","34226453","","Clinical Features of Covid-19 Infection: a Study of SARS-CoV-2 Positive Patients from Mymensingh Region, in Bangladesh.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread to almost every country on the globe and it is considered by World Health Organization as a pandemic. SARS-CoV-2 causes the Coronavirus disease 2019 (COVID-19). Many of country are reporting the symptomatic characteristics of their cases to give better observations into the various clinical presentations of SARS-CoV-2 infection. However, the symptomatic literature is limited in Bangladesh. The aim of the study is to analyze ","2021","07","07","Mymensingh Med J","Mymensingh medical journal : MMJ","Bangladesh; COVID-19; Female; Humans; Male; Pandemics; Real-Time Polymerase Chain Reaction; SARS-CoV-2","Nasreen","S A","Dr Tridip Kanti Barman, Assistant Professor, Department of Medicine, Mymensingh Medical College (MMC), Mymensingh, Bangladesh",NA
"1094","34226453","","Clinical Features of Covid-19 Infection: a Study of SARS-CoV-2 Positive Patients from Mymensingh Region, in Bangladesh.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread to almost every country on the globe and it is considered by World Health Organization as a pandemic. SARS-CoV-2 causes the Coronavirus disease 2019 (COVID-19). Many of country are reporting the symptomatic characteristics of their cases to give better observations into the various clinical presentations of SARS-CoV-2 infection. However, the symptomatic literature is limited in Bangladesh. The aim of the study is to analyze ","2021","07","07","Mymensingh Med J","Mymensingh medical journal : MMJ","Bangladesh; COVID-19; Female; Humans; Male; Pandemics; Real-Time Polymerase Chain Reaction; SARS-CoV-2","Ahmed","S","Dr Tridip Kanti Barman, Assistant Professor, Department of Medicine, Mymensingh Medical College (MMC), Mymensingh, Bangladesh",NA
"1095","34226453","","Clinical Features of Covid-19 Infection: a Study of SARS-CoV-2 Positive Patients from Mymensingh Region, in Bangladesh.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread to almost every country on the globe and it is considered by World Health Organization as a pandemic. SARS-CoV-2 causes the Coronavirus disease 2019 (COVID-19). Many of country are reporting the symptomatic characteristics of their cases to give better observations into the various clinical presentations of SARS-CoV-2 infection. However, the symptomatic literature is limited in Bangladesh. The aim of the study is to analyze ","2021","07","07","Mymensingh Med J","Mymensingh medical journal : MMJ","Bangladesh; COVID-19; Female; Humans; Male; Pandemics; Real-Time Polymerase Chain Reaction; SARS-CoV-2","Khanam","J","Dr Tridip Kanti Barman, Assistant Professor, Department of Medicine, Mymensingh Medical College (MMC), Mymensingh, Bangladesh",NA
"1096","34226453","","Clinical Features of Covid-19 Infection: a Study of SARS-CoV-2 Positive Patients from Mymensingh Region, in Bangladesh.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread to almost every country on the globe and it is considered by World Health Organization as a pandemic. SARS-CoV-2 causes the Coronavirus disease 2019 (COVID-19). Many of country are reporting the symptomatic characteristics of their cases to give better observations into the various clinical presentations of SARS-CoV-2 infection. However, the symptomatic literature is limited in Bangladesh. The aim of the study is to analyze ","2021","07","07","Mymensingh Med J","Mymensingh medical journal : MMJ","Bangladesh; COVID-19; Female; Humans; Male; Pandemics; Real-Time Polymerase Chain Reaction; SARS-CoV-2","Nila","S S","Dr Tridip Kanti Barman, Assistant Professor, Department of Medicine, Mymensingh Medical College (MMC), Mymensingh, Bangladesh",NA
"1097","34226453","","Clinical Features of Covid-19 Infection: a Study of SARS-CoV-2 Positive Patients from Mymensingh Region, in Bangladesh.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread to almost every country on the globe and it is considered by World Health Organization as a pandemic. SARS-CoV-2 causes the Coronavirus disease 2019 (COVID-19). Many of country are reporting the symptomatic characteristics of their cases to give better observations into the various clinical presentations of SARS-CoV-2 infection. However, the symptomatic literature is limited in Bangladesh. The aim of the study is to analyze ","2021","07","07","Mymensingh Med J","Mymensingh medical journal : MMJ","Bangladesh; COVID-19; Female; Humans; Male; Pandemics; Real-Time Polymerase Chain Reaction; SARS-CoV-2","Debnath","P","Dr Tridip Kanti Barman, Assistant Professor, Department of Medicine, Mymensingh Medical College (MMC), Mymensingh, Bangladesh",NA
"1098","34226453","","Clinical Features of Covid-19 Infection: a Study of SARS-CoV-2 Positive Patients from Mymensingh Region, in Bangladesh.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread to almost every country on the globe and it is considered by World Health Organization as a pandemic. SARS-CoV-2 causes the Coronavirus disease 2019 (COVID-19). Many of country are reporting the symptomatic characteristics of their cases to give better observations into the various clinical presentations of SARS-CoV-2 infection. However, the symptomatic literature is limited in Bangladesh. The aim of the study is to analyze ","2021","07","07","Mymensingh Med J","Mymensingh medical journal : MMJ","Bangladesh; COVID-19; Female; Humans; Male; Pandemics; Real-Time Polymerase Chain Reaction; SARS-CoV-2","Khaled","F I","Dr Tridip Kanti Barman, Assistant Professor, Department of Medicine, Mymensingh Medical College (MMC), Mymensingh, Bangladesh",NA
"1099","34226453","","Clinical Features of Covid-19 Infection: a Study of SARS-CoV-2 Positive Patients from Mymensingh Region, in Bangladesh.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread to almost every country on the globe and it is considered by World Health Organization as a pandemic. SARS-CoV-2 causes the Coronavirus disease 2019 (COVID-19). Many of country are reporting the symptomatic characteristics of their cases to give better observations into the various clinical presentations of SARS-CoV-2 infection. However, the symptomatic literature is limited in Bangladesh. The aim of the study is to analyze ","2021","07","07","Mymensingh Med J","Mymensingh medical journal : MMJ","Bangladesh; COVID-19; Female; Humans; Male; Pandemics; Real-Time Polymerase Chain Reaction; SARS-CoV-2","Paul","S K","Dr Tridip Kanti Barman, Assistant Professor, Department of Medicine, Mymensingh Medical College (MMC), Mymensingh, Bangladesh",NA
"1100","34226440","","Pulmonary Rehabilitation: A Weapon to Fight against COVID-19.","No Abstract.","2021","07","07","Mymensingh Med J","Mymensingh medical journal : MMJ","COVID-19; Humans; SARS-CoV-2","Rahman","M A","Dr Mohammad Azizur Rahman, Assistant Professor and Head, Department of Physical Medicine and Rehabilitation, Mymensingh Medical College (MMC), Bangladesh","azizpmr@gmail.com"
"1101","34226440","","Pulmonary Rehabilitation: A Weapon to Fight against COVID-19.","No Abstract.","2021","07","07","Mymensingh Med J","Mymensingh medical journal : MMJ","COVID-19; Humans; SARS-CoV-2","Nessa","A","Dr Mohammad Azizur Rahman, Assistant Professor and Head, Department of Physical Medicine and Rehabilitation, Mymensingh Medical College (MMC), Bangladesh",NA
"1102","34226440","","Pulmonary Rehabilitation: A Weapon to Fight against COVID-19.","No Abstract.","2021","07","07","Mymensingh Med J","Mymensingh medical journal : MMJ","COVID-19; Humans; SARS-CoV-2","Debnath","C R","Dr Mohammad Azizur Rahman, Assistant Professor and Head, Department of Physical Medicine and Rehabilitation, Mymensingh Medical College (MMC), Bangladesh",NA
"1103","34226432","","Impact of the mandatory confinement during the first wave of the SARS-CoV-2/COVID-19 pandemic in Portuguese patients with rheumatoid arthritis: results from the COVID in RA (COVIDRA) survey.","The aim of this study was to evaluate the self-reported impact of mandatory confinement occurring in the first wave of the SARS-CoV-2 pandemic in Portuguese patients with rheumatoid arthritis (RA), as a means to improve care during this and in future pandemics. The web-based survey COVIDRA was developed to assess 5 domains including RA symptoms, attitudes towards medication, employment status, physical exercise and mental health. The questionnaire was sent to RA patients through e-mail and socia","2021","07","15","Acta Reumatol Port","Acta reumatologica portuguesa","Aged; Anxiety; Arthritis, Rheumatoid; COVID-19; Depression; Female; Humans; Male; Middle Aged; Portugal; Quarantine; Self Report","Araújo","Filipe C","Rheumatology and Osteoporosis Unit, Hospital de Sant'Ana, SCML",NA
"1104","34226432","","Impact of the mandatory confinement during the first wave of the SARS-CoV-2/COVID-19 pandemic in Portuguese patients with rheumatoid arthritis: results from the COVID in RA (COVIDRA) survey.","The aim of this study was to evaluate the self-reported impact of mandatory confinement occurring in the first wave of the SARS-CoV-2 pandemic in Portuguese patients with rheumatoid arthritis (RA), as a means to improve care during this and in future pandemics. The web-based survey COVIDRA was developed to assess 5 domains including RA symptoms, attitudes towards medication, employment status, physical exercise and mental health. The questionnaire was sent to RA patients through e-mail and socia","2021","07","15","Acta Reumatol Port","Acta reumatologica portuguesa","Aged; Anxiety; Arthritis, Rheumatoid; COVID-19; Depression; Female; Humans; Male; Middle Aged; Portugal; Quarantine; Self Report","Gonçalves","Nuno Pina","Department of Rheumatology, Centro Hospitalar de Lisboa Ocidental EPE - Hospital de Egas Moniz",NA
"1105","34226432","","Impact of the mandatory confinement during the first wave of the SARS-CoV-2/COVID-19 pandemic in Portuguese patients with rheumatoid arthritis: results from the COVID in RA (COVIDRA) survey.","The aim of this study was to evaluate the self-reported impact of mandatory confinement occurring in the first wave of the SARS-CoV-2 pandemic in Portuguese patients with rheumatoid arthritis (RA), as a means to improve care during this and in future pandemics. The web-based survey COVIDRA was developed to assess 5 domains including RA symptoms, attitudes towards medication, employment status, physical exercise and mental health. The questionnaire was sent to RA patients through e-mail and socia","2021","07","15","Acta Reumatol Port","Acta reumatologica portuguesa","Aged; Anxiety; Arthritis, Rheumatoid; COVID-19; Depression; Female; Humans; Male; Middle Aged; Portugal; Quarantine; Self Report","Mourão","Ana Filipa","Department of Rheumatology, Centro Hospitalar de Lisboa Ocidental EPE - Hospital de Egas Moniz",NA
"1106","34226277","10.26508/lsa.202101099","A serum proteome signature to predict mortality in severe COVID-19 patients.","Here, we recorded serum proteome profiles of 33 severe COVID-19 patients admitted to respiratory and intensive care units because of respiratory failure. We received, for most patients, blood samples just after admission and at two more later time points. With the aim to predict treatment outcome, we focused on serum proteins different in abundance between the group of survivors and non-survivors. We observed that a small panel of about a dozen proteins were significantly different in abundance ","2021","07","14","Life Sci Alliance","Life science alliance","Aged; COVID-19; Cohort Studies; Female; Hospitalization; Humans; Immunoglobulins; Male; Proteome; SARS-CoV-2; Severity of Illness Index; Survivors","Völlmy","Franziska","Biomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research and Utrecht Institute for Pharmaceutical Sciences, University of Utrecht, Utrecht, The Netherlands",NA
"1107","34226277","10.26508/lsa.202101099","A serum proteome signature to predict mortality in severe COVID-19 patients.","Here, we recorded serum proteome profiles of 33 severe COVID-19 patients admitted to respiratory and intensive care units because of respiratory failure. We received, for most patients, blood samples just after admission and at two more later time points. With the aim to predict treatment outcome, we focused on serum proteins different in abundance between the group of survivors and non-survivors. We observed that a small panel of about a dozen proteins were significantly different in abundance ","2021","07","14","Life Sci Alliance","Life science alliance","Aged; COVID-19; Cohort Studies; Female; Hospitalization; Humans; Immunoglobulins; Male; Proteome; SARS-CoV-2; Severity of Illness Index; Survivors","van den Toorn","Henk","Biomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research and Utrecht Institute for Pharmaceutical Sciences, University of Utrecht, Utrecht, The Netherlands",NA
"1108","34226277","10.26508/lsa.202101099","A serum proteome signature to predict mortality in severe COVID-19 patients.","Here, we recorded serum proteome profiles of 33 severe COVID-19 patients admitted to respiratory and intensive care units because of respiratory failure. We received, for most patients, blood samples just after admission and at two more later time points. With the aim to predict treatment outcome, we focused on serum proteins different in abundance between the group of survivors and non-survivors. We observed that a small panel of about a dozen proteins were significantly different in abundance ","2021","07","14","Life Sci Alliance","Life science alliance","Aged; COVID-19; Cohort Studies; Female; Hospitalization; Humans; Immunoglobulins; Male; Proteome; SARS-CoV-2; Severity of Illness Index; Survivors","Zenezini Chiozzi","Riccardo","Biomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research and Utrecht Institute for Pharmaceutical Sciences, University of Utrecht, Utrecht, The Netherlands",NA
"1109","34226277","10.26508/lsa.202101099","A serum proteome signature to predict mortality in severe COVID-19 patients.","Here, we recorded serum proteome profiles of 33 severe COVID-19 patients admitted to respiratory and intensive care units because of respiratory failure. We received, for most patients, blood samples just after admission and at two more later time points. With the aim to predict treatment outcome, we focused on serum proteins different in abundance between the group of survivors and non-survivors. We observed that a small panel of about a dozen proteins were significantly different in abundance ","2021","07","14","Life Sci Alliance","Life science alliance","Aged; COVID-19; Cohort Studies; Female; Hospitalization; Humans; Immunoglobulins; Male; Proteome; SARS-CoV-2; Severity of Illness Index; Survivors","Zucchetti","Ottavio","Cardiology Unit, Azienda Ospedaliero-Universitaria di Ferrara, University of Ferrara, Ferrara, Italy",NA
"1110","34226277","10.26508/lsa.202101099","A serum proteome signature to predict mortality in severe COVID-19 patients.","Here, we recorded serum proteome profiles of 33 severe COVID-19 patients admitted to respiratory and intensive care units because of respiratory failure. We received, for most patients, blood samples just after admission and at two more later time points. With the aim to predict treatment outcome, we focused on serum proteins different in abundance between the group of survivors and non-survivors. We observed that a small panel of about a dozen proteins were significantly different in abundance ","2021","07","14","Life Sci Alliance","Life science alliance","Aged; COVID-19; Cohort Studies; Female; Hospitalization; Humans; Immunoglobulins; Male; Proteome; SARS-CoV-2; Severity of Illness Index; Survivors","Papi","Alberto","Respiratory Section, Department of Translational Medicine, University of Ferrara, Ferrara, Italy and Respiratory Disease Unit, Azienda Ospedaliero-Universitaria di Ferrara, Ferrara, Italy",NA
"1111","34226277","10.26508/lsa.202101099","A serum proteome signature to predict mortality in severe COVID-19 patients.","Here, we recorded serum proteome profiles of 33 severe COVID-19 patients admitted to respiratory and intensive care units because of respiratory failure. We received, for most patients, blood samples just after admission and at two more later time points. With the aim to predict treatment outcome, we focused on serum proteins different in abundance between the group of survivors and non-survivors. We observed that a small panel of about a dozen proteins were significantly different in abundance ","2021","07","14","Life Sci Alliance","Life science alliance","Aged; COVID-19; Cohort Studies; Female; Hospitalization; Humans; Immunoglobulins; Male; Proteome; SARS-CoV-2; Severity of Illness Index; Survivors","Volta","Carlo Alberto","Department of Translational Medicine University of Ferrara, Ferrara, Italy and Intensive Care Unit, Azienda Ospedaliero-Universitaria di Ferrara, Italy",NA
"1112","34226277","10.26508/lsa.202101099","A serum proteome signature to predict mortality in severe COVID-19 patients.","Here, we recorded serum proteome profiles of 33 severe COVID-19 patients admitted to respiratory and intensive care units because of respiratory failure. We received, for most patients, blood samples just after admission and at two more later time points. With the aim to predict treatment outcome, we focused on serum proteins different in abundance between the group of survivors and non-survivors. We observed that a small panel of about a dozen proteins were significantly different in abundance ","2021","07","14","Life Sci Alliance","Life science alliance","Aged; COVID-19; Cohort Studies; Female; Hospitalization; Humans; Immunoglobulins; Male; Proteome; SARS-CoV-2; Severity of Illness Index; Survivors","Marracino","Luisa","Department of Translational Medicine and Laboratory for Technology of Advanced Therapies (LTTA), University of Ferrara, Ferrara, Italy",NA
"1113","34226277","10.26508/lsa.202101099","A serum proteome signature to predict mortality in severe COVID-19 patients.","Here, we recorded serum proteome profiles of 33 severe COVID-19 patients admitted to respiratory and intensive care units because of respiratory failure. We received, for most patients, blood samples just after admission and at two more later time points. With the aim to predict treatment outcome, we focused on serum proteins different in abundance between the group of survivors and non-survivors. We observed that a small panel of about a dozen proteins were significantly different in abundance ","2021","07","14","Life Sci Alliance","Life science alliance","Aged; COVID-19; Cohort Studies; Female; Hospitalization; Humans; Immunoglobulins; Male; Proteome; SARS-CoV-2; Severity of Illness Index; Survivors","Vieceli Dalla Sega","Francesco","Maria Cecilia Hospital, GVM Care &amp",NA
"1114","34226277","10.26508/lsa.202101099","A serum proteome signature to predict mortality in severe COVID-19 patients.","Here, we recorded serum proteome profiles of 33 severe COVID-19 patients admitted to respiratory and intensive care units because of respiratory failure. We received, for most patients, blood samples just after admission and at two more later time points. With the aim to predict treatment outcome, we focused on serum proteins different in abundance between the group of survivors and non-survivors. We observed that a small panel of about a dozen proteins were significantly different in abundance ","2021","07","14","Life Sci Alliance","Life science alliance","Aged; COVID-19; Cohort Studies; Female; Hospitalization; Humans; Immunoglobulins; Male; Proteome; SARS-CoV-2; Severity of Illness Index; Survivors","Fortini","Francesca","Maria Cecilia Hospital, GVM Care &amp",NA
"1115","34226277","10.26508/lsa.202101099","A serum proteome signature to predict mortality in severe COVID-19 patients.","Here, we recorded serum proteome profiles of 33 severe COVID-19 patients admitted to respiratory and intensive care units because of respiratory failure. We received, for most patients, blood samples just after admission and at two more later time points. With the aim to predict treatment outcome, we focused on serum proteins different in abundance between the group of survivors and non-survivors. We observed that a small panel of about a dozen proteins were significantly different in abundance ","2021","07","14","Life Sci Alliance","Life science alliance","Aged; COVID-19; Cohort Studies; Female; Hospitalization; Humans; Immunoglobulins; Male; Proteome; SARS-CoV-2; Severity of Illness Index; Survivors","Demichev","Vadim","Charité-Universitätsmedizin Berlin, Department of Biochemistry, Berlin, Germany",NA
"1116","34226277","10.26508/lsa.202101099","A serum proteome signature to predict mortality in severe COVID-19 patients.","Here, we recorded serum proteome profiles of 33 severe COVID-19 patients admitted to respiratory and intensive care units because of respiratory failure. We received, for most patients, blood samples just after admission and at two more later time points. With the aim to predict treatment outcome, we focused on serum proteins different in abundance between the group of survivors and non-survivors. We observed that a small panel of about a dozen proteins were significantly different in abundance ","2021","07","14","Life Sci Alliance","Life science alliance","Aged; COVID-19; Cohort Studies; Female; Hospitalization; Humans; Immunoglobulins; Male; Proteome; SARS-CoV-2; Severity of Illness Index; Survivors","Tober-Lau","Pinkus","Charité-Universitätsmedizin Berlin, Department of Infectious Diseases and Respiratory Medicine, Berlin, Germany",NA
"1117","34226277","10.26508/lsa.202101099","A serum proteome signature to predict mortality in severe COVID-19 patients.","Here, we recorded serum proteome profiles of 33 severe COVID-19 patients admitted to respiratory and intensive care units because of respiratory failure. We received, for most patients, blood samples just after admission and at two more later time points. With the aim to predict treatment outcome, we focused on serum proteins different in abundance between the group of survivors and non-survivors. We observed that a small panel of about a dozen proteins were significantly different in abundance ","2021","07","14","Life Sci Alliance","Life science alliance","Aged; COVID-19; Cohort Studies; Female; Hospitalization; Humans; Immunoglobulins; Male; Proteome; SARS-CoV-2; Severity of Illness Index; Survivors","Campo","Gianluca","Cardiology Unit, Azienda Ospedaliero-Universitaria di Ferrara, University of Ferrara, Ferrara, Italy",NA
"1118","34226277","10.26508/lsa.202101099","A serum proteome signature to predict mortality in severe COVID-19 patients.","Here, we recorded serum proteome profiles of 33 severe COVID-19 patients admitted to respiratory and intensive care units because of respiratory failure. We received, for most patients, blood samples just after admission and at two more later time points. With the aim to predict treatment outcome, we focused on serum proteins different in abundance between the group of survivors and non-survivors. We observed that a small panel of about a dozen proteins were significantly different in abundance ","2021","07","14","Life Sci Alliance","Life science alliance","Aged; COVID-19; Cohort Studies; Female; Hospitalization; Humans; Immunoglobulins; Male; Proteome; SARS-CoV-2; Severity of Illness Index; Survivors","Contoli","Marco","Respiratory Section, Department of Translational Medicine, University of Ferrara, Ferrara, Italy and Respiratory Disease Unit, Azienda Ospedaliero-Universitaria di Ferrara, Ferrara, Italy",NA
"1119","34226277","10.26508/lsa.202101099","A serum proteome signature to predict mortality in severe COVID-19 patients.","Here, we recorded serum proteome profiles of 33 severe COVID-19 patients admitted to respiratory and intensive care units because of respiratory failure. We received, for most patients, blood samples just after admission and at two more later time points. With the aim to predict treatment outcome, we focused on serum proteins different in abundance between the group of survivors and non-survivors. We observed that a small panel of about a dozen proteins were significantly different in abundance ","2021","07","14","Life Sci Alliance","Life science alliance","Aged; COVID-19; Cohort Studies; Female; Hospitalization; Humans; Immunoglobulins; Male; Proteome; SARS-CoV-2; Severity of Illness Index; Survivors","Ralser","Markus","Charité-Universitätsmedizin Berlin, Department of Biochemistry, Berlin, Germany",NA
"1120","34226277","10.26508/lsa.202101099","A serum proteome signature to predict mortality in severe COVID-19 patients.","Here, we recorded serum proteome profiles of 33 severe COVID-19 patients admitted to respiratory and intensive care units because of respiratory failure. We received, for most patients, blood samples just after admission and at two more later time points. With the aim to predict treatment outcome, we focused on serum proteins different in abundance between the group of survivors and non-survivors. We observed that a small panel of about a dozen proteins were significantly different in abundance ","2021","07","14","Life Sci Alliance","Life science alliance","Aged; COVID-19; Cohort Studies; Female; Hospitalization; Humans; Immunoglobulins; Male; Proteome; SARS-CoV-2; Severity of Illness Index; Survivors","Kurth","Florian","Charité-Universitätsmedizin Berlin, Department of Infectious Diseases and Respiratory Medicine, Berlin, Germany",NA
"1121","34226277","10.26508/lsa.202101099","A serum proteome signature to predict mortality in severe COVID-19 patients.","Here, we recorded serum proteome profiles of 33 severe COVID-19 patients admitted to respiratory and intensive care units because of respiratory failure. We received, for most patients, blood samples just after admission and at two more later time points. With the aim to predict treatment outcome, we focused on serum proteins different in abundance between the group of survivors and non-survivors. We observed that a small panel of about a dozen proteins were significantly different in abundance ","2021","07","14","Life Sci Alliance","Life science alliance","Aged; COVID-19; Cohort Studies; Female; Hospitalization; Humans; Immunoglobulins; Male; Proteome; SARS-CoV-2; Severity of Illness Index; Survivors","Spadaro","Savino","Department of Translational Medicine University of Ferrara, Ferrara, Italy and Intensive Care Unit, Azienda Ospedaliero-Universitaria di Ferrara, Italy",NA
"1122","34226277","10.26508/lsa.202101099","A serum proteome signature to predict mortality in severe COVID-19 patients.","Here, we recorded serum proteome profiles of 33 severe COVID-19 patients admitted to respiratory and intensive care units because of respiratory failure. We received, for most patients, blood samples just after admission and at two more later time points. With the aim to predict treatment outcome, we focused on serum proteins different in abundance between the group of survivors and non-survivors. We observed that a small panel of about a dozen proteins were significantly different in abundance ","2021","07","14","Life Sci Alliance","Life science alliance","Aged; COVID-19; Cohort Studies; Female; Hospitalization; Humans; Immunoglobulins; Male; Proteome; SARS-CoV-2; Severity of Illness Index; Survivors","Rizzo","Paola","Department of Translational Medicine and Laboratory for Technology of Advanced Therapies (LTTA), University of Ferrara, Ferrara, Italy",NA
"1123","34226277","10.26508/lsa.202101099","A serum proteome signature to predict mortality in severe COVID-19 patients.","Here, we recorded serum proteome profiles of 33 severe COVID-19 patients admitted to respiratory and intensive care units because of respiratory failure. We received, for most patients, blood samples just after admission and at two more later time points. With the aim to predict treatment outcome, we focused on serum proteins different in abundance between the group of survivors and non-survivors. We observed that a small panel of about a dozen proteins were significantly different in abundance ","2021","07","14","Life Sci Alliance","Life science alliance","Aged; COVID-19; Cohort Studies; Female; Hospitalization; Humans; Immunoglobulins; Male; Proteome; SARS-CoV-2; Severity of Illness Index; Survivors","Heck","Albert Jr","Biomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research and Utrecht Institute for Pharmaceutical Sciences, University of Utrecht, Utrecht, The Netherlands a.j.r.heck@uu",NA
"1124","34226272","10.1503/cmaj.210066-f",NA,NA,"2021","07","13","CMAJ","CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne","Antibodies, Monoclonal, Humanized; COVID-19; Hospitalization; Humans; Pandemics; SARS-CoV-2; Treatment Outcome","Afra","Kevin","Division des maladies infectieuses (Afra) et Division d'hématologie (Chen), Département de médecine","kevin.afra@fraserhealth.ca"
"1125","34226272","10.1503/cmaj.210066-f",NA,NA,"2021","07","13","CMAJ","CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne","Antibodies, Monoclonal, Humanized; COVID-19; Hospitalization; Humans; Pandemics; SARS-CoV-2; Treatment Outcome","Chen","Luke Y C","Division des maladies infectieuses (Afra) et Division d'hématologie (Chen), Département de médecine",NA
"1126","34226272","10.1503/cmaj.210066-f",NA,NA,"2021","07","13","CMAJ","CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne","Antibodies, Monoclonal, Humanized; COVID-19; Hospitalization; Humans; Pandemics; SARS-CoV-2; Treatment Outcome","Sweet","David","Division des maladies infectieuses (Afra) et Division d'hématologie (Chen), Département de médecine",NA
"1127","34226271","10.1503/cmaj.210795-f",NA,NA,"2021","07","13","CMAJ","CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne","COVID-19; COVID-19 Vaccines; Extremities; Humans; Ischemia; Male; Middle Aged; Pandemics; Pulmonary Artery; SARS-CoV-2; Thrombosis; Tomography, X-Ray Computed; Vaccination","Jones","Melissa","Section de la chirurgie vasculaire (Jones, Boisvert, Petrasek) et Division de médecine interne générale (Landry), Centre Peter Lougheed et École de médecine Cumming, Université de Calgary, Calgary, Alb",NA
"1128","34226271","10.1503/cmaj.210795-f",NA,NA,"2021","07","13","CMAJ","CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne","COVID-19; COVID-19 Vaccines; Extremities; Humans; Ischemia; Male; Middle Aged; Pandemics; Pulmonary Artery; SARS-CoV-2; Thrombosis; Tomography, X-Ray Computed; Vaccination","Boisvert","Annie","Section de la chirurgie vasculaire (Jones, Boisvert, Petrasek) et Division de médecine interne générale (Landry), Centre Peter Lougheed et École de médecine Cumming, Université de Calgary, Calgary, Alb",NA
"1129","34226271","10.1503/cmaj.210795-f",NA,NA,"2021","07","13","CMAJ","CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne","COVID-19; COVID-19 Vaccines; Extremities; Humans; Ischemia; Male; Middle Aged; Pandemics; Pulmonary Artery; SARS-CoV-2; Thrombosis; Tomography, X-Ray Computed; Vaccination","Landry","Jennifer","Section de la chirurgie vasculaire (Jones, Boisvert, Petrasek) et Division de médecine interne générale (Landry), Centre Peter Lougheed et École de médecine Cumming, Université de Calgary, Calgary, Alb",NA
"1130","34226271","10.1503/cmaj.210795-f",NA,NA,"2021","07","13","CMAJ","CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne","COVID-19; COVID-19 Vaccines; Extremities; Humans; Ischemia; Male; Middle Aged; Pandemics; Pulmonary Artery; SARS-CoV-2; Thrombosis; Tomography, X-Ray Computed; Vaccination","Petrasek","Paul F","Section de la chirurgie vasculaire (Jones, Boisvert, Petrasek) et Division de médecine interne générale (Landry), Centre Peter Lougheed et École de médecine Cumming, Université de Calgary, Calgary, Alb. paul.petrasek@albertahealthservices","paul.petrasek@albertahealthservices.ca"
"1131","34226261","10.1136/tobaccocontrol-2020-056293","COVID-19 and a temporary ban on tobacco sales in South Africa: impact on smoking cessation.","To evaluate the impact of COVID-19 plus a temporary ban on the sale of tobacco and vaping products, on smoking cessation in South Africa, by reviewing research surveys conducted while the prohibition was in place. An internet search was conducted on 20 August 2020, using the key words: 'South Africa', 'survey', 'poll', 'smoking', 'cigarettes', 'tobacco"", 'vaping', and 'COVID-19'. There were no language restrictions. Additional studies were identified through press reports. Only studies conducted","2021","07","06","Tob Control","Tobacco control","COVID-19; cessation; public opinion; public policy","Saloojee","Yussuf","Johannesburg, South Africa ysalooje@iafrica","ysalooje@iafrica.com"
"1132","34226261","10.1136/tobaccocontrol-2020-056293","COVID-19 and a temporary ban on tobacco sales in South Africa: impact on smoking cessation.","To evaluate the impact of COVID-19 plus a temporary ban on the sale of tobacco and vaping products, on smoking cessation in South Africa, by reviewing research surveys conducted while the prohibition was in place. An internet search was conducted on 20 August 2020, using the key words: 'South Africa', 'survey', 'poll', 'smoking', 'cigarettes', 'tobacco"", 'vaping', and 'COVID-19'. There were no language restrictions. Additional studies were identified through press reports. Only studies conducted","2021","07","06","Tob Control","Tobacco control","COVID-19; cessation; public opinion; public policy","Mathee","Angela","Environment &amp",NA
"1133","34226259","10.1136/jech-2021-216764","Housing and health inequities during COVID-19: findings from the national Household Pulse Survey.","COVID-19 has exploited the inequities within the US housing system. Examining the association between housing and health during the pandemic is imperative to reducing health inequities and improving population health. We analysed 957 714 responses from the Household Pulse Survey Study, collected between April and July 2020. Using survey-weighted multivariable regression analyses, we assessed the relationships between housing tenure and health, both on average and over time, as well as how these ","2021","07","10","J Epidemiol Community Health","Journal of epidemiology and community health","COVID-19; health inequalities; housing; mental health; self-rated health","Bushman","Gregory","Department of Health Behavior and Health Education, University of Michigan School of Public Health, Ann Arbor, Michigan, USA gbushman@umich","gbushman@umich.edu"
"1134","34226259","10.1136/jech-2021-216764","Housing and health inequities during COVID-19: findings from the national Household Pulse Survey.","COVID-19 has exploited the inequities within the US housing system. Examining the association between housing and health during the pandemic is imperative to reducing health inequities and improving population health. We analysed 957 714 responses from the Household Pulse Survey Study, collected between April and July 2020. Using survey-weighted multivariable regression analyses, we assessed the relationships between housing tenure and health, both on average and over time, as well as how these ","2021","07","10","J Epidemiol Community Health","Journal of epidemiology and community health","COVID-19; health inequalities; housing; mental health; self-rated health","Mehdipanah","Roshanak","Department of Health Behavior and Health Education, University of Michigan School of Public Health, Ann Arbor, Michigan, USA",NA
"1135","34226258","10.1136/bcr-2021-244687","Acute longitudinal extensive transverse myelitis secondary to asymptomatic SARS-CoV-2 infection.","A 35-year-old woman, 6 months post partum, presented with acute onset back pain at the T8 level progressing to bilateral lower limb weakness and sensory loss with urinary retention and constipation. This patient had a pre-existing inflammatory disease, having recently developed ulcerative colitis antenatally. Five days prior to admission, she had tested positive asymptomatically on a SARS-CoV-2 reverse-transcriptase PCR nasopharyngeal swab. The positive swab result was confirmed on admission. Cl","2021","07","07","BMJ Case Rep","BMJ case reports","COVID-19; neurology (drugs and medicines); obstetrics and gynaecology; spinal cord; ulcerative colitis; Adult; COVID-19; Female; Humans; Magnetic Resonance Imaging; Myelitis, Transverse; SARS-CoV-2","Lee","Gabriel","Acute Internal Medicine, St Thomas' Hospital, London, UK Gabriel.q.lee@gmail","Gabriel.q.lee@gmail.com"
"1136","34226241","10.1136/bmjgh-2021-006651","World Committee on Tourism Ethics (WCTE) recommendation on COVID-19 certificates for international travel.",NA,"2021","07","09","BMJ Glob Health","BMJ global health","Health policies and all other topics; Vaccines; COVID-19; Humans; SARS-CoV-2; Tourism; Travel","Matsuura","Hiroaki","Faculty of Tourism, Media, and Cultural Studies, Shoin University, Atsugi, Japan hiroaki.matsuura@shoin-u.ac",NA
"1137","34226238","10.1136/bmjopen-2021-051326","Work-related stress: the impact of COVID-19 on critical care and redeployed nurses: a mixed-methods study.","We need to understand the impact of COVID-19 on critical care nurses (CCNs) and redeployed nurses and National Health Service (NHS) organisations. This is a mixed-methods study (QUANT-QUAL), underpinned by a theoretical model of occupational stress, the Job Demand-Resources Model (JD-R). Participants are critical care and redeployed nurses from Scottish and three large English units.Phase 1 is a cross-sectional survey in part replicating a pre-COVID-19 study and results will be compared with thi","2021","07","09","BMJ Open","BMJ open","COVID-19; adult intensive &amp; critical care; qualitative research; Burnout, Professional; COVID-19; Critical Care; Cross-Sectional Studies; Humans; Nurses; Occupational Stress; SARS-CoV-2; State Medicine","Rattray","Janice","Institute of Applied Health Sciences, University of Aberdeen, Aberdeen, UK janice.rattray@abdn.ac","janice.rattray@abdn.ac.uk"
"1138","34226238","10.1136/bmjopen-2021-051326","Work-related stress: the impact of COVID-19 on critical care and redeployed nurses: a mixed-methods study.","We need to understand the impact of COVID-19 on critical care nurses (CCNs) and redeployed nurses and National Health Service (NHS) organisations. This is a mixed-methods study (QUANT-QUAL), underpinned by a theoretical model of occupational stress, the Job Demand-Resources Model (JD-R). Participants are critical care and redeployed nurses from Scottish and three large English units.Phase 1 is a cross-sectional survey in part replicating a pre-COVID-19 study and results will be compared with thi","2021","07","09","BMJ Open","BMJ open","COVID-19; adult intensive &amp; critical care; qualitative research; Burnout, Professional; COVID-19; Critical Care; Cross-Sectional Studies; Humans; Nurses; Occupational Stress; SARS-CoV-2; State Medicine","McCallum","Louise","Nursing and Health Care, University of Glasgow, Glasgow, UK",NA
"1139","34226238","10.1136/bmjopen-2021-051326","Work-related stress: the impact of COVID-19 on critical care and redeployed nurses: a mixed-methods study.","We need to understand the impact of COVID-19 on critical care nurses (CCNs) and redeployed nurses and National Health Service (NHS) organisations. This is a mixed-methods study (QUANT-QUAL), underpinned by a theoretical model of occupational stress, the Job Demand-Resources Model (JD-R). Participants are critical care and redeployed nurses from Scottish and three large English units.Phase 1 is a cross-sectional survey in part replicating a pre-COVID-19 study and results will be compared with thi","2021","07","09","BMJ Open","BMJ open","COVID-19; adult intensive &amp; critical care; qualitative research; Burnout, Professional; COVID-19; Critical Care; Cross-Sectional Studies; Humans; Nurses; Occupational Stress; SARS-CoV-2; State Medicine","Hull","Alastair","Multidisciplinary Adult Psychotherapy Service, NHS Tayside, Dundee, UK",NA
"1140","34226238","10.1136/bmjopen-2021-051326","Work-related stress: the impact of COVID-19 on critical care and redeployed nurses: a mixed-methods study.","We need to understand the impact of COVID-19 on critical care nurses (CCNs) and redeployed nurses and National Health Service (NHS) organisations. This is a mixed-methods study (QUANT-QUAL), underpinned by a theoretical model of occupational stress, the Job Demand-Resources Model (JD-R). Participants are critical care and redeployed nurses from Scottish and three large English units.Phase 1 is a cross-sectional survey in part replicating a pre-COVID-19 study and results will be compared with thi","2021","07","09","BMJ Open","BMJ open","COVID-19; adult intensive &amp; critical care; qualitative research; Burnout, Professional; COVID-19; Critical Care; Cross-Sectional Studies; Humans; Nurses; Occupational Stress; SARS-CoV-2; State Medicine","Ramsay","Pam","School of Health Sciences, University of Dundee, Dundee, UK",NA
"1141","34226238","10.1136/bmjopen-2021-051326","Work-related stress: the impact of COVID-19 on critical care and redeployed nurses: a mixed-methods study.","We need to understand the impact of COVID-19 on critical care nurses (CCNs) and redeployed nurses and National Health Service (NHS) organisations. This is a mixed-methods study (QUANT-QUAL), underpinned by a theoretical model of occupational stress, the Job Demand-Resources Model (JD-R). Participants are critical care and redeployed nurses from Scottish and three large English units.Phase 1 is a cross-sectional survey in part replicating a pre-COVID-19 study and results will be compared with thi","2021","07","09","BMJ Open","BMJ open","COVID-19; adult intensive &amp; critical care; qualitative research; Burnout, Professional; COVID-19; Critical Care; Cross-Sectional Studies; Humans; Nurses; Occupational Stress; SARS-CoV-2; State Medicine","Salisbury","Lisa","Division of Dietetics, Nutrition and Biological Sciences, Queen Margaret University Edinburgh, Musselburgh, UK",NA
"1142","34226238","10.1136/bmjopen-2021-051326","Work-related stress: the impact of COVID-19 on critical care and redeployed nurses: a mixed-methods study.","We need to understand the impact of COVID-19 on critical care nurses (CCNs) and redeployed nurses and National Health Service (NHS) organisations. This is a mixed-methods study (QUANT-QUAL), underpinned by a theoretical model of occupational stress, the Job Demand-Resources Model (JD-R). Participants are critical care and redeployed nurses from Scottish and three large English units.Phase 1 is a cross-sectional survey in part replicating a pre-COVID-19 study and results will be compared with thi","2021","07","09","BMJ Open","BMJ open","COVID-19; adult intensive &amp; critical care; qualitative research; Burnout, Professional; COVID-19; Critical Care; Cross-Sectional Studies; Humans; Nurses; Occupational Stress; SARS-CoV-2; State Medicine","Scott","Teresa","Critical Care, NHS Grampian, Aberdeen, UK",NA
"1143","34226238","10.1136/bmjopen-2021-051326","Work-related stress: the impact of COVID-19 on critical care and redeployed nurses: a mixed-methods study.","We need to understand the impact of COVID-19 on critical care nurses (CCNs) and redeployed nurses and National Health Service (NHS) organisations. This is a mixed-methods study (QUANT-QUAL), underpinned by a theoretical model of occupational stress, the Job Demand-Resources Model (JD-R). Participants are critical care and redeployed nurses from Scottish and three large English units.Phase 1 is a cross-sectional survey in part replicating a pre-COVID-19 study and results will be compared with thi","2021","07","09","BMJ Open","BMJ open","COVID-19; adult intensive &amp; critical care; qualitative research; Burnout, Professional; COVID-19; Critical Care; Cross-Sectional Studies; Humans; Nurses; Occupational Stress; SARS-CoV-2; State Medicine","Cole","Stephen","ICU and Anaesthesia, NHS Tayside, Dundee, UK",NA
"1144","34226238","10.1136/bmjopen-2021-051326","Work-related stress: the impact of COVID-19 on critical care and redeployed nurses: a mixed-methods study.","We need to understand the impact of COVID-19 on critical care nurses (CCNs) and redeployed nurses and National Health Service (NHS) organisations. This is a mixed-methods study (QUANT-QUAL), underpinned by a theoretical model of occupational stress, the Job Demand-Resources Model (JD-R). Participants are critical care and redeployed nurses from Scottish and three large English units.Phase 1 is a cross-sectional survey in part replicating a pre-COVID-19 study and results will be compared with thi","2021","07","09","BMJ Open","BMJ open","COVID-19; adult intensive &amp; critical care; qualitative research; Burnout, Professional; COVID-19; Critical Care; Cross-Sectional Studies; Humans; Nurses; Occupational Stress; SARS-CoV-2; State Medicine","Miller","Jordan","Institute of Applied Health Sciences, University of Aberdeen, Aberdeen, UK",NA
"1145","34226238","10.1136/bmjopen-2021-051326","Work-related stress: the impact of COVID-19 on critical care and redeployed nurses: a mixed-methods study.","We need to understand the impact of COVID-19 on critical care nurses (CCNs) and redeployed nurses and National Health Service (NHS) organisations. This is a mixed-methods study (QUANT-QUAL), underpinned by a theoretical model of occupational stress, the Job Demand-Resources Model (JD-R). Participants are critical care and redeployed nurses from Scottish and three large English units.Phase 1 is a cross-sectional survey in part replicating a pre-COVID-19 study and results will be compared with thi","2021","07","09","BMJ Open","BMJ open","COVID-19; adult intensive &amp; critical care; qualitative research; Burnout, Professional; COVID-19; Critical Care; Cross-Sectional Studies; Humans; Nurses; Occupational Stress; SARS-CoV-2; State Medicine","Dixon","Diane","Institute of Applied Health Sciences, University of Aberdeen, Aberdeen, UK",NA
"1146","34226237","10.1136/bmjopen-2021-051316","Fitness, strength and severity of COVID-19: a prospective register study of 1 559 187 Swedish conscripts.","To investigate the possible connection between cardiorespiratory fitness (CRF) and muscle strength in early adulthood and severity of COVID-19 later in life. Prospective registry-based cohort study. 1 559 187 Swedish men, undergoing military conscription between 1968 and 2005 at a mean age of 18.3 (SD 0.73) years. Hospitalisation, intensive care or death due to COVID-19 from March to September 2020, in relation to CRF and muscle strength. High CRF in late adolescence and early adulthood had a pr","2021","07","09","BMJ Open","BMJ open","COVID-19; epidemiology; public health; Adolescent; Adult; Body Mass Index; COVID-19; Cohort Studies; Humans; Male; Muscle Strength; Physical Fitness; Risk Factors; SARS-CoV-2; Sweden","Af Geijerstam","Agnes","School of Public Health and Community Medicine, Institute of Medicine, University of Gothenburg Sahlgrenska Academy, Goteborg, Sweden agnes.af.geijerstam@gu",NA
"1147","34226237","10.1136/bmjopen-2021-051316","Fitness, strength and severity of COVID-19: a prospective register study of 1 559 187 Swedish conscripts.","To investigate the possible connection between cardiorespiratory fitness (CRF) and muscle strength in early adulthood and severity of COVID-19 later in life. Prospective registry-based cohort study. 1 559 187 Swedish men, undergoing military conscription between 1968 and 2005 at a mean age of 18.3 (SD 0.73) years. Hospitalisation, intensive care or death due to COVID-19 from March to September 2020, in relation to CRF and muscle strength. High CRF in late adolescence and early adulthood had a pr","2021","07","09","BMJ Open","BMJ open","COVID-19; epidemiology; public health; Adolescent; Adult; Body Mass Index; COVID-19; Cohort Studies; Humans; Male; Muscle Strength; Physical Fitness; Risk Factors; SARS-CoV-2; Sweden","Mehlig","Kirsten","School of Public Health and Community Medicine, Institute of Medicine, University of Gothenburg Sahlgrenska Academy, Goteborg, Sweden",NA
"1148","34226237","10.1136/bmjopen-2021-051316","Fitness, strength and severity of COVID-19: a prospective register study of 1 559 187 Swedish conscripts.","To investigate the possible connection between cardiorespiratory fitness (CRF) and muscle strength in early adulthood and severity of COVID-19 later in life. Prospective registry-based cohort study. 1 559 187 Swedish men, undergoing military conscription between 1968 and 2005 at a mean age of 18.3 (SD 0.73) years. Hospitalisation, intensive care or death due to COVID-19 from March to September 2020, in relation to CRF and muscle strength. High CRF in late adolescence and early adulthood had a pr","2021","07","09","BMJ Open","BMJ open","COVID-19; epidemiology; public health; Adolescent; Adult; Body Mass Index; COVID-19; Cohort Studies; Humans; Male; Muscle Strength; Physical Fitness; Risk Factors; SARS-CoV-2; Sweden","Börjesson","Mats","Department of Molecular and Clinical Medicine, University of Gothenburg Sahlgrenska Academy, Goteborg, Sweden",NA
"1149","34226237","10.1136/bmjopen-2021-051316","Fitness, strength and severity of COVID-19: a prospective register study of 1 559 187 Swedish conscripts.","To investigate the possible connection between cardiorespiratory fitness (CRF) and muscle strength in early adulthood and severity of COVID-19 later in life. Prospective registry-based cohort study. 1 559 187 Swedish men, undergoing military conscription between 1968 and 2005 at a mean age of 18.3 (SD 0.73) years. Hospitalisation, intensive care or death due to COVID-19 from March to September 2020, in relation to CRF and muscle strength. High CRF in late adolescence and early adulthood had a pr","2021","07","09","BMJ Open","BMJ open","COVID-19; epidemiology; public health; Adolescent; Adult; Body Mass Index; COVID-19; Cohort Studies; Humans; Male; Muscle Strength; Physical Fitness; Risk Factors; SARS-CoV-2; Sweden","Robertson","Josefina","School of Public Health and Community Medicine, Institute of Medicine, University of Gothenburg Sahlgrenska Academy, Goteborg, Sweden",NA
"1150","34226237","10.1136/bmjopen-2021-051316","Fitness, strength and severity of COVID-19: a prospective register study of 1 559 187 Swedish conscripts.","To investigate the possible connection between cardiorespiratory fitness (CRF) and muscle strength in early adulthood and severity of COVID-19 later in life. Prospective registry-based cohort study. 1 559 187 Swedish men, undergoing military conscription between 1968 and 2005 at a mean age of 18.3 (SD 0.73) years. Hospitalisation, intensive care or death due to COVID-19 from March to September 2020, in relation to CRF and muscle strength. High CRF in late adolescence and early adulthood had a pr","2021","07","09","BMJ Open","BMJ open","COVID-19; epidemiology; public health; Adolescent; Adult; Body Mass Index; COVID-19; Cohort Studies; Humans; Male; Muscle Strength; Physical Fitness; Risk Factors; SARS-CoV-2; Sweden","Nyberg","Jenny","Section for Clinical Neuroscience, Institute of Neuroscience and Physiology, University of Gothenburg Sahlgrenska Academy, Goteborg, Sweden",NA
"1151","34226237","10.1136/bmjopen-2021-051316","Fitness, strength and severity of COVID-19: a prospective register study of 1 559 187 Swedish conscripts.","To investigate the possible connection between cardiorespiratory fitness (CRF) and muscle strength in early adulthood and severity of COVID-19 later in life. Prospective registry-based cohort study. 1 559 187 Swedish men, undergoing military conscription between 1968 and 2005 at a mean age of 18.3 (SD 0.73) years. Hospitalisation, intensive care or death due to COVID-19 from March to September 2020, in relation to CRF and muscle strength. High CRF in late adolescence and early adulthood had a pr","2021","07","09","BMJ Open","BMJ open","COVID-19; epidemiology; public health; Adolescent; Adult; Body Mass Index; COVID-19; Cohort Studies; Humans; Male; Muscle Strength; Physical Fitness; Risk Factors; SARS-CoV-2; Sweden","Adiels","Martin","School of Public Health and Community Medicine, Institute of Medicine, University of Gothenburg Sahlgrenska Academy, Goteborg, Sweden",NA
"1152","34226237","10.1136/bmjopen-2021-051316","Fitness, strength and severity of COVID-19: a prospective register study of 1 559 187 Swedish conscripts.","To investigate the possible connection between cardiorespiratory fitness (CRF) and muscle strength in early adulthood and severity of COVID-19 later in life. Prospective registry-based cohort study. 1 559 187 Swedish men, undergoing military conscription between 1968 and 2005 at a mean age of 18.3 (SD 0.73) years. Hospitalisation, intensive care or death due to COVID-19 from March to September 2020, in relation to CRF and muscle strength. High CRF in late adolescence and early adulthood had a pr","2021","07","09","BMJ Open","BMJ open","COVID-19; epidemiology; public health; Adolescent; Adult; Body Mass Index; COVID-19; Cohort Studies; Humans; Male; Muscle Strength; Physical Fitness; Risk Factors; SARS-CoV-2; Sweden","Rosengren","Annika","Department of Molecular and Clinical Medicine, University of Gothenburg Sahlgrenska Academy, Goteborg, Sweden",NA
"1153","34226237","10.1136/bmjopen-2021-051316","Fitness, strength and severity of COVID-19: a prospective register study of 1 559 187 Swedish conscripts.","To investigate the possible connection between cardiorespiratory fitness (CRF) and muscle strength in early adulthood and severity of COVID-19 later in life. Prospective registry-based cohort study. 1 559 187 Swedish men, undergoing military conscription between 1968 and 2005 at a mean age of 18.3 (SD 0.73) years. Hospitalisation, intensive care or death due to COVID-19 from March to September 2020, in relation to CRF and muscle strength. High CRF in late adolescence and early adulthood had a pr","2021","07","09","BMJ Open","BMJ open","COVID-19; epidemiology; public health; Adolescent; Adult; Body Mass Index; COVID-19; Cohort Studies; Humans; Male; Muscle Strength; Physical Fitness; Risk Factors; SARS-CoV-2; Sweden","Åberg","Maria","School of Public Health and Community Medicine, Institute of Medicine, University of Gothenburg Sahlgrenska Academy, Goteborg, Sweden",NA
"1154","34226237","10.1136/bmjopen-2021-051316","Fitness, strength and severity of COVID-19: a prospective register study of 1 559 187 Swedish conscripts.","To investigate the possible connection between cardiorespiratory fitness (CRF) and muscle strength in early adulthood and severity of COVID-19 later in life. Prospective registry-based cohort study. 1 559 187 Swedish men, undergoing military conscription between 1968 and 2005 at a mean age of 18.3 (SD 0.73) years. Hospitalisation, intensive care or death due to COVID-19 from March to September 2020, in relation to CRF and muscle strength. High CRF in late adolescence and early adulthood had a pr","2021","07","09","BMJ Open","BMJ open","COVID-19; epidemiology; public health; Adolescent; Adult; Body Mass Index; COVID-19; Cohort Studies; Humans; Male; Muscle Strength; Physical Fitness; Risk Factors; SARS-CoV-2; Sweden","Lissner","Lauren","School of Public Health and Community Medicine, Institute of Medicine, University of Gothenburg Sahlgrenska Academy, Goteborg, Sweden",NA
"1155","34226236","10.1136/bmjopen-2021-051115","Factors associated with serious psychological distress during the COVID-19 pandemic in Japan: a nationwide cross-sectional internet-based study.","To investigate the factors associated with serious psychological distress (SPD) during the COVID-19 pandemic in Japan. Nationwide cross-sectional study using survey data. Internet survey using sampling weights for national estimates conducted between 25 August and 30 September 2020 in Japan. Demographics (age, gender), socioeconomic status (income level, employment type, educational attainment, marital status, family composition and caregiving burden); the experience of domestic violence (DV), t","2021","07","09","BMJ Open","BMJ open","COVID-19; health policy; mental health; Adolescent; Adult; COVID-19; Cross-Sectional Studies; Female; Humans; Internet; Japan; Middle Aged; Pandemics; Psychological Distress; SARS-CoV-2; Stress, Psychological; Young Adult","Yoshioka","Takashi","Center for Innovative Research for Communities and Clinical Excellence, Fukushima Medical University, Fukushima-shi, Fukushima, Japan yoshioka.takashi.52a@kyoto-u",NA
"1156","34226236","10.1136/bmjopen-2021-051115","Factors associated with serious psychological distress during the COVID-19 pandemic in Japan: a nationwide cross-sectional internet-based study.","To investigate the factors associated with serious psychological distress (SPD) during the COVID-19 pandemic in Japan. Nationwide cross-sectional study using survey data. Internet survey using sampling weights for national estimates conducted between 25 August and 30 September 2020 in Japan. Demographics (age, gender), socioeconomic status (income level, employment type, educational attainment, marital status, family composition and caregiving burden); the experience of domestic violence (DV), t","2021","07","09","BMJ Open","BMJ open","COVID-19; health policy; mental health; Adolescent; Adult; COVID-19; Cross-Sectional Studies; Female; Humans; Internet; Japan; Middle Aged; Pandemics; Psychological Distress; SARS-CoV-2; Stress, Psychological; Young Adult","Okubo","Ryo","Department of Clinical Epidemiology, Translational Medical Center, National Center of Neurology and Psychiatry, Kodaira-shi, Tokyo, Japan",NA
"1157","34226236","10.1136/bmjopen-2021-051115","Factors associated with serious psychological distress during the COVID-19 pandemic in Japan: a nationwide cross-sectional internet-based study.","To investigate the factors associated with serious psychological distress (SPD) during the COVID-19 pandemic in Japan. Nationwide cross-sectional study using survey data. Internet survey using sampling weights for national estimates conducted between 25 August and 30 September 2020 in Japan. Demographics (age, gender), socioeconomic status (income level, employment type, educational attainment, marital status, family composition and caregiving burden); the experience of domestic violence (DV), t","2021","07","09","BMJ Open","BMJ open","COVID-19; health policy; mental health; Adolescent; Adult; COVID-19; Cross-Sectional Studies; Female; Humans; Internet; Japan; Middle Aged; Pandemics; Psychological Distress; SARS-CoV-2; Stress, Psychological; Young Adult","Tabuchi","Takahiro","Cancer Control Center, Osaka International Cancer Institute, Osaka-shi, Osaka, Japan",NA
"1158","34226236","10.1136/bmjopen-2021-051115","Factors associated with serious psychological distress during the COVID-19 pandemic in Japan: a nationwide cross-sectional internet-based study.","To investigate the factors associated with serious psychological distress (SPD) during the COVID-19 pandemic in Japan. Nationwide cross-sectional study using survey data. Internet survey using sampling weights for national estimates conducted between 25 August and 30 September 2020 in Japan. Demographics (age, gender), socioeconomic status (income level, employment type, educational attainment, marital status, family composition and caregiving burden); the experience of domestic violence (DV), t","2021","07","09","BMJ Open","BMJ open","COVID-19; health policy; mental health; Adolescent; Adult; COVID-19; Cross-Sectional Studies; Female; Humans; Internet; Japan; Middle Aged; Pandemics; Psychological Distress; SARS-CoV-2; Stress, Psychological; Young Adult","Odani","Satomi","Cancer Control Center, Osaka International Cancer Institute, Osaka-shi, Osaka, Japan",NA
"1159","34226236","10.1136/bmjopen-2021-051115","Factors associated with serious psychological distress during the COVID-19 pandemic in Japan: a nationwide cross-sectional internet-based study.","To investigate the factors associated with serious psychological distress (SPD) during the COVID-19 pandemic in Japan. Nationwide cross-sectional study using survey data. Internet survey using sampling weights for national estimates conducted between 25 August and 30 September 2020 in Japan. Demographics (age, gender), socioeconomic status (income level, employment type, educational attainment, marital status, family composition and caregiving burden); the experience of domestic violence (DV), t","2021","07","09","BMJ Open","BMJ open","COVID-19; health policy; mental health; Adolescent; Adult; COVID-19; Cross-Sectional Studies; Female; Humans; Internet; Japan; Middle Aged; Pandemics; Psychological Distress; SARS-CoV-2; Stress, Psychological; Young Adult","Shinozaki","Tomohiro","Department of Information and Computer Technology, Faculty of Engineering, Tokyo University of Science, Katsushika-ku, Tokyo, Japan",NA
"1160","34226236","10.1136/bmjopen-2021-051115","Factors associated with serious psychological distress during the COVID-19 pandemic in Japan: a nationwide cross-sectional internet-based study.","To investigate the factors associated with serious psychological distress (SPD) during the COVID-19 pandemic in Japan. Nationwide cross-sectional study using survey data. Internet survey using sampling weights for national estimates conducted between 25 August and 30 September 2020 in Japan. Demographics (age, gender), socioeconomic status (income level, employment type, educational attainment, marital status, family composition and caregiving burden); the experience of domestic violence (DV), t","2021","07","09","BMJ Open","BMJ open","COVID-19; health policy; mental health; Adolescent; Adult; COVID-19; Cross-Sectional Studies; Female; Humans; Internet; Japan; Middle Aged; Pandemics; Psychological Distress; SARS-CoV-2; Stress, Psychological; Young Adult","Tsugawa","Yusuke","Division of General Internal Medicine and Health Services Research, David Geffen School of Medicine at UCLA, Los Angeles, California, USA",NA
"1161","34226231","10.1136/bmjopen-2021-049232","SARS-CoV-2 seroprevalence in healthcare workers of a Swiss tertiary care centre at the end of the first wave: a cross-sectional study.","To assess the SARS-CoV-2 transmission in healthcare workers (HCWs) using seroprevalence as a surrogate marker of infection in our tertiary care centre according to exposure. Seroprevalence cross-sectional study. Single centre at the end of the first COVID-19 wave in Lausanne, Switzerland. 1874 of 4074 responders randomly selected (46% response rate), stratified by work category among the 13 474 (13.9%) HCWs. Evaluation of SARS-CoV-2 serostatus paired with a questionnaire of SARS-CoV-2 acquisitio","2021","07","09","BMJ Open","BMJ open","COVID-19; epidemiology; infection control; occupational &amp; industrial medicine; preventive medicine; virology; COVID-19; Cross-Sectional Studies; Health Personnel; Humans; SARS-CoV-2; Seroepidemiologic Studies; Switzerland; Tertiary Care Centers","Meylan","Sylvain","Infectious Diseases Service, Internal Medicine, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland sylvain.meylan@chuv","sylvain.meylan@chuv.ch"
"1162","34226231","10.1136/bmjopen-2021-049232","SARS-CoV-2 seroprevalence in healthcare workers of a Swiss tertiary care centre at the end of the first wave: a cross-sectional study.","To assess the SARS-CoV-2 transmission in healthcare workers (HCWs) using seroprevalence as a surrogate marker of infection in our tertiary care centre according to exposure. Seroprevalence cross-sectional study. Single centre at the end of the first COVID-19 wave in Lausanne, Switzerland. 1874 of 4074 responders randomly selected (46% response rate), stratified by work category among the 13 474 (13.9%) HCWs. Evaluation of SARS-CoV-2 serostatus paired with a questionnaire of SARS-CoV-2 acquisitio","2021","07","09","BMJ Open","BMJ open","COVID-19; epidemiology; infection control; occupational &amp; industrial medicine; preventive medicine; virology; COVID-19; Cross-Sectional Studies; Health Personnel; Humans; SARS-CoV-2; Seroepidemiologic Studies; Switzerland; Tertiary Care Centers","Dafni","Urania","Laboratory of Biostatistics, School of Health Sciences, Frontier Science Foundation-Hellas and University of Athens, Athens, Greece",NA
"1163","34226231","10.1136/bmjopen-2021-049232","SARS-CoV-2 seroprevalence in healthcare workers of a Swiss tertiary care centre at the end of the first wave: a cross-sectional study.","To assess the SARS-CoV-2 transmission in healthcare workers (HCWs) using seroprevalence as a surrogate marker of infection in our tertiary care centre according to exposure. Seroprevalence cross-sectional study. Single centre at the end of the first COVID-19 wave in Lausanne, Switzerland. 1874 of 4074 responders randomly selected (46% response rate), stratified by work category among the 13 474 (13.9%) HCWs. Evaluation of SARS-CoV-2 serostatus paired with a questionnaire of SARS-CoV-2 acquisitio","2021","07","09","BMJ Open","BMJ open","COVID-19; epidemiology; infection control; occupational &amp; industrial medicine; preventive medicine; virology; COVID-19; Cross-Sectional Studies; Health Personnel; Humans; SARS-CoV-2; Seroepidemiologic Studies; Switzerland; Tertiary Care Centers","Lamoth","Frederic","Infectious Diseases Service, Internal Medicine, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland",NA
"1164","34226231","10.1136/bmjopen-2021-049232","SARS-CoV-2 seroprevalence in healthcare workers of a Swiss tertiary care centre at the end of the first wave: a cross-sectional study.","To assess the SARS-CoV-2 transmission in healthcare workers (HCWs) using seroprevalence as a surrogate marker of infection in our tertiary care centre according to exposure. Seroprevalence cross-sectional study. Single centre at the end of the first COVID-19 wave in Lausanne, Switzerland. 1874 of 4074 responders randomly selected (46% response rate), stratified by work category among the 13 474 (13.9%) HCWs. Evaluation of SARS-CoV-2 serostatus paired with a questionnaire of SARS-CoV-2 acquisitio","2021","07","09","BMJ Open","BMJ open","COVID-19; epidemiology; infection control; occupational &amp; industrial medicine; preventive medicine; virology; COVID-19; Cross-Sectional Studies; Health Personnel; Humans; SARS-CoV-2; Seroepidemiologic Studies; Switzerland; Tertiary Care Centers","Tsourti","Zoi","Laboratory of Biostatistics, School of Health Sciences, Frontier Science Foundation-Hellas and University of Athens, Athens, Greece",NA
"1165","34226231","10.1136/bmjopen-2021-049232","SARS-CoV-2 seroprevalence in healthcare workers of a Swiss tertiary care centre at the end of the first wave: a cross-sectional study.","To assess the SARS-CoV-2 transmission in healthcare workers (HCWs) using seroprevalence as a surrogate marker of infection in our tertiary care centre according to exposure. Seroprevalence cross-sectional study. Single centre at the end of the first COVID-19 wave in Lausanne, Switzerland. 1874 of 4074 responders randomly selected (46% response rate), stratified by work category among the 13 474 (13.9%) HCWs. Evaluation of SARS-CoV-2 serostatus paired with a questionnaire of SARS-CoV-2 acquisitio","2021","07","09","BMJ Open","BMJ open","COVID-19; epidemiology; infection control; occupational &amp; industrial medicine; preventive medicine; virology; COVID-19; Cross-Sectional Studies; Health Personnel; Humans; SARS-CoV-2; Seroepidemiologic Studies; Switzerland; Tertiary Care Centers","Lobritz","Michael A","Roche Biomedical, Basel, Switzerland",NA
"1166","34226231","10.1136/bmjopen-2021-049232","SARS-CoV-2 seroprevalence in healthcare workers of a Swiss tertiary care centre at the end of the first wave: a cross-sectional study.","To assess the SARS-CoV-2 transmission in healthcare workers (HCWs) using seroprevalence as a surrogate marker of infection in our tertiary care centre according to exposure. Seroprevalence cross-sectional study. Single centre at the end of the first COVID-19 wave in Lausanne, Switzerland. 1874 of 4074 responders randomly selected (46% response rate), stratified by work category among the 13 474 (13.9%) HCWs. Evaluation of SARS-CoV-2 serostatus paired with a questionnaire of SARS-CoV-2 acquisitio","2021","07","09","BMJ Open","BMJ open","COVID-19; epidemiology; infection control; occupational &amp; industrial medicine; preventive medicine; virology; COVID-19; Cross-Sectional Studies; Health Personnel; Humans; SARS-CoV-2; Seroepidemiologic Studies; Switzerland; Tertiary Care Centers","Regina","Jean","Infectious Diseases Service, Internal Medicine, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland",NA
"1167","34226231","10.1136/bmjopen-2021-049232","SARS-CoV-2 seroprevalence in healthcare workers of a Swiss tertiary care centre at the end of the first wave: a cross-sectional study.","To assess the SARS-CoV-2 transmission in healthcare workers (HCWs) using seroprevalence as a surrogate marker of infection in our tertiary care centre according to exposure. Seroprevalence cross-sectional study. Single centre at the end of the first COVID-19 wave in Lausanne, Switzerland. 1874 of 4074 responders randomly selected (46% response rate), stratified by work category among the 13 474 (13.9%) HCWs. Evaluation of SARS-CoV-2 serostatus paired with a questionnaire of SARS-CoV-2 acquisitio","2021","07","09","BMJ Open","BMJ open","COVID-19; epidemiology; infection control; occupational &amp; industrial medicine; preventive medicine; virology; COVID-19; Cross-Sectional Studies; Health Personnel; Humans; SARS-CoV-2; Seroepidemiologic Studies; Switzerland; Tertiary Care Centers","Bressin","Philippe","Occupational Health Service, Lausanne University Hospital, Lausanne, Switzerland",NA
"1168","34226231","10.1136/bmjopen-2021-049232","SARS-CoV-2 seroprevalence in healthcare workers of a Swiss tertiary care centre at the end of the first wave: a cross-sectional study.","To assess the SARS-CoV-2 transmission in healthcare workers (HCWs) using seroprevalence as a surrogate marker of infection in our tertiary care centre according to exposure. Seroprevalence cross-sectional study. Single centre at the end of the first COVID-19 wave in Lausanne, Switzerland. 1874 of 4074 responders randomly selected (46% response rate), stratified by work category among the 13 474 (13.9%) HCWs. Evaluation of SARS-CoV-2 serostatus paired with a questionnaire of SARS-CoV-2 acquisitio","2021","07","09","BMJ Open","BMJ open","COVID-19; epidemiology; infection control; occupational &amp; industrial medicine; preventive medicine; virology; COVID-19; Cross-Sectional Studies; Health Personnel; Humans; SARS-CoV-2; Seroepidemiologic Studies; Switzerland; Tertiary Care Centers","Senn","Laurence","Service of Hospital Preventive Medicine, Lausanne University Hospital, Lausanne, Switzerland",NA
"1169","34226231","10.1136/bmjopen-2021-049232","SARS-CoV-2 seroprevalence in healthcare workers of a Swiss tertiary care centre at the end of the first wave: a cross-sectional study.","To assess the SARS-CoV-2 transmission in healthcare workers (HCWs) using seroprevalence as a surrogate marker of infection in our tertiary care centre according to exposure. Seroprevalence cross-sectional study. Single centre at the end of the first COVID-19 wave in Lausanne, Switzerland. 1874 of 4074 responders randomly selected (46% response rate), stratified by work category among the 13 474 (13.9%) HCWs. Evaluation of SARS-CoV-2 serostatus paired with a questionnaire of SARS-CoV-2 acquisitio","2021","07","09","BMJ Open","BMJ open","COVID-19; epidemiology; infection control; occupational &amp; industrial medicine; preventive medicine; virology; COVID-19; Cross-Sectional Studies; Health Personnel; Humans; SARS-CoV-2; Seroepidemiologic Studies; Switzerland; Tertiary Care Centers","Grandbastien","Bruno","Service of Hospital Preventive Medicine, Lausanne University Hospital, Lausanne, Switzerland",NA
"1170","34226231","10.1136/bmjopen-2021-049232","SARS-CoV-2 seroprevalence in healthcare workers of a Swiss tertiary care centre at the end of the first wave: a cross-sectional study.","To assess the SARS-CoV-2 transmission in healthcare workers (HCWs) using seroprevalence as a surrogate marker of infection in our tertiary care centre according to exposure. Seroprevalence cross-sectional study. Single centre at the end of the first COVID-19 wave in Lausanne, Switzerland. 1874 of 4074 responders randomly selected (46% response rate), stratified by work category among the 13 474 (13.9%) HCWs. Evaluation of SARS-CoV-2 serostatus paired with a questionnaire of SARS-CoV-2 acquisitio","2021","07","09","BMJ Open","BMJ open","COVID-19; epidemiology; infection control; occupational &amp; industrial medicine; preventive medicine; virology; COVID-19; Cross-Sectional Studies; Health Personnel; Humans; SARS-CoV-2; Seroepidemiologic Studies; Switzerland; Tertiary Care Centers","Andre","Cyril","Immunology Service, Department of Medicine, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland",NA
"1171","34226231","10.1136/bmjopen-2021-049232","SARS-CoV-2 seroprevalence in healthcare workers of a Swiss tertiary care centre at the end of the first wave: a cross-sectional study.","To assess the SARS-CoV-2 transmission in healthcare workers (HCWs) using seroprevalence as a surrogate marker of infection in our tertiary care centre according to exposure. Seroprevalence cross-sectional study. Single centre at the end of the first COVID-19 wave in Lausanne, Switzerland. 1874 of 4074 responders randomly selected (46% response rate), stratified by work category among the 13 474 (13.9%) HCWs. Evaluation of SARS-CoV-2 serostatus paired with a questionnaire of SARS-CoV-2 acquisitio","2021","07","09","BMJ Open","BMJ open","COVID-19; epidemiology; infection control; occupational &amp; industrial medicine; preventive medicine; virology; COVID-19; Cross-Sectional Studies; Health Personnel; Humans; SARS-CoV-2; Seroepidemiologic Studies; Switzerland; Tertiary Care Centers","Fenwick","Craig","Institute of Microbiology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland",NA
"1172","34226231","10.1136/bmjopen-2021-049232","SARS-CoV-2 seroprevalence in healthcare workers of a Swiss tertiary care centre at the end of the first wave: a cross-sectional study.","To assess the SARS-CoV-2 transmission in healthcare workers (HCWs) using seroprevalence as a surrogate marker of infection in our tertiary care centre according to exposure. Seroprevalence cross-sectional study. Single centre at the end of the first COVID-19 wave in Lausanne, Switzerland. 1874 of 4074 responders randomly selected (46% response rate), stratified by work category among the 13 474 (13.9%) HCWs. Evaluation of SARS-CoV-2 serostatus paired with a questionnaire of SARS-CoV-2 acquisitio","2021","07","09","BMJ Open","BMJ open","COVID-19; epidemiology; infection control; occupational &amp; industrial medicine; preventive medicine; virology; COVID-19; Cross-Sectional Studies; Health Personnel; Humans; SARS-CoV-2; Seroepidemiologic Studies; Switzerland; Tertiary Care Centers","D'Acremont","Valerie","Department of Ambulatory Care and Community Medicine, Centre for Primary Care and Public Health (Unisanté), Lausanne, Switzerland",NA
"1173","34226231","10.1136/bmjopen-2021-049232","SARS-CoV-2 seroprevalence in healthcare workers of a Swiss tertiary care centre at the end of the first wave: a cross-sectional study.","To assess the SARS-CoV-2 transmission in healthcare workers (HCWs) using seroprevalence as a surrogate marker of infection in our tertiary care centre according to exposure. Seroprevalence cross-sectional study. Single centre at the end of the first COVID-19 wave in Lausanne, Switzerland. 1874 of 4074 responders randomly selected (46% response rate), stratified by work category among the 13 474 (13.9%) HCWs. Evaluation of SARS-CoV-2 serostatus paired with a questionnaire of SARS-CoV-2 acquisitio","2021","07","09","BMJ Open","BMJ open","COVID-19; epidemiology; infection control; occupational &amp; industrial medicine; preventive medicine; virology; COVID-19; Cross-Sectional Studies; Health Personnel; Humans; SARS-CoV-2; Seroepidemiologic Studies; Switzerland; Tertiary Care Centers","Croxatto","Antony","Institute of Microbiology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland",NA
"1174","34226231","10.1136/bmjopen-2021-049232","SARS-CoV-2 seroprevalence in healthcare workers of a Swiss tertiary care centre at the end of the first wave: a cross-sectional study.","To assess the SARS-CoV-2 transmission in healthcare workers (HCWs) using seroprevalence as a surrogate marker of infection in our tertiary care centre according to exposure. Seroprevalence cross-sectional study. Single centre at the end of the first COVID-19 wave in Lausanne, Switzerland. 1874 of 4074 responders randomly selected (46% response rate), stratified by work category among the 13 474 (13.9%) HCWs. Evaluation of SARS-CoV-2 serostatus paired with a questionnaire of SARS-CoV-2 acquisitio","2021","07","09","BMJ Open","BMJ open","COVID-19; epidemiology; infection control; occupational &amp; industrial medicine; preventive medicine; virology; COVID-19; Cross-Sectional Studies; Health Personnel; Humans; SARS-CoV-2; Seroepidemiologic Studies; Switzerland; Tertiary Care Centers","Guilleret","Isabelle","Clinical Trial Unit, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland",NA
"1175","34226231","10.1136/bmjopen-2021-049232","SARS-CoV-2 seroprevalence in healthcare workers of a Swiss tertiary care centre at the end of the first wave: a cross-sectional study.","To assess the SARS-CoV-2 transmission in healthcare workers (HCWs) using seroprevalence as a surrogate marker of infection in our tertiary care centre according to exposure. Seroprevalence cross-sectional study. Single centre at the end of the first COVID-19 wave in Lausanne, Switzerland. 1874 of 4074 responders randomly selected (46% response rate), stratified by work category among the 13 474 (13.9%) HCWs. Evaluation of SARS-CoV-2 serostatus paired with a questionnaire of SARS-CoV-2 acquisitio","2021","07","09","BMJ Open","BMJ open","COVID-19; epidemiology; infection control; occupational &amp; industrial medicine; preventive medicine; virology; COVID-19; Cross-Sectional Studies; Health Personnel; Humans; SARS-CoV-2; Seroepidemiologic Studies; Switzerland; Tertiary Care Centers","Greub","Gilbert","Institute of Microbiology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland",NA
"1176","34226231","10.1136/bmjopen-2021-049232","SARS-CoV-2 seroprevalence in healthcare workers of a Swiss tertiary care centre at the end of the first wave: a cross-sectional study.","To assess the SARS-CoV-2 transmission in healthcare workers (HCWs) using seroprevalence as a surrogate marker of infection in our tertiary care centre according to exposure. Seroprevalence cross-sectional study. Single centre at the end of the first COVID-19 wave in Lausanne, Switzerland. 1874 of 4074 responders randomly selected (46% response rate), stratified by work category among the 13 474 (13.9%) HCWs. Evaluation of SARS-CoV-2 serostatus paired with a questionnaire of SARS-CoV-2 acquisitio","2021","07","09","BMJ Open","BMJ open","COVID-19; epidemiology; infection control; occupational &amp; industrial medicine; preventive medicine; virology; COVID-19; Cross-Sectional Studies; Health Personnel; Humans; SARS-CoV-2; Seroepidemiologic Studies; Switzerland; Tertiary Care Centers","Manuel","Oriol","Infectious Diseases Service, Internal Medicine, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland",NA
"1177","34226231","10.1136/bmjopen-2021-049232","SARS-CoV-2 seroprevalence in healthcare workers of a Swiss tertiary care centre at the end of the first wave: a cross-sectional study.","To assess the SARS-CoV-2 transmission in healthcare workers (HCWs) using seroprevalence as a surrogate marker of infection in our tertiary care centre according to exposure. Seroprevalence cross-sectional study. Single centre at the end of the first COVID-19 wave in Lausanne, Switzerland. 1874 of 4074 responders randomly selected (46% response rate), stratified by work category among the 13 474 (13.9%) HCWs. Evaluation of SARS-CoV-2 serostatus paired with a questionnaire of SARS-CoV-2 acquisitio","2021","07","09","BMJ Open","BMJ open","COVID-19; epidemiology; infection control; occupational &amp; industrial medicine; preventive medicine; virology; COVID-19; Cross-Sectional Studies; Health Personnel; Humans; SARS-CoV-2; Seroepidemiologic Studies; Switzerland; Tertiary Care Centers","Calandra","Thierry","Infectious Diseases Service, Internal Medicine, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland",NA
"1178","34226231","10.1136/bmjopen-2021-049232","SARS-CoV-2 seroprevalence in healthcare workers of a Swiss tertiary care centre at the end of the first wave: a cross-sectional study.","To assess the SARS-CoV-2 transmission in healthcare workers (HCWs) using seroprevalence as a surrogate marker of infection in our tertiary care centre according to exposure. Seroprevalence cross-sectional study. Single centre at the end of the first COVID-19 wave in Lausanne, Switzerland. 1874 of 4074 responders randomly selected (46% response rate), stratified by work category among the 13 474 (13.9%) HCWs. Evaluation of SARS-CoV-2 serostatus paired with a questionnaire of SARS-CoV-2 acquisitio","2021","07","09","BMJ Open","BMJ open","COVID-19; epidemiology; infection control; occupational &amp; industrial medicine; preventive medicine; virology; COVID-19; Cross-Sectional Studies; Health Personnel; Humans; SARS-CoV-2; Seroepidemiologic Studies; Switzerland; Tertiary Care Centers","Pantaleo","Giuseppe","Immunology Service, Department of Medicine, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland",NA
"1179","34226231","10.1136/bmjopen-2021-049232","SARS-CoV-2 seroprevalence in healthcare workers of a Swiss tertiary care centre at the end of the first wave: a cross-sectional study.","To assess the SARS-CoV-2 transmission in healthcare workers (HCWs) using seroprevalence as a surrogate marker of infection in our tertiary care centre according to exposure. Seroprevalence cross-sectional study. Single centre at the end of the first COVID-19 wave in Lausanne, Switzerland. 1874 of 4074 responders randomly selected (46% response rate), stratified by work category among the 13 474 (13.9%) HCWs. Evaluation of SARS-CoV-2 serostatus paired with a questionnaire of SARS-CoV-2 acquisitio","2021","07","09","BMJ Open","BMJ open","COVID-19; epidemiology; infection control; occupational &amp; industrial medicine; preventive medicine; virology; COVID-19; Cross-Sectional Studies; Health Personnel; Humans; SARS-CoV-2; Seroepidemiologic Studies; Switzerland; Tertiary Care Centers","Lazor-Blanchet","Catherine","Occupational Health Service, Lausanne University Hospital, Lausanne, Switzerland",NA
"1180","34226230","10.1136/bmjopen-2021-048995","Are COVID-19 models blind to the social determinants of health? A systematic review protocol.","Infectious disease models are important tools to inform public health policy decisions. These models are primarily based on an average population approach and often ignore the role of social determinants in predicting the course of a pandemic and the impact of policy interventions. Ignoring social determinants in models may cause or exacerbate inequalities. This limitation has not been previously explored in the context of the current pandemic, where COVID-19 has been found to disproportionately","2021","07","09","BMJ Open","BMJ open","COVID-19; epidemiology; public health; social medicine; COVID-19; Humans; Pandemics; SARS-CoV-2; Social Determinants of Health; Systematic Reviews as Topic","John-Baptiste","Ava","Department of Anesthesia and Perioperative Medicine, Western University, London, Ontario, Canada ajohnbap@uwo","ajohnbap@uwo.ca"
"1181","34226230","10.1136/bmjopen-2021-048995","Are COVID-19 models blind to the social determinants of health? A systematic review protocol.","Infectious disease models are important tools to inform public health policy decisions. These models are primarily based on an average population approach and often ignore the role of social determinants in predicting the course of a pandemic and the impact of policy interventions. Ignoring social determinants in models may cause or exacerbate inequalities. This limitation has not been previously explored in the context of the current pandemic, where COVID-19 has been found to disproportionately","2021","07","09","BMJ Open","BMJ open","COVID-19; epidemiology; public health; social medicine; COVID-19; Humans; Pandemics; SARS-CoV-2; Social Determinants of Health; Systematic Reviews as Topic","Moulin","Marc S","Department of Anesthesia and Perioperative Medicine, Western University, London, Ontario, Canada",NA
"1182","34226230","10.1136/bmjopen-2021-048995","Are COVID-19 models blind to the social determinants of health? A systematic review protocol.","Infectious disease models are important tools to inform public health policy decisions. These models are primarily based on an average population approach and often ignore the role of social determinants in predicting the course of a pandemic and the impact of policy interventions. Ignoring social determinants in models may cause or exacerbate inequalities. This limitation has not been previously explored in the context of the current pandemic, where COVID-19 has been found to disproportionately","2021","07","09","BMJ Open","BMJ open","COVID-19; epidemiology; public health; social medicine; COVID-19; Humans; Pandemics; SARS-CoV-2; Social Determinants of Health; Systematic Reviews as Topic","Ali","Shehzad","Department of Anesthesia and Perioperative Medicine, Western University, London, Ontario, Canada",NA
"1183","34226219","10.1136/bmjopen-2020-046738","Randomised, controlled, open label, multicentre clinical trial to explore safety and efficacy of hyperbaric oxygen for preventing ICU admission, morbidity and mortality in adult patients with COVID-19.","COVID-19 may cause severe pneumonitis and trigger a massive inflammatory response that requires ventilatory support. The intensive care unit (ICU)-mortality has been reported to be as high as 62%. Dexamethasone is the only of all anti-inflammatory drugs that have been tested to date that has shown a positive effect on mortality. We aim to explore if treatment with hyperbaric oxygen (HBO) is safe and effective for patients with severe COVID-19. Our hypothesis is that HBO can prevent ICU admission","2021","07","09","BMJ Open","BMJ open","COVID-19; immunology; infectious diseases; intensive &amp; critical care; thoracic medicine; Adult; COVID-19; Humans; Hyperbaric Oxygenation; Intensive Care Units; Morbidity; Pharmaceutical Preparations; SARS-CoV-2; Sweden; Treatment Outcome","Kjellberg","Anders","Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden anders.kjellberg@ki",NA
"1184","34226219","10.1136/bmjopen-2020-046738","Randomised, controlled, open label, multicentre clinical trial to explore safety and efficacy of hyperbaric oxygen for preventing ICU admission, morbidity and mortality in adult patients with COVID-19.","COVID-19 may cause severe pneumonitis and trigger a massive inflammatory response that requires ventilatory support. The intensive care unit (ICU)-mortality has been reported to be as high as 62%. Dexamethasone is the only of all anti-inflammatory drugs that have been tested to date that has shown a positive effect on mortality. We aim to explore if treatment with hyperbaric oxygen (HBO) is safe and effective for patients with severe COVID-19. Our hypothesis is that HBO can prevent ICU admission","2021","07","09","BMJ Open","BMJ open","COVID-19; immunology; infectious diseases; intensive &amp; critical care; thoracic medicine; Adult; COVID-19; Humans; Hyperbaric Oxygenation; Intensive Care Units; Morbidity; Pharmaceutical Preparations; SARS-CoV-2; Sweden; Treatment Outcome","Douglas","Johan","Department of Anaesthesia and Intensive Care, Blekinge Hospital Karlskrona, Karlskrona, Sweden",NA
"1185","34226219","10.1136/bmjopen-2020-046738","Randomised, controlled, open label, multicentre clinical trial to explore safety and efficacy of hyperbaric oxygen for preventing ICU admission, morbidity and mortality in adult patients with COVID-19.","COVID-19 may cause severe pneumonitis and trigger a massive inflammatory response that requires ventilatory support. The intensive care unit (ICU)-mortality has been reported to be as high as 62%. Dexamethasone is the only of all anti-inflammatory drugs that have been tested to date that has shown a positive effect on mortality. We aim to explore if treatment with hyperbaric oxygen (HBO) is safe and effective for patients with severe COVID-19. Our hypothesis is that HBO can prevent ICU admission","2021","07","09","BMJ Open","BMJ open","COVID-19; immunology; infectious diseases; intensive &amp; critical care; thoracic medicine; Adult; COVID-19; Humans; Hyperbaric Oxygenation; Intensive Care Units; Morbidity; Pharmaceutical Preparations; SARS-CoV-2; Sweden; Treatment Outcome","Pawlik","Michael T","Department of Anaesthesiology and Intensive Care Medicine, Catholic Charities Hospital, St. Josef, Regensburg, Germany",NA
"1186","34226219","10.1136/bmjopen-2020-046738","Randomised, controlled, open label, multicentre clinical trial to explore safety and efficacy of hyperbaric oxygen for preventing ICU admission, morbidity and mortality in adult patients with COVID-19.","COVID-19 may cause severe pneumonitis and trigger a massive inflammatory response that requires ventilatory support. The intensive care unit (ICU)-mortality has been reported to be as high as 62%. Dexamethasone is the only of all anti-inflammatory drugs that have been tested to date that has shown a positive effect on mortality. We aim to explore if treatment with hyperbaric oxygen (HBO) is safe and effective for patients with severe COVID-19. Our hypothesis is that HBO can prevent ICU admission","2021","07","09","BMJ Open","BMJ open","COVID-19; immunology; infectious diseases; intensive &amp; critical care; thoracic medicine; Adult; COVID-19; Humans; Hyperbaric Oxygenation; Intensive Care Units; Morbidity; Pharmaceutical Preparations; SARS-CoV-2; Sweden; Treatment Outcome","Kraus","Michael","Department of Anaesthesiology and Intensive Care Medicine, Bergmannsheil und Kinderklinik Buer GmbH, Gelsenkirchen, Germany",NA
"1187","34226219","10.1136/bmjopen-2020-046738","Randomised, controlled, open label, multicentre clinical trial to explore safety and efficacy of hyperbaric oxygen for preventing ICU admission, morbidity and mortality in adult patients with COVID-19.","COVID-19 may cause severe pneumonitis and trigger a massive inflammatory response that requires ventilatory support. The intensive care unit (ICU)-mortality has been reported to be as high as 62%. Dexamethasone is the only of all anti-inflammatory drugs that have been tested to date that has shown a positive effect on mortality. We aim to explore if treatment with hyperbaric oxygen (HBO) is safe and effective for patients with severe COVID-19. Our hypothesis is that HBO can prevent ICU admission","2021","07","09","BMJ Open","BMJ open","COVID-19; immunology; infectious diseases; intensive &amp; critical care; thoracic medicine; Adult; COVID-19; Humans; Hyperbaric Oxygenation; Intensive Care Units; Morbidity; Pharmaceutical Preparations; SARS-CoV-2; Sweden; Treatment Outcome","Oscarsson","Nicklas","Department of Anesthesiology and Intensive Care, University of Gothenburg Sahlgrenska Academy, Goteborg, Sweden",NA
"1188","34226219","10.1136/bmjopen-2020-046738","Randomised, controlled, open label, multicentre clinical trial to explore safety and efficacy of hyperbaric oxygen for preventing ICU admission, morbidity and mortality in adult patients with COVID-19.","COVID-19 may cause severe pneumonitis and trigger a massive inflammatory response that requires ventilatory support. The intensive care unit (ICU)-mortality has been reported to be as high as 62%. Dexamethasone is the only of all anti-inflammatory drugs that have been tested to date that has shown a positive effect on mortality. We aim to explore if treatment with hyperbaric oxygen (HBO) is safe and effective for patients with severe COVID-19. Our hypothesis is that HBO can prevent ICU admission","2021","07","09","BMJ Open","BMJ open","COVID-19; immunology; infectious diseases; intensive &amp; critical care; thoracic medicine; Adult; COVID-19; Humans; Hyperbaric Oxygenation; Intensive Care Units; Morbidity; Pharmaceutical Preparations; SARS-CoV-2; Sweden; Treatment Outcome","Zheng","Xiaowei","Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden",NA
"1189","34226219","10.1136/bmjopen-2020-046738","Randomised, controlled, open label, multicentre clinical trial to explore safety and efficacy of hyperbaric oxygen for preventing ICU admission, morbidity and mortality in adult patients with COVID-19.","COVID-19 may cause severe pneumonitis and trigger a massive inflammatory response that requires ventilatory support. The intensive care unit (ICU)-mortality has been reported to be as high as 62%. Dexamethasone is the only of all anti-inflammatory drugs that have been tested to date that has shown a positive effect on mortality. We aim to explore if treatment with hyperbaric oxygen (HBO) is safe and effective for patients with severe COVID-19. Our hypothesis is that HBO can prevent ICU admission","2021","07","09","BMJ Open","BMJ open","COVID-19; immunology; infectious diseases; intensive &amp; critical care; thoracic medicine; Adult; COVID-19; Humans; Hyperbaric Oxygenation; Intensive Care Units; Morbidity; Pharmaceutical Preparations; SARS-CoV-2; Sweden; Treatment Outcome","Bergman","Peter","Department of Laboratory Medicine, Division of Clinical Microbiology, Karolinska Institute, Stockholm, Sweden",NA
"1190","34226219","10.1136/bmjopen-2020-046738","Randomised, controlled, open label, multicentre clinical trial to explore safety and efficacy of hyperbaric oxygen for preventing ICU admission, morbidity and mortality in adult patients with COVID-19.","COVID-19 may cause severe pneumonitis and trigger a massive inflammatory response that requires ventilatory support. The intensive care unit (ICU)-mortality has been reported to be as high as 62%. Dexamethasone is the only of all anti-inflammatory drugs that have been tested to date that has shown a positive effect on mortality. We aim to explore if treatment with hyperbaric oxygen (HBO) is safe and effective for patients with severe COVID-19. Our hypothesis is that HBO can prevent ICU admission","2021","07","09","BMJ Open","BMJ open","COVID-19; immunology; infectious diseases; intensive &amp; critical care; thoracic medicine; Adult; COVID-19; Humans; Hyperbaric Oxygenation; Intensive Care Units; Morbidity; Pharmaceutical Preparations; SARS-CoV-2; Sweden; Treatment Outcome","Frånberg","Oskar","Department of Mathematics and Natural Science, Blekinge Institute of Technology, Karlskrona, Sweden",NA
"1191","34226219","10.1136/bmjopen-2020-046738","Randomised, controlled, open label, multicentre clinical trial to explore safety and efficacy of hyperbaric oxygen for preventing ICU admission, morbidity and mortality in adult patients with COVID-19.","COVID-19 may cause severe pneumonitis and trigger a massive inflammatory response that requires ventilatory support. The intensive care unit (ICU)-mortality has been reported to be as high as 62%. Dexamethasone is the only of all anti-inflammatory drugs that have been tested to date that has shown a positive effect on mortality. We aim to explore if treatment with hyperbaric oxygen (HBO) is safe and effective for patients with severe COVID-19. Our hypothesis is that HBO can prevent ICU admission","2021","07","09","BMJ Open","BMJ open","COVID-19; immunology; infectious diseases; intensive &amp; critical care; thoracic medicine; Adult; COVID-19; Humans; Hyperbaric Oxygenation; Intensive Care Units; Morbidity; Pharmaceutical Preparations; SARS-CoV-2; Sweden; Treatment Outcome","Kowalski","Jan H","JK Biostatistics AB, Stockholm, Sweden",NA
"1192","34226219","10.1136/bmjopen-2020-046738","Randomised, controlled, open label, multicentre clinical trial to explore safety and efficacy of hyperbaric oxygen for preventing ICU admission, morbidity and mortality in adult patients with COVID-19.","COVID-19 may cause severe pneumonitis and trigger a massive inflammatory response that requires ventilatory support. The intensive care unit (ICU)-mortality has been reported to be as high as 62%. Dexamethasone is the only of all anti-inflammatory drugs that have been tested to date that has shown a positive effect on mortality. We aim to explore if treatment with hyperbaric oxygen (HBO) is safe and effective for patients with severe COVID-19. Our hypothesis is that HBO can prevent ICU admission","2021","07","09","BMJ Open","BMJ open","COVID-19; immunology; infectious diseases; intensive &amp; critical care; thoracic medicine; Adult; COVID-19; Humans; Hyperbaric Oxygenation; Intensive Care Units; Morbidity; Pharmaceutical Preparations; SARS-CoV-2; Sweden; Treatment Outcome","Nyren","Sven Paul","Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden",NA
"1193","34226219","10.1136/bmjopen-2020-046738","Randomised, controlled, open label, multicentre clinical trial to explore safety and efficacy of hyperbaric oxygen for preventing ICU admission, morbidity and mortality in adult patients with COVID-19.","COVID-19 may cause severe pneumonitis and trigger a massive inflammatory response that requires ventilatory support. The intensive care unit (ICU)-mortality has been reported to be as high as 62%. Dexamethasone is the only of all anti-inflammatory drugs that have been tested to date that has shown a positive effect on mortality. We aim to explore if treatment with hyperbaric oxygen (HBO) is safe and effective for patients with severe COVID-19. Our hypothesis is that HBO can prevent ICU admission","2021","07","09","BMJ Open","BMJ open","COVID-19; immunology; infectious diseases; intensive &amp; critical care; thoracic medicine; Adult; COVID-19; Humans; Hyperbaric Oxygenation; Intensive Care Units; Morbidity; Pharmaceutical Preparations; SARS-CoV-2; Sweden; Treatment Outcome","Silvanius","Mårten","Department of Mathematics and Natural Sciences, TIMN, Blekinge Institute of Technology, Karlskrona, Sweden",NA
"1194","34226219","10.1136/bmjopen-2020-046738","Randomised, controlled, open label, multicentre clinical trial to explore safety and efficacy of hyperbaric oxygen for preventing ICU admission, morbidity and mortality in adult patients with COVID-19.","COVID-19 may cause severe pneumonitis and trigger a massive inflammatory response that requires ventilatory support. The intensive care unit (ICU)-mortality has been reported to be as high as 62%. Dexamethasone is the only of all anti-inflammatory drugs that have been tested to date that has shown a positive effect on mortality. We aim to explore if treatment with hyperbaric oxygen (HBO) is safe and effective for patients with severe COVID-19. Our hypothesis is that HBO can prevent ICU admission","2021","07","09","BMJ Open","BMJ open","COVID-19; immunology; infectious diseases; intensive &amp; critical care; thoracic medicine; Adult; COVID-19; Humans; Hyperbaric Oxygenation; Intensive Care Units; Morbidity; Pharmaceutical Preparations; SARS-CoV-2; Sweden; Treatment Outcome","Skold","Magnus","Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden",NA
"1195","34226219","10.1136/bmjopen-2020-046738","Randomised, controlled, open label, multicentre clinical trial to explore safety and efficacy of hyperbaric oxygen for preventing ICU admission, morbidity and mortality in adult patients with COVID-19.","COVID-19 may cause severe pneumonitis and trigger a massive inflammatory response that requires ventilatory support. The intensive care unit (ICU)-mortality has been reported to be as high as 62%. Dexamethasone is the only of all anti-inflammatory drugs that have been tested to date that has shown a positive effect on mortality. We aim to explore if treatment with hyperbaric oxygen (HBO) is safe and effective for patients with severe COVID-19. Our hypothesis is that HBO can prevent ICU admission","2021","07","09","BMJ Open","BMJ open","COVID-19; immunology; infectious diseases; intensive &amp; critical care; thoracic medicine; Adult; COVID-19; Humans; Hyperbaric Oxygenation; Intensive Care Units; Morbidity; Pharmaceutical Preparations; SARS-CoV-2; Sweden; Treatment Outcome","Catrina","Sergiu-Bogdan","Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden",NA
"1196","34226219","10.1136/bmjopen-2020-046738","Randomised, controlled, open label, multicentre clinical trial to explore safety and efficacy of hyperbaric oxygen for preventing ICU admission, morbidity and mortality in adult patients with COVID-19.","COVID-19 may cause severe pneumonitis and trigger a massive inflammatory response that requires ventilatory support. The intensive care unit (ICU)-mortality has been reported to be as high as 62%. Dexamethasone is the only of all anti-inflammatory drugs that have been tested to date that has shown a positive effect on mortality. We aim to explore if treatment with hyperbaric oxygen (HBO) is safe and effective for patients with severe COVID-19. Our hypothesis is that HBO can prevent ICU admission","2021","07","09","BMJ Open","BMJ open","COVID-19; immunology; infectious diseases; intensive &amp; critical care; thoracic medicine; Adult; COVID-19; Humans; Hyperbaric Oxygenation; Intensive Care Units; Morbidity; Pharmaceutical Preparations; SARS-CoV-2; Sweden; Treatment Outcome","Rodriguez-Wallberg","Kenny A","Department of Reproductive Medicine, Division of Gynecology and Reproduction, Karolinska Universitetssjukhuset, Stockholm, Sweden",NA
"1197","34226219","10.1136/bmjopen-2020-046738","Randomised, controlled, open label, multicentre clinical trial to explore safety and efficacy of hyperbaric oxygen for preventing ICU admission, morbidity and mortality in adult patients with COVID-19.","COVID-19 may cause severe pneumonitis and trigger a massive inflammatory response that requires ventilatory support. The intensive care unit (ICU)-mortality has been reported to be as high as 62%. Dexamethasone is the only of all anti-inflammatory drugs that have been tested to date that has shown a positive effect on mortality. We aim to explore if treatment with hyperbaric oxygen (HBO) is safe and effective for patients with severe COVID-19. Our hypothesis is that HBO can prevent ICU admission","2021","07","09","BMJ Open","BMJ open","COVID-19; immunology; infectious diseases; intensive &amp; critical care; thoracic medicine; Adult; COVID-19; Humans; Hyperbaric Oxygenation; Intensive Care Units; Morbidity; Pharmaceutical Preparations; SARS-CoV-2; Sweden; Treatment Outcome","Lindholm","Peter","Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden",NA
"1198","34226206","10.1136/thoraxjnl-2021-216949","Clinical phenotypes and outcomes of SARS-CoV-2, influenza, RSV and seven other respiratory viruses: a retrospective study using complete hospital data.","An understanding of differences in clinical phenotypes and outcomes COVID-19 compared with other respiratory viral infections is important to optimise the management of patients and plan healthcare. Herein we sought to investigate such differences in patients positive for SARS-CoV-2 compared with influenza, respiratory syncytial virus (RSV) and other respiratory viruses. We performed a retrospective cohort study of hospitalised adults and children (=15 years) who tested positive for SARS-CoV-2, ","2021","07","10","Thorax","Thorax","COVID-19; pneumonia; respiratory infection; viral infection","Hedberg","Pontus","Department of Microbiology, Tumor and Cell Biology, Karolinska Institute, Stockholm, Sweden Pontus.hedberg@ki",NA
"1199","34226206","10.1136/thoraxjnl-2021-216949","Clinical phenotypes and outcomes of SARS-CoV-2, influenza, RSV and seven other respiratory viruses: a retrospective study using complete hospital data.","An understanding of differences in clinical phenotypes and outcomes COVID-19 compared with other respiratory viral infections is important to optimise the management of patients and plan healthcare. Herein we sought to investigate such differences in patients positive for SARS-CoV-2 compared with influenza, respiratory syncytial virus (RSV) and other respiratory viruses. We performed a retrospective cohort study of hospitalised adults and children (=15 years) who tested positive for SARS-CoV-2, ","2021","07","10","Thorax","Thorax","COVID-19; pneumonia; respiratory infection; viral infection","Karlsson Valik","John","Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden",NA
"1200","34226206","10.1136/thoraxjnl-2021-216949","Clinical phenotypes and outcomes of SARS-CoV-2, influenza, RSV and seven other respiratory viruses: a retrospective study using complete hospital data.","An understanding of differences in clinical phenotypes and outcomes COVID-19 compared with other respiratory viral infections is important to optimise the management of patients and plan healthcare. Herein we sought to investigate such differences in patients positive for SARS-CoV-2 compared with influenza, respiratory syncytial virus (RSV) and other respiratory viruses. We performed a retrospective cohort study of hospitalised adults and children (=15 years) who tested positive for SARS-CoV-2, ","2021","07","10","Thorax","Thorax","COVID-19; pneumonia; respiratory infection; viral infection","van der Werff","Suzanne","Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden",NA
"1201","34226206","10.1136/thoraxjnl-2021-216949","Clinical phenotypes and outcomes of SARS-CoV-2, influenza, RSV and seven other respiratory viruses: a retrospective study using complete hospital data.","An understanding of differences in clinical phenotypes and outcomes COVID-19 compared with other respiratory viral infections is important to optimise the management of patients and plan healthcare. Herein we sought to investigate such differences in patients positive for SARS-CoV-2 compared with influenza, respiratory syncytial virus (RSV) and other respiratory viruses. We performed a retrospective cohort study of hospitalised adults and children (=15 years) who tested positive for SARS-CoV-2, ","2021","07","10","Thorax","Thorax","COVID-19; pneumonia; respiratory infection; viral infection","Tanushi","Hideyuki","Department of Medicine Solna, Karolinska Institute, Stockholm, Sweden",NA
"1202","34226206","10.1136/thoraxjnl-2021-216949","Clinical phenotypes and outcomes of SARS-CoV-2, influenza, RSV and seven other respiratory viruses: a retrospective study using complete hospital data.","An understanding of differences in clinical phenotypes and outcomes COVID-19 compared with other respiratory viral infections is important to optimise the management of patients and plan healthcare. Herein we sought to investigate such differences in patients positive for SARS-CoV-2 compared with influenza, respiratory syncytial virus (RSV) and other respiratory viruses. We performed a retrospective cohort study of hospitalised adults and children (=15 years) who tested positive for SARS-CoV-2, ","2021","07","10","Thorax","Thorax","COVID-19; pneumonia; respiratory infection; viral infection","Requena Mendez","Ana","Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden",NA
"1203","34226206","10.1136/thoraxjnl-2021-216949","Clinical phenotypes and outcomes of SARS-CoV-2, influenza, RSV and seven other respiratory viruses: a retrospective study using complete hospital data.","An understanding of differences in clinical phenotypes and outcomes COVID-19 compared with other respiratory viral infections is important to optimise the management of patients and plan healthcare. Herein we sought to investigate such differences in patients positive for SARS-CoV-2 compared with influenza, respiratory syncytial virus (RSV) and other respiratory viruses. We performed a retrospective cohort study of hospitalised adults and children (=15 years) who tested positive for SARS-CoV-2, ","2021","07","10","Thorax","Thorax","COVID-19; pneumonia; respiratory infection; viral infection","Granath","Fredrik","Department of Medicine Solna, Karolinska Institute, Stockholm, Sweden",NA
"1204","34226206","10.1136/thoraxjnl-2021-216949","Clinical phenotypes and outcomes of SARS-CoV-2, influenza, RSV and seven other respiratory viruses: a retrospective study using complete hospital data.","An understanding of differences in clinical phenotypes and outcomes COVID-19 compared with other respiratory viral infections is important to optimise the management of patients and plan healthcare. Herein we sought to investigate such differences in patients positive for SARS-CoV-2 compared with influenza, respiratory syncytial virus (RSV) and other respiratory viruses. We performed a retrospective cohort study of hospitalised adults and children (=15 years) who tested positive for SARS-CoV-2, ","2021","07","10","Thorax","Thorax","COVID-19; pneumonia; respiratory infection; viral infection","Bell","Max","Department of Physiology and Pharmacology, Karolinska Institute, Stockholm, Sweden",NA
"1205","34226206","10.1136/thoraxjnl-2021-216949","Clinical phenotypes and outcomes of SARS-CoV-2, influenza, RSV and seven other respiratory viruses: a retrospective study using complete hospital data.","An understanding of differences in clinical phenotypes and outcomes COVID-19 compared with other respiratory viral infections is important to optimise the management of patients and plan healthcare. Herein we sought to investigate such differences in patients positive for SARS-CoV-2 compared with influenza, respiratory syncytial virus (RSV) and other respiratory viruses. We performed a retrospective cohort study of hospitalised adults and children (=15 years) who tested positive for SARS-CoV-2, ","2021","07","10","Thorax","Thorax","COVID-19; pneumonia; respiratory infection; viral infection","Mårtensson","Johan","Department of Physiology and Pharmacology, Karolinska Institute, Stockholm, Sweden",NA
"1206","34226206","10.1136/thoraxjnl-2021-216949","Clinical phenotypes and outcomes of SARS-CoV-2, influenza, RSV and seven other respiratory viruses: a retrospective study using complete hospital data.","An understanding of differences in clinical phenotypes and outcomes COVID-19 compared with other respiratory viral infections is important to optimise the management of patients and plan healthcare. Herein we sought to investigate such differences in patients positive for SARS-CoV-2 compared with influenza, respiratory syncytial virus (RSV) and other respiratory viruses. We performed a retrospective cohort study of hospitalised adults and children (=15 years) who tested positive for SARS-CoV-2, ","2021","07","10","Thorax","Thorax","COVID-19; pneumonia; respiratory infection; viral infection","Dyrdak","Robert","Department of Microbiology, Tumor and Cell Biology, Karolinska Institute, Stockholm, Sweden",NA
"1207","34226206","10.1136/thoraxjnl-2021-216949","Clinical phenotypes and outcomes of SARS-CoV-2, influenza, RSV and seven other respiratory viruses: a retrospective study using complete hospital data.","An understanding of differences in clinical phenotypes and outcomes COVID-19 compared with other respiratory viral infections is important to optimise the management of patients and plan healthcare. Herein we sought to investigate such differences in patients positive for SARS-CoV-2 compared with influenza, respiratory syncytial virus (RSV) and other respiratory viruses. We performed a retrospective cohort study of hospitalised adults and children (=15 years) who tested positive for SARS-CoV-2, ","2021","07","10","Thorax","Thorax","COVID-19; pneumonia; respiratory infection; viral infection","Hertting","Olof","Department of Women's and Children's Health, Karolinska Institute, Stockholm, Sweden",NA
"1208","34226206","10.1136/thoraxjnl-2021-216949","Clinical phenotypes and outcomes of SARS-CoV-2, influenza, RSV and seven other respiratory viruses: a retrospective study using complete hospital data.","An understanding of differences in clinical phenotypes and outcomes COVID-19 compared with other respiratory viral infections is important to optimise the management of patients and plan healthcare. Herein we sought to investigate such differences in patients positive for SARS-CoV-2 compared with influenza, respiratory syncytial virus (RSV) and other respiratory viruses. We performed a retrospective cohort study of hospitalised adults and children (=15 years) who tested positive for SARS-CoV-2, ","2021","07","10","Thorax","Thorax","COVID-19; pneumonia; respiratory infection; viral infection","Färnert","Anna","Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden",NA
"1209","34226206","10.1136/thoraxjnl-2021-216949","Clinical phenotypes and outcomes of SARS-CoV-2, influenza, RSV and seven other respiratory viruses: a retrospective study using complete hospital data.","An understanding of differences in clinical phenotypes and outcomes COVID-19 compared with other respiratory viral infections is important to optimise the management of patients and plan healthcare. Herein we sought to investigate such differences in patients positive for SARS-CoV-2 compared with influenza, respiratory syncytial virus (RSV) and other respiratory viruses. We performed a retrospective cohort study of hospitalised adults and children (=15 years) who tested positive for SARS-CoV-2, ","2021","07","10","Thorax","Thorax","COVID-19; pneumonia; respiratory infection; viral infection","Ternhag","Anders","Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden",NA
"1210","34226206","10.1136/thoraxjnl-2021-216949","Clinical phenotypes and outcomes of SARS-CoV-2, influenza, RSV and seven other respiratory viruses: a retrospective study using complete hospital data.","An understanding of differences in clinical phenotypes and outcomes COVID-19 compared with other respiratory viral infections is important to optimise the management of patients and plan healthcare. Herein we sought to investigate such differences in patients positive for SARS-CoV-2 compared with influenza, respiratory syncytial virus (RSV) and other respiratory viruses. We performed a retrospective cohort study of hospitalised adults and children (=15 years) who tested positive for SARS-CoV-2, ","2021","07","10","Thorax","Thorax","COVID-19; pneumonia; respiratory infection; viral infection","Naucler","Pontus","Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden",NA
"1211","34226202","10.1136/sextrans-2021-055055","Safeguarding teenagers in a sexual health service during the COVID-19 pandemic.","The first aim was to examine how the COVID-19 restrictions on movement impacted on teenagers' access to a local sexual health service (SHS). The second aim was to audit whether safeguarding assessments were carried out for those accessing the service remotely. April-September 2020 consultation numbers for teenagers aged 17 years and under were compared with the 2019 equivalent. Service safeguarding assessment standards were reviewed for teenagers receiving telephone consultations for the first 6","2021","07","06","Sex Transm Infect","Sexually transmitted infections","COVID-19; patient care management; public health; risk assessment; sexual health","Bekaert","Sarah","Oxfordshire Sexual Health Service, Oxford University Hospitals NHS Foundation Trust, Oxford, UK sbekaert@brookes.ac","sbekaert@brookes.ac.uk"
"1212","34226202","10.1136/sextrans-2021-055055","Safeguarding teenagers in a sexual health service during the COVID-19 pandemic.","The first aim was to examine how the COVID-19 restrictions on movement impacted on teenagers' access to a local sexual health service (SHS). The second aim was to audit whether safeguarding assessments were carried out for those accessing the service remotely. April-September 2020 consultation numbers for teenagers aged 17 years and under were compared with the 2019 equivalent. Service safeguarding assessment standards were reviewed for teenagers receiving telephone consultations for the first 6","2021","07","06","Sex Transm Infect","Sexually transmitted infections","COVID-19; patient care management; public health; risk assessment; sexual health","Azzopardi","Liz","Oxfordshire Sexual Health Service, Oxford University Hospitals NHS Foundation Trust, Oxford, UK",NA
"1213","34226184","10.1136/bjsports-2021-104431","High SARS-CoV-2 infection rate after resuming professional football in São Paulo, Brazil.","To examine the SARS-CoV-2 infection rate in a cohort of 6500 professional athletes and staff during the 2020 football (soccer) season in São Paulo, Brazil. This retrospective cohort study included 4269 players (87% male, age: 21.7±4.2 years) and 2231 staff (87% male, age: 42.6±11.9 years) from 122 teams (women: n=16) involved in eight leagues (women: n=2), which took place in São Paulo, Brazil. Between 4 July 2020 and 21 December 2020, swab samples were collected weekly (n=29 507) and tested for","2021","07","10","Br J Sports Med","British journal of sports medicine","Covid-19; communicable diseases; soccer","Gualano","Bruno","Applied Physiology &amp","gualano@usp.br"
"1214","34226184","10.1136/bjsports-2021-104431","High SARS-CoV-2 infection rate after resuming professional football in São Paulo, Brazil.","To examine the SARS-CoV-2 infection rate in a cohort of 6500 professional athletes and staff during the 2020 football (soccer) season in São Paulo, Brazil. This retrospective cohort study included 4269 players (87% male, age: 21.7±4.2 years) and 2231 staff (87% male, age: 42.6±11.9 years) from 122 teams (women: n=16) involved in eight leagues (women: n=2), which took place in São Paulo, Brazil. Between 4 July 2020 and 21 December 2020, swab samples were collected weekly (n=29 507) and tested for","2021","07","10","Br J Sports Med","British journal of sports medicine","Covid-19; communicable diseases; soccer","Brito","Gisele Mendes","Applied Physiology &amp",NA
"1215","34226184","10.1136/bjsports-2021-104431","High SARS-CoV-2 infection rate after resuming professional football in São Paulo, Brazil.","To examine the SARS-CoV-2 infection rate in a cohort of 6500 professional athletes and staff during the 2020 football (soccer) season in São Paulo, Brazil. This retrospective cohort study included 4269 players (87% male, age: 21.7±4.2 years) and 2231 staff (87% male, age: 42.6±11.9 years) from 122 teams (women: n=16) involved in eight leagues (women: n=2), which took place in São Paulo, Brazil. Between 4 July 2020 and 21 December 2020, swab samples were collected weekly (n=29 507) and tested for","2021","07","10","Br J Sports Med","British journal of sports medicine","Covid-19; communicable diseases; soccer","Pinto","Ana Jéssica","Applied Physiology &amp",NA
"1216","34226184","10.1136/bjsports-2021-104431","High SARS-CoV-2 infection rate after resuming professional football in São Paulo, Brazil.","To examine the SARS-CoV-2 infection rate in a cohort of 6500 professional athletes and staff during the 2020 football (soccer) season in São Paulo, Brazil. This retrospective cohort study included 4269 players (87% male, age: 21.7±4.2 years) and 2231 staff (87% male, age: 42.6±11.9 years) from 122 teams (women: n=16) involved in eight leagues (women: n=2), which took place in São Paulo, Brazil. Between 4 July 2020 and 21 December 2020, swab samples were collected weekly (n=29 507) and tested for","2021","07","10","Br J Sports Med","British journal of sports medicine","Covid-19; communicable diseases; soccer","Lemes","Italo Ribeiro","Applied Physiology &amp",NA
"1217","34226184","10.1136/bjsports-2021-104431","High SARS-CoV-2 infection rate after resuming professional football in São Paulo, Brazil.","To examine the SARS-CoV-2 infection rate in a cohort of 6500 professional athletes and staff during the 2020 football (soccer) season in São Paulo, Brazil. This retrospective cohort study included 4269 players (87% male, age: 21.7±4.2 years) and 2231 staff (87% male, age: 42.6±11.9 years) from 122 teams (women: n=16) involved in eight leagues (women: n=2), which took place in São Paulo, Brazil. Between 4 July 2020 and 21 December 2020, swab samples were collected weekly (n=29 507) and tested for","2021","07","10","Br J Sports Med","British journal of sports medicine","Covid-19; communicable diseases; soccer","Matos","Luciana Diniz Nagem Janot","Hospital Israelita Albert Einstein, São Paulo, Brazil",NA
"1218","34226184","10.1136/bjsports-2021-104431","High SARS-CoV-2 infection rate after resuming professional football in São Paulo, Brazil.","To examine the SARS-CoV-2 infection rate in a cohort of 6500 professional athletes and staff during the 2020 football (soccer) season in São Paulo, Brazil. This retrospective cohort study included 4269 players (87% male, age: 21.7±4.2 years) and 2231 staff (87% male, age: 42.6±11.9 years) from 122 teams (women: n=16) involved in eight leagues (women: n=2), which took place in São Paulo, Brazil. Between 4 July 2020 and 21 December 2020, swab samples were collected weekly (n=29 507) and tested for","2021","07","10","Br J Sports Med","British journal of sports medicine","Covid-19; communicable diseases; soccer","de Sá Pinto","Ana Lúcia","Applied Physiology &amp",NA
"1219","34226184","10.1136/bjsports-2021-104431","High SARS-CoV-2 infection rate after resuming professional football in São Paulo, Brazil.","To examine the SARS-CoV-2 infection rate in a cohort of 6500 professional athletes and staff during the 2020 football (soccer) season in São Paulo, Brazil. This retrospective cohort study included 4269 players (87% male, age: 21.7±4.2 years) and 2231 staff (87% male, age: 42.6±11.9 years) from 122 teams (women: n=16) involved in eight leagues (women: n=2), which took place in São Paulo, Brazil. Between 4 July 2020 and 21 December 2020, swab samples were collected weekly (n=29 507) and tested for","2021","07","10","Br J Sports Med","British journal of sports medicine","Covid-19; communicable diseases; soccer","Loturco","Irineu","Nucleus of High Performance in Sport - São Paulo, São Paulo, Brazil",NA
"1220","34226182","10.1136/bmj.n1692","Covid-19 cough: use all your senses to make a diagnosis.",NA,"2021","07","09","BMJ","BMJ (Clinical research ed.)","COVID-19; Cough; Dyspnea; Humans; SARS-CoV-2","Zermansky","Arnold G","Leeds, UK",NA
"1221","34226169","10.1016/j.neucie.2021.06.003","Endoscopic endonasal surgery during COVID-19 pandemic: Management guideline.","Current SARS-CoV-2 coronavirus pandemic is challenging medical and surgical activities. Specifically, within neurosurgery, endoscopic endonasal approaches pose a high risk of contagion for healthcare personnel involved in it. Initially, the recommendation was to avoid such surgeries. However, the pandemic has dragged on and new solutions must be proposed to continue carrying out these approaches safely. Given the lack of established protocols, we propose the following one, which concisely establ","2021","07","08","Neurocirugia (Astur : Engl Ed)","Neurocirugia (English Edition)","Base de cráneo; COVID-19; Cirugía endoscópica; Endoscopic surgery; Guideline; Protocolo; SARS-CoV-2; Skull base; <U+FEFF>SARS-CoV-2","Mato-Mañas","David","Servicio de Neurocirugía, Hospital Universitario Marqués de Valdecilla, Santander, Spain",NA
"1222","34226169","10.1016/j.neucie.2021.06.003","Endoscopic endonasal surgery during COVID-19 pandemic: Management guideline.","Current SARS-CoV-2 coronavirus pandemic is challenging medical and surgical activities. Specifically, within neurosurgery, endoscopic endonasal approaches pose a high risk of contagion for healthcare personnel involved in it. Initially, the recommendation was to avoid such surgeries. However, the pandemic has dragged on and new solutions must be proposed to continue carrying out these approaches safely. Given the lack of established protocols, we propose the following one, which concisely establ","2021","07","08","Neurocirugia (Astur : Engl Ed)","Neurocirugia (English Edition)","Base de cráneo; COVID-19; Cirugía endoscópica; Endoscopic surgery; Guideline; Protocolo; SARS-CoV-2; Skull base; <U+FEFF>SARS-CoV-2","López-Gómez","Patricia","Servicio de Neurocirugía, Hospital Universitario Marqués de Valdecilla, Santander, Spain. Electronic address: patricia91lpz@gmail","patricia91lpz@gmail.com"
"1223","34226169","10.1016/j.neucie.2021.06.003","Endoscopic endonasal surgery during COVID-19 pandemic: Management guideline.","Current SARS-CoV-2 coronavirus pandemic is challenging medical and surgical activities. Specifically, within neurosurgery, endoscopic endonasal approaches pose a high risk of contagion for healthcare personnel involved in it. Initially, the recommendation was to avoid such surgeries. However, the pandemic has dragged on and new solutions must be proposed to continue carrying out these approaches safely. Given the lack of established protocols, we propose the following one, which concisely establ","2021","07","08","Neurocirugia (Astur : Engl Ed)","Neurocirugia (English Edition)","Base de cráneo; COVID-19; Cirugía endoscópica; Endoscopic surgery; Guideline; Protocolo; SARS-CoV-2; Skull base; <U+FEFF>SARS-CoV-2","Viera-Artiles","Jaime","Servicio de Otorrinolaringología, Hospital Universitario Marqués de Valdecilla, Santander, Spain",NA
"1224","34226169","10.1016/j.neucie.2021.06.003","Endoscopic endonasal surgery during COVID-19 pandemic: Management guideline.","Current SARS-CoV-2 coronavirus pandemic is challenging medical and surgical activities. Specifically, within neurosurgery, endoscopic endonasal approaches pose a high risk of contagion for healthcare personnel involved in it. Initially, the recommendation was to avoid such surgeries. However, the pandemic has dragged on and new solutions must be proposed to continue carrying out these approaches safely. Given the lack of established protocols, we propose the following one, which concisely establ","2021","07","08","Neurocirugia (Astur : Engl Ed)","Neurocirugia (English Edition)","Base de cráneo; COVID-19; Cirugía endoscópica; Endoscopic surgery; Guideline; Protocolo; SARS-CoV-2; Skull base; <U+FEFF>SARS-CoV-2","García-Milán","Víctor","Servicio de Neurocirugía, Hospital Universitario Marqués de Valdecilla, Santander, Spain",NA
"1225","34226169","10.1016/j.neucie.2021.06.003","Endoscopic endonasal surgery during COVID-19 pandemic: Management guideline.","Current SARS-CoV-2 coronavirus pandemic is challenging medical and surgical activities. Specifically, within neurosurgery, endoscopic endonasal approaches pose a high risk of contagion for healthcare personnel involved in it. Initially, the recommendation was to avoid such surgeries. However, the pandemic has dragged on and new solutions must be proposed to continue carrying out these approaches safely. Given the lack of established protocols, we propose the following one, which concisely establ","2021","07","08","Neurocirugia (Astur : Engl Ed)","Neurocirugia (English Edition)","Base de cráneo; COVID-19; Cirugía endoscópica; Endoscopic surgery; Guideline; Protocolo; SARS-CoV-2; Skull base; <U+FEFF>SARS-CoV-2","Morales-Angulo","Carmelo","Servicio de Otorrinolaringología, Hospital Universitario Marqués de Valdecilla, Santander, Spain",NA
"1226","34226169","10.1016/j.neucie.2021.06.003","Endoscopic endonasal surgery during COVID-19 pandemic: Management guideline.","Current SARS-CoV-2 coronavirus pandemic is challenging medical and surgical activities. Specifically, within neurosurgery, endoscopic endonasal approaches pose a high risk of contagion for healthcare personnel involved in it. Initially, the recommendation was to avoid such surgeries. However, the pandemic has dragged on and new solutions must be proposed to continue carrying out these approaches safely. Given the lack of established protocols, we propose the following one, which concisely establ","2021","07","08","Neurocirugia (Astur : Engl Ed)","Neurocirugia (English Edition)","Base de cráneo; COVID-19; Cirugía endoscópica; Endoscopic surgery; Guideline; Protocolo; SARS-CoV-2; Skull base; <U+FEFF>SARS-CoV-2","Ruíz-García","Isabel","Servicio de Anestesiología y Reanimación, Hospital Universitario Marqués de Valdecilla, Santander, Spain",NA
"1227","34226169","10.1016/j.neucie.2021.06.003","Endoscopic endonasal surgery during COVID-19 pandemic: Management guideline.","Current SARS-CoV-2 coronavirus pandemic is challenging medical and surgical activities. Specifically, within neurosurgery, endoscopic endonasal approaches pose a high risk of contagion for healthcare personnel involved in it. Initially, the recommendation was to avoid such surgeries. However, the pandemic has dragged on and new solutions must be proposed to continue carrying out these approaches safely. Given the lack of established protocols, we propose the following one, which concisely establ","2021","07","08","Neurocirugia (Astur : Engl Ed)","Neurocirugia (English Edition)","Base de cráneo; COVID-19; Cirugía endoscópica; Endoscopic surgery; Guideline; Protocolo; SARS-CoV-2; Skull base; <U+FEFF>SARS-CoV-2","Rabanal-Llevot","José Manuel","Servicio de Anestesiología y Reanimación, Hospital Universitario Marqués de Valdecilla, Santander, Spain",NA
"1228","34226169","10.1016/j.neucie.2021.06.003","Endoscopic endonasal surgery during COVID-19 pandemic: Management guideline.","Current SARS-CoV-2 coronavirus pandemic is challenging medical and surgical activities. Specifically, within neurosurgery, endoscopic endonasal approaches pose a high risk of contagion for healthcare personnel involved in it. Initially, the recommendation was to avoid such surgeries. However, the pandemic has dragged on and new solutions must be proposed to continue carrying out these approaches safely. Given the lack of established protocols, we propose the following one, which concisely establ","2021","07","08","Neurocirugia (Astur : Engl Ed)","Neurocirugia (English Edition)","Base de cráneo; COVID-19; Cirugía endoscópica; Endoscopic surgery; Guideline; Protocolo; SARS-CoV-2; Skull base; <U+FEFF>SARS-CoV-2","Fariñas-Álvarez","María Carmen","Servicio de Enfermedades Infecciosas, Hospital Universitario Marqués de Valdecilla, Santander, Spain",NA
"1229","34226169","10.1016/j.neucie.2021.06.003","Endoscopic endonasal surgery during COVID-19 pandemic: Management guideline.","Current SARS-CoV-2 coronavirus pandemic is challenging medical and surgical activities. Specifically, within neurosurgery, endoscopic endonasal approaches pose a high risk of contagion for healthcare personnel involved in it. Initially, the recommendation was to avoid such surgeries. However, the pandemic has dragged on and new solutions must be proposed to continue carrying out these approaches safely. Given the lack of established protocols, we propose the following one, which concisely establ","2021","07","08","Neurocirugia (Astur : Engl Ed)","Neurocirugia (English Edition)","Base de cráneo; COVID-19; Cirugía endoscópica; Endoscopic surgery; Guideline; Protocolo; SARS-CoV-2; Skull base; <U+FEFF>SARS-CoV-2","Rebollo-Rodrigo","María Henar","Servicio de Medicina Preventiva, Hospital Universitario Marqués de Valdecilla, Santander, Spain",NA
"1230","34226169","10.1016/j.neucie.2021.06.003","Endoscopic endonasal surgery during COVID-19 pandemic: Management guideline.","Current SARS-CoV-2 coronavirus pandemic is challenging medical and surgical activities. Specifically, within neurosurgery, endoscopic endonasal approaches pose a high risk of contagion for healthcare personnel involved in it. Initially, the recommendation was to avoid such surgeries. However, the pandemic has dragged on and new solutions must be proposed to continue carrying out these approaches safely. Given the lack of established protocols, we propose the following one, which concisely establ","2021","07","08","Neurocirugia (Astur : Engl Ed)","Neurocirugia (English Edition)","Base de cráneo; COVID-19; Cirugía endoscópica; Endoscopic surgery; Guideline; Protocolo; SARS-CoV-2; Skull base; <U+FEFF>SARS-CoV-2","Martín-Láez","Rubén","Servicio de Neurocirugía, Hospital Universitario Marqués de Valdecilla, Santander, Spain",NA
"1231","34226166","10.1016/j.idh.2021.06.002","COVID-19 personal protective equipment protocol compliance audit.","Personal protective equipment (PPE) compliance is important to reduce the rate of transmission of virulent pathogens to health care workers. Medical officer compliance with PPE protocol for COVID-19 was audited in a regional hospital in Australia early in the pandemic response. Compliance was assessed based on the order and technique of donning and doffing PPE, with medical officers from multiple departments and levels of seniority audited. Average compliance from all participants was 58.61% wit","2021","07","08","Infect Dis Health","Infection, disease &amp; health","Covid-19; Hospital; Medical officer; Pandemic; Personal protective equipment","Wotherspoon","Shoena","Medical Education Unit, Toowoomba Hospital, Toowoomba, 4350, Australia",NA
"1232","34226166","10.1016/j.idh.2021.06.002","COVID-19 personal protective equipment protocol compliance audit.","Personal protective equipment (PPE) compliance is important to reduce the rate of transmission of virulent pathogens to health care workers. Medical officer compliance with PPE protocol for COVID-19 was audited in a regional hospital in Australia early in the pandemic response. Compliance was assessed based on the order and technique of donning and doffing PPE, with medical officers from multiple departments and levels of seniority audited. Average compliance from all participants was 58.61% wit","2021","07","08","Infect Dis Health","Infection, disease &amp; health","Covid-19; Hospital; Medical officer; Pandemic; Personal protective equipment","Conroy","Sheree","Medical Education Unit, Toowoomba Hospital, Toowoomba, 4350, Australia","Sheree.conroy@health.qld.gov.au"
"1233","34226141","10.1016/j.zefq.2021.04.005","[Cardiac rehabilitation during the COVID-19 pandemic in Germany - a quick poll of the German Society of rehabilitation and Prevention of Heart and Circulation Diseases (DGPR)].","In Germany, the COVID-19 pandemic has significantly changed cardiological care in both the outpatient and inpatient setting, including the cancellation of elective interventions. The investigation presented here was carried out in order to obtain information on the extent to which this also applies to cardiac rehabilitation facilities. In August 2020, all 107 member institutions of the DGPR were contacted and asked to take part in an online survey containing 12 sets of questions on the topic. At","2021","07","08","Z Evid Fortbild Qual Gesundhwes","Zeitschrift fur Evidenz, Fortbildung und Qualitat im Gesundheitswesen","COVID-19; Cardiac rehabilitation; Kardiologische Rehabilitation","Schlitt","Axel","Abteilung für Kardiologie und Diabetologie, Paracelsus-Harz-Klinik Bad Suderode, Quedlinburg, Deutschland","axel.schlitt@pkd.de"
"1234","34226141","10.1016/j.zefq.2021.04.005","[Cardiac rehabilitation during the COVID-19 pandemic in Germany - a quick poll of the German Society of rehabilitation and Prevention of Heart and Circulation Diseases (DGPR)].","In Germany, the COVID-19 pandemic has significantly changed cardiological care in both the outpatient and inpatient setting, including the cancellation of elective interventions. The investigation presented here was carried out in order to obtain information on the extent to which this also applies to cardiac rehabilitation facilities. In August 2020, all 107 member institutions of the DGPR were contacted and asked to take part in an online survey containing 12 sets of questions on the topic. At","2021","07","08","Z Evid Fortbild Qual Gesundhwes","Zeitschrift fur Evidenz, Fortbildung und Qualitat im Gesundheitswesen","COVID-19; Cardiac rehabilitation; Kardiologische Rehabilitation","Bestehorn","Kurt","Institut für Klinische Pharmakologie, TU Dresden, Dresden, Deutschland",NA
"1235","34226141","10.1016/j.zefq.2021.04.005","[Cardiac rehabilitation during the COVID-19 pandemic in Germany - a quick poll of the German Society of rehabilitation and Prevention of Heart and Circulation Diseases (DGPR)].","In Germany, the COVID-19 pandemic has significantly changed cardiological care in both the outpatient and inpatient setting, including the cancellation of elective interventions. The investigation presented here was carried out in order to obtain information on the extent to which this also applies to cardiac rehabilitation facilities. In August 2020, all 107 member institutions of the DGPR were contacted and asked to take part in an online survey containing 12 sets of questions on the topic. At","2021","07","08","Z Evid Fortbild Qual Gesundhwes","Zeitschrift fur Evidenz, Fortbildung und Qualitat im Gesundheitswesen","COVID-19; Cardiac rehabilitation; Kardiologische Rehabilitation","Schwaab","Bernhard","Curschmann-Klinik Timmendorfer Strand, Timmendorfer Strand, Deutschland",NA
"1236","34226134","10.1016/j.bjpt.2021.06.003","Pain in COVID-19 patients: A call to action for physical therapists to provide pain management after an episode of COVID-19.",NA,"2021","07","08","Braz J Phys Ther","Brazilian journal of physical therapy",NA,"Bittencourt","Juliana Valentim","Rehabilitation Science Postgraduate Program, Centro Universitário Augusto Motta (UNISUAM), Avenida Paris, 84, Bonsucesso, CEP 21041-020 Rio de Janeiro, RJ, Brazil. Electronic address: julianavalentim@souunisuam.com","julianavalentim@souunisuam.com.br"
"1237","34226134","10.1016/j.bjpt.2021.06.003","Pain in COVID-19 patients: A call to action for physical therapists to provide pain management after an episode of COVID-19.",NA,"2021","07","08","Braz J Phys Ther","Brazilian journal of physical therapy",NA,"Reis","Felipe José Jandre","Physical Therapy Department, Instituto Federal do Rio de Janeiro (IFRJ), Rio de Janeiro, RJ, Brazil",NA
"1238","34226134","10.1016/j.bjpt.2021.06.003","Pain in COVID-19 patients: A call to action for physical therapists to provide pain management after an episode of COVID-19.",NA,"2021","07","08","Braz J Phys Ther","Brazilian journal of physical therapy",NA,"Nogueira","Leandro Alberto Calazans","Rehabilitation Science Postgraduate Program, Centro Universitário Augusto Motta (UNISUAM), Avenida Paris, 84, Bonsucesso, CEP 21041-020 Rio de Janeiro, RJ, Brazil",NA
"1239","34226102","10.1016/j.vaccine.2021.06.068","Laser-facilitated epicutaneous immunization of mice with SARS-CoV-2 spike protein induces antibodies inhibiting spike/ACE2 binding.","The skin represents an attractive target tissue for vaccination against respiratory viruses such as SARS-CoV-2. Laser-facilitated epicutaneous immunization (EPI) has been established as a novel technology to overcome the skin barrier, which combines efficient delivery via micropores with an inherent adjuvant effect due to the release of danger-associated molecular patterns. Here we delivered the S1 subunit of the Spike protein of SARS-CoV-2 to the skin of BALB/c mice via laser-generated micropor","2021","07","19","Vaccine","Vaccine","Epicutaneous immunization; Laser; SARS-CoV-2; Skin micropores; Spike protein; Animals; Antibodies, Viral; COVID-19; COVID-19 Vaccines; Humans; Immunization; Lasers; Mice; Mice, Inbred BALB C; Peptidyl-Dipeptidase A; Protein Binding; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Vaccination","Scheiblhofer","Sandra","University of Salzburg, Department of Biosciences, Salzburg, Austria",NA
"1240","34226102","10.1016/j.vaccine.2021.06.068","Laser-facilitated epicutaneous immunization of mice with SARS-CoV-2 spike protein induces antibodies inhibiting spike/ACE2 binding.","The skin represents an attractive target tissue for vaccination against respiratory viruses such as SARS-CoV-2. Laser-facilitated epicutaneous immunization (EPI) has been established as a novel technology to overcome the skin barrier, which combines efficient delivery via micropores with an inherent adjuvant effect due to the release of danger-associated molecular patterns. Here we delivered the S1 subunit of the Spike protein of SARS-CoV-2 to the skin of BALB/c mice via laser-generated micropor","2021","07","19","Vaccine","Vaccine","Epicutaneous immunization; Laser; SARS-CoV-2; Skin micropores; Spike protein; Animals; Antibodies, Viral; COVID-19; COVID-19 Vaccines; Humans; Immunization; Lasers; Mice; Mice, Inbred BALB C; Peptidyl-Dipeptidase A; Protein Binding; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Vaccination","Drothler","Stephan","University of Salzburg, Department of Biosciences, Salzburg, Austria",NA
"1241","34226102","10.1016/j.vaccine.2021.06.068","Laser-facilitated epicutaneous immunization of mice with SARS-CoV-2 spike protein induces antibodies inhibiting spike/ACE2 binding.","The skin represents an attractive target tissue for vaccination against respiratory viruses such as SARS-CoV-2. Laser-facilitated epicutaneous immunization (EPI) has been established as a novel technology to overcome the skin barrier, which combines efficient delivery via micropores with an inherent adjuvant effect due to the release of danger-associated molecular patterns. Here we delivered the S1 subunit of the Spike protein of SARS-CoV-2 to the skin of BALB/c mice via laser-generated micropor","2021","07","19","Vaccine","Vaccine","Epicutaneous immunization; Laser; SARS-CoV-2; Skin micropores; Spike protein; Animals; Antibodies, Viral; COVID-19; COVID-19 Vaccines; Humans; Immunization; Lasers; Mice; Mice, Inbred BALB C; Peptidyl-Dipeptidase A; Protein Binding; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Vaccination","Braun","Werner","Pantec Biosolutions AG, Ruggell, Liechtenstein",NA
"1242","34226102","10.1016/j.vaccine.2021.06.068","Laser-facilitated epicutaneous immunization of mice with SARS-CoV-2 spike protein induces antibodies inhibiting spike/ACE2 binding.","The skin represents an attractive target tissue for vaccination against respiratory viruses such as SARS-CoV-2. Laser-facilitated epicutaneous immunization (EPI) has been established as a novel technology to overcome the skin barrier, which combines efficient delivery via micropores with an inherent adjuvant effect due to the release of danger-associated molecular patterns. Here we delivered the S1 subunit of the Spike protein of SARS-CoV-2 to the skin of BALB/c mice via laser-generated micropor","2021","07","19","Vaccine","Vaccine","Epicutaneous immunization; Laser; SARS-CoV-2; Skin micropores; Spike protein; Animals; Antibodies, Viral; COVID-19; COVID-19 Vaccines; Humans; Immunization; Lasers; Mice; Mice, Inbred BALB C; Peptidyl-Dipeptidase A; Protein Binding; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Vaccination","Braun","Reinhard","Pantec Biosolutions AG, Ruggell, Liechtenstein",NA
"1243","34226102","10.1016/j.vaccine.2021.06.068","Laser-facilitated epicutaneous immunization of mice with SARS-CoV-2 spike protein induces antibodies inhibiting spike/ACE2 binding.","The skin represents an attractive target tissue for vaccination against respiratory viruses such as SARS-CoV-2. Laser-facilitated epicutaneous immunization (EPI) has been established as a novel technology to overcome the skin barrier, which combines efficient delivery via micropores with an inherent adjuvant effect due to the release of danger-associated molecular patterns. Here we delivered the S1 subunit of the Spike protein of SARS-CoV-2 to the skin of BALB/c mice via laser-generated micropor","2021","07","19","Vaccine","Vaccine","Epicutaneous immunization; Laser; SARS-CoV-2; Skin micropores; Spike protein; Animals; Antibodies, Viral; COVID-19; COVID-19 Vaccines; Humans; Immunization; Lasers; Mice; Mice, Inbred BALB C; Peptidyl-Dipeptidase A; Protein Binding; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Vaccination","Boesch","Maximilian","Pantec Biosolutions AG, Ruggell, Liechtenstein",NA
"1244","34226102","10.1016/j.vaccine.2021.06.068","Laser-facilitated epicutaneous immunization of mice with SARS-CoV-2 spike protein induces antibodies inhibiting spike/ACE2 binding.","The skin represents an attractive target tissue for vaccination against respiratory viruses such as SARS-CoV-2. Laser-facilitated epicutaneous immunization (EPI) has been established as a novel technology to overcome the skin barrier, which combines efficient delivery via micropores with an inherent adjuvant effect due to the release of danger-associated molecular patterns. Here we delivered the S1 subunit of the Spike protein of SARS-CoV-2 to the skin of BALB/c mice via laser-generated micropor","2021","07","19","Vaccine","Vaccine","Epicutaneous immunization; Laser; SARS-CoV-2; Skin micropores; Spike protein; Animals; Antibodies, Viral; COVID-19; COVID-19 Vaccines; Humans; Immunization; Lasers; Mice; Mice, Inbred BALB C; Peptidyl-Dipeptidase A; Protein Binding; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Vaccination","Weiss","Richard","University of Salzburg, Department of Biosciences, Salzburg, Austria. Electronic address: Richard.Weiss@sbg.ac","Richard.Weiss@sbg.ac.at"
"1245","34226070","10.1016/j.annemergmed.2021.04.035","Early Outcomes of Bivalirudin Therapy for Thrombotic Thrombocytopenia and Cerebral Venous Sinus Thrombosis After Ad26.COV2.S Vaccination.","Vaccine-induced thrombotic thrombocytopenia is a newly described disease process in the setting of expanding access to COVID-19 vaccination. The United States Centers for Disease Control and Prevention recommends treatment with an alternative to heparin in patients suspected of having vaccine-induced thrombotic thrombocytopenia. At this time there have been no reported outcomes from the treatment of vaccine-induced thrombotic thrombocytopenia with bivalirudin as a heparin alternative. We describ","2021","07","08","Ann Emerg Med","Annals of emergency medicine",NA,"Clark","Richard Todd","Department of Emergency Medicine, University of Colorado School of Medicine, Aurora, CO. Electronic address: todd.clark@cuanschutz","todd.clark@cuanschutz.edu"
"1246","34226070","10.1016/j.annemergmed.2021.04.035","Early Outcomes of Bivalirudin Therapy for Thrombotic Thrombocytopenia and Cerebral Venous Sinus Thrombosis After Ad26.COV2.S Vaccination.","Vaccine-induced thrombotic thrombocytopenia is a newly described disease process in the setting of expanding access to COVID-19 vaccination. The United States Centers for Disease Control and Prevention recommends treatment with an alternative to heparin in patients suspected of having vaccine-induced thrombotic thrombocytopenia. At this time there have been no reported outcomes from the treatment of vaccine-induced thrombotic thrombocytopenia with bivalirudin as a heparin alternative. We describ","2021","07","08","Ann Emerg Med","Annals of emergency medicine",NA,"Johnson","Lee","Department of Emergency Medicine, Denver Health Hospital, Denver, CO",NA
"1247","34226070","10.1016/j.annemergmed.2021.04.035","Early Outcomes of Bivalirudin Therapy for Thrombotic Thrombocytopenia and Cerebral Venous Sinus Thrombosis After Ad26.COV2.S Vaccination.","Vaccine-induced thrombotic thrombocytopenia is a newly described disease process in the setting of expanding access to COVID-19 vaccination. The United States Centers for Disease Control and Prevention recommends treatment with an alternative to heparin in patients suspected of having vaccine-induced thrombotic thrombocytopenia. At this time there have been no reported outcomes from the treatment of vaccine-induced thrombotic thrombocytopenia with bivalirudin as a heparin alternative. We describ","2021","07","08","Ann Emerg Med","Annals of emergency medicine",NA,"Billotti","Jamie","Department of Pharmacy, University of Colorado Hospital, Aurora, CO",NA
"1248","34226070","10.1016/j.annemergmed.2021.04.035","Early Outcomes of Bivalirudin Therapy for Thrombotic Thrombocytopenia and Cerebral Venous Sinus Thrombosis After Ad26.COV2.S Vaccination.","Vaccine-induced thrombotic thrombocytopenia is a newly described disease process in the setting of expanding access to COVID-19 vaccination. The United States Centers for Disease Control and Prevention recommends treatment with an alternative to heparin in patients suspected of having vaccine-induced thrombotic thrombocytopenia. At this time there have been no reported outcomes from the treatment of vaccine-induced thrombotic thrombocytopenia with bivalirudin as a heparin alternative. We describ","2021","07","08","Ann Emerg Med","Annals of emergency medicine",NA,"Foulds","Georgia","Department of Emergency Medicine, University of Colorado School of Medicine, Aurora, CO",NA
"1249","34226070","10.1016/j.annemergmed.2021.04.035","Early Outcomes of Bivalirudin Therapy for Thrombotic Thrombocytopenia and Cerebral Venous Sinus Thrombosis After Ad26.COV2.S Vaccination.","Vaccine-induced thrombotic thrombocytopenia is a newly described disease process in the setting of expanding access to COVID-19 vaccination. The United States Centers for Disease Control and Prevention recommends treatment with an alternative to heparin in patients suspected of having vaccine-induced thrombotic thrombocytopenia. At this time there have been no reported outcomes from the treatment of vaccine-induced thrombotic thrombocytopenia with bivalirudin as a heparin alternative. We describ","2021","07","08","Ann Emerg Med","Annals of emergency medicine",NA,"Ketels","Taryn","Department of Emergency Medicine, University of Colorado Hospital, Aurora, CO",NA
"1250","34226070","10.1016/j.annemergmed.2021.04.035","Early Outcomes of Bivalirudin Therapy for Thrombotic Thrombocytopenia and Cerebral Venous Sinus Thrombosis After Ad26.COV2.S Vaccination.","Vaccine-induced thrombotic thrombocytopenia is a newly described disease process in the setting of expanding access to COVID-19 vaccination. The United States Centers for Disease Control and Prevention recommends treatment with an alternative to heparin in patients suspected of having vaccine-induced thrombotic thrombocytopenia. At this time there have been no reported outcomes from the treatment of vaccine-induced thrombotic thrombocytopenia with bivalirudin as a heparin alternative. We describ","2021","07","08","Ann Emerg Med","Annals of emergency medicine",NA,"Heard","Kennon","Department of Emergency Medicine, University of Colorado School of Medicine, Aurora, CO",NA
"1251","34226070","10.1016/j.annemergmed.2021.04.035","Early Outcomes of Bivalirudin Therapy for Thrombotic Thrombocytopenia and Cerebral Venous Sinus Thrombosis After Ad26.COV2.S Vaccination.","Vaccine-induced thrombotic thrombocytopenia is a newly described disease process in the setting of expanding access to COVID-19 vaccination. The United States Centers for Disease Control and Prevention recommends treatment with an alternative to heparin in patients suspected of having vaccine-induced thrombotic thrombocytopenia. At this time there have been no reported outcomes from the treatment of vaccine-induced thrombotic thrombocytopenia with bivalirudin as a heparin alternative. We describ","2021","07","08","Ann Emerg Med","Annals of emergency medicine",NA,"Calvello Hynes","Emilie","Department of Emergency Medicine, University of Colorado School of Medicine, Aurora, CO",NA
"1252","34226066","10.1016/j.identj.2021.05.006","Prevalence of Anosmia or Ageusia in Patients With COVID-19 Among United Arab Emirates Population.","The aim of this research was to determine the relationship and prevalence of taste and smell dysfunction in patients with COVID-19 in the United Arab Emirates (UAE) population. Enrolled participants were interviewed online via a phone call after obtaining their informed consent. Quantification of smell, taste, and other sensations before, during, and after COVID-19 infection was correlated with the severity of COVID-19 symptoms. A total of 500 patients with (mild-severe) COVID-19 completed the s","2021","07","08","Int Dent J","International dental journal","Ageusia; Anosmia; Covid-19","Al-Rawi","Natheer H","Department of Oral and Craniofacial Health Sciences, College of Dental Medicine, University of Sharjah, Sharjah, United Arab Emirates. Electronic address: nhabdulla@sharjah.ac","nhabdulla@sharjah.ac.ae"
"1253","34226066","10.1016/j.identj.2021.05.006","Prevalence of Anosmia or Ageusia in Patients With COVID-19 Among United Arab Emirates Population.","The aim of this research was to determine the relationship and prevalence of taste and smell dysfunction in patients with COVID-19 in the United Arab Emirates (UAE) population. Enrolled participants were interviewed online via a phone call after obtaining their informed consent. Quantification of smell, taste, and other sensations before, during, and after COVID-19 infection was correlated with the severity of COVID-19 symptoms. A total of 500 patients with (mild-severe) COVID-19 completed the s","2021","07","08","Int Dent J","International dental journal","Ageusia; Anosmia; Covid-19","Sammouda","Ayat R","Department of Oral and Craniofacial Health Sciences, College of Dental Medicine, University of Sharjah, Sharjah, United Arab Emirates",NA
"1254","34226066","10.1016/j.identj.2021.05.006","Prevalence of Anosmia or Ageusia in Patients With COVID-19 Among United Arab Emirates Population.","The aim of this research was to determine the relationship and prevalence of taste and smell dysfunction in patients with COVID-19 in the United Arab Emirates (UAE) population. Enrolled participants were interviewed online via a phone call after obtaining their informed consent. Quantification of smell, taste, and other sensations before, during, and after COVID-19 infection was correlated with the severity of COVID-19 symptoms. A total of 500 patients with (mild-severe) COVID-19 completed the s","2021","07","08","Int Dent J","International dental journal","Ageusia; Anosmia; Covid-19","AlRahin","Eman A","Department of Oral and Craniofacial Health Sciences, College of Dental Medicine, University of Sharjah, Sharjah, United Arab Emirates",NA
"1255","34226066","10.1016/j.identj.2021.05.006","Prevalence of Anosmia or Ageusia in Patients With COVID-19 Among United Arab Emirates Population.","The aim of this research was to determine the relationship and prevalence of taste and smell dysfunction in patients with COVID-19 in the United Arab Emirates (UAE) population. Enrolled participants were interviewed online via a phone call after obtaining their informed consent. Quantification of smell, taste, and other sensations before, during, and after COVID-19 infection was correlated with the severity of COVID-19 symptoms. A total of 500 patients with (mild-severe) COVID-19 completed the s","2021","07","08","Int Dent J","International dental journal","Ageusia; Anosmia; Covid-19","Ali","Fatma A Al","Dubai Health Authority, Dubai, United Arab Emirates",NA
"1256","34226066","10.1016/j.identj.2021.05.006","Prevalence of Anosmia or Ageusia in Patients With COVID-19 Among United Arab Emirates Population.","The aim of this research was to determine the relationship and prevalence of taste and smell dysfunction in patients with COVID-19 in the United Arab Emirates (UAE) population. Enrolled participants were interviewed online via a phone call after obtaining their informed consent. Quantification of smell, taste, and other sensations before, during, and after COVID-19 infection was correlated with the severity of COVID-19 symptoms. A total of 500 patients with (mild-severe) COVID-19 completed the s","2021","07","08","Int Dent J","International dental journal","Ageusia; Anosmia; Covid-19","Arayedh","Ghadeer S Al","Department of Oral and Craniofacial Health Sciences, College of Dental Medicine, University of Sharjah, Sharjah, United Arab Emirates",NA
"1257","34226066","10.1016/j.identj.2021.05.006","Prevalence of Anosmia or Ageusia in Patients With COVID-19 Among United Arab Emirates Population.","The aim of this research was to determine the relationship and prevalence of taste and smell dysfunction in patients with COVID-19 in the United Arab Emirates (UAE) population. Enrolled participants were interviewed online via a phone call after obtaining their informed consent. Quantification of smell, taste, and other sensations before, during, and after COVID-19 infection was correlated with the severity of COVID-19 symptoms. A total of 500 patients with (mild-severe) COVID-19 completed the s","2021","07","08","Int Dent J","International dental journal","Ageusia; Anosmia; Covid-19","Daryanavard","Hamideh A","Dubai Health Authority, Dubai, United Arab Emirates",NA
"1258","34226066","10.1016/j.identj.2021.05.006","Prevalence of Anosmia or Ageusia in Patients With COVID-19 Among United Arab Emirates Population.","The aim of this research was to determine the relationship and prevalence of taste and smell dysfunction in patients with COVID-19 in the United Arab Emirates (UAE) population. Enrolled participants were interviewed online via a phone call after obtaining their informed consent. Quantification of smell, taste, and other sensations before, during, and after COVID-19 infection was correlated with the severity of COVID-19 symptoms. A total of 500 patients with (mild-severe) COVID-19 completed the s","2021","07","08","Int Dent J","International dental journal","Ageusia; Anosmia; Covid-19","Saeed","Musab H","Department of Clinical Sciences, College of Dentistry, Ajman University, Ajman, United Arab Emirates",NA
"1259","34226066","10.1016/j.identj.2021.05.006","Prevalence of Anosmia or Ageusia in Patients With COVID-19 Among United Arab Emirates Population.","The aim of this research was to determine the relationship and prevalence of taste and smell dysfunction in patients with COVID-19 in the United Arab Emirates (UAE) population. Enrolled participants were interviewed online via a phone call after obtaining their informed consent. Quantification of smell, taste, and other sensations before, during, and after COVID-19 infection was correlated with the severity of COVID-19 symptoms. A total of 500 patients with (mild-severe) COVID-19 completed the s","2021","07","08","Int Dent J","International dental journal","Ageusia; Anosmia; Covid-19","Nuaimi","Ahmed S Al","Primary Health Care Corporation (PHCC), Doha, Qatar",NA
"1260","34226057","10.1016/j.medcli.2021.06.013","Acute necro-hemorrhagic pancreatitis during SARS-CoV-2 infection.",NA,"2021","07","08","Med Clin (Barc)","Medicina clinica",NA,"Arche Banzo","María José","Servicio de Medicina Intensiva, Hospital Clínico Universitario Lozano Blesa, Zaragoza, España. Electronic address: mariajosearchebanzo@gmail","mariajosearchebanzo@gmail.com"
"1261","34226057","10.1016/j.medcli.2021.06.013","Acute necro-hemorrhagic pancreatitis during SARS-CoV-2 infection.",NA,"2021","07","08","Med Clin (Barc)","Medicina clinica",NA,"Matute Guerrero","Almudena","Servicio de Medicina Intensiva, Hospital Clínico Universitario Lozano Blesa, Zaragoza, España",NA
"1262","34226057","10.1016/j.medcli.2021.06.013","Acute necro-hemorrhagic pancreatitis during SARS-CoV-2 infection.",NA,"2021","07","08","Med Clin (Barc)","Medicina clinica",NA,"Herrero García","Sandra","Servicio de Medicina Intensiva, Hospital Clínico Universitario Lozano Blesa, Zaragoza, España",NA
"1263","34226044","10.1016/j.surg.2021.06.015","In-person versus virtual suturing and knot-tying curricula: Skills training during the COVID-19 era.","The coronavirus disease 2019 restrictions on in-person simulation activities necessitated modifying the traditional boot camp skills curriculum for matriculating PGY1 general surgery residents to a virtual format. This study investigated the relative effectiveness of in-person versus virtual instruction on the development of suturing and knot-tying skills. In all, 55 residents participated in a validated, proficiency-based, preinternship skills curriculum, 26 in 2019 and 29 in 2020. Both groups ","2021","07","06","Surgery","Surgery",NA,"Tellez","Juan","Department of Surgery, University of Texas Southwestern Medical Center, Dallas, TX. Electronic address: juan.tellez@utsouthwestern","juan.tellez@utsouthwestern.edu"
"1264","34226044","10.1016/j.surg.2021.06.015","In-person versus virtual suturing and knot-tying curricula: Skills training during the COVID-19 era.","The coronavirus disease 2019 restrictions on in-person simulation activities necessitated modifying the traditional boot camp skills curriculum for matriculating PGY1 general surgery residents to a virtual format. This study investigated the relative effectiveness of in-person versus virtual instruction on the development of suturing and knot-tying skills. In all, 55 residents participated in a validated, proficiency-based, preinternship skills curriculum, 26 in 2019 and 29 in 2020. Both groups ","2021","07","06","Surgery","Surgery",NA,"Abdelfattah","Kareem","Department of Surgery, University of Texas Southwestern Medical Center, Dallas, TX. Electronic address: https://twitter.com/DVFelaine",NA
"1265","34226044","10.1016/j.surg.2021.06.015","In-person versus virtual suturing and knot-tying curricula: Skills training during the COVID-19 era.","The coronavirus disease 2019 restrictions on in-person simulation activities necessitated modifying the traditional boot camp skills curriculum for matriculating PGY1 general surgery residents to a virtual format. This study investigated the relative effectiveness of in-person versus virtual instruction on the development of suturing and knot-tying skills. In all, 55 residents participated in a validated, proficiency-based, preinternship skills curriculum, 26 in 2019 and 29 in 2020. Both groups ","2021","07","06","Surgery","Surgery",NA,"Farr","Deborah","Department of Surgery, University of Texas Southwestern Medical Center, Dallas, TX. Electronic address: https://twitter.com/dallastrauma",NA
"1266","34226036","10.1016/j.rcp.2021.05.004","Repercussions of COVID-19 on psychiatric inpatient care in Latin America and the Caribbean.","To characterise the impact of the COVID-19 pandemic on psychiatric hospitalisations in the Latin American and Caribbean (LAC) region. Descriptive study. 85 semi-structured interviews were conducted with health workers involved with psychiatric hospitalisations in general hospitals (GHs) and specialised psychiatric hospitals (SHs) from 18 LAC countries. The interviews were done between 8 May and 30 June 2020. The data were analysed quantitatively and qualitatively. An initial decrease in the dema","2021","07","08","Rev Colomb Psiquiatr","Revista colombiana de psiquiatria","Coronavirus infections; General hospitals; Hospitales generales; Hospitales psiquiátricos; Hospitalisation; Hospitalización; Infecciones por coronavirus; Mental health services; Psychiatric hospitals; Servicios de salud mental","Ardila-Gómez","Sara","Instituto de Investigaciones, Facultad de Psicología, Universidad de Buenos Aires, Argentina. Electronic address: saraardi.cursos@gmail","saraardi.cursos@gmail.com"
"1267","34226036","10.1016/j.rcp.2021.05.004","Repercussions of COVID-19 on psychiatric inpatient care in Latin America and the Caribbean.","To characterise the impact of the COVID-19 pandemic on psychiatric hospitalisations in the Latin American and Caribbean (LAC) region. Descriptive study. 85 semi-structured interviews were conducted with health workers involved with psychiatric hospitalisations in general hospitals (GHs) and specialised psychiatric hospitals (SHs) from 18 LAC countries. The interviews were done between 8 May and 30 June 2020. The data were analysed quantitatively and qualitatively. An initial decrease in the dema","2021","07","08","Rev Colomb Psiquiatr","Revista colombiana de psiquiatria","Coronavirus infections; General hospitals; Hospitales generales; Hospitales psiquiátricos; Hospitalisation; Hospitalización; Infecciones por coronavirus; Mental health services; Psychiatric hospitals; Servicios de salud mental","Fernández","Marina","Instituto de Investigaciones, Facultad de Psicología, Universidad de Buenos Aires, Argentina",NA
"1268","34226036","10.1016/j.rcp.2021.05.004","Repercussions of COVID-19 on psychiatric inpatient care in Latin America and the Caribbean.","To characterise the impact of the COVID-19 pandemic on psychiatric hospitalisations in the Latin American and Caribbean (LAC) region. Descriptive study. 85 semi-structured interviews were conducted with health workers involved with psychiatric hospitalisations in general hospitals (GHs) and specialised psychiatric hospitals (SHs) from 18 LAC countries. The interviews were done between 8 May and 30 June 2020. The data were analysed quantitatively and qualitatively. An initial decrease in the dema","2021","07","08","Rev Colomb Psiquiatr","Revista colombiana de psiquiatria","Coronavirus infections; General hospitals; Hospitales generales; Hospitales psiquiátricos; Hospitalisation; Hospitalización; Infecciones por coronavirus; Mental health services; Psychiatric hospitals; Servicios de salud mental","Matkovich","Andrés","Facultad de Psicología, Universidad Nacional de Rosario, Argentina",NA
"1269","34226036","10.1016/j.rcp.2021.05.004","Repercussions of COVID-19 on psychiatric inpatient care in Latin America and the Caribbean.","To characterise the impact of the COVID-19 pandemic on psychiatric hospitalisations in the Latin American and Caribbean (LAC) region. Descriptive study. 85 semi-structured interviews were conducted with health workers involved with psychiatric hospitalisations in general hospitals (GHs) and specialised psychiatric hospitals (SHs) from 18 LAC countries. The interviews were done between 8 May and 30 June 2020. The data were analysed quantitatively and qualitatively. An initial decrease in the dema","2021","07","08","Rev Colomb Psiquiatr","Revista colombiana de psiquiatria","Coronavirus infections; General hospitals; Hospitales generales; Hospitales psiquiátricos; Hospitalisation; Hospitalización; Infecciones por coronavirus; Mental health services; Psychiatric hospitals; Servicios de salud mental","Rosales","Melina","Instituto de Investigaciones, Facultad de Psicología, Universidad de Buenos Aires, Argentina",NA
"1270","34226036","10.1016/j.rcp.2021.05.004","Repercussions of COVID-19 on psychiatric inpatient care in Latin America and the Caribbean.","To characterise the impact of the COVID-19 pandemic on psychiatric hospitalisations in the Latin American and Caribbean (LAC) region. Descriptive study. 85 semi-structured interviews were conducted with health workers involved with psychiatric hospitalisations in general hospitals (GHs) and specialised psychiatric hospitals (SHs) from 18 LAC countries. The interviews were done between 8 May and 30 June 2020. The data were analysed quantitatively and qualitatively. An initial decrease in the dema","2021","07","08","Rev Colomb Psiquiatr","Revista colombiana de psiquiatria","Coronavirus infections; General hospitals; Hospitales generales; Hospitales psiquiátricos; Hospitalisation; Hospitalización; Infecciones por coronavirus; Mental health services; Psychiatric hospitals; Servicios de salud mental","Alonso","Rocío","Red Investigaciones en Salud Mental, Buenos Aires, Argentina",NA
"1271","34226036","10.1016/j.rcp.2021.05.004","Repercussions of COVID-19 on psychiatric inpatient care in Latin America and the Caribbean.","To characterise the impact of the COVID-19 pandemic on psychiatric hospitalisations in the Latin American and Caribbean (LAC) region. Descriptive study. 85 semi-structured interviews were conducted with health workers involved with psychiatric hospitalisations in general hospitals (GHs) and specialised psychiatric hospitals (SHs) from 18 LAC countries. The interviews were done between 8 May and 30 June 2020. The data were analysed quantitatively and qualitatively. An initial decrease in the dema","2021","07","08","Rev Colomb Psiquiatr","Revista colombiana de psiquiatria","Coronavirus infections; General hospitals; Hospitales generales; Hospitales psiquiátricos; Hospitalisation; Hospitalización; Infecciones por coronavirus; Mental health services; Psychiatric hospitals; Servicios de salud mental","Agrest","Martín","Proyecto Suma, Buenos Aires, Argentina",NA
"1272","34226036","10.1016/j.rcp.2021.05.004","Repercussions of COVID-19 on psychiatric inpatient care in Latin America and the Caribbean.","To characterise the impact of the COVID-19 pandemic on psychiatric hospitalisations in the Latin American and Caribbean (LAC) region. Descriptive study. 85 semi-structured interviews were conducted with health workers involved with psychiatric hospitalisations in general hospitals (GHs) and specialised psychiatric hospitals (SHs) from 18 LAC countries. The interviews were done between 8 May and 30 June 2020. The data were analysed quantitatively and qualitatively. An initial decrease in the dema","2021","07","08","Rev Colomb Psiquiatr","Revista colombiana de psiquiatria","Coronavirus infections; General hospitals; Hospitales generales; Hospitales psiquiátricos; Hospitalisation; Hospitalización; Infecciones por coronavirus; Mental health services; Psychiatric hospitals; Servicios de salud mental","Paternina","Julia","Instituto de Investigaciones, Facultad de Psicología, Universidad de Buenos Aires, Argentina",NA
"1273","34226036","10.1016/j.rcp.2021.05.004","Repercussions of COVID-19 on psychiatric inpatient care in Latin America and the Caribbean.","To characterise the impact of the COVID-19 pandemic on psychiatric hospitalisations in the Latin American and Caribbean (LAC) region. Descriptive study. 85 semi-structured interviews were conducted with health workers involved with psychiatric hospitalisations in general hospitals (GHs) and specialised psychiatric hospitals (SHs) from 18 LAC countries. The interviews were done between 8 May and 30 June 2020. The data were analysed quantitatively and qualitatively. An initial decrease in the dema","2021","07","08","Rev Colomb Psiquiatr","Revista colombiana de psiquiatria","Coronavirus infections; General hospitals; Hospitales generales; Hospitales psiquiátricos; Hospitalisation; Hospitalización; Infecciones por coronavirus; Mental health services; Psychiatric hospitals; Servicios de salud mental","Díaz","Alberto Velzi","Facultad de Psicología, Universidad Nacional de Rosario, Argentina",NA
"1274","34226027","10.1016/j.mayocp.2021.05.025","Readability of Participant Informed Consent Forms and Informational Documents: From Phase 3 COVID-19 Vaccine Clinical Trials in the United States.","To assess the readability of the informed consent forms from the phase 3 COVID-19 vaccine trials conducted in the United States. English consent forms were used for patients in phase 3 COVID-19 vaccine clinical trials. Consent forms were obtained in October 2020. Using Microsoft Word tools, we analyzed the readability (ie, the ease of reading) of written consent forms and informational documents from phase 3 COVID-19 vaccine clinical trials in the United States from the following manufacturers: ","2021","07","08","Mayo Clin Proc","Mayo Clinic proceedings",NA,"Bothun","Luke S","Mayo Vaccine Research Group, Mayo Clinic, Rochester, MN",NA
"1275","34226027","10.1016/j.mayocp.2021.05.025","Readability of Participant Informed Consent Forms and Informational Documents: From Phase 3 COVID-19 Vaccine Clinical Trials in the United States.","To assess the readability of the informed consent forms from the phase 3 COVID-19 vaccine trials conducted in the United States. English consent forms were used for patients in phase 3 COVID-19 vaccine clinical trials. Consent forms were obtained in October 2020. Using Microsoft Word tools, we analyzed the readability (ie, the ease of reading) of written consent forms and informational documents from phase 3 COVID-19 vaccine clinical trials in the United States from the following manufacturers: ","2021","07","08","Mayo Clin Proc","Mayo Clinic proceedings",NA,"Feeder","Scott E","Mayo Vaccine Research Group, Mayo Clinic, Rochester, MN",NA
"1276","34226027","10.1016/j.mayocp.2021.05.025","Readability of Participant Informed Consent Forms and Informational Documents: From Phase 3 COVID-19 Vaccine Clinical Trials in the United States.","To assess the readability of the informed consent forms from the phase 3 COVID-19 vaccine trials conducted in the United States. English consent forms were used for patients in phase 3 COVID-19 vaccine clinical trials. Consent forms were obtained in October 2020. Using Microsoft Word tools, we analyzed the readability (ie, the ease of reading) of written consent forms and informational documents from phase 3 COVID-19 vaccine clinical trials in the United States from the following manufacturers: ","2021","07","08","Mayo Clin Proc","Mayo Clinic proceedings",NA,"Poland","Gregory A","Mayo Vaccine Research Group, Mayo Clinic, Rochester, MN. Electronic address: poland.gregory@mayo","poland.gregory@mayo.edu"
"1277","34225817","10.1186/s43058-021-00178-x","Adapting coordinated specialty care in the post-COVID-19 era: study protocol for an integrative mixed-methods study.","Coordinated Specialty Care (CSC) programs provide evidence-based services for young people with a recent onset of a psychotic disorder. OnTrackNY is a nationally recognized model of CSC treatment in New York state. In 2019, OnTrackNY was awarded a hub within the Early Psychosis Intervention Network (EPINET) to advance its learning health care system (LHS). The OnTrackNY network is comprised of 23 CSC teams across New York state. OnTrack Central, an intermediary organization, provides training an","2021","07","13","Implement Sci Commun","Implementation science communications","COVID-19; Coordinated specialty care; Early psychosis; Fidelity; First episode psychosis; Framework for reporting adaptations and modification-enhanced; Learning healthcare system; Specialized treatment; Telehealth; Youth and young adults","Patel","Sapana R","New York State Psychiatric Institute, 1051 Riverside Drive, Unit 100, New York, NY, 10032, USA. Sapana.Patel@nyspi.columbia","Sapana.Patel@nyspi.columbia.edu"
"1278","34225817","10.1186/s43058-021-00178-x","Adapting coordinated specialty care in the post-COVID-19 era: study protocol for an integrative mixed-methods study.","Coordinated Specialty Care (CSC) programs provide evidence-based services for young people with a recent onset of a psychotic disorder. OnTrackNY is a nationally recognized model of CSC treatment in New York state. In 2019, OnTrackNY was awarded a hub within the Early Psychosis Intervention Network (EPINET) to advance its learning health care system (LHS). The OnTrackNY network is comprised of 23 CSC teams across New York state. OnTrack Central, an intermediary organization, provides training an","2021","07","13","Implement Sci Commun","Implementation science communications","COVID-19; Coordinated specialty care; Early psychosis; Fidelity; First episode psychosis; Framework for reporting adaptations and modification-enhanced; Learning healthcare system; Specialized treatment; Telehealth; Youth and young adults","Bello","Iruma","New York State Psychiatric Institute, 1051 Riverside Drive, Unit 100, New York, NY, 10032, USA",NA
"1279","34225817","10.1186/s43058-021-00178-x","Adapting coordinated specialty care in the post-COVID-19 era: study protocol for an integrative mixed-methods study.","Coordinated Specialty Care (CSC) programs provide evidence-based services for young people with a recent onset of a psychotic disorder. OnTrackNY is a nationally recognized model of CSC treatment in New York state. In 2019, OnTrackNY was awarded a hub within the Early Psychosis Intervention Network (EPINET) to advance its learning health care system (LHS). The OnTrackNY network is comprised of 23 CSC teams across New York state. OnTrack Central, an intermediary organization, provides training an","2021","07","13","Implement Sci Commun","Implementation science communications","COVID-19; Coordinated specialty care; Early psychosis; Fidelity; First episode psychosis; Framework for reporting adaptations and modification-enhanced; Learning healthcare system; Specialized treatment; Telehealth; Youth and young adults","Cabassa","Leopoldo J","Brown School of Social Work at Washington University in St. Louis, St. Louis, MO, 63130, USA",NA
"1280","34225817","10.1186/s43058-021-00178-x","Adapting coordinated specialty care in the post-COVID-19 era: study protocol for an integrative mixed-methods study.","Coordinated Specialty Care (CSC) programs provide evidence-based services for young people with a recent onset of a psychotic disorder. OnTrackNY is a nationally recognized model of CSC treatment in New York state. In 2019, OnTrackNY was awarded a hub within the Early Psychosis Intervention Network (EPINET) to advance its learning health care system (LHS). The OnTrackNY network is comprised of 23 CSC teams across New York state. OnTrack Central, an intermediary organization, provides training an","2021","07","13","Implement Sci Commun","Implementation science communications","COVID-19; Coordinated specialty care; Early psychosis; Fidelity; First episode psychosis; Framework for reporting adaptations and modification-enhanced; Learning healthcare system; Specialized treatment; Telehealth; Youth and young adults","Nossel","Ilana R","New York State Psychiatric Institute, 1051 Riverside Drive, Unit 100, New York, NY, 10032, USA",NA
"1281","34225817","10.1186/s43058-021-00178-x","Adapting coordinated specialty care in the post-COVID-19 era: study protocol for an integrative mixed-methods study.","Coordinated Specialty Care (CSC) programs provide evidence-based services for young people with a recent onset of a psychotic disorder. OnTrackNY is a nationally recognized model of CSC treatment in New York state. In 2019, OnTrackNY was awarded a hub within the Early Psychosis Intervention Network (EPINET) to advance its learning health care system (LHS). The OnTrackNY network is comprised of 23 CSC teams across New York state. OnTrack Central, an intermediary organization, provides training an","2021","07","13","Implement Sci Commun","Implementation science communications","COVID-19; Coordinated specialty care; Early psychosis; Fidelity; First episode psychosis; Framework for reporting adaptations and modification-enhanced; Learning healthcare system; Specialized treatment; Telehealth; Youth and young adults","Wall","Melanie M","Columbia University Vagelos College of Physicians and Surgeons, 630 W 168th St, New York, NY, 10032, USA",NA
"1282","34225817","10.1186/s43058-021-00178-x","Adapting coordinated specialty care in the post-COVID-19 era: study protocol for an integrative mixed-methods study.","Coordinated Specialty Care (CSC) programs provide evidence-based services for young people with a recent onset of a psychotic disorder. OnTrackNY is a nationally recognized model of CSC treatment in New York state. In 2019, OnTrackNY was awarded a hub within the Early Psychosis Intervention Network (EPINET) to advance its learning health care system (LHS). The OnTrackNY network is comprised of 23 CSC teams across New York state. OnTrack Central, an intermediary organization, provides training an","2021","07","13","Implement Sci Commun","Implementation science communications","COVID-19; Coordinated specialty care; Early psychosis; Fidelity; First episode psychosis; Framework for reporting adaptations and modification-enhanced; Learning healthcare system; Specialized treatment; Telehealth; Youth and young adults","Montague","Elaina","New York State Psychiatric Institute, 1051 Riverside Drive, Unit 100, New York, NY, 10032, USA",NA
"1283","34225817","10.1186/s43058-021-00178-x","Adapting coordinated specialty care in the post-COVID-19 era: study protocol for an integrative mixed-methods study.","Coordinated Specialty Care (CSC) programs provide evidence-based services for young people with a recent onset of a psychotic disorder. OnTrackNY is a nationally recognized model of CSC treatment in New York state. In 2019, OnTrackNY was awarded a hub within the Early Psychosis Intervention Network (EPINET) to advance its learning health care system (LHS). The OnTrackNY network is comprised of 23 CSC teams across New York state. OnTrack Central, an intermediary organization, provides training an","2021","07","13","Implement Sci Commun","Implementation science communications","COVID-19; Coordinated specialty care; Early psychosis; Fidelity; First episode psychosis; Framework for reporting adaptations and modification-enhanced; Learning healthcare system; Specialized treatment; Telehealth; Youth and young adults","Rahim","Reanne","New York State Psychiatric Institute, 1051 Riverside Drive, Unit 100, New York, NY, 10032, USA",NA
"1284","34225817","10.1186/s43058-021-00178-x","Adapting coordinated specialty care in the post-COVID-19 era: study protocol for an integrative mixed-methods study.","Coordinated Specialty Care (CSC) programs provide evidence-based services for young people with a recent onset of a psychotic disorder. OnTrackNY is a nationally recognized model of CSC treatment in New York state. In 2019, OnTrackNY was awarded a hub within the Early Psychosis Intervention Network (EPINET) to advance its learning health care system (LHS). The OnTrackNY network is comprised of 23 CSC teams across New York state. OnTrack Central, an intermediary organization, provides training an","2021","07","13","Implement Sci Commun","Implementation science communications","COVID-19; Coordinated specialty care; Early psychosis; Fidelity; First episode psychosis; Framework for reporting adaptations and modification-enhanced; Learning healthcare system; Specialized treatment; Telehealth; Youth and young adults","Mathai","Chacku M","New York State Psychiatric Institute, 1051 Riverside Drive, Unit 100, New York, NY, 10032, USA",NA
"1285","34225817","10.1186/s43058-021-00178-x","Adapting coordinated specialty care in the post-COVID-19 era: study protocol for an integrative mixed-methods study.","Coordinated Specialty Care (CSC) programs provide evidence-based services for young people with a recent onset of a psychotic disorder. OnTrackNY is a nationally recognized model of CSC treatment in New York state. In 2019, OnTrackNY was awarded a hub within the Early Psychosis Intervention Network (EPINET) to advance its learning health care system (LHS). The OnTrackNY network is comprised of 23 CSC teams across New York state. OnTrack Central, an intermediary organization, provides training an","2021","07","13","Implement Sci Commun","Implementation science communications","COVID-19; Coordinated specialty care; Early psychosis; Fidelity; First episode psychosis; Framework for reporting adaptations and modification-enhanced; Learning healthcare system; Specialized treatment; Telehealth; Youth and young adults","Dixon","Lisa B","New York State Psychiatric Institute, 1051 Riverside Drive, Unit 100, New York, NY, 10032, USA",NA
"1286","34225801","10.1186/s13690-021-00651-y","Levels of physical activity in four domains and affective wellbeing before and during the Covid-19 pandemic.","Latest studies indicated that the general mental health level is low during the pandemic. Probably, this deterioration of the mental health situation is partly due to declines in physical activity. The aim of this study was to investigate differences in and the association between affective wellbeing and levels of different domains of physical activity at three time points before and during the pandemic. We used a nationwide online panel with a trend data design encompassing a total sample of N ","2021","07","09","Arch Public Health","Archives of public health = Archives belges de sante publique","Affective wellbeing; Covid-19 pandemic; Domains of physical activity; Gender; Trend data","Engels","Eliane S","Friedrich-Alexander-University Erlangen-Nuremberg, Gebbertstr. 123b, 91052, Erlangen, Germany. Eliane.Engels@fau","Eliane.Engels@fau.de"
"1287","34225801","10.1186/s13690-021-00651-y","Levels of physical activity in four domains and affective wellbeing before and during the Covid-19 pandemic.","Latest studies indicated that the general mental health level is low during the pandemic. Probably, this deterioration of the mental health situation is partly due to declines in physical activity. The aim of this study was to investigate differences in and the association between affective wellbeing and levels of different domains of physical activity at three time points before and during the pandemic. We used a nationwide online panel with a trend data design encompassing a total sample of N ","2021","07","09","Arch Public Health","Archives of public health = Archives belges de sante publique","Affective wellbeing; Covid-19 pandemic; Domains of physical activity; Gender; Trend data","Mutz","Michael","Justus-Liebig-University Giessen, Kugelberg 62, 35394, Giessen, Germany",NA
"1288","34225801","10.1186/s13690-021-00651-y","Levels of physical activity in four domains and affective wellbeing before and during the Covid-19 pandemic.","Latest studies indicated that the general mental health level is low during the pandemic. Probably, this deterioration of the mental health situation is partly due to declines in physical activity. The aim of this study was to investigate differences in and the association between affective wellbeing and levels of different domains of physical activity at three time points before and during the pandemic. We used a nationwide online panel with a trend data design encompassing a total sample of N ","2021","07","09","Arch Public Health","Archives of public health = Archives belges de sante publique","Affective wellbeing; Covid-19 pandemic; Domains of physical activity; Gender; Trend data","Demetriou","Yolanda","Technical University of Munich, Georg-Brauchle-Ring 60/62, 80992, Munich, Germany",NA
"1289","34225801","10.1186/s13690-021-00651-y","Levels of physical activity in four domains and affective wellbeing before and during the Covid-19 pandemic.","Latest studies indicated that the general mental health level is low during the pandemic. Probably, this deterioration of the mental health situation is partly due to declines in physical activity. The aim of this study was to investigate differences in and the association between affective wellbeing and levels of different domains of physical activity at three time points before and during the pandemic. We used a nationwide online panel with a trend data design encompassing a total sample of N ","2021","07","09","Arch Public Health","Archives of public health = Archives belges de sante publique","Affective wellbeing; Covid-19 pandemic; Domains of physical activity; Gender; Trend data","Reimers","Anne K","Friedrich-Alexander-University Erlangen-Nuremberg, Gebbertstr. 123b, 91052, Erlangen, Germany",NA
"1290","34225798","10.1186/s40621-021-00339-5","Firearm purchasing and firearm violence during the coronavirus pandemic in the United States: a cross-sectional study.","Firearm violence is a significant public health problem in the United States. A surge in firearm purchasing following the onset of the coronavirus pandemic may have contributed to an increase in firearm violence. We sought to estimate the state-level association between firearm purchasing and interpersonal firearm violence during the pandemic. Cross-sectional study of the 48 contiguous states and the District of Columbia from January 2018 through July 2020. Data were obtained from the National I","2021","07","09","Inj Epidemiol","Injury epidemiology","COVID-19; Coronavirus; Domestic violence; Firearm; Gun; Violence","Schleimer","Julia P","Violence Prevention Research Program, Department of Emergency Medicine, University of California, Davis, Sacramento, CA, USA. jpschleimer@ucdavis","jpschleimer@ucdavis.edu"
"1291","34225798","10.1186/s40621-021-00339-5","Firearm purchasing and firearm violence during the coronavirus pandemic in the United States: a cross-sectional study.","Firearm violence is a significant public health problem in the United States. A surge in firearm purchasing following the onset of the coronavirus pandemic may have contributed to an increase in firearm violence. We sought to estimate the state-level association between firearm purchasing and interpersonal firearm violence during the pandemic. Cross-sectional study of the 48 contiguous states and the District of Columbia from January 2018 through July 2020. Data were obtained from the National I","2021","07","09","Inj Epidemiol","Injury epidemiology","COVID-19; Coronavirus; Domestic violence; Firearm; Gun; Violence","McCort","Christopher D","Violence Prevention Research Program, Department of Emergency Medicine, University of California, Davis, Sacramento, CA, USA",NA
"1292","34225798","10.1186/s40621-021-00339-5","Firearm purchasing and firearm violence during the coronavirus pandemic in the United States: a cross-sectional study.","Firearm violence is a significant public health problem in the United States. A surge in firearm purchasing following the onset of the coronavirus pandemic may have contributed to an increase in firearm violence. We sought to estimate the state-level association between firearm purchasing and interpersonal firearm violence during the pandemic. Cross-sectional study of the 48 contiguous states and the District of Columbia from January 2018 through July 2020. Data were obtained from the National I","2021","07","09","Inj Epidemiol","Injury epidemiology","COVID-19; Coronavirus; Domestic violence; Firearm; Gun; Violence","Shev","Aaron B","Violence Prevention Research Program, Department of Emergency Medicine, University of California, Davis, Sacramento, CA, USA",NA
"1293","34225798","10.1186/s40621-021-00339-5","Firearm purchasing and firearm violence during the coronavirus pandemic in the United States: a cross-sectional study.","Firearm violence is a significant public health problem in the United States. A surge in firearm purchasing following the onset of the coronavirus pandemic may have contributed to an increase in firearm violence. We sought to estimate the state-level association between firearm purchasing and interpersonal firearm violence during the pandemic. Cross-sectional study of the 48 contiguous states and the District of Columbia from January 2018 through July 2020. Data were obtained from the National I","2021","07","09","Inj Epidemiol","Injury epidemiology","COVID-19; Coronavirus; Domestic violence; Firearm; Gun; Violence","Pear","Veronica A","Violence Prevention Research Program, Department of Emergency Medicine, University of California, Davis, Sacramento, CA, USA",NA
"1294","34225798","10.1186/s40621-021-00339-5","Firearm purchasing and firearm violence during the coronavirus pandemic in the United States: a cross-sectional study.","Firearm violence is a significant public health problem in the United States. A surge in firearm purchasing following the onset of the coronavirus pandemic may have contributed to an increase in firearm violence. We sought to estimate the state-level association between firearm purchasing and interpersonal firearm violence during the pandemic. Cross-sectional study of the 48 contiguous states and the District of Columbia from January 2018 through July 2020. Data were obtained from the National I","2021","07","09","Inj Epidemiol","Injury epidemiology","COVID-19; Coronavirus; Domestic violence; Firearm; Gun; Violence","Tomsich","Elizabeth","Violence Prevention Research Program, Department of Emergency Medicine, University of California, Davis, Sacramento, CA, USA",NA
"1295","34225798","10.1186/s40621-021-00339-5","Firearm purchasing and firearm violence during the coronavirus pandemic in the United States: a cross-sectional study.","Firearm violence is a significant public health problem in the United States. A surge in firearm purchasing following the onset of the coronavirus pandemic may have contributed to an increase in firearm violence. We sought to estimate the state-level association between firearm purchasing and interpersonal firearm violence during the pandemic. Cross-sectional study of the 48 contiguous states and the District of Columbia from January 2018 through July 2020. Data were obtained from the National I","2021","07","09","Inj Epidemiol","Injury epidemiology","COVID-19; Coronavirus; Domestic violence; Firearm; Gun; Violence","De Biasi","Alaina","Violence Prevention Research Program, Department of Emergency Medicine, University of California, Davis, Sacramento, CA, USA",NA
"1296","34225798","10.1186/s40621-021-00339-5","Firearm purchasing and firearm violence during the coronavirus pandemic in the United States: a cross-sectional study.","Firearm violence is a significant public health problem in the United States. A surge in firearm purchasing following the onset of the coronavirus pandemic may have contributed to an increase in firearm violence. We sought to estimate the state-level association between firearm purchasing and interpersonal firearm violence during the pandemic. Cross-sectional study of the 48 contiguous states and the District of Columbia from January 2018 through July 2020. Data were obtained from the National I","2021","07","09","Inj Epidemiol","Injury epidemiology","COVID-19; Coronavirus; Domestic violence; Firearm; Gun; Violence","Buggs","Shani","Violence Prevention Research Program, Department of Emergency Medicine, University of California, Davis, Sacramento, CA, USA",NA
"1297","34225798","10.1186/s40621-021-00339-5","Firearm purchasing and firearm violence during the coronavirus pandemic in the United States: a cross-sectional study.","Firearm violence is a significant public health problem in the United States. A surge in firearm purchasing following the onset of the coronavirus pandemic may have contributed to an increase in firearm violence. We sought to estimate the state-level association between firearm purchasing and interpersonal firearm violence during the pandemic. Cross-sectional study of the 48 contiguous states and the District of Columbia from January 2018 through July 2020. Data were obtained from the National I","2021","07","09","Inj Epidemiol","Injury epidemiology","COVID-19; Coronavirus; Domestic violence; Firearm; Gun; Violence","Laqueur","Hannah S","Violence Prevention Research Program, Department of Emergency Medicine, University of California, Davis, Sacramento, CA, USA",NA
"1298","34225798","10.1186/s40621-021-00339-5","Firearm purchasing and firearm violence during the coronavirus pandemic in the United States: a cross-sectional study.","Firearm violence is a significant public health problem in the United States. A surge in firearm purchasing following the onset of the coronavirus pandemic may have contributed to an increase in firearm violence. We sought to estimate the state-level association between firearm purchasing and interpersonal firearm violence during the pandemic. Cross-sectional study of the 48 contiguous states and the District of Columbia from January 2018 through July 2020. Data were obtained from the National I","2021","07","09","Inj Epidemiol","Injury epidemiology","COVID-19; Coronavirus; Domestic violence; Firearm; Gun; Violence","Wintemute","Garen J","Violence Prevention Research Program, Department of Emergency Medicine, University of California, Davis, Sacramento, CA, USA",NA
"1299","34225791","10.1186/s40249-021-00878-5","Safety of SARS-CoV-2 vaccines: a systematic review and meta-analysis of randomized controlled trials.","Various modalities of vaccines against coronavirus disease 2019 (COVID-19), based on different platforms and immunization procedures, have been successively approved for marketing worldwide. A comprehensive review for clinical trials assessing the safety of COVID-19 vaccines is urgently needed to make an accurate judgment for mass vaccination. A systematic review and meta-analysis was conducted to determine the safety of COVID-19 vaccine candidates in randomized controlled trials (RCTs). Data se","2021","07","09","Infect Dis Poverty","Infectious diseases of poverty","Adverse events following immunization; COVID-19 vaccine; Meta-analysis; Randomized controlled trial; Safety; Adolescent; Adult; Aged; Aged, 80 and over; COVID-19; COVID-19 Vaccines; Female; Humans; Male; Middle Aged; Randomized Controlled Trials as Topic; Young Adult","Chen","Musha","School of Public Health (Shenzhen), Sun Yat-Sen University, Shenzhen, China",NA
"1300","34225791","10.1186/s40249-021-00878-5","Safety of SARS-CoV-2 vaccines: a systematic review and meta-analysis of randomized controlled trials.","Various modalities of vaccines against coronavirus disease 2019 (COVID-19), based on different platforms and immunization procedures, have been successively approved for marketing worldwide. A comprehensive review for clinical trials assessing the safety of COVID-19 vaccines is urgently needed to make an accurate judgment for mass vaccination. A systematic review and meta-analysis was conducted to determine the safety of COVID-19 vaccine candidates in randomized controlled trials (RCTs). Data se","2021","07","09","Infect Dis Poverty","Infectious diseases of poverty","Adverse events following immunization; COVID-19 vaccine; Meta-analysis; Randomized controlled trial; Safety; Adolescent; Adult; Aged; Aged, 80 and over; COVID-19; COVID-19 Vaccines; Female; Humans; Male; Middle Aged; Randomized Controlled Trials as Topic; Young Adult","Yuan","Yue","School of Public Health (Shenzhen), Sun Yat-Sen University, Shenzhen, China",NA
"1301","34225791","10.1186/s40249-021-00878-5","Safety of SARS-CoV-2 vaccines: a systematic review and meta-analysis of randomized controlled trials.","Various modalities of vaccines against coronavirus disease 2019 (COVID-19), based on different platforms and immunization procedures, have been successively approved for marketing worldwide. A comprehensive review for clinical trials assessing the safety of COVID-19 vaccines is urgently needed to make an accurate judgment for mass vaccination. A systematic review and meta-analysis was conducted to determine the safety of COVID-19 vaccine candidates in randomized controlled trials (RCTs). Data se","2021","07","09","Infect Dis Poverty","Infectious diseases of poverty","Adverse events following immunization; COVID-19 vaccine; Meta-analysis; Randomized controlled trial; Safety; Adolescent; Adult; Aged; Aged, 80 and over; COVID-19; COVID-19 Vaccines; Female; Humans; Male; Middle Aged; Randomized Controlled Trials as Topic; Young Adult","Zhou","Yiguo","School of Public Health (Shenzhen), Sun Yat-Sen University, Shenzhen, China",NA
"1302","34225791","10.1186/s40249-021-00878-5","Safety of SARS-CoV-2 vaccines: a systematic review and meta-analysis of randomized controlled trials.","Various modalities of vaccines against coronavirus disease 2019 (COVID-19), based on different platforms and immunization procedures, have been successively approved for marketing worldwide. A comprehensive review for clinical trials assessing the safety of COVID-19 vaccines is urgently needed to make an accurate judgment for mass vaccination. A systematic review and meta-analysis was conducted to determine the safety of COVID-19 vaccine candidates in randomized controlled trials (RCTs). Data se","2021","07","09","Infect Dis Poverty","Infectious diseases of poverty","Adverse events following immunization; COVID-19 vaccine; Meta-analysis; Randomized controlled trial; Safety; Adolescent; Adult; Aged; Aged, 80 and over; COVID-19; COVID-19 Vaccines; Female; Humans; Male; Middle Aged; Randomized Controlled Trials as Topic; Young Adult","Deng","Zhaomin","School of Public Health (Shenzhen), Sun Yat-Sen University, Shenzhen, China",NA
"1303","34225791","10.1186/s40249-021-00878-5","Safety of SARS-CoV-2 vaccines: a systematic review and meta-analysis of randomized controlled trials.","Various modalities of vaccines against coronavirus disease 2019 (COVID-19), based on different platforms and immunization procedures, have been successively approved for marketing worldwide. A comprehensive review for clinical trials assessing the safety of COVID-19 vaccines is urgently needed to make an accurate judgment for mass vaccination. A systematic review and meta-analysis was conducted to determine the safety of COVID-19 vaccine candidates in randomized controlled trials (RCTs). Data se","2021","07","09","Infect Dis Poverty","Infectious diseases of poverty","Adverse events following immunization; COVID-19 vaccine; Meta-analysis; Randomized controlled trial; Safety; Adolescent; Adult; Aged; Aged, 80 and over; COVID-19; COVID-19 Vaccines; Female; Humans; Male; Middle Aged; Randomized Controlled Trials as Topic; Young Adult","Zhao","Jin","School of Public Health (Shenzhen), Sun Yat-Sen University, Shenzhen, China",NA
"1304","34225791","10.1186/s40249-021-00878-5","Safety of SARS-CoV-2 vaccines: a systematic review and meta-analysis of randomized controlled trials.","Various modalities of vaccines against coronavirus disease 2019 (COVID-19), based on different platforms and immunization procedures, have been successively approved for marketing worldwide. A comprehensive review for clinical trials assessing the safety of COVID-19 vaccines is urgently needed to make an accurate judgment for mass vaccination. A systematic review and meta-analysis was conducted to determine the safety of COVID-19 vaccine candidates in randomized controlled trials (RCTs). Data se","2021","07","09","Infect Dis Poverty","Infectious diseases of poverty","Adverse events following immunization; COVID-19 vaccine; Meta-analysis; Randomized controlled trial; Safety; Adolescent; Adult; Aged; Aged, 80 and over; COVID-19; COVID-19 Vaccines; Female; Humans; Male; Middle Aged; Randomized Controlled Trials as Topic; Young Adult","Feng","Fengling","School of Public Health (Shenzhen), Sun Yat-Sen University, Shenzhen, China",NA
"1305","34225791","10.1186/s40249-021-00878-5","Safety of SARS-CoV-2 vaccines: a systematic review and meta-analysis of randomized controlled trials.","Various modalities of vaccines against coronavirus disease 2019 (COVID-19), based on different platforms and immunization procedures, have been successively approved for marketing worldwide. A comprehensive review for clinical trials assessing the safety of COVID-19 vaccines is urgently needed to make an accurate judgment for mass vaccination. A systematic review and meta-analysis was conducted to determine the safety of COVID-19 vaccine candidates in randomized controlled trials (RCTs). Data se","2021","07","09","Infect Dis Poverty","Infectious diseases of poverty","Adverse events following immunization; COVID-19 vaccine; Meta-analysis; Randomized controlled trial; Safety; Adolescent; Adult; Aged; Aged, 80 and over; COVID-19; COVID-19 Vaccines; Female; Humans; Male; Middle Aged; Randomized Controlled Trials as Topic; Young Adult","Zou","Huachun","School of Public Health (Shenzhen), Sun Yat-Sen University, Shenzhen, China. zouhuachun@mail.sysu.edu","zouhuachun@mail.sysu.edu.cn"
"1306","34225791","10.1186/s40249-021-00878-5","Safety of SARS-CoV-2 vaccines: a systematic review and meta-analysis of randomized controlled trials.","Various modalities of vaccines against coronavirus disease 2019 (COVID-19), based on different platforms and immunization procedures, have been successively approved for marketing worldwide. A comprehensive review for clinical trials assessing the safety of COVID-19 vaccines is urgently needed to make an accurate judgment for mass vaccination. A systematic review and meta-analysis was conducted to determine the safety of COVID-19 vaccine candidates in randomized controlled trials (RCTs). Data se","2021","07","09","Infect Dis Poverty","Infectious diseases of poverty","Adverse events following immunization; COVID-19 vaccine; Meta-analysis; Randomized controlled trial; Safety; Adolescent; Adult; Aged; Aged, 80 and over; COVID-19; COVID-19 Vaccines; Female; Humans; Male; Middle Aged; Randomized Controlled Trials as Topic; Young Adult","Sun","Caijun","School of Public Health (Shenzhen), Sun Yat-Sen University, Shenzhen, China. suncaijun@mail.sysu.edu","suncaijun@mail.sysu.edu.cn"
"1307","34225789","10.1186/s13063-021-05389-0","Hormonal intervention for the treatment of veterans with COVID-19 requiring hospitalization (HITCH): a multicenter, phase 2 randomized controlled trial of best supportive care vs best supportive care plus degarelix: study protocol for a randomized controlled trial.","Therapeutic targeting of host-cell factors required for SARS-CoV-2 entry is an alternative strategy to ameliorate COVID-19 severity. SARS-CoV-2 entry into lung epithelium requires the TMPRSS2 cell surface protease. Pre-clinical and correlative data in humans suggest that anti-androgenic therapies can reduce the expression of TMPRSS2 on lung epithelium. Accordingly, we hypothesize that therapeutic targeting of androgen receptor signaling via degarelix, a luteinizing hormone-releasing hormone (LHR","2021","07","07","Trials","Trials","Androgen receptor; Androgen suppression; Anti-androgen; COVID-19; Coronavirus; Hormone therapy; SARS-CoV-2; TMPRSS2; COVID-19; Clinical Trials, Phase II as Topic; Hospitalization; Humans; Male; Multicenter Studies as Topic; Oligopeptides; Randomized Controlled Trials as Topic; SARS-CoV-2; Treatment Outcome; Veterans","Nickols","Nicholas G","Radiation Oncology Service, VA Greater Los Angeles Healthcare System, Los Angeles, CA, 90073, USA",NA
"1308","34225789","10.1186/s13063-021-05389-0","Hormonal intervention for the treatment of veterans with COVID-19 requiring hospitalization (HITCH): a multicenter, phase 2 randomized controlled trial of best supportive care vs best supportive care plus degarelix: study protocol for a randomized controlled trial.","Therapeutic targeting of host-cell factors required for SARS-CoV-2 entry is an alternative strategy to ameliorate COVID-19 severity. SARS-CoV-2 entry into lung epithelium requires the TMPRSS2 cell surface protease. Pre-clinical and correlative data in humans suggest that anti-androgenic therapies can reduce the expression of TMPRSS2 on lung epithelium. Accordingly, we hypothesize that therapeutic targeting of androgen receptor signaling via degarelix, a luteinizing hormone-releasing hormone (LHR","2021","07","07","Trials","Trials","Androgen receptor; Androgen suppression; Anti-androgen; COVID-19; Coronavirus; Hormone therapy; SARS-CoV-2; TMPRSS2; COVID-19; Clinical Trials, Phase II as Topic; Hospitalization; Humans; Male; Multicenter Studies as Topic; Oligopeptides; Randomized Controlled Trials as Topic; SARS-CoV-2; Treatment Outcome; Veterans","Goetz","Matthew B","Infectious Diseases Section, VA Greater Los Angeles Healthcare System, Los Angeles, CA, 90073, USA",NA
"1309","34225789","10.1186/s13063-021-05389-0","Hormonal intervention for the treatment of veterans with COVID-19 requiring hospitalization (HITCH): a multicenter, phase 2 randomized controlled trial of best supportive care vs best supportive care plus degarelix: study protocol for a randomized controlled trial.","Therapeutic targeting of host-cell factors required for SARS-CoV-2 entry is an alternative strategy to ameliorate COVID-19 severity. SARS-CoV-2 entry into lung epithelium requires the TMPRSS2 cell surface protease. Pre-clinical and correlative data in humans suggest that anti-androgenic therapies can reduce the expression of TMPRSS2 on lung epithelium. Accordingly, we hypothesize that therapeutic targeting of androgen receptor signaling via degarelix, a luteinizing hormone-releasing hormone (LHR","2021","07","07","Trials","Trials","Androgen receptor; Androgen suppression; Anti-androgen; COVID-19; Coronavirus; Hormone therapy; SARS-CoV-2; TMPRSS2; COVID-19; Clinical Trials, Phase II as Topic; Hospitalization; Humans; Male; Multicenter Studies as Topic; Oligopeptides; Randomized Controlled Trials as Topic; SARS-CoV-2; Treatment Outcome; Veterans","Graber","Christopher J","Infectious Diseases Section, VA Greater Los Angeles Healthcare System, Los Angeles, CA, 90073, USA",NA
"1310","34225789","10.1186/s13063-021-05389-0","Hormonal intervention for the treatment of veterans with COVID-19 requiring hospitalization (HITCH): a multicenter, phase 2 randomized controlled trial of best supportive care vs best supportive care plus degarelix: study protocol for a randomized controlled trial.","Therapeutic targeting of host-cell factors required for SARS-CoV-2 entry is an alternative strategy to ameliorate COVID-19 severity. SARS-CoV-2 entry into lung epithelium requires the TMPRSS2 cell surface protease. Pre-clinical and correlative data in humans suggest that anti-androgenic therapies can reduce the expression of TMPRSS2 on lung epithelium. Accordingly, we hypothesize that therapeutic targeting of androgen receptor signaling via degarelix, a luteinizing hormone-releasing hormone (LHR","2021","07","07","Trials","Trials","Androgen receptor; Androgen suppression; Anti-androgen; COVID-19; Coronavirus; Hormone therapy; SARS-CoV-2; TMPRSS2; COVID-19; Clinical Trials, Phase II as Topic; Hospitalization; Humans; Male; Multicenter Studies as Topic; Oligopeptides; Randomized Controlled Trials as Topic; SARS-CoV-2; Treatment Outcome; Veterans","Bhattacharya","Debika","Infectious Diseases Section, VA Greater Los Angeles Healthcare System, Los Angeles, CA, 90073, USA",NA
"1311","34225789","10.1186/s13063-021-05389-0","Hormonal intervention for the treatment of veterans with COVID-19 requiring hospitalization (HITCH): a multicenter, phase 2 randomized controlled trial of best supportive care vs best supportive care plus degarelix: study protocol for a randomized controlled trial.","Therapeutic targeting of host-cell factors required for SARS-CoV-2 entry is an alternative strategy to ameliorate COVID-19 severity. SARS-CoV-2 entry into lung epithelium requires the TMPRSS2 cell surface protease. Pre-clinical and correlative data in humans suggest that anti-androgenic therapies can reduce the expression of TMPRSS2 on lung epithelium. Accordingly, we hypothesize that therapeutic targeting of androgen receptor signaling via degarelix, a luteinizing hormone-releasing hormone (LHR","2021","07","07","Trials","Trials","Androgen receptor; Androgen suppression; Anti-androgen; COVID-19; Coronavirus; Hormone therapy; SARS-CoV-2; TMPRSS2; COVID-19; Clinical Trials, Phase II as Topic; Hospitalization; Humans; Male; Multicenter Studies as Topic; Oligopeptides; Randomized Controlled Trials as Topic; SARS-CoV-2; Treatment Outcome; Veterans","Soo Hoo","Guy","Division of Pulmonary and Critical Care, VA Greater Los Angeles Healthcare System, Los Angeles, CA, 90073, USA",NA
"1312","34225789","10.1186/s13063-021-05389-0","Hormonal intervention for the treatment of veterans with COVID-19 requiring hospitalization (HITCH): a multicenter, phase 2 randomized controlled trial of best supportive care vs best supportive care plus degarelix: study protocol for a randomized controlled trial.","Therapeutic targeting of host-cell factors required for SARS-CoV-2 entry is an alternative strategy to ameliorate COVID-19 severity. SARS-CoV-2 entry into lung epithelium requires the TMPRSS2 cell surface protease. Pre-clinical and correlative data in humans suggest that anti-androgenic therapies can reduce the expression of TMPRSS2 on lung epithelium. Accordingly, we hypothesize that therapeutic targeting of androgen receptor signaling via degarelix, a luteinizing hormone-releasing hormone (LHR","2021","07","07","Trials","Trials","Androgen receptor; Androgen suppression; Anti-androgen; COVID-19; Coronavirus; Hormone therapy; SARS-CoV-2; TMPRSS2; COVID-19; Clinical Trials, Phase II as Topic; Hospitalization; Humans; Male; Multicenter Studies as Topic; Oligopeptides; Randomized Controlled Trials as Topic; SARS-CoV-2; Treatment Outcome; Veterans","Might","Matthew","Hugh Kaul Precision Medicine Institute, University of Alabama at Birmingham, Birmingham, USA",NA
"1313","34225789","10.1186/s13063-021-05389-0","Hormonal intervention for the treatment of veterans with COVID-19 requiring hospitalization (HITCH): a multicenter, phase 2 randomized controlled trial of best supportive care vs best supportive care plus degarelix: study protocol for a randomized controlled trial.","Therapeutic targeting of host-cell factors required for SARS-CoV-2 entry is an alternative strategy to ameliorate COVID-19 severity. SARS-CoV-2 entry into lung epithelium requires the TMPRSS2 cell surface protease. Pre-clinical and correlative data in humans suggest that anti-androgenic therapies can reduce the expression of TMPRSS2 on lung epithelium. Accordingly, we hypothesize that therapeutic targeting of androgen receptor signaling via degarelix, a luteinizing hormone-releasing hormone (LHR","2021","07","07","Trials","Trials","Androgen receptor; Androgen suppression; Anti-androgen; COVID-19; Coronavirus; Hormone therapy; SARS-CoV-2; TMPRSS2; COVID-19; Clinical Trials, Phase II as Topic; Hospitalization; Humans; Male; Multicenter Studies as Topic; Oligopeptides; Randomized Controlled Trials as Topic; SARS-CoV-2; Treatment Outcome; Veterans","Goldstein","David B","Institute of Genomic Medicine, Columbia University Irving Medical Center, New York, USA",NA
"1314","34225789","10.1186/s13063-021-05389-0","Hormonal intervention for the treatment of veterans with COVID-19 requiring hospitalization (HITCH): a multicenter, phase 2 randomized controlled trial of best supportive care vs best supportive care plus degarelix: study protocol for a randomized controlled trial.","Therapeutic targeting of host-cell factors required for SARS-CoV-2 entry is an alternative strategy to ameliorate COVID-19 severity. SARS-CoV-2 entry into lung epithelium requires the TMPRSS2 cell surface protease. Pre-clinical and correlative data in humans suggest that anti-androgenic therapies can reduce the expression of TMPRSS2 on lung epithelium. Accordingly, we hypothesize that therapeutic targeting of androgen receptor signaling via degarelix, a luteinizing hormone-releasing hormone (LHR","2021","07","07","Trials","Trials","Androgen receptor; Androgen suppression; Anti-androgen; COVID-19; Coronavirus; Hormone therapy; SARS-CoV-2; TMPRSS2; COVID-19; Clinical Trials, Phase II as Topic; Hospitalization; Humans; Male; Multicenter Studies as Topic; Oligopeptides; Randomized Controlled Trials as Topic; SARS-CoV-2; Treatment Outcome; Veterans","Wang","Xinchen","Institute of Genomic Medicine, Columbia University Irving Medical Center, New York, USA",NA
"1315","34225789","10.1186/s13063-021-05389-0","Hormonal intervention for the treatment of veterans with COVID-19 requiring hospitalization (HITCH): a multicenter, phase 2 randomized controlled trial of best supportive care vs best supportive care plus degarelix: study protocol for a randomized controlled trial.","Therapeutic targeting of host-cell factors required for SARS-CoV-2 entry is an alternative strategy to ameliorate COVID-19 severity. SARS-CoV-2 entry into lung epithelium requires the TMPRSS2 cell surface protease. Pre-clinical and correlative data in humans suggest that anti-androgenic therapies can reduce the expression of TMPRSS2 on lung epithelium. Accordingly, we hypothesize that therapeutic targeting of androgen receptor signaling via degarelix, a luteinizing hormone-releasing hormone (LHR","2021","07","07","Trials","Trials","Androgen receptor; Androgen suppression; Anti-androgen; COVID-19; Coronavirus; Hormone therapy; SARS-CoV-2; TMPRSS2; COVID-19; Clinical Trials, Phase II as Topic; Hospitalization; Humans; Male; Multicenter Studies as Topic; Oligopeptides; Randomized Controlled Trials as Topic; SARS-CoV-2; Treatment Outcome; Veterans","Ramoni","Rachel","Office of Research and Development, Veterans Health Administration, Washington, D.C., USA",NA
"1316","34225789","10.1186/s13063-021-05389-0","Hormonal intervention for the treatment of veterans with COVID-19 requiring hospitalization (HITCH): a multicenter, phase 2 randomized controlled trial of best supportive care vs best supportive care plus degarelix: study protocol for a randomized controlled trial.","Therapeutic targeting of host-cell factors required for SARS-CoV-2 entry is an alternative strategy to ameliorate COVID-19 severity. SARS-CoV-2 entry into lung epithelium requires the TMPRSS2 cell surface protease. Pre-clinical and correlative data in humans suggest that anti-androgenic therapies can reduce the expression of TMPRSS2 on lung epithelium. Accordingly, we hypothesize that therapeutic targeting of androgen receptor signaling via degarelix, a luteinizing hormone-releasing hormone (LHR","2021","07","07","Trials","Trials","Androgen receptor; Androgen suppression; Anti-androgen; COVID-19; Coronavirus; Hormone therapy; SARS-CoV-2; TMPRSS2; COVID-19; Clinical Trials, Phase II as Topic; Hospitalization; Humans; Male; Multicenter Studies as Topic; Oligopeptides; Randomized Controlled Trials as Topic; SARS-CoV-2; Treatment Outcome; Veterans","Myrie","Kenute","Office of Research and Development, Veterans Health Administration, Washington, D.C., USA",NA
"1317","34225789","10.1186/s13063-021-05389-0","Hormonal intervention for the treatment of veterans with COVID-19 requiring hospitalization (HITCH): a multicenter, phase 2 randomized controlled trial of best supportive care vs best supportive care plus degarelix: study protocol for a randomized controlled trial.","Therapeutic targeting of host-cell factors required for SARS-CoV-2 entry is an alternative strategy to ameliorate COVID-19 severity. SARS-CoV-2 entry into lung epithelium requires the TMPRSS2 cell surface protease. Pre-clinical and correlative data in humans suggest that anti-androgenic therapies can reduce the expression of TMPRSS2 on lung epithelium. Accordingly, we hypothesize that therapeutic targeting of androgen receptor signaling via degarelix, a luteinizing hormone-releasing hormone (LHR","2021","07","07","Trials","Trials","Androgen receptor; Androgen suppression; Anti-androgen; COVID-19; Coronavirus; Hormone therapy; SARS-CoV-2; TMPRSS2; COVID-19; Clinical Trials, Phase II as Topic; Hospitalization; Humans; Male; Multicenter Studies as Topic; Oligopeptides; Randomized Controlled Trials as Topic; SARS-CoV-2; Treatment Outcome; Veterans","Tran","Samantha","Division of Hematology-Oncology, VA Greater Los Angeles Healthcare System, Los Angeles, CA, 90073, USA",NA
"1318","34225789","10.1186/s13063-021-05389-0","Hormonal intervention for the treatment of veterans with COVID-19 requiring hospitalization (HITCH): a multicenter, phase 2 randomized controlled trial of best supportive care vs best supportive care plus degarelix: study protocol for a randomized controlled trial.","Therapeutic targeting of host-cell factors required for SARS-CoV-2 entry is an alternative strategy to ameliorate COVID-19 severity. SARS-CoV-2 entry into lung epithelium requires the TMPRSS2 cell surface protease. Pre-clinical and correlative data in humans suggest that anti-androgenic therapies can reduce the expression of TMPRSS2 on lung epithelium. Accordingly, we hypothesize that therapeutic targeting of androgen receptor signaling via degarelix, a luteinizing hormone-releasing hormone (LHR","2021","07","07","Trials","Trials","Androgen receptor; Androgen suppression; Anti-androgen; COVID-19; Coronavirus; Hormone therapy; SARS-CoV-2; TMPRSS2; COVID-19; Clinical Trials, Phase II as Topic; Hospitalization; Humans; Male; Multicenter Studies as Topic; Oligopeptides; Randomized Controlled Trials as Topic; SARS-CoV-2; Treatment Outcome; Veterans","Ghayouri","Leila","Division of Hematology-Oncology, VA Greater Los Angeles Healthcare System, Los Angeles, CA, 90073, USA",NA
"1319","34225789","10.1186/s13063-021-05389-0","Hormonal intervention for the treatment of veterans with COVID-19 requiring hospitalization (HITCH): a multicenter, phase 2 randomized controlled trial of best supportive care vs best supportive care plus degarelix: study protocol for a randomized controlled trial.","Therapeutic targeting of host-cell factors required for SARS-CoV-2 entry is an alternative strategy to ameliorate COVID-19 severity. SARS-CoV-2 entry into lung epithelium requires the TMPRSS2 cell surface protease. Pre-clinical and correlative data in humans suggest that anti-androgenic therapies can reduce the expression of TMPRSS2 on lung epithelium. Accordingly, we hypothesize that therapeutic targeting of androgen receptor signaling via degarelix, a luteinizing hormone-releasing hormone (LHR","2021","07","07","Trials","Trials","Androgen receptor; Androgen suppression; Anti-androgen; COVID-19; Coronavirus; Hormone therapy; SARS-CoV-2; TMPRSS2; COVID-19; Clinical Trials, Phase II as Topic; Hospitalization; Humans; Male; Multicenter Studies as Topic; Oligopeptides; Randomized Controlled Trials as Topic; SARS-CoV-2; Treatment Outcome; Veterans","Tsai","Sonny","Division of Hematology-Oncology, VA Greater Los Angeles Healthcare System, Los Angeles, CA, 90073, USA",NA
"1320","34225789","10.1186/s13063-021-05389-0","Hormonal intervention for the treatment of veterans with COVID-19 requiring hospitalization (HITCH): a multicenter, phase 2 randomized controlled trial of best supportive care vs best supportive care plus degarelix: study protocol for a randomized controlled trial.","Therapeutic targeting of host-cell factors required for SARS-CoV-2 entry is an alternative strategy to ameliorate COVID-19 severity. SARS-CoV-2 entry into lung epithelium requires the TMPRSS2 cell surface protease. Pre-clinical and correlative data in humans suggest that anti-androgenic therapies can reduce the expression of TMPRSS2 on lung epithelium. Accordingly, we hypothesize that therapeutic targeting of androgen receptor signaling via degarelix, a luteinizing hormone-releasing hormone (LHR","2021","07","07","Trials","Trials","Androgen receptor; Androgen suppression; Anti-androgen; COVID-19; Coronavirus; Hormone therapy; SARS-CoV-2; TMPRSS2; COVID-19; Clinical Trials, Phase II as Topic; Hospitalization; Humans; Male; Multicenter Studies as Topic; Oligopeptides; Randomized Controlled Trials as Topic; SARS-CoV-2; Treatment Outcome; Veterans","Geelhoed","Michelle","Division of Hematology-Oncology, VA Greater Los Angeles Healthcare System, Los Angeles, CA, 90073, USA",NA
"1321","34225789","10.1186/s13063-021-05389-0","Hormonal intervention for the treatment of veterans with COVID-19 requiring hospitalization (HITCH): a multicenter, phase 2 randomized controlled trial of best supportive care vs best supportive care plus degarelix: study protocol for a randomized controlled trial.","Therapeutic targeting of host-cell factors required for SARS-CoV-2 entry is an alternative strategy to ameliorate COVID-19 severity. SARS-CoV-2 entry into lung epithelium requires the TMPRSS2 cell surface protease. Pre-clinical and correlative data in humans suggest that anti-androgenic therapies can reduce the expression of TMPRSS2 on lung epithelium. Accordingly, we hypothesize that therapeutic targeting of androgen receptor signaling via degarelix, a luteinizing hormone-releasing hormone (LHR","2021","07","07","Trials","Trials","Androgen receptor; Androgen suppression; Anti-androgen; COVID-19; Coronavirus; Hormone therapy; SARS-CoV-2; TMPRSS2; COVID-19; Clinical Trials, Phase II as Topic; Hospitalization; Humans; Male; Multicenter Studies as Topic; Oligopeptides; Randomized Controlled Trials as Topic; SARS-CoV-2; Treatment Outcome; Veterans","Makarov","Danil","Division of Hematology-Oncology, VA New York Harbor Healthcare System, New York, USA",NA
"1322","34225789","10.1186/s13063-021-05389-0","Hormonal intervention for the treatment of veterans with COVID-19 requiring hospitalization (HITCH): a multicenter, phase 2 randomized controlled trial of best supportive care vs best supportive care plus degarelix: study protocol for a randomized controlled trial.","Therapeutic targeting of host-cell factors required for SARS-CoV-2 entry is an alternative strategy to ameliorate COVID-19 severity. SARS-CoV-2 entry into lung epithelium requires the TMPRSS2 cell surface protease. Pre-clinical and correlative data in humans suggest that anti-androgenic therapies can reduce the expression of TMPRSS2 on lung epithelium. Accordingly, we hypothesize that therapeutic targeting of androgen receptor signaling via degarelix, a luteinizing hormone-releasing hormone (LHR","2021","07","07","Trials","Trials","Androgen receptor; Androgen suppression; Anti-androgen; COVID-19; Coronavirus; Hormone therapy; SARS-CoV-2; TMPRSS2; COVID-19; Clinical Trials, Phase II as Topic; Hospitalization; Humans; Male; Multicenter Studies as Topic; Oligopeptides; Randomized Controlled Trials as Topic; SARS-CoV-2; Treatment Outcome; Veterans","Becker","Daniel J","Division of Hematology-Oncology, VA New York Harbor Healthcare System, New York, USA",NA
"1323","34225789","10.1186/s13063-021-05389-0","Hormonal intervention for the treatment of veterans with COVID-19 requiring hospitalization (HITCH): a multicenter, phase 2 randomized controlled trial of best supportive care vs best supportive care plus degarelix: study protocol for a randomized controlled trial.","Therapeutic targeting of host-cell factors required for SARS-CoV-2 entry is an alternative strategy to ameliorate COVID-19 severity. SARS-CoV-2 entry into lung epithelium requires the TMPRSS2 cell surface protease. Pre-clinical and correlative data in humans suggest that anti-androgenic therapies can reduce the expression of TMPRSS2 on lung epithelium. Accordingly, we hypothesize that therapeutic targeting of androgen receptor signaling via degarelix, a luteinizing hormone-releasing hormone (LHR","2021","07","07","Trials","Trials","Androgen receptor; Androgen suppression; Anti-androgen; COVID-19; Coronavirus; Hormone therapy; SARS-CoV-2; TMPRSS2; COVID-19; Clinical Trials, Phase II as Topic; Hospitalization; Humans; Male; Multicenter Studies as Topic; Oligopeptides; Randomized Controlled Trials as Topic; SARS-CoV-2; Treatment Outcome; Veterans","Tsay","Jun-Chieh","Division of Pulmonary and Critical Care, VA New York Harbor Healthcare System, New York, USA",NA
"1324","34225789","10.1186/s13063-021-05389-0","Hormonal intervention for the treatment of veterans with COVID-19 requiring hospitalization (HITCH): a multicenter, phase 2 randomized controlled trial of best supportive care vs best supportive care plus degarelix: study protocol for a randomized controlled trial.","Therapeutic targeting of host-cell factors required for SARS-CoV-2 entry is an alternative strategy to ameliorate COVID-19 severity. SARS-CoV-2 entry into lung epithelium requires the TMPRSS2 cell surface protease. Pre-clinical and correlative data in humans suggest that anti-androgenic therapies can reduce the expression of TMPRSS2 on lung epithelium. Accordingly, we hypothesize that therapeutic targeting of androgen receptor signaling via degarelix, a luteinizing hormone-releasing hormone (LHR","2021","07","07","Trials","Trials","Androgen receptor; Androgen suppression; Anti-androgen; COVID-19; Coronavirus; Hormone therapy; SARS-CoV-2; TMPRSS2; COVID-19; Clinical Trials, Phase II as Topic; Hospitalization; Humans; Male; Multicenter Studies as Topic; Oligopeptides; Randomized Controlled Trials as Topic; SARS-CoV-2; Treatment Outcome; Veterans","Diamond","Melissa","Division of Hematology-Oncology, VA New York Harbor Healthcare System, New York, USA",NA
"1325","34225789","10.1186/s13063-021-05389-0","Hormonal intervention for the treatment of veterans with COVID-19 requiring hospitalization (HITCH): a multicenter, phase 2 randomized controlled trial of best supportive care vs best supportive care plus degarelix: study protocol for a randomized controlled trial.","Therapeutic targeting of host-cell factors required for SARS-CoV-2 entry is an alternative strategy to ameliorate COVID-19 severity. SARS-CoV-2 entry into lung epithelium requires the TMPRSS2 cell surface protease. Pre-clinical and correlative data in humans suggest that anti-androgenic therapies can reduce the expression of TMPRSS2 on lung epithelium. Accordingly, we hypothesize that therapeutic targeting of androgen receptor signaling via degarelix, a luteinizing hormone-releasing hormone (LHR","2021","07","07","Trials","Trials","Androgen receptor; Androgen suppression; Anti-androgen; COVID-19; Coronavirus; Hormone therapy; SARS-CoV-2; TMPRSS2; COVID-19; Clinical Trials, Phase II as Topic; Hospitalization; Humans; Male; Multicenter Studies as Topic; Oligopeptides; Randomized Controlled Trials as Topic; SARS-CoV-2; Treatment Outcome; Veterans","George","Asha","Division of Hematology-Oncology, VA New York Harbor Healthcare System, New York, USA",NA
"1326","34225789","10.1186/s13063-021-05389-0","Hormonal intervention for the treatment of veterans with COVID-19 requiring hospitalization (HITCH): a multicenter, phase 2 randomized controlled trial of best supportive care vs best supportive care plus degarelix: study protocol for a randomized controlled trial.","Therapeutic targeting of host-cell factors required for SARS-CoV-2 entry is an alternative strategy to ameliorate COVID-19 severity. SARS-CoV-2 entry into lung epithelium requires the TMPRSS2 cell surface protease. Pre-clinical and correlative data in humans suggest that anti-androgenic therapies can reduce the expression of TMPRSS2 on lung epithelium. Accordingly, we hypothesize that therapeutic targeting of androgen receptor signaling via degarelix, a luteinizing hormone-releasing hormone (LHR","2021","07","07","Trials","Trials","Androgen receptor; Androgen suppression; Anti-androgen; COVID-19; Coronavirus; Hormone therapy; SARS-CoV-2; TMPRSS2; COVID-19; Clinical Trials, Phase II as Topic; Hospitalization; Humans; Male; Multicenter Studies as Topic; Oligopeptides; Randomized Controlled Trials as Topic; SARS-CoV-2; Treatment Outcome; Veterans","Al-Ajam","Mohammad","Division of Pulmonary and Critical Care, VA New York Harbor Healthcare System, New York, USA",NA
"1327","34225789","10.1186/s13063-021-05389-0","Hormonal intervention for the treatment of veterans with COVID-19 requiring hospitalization (HITCH): a multicenter, phase 2 randomized controlled trial of best supportive care vs best supportive care plus degarelix: study protocol for a randomized controlled trial.","Therapeutic targeting of host-cell factors required for SARS-CoV-2 entry is an alternative strategy to ameliorate COVID-19 severity. SARS-CoV-2 entry into lung epithelium requires the TMPRSS2 cell surface protease. Pre-clinical and correlative data in humans suggest that anti-androgenic therapies can reduce the expression of TMPRSS2 on lung epithelium. Accordingly, we hypothesize that therapeutic targeting of androgen receptor signaling via degarelix, a luteinizing hormone-releasing hormone (LHR","2021","07","07","Trials","Trials","Androgen receptor; Androgen suppression; Anti-androgen; COVID-19; Coronavirus; Hormone therapy; SARS-CoV-2; TMPRSS2; COVID-19; Clinical Trials, Phase II as Topic; Hospitalization; Humans; Male; Multicenter Studies as Topic; Oligopeptides; Randomized Controlled Trials as Topic; SARS-CoV-2; Treatment Outcome; Veterans","Belligund","Pooja","Division of Pulmonary and Critical Care, VA New York Harbor Healthcare System, New York, USA",NA
"1328","34225789","10.1186/s13063-021-05389-0","Hormonal intervention for the treatment of veterans with COVID-19 requiring hospitalization (HITCH): a multicenter, phase 2 randomized controlled trial of best supportive care vs best supportive care plus degarelix: study protocol for a randomized controlled trial.","Therapeutic targeting of host-cell factors required for SARS-CoV-2 entry is an alternative strategy to ameliorate COVID-19 severity. SARS-CoV-2 entry into lung epithelium requires the TMPRSS2 cell surface protease. Pre-clinical and correlative data in humans suggest that anti-androgenic therapies can reduce the expression of TMPRSS2 on lung epithelium. Accordingly, we hypothesize that therapeutic targeting of androgen receptor signaling via degarelix, a luteinizing hormone-releasing hormone (LHR","2021","07","07","Trials","Trials","Androgen receptor; Androgen suppression; Anti-androgen; COVID-19; Coronavirus; Hormone therapy; SARS-CoV-2; TMPRSS2; COVID-19; Clinical Trials, Phase II as Topic; Hospitalization; Humans; Male; Multicenter Studies as Topic; Oligopeptides; Randomized Controlled Trials as Topic; SARS-CoV-2; Treatment Outcome; Veterans","Montgomery","R Bruce","Division of Hematology-Oncology, VA Puget Sound Healthcare System, Seattle, USA",NA
"1329","34225789","10.1186/s13063-021-05389-0","Hormonal intervention for the treatment of veterans with COVID-19 requiring hospitalization (HITCH): a multicenter, phase 2 randomized controlled trial of best supportive care vs best supportive care plus degarelix: study protocol for a randomized controlled trial.","Therapeutic targeting of host-cell factors required for SARS-CoV-2 entry is an alternative strategy to ameliorate COVID-19 severity. SARS-CoV-2 entry into lung epithelium requires the TMPRSS2 cell surface protease. Pre-clinical and correlative data in humans suggest that anti-androgenic therapies can reduce the expression of TMPRSS2 on lung epithelium. Accordingly, we hypothesize that therapeutic targeting of androgen receptor signaling via degarelix, a luteinizing hormone-releasing hormone (LHR","2021","07","07","Trials","Trials","Androgen receptor; Androgen suppression; Anti-androgen; COVID-19; Coronavirus; Hormone therapy; SARS-CoV-2; TMPRSS2; COVID-19; Clinical Trials, Phase II as Topic; Hospitalization; Humans; Male; Multicenter Studies as Topic; Oligopeptides; Randomized Controlled Trials as Topic; SARS-CoV-2; Treatment Outcome; Veterans","Mostaghel","Elahe A","Geriatric Research Education and Clinical Care (GRECC), VA Puget Sound Health Care System, Seattle, USA",NA
"1330","34225789","10.1186/s13063-021-05389-0","Hormonal intervention for the treatment of veterans with COVID-19 requiring hospitalization (HITCH): a multicenter, phase 2 randomized controlled trial of best supportive care vs best supportive care plus degarelix: study protocol for a randomized controlled trial.","Therapeutic targeting of host-cell factors required for SARS-CoV-2 entry is an alternative strategy to ameliorate COVID-19 severity. SARS-CoV-2 entry into lung epithelium requires the TMPRSS2 cell surface protease. Pre-clinical and correlative data in humans suggest that anti-androgenic therapies can reduce the expression of TMPRSS2 on lung epithelium. Accordingly, we hypothesize that therapeutic targeting of androgen receptor signaling via degarelix, a luteinizing hormone-releasing hormone (LHR","2021","07","07","Trials","Trials","Androgen receptor; Androgen suppression; Anti-androgen; COVID-19; Coronavirus; Hormone therapy; SARS-CoV-2; TMPRSS2; COVID-19; Clinical Trials, Phase II as Topic; Hospitalization; Humans; Male; Multicenter Studies as Topic; Oligopeptides; Randomized Controlled Trials as Topic; SARS-CoV-2; Treatment Outcome; Veterans","Sulpizio","Carlie","Division of Hematology-Oncology, VA Puget Sound Healthcare System, Seattle, USA",NA
"1331","34225789","10.1186/s13063-021-05389-0","Hormonal intervention for the treatment of veterans with COVID-19 requiring hospitalization (HITCH): a multicenter, phase 2 randomized controlled trial of best supportive care vs best supportive care plus degarelix: study protocol for a randomized controlled trial.","Therapeutic targeting of host-cell factors required for SARS-CoV-2 entry is an alternative strategy to ameliorate COVID-19 severity. SARS-CoV-2 entry into lung epithelium requires the TMPRSS2 cell surface protease. Pre-clinical and correlative data in humans suggest that anti-androgenic therapies can reduce the expression of TMPRSS2 on lung epithelium. Accordingly, we hypothesize that therapeutic targeting of androgen receptor signaling via degarelix, a luteinizing hormone-releasing hormone (LHR","2021","07","07","Trials","Trials","Androgen receptor; Androgen suppression; Anti-androgen; COVID-19; Coronavirus; Hormone therapy; SARS-CoV-2; TMPRSS2; COVID-19; Clinical Trials, Phase II as Topic; Hospitalization; Humans; Male; Multicenter Studies as Topic; Oligopeptides; Randomized Controlled Trials as Topic; SARS-CoV-2; Treatment Outcome; Veterans","Mi","Zhibao","VA Cooperative Studies Program Coordinating Center, Point, Perry, MD, USA",NA
"1332","34225789","10.1186/s13063-021-05389-0","Hormonal intervention for the treatment of veterans with COVID-19 requiring hospitalization (HITCH): a multicenter, phase 2 randomized controlled trial of best supportive care vs best supportive care plus degarelix: study protocol for a randomized controlled trial.","Therapeutic targeting of host-cell factors required for SARS-CoV-2 entry is an alternative strategy to ameliorate COVID-19 severity. SARS-CoV-2 entry into lung epithelium requires the TMPRSS2 cell surface protease. Pre-clinical and correlative data in humans suggest that anti-androgenic therapies can reduce the expression of TMPRSS2 on lung epithelium. Accordingly, we hypothesize that therapeutic targeting of androgen receptor signaling via degarelix, a luteinizing hormone-releasing hormone (LHR","2021","07","07","Trials","Trials","Androgen receptor; Androgen suppression; Anti-androgen; COVID-19; Coronavirus; Hormone therapy; SARS-CoV-2; TMPRSS2; COVID-19; Clinical Trials, Phase II as Topic; Hospitalization; Humans; Male; Multicenter Studies as Topic; Oligopeptides; Randomized Controlled Trials as Topic; SARS-CoV-2; Treatment Outcome; Veterans","Dematt","Ellen","VA Cooperative Studies Program Coordinating Center, Point, Perry, MD, USA",NA
"1333","34225789","10.1186/s13063-021-05389-0","Hormonal intervention for the treatment of veterans with COVID-19 requiring hospitalization (HITCH): a multicenter, phase 2 randomized controlled trial of best supportive care vs best supportive care plus degarelix: study protocol for a randomized controlled trial.","Therapeutic targeting of host-cell factors required for SARS-CoV-2 entry is an alternative strategy to ameliorate COVID-19 severity. SARS-CoV-2 entry into lung epithelium requires the TMPRSS2 cell surface protease. Pre-clinical and correlative data in humans suggest that anti-androgenic therapies can reduce the expression of TMPRSS2 on lung epithelium. Accordingly, we hypothesize that therapeutic targeting of androgen receptor signaling via degarelix, a luteinizing hormone-releasing hormone (LHR","2021","07","07","Trials","Trials","Androgen receptor; Androgen suppression; Anti-androgen; COVID-19; Coronavirus; Hormone therapy; SARS-CoV-2; TMPRSS2; COVID-19; Clinical Trials, Phase II as Topic; Hospitalization; Humans; Male; Multicenter Studies as Topic; Oligopeptides; Randomized Controlled Trials as Topic; SARS-CoV-2; Treatment Outcome; Veterans","Tadalan","Joseph","VA Cooperative Studies Program Coordinating Center, Point, Perry, MD, USA",NA
"1334","34225789","10.1186/s13063-021-05389-0","Hormonal intervention for the treatment of veterans with COVID-19 requiring hospitalization (HITCH): a multicenter, phase 2 randomized controlled trial of best supportive care vs best supportive care plus degarelix: study protocol for a randomized controlled trial.","Therapeutic targeting of host-cell factors required for SARS-CoV-2 entry is an alternative strategy to ameliorate COVID-19 severity. SARS-CoV-2 entry into lung epithelium requires the TMPRSS2 cell surface protease. Pre-clinical and correlative data in humans suggest that anti-androgenic therapies can reduce the expression of TMPRSS2 on lung epithelium. Accordingly, we hypothesize that therapeutic targeting of androgen receptor signaling via degarelix, a luteinizing hormone-releasing hormone (LHR","2021","07","07","Trials","Trials","Androgen receptor; Androgen suppression; Anti-androgen; COVID-19; Coronavirus; Hormone therapy; SARS-CoV-2; TMPRSS2; COVID-19; Clinical Trials, Phase II as Topic; Hospitalization; Humans; Male; Multicenter Studies as Topic; Oligopeptides; Randomized Controlled Trials as Topic; SARS-CoV-2; Treatment Outcome; Veterans","Norman","Leslie E","VA Cooperative Studies Program Coordinating Center, Point, Perry, MD, USA",NA
"1335","34225789","10.1186/s13063-021-05389-0","Hormonal intervention for the treatment of veterans with COVID-19 requiring hospitalization (HITCH): a multicenter, phase 2 randomized controlled trial of best supportive care vs best supportive care plus degarelix: study protocol for a randomized controlled trial.","Therapeutic targeting of host-cell factors required for SARS-CoV-2 entry is an alternative strategy to ameliorate COVID-19 severity. SARS-CoV-2 entry into lung epithelium requires the TMPRSS2 cell surface protease. Pre-clinical and correlative data in humans suggest that anti-androgenic therapies can reduce the expression of TMPRSS2 on lung epithelium. Accordingly, we hypothesize that therapeutic targeting of androgen receptor signaling via degarelix, a luteinizing hormone-releasing hormone (LHR","2021","07","07","Trials","Trials","Androgen receptor; Androgen suppression; Anti-androgen; COVID-19; Coronavirus; Hormone therapy; SARS-CoV-2; TMPRSS2; COVID-19; Clinical Trials, Phase II as Topic; Hospitalization; Humans; Male; Multicenter Studies as Topic; Oligopeptides; Randomized Controlled Trials as Topic; SARS-CoV-2; Treatment Outcome; Veterans","Briones","Daniel","VA Cooperative Studies Program Coordinating Center, Point, Perry, MD, USA",NA
"1336","34225789","10.1186/s13063-021-05389-0","Hormonal intervention for the treatment of veterans with COVID-19 requiring hospitalization (HITCH): a multicenter, phase 2 randomized controlled trial of best supportive care vs best supportive care plus degarelix: study protocol for a randomized controlled trial.","Therapeutic targeting of host-cell factors required for SARS-CoV-2 entry is an alternative strategy to ameliorate COVID-19 severity. SARS-CoV-2 entry into lung epithelium requires the TMPRSS2 cell surface protease. Pre-clinical and correlative data in humans suggest that anti-androgenic therapies can reduce the expression of TMPRSS2 on lung epithelium. Accordingly, we hypothesize that therapeutic targeting of androgen receptor signaling via degarelix, a luteinizing hormone-releasing hormone (LHR","2021","07","07","Trials","Trials","Androgen receptor; Androgen suppression; Anti-androgen; COVID-19; Coronavirus; Hormone therapy; SARS-CoV-2; TMPRSS2; COVID-19; Clinical Trials, Phase II as Topic; Hospitalization; Humans; Male; Multicenter Studies as Topic; Oligopeptides; Randomized Controlled Trials as Topic; SARS-CoV-2; Treatment Outcome; Veterans","Clise","Christina E","VA Cooperative Studies Program Coordinating Center, Point, Perry, MD, USA",NA
"1337","34225789","10.1186/s13063-021-05389-0","Hormonal intervention for the treatment of veterans with COVID-19 requiring hospitalization (HITCH): a multicenter, phase 2 randomized controlled trial of best supportive care vs best supportive care plus degarelix: study protocol for a randomized controlled trial.","Therapeutic targeting of host-cell factors required for SARS-CoV-2 entry is an alternative strategy to ameliorate COVID-19 severity. SARS-CoV-2 entry into lung epithelium requires the TMPRSS2 cell surface protease. Pre-clinical and correlative data in humans suggest that anti-androgenic therapies can reduce the expression of TMPRSS2 on lung epithelium. Accordingly, we hypothesize that therapeutic targeting of androgen receptor signaling via degarelix, a luteinizing hormone-releasing hormone (LHR","2021","07","07","Trials","Trials","Androgen receptor; Androgen suppression; Anti-androgen; COVID-19; Coronavirus; Hormone therapy; SARS-CoV-2; TMPRSS2; COVID-19; Clinical Trials, Phase II as Topic; Hospitalization; Humans; Male; Multicenter Studies as Topic; Oligopeptides; Randomized Controlled Trials as Topic; SARS-CoV-2; Treatment Outcome; Veterans","Taylor","Zachary W","VA Cooperative Research Pharmacy Coordinating Center, Albuquerque, NM, USA",NA
"1338","34225789","10.1186/s13063-021-05389-0","Hormonal intervention for the treatment of veterans with COVID-19 requiring hospitalization (HITCH): a multicenter, phase 2 randomized controlled trial of best supportive care vs best supportive care plus degarelix: study protocol for a randomized controlled trial.","Therapeutic targeting of host-cell factors required for SARS-CoV-2 entry is an alternative strategy to ameliorate COVID-19 severity. SARS-CoV-2 entry into lung epithelium requires the TMPRSS2 cell surface protease. Pre-clinical and correlative data in humans suggest that anti-androgenic therapies can reduce the expression of TMPRSS2 on lung epithelium. Accordingly, we hypothesize that therapeutic targeting of androgen receptor signaling via degarelix, a luteinizing hormone-releasing hormone (LHR","2021","07","07","Trials","Trials","Androgen receptor; Androgen suppression; Anti-androgen; COVID-19; Coronavirus; Hormone therapy; SARS-CoV-2; TMPRSS2; COVID-19; Clinical Trials, Phase II as Topic; Hospitalization; Humans; Male; Multicenter Studies as Topic; Oligopeptides; Randomized Controlled Trials as Topic; SARS-CoV-2; Treatment Outcome; Veterans","Huminik","Jeffrey R","VA Cooperative Research Pharmacy Coordinating Center, Albuquerque, NM, USA",NA
"1339","34225789","10.1186/s13063-021-05389-0","Hormonal intervention for the treatment of veterans with COVID-19 requiring hospitalization (HITCH): a multicenter, phase 2 randomized controlled trial of best supportive care vs best supportive care plus degarelix: study protocol for a randomized controlled trial.","Therapeutic targeting of host-cell factors required for SARS-CoV-2 entry is an alternative strategy to ameliorate COVID-19 severity. SARS-CoV-2 entry into lung epithelium requires the TMPRSS2 cell surface protease. Pre-clinical and correlative data in humans suggest that anti-androgenic therapies can reduce the expression of TMPRSS2 on lung epithelium. Accordingly, we hypothesize that therapeutic targeting of androgen receptor signaling via degarelix, a luteinizing hormone-releasing hormone (LHR","2021","07","07","Trials","Trials","Androgen receptor; Androgen suppression; Anti-androgen; COVID-19; Coronavirus; Hormone therapy; SARS-CoV-2; TMPRSS2; COVID-19; Clinical Trials, Phase II as Topic; Hospitalization; Humans; Male; Multicenter Studies as Topic; Oligopeptides; Randomized Controlled Trials as Topic; SARS-CoV-2; Treatment Outcome; Veterans","Biswas","Kousick","VA Cooperative Studies Program Coordinating Center, Point, Perry, MD, USA",NA
"1340","34225789","10.1186/s13063-021-05389-0","Hormonal intervention for the treatment of veterans with COVID-19 requiring hospitalization (HITCH): a multicenter, phase 2 randomized controlled trial of best supportive care vs best supportive care plus degarelix: study protocol for a randomized controlled trial.","Therapeutic targeting of host-cell factors required for SARS-CoV-2 entry is an alternative strategy to ameliorate COVID-19 severity. SARS-CoV-2 entry into lung epithelium requires the TMPRSS2 cell surface protease. Pre-clinical and correlative data in humans suggest that anti-androgenic therapies can reduce the expression of TMPRSS2 on lung epithelium. Accordingly, we hypothesize that therapeutic targeting of androgen receptor signaling via degarelix, a luteinizing hormone-releasing hormone (LHR","2021","07","07","Trials","Trials","Androgen receptor; Androgen suppression; Anti-androgen; COVID-19; Coronavirus; Hormone therapy; SARS-CoV-2; TMPRSS2; COVID-19; Clinical Trials, Phase II as Topic; Hospitalization; Humans; Male; Multicenter Studies as Topic; Oligopeptides; Randomized Controlled Trials as Topic; SARS-CoV-2; Treatment Outcome; Veterans","Rettig","Matthew B","Division of Hematology-Oncology, VA Greater Los Angeles Healthcare System, Los Angeles, CA, 90073, USA. matthew.rettig@va",NA
"1341","34225774","10.1186/s40249-021-00880-x","The relationship between time to a high COVID-19 response level and timing of peak daily incidence: an analysis of governments' Stringency Index from 148 countries.","The transmission dynamics and severity of coronavirus disease 2019 (COVID-19) pandemic is different across countries or regions. Differences in governments' policy responses may explain some of these differences. We aimed to compare worldwide government responses to the spread of COVID-19, to examine the relationship between response level, response timing and the epidemic trajectory. Free publicly-accessible data collected by the Coronavirus Government Response Tracker (OxCGRT) were used. Nine ","2021","07","09","Infect Dis Poverty","Infectious diseases of poverty","COVID-19; Multivariable linear regression models; Response; Stringency Index; COVID-19; Global Health; Government; Health Policy; Humans; Multivariate Analysis; Pandemics; Quarantine; Time Factors","Ma","Yan","Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing, China",NA
"1342","34225774","10.1186/s40249-021-00880-x","The relationship between time to a high COVID-19 response level and timing of peak daily incidence: an analysis of governments' Stringency Index from 148 countries.","The transmission dynamics and severity of coronavirus disease 2019 (COVID-19) pandemic is different across countries or regions. Differences in governments' policy responses may explain some of these differences. We aimed to compare worldwide government responses to the spread of COVID-19, to examine the relationship between response level, response timing and the epidemic trajectory. Free publicly-accessible data collected by the Coronavirus Government Response Tracker (OxCGRT) were used. Nine ","2021","07","09","Infect Dis Poverty","Infectious diseases of poverty","COVID-19; Multivariable linear regression models; Response; Stringency Index; COVID-19; Global Health; Government; Health Policy; Humans; Multivariate Analysis; Pandemics; Quarantine; Time Factors","Mishra","Shiva Raj","World Heart Federation, Rue de Malatrex 32, 1201, Geneva, Switzerland",NA
"1343","34225774","10.1186/s40249-021-00880-x","The relationship between time to a high COVID-19 response level and timing of peak daily incidence: an analysis of governments' Stringency Index from 148 countries.","The transmission dynamics and severity of coronavirus disease 2019 (COVID-19) pandemic is different across countries or regions. Differences in governments' policy responses may explain some of these differences. We aimed to compare worldwide government responses to the spread of COVID-19, to examine the relationship between response level, response timing and the epidemic trajectory. Free publicly-accessible data collected by the Coronavirus Government Response Tracker (OxCGRT) were used. Nine ","2021","07","09","Infect Dis Poverty","Infectious diseases of poverty","COVID-19; Multivariable linear regression models; Response; Stringency Index; COVID-19; Global Health; Government; Health Policy; Humans; Multivariate Analysis; Pandemics; Quarantine; Time Factors","Han","Xi-Kun","Statistical Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia",NA
"1344","34225774","10.1186/s40249-021-00880-x","The relationship between time to a high COVID-19 response level and timing of peak daily incidence: an analysis of governments' Stringency Index from 148 countries.","The transmission dynamics and severity of coronavirus disease 2019 (COVID-19) pandemic is different across countries or regions. Differences in governments' policy responses may explain some of these differences. We aimed to compare worldwide government responses to the spread of COVID-19, to examine the relationship between response level, response timing and the epidemic trajectory. Free publicly-accessible data collected by the Coronavirus Government Response Tracker (OxCGRT) were used. Nine ","2021","07","09","Infect Dis Poverty","Infectious diseases of poverty","COVID-19; Multivariable linear regression models; Response; Stringency Index; COVID-19; Global Health; Government; Health Policy; Humans; Multivariate Analysis; Pandemics; Quarantine; Time Factors","Zhu","Dong-Shan","Centre for Health Management and Policy Research, School of Public Health, Cheeloo College of Medicine, Shandong University, 44 Wenhuaxi Road, Jinan, 250012, Shandong, China. dongshan.zhu@uq.net","dongshan.zhu@uq.net.au"
"1345","34225765","10.1186/s13063-021-05373-8","SAVER: sodium valproate for the epigenetic reprogramming of high-risk oral epithelial dysplasia-a phase II randomised control trial study protocol.","Sodium valproate (VPA) has been associated with a reduced risk of head and neck cancer development. The potential protective mechanism of action is believed to be via inhibition of histone deacetylase and subsequent epigenetic reprogramming. SAVER is a phase IIb open-label, randomised control trial of VPA as a chemopreventive agent in patients with high-risk oral epithelial dysplasia (OED). The aim of the trial is to gather preliminary evidence of the clinical and biological effects of VPA upon ","2021","07","07","Trials","Trials","Chemoprevention; Drug repurposing; Epigenetic reprogramming; Oral epithelial dysplasia; Randomised controlled trial; Sodium valproate; COVID-19; Clinical Trials, Phase II as Topic; Epigenesis, Genetic; Female; Humans; Randomized Controlled Trials as Topic; SARS-CoV-2; Treatment Outcome; Valproic Acid","McCarthy","Caroline","Department of Oral Medicine, Liverpool University Dental Hospital, Pembroke Place, Liverpool, L3 5PS, UK. carolmc2@liverpool.ac","carolmc2@liverpool.ac.uk"
"1346","34225765","10.1186/s13063-021-05373-8","SAVER: sodium valproate for the epigenetic reprogramming of high-risk oral epithelial dysplasia-a phase II randomised control trial study protocol.","Sodium valproate (VPA) has been associated with a reduced risk of head and neck cancer development. The potential protective mechanism of action is believed to be via inhibition of histone deacetylase and subsequent epigenetic reprogramming. SAVER is a phase IIb open-label, randomised control trial of VPA as a chemopreventive agent in patients with high-risk oral epithelial dysplasia (OED). The aim of the trial is to gather preliminary evidence of the clinical and biological effects of VPA upon ","2021","07","07","Trials","Trials","Chemoprevention; Drug repurposing; Epigenetic reprogramming; Oral epithelial dysplasia; Randomised controlled trial; Sodium valproate; COVID-19; Clinical Trials, Phase II as Topic; Epigenesis, Genetic; Female; Humans; Randomized Controlled Trials as Topic; SARS-CoV-2; Treatment Outcome; Valproic Acid","Sacco","Joseph","Institute of Systems, Molecular and Integrative Biology, The University of Liverpool, Crown Street, Liverpool, L69 3BX, UK",NA
"1347","34225765","10.1186/s13063-021-05373-8","SAVER: sodium valproate for the epigenetic reprogramming of high-risk oral epithelial dysplasia-a phase II randomised control trial study protocol.","Sodium valproate (VPA) has been associated with a reduced risk of head and neck cancer development. The potential protective mechanism of action is believed to be via inhibition of histone deacetylase and subsequent epigenetic reprogramming. SAVER is a phase IIb open-label, randomised control trial of VPA as a chemopreventive agent in patients with high-risk oral epithelial dysplasia (OED). The aim of the trial is to gather preliminary evidence of the clinical and biological effects of VPA upon ","2021","07","07","Trials","Trials","Chemoprevention; Drug repurposing; Epigenetic reprogramming; Oral epithelial dysplasia; Randomised controlled trial; Sodium valproate; COVID-19; Clinical Trials, Phase II as Topic; Epigenesis, Genetic; Female; Humans; Randomized Controlled Trials as Topic; SARS-CoV-2; Treatment Outcome; Valproic Acid","Fedele","Stefano","University College London, UCL Eastman Dental Institute and NIHR UCLH Biomedical Research Centre, 21 University Street, London, WC1E 6DE, UK",NA
"1348","34225765","10.1186/s13063-021-05373-8","SAVER: sodium valproate for the epigenetic reprogramming of high-risk oral epithelial dysplasia-a phase II randomised control trial study protocol.","Sodium valproate (VPA) has been associated with a reduced risk of head and neck cancer development. The potential protective mechanism of action is believed to be via inhibition of histone deacetylase and subsequent epigenetic reprogramming. SAVER is a phase IIb open-label, randomised control trial of VPA as a chemopreventive agent in patients with high-risk oral epithelial dysplasia (OED). The aim of the trial is to gather preliminary evidence of the clinical and biological effects of VPA upon ","2021","07","07","Trials","Trials","Chemoprevention; Drug repurposing; Epigenetic reprogramming; Oral epithelial dysplasia; Randomised controlled trial; Sodium valproate; COVID-19; Clinical Trials, Phase II as Topic; Epigenesis, Genetic; Female; Humans; Randomized Controlled Trials as Topic; SARS-CoV-2; Treatment Outcome; Valproic Acid","Ho","Michael","Leeds Teaching Hospitals NHS Trust, Oral and Maxillofacial Surgery, Leeds Dental Institute, Clarendon Way, Leeds, LS2 9LU, UK",NA
"1349","34225765","10.1186/s13063-021-05373-8","SAVER: sodium valproate for the epigenetic reprogramming of high-risk oral epithelial dysplasia-a phase II randomised control trial study protocol.","Sodium valproate (VPA) has been associated with a reduced risk of head and neck cancer development. The potential protective mechanism of action is believed to be via inhibition of histone deacetylase and subsequent epigenetic reprogramming. SAVER is a phase IIb open-label, randomised control trial of VPA as a chemopreventive agent in patients with high-risk oral epithelial dysplasia (OED). The aim of the trial is to gather preliminary evidence of the clinical and biological effects of VPA upon ","2021","07","07","Trials","Trials","Chemoprevention; Drug repurposing; Epigenetic reprogramming; Oral epithelial dysplasia; Randomised controlled trial; Sodium valproate; COVID-19; Clinical Trials, Phase II as Topic; Epigenesis, Genetic; Female; Humans; Randomized Controlled Trials as Topic; SARS-CoV-2; Treatment Outcome; Valproic Acid","Porter","Stephen","University College London, UCL Eastman Dental Institute, 21 University Street, London, WC1E 6DE, UK",NA
"1350","34225765","10.1186/s13063-021-05373-8","SAVER: sodium valproate for the epigenetic reprogramming of high-risk oral epithelial dysplasia-a phase II randomised control trial study protocol.","Sodium valproate (VPA) has been associated with a reduced risk of head and neck cancer development. The potential protective mechanism of action is believed to be via inhibition of histone deacetylase and subsequent epigenetic reprogramming. SAVER is a phase IIb open-label, randomised control trial of VPA as a chemopreventive agent in patients with high-risk oral epithelial dysplasia (OED). The aim of the trial is to gather preliminary evidence of the clinical and biological effects of VPA upon ","2021","07","07","Trials","Trials","Chemoprevention; Drug repurposing; Epigenetic reprogramming; Oral epithelial dysplasia; Randomised controlled trial; Sodium valproate; COVID-19; Clinical Trials, Phase II as Topic; Epigenesis, Genetic; Female; Humans; Randomized Controlled Trials as Topic; SARS-CoV-2; Treatment Outcome; Valproic Acid","Liloglou","Triantafillos","Institute of Systems, Molecular and Integrative Biology, The University of Liverpool, Crown Street, Liverpool, L69 3BX, UK",NA
"1351","34225765","10.1186/s13063-021-05373-8","SAVER: sodium valproate for the epigenetic reprogramming of high-risk oral epithelial dysplasia-a phase II randomised control trial study protocol.","Sodium valproate (VPA) has been associated with a reduced risk of head and neck cancer development. The potential protective mechanism of action is believed to be via inhibition of histone deacetylase and subsequent epigenetic reprogramming. SAVER is a phase IIb open-label, randomised control trial of VPA as a chemopreventive agent in patients with high-risk oral epithelial dysplasia (OED). The aim of the trial is to gather preliminary evidence of the clinical and biological effects of VPA upon ","2021","07","07","Trials","Trials","Chemoprevention; Drug repurposing; Epigenetic reprogramming; Oral epithelial dysplasia; Randomised controlled trial; Sodium valproate; COVID-19; Clinical Trials, Phase II as Topic; Epigenesis, Genetic; Female; Humans; Randomized Controlled Trials as Topic; SARS-CoV-2; Treatment Outcome; Valproic Acid","Greenhalf","Bill","GCP Laboratory Facility, Molecular and Clinical Cancer Medicine, University of Liverpool, 3rd Floor UCD Block, Duncan Building, Daulby Street, Liverpool, L69 3GA, UK",NA
"1352","34225765","10.1186/s13063-021-05373-8","SAVER: sodium valproate for the epigenetic reprogramming of high-risk oral epithelial dysplasia-a phase II randomised control trial study protocol.","Sodium valproate (VPA) has been associated with a reduced risk of head and neck cancer development. The potential protective mechanism of action is believed to be via inhibition of histone deacetylase and subsequent epigenetic reprogramming. SAVER is a phase IIb open-label, randomised control trial of VPA as a chemopreventive agent in patients with high-risk oral epithelial dysplasia (OED). The aim of the trial is to gather preliminary evidence of the clinical and biological effects of VPA upon ","2021","07","07","Trials","Trials","Chemoprevention; Drug repurposing; Epigenetic reprogramming; Oral epithelial dysplasia; Randomised controlled trial; Sodium valproate; COVID-19; Clinical Trials, Phase II as Topic; Epigenesis, Genetic; Female; Humans; Randomized Controlled Trials as Topic; SARS-CoV-2; Treatment Outcome; Valproic Acid","Robinson","Max","Dept of Cellular Pathology, Royal Victoria Infirmary, Queen Victoria Road, Newcastle upon Tyne, NE1 4LP, UK",NA
"1353","34225765","10.1186/s13063-021-05373-8","SAVER: sodium valproate for the epigenetic reprogramming of high-risk oral epithelial dysplasia-a phase II randomised control trial study protocol.","Sodium valproate (VPA) has been associated with a reduced risk of head and neck cancer development. The potential protective mechanism of action is believed to be via inhibition of histone deacetylase and subsequent epigenetic reprogramming. SAVER is a phase IIb open-label, randomised control trial of VPA as a chemopreventive agent in patients with high-risk oral epithelial dysplasia (OED). The aim of the trial is to gather preliminary evidence of the clinical and biological effects of VPA upon ","2021","07","07","Trials","Trials","Chemoprevention; Drug repurposing; Epigenetic reprogramming; Oral epithelial dysplasia; Randomised controlled trial; Sodium valproate; COVID-19; Clinical Trials, Phase II as Topic; Epigenesis, Genetic; Female; Humans; Randomized Controlled Trials as Topic; SARS-CoV-2; Treatment Outcome; Valproic Acid","Young","Bridget","Department of Psychological Sciences, Institute of Psychology, Health and Society, University of Liverpool, Whelan Building, Brownlow Hill, Liverpool, L69 3GB, UK",NA
"1354","34225765","10.1186/s13063-021-05373-8","SAVER: sodium valproate for the epigenetic reprogramming of high-risk oral epithelial dysplasia-a phase II randomised control trial study protocol.","Sodium valproate (VPA) has been associated with a reduced risk of head and neck cancer development. The potential protective mechanism of action is believed to be via inhibition of histone deacetylase and subsequent epigenetic reprogramming. SAVER is a phase IIb open-label, randomised control trial of VPA as a chemopreventive agent in patients with high-risk oral epithelial dysplasia (OED). The aim of the trial is to gather preliminary evidence of the clinical and biological effects of VPA upon ","2021","07","07","Trials","Trials","Chemoprevention; Drug repurposing; Epigenetic reprogramming; Oral epithelial dysplasia; Randomised controlled trial; Sodium valproate; COVID-19; Clinical Trials, Phase II as Topic; Epigenesis, Genetic; Female; Humans; Randomized Controlled Trials as Topic; SARS-CoV-2; Treatment Outcome; Valproic Acid","Cicconi","Silvia","Liverpool Clinical Trials Centre, Block C, Waterhouse Building, 1-3 Brownlow Street, Liverpool, L69 3GL, UK",NA
"1355","34225765","10.1186/s13063-021-05373-8","SAVER: sodium valproate for the epigenetic reprogramming of high-risk oral epithelial dysplasia-a phase II randomised control trial study protocol.","Sodium valproate (VPA) has been associated with a reduced risk of head and neck cancer development. The potential protective mechanism of action is believed to be via inhibition of histone deacetylase and subsequent epigenetic reprogramming. SAVER is a phase IIb open-label, randomised control trial of VPA as a chemopreventive agent in patients with high-risk oral epithelial dysplasia (OED). The aim of the trial is to gather preliminary evidence of the clinical and biological effects of VPA upon ","2021","07","07","Trials","Trials","Chemoprevention; Drug repurposing; Epigenetic reprogramming; Oral epithelial dysplasia; Randomised controlled trial; Sodium valproate; COVID-19; Clinical Trials, Phase II as Topic; Epigenesis, Genetic; Female; Humans; Randomized Controlled Trials as Topic; SARS-CoV-2; Treatment Outcome; Valproic Acid","Chauhan","Seema","Liverpool Health Partners SPARK, 1st Floor IC3, Liverpool Science Park, 131 Mount Pleasant, Liverpool, L3 5TF, UK",NA
"1356","34225765","10.1186/s13063-021-05373-8","SAVER: sodium valproate for the epigenetic reprogramming of high-risk oral epithelial dysplasia-a phase II randomised control trial study protocol.","Sodium valproate (VPA) has been associated with a reduced risk of head and neck cancer development. The potential protective mechanism of action is believed to be via inhibition of histone deacetylase and subsequent epigenetic reprogramming. SAVER is a phase IIb open-label, randomised control trial of VPA as a chemopreventive agent in patients with high-risk oral epithelial dysplasia (OED). The aim of the trial is to gather preliminary evidence of the clinical and biological effects of VPA upon ","2021","07","07","Trials","Trials","Chemoprevention; Drug repurposing; Epigenetic reprogramming; Oral epithelial dysplasia; Randomised controlled trial; Sodium valproate; COVID-19; Clinical Trials, Phase II as Topic; Epigenesis, Genetic; Female; Humans; Randomized Controlled Trials as Topic; SARS-CoV-2; Treatment Outcome; Valproic Acid","Tesfaye","Binyam","Liverpool Clinical Trials Centre, University of Liverpool, 1st Floor, Mersey Bio, Liverpool, L69 7ZB, UK",NA
"1357","34225765","10.1186/s13063-021-05373-8","SAVER: sodium valproate for the epigenetic reprogramming of high-risk oral epithelial dysplasia-a phase II randomised control trial study protocol.","Sodium valproate (VPA) has been associated with a reduced risk of head and neck cancer development. The potential protective mechanism of action is believed to be via inhibition of histone deacetylase and subsequent epigenetic reprogramming. SAVER is a phase IIb open-label, randomised control trial of VPA as a chemopreventive agent in patients with high-risk oral epithelial dysplasia (OED). The aim of the trial is to gather preliminary evidence of the clinical and biological effects of VPA upon ","2021","07","07","Trials","Trials","Chemoprevention; Drug repurposing; Epigenetic reprogramming; Oral epithelial dysplasia; Randomised controlled trial; Sodium valproate; COVID-19; Clinical Trials, Phase II as Topic; Epigenesis, Genetic; Female; Humans; Randomized Controlled Trials as Topic; SARS-CoV-2; Treatment Outcome; Valproic Acid","Jackson","Richard","Liverpool Clinical Trials Centre, Block C, Waterhouse Building, 1-3 Brownlow Street, Liverpool, L69 3GL, UK",NA
"1358","34225765","10.1186/s13063-021-05373-8","SAVER: sodium valproate for the epigenetic reprogramming of high-risk oral epithelial dysplasia-a phase II randomised control trial study protocol.","Sodium valproate (VPA) has been associated with a reduced risk of head and neck cancer development. The potential protective mechanism of action is believed to be via inhibition of histone deacetylase and subsequent epigenetic reprogramming. SAVER is a phase IIb open-label, randomised control trial of VPA as a chemopreventive agent in patients with high-risk oral epithelial dysplasia (OED). The aim of the trial is to gather preliminary evidence of the clinical and biological effects of VPA upon ","2021","07","07","Trials","Trials","Chemoprevention; Drug repurposing; Epigenetic reprogramming; Oral epithelial dysplasia; Randomised controlled trial; Sodium valproate; COVID-19; Clinical Trials, Phase II as Topic; Epigenesis, Genetic; Female; Humans; Randomized Controlled Trials as Topic; SARS-CoV-2; Treatment Outcome; Valproic Acid","Sherratt","Frances","Department of Public Health, Policy and Systems, University of Liverpool, B209, 2nd Floor Block B, Waterhouse Building, 1-5 Dover Street, Liverpool, L3 5DA, UK",NA
"1359","34225765","10.1186/s13063-021-05373-8","SAVER: sodium valproate for the epigenetic reprogramming of high-risk oral epithelial dysplasia-a phase II randomised control trial study protocol.","Sodium valproate (VPA) has been associated with a reduced risk of head and neck cancer development. The potential protective mechanism of action is believed to be via inhibition of histone deacetylase and subsequent epigenetic reprogramming. SAVER is a phase IIb open-label, randomised control trial of VPA as a chemopreventive agent in patients with high-risk oral epithelial dysplasia (OED). The aim of the trial is to gather preliminary evidence of the clinical and biological effects of VPA upon ","2021","07","07","Trials","Trials","Chemoprevention; Drug repurposing; Epigenetic reprogramming; Oral epithelial dysplasia; Randomised controlled trial; Sodium valproate; COVID-19; Clinical Trials, Phase II as Topic; Epigenesis, Genetic; Female; Humans; Randomized Controlled Trials as Topic; SARS-CoV-2; Treatment Outcome; Valproic Acid","Shaw","Richard","Liverpool Head and Neck Centre",NA
"1360","34225760","10.1186/s13031-021-00394-1","Community-based surveillance in internally displaced people's camps and urban settings during a complex emergency in Yemen in 2020.","The need for early identification of coronavirus disease (COVID-19) cases in communities was high in Yemen during the first wave of the COVID-19 epidemic because most cases presenting to health facilities were severe. Early detection of cases would allow early interventions to interrupt the transmission chains. This study aimed to describe the implementation of community-based surveillance (CBS) in in internally displaced people (IDP) camps and urban settings in Yemen from 15 April 2020 to 30 Se","2021","07","09","Confl Health","Conflict and health","COVID-19; Community-based surveillance; Complex emergency; IDP camps; Urban settings; Yemen","Baaees","Manal Salem Omar","World Health Organization, Sana'a, Yemen. baaeesm@who","baaeesm@who.int"
"1361","34225760","10.1186/s13031-021-00394-1","Community-based surveillance in internally displaced people's camps and urban settings during a complex emergency in Yemen in 2020.","The need for early identification of coronavirus disease (COVID-19) cases in communities was high in Yemen during the first wave of the COVID-19 epidemic because most cases presenting to health facilities were severe. Early detection of cases would allow early interventions to interrupt the transmission chains. This study aimed to describe the implementation of community-based surveillance (CBS) in in internally displaced people (IDP) camps and urban settings in Yemen from 15 April 2020 to 30 Se","2021","07","09","Confl Health","Conflict and health","COVID-19; Community-based surveillance; Complex emergency; IDP camps; Urban settings; Yemen","Naiene","Jeremias D","World Health Organization, Sana'a, Yemen",NA
"1362","34225760","10.1186/s13031-021-00394-1","Community-based surveillance in internally displaced people's camps and urban settings during a complex emergency in Yemen in 2020.","The need for early identification of coronavirus disease (COVID-19) cases in communities was high in Yemen during the first wave of the COVID-19 epidemic because most cases presenting to health facilities were severe. Early detection of cases would allow early interventions to interrupt the transmission chains. This study aimed to describe the implementation of community-based surveillance (CBS) in in internally displaced people (IDP) camps and urban settings in Yemen from 15 April 2020 to 30 Se","2021","07","09","Confl Health","Conflict and health","COVID-19; Community-based surveillance; Complex emergency; IDP camps; Urban settings; Yemen","Al-Waleedi","Ali Ahmed","Ministry of Public Health and Population, Aden, Yemen",NA
"1363","34225760","10.1186/s13031-021-00394-1","Community-based surveillance in internally displaced people's camps and urban settings during a complex emergency in Yemen in 2020.","The need for early identification of coronavirus disease (COVID-19) cases in communities was high in Yemen during the first wave of the COVID-19 epidemic because most cases presenting to health facilities were severe. Early detection of cases would allow early interventions to interrupt the transmission chains. This study aimed to describe the implementation of community-based surveillance (CBS) in in internally displaced people (IDP) camps and urban settings in Yemen from 15 April 2020 to 30 Se","2021","07","09","Confl Health","Conflict and health","COVID-19; Community-based surveillance; Complex emergency; IDP camps; Urban settings; Yemen","Bin-Azoon","Nasreen Salem","Ministry of Public Health and Population, Aden, Yemen",NA
"1364","34225760","10.1186/s13031-021-00394-1","Community-based surveillance in internally displaced people's camps and urban settings during a complex emergency in Yemen in 2020.","The need for early identification of coronavirus disease (COVID-19) cases in communities was high in Yemen during the first wave of the COVID-19 epidemic because most cases presenting to health facilities were severe. Early detection of cases would allow early interventions to interrupt the transmission chains. This study aimed to describe the implementation of community-based surveillance (CBS) in in internally displaced people (IDP) camps and urban settings in Yemen from 15 April 2020 to 30 Se","2021","07","09","Confl Health","Conflict and health","COVID-19; Community-based surveillance; Complex emergency; IDP camps; Urban settings; Yemen","Khan","Muhammad Fawad","World Health Organization, Sana'a, Yemen",NA
"1365","34225760","10.1186/s13031-021-00394-1","Community-based surveillance in internally displaced people's camps and urban settings during a complex emergency in Yemen in 2020.","The need for early identification of coronavirus disease (COVID-19) cases in communities was high in Yemen during the first wave of the COVID-19 epidemic because most cases presenting to health facilities were severe. Early detection of cases would allow early interventions to interrupt the transmission chains. This study aimed to describe the implementation of community-based surveillance (CBS) in in internally displaced people (IDP) camps and urban settings in Yemen from 15 April 2020 to 30 Se","2021","07","09","Confl Health","Conflict and health","COVID-19; Community-based surveillance; Complex emergency; IDP camps; Urban settings; Yemen","Mahmoud","Nuha","World Health Organization, Sana'a, Yemen",NA
"1366","34225760","10.1186/s13031-021-00394-1","Community-based surveillance in internally displaced people's camps and urban settings during a complex emergency in Yemen in 2020.","The need for early identification of coronavirus disease (COVID-19) cases in communities was high in Yemen during the first wave of the COVID-19 epidemic because most cases presenting to health facilities were severe. Early detection of cases would allow early interventions to interrupt the transmission chains. This study aimed to describe the implementation of community-based surveillance (CBS) in in internally displaced people (IDP) camps and urban settings in Yemen from 15 April 2020 to 30 Se","2021","07","09","Confl Health","Conflict and health","COVID-19; Community-based surveillance; Complex emergency; IDP camps; Urban settings; Yemen","Musani","Altaf","World Health Organization, Sana'a, Yemen",NA
"1367","34225749","10.1186/s12967-021-02965-5","HLA-dependent heterogeneity and macrophage immunoproteasome activation during lung COVID-19 disease.","The worldwide pandemic caused by the SARS-CoV-2 virus is characterized by significant and unpredictable heterogeneity in symptoms that remains poorly understood. Transcriptome and single cell transcriptome of COVID19 lung were integrated with deeplearning analysis of MHC class I immunopeptidome against SARS-COV2 proteome. An analysis of the transcriptomes of lung samples from COVID-19 patients revealed that activation of MHC class I antigen presentation in these tissues was correlated with the a","2021","07","08","J Transl Med","Journal of translational medicine","Antigen presentation; COVID-19; HLA; Immunoproteasome; Integrative analysis; MHC class-I; Macrophage; Peptidome; Transcriptome; COVID-19; COVID-19 Vaccines; Humans; Lung; Macrophages; RNA, Viral; SARS-CoV-2","Desterke","Christophe","INSERM UA9- University Paris-Saclay, 94800, Villejuif, France",NA
"1368","34225749","10.1186/s12967-021-02965-5","HLA-dependent heterogeneity and macrophage immunoproteasome activation during lung COVID-19 disease.","The worldwide pandemic caused by the SARS-CoV-2 virus is characterized by significant and unpredictable heterogeneity in symptoms that remains poorly understood. Transcriptome and single cell transcriptome of COVID19 lung were integrated with deeplearning analysis of MHC class I immunopeptidome against SARS-COV2 proteome. An analysis of the transcriptomes of lung samples from COVID-19 patients revealed that activation of MHC class I antigen presentation in these tissues was correlated with the a","2021","07","08","J Transl Med","Journal of translational medicine","Antigen presentation; COVID-19; HLA; Immunoproteasome; Integrative analysis; MHC class-I; Macrophage; Peptidome; Transcriptome; COVID-19; COVID-19 Vaccines; Humans; Lung; Macrophages; RNA, Viral; SARS-CoV-2","Turhan","Ali G","INSERM UA9- University Paris-Saclay, 94800, Villejuif, France",NA
"1369","34225749","10.1186/s12967-021-02965-5","HLA-dependent heterogeneity and macrophage immunoproteasome activation during lung COVID-19 disease.","The worldwide pandemic caused by the SARS-CoV-2 virus is characterized by significant and unpredictable heterogeneity in symptoms that remains poorly understood. Transcriptome and single cell transcriptome of COVID19 lung were integrated with deeplearning analysis of MHC class I immunopeptidome against SARS-COV2 proteome. An analysis of the transcriptomes of lung samples from COVID-19 patients revealed that activation of MHC class I antigen presentation in these tissues was correlated with the a","2021","07","08","J Transl Med","Journal of translational medicine","Antigen presentation; COVID-19; HLA; Immunoproteasome; Integrative analysis; MHC class-I; Macrophage; Peptidome; Transcriptome; COVID-19; COVID-19 Vaccines; Humans; Lung; Macrophages; RNA, Viral; SARS-CoV-2","Bennaceur-Griscelli","Annelise","INSERM UA9- University Paris-Saclay, 94800, Villejuif, France",NA
"1370","34225749","10.1186/s12967-021-02965-5","HLA-dependent heterogeneity and macrophage immunoproteasome activation during lung COVID-19 disease.","The worldwide pandemic caused by the SARS-CoV-2 virus is characterized by significant and unpredictable heterogeneity in symptoms that remains poorly understood. Transcriptome and single cell transcriptome of COVID19 lung were integrated with deeplearning analysis of MHC class I immunopeptidome against SARS-COV2 proteome. An analysis of the transcriptomes of lung samples from COVID-19 patients revealed that activation of MHC class I antigen presentation in these tissues was correlated with the a","2021","07","08","J Transl Med","Journal of translational medicine","Antigen presentation; COVID-19; HLA; Immunoproteasome; Integrative analysis; MHC class-I; Macrophage; Peptidome; Transcriptome; COVID-19; COVID-19 Vaccines; Humans; Lung; Macrophages; RNA, Viral; SARS-CoV-2","Griscelli","Frank","INSERM UA9- University Paris-Saclay, 94800, Villejuif, France. franck.griscelli@gustaveroussy","franck.griscelli@gustaveroussy.fr"
"1371","34225721","10.1186/s12913-021-06699-4","Difficulties encountered by public health workers in COVID-19 outbreak: a cross-sectional study based on five provinces.","The aim of this study is to address the difficulties encountered by public health workers in the early and middle stages of their efforts to combat COVID-19, compare the gaps among different types of institutions, and identify shortcomings in epidemic control. Using multi-stage sampling, a survey of public health workers involved in the prevention and control of COVID-19 was conducted from 18 February to 1 March 2020 through a self-administered questionnaire. These public health workers were fro","2021","07","07","BMC Health Serv Res","BMC health services research","COVID-19; Difficulties; Public health workers; COVID-19; China; Cross-Sectional Studies; Disease Outbreaks; Humans; Public Health; SARS-CoV-2; Surveys and Questionnaires","Du","Zhicheng","School of Public Health, Global Health Institute, Key Laboratory of Tropical Disease Control, Sun Yat-sen University, 510080, Guangzhou, China",NA
"1372","34225721","10.1186/s12913-021-06699-4","Difficulties encountered by public health workers in COVID-19 outbreak: a cross-sectional study based on five provinces.","The aim of this study is to address the difficulties encountered by public health workers in the early and middle stages of their efforts to combat COVID-19, compare the gaps among different types of institutions, and identify shortcomings in epidemic control. Using multi-stage sampling, a survey of public health workers involved in the prevention and control of COVID-19 was conducted from 18 February to 1 March 2020 through a self-administered questionnaire. These public health workers were fro","2021","07","07","BMC Health Serv Res","BMC health services research","COVID-19; Difficulties; Public health workers; COVID-19; China; Cross-Sectional Studies; Disease Outbreaks; Humans; Public Health; SARS-CoV-2; Surveys and Questionnaires","You","Hua","School of Public Health, Nanjing Medical University, 210000, Nanjing, China",NA
"1373","34225721","10.1186/s12913-021-06699-4","Difficulties encountered by public health workers in COVID-19 outbreak: a cross-sectional study based on five provinces.","The aim of this study is to address the difficulties encountered by public health workers in the early and middle stages of their efforts to combat COVID-19, compare the gaps among different types of institutions, and identify shortcomings in epidemic control. Using multi-stage sampling, a survey of public health workers involved in the prevention and control of COVID-19 was conducted from 18 February to 1 March 2020 through a self-administered questionnaire. These public health workers were fro","2021","07","07","BMC Health Serv Res","BMC health services research","COVID-19; Difficulties; Public health workers; COVID-19; China; Cross-Sectional Studies; Disease Outbreaks; Humans; Public Health; SARS-CoV-2; Surveys and Questionnaires","Zhou","Huan","West China School of Public Health, West China Fourth Hospital, Sichuan University, 610000, Chengdu, China",NA
"1374","34225721","10.1186/s12913-021-06699-4","Difficulties encountered by public health workers in COVID-19 outbreak: a cross-sectional study based on five provinces.","The aim of this study is to address the difficulties encountered by public health workers in the early and middle stages of their efforts to combat COVID-19, compare the gaps among different types of institutions, and identify shortcomings in epidemic control. Using multi-stage sampling, a survey of public health workers involved in the prevention and control of COVID-19 was conducted from 18 February to 1 March 2020 through a self-administered questionnaire. These public health workers were fro","2021","07","07","BMC Health Serv Res","BMC health services research","COVID-19; Difficulties; Public health workers; COVID-19; China; Cross-Sectional Studies; Disease Outbreaks; Humans; Public Health; SARS-CoV-2; Surveys and Questionnaires","Wang","Xiaohui","School of Public Health, Lanzhou University, 730000, Lanzhou, China",NA
"1375","34225721","10.1186/s12913-021-06699-4","Difficulties encountered by public health workers in COVID-19 outbreak: a cross-sectional study based on five provinces.","The aim of this study is to address the difficulties encountered by public health workers in the early and middle stages of their efforts to combat COVID-19, compare the gaps among different types of institutions, and identify shortcomings in epidemic control. Using multi-stage sampling, a survey of public health workers involved in the prevention and control of COVID-19 was conducted from 18 February to 1 March 2020 through a self-administered questionnaire. These public health workers were fro","2021","07","07","BMC Health Serv Res","BMC health services research","COVID-19; Difficulties; Public health workers; COVID-19; China; Cross-Sectional Studies; Disease Outbreaks; Humans; Public Health; SARS-CoV-2; Surveys and Questionnaires","Xu","Jingdong","Hubei Provincial Center for Disease Control and Prevention, 430097, Wuhan, China",NA
"1376","34225721","10.1186/s12913-021-06699-4","Difficulties encountered by public health workers in COVID-19 outbreak: a cross-sectional study based on five provinces.","The aim of this study is to address the difficulties encountered by public health workers in the early and middle stages of their efforts to combat COVID-19, compare the gaps among different types of institutions, and identify shortcomings in epidemic control. Using multi-stage sampling, a survey of public health workers involved in the prevention and control of COVID-19 was conducted from 18 February to 1 March 2020 through a self-administered questionnaire. These public health workers were fro","2021","07","07","BMC Health Serv Res","BMC health services research","COVID-19; Difficulties; Public health workers; COVID-19; China; Cross-Sectional Studies; Disease Outbreaks; Humans; Public Health; SARS-CoV-2; Surveys and Questionnaires","Li","Yan","Guangzhou Center for Disease Control and Prevention, 510440, Guangzhou, China",NA
"1377","34225721","10.1186/s12913-021-06699-4","Difficulties encountered by public health workers in COVID-19 outbreak: a cross-sectional study based on five provinces.","The aim of this study is to address the difficulties encountered by public health workers in the early and middle stages of their efforts to combat COVID-19, compare the gaps among different types of institutions, and identify shortcomings in epidemic control. Using multi-stage sampling, a survey of public health workers involved in the prevention and control of COVID-19 was conducted from 18 February to 1 March 2020 through a self-administered questionnaire. These public health workers were fro","2021","07","07","BMC Health Serv Res","BMC health services research","COVID-19; Difficulties; Public health workers; COVID-19; China; Cross-Sectional Studies; Disease Outbreaks; Humans; Public Health; SARS-CoV-2; Surveys and Questionnaires","Li","Shan","Zigong Center for Disease Control and Prevention, 643000, Zigong, China",NA
"1378","34225721","10.1186/s12913-021-06699-4","Difficulties encountered by public health workers in COVID-19 outbreak: a cross-sectional study based on five provinces.","The aim of this study is to address the difficulties encountered by public health workers in the early and middle stages of their efforts to combat COVID-19, compare the gaps among different types of institutions, and identify shortcomings in epidemic control. Using multi-stage sampling, a survey of public health workers involved in the prevention and control of COVID-19 was conducted from 18 February to 1 March 2020 through a self-administered questionnaire. These public health workers were fro","2021","07","07","BMC Health Serv Res","BMC health services research","COVID-19; Difficulties; Public health workers; COVID-19; China; Cross-Sectional Studies; Disease Outbreaks; Humans; Public Health; SARS-CoV-2; Surveys and Questionnaires","Ma","Lina","Hubei Provincial Center for Disease Control and Prevention, 430097, Wuhan, China",NA
"1379","34225721","10.1186/s12913-021-06699-4","Difficulties encountered by public health workers in COVID-19 outbreak: a cross-sectional study based on five provinces.","The aim of this study is to address the difficulties encountered by public health workers in the early and middle stages of their efforts to combat COVID-19, compare the gaps among different types of institutions, and identify shortcomings in epidemic control. Using multi-stage sampling, a survey of public health workers involved in the prevention and control of COVID-19 was conducted from 18 February to 1 March 2020 through a self-administered questionnaire. These public health workers were fro","2021","07","07","BMC Health Serv Res","BMC health services research","COVID-19; Difficulties; Public health workers; COVID-19; China; Cross-Sectional Studies; Disease Outbreaks; Humans; Public Health; SARS-CoV-2; Surveys and Questionnaires","Gu","Jing","School of Public Health, Global Health Institute, Key Laboratory of Tropical Disease Control, Sun Yat-sen University, 510080, Guangzhou, China. gujing5@mail.sysu.edu","gujing5@mail.sysu.edu.cn"
"1380","34225721","10.1186/s12913-021-06699-4","Difficulties encountered by public health workers in COVID-19 outbreak: a cross-sectional study based on five provinces.","The aim of this study is to address the difficulties encountered by public health workers in the early and middle stages of their efforts to combat COVID-19, compare the gaps among different types of institutions, and identify shortcomings in epidemic control. Using multi-stage sampling, a survey of public health workers involved in the prevention and control of COVID-19 was conducted from 18 February to 1 March 2020 through a self-administered questionnaire. These public health workers were fro","2021","07","07","BMC Health Serv Res","BMC health services research","COVID-19; Difficulties; Public health workers; COVID-19; China; Cross-Sectional Studies; Disease Outbreaks; Humans; Public Health; SARS-CoV-2; Surveys and Questionnaires","Hao","Yuantao","School of Public Health, Global Health Institute, Key Laboratory of Tropical Disease Control, Sun Yat-sen University, 510080, Guangzhou, China",NA
"1381","34225676","10.1186/s12883-021-02295-5","How to forget a ""traumatic"" experience: a case report of transient global amnesia after nasopharyngeal swab for Coronavirus disease 19.","Transient global amnesia (TGA) is a clinical syndrome characterized by a temporary short-term memory loss with inability to retain new memories, usually lasting 2 to 8 h. TGA may be related to several medical procedures, including angiography, general anesthesia, gastroscopy. We report a 58-year-old woman who experiencing TGA one hour after the execution of her first-time nasopharyngeal swab for COVID-19. Brain MRI showed a typical punctate Diffusion Weight Image (DWI) hippocampal lesion. This i","2021","07","16","BMC Neurol","BMC neurology","COVID-19; Case report; Nasopharyngeal swab; SARS-COV-2; TGA; Amnesia, Transient Global; COVID-19; COVID-19 Testing; Female; Humans; Magnetic Resonance Imaging; Middle Aged; Nasopharynx; Specimen Handling","Ravaglia","Sabrina","IRCCS, Mondino Foundation, 27100, Pavia, Italy",NA
"1382","34225676","10.1186/s12883-021-02295-5","How to forget a ""traumatic"" experience: a case report of transient global amnesia after nasopharyngeal swab for Coronavirus disease 19.","Transient global amnesia (TGA) is a clinical syndrome characterized by a temporary short-term memory loss with inability to retain new memories, usually lasting 2 to 8 h. TGA may be related to several medical procedures, including angiography, general anesthesia, gastroscopy. We report a 58-year-old woman who experiencing TGA one hour after the execution of her first-time nasopharyngeal swab for COVID-19. Brain MRI showed a typical punctate Diffusion Weight Image (DWI) hippocampal lesion. This i","2021","07","16","BMC Neurol","BMC neurology","COVID-19; Case report; Nasopharyngeal swab; SARS-COV-2; TGA; Amnesia, Transient Global; COVID-19; COVID-19 Testing; Female; Humans; Magnetic Resonance Imaging; Middle Aged; Nasopharynx; Specimen Handling","Zito","Antonio","IRCCS, Mondino Foundation, 27100, Pavia, Italy. antonio.zito01@universitadipavia","antonio.zito01@universitadipavia.it"
"1383","34225676","10.1186/s12883-021-02295-5","How to forget a ""traumatic"" experience: a case report of transient global amnesia after nasopharyngeal swab for Coronavirus disease 19.","Transient global amnesia (TGA) is a clinical syndrome characterized by a temporary short-term memory loss with inability to retain new memories, usually lasting 2 to 8 h. TGA may be related to several medical procedures, including angiography, general anesthesia, gastroscopy. We report a 58-year-old woman who experiencing TGA one hour after the execution of her first-time nasopharyngeal swab for COVID-19. Brain MRI showed a typical punctate Diffusion Weight Image (DWI) hippocampal lesion. This i","2021","07","16","BMC Neurol","BMC neurology","COVID-19; Case report; Nasopharyngeal swab; SARS-COV-2; TGA; Amnesia, Transient Global; COVID-19; COVID-19 Testing; Female; Humans; Magnetic Resonance Imaging; Middle Aged; Nasopharynx; Specimen Handling","Ahmad","Lara","IRCCS, Mondino Foundation, 27100, Pavia, Italy",NA
"1384","34225676","10.1186/s12883-021-02295-5","How to forget a ""traumatic"" experience: a case report of transient global amnesia after nasopharyngeal swab for Coronavirus disease 19.","Transient global amnesia (TGA) is a clinical syndrome characterized by a temporary short-term memory loss with inability to retain new memories, usually lasting 2 to 8 h. TGA may be related to several medical procedures, including angiography, general anesthesia, gastroscopy. We report a 58-year-old woman who experiencing TGA one hour after the execution of her first-time nasopharyngeal swab for COVID-19. Brain MRI showed a typical punctate Diffusion Weight Image (DWI) hippocampal lesion. This i","2021","07","16","BMC Neurol","BMC neurology","COVID-19; Case report; Nasopharyngeal swab; SARS-COV-2; TGA; Amnesia, Transient Global; COVID-19; COVID-19 Testing; Female; Humans; Magnetic Resonance Imaging; Middle Aged; Nasopharynx; Specimen Handling","Canavero","Isabella","Cerebrovascular Diseases Unit, Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta, Milan, Italy",NA
"1385","34225674","10.1186/s12889-021-11378-4","Reach, engagement and effectiveness of in-person and online lifestyle change programs to prevent diabetes.","COVID-19 has accelerated interest in and need for online delivery of healthcare. We examined the reach, engagement and effectiveness of online delivery of lifestyle change programs (LCP) modelled after the Diabetes Prevention Program (DPP) in a multistate, real-world setting. Longitudinal, non-randomized study comparing online and in-person LCP in a large multistate sample delivered over 1 year. Sample included at-risk adults (n = 26,743) referred to online (n = 9) and in-person (n = 11) CDC-rec","2021","07","09","BMC Public Health","BMC public health","DPP; Diabetes prevention programs; Digital; LCP; Lifestyle change programs; Virtual; Adult; COVID-19; Colorado; Diabetes Mellitus, Type 2; Florida; Humans; Life Style; SARS-CoV-2; Weight Reduction Programs","Golovaty","Ilya","Division of General Internal Medicine, University of Washington School of Medicine, Seattle, WA, USA. ilyamg@uw",NA
"1386","34225674","10.1186/s12889-021-11378-4","Reach, engagement and effectiveness of in-person and online lifestyle change programs to prevent diabetes.","COVID-19 has accelerated interest in and need for online delivery of healthcare. We examined the reach, engagement and effectiveness of online delivery of lifestyle change programs (LCP) modelled after the Diabetes Prevention Program (DPP) in a multistate, real-world setting. Longitudinal, non-randomized study comparing online and in-person LCP in a large multistate sample delivered over 1 year. Sample included at-risk adults (n = 26,743) referred to online (n = 9) and in-person (n = 11) CDC-rec","2021","07","09","BMC Public Health","BMC public health","DPP; Diabetes prevention programs; Digital; LCP; Lifestyle change programs; Virtual; Adult; COVID-19; Colorado; Diabetes Mellitus, Type 2; Florida; Humans; Life Style; SARS-CoV-2; Weight Reduction Programs","Wadhwa","Sandeep","Division of Geriatric Medicine, University of Colorado School of Medicine, Aurora, CO, USA",NA
"1387","34225674","10.1186/s12889-021-11378-4","Reach, engagement and effectiveness of in-person and online lifestyle change programs to prevent diabetes.","COVID-19 has accelerated interest in and need for online delivery of healthcare. We examined the reach, engagement and effectiveness of online delivery of lifestyle change programs (LCP) modelled after the Diabetes Prevention Program (DPP) in a multistate, real-world setting. Longitudinal, non-randomized study comparing online and in-person LCP in a large multistate sample delivered over 1 year. Sample included at-risk adults (n = 26,743) referred to online (n = 9) and in-person (n = 11) CDC-rec","2021","07","09","BMC Public Health","BMC public health","DPP; Diabetes prevention programs; Digital; LCP; Lifestyle change programs; Virtual; Adult; COVID-19; Colorado; Diabetes Mellitus, Type 2; Florida; Humans; Life Style; SARS-CoV-2; Weight Reduction Programs","Fisher","Lois","Division of General Internal Medicine, Department of Medicine, University of California San Francisco, San Francisco, CA, USA",NA
"1388","34225674","10.1186/s12889-021-11378-4","Reach, engagement and effectiveness of in-person and online lifestyle change programs to prevent diabetes.","COVID-19 has accelerated interest in and need for online delivery of healthcare. We examined the reach, engagement and effectiveness of online delivery of lifestyle change programs (LCP) modelled after the Diabetes Prevention Program (DPP) in a multistate, real-world setting. Longitudinal, non-randomized study comparing online and in-person LCP in a large multistate sample delivered over 1 year. Sample included at-risk adults (n = 26,743) referred to online (n = 9) and in-person (n = 11) CDC-rec","2021","07","09","BMC Public Health","BMC public health","DPP; Diabetes prevention programs; Digital; LCP; Lifestyle change programs; Virtual; Adult; COVID-19; Colorado; Diabetes Mellitus, Type 2; Florida; Humans; Life Style; SARS-CoV-2; Weight Reduction Programs","Lobach","Iryna","Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA, USA",NA
"1389","34225674","10.1186/s12889-021-11378-4","Reach, engagement and effectiveness of in-person and online lifestyle change programs to prevent diabetes.","COVID-19 has accelerated interest in and need for online delivery of healthcare. We examined the reach, engagement and effectiveness of online delivery of lifestyle change programs (LCP) modelled after the Diabetes Prevention Program (DPP) in a multistate, real-world setting. Longitudinal, non-randomized study comparing online and in-person LCP in a large multistate sample delivered over 1 year. Sample included at-risk adults (n = 26,743) referred to online (n = 9) and in-person (n = 11) CDC-rec","2021","07","09","BMC Public Health","BMC public health","DPP; Diabetes prevention programs; Digital; LCP; Lifestyle change programs; Virtual; Adult; COVID-19; Colorado; Diabetes Mellitus, Type 2; Florida; Humans; Life Style; SARS-CoV-2; Weight Reduction Programs","Crowe","Byron","Division of Geriatric Medicine, University of Colorado School of Medicine, Aurora, CO, USA",NA
"1390","34225674","10.1186/s12889-021-11378-4","Reach, engagement and effectiveness of in-person and online lifestyle change programs to prevent diabetes.","COVID-19 has accelerated interest in and need for online delivery of healthcare. We examined the reach, engagement and effectiveness of online delivery of lifestyle change programs (LCP) modelled after the Diabetes Prevention Program (DPP) in a multistate, real-world setting. Longitudinal, non-randomized study comparing online and in-person LCP in a large multistate sample delivered over 1 year. Sample included at-risk adults (n = 26,743) referred to online (n = 9) and in-person (n = 11) CDC-rec","2021","07","09","BMC Public Health","BMC public health","DPP; Diabetes prevention programs; Digital; LCP; Lifestyle change programs; Virtual; Adult; COVID-19; Colorado; Diabetes Mellitus, Type 2; Florida; Humans; Life Style; SARS-CoV-2; Weight Reduction Programs","Levi","Ronli","Division of General Internal Medicine, Department of Medicine, University of California San Francisco, San Francisco, CA, USA",NA
"1391","34225674","10.1186/s12889-021-11378-4","Reach, engagement and effectiveness of in-person and online lifestyle change programs to prevent diabetes.","COVID-19 has accelerated interest in and need for online delivery of healthcare. We examined the reach, engagement and effectiveness of online delivery of lifestyle change programs (LCP) modelled after the Diabetes Prevention Program (DPP) in a multistate, real-world setting. Longitudinal, non-randomized study comparing online and in-person LCP in a large multistate sample delivered over 1 year. Sample included at-risk adults (n = 26,743) referred to online (n = 9) and in-person (n = 11) CDC-rec","2021","07","09","BMC Public Health","BMC public health","DPP; Diabetes prevention programs; Digital; LCP; Lifestyle change programs; Virtual; Adult; COVID-19; Colorado; Diabetes Mellitus, Type 2; Florida; Humans; Life Style; SARS-CoV-2; Weight Reduction Programs","Seligman","Hilary","Division of General Internal Medicine, Department of Medicine, University of California San Francisco, San Francisco, CA, USA",NA
"1392","34225657","10.1186/s12879-021-06251-z","Epidemiology of SARS-CoV2 in Qatar's primary care population aged 10 years and above.","There is an urgent need to elucidate the epidemiology of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2) and characterize its potential impact. Investing in characterising the SARS-CoV2 will help plan and improve the response to the pandemic. Furthermore, it will help identify the most efficient ways of managing the pandemic, avoiding public health policies and interventions that may be unduly restrictive of normal activity or unnecessarily costly. This paper describes the design","2021","07","20","BMC Infect Dis","BMC infectious diseases","COVID-19; Epidemiology; Primary care; SARS-CoV2; Adolescent; Adult; Aged; Aged, 80 and over; COVID-19; Child; Female; Humans; Male; Middle Aged; Prevalence; Primary Health Care; Qatar; SARS-CoV-2; Young Adult","Syed","Mohamed Ahmed","Department of Clinical Research, Primary Health Care Corporation, P.O. Box 26555, Doha, Qatar. ahmed.sy3d@gmail","ahmed.sy3d@gmail.com"
"1393","34225657","10.1186/s12879-021-06251-z","Epidemiology of SARS-CoV2 in Qatar's primary care population aged 10 years and above.","There is an urgent need to elucidate the epidemiology of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2) and characterize its potential impact. Investing in characterising the SARS-CoV2 will help plan and improve the response to the pandemic. Furthermore, it will help identify the most efficient ways of managing the pandemic, avoiding public health policies and interventions that may be unduly restrictive of normal activity or unnecessarily costly. This paper describes the design","2021","07","20","BMC Infect Dis","BMC infectious diseases","COVID-19; Epidemiology; Primary care; SARS-CoV2; Adolescent; Adult; Aged; Aged, 80 and over; COVID-19; Child; Female; Humans; Male; Middle Aged; Prevalence; Primary Health Care; Qatar; SARS-CoV-2; Young Adult","Al Nuaimi","Ahmed Sameer","Department of Clinical Research, Primary Health Care Corporation, P.O. Box 26555, Doha, Qatar",NA
"1394","34225657","10.1186/s12879-021-06251-z","Epidemiology of SARS-CoV2 in Qatar's primary care population aged 10 years and above.","There is an urgent need to elucidate the epidemiology of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2) and characterize its potential impact. Investing in characterising the SARS-CoV2 will help plan and improve the response to the pandemic. Furthermore, it will help identify the most efficient ways of managing the pandemic, avoiding public health policies and interventions that may be unduly restrictive of normal activity or unnecessarily costly. This paper describes the design","2021","07","20","BMC Infect Dis","BMC infectious diseases","COVID-19; Epidemiology; Primary care; SARS-CoV2; Adolescent; Adult; Aged; Aged, 80 and over; COVID-19; Child; Female; Humans; Male; Middle Aged; Prevalence; Primary Health Care; Qatar; SARS-CoV-2; Young Adult","A/Qotba","Hamda Abdulla","Department of Clinical Research, Primary Health Care Corporation, P.O. Box 26555, Doha, Qatar",NA
"1395","34225657","10.1186/s12879-021-06251-z","Epidemiology of SARS-CoV2 in Qatar's primary care population aged 10 years and above.","There is an urgent need to elucidate the epidemiology of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2) and characterize its potential impact. Investing in characterising the SARS-CoV2 will help plan and improve the response to the pandemic. Furthermore, it will help identify the most efficient ways of managing the pandemic, avoiding public health policies and interventions that may be unduly restrictive of normal activity or unnecessarily costly. This paper describes the design","2021","07","20","BMC Infect Dis","BMC infectious diseases","COVID-19; Epidemiology; Primary care; SARS-CoV2; Adolescent; Adult; Aged; Aged, 80 and over; COVID-19; Child; Female; Humans; Male; Middle Aged; Prevalence; Primary Health Care; Qatar; SARS-CoV-2; Young Adult","Nasrallah","Gheyath K","Biomedical Research Center, Qatar University, P.O. Box 2713, Doha, Qatar",NA
"1396","34225657","10.1186/s12879-021-06251-z","Epidemiology of SARS-CoV2 in Qatar's primary care population aged 10 years and above.","There is an urgent need to elucidate the epidemiology of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2) and characterize its potential impact. Investing in characterising the SARS-CoV2 will help plan and improve the response to the pandemic. Furthermore, it will help identify the most efficient ways of managing the pandemic, avoiding public health policies and interventions that may be unduly restrictive of normal activity or unnecessarily costly. This paper describes the design","2021","07","20","BMC Infect Dis","BMC infectious diseases","COVID-19; Epidemiology; Primary care; SARS-CoV2; Adolescent; Adult; Aged; Aged, 80 and over; COVID-19; Child; Female; Humans; Male; Middle Aged; Prevalence; Primary Health Care; Qatar; SARS-CoV-2; Young Adult","Althani","Asmaa A","Biomedical Research Center, Qatar University, P.O. Box 2713, Doha, Qatar",NA
"1397","34225657","10.1186/s12879-021-06251-z","Epidemiology of SARS-CoV2 in Qatar's primary care population aged 10 years and above.","There is an urgent need to elucidate the epidemiology of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2) and characterize its potential impact. Investing in characterising the SARS-CoV2 will help plan and improve the response to the pandemic. Furthermore, it will help identify the most efficient ways of managing the pandemic, avoiding public health policies and interventions that may be unduly restrictive of normal activity or unnecessarily costly. This paper describes the design","2021","07","20","BMC Infect Dis","BMC infectious diseases","COVID-19; Epidemiology; Primary care; SARS-CoV2; Adolescent; Adult; Aged; Aged, 80 and over; COVID-19; Child; Female; Humans; Male; Middle Aged; Prevalence; Primary Health Care; Qatar; SARS-CoV-2; Young Adult","Yassine","Hadi M","Biomedical Research Center, Qatar University, P.O. Box 2713, Doha, Qatar",NA
"1398","34225657","10.1186/s12879-021-06251-z","Epidemiology of SARS-CoV2 in Qatar's primary care population aged 10 years and above.","There is an urgent need to elucidate the epidemiology of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2) and characterize its potential impact. Investing in characterising the SARS-CoV2 will help plan and improve the response to the pandemic. Furthermore, it will help identify the most efficient ways of managing the pandemic, avoiding public health policies and interventions that may be unduly restrictive of normal activity or unnecessarily costly. This paper describes the design","2021","07","20","BMC Infect Dis","BMC infectious diseases","COVID-19; Epidemiology; Primary care; SARS-CoV2; Adolescent; Adult; Aged; Aged, 80 and over; COVID-19; Child; Female; Humans; Male; Middle Aged; Prevalence; Primary Health Care; Qatar; SARS-CoV-2; Young Adult","Zainel","Abduljaleel Abdullatif","Department of Clinical Research, Primary Health Care Corporation, P.O. Box 26555, Doha, Qatar",NA
"1399","34225657","10.1186/s12879-021-06251-z","Epidemiology of SARS-CoV2 in Qatar's primary care population aged 10 years and above.","There is an urgent need to elucidate the epidemiology of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2) and characterize its potential impact. Investing in characterising the SARS-CoV2 will help plan and improve the response to the pandemic. Furthermore, it will help identify the most efficient ways of managing the pandemic, avoiding public health policies and interventions that may be unduly restrictive of normal activity or unnecessarily costly. This paper describes the design","2021","07","20","BMC Infect Dis","BMC infectious diseases","COVID-19; Epidemiology; Primary care; SARS-CoV2; Adolescent; Adult; Aged; Aged, 80 and over; COVID-19; Child; Female; Humans; Male; Middle Aged; Prevalence; Primary Health Care; Qatar; SARS-CoV-2; Young Adult","Khudadad","Hanan","Department of Clinical Research, Primary Health Care Corporation, P.O. Box 26555, Doha, Qatar",NA
"1400","34225657","10.1186/s12879-021-06251-z","Epidemiology of SARS-CoV2 in Qatar's primary care population aged 10 years and above.","There is an urgent need to elucidate the epidemiology of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2) and characterize its potential impact. Investing in characterising the SARS-CoV2 will help plan and improve the response to the pandemic. Furthermore, it will help identify the most efficient ways of managing the pandemic, avoiding public health policies and interventions that may be unduly restrictive of normal activity or unnecessarily costly. This paper describes the design","2021","07","20","BMC Infect Dis","BMC infectious diseases","COVID-19; Epidemiology; Primary care; SARS-CoV2; Adolescent; Adult; Aged; Aged, 80 and over; COVID-19; Child; Female; Humans; Male; Middle Aged; Prevalence; Primary Health Care; Qatar; SARS-CoV-2; Young Adult","Marji","Tamara","Department of Clinical Research, Primary Health Care Corporation, P.O. Box 26555, Doha, Qatar",NA
"1401","34225657","10.1186/s12879-021-06251-z","Epidemiology of SARS-CoV2 in Qatar's primary care population aged 10 years and above.","There is an urgent need to elucidate the epidemiology of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2) and characterize its potential impact. Investing in characterising the SARS-CoV2 will help plan and improve the response to the pandemic. Furthermore, it will help identify the most efficient ways of managing the pandemic, avoiding public health policies and interventions that may be unduly restrictive of normal activity or unnecessarily costly. This paper describes the design","2021","07","20","BMC Infect Dis","BMC infectious diseases","COVID-19; Epidemiology; Primary care; SARS-CoV2; Adolescent; Adult; Aged; Aged, 80 and over; COVID-19; Child; Female; Humans; Male; Middle Aged; Prevalence; Primary Health Care; Qatar; SARS-CoV-2; Young Adult","Veettil","Shajitha Thekke","Department of Clinical Research, Primary Health Care Corporation, P.O. Box 26555, Doha, Qatar",NA
"1402","34225657","10.1186/s12879-021-06251-z","Epidemiology of SARS-CoV2 in Qatar's primary care population aged 10 years and above.","There is an urgent need to elucidate the epidemiology of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2) and characterize its potential impact. Investing in characterising the SARS-CoV2 will help plan and improve the response to the pandemic. Furthermore, it will help identify the most efficient ways of managing the pandemic, avoiding public health policies and interventions that may be unduly restrictive of normal activity or unnecessarily costly. This paper describes the design","2021","07","20","BMC Infect Dis","BMC infectious diseases","COVID-19; Epidemiology; Primary care; SARS-CoV2; Adolescent; Adult; Aged; Aged, 80 and over; COVID-19; Child; Female; Humans; Male; Middle Aged; Prevalence; Primary Health Care; Qatar; SARS-CoV-2; Young Adult","Al-Jighefee","Hadeel T","Biomedical Research Center, Qatar University, P.O. Box 2713, Doha, Qatar",NA
"1403","34225657","10.1186/s12879-021-06251-z","Epidemiology of SARS-CoV2 in Qatar's primary care population aged 10 years and above.","There is an urgent need to elucidate the epidemiology of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2) and characterize its potential impact. Investing in characterising the SARS-CoV2 will help plan and improve the response to the pandemic. Furthermore, it will help identify the most efficient ways of managing the pandemic, avoiding public health policies and interventions that may be unduly restrictive of normal activity or unnecessarily costly. This paper describes the design","2021","07","20","BMC Infect Dis","BMC infectious diseases","COVID-19; Epidemiology; Primary care; SARS-CoV2; Adolescent; Adult; Aged; Aged, 80 and over; COVID-19; Child; Female; Humans; Male; Middle Aged; Prevalence; Primary Health Care; Qatar; SARS-CoV-2; Young Adult","Younes","Salma","Biomedical Research Center, Qatar University, P.O. Box 2713, Doha, Qatar",NA
"1404","34225657","10.1186/s12879-021-06251-z","Epidemiology of SARS-CoV2 in Qatar's primary care population aged 10 years and above.","There is an urgent need to elucidate the epidemiology of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2) and characterize its potential impact. Investing in characterising the SARS-CoV2 will help plan and improve the response to the pandemic. Furthermore, it will help identify the most efficient ways of managing the pandemic, avoiding public health policies and interventions that may be unduly restrictive of normal activity or unnecessarily costly. This paper describes the design","2021","07","20","BMC Infect Dis","BMC infectious diseases","COVID-19; Epidemiology; Primary care; SARS-CoV2; Adolescent; Adult; Aged; Aged, 80 and over; COVID-19; Child; Female; Humans; Male; Middle Aged; Prevalence; Primary Health Care; Qatar; SARS-CoV-2; Young Adult","Shurrab","Farah","Biomedical Research Center, Qatar University, P.O. Box 2713, Doha, Qatar",NA
"1405","34225657","10.1186/s12879-021-06251-z","Epidemiology of SARS-CoV2 in Qatar's primary care population aged 10 years and above.","There is an urgent need to elucidate the epidemiology of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2) and characterize its potential impact. Investing in characterising the SARS-CoV2 will help plan and improve the response to the pandemic. Furthermore, it will help identify the most efficient ways of managing the pandemic, avoiding public health policies and interventions that may be unduly restrictive of normal activity or unnecessarily costly. This paper describes the design","2021","07","20","BMC Infect Dis","BMC infectious diseases","COVID-19; Epidemiology; Primary care; SARS-CoV2; Adolescent; Adult; Aged; Aged, 80 and over; COVID-19; Child; Female; Humans; Male; Middle Aged; Prevalence; Primary Health Care; Qatar; SARS-CoV-2; Young Adult","Al-Sadeq","Duaa W","Biomedical Research Center, Qatar University, P.O. Box 2713, Doha, Qatar",NA
"1406","34225657","10.1186/s12879-021-06251-z","Epidemiology of SARS-CoV2 in Qatar's primary care population aged 10 years and above.","There is an urgent need to elucidate the epidemiology of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2) and characterize its potential impact. Investing in characterising the SARS-CoV2 will help plan and improve the response to the pandemic. Furthermore, it will help identify the most efficient ways of managing the pandemic, avoiding public health policies and interventions that may be unduly restrictive of normal activity or unnecessarily costly. This paper describes the design","2021","07","20","BMC Infect Dis","BMC infectious diseases","COVID-19; Epidemiology; Primary care; SARS-CoV2; Adolescent; Adult; Aged; Aged, 80 and over; COVID-19; Child; Female; Humans; Male; Middle Aged; Prevalence; Primary Health Care; Qatar; SARS-CoV-2; Young Adult","AlFehaidi","Al Anoud Saleh","Department of Clinical Research, Primary Health Care Corporation, P.O. Box 26555, Doha, Qatar",NA
"1407","34225657","10.1186/s12879-021-06251-z","Epidemiology of SARS-CoV2 in Qatar's primary care population aged 10 years and above.","There is an urgent need to elucidate the epidemiology of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2) and characterize its potential impact. Investing in characterising the SARS-CoV2 will help plan and improve the response to the pandemic. Furthermore, it will help identify the most efficient ways of managing the pandemic, avoiding public health policies and interventions that may be unduly restrictive of normal activity or unnecessarily costly. This paper describes the design","2021","07","20","BMC Infect Dis","BMC infectious diseases","COVID-19; Epidemiology; Primary care; SARS-CoV2; Adolescent; Adult; Aged; Aged, 80 and over; COVID-19; Child; Female; Humans; Male; Middle Aged; Prevalence; Primary Health Care; Qatar; SARS-CoV-2; Young Adult","Yfakhroo","Ameena Ibrahim","Department of Clinical Research, Primary Health Care Corporation, P.O. Box 26555, Doha, Qatar",NA
"1408","34225657","10.1186/s12879-021-06251-z","Epidemiology of SARS-CoV2 in Qatar's primary care population aged 10 years and above.","There is an urgent need to elucidate the epidemiology of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2) and characterize its potential impact. Investing in characterising the SARS-CoV2 will help plan and improve the response to the pandemic. Furthermore, it will help identify the most efficient ways of managing the pandemic, avoiding public health policies and interventions that may be unduly restrictive of normal activity or unnecessarily costly. This paper describes the design","2021","07","20","BMC Infect Dis","BMC infectious diseases","COVID-19; Epidemiology; Primary care; SARS-CoV2; Adolescent; Adult; Aged; Aged, 80 and over; COVID-19; Child; Female; Humans; Male; Middle Aged; Prevalence; Primary Health Care; Qatar; SARS-CoV-2; Young Adult","AlMesaifri","Meshal Abdulla","Department of Clinical Research, Primary Health Care Corporation, P.O. Box 26555, Doha, Qatar",NA
"1409","34225657","10.1186/s12879-021-06251-z","Epidemiology of SARS-CoV2 in Qatar's primary care population aged 10 years and above.","There is an urgent need to elucidate the epidemiology of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2) and characterize its potential impact. Investing in characterising the SARS-CoV2 will help plan and improve the response to the pandemic. Furthermore, it will help identify the most efficient ways of managing the pandemic, avoiding public health policies and interventions that may be unduly restrictive of normal activity or unnecessarily costly. This paper describes the design","2021","07","20","BMC Infect Dis","BMC infectious diseases","COVID-19; Epidemiology; Primary care; SARS-CoV2; Adolescent; Adult; Aged; Aged, 80 and over; COVID-19; Child; Female; Humans; Male; Middle Aged; Prevalence; Primary Health Care; Qatar; SARS-CoV-2; Young Adult","Al Mujalli","Hanan","Directorate of Clinical Affairs, Primary Health Care Corporation, P.O. Box 26555, Doha, Qatar",NA
"1410","34225657","10.1186/s12879-021-06251-z","Epidemiology of SARS-CoV2 in Qatar's primary care population aged 10 years and above.","There is an urgent need to elucidate the epidemiology of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2) and characterize its potential impact. Investing in characterising the SARS-CoV2 will help plan and improve the response to the pandemic. Furthermore, it will help identify the most efficient ways of managing the pandemic, avoiding public health policies and interventions that may be unduly restrictive of normal activity or unnecessarily costly. This paper describes the design","2021","07","20","BMC Infect Dis","BMC infectious diseases","COVID-19; Epidemiology; Primary care; SARS-CoV2; Adolescent; Adult; Aged; Aged, 80 and over; COVID-19; Child; Female; Humans; Male; Middle Aged; Prevalence; Primary Health Care; Qatar; SARS-CoV-2; Young Adult","Al Abdulla","Samya Ahmad","Directorate of Clinical Operations, Primary Health Care Corporation, P.O. Box 26555, Doha, Qatar",NA
"1411","34225657","10.1186/s12879-021-06251-z","Epidemiology of SARS-CoV2 in Qatar's primary care population aged 10 years and above.","There is an urgent need to elucidate the epidemiology of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2) and characterize its potential impact. Investing in characterising the SARS-CoV2 will help plan and improve the response to the pandemic. Furthermore, it will help identify the most efficient ways of managing the pandemic, avoiding public health policies and interventions that may be unduly restrictive of normal activity or unnecessarily costly. This paper describes the design","2021","07","20","BMC Infect Dis","BMC infectious diseases","COVID-19; Epidemiology; Primary care; SARS-CoV2; Adolescent; Adult; Aged; Aged, 80 and over; COVID-19; Child; Female; Humans; Male; Middle Aged; Prevalence; Primary Health Care; Qatar; SARS-CoV-2; Young Adult","Al Kuwari","Mohamed Ghaith","Directorate of Strategy Planning and Health Intelligence, Primary Health Care Corporation, P.O. Box 26555, Doha, Qatar",NA
"1412","34225657","10.1186/s12879-021-06251-z","Epidemiology of SARS-CoV2 in Qatar's primary care population aged 10 years and above.","There is an urgent need to elucidate the epidemiology of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2) and characterize its potential impact. Investing in characterising the SARS-CoV2 will help plan and improve the response to the pandemic. Furthermore, it will help identify the most efficient ways of managing the pandemic, avoiding public health policies and interventions that may be unduly restrictive of normal activity or unnecessarily costly. This paper describes the design","2021","07","20","BMC Infect Dis","BMC infectious diseases","COVID-19; Epidemiology; Primary care; SARS-CoV2; Adolescent; Adult; Aged; Aged, 80 and over; COVID-19; Child; Female; Humans; Male; Middle Aged; Prevalence; Primary Health Care; Qatar; SARS-CoV-2; Young Adult","Azad","Faruk Mohammed","Department of Health Affairs, Ministry of Public Health, P.O. Box 42, Doha, Qatar",NA
"1413","34225657","10.1186/s12879-021-06251-z","Epidemiology of SARS-CoV2 in Qatar's primary care population aged 10 years and above.","There is an urgent need to elucidate the epidemiology of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2) and characterize its potential impact. Investing in characterising the SARS-CoV2 will help plan and improve the response to the pandemic. Furthermore, it will help identify the most efficient ways of managing the pandemic, avoiding public health policies and interventions that may be unduly restrictive of normal activity or unnecessarily costly. This paper describes the design","2021","07","20","BMC Infect Dis","BMC infectious diseases","COVID-19; Epidemiology; Primary care; SARS-CoV2; Adolescent; Adult; Aged; Aged, 80 and over; COVID-19; Child; Female; Humans; Male; Middle Aged; Prevalence; Primary Health Care; Qatar; SARS-CoV-2; Young Adult","Al Malki","Badria Ali Mohamed","Department of Clinical Research, Primary Health Care Corporation, P.O. Box 26555, Doha, Qatar",NA
"1414","34225657","10.1186/s12879-021-06251-z","Epidemiology of SARS-CoV2 in Qatar's primary care population aged 10 years and above.","There is an urgent need to elucidate the epidemiology of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2) and characterize its potential impact. Investing in characterising the SARS-CoV2 will help plan and improve the response to the pandemic. Furthermore, it will help identify the most efficient ways of managing the pandemic, avoiding public health policies and interventions that may be unduly restrictive of normal activity or unnecessarily costly. This paper describes the design","2021","07","20","BMC Infect Dis","BMC infectious diseases","COVID-19; Epidemiology; Primary care; SARS-CoV2; Adolescent; Adult; Aged; Aged, 80 and over; COVID-19; Child; Female; Humans; Male; Middle Aged; Prevalence; Primary Health Care; Qatar; SARS-CoV-2; Young Adult","Abdulmalik","Mariam Ali","Department of Clinical Research, Primary Health Care Corporation, P.O. Box 26555, Doha, Qatar",NA
"1415","34225656","10.1186/s12879-021-06343-w","Comparison of saliva with healthcare workers- and patient-collected swabs in the diagnosis of COVID-19 in a large cohort.","A considerable amount of evidence demonstrates the potential of saliva in the diagnosis of COVID-19. Our aim was to determine the sensitivity of saliva versus swabs collected by healthcare workers (HCWs) and patients themselves to assess whether saliva detection can be offered as a cost-effective, risk-free method of SARS-CoV-2 detection. This study was conducted in a hospital involving outpatients and hospitalized patients. A total of 3018 outpatients were tested. Of these, 200 qRT-PCR-confirme","2021","07","20","BMC Infect Dis","BMC infectious diseases","Healthcare worker; Nasopharyngeal swab; SARS-COV-2; Saliva; Adult; Aged; COVID-19; COVID-19 Testing; Cohort Studies; Female; Health Personnel; Humans; Male; Middle Aged; SARS-CoV-2; Saliva; Specimen Handling","Sasikala","Mitnala","Department of Molecular Biology, Institute of Translational Research, Asian Healthcare Foundation, AIG Hospitals, Survey No 136, Plot No 2/3/4/5, 1, Mindspace Road, Gachibowli, Hyderabad, Telangana, 500032, India. aigres.mit@gmail","aigres.mit@gmail.om"
"1416","34225656","10.1186/s12879-021-06343-w","Comparison of saliva with healthcare workers- and patient-collected swabs in the diagnosis of COVID-19 in a large cohort.","A considerable amount of evidence demonstrates the potential of saliva in the diagnosis of COVID-19. Our aim was to determine the sensitivity of saliva versus swabs collected by healthcare workers (HCWs) and patients themselves to assess whether saliva detection can be offered as a cost-effective, risk-free method of SARS-CoV-2 detection. This study was conducted in a hospital involving outpatients and hospitalized patients. A total of 3018 outpatients were tested. Of these, 200 qRT-PCR-confirme","2021","07","20","BMC Infect Dis","BMC infectious diseases","Healthcare worker; Nasopharyngeal swab; SARS-COV-2; Saliva; Adult; Aged; COVID-19; COVID-19 Testing; Cohort Studies; Female; Health Personnel; Humans; Male; Middle Aged; SARS-CoV-2; Saliva; Specimen Handling","Sadhana","Yelamanchili","Department of Microbiology, AIG Hospitals, Survey No 136, Plot No 2/3/4/5, 1, Mindspace Road, Gachibowli, Hyderabad, Telangana, 500032, India",NA
"1417","34225656","10.1186/s12879-021-06343-w","Comparison of saliva with healthcare workers- and patient-collected swabs in the diagnosis of COVID-19 in a large cohort.","A considerable amount of evidence demonstrates the potential of saliva in the diagnosis of COVID-19. Our aim was to determine the sensitivity of saliva versus swabs collected by healthcare workers (HCWs) and patients themselves to assess whether saliva detection can be offered as a cost-effective, risk-free method of SARS-CoV-2 detection. This study was conducted in a hospital involving outpatients and hospitalized patients. A total of 3018 outpatients were tested. Of these, 200 qRT-PCR-confirme","2021","07","20","BMC Infect Dis","BMC infectious diseases","Healthcare worker; Nasopharyngeal swab; SARS-COV-2; Saliva; Adult; Aged; COVID-19; COVID-19 Testing; Cohort Studies; Female; Health Personnel; Humans; Male; Middle Aged; SARS-CoV-2; Saliva; Specimen Handling","Vijayasarathy","Ketavarapu","Department of Molecular Biology, Institute of Translational Research, Asian Healthcare Foundation, AIG Hospitals, Survey No 136, Plot No 2/3/4/5, 1, Mindspace Road, Gachibowli, Hyderabad, Telangana, 500032, India",NA
"1418","34225656","10.1186/s12879-021-06343-w","Comparison of saliva with healthcare workers- and patient-collected swabs in the diagnosis of COVID-19 in a large cohort.","A considerable amount of evidence demonstrates the potential of saliva in the diagnosis of COVID-19. Our aim was to determine the sensitivity of saliva versus swabs collected by healthcare workers (HCWs) and patients themselves to assess whether saliva detection can be offered as a cost-effective, risk-free method of SARS-CoV-2 detection. This study was conducted in a hospital involving outpatients and hospitalized patients. A total of 3018 outpatients were tested. Of these, 200 qRT-PCR-confirme","2021","07","20","BMC Infect Dis","BMC infectious diseases","Healthcare worker; Nasopharyngeal swab; SARS-COV-2; Saliva; Adult; Aged; COVID-19; COVID-19 Testing; Cohort Studies; Female; Health Personnel; Humans; Male; Middle Aged; SARS-CoV-2; Saliva; Specimen Handling","Gupta","Anand","Department of Critical Care Medicine, AIG Hospitals, Survey No 136, Plot No 2/3/4/5, 1, Mindspace Road, Gachibowli, Hyderabad, Telangana, 500032, India",NA
"1419","34225656","10.1186/s12879-021-06343-w","Comparison of saliva with healthcare workers- and patient-collected swabs in the diagnosis of COVID-19 in a large cohort.","A considerable amount of evidence demonstrates the potential of saliva in the diagnosis of COVID-19. Our aim was to determine the sensitivity of saliva versus swabs collected by healthcare workers (HCWs) and patients themselves to assess whether saliva detection can be offered as a cost-effective, risk-free method of SARS-CoV-2 detection. This study was conducted in a hospital involving outpatients and hospitalized patients. A total of 3018 outpatients were tested. Of these, 200 qRT-PCR-confirme","2021","07","20","BMC Infect Dis","BMC infectious diseases","Healthcare worker; Nasopharyngeal swab; SARS-COV-2; Saliva; Adult; Aged; COVID-19; COVID-19 Testing; Cohort Studies; Female; Health Personnel; Humans; Male; Middle Aged; SARS-CoV-2; Saliva; Specimen Handling","Daram","Sarala Kumari","Department of Critical Care Medicine, AIG Hospitals, Survey No 136, Plot No 2/3/4/5, 1, Mindspace Road, Gachibowli, Hyderabad, Telangana, 500032, India",NA
"1420","34225656","10.1186/s12879-021-06343-w","Comparison of saliva with healthcare workers- and patient-collected swabs in the diagnosis of COVID-19 in a large cohort.","A considerable amount of evidence demonstrates the potential of saliva in the diagnosis of COVID-19. Our aim was to determine the sensitivity of saliva versus swabs collected by healthcare workers (HCWs) and patients themselves to assess whether saliva detection can be offered as a cost-effective, risk-free method of SARS-CoV-2 detection. This study was conducted in a hospital involving outpatients and hospitalized patients. A total of 3018 outpatients were tested. Of these, 200 qRT-PCR-confirme","2021","07","20","BMC Infect Dis","BMC infectious diseases","Healthcare worker; Nasopharyngeal swab; SARS-COV-2; Saliva; Adult; Aged; COVID-19; COVID-19 Testing; Cohort Studies; Female; Health Personnel; Humans; Male; Middle Aged; SARS-CoV-2; Saliva; Specimen Handling","Podduturi","Naveen Chander Reddy","Department of Critical Care Medicine, AIG Hospitals, Survey No 136, Plot No 2/3/4/5, 1, Mindspace Road, Gachibowli, Hyderabad, Telangana, 500032, India",NA
"1421","34225656","10.1186/s12879-021-06343-w","Comparison of saliva with healthcare workers- and patient-collected swabs in the diagnosis of COVID-19 in a large cohort.","A considerable amount of evidence demonstrates the potential of saliva in the diagnosis of COVID-19. Our aim was to determine the sensitivity of saliva versus swabs collected by healthcare workers (HCWs) and patients themselves to assess whether saliva detection can be offered as a cost-effective, risk-free method of SARS-CoV-2 detection. This study was conducted in a hospital involving outpatients and hospitalized patients. A total of 3018 outpatients were tested. Of these, 200 qRT-PCR-confirme","2021","07","20","BMC Infect Dis","BMC infectious diseases","Healthcare worker; Nasopharyngeal swab; SARS-COV-2; Saliva; Adult; Aged; COVID-19; COVID-19 Testing; Cohort Studies; Female; Health Personnel; Humans; Male; Middle Aged; SARS-CoV-2; Saliva; Specimen Handling","Reddy","Duvvur Nageshwar","Department of Medical Gastroenterology, AIG Hospitals, Survey No 136, Plot No 2/3/4/5, 1, Mindspace Road, Gachibowli, Hyderabad, Telangana, 500032, India",NA
"1422","34225645","10.1186/s12879-021-06278-2","Immune cell profiling and antibody responses in patients with COVID-19.","Although there are a growing number of studies on evaluating lymphocyte subset counts as prognostic factors for COVID-19 disease severity, the lymphocyte subsets' analyses of both IgM and IgG responders and non-responders during the periods after onset of symptoms, have not been conducted yet. So, this study aimed to evaluate immune cell profiling of COVID-19 patients with and without antibody responses. In this cross-sectional study, the levels of peripheral lymphocyte subsets were measured usi","2021","07","20","BMC Infect Dis","BMC infectious diseases","Antibody response; COVID-19; Lymphocyte subsets; SARS-CoV-2; Adult; Aged; Antibodies, Viral; Antibody Formation; COVID-19; Cross-Sectional Studies; Female; Humans; Immunoglobulin G; Immunoglobulin M; Lymphocyte Subsets; Male; Middle Aged; SARS-CoV-2","Rezaei","Mitra","Virology Research Center, National Research Institute of Tuberculosis and Lung diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran",NA
"1423","34225645","10.1186/s12879-021-06278-2","Immune cell profiling and antibody responses in patients with COVID-19.","Although there are a growing number of studies on evaluating lymphocyte subset counts as prognostic factors for COVID-19 disease severity, the lymphocyte subsets' analyses of both IgM and IgG responders and non-responders during the periods after onset of symptoms, have not been conducted yet. So, this study aimed to evaluate immune cell profiling of COVID-19 patients with and without antibody responses. In this cross-sectional study, the levels of peripheral lymphocyte subsets were measured usi","2021","07","20","BMC Infect Dis","BMC infectious diseases","Antibody response; COVID-19; Lymphocyte subsets; SARS-CoV-2; Adult; Aged; Antibodies, Viral; Antibody Formation; COVID-19; Cross-Sectional Studies; Female; Humans; Immunoglobulin G; Immunoglobulin M; Lymphocyte Subsets; Male; Middle Aged; SARS-CoV-2","Mahmoudi","Shima","Pediatric Infectious Disease Research Center, Pediatrics Center of Excellence, Children's Medical Center Hospital, Tehran University of Medical Sciences, Dr. Gharib Street, Keshavarz Boulevard, Tehran, Iran. sh-mahmoudi@sina.tums.ac","mahmoudi@sina.tums.ac.ir"
"1424","34225645","10.1186/s12879-021-06278-2","Immune cell profiling and antibody responses in patients with COVID-19.","Although there are a growing number of studies on evaluating lymphocyte subset counts as prognostic factors for COVID-19 disease severity, the lymphocyte subsets' analyses of both IgM and IgG responders and non-responders during the periods after onset of symptoms, have not been conducted yet. So, this study aimed to evaluate immune cell profiling of COVID-19 patients with and without antibody responses. In this cross-sectional study, the levels of peripheral lymphocyte subsets were measured usi","2021","07","20","BMC Infect Dis","BMC infectious diseases","Antibody response; COVID-19; Lymphocyte subsets; SARS-CoV-2; Adult; Aged; Antibodies, Viral; Antibody Formation; COVID-19; Cross-Sectional Studies; Female; Humans; Immunoglobulin G; Immunoglobulin M; Lymphocyte Subsets; Male; Middle Aged; SARS-CoV-2","Mortaz","Esmaeil","Clinical Tuberculosis and Epidemiology Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran",NA
"1425","34225645","10.1186/s12879-021-06278-2","Immune cell profiling and antibody responses in patients with COVID-19.","Although there are a growing number of studies on evaluating lymphocyte subset counts as prognostic factors for COVID-19 disease severity, the lymphocyte subsets' analyses of both IgM and IgG responders and non-responders during the periods after onset of symptoms, have not been conducted yet. So, this study aimed to evaluate immune cell profiling of COVID-19 patients with and without antibody responses. In this cross-sectional study, the levels of peripheral lymphocyte subsets were measured usi","2021","07","20","BMC Infect Dis","BMC infectious diseases","Antibody response; COVID-19; Lymphocyte subsets; SARS-CoV-2; Adult; Aged; Antibodies, Viral; Antibody Formation; COVID-19; Cross-Sectional Studies; Female; Humans; Immunoglobulin G; Immunoglobulin M; Lymphocyte Subsets; Male; Middle Aged; SARS-CoV-2","Marjani","Majid","Clinical Tuberculosis and Epidemiology Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran",NA
"1426","34225644","10.1186/s12879-021-06313-2","Sex-based clinical and immunological differences in COVID-19.","Males and females differ in their immunological responses to foreign pathogens. However, most of the current COVID-19 clinical practices and trials do not take the sex factor into consideration. We performed a sex-based comparative analysis for the clinical outcomes, peripheral immune cells, and severe acute respiratory syndrome coronavirus (SARS-CoV-2) specific antibody levels of 1558 males and 1499 females COVID-19 patients from a single center. The lymphocyte subgroups were measured by Flow c","2021","07","20","BMC Infect Dis","BMC infectious diseases","COVID-19; Immunology; Prognosis; SARS-CoV-2; Sex; Adult; Aged; Antibodies, Viral; Antibody Formation; COVID-19; Female; Humans; Immunoglobulin G; Lymphocyte Subsets; Male; Middle Aged; SARS-CoV-2; Sex Characteristics","Huang","Bin","Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, 211166, Jiangsu, China",NA
"1427","34225644","10.1186/s12879-021-06313-2","Sex-based clinical and immunological differences in COVID-19.","Males and females differ in their immunological responses to foreign pathogens. However, most of the current COVID-19 clinical practices and trials do not take the sex factor into consideration. We performed a sex-based comparative analysis for the clinical outcomes, peripheral immune cells, and severe acute respiratory syndrome coronavirus (SARS-CoV-2) specific antibody levels of 1558 males and 1499 females COVID-19 patients from a single center. The lymphocyte subgroups were measured by Flow c","2021","07","20","BMC Infect Dis","BMC infectious diseases","COVID-19; Immunology; Prognosis; SARS-CoV-2; Sex; Adult; Aged; Antibodies, Viral; Antibody Formation; COVID-19; Female; Humans; Immunoglobulin G; Lymphocyte Subsets; Male; Middle Aged; SARS-CoV-2; Sex Characteristics","Cai","Yun","Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, 211166, Jiangsu, China",NA
"1428","34225644","10.1186/s12879-021-06313-2","Sex-based clinical and immunological differences in COVID-19.","Males and females differ in their immunological responses to foreign pathogens. However, most of the current COVID-19 clinical practices and trials do not take the sex factor into consideration. We performed a sex-based comparative analysis for the clinical outcomes, peripheral immune cells, and severe acute respiratory syndrome coronavirus (SARS-CoV-2) specific antibody levels of 1558 males and 1499 females COVID-19 patients from a single center. The lymphocyte subgroups were measured by Flow c","2021","07","20","BMC Infect Dis","BMC infectious diseases","COVID-19; Immunology; Prognosis; SARS-CoV-2; Sex; Adult; Aged; Antibodies, Viral; Antibody Formation; COVID-19; Female; Humans; Immunoglobulin G; Lymphocyte Subsets; Male; Middle Aged; SARS-CoV-2; Sex Characteristics","Li","Ning","Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, 211166, Jiangsu, China",NA
"1429","34225644","10.1186/s12879-021-06313-2","Sex-based clinical and immunological differences in COVID-19.","Males and females differ in their immunological responses to foreign pathogens. However, most of the current COVID-19 clinical practices and trials do not take the sex factor into consideration. We performed a sex-based comparative analysis for the clinical outcomes, peripheral immune cells, and severe acute respiratory syndrome coronavirus (SARS-CoV-2) specific antibody levels of 1558 males and 1499 females COVID-19 patients from a single center. The lymphocyte subgroups were measured by Flow c","2021","07","20","BMC Infect Dis","BMC infectious diseases","COVID-19; Immunology; Prognosis; SARS-CoV-2; Sex; Adult; Aged; Antibodies, Viral; Antibody Formation; COVID-19; Female; Humans; Immunoglobulin G; Lymphocyte Subsets; Male; Middle Aged; SARS-CoV-2; Sex Characteristics","Li","Kening","Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, 211166, Jiangsu, China",NA
"1430","34225644","10.1186/s12879-021-06313-2","Sex-based clinical and immunological differences in COVID-19.","Males and females differ in their immunological responses to foreign pathogens. However, most of the current COVID-19 clinical practices and trials do not take the sex factor into consideration. We performed a sex-based comparative analysis for the clinical outcomes, peripheral immune cells, and severe acute respiratory syndrome coronavirus (SARS-CoV-2) specific antibody levels of 1558 males and 1499 females COVID-19 patients from a single center. The lymphocyte subgroups were measured by Flow c","2021","07","20","BMC Infect Dis","BMC infectious diseases","COVID-19; Immunology; Prognosis; SARS-CoV-2; Sex; Adult; Aged; Antibodies, Viral; Antibody Formation; COVID-19; Female; Humans; Immunoglobulin G; Lymphocyte Subsets; Male; Middle Aged; SARS-CoV-2; Sex Characteristics","Wang","Zhihua","Department of Laboratory Medicine &amp",NA
"1431","34225644","10.1186/s12879-021-06313-2","Sex-based clinical and immunological differences in COVID-19.","Males and females differ in their immunological responses to foreign pathogens. However, most of the current COVID-19 clinical practices and trials do not take the sex factor into consideration. We performed a sex-based comparative analysis for the clinical outcomes, peripheral immune cells, and severe acute respiratory syndrome coronavirus (SARS-CoV-2) specific antibody levels of 1558 males and 1499 females COVID-19 patients from a single center. The lymphocyte subgroups were measured by Flow c","2021","07","20","BMC Infect Dis","BMC infectious diseases","COVID-19; Immunology; Prognosis; SARS-CoV-2; Sex; Adult; Aged; Antibodies, Viral; Antibody Formation; COVID-19; Female; Humans; Immunoglobulin G; Lymphocyte Subsets; Male; Middle Aged; SARS-CoV-2; Sex Characteristics","Li","Lu","Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, 211166, Jiangsu, China",NA
"1432","34225644","10.1186/s12879-021-06313-2","Sex-based clinical and immunological differences in COVID-19.","Males and females differ in their immunological responses to foreign pathogens. However, most of the current COVID-19 clinical practices and trials do not take the sex factor into consideration. We performed a sex-based comparative analysis for the clinical outcomes, peripheral immune cells, and severe acute respiratory syndrome coronavirus (SARS-CoV-2) specific antibody levels of 1558 males and 1499 females COVID-19 patients from a single center. The lymphocyte subgroups were measured by Flow c","2021","07","20","BMC Infect Dis","BMC infectious diseases","COVID-19; Immunology; Prognosis; SARS-CoV-2; Sex; Adult; Aged; Antibodies, Viral; Antibody Formation; COVID-19; Female; Humans; Immunoglobulin G; Lymphocyte Subsets; Male; Middle Aged; SARS-CoV-2; Sex Characteristics","Wu","Lingxiang","Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, 211166, Jiangsu, China",NA
"1433","34225644","10.1186/s12879-021-06313-2","Sex-based clinical and immunological differences in COVID-19.","Males and females differ in their immunological responses to foreign pathogens. However, most of the current COVID-19 clinical practices and trials do not take the sex factor into consideration. We performed a sex-based comparative analysis for the clinical outcomes, peripheral immune cells, and severe acute respiratory syndrome coronavirus (SARS-CoV-2) specific antibody levels of 1558 males and 1499 females COVID-19 patients from a single center. The lymphocyte subgroups were measured by Flow c","2021","07","20","BMC Infect Dis","BMC infectious diseases","COVID-19; Immunology; Prognosis; SARS-CoV-2; Sex; Adult; Aged; Antibodies, Viral; Antibody Formation; COVID-19; Female; Humans; Immunoglobulin G; Lymphocyte Subsets; Male; Middle Aged; SARS-CoV-2; Sex Characteristics","Zhu","Mengyan","Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, 211166, Jiangsu, China",NA
"1434","34225644","10.1186/s12879-021-06313-2","Sex-based clinical and immunological differences in COVID-19.","Males and females differ in their immunological responses to foreign pathogens. However, most of the current COVID-19 clinical practices and trials do not take the sex factor into consideration. We performed a sex-based comparative analysis for the clinical outcomes, peripheral immune cells, and severe acute respiratory syndrome coronavirus (SARS-CoV-2) specific antibody levels of 1558 males and 1499 females COVID-19 patients from a single center. The lymphocyte subgroups were measured by Flow c","2021","07","20","BMC Infect Dis","BMC infectious diseases","COVID-19; Immunology; Prognosis; SARS-CoV-2; Sex; Adult; Aged; Antibodies, Viral; Antibody Formation; COVID-19; Female; Humans; Immunoglobulin G; Lymphocyte Subsets; Male; Middle Aged; SARS-CoV-2; Sex Characteristics","Li","Jie","Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, 211166, Jiangsu, China",NA
"1435","34225644","10.1186/s12879-021-06313-2","Sex-based clinical and immunological differences in COVID-19.","Males and females differ in their immunological responses to foreign pathogens. However, most of the current COVID-19 clinical practices and trials do not take the sex factor into consideration. We performed a sex-based comparative analysis for the clinical outcomes, peripheral immune cells, and severe acute respiratory syndrome coronavirus (SARS-CoV-2) specific antibody levels of 1558 males and 1499 females COVID-19 patients from a single center. The lymphocyte subgroups were measured by Flow c","2021","07","20","BMC Infect Dis","BMC infectious diseases","COVID-19; Immunology; Prognosis; SARS-CoV-2; Sex; Adult; Aged; Antibodies, Viral; Antibody Formation; COVID-19; Female; Humans; Immunoglobulin G; Lymphocyte Subsets; Male; Middle Aged; SARS-CoV-2; Sex Characteristics","Wang","Ziyu","Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, 211166, Jiangsu, China",NA
"1436","34225644","10.1186/s12879-021-06313-2","Sex-based clinical and immunological differences in COVID-19.","Males and females differ in their immunological responses to foreign pathogens. However, most of the current COVID-19 clinical practices and trials do not take the sex factor into consideration. We performed a sex-based comparative analysis for the clinical outcomes, peripheral immune cells, and severe acute respiratory syndrome coronavirus (SARS-CoV-2) specific antibody levels of 1558 males and 1499 females COVID-19 patients from a single center. The lymphocyte subgroups were measured by Flow c","2021","07","20","BMC Infect Dis","BMC infectious diseases","COVID-19; Immunology; Prognosis; SARS-CoV-2; Sex; Adult; Aged; Antibodies, Viral; Antibody Formation; COVID-19; Female; Humans; Immunoglobulin G; Lymphocyte Subsets; Male; Middle Aged; SARS-CoV-2; Sex Characteristics","Wu","Min","Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, 211166, Jiangsu, China",NA
"1437","34225644","10.1186/s12879-021-06313-2","Sex-based clinical and immunological differences in COVID-19.","Males and females differ in their immunological responses to foreign pathogens. However, most of the current COVID-19 clinical practices and trials do not take the sex factor into consideration. We performed a sex-based comparative analysis for the clinical outcomes, peripheral immune cells, and severe acute respiratory syndrome coronavirus (SARS-CoV-2) specific antibody levels of 1558 males and 1499 females COVID-19 patients from a single center. The lymphocyte subgroups were measured by Flow c","2021","07","20","BMC Infect Dis","BMC infectious diseases","COVID-19; Immunology; Prognosis; SARS-CoV-2; Sex; Adult; Aged; Antibodies, Viral; Antibody Formation; COVID-19; Female; Humans; Immunoglobulin G; Lymphocyte Subsets; Male; Middle Aged; SARS-CoV-2; Sex Characteristics","Li","Wanlin","Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, 211166, Jiangsu, China",NA
"1438","34225644","10.1186/s12879-021-06313-2","Sex-based clinical and immunological differences in COVID-19.","Males and females differ in their immunological responses to foreign pathogens. However, most of the current COVID-19 clinical practices and trials do not take the sex factor into consideration. We performed a sex-based comparative analysis for the clinical outcomes, peripheral immune cells, and severe acute respiratory syndrome coronavirus (SARS-CoV-2) specific antibody levels of 1558 males and 1499 females COVID-19 patients from a single center. The lymphocyte subgroups were measured by Flow c","2021","07","20","BMC Infect Dis","BMC infectious diseases","COVID-19; Immunology; Prognosis; SARS-CoV-2; Sex; Adult; Aged; Antibodies, Viral; Antibody Formation; COVID-19; Female; Humans; Immunoglobulin G; Lymphocyte Subsets; Male; Middle Aged; SARS-CoV-2; Sex Characteristics","Wu","Wei","Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, 211166, Jiangsu, China",NA
"1439","34225644","10.1186/s12879-021-06313-2","Sex-based clinical and immunological differences in COVID-19.","Males and females differ in their immunological responses to foreign pathogens. However, most of the current COVID-19 clinical practices and trials do not take the sex factor into consideration. We performed a sex-based comparative analysis for the clinical outcomes, peripheral immune cells, and severe acute respiratory syndrome coronavirus (SARS-CoV-2) specific antibody levels of 1558 males and 1499 females COVID-19 patients from a single center. The lymphocyte subgroups were measured by Flow c","2021","07","20","BMC Infect Dis","BMC infectious diseases","COVID-19; Immunology; Prognosis; SARS-CoV-2; Sex; Adult; Aged; Antibodies, Viral; Antibody Formation; COVID-19; Female; Humans; Immunoglobulin G; Lymphocyte Subsets; Male; Middle Aged; SARS-CoV-2; Sex Characteristics","Zhang","Lishen","Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, 211166, Jiangsu, China",NA
"1440","34225644","10.1186/s12879-021-06313-2","Sex-based clinical and immunological differences in COVID-19.","Males and females differ in their immunological responses to foreign pathogens. However, most of the current COVID-19 clinical practices and trials do not take the sex factor into consideration. We performed a sex-based comparative analysis for the clinical outcomes, peripheral immune cells, and severe acute respiratory syndrome coronavirus (SARS-CoV-2) specific antibody levels of 1558 males and 1499 females COVID-19 patients from a single center. The lymphocyte subgroups were measured by Flow c","2021","07","20","BMC Infect Dis","BMC infectious diseases","COVID-19; Immunology; Prognosis; SARS-CoV-2; Sex; Adult; Aged; Antibodies, Viral; Antibody Formation; COVID-19; Female; Humans; Immunoglobulin G; Lymphocyte Subsets; Male; Middle Aged; SARS-CoV-2; Sex Characteristics","Xia","Xinyi","Joint Expert Group for COVID-19, Department of Laboratory Medicine &amp","xiaxynju@163.com"
"1441","34225644","10.1186/s12879-021-06313-2","Sex-based clinical and immunological differences in COVID-19.","Males and females differ in their immunological responses to foreign pathogens. However, most of the current COVID-19 clinical practices and trials do not take the sex factor into consideration. We performed a sex-based comparative analysis for the clinical outcomes, peripheral immune cells, and severe acute respiratory syndrome coronavirus (SARS-CoV-2) specific antibody levels of 1558 males and 1499 females COVID-19 patients from a single center. The lymphocyte subgroups were measured by Flow c","2021","07","20","BMC Infect Dis","BMC infectious diseases","COVID-19; Immunology; Prognosis; SARS-CoV-2; Sex; Adult; Aged; Antibodies, Viral; Antibody Formation; COVID-19; Female; Humans; Immunoglobulin G; Lymphocyte Subsets; Male; Middle Aged; SARS-CoV-2; Sex Characteristics","Wang","Shukui","Department of Laboratory Medicine, Nanjing First Hospital, Nanjing Medical University, Nanjing, 210006, Jiangsu, China. sk_wang@njmu.edu","wang@njmu.edu.cn"
"1442","34225644","10.1186/s12879-021-06313-2","Sex-based clinical and immunological differences in COVID-19.","Males and females differ in their immunological responses to foreign pathogens. However, most of the current COVID-19 clinical practices and trials do not take the sex factor into consideration. We performed a sex-based comparative analysis for the clinical outcomes, peripheral immune cells, and severe acute respiratory syndrome coronavirus (SARS-CoV-2) specific antibody levels of 1558 males and 1499 females COVID-19 patients from a single center. The lymphocyte subgroups were measured by Flow c","2021","07","20","BMC Infect Dis","BMC infectious diseases","COVID-19; Immunology; Prognosis; SARS-CoV-2; Sex; Adult; Aged; Antibodies, Viral; Antibody Formation; COVID-19; Female; Humans; Immunoglobulin G; Lymphocyte Subsets; Male; Middle Aged; SARS-CoV-2; Sex Characteristics","Chen","Hongshan","Key Laboratory of Cardiovascular &amp","hongshanchen@njmu.edu.cn"
"1443","34225644","10.1186/s12879-021-06313-2","Sex-based clinical and immunological differences in COVID-19.","Males and females differ in their immunological responses to foreign pathogens. However, most of the current COVID-19 clinical practices and trials do not take the sex factor into consideration. We performed a sex-based comparative analysis for the clinical outcomes, peripheral immune cells, and severe acute respiratory syndrome coronavirus (SARS-CoV-2) specific antibody levels of 1558 males and 1499 females COVID-19 patients from a single center. The lymphocyte subgroups were measured by Flow c","2021","07","20","BMC Infect Dis","BMC infectious diseases","COVID-19; Immunology; Prognosis; SARS-CoV-2; Sex; Adult; Aged; Antibodies, Viral; Antibody Formation; COVID-19; Female; Humans; Immunoglobulin G; Lymphocyte Subsets; Male; Middle Aged; SARS-CoV-2; Sex Characteristics","Wang","Qianghu","Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, 211166, Jiangsu, China. wangqh@njmu.edu","wangqh@njmu.edu.cn"
"1444","34225625","10.2174/1573405617666210702161433","Diagnostic Performance Of Radiology Residents In Thoracic Ct Imaging In Emergency Radiology During The Covid-19 Pandemic.","During the COVID-19 pandemic, the workload of all radiologists and radiology residents, as well as other clinical physicians, has increased. This study aims to determine the diagnostic performance of radiology residents, who effectively contribute to the diagnosis of COVID-19. The thoracic computed tomography (CT) images of 135 patients aged 20-83 diagnosed with COVID-19 were evaluated retrospectively by five radiology residents and a radiologist with 10 years of experience. The diagnostic perfo","2021","07","06","Curr Med Imaging","Current medical imaging","COVID-19; chest; computed tomography; pneumonia; radiologist.","Cakmak","Vefa","Department of Radiology, Faculty of Medicine, Pamukkale University, Denizli. Turkey",NA
"1445","34225625","10.2174/1573405617666210702161433","Diagnostic Performance Of Radiology Residents In Thoracic Ct Imaging In Emergency Radiology During The Covid-19 Pandemic.","During the COVID-19 pandemic, the workload of all radiologists and radiology residents, as well as other clinical physicians, has increased. This study aims to determine the diagnostic performance of radiology residents, who effectively contribute to the diagnosis of COVID-19. The thoracic computed tomography (CT) images of 135 patients aged 20-83 diagnosed with COVID-19 were evaluated retrospectively by five radiology residents and a radiologist with 10 years of experience. The diagnostic perfo","2021","07","06","Curr Med Imaging","Current medical imaging","COVID-19; chest; computed tomography; pneumonia; radiologist.","Herek","Duygu","Department of Radiology, Faculty of Medicine, Pamukkale University, Denizli. Turkey",NA
"1446","34225625","10.2174/1573405617666210702161433","Diagnostic Performance Of Radiology Residents In Thoracic Ct Imaging In Emergency Radiology During The Covid-19 Pandemic.","During the COVID-19 pandemic, the workload of all radiologists and radiology residents, as well as other clinical physicians, has increased. This study aims to determine the diagnostic performance of radiology residents, who effectively contribute to the diagnosis of COVID-19. The thoracic computed tomography (CT) images of 135 patients aged 20-83 diagnosed with COVID-19 were evaluated retrospectively by five radiology residents and a radiologist with 10 years of experience. The diagnostic perfo","2021","07","06","Curr Med Imaging","Current medical imaging","COVID-19; chest; computed tomography; pneumonia; radiologist.","Cakmak","Pinar","Department of Radiology, Faculty of Medicine, Pamukkale University, Denizli. Turkey",NA
"1447","34225610","10.2174/1381612827666210705163807","Phytotherapic Drugs For Covid19 Treatment: A Scoping Review.","The rapid eruption of Coronavirus at the end of 2019 has caused global health crisis and significant loss to the economy and social well-being. This created a massive shortage of advanced health facilities with inadequate medicinal supply, further deteriorating human health conditions. On the basis of adverse effects of the ongoing pandemic, this review is proposed to evaluate the antiviral efficacy of plant-based therapeutics against SARS-CoV-2 (commonly called COVID19) infection. It highlights","2021","07","06","Curr Pharm Des","Current pharmaceutical design","Bioactive metabolites; Clinical trials; Herbal extracts; Medicinal plants; Phytotherapic drugs; Plant-derived Immunomodulatory agents; SARS-CoV-2","Singh","Meenakshi","Department of Botany, Faculty of Science, The Maharaja Sayajirao University of Baroda, Vadodara, Gujarat - 390002, India",NA
"1448","34225610","10.2174/1381612827666210705163807","Phytotherapic Drugs For Covid19 Treatment: A Scoping Review.","The rapid eruption of Coronavirus at the end of 2019 has caused global health crisis and significant loss to the economy and social well-being. This created a massive shortage of advanced health facilities with inadequate medicinal supply, further deteriorating human health conditions. On the basis of adverse effects of the ongoing pandemic, this review is proposed to evaluate the antiviral efficacy of plant-based therapeutics against SARS-CoV-2 (commonly called COVID19) infection. It highlights","2021","07","06","Curr Pharm Des","Current pharmaceutical design","Bioactive metabolites; Clinical trials; Herbal extracts; Medicinal plants; Phytotherapic drugs; Plant-derived Immunomodulatory agents; SARS-CoV-2","Trivedi","Darshini","Department of Botany, Faculty of Science, The Maharaja Sayajirao University of Baroda, Vadodara, Gujarat - 390002, India",NA
"1449","34225610","10.2174/1381612827666210705163807","Phytotherapic Drugs For Covid19 Treatment: A Scoping Review.","The rapid eruption of Coronavirus at the end of 2019 has caused global health crisis and significant loss to the economy and social well-being. This created a massive shortage of advanced health facilities with inadequate medicinal supply, further deteriorating human health conditions. On the basis of adverse effects of the ongoing pandemic, this review is proposed to evaluate the antiviral efficacy of plant-based therapeutics against SARS-CoV-2 (commonly called COVID19) infection. It highlights","2021","07","06","Curr Pharm Des","Current pharmaceutical design","Bioactive metabolites; Clinical trials; Herbal extracts; Medicinal plants; Phytotherapic drugs; Plant-derived Immunomodulatory agents; SARS-CoV-2","Mohapatra","Reecha","Department of Lifescience, NIT Rourkela, Odisha - 769008, India",NA
"1450","34225610","10.2174/1381612827666210705163807","Phytotherapic Drugs For Covid19 Treatment: A Scoping Review.","The rapid eruption of Coronavirus at the end of 2019 has caused global health crisis and significant loss to the economy and social well-being. This created a massive shortage of advanced health facilities with inadequate medicinal supply, further deteriorating human health conditions. On the basis of adverse effects of the ongoing pandemic, this review is proposed to evaluate the antiviral efficacy of plant-based therapeutics against SARS-CoV-2 (commonly called COVID19) infection. It highlights","2021","07","06","Curr Pharm Des","Current pharmaceutical design","Bioactive metabolites; Clinical trials; Herbal extracts; Medicinal plants; Phytotherapic drugs; Plant-derived Immunomodulatory agents; SARS-CoV-2","Bagchi","Trisha","Department of Botany, West Bengal State University, Berunanpukuria Malikapur, 24, Parganas [N], Barasat, West Bengal -700126, India",NA
"1451","34225610","10.2174/1381612827666210705163807","Phytotherapic Drugs For Covid19 Treatment: A Scoping Review.","The rapid eruption of Coronavirus at the end of 2019 has caused global health crisis and significant loss to the economy and social well-being. This created a massive shortage of advanced health facilities with inadequate medicinal supply, further deteriorating human health conditions. On the basis of adverse effects of the ongoing pandemic, this review is proposed to evaluate the antiviral efficacy of plant-based therapeutics against SARS-CoV-2 (commonly called COVID19) infection. It highlights","2021","07","06","Curr Pharm Des","Current pharmaceutical design","Bioactive metabolites; Clinical trials; Herbal extracts; Medicinal plants; Phytotherapic drugs; Plant-derived Immunomodulatory agents; SARS-CoV-2","Durthi","Chandra Sai Potla","Department of Biotechnology, National Institute of Technology Warangal, Waranagal, Telangana, 506004, India",NA
"1452","34225610","10.2174/1381612827666210705163807","Phytotherapic Drugs For Covid19 Treatment: A Scoping Review.","The rapid eruption of Coronavirus at the end of 2019 has caused global health crisis and significant loss to the economy and social well-being. This created a massive shortage of advanced health facilities with inadequate medicinal supply, further deteriorating human health conditions. On the basis of adverse effects of the ongoing pandemic, this review is proposed to evaluate the antiviral efficacy of plant-based therapeutics against SARS-CoV-2 (commonly called COVID19) infection. It highlights","2021","07","06","Curr Pharm Des","Current pharmaceutical design","Bioactive metabolites; Clinical trials; Herbal extracts; Medicinal plants; Phytotherapic drugs; Plant-derived Immunomodulatory agents; SARS-CoV-2","Kuppam","Chandrasekhar","School of Civil and Environmental Engineering, Yonsei University, Seoul 03722. Korea",NA
"1453","34225607","10.2174/1381612827666210705160130","Mechanistic Aspects of Medicinal Plants and Secondary Metabolites against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).","The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), a highly pathogenic virus, is responsible for a respiratory disease termed coronavirus disease 2019 (COVID-19). SARS-CoV-2 genome encodes various structural and non-structural proteins, which are necessary for viral entry and replication. Among these proteins, papain-like protease (PLpro), 3C-like protease (3CLpro), RNA-dependent RNA polymerase (RdRp), helicase, a serine protease, and spike protein are potential targets of herbal ","2021","07","06","Curr Pharm Des","Current pharmaceutical design","Biological compounds; COVID-19; Medicinal plants; Novel coronavirus; Phytochemicals; SARS-CoV-2; Secondary metabolites; Severe Acute Respiratory Syndrome-2","Malekmohammad","Khojasteh","Department of Biology, College of Sciences, Shiraz University, Shiraz, Iran",NA
"1454","34225607","10.2174/1381612827666210705160130","Mechanistic Aspects of Medicinal Plants and Secondary Metabolites against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).","The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), a highly pathogenic virus, is responsible for a respiratory disease termed coronavirus disease 2019 (COVID-19). SARS-CoV-2 genome encodes various structural and non-structural proteins, which are necessary for viral entry and replication. Among these proteins, papain-like protease (PLpro), 3C-like protease (3CLpro), RNA-dependent RNA polymerase (RdRp), helicase, a serine protease, and spike protein are potential targets of herbal ","2021","07","06","Curr Pharm Des","Current pharmaceutical design","Biological compounds; COVID-19; Medicinal plants; Novel coronavirus; Phytochemicals; SARS-CoV-2; Secondary metabolites; Severe Acute Respiratory Syndrome-2","Rafieian-Kopaei","Mahmoud","Medical Plants Research Center, Basic Health Sciences Institute, Shahrekord University of Medical Sciences, Shahrekord, Iran",NA
"1455","34225580","10.1142/S0192415X21500506","Application of Traditional Chinese Medicine and Systems Pharmacology in Drug Prevention and Treatment against COVID-19.","A novel coronavirus named SARS-CoV-2 is causing the severe acute pneumonia (COVID-19) and rapid spread nationally and internationally, resulting in a major global health emergency. Chinese governments and scientists have implemented a series of rigorous measures and scientific research to prevent and control the SARS-CoV-2 infection. However, there is still no specific antiviral drug or vaccine against SARS-CoV-2. It has been proven that traditional Chinese medicine (TCM) exerts an important rol","2021","07","09","Am J Chin Med","The American journal of Chinese medicine","COVID-19; Drug Discovery; Review; SARS-CoV-2; Systems Pharmacology; Traditional Chinese Medicine; Animals; Antiviral Agents; COVID-19; Drugs, Chinese Herbal; Humans; Medicine, Chinese Traditional; SARS-CoV-2","Zhou","Wei","State Key Laboratory of Respiratory Disease for Allergy, Shenzhen Key Laboratory of Allergy &amp",NA
"1456","34225580","10.1142/S0192415X21500506","Application of Traditional Chinese Medicine and Systems Pharmacology in Drug Prevention and Treatment against COVID-19.","A novel coronavirus named SARS-CoV-2 is causing the severe acute pneumonia (COVID-19) and rapid spread nationally and internationally, resulting in a major global health emergency. Chinese governments and scientists have implemented a series of rigorous measures and scientific research to prevent and control the SARS-CoV-2 infection. However, there is still no specific antiviral drug or vaccine against SARS-CoV-2. It has been proven that traditional Chinese medicine (TCM) exerts an important rol","2021","07","09","Am J Chin Med","The American journal of Chinese medicine","COVID-19; Drug Discovery; Review; SARS-CoV-2; Systems Pharmacology; Traditional Chinese Medicine; Animals; Antiviral Agents; COVID-19; Drugs, Chinese Herbal; Humans; Medicine, Chinese Traditional; SARS-CoV-2","Chen","Ziyi","Musculoskeletal Research Laboratory, Department of Orthopaedics &amp",NA
"1457","34225580","10.1142/S0192415X21500506","Application of Traditional Chinese Medicine and Systems Pharmacology in Drug Prevention and Treatment against COVID-19.","A novel coronavirus named SARS-CoV-2 is causing the severe acute pneumonia (COVID-19) and rapid spread nationally and internationally, resulting in a major global health emergency. Chinese governments and scientists have implemented a series of rigorous measures and scientific research to prevent and control the SARS-CoV-2 infection. However, there is still no specific antiviral drug or vaccine against SARS-CoV-2. It has been proven that traditional Chinese medicine (TCM) exerts an important rol","2021","07","09","Am J Chin Med","The American journal of Chinese medicine","COVID-19; Drug Discovery; Review; SARS-CoV-2; Systems Pharmacology; Traditional Chinese Medicine; Animals; Antiviral Agents; COVID-19; Drugs, Chinese Herbal; Humans; Medicine, Chinese Traditional; SARS-CoV-2","Sun","Xizhuo","Department of Respirology &amp",NA
"1458","34225580","10.1142/S0192415X21500506","Application of Traditional Chinese Medicine and Systems Pharmacology in Drug Prevention and Treatment against COVID-19.","A novel coronavirus named SARS-CoV-2 is causing the severe acute pneumonia (COVID-19) and rapid spread nationally and internationally, resulting in a major global health emergency. Chinese governments and scientists have implemented a series of rigorous measures and scientific research to prevent and control the SARS-CoV-2 infection. However, there is still no specific antiviral drug or vaccine against SARS-CoV-2. It has been proven that traditional Chinese medicine (TCM) exerts an important rol","2021","07","09","Am J Chin Med","The American journal of Chinese medicine","COVID-19; Drug Discovery; Review; SARS-CoV-2; Systems Pharmacology; Traditional Chinese Medicine; Animals; Antiviral Agents; COVID-19; Drugs, Chinese Herbal; Humans; Medicine, Chinese Traditional; SARS-CoV-2","Zhong","Nanshan","State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University, Guangzhou, P. R. China",NA
"1459","34225580","10.1142/S0192415X21500506","Application of Traditional Chinese Medicine and Systems Pharmacology in Drug Prevention and Treatment against COVID-19.","A novel coronavirus named SARS-CoV-2 is causing the severe acute pneumonia (COVID-19) and rapid spread nationally and internationally, resulting in a major global health emergency. Chinese governments and scientists have implemented a series of rigorous measures and scientific research to prevent and control the SARS-CoV-2 infection. However, there is still no specific antiviral drug or vaccine against SARS-CoV-2. It has been proven that traditional Chinese medicine (TCM) exerts an important rol","2021","07","09","Am J Chin Med","The American journal of Chinese medicine","COVID-19; Drug Discovery; Review; SARS-CoV-2; Systems Pharmacology; Traditional Chinese Medicine; Animals; Antiviral Agents; COVID-19; Drugs, Chinese Herbal; Humans; Medicine, Chinese Traditional; SARS-CoV-2","Liu","Zhigang","State Key Laboratory of Respiratory Disease for Allergy, Shenzhen Key Laboratory of Allergy &amp",NA
"1460","34225566","10.1080/19371918.2021.1937435","Association between Fear of COVID-19 with Self-care Behaviors in Elderly: A Cross- Sectional Study.","This study aims to determine the association between fear of COVID-19 with self-care in the elderly. This is a cross-sectional study, in which data were collected using the online survey method with three questionnaires: social demographic characteristics, fear of COVID-19, and elderly self-care. The 350 elderly people were selected by multi-stage sampling from the list of households registered in the integrated health system. According to the result, the mean (SD) age of participants was 69.91 ","2021","07","19","Soc Work Public Health","Social work in public health","COVID-19; elderly; fear; self-care; Aged; COVID-19; Cross-Sectional Studies; Fear; Humans; Self Care; Surveys and Questionnaires","Sharifi","Nasibeh","Department of Midwifery, School of Nursing&amp",NA
"1461","34225566","10.1080/19371918.2021.1937435","Association between Fear of COVID-19 with Self-care Behaviors in Elderly: A Cross- Sectional Study.","This study aims to determine the association between fear of COVID-19 with self-care in the elderly. This is a cross-sectional study, in which data were collected using the online survey method with three questionnaires: social demographic characteristics, fear of COVID-19, and elderly self-care. The 350 elderly people were selected by multi-stage sampling from the list of households registered in the integrated health system. According to the result, the mean (SD) age of participants was 69.91 ","2021","07","19","Soc Work Public Health","Social work in public health","COVID-19; elderly; fear; self-care; Aged; COVID-19; Cross-Sectional Studies; Fear; Humans; Self Care; Surveys and Questionnaires","Rezaei","Nazanin","Department of Midwifery, School of Nursing&amp",NA
"1462","34225566","10.1080/19371918.2021.1937435","Association between Fear of COVID-19 with Self-care Behaviors in Elderly: A Cross- Sectional Study.","This study aims to determine the association between fear of COVID-19 with self-care in the elderly. This is a cross-sectional study, in which data were collected using the online survey method with three questionnaires: social demographic characteristics, fear of COVID-19, and elderly self-care. The 350 elderly people were selected by multi-stage sampling from the list of households registered in the integrated health system. According to the result, the mean (SD) age of participants was 69.91 ","2021","07","19","Soc Work Public Health","Social work in public health","COVID-19; elderly; fear; self-care; Aged; COVID-19; Cross-Sectional Studies; Fear; Humans; Self Care; Surveys and Questionnaires","Fathnezhad-Kazemi","Azita","Department of Midwifery, Faculty of Nursing and Midwifery, Islamic Azad University, Tabriz, Iran",NA
"1463","34225566","10.1080/19371918.2021.1937435","Association between Fear of COVID-19 with Self-care Behaviors in Elderly: A Cross- Sectional Study.","This study aims to determine the association between fear of COVID-19 with self-care in the elderly. This is a cross-sectional study, in which data were collected using the online survey method with three questionnaires: social demographic characteristics, fear of COVID-19, and elderly self-care. The 350 elderly people were selected by multi-stage sampling from the list of households registered in the integrated health system. According to the result, the mean (SD) age of participants was 69.91 ","2021","07","19","Soc Work Public Health","Social work in public health","COVID-19; elderly; fear; self-care; Aged; COVID-19; Cross-Sectional Studies; Fear; Humans; Self Care; Surveys and Questionnaires","Ghiasi","Fatemeh","Department of Anesthesiology, School of Allied Medical Sciences, Ilam University of Medical Science, Ilam, Iran",NA
"1464","34225565","10.1080/07391102.2021.1947384","Plant derived active compounds as potential anti SARS-CoV-2 agents: an <i>in-silico</i> study.","Plants are a valued potential source of drugs for a variety of diseases and are often considered less toxic to humans. We investigated antiviral compounds that may potentially target SARS-CoV-2 antigenic spike (S) and host proteins; angiotensin-converting enzyme2 (ACE2), and transmembrane serine protease2 (TMPRSS2). We scrutinized 36 phytochemicals from 15 Indian medicinal plants known to be effective against RNA viruses via molecular docking. Besides, the TMPRSS2 structure was modeled an","2021","07","06","J Biomol Struct Dyn","Journal of biomolecular structure &amp; dynamics","ACE2; COVID-19; MD simulation; SARS-CoV-2; TMPRSS2; homology modelling; molecular docking; natural products; spike protein","Kashyap","Dharmendra","Department of Biosciences and Biomedical Engineering, Indian Institute of Technology Indore, Indore, India",NA
"1465","34225565","10.1080/07391102.2021.1947384","Plant derived active compounds as potential anti SARS-CoV-2 agents: an <i>in-silico</i> study.","Plants are a valued potential source of drugs for a variety of diseases and are often considered less toxic to humans. We investigated antiviral compounds that may potentially target SARS-CoV-2 antigenic spike (S) and host proteins; angiotensin-converting enzyme2 (ACE2), and transmembrane serine protease2 (TMPRSS2). We scrutinized 36 phytochemicals from 15 Indian medicinal plants known to be effective against RNA viruses via molecular docking. Besides, the TMPRSS2 structure was modeled an","2021","07","06","J Biomol Struct Dyn","Journal of biomolecular structure &amp; dynamics","ACE2; COVID-19; MD simulation; SARS-CoV-2; TMPRSS2; homology modelling; molecular docking; natural products; spike protein","Jakhmola","Shweta","Department of Biosciences and Biomedical Engineering, Indian Institute of Technology Indore, Indore, India",NA
"1466","34225565","10.1080/07391102.2021.1947384","Plant derived active compounds as potential anti SARS-CoV-2 agents: an <i>in-silico</i> study.","Plants are a valued potential source of drugs for a variety of diseases and are often considered less toxic to humans. We investigated antiviral compounds that may potentially target SARS-CoV-2 antigenic spike (S) and host proteins; angiotensin-converting enzyme2 (ACE2), and transmembrane serine protease2 (TMPRSS2). We scrutinized 36 phytochemicals from 15 Indian medicinal plants known to be effective against RNA viruses via molecular docking. Besides, the TMPRSS2 structure was modeled an","2021","07","06","J Biomol Struct Dyn","Journal of biomolecular structure &amp; dynamics","ACE2; COVID-19; MD simulation; SARS-CoV-2; TMPRSS2; homology modelling; molecular docking; natural products; spike protein","Tiwari","Deeksha","Department of Biosciences and Biomedical Engineering, Indian Institute of Technology Indore, Indore, India",NA
"1467","34225565","10.1080/07391102.2021.1947384","Plant derived active compounds as potential anti SARS-CoV-2 agents: an <i>in-silico</i> study.","Plants are a valued potential source of drugs for a variety of diseases and are often considered less toxic to humans. We investigated antiviral compounds that may potentially target SARS-CoV-2 antigenic spike (S) and host proteins; angiotensin-converting enzyme2 (ACE2), and transmembrane serine protease2 (TMPRSS2). We scrutinized 36 phytochemicals from 15 Indian medicinal plants known to be effective against RNA viruses via molecular docking. Besides, the TMPRSS2 structure was modeled an","2021","07","06","J Biomol Struct Dyn","Journal of biomolecular structure &amp; dynamics","ACE2; COVID-19; MD simulation; SARS-CoV-2; TMPRSS2; homology modelling; molecular docking; natural products; spike protein","Kumar","Rajesh","Department of Physics, Indian Institute of Technology Indore, Indore, India",NA
"1468","34225565","10.1080/07391102.2021.1947384","Plant derived active compounds as potential anti SARS-CoV-2 agents: an <i>in-silico</i> study.","Plants are a valued potential source of drugs for a variety of diseases and are often considered less toxic to humans. We investigated antiviral compounds that may potentially target SARS-CoV-2 antigenic spike (S) and host proteins; angiotensin-converting enzyme2 (ACE2), and transmembrane serine protease2 (TMPRSS2). We scrutinized 36 phytochemicals from 15 Indian medicinal plants known to be effective against RNA viruses via molecular docking. Besides, the TMPRSS2 structure was modeled an","2021","07","06","J Biomol Struct Dyn","Journal of biomolecular structure &amp; dynamics","ACE2; COVID-19; MD simulation; SARS-CoV-2; TMPRSS2; homology modelling; molecular docking; natural products; spike protein","Moorthy","N S Hari Narayana","Department of Pharmacy, Indira Gandhi National Tribal University, Amarkantak, India",NA
"1469","34225565","10.1080/07391102.2021.1947384","Plant derived active compounds as potential anti SARS-CoV-2 agents: an <i>in-silico</i> study.","Plants are a valued potential source of drugs for a variety of diseases and are often considered less toxic to humans. We investigated antiviral compounds that may potentially target SARS-CoV-2 antigenic spike (S) and host proteins; angiotensin-converting enzyme2 (ACE2), and transmembrane serine protease2 (TMPRSS2). We scrutinized 36 phytochemicals from 15 Indian medicinal plants known to be effective against RNA viruses via molecular docking. Besides, the TMPRSS2 structure was modeled an","2021","07","06","J Biomol Struct Dyn","Journal of biomolecular structure &amp; dynamics","ACE2; COVID-19; MD simulation; SARS-CoV-2; TMPRSS2; homology modelling; molecular docking; natural products; spike protein","Elangovan","Manivannan","School of Pharmacy, Devi Ahilya Vishwavidyalaya, Indore, India",NA
"1470","34225565","10.1080/07391102.2021.1947384","Plant derived active compounds as potential anti SARS-CoV-2 agents: an <i>in-silico</i> study.","Plants are a valued potential source of drugs for a variety of diseases and are often considered less toxic to humans. We investigated antiviral compounds that may potentially target SARS-CoV-2 antigenic spike (S) and host proteins; angiotensin-converting enzyme2 (ACE2), and transmembrane serine protease2 (TMPRSS2). We scrutinized 36 phytochemicals from 15 Indian medicinal plants known to be effective against RNA viruses via molecular docking. Besides, the TMPRSS2 structure was modeled an","2021","07","06","J Biomol Struct Dyn","Journal of biomolecular structure &amp; dynamics","ACE2; COVID-19; MD simulation; SARS-CoV-2; TMPRSS2; homology modelling; molecular docking; natural products; spike protein","Brás","Natércia F","LAQV, REQUIMTE, Departamento de Química e Bioquímica, Faculdade de Ciências, Universidade do Porto, Porto, Portugal",NA
"1471","34225565","10.1080/07391102.2021.1947384","Plant derived active compounds as potential anti SARS-CoV-2 agents: an <i>in-silico</i> study.","Plants are a valued potential source of drugs for a variety of diseases and are often considered less toxic to humans. We investigated antiviral compounds that may potentially target SARS-CoV-2 antigenic spike (S) and host proteins; angiotensin-converting enzyme2 (ACE2), and transmembrane serine protease2 (TMPRSS2). We scrutinized 36 phytochemicals from 15 Indian medicinal plants known to be effective against RNA viruses via molecular docking. Besides, the TMPRSS2 structure was modeled an","2021","07","06","J Biomol Struct Dyn","Journal of biomolecular structure &amp; dynamics","ACE2; COVID-19; MD simulation; SARS-CoV-2; TMPRSS2; homology modelling; molecular docking; natural products; spike protein","Jha","Hem Chandra","Department of Biosciences and Biomedical Engineering, Indian Institute of Technology Indore, Indore, India",NA
"1472","34225545","10.1080/14787210.2021.1951705","Antimicrobial resistance in low- and middle-income countries: current status and future directions.","Introduction: Rising rates of antimicrobial resistance (AMR) globally continue to pose agrave threat to human health. Low- and middle-income countries (LMICs) are disproportionately affected, partly due to the high burden of communicable diseases.Areas covered: We reviewed current trends in AMR in LMICs and examined the forces driving AMR in those regions. The state of interventions being undertaken to curb AMR across the developing world are discussed, and the impact of the curren","2021","07","19","Expert Rev Anti Infect Ther","Expert review of anti-infective therapy","Antibiotic use; Antimicrobial resistance (AMR); Antimicrobial stewardship; Low- and middle-income countries (LMICs); Review","Sulis","Giorgia","Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Canada",NA
"1473","34225545","10.1080/14787210.2021.1951705","Antimicrobial resistance in low- and middle-income countries: current status and future directions.","Introduction: Rising rates of antimicrobial resistance (AMR) globally continue to pose agrave threat to human health. Low- and middle-income countries (LMICs) are disproportionately affected, partly due to the high burden of communicable diseases.Areas covered: We reviewed current trends in AMR in LMICs and examined the forces driving AMR in those regions. The state of interventions being undertaken to curb AMR across the developing world are discussed, and the impact of the curren","2021","07","19","Expert Rev Anti Infect Ther","Expert review of anti-infective therapy","Antibiotic use; Antimicrobial resistance (AMR); Antimicrobial stewardship; Low- and middle-income countries (LMICs); Review","Sayood","Sena","Department of Internal Medicine, Division of Infectious Diseases, Washington University School of Medicine, St Louis",NA
"1474","34225545","10.1080/14787210.2021.1951705","Antimicrobial resistance in low- and middle-income countries: current status and future directions.","Introduction: Rising rates of antimicrobial resistance (AMR) globally continue to pose agrave threat to human health. Low- and middle-income countries (LMICs) are disproportionately affected, partly due to the high burden of communicable diseases.Areas covered: We reviewed current trends in AMR in LMICs and examined the forces driving AMR in those regions. The state of interventions being undertaken to curb AMR across the developing world are discussed, and the impact of the curren","2021","07","19","Expert Rev Anti Infect Ther","Expert review of anti-infective therapy","Antibiotic use; Antimicrobial resistance (AMR); Antimicrobial stewardship; Low- and middle-income countries (LMICs); Review","Gandra","Sumanth","Department of Internal Medicine, Division of Infectious Diseases, Washington University School of Medicine, St Louis",NA
"1475","34225541","10.1080/14787210.2021.1950532","Efficacy of combined Sofosbuvir and Daclatasvir in the treatment of COVID-19 patients with pneumonia: a multicenter Egyptian study.","Limited experimental and clinical evidence suggests a potential role for sofosbuvir/daclatasvir in treating COVID19. We aim to evaluate the efficacy of generic sofosbuvir/daclatasvir in treating COVID-19 patients with pneumonia. This multicenter prospective study involved 174 patients with COVID-19. Patients were randomized into two groups. Group A (96 patients) received sofosbuvir (400 mg)/daclatasvir (60 mg) for 14 days in combination with conventional therapy. Group B (78 patients) received c","2021","07","15","Expert Rev Anti Infect Ther","Expert review of anti-infective therapy","COVID-19; Daclatasvir; Sofosbuvir; efficacy; safety","El-Bendary","Mahmoud","Tropical medicine and Hepatogastroenterology department, Mansoura University, Mansoura, Egypt",NA
"1476","34225541","10.1080/14787210.2021.1950532","Efficacy of combined Sofosbuvir and Daclatasvir in the treatment of COVID-19 patients with pneumonia: a multicenter Egyptian study.","Limited experimental and clinical evidence suggests a potential role for sofosbuvir/daclatasvir in treating COVID19. We aim to evaluate the efficacy of generic sofosbuvir/daclatasvir in treating COVID-19 patients with pneumonia. This multicenter prospective study involved 174 patients with COVID-19. Patients were randomized into two groups. Group A (96 patients) received sofosbuvir (400 mg)/daclatasvir (60 mg) for 14 days in combination with conventional therapy. Group B (78 patients) received c","2021","07","15","Expert Rev Anti Infect Ther","Expert review of anti-infective therapy","COVID-19; Daclatasvir; Sofosbuvir; efficacy; safety","Abd-Elsalam","Sherief","Tropical Medicine and Infectious diseases department, Tanta University, Tanta, Egypt",NA
"1477","34225541","10.1080/14787210.2021.1950532","Efficacy of combined Sofosbuvir and Daclatasvir in the treatment of COVID-19 patients with pneumonia: a multicenter Egyptian study.","Limited experimental and clinical evidence suggests a potential role for sofosbuvir/daclatasvir in treating COVID19. We aim to evaluate the efficacy of generic sofosbuvir/daclatasvir in treating COVID-19 patients with pneumonia. This multicenter prospective study involved 174 patients with COVID-19. Patients were randomized into two groups. Group A (96 patients) received sofosbuvir (400 mg)/daclatasvir (60 mg) for 14 days in combination with conventional therapy. Group B (78 patients) received c","2021","07","15","Expert Rev Anti Infect Ther","Expert review of anti-infective therapy","COVID-19; Daclatasvir; Sofosbuvir; efficacy; safety","Elbaz","Tamer","Endemic medicine department, Cairo University Hospitals, Cairo, Egypt",NA
"1478","34225541","10.1080/14787210.2021.1950532","Efficacy of combined Sofosbuvir and Daclatasvir in the treatment of COVID-19 patients with pneumonia: a multicenter Egyptian study.","Limited experimental and clinical evidence suggests a potential role for sofosbuvir/daclatasvir in treating COVID19. We aim to evaluate the efficacy of generic sofosbuvir/daclatasvir in treating COVID-19 patients with pneumonia. This multicenter prospective study involved 174 patients with COVID-19. Patients were randomized into two groups. Group A (96 patients) received sofosbuvir (400 mg)/daclatasvir (60 mg) for 14 days in combination with conventional therapy. Group B (78 patients) received c","2021","07","15","Expert Rev Anti Infect Ther","Expert review of anti-infective therapy","COVID-19; Daclatasvir; Sofosbuvir; efficacy; safety","El-Akel","Wafaa","Endemic medicine department, Cairo University Hospitals, Cairo, Egypt",NA
"1479","34225541","10.1080/14787210.2021.1950532","Efficacy of combined Sofosbuvir and Daclatasvir in the treatment of COVID-19 patients with pneumonia: a multicenter Egyptian study.","Limited experimental and clinical evidence suggests a potential role for sofosbuvir/daclatasvir in treating COVID19. We aim to evaluate the efficacy of generic sofosbuvir/daclatasvir in treating COVID-19 patients with pneumonia. This multicenter prospective study involved 174 patients with COVID-19. Patients were randomized into two groups. Group A (96 patients) received sofosbuvir (400 mg)/daclatasvir (60 mg) for 14 days in combination with conventional therapy. Group B (78 patients) received c","2021","07","15","Expert Rev Anti Infect Ther","Expert review of anti-infective therapy","COVID-19; Daclatasvir; Sofosbuvir; efficacy; safety","Cordie","Ahmed","Endemic medicine department, Cairo University Hospitals, Cairo, Egypt",NA
"1480","34225541","10.1080/14787210.2021.1950532","Efficacy of combined Sofosbuvir and Daclatasvir in the treatment of COVID-19 patients with pneumonia: a multicenter Egyptian study.","Limited experimental and clinical evidence suggests a potential role for sofosbuvir/daclatasvir in treating COVID19. We aim to evaluate the efficacy of generic sofosbuvir/daclatasvir in treating COVID-19 patients with pneumonia. This multicenter prospective study involved 174 patients with COVID-19. Patients were randomized into two groups. Group A (96 patients) received sofosbuvir (400 mg)/daclatasvir (60 mg) for 14 days in combination with conventional therapy. Group B (78 patients) received c","2021","07","15","Expert Rev Anti Infect Ther","Expert review of anti-infective therapy","COVID-19; Daclatasvir; Sofosbuvir; efficacy; safety","Elhadidy","Tamer","Chest department, Mansoura University, Mansoura, Egypt",NA
"1481","34225541","10.1080/14787210.2021.1950532","Efficacy of combined Sofosbuvir and Daclatasvir in the treatment of COVID-19 patients with pneumonia: a multicenter Egyptian study.","Limited experimental and clinical evidence suggests a potential role for sofosbuvir/daclatasvir in treating COVID19. We aim to evaluate the efficacy of generic sofosbuvir/daclatasvir in treating COVID-19 patients with pneumonia. This multicenter prospective study involved 174 patients with COVID-19. Patients were randomized into two groups. Group A (96 patients) received sofosbuvir (400 mg)/daclatasvir (60 mg) for 14 days in combination with conventional therapy. Group B (78 patients) received c","2021","07","15","Expert Rev Anti Infect Ther","Expert review of anti-infective therapy","COVID-19; Daclatasvir; Sofosbuvir; efficacy; safety","Elalfy","Hatem","Tropical medicine and Hepatogastroenterology department, Mansoura University, Mansoura, Egypt",NA
"1482","34225541","10.1080/14787210.2021.1950532","Efficacy of combined Sofosbuvir and Daclatasvir in the treatment of COVID-19 patients with pneumonia: a multicenter Egyptian study.","Limited experimental and clinical evidence suggests a potential role for sofosbuvir/daclatasvir in treating COVID19. We aim to evaluate the efficacy of generic sofosbuvir/daclatasvir in treating COVID-19 patients with pneumonia. This multicenter prospective study involved 174 patients with COVID-19. Patients were randomized into two groups. Group A (96 patients) received sofosbuvir (400 mg)/daclatasvir (60 mg) for 14 days in combination with conventional therapy. Group B (78 patients) received c","2021","07","15","Expert Rev Anti Infect Ther","Expert review of anti-infective therapy","COVID-19; Daclatasvir; Sofosbuvir; efficacy; safety","Farid","Khaled","Tropical medicine and Hepatogastroenterology department, Mansoura University, Mansoura, Egypt",NA
"1483","34225541","10.1080/14787210.2021.1950532","Efficacy of combined Sofosbuvir and Daclatasvir in the treatment of COVID-19 patients with pneumonia: a multicenter Egyptian study.","Limited experimental and clinical evidence suggests a potential role for sofosbuvir/daclatasvir in treating COVID19. We aim to evaluate the efficacy of generic sofosbuvir/daclatasvir in treating COVID-19 patients with pneumonia. This multicenter prospective study involved 174 patients with COVID-19. Patients were randomized into two groups. Group A (96 patients) received sofosbuvir (400 mg)/daclatasvir (60 mg) for 14 days in combination with conventional therapy. Group B (78 patients) received c","2021","07","15","Expert Rev Anti Infect Ther","Expert review of anti-infective therapy","COVID-19; Daclatasvir; Sofosbuvir; efficacy; safety","Elegezy","Mohamed","Tropical medicine and Hepatogastroenterology department, Mansoura University, Mansoura, Egypt",NA
"1484","34225541","10.1080/14787210.2021.1950532","Efficacy of combined Sofosbuvir and Daclatasvir in the treatment of COVID-19 patients with pneumonia: a multicenter Egyptian study.","Limited experimental and clinical evidence suggests a potential role for sofosbuvir/daclatasvir in treating COVID19. We aim to evaluate the efficacy of generic sofosbuvir/daclatasvir in treating COVID-19 patients with pneumonia. This multicenter prospective study involved 174 patients with COVID-19. Patients were randomized into two groups. Group A (96 patients) received sofosbuvir (400 mg)/daclatasvir (60 mg) for 14 days in combination with conventional therapy. Group B (78 patients) received c","2021","07","15","Expert Rev Anti Infect Ther","Expert review of anti-infective therapy","COVID-19; Daclatasvir; Sofosbuvir; efficacy; safety","El-Badrawy","Adel","Radiology department, Mansoura University, Mansoura, Egypt",NA
"1485","34225541","10.1080/14787210.2021.1950532","Efficacy of combined Sofosbuvir and Daclatasvir in the treatment of COVID-19 patients with pneumonia: a multicenter Egyptian study.","Limited experimental and clinical evidence suggests a potential role for sofosbuvir/daclatasvir in treating COVID19. We aim to evaluate the efficacy of generic sofosbuvir/daclatasvir in treating COVID-19 patients with pneumonia. This multicenter prospective study involved 174 patients with COVID-19. Patients were randomized into two groups. Group A (96 patients) received sofosbuvir (400 mg)/daclatasvir (60 mg) for 14 days in combination with conventional therapy. Group B (78 patients) received c","2021","07","15","Expert Rev Anti Infect Ther","Expert review of anti-infective therapy","COVID-19; Daclatasvir; Sofosbuvir; efficacy; safety","Neamatallah","Mustafa","Medical Biochemistry department, Mansoura University, Mansoura, Egypt",NA
"1486","34225541","10.1080/14787210.2021.1950532","Efficacy of combined Sofosbuvir and Daclatasvir in the treatment of COVID-19 patients with pneumonia: a multicenter Egyptian study.","Limited experimental and clinical evidence suggests a potential role for sofosbuvir/daclatasvir in treating COVID19. We aim to evaluate the efficacy of generic sofosbuvir/daclatasvir in treating COVID-19 patients with pneumonia. This multicenter prospective study involved 174 patients with COVID-19. Patients were randomized into two groups. Group A (96 patients) received sofosbuvir (400 mg)/daclatasvir (60 mg) for 14 days in combination with conventional therapy. Group B (78 patients) received c","2021","07","15","Expert Rev Anti Infect Ther","Expert review of anti-infective therapy","COVID-19; Daclatasvir; Sofosbuvir; efficacy; safety","Abd Elghafar","Mohamed","Anesthesia, Surgical Intensive Care and Pain Medicine Department, Tanta University, Tanta, Egypt",NA
"1487","34225541","10.1080/14787210.2021.1950532","Efficacy of combined Sofosbuvir and Daclatasvir in the treatment of COVID-19 patients with pneumonia: a multicenter Egyptian study.","Limited experimental and clinical evidence suggests a potential role for sofosbuvir/daclatasvir in treating COVID19. We aim to evaluate the efficacy of generic sofosbuvir/daclatasvir in treating COVID-19 patients with pneumonia. This multicenter prospective study involved 174 patients with COVID-19. Patients were randomized into two groups. Group A (96 patients) received sofosbuvir (400 mg)/daclatasvir (60 mg) for 14 days in combination with conventional therapy. Group B (78 patients) received c","2021","07","15","Expert Rev Anti Infect Ther","Expert review of anti-infective therapy","COVID-19; Daclatasvir; Sofosbuvir; efficacy; safety","Salama","Marwa","Tropical Medicine and Infectious diseases department, Tanta University, Tanta, Egypt",NA
"1488","34225541","10.1080/14787210.2021.1950532","Efficacy of combined Sofosbuvir and Daclatasvir in the treatment of COVID-19 patients with pneumonia: a multicenter Egyptian study.","Limited experimental and clinical evidence suggests a potential role for sofosbuvir/daclatasvir in treating COVID19. We aim to evaluate the efficacy of generic sofosbuvir/daclatasvir in treating COVID-19 patients with pneumonia. This multicenter prospective study involved 174 patients with COVID-19. Patients were randomized into two groups. Group A (96 patients) received sofosbuvir (400 mg)/daclatasvir (60 mg) for 14 days in combination with conventional therapy. Group B (78 patients) received c","2021","07","15","Expert Rev Anti Infect Ther","Expert review of anti-infective therapy","COVID-19; Daclatasvir; Sofosbuvir; efficacy; safety","AbdAllah","Mohamed","Medical Research Division, National Research Center, Giza, Egypt",NA
"1489","34225541","10.1080/14787210.2021.1950532","Efficacy of combined Sofosbuvir and Daclatasvir in the treatment of COVID-19 patients with pneumonia: a multicenter Egyptian study.","Limited experimental and clinical evidence suggests a potential role for sofosbuvir/daclatasvir in treating COVID19. We aim to evaluate the efficacy of generic sofosbuvir/daclatasvir in treating COVID-19 patients with pneumonia. This multicenter prospective study involved 174 patients with COVID-19. Patients were randomized into two groups. Group A (96 patients) received sofosbuvir (400 mg)/daclatasvir (60 mg) for 14 days in combination with conventional therapy. Group B (78 patients) received c","2021","07","15","Expert Rev Anti Infect Ther","Expert review of anti-infective therapy","COVID-19; Daclatasvir; Sofosbuvir; efficacy; safety","Essam","Mahmoud","Endemic medicine department, Cairo University Hospitals, Cairo, Egypt",NA
"1490","34225541","10.1080/14787210.2021.1950532","Efficacy of combined Sofosbuvir and Daclatasvir in the treatment of COVID-19 patients with pneumonia: a multicenter Egyptian study.","Limited experimental and clinical evidence suggests a potential role for sofosbuvir/daclatasvir in treating COVID19. We aim to evaluate the efficacy of generic sofosbuvir/daclatasvir in treating COVID-19 patients with pneumonia. This multicenter prospective study involved 174 patients with COVID-19. Patients were randomized into two groups. Group A (96 patients) received sofosbuvir (400 mg)/daclatasvir (60 mg) for 14 days in combination with conventional therapy. Group B (78 patients) received c","2021","07","15","Expert Rev Anti Infect Ther","Expert review of anti-infective therapy","COVID-19; Daclatasvir; Sofosbuvir; efficacy; safety","El-Shazly","Mostafa","Chest department, Cairo University Hospitals, Cairo, Egypt",NA
"1491","34225541","10.1080/14787210.2021.1950532","Efficacy of combined Sofosbuvir and Daclatasvir in the treatment of COVID-19 patients with pneumonia: a multicenter Egyptian study.","Limited experimental and clinical evidence suggests a potential role for sofosbuvir/daclatasvir in treating COVID19. We aim to evaluate the efficacy of generic sofosbuvir/daclatasvir in treating COVID-19 patients with pneumonia. This multicenter prospective study involved 174 patients with COVID-19. Patients were randomized into two groups. Group A (96 patients) received sofosbuvir (400 mg)/daclatasvir (60 mg) for 14 days in combination with conventional therapy. Group B (78 patients) received c","2021","07","15","Expert Rev Anti Infect Ther","Expert review of anti-infective therapy","COVID-19; Daclatasvir; Sofosbuvir; efficacy; safety","Esmat","Gamal","Endemic medicine department, Cairo University Hospitals, Cairo, Egypt",NA
"1492","34225540","10.1080/14787210.2021.1949986","Molecular detections of coronavirus: current and emerging methodologies.","Introduction: Seven coronavirus species have been identified that can infect humans. While human coronavirus infections had been historically associated with only mild respiratory symptoms similar to the common cold, three coronaviruses identified since 2003, Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV), Middle East Respiratory Syndrome Coronavirus (MERS-CoV), and SARS-CoV-2, cause life-threatening severe respiratory syndromes. The coronavirus disease 2019 (COVID-19) caused by","2021","07","21","Expert Rev Anti Infect Ther","Expert review of anti-infective therapy","COVID-19; CRISPR; Coronavirus; ELISA; LAMP; LFA; RT-PCR; SARS-CoV-2; diagnosis; molecular detection","Diao","Mingkun","College of Health Science and Environmental Engineering, Shenzhen Technology University, Shenzhen, China",NA
"1493","34225540","10.1080/14787210.2021.1949986","Molecular detections of coronavirus: current and emerging methodologies.","Introduction: Seven coronavirus species have been identified that can infect humans. While human coronavirus infections had been historically associated with only mild respiratory symptoms similar to the common cold, three coronaviruses identified since 2003, Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV), Middle East Respiratory Syndrome Coronavirus (MERS-CoV), and SARS-CoV-2, cause life-threatening severe respiratory syndromes. The coronavirus disease 2019 (COVID-19) caused by","2021","07","21","Expert Rev Anti Infect Ther","Expert review of anti-infective therapy","COVID-19; CRISPR; Coronavirus; ELISA; LAMP; LFA; RT-PCR; SARS-CoV-2; diagnosis; molecular detection","Lang","Lang","College of Health Science and Environmental Engineering, Shenzhen Technology University, Shenzhen, China",NA
"1494","34225540","10.1080/14787210.2021.1949986","Molecular detections of coronavirus: current and emerging methodologies.","Introduction: Seven coronavirus species have been identified that can infect humans. While human coronavirus infections had been historically associated with only mild respiratory symptoms similar to the common cold, three coronaviruses identified since 2003, Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV), Middle East Respiratory Syndrome Coronavirus (MERS-CoV), and SARS-CoV-2, cause life-threatening severe respiratory syndromes. The coronavirus disease 2019 (COVID-19) caused by","2021","07","21","Expert Rev Anti Infect Ther","Expert review of anti-infective therapy","COVID-19; CRISPR; Coronavirus; ELISA; LAMP; LFA; RT-PCR; SARS-CoV-2; diagnosis; molecular detection","Feng","Juan","College of Health Science and Environmental Engineering, Shenzhen Technology University, Shenzhen, China",NA
"1495","34225540","10.1080/14787210.2021.1949986","Molecular detections of coronavirus: current and emerging methodologies.","Introduction: Seven coronavirus species have been identified that can infect humans. While human coronavirus infections had been historically associated with only mild respiratory symptoms similar to the common cold, three coronaviruses identified since 2003, Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV), Middle East Respiratory Syndrome Coronavirus (MERS-CoV), and SARS-CoV-2, cause life-threatening severe respiratory syndromes. The coronavirus disease 2019 (COVID-19) caused by","2021","07","21","Expert Rev Anti Infect Ther","Expert review of anti-infective therapy","COVID-19; CRISPR; Coronavirus; ELISA; LAMP; LFA; RT-PCR; SARS-CoV-2; diagnosis; molecular detection","Li","Rongsong","College of Health Science and Environmental Engineering, Shenzhen Technology University, Shenzhen, China",NA
"1496","34225513","10.1177/00332941211028105","Getting to the Sandbar: Understanding the Emotional Phases of COVID-19 Among College and University Students.","This paper provides a framework for understanding the emotional and behavioral responses of college and university students during the COVID-19 pandemic. It builds on the Substance Abuse and Mental Health Services Administration (SAMHSA) Phases of Disaster Model and Maslow's Hierarchy of Needs. Additionally, we conceptualize a new phase in the Phases of Disaster Model, which we refer to as the ""Sandbar Phase,"" to address the unique factors of COVID-19 for college and university students. For eac","2021","07","22","Psychol Rep","Psychological reports","Mental health, awareness; anxiety, college, university; public health issues; sociocultural issues in psychology; well-being","Stowe","Angela","Student Counseling Services, University of Alabama at Birmingham, AL, USA",NA
"1497","34225513","10.1177/00332941211028105","Getting to the Sandbar: Understanding the Emotional Phases of COVID-19 Among College and University Students.","This paper provides a framework for understanding the emotional and behavioral responses of college and university students during the COVID-19 pandemic. It builds on the Substance Abuse and Mental Health Services Administration (SAMHSA) Phases of Disaster Model and Maslow's Hierarchy of Needs. Additionally, we conceptualize a new phase in the Phases of Disaster Model, which we refer to as the ""Sandbar Phase,"" to address the unique factors of COVID-19 for college and university students. For eac","2021","07","22","Psychol Rep","Psychological reports","Mental health, awareness; anxiety, college, university; public health issues; sociocultural issues in psychology; well-being","Upshaw","Kalani","Department of Health Behavior, School of Public Health, University of Alabama at Birmingham, AL, USA",NA
"1498","34225513","10.1177/00332941211028105","Getting to the Sandbar: Understanding the Emotional Phases of COVID-19 Among College and University Students.","This paper provides a framework for understanding the emotional and behavioral responses of college and university students during the COVID-19 pandemic. It builds on the Substance Abuse and Mental Health Services Administration (SAMHSA) Phases of Disaster Model and Maslow's Hierarchy of Needs. Additionally, we conceptualize a new phase in the Phases of Disaster Model, which we refer to as the ""Sandbar Phase,"" to address the unique factors of COVID-19 for college and university students. For eac","2021","07","22","Psychol Rep","Psychological reports","Mental health, awareness; anxiety, college, university; public health issues; sociocultural issues in psychology; well-being","Estep","Claire","Department of Health Behavior, School of Public Health, University of Alabama at Birmingham, AL, USA",NA
"1499","34225513","10.1177/00332941211028105","Getting to the Sandbar: Understanding the Emotional Phases of COVID-19 Among College and University Students.","This paper provides a framework for understanding the emotional and behavioral responses of college and university students during the COVID-19 pandemic. It builds on the Substance Abuse and Mental Health Services Administration (SAMHSA) Phases of Disaster Model and Maslow's Hierarchy of Needs. Additionally, we conceptualize a new phase in the Phases of Disaster Model, which we refer to as the ""Sandbar Phase,"" to address the unique factors of COVID-19 for college and university students. For eac","2021","07","22","Psychol Rep","Psychological reports","Mental health, awareness; anxiety, college, university; public health issues; sociocultural issues in psychology; well-being","Lanzi","Robin Gaines","Department of Health Behavior, School of Public Health, University of Alabama at Birmingham, AL, USA",NA
"1500","34225510","10.1080/87565641.2021.1943398","Cognitive Stabilization Intervention during the Era of COVID-19.","As COVID-19 halted traditional neuropsychological assessment due to infection risk, neuropsychologists considered alternative practice models. Cognitive stabilization intervention (CSI) via telehealth, was developed to stabilize cognition in advance of neuropsychological assessment. It incorporates elements of evidence-based treatments, including cognitive training, sleep training, and medication adherence training within a motivational interview framework. Two case vignettes are described. One ","2021","07","06","Dev Neuropsychol","Developmental neuropsychology",NA,"Lanca","Margaret","Department of Psychiatry, Harvard Medical School/Cambridge Health Alliance, Cambridge, USA",NA
"1501","34225510","10.1080/87565641.2021.1943398","Cognitive Stabilization Intervention during the Era of COVID-19.","As COVID-19 halted traditional neuropsychological assessment due to infection risk, neuropsychologists considered alternative practice models. Cognitive stabilization intervention (CSI) via telehealth, was developed to stabilize cognition in advance of neuropsychological assessment. It incorporates elements of evidence-based treatments, including cognitive training, sleep training, and medication adherence training within a motivational interview framework. Two case vignettes are described. One ","2021","07","06","Dev Neuropsychol","Developmental neuropsychology",NA,"Abrams","Danielle N","Department of Psychiatry, Harvard Medical School/Cambridge Health Alliance, Cambridge, USA",NA
"1502","34225510","10.1080/87565641.2021.1943398","Cognitive Stabilization Intervention during the Era of COVID-19.","As COVID-19 halted traditional neuropsychological assessment due to infection risk, neuropsychologists considered alternative practice models. Cognitive stabilization intervention (CSI) via telehealth, was developed to stabilize cognition in advance of neuropsychological assessment. It incorporates elements of evidence-based treatments, including cognitive training, sleep training, and medication adherence training within a motivational interview framework. Two case vignettes are described. One ","2021","07","06","Dev Neuropsychol","Developmental neuropsychology",NA,"Crittenden","Persephone","Department of Psychiatry, Harvard Medical School/Cambridge Health Alliance, Cambridge, USA",NA
"1503","34225510","10.1080/87565641.2021.1943398","Cognitive Stabilization Intervention during the Era of COVID-19.","As COVID-19 halted traditional neuropsychological assessment due to infection risk, neuropsychologists considered alternative practice models. Cognitive stabilization intervention (CSI) via telehealth, was developed to stabilize cognition in advance of neuropsychological assessment. It incorporates elements of evidence-based treatments, including cognitive training, sleep training, and medication adherence training within a motivational interview framework. Two case vignettes are described. One ","2021","07","06","Dev Neuropsychol","Developmental neuropsychology",NA,"Jones","Kelly M","Private Practice, Boston &amp",NA
"1504","34225507","10.1080/13607863.2021.1942431","Factors associated with depressive and anxiety symptoms in older adults during the COVID-19 pandemic: a Brazilian study.","Objectives: Older adults are one of the most vulnerable age groups to the social distance measures imposed by the COVID-19 pandemic. This study aimed to assess factors associated with depressive and anxiety symptoms in Brazilian older adults during the pandemic.Method: This cross-sectional online study assessed 380 older adults (over 60 years of age) living in Brazil, from 26th May 2020 to 29th June 2020. A self-reported questionnaire included sociodemographic data, lifestyle, heal","2021","07","06","Aging Ment Health","Aging &amp; mental health","COVID-19; Mental health; psychology of aging; social isolation","de Oliveira Andrade","Nathália","Universidade Federal de Mato Grosso do Sul, Três Lagoas Campus, Três Lagoas, MS, Brazil",NA
"1505","34225507","10.1080/13607863.2021.1942431","Factors associated with depressive and anxiety symptoms in older adults during the COVID-19 pandemic: a Brazilian study.","Objectives: Older adults are one of the most vulnerable age groups to the social distance measures imposed by the COVID-19 pandemic. This study aimed to assess factors associated with depressive and anxiety symptoms in Brazilian older adults during the pandemic.Method: This cross-sectional online study assessed 380 older adults (over 60 years of age) living in Brazil, from 26th May 2020 to 29th June 2020. A self-reported questionnaire included sociodemographic data, lifestyle, heal","2021","07","06","Aging Ment Health","Aging &amp; mental health","COVID-19; Mental health; psychology of aging; social isolation","Correia Silva Azambuja","Humberta","Universidade Federal de Mato Grosso do Sul, Três Lagoas Campus, Três Lagoas, MS, Brazil",NA
"1506","34225507","10.1080/13607863.2021.1942431","Factors associated with depressive and anxiety symptoms in older adults during the COVID-19 pandemic: a Brazilian study.","Objectives: Older adults are one of the most vulnerable age groups to the social distance measures imposed by the COVID-19 pandemic. This study aimed to assess factors associated with depressive and anxiety symptoms in Brazilian older adults during the pandemic.Method: This cross-sectional online study assessed 380 older adults (over 60 years of age) living in Brazil, from 26th May 2020 to 29th June 2020. A self-reported questionnaire included sociodemographic data, lifestyle, heal","2021","07","06","Aging Ment Health","Aging &amp; mental health","COVID-19; Mental health; psychology of aging; social isolation","Carvalho Reis Martins","Tatiana","Universidade Federal de Mato Grosso do Sul, Três Lagoas Campus, Três Lagoas, MS, Brazil",NA
"1507","34225507","10.1080/13607863.2021.1942431","Factors associated with depressive and anxiety symptoms in older adults during the COVID-19 pandemic: a Brazilian study.","Objectives: Older adults are one of the most vulnerable age groups to the social distance measures imposed by the COVID-19 pandemic. This study aimed to assess factors associated with depressive and anxiety symptoms in Brazilian older adults during the pandemic.Method: This cross-sectional online study assessed 380 older adults (over 60 years of age) living in Brazil, from 26th May 2020 to 29th June 2020. A self-reported questionnaire included sociodemographic data, lifestyle, heal","2021","07","06","Aging Ment Health","Aging &amp; mental health","COVID-19; Mental health; psychology of aging; social isolation","Manoel Seixas","Rosimeire Aparecida","Faculdade de Medicina, Universidade Federal de Mato Grosso do Sul, Campo Grande, MS, Brazil",NA
"1508","34225507","10.1080/13607863.2021.1942431","Factors associated with depressive and anxiety symptoms in older adults during the COVID-19 pandemic: a Brazilian study.","Objectives: Older adults are one of the most vulnerable age groups to the social distance measures imposed by the COVID-19 pandemic. This study aimed to assess factors associated with depressive and anxiety symptoms in Brazilian older adults during the pandemic.Method: This cross-sectional online study assessed 380 older adults (over 60 years of age) living in Brazil, from 26th May 2020 to 29th June 2020. A self-reported questionnaire included sociodemographic data, lifestyle, heal","2021","07","06","Aging Ment Health","Aging &amp; mental health","COVID-19; Mental health; psychology of aging; social isolation","Moretti Luchesi","Bruna","Universidade Federal de Mato Grosso do Sul, Três Lagoas Campus, Três Lagoas, MS, Brazil",NA
"1509","34225505","10.1080/10641963.2021.1937205","Prognostic value of C-reactive protein/albumin ratio in hypertensive COVID-19 patients.","The aim of this study was to investigate the relationship between the C-reactive protein/albumin ratio and the prognosis of hypertensive COVID-19 patients. It was designed as a single center retrospective study. PCR positive COVID-19 patients who were followed up in the intensive care unit (ICU) and received antihypertensive treatment were included in the study. The patients were divided into two groups as survivor and non-survivor. C-reactive protein/albumin (CAR) ratios of the patients were co","2021","07","06","Clin Exp Hypertens","Clinical and experimental hypertension (New York, N.Y. : 1993)","C-reactive protein; COVID-19; albumin; c-reactive protein/albumin ratio; hypertension","Özdemir","Ibrahim Halil","Department of Cardiology, Manisa City Hospital, Manisa, TURKEY",NA
"1510","34225505","10.1080/10641963.2021.1937205","Prognostic value of C-reactive protein/albumin ratio in hypertensive COVID-19 patients.","The aim of this study was to investigate the relationship between the C-reactive protein/albumin ratio and the prognosis of hypertensive COVID-19 patients. It was designed as a single center retrospective study. PCR positive COVID-19 patients who were followed up in the intensive care unit (ICU) and received antihypertensive treatment were included in the study. The patients were divided into two groups as survivor and non-survivor. C-reactive protein/albumin (CAR) ratios of the patients were co","2021","07","06","Clin Exp Hypertens","Clinical and experimental hypertension (New York, N.Y. : 1993)","C-reactive protein; COVID-19; albumin; c-reactive protein/albumin ratio; hypertension","Özlek","Bülent","Department of Cardiology, Mugla Sitki Kocman University Faculty of Medicine, Mugla, TURKEY",NA
"1511","34225505","10.1080/10641963.2021.1937205","Prognostic value of C-reactive protein/albumin ratio in hypertensive COVID-19 patients.","The aim of this study was to investigate the relationship between the C-reactive protein/albumin ratio and the prognosis of hypertensive COVID-19 patients. It was designed as a single center retrospective study. PCR positive COVID-19 patients who were followed up in the intensive care unit (ICU) and received antihypertensive treatment were included in the study. The patients were divided into two groups as survivor and non-survivor. C-reactive protein/albumin (CAR) ratios of the patients were co","2021","07","06","Clin Exp Hypertens","Clinical and experimental hypertension (New York, N.Y. : 1993)","C-reactive protein; COVID-19; albumin; c-reactive protein/albumin ratio; hypertension","Özen","Mehmet Burak","Department of Cardiology, Manisa City Hospital, Manisa, TURKEY",NA
"1512","34225505","10.1080/10641963.2021.1937205","Prognostic value of C-reactive protein/albumin ratio in hypertensive COVID-19 patients.","The aim of this study was to investigate the relationship between the C-reactive protein/albumin ratio and the prognosis of hypertensive COVID-19 patients. It was designed as a single center retrospective study. PCR positive COVID-19 patients who were followed up in the intensive care unit (ICU) and received antihypertensive treatment were included in the study. The patients were divided into two groups as survivor and non-survivor. C-reactive protein/albumin (CAR) ratios of the patients were co","2021","07","06","Clin Exp Hypertens","Clinical and experimental hypertension (New York, N.Y. : 1993)","C-reactive protein; COVID-19; albumin; c-reactive protein/albumin ratio; hypertension","Gündüz","Ramazan","Department of Cardiology, Manisa City Hospital, Manisa, TURKEY",NA
"1513","34225505","10.1080/10641963.2021.1937205","Prognostic value of C-reactive protein/albumin ratio in hypertensive COVID-19 patients.","The aim of this study was to investigate the relationship between the C-reactive protein/albumin ratio and the prognosis of hypertensive COVID-19 patients. It was designed as a single center retrospective study. PCR positive COVID-19 patients who were followed up in the intensive care unit (ICU) and received antihypertensive treatment were included in the study. The patients were divided into two groups as survivor and non-survivor. C-reactive protein/albumin (CAR) ratios of the patients were co","2021","07","06","Clin Exp Hypertens","Clinical and experimental hypertension (New York, N.Y. : 1993)","C-reactive protein; COVID-19; albumin; c-reactive protein/albumin ratio; hypertension","Çetin","Nurullah","Department of Cardiology, Celal Bayar University Faculty of Medicine, Manisa, TURKEY",NA
"1514","34225505","10.1080/10641963.2021.1937205","Prognostic value of C-reactive protein/albumin ratio in hypertensive COVID-19 patients.","The aim of this study was to investigate the relationship between the C-reactive protein/albumin ratio and the prognosis of hypertensive COVID-19 patients. It was designed as a single center retrospective study. PCR positive COVID-19 patients who were followed up in the intensive care unit (ICU) and received antihypertensive treatment were included in the study. The patients were divided into two groups as survivor and non-survivor. C-reactive protein/albumin (CAR) ratios of the patients were co","2021","07","06","Clin Exp Hypertens","Clinical and experimental hypertension (New York, N.Y. : 1993)","C-reactive protein; COVID-19; albumin; c-reactive protein/albumin ratio; hypertension","Özlek","Eda","Department of Cardiology, Mugla Sitki Kocman University Faculty of Medicine, Mugla, TURKEY",NA
"1515","34225505","10.1080/10641963.2021.1937205","Prognostic value of C-reactive protein/albumin ratio in hypertensive COVID-19 patients.","The aim of this study was to investigate the relationship between the C-reactive protein/albumin ratio and the prognosis of hypertensive COVID-19 patients. It was designed as a single center retrospective study. PCR positive COVID-19 patients who were followed up in the intensive care unit (ICU) and received antihypertensive treatment were included in the study. The patients were divided into two groups as survivor and non-survivor. C-reactive protein/albumin (CAR) ratios of the patients were co","2021","07","06","Clin Exp Hypertens","Clinical and experimental hypertension (New York, N.Y. : 1993)","C-reactive protein; COVID-19; albumin; c-reactive protein/albumin ratio; hypertension","Yildiz","Bekir Serhat","Department of Cardiology, Celal Bayar University Faculty of Medicine, Manisa, TURKEY",NA
"1516","34225505","10.1080/10641963.2021.1937205","Prognostic value of C-reactive protein/albumin ratio in hypertensive COVID-19 patients.","The aim of this study was to investigate the relationship between the C-reactive protein/albumin ratio and the prognosis of hypertensive COVID-19 patients. It was designed as a single center retrospective study. PCR positive COVID-19 patients who were followed up in the intensive care unit (ICU) and received antihypertensive treatment were included in the study. The patients were divided into two groups as survivor and non-survivor. C-reactive protein/albumin (CAR) ratios of the patients were co","2021","07","06","Clin Exp Hypertens","Clinical and experimental hypertension (New York, N.Y. : 1993)","C-reactive protein; COVID-19; albumin; c-reactive protein/albumin ratio; hypertension","Bilge","Ali Riza","Department of Cardiology, Celal Bayar University Faculty of Medicine, Manisa, TURKEY",NA
"1517","34225494","10.1128/mBio.01214-21","An Open-Source Toolkit To Expand Bioinformatics Training in Infectious Diseases.","As access to high-throughput sequencing technology has increased, the bottleneck in biomedical research has shifted from data generation to data analysis. Here, we describe a modular and extensible framework for didactic instruction in bioinformatics using publicly available RNA sequencing data sets from infectious disease studies, with a focus on host-parasite interactions. We highlight lessons learned from adapting this course for virtual learners during the coronavirus disease 2019 (COVID-19)","2021","07","06","mBio","mBio","bioinformatics; education; genomics; infectious disease; transcription","Berry","Alexander S F","Department of Pathobiology, University of Pennsylvaniagrid.25879.31, Philadelphia, Pennsylvania, USA",NA
"1518","34225494","10.1128/mBio.01214-21","An Open-Source Toolkit To Expand Bioinformatics Training in Infectious Diseases.","As access to high-throughput sequencing technology has increased, the bottleneck in biomedical research has shifted from data generation to data analysis. Here, we describe a modular and extensible framework for didactic instruction in bioinformatics using publicly available RNA sequencing data sets from infectious disease studies, with a focus on host-parasite interactions. We highlight lessons learned from adapting this course for virtual learners during the coronavirus disease 2019 (COVID-19)","2021","07","06","mBio","mBio","bioinformatics; education; genomics; infectious disease; transcription","Farias Amorim","Camila","Department of Pathobiology, University of Pennsylvaniagrid.25879.31, Philadelphia, Pennsylvania, USA",NA
"1519","34225494","10.1128/mBio.01214-21","An Open-Source Toolkit To Expand Bioinformatics Training in Infectious Diseases.","As access to high-throughput sequencing technology has increased, the bottleneck in biomedical research has shifted from data generation to data analysis. Here, we describe a modular and extensible framework for didactic instruction in bioinformatics using publicly available RNA sequencing data sets from infectious disease studies, with a focus on host-parasite interactions. We highlight lessons learned from adapting this course for virtual learners during the coronavirus disease 2019 (COVID-19)","2021","07","06","mBio","mBio","bioinformatics; education; genomics; infectious disease; transcription","Berry","Corbett L","Department of Pathobiology, University of Pennsylvaniagrid.25879.31, Philadelphia, Pennsylvania, USA",NA
"1520","34225494","10.1128/mBio.01214-21","An Open-Source Toolkit To Expand Bioinformatics Training in Infectious Diseases.","As access to high-throughput sequencing technology has increased, the bottleneck in biomedical research has shifted from data generation to data analysis. Here, we describe a modular and extensible framework for didactic instruction in bioinformatics using publicly available RNA sequencing data sets from infectious disease studies, with a focus on host-parasite interactions. We highlight lessons learned from adapting this course for virtual learners during the coronavirus disease 2019 (COVID-19)","2021","07","06","mBio","mBio","bioinformatics; education; genomics; infectious disease; transcription","Syrett","Camille M","Department of Biomedical Sciences, School of Veterinary Medicine, University of Pennsylvaniagrid.25879.31, Philadelphia, Pennsylvania, USA",NA
"1521","34225494","10.1128/mBio.01214-21","An Open-Source Toolkit To Expand Bioinformatics Training in Infectious Diseases.","As access to high-throughput sequencing technology has increased, the bottleneck in biomedical research has shifted from data generation to data analysis. Here, we describe a modular and extensible framework for didactic instruction in bioinformatics using publicly available RNA sequencing data sets from infectious disease studies, with a focus on host-parasite interactions. We highlight lessons learned from adapting this course for virtual learners during the coronavirus disease 2019 (COVID-19)","2021","07","06","mBio","mBio","bioinformatics; education; genomics; infectious disease; transcription","English","Elise D","Department of Pathobiology, University of Pennsylvaniagrid.25879.31, Philadelphia, Pennsylvania, USA",NA
"1522","34225494","10.1128/mBio.01214-21","An Open-Source Toolkit To Expand Bioinformatics Training in Infectious Diseases.","As access to high-throughput sequencing technology has increased, the bottleneck in biomedical research has shifted from data generation to data analysis. Here, we describe a modular and extensible framework for didactic instruction in bioinformatics using publicly available RNA sequencing data sets from infectious disease studies, with a focus on host-parasite interactions. We highlight lessons learned from adapting this course for virtual learners during the coronavirus disease 2019 (COVID-19)","2021","07","06","mBio","mBio","bioinformatics; education; genomics; infectious disease; transcription","Beiting","Daniel P","Department of Pathobiology, University of Pennsylvaniagrid.25879.31, Philadelphia, Pennsylvania, USA",NA
"1523","34225491","10.1128/mBio.01067-21","Methyltransferase-like 3 Modulates Severe Acute Respiratory Syndrome Coronavirus-2 RNA N6-Methyladenosine Modification and Replication.","The coronavirus disease 2019 pandemic caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is an ongoing global public crisis. Although viral RNA modification has been reported based on the transcriptome architecture, the types and functions of RNA modification are still unknown. In this study, we evaluated the roles of RNA N6-methyladenosine (m<sup>6</sup>A) modification in SARS-CoV-2. Our methylated RNA immunoprecipitation sequencing (MeRIP-Seq) and Nanopore direct RNA sequen","2021","07","06","mBio","mBio","N6-methyladenosine; methyltransferase-like 3; respiratory syndrome coronavirus-2; viral replication","Zhang","Xueyan","Center for Emerging Infectious Diseases, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, Hubei, China",NA
"1524","34225491","10.1128/mBio.01067-21","Methyltransferase-like 3 Modulates Severe Acute Respiratory Syndrome Coronavirus-2 RNA N6-Methyladenosine Modification and Replication.","The coronavirus disease 2019 pandemic caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is an ongoing global public crisis. Although viral RNA modification has been reported based on the transcriptome architecture, the types and functions of RNA modification are still unknown. In this study, we evaluated the roles of RNA N6-methyladenosine (m<sup>6</sup>A) modification in SARS-CoV-2. Our methylated RNA immunoprecipitation sequencing (MeRIP-Seq) and Nanopore direct RNA sequen","2021","07","06","mBio","mBio","N6-methyladenosine; methyltransferase-like 3; respiratory syndrome coronavirus-2; viral replication","Hao","Haojie","College of Life Sciences and Oceanography, Shenzhen University, Shenzhen, China",NA
"1525","34225491","10.1128/mBio.01067-21","Methyltransferase-like 3 Modulates Severe Acute Respiratory Syndrome Coronavirus-2 RNA N6-Methyladenosine Modification and Replication.","The coronavirus disease 2019 pandemic caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is an ongoing global public crisis. Although viral RNA modification has been reported based on the transcriptome architecture, the types and functions of RNA modification are still unknown. In this study, we evaluated the roles of RNA N6-methyladenosine (m<sup>6</sup>A) modification in SARS-CoV-2. Our methylated RNA immunoprecipitation sequencing (MeRIP-Seq) and Nanopore direct RNA sequen","2021","07","06","mBio","mBio","N6-methyladenosine; methyltransferase-like 3; respiratory syndrome coronavirus-2; viral replication","Ma","Li","Center for Emerging Infectious Diseases, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, Hubei, China",NA
"1526","34225491","10.1128/mBio.01067-21","Methyltransferase-like 3 Modulates Severe Acute Respiratory Syndrome Coronavirus-2 RNA N6-Methyladenosine Modification and Replication.","The coronavirus disease 2019 pandemic caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is an ongoing global public crisis. Although viral RNA modification has been reported based on the transcriptome architecture, the types and functions of RNA modification are still unknown. In this study, we evaluated the roles of RNA N6-methyladenosine (m<sup>6</sup>A) modification in SARS-CoV-2. Our methylated RNA immunoprecipitation sequencing (MeRIP-Seq) and Nanopore direct RNA sequen","2021","07","06","mBio","mBio","N6-methyladenosine; methyltransferase-like 3; respiratory syndrome coronavirus-2; viral replication","Zhang","Yecheng","Center for Emerging Infectious Diseases, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, Hubei, China",NA
"1527","34225491","10.1128/mBio.01067-21","Methyltransferase-like 3 Modulates Severe Acute Respiratory Syndrome Coronavirus-2 RNA N6-Methyladenosine Modification and Replication.","The coronavirus disease 2019 pandemic caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is an ongoing global public crisis. Although viral RNA modification has been reported based on the transcriptome architecture, the types and functions of RNA modification are still unknown. In this study, we evaluated the roles of RNA N6-methyladenosine (m<sup>6</sup>A) modification in SARS-CoV-2. Our methylated RNA immunoprecipitation sequencing (MeRIP-Seq) and Nanopore direct RNA sequen","2021","07","06","mBio","mBio","N6-methyladenosine; methyltransferase-like 3; respiratory syndrome coronavirus-2; viral replication","Hu","Xiao","Center for Emerging Infectious Diseases, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, Hubei, China",NA
"1528","34225491","10.1128/mBio.01067-21","Methyltransferase-like 3 Modulates Severe Acute Respiratory Syndrome Coronavirus-2 RNA N6-Methyladenosine Modification and Replication.","The coronavirus disease 2019 pandemic caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is an ongoing global public crisis. Although viral RNA modification has been reported based on the transcriptome architecture, the types and functions of RNA modification are still unknown. In this study, we evaluated the roles of RNA N6-methyladenosine (m<sup>6</sup>A) modification in SARS-CoV-2. Our methylated RNA immunoprecipitation sequencing (MeRIP-Seq) and Nanopore direct RNA sequen","2021","07","06","mBio","mBio","N6-methyladenosine; methyltransferase-like 3; respiratory syndrome coronavirus-2; viral replication","Chen","Zhen","Center for Emerging Infectious Diseases, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, Hubei, China",NA
"1529","34225491","10.1128/mBio.01067-21","Methyltransferase-like 3 Modulates Severe Acute Respiratory Syndrome Coronavirus-2 RNA N6-Methyladenosine Modification and Replication.","The coronavirus disease 2019 pandemic caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is an ongoing global public crisis. Although viral RNA modification has been reported based on the transcriptome architecture, the types and functions of RNA modification are still unknown. In this study, we evaluated the roles of RNA N6-methyladenosine (m<sup>6</sup>A) modification in SARS-CoV-2. Our methylated RNA immunoprecipitation sequencing (MeRIP-Seq) and Nanopore direct RNA sequen","2021","07","06","mBio","mBio","N6-methyladenosine; methyltransferase-like 3; respiratory syndrome coronavirus-2; viral replication","Liu","Di","Center for Emerging Infectious Diseases, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, Hubei, China",NA
"1530","34225491","10.1128/mBio.01067-21","Methyltransferase-like 3 Modulates Severe Acute Respiratory Syndrome Coronavirus-2 RNA N6-Methyladenosine Modification and Replication.","The coronavirus disease 2019 pandemic caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is an ongoing global public crisis. Although viral RNA modification has been reported based on the transcriptome architecture, the types and functions of RNA modification are still unknown. In this study, we evaluated the roles of RNA N6-methyladenosine (m<sup>6</sup>A) modification in SARS-CoV-2. Our methylated RNA immunoprecipitation sequencing (MeRIP-Seq) and Nanopore direct RNA sequen","2021","07","06","mBio","mBio","N6-methyladenosine; methyltransferase-like 3; respiratory syndrome coronavirus-2; viral replication","Yuan","Jianhui","Nanshan District Center for Disease Control and Prevention, Shenzhen, China",NA
"1531","34225491","10.1128/mBio.01067-21","Methyltransferase-like 3 Modulates Severe Acute Respiratory Syndrome Coronavirus-2 RNA N6-Methyladenosine Modification and Replication.","The coronavirus disease 2019 pandemic caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is an ongoing global public crisis. Although viral RNA modification has been reported based on the transcriptome architecture, the types and functions of RNA modification are still unknown. In this study, we evaluated the roles of RNA N6-methyladenosine (m<sup>6</sup>A) modification in SARS-CoV-2. Our methylated RNA immunoprecipitation sequencing (MeRIP-Seq) and Nanopore direct RNA sequen","2021","07","06","mBio","mBio","N6-methyladenosine; methyltransferase-like 3; respiratory syndrome coronavirus-2; viral replication","Hu","Zhangli","College of Life Sciences and Oceanography, Shenzhen University, Shenzhen, China",NA
"1532","34225491","10.1128/mBio.01067-21","Methyltransferase-like 3 Modulates Severe Acute Respiratory Syndrome Coronavirus-2 RNA N6-Methyladenosine Modification and Replication.","The coronavirus disease 2019 pandemic caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is an ongoing global public crisis. Although viral RNA modification has been reported based on the transcriptome architecture, the types and functions of RNA modification are still unknown. In this study, we evaluated the roles of RNA N6-methyladenosine (m<sup>6</sup>A) modification in SARS-CoV-2. Our methylated RNA immunoprecipitation sequencing (MeRIP-Seq) and Nanopore direct RNA sequen","2021","07","06","mBio","mBio","N6-methyladenosine; methyltransferase-like 3; respiratory syndrome coronavirus-2; viral replication","Guan","Wuxiang","Center for Emerging Infectious Diseases, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, Hubei, China",NA
"1533","34225487","10.1128/mBio.00850-21","Replicative Fitness of a SARS-CoV-2 20I/501Y.V1 Variant from Lineage B.1.1.7 in Human Reconstituted Bronchial Epithelium.","Since its emergence in 2019, circulating populations of the new coronavirus (CoV) continuously acquired genetic diversity. At the end of 2020, a variant named 20I/501Y.V1 (lineage B.1.1.7) emerged and replaced other circulating strains in several regions. This phenomenon has been poorly associated with biological evidence that this variant and the original strain exhibit different phenotypic characteristics. Here, we analyze the replication ability of this new variant in different cellular model","2021","07","06","mBio","mBio","20I/501Y.V1; B.1.1.7; SARS-CoV-2; ex vivo; in vitro; replicative fitness; variant","Touret","Franck","Unité des Virus Émergents, Aix-Marseille University, IRD 190, Inserm 1207, Marseille, France",NA
"1534","34225487","10.1128/mBio.00850-21","Replicative Fitness of a SARS-CoV-2 20I/501Y.V1 Variant from Lineage B.1.1.7 in Human Reconstituted Bronchial Epithelium.","Since its emergence in 2019, circulating populations of the new coronavirus (CoV) continuously acquired genetic diversity. At the end of 2020, a variant named 20I/501Y.V1 (lineage B.1.1.7) emerged and replaced other circulating strains in several regions. This phenomenon has been poorly associated with biological evidence that this variant and the original strain exhibit different phenotypic characteristics. Here, we analyze the replication ability of this new variant in different cellular model","2021","07","06","mBio","mBio","20I/501Y.V1; B.1.1.7; SARS-CoV-2; ex vivo; in vitro; replicative fitness; variant","Luciani","Léa","Unité des Virus Émergents, Aix-Marseille University, IRD 190, Inserm 1207, Marseille, France",NA
"1535","34225487","10.1128/mBio.00850-21","Replicative Fitness of a SARS-CoV-2 20I/501Y.V1 Variant from Lineage B.1.1.7 in Human Reconstituted Bronchial Epithelium.","Since its emergence in 2019, circulating populations of the new coronavirus (CoV) continuously acquired genetic diversity. At the end of 2020, a variant named 20I/501Y.V1 (lineage B.1.1.7) emerged and replaced other circulating strains in several regions. This phenomenon has been poorly associated with biological evidence that this variant and the original strain exhibit different phenotypic characteristics. Here, we analyze the replication ability of this new variant in different cellular model","2021","07","06","mBio","mBio","20I/501Y.V1; B.1.1.7; SARS-CoV-2; ex vivo; in vitro; replicative fitness; variant","Baronti","Cécile","Unité des Virus Émergents, Aix-Marseille University, IRD 190, Inserm 1207, Marseille, France",NA
"1536","34225487","10.1128/mBio.00850-21","Replicative Fitness of a SARS-CoV-2 20I/501Y.V1 Variant from Lineage B.1.1.7 in Human Reconstituted Bronchial Epithelium.","Since its emergence in 2019, circulating populations of the new coronavirus (CoV) continuously acquired genetic diversity. At the end of 2020, a variant named 20I/501Y.V1 (lineage B.1.1.7) emerged and replaced other circulating strains in several regions. This phenomenon has been poorly associated with biological evidence that this variant and the original strain exhibit different phenotypic characteristics. Here, we analyze the replication ability of this new variant in different cellular model","2021","07","06","mBio","mBio","20I/501Y.V1; B.1.1.7; SARS-CoV-2; ex vivo; in vitro; replicative fitness; variant","Cochin","Maxime","Unité des Virus Émergents, Aix-Marseille University, IRD 190, Inserm 1207, Marseille, France",NA
"1537","34225487","10.1128/mBio.00850-21","Replicative Fitness of a SARS-CoV-2 20I/501Y.V1 Variant from Lineage B.1.1.7 in Human Reconstituted Bronchial Epithelium.","Since its emergence in 2019, circulating populations of the new coronavirus (CoV) continuously acquired genetic diversity. At the end of 2020, a variant named 20I/501Y.V1 (lineage B.1.1.7) emerged and replaced other circulating strains in several regions. This phenomenon has been poorly associated with biological evidence that this variant and the original strain exhibit different phenotypic characteristics. Here, we analyze the replication ability of this new variant in different cellular model","2021","07","06","mBio","mBio","20I/501Y.V1; B.1.1.7; SARS-CoV-2; ex vivo; in vitro; replicative fitness; variant","Driouich","Jean-Sélim","Unité des Virus Émergents, Aix-Marseille University, IRD 190, Inserm 1207, Marseille, France",NA
"1538","34225487","10.1128/mBio.00850-21","Replicative Fitness of a SARS-CoV-2 20I/501Y.V1 Variant from Lineage B.1.1.7 in Human Reconstituted Bronchial Epithelium.","Since its emergence in 2019, circulating populations of the new coronavirus (CoV) continuously acquired genetic diversity. At the end of 2020, a variant named 20I/501Y.V1 (lineage B.1.1.7) emerged and replaced other circulating strains in several regions. This phenomenon has been poorly associated with biological evidence that this variant and the original strain exhibit different phenotypic characteristics. Here, we analyze the replication ability of this new variant in different cellular model","2021","07","06","mBio","mBio","20I/501Y.V1; B.1.1.7; SARS-CoV-2; ex vivo; in vitro; replicative fitness; variant","Gilles","Magali","Unité des Virus Émergents, Aix-Marseille University, IRD 190, Inserm 1207, Marseille, France",NA
"1539","34225487","10.1128/mBio.00850-21","Replicative Fitness of a SARS-CoV-2 20I/501Y.V1 Variant from Lineage B.1.1.7 in Human Reconstituted Bronchial Epithelium.","Since its emergence in 2019, circulating populations of the new coronavirus (CoV) continuously acquired genetic diversity. At the end of 2020, a variant named 20I/501Y.V1 (lineage B.1.1.7) emerged and replaced other circulating strains in several regions. This phenomenon has been poorly associated with biological evidence that this variant and the original strain exhibit different phenotypic characteristics. Here, we analyze the replication ability of this new variant in different cellular model","2021","07","06","mBio","mBio","20I/501Y.V1; B.1.1.7; SARS-CoV-2; ex vivo; in vitro; replicative fitness; variant","Thirion","Laurence","Unité des Virus Émergents, Aix-Marseille University, IRD 190, Inserm 1207, Marseille, France",NA
"1540","34225487","10.1128/mBio.00850-21","Replicative Fitness of a SARS-CoV-2 20I/501Y.V1 Variant from Lineage B.1.1.7 in Human Reconstituted Bronchial Epithelium.","Since its emergence in 2019, circulating populations of the new coronavirus (CoV) continuously acquired genetic diversity. At the end of 2020, a variant named 20I/501Y.V1 (lineage B.1.1.7) emerged and replaced other circulating strains in several regions. This phenomenon has been poorly associated with biological evidence that this variant and the original strain exhibit different phenotypic characteristics. Here, we analyze the replication ability of this new variant in different cellular model","2021","07","06","mBio","mBio","20I/501Y.V1; B.1.1.7; SARS-CoV-2; ex vivo; in vitro; replicative fitness; variant","Nougairède","Antoine","Unité des Virus Émergents, Aix-Marseille University, IRD 190, Inserm 1207, Marseille, France",NA
"1541","34225487","10.1128/mBio.00850-21","Replicative Fitness of a SARS-CoV-2 20I/501Y.V1 Variant from Lineage B.1.1.7 in Human Reconstituted Bronchial Epithelium.","Since its emergence in 2019, circulating populations of the new coronavirus (CoV) continuously acquired genetic diversity. At the end of 2020, a variant named 20I/501Y.V1 (lineage B.1.1.7) emerged and replaced other circulating strains in several regions. This phenomenon has been poorly associated with biological evidence that this variant and the original strain exhibit different phenotypic characteristics. Here, we analyze the replication ability of this new variant in different cellular model","2021","07","06","mBio","mBio","20I/501Y.V1; B.1.1.7; SARS-CoV-2; ex vivo; in vitro; replicative fitness; variant","de Lamballerie","Xavier","Unité des Virus Émergents, Aix-Marseille University, IRD 190, Inserm 1207, Marseille, France",NA
"1542","34225477","10.2217/epi-2021-0104","Implication of epitranscriptomics in trained innate immunity and COVID-19.",NA,"2021","07","20","Epigenomics","Epigenomics","COVID-19; epitranscriptomics; m6A modification; myeloid cells; trained immunity","Arumugam","Paramasivam","Cellular &amp",NA
"1543","34225477","10.2217/epi-2021-0104","Implication of epitranscriptomics in trained innate immunity and COVID-19.",NA,"2021","07","20","Epigenomics","Epigenomics","COVID-19; epitranscriptomics; m6A modification; myeloid cells; trained immunity","Jayaseelan","Vijayashree Priyadharsini","Cellular &amp",NA
"1544","34225463","10.1177/2515690X211026193","20-Week Study of Clinical Outcomes of Over-the-Counter COVID-19 Prophylaxis and Treatment.","As the lethal COVID-19 pandemic enters its second year, the need for effective modalities of alleviation remains urgent. This includes modalities that can readily be used by the public to reduce disease spread and severity. Such preventive measures and early-stage treatments may temper the immediacy of demand for advanced anti-COVID measures (drugs, antibodies, vaccines) and help relieve strain also on other health system resources. We present results of a clinical study with a multi-component O","2021","07","14","J Evid Based Integr Med","Journal of evidence-based integrative medicine","COVID-19; OTC; SARS-CoV-2; early-stage treatment; immunity enhancement; ionophores; prophylaxis; regimen compliance; zinc; Adult; Antiviral Agents; COVID-19; Cinchona; Communicable Disease Control; Dietary Supplements; Female; Humans; Ionophores; Lysine; Male; Middle Aged; Nonprescription Drugs; Pandemics; Quercetin; SARS-CoV-2; Severity of Illness Index; Treatment Outcome; Vitamins; Zinc","Margolin","Leon","Comprehensive Pain Management Institute, LLC, Columbus, OH, USA",NA
"1545","34225463","10.1177/2515690X211026193","20-Week Study of Clinical Outcomes of Over-the-Counter COVID-19 Prophylaxis and Treatment.","As the lethal COVID-19 pandemic enters its second year, the need for effective modalities of alleviation remains urgent. This includes modalities that can readily be used by the public to reduce disease spread and severity. Such preventive measures and early-stage treatments may temper the immediacy of demand for advanced anti-COVID measures (drugs, antibodies, vaccines) and help relieve strain also on other health system resources. We present results of a clinical study with a multi-component O","2021","07","14","J Evid Based Integr Med","Journal of evidence-based integrative medicine","COVID-19; OTC; SARS-CoV-2; early-stage treatment; immunity enhancement; ionophores; prophylaxis; regimen compliance; zinc; Adult; Antiviral Agents; COVID-19; Cinchona; Communicable Disease Control; Dietary Supplements; Female; Humans; Ionophores; Lysine; Male; Middle Aged; Nonprescription Drugs; Pandemics; Quercetin; SARS-CoV-2; Severity of Illness Index; Treatment Outcome; Vitamins; Zinc","Luchins","Jeremy","Comprehensive Pain Management Institute, LLC, Columbus, OH, USA",NA
"1546","34225463","10.1177/2515690X211026193","20-Week Study of Clinical Outcomes of Over-the-Counter COVID-19 Prophylaxis and Treatment.","As the lethal COVID-19 pandemic enters its second year, the need for effective modalities of alleviation remains urgent. This includes modalities that can readily be used by the public to reduce disease spread and severity. Such preventive measures and early-stage treatments may temper the immediacy of demand for advanced anti-COVID measures (drugs, antibodies, vaccines) and help relieve strain also on other health system resources. We present results of a clinical study with a multi-component O","2021","07","14","J Evid Based Integr Med","Journal of evidence-based integrative medicine","COVID-19; OTC; SARS-CoV-2; early-stage treatment; immunity enhancement; ionophores; prophylaxis; regimen compliance; zinc; Adult; Antiviral Agents; COVID-19; Cinchona; Communicable Disease Control; Dietary Supplements; Female; Humans; Ionophores; Lysine; Male; Middle Aged; Nonprescription Drugs; Pandemics; Quercetin; SARS-CoV-2; Severity of Illness Index; Treatment Outcome; Vitamins; Zinc","Margolin","Daniel","Comprehensive Pain Management Institute, LLC, Columbus, OH, USA",NA
"1547","34225463","10.1177/2515690X211026193","20-Week Study of Clinical Outcomes of Over-the-Counter COVID-19 Prophylaxis and Treatment.","As the lethal COVID-19 pandemic enters its second year, the need for effective modalities of alleviation remains urgent. This includes modalities that can readily be used by the public to reduce disease spread and severity. Such preventive measures and early-stage treatments may temper the immediacy of demand for advanced anti-COVID measures (drugs, antibodies, vaccines) and help relieve strain also on other health system resources. We present results of a clinical study with a multi-component O","2021","07","14","J Evid Based Integr Med","Journal of evidence-based integrative medicine","COVID-19; OTC; SARS-CoV-2; early-stage treatment; immunity enhancement; ionophores; prophylaxis; regimen compliance; zinc; Adult; Antiviral Agents; COVID-19; Cinchona; Communicable Disease Control; Dietary Supplements; Female; Humans; Ionophores; Lysine; Male; Middle Aged; Nonprescription Drugs; Pandemics; Quercetin; SARS-CoV-2; Severity of Illness Index; Treatment Outcome; Vitamins; Zinc","Margolin","Michelle","Comprehensive Pain Management Institute, LLC, Columbus, OH, USA",NA
"1548","34225463","10.1177/2515690X211026193","20-Week Study of Clinical Outcomes of Over-the-Counter COVID-19 Prophylaxis and Treatment.","As the lethal COVID-19 pandemic enters its second year, the need for effective modalities of alleviation remains urgent. This includes modalities that can readily be used by the public to reduce disease spread and severity. Such preventive measures and early-stage treatments may temper the immediacy of demand for advanced anti-COVID measures (drugs, antibodies, vaccines) and help relieve strain also on other health system resources. We present results of a clinical study with a multi-component O","2021","07","14","J Evid Based Integr Med","Journal of evidence-based integrative medicine","COVID-19; OTC; SARS-CoV-2; early-stage treatment; immunity enhancement; ionophores; prophylaxis; regimen compliance; zinc; Adult; Antiviral Agents; COVID-19; Cinchona; Communicable Disease Control; Dietary Supplements; Female; Humans; Ionophores; Lysine; Male; Middle Aged; Nonprescription Drugs; Pandemics; Quercetin; SARS-CoV-2; Severity of Illness Index; Treatment Outcome; Vitamins; Zinc","Lefkowitz","Sanford","Comprehensive Pain Management Institute, LLC, Columbus, OH, USA",NA
"1549","34225441","10.52547/ibj.25.4.308","ORF8 <U+2206>382 Mutation: A Possible Viral Prognostic Biomarker for the Severity of the COVID-19.",NA,"2021","07","14","Iran Biomed J","Iranian biomedical journal","Biomarkers; COVID-19; Humans; Mutation; Prognosis; Severity of Illness Index; Viral Proteins","Tabibzadeh","Alireza","Department of Virology, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran",NA
"1550","34225441","10.52547/ibj.25.4.308","ORF8 <U+2206>382 Mutation: A Possible Viral Prognostic Biomarker for the Severity of the COVID-19.",NA,"2021","07","14","Iran Biomed J","Iranian biomedical journal","Biomarkers; COVID-19; Humans; Mutation; Prognosis; Severity of Illness Index; Viral Proteins","Esghaei","Maryam","Department of Virology, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran",NA
"1551","34225441","10.52547/ibj.25.4.308","ORF8 <U+2206>382 Mutation: A Possible Viral Prognostic Biomarker for the Severity of the COVID-19.",NA,"2021","07","14","Iran Biomed J","Iranian biomedical journal","Biomarkers; COVID-19; Humans; Mutation; Prognosis; Severity of Illness Index; Viral Proteins","Zamani","Farhad","Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran",NA
"1552","34225441","10.52547/ibj.25.4.308","ORF8 <U+2206>382 Mutation: A Possible Viral Prognostic Biomarker for the Severity of the COVID-19.",NA,"2021","07","14","Iran Biomed J","Iranian biomedical journal","Biomarkers; COVID-19; Humans; Mutation; Prognosis; Severity of Illness Index; Viral Proteins","Soltani","Saber","Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran",NA
"1553","34225441","10.52547/ibj.25.4.308","ORF8 <U+2206>382 Mutation: A Possible Viral Prognostic Biomarker for the Severity of the COVID-19.",NA,"2021","07","14","Iran Biomed J","Iranian biomedical journal","Biomarkers; COVID-19; Humans; Mutation; Prognosis; Severity of Illness Index; Viral Proteins","Yousefi","Parastoo","Gastrointestinal and Liver Diseases Research Center, Iran University of Medical Sciences, Tehran, Iran",NA
"1554","34225441","10.52547/ibj.25.4.308","ORF8 <U+2206>382 Mutation: A Possible Viral Prognostic Biomarker for the Severity of the COVID-19.",NA,"2021","07","14","Iran Biomed J","Iranian biomedical journal","Biomarkers; COVID-19; Humans; Mutation; Prognosis; Severity of Illness Index; Viral Proteins","Karbalaie Niya","Mohammad Hadi","Department of Virology, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran",NA
"1555","34225401","10.4097/kja.21199","Clot-in-transit cardio-pulmonary thrombosis during convalescent phase of COVID-19.",NA,"2021","07","05","Korean J Anesthesiol","Korean journal of anesthesiology","COVID-19; Clot-in-transit; cardiac; convalescent; echocardiography; thrombosis","Karippacheril","John George","Anesthesiology Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, UAE",NA
"1556","34225401","10.4097/kja.21199","Clot-in-transit cardio-pulmonary thrombosis during convalescent phase of COVID-19.",NA,"2021","07","05","Korean J Anesthesiol","Korean journal of anesthesiology","COVID-19; Clot-in-transit; cardiac; convalescent; echocardiography; thrombosis","Jain","Amit","Anesthesiology Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, UAE",NA
"1557","34225390","10.1515/revneuro-2021-0047","Triangle of cytokine storm, central nervous system involvement, and viral infection in COVID-19: the role of sFasL and neuropilin-1.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) is identified as the cause of coronavirus disease 2019 (COVID-19), and is often linked to extreme inflammatory responses by over activation of neutrophil extracellular traps (NETs), cytokine storm, and sepsis. These are robust causes for multi-organ damage. In particular, potential routes of SARS-CoV2 entry, such as angiotensin-converting enzyme 2 (ACE2), have been linked to central nervous system (CNS) involvement. CNS has been recogni","2021","07","05","Rev Neurosci","Reviews in the neurosciences","COVID-19; central nervous system; coronavirus; cytokine storm; hyperinflammation; neuropilin-1","Saleki","Kiarash","Student Research Committee, Babol University of Medical Sciences, Babol, 47176-47745, Iran",NA
"1558","34225390","10.1515/revneuro-2021-0047","Triangle of cytokine storm, central nervous system involvement, and viral infection in COVID-19: the role of sFasL and neuropilin-1.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) is identified as the cause of coronavirus disease 2019 (COVID-19), and is often linked to extreme inflammatory responses by over activation of neutrophil extracellular traps (NETs), cytokine storm, and sepsis. These are robust causes for multi-organ damage. In particular, potential routes of SARS-CoV2 entry, such as angiotensin-converting enzyme 2 (ACE2), have been linked to central nervous system (CNS) involvement. CNS has been recogni","2021","07","05","Rev Neurosci","Reviews in the neurosciences","COVID-19; central nervous system; coronavirus; cytokine storm; hyperinflammation; neuropilin-1","Banazadeh","Mohammad","Pharmaceutical Sciences and Cosmetic Products Research Center, Kerman University of Medical Sciences, Kerman, 76169-13555, Iran",NA
"1559","34225390","10.1515/revneuro-2021-0047","Triangle of cytokine storm, central nervous system involvement, and viral infection in COVID-19: the role of sFasL and neuropilin-1.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) is identified as the cause of coronavirus disease 2019 (COVID-19), and is often linked to extreme inflammatory responses by over activation of neutrophil extracellular traps (NETs), cytokine storm, and sepsis. These are robust causes for multi-organ damage. In particular, potential routes of SARS-CoV2 entry, such as angiotensin-converting enzyme 2 (ACE2), have been linked to central nervous system (CNS) involvement. CNS has been recogni","2021","07","05","Rev Neurosci","Reviews in the neurosciences","COVID-19; central nervous system; coronavirus; cytokine storm; hyperinflammation; neuropilin-1","Miri","Niloufar Sadat","Cellular and Molecular Biology Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, 47176-47745, Iran",NA
"1560","34225390","10.1515/revneuro-2021-0047","Triangle of cytokine storm, central nervous system involvement, and viral infection in COVID-19: the role of sFasL and neuropilin-1.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) is identified as the cause of coronavirus disease 2019 (COVID-19), and is often linked to extreme inflammatory responses by over activation of neutrophil extracellular traps (NETs), cytokine storm, and sepsis. These are robust causes for multi-organ damage. In particular, potential routes of SARS-CoV2 entry, such as angiotensin-converting enzyme 2 (ACE2), have been linked to central nervous system (CNS) involvement. CNS has been recogni","2021","07","05","Rev Neurosci","Reviews in the neurosciences","COVID-19; central nervous system; coronavirus; cytokine storm; hyperinflammation; neuropilin-1","Azadmehr","Abbas","National Elite Foundation, Mazandaran Province Branch, Tehran, 48157-66435, Iran",NA
"1561","34225383","10.1111/nep.13919","Renal graft artery thrombosis following COVID-19 infection.",NA,"2021","07","05","Nephrology (Carlton)","Nephrology (Carlton, Vic.)",NA,"Varma","Prem P","Department of Nephrology, Primus Hospital, New Delhi, India",NA
"1562","34225383","10.1111/nep.13919","Renal graft artery thrombosis following COVID-19 infection.",NA,"2021","07","05","Nephrology (Carlton)","Nephrology (Carlton, Vic.)",NA,"Kute","Vivek B","Department of Nephrology, Institute of Kidney Diseases and Research Center, Dr HL Trivedi Institute of Transplantation Sciences (IKDRC-ITS), Ahmedabad, India",NA
"1563","34225383","10.1111/nep.13919","Renal graft artery thrombosis following COVID-19 infection.",NA,"2021","07","05","Nephrology (Carlton)","Nephrology (Carlton, Vic.)",NA,"Bajpai","Geet","Department of Nephrology, Venkateshwar Hospital, Delhi, India",NA
"1564","34225375","10.1055/a-1528-1418","Conception and Feasibility of a Digital Tele-Guided Abdomen, Thorax, and Thyroid Gland Ultrasound Course for Medical Students (TELUS study)."," Medical education has been transformed during the COVID-19 pandemic, creating challenges regarding adequate training in ultrasound (US). Due to the discontinuation of traditional classroom teaching, the need to expand digital learning opportunities is undeniable. The aim of our study is to develop a tele-guided US course for undergraduate medical students and test the feasibility and efficacy of this digital US teaching method.  A tele-guided US course was established for medical students. Stud","2021","07","05","Ultraschall Med","Ultraschall in der Medizin (Stuttgart, Germany : 1980)",NA,"Höhne","Elena","Clinic of Internal Medicine III, Oncology, Hematology, Rheumatology and Clinical Immunology, University Hospital Bonn, Germany",NA
"1565","34225375","10.1055/a-1528-1418","Conception and Feasibility of a Digital Tele-Guided Abdomen, Thorax, and Thyroid Gland Ultrasound Course for Medical Students (TELUS study)."," Medical education has been transformed during the COVID-19 pandemic, creating challenges regarding adequate training in ultrasound (US). Due to the discontinuation of traditional classroom teaching, the need to expand digital learning opportunities is undeniable. The aim of our study is to develop a tele-guided US course for undergraduate medical students and test the feasibility and efficacy of this digital US teaching method.  A tele-guided US course was established for medical students. Stud","2021","07","05","Ultraschall Med","Ultraschall in der Medizin (Stuttgart, Germany : 1980)",NA,"Recker","Florian","Department of Obstetrics and Prenatal Medicine, University Hospital Bonn, Germany",NA
"1566","34225375","10.1055/a-1528-1418","Conception and Feasibility of a Digital Tele-Guided Abdomen, Thorax, and Thyroid Gland Ultrasound Course for Medical Students (TELUS study)."," Medical education has been transformed during the COVID-19 pandemic, creating challenges regarding adequate training in ultrasound (US). Due to the discontinuation of traditional classroom teaching, the need to expand digital learning opportunities is undeniable. The aim of our study is to develop a tele-guided US course for undergraduate medical students and test the feasibility and efficacy of this digital US teaching method.  A tele-guided US course was established for medical students. Stud","2021","07","05","Ultraschall Med","Ultraschall in der Medizin (Stuttgart, Germany : 1980)",NA,"Schmok","Erik","Amboss, AMBOSS GmbH, Berlin, Germany",NA
"1567","34225375","10.1055/a-1528-1418","Conception and Feasibility of a Digital Tele-Guided Abdomen, Thorax, and Thyroid Gland Ultrasound Course for Medical Students (TELUS study)."," Medical education has been transformed during the COVID-19 pandemic, creating challenges regarding adequate training in ultrasound (US). Due to the discontinuation of traditional classroom teaching, the need to expand digital learning opportunities is undeniable. The aim of our study is to develop a tele-guided US course for undergraduate medical students and test the feasibility and efficacy of this digital US teaching method.  A tele-guided US course was established for medical students. Stud","2021","07","05","Ultraschall Med","Ultraschall in der Medizin (Stuttgart, Germany : 1980)",NA,"Brossart","Peter","Clinic of Internal Medicine III, Oncology, Hematology, Rheumatology and Clinical Immunology, University Hospital Bonn, Germany",NA
"1568","34225375","10.1055/a-1528-1418","Conception and Feasibility of a Digital Tele-Guided Abdomen, Thorax, and Thyroid Gland Ultrasound Course for Medical Students (TELUS study)."," Medical education has been transformed during the COVID-19 pandemic, creating challenges regarding adequate training in ultrasound (US). Due to the discontinuation of traditional classroom teaching, the need to expand digital learning opportunities is undeniable. The aim of our study is to develop a tele-guided US course for undergraduate medical students and test the feasibility and efficacy of this digital US teaching method.  A tele-guided US course was established for medical students. Stud","2021","07","05","Ultraschall Med","Ultraschall in der Medizin (Stuttgart, Germany : 1980)",NA,"Raupach","Tobias","Institute for Medical Education, University Hospital Bonn, Germany",NA
"1569","34225375","10.1055/a-1528-1418","Conception and Feasibility of a Digital Tele-Guided Abdomen, Thorax, and Thyroid Gland Ultrasound Course for Medical Students (TELUS study)."," Medical education has been transformed during the COVID-19 pandemic, creating challenges regarding adequate training in ultrasound (US). Due to the discontinuation of traditional classroom teaching, the need to expand digital learning opportunities is undeniable. The aim of our study is to develop a tele-guided US course for undergraduate medical students and test the feasibility and efficacy of this digital US teaching method.  A tele-guided US course was established for medical students. Stud","2021","07","05","Ultraschall Med","Ultraschall in der Medizin (Stuttgart, Germany : 1980)",NA,"Schäfer","Valentin Sebastian","Clinic of Internal Medicine III, Oncology, Hematology, Rheumatology and Clinical Immunology, University Hospital Bonn, Germany",NA
"1570","34225372","10.1055/s-0041-1731649","Impacts of Neonatal Hospitalization on Families during the 2019 Coronavirus Pandemic."," Limited data are available regarding family and financial well-being among parents whose infants were hospitalized during the 2019 coronavirus (COVID-19) pandemic. The study objective was to evaluate the family and financial well-being of parents whose infants were hospitalized in the neonatal intensive care unit (NICU) during COVID-19.  Parents were recruited for this online, cross-sectional survey via support groups on social media. Data collection was completed between May 18, 2020 and July ","2021","07","05","Am J Perinatol","American journal of perinatology",NA,"Vance","Ashlee J","National Clinician Scholars Program, University of Michigan, School of Nursing, Ann Arbor, Michigan",NA
"1571","34225372","10.1055/s-0041-1731649","Impacts of Neonatal Hospitalization on Families during the 2019 Coronavirus Pandemic."," Limited data are available regarding family and financial well-being among parents whose infants were hospitalized during the 2019 coronavirus (COVID-19) pandemic. The study objective was to evaluate the family and financial well-being of parents whose infants were hospitalized in the neonatal intensive care unit (NICU) during COVID-19.  Parents were recruited for this online, cross-sectional survey via support groups on social media. Data collection was completed between May 18, 2020 and July ","2021","07","05","Am J Perinatol","American journal of perinatology",NA,"Malin","Kathryn J","College of Nursing, Marquette University, Milwaukee, Wisconsin",NA
"1572","34225372","10.1055/s-0041-1731649","Impacts of Neonatal Hospitalization on Families during the 2019 Coronavirus Pandemic."," Limited data are available regarding family and financial well-being among parents whose infants were hospitalized during the 2019 coronavirus (COVID-19) pandemic. The study objective was to evaluate the family and financial well-being of parents whose infants were hospitalized in the neonatal intensive care unit (NICU) during COVID-19.  Parents were recruited for this online, cross-sectional survey via support groups on social media. Data collection was completed between May 18, 2020 and July ","2021","07","05","Am J Perinatol","American journal of perinatology",NA,"Chen","Bingxin","School of Nursing, University of Michigan, Ann Arbor, Michigan",NA
"1573","34225372","10.1055/s-0041-1731649","Impacts of Neonatal Hospitalization on Families during the 2019 Coronavirus Pandemic."," Limited data are available regarding family and financial well-being among parents whose infants were hospitalized during the 2019 coronavirus (COVID-19) pandemic. The study objective was to evaluate the family and financial well-being of parents whose infants were hospitalized in the neonatal intensive care unit (NICU) during COVID-19.  Parents were recruited for this online, cross-sectional survey via support groups on social media. Data collection was completed between May 18, 2020 and July ","2021","07","05","Am J Perinatol","American journal of perinatology",NA,"Shuman","Clayton J","School of Nursing, University of Michigan, Ann Arbor, Michigan",NA
"1574","34225372","10.1055/s-0041-1731649","Impacts of Neonatal Hospitalization on Families during the 2019 Coronavirus Pandemic."," Limited data are available regarding family and financial well-being among parents whose infants were hospitalized during the 2019 coronavirus (COVID-19) pandemic. The study objective was to evaluate the family and financial well-being of parents whose infants were hospitalized in the neonatal intensive care unit (NICU) during COVID-19.  Parents were recruited for this online, cross-sectional survey via support groups on social media. Data collection was completed between May 18, 2020 and July ","2021","07","05","Am J Perinatol","American journal of perinatology",NA,"Moore","Tiffany A","College of Nursing, University of Nebraska Medical Center, Omaha, Nebraska",NA
"1575","34225337","10.1097/JCMA.0000000000000574","Development and optimization of heavy metal lead biosensors in bio-medical and environmental applications.","The dangerous impact of heavy metal lead (Pb) to human health has been studied for years. While the fact that Pb impairments human body has been learned from countless of painful and sad historical events. Nowadays, World Health Organization (WHO) and many developmental countries have established regulations to Pb. Measuring the blood lead level (BLL) is so far the only way to evaluate the degree of Pb exposure officially but the so-called safety value (10 µg/dL in adults, and 5 µg/dL in childre","2021","07","14","J Chin Med Assoc","Journal of the Chinese Medical Association : JCMA",NA,"Chang","Tai-Jay","Laboratory of Genome Research, Basic Research Division, Department of Medical Research, Taipei Veterans General Hospital, Taipei, Taiwan, ROC School of Biomedical science and Engineering, National Yang Ming Chiao Tung University, Taipei, Taiwan, ROC Microscopy Service Laboratory, Basic Research Division, Department of Medical Research, Taipei Veterans General Hospital, Taipei, Taiwan, ROC Institute of Biophotonics, School of Biomedical Science and Engineering, National Yang Ming Chiao Tung University, Taipei, Taiwan, ROC LumiSTAR Biotechnology, Inc., Taipei City, Taiwan, ROC",NA
"1576","34225337","10.1097/JCMA.0000000000000574","Development and optimization of heavy metal lead biosensors in bio-medical and environmental applications.","The dangerous impact of heavy metal lead (Pb) to human health has been studied for years. While the fact that Pb impairments human body has been learned from countless of painful and sad historical events. Nowadays, World Health Organization (WHO) and many developmental countries have established regulations to Pb. Measuring the blood lead level (BLL) is so far the only way to evaluate the degree of Pb exposure officially but the so-called safety value (10 µg/dL in adults, and 5 µg/dL in childre","2021","07","14","J Chin Med Assoc","Journal of the Chinese Medical Association : JCMA",NA,"Lai","Wei-Qun","Laboratory of Genome Research, Basic Research Division, Department of Medical Research, Taipei Veterans General Hospital, Taipei, Taiwan, ROC School of Biomedical science and Engineering, National Yang Ming Chiao Tung University, Taipei, Taiwan, ROC Microscopy Service Laboratory, Basic Research Division, Department of Medical Research, Taipei Veterans General Hospital, Taipei, Taiwan, ROC Institute of Biophotonics, School of Biomedical Science and Engineering, National Yang Ming Chiao Tung University, Taipei, Taiwan, ROC LumiSTAR Biotechnology, Inc., Taipei City, Taiwan, ROC",NA
"1577","34225337","10.1097/JCMA.0000000000000574","Development and optimization of heavy metal lead biosensors in bio-medical and environmental applications.","The dangerous impact of heavy metal lead (Pb) to human health has been studied for years. While the fact that Pb impairments human body has been learned from countless of painful and sad historical events. Nowadays, World Health Organization (WHO) and many developmental countries have established regulations to Pb. Measuring the blood lead level (BLL) is so far the only way to evaluate the degree of Pb exposure officially but the so-called safety value (10 µg/dL in adults, and 5 µg/dL in childre","2021","07","14","J Chin Med Assoc","Journal of the Chinese Medical Association : JCMA",NA,"Chang","Yu-Fen","Laboratory of Genome Research, Basic Research Division, Department of Medical Research, Taipei Veterans General Hospital, Taipei, Taiwan, ROC School of Biomedical science and Engineering, National Yang Ming Chiao Tung University, Taipei, Taiwan, ROC Microscopy Service Laboratory, Basic Research Division, Department of Medical Research, Taipei Veterans General Hospital, Taipei, Taiwan, ROC Institute of Biophotonics, School of Biomedical Science and Engineering, National Yang Ming Chiao Tung University, Taipei, Taiwan, ROC LumiSTAR Biotechnology, Inc., Taipei City, Taiwan, ROC",NA
"1578","34225337","10.1097/JCMA.0000000000000574","Development and optimization of heavy metal lead biosensors in bio-medical and environmental applications.","The dangerous impact of heavy metal lead (Pb) to human health has been studied for years. While the fact that Pb impairments human body has been learned from countless of painful and sad historical events. Nowadays, World Health Organization (WHO) and many developmental countries have established regulations to Pb. Measuring the blood lead level (BLL) is so far the only way to evaluate the degree of Pb exposure officially but the so-called safety value (10 µg/dL in adults, and 5 µg/dL in childre","2021","07","14","J Chin Med Assoc","Journal of the Chinese Medical Association : JCMA",NA,"Wang","Chia-Lin","Laboratory of Genome Research, Basic Research Division, Department of Medical Research, Taipei Veterans General Hospital, Taipei, Taiwan, ROC School of Biomedical science and Engineering, National Yang Ming Chiao Tung University, Taipei, Taiwan, ROC Microscopy Service Laboratory, Basic Research Division, Department of Medical Research, Taipei Veterans General Hospital, Taipei, Taiwan, ROC Institute of Biophotonics, School of Biomedical Science and Engineering, National Yang Ming Chiao Tung University, Taipei, Taiwan, ROC LumiSTAR Biotechnology, Inc., Taipei City, Taiwan, ROC",NA
"1579","34225337","10.1097/JCMA.0000000000000574","Development and optimization of heavy metal lead biosensors in bio-medical and environmental applications.","The dangerous impact of heavy metal lead (Pb) to human health has been studied for years. While the fact that Pb impairments human body has been learned from countless of painful and sad historical events. Nowadays, World Health Organization (WHO) and many developmental countries have established regulations to Pb. Measuring the blood lead level (BLL) is so far the only way to evaluate the degree of Pb exposure officially but the so-called safety value (10 µg/dL in adults, and 5 µg/dL in childre","2021","07","14","J Chin Med Assoc","Journal of the Chinese Medical Association : JCMA",NA,"Yang","De-Ming","Laboratory of Genome Research, Basic Research Division, Department of Medical Research, Taipei Veterans General Hospital, Taipei, Taiwan, ROC School of Biomedical science and Engineering, National Yang Ming Chiao Tung University, Taipei, Taiwan, ROC Microscopy Service Laboratory, Basic Research Division, Department of Medical Research, Taipei Veterans General Hospital, Taipei, Taiwan, ROC Institute of Biophotonics, School of Biomedical Science and Engineering, National Yang Ming Chiao Tung University, Taipei, Taiwan, ROC LumiSTAR Biotechnology, Inc., Taipei City, Taiwan, ROC",NA
"1580","34225328","10.1097/PEC.0000000000002509","Evaluation of COVID-19-Associated Myocarditis Via Point-of-Care Ultrasound in a Pediatric Patient.","Coronavirus disease 2019 (COVID-19)-associated myocarditis has been reported from the onset of the pandemic. The presumed etiology is direct damage to the myocardium from severe acute respiratory syndrome coronavirus 2. Common findings include electrocardiogram abnormalities, elevated cardiac markers, and diminished cardiac function. This can lead to heart failure and cardiogenic shock with resultant poor perfusion. Thus, myocarditis has been recognized as a cause of death in patients with COVID","2021","07","05","Pediatr Emerg Care","Pediatric emergency care",NA,"Poteh","Ndah Akwesi","From the Department of Pediatric Emergency Medicine, University of Louisville, Louisville, KY",NA
"1581","34225328","10.1097/PEC.0000000000002509","Evaluation of COVID-19-Associated Myocarditis Via Point-of-Care Ultrasound in a Pediatric Patient.","Coronavirus disease 2019 (COVID-19)-associated myocarditis has been reported from the onset of the pandemic. The presumed etiology is direct damage to the myocardium from severe acute respiratory syndrome coronavirus 2. Common findings include electrocardiogram abnormalities, elevated cardiac markers, and diminished cardiac function. This can lead to heart failure and cardiogenic shock with resultant poor perfusion. Thus, myocarditis has been recognized as a cause of death in patients with COVID","2021","07","05","Pediatr Emerg Care","Pediatric emergency care",NA,"Singh","Amar Chetram","From the Department of Pediatric Emergency Medicine, University of Louisville, Louisville, KY",NA
"1582","34225328","10.1097/PEC.0000000000002509","Evaluation of COVID-19-Associated Myocarditis Via Point-of-Care Ultrasound in a Pediatric Patient.","Coronavirus disease 2019 (COVID-19)-associated myocarditis has been reported from the onset of the pandemic. The presumed etiology is direct damage to the myocardium from severe acute respiratory syndrome coronavirus 2. Common findings include electrocardiogram abnormalities, elevated cardiac markers, and diminished cardiac function. This can lead to heart failure and cardiogenic shock with resultant poor perfusion. Thus, myocarditis has been recognized as a cause of death in patients with COVID","2021","07","05","Pediatr Emerg Care","Pediatric emergency care",NA,"Starr Seal","Rebecca","From the Department of Pediatric Emergency Medicine, University of Louisville, Louisville, KY",NA
"1583","34225328","10.1097/PEC.0000000000002509","Evaluation of COVID-19-Associated Myocarditis Via Point-of-Care Ultrasound in a Pediatric Patient.","Coronavirus disease 2019 (COVID-19)-associated myocarditis has been reported from the onset of the pandemic. The presumed etiology is direct damage to the myocardium from severe acute respiratory syndrome coronavirus 2. Common findings include electrocardiogram abnormalities, elevated cardiac markers, and diminished cardiac function. This can lead to heart failure and cardiogenic shock with resultant poor perfusion. Thus, myocarditis has been recognized as a cause of death in patients with COVID","2021","07","05","Pediatr Emerg Care","Pediatric emergency care",NA,"Khalil","Paul Adeeb","From the Department of Pediatric Emergency Medicine, University of Louisville, Louisville, KY",NA
"1584","34225303","10.1097/PHH.0000000000001398","Liability Waivers for COVID-19: Law, Policy, and Practice.","As businesses reopen, the practice of asking customers to sign COVID-19 liability waivers is increasing throughout the United States. Although the courts have not yet decided the enforceability of COVID-19-related liability waivers, existing case law, as well as new executive and legislative actions, suggests that such waivers may offer some protection to businesses from liability. Nevertheless, we believe that the legal and ethical rationales underlying liability waivers are not applicable to a","2021","07","05","J Public Health Manag Pract","Journal of public health management and practice : JPHMP",NA,"Yang","Y Tony","Center for Health Policy and Media Engagement, George Washington University, Washington, District of Columbia (Dr Yang)",NA
"1585","34225303","10.1097/PHH.0000000000001398","Liability Waivers for COVID-19: Law, Policy, and Practice.","As businesses reopen, the practice of asking customers to sign COVID-19 liability waivers is increasing throughout the United States. Although the courts have not yet decided the enforceability of COVID-19-related liability waivers, existing case law, as well as new executive and legislative actions, suggests that such waivers may offer some protection to businesses from liability. Nevertheless, we believe that the legal and ethical rationales underlying liability waivers are not applicable to a","2021","07","05","J Public Health Manag Pract","Journal of public health management and practice : JPHMP",NA,"Chen","Brian K","Center for Health Policy and Media Engagement, George Washington University, Washington, District of Columbia (Dr Yang)",NA
"1586","34225300","10.1097/SLA.0000000000005048","Perioperative Provider Safety in Low-and Middle-Income Countries During the COVID-19 Pandemic: A Call for Renewed Investments in Resources and Training.",NA,"2021","07","05","Ann Surg","Annals of surgery",NA,"Starr","Nichole","University of California, San Francisco Lifebox Foundation, Inc Smile Train University of Aberdeen World Federation of Societies of Anaesthesiologists Emory University Tata Memorial Centre, Homi Bhabha National Institute Jhpiego Department of Surgery, Faculty of Clinical Sciences, College of Medicine, University of Lagos Kampot Provincial Referral Hospital Department of Surgery, University Teaching Hospital of Kigali, University of Rwanda Stanford University University of Edinburgh Addis Ababa University Harvard Medical School",NA
"1587","34225300","10.1097/SLA.0000000000005048","Perioperative Provider Safety in Low-and Middle-Income Countries During the COVID-19 Pandemic: A Call for Renewed Investments in Resources and Training.",NA,"2021","07","05","Ann Surg","Annals of surgery",NA,"Capo-Chichi","Nina","University of California, San Francisco Lifebox Foundation, Inc Smile Train University of Aberdeen World Federation of Societies of Anaesthesiologists Emory University Tata Memorial Centre, Homi Bhabha National Institute Jhpiego Department of Surgery, Faculty of Clinical Sciences, College of Medicine, University of Lagos Kampot Provincial Referral Hospital Department of Surgery, University Teaching Hospital of Kigali, University of Rwanda Stanford University University of Edinburgh Addis Ababa University Harvard Medical School",NA
"1588","34225300","10.1097/SLA.0000000000005048","Perioperative Provider Safety in Low-and Middle-Income Countries During the COVID-19 Pandemic: A Call for Renewed Investments in Resources and Training.",NA,"2021","07","05","Ann Surg","Annals of surgery",NA,"Moore","Jolene","University of California, San Francisco Lifebox Foundation, Inc Smile Train University of Aberdeen World Federation of Societies of Anaesthesiologists Emory University Tata Memorial Centre, Homi Bhabha National Institute Jhpiego Department of Surgery, Faculty of Clinical Sciences, College of Medicine, University of Lagos Kampot Provincial Referral Hospital Department of Surgery, University Teaching Hospital of Kigali, University of Rwanda Stanford University University of Edinburgh Addis Ababa University Harvard Medical School",NA
"1589","34225300","10.1097/SLA.0000000000005048","Perioperative Provider Safety in Low-and Middle-Income Countries During the COVID-19 Pandemic: A Call for Renewed Investments in Resources and Training.",NA,"2021","07","05","Ann Surg","Annals of surgery",NA,"Shreckengost","Constance Harrell","University of California, San Francisco Lifebox Foundation, Inc Smile Train University of Aberdeen World Federation of Societies of Anaesthesiologists Emory University Tata Memorial Centre, Homi Bhabha National Institute Jhpiego Department of Surgery, Faculty of Clinical Sciences, College of Medicine, University of Lagos Kampot Provincial Referral Hospital Department of Surgery, University Teaching Hospital of Kigali, University of Rwanda Stanford University University of Edinburgh Addis Ababa University Harvard Medical School",NA
"1590","34225300","10.1097/SLA.0000000000005048","Perioperative Provider Safety in Low-and Middle-Income Countries During the COVID-19 Pandemic: A Call for Renewed Investments in Resources and Training.",NA,"2021","07","05","Ann Surg","Annals of surgery",NA,"Fernandez","Katie","University of California, San Francisco Lifebox Foundation, Inc Smile Train University of Aberdeen World Federation of Societies of Anaesthesiologists Emory University Tata Memorial Centre, Homi Bhabha National Institute Jhpiego Department of Surgery, Faculty of Clinical Sciences, College of Medicine, University of Lagos Kampot Provincial Referral Hospital Department of Surgery, University Teaching Hospital of Kigali, University of Rwanda Stanford University University of Edinburgh Addis Ababa University Harvard Medical School",NA
"1591","34225300","10.1097/SLA.0000000000005048","Perioperative Provider Safety in Low-and Middle-Income Countries During the COVID-19 Pandemic: A Call for Renewed Investments in Resources and Training.",NA,"2021","07","05","Ann Surg","Annals of surgery",NA,"Ambulkar","Reshma","University of California, San Francisco Lifebox Foundation, Inc Smile Train University of Aberdeen World Federation of Societies of Anaesthesiologists Emory University Tata Memorial Centre, Homi Bhabha National Institute Jhpiego Department of Surgery, Faculty of Clinical Sciences, College of Medicine, University of Lagos Kampot Provincial Referral Hospital Department of Surgery, University Teaching Hospital of Kigali, University of Rwanda Stanford University University of Edinburgh Addis Ababa University Harvard Medical School",NA
"1592","34225300","10.1097/SLA.0000000000005048","Perioperative Provider Safety in Low-and Middle-Income Countries During the COVID-19 Pandemic: A Call for Renewed Investments in Resources and Training.",NA,"2021","07","05","Ann Surg","Annals of surgery",NA,"Varallo","John E","University of California, San Francisco Lifebox Foundation, Inc Smile Train University of Aberdeen World Federation of Societies of Anaesthesiologists Emory University Tata Memorial Centre, Homi Bhabha National Institute Jhpiego Department of Surgery, Faculty of Clinical Sciences, College of Medicine, University of Lagos Kampot Provincial Referral Hospital Department of Surgery, University Teaching Hospital of Kigali, University of Rwanda Stanford University University of Edinburgh Addis Ababa University Harvard Medical School",NA
"1593","34225300","10.1097/SLA.0000000000005048","Perioperative Provider Safety in Low-and Middle-Income Countries During the COVID-19 Pandemic: A Call for Renewed Investments in Resources and Training.",NA,"2021","07","05","Ann Surg","Annals of surgery",NA,"Ademuyiwa","Adesoji O","University of California, San Francisco Lifebox Foundation, Inc Smile Train University of Aberdeen World Federation of Societies of Anaesthesiologists Emory University Tata Memorial Centre, Homi Bhabha National Institute Jhpiego Department of Surgery, Faculty of Clinical Sciences, College of Medicine, University of Lagos Kampot Provincial Referral Hospital Department of Surgery, University Teaching Hospital of Kigali, University of Rwanda Stanford University University of Edinburgh Addis Ababa University Harvard Medical School",NA
"1594","34225300","10.1097/SLA.0000000000005048","Perioperative Provider Safety in Low-and Middle-Income Countries During the COVID-19 Pandemic: A Call for Renewed Investments in Resources and Training.",NA,"2021","07","05","Ann Surg","Annals of surgery",NA,"Krouch","Sophallyda","University of California, San Francisco Lifebox Foundation, Inc Smile Train University of Aberdeen World Federation of Societies of Anaesthesiologists Emory University Tata Memorial Centre, Homi Bhabha National Institute Jhpiego Department of Surgery, Faculty of Clinical Sciences, College of Medicine, University of Lagos Kampot Provincial Referral Hospital Department of Surgery, University Teaching Hospital of Kigali, University of Rwanda Stanford University University of Edinburgh Addis Ababa University Harvard Medical School",NA
"1595","34225300","10.1097/SLA.0000000000005048","Perioperative Provider Safety in Low-and Middle-Income Countries During the COVID-19 Pandemic: A Call for Renewed Investments in Resources and Training.",NA,"2021","07","05","Ann Surg","Annals of surgery",NA,"Rana","Pankaj Singh","University of California, San Francisco Lifebox Foundation, Inc Smile Train University of Aberdeen World Federation of Societies of Anaesthesiologists Emory University Tata Memorial Centre, Homi Bhabha National Institute Jhpiego Department of Surgery, Faculty of Clinical Sciences, College of Medicine, University of Lagos Kampot Provincial Referral Hospital Department of Surgery, University Teaching Hospital of Kigali, University of Rwanda Stanford University University of Edinburgh Addis Ababa University Harvard Medical School",NA
"1596","34225300","10.1097/SLA.0000000000005048","Perioperative Provider Safety in Low-and Middle-Income Countries During the COVID-19 Pandemic: A Call for Renewed Investments in Resources and Training.",NA,"2021","07","05","Ann Surg","Annals of surgery",NA,"Ingabire","J C Allen","University of California, San Francisco Lifebox Foundation, Inc Smile Train University of Aberdeen World Federation of Societies of Anaesthesiologists Emory University Tata Memorial Centre, Homi Bhabha National Institute Jhpiego Department of Surgery, Faculty of Clinical Sciences, College of Medicine, University of Lagos Kampot Provincial Referral Hospital Department of Surgery, University Teaching Hospital of Kigali, University of Rwanda Stanford University University of Edinburgh Addis Ababa University Harvard Medical School",NA
"1597","34225300","10.1097/SLA.0000000000005048","Perioperative Provider Safety in Low-and Middle-Income Countries During the COVID-19 Pandemic: A Call for Renewed Investments in Resources and Training.",NA,"2021","07","05","Ann Surg","Annals of surgery",NA,"Weiser","Thomas G","University of California, San Francisco Lifebox Foundation, Inc Smile Train University of Aberdeen World Federation of Societies of Anaesthesiologists Emory University Tata Memorial Centre, Homi Bhabha National Institute Jhpiego Department of Surgery, Faculty of Clinical Sciences, College of Medicine, University of Lagos Kampot Provincial Referral Hospital Department of Surgery, University Teaching Hospital of Kigali, University of Rwanda Stanford University University of Edinburgh Addis Ababa University Harvard Medical School",NA
"1598","34225300","10.1097/SLA.0000000000005048","Perioperative Provider Safety in Low-and Middle-Income Countries During the COVID-19 Pandemic: A Call for Renewed Investments in Resources and Training.",NA,"2021","07","05","Ann Surg","Annals of surgery",NA,"Mammo","Tihitena Negussie","University of California, San Francisco Lifebox Foundation, Inc Smile Train University of Aberdeen World Federation of Societies of Anaesthesiologists Emory University Tata Memorial Centre, Homi Bhabha National Institute Jhpiego Department of Surgery, Faculty of Clinical Sciences, College of Medicine, University of Lagos Kampot Provincial Referral Hospital Department of Surgery, University Teaching Hospital of Kigali, University of Rwanda Stanford University University of Edinburgh Addis Ababa University Harvard Medical School",NA
"1599","34225300","10.1097/SLA.0000000000005048","Perioperative Provider Safety in Low-and Middle-Income Countries During the COVID-19 Pandemic: A Call for Renewed Investments in Resources and Training.",NA,"2021","07","05","Ann Surg","Annals of surgery",NA,"Evans","Faye","University of California, San Francisco Lifebox Foundation, Inc Smile Train University of Aberdeen World Federation of Societies of Anaesthesiologists Emory University Tata Memorial Centre, Homi Bhabha National Institute Jhpiego Department of Surgery, Faculty of Clinical Sciences, College of Medicine, University of Lagos Kampot Provincial Referral Hospital Department of Surgery, University Teaching Hospital of Kigali, University of Rwanda Stanford University University of Edinburgh Addis Ababa University Harvard Medical School",NA
"1600","34225293","10.1097/SLA.0000000000005039","Response to COMMENT on: ""The Relationship between Surgeon Gender and Stress During the Covid-19 Pandemic"".",NA,"2021","07","05","Ann Surg","Annals of surgery",NA,"Mavroudis","Catherine L","University of Pennsylvania, Department of Surgery University of Pennsylvania, Perelman School of Medicine University of Pennsylvania, Perelman School of Medicine Harvard Medical School and Brigham and Women's Hospital University of Michigan Harvard Medical School and Brigham and Women's Hospital Weill Cornell Medical College University of California, San Francisco University of Michigan University of California, San Francisco Weill Cornell Medical College University of Pennsylvania, Department of Surgery University of Pennsylvania, Department of Surgery",NA
"1601","34225293","10.1097/SLA.0000000000005039","Response to COMMENT on: ""The Relationship between Surgeon Gender and Stress During the Covid-19 Pandemic"".",NA,"2021","07","05","Ann Surg","Annals of surgery",NA,"Landau","Sarah","University of Pennsylvania, Department of Surgery University of Pennsylvania, Perelman School of Medicine University of Pennsylvania, Perelman School of Medicine Harvard Medical School and Brigham and Women's Hospital University of Michigan Harvard Medical School and Brigham and Women's Hospital Weill Cornell Medical College University of California, San Francisco University of Michigan University of California, San Francisco Weill Cornell Medical College University of Pennsylvania, Department of Surgery University of Pennsylvania, Department of Surgery",NA
"1602","34225293","10.1097/SLA.0000000000005039","Response to COMMENT on: ""The Relationship between Surgeon Gender and Stress During the Covid-19 Pandemic"".",NA,"2021","07","05","Ann Surg","Annals of surgery",NA,"Brooks","Ezra","University of Pennsylvania, Department of Surgery University of Pennsylvania, Perelman School of Medicine University of Pennsylvania, Perelman School of Medicine Harvard Medical School and Brigham and Women's Hospital University of Michigan Harvard Medical School and Brigham and Women's Hospital Weill Cornell Medical College University of California, San Francisco University of Michigan University of California, San Francisco Weill Cornell Medical College University of Pennsylvania, Department of Surgery University of Pennsylvania, Department of Surgery",NA
"1603","34225293","10.1097/SLA.0000000000005039","Response to COMMENT on: ""The Relationship between Surgeon Gender and Stress During the Covid-19 Pandemic"".",NA,"2021","07","05","Ann Surg","Annals of surgery",NA,"Bergmark","Regan","University of Pennsylvania, Department of Surgery University of Pennsylvania, Perelman School of Medicine University of Pennsylvania, Perelman School of Medicine Harvard Medical School and Brigham and Women's Hospital University of Michigan Harvard Medical School and Brigham and Women's Hospital Weill Cornell Medical College University of California, San Francisco University of Michigan University of California, San Francisco Weill Cornell Medical College University of Pennsylvania, Department of Surgery University of Pennsylvania, Department of Surgery",NA
"1604","34225293","10.1097/SLA.0000000000005039","Response to COMMENT on: ""The Relationship between Surgeon Gender and Stress During the Covid-19 Pandemic"".",NA,"2021","07","05","Ann Surg","Annals of surgery",NA,"Berlin","Nicholas L","University of Pennsylvania, Department of Surgery University of Pennsylvania, Perelman School of Medicine University of Pennsylvania, Perelman School of Medicine Harvard Medical School and Brigham and Women's Hospital University of Michigan Harvard Medical School and Brigham and Women's Hospital Weill Cornell Medical College University of California, San Francisco University of Michigan University of California, San Francisco Weill Cornell Medical College University of Pennsylvania, Department of Surgery University of Pennsylvania, Department of Surgery",NA
"1605","34225293","10.1097/SLA.0000000000005039","Response to COMMENT on: ""The Relationship between Surgeon Gender and Stress During the Covid-19 Pandemic"".",NA,"2021","07","05","Ann Surg","Annals of surgery",NA,"Cooper","Zara","University of Pennsylvania, Department of Surgery University of Pennsylvania, Perelman School of Medicine University of Pennsylvania, Perelman School of Medicine Harvard Medical School and Brigham and Women's Hospital University of Michigan Harvard Medical School and Brigham and Women's Hospital Weill Cornell Medical College University of California, San Francisco University of Michigan University of California, San Francisco Weill Cornell Medical College University of Pennsylvania, Department of Surgery University of Pennsylvania, Department of Surgery",NA
"1606","34225293","10.1097/SLA.0000000000005039","Response to COMMENT on: ""The Relationship between Surgeon Gender and Stress During the Covid-19 Pandemic"".",NA,"2021","07","05","Ann Surg","Annals of surgery",NA,"Hwang","Eun Kyeong","University of Pennsylvania, Department of Surgery University of Pennsylvania, Perelman School of Medicine University of Pennsylvania, Perelman School of Medicine Harvard Medical School and Brigham and Women's Hospital University of Michigan Harvard Medical School and Brigham and Women's Hospital Weill Cornell Medical College University of California, San Francisco University of Michigan University of California, San Francisco Weill Cornell Medical College University of Pennsylvania, Department of Surgery University of Pennsylvania, Department of Surgery",NA
"1607","34225293","10.1097/SLA.0000000000005039","Response to COMMENT on: ""The Relationship between Surgeon Gender and Stress During the Covid-19 Pandemic"".",NA,"2021","07","05","Ann Surg","Annals of surgery",NA,"Lancaster","Elizabeth","University of Pennsylvania, Department of Surgery University of Pennsylvania, Perelman School of Medicine University of Pennsylvania, Perelman School of Medicine Harvard Medical School and Brigham and Women's Hospital University of Michigan Harvard Medical School and Brigham and Women's Hospital Weill Cornell Medical College University of California, San Francisco University of Michigan University of California, San Francisco Weill Cornell Medical College University of Pennsylvania, Department of Surgery University of Pennsylvania, Department of Surgery",NA
"1608","34225293","10.1097/SLA.0000000000005039","Response to COMMENT on: ""The Relationship between Surgeon Gender and Stress During the Covid-19 Pandemic"".",NA,"2021","07","05","Ann Surg","Annals of surgery",NA,"Waljee","Jennifer","University of Pennsylvania, Department of Surgery University of Pennsylvania, Perelman School of Medicine University of Pennsylvania, Perelman School of Medicine Harvard Medical School and Brigham and Women's Hospital University of Michigan Harvard Medical School and Brigham and Women's Hospital Weill Cornell Medical College University of California, San Francisco University of Michigan University of California, San Francisco Weill Cornell Medical College University of Pennsylvania, Department of Surgery University of Pennsylvania, Department of Surgery",NA
"1609","34225293","10.1097/SLA.0000000000005039","Response to COMMENT on: ""The Relationship between Surgeon Gender and Stress During the Covid-19 Pandemic"".",NA,"2021","07","05","Ann Surg","Annals of surgery",NA,"Wick","Elizabeth","University of Pennsylvania, Department of Surgery University of Pennsylvania, Perelman School of Medicine University of Pennsylvania, Perelman School of Medicine Harvard Medical School and Brigham and Women's Hospital University of Michigan Harvard Medical School and Brigham and Women's Hospital Weill Cornell Medical College University of California, San Francisco University of Michigan University of California, San Francisco Weill Cornell Medical College University of Pennsylvania, Department of Surgery University of Pennsylvania, Department of Surgery",NA
"1610","34225293","10.1097/SLA.0000000000005039","Response to COMMENT on: ""The Relationship between Surgeon Gender and Stress During the Covid-19 Pandemic"".",NA,"2021","07","05","Ann Surg","Annals of surgery",NA,"Yeo","Heather","University of Pennsylvania, Department of Surgery University of Pennsylvania, Perelman School of Medicine University of Pennsylvania, Perelman School of Medicine Harvard Medical School and Brigham and Women's Hospital University of Michigan Harvard Medical School and Brigham and Women's Hospital Weill Cornell Medical College University of California, San Francisco University of Michigan University of California, San Francisco Weill Cornell Medical College University of Pennsylvania, Department of Surgery University of Pennsylvania, Department of Surgery",NA
"1611","34225293","10.1097/SLA.0000000000005039","Response to COMMENT on: ""The Relationship between Surgeon Gender and Stress During the Covid-19 Pandemic"".",NA,"2021","07","05","Ann Surg","Annals of surgery",NA,"Wirtalla","Christopher","University of Pennsylvania, Department of Surgery University of Pennsylvania, Perelman School of Medicine University of Pennsylvania, Perelman School of Medicine Harvard Medical School and Brigham and Women's Hospital University of Michigan Harvard Medical School and Brigham and Women's Hospital Weill Cornell Medical College University of California, San Francisco University of Michigan University of California, San Francisco Weill Cornell Medical College University of Pennsylvania, Department of Surgery University of Pennsylvania, Department of Surgery",NA
"1612","34225293","10.1097/SLA.0000000000005039","Response to COMMENT on: ""The Relationship between Surgeon Gender and Stress During the Covid-19 Pandemic"".",NA,"2021","07","05","Ann Surg","Annals of surgery",NA,"Kelz","Rachel R","University of Pennsylvania, Department of Surgery University of Pennsylvania, Perelman School of Medicine University of Pennsylvania, Perelman School of Medicine Harvard Medical School and Brigham and Women's Hospital University of Michigan Harvard Medical School and Brigham and Women's Hospital Weill Cornell Medical College University of California, San Francisco University of Michigan University of California, San Francisco Weill Cornell Medical College University of Pennsylvania, Department of Surgery University of Pennsylvania, Department of Surgery",NA
"1613","34225276","10.1097/01.JMQ.0000743384.54212.e7","COVID-19 Level-Loading: Transferring Emergency Department Patients to a Partner Academic Medical Center Within a Healthcare System.","COVID-19 continues to challenge bed capacity and the ability of hospitals to provide quality care for patients around the country. However, the COVID-19 pandemic at a given point in time does not impact all hospitals equally-even within a single healthcare system, one hospital may be caring for patients in the hallways, while another has available inpatient beds. Here, we demonstrate a program to level-load COVID-19 patients between 2 academic medical centers in a healthcare system by transferri","2021","07","05","Am J Med Qual","American journal of medical quality : the official journal of the American College of Medical Quality",NA,"Lee","Andy H","Harvard Medical School, Boston, MA Department of Emergency Medicine, Brigham and Women's Hospital, Boston, MA Department of Emergency Medicine, Massachusetts General Hospital, Boston, MA Department of Anesthesia, Critical Care, and Pain Medicine, Massachusetts General Hospital, Boston, MA",NA
"1614","34225276","10.1097/01.JMQ.0000743384.54212.e7","COVID-19 Level-Loading: Transferring Emergency Department Patients to a Partner Academic Medical Center Within a Healthcare System.","COVID-19 continues to challenge bed capacity and the ability of hospitals to provide quality care for patients around the country. However, the COVID-19 pandemic at a given point in time does not impact all hospitals equally-even within a single healthcare system, one hospital may be caring for patients in the hallways, while another has available inpatient beds. Here, we demonstrate a program to level-load COVID-19 patients between 2 academic medical centers in a healthcare system by transferri","2021","07","05","Am J Med Qual","American journal of medical quality : the official journal of the American College of Medical Quality",NA,"Dunn","Peter F","Harvard Medical School, Boston, MA Department of Emergency Medicine, Brigham and Women's Hospital, Boston, MA Department of Emergency Medicine, Massachusetts General Hospital, Boston, MA Department of Anesthesia, Critical Care, and Pain Medicine, Massachusetts General Hospital, Boston, MA",NA
"1615","34225276","10.1097/01.JMQ.0000743384.54212.e7","COVID-19 Level-Loading: Transferring Emergency Department Patients to a Partner Academic Medical Center Within a Healthcare System.","COVID-19 continues to challenge bed capacity and the ability of hospitals to provide quality care for patients around the country. However, the COVID-19 pandemic at a given point in time does not impact all hospitals equally-even within a single healthcare system, one hospital may be caring for patients in the hallways, while another has available inpatient beds. Here, we demonstrate a program to level-load COVID-19 patients between 2 academic medical centers in a healthcare system by transferri","2021","07","05","Am J Med Qual","American journal of medical quality : the official journal of the American College of Medical Quality",NA,"Cooper","Stephanie","Harvard Medical School, Boston, MA Department of Emergency Medicine, Brigham and Women's Hospital, Boston, MA Department of Emergency Medicine, Massachusetts General Hospital, Boston, MA Department of Anesthesia, Critical Care, and Pain Medicine, Massachusetts General Hospital, Boston, MA",NA
"1616","34225276","10.1097/01.JMQ.0000743384.54212.e7","COVID-19 Level-Loading: Transferring Emergency Department Patients to a Partner Academic Medical Center Within a Healthcare System.","COVID-19 continues to challenge bed capacity and the ability of hospitals to provide quality care for patients around the country. However, the COVID-19 pandemic at a given point in time does not impact all hospitals equally-even within a single healthcare system, one hospital may be caring for patients in the hallways, while another has available inpatient beds. Here, we demonstrate a program to level-load COVID-19 patients between 2 academic medical centers in a healthcare system by transferri","2021","07","05","Am J Med Qual","American journal of medical quality : the official journal of the American College of Medical Quality",NA,"Seger","Robert","Harvard Medical School, Boston, MA Department of Emergency Medicine, Brigham and Women's Hospital, Boston, MA Department of Emergency Medicine, Massachusetts General Hospital, Boston, MA Department of Anesthesia, Critical Care, and Pain Medicine, Massachusetts General Hospital, Boston, MA",NA
"1617","34225276","10.1097/01.JMQ.0000743384.54212.e7","COVID-19 Level-Loading: Transferring Emergency Department Patients to a Partner Academic Medical Center Within a Healthcare System.","COVID-19 continues to challenge bed capacity and the ability of hospitals to provide quality care for patients around the country. However, the COVID-19 pandemic at a given point in time does not impact all hospitals equally-even within a single healthcare system, one hospital may be caring for patients in the hallways, while another has available inpatient beds. Here, we demonstrate a program to level-load COVID-19 patients between 2 academic medical centers in a healthcare system by transferri","2021","07","05","Am J Med Qual","American journal of medical quality : the official journal of the American College of Medical Quality",NA,"Raja","Ali S","Harvard Medical School, Boston, MA Department of Emergency Medicine, Brigham and Women's Hospital, Boston, MA Department of Emergency Medicine, Massachusetts General Hospital, Boston, MA Department of Anesthesia, Critical Care, and Pain Medicine, Massachusetts General Hospital, Boston, MA",NA
"1618","34225276","10.1097/01.JMQ.0000743384.54212.e7","COVID-19 Level-Loading: Transferring Emergency Department Patients to a Partner Academic Medical Center Within a Healthcare System.","COVID-19 continues to challenge bed capacity and the ability of hospitals to provide quality care for patients around the country. However, the COVID-19 pandemic at a given point in time does not impact all hospitals equally-even within a single healthcare system, one hospital may be caring for patients in the hallways, while another has available inpatient beds. Here, we demonstrate a program to level-load COVID-19 patients between 2 academic medical centers in a healthcare system by transferri","2021","07","05","Am J Med Qual","American journal of medical quality : the official journal of the American College of Medical Quality",NA,"Safavi","Kyan C","Harvard Medical School, Boston, MA Department of Emergency Medicine, Brigham and Women's Hospital, Boston, MA Department of Emergency Medicine, Massachusetts General Hospital, Boston, MA Department of Anesthesia, Critical Care, and Pain Medicine, Massachusetts General Hospital, Boston, MA",NA
"1619","34225276","10.1097/01.JMQ.0000743384.54212.e7","COVID-19 Level-Loading: Transferring Emergency Department Patients to a Partner Academic Medical Center Within a Healthcare System.","COVID-19 continues to challenge bed capacity and the ability of hospitals to provide quality care for patients around the country. However, the COVID-19 pandemic at a given point in time does not impact all hospitals equally-even within a single healthcare system, one hospital may be caring for patients in the hallways, while another has available inpatient beds. Here, we demonstrate a program to level-load COVID-19 patients between 2 academic medical centers in a healthcare system by transferri","2021","07","05","Am J Med Qual","American journal of medical quality : the official journal of the American College of Medical Quality",NA,"Yun","Brian J","Harvard Medical School, Boston, MA Department of Emergency Medicine, Brigham and Women's Hospital, Boston, MA Department of Emergency Medicine, Massachusetts General Hospital, Boston, MA Department of Anesthesia, Critical Care, and Pain Medicine, Massachusetts General Hospital, Boston, MA",NA
"1620","34225272","10.1097/01.JMQ.0000743376.85910.1a","Virus out, Safety in: Using Quality Improvement to Rapidly Respond to Occupational Health Needs During the COVID-19 Pandemic.",NA,"2021","07","05","Am J Med Qual","American journal of medical quality : the official journal of the American College of Medical Quality",NA,"Falconer","Elissa A","Department of Surgery, Emory University School of Medicine, Atlanta, GA, USA VA Quality Scholars Fellowship Program (VAQS), Atlanta VA Health Care System, Decatur, GA, USA Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA",NA
"1621","34225272","10.1097/01.JMQ.0000743376.85910.1a","Virus out, Safety in: Using Quality Improvement to Rapidly Respond to Occupational Health Needs During the COVID-19 Pandemic.",NA,"2021","07","05","Am J Med Qual","American journal of medical quality : the official journal of the American College of Medical Quality",NA,"Tomolo","Anne","Department of Surgery, Emory University School of Medicine, Atlanta, GA, USA VA Quality Scholars Fellowship Program (VAQS), Atlanta VA Health Care System, Decatur, GA, USA Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA",NA
"1622","34225251","10.1016/j.jaut.2021.102688","Auto-immune hepatitis following COVID vaccination.","Unprecedented loss of life due to the COVID pandemic has necessitated the development of several vaccines in record time. Most of these vaccines have received approval without being extensively whetted for their adverse effect and efficacy profiles. Most adverse effects have been mild, nonetheless, more serious thromboembolic events have also been reported. Autoimmune hepatitis (AIH) can occur in predisposed individuals where an immune mediated reaction against hepatocytes is triggered by enviro","2021","07","24","J Autoimmun","Journal of autoimmunity","Adverse effects; Auto-immune hepatitis; COVID-19; Covishield; Molecular mimicry; Outcomes; Pharmacovigilance; SARS-CoV-2; Treatment; Vaccination","Rela","Mohamed","The Institute of Liver Disease &amp","mohamed.rela@gmail.com"
"1623","34225251","10.1016/j.jaut.2021.102688","Auto-immune hepatitis following COVID vaccination.","Unprecedented loss of life due to the COVID pandemic has necessitated the development of several vaccines in record time. Most of these vaccines have received approval without being extensively whetted for their adverse effect and efficacy profiles. Most adverse effects have been mild, nonetheless, more serious thromboembolic events have also been reported. Autoimmune hepatitis (AIH) can occur in predisposed individuals where an immune mediated reaction against hepatocytes is triggered by enviro","2021","07","24","J Autoimmun","Journal of autoimmunity","Adverse effects; Auto-immune hepatitis; COVID-19; Covishield; Molecular mimicry; Outcomes; Pharmacovigilance; SARS-CoV-2; Treatment; Vaccination","Jothimani","Dinesh","The Institute of Liver Disease &amp","jdineshis@yahoo.co.uk"
"1624","34225251","10.1016/j.jaut.2021.102688","Auto-immune hepatitis following COVID vaccination.","Unprecedented loss of life due to the COVID pandemic has necessitated the development of several vaccines in record time. Most of these vaccines have received approval without being extensively whetted for their adverse effect and efficacy profiles. Most adverse effects have been mild, nonetheless, more serious thromboembolic events have also been reported. Autoimmune hepatitis (AIH) can occur in predisposed individuals where an immune mediated reaction against hepatocytes is triggered by enviro","2021","07","24","J Autoimmun","Journal of autoimmunity","Adverse effects; Auto-immune hepatitis; COVID-19; Covishield; Molecular mimicry; Outcomes; Pharmacovigilance; SARS-CoV-2; Treatment; Vaccination","Vij","Mukul","The Institute of Liver Disease &amp","mukul.vij.path@gmail.com"
"1625","34225251","10.1016/j.jaut.2021.102688","Auto-immune hepatitis following COVID vaccination.","Unprecedented loss of life due to the COVID pandemic has necessitated the development of several vaccines in record time. Most of these vaccines have received approval without being extensively whetted for their adverse effect and efficacy profiles. Most adverse effects have been mild, nonetheless, more serious thromboembolic events have also been reported. Autoimmune hepatitis (AIH) can occur in predisposed individuals where an immune mediated reaction against hepatocytes is triggered by enviro","2021","07","24","J Autoimmun","Journal of autoimmunity","Adverse effects; Auto-immune hepatitis; COVID-19; Covishield; Molecular mimicry; Outcomes; Pharmacovigilance; SARS-CoV-2; Treatment; Vaccination","Rajakumar","Akila","The Institute of Liver Disease &amp","drakila.rajakumar@gmail.com"
"1626","34225251","10.1016/j.jaut.2021.102688","Auto-immune hepatitis following COVID vaccination.","Unprecedented loss of life due to the COVID pandemic has necessitated the development of several vaccines in record time. Most of these vaccines have received approval without being extensively whetted for their adverse effect and efficacy profiles. Most adverse effects have been mild, nonetheless, more serious thromboembolic events have also been reported. Autoimmune hepatitis (AIH) can occur in predisposed individuals where an immune mediated reaction against hepatocytes is triggered by enviro","2021","07","24","J Autoimmun","Journal of autoimmunity","Adverse effects; Auto-immune hepatitis; COVID-19; Covishield; Molecular mimicry; Outcomes; Pharmacovigilance; SARS-CoV-2; Treatment; Vaccination","Rammohan","Ashwin","The Institute of Liver Disease &amp","ashwin.rammohan@relainstitute.com"
"1627","34225188","10.1016/j.jclinane.2021.110409","Increased incidence of post-operative respiratory failure in patients with pre-operative SARS-CoV-2 infection.","While studies have reported increased post-operative pulmonary complications with SARS-CoV-2 infection, many are limited by use of historical controls or focus on less severe respiratory complications. We characterized the association between pre-operative SARS-CoV-2 infection and post-operative respiratory failure (PORF). This was a single center retrospective cohort study in New York City between March 14-June 14, 2020. Exclusion criteria were age &lt; 18-years, obstetric procedures, absence o","2021","07","19","J Clin Anesth","Journal of clinical anesthesia","Coronavirus disease 2019 (COVID-19); Invasive mechanical ventilation; Perioperative care; Pneumonia; Post-operative respiratory failure; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)","Kiyatkin","Michael E","Department of Anesthesiology, Montefiore Medical Center, Bronx, NY, USA","mkiyatkin@montefiore.org"
"1628","34225188","10.1016/j.jclinane.2021.110409","Increased incidence of post-operative respiratory failure in patients with pre-operative SARS-CoV-2 infection.","While studies have reported increased post-operative pulmonary complications with SARS-CoV-2 infection, many are limited by use of historical controls or focus on less severe respiratory complications. We characterized the association between pre-operative SARS-CoV-2 infection and post-operative respiratory failure (PORF). This was a single center retrospective cohort study in New York City between March 14-June 14, 2020. Exclusion criteria were age &lt; 18-years, obstetric procedures, absence o","2021","07","19","J Clin Anesth","Journal of clinical anesthesia","Coronavirus disease 2019 (COVID-19); Invasive mechanical ventilation; Perioperative care; Pneumonia; Post-operative respiratory failure; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)","Levine","Samantha P","Albert Einstein College of Medicine, Bronx, NY, USA",NA
"1629","34225188","10.1016/j.jclinane.2021.110409","Increased incidence of post-operative respiratory failure in patients with pre-operative SARS-CoV-2 infection.","While studies have reported increased post-operative pulmonary complications with SARS-CoV-2 infection, many are limited by use of historical controls or focus on less severe respiratory complications. We characterized the association between pre-operative SARS-CoV-2 infection and post-operative respiratory failure (PORF). This was a single center retrospective cohort study in New York City between March 14-June 14, 2020. Exclusion criteria were age &lt; 18-years, obstetric procedures, absence o","2021","07","19","J Clin Anesth","Journal of clinical anesthesia","Coronavirus disease 2019 (COVID-19); Invasive mechanical ventilation; Perioperative care; Pneumonia; Post-operative respiratory failure; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)","Kimura","Atsumi","Albert Einstein College of Medicine, Bronx, NY, USA",NA
"1630","34225188","10.1016/j.jclinane.2021.110409","Increased incidence of post-operative respiratory failure in patients with pre-operative SARS-CoV-2 infection.","While studies have reported increased post-operative pulmonary complications with SARS-CoV-2 infection, many are limited by use of historical controls or focus on less severe respiratory complications. We characterized the association between pre-operative SARS-CoV-2 infection and post-operative respiratory failure (PORF). This was a single center retrospective cohort study in New York City between March 14-June 14, 2020. Exclusion criteria were age &lt; 18-years, obstetric procedures, absence o","2021","07","19","J Clin Anesth","Journal of clinical anesthesia","Coronavirus disease 2019 (COVID-19); Invasive mechanical ventilation; Perioperative care; Pneumonia; Post-operative respiratory failure; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)","Linzer","Ryan W","Albert Einstein College of Medicine, Bronx, NY, USA",NA
"1631","34225188","10.1016/j.jclinane.2021.110409","Increased incidence of post-operative respiratory failure in patients with pre-operative SARS-CoV-2 infection.","While studies have reported increased post-operative pulmonary complications with SARS-CoV-2 infection, many are limited by use of historical controls or focus on less severe respiratory complications. We characterized the association between pre-operative SARS-CoV-2 infection and post-operative respiratory failure (PORF). This was a single center retrospective cohort study in New York City between March 14-June 14, 2020. Exclusion criteria were age &lt; 18-years, obstetric procedures, absence o","2021","07","19","J Clin Anesth","Journal of clinical anesthesia","Coronavirus disease 2019 (COVID-19); Invasive mechanical ventilation; Perioperative care; Pneumonia; Post-operative respiratory failure; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)","Labins","Jacqueline R","Albert Einstein College of Medicine, Bronx, NY, USA",NA
"1632","34225188","10.1016/j.jclinane.2021.110409","Increased incidence of post-operative respiratory failure in patients with pre-operative SARS-CoV-2 infection.","While studies have reported increased post-operative pulmonary complications with SARS-CoV-2 infection, many are limited by use of historical controls or focus on less severe respiratory complications. We characterized the association between pre-operative SARS-CoV-2 infection and post-operative respiratory failure (PORF). This was a single center retrospective cohort study in New York City between March 14-June 14, 2020. Exclusion criteria were age &lt; 18-years, obstetric procedures, absence o","2021","07","19","J Clin Anesth","Journal of clinical anesthesia","Coronavirus disease 2019 (COVID-19); Invasive mechanical ventilation; Perioperative care; Pneumonia; Post-operative respiratory failure; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)","Kim","Joseph I","Albert Einstein College of Medicine, Bronx, NY, USA",NA
"1633","34225188","10.1016/j.jclinane.2021.110409","Increased incidence of post-operative respiratory failure in patients with pre-operative SARS-CoV-2 infection.","While studies have reported increased post-operative pulmonary complications with SARS-CoV-2 infection, many are limited by use of historical controls or focus on less severe respiratory complications. We characterized the association between pre-operative SARS-CoV-2 infection and post-operative respiratory failure (PORF). This was a single center retrospective cohort study in New York City between March 14-June 14, 2020. Exclusion criteria were age &lt; 18-years, obstetric procedures, absence o","2021","07","19","J Clin Anesth","Journal of clinical anesthesia","Coronavirus disease 2019 (COVID-19); Invasive mechanical ventilation; Perioperative care; Pneumonia; Post-operative respiratory failure; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)","Gurvich","Aryeh","Albert Einstein College of Medicine, Bronx, NY, USA",NA
"1634","34225188","10.1016/j.jclinane.2021.110409","Increased incidence of post-operative respiratory failure in patients with pre-operative SARS-CoV-2 infection.","While studies have reported increased post-operative pulmonary complications with SARS-CoV-2 infection, many are limited by use of historical controls or focus on less severe respiratory complications. We characterized the association between pre-operative SARS-CoV-2 infection and post-operative respiratory failure (PORF). This was a single center retrospective cohort study in New York City between March 14-June 14, 2020. Exclusion criteria were age &lt; 18-years, obstetric procedures, absence o","2021","07","19","J Clin Anesth","Journal of clinical anesthesia","Coronavirus disease 2019 (COVID-19); Invasive mechanical ventilation; Perioperative care; Pneumonia; Post-operative respiratory failure; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)","Gong","Michelle N","Department of Medicine, Montefiore Medical Center, Bronx, NY, USA",NA
"1635","34225159","10.1016/j.scitotenv.2021.148770","COVID-19 pandemic and global carbon dioxide emissions: A first assessment.","Anthropogenic carbon dioxide emissions are the main cause of global climate change. The COVID-19 pandemic has been one of the worst of its kind in the last century with regard to global deaths and, in the absence of any effective treatment, it led to governments worldwide mandating lock-down measures, as well as citizens voluntarily reducing non-essential trips and activities. In this study, the influence of decreased activity on CO2 emissions and on the economy was assessed. The US, ","2021","07","07","Sci Total Environ","The Science of the total environment","CO(2) emissions; COVID-19; Economy; Industry; Power generation; Transportation","Sikarwar","Vineet Singh","Institute of Plasma Physics, Czech Academy of Sciences, Za Slovankou 1782/3, 182 00 Prague 8, Czech Republic","sikarwar@ipp.cas.cz"
"1636","34225159","10.1016/j.scitotenv.2021.148770","COVID-19 pandemic and global carbon dioxide emissions: A first assessment.","Anthropogenic carbon dioxide emissions are the main cause of global climate change. The COVID-19 pandemic has been one of the worst of its kind in the last century with regard to global deaths and, in the absence of any effective treatment, it led to governments worldwide mandating lock-down measures, as well as citizens voluntarily reducing non-essential trips and activities. In this study, the influence of decreased activity on CO2 emissions and on the economy was assessed. The US, ","2021","07","07","Sci Total Environ","The Science of the total environment","CO(2) emissions; COVID-19; Economy; Industry; Power generation; Transportation","Reichert","Annika","School of Environment, Tsinghua University, Beijing 100084, China",NA
"1637","34225159","10.1016/j.scitotenv.2021.148770","COVID-19 pandemic and global carbon dioxide emissions: A first assessment.","Anthropogenic carbon dioxide emissions are the main cause of global climate change. The COVID-19 pandemic has been one of the worst of its kind in the last century with regard to global deaths and, in the absence of any effective treatment, it led to governments worldwide mandating lock-down measures, as well as citizens voluntarily reducing non-essential trips and activities. In this study, the influence of decreased activity on CO2 emissions and on the economy was assessed. The US, ","2021","07","07","Sci Total Environ","The Science of the total environment","CO(2) emissions; COVID-19; Economy; Industry; Power generation; Transportation","Jeremias","Michal","Institute of Plasma Physics, Czech Academy of Sciences, Za Slovankou 1782/3, 182 00 Prague 8, Czech Republic",NA
"1638","34225159","10.1016/j.scitotenv.2021.148770","COVID-19 pandemic and global carbon dioxide emissions: A first assessment.","Anthropogenic carbon dioxide emissions are the main cause of global climate change. The COVID-19 pandemic has been one of the worst of its kind in the last century with regard to global deaths and, in the absence of any effective treatment, it led to governments worldwide mandating lock-down measures, as well as citizens voluntarily reducing non-essential trips and activities. In this study, the influence of decreased activity on CO2 emissions and on the economy was assessed. The US, ","2021","07","07","Sci Total Environ","The Science of the total environment","CO(2) emissions; COVID-19; Economy; Industry; Power generation; Transportation","Manovic","Vasilije","Centre for Climate and Environmental Protection, Cranfield University, Bedford MK43 0AL, United Kingdom. Electronic address: v.manovic@cranfield.ac","v.manovic@cranfield.ac.uk"
"1639","34225157","10.1016/j.scitotenv.2021.148749","Close proximity risk assessment for SARS-CoV-2 infection.","Although the interpersonal distance represents an important parameter affecting the risk of infection due to respiratory viruses, the mechanism of exposure to exhaled droplets remains insufficiently characterized. In this study, an integrated risk assessment is presented for SARS-CoV-2 close proximity exposure between a speaking infectious subject and a susceptible subject. It is based on a three-dimensional transient numerical model for the description of exhaled droplet spread once emitted by ","2021","07","08","Sci Total Environ","The Science of the total environment","CFD analysis; Close proximity; Droplets; PIV; SARS-CoV-2; Virus transmission","Cortellessa","G","Department of Civil and Mechanical Engineering, University of Cassino and Southern Lazio, Cassino, FR, Italy",NA
"1640","34225157","10.1016/j.scitotenv.2021.148749","Close proximity risk assessment for SARS-CoV-2 infection.","Although the interpersonal distance represents an important parameter affecting the risk of infection due to respiratory viruses, the mechanism of exposure to exhaled droplets remains insufficiently characterized. In this study, an integrated risk assessment is presented for SARS-CoV-2 close proximity exposure between a speaking infectious subject and a susceptible subject. It is based on a three-dimensional transient numerical model for the description of exhaled droplet spread once emitted by ","2021","07","08","Sci Total Environ","The Science of the total environment","CFD analysis; Close proximity; Droplets; PIV; SARS-CoV-2; Virus transmission","Stabile","L","Department of Civil and Mechanical Engineering, University of Cassino and Southern Lazio, Cassino, FR, Italy",NA
"1641","34225157","10.1016/j.scitotenv.2021.148749","Close proximity risk assessment for SARS-CoV-2 infection.","Although the interpersonal distance represents an important parameter affecting the risk of infection due to respiratory viruses, the mechanism of exposure to exhaled droplets remains insufficiently characterized. In this study, an integrated risk assessment is presented for SARS-CoV-2 close proximity exposure between a speaking infectious subject and a susceptible subject. It is based on a three-dimensional transient numerical model for the description of exhaled droplet spread once emitted by ","2021","07","08","Sci Total Environ","The Science of the total environment","CFD analysis; Close proximity; Droplets; PIV; SARS-CoV-2; Virus transmission","Arpino","F","Department of Civil and Mechanical Engineering, University of Cassino and Southern Lazio, Cassino, FR, Italy",NA
"1642","34225157","10.1016/j.scitotenv.2021.148749","Close proximity risk assessment for SARS-CoV-2 infection.","Although the interpersonal distance represents an important parameter affecting the risk of infection due to respiratory viruses, the mechanism of exposure to exhaled droplets remains insufficiently characterized. In this study, an integrated risk assessment is presented for SARS-CoV-2 close proximity exposure between a speaking infectious subject and a susceptible subject. It is based on a three-dimensional transient numerical model for the description of exhaled droplet spread once emitted by ","2021","07","08","Sci Total Environ","The Science of the total environment","CFD analysis; Close proximity; Droplets; PIV; SARS-CoV-2; Virus transmission","Faleiros","D E","Maritime and Transport Technology, TU Delft, Netherlands",NA
"1643","34225157","10.1016/j.scitotenv.2021.148749","Close proximity risk assessment for SARS-CoV-2 infection.","Although the interpersonal distance represents an important parameter affecting the risk of infection due to respiratory viruses, the mechanism of exposure to exhaled droplets remains insufficiently characterized. In this study, an integrated risk assessment is presented for SARS-CoV-2 close proximity exposure between a speaking infectious subject and a susceptible subject. It is based on a three-dimensional transient numerical model for the description of exhaled droplet spread once emitted by ","2021","07","08","Sci Total Environ","The Science of the total environment","CFD analysis; Close proximity; Droplets; PIV; SARS-CoV-2; Virus transmission","van den Bos","W","Maritime and Transport Technology, TU Delft, Netherlands",NA
"1644","34225157","10.1016/j.scitotenv.2021.148749","Close proximity risk assessment for SARS-CoV-2 infection.","Although the interpersonal distance represents an important parameter affecting the risk of infection due to respiratory viruses, the mechanism of exposure to exhaled droplets remains insufficiently characterized. In this study, an integrated risk assessment is presented for SARS-CoV-2 close proximity exposure between a speaking infectious subject and a susceptible subject. It is based on a three-dimensional transient numerical model for the description of exhaled droplet spread once emitted by ","2021","07","08","Sci Total Environ","The Science of the total environment","CFD analysis; Close proximity; Droplets; PIV; SARS-CoV-2; Virus transmission","Morawska","L","International Laboratory for Air Quality and Health, Queensland University of Technology, Brisbane, Qld, Australia",NA
"1645","34225157","10.1016/j.scitotenv.2021.148749","Close proximity risk assessment for SARS-CoV-2 infection.","Although the interpersonal distance represents an important parameter affecting the risk of infection due to respiratory viruses, the mechanism of exposure to exhaled droplets remains insufficiently characterized. In this study, an integrated risk assessment is presented for SARS-CoV-2 close proximity exposure between a speaking infectious subject and a susceptible subject. It is based on a three-dimensional transient numerical model for the description of exhaled droplet spread once emitted by ","2021","07","08","Sci Total Environ","The Science of the total environment","CFD analysis; Close proximity; Droplets; PIV; SARS-CoV-2; Virus transmission","Buonanno","G","Department of Civil and Mechanical Engineering, University of Cassino and Southern Lazio, Cassino, FR, Italy","buonanno@unicas.it"
"1646","34225131","10.1016/j.ejogrb.2021.06.001","Severe acute respiratory syndrome (SARS) coronavirus-2 infection (COVID-19) in pregnancy - An overview.","The novel severe acute respiratory syndrome (SARS) coronavirus-2 which causes COVID-19 disease results in severe morbidity and mortality especially in vulnerable groups. Pregnancy by virtue of its physiological and anatomical adaptations increases the risk of severe infections especially those of the respiratory tract. This single stranded RNA virus is transmitted by droplets as well as soiled fomites. There are various degrees of disease severity- asymptomatic, mild, moderate severe and critica","2021","07","20","Eur J Obstet Gynecol Reprod Biol","European journal of obstetrics, gynecology, and reproductive biology","COVID-190; Coronavirus; Pregnancy; SARS-2; Vaccination; Vertical transmission","Hammad","Wafaa Ali Belail","Department of Obstetrics and Gynaecology Basildon and Thurrock University Hospitals NHS Foundation Trust Nethermayne, Basildon Essex SS16 5NL, United Kingdom",NA
"1647","34225131","10.1016/j.ejogrb.2021.06.001","Severe acute respiratory syndrome (SARS) coronavirus-2 infection (COVID-19) in pregnancy - An overview.","The novel severe acute respiratory syndrome (SARS) coronavirus-2 which causes COVID-19 disease results in severe morbidity and mortality especially in vulnerable groups. Pregnancy by virtue of its physiological and anatomical adaptations increases the risk of severe infections especially those of the respiratory tract. This single stranded RNA virus is transmitted by droplets as well as soiled fomites. There are various degrees of disease severity- asymptomatic, mild, moderate severe and critica","2021","07","20","Eur J Obstet Gynecol Reprod Biol","European journal of obstetrics, gynecology, and reproductive biology","COVID-190; Coronavirus; Pregnancy; SARS-2; Vaccination; Vertical transmission","Al Beloushi","Mariam","Women's Wellness Research Center, Hamad Medical Corporation, Doha, Qatar and Department of Obstetrics and Gynaecology, Qatar University, Doha Qata and Weil Cornell Medicine, Qatar",NA
"1648","34225131","10.1016/j.ejogrb.2021.06.001","Severe acute respiratory syndrome (SARS) coronavirus-2 infection (COVID-19) in pregnancy - An overview.","The novel severe acute respiratory syndrome (SARS) coronavirus-2 which causes COVID-19 disease results in severe morbidity and mortality especially in vulnerable groups. Pregnancy by virtue of its physiological and anatomical adaptations increases the risk of severe infections especially those of the respiratory tract. This single stranded RNA virus is transmitted by droplets as well as soiled fomites. There are various degrees of disease severity- asymptomatic, mild, moderate severe and critica","2021","07","20","Eur J Obstet Gynecol Reprod Biol","European journal of obstetrics, gynecology, and reproductive biology","COVID-190; Coronavirus; Pregnancy; SARS-2; Vaccination; Vertical transmission","Ahmed","Badreleden","Feto-Maternal Medicine Center, Doha Qatar and Department of Obstetrics and Gynaecology, Qatar University Doha Qata and Weil Cornell Medicine, Qatar",NA
"1649","34225131","10.1016/j.ejogrb.2021.06.001","Severe acute respiratory syndrome (SARS) coronavirus-2 infection (COVID-19) in pregnancy - An overview.","The novel severe acute respiratory syndrome (SARS) coronavirus-2 which causes COVID-19 disease results in severe morbidity and mortality especially in vulnerable groups. Pregnancy by virtue of its physiological and anatomical adaptations increases the risk of severe infections especially those of the respiratory tract. This single stranded RNA virus is transmitted by droplets as well as soiled fomites. There are various degrees of disease severity- asymptomatic, mild, moderate severe and critica","2021","07","20","Eur J Obstet Gynecol Reprod Biol","European journal of obstetrics, gynecology, and reproductive biology","COVID-190; Coronavirus; Pregnancy; SARS-2; Vaccination; Vertical transmission","Konje","Justin C","Department of Health Sciences, University of Leicester, Leicester, UK. Electronic address: jck4@leicester.ac","jck4@leicester.ac.uk"
"1650","34225097","10.1016/j.archger.2021.104468","Association between family caregivers and depressive symptoms among community-dwelling older adults in Japan: A cross-sectional study during the COVID-19 pandemic.","Novel coronavirus disease (COVID-19) pandemic could increase the mental health burden of family caregivers of older adults, but related reports are limited. We examined the association between family caregiving and changes in the depressive symptom status during the pandemic. This cross-sectional study included 957 (mean age [standard deviation] = 80.8 [4.8] years; 53.5% females) community-dwelling older adults aged = 65 years from a semi-urban area of Japan, who completed a mailed questionnaire","2021","07","21","Arch Gerontol Geriatr","Archives of gerontology and geriatrics","COVID-19; Depressive symptoms; Family caregiver; Mental health; Novel coronavirus disease infection","Noguchi","Taiji","Department of Social Science, Center for Gerontology and Social Science, National Center for Geriatrics and Gerontology, Aichi, Japan","noguchi.taiji0415@gmail.com"
"1651","34225097","10.1016/j.archger.2021.104468","Association between family caregivers and depressive symptoms among community-dwelling older adults in Japan: A cross-sectional study during the COVID-19 pandemic.","Novel coronavirus disease (COVID-19) pandemic could increase the mental health burden of family caregivers of older adults, but related reports are limited. We examined the association between family caregiving and changes in the depressive symptom status during the pandemic. This cross-sectional study included 957 (mean age [standard deviation] = 80.8 [4.8] years; 53.5% females) community-dwelling older adults aged = 65 years from a semi-urban area of Japan, who completed a mailed questionnaire","2021","07","21","Arch Gerontol Geriatr","Archives of gerontology and geriatrics","COVID-19; Depressive symptoms; Family caregiver; Mental health; Novel coronavirus disease infection","Hayashi","Takahiro","Department of Rehabilitation and Care, Seijoh University, Aicihi, Japan. Electronic address: hayashi-taka@seijoh-u.ac",NA
"1652","34225097","10.1016/j.archger.2021.104468","Association between family caregivers and depressive symptoms among community-dwelling older adults in Japan: A cross-sectional study during the COVID-19 pandemic.","Novel coronavirus disease (COVID-19) pandemic could increase the mental health burden of family caregivers of older adults, but related reports are limited. We examined the association between family caregiving and changes in the depressive symptom status during the pandemic. This cross-sectional study included 957 (mean age [standard deviation] = 80.8 [4.8] years; 53.5% females) community-dwelling older adults aged = 65 years from a semi-urban area of Japan, who completed a mailed questionnaire","2021","07","21","Arch Gerontol Geriatr","Archives of gerontology and geriatrics","COVID-19; Depressive symptoms; Family caregiver; Mental health; Novel coronavirus disease infection","Kubo","Yuta","Department of Rehabilitation and Care, Seijoh University, Aicihi, Japan. Electronic address: kubo-yu@seijoh-u.ac",NA
"1653","34225097","10.1016/j.archger.2021.104468","Association between family caregivers and depressive symptoms among community-dwelling older adults in Japan: A cross-sectional study during the COVID-19 pandemic.","Novel coronavirus disease (COVID-19) pandemic could increase the mental health burden of family caregivers of older adults, but related reports are limited. We examined the association between family caregiving and changes in the depressive symptom status during the pandemic. This cross-sectional study included 957 (mean age [standard deviation] = 80.8 [4.8] years; 53.5% females) community-dwelling older adults aged = 65 years from a semi-urban area of Japan, who completed a mailed questionnaire","2021","07","21","Arch Gerontol Geriatr","Archives of gerontology and geriatrics","COVID-19; Depressive symptoms; Family caregiver; Mental health; Novel coronavirus disease infection","Tomiyama","Naoki","Department of Rehabilitation and Care, Seijoh University, Aicihi, Japan. Electronic address: tomiyama@seijoh-u.ac",NA
"1654","34225097","10.1016/j.archger.2021.104468","Association between family caregivers and depressive symptoms among community-dwelling older adults in Japan: A cross-sectional study during the COVID-19 pandemic.","Novel coronavirus disease (COVID-19) pandemic could increase the mental health burden of family caregivers of older adults, but related reports are limited. We examined the association between family caregiving and changes in the depressive symptom status during the pandemic. This cross-sectional study included 957 (mean age [standard deviation] = 80.8 [4.8] years; 53.5% females) community-dwelling older adults aged = 65 years from a semi-urban area of Japan, who completed a mailed questionnaire","2021","07","21","Arch Gerontol Geriatr","Archives of gerontology and geriatrics","COVID-19; Depressive symptoms; Family caregiver; Mental health; Novel coronavirus disease infection","Ochi","Akira","Department of Rehabilitation and Care, Seijoh University, Aicihi, Japan. Electronic address: ochi@seijoh-u.ac",NA
"1655","34225097","10.1016/j.archger.2021.104468","Association between family caregivers and depressive symptoms among community-dwelling older adults in Japan: A cross-sectional study during the COVID-19 pandemic.","Novel coronavirus disease (COVID-19) pandemic could increase the mental health burden of family caregivers of older adults, but related reports are limited. We examined the association between family caregiving and changes in the depressive symptom status during the pandemic. This cross-sectional study included 957 (mean age [standard deviation] = 80.8 [4.8] years; 53.5% females) community-dwelling older adults aged = 65 years from a semi-urban area of Japan, who completed a mailed questionnaire","2021","07","21","Arch Gerontol Geriatr","Archives of gerontology and geriatrics","COVID-19; Depressive symptoms; Family caregiver; Mental health; Novel coronavirus disease infection","Hayashi","Hiroyuki","Department of Rehabilitation and Care, Seijoh University, Aicihi, Japan. Electronic address: hayashi-h@seijoh-u.ac",NA
"1656","34225090","10.1016/j.breast.2021.06.006","Characteristics and outcomes of COVID-19 infection in 45 patients with breast cancer: A multi-center retrospective study in Hubei, China.","The COVID-19 pandemic is a significant worldwide health crisis. Breast cancer patients with COVID-19 are fragile and require particular clinical care. This study aimed to identify the clinical characteristics of breast cancer patients with COVID-19 and the risks associated with anti-cancer treatment. The medical records of breast cancer patients with laboratory-confirmed COVID-19 were collected among 9559 COVID-19 patients from seven designated hospitals from 13th January to 18th March 2020 in H","2021","07","21","Breast","Breast (Edinburgh, Scotland)","Anti-cancer treatment; Breast cancer; COVID-19; Chemotherapy; Retrospective study","Wei","Jielin","Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, 430022, China. Electronic address: weijielin@hust.edu","weijielin@hust.edu.cn"
"1657","34225090","10.1016/j.breast.2021.06.006","Characteristics and outcomes of COVID-19 infection in 45 patients with breast cancer: A multi-center retrospective study in Hubei, China.","The COVID-19 pandemic is a significant worldwide health crisis. Breast cancer patients with COVID-19 are fragile and require particular clinical care. This study aimed to identify the clinical characteristics of breast cancer patients with COVID-19 and the risks associated with anti-cancer treatment. The medical records of breast cancer patients with laboratory-confirmed COVID-19 were collected among 9559 COVID-19 patients from seven designated hospitals from 13th January to 18th March 2020 in H","2021","07","21","Breast","Breast (Edinburgh, Scotland)","Anti-cancer treatment; Breast cancer; COVID-19; Chemotherapy; Retrospective study","Wu","Mengjiao","Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, 430022, China. Electronic address: wumengjiaos@163","wumengjiaos@163.com"
"1658","34225090","10.1016/j.breast.2021.06.006","Characteristics and outcomes of COVID-19 infection in 45 patients with breast cancer: A multi-center retrospective study in Hubei, China.","The COVID-19 pandemic is a significant worldwide health crisis. Breast cancer patients with COVID-19 are fragile and require particular clinical care. This study aimed to identify the clinical characteristics of breast cancer patients with COVID-19 and the risks associated with anti-cancer treatment. The medical records of breast cancer patients with laboratory-confirmed COVID-19 were collected among 9559 COVID-19 patients from seven designated hospitals from 13th January to 18th March 2020 in H","2021","07","21","Breast","Breast (Edinburgh, Scotland)","Anti-cancer treatment; Breast cancer; COVID-19; Chemotherapy; Retrospective study","Liu","Jing","Department of Medical Oncology, Huanggang Central Hospital, Huanggang, Hubei, 438000, China. Electronic address: liujingzhongliu@163","liujingzhongliu@163.com"
"1659","34225090","10.1016/j.breast.2021.06.006","Characteristics and outcomes of COVID-19 infection in 45 patients with breast cancer: A multi-center retrospective study in Hubei, China.","The COVID-19 pandemic is a significant worldwide health crisis. Breast cancer patients with COVID-19 are fragile and require particular clinical care. This study aimed to identify the clinical characteristics of breast cancer patients with COVID-19 and the risks associated with anti-cancer treatment. The medical records of breast cancer patients with laboratory-confirmed COVID-19 were collected among 9559 COVID-19 patients from seven designated hospitals from 13th January to 18th March 2020 in H","2021","07","21","Breast","Breast (Edinburgh, Scotland)","Anti-cancer treatment; Breast cancer; COVID-19; Chemotherapy; Retrospective study","Wang","Xu","Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, 430022, China. Electronic address: tjmuwangxu@163","tjmuwangxu@163.com"
"1660","34225090","10.1016/j.breast.2021.06.006","Characteristics and outcomes of COVID-19 infection in 45 patients with breast cancer: A multi-center retrospective study in Hubei, China.","The COVID-19 pandemic is a significant worldwide health crisis. Breast cancer patients with COVID-19 are fragile and require particular clinical care. This study aimed to identify the clinical characteristics of breast cancer patients with COVID-19 and the risks associated with anti-cancer treatment. The medical records of breast cancer patients with laboratory-confirmed COVID-19 were collected among 9559 COVID-19 patients from seven designated hospitals from 13th January to 18th March 2020 in H","2021","07","21","Breast","Breast (Edinburgh, Scotland)","Anti-cancer treatment; Breast cancer; COVID-19; Chemotherapy; Retrospective study","Yang","Hua","Department of Thyroid and Breast Surgery, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, 430014, China. Electronic address: yeoh34@hotmail","yeoh34@hotmail.com"
"1661","34225090","10.1016/j.breast.2021.06.006","Characteristics and outcomes of COVID-19 infection in 45 patients with breast cancer: A multi-center retrospective study in Hubei, China.","The COVID-19 pandemic is a significant worldwide health crisis. Breast cancer patients with COVID-19 are fragile and require particular clinical care. This study aimed to identify the clinical characteristics of breast cancer patients with COVID-19 and the risks associated with anti-cancer treatment. The medical records of breast cancer patients with laboratory-confirmed COVID-19 were collected among 9559 COVID-19 patients from seven designated hospitals from 13th January to 18th March 2020 in H","2021","07","21","Breast","Breast (Edinburgh, Scotland)","Anti-cancer treatment; Breast cancer; COVID-19; Chemotherapy; Retrospective study","Xia","Pengfei","Department of Epidemiology and Biostatistics, Ministry of Education Key Laboratory of Environment and Health and State Key Laboratory of Environmental Health (incubation), School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, 430030, China. Electronic address: xiapengfei@hust.edu","xiapengfei@hust.edu.cn"
"1662","34225090","10.1016/j.breast.2021.06.006","Characteristics and outcomes of COVID-19 infection in 45 patients with breast cancer: A multi-center retrospective study in Hubei, China.","The COVID-19 pandemic is a significant worldwide health crisis. Breast cancer patients with COVID-19 are fragile and require particular clinical care. This study aimed to identify the clinical characteristics of breast cancer patients with COVID-19 and the risks associated with anti-cancer treatment. The medical records of breast cancer patients with laboratory-confirmed COVID-19 were collected among 9559 COVID-19 patients from seven designated hospitals from 13th January to 18th March 2020 in H","2021","07","21","Breast","Breast (Edinburgh, Scotland)","Anti-cancer treatment; Breast cancer; COVID-19; Chemotherapy; Retrospective study","Peng","Ling","Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, 430022, China. Electronic address: 15527306476@163","15527306476@163.com"
"1663","34225090","10.1016/j.breast.2021.06.006","Characteristics and outcomes of COVID-19 infection in 45 patients with breast cancer: A multi-center retrospective study in Hubei, China.","The COVID-19 pandemic is a significant worldwide health crisis. Breast cancer patients with COVID-19 are fragile and require particular clinical care. This study aimed to identify the clinical characteristics of breast cancer patients with COVID-19 and the risks associated with anti-cancer treatment. The medical records of breast cancer patients with laboratory-confirmed COVID-19 were collected among 9559 COVID-19 patients from seven designated hospitals from 13th January to 18th March 2020 in H","2021","07","21","Breast","Breast (Edinburgh, Scotland)","Anti-cancer treatment; Breast cancer; COVID-19; Chemotherapy; Retrospective study","Huang","Yu","Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, 430022, China. Electronic address: riguangbed@126","riguangbed@126.com"
"1664","34225090","10.1016/j.breast.2021.06.006","Characteristics and outcomes of COVID-19 infection in 45 patients with breast cancer: A multi-center retrospective study in Hubei, China.","The COVID-19 pandemic is a significant worldwide health crisis. Breast cancer patients with COVID-19 are fragile and require particular clinical care. This study aimed to identify the clinical characteristics of breast cancer patients with COVID-19 and the risks associated with anti-cancer treatment. The medical records of breast cancer patients with laboratory-confirmed COVID-19 were collected among 9559 COVID-19 patients from seven designated hospitals from 13th January to 18th March 2020 in H","2021","07","21","Breast","Breast (Edinburgh, Scotland)","Anti-cancer treatment; Breast cancer; COVID-19; Chemotherapy; Retrospective study","Liu","Cuiwei","Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, 430022, China. Electronic address: cuiweiliu19870620@163","cuiweiliu19870620@163.com"
"1665","34225090","10.1016/j.breast.2021.06.006","Characteristics and outcomes of COVID-19 infection in 45 patients with breast cancer: A multi-center retrospective study in Hubei, China.","The COVID-19 pandemic is a significant worldwide health crisis. Breast cancer patients with COVID-19 are fragile and require particular clinical care. This study aimed to identify the clinical characteristics of breast cancer patients with COVID-19 and the risks associated with anti-cancer treatment. The medical records of breast cancer patients with laboratory-confirmed COVID-19 were collected among 9559 COVID-19 patients from seven designated hospitals from 13th January to 18th March 2020 in H","2021","07","21","Breast","Breast (Edinburgh, Scotland)","Anti-cancer treatment; Breast cancer; COVID-19; Chemotherapy; Retrospective study","Xia","Zihan","Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, 430022, China. Electronic address: xiazihan0623@gmail","xiazihan0623@gmail.com"
"1666","34225090","10.1016/j.breast.2021.06.006","Characteristics and outcomes of COVID-19 infection in 45 patients with breast cancer: A multi-center retrospective study in Hubei, China.","The COVID-19 pandemic is a significant worldwide health crisis. Breast cancer patients with COVID-19 are fragile and require particular clinical care. This study aimed to identify the clinical characteristics of breast cancer patients with COVID-19 and the risks associated with anti-cancer treatment. The medical records of breast cancer patients with laboratory-confirmed COVID-19 were collected among 9559 COVID-19 patients from seven designated hospitals from 13th January to 18th March 2020 in H","2021","07","21","Breast","Breast (Edinburgh, Scotland)","Anti-cancer treatment; Breast cancer; COVID-19; Chemotherapy; Retrospective study","Chen","Chuang","Department of Breast and Thyroid Surgery, Renmin Hospital of Wuhan University, Wuhan, Hubei, 430060, China. Electronic address: chenc2469@163","chenc2469@163.com"
"1667","34225090","10.1016/j.breast.2021.06.006","Characteristics and outcomes of COVID-19 infection in 45 patients with breast cancer: A multi-center retrospective study in Hubei, China.","The COVID-19 pandemic is a significant worldwide health crisis. Breast cancer patients with COVID-19 are fragile and require particular clinical care. This study aimed to identify the clinical characteristics of breast cancer patients with COVID-19 and the risks associated with anti-cancer treatment. The medical records of breast cancer patients with laboratory-confirmed COVID-19 were collected among 9559 COVID-19 patients from seven designated hospitals from 13th January to 18th March 2020 in H","2021","07","21","Breast","Breast (Edinburgh, Scotland)","Anti-cancer treatment; Breast cancer; COVID-19; Chemotherapy; Retrospective study","Zhao","Yanxia","Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, 430022, China. Electronic address: sophia7781@126","sophia7781@126.com"
"1668","34225084","10.1016/j.jcrc.2021.06.014","Management of SARS-CoV-2 pneumonia in intensive care unit: An observational retrospective study comparing two bundles.","To compare the effects of two therapeutic bundles of management in SARS-CoV2 ICU patients. Our retrospective, observational study was performed in a university ICU from March to June 2020 (first wave) and from September 2020 to January 2021 (second wave). In first wave, patients received bundle 1 including early invasive ventilation, hydroxychloroquine, cefotaxime and azithromycin. In second wave, bundle 2 included non-invasive oxygenation support and dexamethasone. The main outcome was in-hospi","2021","07","21","J Crit Care","Journal of critical care","Bundle; COVID-19; Dexamethasone; Hydroxychloroquine; Intensive care unit; Treatment","Lopez","Alexandre","Aix-Marseille University, Assistance Publique Hôpitaux de Marseille, Department of Anesthesiology and Intensive Care, Hôpital Nord, Marseille 13015, France. Electronic address: alexandre.lopez@ap-hm",NA
"1669","34225084","10.1016/j.jcrc.2021.06.014","Management of SARS-CoV-2 pneumonia in intensive care unit: An observational retrospective study comparing two bundles.","To compare the effects of two therapeutic bundles of management in SARS-CoV2 ICU patients. Our retrospective, observational study was performed in a university ICU from March to June 2020 (first wave) and from September 2020 to January 2021 (second wave). In first wave, patients received bundle 1 including early invasive ventilation, hydroxychloroquine, cefotaxime and azithromycin. In second wave, bundle 2 included non-invasive oxygenation support and dexamethasone. The main outcome was in-hospi","2021","07","21","J Crit Care","Journal of critical care","Bundle; COVID-19; Dexamethasone; Hydroxychloroquine; Intensive care unit; Treatment","Lakbar","Ines","Department of Anesthesiology and Intensive Care Unit, Hôpital Nord, Toulouse, France",NA
"1670","34225084","10.1016/j.jcrc.2021.06.014","Management of SARS-CoV-2 pneumonia in intensive care unit: An observational retrospective study comparing two bundles.","To compare the effects of two therapeutic bundles of management in SARS-CoV2 ICU patients. Our retrospective, observational study was performed in a university ICU from March to June 2020 (first wave) and from September 2020 to January 2021 (second wave). In first wave, patients received bundle 1 including early invasive ventilation, hydroxychloroquine, cefotaxime and azithromycin. In second wave, bundle 2 included non-invasive oxygenation support and dexamethasone. The main outcome was in-hospi","2021","07","21","J Crit Care","Journal of critical care","Bundle; COVID-19; Dexamethasone; Hydroxychloroquine; Intensive care unit; Treatment","Delamarre","Louis","Department of Anesthesiology and Intensive Care Unit, Hôpital Nord, Toulouse, France",NA
"1671","34225084","10.1016/j.jcrc.2021.06.014","Management of SARS-CoV-2 pneumonia in intensive care unit: An observational retrospective study comparing two bundles.","To compare the effects of two therapeutic bundles of management in SARS-CoV2 ICU patients. Our retrospective, observational study was performed in a university ICU from March to June 2020 (first wave) and from September 2020 to January 2021 (second wave). In first wave, patients received bundle 1 including early invasive ventilation, hydroxychloroquine, cefotaxime and azithromycin. In second wave, bundle 2 included non-invasive oxygenation support and dexamethasone. The main outcome was in-hospi","2021","07","21","J Crit Care","Journal of critical care","Bundle; COVID-19; Dexamethasone; Hydroxychloroquine; Intensive care unit; Treatment","Culver","Aurélien","Aix-Marseille University, Assistance Publique Hôpitaux de Marseille, Department of Anesthesiology and Intensive Care, Hôpital Nord, Marseille 13015, France",NA
"1672","34225084","10.1016/j.jcrc.2021.06.014","Management of SARS-CoV-2 pneumonia in intensive care unit: An observational retrospective study comparing two bundles.","To compare the effects of two therapeutic bundles of management in SARS-CoV2 ICU patients. Our retrospective, observational study was performed in a university ICU from March to June 2020 (first wave) and from September 2020 to January 2021 (second wave). In first wave, patients received bundle 1 including early invasive ventilation, hydroxychloroquine, cefotaxime and azithromycin. In second wave, bundle 2 included non-invasive oxygenation support and dexamethasone. The main outcome was in-hospi","2021","07","21","J Crit Care","Journal of critical care","Bundle; COVID-19; Dexamethasone; Hydroxychloroquine; Intensive care unit; Treatment","Arbelot","Charlotte","Aix-Marseille University, Assistance Publique Hôpitaux de Marseille, Department of Anesthesiology and Intensive Care, Hôpital Nord, Marseille 13015, France",NA
"1673","34225084","10.1016/j.jcrc.2021.06.014","Management of SARS-CoV-2 pneumonia in intensive care unit: An observational retrospective study comparing two bundles.","To compare the effects of two therapeutic bundles of management in SARS-CoV2 ICU patients. Our retrospective, observational study was performed in a university ICU from March to June 2020 (first wave) and from September 2020 to January 2021 (second wave). In first wave, patients received bundle 1 including early invasive ventilation, hydroxychloroquine, cefotaxime and azithromycin. In second wave, bundle 2 included non-invasive oxygenation support and dexamethasone. The main outcome was in-hospi","2021","07","21","J Crit Care","Journal of critical care","Bundle; COVID-19; Dexamethasone; Hydroxychloroquine; Intensive care unit; Treatment","Duclos","Gary","Aix-Marseille University, Assistance Publique Hôpitaux de Marseille, Department of Anesthesiology and Intensive Care, Hôpital Nord, Marseille 13015, France",NA
"1674","34225084","10.1016/j.jcrc.2021.06.014","Management of SARS-CoV-2 pneumonia in intensive care unit: An observational retrospective study comparing two bundles.","To compare the effects of two therapeutic bundles of management in SARS-CoV2 ICU patients. Our retrospective, observational study was performed in a university ICU from March to June 2020 (first wave) and from September 2020 to January 2021 (second wave). In first wave, patients received bundle 1 including early invasive ventilation, hydroxychloroquine, cefotaxime and azithromycin. In second wave, bundle 2 included non-invasive oxygenation support and dexamethasone. The main outcome was in-hospi","2021","07","21","J Crit Care","Journal of critical care","Bundle; COVID-19; Dexamethasone; Hydroxychloroquine; Intensive care unit; Treatment","Hammad","Emmanuelle","Aix-Marseille University, Assistance Publique Hôpitaux de Marseille, Department of Anesthesiology and Intensive Care, Hôpital Nord, Marseille 13015, France",NA
"1675","34225084","10.1016/j.jcrc.2021.06.014","Management of SARS-CoV-2 pneumonia in intensive care unit: An observational retrospective study comparing two bundles.","To compare the effects of two therapeutic bundles of management in SARS-CoV2 ICU patients. Our retrospective, observational study was performed in a university ICU from March to June 2020 (first wave) and from September 2020 to January 2021 (second wave). In first wave, patients received bundle 1 including early invasive ventilation, hydroxychloroquine, cefotaxime and azithromycin. In second wave, bundle 2 included non-invasive oxygenation support and dexamethasone. The main outcome was in-hospi","2021","07","21","J Crit Care","Journal of critical care","Bundle; COVID-19; Dexamethasone; Hydroxychloroquine; Intensive care unit; Treatment","Pastene","Bruno","Aix-Marseille University, Assistance Publique Hôpitaux de Marseille, Department of Anesthesiology and Intensive Care, Hôpital Nord, Marseille 13015, France",NA
"1676","34225084","10.1016/j.jcrc.2021.06.014","Management of SARS-CoV-2 pneumonia in intensive care unit: An observational retrospective study comparing two bundles.","To compare the effects of two therapeutic bundles of management in SARS-CoV2 ICU patients. Our retrospective, observational study was performed in a university ICU from March to June 2020 (first wave) and from September 2020 to January 2021 (second wave). In first wave, patients received bundle 1 including early invasive ventilation, hydroxychloroquine, cefotaxime and azithromycin. In second wave, bundle 2 included non-invasive oxygenation support and dexamethasone. The main outcome was in-hospi","2021","07","21","J Crit Care","Journal of critical care","Bundle; COVID-19; Dexamethasone; Hydroxychloroquine; Intensive care unit; Treatment","Antonini","François","Aix-Marseille University, Assistance Publique Hôpitaux de Marseille, Department of Anesthesiology and Intensive Care, Hôpital Nord, Marseille 13015, France",NA
"1677","34225084","10.1016/j.jcrc.2021.06.014","Management of SARS-CoV-2 pneumonia in intensive care unit: An observational retrospective study comparing two bundles.","To compare the effects of two therapeutic bundles of management in SARS-CoV2 ICU patients. Our retrospective, observational study was performed in a university ICU from March to June 2020 (first wave) and from September 2020 to January 2021 (second wave). In first wave, patients received bundle 1 including early invasive ventilation, hydroxychloroquine, cefotaxime and azithromycin. In second wave, bundle 2 included non-invasive oxygenation support and dexamethasone. The main outcome was in-hospi","2021","07","21","J Crit Care","Journal of critical care","Bundle; COVID-19; Dexamethasone; Hydroxychloroquine; Intensive care unit; Treatment","Zieleskiewicz","Laurent","Aix-Marseille University, Assistance Publique Hôpitaux de Marseille, Department of Anesthesiology and Intensive Care, Hôpital Nord, Marseille 13015, France",NA
"1678","34225084","10.1016/j.jcrc.2021.06.014","Management of SARS-CoV-2 pneumonia in intensive care unit: An observational retrospective study comparing two bundles.","To compare the effects of two therapeutic bundles of management in SARS-CoV2 ICU patients. Our retrospective, observational study was performed in a university ICU from March to June 2020 (first wave) and from September 2020 to January 2021 (second wave). In first wave, patients received bundle 1 including early invasive ventilation, hydroxychloroquine, cefotaxime and azithromycin. In second wave, bundle 2 included non-invasive oxygenation support and dexamethasone. The main outcome was in-hospi","2021","07","21","J Crit Care","Journal of critical care","Bundle; COVID-19; Dexamethasone; Hydroxychloroquine; Intensive care unit; Treatment","Leone","Marc","Aix-Marseille University, Assistance Publique Hôpitaux de Marseille, Department of Anesthesiology and Intensive Care, Hôpital Nord, Marseille 13015, France",NA
"1679","34225024","10.1016/j.schres.2021.06.006","Sedentary behaviour in young people presenting with a first episode of psychosis before and during the covid-19 pandemic restrictions.",NA,"2021","07","14","Schizophr Res","Schizophrenia research",NA,"O'Donoghue","Brian","Orygen, 35 Poplar rd, Parkville, VIC 3052, Australia","brian.odonoghue@orygen.org.au"
"1680","34225024","10.1016/j.schres.2021.06.006","Sedentary behaviour in young people presenting with a first episode of psychosis before and during the covid-19 pandemic restrictions.",NA,"2021","07","14","Schizophr Res","Schizophrenia research",NA,"Castagnini","Emily","Orygen, 35 Poplar rd, Parkville, VIC 3052, Australia",NA
"1681","34225024","10.1016/j.schres.2021.06.006","Sedentary behaviour in young people presenting with a first episode of psychosis before and during the covid-19 pandemic restrictions.",NA,"2021","07","14","Schizophr Res","Schizophrenia research",NA,"Langstone","Alison","Orygen, 35 Poplar rd, Parkville, VIC 3052, Australia",NA
"1682","34225024","10.1016/j.schres.2021.06.006","Sedentary behaviour in young people presenting with a first episode of psychosis before and during the covid-19 pandemic restrictions.",NA,"2021","07","14","Schizophr Res","Schizophrenia research",NA,"Mifsud","Nathan","Orygen, 35 Poplar rd, Parkville, VIC 3052, Australia",NA
"1683","34225024","10.1016/j.schres.2021.06.006","Sedentary behaviour in young people presenting with a first episode of psychosis before and during the covid-19 pandemic restrictions.",NA,"2021","07","14","Schizophr Res","Schizophrenia research",NA,"Thompson","Andrew","Orygen, 35 Poplar rd, Parkville, VIC 3052, Australia",NA
"1684","34225024","10.1016/j.schres.2021.06.006","Sedentary behaviour in young people presenting with a first episode of psychosis before and during the covid-19 pandemic restrictions.",NA,"2021","07","14","Schizophr Res","Schizophrenia research",NA,"Killackey","Eoin","Orygen, 35 Poplar rd, Parkville, VIC 3052, Australia",NA
"1685","34225024","10.1016/j.schres.2021.06.006","Sedentary behaviour in young people presenting with a first episode of psychosis before and during the covid-19 pandemic restrictions.",NA,"2021","07","14","Schizophr Res","Schizophrenia research",NA,"McGorry","Patrick","Orygen, 35 Poplar rd, Parkville, VIC 3052, Australia",NA
"1686","34225003","10.1016/j.clineuro.2021.106793","Risk of contracting SARS-CoV-2 (COVID-19) from hospital admission and the impact of protection efforts on acute stroke treatment.","It is unclear how interventions designed to restrict community and in-hospital exposure to the SARS-CoV-2 (COVID-19) virus influenced stroke care for patients seeking acute treatment. Therefore, we aimed to determine how these COVID-19 interventions impacted acute stroke treatment times and to assess the risk of contracting COVID-19 due to their stay in our medical center. Retrospective, single center, two-phase study evaluating hospital and community trends from 12/2019 - 04/2020 compared to th","2021","07","23","Clin Neurol Neurosurg","Clinical neurology and neurosurgery",NA,"Greenwood","Jessica","Miami Neuroscience Institute, Baptist Health South Florida, Miami, FL, USA",NA
"1687","34225003","10.1016/j.clineuro.2021.106793","Risk of contracting SARS-CoV-2 (COVID-19) from hospital admission and the impact of protection efforts on acute stroke treatment.","It is unclear how interventions designed to restrict community and in-hospital exposure to the SARS-CoV-2 (COVID-19) virus influenced stroke care for patients seeking acute treatment. Therefore, we aimed to determine how these COVID-19 interventions impacted acute stroke treatment times and to assess the risk of contracting COVID-19 due to their stay in our medical center. Retrospective, single center, two-phase study evaluating hospital and community trends from 12/2019 - 04/2020 compared to th","2021","07","23","Clin Neurol Neurosurg","Clinical neurology and neurosurgery",NA,"Belnap","Starlie","Miami Neuroscience Institute, Baptist Health South Florida, Miami, FL, USA",NA
"1688","34225003","10.1016/j.clineuro.2021.106793","Risk of contracting SARS-CoV-2 (COVID-19) from hospital admission and the impact of protection efforts on acute stroke treatment.","It is unclear how interventions designed to restrict community and in-hospital exposure to the SARS-CoV-2 (COVID-19) virus influenced stroke care for patients seeking acute treatment. Therefore, we aimed to determine how these COVID-19 interventions impacted acute stroke treatment times and to assess the risk of contracting COVID-19 due to their stay in our medical center. Retrospective, single center, two-phase study evaluating hospital and community trends from 12/2019 - 04/2020 compared to th","2021","07","23","Clin Neurol Neurosurg","Clinical neurology and neurosurgery",NA,"Dabus","Guilherme","Miami Neuroscience Institute, Baptist Health South Florida, Miami, FL, USA",NA
"1689","34225003","10.1016/j.clineuro.2021.106793","Risk of contracting SARS-CoV-2 (COVID-19) from hospital admission and the impact of protection efforts on acute stroke treatment.","It is unclear how interventions designed to restrict community and in-hospital exposure to the SARS-CoV-2 (COVID-19) virus influenced stroke care for patients seeking acute treatment. Therefore, we aimed to determine how these COVID-19 interventions impacted acute stroke treatment times and to assess the risk of contracting COVID-19 due to their stay in our medical center. Retrospective, single center, two-phase study evaluating hospital and community trends from 12/2019 - 04/2020 compared to th","2021","07","23","Clin Neurol Neurosurg","Clinical neurology and neurosurgery",NA,"Linfante","Italo","Miami Neuroscience Institute, Baptist Health South Florida, Miami, FL, USA",NA
"1690","34225003","10.1016/j.clineuro.2021.106793","Risk of contracting SARS-CoV-2 (COVID-19) from hospital admission and the impact of protection efforts on acute stroke treatment.","It is unclear how interventions designed to restrict community and in-hospital exposure to the SARS-CoV-2 (COVID-19) virus influenced stroke care for patients seeking acute treatment. Therefore, we aimed to determine how these COVID-19 interventions impacted acute stroke treatment times and to assess the risk of contracting COVID-19 due to their stay in our medical center. Retrospective, single center, two-phase study evaluating hospital and community trends from 12/2019 - 04/2020 compared to th","2021","07","23","Clin Neurol Neurosurg","Clinical neurology and neurosurgery",NA,"De Los Rios La Rosa","Felipe","Miami Neuroscience Institute, Baptist Health South Florida, Miami, FL, USA. Electronic address: FelipeDL@baptisthealth","FelipeDL@baptisthealth.net"
"1691","34224999","10.1016/j.thromres.2021.06.009","Comparison of Fibrin Monomers and D-dimers to predict thrombotic events in critically ill patients with COVID-19 pneumonia: A retrospective study.",NA,"2021","07","23","Thromb Res","Thrombosis research",NA,"Godon","Alexandre","Department of Anesthesiology and Critical Care, Grenoble Alpes University Hospital, Grenoble, France. Electronic address: agodon1@chu-grenoble",NA
"1692","34224999","10.1016/j.thromres.2021.06.009","Comparison of Fibrin Monomers and D-dimers to predict thrombotic events in critically ill patients with COVID-19 pneumonia: A retrospective study.",NA,"2021","07","23","Thromb Res","Thrombosis research",NA,"Durand","Zoé","Department of Anesthesiology and Critical Care, Grenoble Alpes University Hospital, Grenoble, France",NA
"1693","34224999","10.1016/j.thromres.2021.06.009","Comparison of Fibrin Monomers and D-dimers to predict thrombotic events in critically ill patients with COVID-19 pneumonia: A retrospective study.",NA,"2021","07","23","Thromb Res","Thrombosis research",NA,"Agier","Lydiane","Data-stat Department, Grenoble Alpes University Hospital, Grenoble, France",NA
"1694","34224999","10.1016/j.thromres.2021.06.009","Comparison of Fibrin Monomers and D-dimers to predict thrombotic events in critically ill patients with COVID-19 pneumonia: A retrospective study.",NA,"2021","07","23","Thromb Res","Thrombosis research",NA,"Lecompte","Thomas","Département de Médecine, Hôpitaux Universitaires de Genève, service d'angiologie et d'hémostase et Faculté de Médecine, Geneva Platelet Group (GpG), Université de Genève, Geneva, Switzerland",NA
"1695","34224999","10.1016/j.thromres.2021.06.009","Comparison of Fibrin Monomers and D-dimers to predict thrombotic events in critically ill patients with COVID-19 pneumonia: A retrospective study.",NA,"2021","07","23","Thromb Res","Thrombosis research",NA,"Mullier","François","Université catholique de Louvain, CHU UCL Namur, Hematology Laboratory, Namur Thrombosis and Hemostasis Center (NTHC), Namur Research Institute for Life Sciences (NARILIS), Yvoir, Belgium",NA
"1696","34224999","10.1016/j.thromres.2021.06.009","Comparison of Fibrin Monomers and D-dimers to predict thrombotic events in critically ill patients with COVID-19 pneumonia: A retrospective study.",NA,"2021","07","23","Thromb Res","Thrombosis research",NA,"Marlu","Raphaël","Université Grenoble Alpes, Hemostasis Laboratory, Centre Hospitalier Universitaire Grenoble-Alpes, Grenoble, France",NA
"1697","34224999","10.1016/j.thromres.2021.06.009","Comparison of Fibrin Monomers and D-dimers to predict thrombotic events in critically ill patients with COVID-19 pneumonia: A retrospective study.",NA,"2021","07","23","Thromb Res","Thrombosis research",NA,"de Maistre","Emmanuel","Haemostasis Lab, Centre Hospitalier Universitaire de Dijon, 36659 Dijon, Bourgogne, France",NA
"1698","34224999","10.1016/j.thromres.2021.06.009","Comparison of Fibrin Monomers and D-dimers to predict thrombotic events in critically ill patients with COVID-19 pneumonia: A retrospective study.",NA,"2021","07","23","Thromb Res","Thrombosis research",NA,"Tacquard","Charles","Department of Anesthesiology and Intensive Care, Hôpitaux Universitaires de Strasbourg, Strasbourg, France",NA
"1699","34224999","10.1016/j.thromres.2021.06.009","Comparison of Fibrin Monomers and D-dimers to predict thrombotic events in critically ill patients with COVID-19 pneumonia: A retrospective study.",NA,"2021","07","23","Thromb Res","Thrombosis research",NA,"Levy","Jerrold H","Departments of Anesthesiology, Critical Care, and Surgery, Duke University School of Medicine, Durham, NC, United States",NA
"1700","34224999","10.1016/j.thromres.2021.06.009","Comparison of Fibrin Monomers and D-dimers to predict thrombotic events in critically ill patients with COVID-19 pneumonia: A retrospective study.",NA,"2021","07","23","Thromb Res","Thrombosis research",NA,"Godier","Anne","Department of Anesthesiology and Critical Care, European Georges Pompidou Hospital, Assistance Publique-Hôpitaux de Paris, Paris University, Paris, France",NA
"1701","34224999","10.1016/j.thromres.2021.06.009","Comparison of Fibrin Monomers and D-dimers to predict thrombotic events in critically ill patients with COVID-19 pneumonia: A retrospective study.",NA,"2021","07","23","Thromb Res","Thrombosis research",NA,"Susen","Sophie","Heart and Lung Institute, Hemostasis Department, CHU Lille, 59037 Lille cedex, France",NA
"1702","34224999","10.1016/j.thromres.2021.06.009","Comparison of Fibrin Monomers and D-dimers to predict thrombotic events in critically ill patients with COVID-19 pneumonia: A retrospective study.",NA,"2021","07","23","Thromb Res","Thrombosis research",NA,"Albaladejo","Pierre","Department of Anesthesiology and Critical Care, Grenoble Alpes University Hospital, Grenoble, France",NA
"1703","34224994","10.1016/j.intimp.2021.107916","An investigation into the beneficial effects of high-dose interferon beta 1-a, compared to low-dose interferon beta 1-a in severe COVID-19: The COVIFERON II randomized controlled trial.","Coronavirus disease 2019 (COVID-19) has been a serious obstacle in front of public health. Interferon-beta 1a (IFN-ß 1a) has been used to treat patients with COVID-19. We aimed to compare the effectiveness of high-dose IFN-ß 1a compared to low dose IFN-ß 1a in severe COVID-19 cases. In this randomized, controlled, and clinical trial, eligible patients with confirmed SARS-CoV-2 infections were randomly assigned to receive one of the two following therapeutic regimens: The intervention group was t","2021","07","23","Int Immunopharmacol","International immunopharmacology","COVID-19; Interferon-ß 1a; Lopinavir/ritonavir; Randomized controlled trial; SARS-COV-2","Alavi Darazam","Ilad","Department of Infectious Diseases and Tropical Medicine, Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran","ilad13@yahoo.com"
"1704","34224994","10.1016/j.intimp.2021.107916","An investigation into the beneficial effects of high-dose interferon beta 1-a, compared to low-dose interferon beta 1-a in severe COVID-19: The COVIFERON II randomized controlled trial.","Coronavirus disease 2019 (COVID-19) has been a serious obstacle in front of public health. Interferon-beta 1a (IFN-ß 1a) has been used to treat patients with COVID-19. We aimed to compare the effectiveness of high-dose IFN-ß 1a compared to low dose IFN-ß 1a in severe COVID-19 cases. In this randomized, controlled, and clinical trial, eligible patients with confirmed SARS-CoV-2 infections were randomly assigned to receive one of the two following therapeutic regimens: The intervention group was t","2021","07","23","Int Immunopharmacol","International immunopharmacology","COVID-19; Interferon-ß 1a; Lopinavir/ritonavir; Randomized controlled trial; SARS-COV-2","Hatami","Firouze","Department of Infectious Diseases and Tropical Medicine, Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran",NA
"1705","34224994","10.1016/j.intimp.2021.107916","An investigation into the beneficial effects of high-dose interferon beta 1-a, compared to low-dose interferon beta 1-a in severe COVID-19: The COVIFERON II randomized controlled trial.","Coronavirus disease 2019 (COVID-19) has been a serious obstacle in front of public health. Interferon-beta 1a (IFN-ß 1a) has been used to treat patients with COVID-19. We aimed to compare the effectiveness of high-dose IFN-ß 1a compared to low dose IFN-ß 1a in severe COVID-19 cases. In this randomized, controlled, and clinical trial, eligible patients with confirmed SARS-CoV-2 infections were randomly assigned to receive one of the two following therapeutic regimens: The intervention group was t","2021","07","23","Int Immunopharmacol","International immunopharmacology","COVID-19; Interferon-ß 1a; Lopinavir/ritonavir; Randomized controlled trial; SARS-COV-2","Mahdi Rabiei","Mohammad","Department of Infectious Diseases and Tropical Medicine, Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran",NA
"1706","34224994","10.1016/j.intimp.2021.107916","An investigation into the beneficial effects of high-dose interferon beta 1-a, compared to low-dose interferon beta 1-a in severe COVID-19: The COVIFERON II randomized controlled trial.","Coronavirus disease 2019 (COVID-19) has been a serious obstacle in front of public health. Interferon-beta 1a (IFN-ß 1a) has been used to treat patients with COVID-19. We aimed to compare the effectiveness of high-dose IFN-ß 1a compared to low dose IFN-ß 1a in severe COVID-19 cases. In this randomized, controlled, and clinical trial, eligible patients with confirmed SARS-CoV-2 infections were randomly assigned to receive one of the two following therapeutic regimens: The intervention group was t","2021","07","23","Int Immunopharmacol","International immunopharmacology","COVID-19; Interferon-ß 1a; Lopinavir/ritonavir; Randomized controlled trial; SARS-COV-2","Amin Pourhoseingholi","Mohamad","SBMU (Shahid Beheshti University of Medical Sciences) Task Force on the COVIFERON",NA
"1707","34224994","10.1016/j.intimp.2021.107916","An investigation into the beneficial effects of high-dose interferon beta 1-a, compared to low-dose interferon beta 1-a in severe COVID-19: The COVIFERON II randomized controlled trial.","Coronavirus disease 2019 (COVID-19) has been a serious obstacle in front of public health. Interferon-beta 1a (IFN-ß 1a) has been used to treat patients with COVID-19. We aimed to compare the effectiveness of high-dose IFN-ß 1a compared to low dose IFN-ß 1a in severe COVID-19 cases. In this randomized, controlled, and clinical trial, eligible patients with confirmed SARS-CoV-2 infections were randomly assigned to receive one of the two following therapeutic regimens: The intervention group was t","2021","07","23","Int Immunopharmacol","International immunopharmacology","COVID-19; Interferon-ß 1a; Lopinavir/ritonavir; Randomized controlled trial; SARS-COV-2","Shabani","Minoosh","Department of Infectious Diseases and Tropical Medicine, Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran",NA
"1708","34224994","10.1016/j.intimp.2021.107916","An investigation into the beneficial effects of high-dose interferon beta 1-a, compared to low-dose interferon beta 1-a in severe COVID-19: The COVIFERON II randomized controlled trial.","Coronavirus disease 2019 (COVID-19) has been a serious obstacle in front of public health. Interferon-beta 1a (IFN-ß 1a) has been used to treat patients with COVID-19. We aimed to compare the effectiveness of high-dose IFN-ß 1a compared to low dose IFN-ß 1a in severe COVID-19 cases. In this randomized, controlled, and clinical trial, eligible patients with confirmed SARS-CoV-2 infections were randomly assigned to receive one of the two following therapeutic regimens: The intervention group was t","2021","07","23","Int Immunopharmacol","International immunopharmacology","COVID-19; Interferon-ß 1a; Lopinavir/ritonavir; Randomized controlled trial; SARS-COV-2","Shokouhi","Shervin","Department of Infectious Diseases and Tropical Medicine, Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran",NA
"1709","34224994","10.1016/j.intimp.2021.107916","An investigation into the beneficial effects of high-dose interferon beta 1-a, compared to low-dose interferon beta 1-a in severe COVID-19: The COVIFERON II randomized controlled trial.","Coronavirus disease 2019 (COVID-19) has been a serious obstacle in front of public health. Interferon-beta 1a (IFN-ß 1a) has been used to treat patients with COVID-19. We aimed to compare the effectiveness of high-dose IFN-ß 1a compared to low dose IFN-ß 1a in severe COVID-19 cases. In this randomized, controlled, and clinical trial, eligible patients with confirmed SARS-CoV-2 infections were randomly assigned to receive one of the two following therapeutic regimens: The intervention group was t","2021","07","23","Int Immunopharmacol","International immunopharmacology","COVID-19; Interferon-ß 1a; Lopinavir/ritonavir; Randomized controlled trial; SARS-COV-2","Mardani","Masoud","Department of Infectious Diseases and Tropical Medicine, Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran",NA
"1710","34224994","10.1016/j.intimp.2021.107916","An investigation into the beneficial effects of high-dose interferon beta 1-a, compared to low-dose interferon beta 1-a in severe COVID-19: The COVIFERON II randomized controlled trial.","Coronavirus disease 2019 (COVID-19) has been a serious obstacle in front of public health. Interferon-beta 1a (IFN-ß 1a) has been used to treat patients with COVID-19. We aimed to compare the effectiveness of high-dose IFN-ß 1a compared to low dose IFN-ß 1a in severe COVID-19 cases. In this randomized, controlled, and clinical trial, eligible patients with confirmed SARS-CoV-2 infections were randomly assigned to receive one of the two following therapeutic regimens: The intervention group was t","2021","07","23","Int Immunopharmacol","International immunopharmacology","COVID-19; Interferon-ß 1a; Lopinavir/ritonavir; Randomized controlled trial; SARS-COV-2","Moradi","Omid","SBMU (Shahid Beheshti University of Medical Sciences) Task Force on the COVIFERON",NA
"1711","34224994","10.1016/j.intimp.2021.107916","An investigation into the beneficial effects of high-dose interferon beta 1-a, compared to low-dose interferon beta 1-a in severe COVID-19: The COVIFERON II randomized controlled trial.","Coronavirus disease 2019 (COVID-19) has been a serious obstacle in front of public health. Interferon-beta 1a (IFN-ß 1a) has been used to treat patients with COVID-19. We aimed to compare the effectiveness of high-dose IFN-ß 1a compared to low dose IFN-ß 1a in severe COVID-19 cases. In this randomized, controlled, and clinical trial, eligible patients with confirmed SARS-CoV-2 infections were randomly assigned to receive one of the two following therapeutic regimens: The intervention group was t","2021","07","23","Int Immunopharmacol","International immunopharmacology","COVID-19; Interferon-ß 1a; Lopinavir/ritonavir; Randomized controlled trial; SARS-COV-2","Javandoust Gharehbagh","Farid","Infectious Diseases and Tropical Medicine Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran",NA
"1712","34224994","10.1016/j.intimp.2021.107916","An investigation into the beneficial effects of high-dose interferon beta 1-a, compared to low-dose interferon beta 1-a in severe COVID-19: The COVIFERON II randomized controlled trial.","Coronavirus disease 2019 (COVID-19) has been a serious obstacle in front of public health. Interferon-beta 1a (IFN-ß 1a) has been used to treat patients with COVID-19. We aimed to compare the effectiveness of high-dose IFN-ß 1a compared to low dose IFN-ß 1a in severe COVID-19 cases. In this randomized, controlled, and clinical trial, eligible patients with confirmed SARS-CoV-2 infections were randomly assigned to receive one of the two following therapeutic regimens: The intervention group was t","2021","07","23","Int Immunopharmacol","International immunopharmacology","COVID-19; Interferon-ß 1a; Lopinavir/ritonavir; Randomized controlled trial; SARS-COV-2","Mirtalaee","Nasrinsadat","Department of Infectious Diseases and Tropical Medicine, Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran",NA
"1713","34224994","10.1016/j.intimp.2021.107916","An investigation into the beneficial effects of high-dose interferon beta 1-a, compared to low-dose interferon beta 1-a in severe COVID-19: The COVIFERON II randomized controlled trial.","Coronavirus disease 2019 (COVID-19) has been a serious obstacle in front of public health. Interferon-beta 1a (IFN-ß 1a) has been used to treat patients with COVID-19. We aimed to compare the effectiveness of high-dose IFN-ß 1a compared to low dose IFN-ß 1a in severe COVID-19 cases. In this randomized, controlled, and clinical trial, eligible patients with confirmed SARS-CoV-2 infections were randomly assigned to receive one of the two following therapeutic regimens: The intervention group was t","2021","07","23","Int Immunopharmacol","International immunopharmacology","COVID-19; Interferon-ß 1a; Lopinavir/ritonavir; Randomized controlled trial; SARS-COV-2","Negahban","Halimeh","Department of Infectious Diseases and Tropical Medicine, Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran",NA
"1714","34224994","10.1016/j.intimp.2021.107916","An investigation into the beneficial effects of high-dose interferon beta 1-a, compared to low-dose interferon beta 1-a in severe COVID-19: The COVIFERON II randomized controlled trial.","Coronavirus disease 2019 (COVID-19) has been a serious obstacle in front of public health. Interferon-beta 1a (IFN-ß 1a) has been used to treat patients with COVID-19. We aimed to compare the effectiveness of high-dose IFN-ß 1a compared to low dose IFN-ß 1a in severe COVID-19 cases. In this randomized, controlled, and clinical trial, eligible patients with confirmed SARS-CoV-2 infections were randomly assigned to receive one of the two following therapeutic regimens: The intervention group was t","2021","07","23","Int Immunopharmacol","International immunopharmacology","COVID-19; Interferon-ß 1a; Lopinavir/ritonavir; Randomized controlled trial; SARS-COV-2","Amirdosara","Mahdi","SBMU (Shahid Beheshti University of Medical Sciences) Task Force on the COVIFERON",NA
"1715","34224994","10.1016/j.intimp.2021.107916","An investigation into the beneficial effects of high-dose interferon beta 1-a, compared to low-dose interferon beta 1-a in severe COVID-19: The COVIFERON II randomized controlled trial.","Coronavirus disease 2019 (COVID-19) has been a serious obstacle in front of public health. Interferon-beta 1a (IFN-ß 1a) has been used to treat patients with COVID-19. We aimed to compare the effectiveness of high-dose IFN-ß 1a compared to low dose IFN-ß 1a in severe COVID-19 cases. In this randomized, controlled, and clinical trial, eligible patients with confirmed SARS-CoV-2 infections were randomly assigned to receive one of the two following therapeutic regimens: The intervention group was t","2021","07","23","Int Immunopharmacol","International immunopharmacology","COVID-19; Interferon-ß 1a; Lopinavir/ritonavir; Randomized controlled trial; SARS-COV-2","Zangi","Masoud","Brain Mapping Research Center, Loghman Hakim Hospital, Shahid Beheshti University of Medical Science, Tehran, Iran",NA
"1716","34224994","10.1016/j.intimp.2021.107916","An investigation into the beneficial effects of high-dose interferon beta 1-a, compared to low-dose interferon beta 1-a in severe COVID-19: The COVIFERON II randomized controlled trial.","Coronavirus disease 2019 (COVID-19) has been a serious obstacle in front of public health. Interferon-beta 1a (IFN-ß 1a) has been used to treat patients with COVID-19. We aimed to compare the effectiveness of high-dose IFN-ß 1a compared to low dose IFN-ß 1a in severe COVID-19 cases. In this randomized, controlled, and clinical trial, eligible patients with confirmed SARS-CoV-2 infections were randomly assigned to receive one of the two following therapeutic regimens: The intervention group was t","2021","07","23","Int Immunopharmacol","International immunopharmacology","COVID-19; Interferon-ß 1a; Lopinavir/ritonavir; Randomized controlled trial; SARS-COV-2","Hajiesmaeili","Mohammadreza","SBMU (Shahid Beheshti University of Medical Sciences) Task Force on the COVIFERON",NA
"1717","34224994","10.1016/j.intimp.2021.107916","An investigation into the beneficial effects of high-dose interferon beta 1-a, compared to low-dose interferon beta 1-a in severe COVID-19: The COVIFERON II randomized controlled trial.","Coronavirus disease 2019 (COVID-19) has been a serious obstacle in front of public health. Interferon-beta 1a (IFN-ß 1a) has been used to treat patients with COVID-19. We aimed to compare the effectiveness of high-dose IFN-ß 1a compared to low dose IFN-ß 1a in severe COVID-19 cases. In this randomized, controlled, and clinical trial, eligible patients with confirmed SARS-CoV-2 infections were randomly assigned to receive one of the two following therapeutic regimens: The intervention group was t","2021","07","23","Int Immunopharmacol","International immunopharmacology","COVID-19; Interferon-ß 1a; Lopinavir/ritonavir; Randomized controlled trial; SARS-COV-2","Kazempour","Muhanna","SBMU (Shahid Beheshti University of Medical Sciences) Task Force on the COVIFERON",NA
"1718","34224994","10.1016/j.intimp.2021.107916","An investigation into the beneficial effects of high-dose interferon beta 1-a, compared to low-dose interferon beta 1-a in severe COVID-19: The COVIFERON II randomized controlled trial.","Coronavirus disease 2019 (COVID-19) has been a serious obstacle in front of public health. Interferon-beta 1a (IFN-ß 1a) has been used to treat patients with COVID-19. We aimed to compare the effectiveness of high-dose IFN-ß 1a compared to low dose IFN-ß 1a in severe COVID-19 cases. In this randomized, controlled, and clinical trial, eligible patients with confirmed SARS-CoV-2 infections were randomly assigned to receive one of the two following therapeutic regimens: The intervention group was t","2021","07","23","Int Immunopharmacol","International immunopharmacology","COVID-19; Interferon-ß 1a; Lopinavir/ritonavir; Randomized controlled trial; SARS-COV-2","Shafigh","Navid","SBMU (Shahid Beheshti University of Medical Sciences) Task Force on the COVIFERON",NA
"1719","34224950","10.1016/j.clinimag.2021.06.035","Modern radiation techniques in early stage breast cancer for the breast radiologist.","Partial breast irradiation (PBI) and ultra-hypofractionated whole breast irradiation (uWBI) are contemporary alternatives to conventional and standard hypofractionated whole breast irradiation (WBI), which shorten treatment from 3 to 6 weeks to 1-2 weeks for select patients. PBI and accelerated PBI (APBI) can be delivered with external beam radiation (3D conformal radiation therapy (3D-CRT) or intensity modulated radiation therapy (IMRT)), intraoperative radiation (IORT), or brachytherapy. These","2021","07","24","Clin Imaging","Clinical imaging","Accelerated partial breast irradiation; Breast; Imaging; Radiotherapy; Ultra-hypofractionation","Jones","Brianna M","Icahn School of Medicine at Mount Sinai, United States of America. Electronic address: Brianna.jones@mountsinai","Brianna.jones@mountsinai.org"
"1720","34224950","10.1016/j.clinimag.2021.06.035","Modern radiation techniques in early stage breast cancer for the breast radiologist.","Partial breast irradiation (PBI) and ultra-hypofractionated whole breast irradiation (uWBI) are contemporary alternatives to conventional and standard hypofractionated whole breast irradiation (WBI), which shorten treatment from 3 to 6 weeks to 1-2 weeks for select patients. PBI and accelerated PBI (APBI) can be delivered with external beam radiation (3D conformal radiation therapy (3D-CRT) or intensity modulated radiation therapy (IMRT)), intraoperative radiation (IORT), or brachytherapy. These","2021","07","24","Clin Imaging","Clinical imaging","Accelerated partial breast irradiation; Breast; Imaging; Radiotherapy; Ultra-hypofractionation","Green","Sheryl","Icahn School of Medicine at Mount Sinai, United States of America. Electronic address: Sheryl.green@mountsinai","Sheryl.green@mountsinai.org"
"1721","34224948","10.1016/j.epidem.2021.100476","Modelling SARS-CoV-2 transmission in a UK university setting.","Around 40% of school leavers in the UK attend university and individual universities generally host thousands of students each academic year. Bringing together these student communities during the COVID-19 pandemic may require strong interventions to control transmission. Prior modelling analyses of SARS-CoV-2 transmission within universities using compartmental modelling approaches suggest that outbreaks are almost inevitable. We constructed a network-based model to capture the interactions of ","2021","07","21","Epidemics","Epidemics","COVID-19; Infectious disease model; Mathematical epidemiology; SARS-CoV-2; Universities","Hill","Edward M","The Zeeman Institute for Systems Biology &amp","Edward.Hill@warwick.ac.uk"
"1722","34224948","10.1016/j.epidem.2021.100476","Modelling SARS-CoV-2 transmission in a UK university setting.","Around 40% of school leavers in the UK attend university and individual universities generally host thousands of students each academic year. Bringing together these student communities during the COVID-19 pandemic may require strong interventions to control transmission. Prior modelling analyses of SARS-CoV-2 transmission within universities using compartmental modelling approaches suggest that outbreaks are almost inevitable. We constructed a network-based model to capture the interactions of ","2021","07","21","Epidemics","Epidemics","COVID-19; Infectious disease model; Mathematical epidemiology; SARS-CoV-2; Universities","Atkins","Benjamin D","The Zeeman Institute for Systems Biology &amp",NA
"1723","34224948","10.1016/j.epidem.2021.100476","Modelling SARS-CoV-2 transmission in a UK university setting.","Around 40% of school leavers in the UK attend university and individual universities generally host thousands of students each academic year. Bringing together these student communities during the COVID-19 pandemic may require strong interventions to control transmission. Prior modelling analyses of SARS-CoV-2 transmission within universities using compartmental modelling approaches suggest that outbreaks are almost inevitable. We constructed a network-based model to capture the interactions of ","2021","07","21","Epidemics","Epidemics","COVID-19; Infectious disease model; Mathematical epidemiology; SARS-CoV-2; Universities","Keeling","Matt J","The Zeeman Institute for Systems Biology &amp",NA
"1724","34224948","10.1016/j.epidem.2021.100476","Modelling SARS-CoV-2 transmission in a UK university setting.","Around 40% of school leavers in the UK attend university and individual universities generally host thousands of students each academic year. Bringing together these student communities during the COVID-19 pandemic may require strong interventions to control transmission. Prior modelling analyses of SARS-CoV-2 transmission within universities using compartmental modelling approaches suggest that outbreaks are almost inevitable. We constructed a network-based model to capture the interactions of ","2021","07","21","Epidemics","Epidemics","COVID-19; Infectious disease model; Mathematical epidemiology; SARS-CoV-2; Universities","Tildesley","Michael J","The Zeeman Institute for Systems Biology &amp",NA
"1725","34224948","10.1016/j.epidem.2021.100476","Modelling SARS-CoV-2 transmission in a UK university setting.","Around 40% of school leavers in the UK attend university and individual universities generally host thousands of students each academic year. Bringing together these student communities during the COVID-19 pandemic may require strong interventions to control transmission. Prior modelling analyses of SARS-CoV-2 transmission within universities using compartmental modelling approaches suggest that outbreaks are almost inevitable. We constructed a network-based model to capture the interactions of ","2021","07","21","Epidemics","Epidemics","COVID-19; Infectious disease model; Mathematical epidemiology; SARS-CoV-2; Universities","Dyson","Louise","The Zeeman Institute for Systems Biology &amp",NA
"1726","34224947","10.1016/j.dsx.2021.102192","Clinical characteristics and outcomes of COVID-19 patients with prediabetes.","We aimed to examine the clinical characteristics and outcomes of coronavirus disease 2019 (COVID-19) patients with prediabetes. This was a retrospective cohort study of 102 COVID-19 patients admitted to a tertiary care hospital in India between May and October 2020. Most patients had a poor clinical profile on admission. They had high rates of invasive mechanical ventilation (48%), intensive care unit admission (48%), complications (72.6%), and mortality (32.4%). People with prediabetes are at h","2021","07","19","Diabetes Metab Syndr","Diabetes &amp; metabolic syndrome","COVID-19; Diabetes; HbA1c; Mortality; Prediabetes; Severity","Chandrasekaran","Nirmala Devi","Department of General Medicine, Chettinad Hospital and Research Institute, Kelambakkam, Tamil Nadu, India",NA
"1727","34224947","10.1016/j.dsx.2021.102192","Clinical characteristics and outcomes of COVID-19 patients with prediabetes.","We aimed to examine the clinical characteristics and outcomes of coronavirus disease 2019 (COVID-19) patients with prediabetes. This was a retrospective cohort study of 102 COVID-19 patients admitted to a tertiary care hospital in India between May and October 2020. Most patients had a poor clinical profile on admission. They had high rates of invasive mechanical ventilation (48%), intensive care unit admission (48%), complications (72.6%), and mortality (32.4%). People with prediabetes are at h","2021","07","19","Diabetes Metab Syndr","Diabetes &amp; metabolic syndrome","COVID-19; Diabetes; HbA1c; Mortality; Prediabetes; Severity","Velure Raja Rao","Mohan Rao","Population Health Research Institute, McMaster University, Hamilton, Ontario, Canada",NA
"1728","34224947","10.1016/j.dsx.2021.102192","Clinical characteristics and outcomes of COVID-19 patients with prediabetes.","We aimed to examine the clinical characteristics and outcomes of coronavirus disease 2019 (COVID-19) patients with prediabetes. This was a retrospective cohort study of 102 COVID-19 patients admitted to a tertiary care hospital in India between May and October 2020. Most patients had a poor clinical profile on admission. They had high rates of invasive mechanical ventilation (48%), intensive care unit admission (48%), complications (72.6%), and mortality (32.4%). People with prediabetes are at h","2021","07","19","Diabetes Metab Syndr","Diabetes &amp; metabolic syndrome","COVID-19; Diabetes; HbA1c; Mortality; Prediabetes; Severity","Sathish","Thirunavukkarasu","Population Health Research Institute, McMaster University, Hamilton, Ontario, Canada. Electronic address: speaktosat@gmail","speaktosat@gmail.com"
"1729","34224946","10.1016/j.dsx.2021.06.020","COVID-19 and importance of air filtration.",NA,"2021","07","19","Diabetes Metab Syndr","Diabetes &amp; metabolic syndrome","Air filtration; COVID-19; Indoor environment; Infection control; Review","Kapilan","N","Nitte Meenakshi Institute of Technology, Bangalore, India. Electronic address: kapil_krecmech@yahoo","krecmech@yahoo.com"
"1730","34224946","10.1016/j.dsx.2021.06.020","COVID-19 and importance of air filtration.",NA,"2021","07","19","Diabetes Metab Syndr","Diabetes &amp; metabolic syndrome","Air filtration; COVID-19; Indoor environment; Infection control; Review","Rao","Lakshmi Nidhi","A B Shetty Memorial Institute of Dental Science, Nitte Deemed to be University, Mangalore, India",NA
"1731","34224944","10.1016/j.diagmicrobio.2021.115449","Evaluation of 2 commercial anti-SARS-CoV-2 antibody assays in an immunocompetent and immunocompromised inpatient population with COVID-19.","During the COVID-19 pandemic, widespread introduction of SARS-CoV-2 antibody testing was introduced without a full understanding of the assays performance or the antibody kinetics following infection with SARS-CoV-2. We performed an evaluation of 2 anti-SARS-CoV-2 antibody assays with a more detailed look into the effect of immune status on antibody sensitivity. Both assays demonstrated 100% specificity. The overall sensitivity of the Roche was 92.1% at =14 days and 94.8% at =21 days, and the ov","2021","07","21","Diagn Microbiol Infect Dis","Diagnostic microbiology and infectious disease","Anti-SARSCoV-2 Antibody; Antibody waning; COVID-19; Immunocompromised; Immunosuppressed; SARS-CoV-2","Harrington","David","Department of Virology, Barts Health NHS Trust, London, UK. Electronic address: davidharrington@nhs","davidharrington@nhs.net"
"1732","34224944","10.1016/j.diagmicrobio.2021.115449","Evaluation of 2 commercial anti-SARS-CoV-2 antibody assays in an immunocompetent and immunocompromised inpatient population with COVID-19.","During the COVID-19 pandemic, widespread introduction of SARS-CoV-2 antibody testing was introduced without a full understanding of the assays performance or the antibody kinetics following infection with SARS-CoV-2. We performed an evaluation of 2 anti-SARS-CoV-2 antibody assays with a more detailed look into the effect of immune status on antibody sensitivity. Both assays demonstrated 100% specificity. The overall sensitivity of the Roche was 92.1% at =14 days and 94.8% at =21 days, and the ov","2021","07","21","Diagn Microbiol Infect Dis","Diagnostic microbiology and infectious disease","Anti-SARSCoV-2 Antibody; Antibody waning; COVID-19; Immunocompromised; Immunosuppressed; SARS-CoV-2","Azim","Tahira","Department of Virology, Barts Health NHS Trust, London, UK",NA
"1733","34224944","10.1016/j.diagmicrobio.2021.115449","Evaluation of 2 commercial anti-SARS-CoV-2 antibody assays in an immunocompetent and immunocompromised inpatient population with COVID-19.","During the COVID-19 pandemic, widespread introduction of SARS-CoV-2 antibody testing was introduced without a full understanding of the assays performance or the antibody kinetics following infection with SARS-CoV-2. We performed an evaluation of 2 anti-SARS-CoV-2 antibody assays with a more detailed look into the effect of immune status on antibody sensitivity. Both assays demonstrated 100% specificity. The overall sensitivity of the Roche was 92.1% at =14 days and 94.8% at =21 days, and the ov","2021","07","21","Diagn Microbiol Infect Dis","Diagnostic microbiology and infectious disease","Anti-SARSCoV-2 Antibody; Antibody waning; COVID-19; Immunocompromised; Immunosuppressed; SARS-CoV-2","Rosmarin","Caryn","Division of Infection, Barts Health NHS Trust, London, UK",NA
"1734","34224944","10.1016/j.diagmicrobio.2021.115449","Evaluation of 2 commercial anti-SARS-CoV-2 antibody assays in an immunocompetent and immunocompromised inpatient population with COVID-19.","During the COVID-19 pandemic, widespread introduction of SARS-CoV-2 antibody testing was introduced without a full understanding of the assays performance or the antibody kinetics following infection with SARS-CoV-2. We performed an evaluation of 2 anti-SARS-CoV-2 antibody assays with a more detailed look into the effect of immune status on antibody sensitivity. Both assays demonstrated 100% specificity. The overall sensitivity of the Roche was 92.1% at =14 days and 94.8% at =21 days, and the ov","2021","07","21","Diagn Microbiol Infect Dis","Diagnostic microbiology and infectious disease","Anti-SARSCoV-2 Antibody; Antibody waning; COVID-19; Immunocompromised; Immunosuppressed; SARS-CoV-2","Cutino-Moguel","Teresa","Department of Virology, Barts Health NHS Trust, London, UK",NA
"1735","34224944","10.1016/j.diagmicrobio.2021.115449","Evaluation of 2 commercial anti-SARS-CoV-2 antibody assays in an immunocompetent and immunocompromised inpatient population with COVID-19.","During the COVID-19 pandemic, widespread introduction of SARS-CoV-2 antibody testing was introduced without a full understanding of the assays performance or the antibody kinetics following infection with SARS-CoV-2. We performed an evaluation of 2 anti-SARS-CoV-2 antibody assays with a more detailed look into the effect of immune status on antibody sensitivity. Both assays demonstrated 100% specificity. The overall sensitivity of the Roche was 92.1% at =14 days and 94.8% at =21 days, and the ov","2021","07","21","Diagn Microbiol Infect Dis","Diagnostic microbiology and infectious disease","Anti-SARSCoV-2 Antibody; Antibody waning; COVID-19; Immunocompromised; Immunosuppressed; SARS-CoV-2","Hopkins","Mark","Department of Virology, Barts Health NHS Trust, London, UK",NA
"1736","34224924","10.1016/j.jaip.2021.06.032","Safety of BNT162b2 mRNA COVID-19 vaccine in patients with mast cell disorders.",NA,"2021","07","17","J Allergy Clin Immunol Pract","The journal of allergy and clinical immunology. In practice",NA,"Rosman","Yossi","Allergy and Clinical Immunology Unit, Meir General Hospital, Kfar-Saba, Israel","yossi.rosman@clalit.org.il"
"1737","34224924","10.1016/j.jaip.2021.06.032","Safety of BNT162b2 mRNA COVID-19 vaccine in patients with mast cell disorders.",NA,"2021","07","17","J Allergy Clin Immunol Pract","The journal of allergy and clinical immunology. In practice",NA,"Lavi","Noa","Hematology Division, Rambam Medical Center, Haifa, Israel",NA
"1738","34224924","10.1016/j.jaip.2021.06.032","Safety of BNT162b2 mRNA COVID-19 vaccine in patients with mast cell disorders.",NA,"2021","07","17","J Allergy Clin Immunol Pract","The journal of allergy and clinical immunology. In practice",NA,"Meir-Shafrir","Keren","Allergy and Clinical Immunology Unit, Meir General Hospital, Kfar-Saba, Israel",NA
"1739","34224924","10.1016/j.jaip.2021.06.032","Safety of BNT162b2 mRNA COVID-19 vaccine in patients with mast cell disorders.",NA,"2021","07","17","J Allergy Clin Immunol Pract","The journal of allergy and clinical immunology. In practice",NA,"Lachover-Roth","Idit","Allergy and Clinical Immunology Unit, Meir General Hospital, Kfar-Saba, Israel",NA
"1740","34224924","10.1016/j.jaip.2021.06.032","Safety of BNT162b2 mRNA COVID-19 vaccine in patients with mast cell disorders.",NA,"2021","07","17","J Allergy Clin Immunol Pract","The journal of allergy and clinical immunology. In practice",NA,"Cohen-Engler","Anat","Allergy and Clinical Immunology Unit, Meir General Hospital, Kfar-Saba, Israel",NA
"1741","34224924","10.1016/j.jaip.2021.06.032","Safety of BNT162b2 mRNA COVID-19 vaccine in patients with mast cell disorders.",NA,"2021","07","17","J Allergy Clin Immunol Pract","The journal of allergy and clinical immunology. In practice",NA,"Mekori","Yoseph A","Allergy and Clinical Immunology Unit, Meir General Hospital, Kfar-Saba, Israel",NA
"1742","34224924","10.1016/j.jaip.2021.06.032","Safety of BNT162b2 mRNA COVID-19 vaccine in patients with mast cell disorders.",NA,"2021","07","17","J Allergy Clin Immunol Pract","The journal of allergy and clinical immunology. In practice",NA,"Confino-Cohen","Ronit","Allergy and Clinical Immunology Unit, Meir General Hospital, Kfar-Saba, Israel",NA
"1743","34224908","10.1016/j.parint.2021.102417","SARS-CoV-2 infection and parasitic diseases: A possible role for microbiome interaction?",NA,"2021","07","10","Parasitol Int","Parasitology international","Amebiasis; COVID-19; Entamoeba histolytica; Microbiome; SARS-CoV-2","Montrucchio","Giorgia","Department of Surgical Sciences, University of Turin, Turin, Italy","g.montrucchio@gmail.com"
"1744","34224908","10.1016/j.parint.2021.102417","SARS-CoV-2 infection and parasitic diseases: A possible role for microbiome interaction?",NA,"2021","07","10","Parasitol Int","Parasitology international","Amebiasis; COVID-19; Entamoeba histolytica; Microbiome; SARS-CoV-2","Pomero","Fulvio","Department of Internal Medicine, Michele e Pietro Ferrero Hospital, Verduno, (CN), Italy",NA
"1745","34224908","10.1016/j.parint.2021.102417","SARS-CoV-2 infection and parasitic diseases: A possible role for microbiome interaction?",NA,"2021","07","10","Parasitol Int","Parasitology international","Amebiasis; COVID-19; Entamoeba histolytica; Microbiome; SARS-CoV-2","Perotto","Massimo","Department of Internal Medicine, Michele e Pietro Ferrero Hospital, Verduno, (CN), Italy",NA
"1746","34224908","10.1016/j.parint.2021.102417","SARS-CoV-2 infection and parasitic diseases: A possible role for microbiome interaction?",NA,"2021","07","10","Parasitol Int","Parasitology international","Amebiasis; COVID-19; Entamoeba histolytica; Microbiome; SARS-CoV-2","Fanti","Edoardo","Department of Internal Medicine, Michele e Pietro Ferrero Hospital, Verduno, (CN), Italy",NA
"1747","34224908","10.1016/j.parint.2021.102417","SARS-CoV-2 infection and parasitic diseases: A possible role for microbiome interaction?",NA,"2021","07","10","Parasitol Int","Parasitology international","Amebiasis; COVID-19; Entamoeba histolytica; Microbiome; SARS-CoV-2","Brazzi","Luca","Department of Surgical Sciences, University of Turin, Turin, Italy",NA
"1748","34224898","10.1016/j.jbi.2021.103861","Visual Comprehension and Orientation into the COVID-19 CIDO Ontology.","The current intensive research on potential remedies and vaccinations for COVID-19 would greatly benefit from an ontology of standardized COVID terms. The Coronavirus Infectious Disease Ontology (CIDO) is the largest among several COVID ontologies, and it keeps growing, but it is still a medium sized ontology. Sophisticated CIDO users, who need more than searching for a specific concept, require orientation and comprehension of CIDO. In previous research, we designed a summarization network call","2021","07","08","J Biomed Inform","Journal of biomedical informatics","Coronavirus Infectious Disease Ontology; comprehension of an ontology; ontology orientation; ontology summarization; ontology visualization; summarization networks","Zheng","Ling","Computer Science and Software Engineering Department, Monmouth University, West Long Branch, NJ, USA. Electronic address: lzheng@monmouth","lzheng@monmouth.edu"
"1749","34224898","10.1016/j.jbi.2021.103861","Visual Comprehension and Orientation into the COVID-19 CIDO Ontology.","The current intensive research on potential remedies and vaccinations for COVID-19 would greatly benefit from an ontology of standardized COVID terms. The Coronavirus Infectious Disease Ontology (CIDO) is the largest among several COVID ontologies, and it keeps growing, but it is still a medium sized ontology. Sophisticated CIDO users, who need more than searching for a specific concept, require orientation and comprehension of CIDO. In previous research, we designed a summarization network call","2021","07","08","J Biomed Inform","Journal of biomedical informatics","Coronavirus Infectious Disease Ontology; comprehension of an ontology; ontology orientation; ontology summarization; ontology visualization; summarization networks","Perl","Yehoshua","Department of Computer Science, New Jersey Institute of Technology, Newark, NJ, USA",NA
"1750","34224898","10.1016/j.jbi.2021.103861","Visual Comprehension and Orientation into the COVID-19 CIDO Ontology.","The current intensive research on potential remedies and vaccinations for COVID-19 would greatly benefit from an ontology of standardized COVID terms. The Coronavirus Infectious Disease Ontology (CIDO) is the largest among several COVID ontologies, and it keeps growing, but it is still a medium sized ontology. Sophisticated CIDO users, who need more than searching for a specific concept, require orientation and comprehension of CIDO. In previous research, we designed a summarization network call","2021","07","08","J Biomed Inform","Journal of biomedical informatics","Coronavirus Infectious Disease Ontology; comprehension of an ontology; ontology orientation; ontology summarization; ontology visualization; summarization networks","He","Yongqun","Department of Computational Medicine and Bioinformatics, University of Michigan Medical School, Ann Arbor, MI, USA",NA
"1751","34224898","10.1016/j.jbi.2021.103861","Visual Comprehension and Orientation into the COVID-19 CIDO Ontology.","The current intensive research on potential remedies and vaccinations for COVID-19 would greatly benefit from an ontology of standardized COVID terms. The Coronavirus Infectious Disease Ontology (CIDO) is the largest among several COVID ontologies, and it keeps growing, but it is still a medium sized ontology. Sophisticated CIDO users, who need more than searching for a specific concept, require orientation and comprehension of CIDO. In previous research, we designed a summarization network call","2021","07","08","J Biomed Inform","Journal of biomedical informatics","Coronavirus Infectious Disease Ontology; comprehension of an ontology; ontology orientation; ontology summarization; ontology visualization; summarization networks","Ochs","Christopher","Nokia Bell Labs, Murray Hills, NJ, USA",NA
"1752","34224898","10.1016/j.jbi.2021.103861","Visual Comprehension and Orientation into the COVID-19 CIDO Ontology.","The current intensive research on potential remedies and vaccinations for COVID-19 would greatly benefit from an ontology of standardized COVID terms. The Coronavirus Infectious Disease Ontology (CIDO) is the largest among several COVID ontologies, and it keeps growing, but it is still a medium sized ontology. Sophisticated CIDO users, who need more than searching for a specific concept, require orientation and comprehension of CIDO. In previous research, we designed a summarization network call","2021","07","08","J Biomed Inform","Journal of biomedical informatics","Coronavirus Infectious Disease Ontology; comprehension of an ontology; ontology orientation; ontology summarization; ontology visualization; summarization networks","Geller","James","Department of Computer Science, New Jersey Institute of Technology, Newark, NJ, USA",NA
"1753","34224898","10.1016/j.jbi.2021.103861","Visual Comprehension and Orientation into the COVID-19 CIDO Ontology.","The current intensive research on potential remedies and vaccinations for COVID-19 would greatly benefit from an ontology of standardized COVID terms. The Coronavirus Infectious Disease Ontology (CIDO) is the largest among several COVID ontologies, and it keeps growing, but it is still a medium sized ontology. Sophisticated CIDO users, who need more than searching for a specific concept, require orientation and comprehension of CIDO. In previous research, we designed a summarization network call","2021","07","08","J Biomed Inform","Journal of biomedical informatics","Coronavirus Infectious Disease Ontology; comprehension of an ontology; ontology orientation; ontology summarization; ontology visualization; summarization networks","Liu","Hao","Columbia University Irving Medical Center, New York, NY, USA",NA
"1754","34224898","10.1016/j.jbi.2021.103861","Visual Comprehension and Orientation into the COVID-19 CIDO Ontology.","The current intensive research on potential remedies and vaccinations for COVID-19 would greatly benefit from an ontology of standardized COVID terms. The Coronavirus Infectious Disease Ontology (CIDO) is the largest among several COVID ontologies, and it keeps growing, but it is still a medium sized ontology. Sophisticated CIDO users, who need more than searching for a specific concept, require orientation and comprehension of CIDO. In previous research, we designed a summarization network call","2021","07","08","J Biomed Inform","Journal of biomedical informatics","Coronavirus Infectious Disease Ontology; comprehension of an ontology; ontology orientation; ontology summarization; ontology visualization; summarization networks","Keloth","Vipina K","Department of Computer Science, New Jersey Institute of Technology, Newark, NJ, USA",NA
"1755","34224882","10.1016/j.wneu.2021.06.120","Predictors of Telemedicine Utilization in a Pediatric Neurosurgical Population During the COVID-19 Pandemic.","In the wake of the COVID-19 pandemic, telemedicine has become rapidly adopted by the neurosurgical community; however, few studies have examined predictors of telemedicine utilization. Here, we analyze patient variables associated with the acceptance of a telemedicine encounter by a pediatric neurosurgical population during the early phases of the COVID-19 pandemic. All patients seen in a single institution's outpatient pediatric neurosurgery clinic between April 1, 2020 and July 31, 2020 were r","2021","07","23","World Neurosurg","World neurosurgery","COVID-19; Pediatric neurosurgery; Telehealth; Telemedicine","Lambert","William A","UConn School of Medicine, Farmington, Connecticut, USA",NA
"1756","34224882","10.1016/j.wneu.2021.06.120","Predictors of Telemedicine Utilization in a Pediatric Neurosurgical Population During the COVID-19 Pandemic.","In the wake of the COVID-19 pandemic, telemedicine has become rapidly adopted by the neurosurgical community; however, few studies have examined predictors of telemedicine utilization. Here, we analyze patient variables associated with the acceptance of a telemedicine encounter by a pediatric neurosurgical population during the early phases of the COVID-19 pandemic. All patients seen in a single institution's outpatient pediatric neurosurgery clinic between April 1, 2020 and July 31, 2020 were r","2021","07","23","World Neurosurg","World neurosurgery","COVID-19; Pediatric neurosurgery; Telehealth; Telemedicine","Leclair","Nathan K","UConn School of Medicine, Farmington, Connecticut, USA",NA
"1757","34224882","10.1016/j.wneu.2021.06.120","Predictors of Telemedicine Utilization in a Pediatric Neurosurgical Population During the COVID-19 Pandemic.","In the wake of the COVID-19 pandemic, telemedicine has become rapidly adopted by the neurosurgical community; however, few studies have examined predictors of telemedicine utilization. Here, we analyze patient variables associated with the acceptance of a telemedicine encounter by a pediatric neurosurgical population during the early phases of the COVID-19 pandemic. All patients seen in a single institution's outpatient pediatric neurosurgery clinic between April 1, 2020 and July 31, 2020 were r","2021","07","23","World Neurosurg","World neurosurgery","COVID-19; Pediatric neurosurgery; Telehealth; Telemedicine","Knopf","Joshua","UConn School of Medicine, Farmington, Connecticut, USA",NA
"1758","34224882","10.1016/j.wneu.2021.06.120","Predictors of Telemedicine Utilization in a Pediatric Neurosurgical Population During the COVID-19 Pandemic.","In the wake of the COVID-19 pandemic, telemedicine has become rapidly adopted by the neurosurgical community; however, few studies have examined predictors of telemedicine utilization. Here, we analyze patient variables associated with the acceptance of a telemedicine encounter by a pediatric neurosurgical population during the early phases of the COVID-19 pandemic. All patients seen in a single institution's outpatient pediatric neurosurgery clinic between April 1, 2020 and July 31, 2020 were r","2021","07","23","World Neurosurg","World neurosurgery","COVID-19; Pediatric neurosurgery; Telehealth; Telemedicine","Mosha","Maua H","Department of Research, Connecticut Children's, Hartford, Connecticut, USA",NA
"1759","34224882","10.1016/j.wneu.2021.06.120","Predictors of Telemedicine Utilization in a Pediatric Neurosurgical Population During the COVID-19 Pandemic.","In the wake of the COVID-19 pandemic, telemedicine has become rapidly adopted by the neurosurgical community; however, few studies have examined predictors of telemedicine utilization. Here, we analyze patient variables associated with the acceptance of a telemedicine encounter by a pediatric neurosurgical population during the early phases of the COVID-19 pandemic. All patients seen in a single institution's outpatient pediatric neurosurgery clinic between April 1, 2020 and July 31, 2020 were r","2021","07","23","World Neurosurg","World neurosurgery","COVID-19; Pediatric neurosurgery; Telehealth; Telemedicine","Bookland","Markus J","Departments of Surgery, UConn School of Medicine, Farmington, Connecticut, USA",NA
"1760","34224882","10.1016/j.wneu.2021.06.120","Predictors of Telemedicine Utilization in a Pediatric Neurosurgical Population During the COVID-19 Pandemic.","In the wake of the COVID-19 pandemic, telemedicine has become rapidly adopted by the neurosurgical community; however, few studies have examined predictors of telemedicine utilization. Here, we analyze patient variables associated with the acceptance of a telemedicine encounter by a pediatric neurosurgical population during the early phases of the COVID-19 pandemic. All patients seen in a single institution's outpatient pediatric neurosurgery clinic between April 1, 2020 and July 31, 2020 were r","2021","07","23","World Neurosurg","World neurosurgery","COVID-19; Pediatric neurosurgery; Telehealth; Telemedicine","Martin","Jonathan E","Departments of Surgery, UConn School of Medicine, Farmington, Connecticut, USA",NA
"1761","34224882","10.1016/j.wneu.2021.06.120","Predictors of Telemedicine Utilization in a Pediatric Neurosurgical Population During the COVID-19 Pandemic.","In the wake of the COVID-19 pandemic, telemedicine has become rapidly adopted by the neurosurgical community; however, few studies have examined predictors of telemedicine utilization. Here, we analyze patient variables associated with the acceptance of a telemedicine encounter by a pediatric neurosurgical population during the early phases of the COVID-19 pandemic. All patients seen in a single institution's outpatient pediatric neurosurgery clinic between April 1, 2020 and July 31, 2020 were r","2021","07","23","World Neurosurg","World neurosurgery","COVID-19; Pediatric neurosurgery; Telehealth; Telemedicine","Hersh","David S","Departments of Surgery, UConn School of Medicine, Farmington, Connecticut, USA","dhersh@connecticutchildrens.org"
"1762","34224870","10.1016/j.ijid.2021.06.063","Prevalence of and factors associated with long-term COVID-19 sick leave in working-age patients followed in general practices in Germany.","To investigate the prevalence of and the factors associated with long-term sick leave in working-age patients diagnosed with coronavirus disease (COVID-19) in general practices in Germany. Patients aged 18-65 years who were diagnosed with COVID-19 in one of 1,255 general practices in Germany between March 2020 and February 2021 were included in this study. Long-term sick leave was defined as sick leave of at least four weeks. The association between these independent variables and long-term sick","2021","07","05","Int J Infect Dis","International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases","COVID-19; Germany; coronavirus disease; general practices; long-term sick leave","Jacob","Louis","Research and Development Unit, Parc Sanitari Sant Joan de Déu, CIBERSAM, Dr. Antoni Pujadas, 42, Sant Boi de Llobregat, Barcelona 08830, Spain",NA
"1763","34224870","10.1016/j.ijid.2021.06.063","Prevalence of and factors associated with long-term COVID-19 sick leave in working-age patients followed in general practices in Germany.","To investigate the prevalence of and the factors associated with long-term sick leave in working-age patients diagnosed with coronavirus disease (COVID-19) in general practices in Germany. Patients aged 18-65 years who were diagnosed with COVID-19 in one of 1,255 general practices in Germany between March 2020 and February 2021 were included in this study. Long-term sick leave was defined as sick leave of at least four weeks. The association between these independent variables and long-term sick","2021","07","05","Int J Infect Dis","International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases","COVID-19; Germany; coronavirus disease; general practices; long-term sick leave","Koyanagi","Ai","Institució Catalana de Recerca i Estudis Avançats (ICREA), Pg. Lluis Companys 23, 08010 Barcelona, Spain",NA
"1764","34224870","10.1016/j.ijid.2021.06.063","Prevalence of and factors associated with long-term COVID-19 sick leave in working-age patients followed in general practices in Germany.","To investigate the prevalence of and the factors associated with long-term sick leave in working-age patients diagnosed with coronavirus disease (COVID-19) in general practices in Germany. Patients aged 18-65 years who were diagnosed with COVID-19 in one of 1,255 general practices in Germany between March 2020 and February 2021 were included in this study. Long-term sick leave was defined as sick leave of at least four weeks. The association between these independent variables and long-term sick","2021","07","05","Int J Infect Dis","International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases","COVID-19; Germany; coronavirus disease; general practices; long-term sick leave","Smith","Lee","The Cambridge Centre for Sport and Exercise Sciences, Anglia Ruskin University, Cambridge, UK",NA
"1765","34224870","10.1016/j.ijid.2021.06.063","Prevalence of and factors associated with long-term COVID-19 sick leave in working-age patients followed in general practices in Germany.","To investigate the prevalence of and the factors associated with long-term sick leave in working-age patients diagnosed with coronavirus disease (COVID-19) in general practices in Germany. Patients aged 18-65 years who were diagnosed with COVID-19 in one of 1,255 general practices in Germany between March 2020 and February 2021 were included in this study. Long-term sick leave was defined as sick leave of at least four weeks. The association between these independent variables and long-term sick","2021","07","05","Int J Infect Dis","International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases","COVID-19; Germany; coronavirus disease; general practices; long-term sick leave","Tanislav","Christian","Department of Geriatrics and Neurology, Diakonie Hospital Jung Stilling Siegen, Germany",NA
"1766","34224870","10.1016/j.ijid.2021.06.063","Prevalence of and factors associated with long-term COVID-19 sick leave in working-age patients followed in general practices in Germany.","To investigate the prevalence of and the factors associated with long-term sick leave in working-age patients diagnosed with coronavirus disease (COVID-19) in general practices in Germany. Patients aged 18-65 years who were diagnosed with COVID-19 in one of 1,255 general practices in Germany between March 2020 and February 2021 were included in this study. Long-term sick leave was defined as sick leave of at least four weeks. The association between these independent variables and long-term sick","2021","07","05","Int J Infect Dis","International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases","COVID-19; Germany; coronavirus disease; general practices; long-term sick leave","Konrad","Marcel","Health &amp",NA
"1767","34224870","10.1016/j.ijid.2021.06.063","Prevalence of and factors associated with long-term COVID-19 sick leave in working-age patients followed in general practices in Germany.","To investigate the prevalence of and the factors associated with long-term sick leave in working-age patients diagnosed with coronavirus disease (COVID-19) in general practices in Germany. Patients aged 18-65 years who were diagnosed with COVID-19 in one of 1,255 general practices in Germany between March 2020 and February 2021 were included in this study. Long-term sick leave was defined as sick leave of at least four weeks. The association between these independent variables and long-term sick","2021","07","05","Int J Infect Dis","International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases","COVID-19; Germany; coronavirus disease; general practices; long-term sick leave","van der Beck","Susanne","Epidemiology, IQVIA, Frankfurt, Germany",NA
"1768","34224870","10.1016/j.ijid.2021.06.063","Prevalence of and factors associated with long-term COVID-19 sick leave in working-age patients followed in general practices in Germany.","To investigate the prevalence of and the factors associated with long-term sick leave in working-age patients diagnosed with coronavirus disease (COVID-19) in general practices in Germany. Patients aged 18-65 years who were diagnosed with COVID-19 in one of 1,255 general practices in Germany between March 2020 and February 2021 were included in this study. Long-term sick leave was defined as sick leave of at least four weeks. The association between these independent variables and long-term sick","2021","07","05","Int J Infect Dis","International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases","COVID-19; Germany; coronavirus disease; general practices; long-term sick leave","Kostev","Karel","Epidemiology, IQVIA, Frankfurt, Germany. Electronic address: karel.kostev@iqvia","karel.kostev@iqvia.com"
"1769","34224838","10.1016/j.jaac.2021.06.016","Crisis Preparedness in Acute and Intensive Treatment Settings: Lessons Learned From a Year of COVID-19.",NA,"2021","07","14","J Am Acad Child Adolesc Psychiatry","Journal of the American Academy of Child and Adolescent Psychiatry",NA,"Leffler","Jarrod M","Mayo Clinic, Rochester, Minnesota. Electronic address: leffler.jarrod@mayo","leffler.jarrod@mayo.edu"
"1770","34224838","10.1016/j.jaac.2021.06.016","Crisis Preparedness in Acute and Intensive Treatment Settings: Lessons Learned From a Year of COVID-19.",NA,"2021","07","14","J Am Acad Child Adolesc Psychiatry","Journal of the American Academy of Child and Adolescent Psychiatry",NA,"Esposito","Cassandra L","Cincinnati Children's Hospital Medical Center, Ohio",NA
"1771","34224838","10.1016/j.jaac.2021.06.016","Crisis Preparedness in Acute and Intensive Treatment Settings: Lessons Learned From a Year of COVID-19.",NA,"2021","07","14","J Am Acad Child Adolesc Psychiatry","Journal of the American Academy of Child and Adolescent Psychiatry",NA,"Frazier","Elisabeth A","Dr. Frazier is with Warren Alpert Medical School, Brown University, Riverside, Rhode Island",NA
"1772","34224838","10.1016/j.jaac.2021.06.016","Crisis Preparedness in Acute and Intensive Treatment Settings: Lessons Learned From a Year of COVID-19.",NA,"2021","07","14","J Am Acad Child Adolesc Psychiatry","Journal of the American Academy of Child and Adolescent Psychiatry",NA,"Patriquin","Michelle A","Dr. Patriquin is with The Menninger Clinic and Baylor College of Medicine, Houston, Texas",NA
"1773","34224838","10.1016/j.jaac.2021.06.016","Crisis Preparedness in Acute and Intensive Treatment Settings: Lessons Learned From a Year of COVID-19.",NA,"2021","07","14","J Am Acad Child Adolesc Psychiatry","Journal of the American Academy of Child and Adolescent Psychiatry",NA,"Reiman","Meredith K","Mayo Clinic, Rochester, Minnesota",NA
"1774","34224838","10.1016/j.jaac.2021.06.016","Crisis Preparedness in Acute and Intensive Treatment Settings: Lessons Learned From a Year of COVID-19.",NA,"2021","07","14","J Am Acad Child Adolesc Psychiatry","Journal of the American Academy of Child and Adolescent Psychiatry",NA,"Thompson","Alysha D","Dr. Thompson is with Seattle Children's Hospital, University of Washington",NA
"1775","34224838","10.1016/j.jaac.2021.06.016","Crisis Preparedness in Acute and Intensive Treatment Settings: Lessons Learned From a Year of COVID-19.",NA,"2021","07","14","J Am Acad Child Adolesc Psychiatry","Journal of the American Academy of Child and Adolescent Psychiatry",NA,"Waitz","Carl","Dr. Waitz is with Boston Children's Hospital, Harvard Medical School, Massachusetts",NA
"1776","34224834","10.1016/j.jclinepi.2021.06.027","Abstracts for reports of randomised trials of COVID-19 interventions had low quality and high spin.","To assess the reporting quality of abstracts for published randomized controlled trials (RCTs) of interventions for coronavirus disease 2019 (COVID-19), including the use of spin strategies and the level of spin for RCTs with statistically non-significant primary outcomes, and to explore potential predictors for reporting quality and the severity of spin. PubMed was searched to find RCTs that tested interventions for COVID-19, and the reporting quality and spin in the abstracts were assessed. Li","2021","07","08","J Clin Epidemiol","Journal of clinical epidemiology","CONSORT: consolidated standards of reporting trials; COVID-19: coronavirus disease 2019; IQR: interquartile range; SARS-CoV-2: severe acute respiratory syndrome coronavirus 2; abstract, COVID-19, randomized controlled trial, primary outcome, reporting quality, spin Abbreviations RCT: randomized controlled trial","Wang","Dongguang","Department of Respiratory and Critical Care Medicine, West China Hospital/West China School of Medicine, Sichuan University, Chengdu, China",NA
"1777","34224834","10.1016/j.jclinepi.2021.06.027","Abstracts for reports of randomised trials of COVID-19 interventions had low quality and high spin.","To assess the reporting quality of abstracts for published randomized controlled trials (RCTs) of interventions for coronavirus disease 2019 (COVID-19), including the use of spin strategies and the level of spin for RCTs with statistically non-significant primary outcomes, and to explore potential predictors for reporting quality and the severity of spin. PubMed was searched to find RCTs that tested interventions for COVID-19, and the reporting quality and spin in the abstracts were assessed. Li","2021","07","08","J Clin Epidemiol","Journal of clinical epidemiology","CONSORT: consolidated standards of reporting trials; COVID-19: coronavirus disease 2019; IQR: interquartile range; SARS-CoV-2: severe acute respiratory syndrome coronavirus 2; abstract, COVID-19, randomized controlled trial, primary outcome, reporting quality, spin Abbreviations RCT: randomized controlled trial","Chen","Lingmin","Department of Anesthesiology and National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University &amp",NA
"1778","34224834","10.1016/j.jclinepi.2021.06.027","Abstracts for reports of randomised trials of COVID-19 interventions had low quality and high spin.","To assess the reporting quality of abstracts for published randomized controlled trials (RCTs) of interventions for coronavirus disease 2019 (COVID-19), including the use of spin strategies and the level of spin for RCTs with statistically non-significant primary outcomes, and to explore potential predictors for reporting quality and the severity of spin. PubMed was searched to find RCTs that tested interventions for COVID-19, and the reporting quality and spin in the abstracts were assessed. Li","2021","07","08","J Clin Epidemiol","Journal of clinical epidemiology","CONSORT: consolidated standards of reporting trials; COVID-19: coronavirus disease 2019; IQR: interquartile range; SARS-CoV-2: severe acute respiratory syndrome coronavirus 2; abstract, COVID-19, randomized controlled trial, primary outcome, reporting quality, spin Abbreviations RCT: randomized controlled trial","Wang","Lian","Department of Respiratory and Critical Care Medicine, West China Hospital/West China School of Medicine, Sichuan University, Chengdu, China",NA
"1779","34224834","10.1016/j.jclinepi.2021.06.027","Abstracts for reports of randomised trials of COVID-19 interventions had low quality and high spin.","To assess the reporting quality of abstracts for published randomized controlled trials (RCTs) of interventions for coronavirus disease 2019 (COVID-19), including the use of spin strategies and the level of spin for RCTs with statistically non-significant primary outcomes, and to explore potential predictors for reporting quality and the severity of spin. PubMed was searched to find RCTs that tested interventions for COVID-19, and the reporting quality and spin in the abstracts were assessed. Li","2021","07","08","J Clin Epidemiol","Journal of clinical epidemiology","CONSORT: consolidated standards of reporting trials; COVID-19: coronavirus disease 2019; IQR: interquartile range; SARS-CoV-2: severe acute respiratory syndrome coronavirus 2; abstract, COVID-19, randomized controlled trial, primary outcome, reporting quality, spin Abbreviations RCT: randomized controlled trial","Hua","Fang","Center for Evidenced-Based Stomatology, School &amp",NA
"1780","34224834","10.1016/j.jclinepi.2021.06.027","Abstracts for reports of randomised trials of COVID-19 interventions had low quality and high spin.","To assess the reporting quality of abstracts for published randomized controlled trials (RCTs) of interventions for coronavirus disease 2019 (COVID-19), including the use of spin strategies and the level of spin for RCTs with statistically non-significant primary outcomes, and to explore potential predictors for reporting quality and the severity of spin. PubMed was searched to find RCTs that tested interventions for COVID-19, and the reporting quality and spin in the abstracts were assessed. Li","2021","07","08","J Clin Epidemiol","Journal of clinical epidemiology","CONSORT: consolidated standards of reporting trials; COVID-19: coronavirus disease 2019; IQR: interquartile range; SARS-CoV-2: severe acute respiratory syndrome coronavirus 2; abstract, COVID-19, randomized controlled trial, primary outcome, reporting quality, spin Abbreviations RCT: randomized controlled trial","Li","Juan","School of Health Preservation and Rehabilitation, Chengdu University of Traditional Chinese Medicine, Chengdu, China",NA
"1781","34224834","10.1016/j.jclinepi.2021.06.027","Abstracts for reports of randomised trials of COVID-19 interventions had low quality and high spin.","To assess the reporting quality of abstracts for published randomized controlled trials (RCTs) of interventions for coronavirus disease 2019 (COVID-19), including the use of spin strategies and the level of spin for RCTs with statistically non-significant primary outcomes, and to explore potential predictors for reporting quality and the severity of spin. PubMed was searched to find RCTs that tested interventions for COVID-19, and the reporting quality and spin in the abstracts were assessed. Li","2021","07","08","J Clin Epidemiol","Journal of clinical epidemiology","CONSORT: consolidated standards of reporting trials; COVID-19: coronavirus disease 2019; IQR: interquartile range; SARS-CoV-2: severe acute respiratory syndrome coronavirus 2; abstract, COVID-19, randomized controlled trial, primary outcome, reporting quality, spin Abbreviations RCT: randomized controlled trial","Li","Yuxi","School of Health Preservation and Rehabilitation, Chengdu University of Traditional Chinese Medicine, Chengdu, China",NA
"1782","34224834","10.1016/j.jclinepi.2021.06.027","Abstracts for reports of randomised trials of COVID-19 interventions had low quality and high spin.","To assess the reporting quality of abstracts for published randomized controlled trials (RCTs) of interventions for coronavirus disease 2019 (COVID-19), including the use of spin strategies and the level of spin for RCTs with statistically non-significant primary outcomes, and to explore potential predictors for reporting quality and the severity of spin. PubMed was searched to find RCTs that tested interventions for COVID-19, and the reporting quality and spin in the abstracts were assessed. Li","2021","07","08","J Clin Epidemiol","Journal of clinical epidemiology","CONSORT: consolidated standards of reporting trials; COVID-19: coronavirus disease 2019; IQR: interquartile range; SARS-CoV-2: severe acute respiratory syndrome coronavirus 2; abstract, COVID-19, randomized controlled trial, primary outcome, reporting quality, spin Abbreviations RCT: randomized controlled trial","Zhang","Yonggang","Department of Periodical Press, West China Hospital, Sichuan University, Chengdu, China",NA
"1783","34224834","10.1016/j.jclinepi.2021.06.027","Abstracts for reports of randomised trials of COVID-19 interventions had low quality and high spin.","To assess the reporting quality of abstracts for published randomized controlled trials (RCTs) of interventions for coronavirus disease 2019 (COVID-19), including the use of spin strategies and the level of spin for RCTs with statistically non-significant primary outcomes, and to explore potential predictors for reporting quality and the severity of spin. PubMed was searched to find RCTs that tested interventions for COVID-19, and the reporting quality and spin in the abstracts were assessed. Li","2021","07","08","J Clin Epidemiol","Journal of clinical epidemiology","CONSORT: consolidated standards of reporting trials; COVID-19: coronavirus disease 2019; IQR: interquartile range; SARS-CoV-2: severe acute respiratory syndrome coronavirus 2; abstract, COVID-19, randomized controlled trial, primary outcome, reporting quality, spin Abbreviations RCT: randomized controlled trial","Fan","Hong","Department of Respiratory and Critical Care Medicine, West China Hospital/West China School of Medicine, Sichuan University, Chengdu, China. Electronic address: fanhongfan@qq",NA
"1784","34224834","10.1016/j.jclinepi.2021.06.027","Abstracts for reports of randomised trials of COVID-19 interventions had low quality and high spin.","To assess the reporting quality of abstracts for published randomized controlled trials (RCTs) of interventions for coronavirus disease 2019 (COVID-19), including the use of spin strategies and the level of spin for RCTs with statistically non-significant primary outcomes, and to explore potential predictors for reporting quality and the severity of spin. PubMed was searched to find RCTs that tested interventions for COVID-19, and the reporting quality and spin in the abstracts were assessed. Li","2021","07","08","J Clin Epidemiol","Journal of clinical epidemiology","CONSORT: consolidated standards of reporting trials; COVID-19: coronavirus disease 2019; IQR: interquartile range; SARS-CoV-2: severe acute respiratory syndrome coronavirus 2; abstract, COVID-19, randomized controlled trial, primary outcome, reporting quality, spin Abbreviations RCT: randomized controlled trial","Li","Weimin","Department of Respiratory and Critical Care Medicine, West China Hospital/West China School of Medicine, Sichuan University, Chengdu, China. Electronic address: weimi003@yahoo","weimi003@yahoo.com"
"1785","34224834","10.1016/j.jclinepi.2021.06.027","Abstracts for reports of randomised trials of COVID-19 interventions had low quality and high spin.","To assess the reporting quality of abstracts for published randomized controlled trials (RCTs) of interventions for coronavirus disease 2019 (COVID-19), including the use of spin strategies and the level of spin for RCTs with statistically non-significant primary outcomes, and to explore potential predictors for reporting quality and the severity of spin. PubMed was searched to find RCTs that tested interventions for COVID-19, and the reporting quality and spin in the abstracts were assessed. Li","2021","07","08","J Clin Epidemiol","Journal of clinical epidemiology","CONSORT: consolidated standards of reporting trials; COVID-19: coronavirus disease 2019; IQR: interquartile range; SARS-CoV-2: severe acute respiratory syndrome coronavirus 2; abstract, COVID-19, randomized controlled trial, primary outcome, reporting quality, spin Abbreviations RCT: randomized controlled trial","Clarke","Mike","Northern Ireland Clinical Trials Unit and Methodology Hub, Centre for Public Health, Queen's University Belfast, Belfast, UK. Electronic address: m.clarke@qub.ac","m.clarke@qub.ac.uk"
"1786","34224801","10.1016/j.jhin.2021.06.008","Increased Number of Positive Coagulase Negative Staphylococci in Blood Cultures is Partly Explained by Increased Use of Intra Arterial Catheters in COVID-19 Patients.",NA,"2021","07","08","J Hosp Infect","The Journal of hospital infection","COVID-19; blood culture; coagulase negative Staphylococci; contamination","Yusuf","Erlangga","Department of Medical Microbiology and Infectious Diseases, Erasmus University Medical Centre, Rotterdam, The Netherlands. Electronic address: e.yusuf@erasmusmc","e.yusuf@erasmusmc.nl"
"1787","34224801","10.1016/j.jhin.2021.06.008","Increased Number of Positive Coagulase Negative Staphylococci in Blood Cultures is Partly Explained by Increased Use of Intra Arterial Catheters in COVID-19 Patients.",NA,"2021","07","08","J Hosp Infect","The Journal of hospital infection","COVID-19; blood culture; coagulase negative Staphylococci; contamination","de Haan","Jubi E","Department of Intensive Care Medicine, Erasmus University Medical Centre, Rotterdam, The Netherlands",NA
"1788","34224801","10.1016/j.jhin.2021.06.008","Increased Number of Positive Coagulase Negative Staphylococci in Blood Cultures is Partly Explained by Increased Use of Intra Arterial Catheters in COVID-19 Patients.",NA,"2021","07","08","J Hosp Infect","The Journal of hospital infection","COVID-19; blood culture; coagulase negative Staphylococci; contamination","van den Akker","Johannes P C","Department of Intensive Care Medicine, Erasmus University Medical Centre, Rotterdam, The Netherlands",NA
"1789","34224801","10.1016/j.jhin.2021.06.008","Increased Number of Positive Coagulase Negative Staphylococci in Blood Cultures is Partly Explained by Increased Use of Intra Arterial Catheters in COVID-19 Patients.",NA,"2021","07","08","J Hosp Infect","The Journal of hospital infection","COVID-19; blood culture; coagulase negative Staphylococci; contamination","Vogel","Marius","Department of Medical Microbiology and Infectious Diseases, Erasmus University Medical Centre, Rotterdam, The Netherlands",NA
"1790","34224801","10.1016/j.jhin.2021.06.008","Increased Number of Positive Coagulase Negative Staphylococci in Blood Cultures is Partly Explained by Increased Use of Intra Arterial Catheters in COVID-19 Patients.",NA,"2021","07","08","J Hosp Infect","The Journal of hospital infection","COVID-19; blood culture; coagulase negative Staphylococci; contamination","de Steenwinkel","Jurriaan E M","Department of Medical Microbiology and Infectious Diseases, Erasmus University Medical Centre, Rotterdam, The Netherlands",NA
"1791","34224801","10.1016/j.jhin.2021.06.008","Increased Number of Positive Coagulase Negative Staphylococci in Blood Cultures is Partly Explained by Increased Use of Intra Arterial Catheters in COVID-19 Patients.",NA,"2021","07","08","J Hosp Infect","The Journal of hospital infection","COVID-19; blood culture; coagulase negative Staphylococci; contamination","Rijnders","Bart J A","Department of Medical Microbiology and Infectious Diseases, Erasmus University Medical Centre, Rotterdam, The Netherlands",NA
"1792","34224801","10.1016/j.jhin.2021.06.008","Increased Number of Positive Coagulase Negative Staphylococci in Blood Cultures is Partly Explained by Increased Use of Intra Arterial Catheters in COVID-19 Patients.",NA,"2021","07","08","J Hosp Infect","The Journal of hospital infection","COVID-19; blood culture; coagulase negative Staphylococci; contamination","Bode","Lonneke G M","Department of Medical Microbiology and Infectious Diseases, Erasmus University Medical Centre, Rotterdam, The Netherlands",NA
"1793","34224783","10.1016/j.jaci.2021.06.024","Mechanisms underlying genetic susceptibility to Multisystem Inflammatory Syndrome in Children (MIS-C).","Multisystem Inflammatory Syndrome in Children (MIS-C) is a pediatric complication of SARS-CoV-2 infection characterized by multiorgan inflammation and frequently, cardiovascular dysfunction. It occurs predominantly in otherwise healthy children. We previously reported haploinsufficiency of Suppressor of Cytokine Signaling 1 (SOCS1), a negative regulator of Type I and II interferons, as a genetic risk factor for MIS-C. We aimed to identify additional genetic mechanisms underlying susceptibility t","2021","07","15","J Allergy Clin Immunol","The Journal of allergy and clinical immunology","COVID-19; MIS-C; Multisystem Inflammatory Syndrome in Children; SARS-CoV-2; whole exome sequencing","Chou","Janet","Division of Immunology. Electronic address: Janet.Chou@childrens.harvard","Janet.Chou@childrens.harvard.edu"
"1794","34224783","10.1016/j.jaci.2021.06.024","Mechanisms underlying genetic susceptibility to Multisystem Inflammatory Syndrome in Children (MIS-C).","Multisystem Inflammatory Syndrome in Children (MIS-C) is a pediatric complication of SARS-CoV-2 infection characterized by multiorgan inflammation and frequently, cardiovascular dysfunction. It occurs predominantly in otherwise healthy children. We previously reported haploinsufficiency of Suppressor of Cytokine Signaling 1 (SOCS1), a negative regulator of Type I and II interferons, as a genetic risk factor for MIS-C. We aimed to identify additional genetic mechanisms underlying susceptibility t","2021","07","15","J Allergy Clin Immunol","The Journal of allergy and clinical immunology","COVID-19; MIS-C; Multisystem Inflammatory Syndrome in Children; SARS-CoV-2; whole exome sequencing","Platt","Craig D","Division of Immunology",NA
"1795","34224783","10.1016/j.jaci.2021.06.024","Mechanisms underlying genetic susceptibility to Multisystem Inflammatory Syndrome in Children (MIS-C).","Multisystem Inflammatory Syndrome in Children (MIS-C) is a pediatric complication of SARS-CoV-2 infection characterized by multiorgan inflammation and frequently, cardiovascular dysfunction. It occurs predominantly in otherwise healthy children. We previously reported haploinsufficiency of Suppressor of Cytokine Signaling 1 (SOCS1), a negative regulator of Type I and II interferons, as a genetic risk factor for MIS-C. We aimed to identify additional genetic mechanisms underlying susceptibility t","2021","07","15","J Allergy Clin Immunol","The Journal of allergy and clinical immunology","COVID-19; MIS-C; Multisystem Inflammatory Syndrome in Children; SARS-CoV-2; whole exome sequencing","Habiballah","Saddiq","Division of Immunology",NA
"1796","34224783","10.1016/j.jaci.2021.06.024","Mechanisms underlying genetic susceptibility to Multisystem Inflammatory Syndrome in Children (MIS-C).","Multisystem Inflammatory Syndrome in Children (MIS-C) is a pediatric complication of SARS-CoV-2 infection characterized by multiorgan inflammation and frequently, cardiovascular dysfunction. It occurs predominantly in otherwise healthy children. We previously reported haploinsufficiency of Suppressor of Cytokine Signaling 1 (SOCS1), a negative regulator of Type I and II interferons, as a genetic risk factor for MIS-C. We aimed to identify additional genetic mechanisms underlying susceptibility t","2021","07","15","J Allergy Clin Immunol","The Journal of allergy and clinical immunology","COVID-19; MIS-C; Multisystem Inflammatory Syndrome in Children; SARS-CoV-2; whole exome sequencing","Nguyen","Alan A","Division of Immunology",NA
"1797","34224783","10.1016/j.jaci.2021.06.024","Mechanisms underlying genetic susceptibility to Multisystem Inflammatory Syndrome in Children (MIS-C).","Multisystem Inflammatory Syndrome in Children (MIS-C) is a pediatric complication of SARS-CoV-2 infection characterized by multiorgan inflammation and frequently, cardiovascular dysfunction. It occurs predominantly in otherwise healthy children. We previously reported haploinsufficiency of Suppressor of Cytokine Signaling 1 (SOCS1), a negative regulator of Type I and II interferons, as a genetic risk factor for MIS-C. We aimed to identify additional genetic mechanisms underlying susceptibility t","2021","07","15","J Allergy Clin Immunol","The Journal of allergy and clinical immunology","COVID-19; MIS-C; Multisystem Inflammatory Syndrome in Children; SARS-CoV-2; whole exome sequencing","Elkins","Megan","Division of Immunology",NA
"1798","34224783","10.1016/j.jaci.2021.06.024","Mechanisms underlying genetic susceptibility to Multisystem Inflammatory Syndrome in Children (MIS-C).","Multisystem Inflammatory Syndrome in Children (MIS-C) is a pediatric complication of SARS-CoV-2 infection characterized by multiorgan inflammation and frequently, cardiovascular dysfunction. It occurs predominantly in otherwise healthy children. We previously reported haploinsufficiency of Suppressor of Cytokine Signaling 1 (SOCS1), a negative regulator of Type I and II interferons, as a genetic risk factor for MIS-C. We aimed to identify additional genetic mechanisms underlying susceptibility t","2021","07","15","J Allergy Clin Immunol","The Journal of allergy and clinical immunology","COVID-19; MIS-C; Multisystem Inflammatory Syndrome in Children; SARS-CoV-2; whole exome sequencing","Weeks","Sabrina","Division of Immunology",NA
"1799","34224783","10.1016/j.jaci.2021.06.024","Mechanisms underlying genetic susceptibility to Multisystem Inflammatory Syndrome in Children (MIS-C).","Multisystem Inflammatory Syndrome in Children (MIS-C) is a pediatric complication of SARS-CoV-2 infection characterized by multiorgan inflammation and frequently, cardiovascular dysfunction. It occurs predominantly in otherwise healthy children. We previously reported haploinsufficiency of Suppressor of Cytokine Signaling 1 (SOCS1), a negative regulator of Type I and II interferons, as a genetic risk factor for MIS-C. We aimed to identify additional genetic mechanisms underlying susceptibility t","2021","07","15","J Allergy Clin Immunol","The Journal of allergy and clinical immunology","COVID-19; MIS-C; Multisystem Inflammatory Syndrome in Children; SARS-CoV-2; whole exome sequencing","Peters","Zachary","Division of Immunology",NA
"1800","34224783","10.1016/j.jaci.2021.06.024","Mechanisms underlying genetic susceptibility to Multisystem Inflammatory Syndrome in Children (MIS-C).","Multisystem Inflammatory Syndrome in Children (MIS-C) is a pediatric complication of SARS-CoV-2 infection characterized by multiorgan inflammation and frequently, cardiovascular dysfunction. It occurs predominantly in otherwise healthy children. We previously reported haploinsufficiency of Suppressor of Cytokine Signaling 1 (SOCS1), a negative regulator of Type I and II interferons, as a genetic risk factor for MIS-C. We aimed to identify additional genetic mechanisms underlying susceptibility t","2021","07","15","J Allergy Clin Immunol","The Journal of allergy and clinical immunology","COVID-19; MIS-C; Multisystem Inflammatory Syndrome in Children; SARS-CoV-2; whole exome sequencing","Day-Lewis","Megan","Division of Immunology",NA
"1801","34224783","10.1016/j.jaci.2021.06.024","Mechanisms underlying genetic susceptibility to Multisystem Inflammatory Syndrome in Children (MIS-C).","Multisystem Inflammatory Syndrome in Children (MIS-C) is a pediatric complication of SARS-CoV-2 infection characterized by multiorgan inflammation and frequently, cardiovascular dysfunction. It occurs predominantly in otherwise healthy children. We previously reported haploinsufficiency of Suppressor of Cytokine Signaling 1 (SOCS1), a negative regulator of Type I and II interferons, as a genetic risk factor for MIS-C. We aimed to identify additional genetic mechanisms underlying susceptibility t","2021","07","15","J Allergy Clin Immunol","The Journal of allergy and clinical immunology","COVID-19; MIS-C; Multisystem Inflammatory Syndrome in Children; SARS-CoV-2; whole exome sequencing","Novak","Tanya","Division of Critical Care Medicine, Department of Anesthesiology, Critical Care and Pain Medicine",NA
"1802","34224783","10.1016/j.jaci.2021.06.024","Mechanisms underlying genetic susceptibility to Multisystem Inflammatory Syndrome in Children (MIS-C).","Multisystem Inflammatory Syndrome in Children (MIS-C) is a pediatric complication of SARS-CoV-2 infection characterized by multiorgan inflammation and frequently, cardiovascular dysfunction. It occurs predominantly in otherwise healthy children. We previously reported haploinsufficiency of Suppressor of Cytokine Signaling 1 (SOCS1), a negative regulator of Type I and II interferons, as a genetic risk factor for MIS-C. We aimed to identify additional genetic mechanisms underlying susceptibility t","2021","07","15","J Allergy Clin Immunol","The Journal of allergy and clinical immunology","COVID-19; MIS-C; Multisystem Inflammatory Syndrome in Children; SARS-CoV-2; whole exome sequencing","Armant","Myriam","The TransLab",NA
"1803","34224783","10.1016/j.jaci.2021.06.024","Mechanisms underlying genetic susceptibility to Multisystem Inflammatory Syndrome in Children (MIS-C).","Multisystem Inflammatory Syndrome in Children (MIS-C) is a pediatric complication of SARS-CoV-2 infection characterized by multiorgan inflammation and frequently, cardiovascular dysfunction. It occurs predominantly in otherwise healthy children. We previously reported haploinsufficiency of Suppressor of Cytokine Signaling 1 (SOCS1), a negative regulator of Type I and II interferons, as a genetic risk factor for MIS-C. We aimed to identify additional genetic mechanisms underlying susceptibility t","2021","07","15","J Allergy Clin Immunol","The Journal of allergy and clinical immunology","COVID-19; MIS-C; Multisystem Inflammatory Syndrome in Children; SARS-CoV-2; whole exome sequencing","Williams","Lucinda","The Institutional Centers for Clinical and Translational Research",NA
"1804","34224783","10.1016/j.jaci.2021.06.024","Mechanisms underlying genetic susceptibility to Multisystem Inflammatory Syndrome in Children (MIS-C).","Multisystem Inflammatory Syndrome in Children (MIS-C) is a pediatric complication of SARS-CoV-2 infection characterized by multiorgan inflammation and frequently, cardiovascular dysfunction. It occurs predominantly in otherwise healthy children. We previously reported haploinsufficiency of Suppressor of Cytokine Signaling 1 (SOCS1), a negative regulator of Type I and II interferons, as a genetic risk factor for MIS-C. We aimed to identify additional genetic mechanisms underlying susceptibility t","2021","07","15","J Allergy Clin Immunol","The Journal of allergy and clinical immunology","COVID-19; MIS-C; Multisystem Inflammatory Syndrome in Children; SARS-CoV-2; whole exome sequencing","Rockowitz","Shira","Computational Health Informatics Program",NA
"1805","34224783","10.1016/j.jaci.2021.06.024","Mechanisms underlying genetic susceptibility to Multisystem Inflammatory Syndrome in Children (MIS-C).","Multisystem Inflammatory Syndrome in Children (MIS-C) is a pediatric complication of SARS-CoV-2 infection characterized by multiorgan inflammation and frequently, cardiovascular dysfunction. It occurs predominantly in otherwise healthy children. We previously reported haploinsufficiency of Suppressor of Cytokine Signaling 1 (SOCS1), a negative regulator of Type I and II interferons, as a genetic risk factor for MIS-C. We aimed to identify additional genetic mechanisms underlying susceptibility t","2021","07","15","J Allergy Clin Immunol","The Journal of allergy and clinical immunology","COVID-19; MIS-C; Multisystem Inflammatory Syndrome in Children; SARS-CoV-2; whole exome sequencing","Sliz","Piotr","Computational Health Informatics Program",NA
"1806","34224783","10.1016/j.jaci.2021.06.024","Mechanisms underlying genetic susceptibility to Multisystem Inflammatory Syndrome in Children (MIS-C).","Multisystem Inflammatory Syndrome in Children (MIS-C) is a pediatric complication of SARS-CoV-2 infection characterized by multiorgan inflammation and frequently, cardiovascular dysfunction. It occurs predominantly in otherwise healthy children. We previously reported haploinsufficiency of Suppressor of Cytokine Signaling 1 (SOCS1), a negative regulator of Type I and II interferons, as a genetic risk factor for MIS-C. We aimed to identify additional genetic mechanisms underlying susceptibility t","2021","07","15","J Allergy Clin Immunol","The Journal of allergy and clinical immunology","COVID-19; MIS-C; Multisystem Inflammatory Syndrome in Children; SARS-CoV-2; whole exome sequencing","Williams","David A","Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School",NA
"1807","34224783","10.1016/j.jaci.2021.06.024","Mechanisms underlying genetic susceptibility to Multisystem Inflammatory Syndrome in Children (MIS-C).","Multisystem Inflammatory Syndrome in Children (MIS-C) is a pediatric complication of SARS-CoV-2 infection characterized by multiorgan inflammation and frequently, cardiovascular dysfunction. It occurs predominantly in otherwise healthy children. We previously reported haploinsufficiency of Suppressor of Cytokine Signaling 1 (SOCS1), a negative regulator of Type I and II interferons, as a genetic risk factor for MIS-C. We aimed to identify additional genetic mechanisms underlying susceptibility t","2021","07","15","J Allergy Clin Immunol","The Journal of allergy and clinical immunology","COVID-19; MIS-C; Multisystem Inflammatory Syndrome in Children; SARS-CoV-2; whole exome sequencing","Randolph","Adrienne G","Division of Critical Care Medicine, Department of Anesthesiology, Critical Care and Pain Medicine",NA
"1808","34224783","10.1016/j.jaci.2021.06.024","Mechanisms underlying genetic susceptibility to Multisystem Inflammatory Syndrome in Children (MIS-C).","Multisystem Inflammatory Syndrome in Children (MIS-C) is a pediatric complication of SARS-CoV-2 infection characterized by multiorgan inflammation and frequently, cardiovascular dysfunction. It occurs predominantly in otherwise healthy children. We previously reported haploinsufficiency of Suppressor of Cytokine Signaling 1 (SOCS1), a negative regulator of Type I and II interferons, as a genetic risk factor for MIS-C. We aimed to identify additional genetic mechanisms underlying susceptibility t","2021","07","15","J Allergy Clin Immunol","The Journal of allergy and clinical immunology","COVID-19; MIS-C; Multisystem Inflammatory Syndrome in Children; SARS-CoV-2; whole exome sequencing","Geha","Raif S","Division of Immunology",NA
"1809","34224783","10.1016/j.jaci.2021.06.024","Mechanisms underlying genetic susceptibility to Multisystem Inflammatory Syndrome in Children (MIS-C).","Multisystem Inflammatory Syndrome in Children (MIS-C) is a pediatric complication of SARS-CoV-2 infection characterized by multiorgan inflammation and frequently, cardiovascular dysfunction. It occurs predominantly in otherwise healthy children. We previously reported haploinsufficiency of Suppressor of Cytokine Signaling 1 (SOCS1), a negative regulator of Type I and II interferons, as a genetic risk factor for MIS-C. We aimed to identify additional genetic mechanisms underlying susceptibility t","2021","07","15","J Allergy Clin Immunol","The Journal of allergy and clinical immunology","COVID-19; MIS-C; Multisystem Inflammatory Syndrome in Children; SARS-CoV-2; whole exome sequencing","Almutairi","Abduarahman","Division of Immunology",NA
"1810","34224783","10.1016/j.jaci.2021.06.024","Mechanisms underlying genetic susceptibility to Multisystem Inflammatory Syndrome in Children (MIS-C).","Multisystem Inflammatory Syndrome in Children (MIS-C) is a pediatric complication of SARS-CoV-2 infection characterized by multiorgan inflammation and frequently, cardiovascular dysfunction. It occurs predominantly in otherwise healthy children. We previously reported haploinsufficiency of Suppressor of Cytokine Signaling 1 (SOCS1), a negative regulator of Type I and II interferons, as a genetic risk factor for MIS-C. We aimed to identify additional genetic mechanisms underlying susceptibility t","2021","07","15","J Allergy Clin Immunol","The Journal of allergy and clinical immunology","COVID-19; MIS-C; Multisystem Inflammatory Syndrome in Children; SARS-CoV-2; whole exome sequencing","Jaber","Faris","Division of Immunology",NA
"1811","34224783","10.1016/j.jaci.2021.06.024","Mechanisms underlying genetic susceptibility to Multisystem Inflammatory Syndrome in Children (MIS-C).","Multisystem Inflammatory Syndrome in Children (MIS-C) is a pediatric complication of SARS-CoV-2 infection characterized by multiorgan inflammation and frequently, cardiovascular dysfunction. It occurs predominantly in otherwise healthy children. We previously reported haploinsufficiency of Suppressor of Cytokine Signaling 1 (SOCS1), a negative regulator of Type I and II interferons, as a genetic risk factor for MIS-C. We aimed to identify additional genetic mechanisms underlying susceptibility t","2021","07","15","J Allergy Clin Immunol","The Journal of allergy and clinical immunology","COVID-19; MIS-C; Multisystem Inflammatory Syndrome in Children; SARS-CoV-2; whole exome sequencing","Banzon","Tina","Division of Immunology",NA
"1812","34224783","10.1016/j.jaci.2021.06.024","Mechanisms underlying genetic susceptibility to Multisystem Inflammatory Syndrome in Children (MIS-C).","Multisystem Inflammatory Syndrome in Children (MIS-C) is a pediatric complication of SARS-CoV-2 infection characterized by multiorgan inflammation and frequently, cardiovascular dysfunction. It occurs predominantly in otherwise healthy children. We previously reported haploinsufficiency of Suppressor of Cytokine Signaling 1 (SOCS1), a negative regulator of Type I and II interferons, as a genetic risk factor for MIS-C. We aimed to identify additional genetic mechanisms underlying susceptibility t","2021","07","15","J Allergy Clin Immunol","The Journal of allergy and clinical immunology","COVID-19; MIS-C; Multisystem Inflammatory Syndrome in Children; SARS-CoV-2; whole exome sequencing","Roberts","Jordan","Division of Immunology",NA
"1813","34224783","10.1016/j.jaci.2021.06.024","Mechanisms underlying genetic susceptibility to Multisystem Inflammatory Syndrome in Children (MIS-C).","Multisystem Inflammatory Syndrome in Children (MIS-C) is a pediatric complication of SARS-CoV-2 infection characterized by multiorgan inflammation and frequently, cardiovascular dysfunction. It occurs predominantly in otherwise healthy children. We previously reported haploinsufficiency of Suppressor of Cytokine Signaling 1 (SOCS1), a negative regulator of Type I and II interferons, as a genetic risk factor for MIS-C. We aimed to identify additional genetic mechanisms underlying susceptibility t","2021","07","15","J Allergy Clin Immunol","The Journal of allergy and clinical immunology","COVID-19; MIS-C; Multisystem Inflammatory Syndrome in Children; SARS-CoV-2; whole exome sequencing","Halyabar","Olha","Division of Immunology",NA
"1814","34224783","10.1016/j.jaci.2021.06.024","Mechanisms underlying genetic susceptibility to Multisystem Inflammatory Syndrome in Children (MIS-C).","Multisystem Inflammatory Syndrome in Children (MIS-C) is a pediatric complication of SARS-CoV-2 infection characterized by multiorgan inflammation and frequently, cardiovascular dysfunction. It occurs predominantly in otherwise healthy children. We previously reported haploinsufficiency of Suppressor of Cytokine Signaling 1 (SOCS1), a negative regulator of Type I and II interferons, as a genetic risk factor for MIS-C. We aimed to identify additional genetic mechanisms underlying susceptibility t","2021","07","15","J Allergy Clin Immunol","The Journal of allergy and clinical immunology","COVID-19; MIS-C; Multisystem Inflammatory Syndrome in Children; SARS-CoV-2; whole exome sequencing","Lo","Mindy","Division of Immunology",NA
"1815","34224783","10.1016/j.jaci.2021.06.024","Mechanisms underlying genetic susceptibility to Multisystem Inflammatory Syndrome in Children (MIS-C).","Multisystem Inflammatory Syndrome in Children (MIS-C) is a pediatric complication of SARS-CoV-2 infection characterized by multiorgan inflammation and frequently, cardiovascular dysfunction. It occurs predominantly in otherwise healthy children. We previously reported haploinsufficiency of Suppressor of Cytokine Signaling 1 (SOCS1), a negative regulator of Type I and II interferons, as a genetic risk factor for MIS-C. We aimed to identify additional genetic mechanisms underlying susceptibility t","2021","07","15","J Allergy Clin Immunol","The Journal of allergy and clinical immunology","COVID-19; MIS-C; Multisystem Inflammatory Syndrome in Children; SARS-CoV-2; whole exome sequencing","Kahn","Stacy","Division of Gastroenterology Boston Children's Hospital, Harvard Medical School, Boston, Mass",NA
"1816","34224783","10.1016/j.jaci.2021.06.024","Mechanisms underlying genetic susceptibility to Multisystem Inflammatory Syndrome in Children (MIS-C).","Multisystem Inflammatory Syndrome in Children (MIS-C) is a pediatric complication of SARS-CoV-2 infection characterized by multiorgan inflammation and frequently, cardiovascular dysfunction. It occurs predominantly in otherwise healthy children. We previously reported haploinsufficiency of Suppressor of Cytokine Signaling 1 (SOCS1), a negative regulator of Type I and II interferons, as a genetic risk factor for MIS-C. We aimed to identify additional genetic mechanisms underlying susceptibility t","2021","07","15","J Allergy Clin Immunol","The Journal of allergy and clinical immunology","COVID-19; MIS-C; Multisystem Inflammatory Syndrome in Children; SARS-CoV-2; whole exome sequencing","Henderson","Lauren A","Division of Immunology",NA
"1817","34224783","10.1016/j.jaci.2021.06.024","Mechanisms underlying genetic susceptibility to Multisystem Inflammatory Syndrome in Children (MIS-C).","Multisystem Inflammatory Syndrome in Children (MIS-C) is a pediatric complication of SARS-CoV-2 infection characterized by multiorgan inflammation and frequently, cardiovascular dysfunction. It occurs predominantly in otherwise healthy children. We previously reported haploinsufficiency of Suppressor of Cytokine Signaling 1 (SOCS1), a negative regulator of Type I and II interferons, as a genetic risk factor for MIS-C. We aimed to identify additional genetic mechanisms underlying susceptibility t","2021","07","15","J Allergy Clin Immunol","The Journal of allergy and clinical immunology","COVID-19; MIS-C; Multisystem Inflammatory Syndrome in Children; SARS-CoV-2; whole exome sequencing","Lee","Pui Y","Division of Immunology",NA
"1818","34224783","10.1016/j.jaci.2021.06.024","Mechanisms underlying genetic susceptibility to Multisystem Inflammatory Syndrome in Children (MIS-C).","Multisystem Inflammatory Syndrome in Children (MIS-C) is a pediatric complication of SARS-CoV-2 infection characterized by multiorgan inflammation and frequently, cardiovascular dysfunction. It occurs predominantly in otherwise healthy children. We previously reported haploinsufficiency of Suppressor of Cytokine Signaling 1 (SOCS1), a negative regulator of Type I and II interferons, as a genetic risk factor for MIS-C. We aimed to identify additional genetic mechanisms underlying susceptibility t","2021","07","15","J Allergy Clin Immunol","The Journal of allergy and clinical immunology","COVID-19; MIS-C; Multisystem Inflammatory Syndrome in Children; SARS-CoV-2; whole exome sequencing","Son","Mary Beth","Division of Immunology",NA
"1819","34224783","10.1016/j.jaci.2021.06.024","Mechanisms underlying genetic susceptibility to Multisystem Inflammatory Syndrome in Children (MIS-C).","Multisystem Inflammatory Syndrome in Children (MIS-C) is a pediatric complication of SARS-CoV-2 infection characterized by multiorgan inflammation and frequently, cardiovascular dysfunction. It occurs predominantly in otherwise healthy children. We previously reported haploinsufficiency of Suppressor of Cytokine Signaling 1 (SOCS1), a negative regulator of Type I and II interferons, as a genetic risk factor for MIS-C. We aimed to identify additional genetic mechanisms underlying susceptibility t","2021","07","15","J Allergy Clin Immunol","The Journal of allergy and clinical immunology","COVID-19; MIS-C; Multisystem Inflammatory Syndrome in Children; SARS-CoV-2; whole exome sequencing","Cheng","Leah","The TransLab",NA
"1820","34224770","10.1016/j.jaad.2021.06.871","Quantification of Adverse Skin Reactions Secondary to Mask-Wearing Using 3-D Imaging Technology: A Prospective Cohort Study.",NA,"2021","07","05","J Am Acad Dermatol","Journal of the American Academy of Dermatology","COVID-19; acne; erythema; irritation; mask; mask-wearing; maskne; pandemic; rhytides; skin","Elsanadi","Rachel","University of California, Irvine, Department of Dermatology, 843 Health Sciences Road, Irvine, CA",NA
"1821","34224770","10.1016/j.jaad.2021.06.871","Quantification of Adverse Skin Reactions Secondary to Mask-Wearing Using 3-D Imaging Technology: A Prospective Cohort Study.",NA,"2021","07","05","J Am Acad Dermatol","Journal of the American Academy of Dermatology","COVID-19; acne; erythema; irritation; mask; mask-wearing; maskne; pandemic; rhytides; skin","Casale","Fiore","University of California, Irvine, Department of Dermatology, 843 Health Sciences Road, Irvine, CA. Electronic address: fcasale@hs.uci","fcasale@hs.uci.edu"
"1822","34224770","10.1016/j.jaad.2021.06.871","Quantification of Adverse Skin Reactions Secondary to Mask-Wearing Using 3-D Imaging Technology: A Prospective Cohort Study.",NA,"2021","07","05","J Am Acad Dermatol","Journal of the American Academy of Dermatology","COVID-19; acne; erythema; irritation; mask; mask-wearing; maskne; pandemic; rhytides; skin","Yale","Katerina","University of California, Irvine, Department of Dermatology, 843 Health Sciences Road, Irvine, CA",NA
"1823","34224770","10.1016/j.jaad.2021.06.871","Quantification of Adverse Skin Reactions Secondary to Mask-Wearing Using 3-D Imaging Technology: A Prospective Cohort Study.",NA,"2021","07","05","J Am Acad Dermatol","Journal of the American Academy of Dermatology","COVID-19; acne; erythema; irritation; mask; mask-wearing; maskne; pandemic; rhytides; skin","Nguyen","Cristina","University of California, Irvine, Department of Dermatology, 843 Health Sciences Road, Irvine, CA",NA
"1824","34224770","10.1016/j.jaad.2021.06.871","Quantification of Adverse Skin Reactions Secondary to Mask-Wearing Using 3-D Imaging Technology: A Prospective Cohort Study.",NA,"2021","07","05","J Am Acad Dermatol","Journal of the American Academy of Dermatology","COVID-19; acne; erythema; irritation; mask; mask-wearing; maskne; pandemic; rhytides; skin","Nourmohammadi","Niki","Lake Erie College of Osteopathic Medicine, 20 Seton Hill Drive, Greensburg, PA, 15601",NA
"1825","34224770","10.1016/j.jaad.2021.06.871","Quantification of Adverse Skin Reactions Secondary to Mask-Wearing Using 3-D Imaging Technology: A Prospective Cohort Study.",NA,"2021","07","05","J Am Acad Dermatol","Journal of the American Academy of Dermatology","COVID-19; acne; erythema; irritation; mask; mask-wearing; maskne; pandemic; rhytides; skin","Eckhouse","Vardit","Cherry Imaging Ltd., Beit Hermon 3, Yokneam Ilit, Israel, 20692",NA
"1826","34224770","10.1016/j.jaad.2021.06.871","Quantification of Adverse Skin Reactions Secondary to Mask-Wearing Using 3-D Imaging Technology: A Prospective Cohort Study.",NA,"2021","07","05","J Am Acad Dermatol","Journal of the American Academy of Dermatology","COVID-19; acne; erythema; irritation; mask; mask-wearing; maskne; pandemic; rhytides; skin","Cohen","Yoav","Cherry Imaging Ltd., Beit Hermon 3, Yokneam Ilit, Israel, 20692",NA
"1827","34224770","10.1016/j.jaad.2021.06.871","Quantification of Adverse Skin Reactions Secondary to Mask-Wearing Using 3-D Imaging Technology: A Prospective Cohort Study.",NA,"2021","07","05","J Am Acad Dermatol","Journal of the American Academy of Dermatology","COVID-19; acne; erythema; irritation; mask; mask-wearing; maskne; pandemic; rhytides; skin","Mesinkovska","Natasha Atanaskova","University of California, Irvine, Department of Dermatology, 843 Health Sciences Road, Irvine, CA",NA
"1828","34224766","10.1016/j.ijcard.2021.06.056","Cardiac involvement in consecutive unselected hospitalized COVID-19 population: In-hospital evaluation and one-year follow-up.","Cardiovascular disease (CVD) can occur in COVID-19 and has impact on clinical course. Data on CVD prevalence in hospitalized COVID-19 patients and sequelae in survivors is limited. Aim of this prospective study carried out on consecutive unselected COVID-19 population, was to assess: 1) CVD occurrence among hospitalized COVID-19 patients, 2) persistence or new onset of CVD at one-month and one-year follow-up. Over 30 days n = 152 COVID-19 patients underwent cardiovascular evaluation. Standard el","2021","07","20","Int J Cardiol","International journal of cardiology","COVID-19; Cardiovascular disease; Cardiovascular magnetic resonance; Echocardiography; Follow-up; Myocarditis","Maestrini","Viviana","Department of Clinical, Internal, Anesthesiological and Cardiovascular Sciences, Sapienza University of Rome, ""Policlinico Umberto I"" Hospital, Rome, Italy",NA
"1829","34224766","10.1016/j.ijcard.2021.06.056","Cardiac involvement in consecutive unselected hospitalized COVID-19 population: In-hospital evaluation and one-year follow-up.","Cardiovascular disease (CVD) can occur in COVID-19 and has impact on clinical course. Data on CVD prevalence in hospitalized COVID-19 patients and sequelae in survivors is limited. Aim of this prospective study carried out on consecutive unselected COVID-19 population, was to assess: 1) CVD occurrence among hospitalized COVID-19 patients, 2) persistence or new onset of CVD at one-month and one-year follow-up. Over 30 days n = 152 COVID-19 patients underwent cardiovascular evaluation. Standard el","2021","07","20","Int J Cardiol","International journal of cardiology","COVID-19; Cardiovascular disease; Cardiovascular magnetic resonance; Echocardiography; Follow-up; Myocarditis","Birtolo","Lucia Ilaria","Department of Clinical, Internal, Anesthesiological and Cardiovascular Sciences, Sapienza University of Rome, ""Policlinico Umberto I"" Hospital, Rome, Italy",NA
"1830","34224766","10.1016/j.ijcard.2021.06.056","Cardiac involvement in consecutive unselected hospitalized COVID-19 population: In-hospital evaluation and one-year follow-up.","Cardiovascular disease (CVD) can occur in COVID-19 and has impact on clinical course. Data on CVD prevalence in hospitalized COVID-19 patients and sequelae in survivors is limited. Aim of this prospective study carried out on consecutive unselected COVID-19 population, was to assess: 1) CVD occurrence among hospitalized COVID-19 patients, 2) persistence or new onset of CVD at one-month and one-year follow-up. Over 30 days n = 152 COVID-19 patients underwent cardiovascular evaluation. Standard el","2021","07","20","Int J Cardiol","International journal of cardiology","COVID-19; Cardiovascular disease; Cardiovascular magnetic resonance; Echocardiography; Follow-up; Myocarditis","Francone","Marco","Department of Radiological, Oncological and Pathological Sciences, Sapienza University of Rome, ""Policlinico Umberto I"" Hospital, Rome, Italy",NA
"1831","34224766","10.1016/j.ijcard.2021.06.056","Cardiac involvement in consecutive unselected hospitalized COVID-19 population: In-hospital evaluation and one-year follow-up.","Cardiovascular disease (CVD) can occur in COVID-19 and has impact on clinical course. Data on CVD prevalence in hospitalized COVID-19 patients and sequelae in survivors is limited. Aim of this prospective study carried out on consecutive unselected COVID-19 population, was to assess: 1) CVD occurrence among hospitalized COVID-19 patients, 2) persistence or new onset of CVD at one-month and one-year follow-up. Over 30 days n = 152 COVID-19 patients underwent cardiovascular evaluation. Standard el","2021","07","20","Int J Cardiol","International journal of cardiology","COVID-19; Cardiovascular disease; Cardiovascular magnetic resonance; Echocardiography; Follow-up; Myocarditis","Galardo","Gioacchino","Emergency Department, ""Policlinico Umberto I"" Hospital, Rome, Italy",NA
"1832","34224766","10.1016/j.ijcard.2021.06.056","Cardiac involvement in consecutive unselected hospitalized COVID-19 population: In-hospital evaluation and one-year follow-up.","Cardiovascular disease (CVD) can occur in COVID-19 and has impact on clinical course. Data on CVD prevalence in hospitalized COVID-19 patients and sequelae in survivors is limited. Aim of this prospective study carried out on consecutive unselected COVID-19 population, was to assess: 1) CVD occurrence among hospitalized COVID-19 patients, 2) persistence or new onset of CVD at one-month and one-year follow-up. Over 30 days n = 152 COVID-19 patients underwent cardiovascular evaluation. Standard el","2021","07","20","Int J Cardiol","International journal of cardiology","COVID-19; Cardiovascular disease; Cardiovascular magnetic resonance; Echocardiography; Follow-up; Myocarditis","Galea","Nicola","Department of Radiological, Oncological and Pathological Sciences, Sapienza University of Rome, ""Policlinico Umberto I"" Hospital, Rome, Italy",NA
"1833","34224766","10.1016/j.ijcard.2021.06.056","Cardiac involvement in consecutive unselected hospitalized COVID-19 population: In-hospital evaluation and one-year follow-up.","Cardiovascular disease (CVD) can occur in COVID-19 and has impact on clinical course. Data on CVD prevalence in hospitalized COVID-19 patients and sequelae in survivors is limited. Aim of this prospective study carried out on consecutive unselected COVID-19 population, was to assess: 1) CVD occurrence among hospitalized COVID-19 patients, 2) persistence or new onset of CVD at one-month and one-year follow-up. Over 30 days n = 152 COVID-19 patients underwent cardiovascular evaluation. Standard el","2021","07","20","Int J Cardiol","International journal of cardiology","COVID-19; Cardiovascular disease; Cardiovascular magnetic resonance; Echocardiography; Follow-up; Myocarditis","Severino","Paolo","Department of Clinical, Internal, Anesthesiological and Cardiovascular Sciences, Sapienza University of Rome, ""Policlinico Umberto I"" Hospital, Rome, Italy",NA
"1834","34224766","10.1016/j.ijcard.2021.06.056","Cardiac involvement in consecutive unselected hospitalized COVID-19 population: In-hospital evaluation and one-year follow-up.","Cardiovascular disease (CVD) can occur in COVID-19 and has impact on clinical course. Data on CVD prevalence in hospitalized COVID-19 patients and sequelae in survivors is limited. Aim of this prospective study carried out on consecutive unselected COVID-19 population, was to assess: 1) CVD occurrence among hospitalized COVID-19 patients, 2) persistence or new onset of CVD at one-month and one-year follow-up. Over 30 days n = 152 COVID-19 patients underwent cardiovascular evaluation. Standard el","2021","07","20","Int J Cardiol","International journal of cardiology","COVID-19; Cardiovascular disease; Cardiovascular magnetic resonance; Echocardiography; Follow-up; Myocarditis","Alessandri","Francesco","Department of Anaesthesia and Intensive Care Medicine, Sapienza University of Rome, ""Policlinico Umberto I"" Hospital, Rome, Italy",NA
"1835","34224766","10.1016/j.ijcard.2021.06.056","Cardiac involvement in consecutive unselected hospitalized COVID-19 population: In-hospital evaluation and one-year follow-up.","Cardiovascular disease (CVD) can occur in COVID-19 and has impact on clinical course. Data on CVD prevalence in hospitalized COVID-19 patients and sequelae in survivors is limited. Aim of this prospective study carried out on consecutive unselected COVID-19 population, was to assess: 1) CVD occurrence among hospitalized COVID-19 patients, 2) persistence or new onset of CVD at one-month and one-year follow-up. Over 30 days n = 152 COVID-19 patients underwent cardiovascular evaluation. Standard el","2021","07","20","Int J Cardiol","International journal of cardiology","COVID-19; Cardiovascular disease; Cardiovascular magnetic resonance; Echocardiography; Follow-up; Myocarditis","Colaiacomo","Maria Chiara","Radiology DEA Department, Sapienza University of Rome, ""Policlinico Umberto I"" Hospital, Rome, Italy",NA
"1836","34224766","10.1016/j.ijcard.2021.06.056","Cardiac involvement in consecutive unselected hospitalized COVID-19 population: In-hospital evaluation and one-year follow-up.","Cardiovascular disease (CVD) can occur in COVID-19 and has impact on clinical course. Data on CVD prevalence in hospitalized COVID-19 patients and sequelae in survivors is limited. Aim of this prospective study carried out on consecutive unselected COVID-19 population, was to assess: 1) CVD occurrence among hospitalized COVID-19 patients, 2) persistence or new onset of CVD at one-month and one-year follow-up. Over 30 days n = 152 COVID-19 patients underwent cardiovascular evaluation. Standard el","2021","07","20","Int J Cardiol","International journal of cardiology","COVID-19; Cardiovascular disease; Cardiovascular magnetic resonance; Echocardiography; Follow-up; Myocarditis","Cundari","Giulia","Department of Radiological, Oncological and Pathological Sciences, Sapienza University of Rome, ""Policlinico Umberto I"" Hospital, Rome, Italy",NA
"1837","34224766","10.1016/j.ijcard.2021.06.056","Cardiac involvement in consecutive unselected hospitalized COVID-19 population: In-hospital evaluation and one-year follow-up.","Cardiovascular disease (CVD) can occur in COVID-19 and has impact on clinical course. Data on CVD prevalence in hospitalized COVID-19 patients and sequelae in survivors is limited. Aim of this prospective study carried out on consecutive unselected COVID-19 population, was to assess: 1) CVD occurrence among hospitalized COVID-19 patients, 2) persistence or new onset of CVD at one-month and one-year follow-up. Over 30 days n = 152 COVID-19 patients underwent cardiovascular evaluation. Standard el","2021","07","20","Int J Cardiol","International journal of cardiology","COVID-19; Cardiovascular disease; Cardiovascular magnetic resonance; Echocardiography; Follow-up; Myocarditis","Chimenti","Cristina","Department of Clinical, Internal, Anesthesiological and Cardiovascular Sciences, Sapienza University of Rome, ""Policlinico Umberto I"" Hospital, Rome, Italy",NA
"1838","34224766","10.1016/j.ijcard.2021.06.056","Cardiac involvement in consecutive unselected hospitalized COVID-19 population: In-hospital evaluation and one-year follow-up.","Cardiovascular disease (CVD) can occur in COVID-19 and has impact on clinical course. Data on CVD prevalence in hospitalized COVID-19 patients and sequelae in survivors is limited. Aim of this prospective study carried out on consecutive unselected COVID-19 population, was to assess: 1) CVD occurrence among hospitalized COVID-19 patients, 2) persistence or new onset of CVD at one-month and one-year follow-up. Over 30 days n = 152 COVID-19 patients underwent cardiovascular evaluation. Standard el","2021","07","20","Int J Cardiol","International journal of cardiology","COVID-19; Cardiovascular disease; Cardiovascular magnetic resonance; Echocardiography; Follow-up; Myocarditis","Lavalle","Carlo","Department of Clinical, Internal, Anesthesiological and Cardiovascular Sciences, Sapienza University of Rome, ""Policlinico Umberto I"" Hospital, Rome, Italy",NA
"1839","34224766","10.1016/j.ijcard.2021.06.056","Cardiac involvement in consecutive unselected hospitalized COVID-19 population: In-hospital evaluation and one-year follow-up.","Cardiovascular disease (CVD) can occur in COVID-19 and has impact on clinical course. Data on CVD prevalence in hospitalized COVID-19 patients and sequelae in survivors is limited. Aim of this prospective study carried out on consecutive unselected COVID-19 population, was to assess: 1) CVD occurrence among hospitalized COVID-19 patients, 2) persistence or new onset of CVD at one-month and one-year follow-up. Over 30 days n = 152 COVID-19 patients underwent cardiovascular evaluation. Standard el","2021","07","20","Int J Cardiol","International journal of cardiology","COVID-19; Cardiovascular disease; Cardiovascular magnetic resonance; Echocardiography; Follow-up; Myocarditis","Ciardi","Maria","Department of Public Health and Infectious Diseases, Sapienza University of Rome, ""Policlinico Umberto I"" Hospital, Rome, Italy",NA
"1840","34224766","10.1016/j.ijcard.2021.06.056","Cardiac involvement in consecutive unselected hospitalized COVID-19 population: In-hospital evaluation and one-year follow-up.","Cardiovascular disease (CVD) can occur in COVID-19 and has impact on clinical course. Data on CVD prevalence in hospitalized COVID-19 patients and sequelae in survivors is limited. Aim of this prospective study carried out on consecutive unselected COVID-19 population, was to assess: 1) CVD occurrence among hospitalized COVID-19 patients, 2) persistence or new onset of CVD at one-month and one-year follow-up. Over 30 days n = 152 COVID-19 patients underwent cardiovascular evaluation. Standard el","2021","07","20","Int J Cardiol","International journal of cardiology","COVID-19; Cardiovascular disease; Cardiovascular magnetic resonance; Echocardiography; Follow-up; Myocarditis","Palange","Paolo","Department of Public Health and Infectious Diseases, Division of Pulmonary Medicine, Sapienza University of Rome, ""Policlinico Umberto I"" Hospital, Rome, Italy",NA
"1841","34224766","10.1016/j.ijcard.2021.06.056","Cardiac involvement in consecutive unselected hospitalized COVID-19 population: In-hospital evaluation and one-year follow-up.","Cardiovascular disease (CVD) can occur in COVID-19 and has impact on clinical course. Data on CVD prevalence in hospitalized COVID-19 patients and sequelae in survivors is limited. Aim of this prospective study carried out on consecutive unselected COVID-19 population, was to assess: 1) CVD occurrence among hospitalized COVID-19 patients, 2) persistence or new onset of CVD at one-month and one-year follow-up. Over 30 days n = 152 COVID-19 patients underwent cardiovascular evaluation. Standard el","2021","07","20","Int J Cardiol","International journal of cardiology","COVID-19; Cardiovascular disease; Cardiovascular magnetic resonance; Echocardiography; Follow-up; Myocarditis","Deales","Alberto","""Policlinico Umberto I"" Hospital, Rome, Italy",NA
"1842","34224766","10.1016/j.ijcard.2021.06.056","Cardiac involvement in consecutive unselected hospitalized COVID-19 population: In-hospital evaluation and one-year follow-up.","Cardiovascular disease (CVD) can occur in COVID-19 and has impact on clinical course. Data on CVD prevalence in hospitalized COVID-19 patients and sequelae in survivors is limited. Aim of this prospective study carried out on consecutive unselected COVID-19 population, was to assess: 1) CVD occurrence among hospitalized COVID-19 patients, 2) persistence or new onset of CVD at one-month and one-year follow-up. Over 30 days n = 152 COVID-19 patients underwent cardiovascular evaluation. Standard el","2021","07","20","Int J Cardiol","International journal of cardiology","COVID-19; Cardiovascular disease; Cardiovascular magnetic resonance; Echocardiography; Follow-up; Myocarditis","d'Ettorre","Gabriella","Department of Public Health and Infectious Diseases, Sapienza University of Rome, ""Policlinico Umberto I"" Hospital, Rome, Italy",NA
"1843","34224766","10.1016/j.ijcard.2021.06.056","Cardiac involvement in consecutive unselected hospitalized COVID-19 population: In-hospital evaluation and one-year follow-up.","Cardiovascular disease (CVD) can occur in COVID-19 and has impact on clinical course. Data on CVD prevalence in hospitalized COVID-19 patients and sequelae in survivors is limited. Aim of this prospective study carried out on consecutive unselected COVID-19 population, was to assess: 1) CVD occurrence among hospitalized COVID-19 patients, 2) persistence or new onset of CVD at one-month and one-year follow-up. Over 30 days n = 152 COVID-19 patients underwent cardiovascular evaluation. Standard el","2021","07","20","Int J Cardiol","International journal of cardiology","COVID-19; Cardiovascular disease; Cardiovascular magnetic resonance; Echocardiography; Follow-up; Myocarditis","Mastroianni","Claudio M","Department of Public Health and Infectious Diseases, Sapienza University of Rome, ""Policlinico Umberto I"" Hospital, Rome, Italy",NA
"1844","34224766","10.1016/j.ijcard.2021.06.056","Cardiac involvement in consecutive unselected hospitalized COVID-19 population: In-hospital evaluation and one-year follow-up.","Cardiovascular disease (CVD) can occur in COVID-19 and has impact on clinical course. Data on CVD prevalence in hospitalized COVID-19 patients and sequelae in survivors is limited. Aim of this prospective study carried out on consecutive unselected COVID-19 population, was to assess: 1) CVD occurrence among hospitalized COVID-19 patients, 2) persistence or new onset of CVD at one-month and one-year follow-up. Over 30 days n = 152 COVID-19 patients underwent cardiovascular evaluation. Standard el","2021","07","20","Int J Cardiol","International journal of cardiology","COVID-19; Cardiovascular disease; Cardiovascular magnetic resonance; Echocardiography; Follow-up; Myocarditis","Catalano","Carlo","Department of Radiological, Oncological and Pathological Sciences, Sapienza University of Rome, ""Policlinico Umberto I"" Hospital, Rome, Italy",NA
"1845","34224766","10.1016/j.ijcard.2021.06.056","Cardiac involvement in consecutive unselected hospitalized COVID-19 population: In-hospital evaluation and one-year follow-up.","Cardiovascular disease (CVD) can occur in COVID-19 and has impact on clinical course. Data on CVD prevalence in hospitalized COVID-19 patients and sequelae in survivors is limited. Aim of this prospective study carried out on consecutive unselected COVID-19 population, was to assess: 1) CVD occurrence among hospitalized COVID-19 patients, 2) persistence or new onset of CVD at one-month and one-year follow-up. Over 30 days n = 152 COVID-19 patients underwent cardiovascular evaluation. Standard el","2021","07","20","Int J Cardiol","International journal of cardiology","COVID-19; Cardiovascular disease; Cardiovascular magnetic resonance; Echocardiography; Follow-up; Myocarditis","Ruberto","Franco","Department of Anaesthesia and Intensive Care Medicine, Sapienza University of Rome, ""Policlinico Umberto I"" Hospital, Rome, Italy",NA
"1846","34224766","10.1016/j.ijcard.2021.06.056","Cardiac involvement in consecutive unselected hospitalized COVID-19 population: In-hospital evaluation and one-year follow-up.","Cardiovascular disease (CVD) can occur in COVID-19 and has impact on clinical course. Data on CVD prevalence in hospitalized COVID-19 patients and sequelae in survivors is limited. Aim of this prospective study carried out on consecutive unselected COVID-19 population, was to assess: 1) CVD occurrence among hospitalized COVID-19 patients, 2) persistence or new onset of CVD at one-month and one-year follow-up. Over 30 days n = 152 COVID-19 patients underwent cardiovascular evaluation. Standard el","2021","07","20","Int J Cardiol","International journal of cardiology","COVID-19; Cardiovascular disease; Cardiovascular magnetic resonance; Echocardiography; Follow-up; Myocarditis","Pugliese","Francesco","Department of Anaesthesia and Intensive Care Medicine, Sapienza University of Rome, ""Policlinico Umberto I"" Hospital, Rome, Italy",NA
"1847","34224766","10.1016/j.ijcard.2021.06.056","Cardiac involvement in consecutive unselected hospitalized COVID-19 population: In-hospital evaluation and one-year follow-up.","Cardiovascular disease (CVD) can occur in COVID-19 and has impact on clinical course. Data on CVD prevalence in hospitalized COVID-19 patients and sequelae in survivors is limited. Aim of this prospective study carried out on consecutive unselected COVID-19 population, was to assess: 1) CVD occurrence among hospitalized COVID-19 patients, 2) persistence or new onset of CVD at one-month and one-year follow-up. Over 30 days n = 152 COVID-19 patients underwent cardiovascular evaluation. Standard el","2021","07","20","Int J Cardiol","International journal of cardiology","COVID-19; Cardiovascular disease; Cardiovascular magnetic resonance; Echocardiography; Follow-up; Myocarditis","d'Amati","Giulia","Department of Radiological, Oncological and Pathological Sciences, Sapienza University of Rome, ""Policlinico Umberto I"" Hospital, Rome, Italy",NA
"1848","34224766","10.1016/j.ijcard.2021.06.056","Cardiac involvement in consecutive unselected hospitalized COVID-19 population: In-hospital evaluation and one-year follow-up.","Cardiovascular disease (CVD) can occur in COVID-19 and has impact on clinical course. Data on CVD prevalence in hospitalized COVID-19 patients and sequelae in survivors is limited. Aim of this prospective study carried out on consecutive unselected COVID-19 population, was to assess: 1) CVD occurrence among hospitalized COVID-19 patients, 2) persistence or new onset of CVD at one-month and one-year follow-up. Over 30 days n = 152 COVID-19 patients underwent cardiovascular evaluation. Standard el","2021","07","20","Int J Cardiol","International journal of cardiology","COVID-19; Cardiovascular disease; Cardiovascular magnetic resonance; Echocardiography; Follow-up; Myocarditis","Fedele","Francesco","Department of Clinical, Internal, Anesthesiological and Cardiovascular Sciences, Sapienza University of Rome, ""Policlinico Umberto I"" Hospital, Rome, Italy",NA
"1849","34224766","10.1016/j.ijcard.2021.06.056","Cardiac involvement in consecutive unselected hospitalized COVID-19 population: In-hospital evaluation and one-year follow-up.","Cardiovascular disease (CVD) can occur in COVID-19 and has impact on clinical course. Data on CVD prevalence in hospitalized COVID-19 patients and sequelae in survivors is limited. Aim of this prospective study carried out on consecutive unselected COVID-19 population, was to assess: 1) CVD occurrence among hospitalized COVID-19 patients, 2) persistence or new onset of CVD at one-month and one-year follow-up. Over 30 days n = 152 COVID-19 patients underwent cardiovascular evaluation. Standard el","2021","07","20","Int J Cardiol","International journal of cardiology","COVID-19; Cardiovascular disease; Cardiovascular magnetic resonance; Echocardiography; Follow-up; Myocarditis","Mancone","Massimo","Department of Clinical, Internal, Anesthesiological and Cardiovascular Sciences, Sapienza University of Rome, ""Policlinico Umberto I"" Hospital, Rome, Italy. Electronic address: massimo.mancone@uniroma1","massimo.mancone@uniroma1.it"
"1850","34224754","10.1016/j.jviromet.2021.114228","Evaluation of a surrogate virus neutralization test for high-throughput serosurveillance of SARS-CoV-2.","High-throughput serological tests that can detect neutralizing antibodies against SARS-CoV-2 are desirable for serosurveillance and vaccine efficacy evaluation. Although the conventional neutralization test (cVNT) remains the gold standard to confirm the presence of neutralizing antibodies in sera, the test is too labour-intensive for massive screening programs and less reproducible as live virus and cell culture is involved. Here, we performed an independent evaluation of a commercially availab","2021","07","08","J Virol Methods","Journal of virological methods","Luminex; SARS-CoV-2; cPass; neutralizing antibody test; serosurveillance","Mariën","Joachim","Virology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium","joachim.marien@uantwerpen.be"
"1851","34224754","10.1016/j.jviromet.2021.114228","Evaluation of a surrogate virus neutralization test for high-throughput serosurveillance of SARS-CoV-2.","High-throughput serological tests that can detect neutralizing antibodies against SARS-CoV-2 are desirable for serosurveillance and vaccine efficacy evaluation. Although the conventional neutralization test (cVNT) remains the gold standard to confirm the presence of neutralizing antibodies in sera, the test is too labour-intensive for massive screening programs and less reproducible as live virus and cell culture is involved. Here, we performed an independent evaluation of a commercially availab","2021","07","08","J Virol Methods","Journal of virological methods","Luminex; SARS-CoV-2; cPass; neutralizing antibody test; serosurveillance","Michiels","Johan","Virology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium",NA
"1852","34224754","10.1016/j.jviromet.2021.114228","Evaluation of a surrogate virus neutralization test for high-throughput serosurveillance of SARS-CoV-2.","High-throughput serological tests that can detect neutralizing antibodies against SARS-CoV-2 are desirable for serosurveillance and vaccine efficacy evaluation. Although the conventional neutralization test (cVNT) remains the gold standard to confirm the presence of neutralizing antibodies in sera, the test is too labour-intensive for massive screening programs and less reproducible as live virus and cell culture is involved. Here, we performed an independent evaluation of a commercially availab","2021","07","08","J Virol Methods","Journal of virological methods","Luminex; SARS-CoV-2; cPass; neutralizing antibody test; serosurveillance","Heyndrickx","Leo","Virology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium",NA
"1853","34224754","10.1016/j.jviromet.2021.114228","Evaluation of a surrogate virus neutralization test for high-throughput serosurveillance of SARS-CoV-2.","High-throughput serological tests that can detect neutralizing antibodies against SARS-CoV-2 are desirable for serosurveillance and vaccine efficacy evaluation. Although the conventional neutralization test (cVNT) remains the gold standard to confirm the presence of neutralizing antibodies in sera, the test is too labour-intensive for massive screening programs and less reproducible as live virus and cell culture is involved. Here, we performed an independent evaluation of a commercially availab","2021","07","08","J Virol Methods","Journal of virological methods","Luminex; SARS-CoV-2; cPass; neutralizing antibody test; serosurveillance","Nkuba-Ndaye","Antoine","Department of Virology, Institut National de Recherche Biomédicale, Kinshasa, Democratic Republic of the Congo",NA
"1854","34224754","10.1016/j.jviromet.2021.114228","Evaluation of a surrogate virus neutralization test for high-throughput serosurveillance of SARS-CoV-2.","High-throughput serological tests that can detect neutralizing antibodies against SARS-CoV-2 are desirable for serosurveillance and vaccine efficacy evaluation. Although the conventional neutralization test (cVNT) remains the gold standard to confirm the presence of neutralizing antibodies in sera, the test is too labour-intensive for massive screening programs and less reproducible as live virus and cell culture is involved. Here, we performed an independent evaluation of a commercially availab","2021","07","08","J Virol Methods","Journal of virological methods","Luminex; SARS-CoV-2; cPass; neutralizing antibody test; serosurveillance","Ceulemans","Ann","Virology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium",NA
"1855","34224754","10.1016/j.jviromet.2021.114228","Evaluation of a surrogate virus neutralization test for high-throughput serosurveillance of SARS-CoV-2.","High-throughput serological tests that can detect neutralizing antibodies against SARS-CoV-2 are desirable for serosurveillance and vaccine efficacy evaluation. Although the conventional neutralization test (cVNT) remains the gold standard to confirm the presence of neutralizing antibodies in sera, the test is too labour-intensive for massive screening programs and less reproducible as live virus and cell culture is involved. Here, we performed an independent evaluation of a commercially availab","2021","07","08","J Virol Methods","Journal of virological methods","Luminex; SARS-CoV-2; cPass; neutralizing antibody test; serosurveillance","Bartholomeeusen","Koen","Virology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium",NA
"1856","34224754","10.1016/j.jviromet.2021.114228","Evaluation of a surrogate virus neutralization test for high-throughput serosurveillance of SARS-CoV-2.","High-throughput serological tests that can detect neutralizing antibodies against SARS-CoV-2 are desirable for serosurveillance and vaccine efficacy evaluation. Although the conventional neutralization test (cVNT) remains the gold standard to confirm the presence of neutralizing antibodies in sera, the test is too labour-intensive for massive screening programs and less reproducible as live virus and cell culture is involved. Here, we performed an independent evaluation of a commercially availab","2021","07","08","J Virol Methods","Journal of virological methods","Luminex; SARS-CoV-2; cPass; neutralizing antibody test; serosurveillance","Madinga","Joule","Department of Virology, Institut National de Recherche Biomédicale, Kinshasa, Democratic Republic of the Congo",NA
"1857","34224754","10.1016/j.jviromet.2021.114228","Evaluation of a surrogate virus neutralization test for high-throughput serosurveillance of SARS-CoV-2.","High-throughput serological tests that can detect neutralizing antibodies against SARS-CoV-2 are desirable for serosurveillance and vaccine efficacy evaluation. Although the conventional neutralization test (cVNT) remains the gold standard to confirm the presence of neutralizing antibodies in sera, the test is too labour-intensive for massive screening programs and less reproducible as live virus and cell culture is involved. Here, we performed an independent evaluation of a commercially availab","2021","07","08","J Virol Methods","Journal of virological methods","Luminex; SARS-CoV-2; cPass; neutralizing antibody test; serosurveillance","Mbala-Kingebeni","Placide","Department of Virology, Institut National de Recherche Biomédicale, Kinshasa, Democratic Republic of the Congo",NA
"1858","34224754","10.1016/j.jviromet.2021.114228","Evaluation of a surrogate virus neutralization test for high-throughput serosurveillance of SARS-CoV-2.","High-throughput serological tests that can detect neutralizing antibodies against SARS-CoV-2 are desirable for serosurveillance and vaccine efficacy evaluation. Although the conventional neutralization test (cVNT) remains the gold standard to confirm the presence of neutralizing antibodies in sera, the test is too labour-intensive for massive screening programs and less reproducible as live virus and cell culture is involved. Here, we performed an independent evaluation of a commercially availab","2021","07","08","J Virol Methods","Journal of virological methods","Luminex; SARS-CoV-2; cPass; neutralizing antibody test; serosurveillance","Vanlerberghe","Veerle","Department of Public Health, Institute of Tropical Medicine, Antwerp, Belgium",NA
"1859","34224754","10.1016/j.jviromet.2021.114228","Evaluation of a surrogate virus neutralization test for high-throughput serosurveillance of SARS-CoV-2.","High-throughput serological tests that can detect neutralizing antibodies against SARS-CoV-2 are desirable for serosurveillance and vaccine efficacy evaluation. Although the conventional neutralization test (cVNT) remains the gold standard to confirm the presence of neutralizing antibodies in sera, the test is too labour-intensive for massive screening programs and less reproducible as live virus and cell culture is involved. Here, we performed an independent evaluation of a commercially availab","2021","07","08","J Virol Methods","Journal of virological methods","Luminex; SARS-CoV-2; cPass; neutralizing antibody test; serosurveillance","Ahuka-Mundeke","Steve","Department of Virology, Institut National de Recherche Biomédicale, Kinshasa, Democratic Republic of the Congo",NA
"1860","34224754","10.1016/j.jviromet.2021.114228","Evaluation of a surrogate virus neutralization test for high-throughput serosurveillance of SARS-CoV-2.","High-throughput serological tests that can detect neutralizing antibodies against SARS-CoV-2 are desirable for serosurveillance and vaccine efficacy evaluation. Although the conventional neutralization test (cVNT) remains the gold standard to confirm the presence of neutralizing antibodies in sera, the test is too labour-intensive for massive screening programs and less reproducible as live virus and cell culture is involved. Here, we performed an independent evaluation of a commercially availab","2021","07","08","J Virol Methods","Journal of virological methods","Luminex; SARS-CoV-2; cPass; neutralizing antibody test; serosurveillance","Wang","Lin-Fa","Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore",NA
"1861","34224754","10.1016/j.jviromet.2021.114228","Evaluation of a surrogate virus neutralization test for high-throughput serosurveillance of SARS-CoV-2.","High-throughput serological tests that can detect neutralizing antibodies against SARS-CoV-2 are desirable for serosurveillance and vaccine efficacy evaluation. Although the conventional neutralization test (cVNT) remains the gold standard to confirm the presence of neutralizing antibodies in sera, the test is too labour-intensive for massive screening programs and less reproducible as live virus and cell culture is involved. Here, we performed an independent evaluation of a commercially availab","2021","07","08","J Virol Methods","Journal of virological methods","Luminex; SARS-CoV-2; cPass; neutralizing antibody test; serosurveillance","Ariën","Kevin K","Virology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium",NA
"1862","34224753","10.1016/j.jviromet.2021.114223","Serological response to a single dose of a SARS-CoV-2 mRNA vaccine.","The delays in the production and delivery of COVID-19 vaccines and the growing number of fatal infections across the globe raised the question whether it would be more advantageous to vaccinate a larger group of individuals with one dose instead of a smaller one with two doses. Through a group of vaccinated healthcare workers, we describe the qualitative and quantitative serological response to a single dose of the BNT162b2 vaccine. We found that, before the second dose inoculation, 95.3 % (182/","2021","07","17","J Virol Methods","Journal of virological methods","BNT162b2; Multiplex imunnosassay; SARS-CoV-2; mRNA vaccine","Ramos","Angélica","Serviço de Patologia Clínica, Centro Hospitalar e Universitário de São João, Porto, Portugal","angelica.ramos@chsj.min"
"1863","34224753","10.1016/j.jviromet.2021.114223","Serological response to a single dose of a SARS-CoV-2 mRNA vaccine.","The delays in the production and delivery of COVID-19 vaccines and the growing number of fatal infections across the globe raised the question whether it would be more advantageous to vaccinate a larger group of individuals with one dose instead of a smaller one with two doses. Through a group of vaccinated healthcare workers, we describe the qualitative and quantitative serological response to a single dose of the BNT162b2 vaccine. We found that, before the second dose inoculation, 95.3 % (182/","2021","07","17","J Virol Methods","Journal of virological methods","BNT162b2; Multiplex imunnosassay; SARS-CoV-2; mRNA vaccine","Cardoso","Maria João","Serviço de Patologia Clínica, Centro Hospitalar e Universitário de São João, Porto, Portugal",NA
"1864","34224753","10.1016/j.jviromet.2021.114223","Serological response to a single dose of a SARS-CoV-2 mRNA vaccine.","The delays in the production and delivery of COVID-19 vaccines and the growing number of fatal infections across the globe raised the question whether it would be more advantageous to vaccinate a larger group of individuals with one dose instead of a smaller one with two doses. Through a group of vaccinated healthcare workers, we describe the qualitative and quantitative serological response to a single dose of the BNT162b2 vaccine. We found that, before the second dose inoculation, 95.3 % (182/","2021","07","17","J Virol Methods","Journal of virological methods","BNT162b2; Multiplex imunnosassay; SARS-CoV-2; mRNA vaccine","Norton","Pedro","Serviço de Saúde Ocupacional, Centro Hospitalar e Universitário de São João, Porto, Portugal",NA
"1865","34224753","10.1016/j.jviromet.2021.114223","Serological response to a single dose of a SARS-CoV-2 mRNA vaccine.","The delays in the production and delivery of COVID-19 vaccines and the growing number of fatal infections across the globe raised the question whether it would be more advantageous to vaccinate a larger group of individuals with one dose instead of a smaller one with two doses. Through a group of vaccinated healthcare workers, we describe the qualitative and quantitative serological response to a single dose of the BNT162b2 vaccine. We found that, before the second dose inoculation, 95.3 % (182/","2021","07","17","J Virol Methods","Journal of virological methods","BNT162b2; Multiplex imunnosassay; SARS-CoV-2; mRNA vaccine","Sarmento","António","Serviço de Doenças Infeciosas, Centro Hospitalar e Universitário de São João, Porto, Portugal",NA
"1866","34224753","10.1016/j.jviromet.2021.114223","Serological response to a single dose of a SARS-CoV-2 mRNA vaccine.","The delays in the production and delivery of COVID-19 vaccines and the growing number of fatal infections across the globe raised the question whether it would be more advantageous to vaccinate a larger group of individuals with one dose instead of a smaller one with two doses. Through a group of vaccinated healthcare workers, we describe the qualitative and quantitative serological response to a single dose of the BNT162b2 vaccine. We found that, before the second dose inoculation, 95.3 % (182/","2021","07","17","J Virol Methods","Journal of virological methods","BNT162b2; Multiplex imunnosassay; SARS-CoV-2; mRNA vaccine","Guimarães","João Tiago","Serviço de Patologia Clínica, Centro Hospitalar e Universitário de São João, Porto, Portugal",NA
"1867","34224752","10.1016/j.jviromet.2021.114227","Isothermal recombinase polymerase amplification-lateral flow detection of SARS-CoV-2, the etiological agent of COVID-19.","The rapid detection of novel pathogens including SARS-CoV-2 necessitates the development of easy-to-use diagnostic tests that can be readily adapted and utilized in both clinical laboratories and field settings. Delay in diagnosis has facilitated the rapid spread of this novel virus throughout the world resulting in global mortality that will surpass 2.5 million people. Development of point-of-care diagnostic assays that can be performed in rural or decentralized health care centers to expand te","2021","07","17","J Virol Methods","Journal of virological methods","Coronavirus; Diagnostics; Lateral flow; Point-of-care; RPA; SARS-CoV-2","Shelite","Thomas R","Dept. of Internal Medicine-Infectious Diseases, Univ. of Texas Medical Branch, Galveston, TX, United States. Electronic address: trshelit@utmb","trshelit@utmb.edu"
"1868","34224752","10.1016/j.jviromet.2021.114227","Isothermal recombinase polymerase amplification-lateral flow detection of SARS-CoV-2, the etiological agent of COVID-19.","The rapid detection of novel pathogens including SARS-CoV-2 necessitates the development of easy-to-use diagnostic tests that can be readily adapted and utilized in both clinical laboratories and field settings. Delay in diagnosis has facilitated the rapid spread of this novel virus throughout the world resulting in global mortality that will surpass 2.5 million people. Development of point-of-care diagnostic assays that can be performed in rural or decentralized health care centers to expand te","2021","07","17","J Virol Methods","Journal of virological methods","Coronavirus; Diagnostics; Lateral flow; Point-of-care; RPA; SARS-CoV-2","Uscanga-Palomeque","Ashanti C","Dept. of Internal Medicine-Infectious Diseases, Univ. of Texas Medical Branch, Galveston, TX, United States. Electronic address: asuscang@utmb","asuscang@utmb.edu"
"1869","34224752","10.1016/j.jviromet.2021.114227","Isothermal recombinase polymerase amplification-lateral flow detection of SARS-CoV-2, the etiological agent of COVID-19.","The rapid detection of novel pathogens including SARS-CoV-2 necessitates the development of easy-to-use diagnostic tests that can be readily adapted and utilized in both clinical laboratories and field settings. Delay in diagnosis has facilitated the rapid spread of this novel virus throughout the world resulting in global mortality that will surpass 2.5 million people. Development of point-of-care diagnostic assays that can be performed in rural or decentralized health care centers to expand te","2021","07","17","J Virol Methods","Journal of virological methods","Coronavirus; Diagnostics; Lateral flow; Point-of-care; RPA; SARS-CoV-2","Castellanos-Gonzalez","Alejandro","Dept. of Internal Medicine-Infectious Diseases, Univ. of Texas Medical Branch, Galveston, TX, United States. Electronic address: alcastel@utmb","alcastel@utmb.edu"
"1870","34224752","10.1016/j.jviromet.2021.114227","Isothermal recombinase polymerase amplification-lateral flow detection of SARS-CoV-2, the etiological agent of COVID-19.","The rapid detection of novel pathogens including SARS-CoV-2 necessitates the development of easy-to-use diagnostic tests that can be readily adapted and utilized in both clinical laboratories and field settings. Delay in diagnosis has facilitated the rapid spread of this novel virus throughout the world resulting in global mortality that will surpass 2.5 million people. Development of point-of-care diagnostic assays that can be performed in rural or decentralized health care centers to expand te","2021","07","17","J Virol Methods","Journal of virological methods","Coronavirus; Diagnostics; Lateral flow; Point-of-care; RPA; SARS-CoV-2","Melby","Peter C","Dept. of Internal Medicine-Infectious Diseases, Univ. of Texas Medical Branch, Galveston, TX, United States. Electronic address: pcmelby@utmb","pcmelby@utmb.edu"
"1871","34224752","10.1016/j.jviromet.2021.114227","Isothermal recombinase polymerase amplification-lateral flow detection of SARS-CoV-2, the etiological agent of COVID-19.","The rapid detection of novel pathogens including SARS-CoV-2 necessitates the development of easy-to-use diagnostic tests that can be readily adapted and utilized in both clinical laboratories and field settings. Delay in diagnosis has facilitated the rapid spread of this novel virus throughout the world resulting in global mortality that will surpass 2.5 million people. Development of point-of-care diagnostic assays that can be performed in rural or decentralized health care centers to expand te","2021","07","17","J Virol Methods","Journal of virological methods","Coronavirus; Diagnostics; Lateral flow; Point-of-care; RPA; SARS-CoV-2","Travi","Bruno L","Dept. of Internal Medicine-Infectious Diseases, Univ. of Texas Medical Branch, Galveston, TX, United States. Electronic address: brltravi@utmb","brltravi@utmb.edu"
"1872","34224744","10.1016/j.jpeds.2021.06.082","Effects of Coronavirus Disease 2019 (COVID-19) on Family Functioning.",NA,"2021","07","24","J Pediatr","The Journal of pediatrics",NA,"Ferrara","Pietro","European Paediatric Association/Union of National European Paediatric Societies and Associations (EPA/UNEPSA), Berlin, Germany",NA
"1873","34224744","10.1016/j.jpeds.2021.06.082","Effects of Coronavirus Disease 2019 (COVID-19) on Family Functioning.",NA,"2021","07","24","J Pediatr","The Journal of pediatrics",NA,"Franceschini","Giulia","University Campus BioMedico, Rome, Italy",NA
"1874","34224744","10.1016/j.jpeds.2021.06.082","Effects of Coronavirus Disease 2019 (COVID-19) on Family Functioning.",NA,"2021","07","24","J Pediatr","The Journal of pediatrics",NA,"Corsello","Giovanni","European Paediatric Association/Union of National European Paediatric Societies and Associations (EPA/UNEPSA), Berlin, Germany",NA
"1875","34224744","10.1016/j.jpeds.2021.06.082","Effects of Coronavirus Disease 2019 (COVID-19) on Family Functioning.",NA,"2021","07","24","J Pediatr","The Journal of pediatrics",NA,"Mestrovic","Julije","European Paediatric Association/Union of National European Paediatric Societies and Associations (EPA/UNEPSA), Berlin, Germany",NA
"1876","34224744","10.1016/j.jpeds.2021.06.082","Effects of Coronavirus Disease 2019 (COVID-19) on Family Functioning.",NA,"2021","07","24","J Pediatr","The Journal of pediatrics",NA,"Giardino","Ida","Department of Biomedical Sciences, University of Foggia, Foggia, Italy",NA
"1877","34224744","10.1016/j.jpeds.2021.06.082","Effects of Coronavirus Disease 2019 (COVID-19) on Family Functioning.",NA,"2021","07","24","J Pediatr","The Journal of pediatrics",NA,"Vural","Mehmet","European Paediatric Association/Union of National European Paediatric Societies and Associations (EPA/UNEPSA), Berlin, Germany",NA
"1878","34224744","10.1016/j.jpeds.2021.06.082","Effects of Coronavirus Disease 2019 (COVID-19) on Family Functioning.",NA,"2021","07","24","J Pediatr","The Journal of pediatrics",NA,"PopMD","Tudor Lucian","European Paediatric Association/Union of National European Paediatric Societies and Associations (EPA/UNEPSA), Berlin, Germany",NA
"1879","34224744","10.1016/j.jpeds.2021.06.082","Effects of Coronavirus Disease 2019 (COVID-19) on Family Functioning.",NA,"2021","07","24","J Pediatr","The Journal of pediatrics",NA,"Namazova-BaranovaMD","Leyla","European Paediatric Association/Union of National European Paediatric Societies and Associations (EPA/UNEPSA), Berlin, Germany",NA
"1880","34224744","10.1016/j.jpeds.2021.06.082","Effects of Coronavirus Disease 2019 (COVID-19) on Family Functioning.",NA,"2021","07","24","J Pediatr","The Journal of pediatrics",NA,"Somekh","Eli","European Paediatric Association/Union of National European Paediatric Societies and Associations (EPA/UNEPSA), Berlin, Germany",NA
"1881","34224744","10.1016/j.jpeds.2021.06.082","Effects of Coronavirus Disease 2019 (COVID-19) on Family Functioning.",NA,"2021","07","24","J Pediatr","The Journal of pediatrics",NA,"Indrio","Flavia","European Paediatric Association/Union of National European Paediatric Societies and Associations (EPA/UNEPSA), Berlin, Germany",NA
"1882","34224744","10.1016/j.jpeds.2021.06.082","Effects of Coronavirus Disease 2019 (COVID-19) on Family Functioning.",NA,"2021","07","24","J Pediatr","The Journal of pediatrics",NA,"Pettoello-Mantovani","Massimo","European Paediatric Association/Union of National European Paediatric Societies and Associations (EPA/UNEPSA), Berlin, Germany","mpm@unifg.it"
"1883","34224740","10.1053/j.gastro.2021.06.076","BNT162b2 mRNA COVID-19 Vaccine Effectiveness in Patients with Inflammatory Bowel Disease: Preliminary Real World Data during Mass Vaccination Campaign.",NA,"2021","07","08","Gastroenterology","Gastroenterology",NA,"Ben-Tov","Amir","Maccabi Institute for Research &amp",NA
"1884","34224740","10.1053/j.gastro.2021.06.076","BNT162b2 mRNA COVID-19 Vaccine Effectiveness in Patients with Inflammatory Bowel Disease: Preliminary Real World Data during Mass Vaccination Campaign.",NA,"2021","07","08","Gastroenterology","Gastroenterology",NA,"Banon","Tamar","Maccabi Institute for Research &amp",NA
"1885","34224740","10.1053/j.gastro.2021.06.076","BNT162b2 mRNA COVID-19 Vaccine Effectiveness in Patients with Inflammatory Bowel Disease: Preliminary Real World Data during Mass Vaccination Campaign.",NA,"2021","07","08","Gastroenterology","Gastroenterology",NA,"Chodick","Gabriel","Maccabi Institute for Research &amp",NA
"1886","34224740","10.1053/j.gastro.2021.06.076","BNT162b2 mRNA COVID-19 Vaccine Effectiveness in Patients with Inflammatory Bowel Disease: Preliminary Real World Data during Mass Vaccination Campaign.",NA,"2021","07","08","Gastroenterology","Gastroenterology",NA,"Kariv","Revital","Maccabi Institute for Research &amp",NA
"1887","34224740","10.1053/j.gastro.2021.06.076","BNT162b2 mRNA COVID-19 Vaccine Effectiveness in Patients with Inflammatory Bowel Disease: Preliminary Real World Data during Mass Vaccination Campaign.",NA,"2021","07","08","Gastroenterology","Gastroenterology",NA,"Assa","Amit","Department of Pediatrics, Assuta Ashdod University Hospital, Ashdod",NA
"1888","34224740","10.1053/j.gastro.2021.06.076","BNT162b2 mRNA COVID-19 Vaccine Effectiveness in Patients with Inflammatory Bowel Disease: Preliminary Real World Data during Mass Vaccination Campaign.",NA,"2021","07","08","Gastroenterology","Gastroenterology",NA,"Gazit","Sivan","Maccabi Institute for Research &amp",NA
"1889","34224708","10.1016/j.envres.2021.111560","CO<sub>2</sub> concentration monitoring inside educational buildings as a strategic tool to reduce the risk of Sars-CoV-2 airborne transmission.","In order to avoid SARS-CoV-2 transmission inside educational buildings and promote the safe reopening of schools, the Italian Government, in line with the other European countries and in accordance with the WHO recommendations, adopted a contingency plan including actions able to guarantee adequate air ventilation in classrooms. Therefore, in this pilot study, a surveillance activity based on the real-time monitoring of CO2 levels as a proxy of SARS-CoV-2 transmission risk, was conduc","2021","07","24","Environ Res","Environmental research","CO(2); COVID-19; Indoor ventilation conditions; NDIR sensor; SARS-CoV-2 transmission risk mitigation; School re-opening","Di Gilio","Alessia","Biology Department, University of Bari, via Orabona, 4, 70126, Bari, Italy. Electronic address: alessia.digilio@uniba","alessia.digilio@uniba.it"
"1890","34224708","10.1016/j.envres.2021.111560","CO<sub>2</sub> concentration monitoring inside educational buildings as a strategic tool to reduce the risk of Sars-CoV-2 airborne transmission.","In order to avoid SARS-CoV-2 transmission inside educational buildings and promote the safe reopening of schools, the Italian Government, in line with the other European countries and in accordance with the WHO recommendations, adopted a contingency plan including actions able to guarantee adequate air ventilation in classrooms. Therefore, in this pilot study, a surveillance activity based on the real-time monitoring of CO2 levels as a proxy of SARS-CoV-2 transmission risk, was conduc","2021","07","24","Environ Res","Environmental research","CO(2); COVID-19; Indoor ventilation conditions; NDIR sensor; SARS-CoV-2 transmission risk mitigation; School re-opening","Palmisani","Jolanda","Biology Department, University of Bari, via Orabona, 4, 70126, Bari, Italy. Electronic address: jolanda.palmisani@uniba","jolanda.palmisani@uniba.it"
"1891","34224708","10.1016/j.envres.2021.111560","CO<sub>2</sub> concentration monitoring inside educational buildings as a strategic tool to reduce the risk of Sars-CoV-2 airborne transmission.","In order to avoid SARS-CoV-2 transmission inside educational buildings and promote the safe reopening of schools, the Italian Government, in line with the other European countries and in accordance with the WHO recommendations, adopted a contingency plan including actions able to guarantee adequate air ventilation in classrooms. Therefore, in this pilot study, a surveillance activity based on the real-time monitoring of CO2 levels as a proxy of SARS-CoV-2 transmission risk, was conduc","2021","07","24","Environ Res","Environmental research","CO(2); COVID-19; Indoor ventilation conditions; NDIR sensor; SARS-CoV-2 transmission risk mitigation; School re-opening","Pulimeno","Manuela","UNESCO Chair on Health Education and Sustainable Development, Naples, Italy",NA
"1892","34224708","10.1016/j.envres.2021.111560","CO<sub>2</sub> concentration monitoring inside educational buildings as a strategic tool to reduce the risk of Sars-CoV-2 airborne transmission.","In order to avoid SARS-CoV-2 transmission inside educational buildings and promote the safe reopening of schools, the Italian Government, in line with the other European countries and in accordance with the WHO recommendations, adopted a contingency plan including actions able to guarantee adequate air ventilation in classrooms. Therefore, in this pilot study, a surveillance activity based on the real-time monitoring of CO2 levels as a proxy of SARS-CoV-2 transmission risk, was conduc","2021","07","24","Environ Res","Environmental research","CO(2); COVID-19; Indoor ventilation conditions; NDIR sensor; SARS-CoV-2 transmission risk mitigation; School re-opening","Cerino","Fabio","Befreest srl, viale Virgilio 113, 74121, Taranto, Italy",NA
"1893","34224708","10.1016/j.envres.2021.111560","CO<sub>2</sub> concentration monitoring inside educational buildings as a strategic tool to reduce the risk of Sars-CoV-2 airborne transmission.","In order to avoid SARS-CoV-2 transmission inside educational buildings and promote the safe reopening of schools, the Italian Government, in line with the other European countries and in accordance with the WHO recommendations, adopted a contingency plan including actions able to guarantee adequate air ventilation in classrooms. Therefore, in this pilot study, a surveillance activity based on the real-time monitoring of CO2 levels as a proxy of SARS-CoV-2 transmission risk, was conduc","2021","07","24","Environ Res","Environmental research","CO(2); COVID-19; Indoor ventilation conditions; NDIR sensor; SARS-CoV-2 transmission risk mitigation; School re-opening","Cacace","Mirko","Befreest srl, viale Virgilio 113, 74121, Taranto, Italy",NA
"1894","34224708","10.1016/j.envres.2021.111560","CO<sub>2</sub> concentration monitoring inside educational buildings as a strategic tool to reduce the risk of Sars-CoV-2 airborne transmission.","In order to avoid SARS-CoV-2 transmission inside educational buildings and promote the safe reopening of schools, the Italian Government, in line with the other European countries and in accordance with the WHO recommendations, adopted a contingency plan including actions able to guarantee adequate air ventilation in classrooms. Therefore, in this pilot study, a surveillance activity based on the real-time monitoring of CO2 levels as a proxy of SARS-CoV-2 transmission risk, was conduc","2021","07","24","Environ Res","Environmental research","CO(2); COVID-19; Indoor ventilation conditions; NDIR sensor; SARS-CoV-2 transmission risk mitigation; School re-opening","Miani","Alessandro","Italian Society of Environmental Medicine (SIMA), Milan, Italy",NA
"1895","34224708","10.1016/j.envres.2021.111560","CO<sub>2</sub> concentration monitoring inside educational buildings as a strategic tool to reduce the risk of Sars-CoV-2 airborne transmission.","In order to avoid SARS-CoV-2 transmission inside educational buildings and promote the safe reopening of schools, the Italian Government, in line with the other European countries and in accordance with the WHO recommendations, adopted a contingency plan including actions able to guarantee adequate air ventilation in classrooms. Therefore, in this pilot study, a surveillance activity based on the real-time monitoring of CO2 levels as a proxy of SARS-CoV-2 transmission risk, was conduc","2021","07","24","Environ Res","Environmental research","CO(2); COVID-19; Indoor ventilation conditions; NDIR sensor; SARS-CoV-2 transmission risk mitigation; School re-opening","de Gennaro","Gianluigi","Biology Department, University of Bari, via Orabona, 4, 70126, Bari, Italy",NA
"1896","34224679","10.1016/S2213-2600(21)00267-8","Battling COVID-19-related mortality: from a fight for ventilators to a cry for oxygen.",NA,"2021","07","08","Lancet Respir Med","The Lancet. Respiratory medicine",NA,"Schultz","Marcus J","Mahidol-Oxford Tropical Medicine Research Unit (MORU), Faculty of Tropical Medicine, Mahidol University, Bangkok 10400, Thailand. Electronic address: marcus.j.schultz@gmail","marcus.j.schultz@gmail.com"
"1897","34224679","10.1016/S2213-2600(21)00267-8","Battling COVID-19-related mortality: from a fight for ventilators to a cry for oxygen.",NA,"2021","07","08","Lancet Respir Med","The Lancet. Respiratory medicine",NA,"Neto","Ary Serpa","Australian and New Zealand Intensive Care Research Centre (ANZIC-RC), School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia",NA
"1898","34224679","10.1016/S2213-2600(21)00267-8","Battling COVID-19-related mortality: from a fight for ventilators to a cry for oxygen.",NA,"2021","07","08","Lancet Respir Med","The Lancet. Respiratory medicine",NA,"Paulus","Frederique","Department of Intensive Care, Amsterdam University Medical Centers, location AMC, Amsterdam, Netherlands",NA
"1899","34224678","10.1016/S2213-2600(21)00288-5","Lung transplantation for COVID-19-associated ARDS - Authors' reply.",NA,"2021","07","08","Lancet Respir Med","The Lancet. Respiratory medicine",NA,"Bharat","Ankit","Divisions of Thoracic Surgery and Pulmonary and Critical Care Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA. Electronic address: abharat@nm",NA
"1900","34224678","10.1016/S2213-2600(21)00288-5","Lung transplantation for COVID-19-associated ARDS - Authors' reply.",NA,"2021","07","08","Lancet Respir Med","The Lancet. Respiratory medicine",NA,"Hoetzenecker","Konrad","Department of Thoracic Surgery, Medical University of Vienna, Vienna, Austria",NA
"1901","34224678","10.1016/S2213-2600(21)00288-5","Lung transplantation for COVID-19-associated ARDS - Authors' reply.",NA,"2021","07","08","Lancet Respir Med","The Lancet. Respiratory medicine",NA,"Machuca","Tiago N","Department of Surgery, Division of Thoracic Surgery, University of Florida, Gainesville, FL, USA",NA
"1902","34224676","10.1016/S2213-2600(21)00279-4","Lung transplantation for COVID-19-associated ARDS.",NA,"2021","07","08","Lancet Respir Med","The Lancet. Respiratory medicine",NA,"Messika","Jonathan","APHP, Hôpital Bichat, Service de Pneumologie B et Transplantation Pulmonaire, F-75018 Paris, France","jonathan.messika@aphp.fr"
"1903","34224676","10.1016/S2213-2600(21)00279-4","Lung transplantation for COVID-19-associated ARDS.",NA,"2021","07","08","Lancet Respir Med","The Lancet. Respiratory medicine",NA,"Schmidt","Matthieu","Sorbonne Université, INSERM, UMRS_1166-ICAN, Institute of Cardiometabolism and Nutrition, Paris, France",NA
"1904","34224676","10.1016/S2213-2600(21)00279-4","Lung transplantation for COVID-19-associated ARDS.",NA,"2021","07","08","Lancet Respir Med","The Lancet. Respiratory medicine",NA,"Tran-Dinh","Alexy","Université de Paris, PHERE UMRS 1152, LVTS UMRS 1148, Paris, France",NA
"1905","34224676","10.1016/S2213-2600(21)00279-4","Lung transplantation for COVID-19-associated ARDS.",NA,"2021","07","08","Lancet Respir Med","The Lancet. Respiratory medicine",NA,"Mordant","Pierre","Université de Paris, PHERE UMRS 1152, LVTS UMRS 1148, Paris, France",NA
"1906","34224675","10.1016/S2213-2600(21)00220-4","BNT162b2 COVID-19 vaccine and correlates of humoral immune responses and dynamics: a prospective, single-centre, longitudinal cohort study in health-care workers.","Concurrent with the Pfizer-BioNTech BNT162b2 COVID-19 vaccine roll-out in Israel initiated on Dec 19, 2020, we assessed the early antibody responses and antibody kinetics after each vaccine dose in health-care workers of different ages and sexes, and with different comorbidities. We did a prospective, single-centre, longitudinal cohort study at the Sheba Medical Centre (Tel-Hashomer, Israel). Eligible participants were health-care workers at the centre who had a negative anti-SARS-CoV-2 IgG assa","2021","07","08","Lancet Respir Med","The Lancet. Respiratory medicine",NA,"Lustig","Yaniv","Central Virology Laboratory, Public Health Services, Ministry of Health, Sheba Medical Center, Tel-Hashomer, Israel","yaniv.lustig@sheba.health.gov.il"
"1907","34224675","10.1016/S2213-2600(21)00220-4","BNT162b2 COVID-19 vaccine and correlates of humoral immune responses and dynamics: a prospective, single-centre, longitudinal cohort study in health-care workers.","Concurrent with the Pfizer-BioNTech BNT162b2 COVID-19 vaccine roll-out in Israel initiated on Dec 19, 2020, we assessed the early antibody responses and antibody kinetics after each vaccine dose in health-care workers of different ages and sexes, and with different comorbidities. We did a prospective, single-centre, longitudinal cohort study at the Sheba Medical Centre (Tel-Hashomer, Israel). Eligible participants were health-care workers at the centre who had a negative anti-SARS-CoV-2 IgG assa","2021","07","08","Lancet Respir Med","The Lancet. Respiratory medicine",NA,"Sapir","Einav","Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel",NA
"1908","34224675","10.1016/S2213-2600(21)00220-4","BNT162b2 COVID-19 vaccine and correlates of humoral immune responses and dynamics: a prospective, single-centre, longitudinal cohort study in health-care workers.","Concurrent with the Pfizer-BioNTech BNT162b2 COVID-19 vaccine roll-out in Israel initiated on Dec 19, 2020, we assessed the early antibody responses and antibody kinetics after each vaccine dose in health-care workers of different ages and sexes, and with different comorbidities. We did a prospective, single-centre, longitudinal cohort study at the Sheba Medical Centre (Tel-Hashomer, Israel). Eligible participants were health-care workers at the centre who had a negative anti-SARS-CoV-2 IgG assa","2021","07","08","Lancet Respir Med","The Lancet. Respiratory medicine",NA,"Regev-Yochay","Gili","Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel",NA
"1909","34224675","10.1016/S2213-2600(21)00220-4","BNT162b2 COVID-19 vaccine and correlates of humoral immune responses and dynamics: a prospective, single-centre, longitudinal cohort study in health-care workers.","Concurrent with the Pfizer-BioNTech BNT162b2 COVID-19 vaccine roll-out in Israel initiated on Dec 19, 2020, we assessed the early antibody responses and antibody kinetics after each vaccine dose in health-care workers of different ages and sexes, and with different comorbidities. We did a prospective, single-centre, longitudinal cohort study at the Sheba Medical Centre (Tel-Hashomer, Israel). Eligible participants were health-care workers at the centre who had a negative anti-SARS-CoV-2 IgG assa","2021","07","08","Lancet Respir Med","The Lancet. Respiratory medicine",NA,"Cohen","Carmit","The Infection Prevention &amp",NA
"1910","34224675","10.1016/S2213-2600(21)00220-4","BNT162b2 COVID-19 vaccine and correlates of humoral immune responses and dynamics: a prospective, single-centre, longitudinal cohort study in health-care workers.","Concurrent with the Pfizer-BioNTech BNT162b2 COVID-19 vaccine roll-out in Israel initiated on Dec 19, 2020, we assessed the early antibody responses and antibody kinetics after each vaccine dose in health-care workers of different ages and sexes, and with different comorbidities. We did a prospective, single-centre, longitudinal cohort study at the Sheba Medical Centre (Tel-Hashomer, Israel). Eligible participants were health-care workers at the centre who had a negative anti-SARS-CoV-2 IgG assa","2021","07","08","Lancet Respir Med","The Lancet. Respiratory medicine",NA,"Fluss","Ronen","Bio-statistical and Bio-mathematical Unit, The Gertner Institute of Epidemiology and Health Policy Research, Sheba Medical Center, Tel-Hashomer, Israel",NA
"1911","34224675","10.1016/S2213-2600(21)00220-4","BNT162b2 COVID-19 vaccine and correlates of humoral immune responses and dynamics: a prospective, single-centre, longitudinal cohort study in health-care workers.","Concurrent with the Pfizer-BioNTech BNT162b2 COVID-19 vaccine roll-out in Israel initiated on Dec 19, 2020, we assessed the early antibody responses and antibody kinetics after each vaccine dose in health-care workers of different ages and sexes, and with different comorbidities. We did a prospective, single-centre, longitudinal cohort study at the Sheba Medical Centre (Tel-Hashomer, Israel). Eligible participants were health-care workers at the centre who had a negative anti-SARS-CoV-2 IgG assa","2021","07","08","Lancet Respir Med","The Lancet. Respiratory medicine",NA,"Olmer","Liraz","Bio-statistical and Bio-mathematical Unit, The Gertner Institute of Epidemiology and Health Policy Research, Sheba Medical Center, Tel-Hashomer, Israel",NA
"1912","34224675","10.1016/S2213-2600(21)00220-4","BNT162b2 COVID-19 vaccine and correlates of humoral immune responses and dynamics: a prospective, single-centre, longitudinal cohort study in health-care workers.","Concurrent with the Pfizer-BioNTech BNT162b2 COVID-19 vaccine roll-out in Israel initiated on Dec 19, 2020, we assessed the early antibody responses and antibody kinetics after each vaccine dose in health-care workers of different ages and sexes, and with different comorbidities. We did a prospective, single-centre, longitudinal cohort study at the Sheba Medical Centre (Tel-Hashomer, Israel). Eligible participants were health-care workers at the centre who had a negative anti-SARS-CoV-2 IgG assa","2021","07","08","Lancet Respir Med","The Lancet. Respiratory medicine",NA,"Indenbaum","Victoria","Central Virology Laboratory, Public Health Services, Ministry of Health, Sheba Medical Center, Tel-Hashomer, Israel",NA
"1913","34224675","10.1016/S2213-2600(21)00220-4","BNT162b2 COVID-19 vaccine and correlates of humoral immune responses and dynamics: a prospective, single-centre, longitudinal cohort study in health-care workers.","Concurrent with the Pfizer-BioNTech BNT162b2 COVID-19 vaccine roll-out in Israel initiated on Dec 19, 2020, we assessed the early antibody responses and antibody kinetics after each vaccine dose in health-care workers of different ages and sexes, and with different comorbidities. We did a prospective, single-centre, longitudinal cohort study at the Sheba Medical Centre (Tel-Hashomer, Israel). Eligible participants were health-care workers at the centre who had a negative anti-SARS-CoV-2 IgG assa","2021","07","08","Lancet Respir Med","The Lancet. Respiratory medicine",NA,"Mandelboim","Michal","Central Virology Laboratory, Public Health Services, Ministry of Health, Sheba Medical Center, Tel-Hashomer, Israel",NA
"1914","34224675","10.1016/S2213-2600(21)00220-4","BNT162b2 COVID-19 vaccine and correlates of humoral immune responses and dynamics: a prospective, single-centre, longitudinal cohort study in health-care workers.","Concurrent with the Pfizer-BioNTech BNT162b2 COVID-19 vaccine roll-out in Israel initiated on Dec 19, 2020, we assessed the early antibody responses and antibody kinetics after each vaccine dose in health-care workers of different ages and sexes, and with different comorbidities. We did a prospective, single-centre, longitudinal cohort study at the Sheba Medical Centre (Tel-Hashomer, Israel). Eligible participants were health-care workers at the centre who had a negative anti-SARS-CoV-2 IgG assa","2021","07","08","Lancet Respir Med","The Lancet. Respiratory medicine",NA,"Doolman","Ram","Laboratory Division, Sheba Medical Center, Tel-Hashomer, Israel",NA
"1915","34224675","10.1016/S2213-2600(21)00220-4","BNT162b2 COVID-19 vaccine and correlates of humoral immune responses and dynamics: a prospective, single-centre, longitudinal cohort study in health-care workers.","Concurrent with the Pfizer-BioNTech BNT162b2 COVID-19 vaccine roll-out in Israel initiated on Dec 19, 2020, we assessed the early antibody responses and antibody kinetics after each vaccine dose in health-care workers of different ages and sexes, and with different comorbidities. We did a prospective, single-centre, longitudinal cohort study at the Sheba Medical Centre (Tel-Hashomer, Israel). Eligible participants were health-care workers at the centre who had a negative anti-SARS-CoV-2 IgG assa","2021","07","08","Lancet Respir Med","The Lancet. Respiratory medicine",NA,"Amit","Sharon","Clinical Microbiology, Sheba Medical Center, Tel-Hashomer, Israel",NA
"1916","34224675","10.1016/S2213-2600(21)00220-4","BNT162b2 COVID-19 vaccine and correlates of humoral immune responses and dynamics: a prospective, single-centre, longitudinal cohort study in health-care workers.","Concurrent with the Pfizer-BioNTech BNT162b2 COVID-19 vaccine roll-out in Israel initiated on Dec 19, 2020, we assessed the early antibody responses and antibody kinetics after each vaccine dose in health-care workers of different ages and sexes, and with different comorbidities. We did a prospective, single-centre, longitudinal cohort study at the Sheba Medical Centre (Tel-Hashomer, Israel). Eligible participants were health-care workers at the centre who had a negative anti-SARS-CoV-2 IgG assa","2021","07","08","Lancet Respir Med","The Lancet. Respiratory medicine",NA,"Mendelson","Ella","Central Virology Laboratory, Public Health Services, Ministry of Health, Sheba Medical Center, Tel-Hashomer, Israel",NA
"1917","34224675","10.1016/S2213-2600(21)00220-4","BNT162b2 COVID-19 vaccine and correlates of humoral immune responses and dynamics: a prospective, single-centre, longitudinal cohort study in health-care workers.","Concurrent with the Pfizer-BioNTech BNT162b2 COVID-19 vaccine roll-out in Israel initiated on Dec 19, 2020, we assessed the early antibody responses and antibody kinetics after each vaccine dose in health-care workers of different ages and sexes, and with different comorbidities. We did a prospective, single-centre, longitudinal cohort study at the Sheba Medical Centre (Tel-Hashomer, Israel). Eligible participants were health-care workers at the centre who had a negative anti-SARS-CoV-2 IgG assa","2021","07","08","Lancet Respir Med","The Lancet. Respiratory medicine",NA,"Ziv","Arnona","Bio-statistical and Bio-mathematical Unit, The Gertner Institute of Epidemiology and Health Policy Research, Sheba Medical Center, Tel-Hashomer, Israel",NA
"1918","34224675","10.1016/S2213-2600(21)00220-4","BNT162b2 COVID-19 vaccine and correlates of humoral immune responses and dynamics: a prospective, single-centre, longitudinal cohort study in health-care workers.","Concurrent with the Pfizer-BioNTech BNT162b2 COVID-19 vaccine roll-out in Israel initiated on Dec 19, 2020, we assessed the early antibody responses and antibody kinetics after each vaccine dose in health-care workers of different ages and sexes, and with different comorbidities. We did a prospective, single-centre, longitudinal cohort study at the Sheba Medical Centre (Tel-Hashomer, Israel). Eligible participants were health-care workers at the centre who had a negative anti-SARS-CoV-2 IgG assa","2021","07","08","Lancet Respir Med","The Lancet. Respiratory medicine",NA,"Huppert","Amit","Bio-statistical and Bio-mathematical Unit, The Gertner Institute of Epidemiology and Health Policy Research, Sheba Medical Center, Tel-Hashomer, Israel",NA
"1919","34224675","10.1016/S2213-2600(21)00220-4","BNT162b2 COVID-19 vaccine and correlates of humoral immune responses and dynamics: a prospective, single-centre, longitudinal cohort study in health-care workers.","Concurrent with the Pfizer-BioNTech BNT162b2 COVID-19 vaccine roll-out in Israel initiated on Dec 19, 2020, we assessed the early antibody responses and antibody kinetics after each vaccine dose in health-care workers of different ages and sexes, and with different comorbidities. We did a prospective, single-centre, longitudinal cohort study at the Sheba Medical Centre (Tel-Hashomer, Israel). Eligible participants were health-care workers at the centre who had a negative anti-SARS-CoV-2 IgG assa","2021","07","08","Lancet Respir Med","The Lancet. Respiratory medicine",NA,"Rubin","Carmit","Bio-statistical and Bio-mathematical Unit, The Gertner Institute of Epidemiology and Health Policy Research, Sheba Medical Center, Tel-Hashomer, Israel",NA
"1920","34224675","10.1016/S2213-2600(21)00220-4","BNT162b2 COVID-19 vaccine and correlates of humoral immune responses and dynamics: a prospective, single-centre, longitudinal cohort study in health-care workers.","Concurrent with the Pfizer-BioNTech BNT162b2 COVID-19 vaccine roll-out in Israel initiated on Dec 19, 2020, we assessed the early antibody responses and antibody kinetics after each vaccine dose in health-care workers of different ages and sexes, and with different comorbidities. We did a prospective, single-centre, longitudinal cohort study at the Sheba Medical Centre (Tel-Hashomer, Israel). Eligible participants were health-care workers at the centre who had a negative anti-SARS-CoV-2 IgG assa","2021","07","08","Lancet Respir Med","The Lancet. Respiratory medicine",NA,"Freedman","Laurence","Bio-statistical and Bio-mathematical Unit, The Gertner Institute of Epidemiology and Health Policy Research, Sheba Medical Center, Tel-Hashomer, Israel",NA
"1921","34224675","10.1016/S2213-2600(21)00220-4","BNT162b2 COVID-19 vaccine and correlates of humoral immune responses and dynamics: a prospective, single-centre, longitudinal cohort study in health-care workers.","Concurrent with the Pfizer-BioNTech BNT162b2 COVID-19 vaccine roll-out in Israel initiated on Dec 19, 2020, we assessed the early antibody responses and antibody kinetics after each vaccine dose in health-care workers of different ages and sexes, and with different comorbidities. We did a prospective, single-centre, longitudinal cohort study at the Sheba Medical Centre (Tel-Hashomer, Israel). Eligible participants were health-care workers at the centre who had a negative anti-SARS-CoV-2 IgG assa","2021","07","08","Lancet Respir Med","The Lancet. Respiratory medicine",NA,"Kreiss","Yitshak","Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel",NA
"1922","34224674","10.1016/S2213-2600(21)00229-0","Clinical characteristics and outcomes of invasively ventilated patients with COVID-19 in Argentina (SATICOVID): a prospective, multicentre cohort study.","Although COVID-19 has greatly affected many low-income and middle-income countries, detailed information about patients admitted to the intensive care unit (ICU) is still scarce. Our aim was to examine ventilation characteristics and outcomes in invasively ventilated patients with COVID-19 in Argentina, an upper middle-income country. In this prospective, multicentre cohort study (SATICOVID), we enrolled patients aged 18 years or older with RT-PCR-confirmed COVID-19 who were on invasive mechanic","2021","07","08","Lancet Respir Med","The Lancet. Respiratory medicine",NA,"Estenssoro","Elisa","Hospital Interzonal de Agudos General San Martín, Buenos Aires, Argentina. Electronic address: estenssoro.elisa@gmail","estenssoro.elisa@gmail.com"
"1923","34224674","10.1016/S2213-2600(21)00229-0","Clinical characteristics and outcomes of invasively ventilated patients with COVID-19 in Argentina (SATICOVID): a prospective, multicentre cohort study.","Although COVID-19 has greatly affected many low-income and middle-income countries, detailed information about patients admitted to the intensive care unit (ICU) is still scarce. Our aim was to examine ventilation characteristics and outcomes in invasively ventilated patients with COVID-19 in Argentina, an upper middle-income country. In this prospective, multicentre cohort study (SATICOVID), we enrolled patients aged 18 years or older with RT-PCR-confirmed COVID-19 who were on invasive mechanic","2021","07","08","Lancet Respir Med","The Lancet. Respiratory medicine",NA,"Loudet","Cecilia I","Hospital Interzonal de Agudos General San Martín, Buenos Aires, Argentina",NA
"1924","34224674","10.1016/S2213-2600(21)00229-0","Clinical characteristics and outcomes of invasively ventilated patients with COVID-19 in Argentina (SATICOVID): a prospective, multicentre cohort study.","Although COVID-19 has greatly affected many low-income and middle-income countries, detailed information about patients admitted to the intensive care unit (ICU) is still scarce. Our aim was to examine ventilation characteristics and outcomes in invasively ventilated patients with COVID-19 in Argentina, an upper middle-income country. In this prospective, multicentre cohort study (SATICOVID), we enrolled patients aged 18 years or older with RT-PCR-confirmed COVID-19 who were on invasive mechanic","2021","07","08","Lancet Respir Med","The Lancet. Respiratory medicine",NA,"Ríos","Fernando G","Sanatorio Las Lomas, Buenos Aires, Argentina",NA
"1925","34224674","10.1016/S2213-2600(21)00229-0","Clinical characteristics and outcomes of invasively ventilated patients with COVID-19 in Argentina (SATICOVID): a prospective, multicentre cohort study.","Although COVID-19 has greatly affected many low-income and middle-income countries, detailed information about patients admitted to the intensive care unit (ICU) is still scarce. Our aim was to examine ventilation characteristics and outcomes in invasively ventilated patients with COVID-19 in Argentina, an upper middle-income country. In this prospective, multicentre cohort study (SATICOVID), we enrolled patients aged 18 years or older with RT-PCR-confirmed COVID-19 who were on invasive mechanic","2021","07","08","Lancet Respir Med","The Lancet. Respiratory medicine",NA,"Kanoore Edul","Vanina S","Hospital Juan A Fernández, Buenos Aires, Argentina",NA
"1926","34224674","10.1016/S2213-2600(21)00229-0","Clinical characteristics and outcomes of invasively ventilated patients with COVID-19 in Argentina (SATICOVID): a prospective, multicentre cohort study.","Although COVID-19 has greatly affected many low-income and middle-income countries, detailed information about patients admitted to the intensive care unit (ICU) is still scarce. Our aim was to examine ventilation characteristics and outcomes in invasively ventilated patients with COVID-19 in Argentina, an upper middle-income country. In this prospective, multicentre cohort study (SATICOVID), we enrolled patients aged 18 years or older with RT-PCR-confirmed COVID-19 who were on invasive mechanic","2021","07","08","Lancet Respir Med","The Lancet. Respiratory medicine",NA,"Plotnikow","Gustavo","Sanatorio Anchorena, Buenos Aires, Argentina",NA
"1927","34224674","10.1016/S2213-2600(21)00229-0","Clinical characteristics and outcomes of invasively ventilated patients with COVID-19 in Argentina (SATICOVID): a prospective, multicentre cohort study.","Although COVID-19 has greatly affected many low-income and middle-income countries, detailed information about patients admitted to the intensive care unit (ICU) is still scarce. Our aim was to examine ventilation characteristics and outcomes in invasively ventilated patients with COVID-19 in Argentina, an upper middle-income country. In this prospective, multicentre cohort study (SATICOVID), we enrolled patients aged 18 years or older with RT-PCR-confirmed COVID-19 who were on invasive mechanic","2021","07","08","Lancet Respir Med","The Lancet. Respiratory medicine",NA,"Andrian","Macarena","Hospital Provincial Dr Castro Rendón, Neuquén, Argentina",NA
"1928","34224674","10.1016/S2213-2600(21)00229-0","Clinical characteristics and outcomes of invasively ventilated patients with COVID-19 in Argentina (SATICOVID): a prospective, multicentre cohort study.","Although COVID-19 has greatly affected many low-income and middle-income countries, detailed information about patients admitted to the intensive care unit (ICU) is still scarce. Our aim was to examine ventilation characteristics and outcomes in invasively ventilated patients with COVID-19 in Argentina, an upper middle-income country. In this prospective, multicentre cohort study (SATICOVID), we enrolled patients aged 18 years or older with RT-PCR-confirmed COVID-19 who were on invasive mechanic","2021","07","08","Lancet Respir Med","The Lancet. Respiratory medicine",NA,"Romero","Ignacio","Sanatorio Güemes, Buenos Aires, Argentina",NA
"1929","34224674","10.1016/S2213-2600(21)00229-0","Clinical characteristics and outcomes of invasively ventilated patients with COVID-19 in Argentina (SATICOVID): a prospective, multicentre cohort study.","Although COVID-19 has greatly affected many low-income and middle-income countries, detailed information about patients admitted to the intensive care unit (ICU) is still scarce. Our aim was to examine ventilation characteristics and outcomes in invasively ventilated patients with COVID-19 in Argentina, an upper middle-income country. In this prospective, multicentre cohort study (SATICOVID), we enrolled patients aged 18 years or older with RT-PCR-confirmed COVID-19 who were on invasive mechanic","2021","07","08","Lancet Respir Med","The Lancet. Respiratory medicine",NA,"Piezny","Damián","Hospital A Posadas, Buenos Aires, Argentina",NA
"1930","34224674","10.1016/S2213-2600(21)00229-0","Clinical characteristics and outcomes of invasively ventilated patients with COVID-19 in Argentina (SATICOVID): a prospective, multicentre cohort study.","Although COVID-19 has greatly affected many low-income and middle-income countries, detailed information about patients admitted to the intensive care unit (ICU) is still scarce. Our aim was to examine ventilation characteristics and outcomes in invasively ventilated patients with COVID-19 in Argentina, an upper middle-income country. In this prospective, multicentre cohort study (SATICOVID), we enrolled patients aged 18 years or older with RT-PCR-confirmed COVID-19 who were on invasive mechanic","2021","07","08","Lancet Respir Med","The Lancet. Respiratory medicine",NA,"Bezzi","Marco","Hospital Santojanni, Buenos Aires, Argentina",NA
"1931","34224674","10.1016/S2213-2600(21)00229-0","Clinical characteristics and outcomes of invasively ventilated patients with COVID-19 in Argentina (SATICOVID): a prospective, multicentre cohort study.","Although COVID-19 has greatly affected many low-income and middle-income countries, detailed information about patients admitted to the intensive care unit (ICU) is still scarce. Our aim was to examine ventilation characteristics and outcomes in invasively ventilated patients with COVID-19 in Argentina, an upper middle-income country. In this prospective, multicentre cohort study (SATICOVID), we enrolled patients aged 18 years or older with RT-PCR-confirmed COVID-19 who were on invasive mechanic","2021","07","08","Lancet Respir Med","The Lancet. Respiratory medicine",NA,"Mandich","Verónica","Hospital Santojanni, Buenos Aires, Argentina",NA
"1932","34224674","10.1016/S2213-2600(21)00229-0","Clinical characteristics and outcomes of invasively ventilated patients with COVID-19 in Argentina (SATICOVID): a prospective, multicentre cohort study.","Although COVID-19 has greatly affected many low-income and middle-income countries, detailed information about patients admitted to the intensive care unit (ICU) is still scarce. Our aim was to examine ventilation characteristics and outcomes in invasively ventilated patients with COVID-19 in Argentina, an upper middle-income country. In this prospective, multicentre cohort study (SATICOVID), we enrolled patients aged 18 years or older with RT-PCR-confirmed COVID-19 who were on invasive mechanic","2021","07","08","Lancet Respir Med","The Lancet. Respiratory medicine",NA,"Groer","Carla","Hospital Juan A Fernández, Buenos Aires, Argentina",NA
"1933","34224674","10.1016/S2213-2600(21)00229-0","Clinical characteristics and outcomes of invasively ventilated patients with COVID-19 in Argentina (SATICOVID): a prospective, multicentre cohort study.","Although COVID-19 has greatly affected many low-income and middle-income countries, detailed information about patients admitted to the intensive care unit (ICU) is still scarce. Our aim was to examine ventilation characteristics and outcomes in invasively ventilated patients with COVID-19 in Argentina, an upper middle-income country. In this prospective, multicentre cohort study (SATICOVID), we enrolled patients aged 18 years or older with RT-PCR-confirmed COVID-19 who were on invasive mechanic","2021","07","08","Lancet Respir Med","The Lancet. Respiratory medicine",NA,"Torres","Sebastián","Sanatorio Anchorena San Martín, Buenos Aires, Argentina",NA
"1934","34224674","10.1016/S2213-2600(21)00229-0","Clinical characteristics and outcomes of invasively ventilated patients with COVID-19 in Argentina (SATICOVID): a prospective, multicentre cohort study.","Although COVID-19 has greatly affected many low-income and middle-income countries, detailed information about patients admitted to the intensive care unit (ICU) is still scarce. Our aim was to examine ventilation characteristics and outcomes in invasively ventilated patients with COVID-19 in Argentina, an upper middle-income country. In this prospective, multicentre cohort study (SATICOVID), we enrolled patients aged 18 years or older with RT-PCR-confirmed COVID-19 who were on invasive mechanic","2021","07","08","Lancet Respir Med","The Lancet. Respiratory medicine",NA,"Orlandi","Cristina","Hospital Francisco Lopez Lima, Río Negro, Argentina",NA
"1935","34224674","10.1016/S2213-2600(21)00229-0","Clinical characteristics and outcomes of invasively ventilated patients with COVID-19 in Argentina (SATICOVID): a prospective, multicentre cohort study.","Although COVID-19 has greatly affected many low-income and middle-income countries, detailed information about patients admitted to the intensive care unit (ICU) is still scarce. Our aim was to examine ventilation characteristics and outcomes in invasively ventilated patients with COVID-19 in Argentina, an upper middle-income country. In this prospective, multicentre cohort study (SATICOVID), we enrolled patients aged 18 years or older with RT-PCR-confirmed COVID-19 who were on invasive mechanic","2021","07","08","Lancet Respir Med","The Lancet. Respiratory medicine",NA,"Rubatto Birri","Paolo N","Sanatorio Otamendi, Buenos Aires, Argentina",NA
"1936","34224674","10.1016/S2213-2600(21)00229-0","Clinical characteristics and outcomes of invasively ventilated patients with COVID-19 in Argentina (SATICOVID): a prospective, multicentre cohort study.","Although COVID-19 has greatly affected many low-income and middle-income countries, detailed information about patients admitted to the intensive care unit (ICU) is still scarce. Our aim was to examine ventilation characteristics and outcomes in invasively ventilated patients with COVID-19 in Argentina, an upper middle-income country. In this prospective, multicentre cohort study (SATICOVID), we enrolled patients aged 18 years or older with RT-PCR-confirmed COVID-19 who were on invasive mechanic","2021","07","08","Lancet Respir Med","The Lancet. Respiratory medicine",NA,"Valenti","María F","Sanatorio de Los Arcos, Buenos Aires, Argentina",NA
"1937","34224674","10.1016/S2213-2600(21)00229-0","Clinical characteristics and outcomes of invasively ventilated patients with COVID-19 in Argentina (SATICOVID): a prospective, multicentre cohort study.","Although COVID-19 has greatly affected many low-income and middle-income countries, detailed information about patients admitted to the intensive care unit (ICU) is still scarce. Our aim was to examine ventilation characteristics and outcomes in invasively ventilated patients with COVID-19 in Argentina, an upper middle-income country. In this prospective, multicentre cohort study (SATICOVID), we enrolled patients aged 18 years or older with RT-PCR-confirmed COVID-19 who were on invasive mechanic","2021","07","08","Lancet Respir Med","The Lancet. Respiratory medicine",NA,"Cunto","Eleonora","Hospital Dr F J Muñiz, Buenos Aires, Argentina",NA
"1938","34224674","10.1016/S2213-2600(21)00229-0","Clinical characteristics and outcomes of invasively ventilated patients with COVID-19 in Argentina (SATICOVID): a prospective, multicentre cohort study.","Although COVID-19 has greatly affected many low-income and middle-income countries, detailed information about patients admitted to the intensive care unit (ICU) is still scarce. Our aim was to examine ventilation characteristics and outcomes in invasively ventilated patients with COVID-19 in Argentina, an upper middle-income country. In this prospective, multicentre cohort study (SATICOVID), we enrolled patients aged 18 years or older with RT-PCR-confirmed COVID-19 who were on invasive mechanic","2021","07","08","Lancet Respir Med","The Lancet. Respiratory medicine",NA,"Sáenz","María G","Hospital Interzonal de Agudos General San Martín, Buenos Aires, Argentina",NA
"1939","34224674","10.1016/S2213-2600(21)00229-0","Clinical characteristics and outcomes of invasively ventilated patients with COVID-19 in Argentina (SATICOVID): a prospective, multicentre cohort study.","Although COVID-19 has greatly affected many low-income and middle-income countries, detailed information about patients admitted to the intensive care unit (ICU) is still scarce. Our aim was to examine ventilation characteristics and outcomes in invasively ventilated patients with COVID-19 in Argentina, an upper middle-income country. In this prospective, multicentre cohort study (SATICOVID), we enrolled patients aged 18 years or older with RT-PCR-confirmed COVID-19 who were on invasive mechanic","2021","07","08","Lancet Respir Med","The Lancet. Respiratory medicine",NA,"Tiribelli","Norberto","Complejo Médico de la Policía Federal Argentina Churruca Visca, Buenos Aires, Argentina",NA
"1940","34224674","10.1016/S2213-2600(21)00229-0","Clinical characteristics and outcomes of invasively ventilated patients with COVID-19 in Argentina (SATICOVID): a prospective, multicentre cohort study.","Although COVID-19 has greatly affected many low-income and middle-income countries, detailed information about patients admitted to the intensive care unit (ICU) is still scarce. Our aim was to examine ventilation characteristics and outcomes in invasively ventilated patients with COVID-19 in Argentina, an upper middle-income country. In this prospective, multicentre cohort study (SATICOVID), we enrolled patients aged 18 years or older with RT-PCR-confirmed COVID-19 who were on invasive mechanic","2021","07","08","Lancet Respir Med","The Lancet. Respiratory medicine",NA,"Aphalo","Vanina","Sanatorio Anchorena, Buenos Aires, Argentina",NA
"1941","34224674","10.1016/S2213-2600(21)00229-0","Clinical characteristics and outcomes of invasively ventilated patients with COVID-19 in Argentina (SATICOVID): a prospective, multicentre cohort study.","Although COVID-19 has greatly affected many low-income and middle-income countries, detailed information about patients admitted to the intensive care unit (ICU) is still scarce. Our aim was to examine ventilation characteristics and outcomes in invasively ventilated patients with COVID-19 in Argentina, an upper middle-income country. In this prospective, multicentre cohort study (SATICOVID), we enrolled patients aged 18 years or older with RT-PCR-confirmed COVID-19 who were on invasive mechanic","2021","07","08","Lancet Respir Med","The Lancet. Respiratory medicine",NA,"Reina","Rosa","Sociedad Argentina de Terapia Intensiva, Buenos Aires, Argentina",NA
"1942","34224674","10.1016/S2213-2600(21)00229-0","Clinical characteristics and outcomes of invasively ventilated patients with COVID-19 in Argentina (SATICOVID): a prospective, multicentre cohort study.","Although COVID-19 has greatly affected many low-income and middle-income countries, detailed information about patients admitted to the intensive care unit (ICU) is still scarce. Our aim was to examine ventilation characteristics and outcomes in invasively ventilated patients with COVID-19 in Argentina, an upper middle-income country. In this prospective, multicentre cohort study (SATICOVID), we enrolled patients aged 18 years or older with RT-PCR-confirmed COVID-19 who were on invasive mechanic","2021","07","08","Lancet Respir Med","The Lancet. Respiratory medicine",NA,"Dubin","Arnaldo","Sanatorio Otamendi, Buenos Aires, Argentina",NA
"1943","34224673","10.1016/S2213-2600(21)00278-2","Lung transplantation for COVID-19-associated ARDS.",NA,"2021","07","08","Lancet Respir Med","The Lancet. Respiratory medicine",NA,"Lepper","Philipp M","Department of Pneumology, Allergology and Critical Care Medicine/ECLS-Centre Saar, University Medical Centre, Saarland University, 66421 Homburg, Germany","philipp.lepper@uks.eu"
"1944","34224673","10.1016/S2213-2600(21)00278-2","Lung transplantation for COVID-19-associated ARDS.",NA,"2021","07","08","Lancet Respir Med","The Lancet. Respiratory medicine",NA,"Langer","Frank","Department of Thoracic and Cardiovascular Surgery, University Medical Centre, Saarland University, 66421 Homburg, Germany",NA
"1945","34224673","10.1016/S2213-2600(21)00278-2","Lung transplantation for COVID-19-associated ARDS.",NA,"2021","07","08","Lancet Respir Med","The Lancet. Respiratory medicine",NA,"Wilkens","Heinrike","Department of Pneumology, Allergology and Critical Care Medicine/ECLS-Centre Saar, University Medical Centre, Saarland University, 66421 Homburg, Germany",NA
"1946","34224673","10.1016/S2213-2600(21)00278-2","Lung transplantation for COVID-19-associated ARDS.",NA,"2021","07","08","Lancet Respir Med","The Lancet. Respiratory medicine",NA,"Schäfers","Hans-Joachim","Department of Thoracic and Cardiovascular Surgery, University Medical Centre, Saarland University, 66421 Homburg, Germany",NA
"1947","34224673","10.1016/S2213-2600(21)00278-2","Lung transplantation for COVID-19-associated ARDS.",NA,"2021","07","08","Lancet Respir Med","The Lancet. Respiratory medicine",NA,"Bals","Robert","Department of Pneumology, Allergology and Critical Care Medicine/ECLS-Centre Saar, University Medical Centre, Saarland University, 66421 Homburg, Germany",NA
"1948","34224668","10.1016/S2352-3026(21)00169-1","Immunogenicity of the BNT162b2 COVID-19 mRNA vaccine and early clinical outcomes in patients with haematological malignancies in Lithuania: a national prospective cohort study.","Haematological malignancies and their treatments are likely to affect SARS-CoV-2 vaccine efficacy. We aimed to evaluate serological response to BNT162b2 vaccine in patients with haematological malignancies by type of treatment. Our national prospective cohort study was done in Lithuania and assessed serological response to one and two BNT162b2 (Comirnaty, Pfizer-BioNTech) vaccine doses in healthy health-care workers and in patients with haematological malignancies. Eligible participants were age","2021","07","08","Lancet Haematol","The Lancet. Haematology",NA,"Maneikis","Kazimieras","Hematology, Oncology and Transfusion Medicine Center, Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania","kazimieras.maneikis@santa.lt"
"1949","34224668","10.1016/S2352-3026(21)00169-1","Immunogenicity of the BNT162b2 COVID-19 mRNA vaccine and early clinical outcomes in patients with haematological malignancies in Lithuania: a national prospective cohort study.","Haematological malignancies and their treatments are likely to affect SARS-CoV-2 vaccine efficacy. We aimed to evaluate serological response to BNT162b2 vaccine in patients with haematological malignancies by type of treatment. Our national prospective cohort study was done in Lithuania and assessed serological response to one and two BNT162b2 (Comirnaty, Pfizer-BioNTech) vaccine doses in healthy health-care workers and in patients with haematological malignancies. Eligible participants were age","2021","07","08","Lancet Haematol","The Lancet. Haematology",NA,"ablauskas","Karolis","Hematology, Oncology and Transfusion Medicine Center, Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania",NA
"1950","34224668","10.1016/S2352-3026(21)00169-1","Immunogenicity of the BNT162b2 COVID-19 mRNA vaccine and early clinical outcomes in patients with haematological malignancies in Lithuania: a national prospective cohort study.","Haematological malignancies and their treatments are likely to affect SARS-CoV-2 vaccine efficacy. We aimed to evaluate serological response to BNT162b2 vaccine in patients with haematological malignancies by type of treatment. Our national prospective cohort study was done in Lithuania and assessed serological response to one and two BNT162b2 (Comirnaty, Pfizer-BioNTech) vaccine doses in healthy health-care workers and in patients with haematological malignancies. Eligible participants were age","2021","07","08","Lancet Haematol","The Lancet. Haematology",NA,"Ringeleviciute","Ugne","Hematology, Oncology and Transfusion Medicine Center, Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania",NA
"1951","34224668","10.1016/S2352-3026(21)00169-1","Immunogenicity of the BNT162b2 COVID-19 mRNA vaccine and early clinical outcomes in patients with haematological malignancies in Lithuania: a national prospective cohort study.","Haematological malignancies and their treatments are likely to affect SARS-CoV-2 vaccine efficacy. We aimed to evaluate serological response to BNT162b2 vaccine in patients with haematological malignancies by type of treatment. Our national prospective cohort study was done in Lithuania and assessed serological response to one and two BNT162b2 (Comirnaty, Pfizer-BioNTech) vaccine doses in healthy health-care workers and in patients with haematological malignancies. Eligible participants were age","2021","07","08","Lancet Haematol","The Lancet. Haematology",NA,"Vaitekenaite","Vilmante","Hematology, Oncology and Transfusion Medicine Center, Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania",NA
"1952","34224668","10.1016/S2352-3026(21)00169-1","Immunogenicity of the BNT162b2 COVID-19 mRNA vaccine and early clinical outcomes in patients with haematological malignancies in Lithuania: a national prospective cohort study.","Haematological malignancies and their treatments are likely to affect SARS-CoV-2 vaccine efficacy. We aimed to evaluate serological response to BNT162b2 vaccine in patients with haematological malignancies by type of treatment. Our national prospective cohort study was done in Lithuania and assessed serological response to one and two BNT162b2 (Comirnaty, Pfizer-BioNTech) vaccine doses in healthy health-care workers and in patients with haematological malignancies. Eligible participants were age","2021","07","08","Lancet Haematol","The Lancet. Haematology",NA,"Cekauskiene","Rita","Hematology, Oncology and Transfusion Medicine Center, Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania",NA
"1953","34224668","10.1016/S2352-3026(21)00169-1","Immunogenicity of the BNT162b2 COVID-19 mRNA vaccine and early clinical outcomes in patients with haematological malignancies in Lithuania: a national prospective cohort study.","Haematological malignancies and their treatments are likely to affect SARS-CoV-2 vaccine efficacy. We aimed to evaluate serological response to BNT162b2 vaccine in patients with haematological malignancies by type of treatment. Our national prospective cohort study was done in Lithuania and assessed serological response to one and two BNT162b2 (Comirnaty, Pfizer-BioNTech) vaccine doses in healthy health-care workers and in patients with haematological malignancies. Eligible participants were age","2021","07","08","Lancet Haematol","The Lancet. Haematology",NA,"Kryauskaite","Lina","Hematology, Oncology and Transfusion Medicine Center, Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania",NA
"1954","34224668","10.1016/S2352-3026(21)00169-1","Immunogenicity of the BNT162b2 COVID-19 mRNA vaccine and early clinical outcomes in patients with haematological malignancies in Lithuania: a national prospective cohort study.","Haematological malignancies and their treatments are likely to affect SARS-CoV-2 vaccine efficacy. We aimed to evaluate serological response to BNT162b2 vaccine in patients with haematological malignancies by type of treatment. Our national prospective cohort study was done in Lithuania and assessed serological response to one and two BNT162b2 (Comirnaty, Pfizer-BioNTech) vaccine doses in healthy health-care workers and in patients with haematological malignancies. Eligible participants were age","2021","07","08","Lancet Haematol","The Lancet. Haematology",NA,"Naumovas","Daniel","Hematology, Oncology and Transfusion Medicine Center, Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania",NA
"1955","34224668","10.1016/S2352-3026(21)00169-1","Immunogenicity of the BNT162b2 COVID-19 mRNA vaccine and early clinical outcomes in patients with haematological malignancies in Lithuania: a national prospective cohort study.","Haematological malignancies and their treatments are likely to affect SARS-CoV-2 vaccine efficacy. We aimed to evaluate serological response to BNT162b2 vaccine in patients with haematological malignancies by type of treatment. Our national prospective cohort study was done in Lithuania and assessed serological response to one and two BNT162b2 (Comirnaty, Pfizer-BioNTech) vaccine doses in healthy health-care workers and in patients with haematological malignancies. Eligible participants were age","2021","07","08","Lancet Haematol","The Lancet. Haematology",NA,"Banys","Valdas","Hematology, Oncology and Transfusion Medicine Center, Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania",NA
"1956","34224668","10.1016/S2352-3026(21)00169-1","Immunogenicity of the BNT162b2 COVID-19 mRNA vaccine and early clinical outcomes in patients with haematological malignancies in Lithuania: a national prospective cohort study.","Haematological malignancies and their treatments are likely to affect SARS-CoV-2 vaccine efficacy. We aimed to evaluate serological response to BNT162b2 vaccine in patients with haematological malignancies by type of treatment. Our national prospective cohort study was done in Lithuania and assessed serological response to one and two BNT162b2 (Comirnaty, Pfizer-BioNTech) vaccine doses in healthy health-care workers and in patients with haematological malignancies. Eligible participants were age","2021","07","08","Lancet Haematol","The Lancet. Haematology",NA,"Peceliunas","Valdas","Hematology, Oncology and Transfusion Medicine Center, Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania",NA
"1957","34224668","10.1016/S2352-3026(21)00169-1","Immunogenicity of the BNT162b2 COVID-19 mRNA vaccine and early clinical outcomes in patients with haematological malignancies in Lithuania: a national prospective cohort study.","Haematological malignancies and their treatments are likely to affect SARS-CoV-2 vaccine efficacy. We aimed to evaluate serological response to BNT162b2 vaccine in patients with haematological malignancies by type of treatment. Our national prospective cohort study was done in Lithuania and assessed serological response to one and two BNT162b2 (Comirnaty, Pfizer-BioNTech) vaccine doses in healthy health-care workers and in patients with haematological malignancies. Eligible participants were age","2021","07","08","Lancet Haematol","The Lancet. Haematology",NA,"Beinortas","Tumas","Department of Haematology, Cambridge University Hospitals NHS trust, Cambridge, UK",NA
"1958","34224668","10.1016/S2352-3026(21)00169-1","Immunogenicity of the BNT162b2 COVID-19 mRNA vaccine and early clinical outcomes in patients with haematological malignancies in Lithuania: a national prospective cohort study.","Haematological malignancies and their treatments are likely to affect SARS-CoV-2 vaccine efficacy. We aimed to evaluate serological response to BNT162b2 vaccine in patients with haematological malignancies by type of treatment. Our national prospective cohort study was done in Lithuania and assessed serological response to one and two BNT162b2 (Comirnaty, Pfizer-BioNTech) vaccine doses in healthy health-care workers and in patients with haematological malignancies. Eligible participants were age","2021","07","08","Lancet Haematol","The Lancet. Haematology",NA,"Grikevicius","Laimonas","Hematology, Oncology and Transfusion Medicine Center, Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania",NA
"1959","34224667","10.1016/S2352-3026(21)00199-X","Antibody responses after SARS-CoV-2 vaccination in patients with lymphoma.",NA,"2021","07","08","Lancet Haematol","The Lancet. Haematology",NA,"Lim","Sean H","Centre for Cancer Immunology, University of Southampton, SO16 6YD, UK","s.h.lim@soton.ac.uk"
"1960","34224667","10.1016/S2352-3026(21)00199-X","Antibody responses after SARS-CoV-2 vaccination in patients with lymphoma.",NA,"2021","07","08","Lancet Haematol","The Lancet. Haematology",NA,"Campbell","Nicola","University Hospital Southampton NHS Foundation Trust, Southampton, UK",NA
"1961","34224667","10.1016/S2352-3026(21)00199-X","Antibody responses after SARS-CoV-2 vaccination in patients with lymphoma.",NA,"2021","07","08","Lancet Haematol","The Lancet. Haematology",NA,"Johnson","Marina","Great Ormond Street Institute of Child Health Biomedical Research Centre, University College London, London, UK",NA
"1962","34224667","10.1016/S2352-3026(21)00199-X","Antibody responses after SARS-CoV-2 vaccination in patients with lymphoma.",NA,"2021","07","08","Lancet Haematol","The Lancet. Haematology",NA,"Joseph-Pietras","Debora","NIHR/Cancer Research UK Southampton Experimental Medicine Cancer Centre, WISH Laboratory, University Hospital Southampton, UK",NA
"1963","34224667","10.1016/S2352-3026(21)00199-X","Antibody responses after SARS-CoV-2 vaccination in patients with lymphoma.",NA,"2021","07","08","Lancet Haematol","The Lancet. Haematology",NA,"Collins","Graham P","NIHR Oxford Biomedical Research Centre, Churchill Hospital, Oxford, UK",NA
"1964","34224667","10.1016/S2352-3026(21)00199-X","Antibody responses after SARS-CoV-2 vaccination in patients with lymphoma.",NA,"2021","07","08","Lancet Haematol","The Lancet. Haematology",NA,"O'Callaghan","Ann","Portsmouth Hospitals NHS Trust, Portsmouth, UK",NA
"1965","34224667","10.1016/S2352-3026(21)00199-X","Antibody responses after SARS-CoV-2 vaccination in patients with lymphoma.",NA,"2021","07","08","Lancet Haematol","The Lancet. Haematology",NA,"Fox","Christopher P","Nottingham University Hospitals NHS Trust, Nottingham, UK",NA
"1966","34224667","10.1016/S2352-3026(21)00199-X","Antibody responses after SARS-CoV-2 vaccination in patients with lymphoma.",NA,"2021","07","08","Lancet Haematol","The Lancet. Haematology",NA,"Ahearne","Matthew","University Hospitals of Leicester NHS Trust, Leicester, UK",NA
"1967","34224667","10.1016/S2352-3026(21)00199-X","Antibody responses after SARS-CoV-2 vaccination in patients with lymphoma.",NA,"2021","07","08","Lancet Haematol","The Lancet. Haematology",NA,"Johnson","Peter W M","Centre for Cancer Immunology, University of Southampton, SO16 6YD, UK",NA
"1968","34224667","10.1016/S2352-3026(21)00199-X","Antibody responses after SARS-CoV-2 vaccination in patients with lymphoma.",NA,"2021","07","08","Lancet Haematol","The Lancet. Haematology",NA,"Goldblatt","David","Great Ormond Street Institute of Child Health Biomedical Research Centre, University College London, London, UK",NA
"1969","34224667","10.1016/S2352-3026(21)00199-X","Antibody responses after SARS-CoV-2 vaccination in patients with lymphoma.",NA,"2021","07","08","Lancet Haematol","The Lancet. Haematology",NA,"Davies","Andrew J","Centre for Cancer Immunology, University of Southampton, SO16 6YD, UK",NA
"1970","34224643","10.1111/hex.13280","Experience of patients hospitalized with COVID-19: A qualitative study of a pandemic disease in Iran.","The spread of COVID-19 as an infectious disease brings about many newly arrived challenges, which call for further research on the scope of its effect on life due to the special conditions of this disease. The present study is, therefore, an attempt to understand the lived experience of inpatients hospitalized with COVID-19. In this phenomenological study, among patients with COVID-19 who were hospitalized in COVID-19 referral hospitals, 17 people were selected by random sampling method. Data we","2021","07","05","Health Expect","Health expectations : an international journal of public participation in health care and health policy","COVID-19; Iran; phenomenology; qualitative study","Jamili","Sara","Student Research Committee, Department of health economic and management sciences, Mashhad University of Medical Sciences, Mashhad, Iran",NA
"1971","34224643","10.1111/hex.13280","Experience of patients hospitalized with COVID-19: A qualitative study of a pandemic disease in Iran.","The spread of COVID-19 as an infectious disease brings about many newly arrived challenges, which call for further research on the scope of its effect on life due to the special conditions of this disease. The present study is, therefore, an attempt to understand the lived experience of inpatients hospitalized with COVID-19. In this phenomenological study, among patients with COVID-19 who were hospitalized in COVID-19 referral hospitals, 17 people were selected by random sampling method. Data we","2021","07","05","Health Expect","Health expectations : an international journal of public participation in health care and health policy","COVID-19; Iran; phenomenology; qualitative study","Ebrahimipour","Hosein","Department of Health Economics and Management, Social Determinants of Health Research Centre, Mashhad University of Medical Sciences, Mashhad, Iran",NA
"1972","34224643","10.1111/hex.13280","Experience of patients hospitalized with COVID-19: A qualitative study of a pandemic disease in Iran.","The spread of COVID-19 as an infectious disease brings about many newly arrived challenges, which call for further research on the scope of its effect on life due to the special conditions of this disease. The present study is, therefore, an attempt to understand the lived experience of inpatients hospitalized with COVID-19. In this phenomenological study, among patients with COVID-19 who were hospitalized in COVID-19 referral hospitals, 17 people were selected by random sampling method. Data we","2021","07","05","Health Expect","Health expectations : an international journal of public participation in health care and health policy","COVID-19; Iran; phenomenology; qualitative study","Adel","Amin","Health Management and Economics Research Center, Iran University of Medical Sciences, Tehran, Iran",NA
"1973","34224643","10.1111/hex.13280","Experience of patients hospitalized with COVID-19: A qualitative study of a pandemic disease in Iran.","The spread of COVID-19 as an infectious disease brings about many newly arrived challenges, which call for further research on the scope of its effect on life due to the special conditions of this disease. The present study is, therefore, an attempt to understand the lived experience of inpatients hospitalized with COVID-19. In this phenomenological study, among patients with COVID-19 who were hospitalized in COVID-19 referral hospitals, 17 people were selected by random sampling method. Data we","2021","07","05","Health Expect","Health expectations : an international journal of public participation in health care and health policy","COVID-19; Iran; phenomenology; qualitative study","Badiee Aval","Shapour","Department of Complementary and Chinese Medicine, School of Persian and Complementary Medicine, Mashhad University of Medical Sciences, Mashhad, Iran",NA
"1974","34224643","10.1111/hex.13280","Experience of patients hospitalized with COVID-19: A qualitative study of a pandemic disease in Iran.","The spread of COVID-19 as an infectious disease brings about many newly arrived challenges, which call for further research on the scope of its effect on life due to the special conditions of this disease. The present study is, therefore, an attempt to understand the lived experience of inpatients hospitalized with COVID-19. In this phenomenological study, among patients with COVID-19 who were hospitalized in COVID-19 referral hospitals, 17 people were selected by random sampling method. Data we","2021","07","05","Health Expect","Health expectations : an international journal of public participation in health care and health policy","COVID-19; Iran; phenomenology; qualitative study","Hoseini","Seyed Javad","Department of Medical Technology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran",NA
"1975","34224643","10.1111/hex.13280","Experience of patients hospitalized with COVID-19: A qualitative study of a pandemic disease in Iran.","The spread of COVID-19 as an infectious disease brings about many newly arrived challenges, which call for further research on the scope of its effect on life due to the special conditions of this disease. The present study is, therefore, an attempt to understand the lived experience of inpatients hospitalized with COVID-19. In this phenomenological study, among patients with COVID-19 who were hospitalized in COVID-19 referral hospitals, 17 people were selected by random sampling method. Data we","2021","07","05","Health Expect","Health expectations : an international journal of public participation in health care and health policy","COVID-19; Iran; phenomenology; qualitative study","Vejdani","Marjan","Student Research Committee, Department of health economic and management sciences, Mashhad University of Medical Sciences, Mashhad, Iran",NA
"1976","34224643","10.1111/hex.13280","Experience of patients hospitalized with COVID-19: A qualitative study of a pandemic disease in Iran.","The spread of COVID-19 as an infectious disease brings about many newly arrived challenges, which call for further research on the scope of its effect on life due to the special conditions of this disease. The present study is, therefore, an attempt to understand the lived experience of inpatients hospitalized with COVID-19. In this phenomenological study, among patients with COVID-19 who were hospitalized in COVID-19 referral hospitals, 17 people were selected by random sampling method. Data we","2021","07","05","Health Expect","Health expectations : an international journal of public participation in health care and health policy","COVID-19; Iran; phenomenology; qualitative study","Ebnehoseini","Zahra","Department of Medical Informatics, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran",NA
"1977","34224642","10.1111/dme.14633","August Editorial 'People Power'.","Seismic international events, such as world wars and pandemics, have a global impact on healthcare that continues well beyond the duration of the event. Following the Spanish flu in 1918-1919 there was a baby boom, life expectancy increased, and socialized healthcare systems began to be established. In 1948, following the second world war, the NHS was established. The changes to healthcare that we will see following the Covid-19 pandemic will become apparent over the next few years but it is cle","2021","07","05","Diabet Med","Diabetic medicine : a journal of the British Diabetic Association",NA,"Oliver","Nick","Imperial College London",NA
"1978","34224635","10.1002/jgc4.1462","The COVID-19 pandemic and reproductive genetic counseling: Changes in access and service delivery at an academic medical center in the United States.","The COVID-19 pandemic widely disrupted the delivery of healthcare services, including genetic counseling. To ensure continuity of care, the reproductive genetic counselors at a large academic medical center in the United States rapidly transitioned their practice from 90% in-person patient consultations to a predominantly telehealth model. The present study describes this transition in regard to patient access to genetic counseling and genetic screening. A chart review of patients seen by the re","2021","07","05","J Genet Couns","Journal of genetic counseling","COVID-19; genetic counseling; genetic counselors; genetic services; prenatal genetic counseling; service delivery models; telemedicine","Mann","Caitlin","Department of Obstetrics and Gynecology, Vanderbilt University Medical Center, Nashville, TN, USA",NA
"1979","34224635","10.1002/jgc4.1462","The COVID-19 pandemic and reproductive genetic counseling: Changes in access and service delivery at an academic medical center in the United States.","The COVID-19 pandemic widely disrupted the delivery of healthcare services, including genetic counseling. To ensure continuity of care, the reproductive genetic counselors at a large academic medical center in the United States rapidly transitioned their practice from 90% in-person patient consultations to a predominantly telehealth model. The present study describes this transition in regard to patient access to genetic counseling and genetic screening. A chart review of patients seen by the re","2021","07","05","J Genet Couns","Journal of genetic counseling","COVID-19; genetic counseling; genetic counselors; genetic services; prenatal genetic counseling; service delivery models; telemedicine","Goodhue","Brighton","Department of Obstetrics and Gynecology, Vanderbilt University Medical Center, Nashville, TN, USA",NA
"1980","34224635","10.1002/jgc4.1462","The COVID-19 pandemic and reproductive genetic counseling: Changes in access and service delivery at an academic medical center in the United States.","The COVID-19 pandemic widely disrupted the delivery of healthcare services, including genetic counseling. To ensure continuity of care, the reproductive genetic counselors at a large academic medical center in the United States rapidly transitioned their practice from 90% in-person patient consultations to a predominantly telehealth model. The present study describes this transition in regard to patient access to genetic counseling and genetic screening. A chart review of patients seen by the re","2021","07","05","J Genet Couns","Journal of genetic counseling","COVID-19; genetic counseling; genetic counselors; genetic services; prenatal genetic counseling; service delivery models; telemedicine","Guillard","Arianna","Department of Obstetrics and Gynecology, Vanderbilt University Medical Center, Nashville, TN, USA",NA
"1981","34224635","10.1002/jgc4.1462","The COVID-19 pandemic and reproductive genetic counseling: Changes in access and service delivery at an academic medical center in the United States.","The COVID-19 pandemic widely disrupted the delivery of healthcare services, including genetic counseling. To ensure continuity of care, the reproductive genetic counselors at a large academic medical center in the United States rapidly transitioned their practice from 90% in-person patient consultations to a predominantly telehealth model. The present study describes this transition in regard to patient access to genetic counseling and genetic screening. A chart review of patients seen by the re","2021","07","05","J Genet Couns","Journal of genetic counseling","COVID-19; genetic counseling; genetic counselors; genetic services; prenatal genetic counseling; service delivery models; telemedicine","Slamon","Jill","Department of Obstetrics and Gynecology, Vanderbilt University Medical Center, Nashville, TN, USA",NA
"1982","34224635","10.1002/jgc4.1462","The COVID-19 pandemic and reproductive genetic counseling: Changes in access and service delivery at an academic medical center in the United States.","The COVID-19 pandemic widely disrupted the delivery of healthcare services, including genetic counseling. To ensure continuity of care, the reproductive genetic counselors at a large academic medical center in the United States rapidly transitioned their practice from 90% in-person patient consultations to a predominantly telehealth model. The present study describes this transition in regard to patient access to genetic counseling and genetic screening. A chart review of patients seen by the re","2021","07","05","J Genet Couns","Journal of genetic counseling","COVID-19; genetic counseling; genetic counselors; genetic services; prenatal genetic counseling; service delivery models; telemedicine","Newman","Randa","Department of Obstetrics and Gynecology, Vanderbilt University Medical Center, Nashville, TN, USA",NA
"1983","34224635","10.1002/jgc4.1462","The COVID-19 pandemic and reproductive genetic counseling: Changes in access and service delivery at an academic medical center in the United States.","The COVID-19 pandemic widely disrupted the delivery of healthcare services, including genetic counseling. To ensure continuity of care, the reproductive genetic counselors at a large academic medical center in the United States rapidly transitioned their practice from 90% in-person patient consultations to a predominantly telehealth model. The present study describes this transition in regard to patient access to genetic counseling and genetic screening. A chart review of patients seen by the re","2021","07","05","J Genet Couns","Journal of genetic counseling","COVID-19; genetic counseling; genetic counselors; genetic services; prenatal genetic counseling; service delivery models; telemedicine","Zhao","Zhiguo","Department of Biostatics, Vanderbilt University Medical Center, Nashville, TN, USA",NA
"1984","34224635","10.1002/jgc4.1462","The COVID-19 pandemic and reproductive genetic counseling: Changes in access and service delivery at an academic medical center in the United States.","The COVID-19 pandemic widely disrupted the delivery of healthcare services, including genetic counseling. To ensure continuity of care, the reproductive genetic counselors at a large academic medical center in the United States rapidly transitioned their practice from 90% in-person patient consultations to a predominantly telehealth model. The present study describes this transition in regard to patient access to genetic counseling and genetic screening. A chart review of patients seen by the re","2021","07","05","J Genet Couns","Journal of genetic counseling","COVID-19; genetic counseling; genetic counselors; genetic services; prenatal genetic counseling; service delivery models; telemedicine","Ding","Tan","Department of Biostatics, Vanderbilt University Medical Center, Nashville, TN, USA",NA
"1985","34224635","10.1002/jgc4.1462","The COVID-19 pandemic and reproductive genetic counseling: Changes in access and service delivery at an academic medical center in the United States.","The COVID-19 pandemic widely disrupted the delivery of healthcare services, including genetic counseling. To ensure continuity of care, the reproductive genetic counselors at a large academic medical center in the United States rapidly transitioned their practice from 90% in-person patient consultations to a predominantly telehealth model. The present study describes this transition in regard to patient access to genetic counseling and genetic screening. A chart review of patients seen by the re","2021","07","05","J Genet Couns","Journal of genetic counseling","COVID-19; genetic counseling; genetic counselors; genetic services; prenatal genetic counseling; service delivery models; telemedicine","Petrelli","Gianna","Master's in Genetic Counseling Program, Vanderbilt University School of Medicine, Nashville, TN, USA",NA
"1986","34224635","10.1002/jgc4.1462","The COVID-19 pandemic and reproductive genetic counseling: Changes in access and service delivery at an academic medical center in the United States.","The COVID-19 pandemic widely disrupted the delivery of healthcare services, including genetic counseling. To ensure continuity of care, the reproductive genetic counselors at a large academic medical center in the United States rapidly transitioned their practice from 90% in-person patient consultations to a predominantly telehealth model. The present study describes this transition in regard to patient access to genetic counseling and genetic screening. A chart review of patients seen by the re","2021","07","05","J Genet Couns","Journal of genetic counseling","COVID-19; genetic counseling; genetic counselors; genetic services; prenatal genetic counseling; service delivery models; telemedicine","Dudek","Martha","Department of Obstetrics and Gynecology, Vanderbilt University Medical Center, Nashville, TN, USA",NA
"1987","34224607","10.1002/jgc4.1456","The Accreditation Council for Genetic Counseling's response to COVID-19 impact on genetic counseling programs.",NA,"2021","07","05","J Genet Couns","Journal of genetic counseling","COVID-19; accrediting agency; compliance; education","Allain","Dawn C","Division of Human Genetics, Department of Internal Medicine, College of Medicine, The Ohio State University, Columbus, OH, USA",NA
"1988","34224607","10.1002/jgc4.1456","The Accreditation Council for Genetic Counseling's response to COVID-19 impact on genetic counseling programs.",NA,"2021","07","05","J Genet Couns","Journal of genetic counseling","COVID-19; accrediting agency; compliance; education","Randall Armel","Susan","Department of Medicine, Familial Cancer Clinic, University Health Network, University of Toronto, Toronto, ON, Canada",NA
"1989","34224607","10.1002/jgc4.1456","The Accreditation Council for Genetic Counseling's response to COVID-19 impact on genetic counseling programs.",NA,"2021","07","05","J Genet Couns","Journal of genetic counseling","COVID-19; accrediting agency; compliance; education","Carmany","Erin P","Center for Molecular Medicine and Genetics, Wayne State University School of Medicine, Detroit, MI, USA",NA
"1990","34224607","10.1002/jgc4.1456","The Accreditation Council for Genetic Counseling's response to COVID-19 impact on genetic counseling programs.",NA,"2021","07","05","J Genet Couns","Journal of genetic counseling","COVID-19; accrediting agency; compliance; education","Creswick","Heather","Virginia Commonwealth University, Richmond, VA, USA",NA
"1991","34224607","10.1002/jgc4.1456","The Accreditation Council for Genetic Counseling's response to COVID-19 impact on genetic counseling programs.",NA,"2021","07","05","J Genet Couns","Journal of genetic counseling","COVID-19; accrediting agency; compliance; education","McBrien","Sarah B","College of Allied Health Professions, University of Nebraska Medical Center, Omaha, NB, USA",NA
"1992","34224607","10.1002/jgc4.1456","The Accreditation Council for Genetic Counseling's response to COVID-19 impact on genetic counseling programs.",NA,"2021","07","05","J Genet Couns","Journal of genetic counseling","COVID-19; accrediting agency; compliance; education","Reed","E Kate","The Jackson Laboratory, Bar Harbor, ME, USA",NA
"1993","34224607","10.1002/jgc4.1456","The Accreditation Council for Genetic Counseling's response to COVID-19 impact on genetic counseling programs.",NA,"2021","07","05","J Genet Couns","Journal of genetic counseling","COVID-19; accrediting agency; compliance; education","Williams","Janet L","Genomic Medicine Institute, Geisinger, Danville, PA, USA",NA
"1994","34224594","10.1002/jcop.22657","Investigation of the psychiatric factors that determine the fear of COVID-19 in healthcare workers and hospital staff in a university hospital in Turkey.","To examine the association of health and hospital workers' fears of coronavirus disease 2019 (COVID-19) with anxiety, anxiety sensitivity, depression, and sociodemographic variables during the COVID-19 pandemic. A total of 527 participants (237 men/289 women) were included, 222 of the participants were doctors, 99 nurses, 22 assistant health personnel, and 182 hospital personnel without health education. Participants filled in the sociodemographic data form, Beck Depression Inventory, Beck Anxie","2021","07","05","J Community Psychol","Journal of community psychology","anxiety; anxiety sensitivity; depression; fear of COVID-19; healthcare workers; hospital staff without health education; pandemic","Karadem","Fevziye B","Department of Psychiatry, Isparta City Hospital, Isparta, Turkey",NA
"1995","34224594","10.1002/jcop.22657","Investigation of the psychiatric factors that determine the fear of COVID-19 in healthcare workers and hospital staff in a university hospital in Turkey.","To examine the association of health and hospital workers' fears of coronavirus disease 2019 (COVID-19) with anxiety, anxiety sensitivity, depression, and sociodemographic variables during the COVID-19 pandemic. A total of 527 participants (237 men/289 women) were included, 222 of the participants were doctors, 99 nurses, 22 assistant health personnel, and 182 hospital personnel without health education. Participants filled in the sociodemographic data form, Beck Depression Inventory, Beck Anxie","2021","07","05","J Community Psychol","Journal of community psychology","anxiety; anxiety sensitivity; depression; fear of COVID-19; healthcare workers; hospital staff without health education; pandemic","Demirdas","Arif","Medical Doctor of Psychiatry, Isparta, Turkey",NA
"1996","34224594","10.1002/jcop.22657","Investigation of the psychiatric factors that determine the fear of COVID-19 in healthcare workers and hospital staff in a university hospital in Turkey.","To examine the association of health and hospital workers' fears of coronavirus disease 2019 (COVID-19) with anxiety, anxiety sensitivity, depression, and sociodemographic variables during the COVID-19 pandemic. A total of 527 participants (237 men/289 women) were included, 222 of the participants were doctors, 99 nurses, 22 assistant health personnel, and 182 hospital personnel without health education. Participants filled in the sociodemographic data form, Beck Depression Inventory, Beck Anxie","2021","07","05","J Community Psychol","Journal of community psychology","anxiety; anxiety sensitivity; depression; fear of COVID-19; healthcare workers; hospital staff without health education; pandemic","Isik","Ümit","Department of Child and Adolescent Psychiatry, Faculty of Medicine, Süleyman Demirel University, Isparta, Turkey",NA
"1997","34224594","10.1002/jcop.22657","Investigation of the psychiatric factors that determine the fear of COVID-19 in healthcare workers and hospital staff in a university hospital in Turkey.","To examine the association of health and hospital workers' fears of coronavirus disease 2019 (COVID-19) with anxiety, anxiety sensitivity, depression, and sociodemographic variables during the COVID-19 pandemic. A total of 527 participants (237 men/289 women) were included, 222 of the participants were doctors, 99 nurses, 22 assistant health personnel, and 182 hospital personnel without health education. Participants filled in the sociodemographic data form, Beck Depression Inventory, Beck Anxie","2021","07","05","J Community Psychol","Journal of community psychology","anxiety; anxiety sensitivity; depression; fear of COVID-19; healthcare workers; hospital staff without health education; pandemic","Kiliç","Faruk","Department of Psychiatry, Faculty of Medicine, Süleyman Demirel University, Isparta, Turkey",NA
"1998","34224585","10.1111/bjd.20516","Yet another benefit from sunlight in the fight against COVID-19?",NA,"2021","07","05","Br J Dermatol","The British journal of dermatology",NA,"McKenzie","R L","National Institute of Water and Atmospheric Research, Lauder Atmospheric Research Station, Central Otago, New Zealand",NA
"1999","34224585","10.1111/bjd.20516","Yet another benefit from sunlight in the fight against COVID-19?",NA,"2021","07","05","Br J Dermatol","The British journal of dermatology",NA,"Liley","J B","National Institute of Water and Atmospheric Research, Lauder Atmospheric Research Station, Central Otago, New Zealand",NA
"2000","34224555","10.1093/ageing/afab156","Impact of Covid-19 restrictions on carers of persons with dementia in the UK: A qualitative study.","Informal carers provide the majority of the support for persons with dementia living at home. Restrictions imposed due to COVID-19 have had a profound impact on the daily life of the entire population. This study provides insight into the impact of these restrictions on carers of people with dementia living at home. Qualitative semi-structured interviews. Purposive sample of carers who provide at least 10 hours of care a week for the person with dementia living at home. United Kingdom. Twenty-th","2021","07","05","Age Ageing","Age and ageing","COVID-19; Carer; Dementia; Older people; Qualitative; Thematic analysis","Sriram","Vimal","Health Services Research Unit, Nuffield Department of Population Health, University of Oxford, Richard Doll Building, Old Road Campus, Oxford OX3 7LF",NA
"2001","34224555","10.1093/ageing/afab156","Impact of Covid-19 restrictions on carers of persons with dementia in the UK: A qualitative study.","Informal carers provide the majority of the support for persons with dementia living at home. Restrictions imposed due to COVID-19 have had a profound impact on the daily life of the entire population. This study provides insight into the impact of these restrictions on carers of people with dementia living at home. Qualitative semi-structured interviews. Purposive sample of carers who provide at least 10 hours of care a week for the person with dementia living at home. United Kingdom. Twenty-th","2021","07","05","Age Ageing","Age and ageing","COVID-19; Carer; Dementia; Older people; Qualitative; Thematic analysis","Jenkinson","Crispin","Health Services Research Unit, Nuffield Department of Population Health, University of Oxford, Richard Doll Building, Old Road Campus, Oxford OX3 7LF",NA
"2002","34224555","10.1093/ageing/afab156","Impact of Covid-19 restrictions on carers of persons with dementia in the UK: A qualitative study.","Informal carers provide the majority of the support for persons with dementia living at home. Restrictions imposed due to COVID-19 have had a profound impact on the daily life of the entire population. This study provides insight into the impact of these restrictions on carers of people with dementia living at home. Qualitative semi-structured interviews. Purposive sample of carers who provide at least 10 hours of care a week for the person with dementia living at home. United Kingdom. Twenty-th","2021","07","05","Age Ageing","Age and ageing","COVID-19; Carer; Dementia; Older people; Qualitative; Thematic analysis","Peters","Michele","Health Services Research Unit, Nuffield Department of Population Health, University of Oxford, Richard Doll Building, Old Road Campus, Oxford OX3 7LF",NA
"2003","34224553","10.7416/ai.2021.2460","Validation Checklist for Massive Vaccination Centers.","Starting from the minimum requirements indicated by Lombardy Region, a validation checklist has been developed by experts in design, healthcare layout planning, hygiene and public health, planning and compliance, in order to provide managers of COVID-19 massive vaccination centers with a useful and easy-to-use tool to ensure quality, safety and efficiency of the different activities performed.","2021","07","16","Ann Ig","Annali di igiene : medicina preventiva e di comunita","COVID-19; Massive Vaccination Center; checklist; efficiency; layout; quality; safety; vaccination campaign; COVID-19; COVID-19 Vaccines; Checklist; Community Health Centers; Efficiency, Organizational; Facility Design and Construction; Humans; Hygiene; Italy; Mass Vaccination; Patient Safety; Quality Assurance, Health Care; Quality Indicators, Health Care; SARS-CoV-2; Validation Studies as Topic","Capolongo","S","Politecnico di Milano, Department Architecture Built environment Construction engineering (DABC), Design &amp",NA
"2004","34224553","10.7416/ai.2021.2460","Validation Checklist for Massive Vaccination Centers.","Starting from the minimum requirements indicated by Lombardy Region, a validation checklist has been developed by experts in design, healthcare layout planning, hygiene and public health, planning and compliance, in order to provide managers of COVID-19 massive vaccination centers with a useful and easy-to-use tool to ensure quality, safety and efficiency of the different activities performed.","2021","07","16","Ann Ig","Annali di igiene : medicina preventiva e di comunita","COVID-19; Massive Vaccination Center; checklist; efficiency; layout; quality; safety; vaccination campaign; COVID-19; COVID-19 Vaccines; Checklist; Community Health Centers; Efficiency, Organizational; Facility Design and Construction; Humans; Hygiene; Italy; Mass Vaccination; Patient Safety; Quality Assurance, Health Care; Quality Indicators, Health Care; SARS-CoV-2; Validation Studies as Topic","Brambilla","A","Politecnico di Milano, Department Architecture Built environment Construction engineering (DABC), Design &amp",NA
"2005","34224553","10.7416/ai.2021.2460","Validation Checklist for Massive Vaccination Centers.","Starting from the minimum requirements indicated by Lombardy Region, a validation checklist has been developed by experts in design, healthcare layout planning, hygiene and public health, planning and compliance, in order to provide managers of COVID-19 massive vaccination centers with a useful and easy-to-use tool to ensure quality, safety and efficiency of the different activities performed.","2021","07","16","Ann Ig","Annali di igiene : medicina preventiva e di comunita","COVID-19; Massive Vaccination Center; checklist; efficiency; layout; quality; safety; vaccination campaign; COVID-19; COVID-19 Vaccines; Checklist; Community Health Centers; Efficiency, Organizational; Facility Design and Construction; Humans; Hygiene; Italy; Mass Vaccination; Patient Safety; Quality Assurance, Health Care; Quality Indicators, Health Care; SARS-CoV-2; Validation Studies as Topic","Girardi","A","EY, Risk Advisory, Milan, Italy",NA
"2006","34224553","10.7416/ai.2021.2460","Validation Checklist for Massive Vaccination Centers.","Starting from the minimum requirements indicated by Lombardy Region, a validation checklist has been developed by experts in design, healthcare layout planning, hygiene and public health, planning and compliance, in order to provide managers of COVID-19 massive vaccination centers with a useful and easy-to-use tool to ensure quality, safety and efficiency of the different activities performed.","2021","07","16","Ann Ig","Annali di igiene : medicina preventiva e di comunita","COVID-19; Massive Vaccination Center; checklist; efficiency; layout; quality; safety; vaccination campaign; COVID-19; COVID-19 Vaccines; Checklist; Community Health Centers; Efficiency, Organizational; Facility Design and Construction; Humans; Hygiene; Italy; Mass Vaccination; Patient Safety; Quality Assurance, Health Care; Quality Indicators, Health Care; SARS-CoV-2; Validation Studies as Topic","Signorelli","C","Università Vita-Salute San Raffaele, School of Public Health, Milan, Italy",NA
"2007","34224543","10.1097/TP.0000000000003883","Anti-SARS-Cov-2 Monoclonal Antibodies in Solid-Organ-Transplant Patients.",NA,"2021","07","14","Transplantation","Transplantation",NA,"Del Bello","Arnaud","Department of Nephrology and Organ Transplantation, Toulouse Rangueil University Hospital, Toulouse, France INFINITY- Inserm U1291-CNRS U5051, Toulouse, France. Paul Sabatier University, Toulouse, France Laboratory of Virology, Toulouse Purpan University Hospital, Toulouse, France INSERM",NA
"2008","34224543","10.1097/TP.0000000000003883","Anti-SARS-Cov-2 Monoclonal Antibodies in Solid-Organ-Transplant Patients.",NA,"2021","07","14","Transplantation","Transplantation",NA,"Marion","Olivier","Department of Nephrology and Organ Transplantation, Toulouse Rangueil University Hospital, Toulouse, France INFINITY- Inserm U1291-CNRS U5051, Toulouse, France. Paul Sabatier University, Toulouse, France Laboratory of Virology, Toulouse Purpan University Hospital, Toulouse, France INSERM",NA
"2009","34224543","10.1097/TP.0000000000003883","Anti-SARS-Cov-2 Monoclonal Antibodies in Solid-Organ-Transplant Patients.",NA,"2021","07","14","Transplantation","Transplantation",NA,"Vellas","Camille","Department of Nephrology and Organ Transplantation, Toulouse Rangueil University Hospital, Toulouse, France INFINITY- Inserm U1291-CNRS U5051, Toulouse, France. Paul Sabatier University, Toulouse, France Laboratory of Virology, Toulouse Purpan University Hospital, Toulouse, France INSERM",NA
"2010","34224543","10.1097/TP.0000000000003883","Anti-SARS-Cov-2 Monoclonal Antibodies in Solid-Organ-Transplant Patients.",NA,"2021","07","14","Transplantation","Transplantation",NA,"Faguer","Stanislas","Department of Nephrology and Organ Transplantation, Toulouse Rangueil University Hospital, Toulouse, France INFINITY- Inserm U1291-CNRS U5051, Toulouse, France. Paul Sabatier University, Toulouse, France Laboratory of Virology, Toulouse Purpan University Hospital, Toulouse, France INSERM",NA
"2011","34224543","10.1097/TP.0000000000003883","Anti-SARS-Cov-2 Monoclonal Antibodies in Solid-Organ-Transplant Patients.",NA,"2021","07","14","Transplantation","Transplantation",NA,"Izopet","Jacques","Department of Nephrology and Organ Transplantation, Toulouse Rangueil University Hospital, Toulouse, France INFINITY- Inserm U1291-CNRS U5051, Toulouse, France. Paul Sabatier University, Toulouse, France Laboratory of Virology, Toulouse Purpan University Hospital, Toulouse, France INSERM",NA
"2012","34224543","10.1097/TP.0000000000003883","Anti-SARS-Cov-2 Monoclonal Antibodies in Solid-Organ-Transplant Patients.",NA,"2021","07","14","Transplantation","Transplantation",NA,"Kamar","Nassim","Department of Nephrology and Organ Transplantation, Toulouse Rangueil University Hospital, Toulouse, France INFINITY- Inserm U1291-CNRS U5051, Toulouse, France. Paul Sabatier University, Toulouse, France Laboratory of Virology, Toulouse Purpan University Hospital, Toulouse, France INSERM",NA
"2013","34224542","10.1097/TP.0000000000003882","SARS-CoV-2 Vaccination and Antibody Testing in Immunosuppressed Populations: You Can't Tell the Players Without a Scorecard.",NA,"2021","07","14","Transplantation","Transplantation",NA,"Woodle","E Steve","University of Cincinnati, College of Medicine, Department of Surgery, Division of Transplantation, Cincinnati, OH, USA. Emory University, Department of Pathology, Division of Laboratory Medicine, Atlanta, GA, USA. New York University Langone Transplant Institute, NYU Langone Health, New York, New York, USA. Stanford University School of Medicine, Department of Medicine, and VA Palo Alto Health Care System, Palo Alto, CA, USA",NA
"2014","34224542","10.1097/TP.0000000000003882","SARS-CoV-2 Vaccination and Antibody Testing in Immunosuppressed Populations: You Can't Tell the Players Without a Scorecard.",NA,"2021","07","14","Transplantation","Transplantation",NA,"Gebel","Howard M","University of Cincinnati, College of Medicine, Department of Surgery, Division of Transplantation, Cincinnati, OH, USA. Emory University, Department of Pathology, Division of Laboratory Medicine, Atlanta, GA, USA. New York University Langone Transplant Institute, NYU Langone Health, New York, New York, USA. Stanford University School of Medicine, Department of Medicine, and VA Palo Alto Health Care System, Palo Alto, CA, USA",NA
"2015","34224542","10.1097/TP.0000000000003882","SARS-CoV-2 Vaccination and Antibody Testing in Immunosuppressed Populations: You Can't Tell the Players Without a Scorecard.",NA,"2021","07","14","Transplantation","Transplantation",NA,"Montgomery","Robert A","University of Cincinnati, College of Medicine, Department of Surgery, Division of Transplantation, Cincinnati, OH, USA. Emory University, Department of Pathology, Division of Laboratory Medicine, Atlanta, GA, USA. New York University Langone Transplant Institute, NYU Langone Health, New York, New York, USA. Stanford University School of Medicine, Department of Medicine, and VA Palo Alto Health Care System, Palo Alto, CA, USA",NA
"2016","34224542","10.1097/TP.0000000000003882","SARS-CoV-2 Vaccination and Antibody Testing in Immunosuppressed Populations: You Can't Tell the Players Without a Scorecard.",NA,"2021","07","14","Transplantation","Transplantation",NA,"Maltzman","Jonathan S","University of Cincinnati, College of Medicine, Department of Surgery, Division of Transplantation, Cincinnati, OH, USA. Emory University, Department of Pathology, Division of Laboratory Medicine, Atlanta, GA, USA. New York University Langone Transplant Institute, NYU Langone Health, New York, New York, USA. Stanford University School of Medicine, Department of Medicine, and VA Palo Alto Health Care System, Palo Alto, CA, USA",NA
"2017","34224534","10.1097/NCQ.0000000000000577","Nursing Interventions Increase Influenza Vaccination Quality Measures for Home Telehealth Patients.","Influenza vaccinations are a preventive health quality measure. Home telehealth nursing staff interventions can reduce influenza disease burden and complications. To improve seasonal flu vaccine rates using novel home telehealth clinical and technology interventions. A pre- and postintervention concurrent cohort study for 513 outpatients was conducted. Interventions included automated 2-way patient messaging using remote monitoring equipment, a new note template to record vaccination status in t","2021","07","06","J Nurs Care Qual","Journal of nursing care quality",NA,"Rand","Maxine L","San Francisco Veterans Administration Health Care System, San Francisco, California",NA
"2018","34224532","10.1097/NND.0000000000000782","The Ever-Changing Work Environment During COVID-19: Nurses' Experiences in the Early Phase.","The COVID-19 pandemic is a history-changing event affecting all nurses. This study sought to explore nurses' experiences during the pandemic's early phase using a phenomenological approach. One hundred sixty-one participants enrolled in the study. Demographic data, written narratives, and digital images were collected. Ever-changing environment emerged as the overarching theme, along with six subthemes. Because of a crisis situation created by the pandemic, nurses need specialized support and ed","2021","07","06","J Nurses Prof Dev","Journal for nurses in professional development",NA,"Nair","Julie McCulloh","Julie McCulloh Nair, PhD, RN, APHN-BC, CCRE, is Associate Professor of Nursing, West Chester University of Pennsylvania, West Chester, PA. Susan Birkhoff PhD, RN, is a Postdoctoral Scholar, T32NR008857 Technology: Research in Chronic and Critical Illness, University of Pittsburgh School of Nursing, Department of Acute &amp",NA
"2019","34224532","10.1097/NND.0000000000000782","The Ever-Changing Work Environment During COVID-19: Nurses' Experiences in the Early Phase.","The COVID-19 pandemic is a history-changing event affecting all nurses. This study sought to explore nurses' experiences during the pandemic's early phase using a phenomenological approach. One hundred sixty-one participants enrolled in the study. Demographic data, written narratives, and digital images were collected. Ever-changing environment emerged as the overarching theme, along with six subthemes. Because of a crisis situation created by the pandemic, nurses need specialized support and ed","2021","07","06","J Nurses Prof Dev","Journal for nurses in professional development",NA,"Birkhoff","Susan","Julie McCulloh Nair, PhD, RN, APHN-BC, CCRE, is Associate Professor of Nursing, West Chester University of Pennsylvania, West Chester, PA. Susan Birkhoff PhD, RN, is a Postdoctoral Scholar, T32NR008857 Technology: Research in Chronic and Critical Illness, University of Pittsburgh School of Nursing, Department of Acute &amp",NA
"2020","34224532","10.1097/NND.0000000000000782","The Ever-Changing Work Environment During COVID-19: Nurses' Experiences in the Early Phase.","The COVID-19 pandemic is a history-changing event affecting all nurses. This study sought to explore nurses' experiences during the pandemic's early phase using a phenomenological approach. One hundred sixty-one participants enrolled in the study. Demographic data, written narratives, and digital images were collected. Ever-changing environment emerged as the overarching theme, along with six subthemes. Because of a crisis situation created by the pandemic, nurses need specialized support and ed","2021","07","06","J Nurses Prof Dev","Journal for nurses in professional development",NA,"Mandel","Deborah","Julie McCulloh Nair, PhD, RN, APHN-BC, CCRE, is Associate Professor of Nursing, West Chester University of Pennsylvania, West Chester, PA. Susan Birkhoff PhD, RN, is a Postdoctoral Scholar, T32NR008857 Technology: Research in Chronic and Critical Illness, University of Pittsburgh School of Nursing, Department of Acute &amp",NA
"2021","34224532","10.1097/NND.0000000000000782","The Ever-Changing Work Environment During COVID-19: Nurses' Experiences in the Early Phase.","The COVID-19 pandemic is a history-changing event affecting all nurses. This study sought to explore nurses' experiences during the pandemic's early phase using a phenomenological approach. One hundred sixty-one participants enrolled in the study. Demographic data, written narratives, and digital images were collected. Ever-changing environment emerged as the overarching theme, along with six subthemes. Because of a crisis situation created by the pandemic, nurses need specialized support and ed","2021","07","06","J Nurses Prof Dev","Journal for nurses in professional development",NA,"Thomas","Amanda","Julie McCulloh Nair, PhD, RN, APHN-BC, CCRE, is Associate Professor of Nursing, West Chester University of Pennsylvania, West Chester, PA. Susan Birkhoff PhD, RN, is a Postdoctoral Scholar, T32NR008857 Technology: Research in Chronic and Critical Illness, University of Pittsburgh School of Nursing, Department of Acute &amp",NA
"2022","34224524","10.1097/XEB.0000000000000288","Training women's pelvic floor muscles during pregnancy and postpartum at primary health centers: a best practice implementation project.","Pelvic floor muscle training (PFMT) enhances muscle strength and coordination, and prevents urinary incontinence associated with giving birth. The goal was to improve women's PFMT during pregnancy and postpartum in La Rioja, Spain. This evidence implementation project used the JBI evidence implementation framework. First, we conducted the PFMT baseline audit: to assess the criteria for midwife training, we sent a questionnaire to all midwives. To measure the criteria for PFMT and urinary inconti","2021","07","14","JBI Evid Implement","JBI evidence implementation",NA,"de Viñaspre","Regina Ruiz","University of La Rioja, Logroño (La Rioja) and Spanish Centre for Evidence-Based Nursing and Healthcare: A Joanna Briggs Institute Centre of Excellence, Madrid Health Service of La Rioja, Logroño, Spain",NA
"2023","34224524","10.1097/XEB.0000000000000288","Training women's pelvic floor muscles during pregnancy and postpartum at primary health centers: a best practice implementation project.","Pelvic floor muscle training (PFMT) enhances muscle strength and coordination, and prevents urinary incontinence associated with giving birth. The goal was to improve women's PFMT during pregnancy and postpartum in La Rioja, Spain. This evidence implementation project used the JBI evidence implementation framework. First, we conducted the PFMT baseline audit: to assess the criteria for midwife training, we sent a questionnaire to all midwives. To measure the criteria for PFMT and urinary inconti","2021","07","14","JBI Evid Implement","JBI evidence implementation",NA,"Garrido","Ana Elena","University of La Rioja, Logroño (La Rioja) and Spanish Centre for Evidence-Based Nursing and Healthcare: A Joanna Briggs Institute Centre of Excellence, Madrid Health Service of La Rioja, Logroño, Spain",NA
"2024","34224524","10.1097/XEB.0000000000000288","Training women's pelvic floor muscles during pregnancy and postpartum at primary health centers: a best practice implementation project.","Pelvic floor muscle training (PFMT) enhances muscle strength and coordination, and prevents urinary incontinence associated with giving birth. The goal was to improve women's PFMT during pregnancy and postpartum in La Rioja, Spain. This evidence implementation project used the JBI evidence implementation framework. First, we conducted the PFMT baseline audit: to assess the criteria for midwife training, we sent a questionnaire to all midwives. To measure the criteria for PFMT and urinary inconti","2021","07","14","JBI Evid Implement","JBI evidence implementation",NA,"Alvarez","Maria Angeles","University of La Rioja, Logroño (La Rioja) and Spanish Centre for Evidence-Based Nursing and Healthcare: A Joanna Briggs Institute Centre of Excellence, Madrid Health Service of La Rioja, Logroño, Spain",NA
"2025","34224523","10.1097/OLQ.0000000000001506","Trends in nationally notifiable sexually transmitted disease case reports during the U.S. COVID-19 pandemic, January-December 2020.","To describe changes in reported sexually transmitted diseases (STDs) during the U.S. coronavirus disease 2019 pandemic, we compared the weekly number of reported nationally notifiable STDs in 2020 to 2019. We reviewed cases of chlamydia, gonorrhea, and primary &amp; secondary (P&amp;S) syphilis reported to the U.S. National Notifiable Disease Surveillance System in 2020. For each STD, we compare the number of 2020 cases reported for a given Morbidity and Mortality Weekly Report (MMWR) week to th","2021","07","05","Sex Transm Dis","Sexually transmitted diseases",NA,"Pagaoa","Melissa","Centers for Disease Control and Prevention. National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention. Division of STD Prevention",NA
"2026","34224523","10.1097/OLQ.0000000000001506","Trends in nationally notifiable sexually transmitted disease case reports during the U.S. COVID-19 pandemic, January-December 2020.","To describe changes in reported sexually transmitted diseases (STDs) during the U.S. coronavirus disease 2019 pandemic, we compared the weekly number of reported nationally notifiable STDs in 2020 to 2019. We reviewed cases of chlamydia, gonorrhea, and primary &amp; secondary (P&amp;S) syphilis reported to the U.S. National Notifiable Disease Surveillance System in 2020. For each STD, we compare the number of 2020 cases reported for a given Morbidity and Mortality Weekly Report (MMWR) week to th","2021","07","05","Sex Transm Dis","Sexually transmitted diseases",NA,"Grey","Jeremy","Centers for Disease Control and Prevention. National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention. Division of STD Prevention",NA
"2027","34224523","10.1097/OLQ.0000000000001506","Trends in nationally notifiable sexually transmitted disease case reports during the U.S. COVID-19 pandemic, January-December 2020.","To describe changes in reported sexually transmitted diseases (STDs) during the U.S. coronavirus disease 2019 pandemic, we compared the weekly number of reported nationally notifiable STDs in 2020 to 2019. We reviewed cases of chlamydia, gonorrhea, and primary &amp; secondary (P&amp;S) syphilis reported to the U.S. National Notifiable Disease Surveillance System in 2020. For each STD, we compare the number of 2020 cases reported for a given Morbidity and Mortality Weekly Report (MMWR) week to th","2021","07","05","Sex Transm Dis","Sexually transmitted diseases",NA,"Torrone","Elizabeth","Centers for Disease Control and Prevention. National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention. Division of STD Prevention",NA
"2028","34224523","10.1097/OLQ.0000000000001506","Trends in nationally notifiable sexually transmitted disease case reports during the U.S. COVID-19 pandemic, January-December 2020.","To describe changes in reported sexually transmitted diseases (STDs) during the U.S. coronavirus disease 2019 pandemic, we compared the weekly number of reported nationally notifiable STDs in 2020 to 2019. We reviewed cases of chlamydia, gonorrhea, and primary &amp; secondary (P&amp;S) syphilis reported to the U.S. National Notifiable Disease Surveillance System in 2020. For each STD, we compare the number of 2020 cases reported for a given Morbidity and Mortality Weekly Report (MMWR) week to th","2021","07","05","Sex Transm Dis","Sexually transmitted diseases",NA,"Kreisel","Kristen","Centers for Disease Control and Prevention. National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention. Division of STD Prevention",NA
"2029","34224523","10.1097/OLQ.0000000000001506","Trends in nationally notifiable sexually transmitted disease case reports during the U.S. COVID-19 pandemic, January-December 2020.","To describe changes in reported sexually transmitted diseases (STDs) during the U.S. coronavirus disease 2019 pandemic, we compared the weekly number of reported nationally notifiable STDs in 2020 to 2019. We reviewed cases of chlamydia, gonorrhea, and primary &amp; secondary (P&amp;S) syphilis reported to the U.S. National Notifiable Disease Surveillance System in 2020. For each STD, we compare the number of 2020 cases reported for a given Morbidity and Mortality Weekly Report (MMWR) week to th","2021","07","05","Sex Transm Dis","Sexually transmitted diseases",NA,"Stenger","Mark","Centers for Disease Control and Prevention. National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention. Division of STD Prevention",NA
"2030","34224523","10.1097/OLQ.0000000000001506","Trends in nationally notifiable sexually transmitted disease case reports during the U.S. COVID-19 pandemic, January-December 2020.","To describe changes in reported sexually transmitted diseases (STDs) during the U.S. coronavirus disease 2019 pandemic, we compared the weekly number of reported nationally notifiable STDs in 2020 to 2019. We reviewed cases of chlamydia, gonorrhea, and primary &amp; secondary (P&amp;S) syphilis reported to the U.S. National Notifiable Disease Surveillance System in 2020. For each STD, we compare the number of 2020 cases reported for a given Morbidity and Mortality Weekly Report (MMWR) week to th","2021","07","05","Sex Transm Dis","Sexually transmitted diseases",NA,"Weinstock","Hillard","Centers for Disease Control and Prevention. National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention. Division of STD Prevention",NA
"2031","34224515","10.1097/MPH.0000000000002243","COVID-19-Related Reduction in Emergency Health Care Utilization Among Febrile Pediatric Oncology Patients.","The severe acute respiratory syndrome coronavirus (SARS-CoV-2) pandemic has disrupted normal health care utilization patterns worldwide, including decreasing emergency department (ED) visits for various medical emergencies. We examined whether this pattern was present in febrile pediatric oncology patients. In this single-center cohort study, we conducted a retrospective chart review of ED visits of febrile pediatric oncology patients during the first 4 months of the global SARS-CoV-2 pandemic a","2021","07","05","J Pediatr Hematol Oncol","Journal of pediatric hematology/oncology",NA,"Kram","David E","Division of Pediatric Hematology and Oncology Department of Biostatistics and Data Science, Wake Forest School of Medicine, Winston Salem, NC",NA
"2032","34224515","10.1097/MPH.0000000000002243","COVID-19-Related Reduction in Emergency Health Care Utilization Among Febrile Pediatric Oncology Patients.","The severe acute respiratory syndrome coronavirus (SARS-CoV-2) pandemic has disrupted normal health care utilization patterns worldwide, including decreasing emergency department (ED) visits for various medical emergencies. We examined whether this pattern was present in febrile pediatric oncology patients. In this single-center cohort study, we conducted a retrospective chart review of ED visits of febrile pediatric oncology patients during the first 4 months of the global SARS-CoV-2 pandemic a","2021","07","05","J Pediatr Hematol Oncol","Journal of pediatric hematology/oncology",NA,"Tooze","Janet A","Division of Pediatric Hematology and Oncology Department of Biostatistics and Data Science, Wake Forest School of Medicine, Winston Salem, NC",NA
"2033","34224515","10.1097/MPH.0000000000002243","COVID-19-Related Reduction in Emergency Health Care Utilization Among Febrile Pediatric Oncology Patients.","The severe acute respiratory syndrome coronavirus (SARS-CoV-2) pandemic has disrupted normal health care utilization patterns worldwide, including decreasing emergency department (ED) visits for various medical emergencies. We examined whether this pattern was present in febrile pediatric oncology patients. In this single-center cohort study, we conducted a retrospective chart review of ED visits of febrile pediatric oncology patients during the first 4 months of the global SARS-CoV-2 pandemic a","2021","07","05","J Pediatr Hematol Oncol","Journal of pediatric hematology/oncology",NA,"Russell","Thomas B","Division of Pediatric Hematology and Oncology Department of Biostatistics and Data Science, Wake Forest School of Medicine, Winston Salem, NC",NA
"2034","34224515","10.1097/MPH.0000000000002243","COVID-19-Related Reduction in Emergency Health Care Utilization Among Febrile Pediatric Oncology Patients.","The severe acute respiratory syndrome coronavirus (SARS-CoV-2) pandemic has disrupted normal health care utilization patterns worldwide, including decreasing emergency department (ED) visits for various medical emergencies. We examined whether this pattern was present in febrile pediatric oncology patients. In this single-center cohort study, we conducted a retrospective chart review of ED visits of febrile pediatric oncology patients during the first 4 months of the global SARS-CoV-2 pandemic a","2021","07","05","J Pediatr Hematol Oncol","Journal of pediatric hematology/oncology",NA,"McLean","Thomas W","Division of Pediatric Hematology and Oncology Department of Biostatistics and Data Science, Wake Forest School of Medicine, Winston Salem, NC",NA
"2035","34224465","10.1097/MBC.0000000000001058","Immune thrombocytopenia: options and new perspectives.","Immune thrombocytopenia is a haematological, autoimmune disorder characterized by elevated platelet demolition due to the presence of antiplatelet autoantibodies derived from B cells and to an irregular, deficient process of platelets production in bone marrow. In this review, after a brief presentation of 'old' strategies used nowadays yet, we focused on new drugs used in the treatment of immune thrombocytopenia and their mechanism of action and posology, basing on the last scientific literatur","2021","07","05","Blood Coagul Fibrinolysis","Blood coagulation &amp; fibrinolysis : an international journal in haemostasis and thrombosis",NA,"Caserta","Santino","Division of Hematology, Department of Human Pathology in Adulthood and Childhood 'Gaetano Barresi', University of Messina, Messina, Italy",NA
"2036","34224465","10.1097/MBC.0000000000001058","Immune thrombocytopenia: options and new perspectives.","Immune thrombocytopenia is a haematological, autoimmune disorder characterized by elevated platelet demolition due to the presence of antiplatelet autoantibodies derived from B cells and to an irregular, deficient process of platelets production in bone marrow. In this review, after a brief presentation of 'old' strategies used nowadays yet, we focused on new drugs used in the treatment of immune thrombocytopenia and their mechanism of action and posology, basing on the last scientific literatur","2021","07","05","Blood Coagul Fibrinolysis","Blood coagulation &amp; fibrinolysis : an international journal in haemostasis and thrombosis",NA,"Zaccuri","Anna Maria","Division of Hematology, Department of Human Pathology in Adulthood and Childhood 'Gaetano Barresi', University of Messina, Messina, Italy",NA
"2037","34224465","10.1097/MBC.0000000000001058","Immune thrombocytopenia: options and new perspectives.","Immune thrombocytopenia is a haematological, autoimmune disorder characterized by elevated platelet demolition due to the presence of antiplatelet autoantibodies derived from B cells and to an irregular, deficient process of platelets production in bone marrow. In this review, after a brief presentation of 'old' strategies used nowadays yet, we focused on new drugs used in the treatment of immune thrombocytopenia and their mechanism of action and posology, basing on the last scientific literatur","2021","07","05","Blood Coagul Fibrinolysis","Blood coagulation &amp; fibrinolysis : an international journal in haemostasis and thrombosis",NA,"Innao","Vanessa","Division of Hematology, Department of Human Pathology in Adulthood and Childhood 'Gaetano Barresi', University of Messina, Messina, Italy",NA
"2038","34224465","10.1097/MBC.0000000000001058","Immune thrombocytopenia: options and new perspectives.","Immune thrombocytopenia is a haematological, autoimmune disorder characterized by elevated platelet demolition due to the presence of antiplatelet autoantibodies derived from B cells and to an irregular, deficient process of platelets production in bone marrow. In this review, after a brief presentation of 'old' strategies used nowadays yet, we focused on new drugs used in the treatment of immune thrombocytopenia and their mechanism of action and posology, basing on the last scientific literatur","2021","07","05","Blood Coagul Fibrinolysis","Blood coagulation &amp; fibrinolysis : an international journal in haemostasis and thrombosis",NA,"Musolino","Caterina","Division of Hematology, Department of Human Pathology in Adulthood and Childhood 'Gaetano Barresi', University of Messina, Messina, Italy",NA
"2039","34224465","10.1097/MBC.0000000000001058","Immune thrombocytopenia: options and new perspectives.","Immune thrombocytopenia is a haematological, autoimmune disorder characterized by elevated platelet demolition due to the presence of antiplatelet autoantibodies derived from B cells and to an irregular, deficient process of platelets production in bone marrow. In this review, after a brief presentation of 'old' strategies used nowadays yet, we focused on new drugs used in the treatment of immune thrombocytopenia and their mechanism of action and posology, basing on the last scientific literatur","2021","07","05","Blood Coagul Fibrinolysis","Blood coagulation &amp; fibrinolysis : an international journal in haemostasis and thrombosis",NA,"Allegra","Alessandro","Division of Hematology, Department of Human Pathology in Adulthood and Childhood 'Gaetano Barresi', University of Messina, Messina, Italy",NA
"2040","34224453","10.1097/CCM.0000000000005167","Right Ventricular Dysfunction and Its Association With Mortality in Coronavirus Disease 2019 Acute Respiratory Distress Syndrome.","To assess whether right ventricular dilation or systolic impairment is associated with mortality and/or disease severity in invasively ventilated patients with coronavirus disease 2019 acute respiratory distress syndrome. Retrospective cohort study. Single-center U.K. ICU. Patients with coronavirus disease 2019 acute respiratory distress syndrome undergoing invasive mechanical ventilation that received a transthoracic echocardiogram between March and December 2020. None. Right ventricular dilati","2021","07","06","Crit Care Med","Critical care medicine",NA,"Chotalia","Minesh","Birmingham Acute Care Research Group, University of Birmingham, Birmingham, United Kingdom Department of Anaesthetics and Critical Care, Queen Elizabeth Hospital Birmingham, Birmingham, United Kingdom. Department of Cardiology, Queen Elizabeth Hospital Birmingham, Birmingham, United Kingdom",NA
"2041","34224453","10.1097/CCM.0000000000005167","Right Ventricular Dysfunction and Its Association With Mortality in Coronavirus Disease 2019 Acute Respiratory Distress Syndrome.","To assess whether right ventricular dilation or systolic impairment is associated with mortality and/or disease severity in invasively ventilated patients with coronavirus disease 2019 acute respiratory distress syndrome. Retrospective cohort study. Single-center U.K. ICU. Patients with coronavirus disease 2019 acute respiratory distress syndrome undergoing invasive mechanical ventilation that received a transthoracic echocardiogram between March and December 2020. None. Right ventricular dilati","2021","07","06","Crit Care Med","Critical care medicine",NA,"Ali","Muzzammil","Birmingham Acute Care Research Group, University of Birmingham, Birmingham, United Kingdom Department of Anaesthetics and Critical Care, Queen Elizabeth Hospital Birmingham, Birmingham, United Kingdom. Department of Cardiology, Queen Elizabeth Hospital Birmingham, Birmingham, United Kingdom",NA
"2042","34224453","10.1097/CCM.0000000000005167","Right Ventricular Dysfunction and Its Association With Mortality in Coronavirus Disease 2019 Acute Respiratory Distress Syndrome.","To assess whether right ventricular dilation or systolic impairment is associated with mortality and/or disease severity in invasively ventilated patients with coronavirus disease 2019 acute respiratory distress syndrome. Retrospective cohort study. Single-center U.K. ICU. Patients with coronavirus disease 2019 acute respiratory distress syndrome undergoing invasive mechanical ventilation that received a transthoracic echocardiogram between March and December 2020. None. Right ventricular dilati","2021","07","06","Crit Care Med","Critical care medicine",NA,"Alderman","Joseph E","Birmingham Acute Care Research Group, University of Birmingham, Birmingham, United Kingdom Department of Anaesthetics and Critical Care, Queen Elizabeth Hospital Birmingham, Birmingham, United Kingdom. Department of Cardiology, Queen Elizabeth Hospital Birmingham, Birmingham, United Kingdom",NA
"2043","34224453","10.1097/CCM.0000000000005167","Right Ventricular Dysfunction and Its Association With Mortality in Coronavirus Disease 2019 Acute Respiratory Distress Syndrome.","To assess whether right ventricular dilation or systolic impairment is associated with mortality and/or disease severity in invasively ventilated patients with coronavirus disease 2019 acute respiratory distress syndrome. Retrospective cohort study. Single-center U.K. ICU. Patients with coronavirus disease 2019 acute respiratory distress syndrome undergoing invasive mechanical ventilation that received a transthoracic echocardiogram between March and December 2020. None. Right ventricular dilati","2021","07","06","Crit Care Med","Critical care medicine",NA,"Kalla","Manish","Birmingham Acute Care Research Group, University of Birmingham, Birmingham, United Kingdom Department of Anaesthetics and Critical Care, Queen Elizabeth Hospital Birmingham, Birmingham, United Kingdom. Department of Cardiology, Queen Elizabeth Hospital Birmingham, Birmingham, United Kingdom",NA
"2044","34224453","10.1097/CCM.0000000000005167","Right Ventricular Dysfunction and Its Association With Mortality in Coronavirus Disease 2019 Acute Respiratory Distress Syndrome.","To assess whether right ventricular dilation or systolic impairment is associated with mortality and/or disease severity in invasively ventilated patients with coronavirus disease 2019 acute respiratory distress syndrome. Retrospective cohort study. Single-center U.K. ICU. Patients with coronavirus disease 2019 acute respiratory distress syndrome undergoing invasive mechanical ventilation that received a transthoracic echocardiogram between March and December 2020. None. Right ventricular dilati","2021","07","06","Crit Care Med","Critical care medicine",NA,"Parekh","Dhruv","Birmingham Acute Care Research Group, University of Birmingham, Birmingham, United Kingdom Department of Anaesthetics and Critical Care, Queen Elizabeth Hospital Birmingham, Birmingham, United Kingdom. Department of Cardiology, Queen Elizabeth Hospital Birmingham, Birmingham, United Kingdom",NA
"2045","34224453","10.1097/CCM.0000000000005167","Right Ventricular Dysfunction and Its Association With Mortality in Coronavirus Disease 2019 Acute Respiratory Distress Syndrome.","To assess whether right ventricular dilation or systolic impairment is associated with mortality and/or disease severity in invasively ventilated patients with coronavirus disease 2019 acute respiratory distress syndrome. Retrospective cohort study. Single-center U.K. ICU. Patients with coronavirus disease 2019 acute respiratory distress syndrome undergoing invasive mechanical ventilation that received a transthoracic echocardiogram between March and December 2020. None. Right ventricular dilati","2021","07","06","Crit Care Med","Critical care medicine",NA,"Bangash","Mansoor N","Birmingham Acute Care Research Group, University of Birmingham, Birmingham, United Kingdom Department of Anaesthetics and Critical Care, Queen Elizabeth Hospital Birmingham, Birmingham, United Kingdom. Department of Cardiology, Queen Elizabeth Hospital Birmingham, Birmingham, United Kingdom",NA
"2046","34224453","10.1097/CCM.0000000000005167","Right Ventricular Dysfunction and Its Association With Mortality in Coronavirus Disease 2019 Acute Respiratory Distress Syndrome.","To assess whether right ventricular dilation or systolic impairment is associated with mortality and/or disease severity in invasively ventilated patients with coronavirus disease 2019 acute respiratory distress syndrome. Retrospective cohort study. Single-center U.K. ICU. Patients with coronavirus disease 2019 acute respiratory distress syndrome undergoing invasive mechanical ventilation that received a transthoracic echocardiogram between March and December 2020. None. Right ventricular dilati","2021","07","06","Crit Care Med","Critical care medicine",NA,"Patel","Jaimin M","Birmingham Acute Care Research Group, University of Birmingham, Birmingham, United Kingdom Department of Anaesthetics and Critical Care, Queen Elizabeth Hospital Birmingham, Birmingham, United Kingdom. Department of Cardiology, Queen Elizabeth Hospital Birmingham, Birmingham, United Kingdom",NA
"2047","34224449","10.1097/CRD.0000000000000405","COVID-19 and Cardiometabolic Disease.","Cardiometabolic disease describes a combination of metabolic abnormalities that increases the risk of type 2 diabetes mellitus (T2DM) and cardiovascular diseases (CVD), including pathological changes such as insulin resistance, hyperglycemia, dyslipidemia, abdominal obesity, and hypertension (HTN), and environmental risk factors such as smoking, sedentary lifestyle, poor diet, and poverty. As the number of coronavirus disease 2019 (COVID-19) patients continues to rise, T2DM, CVD, HTN, and obesit","2021","07","06","Cardiol Rev","Cardiology in review",NA,"Kim","Chan W","From the Cardiology Division, and the Department of Medicine, Westchester Medical Center and New York Medical College, Valhalla, NY, USA",NA
"2048","34224449","10.1097/CRD.0000000000000405","COVID-19 and Cardiometabolic Disease.","Cardiometabolic disease describes a combination of metabolic abnormalities that increases the risk of type 2 diabetes mellitus (T2DM) and cardiovascular diseases (CVD), including pathological changes such as insulin resistance, hyperglycemia, dyslipidemia, abdominal obesity, and hypertension (HTN), and environmental risk factors such as smoking, sedentary lifestyle, poor diet, and poverty. As the number of coronavirus disease 2019 (COVID-19) patients continues to rise, T2DM, CVD, HTN, and obesit","2021","07","06","Cardiol Rev","Cardiology in review",NA,"Aronow","Wilbert S","From the Cardiology Division, and the Department of Medicine, Westchester Medical Center and New York Medical College, Valhalla, NY, USA",NA
"2049","34224449","10.1097/CRD.0000000000000405","COVID-19 and Cardiometabolic Disease.","Cardiometabolic disease describes a combination of metabolic abnormalities that increases the risk of type 2 diabetes mellitus (T2DM) and cardiovascular diseases (CVD), including pathological changes such as insulin resistance, hyperglycemia, dyslipidemia, abdominal obesity, and hypertension (HTN), and environmental risk factors such as smoking, sedentary lifestyle, poor diet, and poverty. As the number of coronavirus disease 2019 (COVID-19) patients continues to rise, T2DM, CVD, HTN, and obesit","2021","07","06","Cardiol Rev","Cardiology in review",NA,"Frishman","William H","From the Cardiology Division, and the Department of Medicine, Westchester Medical Center and New York Medical College, Valhalla, NY, USA",NA
"2050","34224445","10.1097/ICL.0000000000000816","Online Vs In-person Education: Evaluating the Potential Influence of Teaching Modality on Dry Eye Symptoms and Risk Factors During the COVID-19 Pandemic.","To assess the potential effects of switching to online lecture format on dry eye symptoms and dry eye disease (DED) risk factors. An anonymous cross-sectional online survey was conducted in 812 university students (mean age, 21.5±4.0 years). Participants were classified according to the number of hours the participants took online lectures into online students or in-person students. Respondents completed a total of three DED questionnaires (Ocular Surface Disease Index [OSDI]; 5-item Dry Eye Que","2021","07","06","Eye Contact Lens","Eye &amp; contact lens",NA,"Talens-Estarelles","Cristian","Optometry Research Group, Department of Optics &amp",NA
"2051","34224445","10.1097/ICL.0000000000000816","Online Vs In-person Education: Evaluating the Potential Influence of Teaching Modality on Dry Eye Symptoms and Risk Factors During the COVID-19 Pandemic.","To assess the potential effects of switching to online lecture format on dry eye symptoms and dry eye disease (DED) risk factors. An anonymous cross-sectional online survey was conducted in 812 university students (mean age, 21.5±4.0 years). Participants were classified according to the number of hours the participants took online lectures into online students or in-person students. Respondents completed a total of three DED questionnaires (Ocular Surface Disease Index [OSDI]; 5-item Dry Eye Que","2021","07","06","Eye Contact Lens","Eye &amp; contact lens",NA,"García-Marqués","José Vicente","Optometry Research Group, Department of Optics &amp",NA
"2052","34224445","10.1097/ICL.0000000000000816","Online Vs In-person Education: Evaluating the Potential Influence of Teaching Modality on Dry Eye Symptoms and Risk Factors During the COVID-19 Pandemic.","To assess the potential effects of switching to online lecture format on dry eye symptoms and dry eye disease (DED) risk factors. An anonymous cross-sectional online survey was conducted in 812 university students (mean age, 21.5±4.0 years). Participants were classified according to the number of hours the participants took online lectures into online students or in-person students. Respondents completed a total of three DED questionnaires (Ocular Surface Disease Index [OSDI]; 5-item Dry Eye Que","2021","07","06","Eye Contact Lens","Eye &amp; contact lens",NA,"Cervino","Alejandro","Optometry Research Group, Department of Optics &amp",NA
"2053","34224445","10.1097/ICL.0000000000000816","Online Vs In-person Education: Evaluating the Potential Influence of Teaching Modality on Dry Eye Symptoms and Risk Factors During the COVID-19 Pandemic.","To assess the potential effects of switching to online lecture format on dry eye symptoms and dry eye disease (DED) risk factors. An anonymous cross-sectional online survey was conducted in 812 university students (mean age, 21.5±4.0 years). Participants were classified according to the number of hours the participants took online lectures into online students or in-person students. Respondents completed a total of three DED questionnaires (Ocular Surface Disease Index [OSDI]; 5-item Dry Eye Que","2021","07","06","Eye Contact Lens","Eye &amp; contact lens",NA,"García-Lázaro","Santiago","Optometry Research Group, Department of Optics &amp",NA
"2054","34224435","10.1097/MED.0000000000000654","Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection and thyroid disease. An update.","Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection is associated with excess morbidity and mortality in patients with hypertension and diabetes but little is known about thyroid diseases. Thus, our goal was to review the literature with respect to: (i) Are patients with underlying hypo- or hyperthyroidism at increased risk of contracting SARS-CoV-2 infection? (ii) do underlying hypo- and hyperthyroidism impact the prognosis of SARS-CoV-2 infection? (iii) does SARS-CoV-2 infec","2021","07","07","Curr Opin Endocrinol Diabetes Obes","Current opinion in endocrinology, diabetes, and obesity",NA,"Brix","Thomas H","Department of Endocrinology, Odense University Hospital, Odense C, Denmark",NA
"2055","34224435","10.1097/MED.0000000000000654","Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection and thyroid disease. An update.","Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection is associated with excess morbidity and mortality in patients with hypertension and diabetes but little is known about thyroid diseases. Thus, our goal was to review the literature with respect to: (i) Are patients with underlying hypo- or hyperthyroidism at increased risk of contracting SARS-CoV-2 infection? (ii) do underlying hypo- and hyperthyroidism impact the prognosis of SARS-CoV-2 infection? (iii) does SARS-CoV-2 infec","2021","07","07","Curr Opin Endocrinol Diabetes Obes","Current opinion in endocrinology, diabetes, and obesity",NA,"Hegedüs","Laszlo","Department of Endocrinology, Odense University Hospital, Odense C, Denmark",NA
"2056","34224431","10.1097/MOH.0000000000000663","Protein S: function, regulation, and clinical perspectives.","Protein S (PS) is an essential natural anticoagulant. PS deficiency is a major contributor to acquired hypercoagulability. Acquired hypercoagulability causes myocardial infarction, stroke, and deep vein thrombosis in millions of individuals. Yet, despite its importance in hemostasis, PS is the least understood anticoagulant. Even after 40 years since PS was first described, we are still uncovering information about how PS functions. The purpose of this review is to highlight recent findings that","2021","07","05","Curr Opin Hematol","Current opinion in hematology",NA,"Majumder","Rinku","Department of Biochemistry &amp",NA
"2057","34224431","10.1097/MOH.0000000000000663","Protein S: function, regulation, and clinical perspectives.","Protein S (PS) is an essential natural anticoagulant. PS deficiency is a major contributor to acquired hypercoagulability. Acquired hypercoagulability causes myocardial infarction, stroke, and deep vein thrombosis in millions of individuals. Yet, despite its importance in hemostasis, PS is the least understood anticoagulant. Even after 40 years since PS was first described, we are still uncovering information about how PS functions. The purpose of this review is to highlight recent findings that","2021","07","05","Curr Opin Hematol","Current opinion in hematology",NA,"Nguyen","Tina","Department of Biochemistry &amp",NA
"2058","34224394","10.1556/650.2021.32282","Post-acute COVID-19 syndrome","Összefoglaló. A posztakut COVID-19 szindróma (PACS) az akut betegséget követo 4-12 hét szubakut, tünetes szakasznak, valamint az ezt követo krónikus poszt-COVID-idoszaknak az együttesét jelenti. A PACS különbözo általános tünetekkel és szervi (pulmonalis, cardiovascularis, neuropszichiátriai, endokrin, mozgásszervi, borgyógyászati, renalis) manifesztációkkal jár. Ebben az összefoglalóban áttekintjük a PACS kialakulásához vezeto patogenetikai és rizikótényezoket. Bemutatjuk a klinikumot és a diag","2021","07","07","Orv Hetil","Orvosi hetilap","COVID-19; COVID19; SARS-CoV-2; multidisciplinary team; multidiszciplináris team; organ symptoms; post-COVID-19 network; post-acute COVID-19 syndrome; poszt-COVID19-hálózat; posztakut COVID19 szindróma; szervi tünetek; COVID-19; General Practitioners; Humans; Risk Factors; SARS-CoV-2; Syndrome","Szekanecz","Zoltán","Debreceni Egyetem, Általános Orvostudományi Kar, Belgyógyászati Intézet, Reumatológiai Tanszék, Debrecen, Nagyerdei krt. 98., 4032",NA
"2059","34224394","10.1556/650.2021.32282","Post-acute COVID-19 syndrome","Összefoglaló. A posztakut COVID-19 szindróma (PACS) az akut betegséget követo 4-12 hét szubakut, tünetes szakasznak, valamint az ezt követo krónikus poszt-COVID-idoszaknak az együttesét jelenti. A PACS különbözo általános tünetekkel és szervi (pulmonalis, cardiovascularis, neuropszichiátriai, endokrin, mozgásszervi, borgyógyászati, renalis) manifesztációkkal jár. Ebben az összefoglalóban áttekintjük a PACS kialakulásához vezeto patogenetikai és rizikótényezoket. Bemutatjuk a klinikumot és a diag","2021","07","07","Orv Hetil","Orvosi hetilap","COVID-19; COVID19; SARS-CoV-2; multidisciplinary team; multidiszciplináris team; organ symptoms; post-COVID-19 network; post-acute COVID-19 syndrome; poszt-COVID19-hálózat; posztakut COVID19 szindróma; szervi tünetek; COVID-19; General Practitioners; Humans; Risk Factors; SARS-CoV-2; Syndrome","Vályi-Nagy","István","Dél-pesti Centrumkórház, Országos Hematológiai és Infektológiai Intézet, Budapest",NA
"2060","34224330","10.1080/21505594.2021.1943275","Modulating the host immune response to fight against COVID-19: Where are we in 2021?",NA,"2021","07","13","Virulence","Virulence","COVID-19; SARS-CoV-2; coronavirus; drug repurposing; immune system; immunology; immunomodulation; pharmacotherapy; Antiviral Agents; COVID-19; Cytokine Release Syndrome; Drug Repositioning; Host-Pathogen Interactions; Humans; Immunity; Immunomodulation; SARS-CoV-2","Hertanto","Decsa Medika","Department of Internal Medicine, Faculty of Medicine, Airlangga University, Surabaya, Indonesia",NA
"2061","34224330","10.1080/21505594.2021.1943275","Modulating the host immune response to fight against COVID-19: Where are we in 2021?",NA,"2021","07","13","Virulence","Virulence","COVID-19; SARS-CoV-2; coronavirus; drug repurposing; immune system; immunology; immunomodulation; pharmacotherapy; Antiviral Agents; COVID-19; Cytokine Release Syndrome; Drug Repositioning; Host-Pathogen Interactions; Humans; Immunity; Immunomodulation; SARS-CoV-2","Sutanto","Henry","Department of Cardiology, CARIM School for Cardiovascular Diseases, Maastricht University, Maastricht, The Netherlands",NA
"2062","34224330","10.1080/21505594.2021.1943275","Modulating the host immune response to fight against COVID-19: Where are we in 2021?",NA,"2021","07","13","Virulence","Virulence","COVID-19; SARS-CoV-2; coronavirus; drug repurposing; immune system; immunology; immunomodulation; pharmacotherapy; Antiviral Agents; COVID-19; Cytokine Release Syndrome; Drug Repositioning; Host-Pathogen Interactions; Humans; Immunity; Immunomodulation; SARS-CoV-2","Wiratama","Bayu Satria","Department of Epidemiology, Biostatistics, and Population Health, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta, Indonesia",NA
"2063","34224330","10.1080/21505594.2021.1943275","Modulating the host immune response to fight against COVID-19: Where are we in 2021?",NA,"2021","07","13","Virulence","Virulence","COVID-19; SARS-CoV-2; coronavirus; drug repurposing; immune system; immunology; immunomodulation; pharmacotherapy; Antiviral Agents; COVID-19; Cytokine Release Syndrome; Drug Repositioning; Host-Pathogen Interactions; Humans; Immunity; Immunomodulation; SARS-CoV-2","Wungu","Citrawati Dyah Kencono","Department of Physiology and Medical Biochemistry, Faculty of Medicine, Airlangga University, Surabaya, Indonesia",NA
"2064","34224292","10.1080/14760584.2021.1951248","Disproportionate COVID-19 vaccine acceptance rate among healthcare professionals on the eve of nationwide vaccine distribution in Bangladesh.",": Acceptance of the COVID-19 vaccine by the target groups would play a crucial role in stemming the pandemic. Healthcare professionals (HCPs) are the priority group for vaccination due to them having the highest risk of exposure to infection. This survey aimed to assess their acceptance of COVID-19 vaccines in Bangladesh. A cross-sectional survey using an online questionnaire was conducted between January 3 to 25, 2021, among HCPs (n=834) in Bangladesh. The main outcome measures were vaccine acc","2021","07","05","Expert Rev Vaccines","Expert review of vaccines","Bangladesh; COVID-19; Healthcare professionals; Vaccine acceptance; Vaccine hesitancy; Vaccine literacy","Alam","A B M Muksudul","Shaheed Suhrawardy Medical College, Dhaka, Bangladesh",NA
"2065","34224292","10.1080/14760584.2021.1951248","Disproportionate COVID-19 vaccine acceptance rate among healthcare professionals on the eve of nationwide vaccine distribution in Bangladesh.",": Acceptance of the COVID-19 vaccine by the target groups would play a crucial role in stemming the pandemic. Healthcare professionals (HCPs) are the priority group for vaccination due to them having the highest risk of exposure to infection. This survey aimed to assess their acceptance of COVID-19 vaccines in Bangladesh. A cross-sectional survey using an online questionnaire was conducted between January 3 to 25, 2021, among HCPs (n=834) in Bangladesh. The main outcome measures were vaccine acc","2021","07","05","Expert Rev Vaccines","Expert review of vaccines","Bangladesh; COVID-19; Healthcare professionals; Vaccine acceptance; Vaccine hesitancy; Vaccine literacy","Majumder","Md Anwarul Azim","The University of the West Indies, Cave Hill Campus, Barbados",NA
"2066","34224292","10.1080/14760584.2021.1951248","Disproportionate COVID-19 vaccine acceptance rate among healthcare professionals on the eve of nationwide vaccine distribution in Bangladesh.",": Acceptance of the COVID-19 vaccine by the target groups would play a crucial role in stemming the pandemic. Healthcare professionals (HCPs) are the priority group for vaccination due to them having the highest risk of exposure to infection. This survey aimed to assess their acceptance of COVID-19 vaccines in Bangladesh. A cross-sectional survey using an online questionnaire was conducted between January 3 to 25, 2021, among HCPs (n=834) in Bangladesh. The main outcome measures were vaccine acc","2021","07","05","Expert Rev Vaccines","Expert review of vaccines","Bangladesh; COVID-19; Healthcare professionals; Vaccine acceptance; Vaccine hesitancy; Vaccine literacy","Haque","Mainul","National Defence University of Malaysia, Kuala Lumpur, Malaysia",NA
"2067","34224292","10.1080/14760584.2021.1951248","Disproportionate COVID-19 vaccine acceptance rate among healthcare professionals on the eve of nationwide vaccine distribution in Bangladesh.",": Acceptance of the COVID-19 vaccine by the target groups would play a crucial role in stemming the pandemic. Healthcare professionals (HCPs) are the priority group for vaccination due to them having the highest risk of exposure to infection. This survey aimed to assess their acceptance of COVID-19 vaccines in Bangladesh. A cross-sectional survey using an online questionnaire was conducted between January 3 to 25, 2021, among HCPs (n=834) in Bangladesh. The main outcome measures were vaccine acc","2021","07","05","Expert Rev Vaccines","Expert review of vaccines","Bangladesh; COVID-19; Healthcare professionals; Vaccine acceptance; Vaccine hesitancy; Vaccine literacy","Ashraf","Fatema","Shaheed Suhrawardy Medical College, Dhaka, Bangladesh",NA
"2068","34224292","10.1080/14760584.2021.1951248","Disproportionate COVID-19 vaccine acceptance rate among healthcare professionals on the eve of nationwide vaccine distribution in Bangladesh.",": Acceptance of the COVID-19 vaccine by the target groups would play a crucial role in stemming the pandemic. Healthcare professionals (HCPs) are the priority group for vaccination due to them having the highest risk of exposure to infection. This survey aimed to assess their acceptance of COVID-19 vaccines in Bangladesh. A cross-sectional survey using an online questionnaire was conducted between January 3 to 25, 2021, among HCPs (n=834) in Bangladesh. The main outcome measures were vaccine acc","2021","07","05","Expert Rev Vaccines","Expert review of vaccines","Bangladesh; COVID-19; Healthcare professionals; Vaccine acceptance; Vaccine hesitancy; Vaccine literacy","Khondoker","Mohib Ullah","Gonoshasthaya Samaj Vittik Medical College, Dhaka, Bangladesh",NA
"2069","34224292","10.1080/14760584.2021.1951248","Disproportionate COVID-19 vaccine acceptance rate among healthcare professionals on the eve of nationwide vaccine distribution in Bangladesh.",": Acceptance of the COVID-19 vaccine by the target groups would play a crucial role in stemming the pandemic. Healthcare professionals (HCPs) are the priority group for vaccination due to them having the highest risk of exposure to infection. This survey aimed to assess their acceptance of COVID-19 vaccines in Bangladesh. A cross-sectional survey using an online questionnaire was conducted between January 3 to 25, 2021, among HCPs (n=834) in Bangladesh. The main outcome measures were vaccine acc","2021","07","05","Expert Rev Vaccines","Expert review of vaccines","Bangladesh; COVID-19; Healthcare professionals; Vaccine acceptance; Vaccine hesitancy; Vaccine literacy","Mashreky","Saidur Rahman","Centre for Injury Prevention and Research Bangladesh (CIPRB), Dhaka, Bangladesh",NA
"2070","34224292","10.1080/14760584.2021.1951248","Disproportionate COVID-19 vaccine acceptance rate among healthcare professionals on the eve of nationwide vaccine distribution in Bangladesh.",": Acceptance of the COVID-19 vaccine by the target groups would play a crucial role in stemming the pandemic. Healthcare professionals (HCPs) are the priority group for vaccination due to them having the highest risk of exposure to infection. This survey aimed to assess their acceptance of COVID-19 vaccines in Bangladesh. A cross-sectional survey using an online questionnaire was conducted between January 3 to 25, 2021, among HCPs (n=834) in Bangladesh. The main outcome measures were vaccine acc","2021","07","05","Expert Rev Vaccines","Expert review of vaccines","Bangladesh; COVID-19; Healthcare professionals; Vaccine acceptance; Vaccine hesitancy; Vaccine literacy","Wahab","Abrar","Centre for Injury Prevention and Research Bangladesh (CIPRB), Dhaka, Bangladesh",NA
"2071","34224292","10.1080/14760584.2021.1951248","Disproportionate COVID-19 vaccine acceptance rate among healthcare professionals on the eve of nationwide vaccine distribution in Bangladesh.",": Acceptance of the COVID-19 vaccine by the target groups would play a crucial role in stemming the pandemic. Healthcare professionals (HCPs) are the priority group for vaccination due to them having the highest risk of exposure to infection. This survey aimed to assess their acceptance of COVID-19 vaccines in Bangladesh. A cross-sectional survey using an online questionnaire was conducted between January 3 to 25, 2021, among HCPs (n=834) in Bangladesh. The main outcome measures were vaccine acc","2021","07","05","Expert Rev Vaccines","Expert review of vaccines","Bangladesh; COVID-19; Healthcare professionals; Vaccine acceptance; Vaccine hesitancy; Vaccine literacy","Siddiqui","Md Tosaddeque Hossain","Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh",NA
"2072","34224292","10.1080/14760584.2021.1951248","Disproportionate COVID-19 vaccine acceptance rate among healthcare professionals on the eve of nationwide vaccine distribution in Bangladesh.",": Acceptance of the COVID-19 vaccine by the target groups would play a crucial role in stemming the pandemic. Healthcare professionals (HCPs) are the priority group for vaccination due to them having the highest risk of exposure to infection. This survey aimed to assess their acceptance of COVID-19 vaccines in Bangladesh. A cross-sectional survey using an online questionnaire was conducted between January 3 to 25, 2021, among HCPs (n=834) in Bangladesh. The main outcome measures were vaccine acc","2021","07","05","Expert Rev Vaccines","Expert review of vaccines","Bangladesh; COVID-19; Healthcare professionals; Vaccine acceptance; Vaccine hesitancy; Vaccine literacy","Uddin","Aftab","McWeadon Education, Florida, USA",NA
"2073","34224292","10.1080/14760584.2021.1951248","Disproportionate COVID-19 vaccine acceptance rate among healthcare professionals on the eve of nationwide vaccine distribution in Bangladesh.",": Acceptance of the COVID-19 vaccine by the target groups would play a crucial role in stemming the pandemic. Healthcare professionals (HCPs) are the priority group for vaccination due to them having the highest risk of exposure to infection. This survey aimed to assess their acceptance of COVID-19 vaccines in Bangladesh. A cross-sectional survey using an online questionnaire was conducted between January 3 to 25, 2021, among HCPs (n=834) in Bangladesh. The main outcome measures were vaccine acc","2021","07","05","Expert Rev Vaccines","Expert review of vaccines","Bangladesh; COVID-19; Healthcare professionals; Vaccine acceptance; Vaccine hesitancy; Vaccine literacy","Joarder","Taufique","Public Health Foundation, Dhaka, Bangladesh",NA
"2074","34224292","10.1080/14760584.2021.1951248","Disproportionate COVID-19 vaccine acceptance rate among healthcare professionals on the eve of nationwide vaccine distribution in Bangladesh.",": Acceptance of the COVID-19 vaccine by the target groups would play a crucial role in stemming the pandemic. Healthcare professionals (HCPs) are the priority group for vaccination due to them having the highest risk of exposure to infection. This survey aimed to assess their acceptance of COVID-19 vaccines in Bangladesh. A cross-sectional survey using an online questionnaire was conducted between January 3 to 25, 2021, among HCPs (n=834) in Bangladesh. The main outcome measures were vaccine acc","2021","07","05","Expert Rev Vaccines","Expert review of vaccines","Bangladesh; COVID-19; Healthcare professionals; Vaccine acceptance; Vaccine hesitancy; Vaccine literacy","Ahmed","S M Moslehuddin","Uttara Adhunik Medical College, Dhaka, Bangladesh",NA
"2075","34224292","10.1080/14760584.2021.1951248","Disproportionate COVID-19 vaccine acceptance rate among healthcare professionals on the eve of nationwide vaccine distribution in Bangladesh.",": Acceptance of the COVID-19 vaccine by the target groups would play a crucial role in stemming the pandemic. Healthcare professionals (HCPs) are the priority group for vaccination due to them having the highest risk of exposure to infection. This survey aimed to assess their acceptance of COVID-19 vaccines in Bangladesh. A cross-sectional survey using an online questionnaire was conducted between January 3 to 25, 2021, among HCPs (n=834) in Bangladesh. The main outcome measures were vaccine acc","2021","07","05","Expert Rev Vaccines","Expert review of vaccines","Bangladesh; COVID-19; Healthcare professionals; Vaccine acceptance; Vaccine hesitancy; Vaccine literacy","Deeba","Farzana","Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh",NA
"2076","34224292","10.1080/14760584.2021.1951248","Disproportionate COVID-19 vaccine acceptance rate among healthcare professionals on the eve of nationwide vaccine distribution in Bangladesh.",": Acceptance of the COVID-19 vaccine by the target groups would play a crucial role in stemming the pandemic. Healthcare professionals (HCPs) are the priority group for vaccination due to them having the highest risk of exposure to infection. This survey aimed to assess their acceptance of COVID-19 vaccines in Bangladesh. A cross-sectional survey using an online questionnaire was conducted between January 3 to 25, 2021, among HCPs (n=834) in Bangladesh. The main outcome measures were vaccine acc","2021","07","05","Expert Rev Vaccines","Expert review of vaccines","Bangladesh; COVID-19; Healthcare professionals; Vaccine acceptance; Vaccine hesitancy; Vaccine literacy","Nessa","Kamrun","Chittagong Medical College, Dhaka, Bangladesh",NA
"2077","34224292","10.1080/14760584.2021.1951248","Disproportionate COVID-19 vaccine acceptance rate among healthcare professionals on the eve of nationwide vaccine distribution in Bangladesh.",": Acceptance of the COVID-19 vaccine by the target groups would play a crucial role in stemming the pandemic. Healthcare professionals (HCPs) are the priority group for vaccination due to them having the highest risk of exposure to infection. This survey aimed to assess their acceptance of COVID-19 vaccines in Bangladesh. A cross-sectional survey using an online questionnaire was conducted between January 3 to 25, 2021, among HCPs (n=834) in Bangladesh. The main outcome measures were vaccine acc","2021","07","05","Expert Rev Vaccines","Expert review of vaccines","Bangladesh; COVID-19; Healthcare professionals; Vaccine acceptance; Vaccine hesitancy; Vaccine literacy","Rahman","Sayeeda","American University of Integrative Sciences, Bridgetown, Barbados",NA
"2078","34224292","10.1080/14760584.2021.1951248","Disproportionate COVID-19 vaccine acceptance rate among healthcare professionals on the eve of nationwide vaccine distribution in Bangladesh.",": Acceptance of the COVID-19 vaccine by the target groups would play a crucial role in stemming the pandemic. Healthcare professionals (HCPs) are the priority group for vaccination due to them having the highest risk of exposure to infection. This survey aimed to assess their acceptance of COVID-19 vaccines in Bangladesh. A cross-sectional survey using an online questionnaire was conducted between January 3 to 25, 2021, among HCPs (n=834) in Bangladesh. The main outcome measures were vaccine acc","2021","07","05","Expert Rev Vaccines","Expert review of vaccines","Bangladesh; COVID-19; Healthcare professionals; Vaccine acceptance; Vaccine hesitancy; Vaccine literacy","Jahan","Iffat","Eastern Medical College, Cumilla, Bangladesh",NA
"2079","34224292","10.1080/14760584.2021.1951248","Disproportionate COVID-19 vaccine acceptance rate among healthcare professionals on the eve of nationwide vaccine distribution in Bangladesh.",": Acceptance of the COVID-19 vaccine by the target groups would play a crucial role in stemming the pandemic. Healthcare professionals (HCPs) are the priority group for vaccination due to them having the highest risk of exposure to infection. This survey aimed to assess their acceptance of COVID-19 vaccines in Bangladesh. A cross-sectional survey using an online questionnaire was conducted between January 3 to 25, 2021, among HCPs (n=834) in Bangladesh. The main outcome measures were vaccine acc","2021","07","05","Expert Rev Vaccines","Expert review of vaccines","Bangladesh; COVID-19; Healthcare professionals; Vaccine acceptance; Vaccine hesitancy; Vaccine literacy","Islam","Md Zakirul","Eastern Medical College, Cumilla, Bangladesh",NA
"2080","34224292","10.1080/14760584.2021.1951248","Disproportionate COVID-19 vaccine acceptance rate among healthcare professionals on the eve of nationwide vaccine distribution in Bangladesh.",": Acceptance of the COVID-19 vaccine by the target groups would play a crucial role in stemming the pandemic. Healthcare professionals (HCPs) are the priority group for vaccination due to them having the highest risk of exposure to infection. This survey aimed to assess their acceptance of COVID-19 vaccines in Bangladesh. A cross-sectional survey using an online questionnaire was conducted between January 3 to 25, 2021, among HCPs (n=834) in Bangladesh. The main outcome measures were vaccine acc","2021","07","05","Expert Rev Vaccines","Expert review of vaccines","Bangladesh; COVID-19; Healthcare professionals; Vaccine acceptance; Vaccine hesitancy; Vaccine literacy","Adnan","Nihad","Jahangirnagar University, Dhaka, Bangladesh",NA
"2081","34224292","10.1080/14760584.2021.1951248","Disproportionate COVID-19 vaccine acceptance rate among healthcare professionals on the eve of nationwide vaccine distribution in Bangladesh.",": Acceptance of the COVID-19 vaccine by the target groups would play a crucial role in stemming the pandemic. Healthcare professionals (HCPs) are the priority group for vaccination due to them having the highest risk of exposure to infection. This survey aimed to assess their acceptance of COVID-19 vaccines in Bangladesh. A cross-sectional survey using an online questionnaire was conducted between January 3 to 25, 2021, among HCPs (n=834) in Bangladesh. The main outcome measures were vaccine acc","2021","07","05","Expert Rev Vaccines","Expert review of vaccines","Bangladesh; COVID-19; Healthcare professionals; Vaccine acceptance; Vaccine hesitancy; Vaccine literacy","E-Murshid","Munzur","Public Health Enthusiast, Rangpur, Bangladesh",NA
"2082","34224292","10.1080/14760584.2021.1951248","Disproportionate COVID-19 vaccine acceptance rate among healthcare professionals on the eve of nationwide vaccine distribution in Bangladesh.",": Acceptance of the COVID-19 vaccine by the target groups would play a crucial role in stemming the pandemic. Healthcare professionals (HCPs) are the priority group for vaccination due to them having the highest risk of exposure to infection. This survey aimed to assess their acceptance of COVID-19 vaccines in Bangladesh. A cross-sectional survey using an online questionnaire was conducted between January 3 to 25, 2021, among HCPs (n=834) in Bangladesh. The main outcome measures were vaccine acc","2021","07","05","Expert Rev Vaccines","Expert review of vaccines","Bangladesh; COVID-19; Healthcare professionals; Vaccine acceptance; Vaccine hesitancy; Vaccine literacy","Islam","Md Shafiqul","Sher-E-Bangla Medical College, Barishal, Bangladesh",NA
"2083","34224292","10.1080/14760584.2021.1951248","Disproportionate COVID-19 vaccine acceptance rate among healthcare professionals on the eve of nationwide vaccine distribution in Bangladesh.",": Acceptance of the COVID-19 vaccine by the target groups would play a crucial role in stemming the pandemic. Healthcare professionals (HCPs) are the priority group for vaccination due to them having the highest risk of exposure to infection. This survey aimed to assess their acceptance of COVID-19 vaccines in Bangladesh. A cross-sectional survey using an online questionnaire was conducted between January 3 to 25, 2021, among HCPs (n=834) in Bangladesh. The main outcome measures were vaccine acc","2021","07","05","Expert Rev Vaccines","Expert review of vaccines","Bangladesh; COVID-19; Healthcare professionals; Vaccine acceptance; Vaccine hesitancy; Vaccine literacy","Urmi","Umme Laila","Rajshahi Medical College, Rajshahi, Bangladesh",NA
"2084","34224292","10.1080/14760584.2021.1951248","Disproportionate COVID-19 vaccine acceptance rate among healthcare professionals on the eve of nationwide vaccine distribution in Bangladesh.",": Acceptance of the COVID-19 vaccine by the target groups would play a crucial role in stemming the pandemic. Healthcare professionals (HCPs) are the priority group for vaccination due to them having the highest risk of exposure to infection. This survey aimed to assess their acceptance of COVID-19 vaccines in Bangladesh. A cross-sectional survey using an online questionnaire was conducted between January 3 to 25, 2021, among HCPs (n=834) in Bangladesh. The main outcome measures were vaccine acc","2021","07","05","Expert Rev Vaccines","Expert review of vaccines","Bangladesh; COVID-19; Healthcare professionals; Vaccine acceptance; Vaccine hesitancy; Vaccine literacy","Yusuf","Abdullah","National Institute of Neuroscience, Dhaka, Bangladesh",NA
"2085","34224292","10.1080/14760584.2021.1951248","Disproportionate COVID-19 vaccine acceptance rate among healthcare professionals on the eve of nationwide vaccine distribution in Bangladesh.",": Acceptance of the COVID-19 vaccine by the target groups would play a crucial role in stemming the pandemic. Healthcare professionals (HCPs) are the priority group for vaccination due to them having the highest risk of exposure to infection. This survey aimed to assess their acceptance of COVID-19 vaccines in Bangladesh. A cross-sectional survey using an online questionnaire was conducted between January 3 to 25, 2021, among HCPs (n=834) in Bangladesh. The main outcome measures were vaccine acc","2021","07","05","Expert Rev Vaccines","Expert review of vaccines","Bangladesh; COVID-19; Healthcare professionals; Vaccine acceptance; Vaccine hesitancy; Vaccine literacy","Sarkar","Nitai Chandra","Shaheed Ziaur Rahman Medical College, Bogura, Bangladesh",NA
"2086","34224292","10.1080/14760584.2021.1951248","Disproportionate COVID-19 vaccine acceptance rate among healthcare professionals on the eve of nationwide vaccine distribution in Bangladesh.",": Acceptance of the COVID-19 vaccine by the target groups would play a crucial role in stemming the pandemic. Healthcare professionals (HCPs) are the priority group for vaccination due to them having the highest risk of exposure to infection. This survey aimed to assess their acceptance of COVID-19 vaccines in Bangladesh. A cross-sectional survey using an online questionnaire was conducted between January 3 to 25, 2021, among HCPs (n=834) in Bangladesh. The main outcome measures were vaccine acc","2021","07","05","Expert Rev Vaccines","Expert review of vaccines","Bangladesh; COVID-19; Healthcare professionals; Vaccine acceptance; Vaccine hesitancy; Vaccine literacy","Mallik","Taslim Sajjad","Dhaka University, Dhaka, Bangladesh",NA
"2087","34224292","10.1080/14760584.2021.1951248","Disproportionate COVID-19 vaccine acceptance rate among healthcare professionals on the eve of nationwide vaccine distribution in Bangladesh.",": Acceptance of the COVID-19 vaccine by the target groups would play a crucial role in stemming the pandemic. Healthcare professionals (HCPs) are the priority group for vaccination due to them having the highest risk of exposure to infection. This survey aimed to assess their acceptance of COVID-19 vaccines in Bangladesh. A cross-sectional survey using an online questionnaire was conducted between January 3 to 25, 2021, among HCPs (n=834) in Bangladesh. The main outcome measures were vaccine acc","2021","07","05","Expert Rev Vaccines","Expert review of vaccines","Bangladesh; COVID-19; Healthcare professionals; Vaccine acceptance; Vaccine hesitancy; Vaccine literacy","Raza","A M Selim","Shaheed Suhrawardy Medical College, Dhaka, Bangladesh",NA
"2088","34224292","10.1080/14760584.2021.1951248","Disproportionate COVID-19 vaccine acceptance rate among healthcare professionals on the eve of nationwide vaccine distribution in Bangladesh.",": Acceptance of the COVID-19 vaccine by the target groups would play a crucial role in stemming the pandemic. Healthcare professionals (HCPs) are the priority group for vaccination due to them having the highest risk of exposure to infection. This survey aimed to assess their acceptance of COVID-19 vaccines in Bangladesh. A cross-sectional survey using an online questionnaire was conducted between January 3 to 25, 2021, among HCPs (n=834) in Bangladesh. The main outcome measures were vaccine acc","2021","07","05","Expert Rev Vaccines","Expert review of vaccines","Bangladesh; COVID-19; Healthcare professionals; Vaccine acceptance; Vaccine hesitancy; Vaccine literacy","Daud","A K M","Jalalabad Ragib-Rabeya Medical College, Sylhet, Bangladesh",NA
"2089","34224292","10.1080/14760584.2021.1951248","Disproportionate COVID-19 vaccine acceptance rate among healthcare professionals on the eve of nationwide vaccine distribution in Bangladesh.",": Acceptance of the COVID-19 vaccine by the target groups would play a crucial role in stemming the pandemic. Healthcare professionals (HCPs) are the priority group for vaccination due to them having the highest risk of exposure to infection. This survey aimed to assess their acceptance of COVID-19 vaccines in Bangladesh. A cross-sectional survey using an online questionnaire was conducted between January 3 to 25, 2021, among HCPs (n=834) in Bangladesh. The main outcome measures were vaccine acc","2021","07","05","Expert Rev Vaccines","Expert review of vaccines","Bangladesh; COVID-19; Healthcare professionals; Vaccine acceptance; Vaccine hesitancy; Vaccine literacy","Razzaque","Mohammed S","Lake Erie College of Osteopathic Medicine, Pennsylvania, USA",NA
"2090","34224291","10.1080/14760584.2021.1951245","Should we be vaccinating children against COVID-19 in high-income countries?",NA,"2021","07","19","Expert Rev Vaccines","Expert review of vaccines","Covid-19; PIMS-TS; Pediatric","Li","Grace","Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Centre for Clinical Vaccinology and Tropical Medicine (CCVTM), Oxford, UK",NA
"2091","34224291","10.1080/14760584.2021.1951245","Should we be vaccinating children against COVID-19 in high-income countries?",NA,"2021","07","19","Expert Rev Vaccines","Expert review of vaccines","Covid-19; PIMS-TS; Pediatric","Finn","Adam","Bristol Vaccine Centre, Schools of Cellular and Molecular Medicine and Population Health Sciences, University of Bristol, Level 6, UHBW Education and Research Centre, Bristol, UK",NA
"2092","34224291","10.1080/14760584.2021.1951245","Should we be vaccinating children against COVID-19 in high-income countries?",NA,"2021","07","19","Expert Rev Vaccines","Expert review of vaccines","Covid-19; PIMS-TS; Pediatric","Pollard","Andrew J","Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Centre for Clinical Vaccinology and Tropical Medicine (CCVTM), Oxford, UK",NA
"2093","34224272","10.7326/ACPJ202107200-083","In adults and children in the ED with COVID-19 symptoms or a confirmed contact, a rapid POC antigen test had =72% sensitivity and =99% specificity vs. RT-PCR.","Möckel M, Corman VM, Stegemann MS, et al. SARS-CoV-2 antigen rapid immunoassay for diagnosis of COVID-19 in the emergency department. Biomarkers. 2021;26:213-20. 33455451.","2021","07","23","Ann Intern Med","Annals of internal medicine","Adult; Antigens, Viral; COVID-19; Child; Humans; Reverse Transcriptase Polymerase Chain Reaction; SARS-CoV-2; Sensitivity and Specificity","Fekete","Thomas","Lewis Katz School of Medicine of Temple University, Philadelphia, Pennsylvania, USA (T",NA
"2094","34224270","10.7326/ACPJ202107200-075","The single-dose J&amp;J vaccine had 67% efficacy against moderate to severe-critical COVID-19 at =14 d.","Sadoff J, Gray G, Vandebosch A, et al. Safety and efficacy of single-dose Ad26.COV2.S vaccine against Covid-19. N Engl J Med. 2021. [Epub ahead of print.] 33882225.","2021","07","23","Ann Intern Med","Annals of internal medicine","COVID-19; COVID-19 Vaccines; Humans; SARS-CoV-2; Vaccines","Sacks","Henry S","Icahn School of Medicine at Mount Sinai, New York, New York, USA (H.S",NA
"2095","34224264","10.7326/M21-2681","When COVID-19 Strikes Your Hospital.",NA,"2021","07","10","Ann Intern Med","Annals of internal medicine",NA,"Chopra","Vineet","Deputy Editor, Annals of Internal Medicine (V",NA
"2096","34224257","10.7326/M21-1213","Association Between Caseload Surge and COVID-19 Survival in 558 U.S. Hospitals, March to August 2020.","Several U.S. hospitals had surges in COVID-19 caseload, but their effect on COVID-19 survival rates remains unclear, especially independent of temporal changes in survival. To determine the association between hospitals' severity-weighted COVID-19 caseload and COVID-19 mortality risk and identify effect modifiers of this relationship. Retrospective cohort study. (ClinicalTrials.gov: NCT04688372). 558 U.S. hospitals in the Premier Healthcare Database. Adult COVID-19-coded inpatients admitted from","2021","07","21","Ann Intern Med","Annals of internal medicine",NA,"Kadri","Sameer S","National Institutes of Health Clinical Center, Bethesda, Maryland (S.S.K., J.S., A.L., M.K., C.Y., S.M., J.K., R.L.D., C.Y.D., S",NA
"2097","34224257","10.7326/M21-1213","Association Between Caseload Surge and COVID-19 Survival in 558 U.S. Hospitals, March to August 2020.","Several U.S. hospitals had surges in COVID-19 caseload, but their effect on COVID-19 survival rates remains unclear, especially independent of temporal changes in survival. To determine the association between hospitals' severity-weighted COVID-19 caseload and COVID-19 mortality risk and identify effect modifiers of this relationship. Retrospective cohort study. (ClinicalTrials.gov: NCT04688372). 558 U.S. hospitals in the Premier Healthcare Database. Adult COVID-19-coded inpatients admitted from","2021","07","21","Ann Intern Med","Annals of internal medicine",NA,"Sun","Junfeng","National Institutes of Health Clinical Center, Bethesda, Maryland (S.S.K., J.S., A.L., M.K., C.Y., S.M., J.K., R.L.D., C.Y.D., S",NA
"2098","34224257","10.7326/M21-1213","Association Between Caseload Surge and COVID-19 Survival in 558 U.S. Hospitals, March to August 2020.","Several U.S. hospitals had surges in COVID-19 caseload, but their effect on COVID-19 survival rates remains unclear, especially independent of temporal changes in survival. To determine the association between hospitals' severity-weighted COVID-19 caseload and COVID-19 mortality risk and identify effect modifiers of this relationship. Retrospective cohort study. (ClinicalTrials.gov: NCT04688372). 558 U.S. hospitals in the Premier Healthcare Database. Adult COVID-19-coded inpatients admitted from","2021","07","21","Ann Intern Med","Annals of internal medicine",NA,"Lawandi","Alexander","National Institutes of Health Clinical Center, Bethesda, Maryland (S.S.K., J.S., A.L., M.K., C.Y., S.M., J.K., R.L.D., C.Y.D., S",NA
"2099","34224257","10.7326/M21-1213","Association Between Caseload Surge and COVID-19 Survival in 558 U.S. Hospitals, March to August 2020.","Several U.S. hospitals had surges in COVID-19 caseload, but their effect on COVID-19 survival rates remains unclear, especially independent of temporal changes in survival. To determine the association between hospitals' severity-weighted COVID-19 caseload and COVID-19 mortality risk and identify effect modifiers of this relationship. Retrospective cohort study. (ClinicalTrials.gov: NCT04688372). 558 U.S. hospitals in the Premier Healthcare Database. Adult COVID-19-coded inpatients admitted from","2021","07","21","Ann Intern Med","Annals of internal medicine",NA,"Strich","Jeffrey R","National Institutes of Health Clinical Center, Bethesda, Maryland, and U.S. Public Health Service, Rockville, Maryland (J.R",NA
"2100","34224257","10.7326/M21-1213","Association Between Caseload Surge and COVID-19 Survival in 558 U.S. Hospitals, March to August 2020.","Several U.S. hospitals had surges in COVID-19 caseload, but their effect on COVID-19 survival rates remains unclear, especially independent of temporal changes in survival. To determine the association between hospitals' severity-weighted COVID-19 caseload and COVID-19 mortality risk and identify effect modifiers of this relationship. Retrospective cohort study. (ClinicalTrials.gov: NCT04688372). 558 U.S. hospitals in the Premier Healthcare Database. Adult COVID-19-coded inpatients admitted from","2021","07","21","Ann Intern Med","Annals of internal medicine",NA,"Busch","Lindsay M","National Institutes of Health Clinical Center, Bethesda, Maryland, and Emory University School of Medicine, Atlanta, Georgia (L.M",NA
"2101","34224257","10.7326/M21-1213","Association Between Caseload Surge and COVID-19 Survival in 558 U.S. Hospitals, March to August 2020.","Several U.S. hospitals had surges in COVID-19 caseload, but their effect on COVID-19 survival rates remains unclear, especially independent of temporal changes in survival. To determine the association between hospitals' severity-weighted COVID-19 caseload and COVID-19 mortality risk and identify effect modifiers of this relationship. Retrospective cohort study. (ClinicalTrials.gov: NCT04688372). 558 U.S. hospitals in the Premier Healthcare Database. Adult COVID-19-coded inpatients admitted from","2021","07","21","Ann Intern Med","Annals of internal medicine",NA,"Keller","Michael","National Institutes of Health Clinical Center, Bethesda, Maryland (S.S.K., J.S., A.L., M.K., C.Y., S.M., J.K., R.L.D., C.Y.D., S",NA
"2102","34224257","10.7326/M21-1213","Association Between Caseload Surge and COVID-19 Survival in 558 U.S. Hospitals, March to August 2020.","Several U.S. hospitals had surges in COVID-19 caseload, but their effect on COVID-19 survival rates remains unclear, especially independent of temporal changes in survival. To determine the association between hospitals' severity-weighted COVID-19 caseload and COVID-19 mortality risk and identify effect modifiers of this relationship. Retrospective cohort study. (ClinicalTrials.gov: NCT04688372). 558 U.S. hospitals in the Premier Healthcare Database. Adult COVID-19-coded inpatients admitted from","2021","07","21","Ann Intern Med","Annals of internal medicine",NA,"Babiker","Ahmed","Emory University School of Medicine, Atlanta, Georgia (A",NA
"2103","34224257","10.7326/M21-1213","Association Between Caseload Surge and COVID-19 Survival in 558 U.S. Hospitals, March to August 2020.","Several U.S. hospitals had surges in COVID-19 caseload, but their effect on COVID-19 survival rates remains unclear, especially independent of temporal changes in survival. To determine the association between hospitals' severity-weighted COVID-19 caseload and COVID-19 mortality risk and identify effect modifiers of this relationship. Retrospective cohort study. (ClinicalTrials.gov: NCT04688372). 558 U.S. hospitals in the Premier Healthcare Database. Adult COVID-19-coded inpatients admitted from","2021","07","21","Ann Intern Med","Annals of internal medicine",NA,"Yek","Christina","National Institutes of Health Clinical Center, Bethesda, Maryland (S.S.K., J.S., A.L., M.K., C.Y., S.M., J.K., R.L.D., C.Y.D., S",NA
"2104","34224257","10.7326/M21-1213","Association Between Caseload Surge and COVID-19 Survival in 558 U.S. Hospitals, March to August 2020.","Several U.S. hospitals had surges in COVID-19 caseload, but their effect on COVID-19 survival rates remains unclear, especially independent of temporal changes in survival. To determine the association between hospitals' severity-weighted COVID-19 caseload and COVID-19 mortality risk and identify effect modifiers of this relationship. Retrospective cohort study. (ClinicalTrials.gov: NCT04688372). 558 U.S. hospitals in the Premier Healthcare Database. Adult COVID-19-coded inpatients admitted from","2021","07","21","Ann Intern Med","Annals of internal medicine",NA,"Malik","Seidu","National Institutes of Health Clinical Center, Bethesda, Maryland (S.S.K., J.S., A.L., M.K., C.Y., S.M., J.K., R.L.D., C.Y.D., S",NA
"2105","34224257","10.7326/M21-1213","Association Between Caseload Surge and COVID-19 Survival in 558 U.S. Hospitals, March to August 2020.","Several U.S. hospitals had surges in COVID-19 caseload, but their effect on COVID-19 survival rates remains unclear, especially independent of temporal changes in survival. To determine the association between hospitals' severity-weighted COVID-19 caseload and COVID-19 mortality risk and identify effect modifiers of this relationship. Retrospective cohort study. (ClinicalTrials.gov: NCT04688372). 558 U.S. hospitals in the Premier Healthcare Database. Adult COVID-19-coded inpatients admitted from","2021","07","21","Ann Intern Med","Annals of internal medicine",NA,"Krack","Janell","National Institutes of Health Clinical Center, Bethesda, Maryland (S.S.K., J.S., A.L., M.K., C.Y., S.M., J.K., R.L.D., C.Y.D., S",NA
"2106","34224257","10.7326/M21-1213","Association Between Caseload Surge and COVID-19 Survival in 558 U.S. Hospitals, March to August 2020.","Several U.S. hospitals had surges in COVID-19 caseload, but their effect on COVID-19 survival rates remains unclear, especially independent of temporal changes in survival. To determine the association between hospitals' severity-weighted COVID-19 caseload and COVID-19 mortality risk and identify effect modifiers of this relationship. Retrospective cohort study. (ClinicalTrials.gov: NCT04688372). 558 U.S. hospitals in the Premier Healthcare Database. Adult COVID-19-coded inpatients admitted from","2021","07","21","Ann Intern Med","Annals of internal medicine",NA,"Dekker","John P","National Institute of Allergy and Infectious Diseases, Bethesda, Maryland (J.P.D., E",NA
"2107","34224257","10.7326/M21-1213","Association Between Caseload Surge and COVID-19 Survival in 558 U.S. Hospitals, March to August 2020.","Several U.S. hospitals had surges in COVID-19 caseload, but their effect on COVID-19 survival rates remains unclear, especially independent of temporal changes in survival. To determine the association between hospitals' severity-weighted COVID-19 caseload and COVID-19 mortality risk and identify effect modifiers of this relationship. Retrospective cohort study. (ClinicalTrials.gov: NCT04688372). 558 U.S. hospitals in the Premier Healthcare Database. Adult COVID-19-coded inpatients admitted from","2021","07","21","Ann Intern Med","Annals of internal medicine",NA,"Spaulding","Alicen B","Children's Minnesota Research Institute, Minneapolis, Minnesota (A.B",NA
"2108","34224257","10.7326/M21-1213","Association Between Caseload Surge and COVID-19 Survival in 558 U.S. Hospitals, March to August 2020.","Several U.S. hospitals had surges in COVID-19 caseload, but their effect on COVID-19 survival rates remains unclear, especially independent of temporal changes in survival. To determine the association between hospitals' severity-weighted COVID-19 caseload and COVID-19 mortality risk and identify effect modifiers of this relationship. Retrospective cohort study. (ClinicalTrials.gov: NCT04688372). 558 U.S. hospitals in the Premier Healthcare Database. Adult COVID-19-coded inpatients admitted from","2021","07","21","Ann Intern Med","Annals of internal medicine",NA,"Ricotta","Emily","National Institute of Allergy and Infectious Diseases, Bethesda, Maryland (J.P.D., E",NA
"2109","34224257","10.7326/M21-1213","Association Between Caseload Surge and COVID-19 Survival in 558 U.S. Hospitals, March to August 2020.","Several U.S. hospitals had surges in COVID-19 caseload, but their effect on COVID-19 survival rates remains unclear, especially independent of temporal changes in survival. To determine the association between hospitals' severity-weighted COVID-19 caseload and COVID-19 mortality risk and identify effect modifiers of this relationship. Retrospective cohort study. (ClinicalTrials.gov: NCT04688372). 558 U.S. hospitals in the Premier Healthcare Database. Adult COVID-19-coded inpatients admitted from","2021","07","21","Ann Intern Med","Annals of internal medicine",NA,"Powers Iii","John H","Frederick National Laboratory for Cancer Research, Frederick, Maryland (J.H",NA
"2110","34224257","10.7326/M21-1213","Association Between Caseload Surge and COVID-19 Survival in 558 U.S. Hospitals, March to August 2020.","Several U.S. hospitals had surges in COVID-19 caseload, but their effect on COVID-19 survival rates remains unclear, especially independent of temporal changes in survival. To determine the association between hospitals' severity-weighted COVID-19 caseload and COVID-19 mortality risk and identify effect modifiers of this relationship. Retrospective cohort study. (ClinicalTrials.gov: NCT04688372). 558 U.S. hospitals in the Premier Healthcare Database. Adult COVID-19-coded inpatients admitted from","2021","07","21","Ann Intern Med","Annals of internal medicine",NA,"Rhee","Chanu","Brigham and Women's Hospital, Harvard Medical School, and Harvard Pilgrim Health Care Institute, Boston, Massachusetts (C.R., M",NA
"2111","34224257","10.7326/M21-1213","Association Between Caseload Surge and COVID-19 Survival in 558 U.S. Hospitals, March to August 2020.","Several U.S. hospitals had surges in COVID-19 caseload, but their effect on COVID-19 survival rates remains unclear, especially independent of temporal changes in survival. To determine the association between hospitals' severity-weighted COVID-19 caseload and COVID-19 mortality risk and identify effect modifiers of this relationship. Retrospective cohort study. (ClinicalTrials.gov: NCT04688372). 558 U.S. hospitals in the Premier Healthcare Database. Adult COVID-19-coded inpatients admitted from","2021","07","21","Ann Intern Med","Annals of internal medicine",NA,"Klompas","Michael","Brigham and Women's Hospital, Harvard Medical School, and Harvard Pilgrim Health Care Institute, Boston, Massachusetts (C.R., M",NA
"2112","34224257","10.7326/M21-1213","Association Between Caseload Surge and COVID-19 Survival in 558 U.S. Hospitals, March to August 2020.","Several U.S. hospitals had surges in COVID-19 caseload, but their effect on COVID-19 survival rates remains unclear, especially independent of temporal changes in survival. To determine the association between hospitals' severity-weighted COVID-19 caseload and COVID-19 mortality risk and identify effect modifiers of this relationship. Retrospective cohort study. (ClinicalTrials.gov: NCT04688372). 558 U.S. hospitals in the Premier Healthcare Database. Adult COVID-19-coded inpatients admitted from","2021","07","21","Ann Intern Med","Annals of internal medicine",NA,"Athale","Janhavi","National Institutes of Health Clinical Center, Bethesda, Maryland, and Mayo Clinic Arizona, Phoenix, Arizona (J",NA
"2113","34224257","10.7326/M21-1213","Association Between Caseload Surge and COVID-19 Survival in 558 U.S. Hospitals, March to August 2020.","Several U.S. hospitals had surges in COVID-19 caseload, but their effect on COVID-19 survival rates remains unclear, especially independent of temporal changes in survival. To determine the association between hospitals' severity-weighted COVID-19 caseload and COVID-19 mortality risk and identify effect modifiers of this relationship. Retrospective cohort study. (ClinicalTrials.gov: NCT04688372). 558 U.S. hospitals in the Premier Healthcare Database. Adult COVID-19-coded inpatients admitted from","2021","07","21","Ann Intern Med","Annals of internal medicine",NA,"Boehmer","Tegan K","U.S. Public Health Service, Rockville, Maryland, and Centers for Disease Control and Prevention, Atlanta, Georgia (T.K",NA
"2114","34224257","10.7326/M21-1213","Association Between Caseload Surge and COVID-19 Survival in 558 U.S. Hospitals, March to August 2020.","Several U.S. hospitals had surges in COVID-19 caseload, but their effect on COVID-19 survival rates remains unclear, especially independent of temporal changes in survival. To determine the association between hospitals' severity-weighted COVID-19 caseload and COVID-19 mortality risk and identify effect modifiers of this relationship. Retrospective cohort study. (ClinicalTrials.gov: NCT04688372). 558 U.S. hospitals in the Premier Healthcare Database. Adult COVID-19-coded inpatients admitted from","2021","07","21","Ann Intern Med","Annals of internal medicine",NA,"Gundlapalli","Adi V","Centers for Disease Control and Prevention, Atlanta, Georgia (A.V.G., S.D",NA
"2115","34224257","10.7326/M21-1213","Association Between Caseload Surge and COVID-19 Survival in 558 U.S. Hospitals, March to August 2020.","Several U.S. hospitals had surges in COVID-19 caseload, but their effect on COVID-19 survival rates remains unclear, especially independent of temporal changes in survival. To determine the association between hospitals' severity-weighted COVID-19 caseload and COVID-19 mortality risk and identify effect modifiers of this relationship. Retrospective cohort study. (ClinicalTrials.gov: NCT04688372). 558 U.S. hospitals in the Premier Healthcare Database. Adult COVID-19-coded inpatients admitted from","2021","07","21","Ann Intern Med","Annals of internal medicine",NA,"Bentley","William","Centers for Disease Control and Prevention, Atlanta, Georgia, and General Dynamics Information Technology, Falls Church, Virginia (W",NA
"2116","34224257","10.7326/M21-1213","Association Between Caseload Surge and COVID-19 Survival in 558 U.S. Hospitals, March to August 2020.","Several U.S. hospitals had surges in COVID-19 caseload, but their effect on COVID-19 survival rates remains unclear, especially independent of temporal changes in survival. To determine the association between hospitals' severity-weighted COVID-19 caseload and COVID-19 mortality risk and identify effect modifiers of this relationship. Retrospective cohort study. (ClinicalTrials.gov: NCT04688372). 558 U.S. hospitals in the Premier Healthcare Database. Adult COVID-19-coded inpatients admitted from","2021","07","21","Ann Intern Med","Annals of internal medicine",NA,"Datta","S Deblina","Centers for Disease Control and Prevention, Atlanta, Georgia (A.V.G., S.D",NA
"2117","34224257","10.7326/M21-1213","Association Between Caseload Surge and COVID-19 Survival in 558 U.S. Hospitals, March to August 2020.","Several U.S. hospitals had surges in COVID-19 caseload, but their effect on COVID-19 survival rates remains unclear, especially independent of temporal changes in survival. To determine the association between hospitals' severity-weighted COVID-19 caseload and COVID-19 mortality risk and identify effect modifiers of this relationship. Retrospective cohort study. (ClinicalTrials.gov: NCT04688372). 558 U.S. hospitals in the Premier Healthcare Database. Adult COVID-19-coded inpatients admitted from","2021","07","21","Ann Intern Med","Annals of internal medicine",NA,"Danner","Robert L","National Institutes of Health Clinical Center, Bethesda, Maryland (S.S.K., J.S., A.L., M.K., C.Y., S.M., J.K., R.L.D., C.Y.D., S",NA
"2118","34224257","10.7326/M21-1213","Association Between Caseload Surge and COVID-19 Survival in 558 U.S. Hospitals, March to August 2020.","Several U.S. hospitals had surges in COVID-19 caseload, but their effect on COVID-19 survival rates remains unclear, especially independent of temporal changes in survival. To determine the association between hospitals' severity-weighted COVID-19 caseload and COVID-19 mortality risk and identify effect modifiers of this relationship. Retrospective cohort study. (ClinicalTrials.gov: NCT04688372). 558 U.S. hospitals in the Premier Healthcare Database. Adult COVID-19-coded inpatients admitted from","2021","07","21","Ann Intern Med","Annals of internal medicine",NA,"Demirkale","Cumhur Y","National Institutes of Health Clinical Center, Bethesda, Maryland (S.S.K., J.S., A.L., M.K., C.Y., S.M., J.K., R.L.D., C.Y.D., S",NA
"2119","34224257","10.7326/M21-1213","Association Between Caseload Surge and COVID-19 Survival in 558 U.S. Hospitals, March to August 2020.","Several U.S. hospitals had surges in COVID-19 caseload, but their effect on COVID-19 survival rates remains unclear, especially independent of temporal changes in survival. To determine the association between hospitals' severity-weighted COVID-19 caseload and COVID-19 mortality risk and identify effect modifiers of this relationship. Retrospective cohort study. (ClinicalTrials.gov: NCT04688372). 558 U.S. hospitals in the Premier Healthcare Database. Adult COVID-19-coded inpatients admitted from","2021","07","21","Ann Intern Med","Annals of internal medicine",NA,"Warner","Sarah","National Institutes of Health Clinical Center, Bethesda, Maryland (S.S.K., J.S., A.L., M.K., C.Y., S.M., J.K., R.L.D., C.Y.D., S",NA
"2120","34224255","10.7326/ACPJ202107200-082","In adults and children, a rapid POC antigen test for COVID-19 (LumiraDx) had =97% sensitivity and specificity vs. RT-PCR.","Drain PK, Ampajwala M, Chappel C, et al. A rapid, high-sensitivity SARS-CoV-2 nucleocapsid immunoassay to aid diagnosis of acute COVID-19 at the point of care: a clinical performance study. Infect Dis Ther. 2021;10:753-61 33629225.","2021","07","23","Ann Intern Med","Annals of internal medicine","Adult; Antigens, Viral; COVID-19; Child; Humans; Reverse Transcriptase Polymerase Chain Reaction; SARS-CoV-2; Sensitivity and Specificity","Fekete","Thomas","Lewis Katz School of Medicine of Temple University, Philadelphia, Pennsylvania, USA (T",NA
"2121","34224254","10.7326/M21-0878","Prevalence of Symptoms More Than Seven Months After Diagnosis of Symptomatic COVID-19 in an Outpatient Setting.","With millions of SARS-CoV-2 infections worldwide, increasing numbers of patients are coming forward with long-term clinical effects of the disease lasting several weeks to months. To characterize symptoms 7 to 9 months after diagnosis of COVID-19. Self-reported surveys and semistructured telephone interviews at enrollment and 30 to 45 days and 7 to 9 months from diagnosis. From 18 March to 15 May 2020, symptomatic persons who tested positive for SARS-CoV-2 at the Geneva University Hospitals were","2021","07","21","Ann Intern Med","Annals of internal medicine",NA,"Nehme","Mayssam","Geneva University Hospitals, Geneva, Switzerland (M.N., O",NA
"2122","34224254","10.7326/M21-0878","Prevalence of Symptoms More Than Seven Months After Diagnosis of Symptomatic COVID-19 in an Outpatient Setting.","With millions of SARS-CoV-2 infections worldwide, increasing numbers of patients are coming forward with long-term clinical effects of the disease lasting several weeks to months. To characterize symptoms 7 to 9 months after diagnosis of COVID-19. Self-reported surveys and semistructured telephone interviews at enrollment and 30 to 45 days and 7 to 9 months from diagnosis. From 18 March to 15 May 2020, symptomatic persons who tested positive for SARS-CoV-2 at the Geneva University Hospitals were","2021","07","21","Ann Intern Med","Annals of internal medicine",NA,"Braillard","Olivia","Geneva University Hospitals, Geneva, Switzerland (M.N., O",NA
"2123","34224254","10.7326/M21-0878","Prevalence of Symptoms More Than Seven Months After Diagnosis of Symptomatic COVID-19 in an Outpatient Setting.","With millions of SARS-CoV-2 infections worldwide, increasing numbers of patients are coming forward with long-term clinical effects of the disease lasting several weeks to months. To characterize symptoms 7 to 9 months after diagnosis of COVID-19. Self-reported surveys and semistructured telephone interviews at enrollment and 30 to 45 days and 7 to 9 months from diagnosis. From 18 March to 15 May 2020, symptomatic persons who tested positive for SARS-CoV-2 at the Geneva University Hospitals were","2021","07","21","Ann Intern Med","Annals of internal medicine",NA,"Chappuis","François","Geneva University Hospitals and University of Geneva, Geneva, Switzerland (F.C., I",NA
"2124","34224254","10.7326/M21-0878","Prevalence of Symptoms More Than Seven Months After Diagnosis of Symptomatic COVID-19 in an Outpatient Setting.","With millions of SARS-CoV-2 infections worldwide, increasing numbers of patients are coming forward with long-term clinical effects of the disease lasting several weeks to months. To characterize symptoms 7 to 9 months after diagnosis of COVID-19. Self-reported surveys and semistructured telephone interviews at enrollment and 30 to 45 days and 7 to 9 months from diagnosis. From 18 March to 15 May 2020, symptomatic persons who tested positive for SARS-CoV-2 at the Geneva University Hospitals were","2021","07","21","Ann Intern Med","Annals of internal medicine",NA,"Courvoisier","Delphine S","Cantonal Health Service and Geneva University Hospitals, Geneva, Switzerland (D.S",NA
"2125","34224254","10.7326/M21-0878","Prevalence of Symptoms More Than Seven Months After Diagnosis of Symptomatic COVID-19 in an Outpatient Setting.","With millions of SARS-CoV-2 infections worldwide, increasing numbers of patients are coming forward with long-term clinical effects of the disease lasting several weeks to months. To characterize symptoms 7 to 9 months after diagnosis of COVID-19. Self-reported surveys and semistructured telephone interviews at enrollment and 30 to 45 days and 7 to 9 months from diagnosis. From 18 March to 15 May 2020, symptomatic persons who tested positive for SARS-CoV-2 at the Geneva University Hospitals were","2021","07","21","Ann Intern Med","Annals of internal medicine",NA,"Guessous","Idris","Geneva University Hospitals and University of Geneva, Geneva, Switzerland (F.C., I",NA
"2126","34224248","10.1177/19714009211029177","A review of neuroradiological abnormalities in patients with coronavirus disease 2019 (COVID-19).","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has led to various neurological manifestations. There is an urgent need for a summary of neuroimaging findings to accelerate diagnosis and treatment plans. We reviewed prospective and retrospective studies to classify neurological abnormalities observed in patients with the SARS-CoV-2 infection. The relevant studies published in Scopus, PubMed and Clarivate Analytics databases were analysed. The search was performed for full-text artic","2021","07","05","Neuroradiol J","The neuroradiology journal","COVID-19; Neuroradiological; brain; computed tomography; magnetic resonance; spinal","Bahranifard","Bahar","Department of Neurology, Bushehr University of Medical Sciences, Iran",NA
"2127","34224248","10.1177/19714009211029177","A review of neuroradiological abnormalities in patients with coronavirus disease 2019 (COVID-19).","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has led to various neurological manifestations. There is an urgent need for a summary of neuroimaging findings to accelerate diagnosis and treatment plans. We reviewed prospective and retrospective studies to classify neurological abnormalities observed in patients with the SARS-CoV-2 infection. The relevant studies published in Scopus, PubMed and Clarivate Analytics databases were analysed. The search was performed for full-text artic","2021","07","05","Neuroradiol J","The neuroradiology journal","COVID-19; Neuroradiological; brain; computed tomography; magnetic resonance; spinal","Mehdizadeh","Somayeh","Department of Pathology, Bushehr University of Medical Sciences, Iran",NA
"2128","34224248","10.1177/19714009211029177","A review of neuroradiological abnormalities in patients with coronavirus disease 2019 (COVID-19).","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has led to various neurological manifestations. There is an urgent need for a summary of neuroimaging findings to accelerate diagnosis and treatment plans. We reviewed prospective and retrospective studies to classify neurological abnormalities observed in patients with the SARS-CoV-2 infection. The relevant studies published in Scopus, PubMed and Clarivate Analytics databases were analysed. The search was performed for full-text artic","2021","07","05","Neuroradiol J","The neuroradiology journal","COVID-19; Neuroradiological; brain; computed tomography; magnetic resonance; spinal","Hamidi","Ali","Department of Medical Library and Information Science, Bushehr University of Medical Sciences, Iran",NA
"2129","34224248","10.1177/19714009211029177","A review of neuroradiological abnormalities in patients with coronavirus disease 2019 (COVID-19).","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has led to various neurological manifestations. There is an urgent need for a summary of neuroimaging findings to accelerate diagnosis and treatment plans. We reviewed prospective and retrospective studies to classify neurological abnormalities observed in patients with the SARS-CoV-2 infection. The relevant studies published in Scopus, PubMed and Clarivate Analytics databases were analysed. The search was performed for full-text artic","2021","07","05","Neuroradiol J","The neuroradiology journal","COVID-19; Neuroradiological; brain; computed tomography; magnetic resonance; spinal","Khosravi","Alireza","Department of Neurology, Zahedan University of Medical Sciences, Iran",NA
"2130","34224248","10.1177/19714009211029177","A review of neuroradiological abnormalities in patients with coronavirus disease 2019 (COVID-19).","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has led to various neurological manifestations. There is an urgent need for a summary of neuroimaging findings to accelerate diagnosis and treatment plans. We reviewed prospective and retrospective studies to classify neurological abnormalities observed in patients with the SARS-CoV-2 infection. The relevant studies published in Scopus, PubMed and Clarivate Analytics databases were analysed. The search was performed for full-text artic","2021","07","05","Neuroradiol J","The neuroradiology journal","COVID-19; Neuroradiological; brain; computed tomography; magnetic resonance; spinal","Emami","Ramin","Department of Neurology, Abhar Medical Clinic, Iran",NA
"2131","34224248","10.1177/19714009211029177","A review of neuroradiological abnormalities in patients with coronavirus disease 2019 (COVID-19).","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has led to various neurological manifestations. There is an urgent need for a summary of neuroimaging findings to accelerate diagnosis and treatment plans. We reviewed prospective and retrospective studies to classify neurological abnormalities observed in patients with the SARS-CoV-2 infection. The relevant studies published in Scopus, PubMed and Clarivate Analytics databases were analysed. The search was performed for full-text artic","2021","07","05","Neuroradiol J","The neuroradiology journal","COVID-19; Neuroradiological; brain; computed tomography; magnetic resonance; spinal","Mirzaei","Kamran","Department of Community Medicine, Bushehr University of Medical Sciences, Iran",NA
"2132","34224248","10.1177/19714009211029177","A review of neuroradiological abnormalities in patients with coronavirus disease 2019 (COVID-19).","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has led to various neurological manifestations. There is an urgent need for a summary of neuroimaging findings to accelerate diagnosis and treatment plans. We reviewed prospective and retrospective studies to classify neurological abnormalities observed in patients with the SARS-CoV-2 infection. The relevant studies published in Scopus, PubMed and Clarivate Analytics databases were analysed. The search was performed for full-text artic","2021","07","05","Neuroradiol J","The neuroradiology journal","COVID-19; Neuroradiological; brain; computed tomography; magnetic resonance; spinal","Nemati","Reza","Department of Neurology, Bushehr University of Medical Sciences, Iran",NA
"2133","34224248","10.1177/19714009211029177","A review of neuroradiological abnormalities in patients with coronavirus disease 2019 (COVID-19).","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has led to various neurological manifestations. There is an urgent need for a summary of neuroimaging findings to accelerate diagnosis and treatment plans. We reviewed prospective and retrospective studies to classify neurological abnormalities observed in patients with the SARS-CoV-2 infection. The relevant studies published in Scopus, PubMed and Clarivate Analytics databases were analysed. The search was performed for full-text artic","2021","07","05","Neuroradiol J","The neuroradiology journal","COVID-19; Neuroradiological; brain; computed tomography; magnetic resonance; spinal","Nemati","Fatemeh","Department of English Language and Literature, Persian Gulf University, Iran",NA
"2134","34224248","10.1177/19714009211029177","A review of neuroradiological abnormalities in patients with coronavirus disease 2019 (COVID-19).","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has led to various neurological manifestations. There is an urgent need for a summary of neuroimaging findings to accelerate diagnosis and treatment plans. We reviewed prospective and retrospective studies to classify neurological abnormalities observed in patients with the SARS-CoV-2 infection. The relevant studies published in Scopus, PubMed and Clarivate Analytics databases were analysed. The search was performed for full-text artic","2021","07","05","Neuroradiol J","The neuroradiology journal","COVID-19; Neuroradiological; brain; computed tomography; magnetic resonance; spinal","Assadi","Majid","Department of Molecular Imaging and Radionuclide Therapy (MIRT), The Persian Gulf Nuclear Medicine Research Center, Iran",NA
"2135","34224248","10.1177/19714009211029177","A review of neuroradiological abnormalities in patients with coronavirus disease 2019 (COVID-19).","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has led to various neurological manifestations. There is an urgent need for a summary of neuroimaging findings to accelerate diagnosis and treatment plans. We reviewed prospective and retrospective studies to classify neurological abnormalities observed in patients with the SARS-CoV-2 infection. The relevant studies published in Scopus, PubMed and Clarivate Analytics databases were analysed. The search was performed for full-text artic","2021","07","05","Neuroradiol J","The neuroradiology journal","COVID-19; Neuroradiological; brain; computed tomography; magnetic resonance; spinal","Gholamrezanezhad","Ali","Keck School of Medicine, University of Southern California (USC), USA",NA
"2136","34224205","10.1111/tbed.14219","SARS-CoV-2 surveillance in Norway rats (Rattus norvegicus) from Antwerp sewer system, Belgium.","SARS-CoV-2 human-to-animal transmission can lead to the establishment of novel reservoirs and the evolution of new variants with the potential to start new outbreaks in humans. We tested Norway rats inhabiting the sewer system of Antwerp, Belgium, for the presence of SARS-CoV-2 following a local COVID-19 epidemic peak. In addition, we discuss the use and interpretation of SARS-CoV-2 serological tests on non-human samples. Between November and December 2020, Norway rat oral swabs, faeces and tiss","2021","07","10","Transbound Emerg Dis","Transboundary and emerging diseases","Belgium; Muridae; SARS-CoV-2; disease outbreaks; rats","Colombo","Valeria Carolina","Evolutionary Ecology Group, Department of Biology, University of Antwerp, Antwerp, Belgium",NA
"2137","34224205","10.1111/tbed.14219","SARS-CoV-2 surveillance in Norway rats (Rattus norvegicus) from Antwerp sewer system, Belgium.","SARS-CoV-2 human-to-animal transmission can lead to the establishment of novel reservoirs and the evolution of new variants with the potential to start new outbreaks in humans. We tested Norway rats inhabiting the sewer system of Antwerp, Belgium, for the presence of SARS-CoV-2 following a local COVID-19 epidemic peak. In addition, we discuss the use and interpretation of SARS-CoV-2 serological tests on non-human samples. Between November and December 2020, Norway rat oral swabs, faeces and tiss","2021","07","10","Transbound Emerg Dis","Transboundary and emerging diseases","Belgium; Muridae; SARS-CoV-2; disease outbreaks; rats","Sluydts","Vincent","Evolutionary Ecology Group, Department of Biology, University of Antwerp, Antwerp, Belgium",NA
"2138","34224205","10.1111/tbed.14219","SARS-CoV-2 surveillance in Norway rats (Rattus norvegicus) from Antwerp sewer system, Belgium.","SARS-CoV-2 human-to-animal transmission can lead to the establishment of novel reservoirs and the evolution of new variants with the potential to start new outbreaks in humans. We tested Norway rats inhabiting the sewer system of Antwerp, Belgium, for the presence of SARS-CoV-2 following a local COVID-19 epidemic peak. In addition, we discuss the use and interpretation of SARS-CoV-2 serological tests on non-human samples. Between November and December 2020, Norway rat oral swabs, faeces and tiss","2021","07","10","Transbound Emerg Dis","Transboundary and emerging diseases","Belgium; Muridae; SARS-CoV-2; disease outbreaks; rats","Mariën","Joachim","Evolutionary Ecology Group, Department of Biology, University of Antwerp, Antwerp, Belgium",NA
"2139","34224205","10.1111/tbed.14219","SARS-CoV-2 surveillance in Norway rats (Rattus norvegicus) from Antwerp sewer system, Belgium.","SARS-CoV-2 human-to-animal transmission can lead to the establishment of novel reservoirs and the evolution of new variants with the potential to start new outbreaks in humans. We tested Norway rats inhabiting the sewer system of Antwerp, Belgium, for the presence of SARS-CoV-2 following a local COVID-19 epidemic peak. In addition, we discuss the use and interpretation of SARS-CoV-2 serological tests on non-human samples. Between November and December 2020, Norway rat oral swabs, faeces and tiss","2021","07","10","Transbound Emerg Dis","Transboundary and emerging diseases","Belgium; Muridae; SARS-CoV-2; disease outbreaks; rats","Vanden Broecke","Bram","Evolutionary Ecology Group, Department of Biology, University of Antwerp, Antwerp, Belgium",NA
"2140","34224205","10.1111/tbed.14219","SARS-CoV-2 surveillance in Norway rats (Rattus norvegicus) from Antwerp sewer system, Belgium.","SARS-CoV-2 human-to-animal transmission can lead to the establishment of novel reservoirs and the evolution of new variants with the potential to start new outbreaks in humans. We tested Norway rats inhabiting the sewer system of Antwerp, Belgium, for the presence of SARS-CoV-2 following a local COVID-19 epidemic peak. In addition, we discuss the use and interpretation of SARS-CoV-2 serological tests on non-human samples. Between November and December 2020, Norway rat oral swabs, faeces and tiss","2021","07","10","Transbound Emerg Dis","Transboundary and emerging diseases","Belgium; Muridae; SARS-CoV-2; disease outbreaks; rats","Van Houtte","Natalie","Evolutionary Ecology Group, Department of Biology, University of Antwerp, Antwerp, Belgium",NA
"2141","34224205","10.1111/tbed.14219","SARS-CoV-2 surveillance in Norway rats (Rattus norvegicus) from Antwerp sewer system, Belgium.","SARS-CoV-2 human-to-animal transmission can lead to the establishment of novel reservoirs and the evolution of new variants with the potential to start new outbreaks in humans. We tested Norway rats inhabiting the sewer system of Antwerp, Belgium, for the presence of SARS-CoV-2 following a local COVID-19 epidemic peak. In addition, we discuss the use and interpretation of SARS-CoV-2 serological tests on non-human samples. Between November and December 2020, Norway rat oral swabs, faeces and tiss","2021","07","10","Transbound Emerg Dis","Transboundary and emerging diseases","Belgium; Muridae; SARS-CoV-2; disease outbreaks; rats","Leirs","Wannes","Evolutionary Ecology Group, Department of Biology, University of Antwerp, Antwerp, Belgium",NA
"2142","34224205","10.1111/tbed.14219","SARS-CoV-2 surveillance in Norway rats (Rattus norvegicus) from Antwerp sewer system, Belgium.","SARS-CoV-2 human-to-animal transmission can lead to the establishment of novel reservoirs and the evolution of new variants with the potential to start new outbreaks in humans. We tested Norway rats inhabiting the sewer system of Antwerp, Belgium, for the presence of SARS-CoV-2 following a local COVID-19 epidemic peak. In addition, we discuss the use and interpretation of SARS-CoV-2 serological tests on non-human samples. Between November and December 2020, Norway rat oral swabs, faeces and tiss","2021","07","10","Transbound Emerg Dis","Transboundary and emerging diseases","Belgium; Muridae; SARS-CoV-2; disease outbreaks; rats","Jacobs","Lotte","Laboratory for Microbiology, Parasitology and Hygiene (LMPH), University of Antwerp, Antwerp, Belgium",NA
"2143","34224205","10.1111/tbed.14219","SARS-CoV-2 surveillance in Norway rats (Rattus norvegicus) from Antwerp sewer system, Belgium.","SARS-CoV-2 human-to-animal transmission can lead to the establishment of novel reservoirs and the evolution of new variants with the potential to start new outbreaks in humans. We tested Norway rats inhabiting the sewer system of Antwerp, Belgium, for the presence of SARS-CoV-2 following a local COVID-19 epidemic peak. In addition, we discuss the use and interpretation of SARS-CoV-2 serological tests on non-human samples. Between November and December 2020, Norway rat oral swabs, faeces and tiss","2021","07","10","Transbound Emerg Dis","Transboundary and emerging diseases","Belgium; Muridae; SARS-CoV-2; disease outbreaks; rats","Iserbyt","Arne","Evolutionary Ecology Group, Department of Biology, University of Antwerp, Antwerp, Belgium",NA
"2144","34224205","10.1111/tbed.14219","SARS-CoV-2 surveillance in Norway rats (Rattus norvegicus) from Antwerp sewer system, Belgium.","SARS-CoV-2 human-to-animal transmission can lead to the establishment of novel reservoirs and the evolution of new variants with the potential to start new outbreaks in humans. We tested Norway rats inhabiting the sewer system of Antwerp, Belgium, for the presence of SARS-CoV-2 following a local COVID-19 epidemic peak. In addition, we discuss the use and interpretation of SARS-CoV-2 serological tests on non-human samples. Between November and December 2020, Norway rat oral swabs, faeces and tiss","2021","07","10","Transbound Emerg Dis","Transboundary and emerging diseases","Belgium; Muridae; SARS-CoV-2; disease outbreaks; rats","Hubert","Marine","Evolutionary Ecology Group, Department of Biology, University of Antwerp, Antwerp, Belgium",NA
"2145","34224205","10.1111/tbed.14219","SARS-CoV-2 surveillance in Norway rats (Rattus norvegicus) from Antwerp sewer system, Belgium.","SARS-CoV-2 human-to-animal transmission can lead to the establishment of novel reservoirs and the evolution of new variants with the potential to start new outbreaks in humans. We tested Norway rats inhabiting the sewer system of Antwerp, Belgium, for the presence of SARS-CoV-2 following a local COVID-19 epidemic peak. In addition, we discuss the use and interpretation of SARS-CoV-2 serological tests on non-human samples. Between November and December 2020, Norway rat oral swabs, faeces and tiss","2021","07","10","Transbound Emerg Dis","Transboundary and emerging diseases","Belgium; Muridae; SARS-CoV-2; disease outbreaks; rats","Heyndrickx","Leo","Virology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium",NA
"2146","34224205","10.1111/tbed.14219","SARS-CoV-2 surveillance in Norway rats (Rattus norvegicus) from Antwerp sewer system, Belgium.","SARS-CoV-2 human-to-animal transmission can lead to the establishment of novel reservoirs and the evolution of new variants with the potential to start new outbreaks in humans. We tested Norway rats inhabiting the sewer system of Antwerp, Belgium, for the presence of SARS-CoV-2 following a local COVID-19 epidemic peak. In addition, we discuss the use and interpretation of SARS-CoV-2 serological tests on non-human samples. Between November and December 2020, Norway rat oral swabs, faeces and tiss","2021","07","10","Transbound Emerg Dis","Transboundary and emerging diseases","Belgium; Muridae; SARS-CoV-2; disease outbreaks; rats","Goris","Hanne","Evolutionary Ecology Group, Department of Biology, University of Antwerp, Antwerp, Belgium",NA
"2147","34224205","10.1111/tbed.14219","SARS-CoV-2 surveillance in Norway rats (Rattus norvegicus) from Antwerp sewer system, Belgium.","SARS-CoV-2 human-to-animal transmission can lead to the establishment of novel reservoirs and the evolution of new variants with the potential to start new outbreaks in humans. We tested Norway rats inhabiting the sewer system of Antwerp, Belgium, for the presence of SARS-CoV-2 following a local COVID-19 epidemic peak. In addition, we discuss the use and interpretation of SARS-CoV-2 serological tests on non-human samples. Between November and December 2020, Norway rat oral swabs, faeces and tiss","2021","07","10","Transbound Emerg Dis","Transboundary and emerging diseases","Belgium; Muridae; SARS-CoV-2; disease outbreaks; rats","Delputte","Peter","Laboratory for Microbiology, Parasitology and Hygiene (LMPH), University of Antwerp, Antwerp, Belgium",NA
"2148","34224205","10.1111/tbed.14219","SARS-CoV-2 surveillance in Norway rats (Rattus norvegicus) from Antwerp sewer system, Belgium.","SARS-CoV-2 human-to-animal transmission can lead to the establishment of novel reservoirs and the evolution of new variants with the potential to start new outbreaks in humans. We tested Norway rats inhabiting the sewer system of Antwerp, Belgium, for the presence of SARS-CoV-2 following a local COVID-19 epidemic peak. In addition, we discuss the use and interpretation of SARS-CoV-2 serological tests on non-human samples. Between November and December 2020, Norway rat oral swabs, faeces and tiss","2021","07","10","Transbound Emerg Dis","Transboundary and emerging diseases","Belgium; Muridae; SARS-CoV-2; disease outbreaks; rats","De Roeck","Naomi","Laboratory for Microbiology, Parasitology and Hygiene (LMPH), University of Antwerp, Antwerp, Belgium",NA
"2149","34224205","10.1111/tbed.14219","SARS-CoV-2 surveillance in Norway rats (Rattus norvegicus) from Antwerp sewer system, Belgium.","SARS-CoV-2 human-to-animal transmission can lead to the establishment of novel reservoirs and the evolution of new variants with the potential to start new outbreaks in humans. We tested Norway rats inhabiting the sewer system of Antwerp, Belgium, for the presence of SARS-CoV-2 following a local COVID-19 epidemic peak. In addition, we discuss the use and interpretation of SARS-CoV-2 serological tests on non-human samples. Between November and December 2020, Norway rat oral swabs, faeces and tiss","2021","07","10","Transbound Emerg Dis","Transboundary and emerging diseases","Belgium; Muridae; SARS-CoV-2; disease outbreaks; rats","Elst","Joris","Evolutionary Ecology Group, Department of Biology, University of Antwerp, Antwerp, Belgium",NA
"2150","34224205","10.1111/tbed.14219","SARS-CoV-2 surveillance in Norway rats (Rattus norvegicus) from Antwerp sewer system, Belgium.","SARS-CoV-2 human-to-animal transmission can lead to the establishment of novel reservoirs and the evolution of new variants with the potential to start new outbreaks in humans. We tested Norway rats inhabiting the sewer system of Antwerp, Belgium, for the presence of SARS-CoV-2 following a local COVID-19 epidemic peak. In addition, we discuss the use and interpretation of SARS-CoV-2 serological tests on non-human samples. Between November and December 2020, Norway rat oral swabs, faeces and tiss","2021","07","10","Transbound Emerg Dis","Transboundary and emerging diseases","Belgium; Muridae; SARS-CoV-2; disease outbreaks; rats","Ariën","Kevin K","Virology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium",NA
"2151","34224205","10.1111/tbed.14219","SARS-CoV-2 surveillance in Norway rats (Rattus norvegicus) from Antwerp sewer system, Belgium.","SARS-CoV-2 human-to-animal transmission can lead to the establishment of novel reservoirs and the evolution of new variants with the potential to start new outbreaks in humans. We tested Norway rats inhabiting the sewer system of Antwerp, Belgium, for the presence of SARS-CoV-2 following a local COVID-19 epidemic peak. In addition, we discuss the use and interpretation of SARS-CoV-2 serological tests on non-human samples. Between November and December 2020, Norway rat oral swabs, faeces and tiss","2021","07","10","Transbound Emerg Dis","Transboundary and emerging diseases","Belgium; Muridae; SARS-CoV-2; disease outbreaks; rats","Leirs","Herwig","Evolutionary Ecology Group, Department of Biology, University of Antwerp, Antwerp, Belgium",NA
"2152","34224205","10.1111/tbed.14219","SARS-CoV-2 surveillance in Norway rats (Rattus norvegicus) from Antwerp sewer system, Belgium.","SARS-CoV-2 human-to-animal transmission can lead to the establishment of novel reservoirs and the evolution of new variants with the potential to start new outbreaks in humans. We tested Norway rats inhabiting the sewer system of Antwerp, Belgium, for the presence of SARS-CoV-2 following a local COVID-19 epidemic peak. In addition, we discuss the use and interpretation of SARS-CoV-2 serological tests on non-human samples. Between November and December 2020, Norway rat oral swabs, faeces and tiss","2021","07","10","Transbound Emerg Dis","Transboundary and emerging diseases","Belgium; Muridae; SARS-CoV-2; disease outbreaks; rats","Gryseels","Sophie","Evolutionary Ecology Group, Department of Biology, University of Antwerp, Antwerp, Belgium",NA
"2153","34224196","10.1111/ans.17044","COVID-19 response by New Zealand general surgical departments in tertiary metropolitan hospitals.","Worldwide, coronavirus disease 2019 (COVID-19) has significantly challenged the delivery of healthcare. New Zealand (NZ) faced similar potential challenges despite being geographically isolated. Given the rapid change in the COVID-19 pandemic, hospitals in NZ were tasked with formulating their own COVID-19 responses based on the Ministry of Health's (MoH) recommendations. This paper evaluates how six metropolitan general surgical departments in NZ had responded to COVID-19 in terms of changes ma","2021","07","05","ANZ J Surg","ANZ journal of surgery","COVID-19; New Zealand; delivery of health care; patient care team; resource allocation","Toh","Karen Hui Qi","North Shore Hospital, Waitemata District Health Board, Auckland, New Zealand",NA
"2154","34224196","10.1111/ans.17044","COVID-19 response by New Zealand general surgical departments in tertiary metropolitan hospitals.","Worldwide, coronavirus disease 2019 (COVID-19) has significantly challenged the delivery of healthcare. New Zealand (NZ) faced similar potential challenges despite being geographically isolated. Given the rapid change in the COVID-19 pandemic, hospitals in NZ were tasked with formulating their own COVID-19 responses based on the Ministry of Health's (MoH) recommendations. This paper evaluates how six metropolitan general surgical departments in NZ had responded to COVID-19 in terms of changes ma","2021","07","05","ANZ J Surg","ANZ journal of surgery","COVID-19; New Zealand; delivery of health care; patient care team; resource allocation","Barazanchi","Ahmed","North Shore Hospital, Waitemata District Health Board, Auckland, New Zealand",NA
"2155","34224196","10.1111/ans.17044","COVID-19 response by New Zealand general surgical departments in tertiary metropolitan hospitals.","Worldwide, coronavirus disease 2019 (COVID-19) has significantly challenged the delivery of healthcare. New Zealand (NZ) faced similar potential challenges despite being geographically isolated. Given the rapid change in the COVID-19 pandemic, hospitals in NZ were tasked with formulating their own COVID-19 responses based on the Ministry of Health's (MoH) recommendations. This paper evaluates how six metropolitan general surgical departments in NZ had responded to COVID-19 in terms of changes ma","2021","07","05","ANZ J Surg","ANZ journal of surgery","COVID-19; New Zealand; delivery of health care; patient care team; resource allocation","Rajaretnam","Nigel S","Waikato Hospital, Waikato District Health Board, Auckland, New Zealand",NA
"2156","34224196","10.1111/ans.17044","COVID-19 response by New Zealand general surgical departments in tertiary metropolitan hospitals.","Worldwide, coronavirus disease 2019 (COVID-19) has significantly challenged the delivery of healthcare. New Zealand (NZ) faced similar potential challenges despite being geographically isolated. Given the rapid change in the COVID-19 pandemic, hospitals in NZ were tasked with formulating their own COVID-19 responses based on the Ministry of Health's (MoH) recommendations. This paper evaluates how six metropolitan general surgical departments in NZ had responded to COVID-19 in terms of changes ma","2021","07","05","ANZ J Surg","ANZ journal of surgery","COVID-19; New Zealand; delivery of health care; patient care team; resource allocation","Tan","Jeffrey","Christchurch Hospital, Canterbury District Health Board, Auckland, New Zealand",NA
"2157","34224196","10.1111/ans.17044","COVID-19 response by New Zealand general surgical departments in tertiary metropolitan hospitals.","Worldwide, coronavirus disease 2019 (COVID-19) has significantly challenged the delivery of healthcare. New Zealand (NZ) faced similar potential challenges despite being geographically isolated. Given the rapid change in the COVID-19 pandemic, hospitals in NZ were tasked with formulating their own COVID-19 responses based on the Ministry of Health's (MoH) recommendations. This paper evaluates how six metropolitan general surgical departments in NZ had responded to COVID-19 in terms of changes ma","2021","07","05","ANZ J Surg","ANZ journal of surgery","COVID-19; New Zealand; delivery of health care; patient care team; resource allocation","Linton","Tara","Middlemore Hospital, Counties Manukau District Health Board, Auckland, New Zealand",NA
"2158","34224196","10.1111/ans.17044","COVID-19 response by New Zealand general surgical departments in tertiary metropolitan hospitals.","Worldwide, coronavirus disease 2019 (COVID-19) has significantly challenged the delivery of healthcare. New Zealand (NZ) faced similar potential challenges despite being geographically isolated. Given the rapid change in the COVID-19 pandemic, hospitals in NZ were tasked with formulating their own COVID-19 responses based on the Ministry of Health's (MoH) recommendations. This paper evaluates how six metropolitan general surgical departments in NZ had responded to COVID-19 in terms of changes ma","2021","07","05","ANZ J Surg","ANZ journal of surgery","COVID-19; New Zealand; delivery of health care; patient care team; resource allocation","Murray","Mark","Wellington Hospital, Capital and Coast District Health Board, Auckland, New Zealand",NA
"2159","34224196","10.1111/ans.17044","COVID-19 response by New Zealand general surgical departments in tertiary metropolitan hospitals.","Worldwide, coronavirus disease 2019 (COVID-19) has significantly challenged the delivery of healthcare. New Zealand (NZ) faced similar potential challenges despite being geographically isolated. Given the rapid change in the COVID-19 pandemic, hospitals in NZ were tasked with formulating their own COVID-19 responses based on the Ministry of Health's (MoH) recommendations. This paper evaluates how six metropolitan general surgical departments in NZ had responded to COVID-19 in terms of changes ma","2021","07","05","ANZ J Surg","ANZ journal of surgery","COVID-19; New Zealand; delivery of health care; patient care team; resource allocation","Fagan","Paul","Auckland City Hospital, Auckland District Health Board, Auckland, New Zealand",NA
"2160","34224196","10.1111/ans.17044","COVID-19 response by New Zealand general surgical departments in tertiary metropolitan hospitals.","Worldwide, coronavirus disease 2019 (COVID-19) has significantly challenged the delivery of healthcare. New Zealand (NZ) faced similar potential challenges despite being geographically isolated. Given the rapid change in the COVID-19 pandemic, hospitals in NZ were tasked with formulating their own COVID-19 responses based on the Ministry of Health's (MoH) recommendations. This paper evaluates how six metropolitan general surgical departments in NZ had responded to COVID-19 in terms of changes ma","2021","07","05","ANZ J Surg","ANZ journal of surgery","COVID-19; New Zealand; delivery of health care; patient care team; resource allocation","Koea","Jonathan","North Shore Hospital, Waitemata District Health Board, Auckland, New Zealand",NA
"2161","34224190","10.1111/ijcp.14556","COVID-19 pandemic shakes the trust between oncologists and their patients.",NA,"2021","07","05","Int J Clin Pract","International journal of clinical practice",NA,"Kattan","Joseph","Department of Hematology-Oncology, Faculty of Medicine, Saint Joseph University, Beirut, Lebanon",NA
"2162","34224190","10.1111/ijcp.14556","COVID-19 pandemic shakes the trust between oncologists and their patients.",NA,"2021","07","05","Int J Clin Pract","International journal of clinical practice",NA,"Assi","Tarek","Department of Hematology-Oncology, Faculty of Medicine, Saint Joseph University, Beirut, Lebanon",NA
"2163","34224187","10.1111/ene.15008","COVID-19 and ischemic stroke.","Since the onset of the COVID-19 pandemic, a substantial proportion of COVID-19 patients had documented thrombotic complications and ischemic stroke. Several mechanisms related to immune-mediated thrombosis, the renin angiotensin system and the effect of SARS-CoV-2 in cardiac and brain tissue may contribute to the pathogenesis of ischemic stroke in patients with COVID-19. Simultaneously, significant strains on global healthcare delivery, including ischemic stroke management, have made treatment o","2021","07","18","Eur J Neurol","European journal of neurology","COVID-19; SARS-CoV-2; ischemic stroke; pathophysiology","Sagris","Dimitrios","Department of Internal Medicine, Faculty of Medicine, School of Health Sciences, University of Thessaly, Larissa, Greece",NA
"2164","34224187","10.1111/ene.15008","COVID-19 and ischemic stroke.","Since the onset of the COVID-19 pandemic, a substantial proportion of COVID-19 patients had documented thrombotic complications and ischemic stroke. Several mechanisms related to immune-mediated thrombosis, the renin angiotensin system and the effect of SARS-CoV-2 in cardiac and brain tissue may contribute to the pathogenesis of ischemic stroke in patients with COVID-19. Simultaneously, significant strains on global healthcare delivery, including ischemic stroke management, have made treatment o","2021","07","18","Eur J Neurol","European journal of neurology","COVID-19; SARS-CoV-2; ischemic stroke; pathophysiology","Papanikolaou","Aikaterini","Department of Internal Medicine, Faculty of Medicine, School of Health Sciences, University of Thessaly, Larissa, Greece",NA
"2165","34224187","10.1111/ene.15008","COVID-19 and ischemic stroke.","Since the onset of the COVID-19 pandemic, a substantial proportion of COVID-19 patients had documented thrombotic complications and ischemic stroke. Several mechanisms related to immune-mediated thrombosis, the renin angiotensin system and the effect of SARS-CoV-2 in cardiac and brain tissue may contribute to the pathogenesis of ischemic stroke in patients with COVID-19. Simultaneously, significant strains on global healthcare delivery, including ischemic stroke management, have made treatment o","2021","07","18","Eur J Neurol","European journal of neurology","COVID-19; SARS-CoV-2; ischemic stroke; pathophysiology","Kvernland","Alexandra","Department of Neurology, NYU Grossman School of Medicine, New York, NY, USA",NA
"2166","34224187","10.1111/ene.15008","COVID-19 and ischemic stroke.","Since the onset of the COVID-19 pandemic, a substantial proportion of COVID-19 patients had documented thrombotic complications and ischemic stroke. Several mechanisms related to immune-mediated thrombosis, the renin angiotensin system and the effect of SARS-CoV-2 in cardiac and brain tissue may contribute to the pathogenesis of ischemic stroke in patients with COVID-19. Simultaneously, significant strains on global healthcare delivery, including ischemic stroke management, have made treatment o","2021","07","18","Eur J Neurol","European journal of neurology","COVID-19; SARS-CoV-2; ischemic stroke; pathophysiology","Korompoki","Eleni","Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece",NA
"2167","34224187","10.1111/ene.15008","COVID-19 and ischemic stroke.","Since the onset of the COVID-19 pandemic, a substantial proportion of COVID-19 patients had documented thrombotic complications and ischemic stroke. Several mechanisms related to immune-mediated thrombosis, the renin angiotensin system and the effect of SARS-CoV-2 in cardiac and brain tissue may contribute to the pathogenesis of ischemic stroke in patients with COVID-19. Simultaneously, significant strains on global healthcare delivery, including ischemic stroke management, have made treatment o","2021","07","18","Eur J Neurol","European journal of neurology","COVID-19; SARS-CoV-2; ischemic stroke; pathophysiology","Frontera","Jennifer A","Department of Neurology, NYU Grossman School of Medicine, New York, NY, USA",NA
"2168","34224187","10.1111/ene.15008","COVID-19 and ischemic stroke.","Since the onset of the COVID-19 pandemic, a substantial proportion of COVID-19 patients had documented thrombotic complications and ischemic stroke. Several mechanisms related to immune-mediated thrombosis, the renin angiotensin system and the effect of SARS-CoV-2 in cardiac and brain tissue may contribute to the pathogenesis of ischemic stroke in patients with COVID-19. Simultaneously, significant strains on global healthcare delivery, including ischemic stroke management, have made treatment o","2021","07","18","Eur J Neurol","European journal of neurology","COVID-19; SARS-CoV-2; ischemic stroke; pathophysiology","Troxel","Andrea B","Department of Population Health, NYU Grossman School of Medicine, New York, NY, USA",NA
"2169","34224187","10.1111/ene.15008","COVID-19 and ischemic stroke.","Since the onset of the COVID-19 pandemic, a substantial proportion of COVID-19 patients had documented thrombotic complications and ischemic stroke. Several mechanisms related to immune-mediated thrombosis, the renin angiotensin system and the effect of SARS-CoV-2 in cardiac and brain tissue may contribute to the pathogenesis of ischemic stroke in patients with COVID-19. Simultaneously, significant strains on global healthcare delivery, including ischemic stroke management, have made treatment o","2021","07","18","Eur J Neurol","European journal of neurology","COVID-19; SARS-CoV-2; ischemic stroke; pathophysiology","Gavriatopoulou","Maria","Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece",NA
"2170","34224187","10.1111/ene.15008","COVID-19 and ischemic stroke.","Since the onset of the COVID-19 pandemic, a substantial proportion of COVID-19 patients had documented thrombotic complications and ischemic stroke. Several mechanisms related to immune-mediated thrombosis, the renin angiotensin system and the effect of SARS-CoV-2 in cardiac and brain tissue may contribute to the pathogenesis of ischemic stroke in patients with COVID-19. Simultaneously, significant strains on global healthcare delivery, including ischemic stroke management, have made treatment o","2021","07","18","Eur J Neurol","European journal of neurology","COVID-19; SARS-CoV-2; ischemic stroke; pathophysiology","Milionis","Haralampos","Department of Internal Medicine, Faculty of Medicine, School of Health Sciences, University of Ioannina, Ioannina, Greece",NA
"2171","34224187","10.1111/ene.15008","COVID-19 and ischemic stroke.","Since the onset of the COVID-19 pandemic, a substantial proportion of COVID-19 patients had documented thrombotic complications and ischemic stroke. Several mechanisms related to immune-mediated thrombosis, the renin angiotensin system and the effect of SARS-CoV-2 in cardiac and brain tissue may contribute to the pathogenesis of ischemic stroke in patients with COVID-19. Simultaneously, significant strains on global healthcare delivery, including ischemic stroke management, have made treatment o","2021","07","18","Eur J Neurol","European journal of neurology","COVID-19; SARS-CoV-2; ischemic stroke; pathophysiology","Lip","Gregory Y H","Liverpool Centre for Cardiovascular Science, University of Liverpool and Liverpool Heart &amp",NA
"2172","34224187","10.1111/ene.15008","COVID-19 and ischemic stroke.","Since the onset of the COVID-19 pandemic, a substantial proportion of COVID-19 patients had documented thrombotic complications and ischemic stroke. Several mechanisms related to immune-mediated thrombosis, the renin angiotensin system and the effect of SARS-CoV-2 in cardiac and brain tissue may contribute to the pathogenesis of ischemic stroke in patients with COVID-19. Simultaneously, significant strains on global healthcare delivery, including ischemic stroke management, have made treatment o","2021","07","18","Eur J Neurol","European journal of neurology","COVID-19; SARS-CoV-2; ischemic stroke; pathophysiology","Michel","Patrik","Stroke Center, Neurology Service, Lausanne University Hospital, Lausanne, Switzerland",NA
"2173","34224187","10.1111/ene.15008","COVID-19 and ischemic stroke.","Since the onset of the COVID-19 pandemic, a substantial proportion of COVID-19 patients had documented thrombotic complications and ischemic stroke. Several mechanisms related to immune-mediated thrombosis, the renin angiotensin system and the effect of SARS-CoV-2 in cardiac and brain tissue may contribute to the pathogenesis of ischemic stroke in patients with COVID-19. Simultaneously, significant strains on global healthcare delivery, including ischemic stroke management, have made treatment o","2021","07","18","Eur J Neurol","European journal of neurology","COVID-19; SARS-CoV-2; ischemic stroke; pathophysiology","Yaghi","Shadi","Department of Neurology, NYU Grossman School of Medicine, New York, NY, USA",NA
"2174","34224187","10.1111/ene.15008","COVID-19 and ischemic stroke.","Since the onset of the COVID-19 pandemic, a substantial proportion of COVID-19 patients had documented thrombotic complications and ischemic stroke. Several mechanisms related to immune-mediated thrombosis, the renin angiotensin system and the effect of SARS-CoV-2 in cardiac and brain tissue may contribute to the pathogenesis of ischemic stroke in patients with COVID-19. Simultaneously, significant strains on global healthcare delivery, including ischemic stroke management, have made treatment o","2021","07","18","Eur J Neurol","European journal of neurology","COVID-19; SARS-CoV-2; ischemic stroke; pathophysiology","Ntaios","George","Department of Internal Medicine, Faculty of Medicine, School of Health Sciences, University of Thessaly, Larissa, Greece",NA
"2175","34224172","10.1002/mpr.1885","Conducting a state-of-the-art mental health survey in a traditional setting: Challenges and lessons from piloting the World Mental Health Survey in Qatar.","A small country in the Arabian Peninsula, Qatar experienced rapid economic growth in the last 3 decades accompanied by major socio-demographic shifts towards a younger and more highly educated population. To date, no national epidemiological study has examined the prevalence, associated factors, or sequelae of mental disorders in Qatar's general population. The World Mental Health Qatar (WMHQ) is a national mental health needs assessment survey and is the first carried out in collaboration with ","2021","07","05","Int J Methods Psychiatr Res","International journal of methods in psychiatric research","Arab; Qatar; WHO CIDI-5; mental health survey; psychiatric Epidemiology","Khaled","Salma M","Social and Economic Survey Research Institute, Qatar University, Doha, Qatar",NA
"2176","34224172","10.1002/mpr.1885","Conducting a state-of-the-art mental health survey in a traditional setting: Challenges and lessons from piloting the World Mental Health Survey in Qatar.","A small country in the Arabian Peninsula, Qatar experienced rapid economic growth in the last 3 decades accompanied by major socio-demographic shifts towards a younger and more highly educated population. To date, no national epidemiological study has examined the prevalence, associated factors, or sequelae of mental disorders in Qatar's general population. The World Mental Health Qatar (WMHQ) is a national mental health needs assessment survey and is the first carried out in collaboration with ","2021","07","05","Int J Methods Psychiatr Res","International journal of methods in psychiatric research","Arab; Qatar; WHO CIDI-5; mental health survey; psychiatric Epidemiology","Petcu","Catalina","Social and Economic Survey Research Institute, Qatar University, Doha, Qatar",NA
"2177","34224172","10.1002/mpr.1885","Conducting a state-of-the-art mental health survey in a traditional setting: Challenges and lessons from piloting the World Mental Health Survey in Qatar.","A small country in the Arabian Peninsula, Qatar experienced rapid economic growth in the last 3 decades accompanied by major socio-demographic shifts towards a younger and more highly educated population. To date, no national epidemiological study has examined the prevalence, associated factors, or sequelae of mental disorders in Qatar's general population. The World Mental Health Qatar (WMHQ) is a national mental health needs assessment survey and is the first carried out in collaboration with ","2021","07","05","Int J Methods Psychiatr Res","International journal of methods in psychiatric research","Arab; Qatar; WHO CIDI-5; mental health survey; psychiatric Epidemiology","Bader","Lina","Social and Economic Survey Research Institute, Qatar University, Doha, Qatar",NA
"2178","34224172","10.1002/mpr.1885","Conducting a state-of-the-art mental health survey in a traditional setting: Challenges and lessons from piloting the World Mental Health Survey in Qatar.","A small country in the Arabian Peninsula, Qatar experienced rapid economic growth in the last 3 decades accompanied by major socio-demographic shifts towards a younger and more highly educated population. To date, no national epidemiological study has examined the prevalence, associated factors, or sequelae of mental disorders in Qatar's general population. The World Mental Health Qatar (WMHQ) is a national mental health needs assessment survey and is the first carried out in collaboration with ","2021","07","05","Int J Methods Psychiatr Res","International journal of methods in psychiatric research","Arab; Qatar; WHO CIDI-5; mental health survey; psychiatric Epidemiology","Amro","Iman","Social and Economic Survey Research Institute, Qatar University, Doha, Qatar",NA
"2179","34224172","10.1002/mpr.1885","Conducting a state-of-the-art mental health survey in a traditional setting: Challenges and lessons from piloting the World Mental Health Survey in Qatar.","A small country in the Arabian Peninsula, Qatar experienced rapid economic growth in the last 3 decades accompanied by major socio-demographic shifts towards a younger and more highly educated population. To date, no national epidemiological study has examined the prevalence, associated factors, or sequelae of mental disorders in Qatar's general population. The World Mental Health Qatar (WMHQ) is a national mental health needs assessment survey and is the first carried out in collaboration with ","2021","07","05","Int J Methods Psychiatr Res","International journal of methods in psychiatric research","Arab; Qatar; WHO CIDI-5; mental health survey; psychiatric Epidemiology","Al-Assi","Marwa","Social and Economic Survey Research Institute, Qatar University, Doha, Qatar",NA
"2180","34224172","10.1002/mpr.1885","Conducting a state-of-the-art mental health survey in a traditional setting: Challenges and lessons from piloting the World Mental Health Survey in Qatar.","A small country in the Arabian Peninsula, Qatar experienced rapid economic growth in the last 3 decades accompanied by major socio-demographic shifts towards a younger and more highly educated population. To date, no national epidemiological study has examined the prevalence, associated factors, or sequelae of mental disorders in Qatar's general population. The World Mental Health Qatar (WMHQ) is a national mental health needs assessment survey and is the first carried out in collaboration with ","2021","07","05","Int J Methods Psychiatr Res","International journal of methods in psychiatric research","Arab; Qatar; WHO CIDI-5; mental health survey; psychiatric Epidemiology","Le Trung","Kien","Social and Economic Survey Research Institute, Qatar University, Doha, Qatar",NA
"2181","34224172","10.1002/mpr.1885","Conducting a state-of-the-art mental health survey in a traditional setting: Challenges and lessons from piloting the World Mental Health Survey in Qatar.","A small country in the Arabian Peninsula, Qatar experienced rapid economic growth in the last 3 decades accompanied by major socio-demographic shifts towards a younger and more highly educated population. To date, no national epidemiological study has examined the prevalence, associated factors, or sequelae of mental disorders in Qatar's general population. The World Mental Health Qatar (WMHQ) is a national mental health needs assessment survey and is the first carried out in collaboration with ","2021","07","05","Int J Methods Psychiatr Res","International journal of methods in psychiatric research","Arab; Qatar; WHO CIDI-5; mental health survey; psychiatric Epidemiology","Mneimneh","Zeina N","Survey Research Center, Institute for Social Research, University of Michigan, Ann Arbor, Michigan, USA",NA
"2182","34224172","10.1002/mpr.1885","Conducting a state-of-the-art mental health survey in a traditional setting: Challenges and lessons from piloting the World Mental Health Survey in Qatar.","A small country in the Arabian Peninsula, Qatar experienced rapid economic growth in the last 3 decades accompanied by major socio-demographic shifts towards a younger and more highly educated population. To date, no national epidemiological study has examined the prevalence, associated factors, or sequelae of mental disorders in Qatar's general population. The World Mental Health Qatar (WMHQ) is a national mental health needs assessment survey and is the first carried out in collaboration with ","2021","07","05","Int J Methods Psychiatr Res","International journal of methods in psychiatric research","Arab; Qatar; WHO CIDI-5; mental health survey; psychiatric Epidemiology","Sampson","Nancy A","Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts, USA",NA
"2183","34224172","10.1002/mpr.1885","Conducting a state-of-the-art mental health survey in a traditional setting: Challenges and lessons from piloting the World Mental Health Survey in Qatar.","A small country in the Arabian Peninsula, Qatar experienced rapid economic growth in the last 3 decades accompanied by major socio-demographic shifts towards a younger and more highly educated population. To date, no national epidemiological study has examined the prevalence, associated factors, or sequelae of mental disorders in Qatar's general population. The World Mental Health Qatar (WMHQ) is a national mental health needs assessment survey and is the first carried out in collaboration with ","2021","07","05","Int J Methods Psychiatr Res","International journal of methods in psychiatric research","Arab; Qatar; WHO CIDI-5; mental health survey; psychiatric Epidemiology","Kessler","Ronald C","Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts, USA",NA
"2184","34224172","10.1002/mpr.1885","Conducting a state-of-the-art mental health survey in a traditional setting: Challenges and lessons from piloting the World Mental Health Survey in Qatar.","A small country in the Arabian Peninsula, Qatar experienced rapid economic growth in the last 3 decades accompanied by major socio-demographic shifts towards a younger and more highly educated population. To date, no national epidemiological study has examined the prevalence, associated factors, or sequelae of mental disorders in Qatar's general population. The World Mental Health Qatar (WMHQ) is a national mental health needs assessment survey and is the first carried out in collaboration with ","2021","07","05","Int J Methods Psychiatr Res","International journal of methods in psychiatric research","Arab; Qatar; WHO CIDI-5; mental health survey; psychiatric Epidemiology","Woodruff","Peter W","Department of Neuroscience, Faculty of Medicine Dentistry and Health, The University of Sheffield, Sheffield, UK",NA
"2185","34224155","10.1002/jmv.27173","What does COVID-19 testing results really say? The real statistics concealed behind the accessible data.","Accurate and comprehensive testing is crucial for practitioners to portray the pandemic. Without testing there is no data; yet, the exact number of infected people cannot be determined due to the lack of comprehensive testing. The number of seropositive for SARS-CoV-2 infection is obviously relative to the extent of testing. However, the true number of infections might be still far higher than the reported values. To compare the countries based on the number of seropositive for SARS-CoV-2 infect","2021","07","21","J Med Virol","Journal of medical virology","CFR; COVID-19; age-demographic; estimation; pandemic; spread","Rashki","Asma","Department of Pharmacology, School of Medicine, Zahedan University of Medicine, Zahedan, Sistan and Balouchetsan Province, Iran",NA
"2186","34224155","10.1002/jmv.27173","What does COVID-19 testing results really say? The real statistics concealed behind the accessible data.","Accurate and comprehensive testing is crucial for practitioners to portray the pandemic. Without testing there is no data; yet, the exact number of infected people cannot be determined due to the lack of comprehensive testing. The number of seropositive for SARS-CoV-2 infection is obviously relative to the extent of testing. However, the true number of infections might be still far higher than the reported values. To compare the countries based on the number of seropositive for SARS-CoV-2 infect","2021","07","21","J Med Virol","Journal of medical virology","CFR; COVID-19; age-demographic; estimation; pandemic; spread","Hoseinpour Dehkordi","Amirhoshang","School of Computer Science, Institute for Research in Fundamental Sciences, Tehran, Iran",NA
"2187","34224155","10.1002/jmv.27173","What does COVID-19 testing results really say? The real statistics concealed behind the accessible data.","Accurate and comprehensive testing is crucial for practitioners to portray the pandemic. Without testing there is no data; yet, the exact number of infected people cannot be determined due to the lack of comprehensive testing. The number of seropositive for SARS-CoV-2 infection is obviously relative to the extent of testing. However, the true number of infections might be still far higher than the reported values. To compare the countries based on the number of seropositive for SARS-CoV-2 infect","2021","07","21","J Med Virol","Journal of medical virology","CFR; COVID-19; age-demographic; estimation; pandemic; spread","Nemati","Reza","Biotherapeutic and Medicinal Sciences, Biogen Inc., Cambridge, Massachusetts, USA",NA
"2188","34224155","10.1002/jmv.27173","What does COVID-19 testing results really say? The real statistics concealed behind the accessible data.","Accurate and comprehensive testing is crucial for practitioners to portray the pandemic. Without testing there is no data; yet, the exact number of infected people cannot be determined due to the lack of comprehensive testing. The number of seropositive for SARS-CoV-2 infection is obviously relative to the extent of testing. However, the true number of infections might be still far higher than the reported values. To compare the countries based on the number of seropositive for SARS-CoV-2 infect","2021","07","21","J Med Virol","Journal of medical virology","CFR; COVID-19; age-demographic; estimation; pandemic; spread","Tavousi","Pouya","UConn Tech Park, University of Connecticut, Storrs, Connecticut, USA",NA
"2189","34224113","10.1007/s40290-021-00392-x","Preparing for the Next Normal: Transformation in the Role of Medical Affairs Following the COVID-19 Pandemic.","The medical affairs function represents one of the scientific interfaces in a pharmaceutical organization. Over the last two decades, medical affairs has evolved from being a support function to a strategic pillar within organizational business units. The COVID-19 pandemic has given rise to unforeseen circumstances resulting in a dramatic change in external stakeholder engagements, catapulting the medical affairs function into leading the way on scientific engagements and patient-centric endeavo","2021","07","08","Pharmaceut Med","Pharmaceutical medicine",NA,"Ghosh","Romik","Medical Affairs, Sanofi India Limited, Mumbai, India",NA
"2190","34224113","10.1007/s40290-021-00392-x","Preparing for the Next Normal: Transformation in the Role of Medical Affairs Following the COVID-19 Pandemic.","The medical affairs function represents one of the scientific interfaces in a pharmaceutical organization. Over the last two decades, medical affairs has evolved from being a support function to a strategic pillar within organizational business units. The COVID-19 pandemic has given rise to unforeseen circumstances resulting in a dramatic change in external stakeholder engagements, catapulting the medical affairs function into leading the way on scientific engagements and patient-centric endeavo","2021","07","08","Pharmaceut Med","Pharmaceutical medicine",NA,"Mohanasundaram","Senthilnathan","Medical Affairs, Sanofi India Limited, Mumbai, India. Senthilnathan.Mohanasundaram@sanofi","Senthilnathan.Mohanasundaram@sanofi.com"
"2191","34224113","10.1007/s40290-021-00392-x","Preparing for the Next Normal: Transformation in the Role of Medical Affairs Following the COVID-19 Pandemic.","The medical affairs function represents one of the scientific interfaces in a pharmaceutical organization. Over the last two decades, medical affairs has evolved from being a support function to a strategic pillar within organizational business units. The COVID-19 pandemic has given rise to unforeseen circumstances resulting in a dramatic change in external stakeholder engagements, catapulting the medical affairs function into leading the way on scientific engagements and patient-centric endeavo","2021","07","08","Pharmaceut Med","Pharmaceutical medicine",NA,"Shetty","Sujatha","Medical Affairs, Sanofi India Limited, Mumbai, India",NA
"2192","34224113","10.1007/s40290-021-00392-x","Preparing for the Next Normal: Transformation in the Role of Medical Affairs Following the COVID-19 Pandemic.","The medical affairs function represents one of the scientific interfaces in a pharmaceutical organization. Over the last two decades, medical affairs has evolved from being a support function to a strategic pillar within organizational business units. The COVID-19 pandemic has given rise to unforeseen circumstances resulting in a dramatic change in external stakeholder engagements, catapulting the medical affairs function into leading the way on scientific engagements and patient-centric endeavo","2021","07","08","Pharmaceut Med","Pharmaceutical medicine",NA,"Menon","Shalini","Medical Affairs, Sanofi India Limited, Mumbai, India",NA
"2193","34224110","10.1007/s12250-021-00409-4","Antibody Cocktail Exhibits Broad Neutralization Activity Against SARS-CoV-2 and SARS-CoV-2 Variants.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has precipitated multiple variants resistant to therapeutic antibodies. In this study, 12 high-affinity antibodies were generated from convalescent donors in early outbreaks using immune antibody phage display libraries. Of them, two RBD-binding antibodies (F61 and H121) showed high-affinity neutralization against SARS-CoV-2, whereas three S2-target antibodies failed to neutralize SARS-CoV-2. Following structure analysis, F61 identifie","2021","07","08","Virol Sin","Virologica Sinica","Angiotensin-converting enzyme 2 (ACE2); Antibody cocktail; Broad neutralization; SARS-CoV-2 variants; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)","Qu","Yuanyuan","State Key Laboratory for Molecular Virology and Genetic Engineering, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, 102206, China",NA
"2194","34224110","10.1007/s12250-021-00409-4","Antibody Cocktail Exhibits Broad Neutralization Activity Against SARS-CoV-2 and SARS-CoV-2 Variants.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has precipitated multiple variants resistant to therapeutic antibodies. In this study, 12 high-affinity antibodies were generated from convalescent donors in early outbreaks using immune antibody phage display libraries. Of them, two RBD-binding antibodies (F61 and H121) showed high-affinity neutralization against SARS-CoV-2, whereas three S2-target antibodies failed to neutralize SARS-CoV-2. Following structure analysis, F61 identifie","2021","07","08","Virol Sin","Virologica Sinica","Angiotensin-converting enzyme 2 (ACE2); Antibody cocktail; Broad neutralization; SARS-CoV-2 variants; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)","Zhang","Xueyan","Center for Emerging Infectious Diseases, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, 430071, Hubei, China",NA
"2195","34224110","10.1007/s12250-021-00409-4","Antibody Cocktail Exhibits Broad Neutralization Activity Against SARS-CoV-2 and SARS-CoV-2 Variants.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has precipitated multiple variants resistant to therapeutic antibodies. In this study, 12 high-affinity antibodies were generated from convalescent donors in early outbreaks using immune antibody phage display libraries. Of them, two RBD-binding antibodies (F61 and H121) showed high-affinity neutralization against SARS-CoV-2, whereas three S2-target antibodies failed to neutralize SARS-CoV-2. Following structure analysis, F61 identifie","2021","07","08","Virol Sin","Virologica Sinica","Angiotensin-converting enzyme 2 (ACE2); Antibody cocktail; Broad neutralization; SARS-CoV-2 variants; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)","Wang","Meiyu","Division of HIV/AIDS and Sex-Transmitted Virus Vaccines, Institute for Biological Product Control, National Institutes for Food and Drug Control (NIFDC), Beijing, 102629, China",NA
"2196","34224110","10.1007/s12250-021-00409-4","Antibody Cocktail Exhibits Broad Neutralization Activity Against SARS-CoV-2 and SARS-CoV-2 Variants.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has precipitated multiple variants resistant to therapeutic antibodies. In this study, 12 high-affinity antibodies were generated from convalescent donors in early outbreaks using immune antibody phage display libraries. Of them, two RBD-binding antibodies (F61 and H121) showed high-affinity neutralization against SARS-CoV-2, whereas three S2-target antibodies failed to neutralize SARS-CoV-2. Following structure analysis, F61 identifie","2021","07","08","Virol Sin","Virologica Sinica","Angiotensin-converting enzyme 2 (ACE2); Antibody cocktail; Broad neutralization; SARS-CoV-2 variants; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)","Sun","Lina","State Key Laboratory for Molecular Virology and Genetic Engineering, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, 102206, China",NA
"2197","34224110","10.1007/s12250-021-00409-4","Antibody Cocktail Exhibits Broad Neutralization Activity Against SARS-CoV-2 and SARS-CoV-2 Variants.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has precipitated multiple variants resistant to therapeutic antibodies. In this study, 12 high-affinity antibodies were generated from convalescent donors in early outbreaks using immune antibody phage display libraries. Of them, two RBD-binding antibodies (F61 and H121) showed high-affinity neutralization against SARS-CoV-2, whereas three S2-target antibodies failed to neutralize SARS-CoV-2. Following structure analysis, F61 identifie","2021","07","08","Virol Sin","Virologica Sinica","Angiotensin-converting enzyme 2 (ACE2); Antibody cocktail; Broad neutralization; SARS-CoV-2 variants; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)","Jiang","Yongzhong","Hubei Provincial Center for Disease Control and Prevention, Wuhan, 430065, China",NA
"2198","34224110","10.1007/s12250-021-00409-4","Antibody Cocktail Exhibits Broad Neutralization Activity Against SARS-CoV-2 and SARS-CoV-2 Variants.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has precipitated multiple variants resistant to therapeutic antibodies. In this study, 12 high-affinity antibodies were generated from convalescent donors in early outbreaks using immune antibody phage display libraries. Of them, two RBD-binding antibodies (F61 and H121) showed high-affinity neutralization against SARS-CoV-2, whereas three S2-target antibodies failed to neutralize SARS-CoV-2. Following structure analysis, F61 identifie","2021","07","08","Virol Sin","Virologica Sinica","Angiotensin-converting enzyme 2 (ACE2); Antibody cocktail; Broad neutralization; SARS-CoV-2 variants; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)","Li","Cheng","Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), School of Basic Medical Sciences, Fudan University, Shanghai, 200032, China",NA
"2199","34224110","10.1007/s12250-021-00409-4","Antibody Cocktail Exhibits Broad Neutralization Activity Against SARS-CoV-2 and SARS-CoV-2 Variants.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has precipitated multiple variants resistant to therapeutic antibodies. In this study, 12 high-affinity antibodies were generated from convalescent donors in early outbreaks using immune antibody phage display libraries. Of them, two RBD-binding antibodies (F61 and H121) showed high-affinity neutralization against SARS-CoV-2, whereas three S2-target antibodies failed to neutralize SARS-CoV-2. Following structure analysis, F61 identifie","2021","07","08","Virol Sin","Virologica Sinica","Angiotensin-converting enzyme 2 (ACE2); Antibody cocktail; Broad neutralization; SARS-CoV-2 variants; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)","Wu","Wei","State Key Laboratory for Molecular Virology and Genetic Engineering, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, 102206, China",NA
"2200","34224110","10.1007/s12250-021-00409-4","Antibody Cocktail Exhibits Broad Neutralization Activity Against SARS-CoV-2 and SARS-CoV-2 Variants.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has precipitated multiple variants resistant to therapeutic antibodies. In this study, 12 high-affinity antibodies were generated from convalescent donors in early outbreaks using immune antibody phage display libraries. Of them, two RBD-binding antibodies (F61 and H121) showed high-affinity neutralization against SARS-CoV-2, whereas three S2-target antibodies failed to neutralize SARS-CoV-2. Following structure analysis, F61 identifie","2021","07","08","Virol Sin","Virologica Sinica","Angiotensin-converting enzyme 2 (ACE2); Antibody cocktail; Broad neutralization; SARS-CoV-2 variants; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)","Chen","Zhen","Center for Emerging Infectious Diseases, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, 430071, Hubei, China",NA
"2201","34224110","10.1007/s12250-021-00409-4","Antibody Cocktail Exhibits Broad Neutralization Activity Against SARS-CoV-2 and SARS-CoV-2 Variants.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has precipitated multiple variants resistant to therapeutic antibodies. In this study, 12 high-affinity antibodies were generated from convalescent donors in early outbreaks using immune antibody phage display libraries. Of them, two RBD-binding antibodies (F61 and H121) showed high-affinity neutralization against SARS-CoV-2, whereas three S2-target antibodies failed to neutralize SARS-CoV-2. Following structure analysis, F61 identifie","2021","07","08","Virol Sin","Virologica Sinica","Angiotensin-converting enzyme 2 (ACE2); Antibody cocktail; Broad neutralization; SARS-CoV-2 variants; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)","Yin","Qiangling","State Key Laboratory for Molecular Virology and Genetic Engineering, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, 102206, China",NA
"2202","34224110","10.1007/s12250-021-00409-4","Antibody Cocktail Exhibits Broad Neutralization Activity Against SARS-CoV-2 and SARS-CoV-2 Variants.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has precipitated multiple variants resistant to therapeutic antibodies. In this study, 12 high-affinity antibodies were generated from convalescent donors in early outbreaks using immune antibody phage display libraries. Of them, two RBD-binding antibodies (F61 and H121) showed high-affinity neutralization against SARS-CoV-2, whereas three S2-target antibodies failed to neutralize SARS-CoV-2. Following structure analysis, F61 identifie","2021","07","08","Virol Sin","Virologica Sinica","Angiotensin-converting enzyme 2 (ACE2); Antibody cocktail; Broad neutralization; SARS-CoV-2 variants; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)","Jiang","Xiaolin","Shandong Center for Disease Control and Prevention, Jinan, 250014, China",NA
"2203","34224110","10.1007/s12250-021-00409-4","Antibody Cocktail Exhibits Broad Neutralization Activity Against SARS-CoV-2 and SARS-CoV-2 Variants.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has precipitated multiple variants resistant to therapeutic antibodies. In this study, 12 high-affinity antibodies were generated from convalescent donors in early outbreaks using immune antibody phage display libraries. Of them, two RBD-binding antibodies (F61 and H121) showed high-affinity neutralization against SARS-CoV-2, whereas three S2-target antibodies failed to neutralize SARS-CoV-2. Following structure analysis, F61 identifie","2021","07","08","Virol Sin","Virologica Sinica","Angiotensin-converting enzyme 2 (ACE2); Antibody cocktail; Broad neutralization; SARS-CoV-2 variants; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)","Liu","Yang","State Key Laboratory for Molecular Virology and Genetic Engineering, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, 102206, China",NA
"2204","34224110","10.1007/s12250-021-00409-4","Antibody Cocktail Exhibits Broad Neutralization Activity Against SARS-CoV-2 and SARS-CoV-2 Variants.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has precipitated multiple variants resistant to therapeutic antibodies. In this study, 12 high-affinity antibodies were generated from convalescent donors in early outbreaks using immune antibody phage display libraries. Of them, two RBD-binding antibodies (F61 and H121) showed high-affinity neutralization against SARS-CoV-2, whereas three S2-target antibodies failed to neutralize SARS-CoV-2. Following structure analysis, F61 identifie","2021","07","08","Virol Sin","Virologica Sinica","Angiotensin-converting enzyme 2 (ACE2); Antibody cocktail; Broad neutralization; SARS-CoV-2 variants; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)","Li","Chuan","State Key Laboratory for Molecular Virology and Genetic Engineering, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, 102206, China",NA
"2205","34224110","10.1007/s12250-021-00409-4","Antibody Cocktail Exhibits Broad Neutralization Activity Against SARS-CoV-2 and SARS-CoV-2 Variants.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has precipitated multiple variants resistant to therapeutic antibodies. In this study, 12 high-affinity antibodies were generated from convalescent donors in early outbreaks using immune antibody phage display libraries. Of them, two RBD-binding antibodies (F61 and H121) showed high-affinity neutralization against SARS-CoV-2, whereas three S2-target antibodies failed to neutralize SARS-CoV-2. Following structure analysis, F61 identifie","2021","07","08","Virol Sin","Virologica Sinica","Angiotensin-converting enzyme 2 (ACE2); Antibody cocktail; Broad neutralization; SARS-CoV-2 variants; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)","Li","Jiandong","State Key Laboratory for Molecular Virology and Genetic Engineering, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, 102206, China",NA
"2206","34224110","10.1007/s12250-021-00409-4","Antibody Cocktail Exhibits Broad Neutralization Activity Against SARS-CoV-2 and SARS-CoV-2 Variants.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has precipitated multiple variants resistant to therapeutic antibodies. In this study, 12 high-affinity antibodies were generated from convalescent donors in early outbreaks using immune antibody phage display libraries. Of them, two RBD-binding antibodies (F61 and H121) showed high-affinity neutralization against SARS-CoV-2, whereas three S2-target antibodies failed to neutralize SARS-CoV-2. Following structure analysis, F61 identifie","2021","07","08","Virol Sin","Virologica Sinica","Angiotensin-converting enzyme 2 (ACE2); Antibody cocktail; Broad neutralization; SARS-CoV-2 variants; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)","Ying","Tianlei","Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), School of Basic Medical Sciences, Fudan University, Shanghai, 200032, China",NA
"2207","34224110","10.1007/s12250-021-00409-4","Antibody Cocktail Exhibits Broad Neutralization Activity Against SARS-CoV-2 and SARS-CoV-2 Variants.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has precipitated multiple variants resistant to therapeutic antibodies. In this study, 12 high-affinity antibodies were generated from convalescent donors in early outbreaks using immune antibody phage display libraries. Of them, two RBD-binding antibodies (F61 and H121) showed high-affinity neutralization against SARS-CoV-2, whereas three S2-target antibodies failed to neutralize SARS-CoV-2. Following structure analysis, F61 identifie","2021","07","08","Virol Sin","Virologica Sinica","Angiotensin-converting enzyme 2 (ACE2); Antibody cocktail; Broad neutralization; SARS-CoV-2 variants; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)","Li","Dexin","State Key Laboratory for Molecular Virology and Genetic Engineering, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, 102206, China",NA
"2208","34224110","10.1007/s12250-021-00409-4","Antibody Cocktail Exhibits Broad Neutralization Activity Against SARS-CoV-2 and SARS-CoV-2 Variants.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has precipitated multiple variants resistant to therapeutic antibodies. In this study, 12 high-affinity antibodies were generated from convalescent donors in early outbreaks using immune antibody phage display libraries. Of them, two RBD-binding antibodies (F61 and H121) showed high-affinity neutralization against SARS-CoV-2, whereas three S2-target antibodies failed to neutralize SARS-CoV-2. Following structure analysis, F61 identifie","2021","07","08","Virol Sin","Virologica Sinica","Angiotensin-converting enzyme 2 (ACE2); Antibody cocktail; Broad neutralization; SARS-CoV-2 variants; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)","Zhan","Faxian","Hubei Provincial Center for Disease Control and Prevention, Wuhan, 430065, China",NA
"2209","34224110","10.1007/s12250-021-00409-4","Antibody Cocktail Exhibits Broad Neutralization Activity Against SARS-CoV-2 and SARS-CoV-2 Variants.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has precipitated multiple variants resistant to therapeutic antibodies. In this study, 12 high-affinity antibodies were generated from convalescent donors in early outbreaks using immune antibody phage display libraries. Of them, two RBD-binding antibodies (F61 and H121) showed high-affinity neutralization against SARS-CoV-2, whereas three S2-target antibodies failed to neutralize SARS-CoV-2. Following structure analysis, F61 identifie","2021","07","08","Virol Sin","Virologica Sinica","Angiotensin-converting enzyme 2 (ACE2); Antibody cocktail; Broad neutralization; SARS-CoV-2 variants; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)","Wang","Youchun","Division of HIV/AIDS and Sex-Transmitted Virus Vaccines, Institute for Biological Product Control, National Institutes for Food and Drug Control (NIFDC), Beijing, 102629, China",NA
"2210","34224110","10.1007/s12250-021-00409-4","Antibody Cocktail Exhibits Broad Neutralization Activity Against SARS-CoV-2 and SARS-CoV-2 Variants.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has precipitated multiple variants resistant to therapeutic antibodies. In this study, 12 high-affinity antibodies were generated from convalescent donors in early outbreaks using immune antibody phage display libraries. Of them, two RBD-binding antibodies (F61 and H121) showed high-affinity neutralization against SARS-CoV-2, whereas three S2-target antibodies failed to neutralize SARS-CoV-2. Following structure analysis, F61 identifie","2021","07","08","Virol Sin","Virologica Sinica","Angiotensin-converting enzyme 2 (ACE2); Antibody cocktail; Broad neutralization; SARS-CoV-2 variants; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)","Guan","Wuxiang","Center for Emerging Infectious Diseases, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, 430071, Hubei, China. guanwx@wh.iov","guanwx@wh.iov.cn"
"2211","34224110","10.1007/s12250-021-00409-4","Antibody Cocktail Exhibits Broad Neutralization Activity Against SARS-CoV-2 and SARS-CoV-2 Variants.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has precipitated multiple variants resistant to therapeutic antibodies. In this study, 12 high-affinity antibodies were generated from convalescent donors in early outbreaks using immune antibody phage display libraries. Of them, two RBD-binding antibodies (F61 and H121) showed high-affinity neutralization against SARS-CoV-2, whereas three S2-target antibodies failed to neutralize SARS-CoV-2. Following structure analysis, F61 identifie","2021","07","08","Virol Sin","Virologica Sinica","Angiotensin-converting enzyme 2 (ACE2); Antibody cocktail; Broad neutralization; SARS-CoV-2 variants; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)","Wang","Shiwen","State Key Laboratory for Molecular Virology and Genetic Engineering, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, 102206, China. wangsw@ivdc.chinacdc","wangsw@ivdc.chinacdc.cn"
"2212","34224110","10.1007/s12250-021-00409-4","Antibody Cocktail Exhibits Broad Neutralization Activity Against SARS-CoV-2 and SARS-CoV-2 Variants.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has precipitated multiple variants resistant to therapeutic antibodies. In this study, 12 high-affinity antibodies were generated from convalescent donors in early outbreaks using immune antibody phage display libraries. Of them, two RBD-binding antibodies (F61 and H121) showed high-affinity neutralization against SARS-CoV-2, whereas three S2-target antibodies failed to neutralize SARS-CoV-2. Following structure analysis, F61 identifie","2021","07","08","Virol Sin","Virologica Sinica","Angiotensin-converting enzyme 2 (ACE2); Antibody cocktail; Broad neutralization; SARS-CoV-2 variants; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)","Liang","Mifang","State Key Laboratory for Molecular Virology and Genetic Engineering, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, 102206, China. liangmf@ivdc.chinacdc","liangmf@ivdc.chinacdc.cn"
"2213","34224085","10.1007/s12020-021-02807-w","Modulation of ACE-2 mRNA by inflammatory cytokines in human thyroid cells: a pilot study.","Angiotensin-converting-enzyme-2 (ACE-2) was demonstrated to be the receptor for cellular entry of SARS-CoV-2. ACE-2 mRNA was identified in several human tissues and recently also in thyroid cells in vitro. Aim of the present study was to investigate the effect of pro-inflammatory cytokines on the ACE-2 mRNA levels in human thyroid cells in primary cultures. Primary thyroid cell cultures were treated with IFN-<U+03B3> and TNF-a alone or in combination for 24 h. ACE-2 mRNA levels were measured by RT-PCR.","2021","07","08","Endocrine","Endocrine","ACE-2; COVID-19; SARS-COV-2; Thyrocytes; Thyroid","Coperchini","Francesca","Laboratory for Endocrine Disruptors, Unit of Internal Medicine and Endocrinology, Istituti Clinici Scientifici Maugeri IRCCS, 27100, Pavia, PV, Italy",NA
"2214","34224085","10.1007/s12020-021-02807-w","Modulation of ACE-2 mRNA by inflammatory cytokines in human thyroid cells: a pilot study.","Angiotensin-converting-enzyme-2 (ACE-2) was demonstrated to be the receptor for cellular entry of SARS-CoV-2. ACE-2 mRNA was identified in several human tissues and recently also in thyroid cells in vitro. Aim of the present study was to investigate the effect of pro-inflammatory cytokines on the ACE-2 mRNA levels in human thyroid cells in primary cultures. Primary thyroid cell cultures were treated with IFN-<U+03B3> and TNF-a alone or in combination for 24 h. ACE-2 mRNA levels were measured by RT-PCR.","2021","07","08","Endocrine","Endocrine","ACE-2; COVID-19; SARS-COV-2; Thyrocytes; Thyroid","Ricci","Gianluca","Laboratory for Endocrine Disruptors, Unit of Internal Medicine and Endocrinology, Istituti Clinici Scientifici Maugeri IRCCS, 27100, Pavia, PV, Italy",NA
"2215","34224085","10.1007/s12020-021-02807-w","Modulation of ACE-2 mRNA by inflammatory cytokines in human thyroid cells: a pilot study.","Angiotensin-converting-enzyme-2 (ACE-2) was demonstrated to be the receptor for cellular entry of SARS-CoV-2. ACE-2 mRNA was identified in several human tissues and recently also in thyroid cells in vitro. Aim of the present study was to investigate the effect of pro-inflammatory cytokines on the ACE-2 mRNA levels in human thyroid cells in primary cultures. Primary thyroid cell cultures were treated with IFN-<U+03B3> and TNF-a alone or in combination for 24 h. ACE-2 mRNA levels were measured by RT-PCR.","2021","07","08","Endocrine","Endocrine","ACE-2; COVID-19; SARS-COV-2; Thyrocytes; Thyroid","Croce","Laura","Laboratory for Endocrine Disruptors, Unit of Internal Medicine and Endocrinology, Istituti Clinici Scientifici Maugeri IRCCS, 27100, Pavia, PV, Italy",NA
"2216","34224085","10.1007/s12020-021-02807-w","Modulation of ACE-2 mRNA by inflammatory cytokines in human thyroid cells: a pilot study.","Angiotensin-converting-enzyme-2 (ACE-2) was demonstrated to be the receptor for cellular entry of SARS-CoV-2. ACE-2 mRNA was identified in several human tissues and recently also in thyroid cells in vitro. Aim of the present study was to investigate the effect of pro-inflammatory cytokines on the ACE-2 mRNA levels in human thyroid cells in primary cultures. Primary thyroid cell cultures were treated with IFN-<U+03B3> and TNF-a alone or in combination for 24 h. ACE-2 mRNA levels were measured by RT-PCR.","2021","07","08","Endocrine","Endocrine","ACE-2; COVID-19; SARS-COV-2; Thyrocytes; Thyroid","Denegri","Marco","Unit of Molecular Cardiology, Istituti Clinici Scientifici Maugeri IRCCS, 27100, Pavia, Italy",NA
"2217","34224085","10.1007/s12020-021-02807-w","Modulation of ACE-2 mRNA by inflammatory cytokines in human thyroid cells: a pilot study.","Angiotensin-converting-enzyme-2 (ACE-2) was demonstrated to be the receptor for cellular entry of SARS-CoV-2. ACE-2 mRNA was identified in several human tissues and recently also in thyroid cells in vitro. Aim of the present study was to investigate the effect of pro-inflammatory cytokines on the ACE-2 mRNA levels in human thyroid cells in primary cultures. Primary thyroid cell cultures were treated with IFN-<U+03B3> and TNF-a alone or in combination for 24 h. ACE-2 mRNA levels were measured by RT-PCR.","2021","07","08","Endocrine","Endocrine","ACE-2; COVID-19; SARS-COV-2; Thyrocytes; Thyroid","Ruggiero","Rubina","Department of General and Minimally Invasive Surgery, Istituti Clinici Scientifici Maugeri IRCCS, 27100, Pavia, PV, Italy",NA
"2218","34224085","10.1007/s12020-021-02807-w","Modulation of ACE-2 mRNA by inflammatory cytokines in human thyroid cells: a pilot study.","Angiotensin-converting-enzyme-2 (ACE-2) was demonstrated to be the receptor for cellular entry of SARS-CoV-2. ACE-2 mRNA was identified in several human tissues and recently also in thyroid cells in vitro. Aim of the present study was to investigate the effect of pro-inflammatory cytokines on the ACE-2 mRNA levels in human thyroid cells in primary cultures. Primary thyroid cell cultures were treated with IFN-<U+03B3> and TNF-a alone or in combination for 24 h. ACE-2 mRNA levels were measured by RT-PCR.","2021","07","08","Endocrine","Endocrine","ACE-2; COVID-19; SARS-COV-2; Thyrocytes; Thyroid","Villani","Laura","Unit of Pathology, Istituti Clinici Scientifici Maugeri IRCCS, 27100, Pavia, PV, Italy",NA
"2219","34224085","10.1007/s12020-021-02807-w","Modulation of ACE-2 mRNA by inflammatory cytokines in human thyroid cells: a pilot study.","Angiotensin-converting-enzyme-2 (ACE-2) was demonstrated to be the receptor for cellular entry of SARS-CoV-2. ACE-2 mRNA was identified in several human tissues and recently also in thyroid cells in vitro. Aim of the present study was to investigate the effect of pro-inflammatory cytokines on the ACE-2 mRNA levels in human thyroid cells in primary cultures. Primary thyroid cell cultures were treated with IFN-<U+03B3> and TNF-a alone or in combination for 24 h. ACE-2 mRNA levels were measured by RT-PCR.","2021","07","08","Endocrine","Endocrine","ACE-2; COVID-19; SARS-COV-2; Thyrocytes; Thyroid","Magri","Flavia","Laboratory for Endocrine Disruptors, Unit of Internal Medicine and Endocrinology, Istituti Clinici Scientifici Maugeri IRCCS, 27100, Pavia, PV, Italy",NA
"2220","34224085","10.1007/s12020-021-02807-w","Modulation of ACE-2 mRNA by inflammatory cytokines in human thyroid cells: a pilot study.","Angiotensin-converting-enzyme-2 (ACE-2) was demonstrated to be the receptor for cellular entry of SARS-CoV-2. ACE-2 mRNA was identified in several human tissues and recently also in thyroid cells in vitro. Aim of the present study was to investigate the effect of pro-inflammatory cytokines on the ACE-2 mRNA levels in human thyroid cells in primary cultures. Primary thyroid cell cultures were treated with IFN-<U+03B3> and TNF-a alone or in combination for 24 h. ACE-2 mRNA levels were measured by RT-PCR.","2021","07","08","Endocrine","Endocrine","ACE-2; COVID-19; SARS-COV-2; Thyrocytes; Thyroid","Chiovato","Luca","Laboratory for Endocrine Disruptors, Unit of Internal Medicine and Endocrinology, Istituti Clinici Scientifici Maugeri IRCCS, 27100, Pavia, PV, Italy. luca.chiovato@icsmaugeri","luca.chiovato@icsmaugeri.it"
"2221","34224085","10.1007/s12020-021-02807-w","Modulation of ACE-2 mRNA by inflammatory cytokines in human thyroid cells: a pilot study.","Angiotensin-converting-enzyme-2 (ACE-2) was demonstrated to be the receptor for cellular entry of SARS-CoV-2. ACE-2 mRNA was identified in several human tissues and recently also in thyroid cells in vitro. Aim of the present study was to investigate the effect of pro-inflammatory cytokines on the ACE-2 mRNA levels in human thyroid cells in primary cultures. Primary thyroid cell cultures were treated with IFN-<U+03B3> and TNF-a alone or in combination for 24 h. ACE-2 mRNA levels were measured by RT-PCR.","2021","07","08","Endocrine","Endocrine","ACE-2; COVID-19; SARS-COV-2; Thyrocytes; Thyroid","Rotondi","Mario","Laboratory for Endocrine Disruptors, Unit of Internal Medicine and Endocrinology, Istituti Clinici Scientifici Maugeri IRCCS, 27100, Pavia, PV, Italy",NA
"2222","34224078","10.1007/s15010-021-01653-2","SARS-CoV-2 seroepidemiological study in healthcare workers and discordant results using seven different diagnostic methods.","The aim of the study was to access the SARS-CoV-2 antibody seroprevalence in healthcare workers (HCWs) of a tertiary pediatric hospital after the first wave of the pandemic and to compare the results among seven commercially available antibody detection assays, including chemiluminescence (CMIA), electroluminescence (ECLIA), <U+0395>nzyme-Linked Immunosorbent Assay (ELISA), and rapid immunochromatography (RIC). SARS-CoV-2 antibody detection was performed in serum samples of 1216 HCWs, using a reference","2021","07","08","Infection","Infection","Antibody; COVID-19; Comparison; Immunity; SARS-CoV-2; Serology","Tatsi","Elizabeth-Barbara","First Department of Pediatrics, Infectious Diseases and Chemotherapy Research Laboratory, Medical School, National and Kapodistrian University of Athens, ""Aghia Sophia"" Children's Hospital, Thivon and Papadiamantopoulou, Athens, 11527, Greece. etatsi@med.uoa","etatsi@med.uoa.gr"
"2223","34224078","10.1007/s15010-021-01653-2","SARS-CoV-2 seroepidemiological study in healthcare workers and discordant results using seven different diagnostic methods.","The aim of the study was to access the SARS-CoV-2 antibody seroprevalence in healthcare workers (HCWs) of a tertiary pediatric hospital after the first wave of the pandemic and to compare the results among seven commercially available antibody detection assays, including chemiluminescence (CMIA), electroluminescence (ECLIA), <U+0395>nzyme-Linked Immunosorbent Assay (ELISA), and rapid immunochromatography (RIC). SARS-CoV-2 antibody detection was performed in serum samples of 1216 HCWs, using a reference","2021","07","08","Infection","Infection","Antibody; COVID-19; Comparison; Immunity; SARS-CoV-2; Serology","Dellis","Charilaos","First Department of Pediatrics, Infectious Diseases and Chemotherapy Research Laboratory, Medical School, National and Kapodistrian University of Athens, ""Aghia Sophia"" Children's Hospital, Thivon and Papadiamantopoulou, Athens, 11527, Greece",NA
"2224","34224078","10.1007/s15010-021-01653-2","SARS-CoV-2 seroepidemiological study in healthcare workers and discordant results using seven different diagnostic methods.","The aim of the study was to access the SARS-CoV-2 antibody seroprevalence in healthcare workers (HCWs) of a tertiary pediatric hospital after the first wave of the pandemic and to compare the results among seven commercially available antibody detection assays, including chemiluminescence (CMIA), electroluminescence (ECLIA), <U+0395>nzyme-Linked Immunosorbent Assay (ELISA), and rapid immunochromatography (RIC). SARS-CoV-2 antibody detection was performed in serum samples of 1216 HCWs, using a reference","2021","07","08","Infection","Infection","Antibody; COVID-19; Comparison; Immunity; SARS-CoV-2; Serology","Petridou","Evangelia","Department of Microbiology, ""Aghia Sophia"" Children's Hospital, Athens, 11527, Greece",NA
"2225","34224078","10.1007/s15010-021-01653-2","SARS-CoV-2 seroepidemiological study in healthcare workers and discordant results using seven different diagnostic methods.","The aim of the study was to access the SARS-CoV-2 antibody seroprevalence in healthcare workers (HCWs) of a tertiary pediatric hospital after the first wave of the pandemic and to compare the results among seven commercially available antibody detection assays, including chemiluminescence (CMIA), electroluminescence (ECLIA), <U+0395>nzyme-Linked Immunosorbent Assay (ELISA), and rapid immunochromatography (RIC). SARS-CoV-2 antibody detection was performed in serum samples of 1216 HCWs, using a reference","2021","07","08","Infection","Infection","Antibody; COVID-19; Comparison; Immunity; SARS-CoV-2; Serology","Banou","Kirkira","Department of Microbiology, ""Aghia Sophia"" Children's Hospital, Athens, 11527, Greece",NA
"2226","34224078","10.1007/s15010-021-01653-2","SARS-CoV-2 seroepidemiological study in healthcare workers and discordant results using seven different diagnostic methods.","The aim of the study was to access the SARS-CoV-2 antibody seroprevalence in healthcare workers (HCWs) of a tertiary pediatric hospital after the first wave of the pandemic and to compare the results among seven commercially available antibody detection assays, including chemiluminescence (CMIA), electroluminescence (ECLIA), <U+0395>nzyme-Linked Immunosorbent Assay (ELISA), and rapid immunochromatography (RIC). SARS-CoV-2 antibody detection was performed in serum samples of 1216 HCWs, using a reference","2021","07","08","Infection","Infection","Antibody; COVID-19; Comparison; Immunity; SARS-CoV-2; Serology","Zachariadou","Levantia","Department of Microbiology, ""Aghia Sophia"" Children's Hospital, Athens, 11527, Greece",NA
"2227","34224078","10.1007/s15010-021-01653-2","SARS-CoV-2 seroepidemiological study in healthcare workers and discordant results using seven different diagnostic methods.","The aim of the study was to access the SARS-CoV-2 antibody seroprevalence in healthcare workers (HCWs) of a tertiary pediatric hospital after the first wave of the pandemic and to compare the results among seven commercially available antibody detection assays, including chemiluminescence (CMIA), electroluminescence (ECLIA), <U+0395>nzyme-Linked Immunosorbent Assay (ELISA), and rapid immunochromatography (RIC). SARS-CoV-2 antibody detection was performed in serum samples of 1216 HCWs, using a reference","2021","07","08","Infection","Infection","Antibody; COVID-19; Comparison; Immunity; SARS-CoV-2; Serology","Syriopoulou","Vassiliki","First Department of Pediatrics, Infectious Diseases and Chemotherapy Research Laboratory, Medical School, National and Kapodistrian University of Athens, ""Aghia Sophia"" Children's Hospital, Thivon and Papadiamantopoulou, Athens, 11527, Greece",NA
"2228","34224078","10.1007/s15010-021-01653-2","SARS-CoV-2 seroepidemiological study in healthcare workers and discordant results using seven different diagnostic methods.","The aim of the study was to access the SARS-CoV-2 antibody seroprevalence in healthcare workers (HCWs) of a tertiary pediatric hospital after the first wave of the pandemic and to compare the results among seven commercially available antibody detection assays, including chemiluminescence (CMIA), electroluminescence (ECLIA), <U+0395>nzyme-Linked Immunosorbent Assay (ELISA), and rapid immunochromatography (RIC). SARS-CoV-2 antibody detection was performed in serum samples of 1216 HCWs, using a reference","2021","07","08","Infection","Infection","Antibody; COVID-19; Comparison; Immunity; SARS-CoV-2; Serology","Michos","Athanasios","First Department of Pediatrics, Infectious Diseases and Chemotherapy Research Laboratory, Medical School, National and Kapodistrian University of Athens, ""Aghia Sophia"" Children's Hospital, Thivon and Papadiamantopoulou, Athens, 11527, Greece",NA
"2229","34224069","10.1007/s10787-021-00841-8","Boswellic acids/Boswellia serrata extract as a potential COVID-19 therapeutic agent in the elderly.","The most severe cases of COVID-19, and the highest rates of death, are among the elderly. There is an urgent need to search for an agent to treat the disease and control its progression. Boswellia serrata is traditionally used to treat chronic inflammatory diseases of the lung. This review aims to highlight currently published research that has shown evidence of potential therapeutic effects of boswellic acids (BA) and B. serrata extract against COVID-19 and associated conditions. We reviewed th","2021","07","23","Inflammopharmacology","Inflammopharmacology","Antioxidant; Antiviral immunomodulator; Boswellic acids/Boswellia serrata; COVID-19; anti-inflammatory","Gomaa","Adel A","Department of Medical Pharmacology, Faculty of Medicine, Assiut University, Assiut, Egypt. a.gomma@aun.edu","a.gomma@aun.edu.eg"
"2230","34224069","10.1007/s10787-021-00841-8","Boswellic acids/Boswellia serrata extract as a potential COVID-19 therapeutic agent in the elderly.","The most severe cases of COVID-19, and the highest rates of death, are among the elderly. There is an urgent need to search for an agent to treat the disease and control its progression. Boswellia serrata is traditionally used to treat chronic inflammatory diseases of the lung. This review aims to highlight currently published research that has shown evidence of potential therapeutic effects of boswellic acids (BA) and B. serrata extract against COVID-19 and associated conditions. We reviewed th","2021","07","23","Inflammopharmacology","Inflammopharmacology","Antioxidant; Antiviral immunomodulator; Boswellic acids/Boswellia serrata; COVID-19; anti-inflammatory","Mohamed","Hamdy S","Department of Internal Medicine, Faculty of Medicine, Sohage University, Sohâg, Egypt",NA
"2231","34224069","10.1007/s10787-021-00841-8","Boswellic acids/Boswellia serrata extract as a potential COVID-19 therapeutic agent in the elderly.","The most severe cases of COVID-19, and the highest rates of death, are among the elderly. There is an urgent need to search for an agent to treat the disease and control its progression. Boswellia serrata is traditionally used to treat chronic inflammatory diseases of the lung. This review aims to highlight currently published research that has shown evidence of potential therapeutic effects of boswellic acids (BA) and B. serrata extract against COVID-19 and associated conditions. We reviewed th","2021","07","23","Inflammopharmacology","Inflammopharmacology","Antioxidant; Antiviral immunomodulator; Boswellic acids/Boswellia serrata; COVID-19; anti-inflammatory","Abd-Ellatief","Rasha Bakheet","Department of Medical Pharmacology, Faculty of Medicine, Assiut University, Assiut, Egypt",NA
"2232","34224069","10.1007/s10787-021-00841-8","Boswellic acids/Boswellia serrata extract as a potential COVID-19 therapeutic agent in the elderly.","The most severe cases of COVID-19, and the highest rates of death, are among the elderly. There is an urgent need to search for an agent to treat the disease and control its progression. Boswellia serrata is traditionally used to treat chronic inflammatory diseases of the lung. This review aims to highlight currently published research that has shown evidence of potential therapeutic effects of boswellic acids (BA) and B. serrata extract against COVID-19 and associated conditions. We reviewed th","2021","07","23","Inflammopharmacology","Inflammopharmacology","Antioxidant; Antiviral immunomodulator; Boswellic acids/Boswellia serrata; COVID-19; anti-inflammatory","Gomaa","Mohamed A","Department of Plastic Surgery, Faculty of Medicine, Assiut University, Assiut, Egypt",NA
"2233","34224062","10.1007/s11604-021-01169-7","Letter to the Editor: Quantitative evaluation of COVID-19 pneumonia severity by CT pneumonia analysis algorithm using deep learning technology and blood test results.",NA,"2021","07","08","Jpn J Radiol","Japanese journal of radiology",NA,"Mungmunpuntipantip","Rujittika","Private Consultant, Bangkok, Thailand. rujittika@gmail","rujittika@gmail.com"
"2234","34224062","10.1007/s11604-021-01169-7","Letter to the Editor: Quantitative evaluation of COVID-19 pneumonia severity by CT pneumonia analysis algorithm using deep learning technology and blood test results.",NA,"2021","07","08","Jpn J Radiol","Japanese journal of radiology",NA,"Wiwanitkit","Viroj","Dr DY Patil University, Pune, India",NA
"2235","34224053","10.1007/s12016-021-08866-1","Improving the Efficacy of Regulatory T Cell Therapy.","Autoimmunity is caused by an unbalanced immune system, giving rise to a variety of organ-specific to system disorders. Patients with autoimmune diseases are commonly treated with broad-acting immunomodulatory drugs, with the risk of severe side effects. Regulatory T cells (Tregs) have the inherent capacity to induce peripheral tolerance as well as tissue regeneration and are therefore a prime candidate to use as cell therapy in patients with autoimmune disorders. (Pre)clinical studies using Treg","2021","07","08","Clin Rev Allergy Immunol","Clinical reviews in allergy &amp; immunology","Autoimmunity; COVID-19; Cell therapy; Gene editing; RNA interference; Regulatory T cells","Baeten","Paulien","Neuro-Immune Connections and Repair Lab, Department of Immunology and Infection, Biomedical Research Institute, Hasselt University, Diepenbeek, Belgium",NA
"2236","34224053","10.1007/s12016-021-08866-1","Improving the Efficacy of Regulatory T Cell Therapy.","Autoimmunity is caused by an unbalanced immune system, giving rise to a variety of organ-specific to system disorders. Patients with autoimmune diseases are commonly treated with broad-acting immunomodulatory drugs, with the risk of severe side effects. Regulatory T cells (Tregs) have the inherent capacity to induce peripheral tolerance as well as tissue regeneration and are therefore a prime candidate to use as cell therapy in patients with autoimmune disorders. (Pre)clinical studies using Treg","2021","07","08","Clin Rev Allergy Immunol","Clinical reviews in allergy &amp; immunology","Autoimmunity; COVID-19; Cell therapy; Gene editing; RNA interference; Regulatory T cells","Van Zeebroeck","Lauren","University MS Center, Campus Diepenbeek, Diepenbeek, Belgium",NA
"2237","34224053","10.1007/s12016-021-08866-1","Improving the Efficacy of Regulatory T Cell Therapy.","Autoimmunity is caused by an unbalanced immune system, giving rise to a variety of organ-specific to system disorders. Patients with autoimmune diseases are commonly treated with broad-acting immunomodulatory drugs, with the risk of severe side effects. Regulatory T cells (Tregs) have the inherent capacity to induce peripheral tolerance as well as tissue regeneration and are therefore a prime candidate to use as cell therapy in patients with autoimmune disorders. (Pre)clinical studies using Treg","2021","07","08","Clin Rev Allergy Immunol","Clinical reviews in allergy &amp; immunology","Autoimmunity; COVID-19; Cell therapy; Gene editing; RNA interference; Regulatory T cells","Kleinewietfeld","Markus","University MS Center, Campus Diepenbeek, Diepenbeek, Belgium",NA
"2238","34224053","10.1007/s12016-021-08866-1","Improving the Efficacy of Regulatory T Cell Therapy.","Autoimmunity is caused by an unbalanced immune system, giving rise to a variety of organ-specific to system disorders. Patients with autoimmune diseases are commonly treated with broad-acting immunomodulatory drugs, with the risk of severe side effects. Regulatory T cells (Tregs) have the inherent capacity to induce peripheral tolerance as well as tissue regeneration and are therefore a prime candidate to use as cell therapy in patients with autoimmune disorders. (Pre)clinical studies using Treg","2021","07","08","Clin Rev Allergy Immunol","Clinical reviews in allergy &amp; immunology","Autoimmunity; COVID-19; Cell therapy; Gene editing; RNA interference; Regulatory T cells","Hellings","Niels","Neuro-Immune Connections and Repair Lab, Department of Immunology and Infection, Biomedical Research Institute, Hasselt University, Diepenbeek, Belgium",NA
"2239","34224053","10.1007/s12016-021-08866-1","Improving the Efficacy of Regulatory T Cell Therapy.","Autoimmunity is caused by an unbalanced immune system, giving rise to a variety of organ-specific to system disorders. Patients with autoimmune diseases are commonly treated with broad-acting immunomodulatory drugs, with the risk of severe side effects. Regulatory T cells (Tregs) have the inherent capacity to induce peripheral tolerance as well as tissue regeneration and are therefore a prime candidate to use as cell therapy in patients with autoimmune disorders. (Pre)clinical studies using Treg","2021","07","08","Clin Rev Allergy Immunol","Clinical reviews in allergy &amp; immunology","Autoimmunity; COVID-19; Cell therapy; Gene editing; RNA interference; Regulatory T cells","Broux","Bieke","Neuro-Immune Connections and Repair Lab, Department of Immunology and Infection, Biomedical Research Institute, Hasselt University, Diepenbeek, Belgium. bieke.broux@uhasselt","bieke.broux@uhasselt.be"
"2240","34224033","10.1007/s10096-021-04302-6","Feasibility and utility of facemask sampling in the detection of SARS-CoV-2 during an ongoing pandemic.","Easy access to screening for timely identification and isolation of infectious COVID-19 patients remains crucial in sustaining the international efforts to control COVID-19 spread. A major barrier limiting broad-based screening is the lack of a simple, rapid, and cost-effective COVID-19 testing method. We evaluated the feasibility and utility of facemask sampling in a cohort of 42 COVID-19-positive and 36 COVID-19-negative patients. We used a prototype of Steri-Strips (3 M) applied to the inner","2021","07","08","Eur J Clin Microbiol Infect Dis","European journal of clinical microbiology &amp; infectious diseases : official publication of the European Society of Clinical Microbiology","COVID-19; Epidemiology; Rapid diagnostics; SARS-CoV-2","Ng","Dorothy Hui Lin","Department of Infectious Diseases, Singapore General Hospital, Singapore, Singapore. huilin.ng@mohh.com","huilin.ng@mohh.com.sg"
"2241","34224033","10.1007/s10096-021-04302-6","Feasibility and utility of facemask sampling in the detection of SARS-CoV-2 during an ongoing pandemic.","Easy access to screening for timely identification and isolation of infectious COVID-19 patients remains crucial in sustaining the international efforts to control COVID-19 spread. A major barrier limiting broad-based screening is the lack of a simple, rapid, and cost-effective COVID-19 testing method. We evaluated the feasibility and utility of facemask sampling in a cohort of 42 COVID-19-positive and 36 COVID-19-negative patients. We used a prototype of Steri-Strips (3 M) applied to the inner","2021","07","08","Eur J Clin Microbiol Infect Dis","European journal of clinical microbiology &amp; infectious diseases : official publication of the European Society of Clinical Microbiology","COVID-19; Epidemiology; Rapid diagnostics; SARS-CoV-2","Sim","Mei Yi","Department of Urology, Singapore General Hospital, Singapore, Singapore",NA
"2242","34224033","10.1007/s10096-021-04302-6","Feasibility and utility of facemask sampling in the detection of SARS-CoV-2 during an ongoing pandemic.","Easy access to screening for timely identification and isolation of infectious COVID-19 patients remains crucial in sustaining the international efforts to control COVID-19 spread. A major barrier limiting broad-based screening is the lack of a simple, rapid, and cost-effective COVID-19 testing method. We evaluated the feasibility and utility of facemask sampling in a cohort of 42 COVID-19-positive and 36 COVID-19-negative patients. We used a prototype of Steri-Strips (3 M) applied to the inner","2021","07","08","Eur J Clin Microbiol Infect Dis","European journal of clinical microbiology &amp; infectious diseases : official publication of the European Society of Clinical Microbiology","COVID-19; Epidemiology; Rapid diagnostics; SARS-CoV-2","Huang","Hong Hong","Department of Urology, Singapore General Hospital, Singapore, Singapore",NA
"2243","34224033","10.1007/s10096-021-04302-6","Feasibility and utility of facemask sampling in the detection of SARS-CoV-2 during an ongoing pandemic.","Easy access to screening for timely identification and isolation of infectious COVID-19 patients remains crucial in sustaining the international efforts to control COVID-19 spread. A major barrier limiting broad-based screening is the lack of a simple, rapid, and cost-effective COVID-19 testing method. We evaluated the feasibility and utility of facemask sampling in a cohort of 42 COVID-19-positive and 36 COVID-19-negative patients. We used a prototype of Steri-Strips (3 M) applied to the inner","2021","07","08","Eur J Clin Microbiol Infect Dis","European journal of clinical microbiology &amp; infectious diseases : official publication of the European Society of Clinical Microbiology","COVID-19; Epidemiology; Rapid diagnostics; SARS-CoV-2","Sim","Jean Xiang Ying","Department of Infectious Diseases, Singapore General Hospital, Singapore, Singapore",NA
"2244","34224033","10.1007/s10096-021-04302-6","Feasibility and utility of facemask sampling in the detection of SARS-CoV-2 during an ongoing pandemic.","Easy access to screening for timely identification and isolation of infectious COVID-19 patients remains crucial in sustaining the international efforts to control COVID-19 spread. A major barrier limiting broad-based screening is the lack of a simple, rapid, and cost-effective COVID-19 testing method. We evaluated the feasibility and utility of facemask sampling in a cohort of 42 COVID-19-positive and 36 COVID-19-negative patients. We used a prototype of Steri-Strips (3 M) applied to the inner","2021","07","08","Eur J Clin Microbiol Infect Dis","European journal of clinical microbiology &amp; infectious diseases : official publication of the European Society of Clinical Microbiology","COVID-19; Epidemiology; Rapid diagnostics; SARS-CoV-2","Low","Jenny Guek Hong","Department of Infectious Diseases, Singapore General Hospital, Singapore, Singapore",NA
"2245","34224033","10.1007/s10096-021-04302-6","Feasibility and utility of facemask sampling in the detection of SARS-CoV-2 during an ongoing pandemic.","Easy access to screening for timely identification and isolation of infectious COVID-19 patients remains crucial in sustaining the international efforts to control COVID-19 spread. A major barrier limiting broad-based screening is the lack of a simple, rapid, and cost-effective COVID-19 testing method. We evaluated the feasibility and utility of facemask sampling in a cohort of 42 COVID-19-positive and 36 COVID-19-negative patients. We used a prototype of Steri-Strips (3 M) applied to the inner","2021","07","08","Eur J Clin Microbiol Infect Dis","European journal of clinical microbiology &amp; infectious diseases : official publication of the European Society of Clinical Microbiology","COVID-19; Epidemiology; Rapid diagnostics; SARS-CoV-2","Lim","Jay Kheng Sit","Department of Urology, Singapore General Hospital, Singapore, Singapore",NA
"2246","34224031","10.1186/s42506-021-00081-2","Vaccine hesitancy: the greatest threat to COVID-19 vaccination programs.",NA,"2021","07","08","J Egypt Public Health Assoc","The Journal of the Egyptian Public Health Association",NA,"Nossier","Samia A","Family Health Department, High Institute of Public Health, University of Alexandria, Alexandria, Egypt. samia_nossier@yahoo","nossier@yahoo.com"
"2247","34224024","10.1186/s12348-021-00251-5","Reactivation of Vogt-Koyanagi-Harada disease under control for more than 6 years, following anti-SARS-CoV-2 vaccination.","Vogt-Koyanagi-Harada (VKH) disease is a primary stromal choroiditis with bilateral granulomatous panuveitis. If initial-onset VKH is treated early and relentlessly the disease can be controlled and even ""cured"" in a substantial number of cases. We are reporting on a patient treated early and in a sustained fashion who was inflammation free for seven years but who presented a reactivation 6 weeks after the second dose of anti-SARS-CoV-2 vaccination. A 43-year-old woman presented with severe initi","2021","07","08","J Ophthalmic Inflamm Infect","Journal of ophthalmic inflammation and infection","Anti-SARS-CoV-2 vaccination; Autoimmune stromal choroiditis; Vogt-Koyanagi-Harada disease: Indocyanine green angiography","Papasavvas","Ioannis","Retinal and Inflammatory Eye Diseases, Centre for Ophthalmic Specialized Care (COS), Teaching Centre Clinic Montchoisi, Lausanne, Switzerland",NA
"2248","34224024","10.1186/s12348-021-00251-5","Reactivation of Vogt-Koyanagi-Harada disease under control for more than 6 years, following anti-SARS-CoV-2 vaccination.","Vogt-Koyanagi-Harada (VKH) disease is a primary stromal choroiditis with bilateral granulomatous panuveitis. If initial-onset VKH is treated early and relentlessly the disease can be controlled and even ""cured"" in a substantial number of cases. We are reporting on a patient treated early and in a sustained fashion who was inflammation free for seven years but who presented a reactivation 6 weeks after the second dose of anti-SARS-CoV-2 vaccination. A 43-year-old woman presented with severe initi","2021","07","08","J Ophthalmic Inflamm Infect","Journal of ophthalmic inflammation and infection","Anti-SARS-CoV-2 vaccination; Autoimmune stromal choroiditis; Vogt-Koyanagi-Harada disease: Indocyanine green angiography","Herbort","Carl P","Retinal and Inflammatory Eye Diseases, Centre for Ophthalmic Specialized Care (COS), Teaching Centre Clinic Montchoisi, Lausanne, Switzerland. cph@herbortuveitis","cph@herbortuveitis.ch"
"2249","34224022","10.1007/s00395-021-00882-8","Increased susceptibility of human endothelial cells to infections by SARS-CoV-2 variants.","Coronavirus disease 2019 (COVID-19) spawned a global health crisis in late 2019 and is caused by the novel coronavirus SARS-CoV-2. SARS-CoV-2 infection can lead to elevated markers of endothelial dysfunction associated with higher risk of mortality. It is unclear whether endothelial dysfunction is caused by direct infection of endothelial cells or is mainly secondary to inflammation. Here, we investigate whether different types of endothelial cells are susceptible to SARS-CoV-2. Human endothelia","2021","07","14","Basic Res Cardiol","Basic research in cardiology","ER stress; Endothelial cells; SARS-CoV-2; Virus trapping; Angiotensin-Converting Enzyme 2; Calnexin; Cells, Cultured; Endoplasmic Reticulum; Endoplasmic Reticulum Stress; Endothelial Cells; Host-Pathogen Interactions; Humans; Membrane Proteins; Receptors, Virus; SARS-CoV-2; Spike Glycoprotein, Coronavirus","Wagner","Julian U G","Institute for Cardiovascular Regeneration, Centre of Molecular Medicine, Goethe University Frankfurt, Theodor Stern Kai 7, 60590, Frankfurt, Germany",NA
"2250","34224022","10.1007/s00395-021-00882-8","Increased susceptibility of human endothelial cells to infections by SARS-CoV-2 variants.","Coronavirus disease 2019 (COVID-19) spawned a global health crisis in late 2019 and is caused by the novel coronavirus SARS-CoV-2. SARS-CoV-2 infection can lead to elevated markers of endothelial dysfunction associated with higher risk of mortality. It is unclear whether endothelial dysfunction is caused by direct infection of endothelial cells or is mainly secondary to inflammation. Here, we investigate whether different types of endothelial cells are susceptible to SARS-CoV-2. Human endothelia","2021","07","14","Basic Res Cardiol","Basic research in cardiology","ER stress; Endothelial cells; SARS-CoV-2; Virus trapping; Angiotensin-Converting Enzyme 2; Calnexin; Cells, Cultured; Endoplasmic Reticulum; Endoplasmic Reticulum Stress; Endothelial Cells; Host-Pathogen Interactions; Humans; Membrane Proteins; Receptors, Virus; SARS-CoV-2; Spike Glycoprotein, Coronavirus","Bojkova","Denisa","Institute of Medical Virology, University Frankfurt, Frankfurt, Germany",NA
"2251","34224022","10.1007/s00395-021-00882-8","Increased susceptibility of human endothelial cells to infections by SARS-CoV-2 variants.","Coronavirus disease 2019 (COVID-19) spawned a global health crisis in late 2019 and is caused by the novel coronavirus SARS-CoV-2. SARS-CoV-2 infection can lead to elevated markers of endothelial dysfunction associated with higher risk of mortality. It is unclear whether endothelial dysfunction is caused by direct infection of endothelial cells or is mainly secondary to inflammation. Here, we investigate whether different types of endothelial cells are susceptible to SARS-CoV-2. Human endothelia","2021","07","14","Basic Res Cardiol","Basic research in cardiology","ER stress; Endothelial cells; SARS-CoV-2; Virus trapping; Angiotensin-Converting Enzyme 2; Calnexin; Cells, Cultured; Endoplasmic Reticulum; Endoplasmic Reticulum Stress; Endothelial Cells; Host-Pathogen Interactions; Humans; Membrane Proteins; Receptors, Virus; SARS-CoV-2; Spike Glycoprotein, Coronavirus","Shumliakivska","Mariana","Institute for Cardiovascular Regeneration, Centre of Molecular Medicine, Goethe University Frankfurt, Theodor Stern Kai 7, 60590, Frankfurt, Germany",NA
"2252","34224022","10.1007/s00395-021-00882-8","Increased susceptibility of human endothelial cells to infections by SARS-CoV-2 variants.","Coronavirus disease 2019 (COVID-19) spawned a global health crisis in late 2019 and is caused by the novel coronavirus SARS-CoV-2. SARS-CoV-2 infection can lead to elevated markers of endothelial dysfunction associated with higher risk of mortality. It is unclear whether endothelial dysfunction is caused by direct infection of endothelial cells or is mainly secondary to inflammation. Here, we investigate whether different types of endothelial cells are susceptible to SARS-CoV-2. Human endothelia","2021","07","14","Basic Res Cardiol","Basic research in cardiology","ER stress; Endothelial cells; SARS-CoV-2; Virus trapping; Angiotensin-Converting Enzyme 2; Calnexin; Cells, Cultured; Endoplasmic Reticulum; Endoplasmic Reticulum Stress; Endothelial Cells; Host-Pathogen Interactions; Humans; Membrane Proteins; Receptors, Virus; SARS-CoV-2; Spike Glycoprotein, Coronavirus","Luxán","Guillermo","Institute for Cardiovascular Regeneration, Centre of Molecular Medicine, Goethe University Frankfurt, Theodor Stern Kai 7, 60590, Frankfurt, Germany",NA
"2253","34224022","10.1007/s00395-021-00882-8","Increased susceptibility of human endothelial cells to infections by SARS-CoV-2 variants.","Coronavirus disease 2019 (COVID-19) spawned a global health crisis in late 2019 and is caused by the novel coronavirus SARS-CoV-2. SARS-CoV-2 infection can lead to elevated markers of endothelial dysfunction associated with higher risk of mortality. It is unclear whether endothelial dysfunction is caused by direct infection of endothelial cells or is mainly secondary to inflammation. Here, we investigate whether different types of endothelial cells are susceptible to SARS-CoV-2. Human endothelia","2021","07","14","Basic Res Cardiol","Basic research in cardiology","ER stress; Endothelial cells; SARS-CoV-2; Virus trapping; Angiotensin-Converting Enzyme 2; Calnexin; Cells, Cultured; Endoplasmic Reticulum; Endoplasmic Reticulum Stress; Endothelial Cells; Host-Pathogen Interactions; Humans; Membrane Proteins; Receptors, Virus; SARS-CoV-2; Spike Glycoprotein, Coronavirus","Nicin","Luka","Institute for Cardiovascular Regeneration, Centre of Molecular Medicine, Goethe University Frankfurt, Theodor Stern Kai 7, 60590, Frankfurt, Germany",NA
"2254","34224022","10.1007/s00395-021-00882-8","Increased susceptibility of human endothelial cells to infections by SARS-CoV-2 variants.","Coronavirus disease 2019 (COVID-19) spawned a global health crisis in late 2019 and is caused by the novel coronavirus SARS-CoV-2. SARS-CoV-2 infection can lead to elevated markers of endothelial dysfunction associated with higher risk of mortality. It is unclear whether endothelial dysfunction is caused by direct infection of endothelial cells or is mainly secondary to inflammation. Here, we investigate whether different types of endothelial cells are susceptible to SARS-CoV-2. Human endothelia","2021","07","14","Basic Res Cardiol","Basic research in cardiology","ER stress; Endothelial cells; SARS-CoV-2; Virus trapping; Angiotensin-Converting Enzyme 2; Calnexin; Cells, Cultured; Endoplasmic Reticulum; Endoplasmic Reticulum Stress; Endothelial Cells; Host-Pathogen Interactions; Humans; Membrane Proteins; Receptors, Virus; SARS-CoV-2; Spike Glycoprotein, Coronavirus","Aslan","Galip S","Institute for Cardiovascular Regeneration, Centre of Molecular Medicine, Goethe University Frankfurt, Theodor Stern Kai 7, 60590, Frankfurt, Germany",NA
"2255","34224022","10.1007/s00395-021-00882-8","Increased susceptibility of human endothelial cells to infections by SARS-CoV-2 variants.","Coronavirus disease 2019 (COVID-19) spawned a global health crisis in late 2019 and is caused by the novel coronavirus SARS-CoV-2. SARS-CoV-2 infection can lead to elevated markers of endothelial dysfunction associated with higher risk of mortality. It is unclear whether endothelial dysfunction is caused by direct infection of endothelial cells or is mainly secondary to inflammation. Here, we investigate whether different types of endothelial cells are susceptible to SARS-CoV-2. Human endothelia","2021","07","14","Basic Res Cardiol","Basic research in cardiology","ER stress; Endothelial cells; SARS-CoV-2; Virus trapping; Angiotensin-Converting Enzyme 2; Calnexin; Cells, Cultured; Endoplasmic Reticulum; Endoplasmic Reticulum Stress; Endothelial Cells; Host-Pathogen Interactions; Humans; Membrane Proteins; Receptors, Virus; SARS-CoV-2; Spike Glycoprotein, Coronavirus","Milting","Hendrik","Clinic for Thoracic and Cardiovascular Surgery, Bad Oeyenhausen, Germany",NA
"2256","34224022","10.1007/s00395-021-00882-8","Increased susceptibility of human endothelial cells to infections by SARS-CoV-2 variants.","Coronavirus disease 2019 (COVID-19) spawned a global health crisis in late 2019 and is caused by the novel coronavirus SARS-CoV-2. SARS-CoV-2 infection can lead to elevated markers of endothelial dysfunction associated with higher risk of mortality. It is unclear whether endothelial dysfunction is caused by direct infection of endothelial cells or is mainly secondary to inflammation. Here, we investigate whether different types of endothelial cells are susceptible to SARS-CoV-2. Human endothelia","2021","07","14","Basic Res Cardiol","Basic research in cardiology","ER stress; Endothelial cells; SARS-CoV-2; Virus trapping; Angiotensin-Converting Enzyme 2; Calnexin; Cells, Cultured; Endoplasmic Reticulum; Endoplasmic Reticulum Stress; Endothelial Cells; Host-Pathogen Interactions; Humans; Membrane Proteins; Receptors, Virus; SARS-CoV-2; Spike Glycoprotein, Coronavirus","Kandler","Joshua D","Institute of Medical Virology, University Frankfurt, Frankfurt, Germany",NA
"2257","34224022","10.1007/s00395-021-00882-8","Increased susceptibility of human endothelial cells to infections by SARS-CoV-2 variants.","Coronavirus disease 2019 (COVID-19) spawned a global health crisis in late 2019 and is caused by the novel coronavirus SARS-CoV-2. SARS-CoV-2 infection can lead to elevated markers of endothelial dysfunction associated with higher risk of mortality. It is unclear whether endothelial dysfunction is caused by direct infection of endothelial cells or is mainly secondary to inflammation. Here, we investigate whether different types of endothelial cells are susceptible to SARS-CoV-2. Human endothelia","2021","07","14","Basic Res Cardiol","Basic research in cardiology","ER stress; Endothelial cells; SARS-CoV-2; Virus trapping; Angiotensin-Converting Enzyme 2; Calnexin; Cells, Cultured; Endoplasmic Reticulum; Endoplasmic Reticulum Stress; Endothelial Cells; Host-Pathogen Interactions; Humans; Membrane Proteins; Receptors, Virus; SARS-CoV-2; Spike Glycoprotein, Coronavirus","Dendorfer","Andreas","German Center for Cardiovascular Research (DZHK), Partner Site Rhein-Main, Frankfurt, Germany",NA
"2258","34224022","10.1007/s00395-021-00882-8","Increased susceptibility of human endothelial cells to infections by SARS-CoV-2 variants.","Coronavirus disease 2019 (COVID-19) spawned a global health crisis in late 2019 and is caused by the novel coronavirus SARS-CoV-2. SARS-CoV-2 infection can lead to elevated markers of endothelial dysfunction associated with higher risk of mortality. It is unclear whether endothelial dysfunction is caused by direct infection of endothelial cells or is mainly secondary to inflammation. Here, we investigate whether different types of endothelial cells are susceptible to SARS-CoV-2. Human endothelia","2021","07","14","Basic Res Cardiol","Basic research in cardiology","ER stress; Endothelial cells; SARS-CoV-2; Virus trapping; Angiotensin-Converting Enzyme 2; Calnexin; Cells, Cultured; Endoplasmic Reticulum; Endoplasmic Reticulum Stress; Endothelial Cells; Host-Pathogen Interactions; Humans; Membrane Proteins; Receptors, Virus; SARS-CoV-2; Spike Glycoprotein, Coronavirus","Heumueller","Andreas W","Institute for Cardiovascular Regeneration, Centre of Molecular Medicine, Goethe University Frankfurt, Theodor Stern Kai 7, 60590, Frankfurt, Germany",NA
"2259","34224022","10.1007/s00395-021-00882-8","Increased susceptibility of human endothelial cells to infections by SARS-CoV-2 variants.","Coronavirus disease 2019 (COVID-19) spawned a global health crisis in late 2019 and is caused by the novel coronavirus SARS-CoV-2. SARS-CoV-2 infection can lead to elevated markers of endothelial dysfunction associated with higher risk of mortality. It is unclear whether endothelial dysfunction is caused by direct infection of endothelial cells or is mainly secondary to inflammation. Here, we investigate whether different types of endothelial cells are susceptible to SARS-CoV-2. Human endothelia","2021","07","14","Basic Res Cardiol","Basic research in cardiology","ER stress; Endothelial cells; SARS-CoV-2; Virus trapping; Angiotensin-Converting Enzyme 2; Calnexin; Cells, Cultured; Endoplasmic Reticulum; Endoplasmic Reticulum Stress; Endothelial Cells; Host-Pathogen Interactions; Humans; Membrane Proteins; Receptors, Virus; SARS-CoV-2; Spike Glycoprotein, Coronavirus","Fleming","Ingrid","German Center for Cardiovascular Research (DZHK), Partner Site Rhein-Main, Frankfurt, Germany",NA
"2260","34224022","10.1007/s00395-021-00882-8","Increased susceptibility of human endothelial cells to infections by SARS-CoV-2 variants.","Coronavirus disease 2019 (COVID-19) spawned a global health crisis in late 2019 and is caused by the novel coronavirus SARS-CoV-2. SARS-CoV-2 infection can lead to elevated markers of endothelial dysfunction associated with higher risk of mortality. It is unclear whether endothelial dysfunction is caused by direct infection of endothelial cells or is mainly secondary to inflammation. Here, we investigate whether different types of endothelial cells are susceptible to SARS-CoV-2. Human endothelia","2021","07","14","Basic Res Cardiol","Basic research in cardiology","ER stress; Endothelial cells; SARS-CoV-2; Virus trapping; Angiotensin-Converting Enzyme 2; Calnexin; Cells, Cultured; Endoplasmic Reticulum; Endoplasmic Reticulum Stress; Endothelial Cells; Host-Pathogen Interactions; Humans; Membrane Proteins; Receptors, Virus; SARS-CoV-2; Spike Glycoprotein, Coronavirus","Bibli","Sofia-Iris","German Center for Cardiovascular Research (DZHK), Partner Site Rhein-Main, Frankfurt, Germany",NA
"2261","34224022","10.1007/s00395-021-00882-8","Increased susceptibility of human endothelial cells to infections by SARS-CoV-2 variants.","Coronavirus disease 2019 (COVID-19) spawned a global health crisis in late 2019 and is caused by the novel coronavirus SARS-CoV-2. SARS-CoV-2 infection can lead to elevated markers of endothelial dysfunction associated with higher risk of mortality. It is unclear whether endothelial dysfunction is caused by direct infection of endothelial cells or is mainly secondary to inflammation. Here, we investigate whether different types of endothelial cells are susceptible to SARS-CoV-2. Human endothelia","2021","07","14","Basic Res Cardiol","Basic research in cardiology","ER stress; Endothelial cells; SARS-CoV-2; Virus trapping; Angiotensin-Converting Enzyme 2; Calnexin; Cells, Cultured; Endoplasmic Reticulum; Endoplasmic Reticulum Stress; Endothelial Cells; Host-Pathogen Interactions; Humans; Membrane Proteins; Receptors, Virus; SARS-CoV-2; Spike Glycoprotein, Coronavirus","Jakobi","Tobias","Department of Internal Medicine and the Center for Translational Cardiovascular Research, University of Arizona, 475 N. 5th Street, Phoenix, AZ, 85004, USA",NA
"2262","34224022","10.1007/s00395-021-00882-8","Increased susceptibility of human endothelial cells to infections by SARS-CoV-2 variants.","Coronavirus disease 2019 (COVID-19) spawned a global health crisis in late 2019 and is caused by the novel coronavirus SARS-CoV-2. SARS-CoV-2 infection can lead to elevated markers of endothelial dysfunction associated with higher risk of mortality. It is unclear whether endothelial dysfunction is caused by direct infection of endothelial cells or is mainly secondary to inflammation. Here, we investigate whether different types of endothelial cells are susceptible to SARS-CoV-2. Human endothelia","2021","07","14","Basic Res Cardiol","Basic research in cardiology","ER stress; Endothelial cells; SARS-CoV-2; Virus trapping; Angiotensin-Converting Enzyme 2; Calnexin; Cells, Cultured; Endoplasmic Reticulum; Endoplasmic Reticulum Stress; Endothelial Cells; Host-Pathogen Interactions; Humans; Membrane Proteins; Receptors, Virus; SARS-CoV-2; Spike Glycoprotein, Coronavirus","Dieterich","Christoph","German Center for Cardiovascular Research (DZHK), Partner Site Rhein-Main, Frankfurt, Germany",NA
"2263","34224022","10.1007/s00395-021-00882-8","Increased susceptibility of human endothelial cells to infections by SARS-CoV-2 variants.","Coronavirus disease 2019 (COVID-19) spawned a global health crisis in late 2019 and is caused by the novel coronavirus SARS-CoV-2. SARS-CoV-2 infection can lead to elevated markers of endothelial dysfunction associated with higher risk of mortality. It is unclear whether endothelial dysfunction is caused by direct infection of endothelial cells or is mainly secondary to inflammation. Here, we investigate whether different types of endothelial cells are susceptible to SARS-CoV-2. Human endothelia","2021","07","14","Basic Res Cardiol","Basic research in cardiology","ER stress; Endothelial cells; SARS-CoV-2; Virus trapping; Angiotensin-Converting Enzyme 2; Calnexin; Cells, Cultured; Endoplasmic Reticulum; Endoplasmic Reticulum Stress; Endothelial Cells; Host-Pathogen Interactions; Humans; Membrane Proteins; Receptors, Virus; SARS-CoV-2; Spike Glycoprotein, Coronavirus","Zeiher","Andreas M","German Center for Cardiovascular Research (DZHK), Partner Site Rhein-Main, Frankfurt, Germany",NA
"2264","34224022","10.1007/s00395-021-00882-8","Increased susceptibility of human endothelial cells to infections by SARS-CoV-2 variants.","Coronavirus disease 2019 (COVID-19) spawned a global health crisis in late 2019 and is caused by the novel coronavirus SARS-CoV-2. SARS-CoV-2 infection can lead to elevated markers of endothelial dysfunction associated with higher risk of mortality. It is unclear whether endothelial dysfunction is caused by direct infection of endothelial cells or is mainly secondary to inflammation. Here, we investigate whether different types of endothelial cells are susceptible to SARS-CoV-2. Human endothelia","2021","07","14","Basic Res Cardiol","Basic research in cardiology","ER stress; Endothelial cells; SARS-CoV-2; Virus trapping; Angiotensin-Converting Enzyme 2; Calnexin; Cells, Cultured; Endoplasmic Reticulum; Endoplasmic Reticulum Stress; Endothelial Cells; Host-Pathogen Interactions; Humans; Membrane Proteins; Receptors, Virus; SARS-CoV-2; Spike Glycoprotein, Coronavirus","Ciesek","Sandra","Institute of Medical Virology, University Frankfurt, Frankfurt, Germany",NA
"2265","34224022","10.1007/s00395-021-00882-8","Increased susceptibility of human endothelial cells to infections by SARS-CoV-2 variants.","Coronavirus disease 2019 (COVID-19) spawned a global health crisis in late 2019 and is caused by the novel coronavirus SARS-CoV-2. SARS-CoV-2 infection can lead to elevated markers of endothelial dysfunction associated with higher risk of mortality. It is unclear whether endothelial dysfunction is caused by direct infection of endothelial cells or is mainly secondary to inflammation. Here, we investigate whether different types of endothelial cells are susceptible to SARS-CoV-2. Human endothelia","2021","07","14","Basic Res Cardiol","Basic research in cardiology","ER stress; Endothelial cells; SARS-CoV-2; Virus trapping; Angiotensin-Converting Enzyme 2; Calnexin; Cells, Cultured; Endoplasmic Reticulum; Endoplasmic Reticulum Stress; Endothelial Cells; Host-Pathogen Interactions; Humans; Membrane Proteins; Receptors, Virus; SARS-CoV-2; Spike Glycoprotein, Coronavirus","Cinatl","Jindrich","Institute of Medical Virology, University Frankfurt, Frankfurt, Germany",NA
"2266","34224022","10.1007/s00395-021-00882-8","Increased susceptibility of human endothelial cells to infections by SARS-CoV-2 variants.","Coronavirus disease 2019 (COVID-19) spawned a global health crisis in late 2019 and is caused by the novel coronavirus SARS-CoV-2. SARS-CoV-2 infection can lead to elevated markers of endothelial dysfunction associated with higher risk of mortality. It is unclear whether endothelial dysfunction is caused by direct infection of endothelial cells or is mainly secondary to inflammation. Here, we investigate whether different types of endothelial cells are susceptible to SARS-CoV-2. Human endothelia","2021","07","14","Basic Res Cardiol","Basic research in cardiology","ER stress; Endothelial cells; SARS-CoV-2; Virus trapping; Angiotensin-Converting Enzyme 2; Calnexin; Cells, Cultured; Endoplasmic Reticulum; Endoplasmic Reticulum Stress; Endothelial Cells; Host-Pathogen Interactions; Humans; Membrane Proteins; Receptors, Virus; SARS-CoV-2; Spike Glycoprotein, Coronavirus","Dimmeler","Stefanie","Institute for Cardiovascular Regeneration, Centre of Molecular Medicine, Goethe University Frankfurt, Theodor Stern Kai 7, 60590, Frankfurt, Germany. dimmeler@em.uni-frankfurt",NA
"2267","34223998","10.1007/s00702-021-02371-7","Neurodegenerative proteinopathies associated with neuroinfections.","Infectious agents, including viruses and bacteria, are proposed to be involved in the pathogenesis of Alzheimer's disease (AD). According to this hypothesis, these agents have capacity to evade the host immune system leading to chronic infection, inflammation, and subsequent deposition of Aß and phosphorylated-tau in the brain. Co-existing proteinopathies and age-related pathologies are common in AD and the brains of elderly individuals, but whether these are also related to neuroinfections rema","2021","07","08","J Neural Transm (Vienna)","Journal of neural transmission (Vienna, Austria : 1996)","Alzheimers disease; Herpes simplex virus; Neuro-infection; Neurosyphilis; Proteinopathy; Tau","Danics","Krisztina","Department of Forensic and Insurance Medicine, Semmelweis University, Budapest, Hungary",NA
"2268","34223998","10.1007/s00702-021-02371-7","Neurodegenerative proteinopathies associated with neuroinfections.","Infectious agents, including viruses and bacteria, are proposed to be involved in the pathogenesis of Alzheimer's disease (AD). According to this hypothesis, these agents have capacity to evade the host immune system leading to chronic infection, inflammation, and subsequent deposition of Aß and phosphorylated-tau in the brain. Co-existing proteinopathies and age-related pathologies are common in AD and the brains of elderly individuals, but whether these are also related to neuroinfections rema","2021","07","08","J Neural Transm (Vienna)","Journal of neural transmission (Vienna, Austria : 1996)","Alzheimers disease; Herpes simplex virus; Neuro-infection; Neurosyphilis; Proteinopathy; Tau","Forrest","Shelley L","Dementia Research Centre, School of Biomedical Sciences, Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, Australia",NA
"2269","34223998","10.1007/s00702-021-02371-7","Neurodegenerative proteinopathies associated with neuroinfections.","Infectious agents, including viruses and bacteria, are proposed to be involved in the pathogenesis of Alzheimer's disease (AD). According to this hypothesis, these agents have capacity to evade the host immune system leading to chronic infection, inflammation, and subsequent deposition of Aß and phosphorylated-tau in the brain. Co-existing proteinopathies and age-related pathologies are common in AD and the brains of elderly individuals, but whether these are also related to neuroinfections rema","2021","07","08","J Neural Transm (Vienna)","Journal of neural transmission (Vienna, Austria : 1996)","Alzheimers disease; Herpes simplex virus; Neuro-infection; Neurosyphilis; Proteinopathy; Tau","Kapas","Istvan","Department of Neurology, St. Janos Hospital, Budapest, Hungary",NA
"2270","34223998","10.1007/s00702-021-02371-7","Neurodegenerative proteinopathies associated with neuroinfections.","Infectious agents, including viruses and bacteria, are proposed to be involved in the pathogenesis of Alzheimer's disease (AD). According to this hypothesis, these agents have capacity to evade the host immune system leading to chronic infection, inflammation, and subsequent deposition of Aß and phosphorylated-tau in the brain. Co-existing proteinopathies and age-related pathologies are common in AD and the brains of elderly individuals, but whether these are also related to neuroinfections rema","2021","07","08","J Neural Transm (Vienna)","Journal of neural transmission (Vienna, Austria : 1996)","Alzheimers disease; Herpes simplex virus; Neuro-infection; Neurosyphilis; Proteinopathy; Tau","Erber","Irene","Division of Neuropathology and Neurochemistry, Department of Neurology, Medical University of Vienna, Vienna, Austria",NA
"2271","34223998","10.1007/s00702-021-02371-7","Neurodegenerative proteinopathies associated with neuroinfections.","Infectious agents, including viruses and bacteria, are proposed to be involved in the pathogenesis of Alzheimer's disease (AD). According to this hypothesis, these agents have capacity to evade the host immune system leading to chronic infection, inflammation, and subsequent deposition of Aß and phosphorylated-tau in the brain. Co-existing proteinopathies and age-related pathologies are common in AD and the brains of elderly individuals, but whether these are also related to neuroinfections rema","2021","07","08","J Neural Transm (Vienna)","Journal of neural transmission (Vienna, Austria : 1996)","Alzheimers disease; Herpes simplex virus; Neuro-infection; Neurosyphilis; Proteinopathy; Tau","Schmid","Susanne","Division of Neuropathology and Neurochemistry, Department of Neurology, Medical University of Vienna, Vienna, Austria",NA
"2272","34223998","10.1007/s00702-021-02371-7","Neurodegenerative proteinopathies associated with neuroinfections.","Infectious agents, including viruses and bacteria, are proposed to be involved in the pathogenesis of Alzheimer's disease (AD). According to this hypothesis, these agents have capacity to evade the host immune system leading to chronic infection, inflammation, and subsequent deposition of Aß and phosphorylated-tau in the brain. Co-existing proteinopathies and age-related pathologies are common in AD and the brains of elderly individuals, but whether these are also related to neuroinfections rema","2021","07","08","J Neural Transm (Vienna)","Journal of neural transmission (Vienna, Austria : 1996)","Alzheimers disease; Herpes simplex virus; Neuro-infection; Neurosyphilis; Proteinopathy; Tau","Töro","Klára","Department of Forensic and Insurance Medicine, Semmelweis University, Budapest, Hungary",NA
"2273","34223998","10.1007/s00702-021-02371-7","Neurodegenerative proteinopathies associated with neuroinfections.","Infectious agents, including viruses and bacteria, are proposed to be involved in the pathogenesis of Alzheimer's disease (AD). According to this hypothesis, these agents have capacity to evade the host immune system leading to chronic infection, inflammation, and subsequent deposition of Aß and phosphorylated-tau in the brain. Co-existing proteinopathies and age-related pathologies are common in AD and the brains of elderly individuals, but whether these are also related to neuroinfections rema","2021","07","08","J Neural Transm (Vienna)","Journal of neural transmission (Vienna, Austria : 1996)","Alzheimers disease; Herpes simplex virus; Neuro-infection; Neurosyphilis; Proteinopathy; Tau","Majtenyi","Katalin","Neuropathology and Prion Disease Reference Center, Department of Forensic and Insurance Medicine, Semmelweis University, Budapest, Hungary",NA
"2274","34223998","10.1007/s00702-021-02371-7","Neurodegenerative proteinopathies associated with neuroinfections.","Infectious agents, including viruses and bacteria, are proposed to be involved in the pathogenesis of Alzheimer's disease (AD). According to this hypothesis, these agents have capacity to evade the host immune system leading to chronic infection, inflammation, and subsequent deposition of Aß and phosphorylated-tau in the brain. Co-existing proteinopathies and age-related pathologies are common in AD and the brains of elderly individuals, but whether these are also related to neuroinfections rema","2021","07","08","J Neural Transm (Vienna)","Journal of neural transmission (Vienna, Austria : 1996)","Alzheimers disease; Herpes simplex virus; Neuro-infection; Neurosyphilis; Proteinopathy; Tau","Kovacs","Gabor G","Tanz Centre for Research in Neurodegenerative Disease and Department of Laboratory Medicine and Pathobiology, University of Toronto, Krembil Discovery Tower, 60 Leonard Ave, Toronto, ON, M5T 0S8, Canada. gabor.kovacs@uhnresearch","gabor.kovacs@uhnresearch.ca"
"2275","34223971","10.1007/s00395-021-00883-7","What the HEC happens around the heart during COVID-19?",NA,"2021","07","15","Basic Res Cardiol","Basic research in cardiology","COVID-19; Heart; Humans; SARS-CoV-2","Trilling","Mirko","Institute for Virology, University Hospital Essen, University of Duisburg-Essen, 45147, Essen, NRW, Germany. mirko.trilling@uni-due",NA
"2276","34223954","10.1007/s00330-021-08049-8","Artificial intelligence for prediction of COVID-19 progression using CT imaging and clinical data.","Early recognition of coronavirus disease 2019 (COVID-19) severity can guide patient management. However, it is challenging to predict when COVID-19 patients will progress to critical illness. This study aimed to develop an artificial intelligence system to predict future deterioration to critical illness in COVID-19 patients. An artificial intelligence (AI) system in a time-to-event analysis framework was developed to integrate chest CT and clinical data for risk prediction of future deteriorati","2021","07","08","Eur Radiol","European radiology","Coronavirus infections; Deep learning; Disease progression; Helical CT","Wang","Robin","Department of Radiology, Xiangya Hospital, Central South University, Changsha, China",NA
"2277","34223954","10.1007/s00330-021-08049-8","Artificial intelligence for prediction of COVID-19 progression using CT imaging and clinical data.","Early recognition of coronavirus disease 2019 (COVID-19) severity can guide patient management. However, it is challenging to predict when COVID-19 patients will progress to critical illness. This study aimed to develop an artificial intelligence system to predict future deterioration to critical illness in COVID-19 patients. An artificial intelligence (AI) system in a time-to-event analysis framework was developed to integrate chest CT and clinical data for risk prediction of future deteriorati","2021","07","08","Eur Radiol","European radiology","Coronavirus infections; Deep learning; Disease progression; Helical CT","Jiao","Zhicheng","Department of Radiology, University of Pennsylvania, Philadelphia, PA, 19104, USA",NA
"2278","34223954","10.1007/s00330-021-08049-8","Artificial intelligence for prediction of COVID-19 progression using CT imaging and clinical data.","Early recognition of coronavirus disease 2019 (COVID-19) severity can guide patient management. However, it is challenging to predict when COVID-19 patients will progress to critical illness. This study aimed to develop an artificial intelligence system to predict future deterioration to critical illness in COVID-19 patients. An artificial intelligence (AI) system in a time-to-event analysis framework was developed to integrate chest CT and clinical data for risk prediction of future deteriorati","2021","07","08","Eur Radiol","European radiology","Coronavirus infections; Deep learning; Disease progression; Helical CT","Yang","Li","Department of Neurology, Second Xiangya Hospital, Central South University, Changsha, China",NA
"2279","34223954","10.1007/s00330-021-08049-8","Artificial intelligence for prediction of COVID-19 progression using CT imaging and clinical data.","Early recognition of coronavirus disease 2019 (COVID-19) severity can guide patient management. However, it is challenging to predict when COVID-19 patients will progress to critical illness. This study aimed to develop an artificial intelligence system to predict future deterioration to critical illness in COVID-19 patients. An artificial intelligence (AI) system in a time-to-event analysis framework was developed to integrate chest CT and clinical data for risk prediction of future deteriorati","2021","07","08","Eur Radiol","European radiology","Coronavirus infections; Deep learning; Disease progression; Helical CT","Choi","Ji Whae","Department of Diagnostic Imaging, Rhode Island Hospital, Providence, RI, 02903, USA",NA
"2280","34223954","10.1007/s00330-021-08049-8","Artificial intelligence for prediction of COVID-19 progression using CT imaging and clinical data.","Early recognition of coronavirus disease 2019 (COVID-19) severity can guide patient management. However, it is challenging to predict when COVID-19 patients will progress to critical illness. This study aimed to develop an artificial intelligence system to predict future deterioration to critical illness in COVID-19 patients. An artificial intelligence (AI) system in a time-to-event analysis framework was developed to integrate chest CT and clinical data for risk prediction of future deteriorati","2021","07","08","Eur Radiol","European radiology","Coronavirus infections; Deep learning; Disease progression; Helical CT","Xiong","Zeng","Department of Radiology, Xiangya Hospital, Central South University, Changsha, China",NA
"2281","34223954","10.1007/s00330-021-08049-8","Artificial intelligence for prediction of COVID-19 progression using CT imaging and clinical data.","Early recognition of coronavirus disease 2019 (COVID-19) severity can guide patient management. However, it is challenging to predict when COVID-19 patients will progress to critical illness. This study aimed to develop an artificial intelligence system to predict future deterioration to critical illness in COVID-19 patients. An artificial intelligence (AI) system in a time-to-event analysis framework was developed to integrate chest CT and clinical data for risk prediction of future deteriorati","2021","07","08","Eur Radiol","European radiology","Coronavirus infections; Deep learning; Disease progression; Helical CT","Halsey","Kasey","Department of Diagnostic Imaging, Rhode Island Hospital, Providence, RI, 02903, USA",NA
"2282","34223954","10.1007/s00330-021-08049-8","Artificial intelligence for prediction of COVID-19 progression using CT imaging and clinical data.","Early recognition of coronavirus disease 2019 (COVID-19) severity can guide patient management. However, it is challenging to predict when COVID-19 patients will progress to critical illness. This study aimed to develop an artificial intelligence system to predict future deterioration to critical illness in COVID-19 patients. An artificial intelligence (AI) system in a time-to-event analysis framework was developed to integrate chest CT and clinical data for risk prediction of future deteriorati","2021","07","08","Eur Radiol","European radiology","Coronavirus infections; Deep learning; Disease progression; Helical CT","Tran","Thi My Linh","Department of Diagnostic Imaging, Rhode Island Hospital, Providence, RI, 02903, USA",NA
"2283","34223954","10.1007/s00330-021-08049-8","Artificial intelligence for prediction of COVID-19 progression using CT imaging and clinical data.","Early recognition of coronavirus disease 2019 (COVID-19) severity can guide patient management. However, it is challenging to predict when COVID-19 patients will progress to critical illness. This study aimed to develop an artificial intelligence system to predict future deterioration to critical illness in COVID-19 patients. An artificial intelligence (AI) system in a time-to-event analysis framework was developed to integrate chest CT and clinical data for risk prediction of future deteriorati","2021","07","08","Eur Radiol","European radiology","Coronavirus infections; Deep learning; Disease progression; Helical CT","Pan","Ian","Department of Diagnostic Imaging, Rhode Island Hospital, Providence, RI, 02903, USA",NA
"2284","34223954","10.1007/s00330-021-08049-8","Artificial intelligence for prediction of COVID-19 progression using CT imaging and clinical data.","Early recognition of coronavirus disease 2019 (COVID-19) severity can guide patient management. However, it is challenging to predict when COVID-19 patients will progress to critical illness. This study aimed to develop an artificial intelligence system to predict future deterioration to critical illness in COVID-19 patients. An artificial intelligence (AI) system in a time-to-event analysis framework was developed to integrate chest CT and clinical data for risk prediction of future deteriorati","2021","07","08","Eur Radiol","European radiology","Coronavirus infections; Deep learning; Disease progression; Helical CT","Collins","Scott A","Department of Diagnostic Imaging, Rhode Island Hospital, Providence, RI, 02903, USA",NA
"2285","34223954","10.1007/s00330-021-08049-8","Artificial intelligence for prediction of COVID-19 progression using CT imaging and clinical data.","Early recognition of coronavirus disease 2019 (COVID-19) severity can guide patient management. However, it is challenging to predict when COVID-19 patients will progress to critical illness. This study aimed to develop an artificial intelligence system to predict future deterioration to critical illness in COVID-19 patients. An artificial intelligence (AI) system in a time-to-event analysis framework was developed to integrate chest CT and clinical data for risk prediction of future deteriorati","2021","07","08","Eur Radiol","European radiology","Coronavirus infections; Deep learning; Disease progression; Helical CT","Feng","Xue","Carina Medical, Carina, Australia",NA
"2286","34223954","10.1007/s00330-021-08049-8","Artificial intelligence for prediction of COVID-19 progression using CT imaging and clinical data.","Early recognition of coronavirus disease 2019 (COVID-19) severity can guide patient management. However, it is challenging to predict when COVID-19 patients will progress to critical illness. This study aimed to develop an artificial intelligence system to predict future deterioration to critical illness in COVID-19 patients. An artificial intelligence (AI) system in a time-to-event analysis framework was developed to integrate chest CT and clinical data for risk prediction of future deteriorati","2021","07","08","Eur Radiol","European radiology","Coronavirus infections; Deep learning; Disease progression; Helical CT","Wu","Jing","Department of Radiology, Second Xiangya Hospital, Central South University, Changsha, China",NA
"2287","34223954","10.1007/s00330-021-08049-8","Artificial intelligence for prediction of COVID-19 progression using CT imaging and clinical data.","Early recognition of coronavirus disease 2019 (COVID-19) severity can guide patient management. However, it is challenging to predict when COVID-19 patients will progress to critical illness. This study aimed to develop an artificial intelligence system to predict future deterioration to critical illness in COVID-19 patients. An artificial intelligence (AI) system in a time-to-event analysis framework was developed to integrate chest CT and clinical data for risk prediction of future deteriorati","2021","07","08","Eur Radiol","European radiology","Coronavirus infections; Deep learning; Disease progression; Helical CT","Chang","Ken","Massachusetts Institute of Technology, Cambridge, MA, USA",NA
"2288","34223954","10.1007/s00330-021-08049-8","Artificial intelligence for prediction of COVID-19 progression using CT imaging and clinical data.","Early recognition of coronavirus disease 2019 (COVID-19) severity can guide patient management. However, it is challenging to predict when COVID-19 patients will progress to critical illness. This study aimed to develop an artificial intelligence system to predict future deterioration to critical illness in COVID-19 patients. An artificial intelligence (AI) system in a time-to-event analysis framework was developed to integrate chest CT and clinical data for risk prediction of future deteriorati","2021","07","08","Eur Radiol","European radiology","Coronavirus infections; Deep learning; Disease progression; Helical CT","Shi","Lin-Bo","Department of Radiology, Yongzhou Central Hospital, Yongzhou, China",NA
"2289","34223954","10.1007/s00330-021-08049-8","Artificial intelligence for prediction of COVID-19 progression using CT imaging and clinical data.","Early recognition of coronavirus disease 2019 (COVID-19) severity can guide patient management. However, it is challenging to predict when COVID-19 patients will progress to critical illness. This study aimed to develop an artificial intelligence system to predict future deterioration to critical illness in COVID-19 patients. An artificial intelligence (AI) system in a time-to-event analysis framework was developed to integrate chest CT and clinical data for risk prediction of future deteriorati","2021","07","08","Eur Radiol","European radiology","Coronavirus infections; Deep learning; Disease progression; Helical CT","Yang","Shuai","Department of Radiology, Xiangya Hospital, Central South University, Changsha, China",NA
"2290","34223954","10.1007/s00330-021-08049-8","Artificial intelligence for prediction of COVID-19 progression using CT imaging and clinical data.","Early recognition of coronavirus disease 2019 (COVID-19) severity can guide patient management. However, it is challenging to predict when COVID-19 patients will progress to critical illness. This study aimed to develop an artificial intelligence system to predict future deterioration to critical illness in COVID-19 patients. An artificial intelligence (AI) system in a time-to-event analysis framework was developed to integrate chest CT and clinical data for risk prediction of future deteriorati","2021","07","08","Eur Radiol","European radiology","Coronavirus infections; Deep learning; Disease progression; Helical CT","Yu","Qi-Zhi","Department of Radiology, The First Hospital of Changsha, Changsha, China",NA
"2291","34223954","10.1007/s00330-021-08049-8","Artificial intelligence for prediction of COVID-19 progression using CT imaging and clinical data.","Early recognition of coronavirus disease 2019 (COVID-19) severity can guide patient management. However, it is challenging to predict when COVID-19 patients will progress to critical illness. This study aimed to develop an artificial intelligence system to predict future deterioration to critical illness in COVID-19 patients. An artificial intelligence (AI) system in a time-to-event analysis framework was developed to integrate chest CT and clinical data for risk prediction of future deteriorati","2021","07","08","Eur Radiol","European radiology","Coronavirus infections; Deep learning; Disease progression; Helical CT","Liu","Jie","Department of Radiology, Changde Second People's Hospital, Changde, China",NA
"2292","34223954","10.1007/s00330-021-08049-8","Artificial intelligence for prediction of COVID-19 progression using CT imaging and clinical data.","Early recognition of coronavirus disease 2019 (COVID-19) severity can guide patient management. However, it is challenging to predict when COVID-19 patients will progress to critical illness. This study aimed to develop an artificial intelligence system to predict future deterioration to critical illness in COVID-19 patients. An artificial intelligence (AI) system in a time-to-event analysis framework was developed to integrate chest CT and clinical data for risk prediction of future deteriorati","2021","07","08","Eur Radiol","European radiology","Coronavirus infections; Deep learning; Disease progression; Helical CT","Fu","Fei-Xian","Department of Radiology, Yiyang City Center Hospital, Yiyang, China",NA
"2293","34223954","10.1007/s00330-021-08049-8","Artificial intelligence for prediction of COVID-19 progression using CT imaging and clinical data.","Early recognition of coronavirus disease 2019 (COVID-19) severity can guide patient management. However, it is challenging to predict when COVID-19 patients will progress to critical illness. This study aimed to develop an artificial intelligence system to predict future deterioration to critical illness in COVID-19 patients. An artificial intelligence (AI) system in a time-to-event analysis framework was developed to integrate chest CT and clinical data for risk prediction of future deteriorati","2021","07","08","Eur Radiol","European radiology","Coronavirus infections; Deep learning; Disease progression; Helical CT","Jiang","Xiao-Long","Department of Radiology, Affiliated Nan Hua Hospital, University of South China, Hengyang, China",NA
"2294","34223954","10.1007/s00330-021-08049-8","Artificial intelligence for prediction of COVID-19 progression using CT imaging and clinical data.","Early recognition of coronavirus disease 2019 (COVID-19) severity can guide patient management. However, it is challenging to predict when COVID-19 patients will progress to critical illness. This study aimed to develop an artificial intelligence system to predict future deterioration to critical illness in COVID-19 patients. An artificial intelligence (AI) system in a time-to-event analysis framework was developed to integrate chest CT and clinical data for risk prediction of future deteriorati","2021","07","08","Eur Radiol","European radiology","Coronavirus infections; Deep learning; Disease progression; Helical CT","Wang","Dong-Cui","Department of Radiology, Xiangya Hospital, Central South University, Changsha, China",NA
"2295","34223954","10.1007/s00330-021-08049-8","Artificial intelligence for prediction of COVID-19 progression using CT imaging and clinical data.","Early recognition of coronavirus disease 2019 (COVID-19) severity can guide patient management. However, it is challenging to predict when COVID-19 patients will progress to critical illness. This study aimed to develop an artificial intelligence system to predict future deterioration to critical illness in COVID-19 patients. An artificial intelligence (AI) system in a time-to-event analysis framework was developed to integrate chest CT and clinical data for risk prediction of future deteriorati","2021","07","08","Eur Radiol","European radiology","Coronavirus infections; Deep learning; Disease progression; Helical CT","Zhu","Li-Ping","Department of Radiology, Xiangya Hospital, Central South University, Changsha, China",NA
"2296","34223954","10.1007/s00330-021-08049-8","Artificial intelligence for prediction of COVID-19 progression using CT imaging and clinical data.","Early recognition of coronavirus disease 2019 (COVID-19) severity can guide patient management. However, it is challenging to predict when COVID-19 patients will progress to critical illness. This study aimed to develop an artificial intelligence system to predict future deterioration to critical illness in COVID-19 patients. An artificial intelligence (AI) system in a time-to-event analysis framework was developed to integrate chest CT and clinical data for risk prediction of future deteriorati","2021","07","08","Eur Radiol","European radiology","Coronavirus infections; Deep learning; Disease progression; Helical CT","Yi","Xiao-Ping","Department of Radiology, Xiangya Hospital, Central South University, Changsha, China",NA
"2297","34223954","10.1007/s00330-021-08049-8","Artificial intelligence for prediction of COVID-19 progression using CT imaging and clinical data.","Early recognition of coronavirus disease 2019 (COVID-19) severity can guide patient management. However, it is challenging to predict when COVID-19 patients will progress to critical illness. This study aimed to develop an artificial intelligence system to predict future deterioration to critical illness in COVID-19 patients. An artificial intelligence (AI) system in a time-to-event analysis framework was developed to integrate chest CT and clinical data for risk prediction of future deteriorati","2021","07","08","Eur Radiol","European radiology","Coronavirus infections; Deep learning; Disease progression; Helical CT","Healey","Terrance T","Department of Diagnostic Imaging, Rhode Island Hospital, Providence, RI, 02903, USA",NA
"2298","34223954","10.1007/s00330-021-08049-8","Artificial intelligence for prediction of COVID-19 progression using CT imaging and clinical data.","Early recognition of coronavirus disease 2019 (COVID-19) severity can guide patient management. However, it is challenging to predict when COVID-19 patients will progress to critical illness. This study aimed to develop an artificial intelligence system to predict future deterioration to critical illness in COVID-19 patients. An artificial intelligence (AI) system in a time-to-event analysis framework was developed to integrate chest CT and clinical data for risk prediction of future deteriorati","2021","07","08","Eur Radiol","European radiology","Coronavirus infections; Deep learning; Disease progression; Helical CT","Zeng","Qiu-Hua","Department of Radiology, Loudi Central Hospital, Loudi, China",NA
"2299","34223954","10.1007/s00330-021-08049-8","Artificial intelligence for prediction of COVID-19 progression using CT imaging and clinical data.","Early recognition of coronavirus disease 2019 (COVID-19) severity can guide patient management. However, it is challenging to predict when COVID-19 patients will progress to critical illness. This study aimed to develop an artificial intelligence system to predict future deterioration to critical illness in COVID-19 patients. An artificial intelligence (AI) system in a time-to-event analysis framework was developed to integrate chest CT and clinical data for risk prediction of future deteriorati","2021","07","08","Eur Radiol","European radiology","Coronavirus infections; Deep learning; Disease progression; Helical CT","Liu","Tao","Brown University School of Public Health, Providence, RI, USA",NA
"2300","34223954","10.1007/s00330-021-08049-8","Artificial intelligence for prediction of COVID-19 progression using CT imaging and clinical data.","Early recognition of coronavirus disease 2019 (COVID-19) severity can guide patient management. However, it is challenging to predict when COVID-19 patients will progress to critical illness. This study aimed to develop an artificial intelligence system to predict future deterioration to critical illness in COVID-19 patients. An artificial intelligence (AI) system in a time-to-event analysis framework was developed to integrate chest CT and clinical data for risk prediction of future deteriorati","2021","07","08","Eur Radiol","European radiology","Coronavirus infections; Deep learning; Disease progression; Helical CT","Hu","Ping-Feng","Department of Radiology, Chenzhou Second People's Hospital, Chenzhou, China",NA
"2301","34223954","10.1007/s00330-021-08049-8","Artificial intelligence for prediction of COVID-19 progression using CT imaging and clinical data.","Early recognition of coronavirus disease 2019 (COVID-19) severity can guide patient management. However, it is challenging to predict when COVID-19 patients will progress to critical illness. This study aimed to develop an artificial intelligence system to predict future deterioration to critical illness in COVID-19 patients. An artificial intelligence (AI) system in a time-to-event analysis framework was developed to integrate chest CT and clinical data for risk prediction of future deteriorati","2021","07","08","Eur Radiol","European radiology","Coronavirus infections; Deep learning; Disease progression; Helical CT","Huang","Raymond Y","Department of Radiology, Brigham and Women's Hospital, Boston, MA, USA",NA
"2302","34223954","10.1007/s00330-021-08049-8","Artificial intelligence for prediction of COVID-19 progression using CT imaging and clinical data.","Early recognition of coronavirus disease 2019 (COVID-19) severity can guide patient management. However, it is challenging to predict when COVID-19 patients will progress to critical illness. This study aimed to develop an artificial intelligence system to predict future deterioration to critical illness in COVID-19 patients. An artificial intelligence (AI) system in a time-to-event analysis framework was developed to integrate chest CT and clinical data for risk prediction of future deteriorati","2021","07","08","Eur Radiol","European radiology","Coronavirus infections; Deep learning; Disease progression; Helical CT","Li","Yi-Hui","Department of Radiology, Zhuzhou Central Hospital, Zhuzhou, China",NA
"2303","34223954","10.1007/s00330-021-08049-8","Artificial intelligence for prediction of COVID-19 progression using CT imaging and clinical data.","Early recognition of coronavirus disease 2019 (COVID-19) severity can guide patient management. However, it is challenging to predict when COVID-19 patients will progress to critical illness. This study aimed to develop an artificial intelligence system to predict future deterioration to critical illness in COVID-19 patients. An artificial intelligence (AI) system in a time-to-event analysis framework was developed to integrate chest CT and clinical data for risk prediction of future deteriorati","2021","07","08","Eur Radiol","European radiology","Coronavirus infections; Deep learning; Disease progression; Helical CT","Sebro","Ronnie A","Department of Radiology, University of Pennsylvania, Philadelphia, PA, 19104, USA",NA
"2304","34223954","10.1007/s00330-021-08049-8","Artificial intelligence for prediction of COVID-19 progression using CT imaging and clinical data.","Early recognition of coronavirus disease 2019 (COVID-19) severity can guide patient management. However, it is challenging to predict when COVID-19 patients will progress to critical illness. This study aimed to develop an artificial intelligence system to predict future deterioration to critical illness in COVID-19 patients. An artificial intelligence (AI) system in a time-to-event analysis framework was developed to integrate chest CT and clinical data for risk prediction of future deteriorati","2021","07","08","Eur Radiol","European radiology","Coronavirus infections; Deep learning; Disease progression; Helical CT","Zhang","Paul J L","Department of Radiology, University of Pennsylvania, Philadelphia, PA, 19104, USA",NA
"2305","34223954","10.1007/s00330-021-08049-8","Artificial intelligence for prediction of COVID-19 progression using CT imaging and clinical data.","Early recognition of coronavirus disease 2019 (COVID-19) severity can guide patient management. However, it is challenging to predict when COVID-19 patients will progress to critical illness. This study aimed to develop an artificial intelligence system to predict future deterioration to critical illness in COVID-19 patients. An artificial intelligence (AI) system in a time-to-event analysis framework was developed to integrate chest CT and clinical data for risk prediction of future deteriorati","2021","07","08","Eur Radiol","European radiology","Coronavirus infections; Deep learning; Disease progression; Helical CT","Wang","Jianxin","School of Computer Science and Engineering, Central South University, Changsha, China",NA
"2306","34223954","10.1007/s00330-021-08049-8","Artificial intelligence for prediction of COVID-19 progression using CT imaging and clinical data.","Early recognition of coronavirus disease 2019 (COVID-19) severity can guide patient management. However, it is challenging to predict when COVID-19 patients will progress to critical illness. This study aimed to develop an artificial intelligence system to predict future deterioration to critical illness in COVID-19 patients. An artificial intelligence (AI) system in a time-to-event analysis framework was developed to integrate chest CT and clinical data for risk prediction of future deteriorati","2021","07","08","Eur Radiol","European radiology","Coronavirus infections; Deep learning; Disease progression; Helical CT","Atalay","Michael K","Department of Diagnostic Imaging, Rhode Island Hospital, Providence, RI, 02903, USA",NA
"2307","34223954","10.1007/s00330-021-08049-8","Artificial intelligence for prediction of COVID-19 progression using CT imaging and clinical data.","Early recognition of coronavirus disease 2019 (COVID-19) severity can guide patient management. However, it is challenging to predict when COVID-19 patients will progress to critical illness. This study aimed to develop an artificial intelligence system to predict future deterioration to critical illness in COVID-19 patients. An artificial intelligence (AI) system in a time-to-event analysis framework was developed to integrate chest CT and clinical data for risk prediction of future deteriorati","2021","07","08","Eur Radiol","European radiology","Coronavirus infections; Deep learning; Disease progression; Helical CT","Liao","Wei-Hua","Department of Radiology, Xiangya Hospital, Central South University, Changsha, China. owenliao@csu.edu","owenliao@csu.edu.cn"
"2308","34223954","10.1007/s00330-021-08049-8","Artificial intelligence for prediction of COVID-19 progression using CT imaging and clinical data.","Early recognition of coronavirus disease 2019 (COVID-19) severity can guide patient management. However, it is challenging to predict when COVID-19 patients will progress to critical illness. This study aimed to develop an artificial intelligence system to predict future deterioration to critical illness in COVID-19 patients. An artificial intelligence (AI) system in a time-to-event analysis framework was developed to integrate chest CT and clinical data for risk prediction of future deteriorati","2021","07","08","Eur Radiol","European radiology","Coronavirus infections; Deep learning; Disease progression; Helical CT","Fan","Yong","Department of Radiology, University of Pennsylvania, Philadelphia, PA, 19104, USA",NA
"2309","34223954","10.1007/s00330-021-08049-8","Artificial intelligence for prediction of COVID-19 progression using CT imaging and clinical data.","Early recognition of coronavirus disease 2019 (COVID-19) severity can guide patient management. However, it is challenging to predict when COVID-19 patients will progress to critical illness. This study aimed to develop an artificial intelligence system to predict future deterioration to critical illness in COVID-19 patients. An artificial intelligence (AI) system in a time-to-event analysis framework was developed to integrate chest CT and clinical data for risk prediction of future deteriorati","2021","07","08","Eur Radiol","European radiology","Coronavirus infections; Deep learning; Disease progression; Helical CT","Bai","Harrison X","Department of Diagnostic Imaging, Rhode Island Hospital, Providence, RI, 02903, USA. harrison_bai@brown","bai@brown.edu"
"2310","34223922","10.1007/s00134-021-06460-9","Do not just sit there, do something  but do no harm: the worrying aspects of COVID-19 experimental interventions.",NA,"2021","07","08","Intensive Care Med","Intensive care medicine",NA,"Singer","Mervyn","Bloomsbury Institute of Intensive Care Medicine, University College London, London, WC1E 6BT, UK. m.singer@ucl.ac","m.singer@ucl.ac.uk"
"2311","34223922","10.1007/s00134-021-06460-9","Do not just sit there, do something  but do no harm: the worrying aspects of COVID-19 experimental interventions.",NA,"2021","07","08","Intensive Care Med","Intensive care medicine",NA,"Kalil","Andre","Division of Infectious Diseases, University of Nebraska Medical Center, Omaha, NE, USA",NA
"2312","34223911","10.1007/s00018-021-03889-5","Host factors facilitating SARS-CoV-2 virus infection and replication in the lungs.","SARS-CoV-2 is the virus causing the major pandemic facing the world today. Although, SARS-CoV-2 primarily causes lung infection, a variety of symptoms have proven a systemic impact on the body. SARS-CoV-2 has spread in the community quickly infecting humans from all age, ethnicities and gender. However, fatal outcomes have been linked to specific host factors and co-morbidities such as age, hypertension, immuno-deficiencies, chronic lung diseases or metabolic disorders. A major shift in the micr","2021","07","08","Cell Mol Life Sci","Cellular and molecular life sciences : CMLS","COVID-19; Co-morbidities; Host factor; Innate immune response; Microbiome; SARS-CoV-2","Boutin","Sébastien","Department of Infectious Diseases, Medical Microbiology and Hygiene, University Hospital Heidelberg, Im Neuenheimer Feld 324, 69120, Heidelberg, Germany. sebastien.boutin@med.uni-heidelberg","sebastien.boutin@med.uni"
"2313","34223911","10.1007/s00018-021-03889-5","Host factors facilitating SARS-CoV-2 virus infection and replication in the lungs.","SARS-CoV-2 is the virus causing the major pandemic facing the world today. Although, SARS-CoV-2 primarily causes lung infection, a variety of symptoms have proven a systemic impact on the body. SARS-CoV-2 has spread in the community quickly infecting humans from all age, ethnicities and gender. However, fatal outcomes have been linked to specific host factors and co-morbidities such as age, hypertension, immuno-deficiencies, chronic lung diseases or metabolic disorders. A major shift in the micr","2021","07","08","Cell Mol Life Sci","Cellular and molecular life sciences : CMLS","COVID-19; Co-morbidities; Host factor; Innate immune response; Microbiome; SARS-CoV-2","Hildebrand","Dagmar","Department of Infectious Diseases, Medical Microbiology and Hygiene, University Hospital Heidelberg, Im Neuenheimer Feld 324, 69120, Heidelberg, Germany",NA
"2314","34223911","10.1007/s00018-021-03889-5","Host factors facilitating SARS-CoV-2 virus infection and replication in the lungs.","SARS-CoV-2 is the virus causing the major pandemic facing the world today. Although, SARS-CoV-2 primarily causes lung infection, a variety of symptoms have proven a systemic impact on the body. SARS-CoV-2 has spread in the community quickly infecting humans from all age, ethnicities and gender. However, fatal outcomes have been linked to specific host factors and co-morbidities such as age, hypertension, immuno-deficiencies, chronic lung diseases or metabolic disorders. A major shift in the micr","2021","07","08","Cell Mol Life Sci","Cellular and molecular life sciences : CMLS","COVID-19; Co-morbidities; Host factor; Innate immune response; Microbiome; SARS-CoV-2","Boulant","Steeve","Division of Cellular Polarity and Viral Infection, German Cancer Research Center (DKFZ), Heidelberg, Germany",NA
"2315","34223911","10.1007/s00018-021-03889-5","Host factors facilitating SARS-CoV-2 virus infection and replication in the lungs.","SARS-CoV-2 is the virus causing the major pandemic facing the world today. Although, SARS-CoV-2 primarily causes lung infection, a variety of symptoms have proven a systemic impact on the body. SARS-CoV-2 has spread in the community quickly infecting humans from all age, ethnicities and gender. However, fatal outcomes have been linked to specific host factors and co-morbidities such as age, hypertension, immuno-deficiencies, chronic lung diseases or metabolic disorders. A major shift in the micr","2021","07","08","Cell Mol Life Sci","Cellular and molecular life sciences : CMLS","COVID-19; Co-morbidities; Host factor; Innate immune response; Microbiome; SARS-CoV-2","Kreuter","Michael","Translational Lung Research Center Heidelberg (TLRC), German Center for Lung Research (DZL), University of Heidelberg, Heidelberg, Germany",NA
"2316","34223911","10.1007/s00018-021-03889-5","Host factors facilitating SARS-CoV-2 virus infection and replication in the lungs.","SARS-CoV-2 is the virus causing the major pandemic facing the world today. Although, SARS-CoV-2 primarily causes lung infection, a variety of symptoms have proven a systemic impact on the body. SARS-CoV-2 has spread in the community quickly infecting humans from all age, ethnicities and gender. However, fatal outcomes have been linked to specific host factors and co-morbidities such as age, hypertension, immuno-deficiencies, chronic lung diseases or metabolic disorders. A major shift in the micr","2021","07","08","Cell Mol Life Sci","Cellular and molecular life sciences : CMLS","COVID-19; Co-morbidities; Host factor; Innate immune response; Microbiome; SARS-CoV-2","Rüter","Jule","Institute of Tropical Medicine, Universitätsklinikum Tübingen, Tübingen, Germany",NA
"2317","34223911","10.1007/s00018-021-03889-5","Host factors facilitating SARS-CoV-2 virus infection and replication in the lungs.","SARS-CoV-2 is the virus causing the major pandemic facing the world today. Although, SARS-CoV-2 primarily causes lung infection, a variety of symptoms have proven a systemic impact on the body. SARS-CoV-2 has spread in the community quickly infecting humans from all age, ethnicities and gender. However, fatal outcomes have been linked to specific host factors and co-morbidities such as age, hypertension, immuno-deficiencies, chronic lung diseases or metabolic disorders. A major shift in the micr","2021","07","08","Cell Mol Life Sci","Cellular and molecular life sciences : CMLS","COVID-19; Co-morbidities; Host factor; Innate immune response; Microbiome; SARS-CoV-2","Pallerla","Srinivas Reddy","Institute of Tropical Medicine, Universitätsklinikum Tübingen, Tübingen, Germany",NA
"2318","34223911","10.1007/s00018-021-03889-5","Host factors facilitating SARS-CoV-2 virus infection and replication in the lungs.","SARS-CoV-2 is the virus causing the major pandemic facing the world today. Although, SARS-CoV-2 primarily causes lung infection, a variety of symptoms have proven a systemic impact on the body. SARS-CoV-2 has spread in the community quickly infecting humans from all age, ethnicities and gender. However, fatal outcomes have been linked to specific host factors and co-morbidities such as age, hypertension, immuno-deficiencies, chronic lung diseases or metabolic disorders. A major shift in the micr","2021","07","08","Cell Mol Life Sci","Cellular and molecular life sciences : CMLS","COVID-19; Co-morbidities; Host factor; Innate immune response; Microbiome; SARS-CoV-2","Velavan","Thirumalaisamy P","Institute of Tropical Medicine, Universitätsklinikum Tübingen, Tübingen, Germany",NA
"2319","34223911","10.1007/s00018-021-03889-5","Host factors facilitating SARS-CoV-2 virus infection and replication in the lungs.","SARS-CoV-2 is the virus causing the major pandemic facing the world today. Although, SARS-CoV-2 primarily causes lung infection, a variety of symptoms have proven a systemic impact on the body. SARS-CoV-2 has spread in the community quickly infecting humans from all age, ethnicities and gender. However, fatal outcomes have been linked to specific host factors and co-morbidities such as age, hypertension, immuno-deficiencies, chronic lung diseases or metabolic disorders. A major shift in the micr","2021","07","08","Cell Mol Life Sci","Cellular and molecular life sciences : CMLS","COVID-19; Co-morbidities; Host factor; Innate immune response; Microbiome; SARS-CoV-2","Nurjadi","Dennis","Department of Infectious Diseases, Medical Microbiology and Hygiene, University Hospital Heidelberg, Im Neuenheimer Feld 324, 69120, Heidelberg, Germany",NA
"2320","34223909","10.1093/infdis/jiab355","Limited neutralization of authentic SARS-CoV-2 variants carrying E484K in vitro.","Whether monoclonal antibodies are able to neutralise SARS-CoV-2 variants of concern has been investigated using pseudoviruses. In this study we show that bamlanivimab, casirivimab, and imdevimab efficiently neutralise authentic SARS-CoV-2 including variant B.1.1.7 (Alpha) but variants B.1.351 (Beta) and P.2 (Zeta) were resistant against bamlanivimab and partially to casirivimab.","2021","07","05","J Infect Dis","The Journal of infectious diseases","SARS-CoV-2; bamlanivimab; casirivimab; corona virus; imdevinab; monoclonal antibodies","Widera","Marek","Institute for Medical Virology, University Hospital Frankfurt, Goethe University Frankfurt, Frankfurt am Main, Germany",NA
"2321","34223909","10.1093/infdis/jiab355","Limited neutralization of authentic SARS-CoV-2 variants carrying E484K in vitro.","Whether monoclonal antibodies are able to neutralise SARS-CoV-2 variants of concern has been investigated using pseudoviruses. In this study we show that bamlanivimab, casirivimab, and imdevimab efficiently neutralise authentic SARS-CoV-2 including variant B.1.1.7 (Alpha) but variants B.1.351 (Beta) and P.2 (Zeta) were resistant against bamlanivimab and partially to casirivimab.","2021","07","05","J Infect Dis","The Journal of infectious diseases","SARS-CoV-2; bamlanivimab; casirivimab; corona virus; imdevinab; monoclonal antibodies","Wilhelm","Alexander","Institute for Medical Virology, University Hospital Frankfurt, Goethe University Frankfurt, Frankfurt am Main, Germany",NA
"2322","34223909","10.1093/infdis/jiab355","Limited neutralization of authentic SARS-CoV-2 variants carrying E484K in vitro.","Whether monoclonal antibodies are able to neutralise SARS-CoV-2 variants of concern has been investigated using pseudoviruses. In this study we show that bamlanivimab, casirivimab, and imdevimab efficiently neutralise authentic SARS-CoV-2 including variant B.1.1.7 (Alpha) but variants B.1.351 (Beta) and P.2 (Zeta) were resistant against bamlanivimab and partially to casirivimab.","2021","07","05","J Infect Dis","The Journal of infectious diseases","SARS-CoV-2; bamlanivimab; casirivimab; corona virus; imdevinab; monoclonal antibodies","Hoehl","Sebastian","Institute for Medical Virology, University Hospital Frankfurt, Goethe University Frankfurt, Frankfurt am Main, Germany",NA
"2323","34223909","10.1093/infdis/jiab355","Limited neutralization of authentic SARS-CoV-2 variants carrying E484K in vitro.","Whether monoclonal antibodies are able to neutralise SARS-CoV-2 variants of concern has been investigated using pseudoviruses. In this study we show that bamlanivimab, casirivimab, and imdevimab efficiently neutralise authentic SARS-CoV-2 including variant B.1.1.7 (Alpha) but variants B.1.351 (Beta) and P.2 (Zeta) were resistant against bamlanivimab and partially to casirivimab.","2021","07","05","J Infect Dis","The Journal of infectious diseases","SARS-CoV-2; bamlanivimab; casirivimab; corona virus; imdevinab; monoclonal antibodies","Pallas","Christiane","Institute for Medical Virology, University Hospital Frankfurt, Goethe University Frankfurt, Frankfurt am Main, Germany",NA
"2324","34223909","10.1093/infdis/jiab355","Limited neutralization of authentic SARS-CoV-2 variants carrying E484K in vitro.","Whether monoclonal antibodies are able to neutralise SARS-CoV-2 variants of concern has been investigated using pseudoviruses. In this study we show that bamlanivimab, casirivimab, and imdevimab efficiently neutralise authentic SARS-CoV-2 including variant B.1.1.7 (Alpha) but variants B.1.351 (Beta) and P.2 (Zeta) were resistant against bamlanivimab and partially to casirivimab.","2021","07","05","J Infect Dis","The Journal of infectious diseases","SARS-CoV-2; bamlanivimab; casirivimab; corona virus; imdevinab; monoclonal antibodies","Kohmer","Niko","Institute for Medical Virology, University Hospital Frankfurt, Goethe University Frankfurt, Frankfurt am Main, Germany",NA
"2325","34223909","10.1093/infdis/jiab355","Limited neutralization of authentic SARS-CoV-2 variants carrying E484K in vitro.","Whether monoclonal antibodies are able to neutralise SARS-CoV-2 variants of concern has been investigated using pseudoviruses. In this study we show that bamlanivimab, casirivimab, and imdevimab efficiently neutralise authentic SARS-CoV-2 including variant B.1.1.7 (Alpha) but variants B.1.351 (Beta) and P.2 (Zeta) were resistant against bamlanivimab and partially to casirivimab.","2021","07","05","J Infect Dis","The Journal of infectious diseases","SARS-CoV-2; bamlanivimab; casirivimab; corona virus; imdevinab; monoclonal antibodies","Wolf","Timo","Department of Internal Medicine, Infectious Diseases, University Hospital Frankfurt, Goethe University Frankfurt, Germany",NA
"2326","34223909","10.1093/infdis/jiab355","Limited neutralization of authentic SARS-CoV-2 variants carrying E484K in vitro.","Whether monoclonal antibodies are able to neutralise SARS-CoV-2 variants of concern has been investigated using pseudoviruses. In this study we show that bamlanivimab, casirivimab, and imdevimab efficiently neutralise authentic SARS-CoV-2 including variant B.1.1.7 (Alpha) but variants B.1.351 (Beta) and P.2 (Zeta) were resistant against bamlanivimab and partially to casirivimab.","2021","07","05","J Infect Dis","The Journal of infectious diseases","SARS-CoV-2; bamlanivimab; casirivimab; corona virus; imdevinab; monoclonal antibodies","Rabenau","Holger F","Institute for Medical Virology, University Hospital Frankfurt, Goethe University Frankfurt, Frankfurt am Main, Germany",NA
"2327","34223909","10.1093/infdis/jiab355","Limited neutralization of authentic SARS-CoV-2 variants carrying E484K in vitro.","Whether monoclonal antibodies are able to neutralise SARS-CoV-2 variants of concern has been investigated using pseudoviruses. In this study we show that bamlanivimab, casirivimab, and imdevimab efficiently neutralise authentic SARS-CoV-2 including variant B.1.1.7 (Alpha) but variants B.1.351 (Beta) and P.2 (Zeta) were resistant against bamlanivimab and partially to casirivimab.","2021","07","05","J Infect Dis","The Journal of infectious diseases","SARS-CoV-2; bamlanivimab; casirivimab; corona virus; imdevinab; monoclonal antibodies","Corman","Victor M","Institute of Virology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany",NA
"2328","34223909","10.1093/infdis/jiab355","Limited neutralization of authentic SARS-CoV-2 variants carrying E484K in vitro.","Whether monoclonal antibodies are able to neutralise SARS-CoV-2 variants of concern has been investigated using pseudoviruses. In this study we show that bamlanivimab, casirivimab, and imdevimab efficiently neutralise authentic SARS-CoV-2 including variant B.1.1.7 (Alpha) but variants B.1.351 (Beta) and P.2 (Zeta) were resistant against bamlanivimab and partially to casirivimab.","2021","07","05","J Infect Dis","The Journal of infectious diseases","SARS-CoV-2; bamlanivimab; casirivimab; corona virus; imdevinab; monoclonal antibodies","Drosten","Christian","Institute of Virology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany",NA
"2329","34223909","10.1093/infdis/jiab355","Limited neutralization of authentic SARS-CoV-2 variants carrying E484K in vitro.","Whether monoclonal antibodies are able to neutralise SARS-CoV-2 variants of concern has been investigated using pseudoviruses. In this study we show that bamlanivimab, casirivimab, and imdevimab efficiently neutralise authentic SARS-CoV-2 including variant B.1.1.7 (Alpha) but variants B.1.351 (Beta) and P.2 (Zeta) were resistant against bamlanivimab and partially to casirivimab.","2021","07","05","J Infect Dis","The Journal of infectious diseases","SARS-CoV-2; bamlanivimab; casirivimab; corona virus; imdevinab; monoclonal antibodies","Vehreschild","Maria J G T","Department of Internal Medicine, Infectious Diseases, University Hospital Frankfurt, Goethe University Frankfurt, Germany",NA
"2330","34223909","10.1093/infdis/jiab355","Limited neutralization of authentic SARS-CoV-2 variants carrying E484K in vitro.","Whether monoclonal antibodies are able to neutralise SARS-CoV-2 variants of concern has been investigated using pseudoviruses. In this study we show that bamlanivimab, casirivimab, and imdevimab efficiently neutralise authentic SARS-CoV-2 including variant B.1.1.7 (Alpha) but variants B.1.351 (Beta) and P.2 (Zeta) were resistant against bamlanivimab and partially to casirivimab.","2021","07","05","J Infect Dis","The Journal of infectious diseases","SARS-CoV-2; bamlanivimab; casirivimab; corona virus; imdevinab; monoclonal antibodies","Goetsch","Udo","Public Health Department of the City of Frankfurt am Main, Frankfurt am Main, Germany",NA
"2331","34223909","10.1093/infdis/jiab355","Limited neutralization of authentic SARS-CoV-2 variants carrying E484K in vitro.","Whether monoclonal antibodies are able to neutralise SARS-CoV-2 variants of concern has been investigated using pseudoviruses. In this study we show that bamlanivimab, casirivimab, and imdevimab efficiently neutralise authentic SARS-CoV-2 including variant B.1.1.7 (Alpha) but variants B.1.351 (Beta) and P.2 (Zeta) were resistant against bamlanivimab and partially to casirivimab.","2021","07","05","J Infect Dis","The Journal of infectious diseases","SARS-CoV-2; bamlanivimab; casirivimab; corona virus; imdevinab; monoclonal antibodies","Gottschalk","Rene","Public Health Department of the City of Frankfurt am Main, Frankfurt am Main, Germany",NA
"2332","34223909","10.1093/infdis/jiab355","Limited neutralization of authentic SARS-CoV-2 variants carrying E484K in vitro.","Whether monoclonal antibodies are able to neutralise SARS-CoV-2 variants of concern has been investigated using pseudoviruses. In this study we show that bamlanivimab, casirivimab, and imdevimab efficiently neutralise authentic SARS-CoV-2 including variant B.1.1.7 (Alpha) but variants B.1.351 (Beta) and P.2 (Zeta) were resistant against bamlanivimab and partially to casirivimab.","2021","07","05","J Infect Dis","The Journal of infectious diseases","SARS-CoV-2; bamlanivimab; casirivimab; corona virus; imdevinab; monoclonal antibodies","Ciesek","Sandra","Institute for Medical Virology, University Hospital Frankfurt, Goethe University Frankfurt, Frankfurt am Main, Germany",NA
"2333","34223908","10.1093/tbm/ibab081","Support policies that foster a healthy food environment and incentivize healthy food purchases to mitigate cancer inequities.","The COVID-19 pandemic has highlighted the inequitable access to resources, leading to a disproportionate burden of disease in vulnerable communities in the USA. However, these inequities in health outcomes are not limited to COVID-19. Approximately 18% of cancers are related to dietary behaviors and excess body weight. Underserved communities, such as minority racial/ethnic groups living in neighborhoods of low socioeconomic status, experience barriers to healthy eating including lack of access ","2021","07","05","Transl Behav Med","Translational behavioral medicine","Cancer; Farm Bill; Health equity; Health policy; Healthy Food Financing Initiative; Supplemental Nutrition Assistance Program","Wolf","Patricia G","Institute for Health Research and Policy, University of Illinois at Chicago, Chicago, IL, USA",NA
"2334","34223908","10.1093/tbm/ibab081","Support policies that foster a healthy food environment and incentivize healthy food purchases to mitigate cancer inequities.","The COVID-19 pandemic has highlighted the inequitable access to resources, leading to a disproportionate burden of disease in vulnerable communities in the USA. However, these inequities in health outcomes are not limited to COVID-19. Approximately 18% of cancers are related to dietary behaviors and excess body weight. Underserved communities, such as minority racial/ethnic groups living in neighborhoods of low socioeconomic status, experience barriers to healthy eating including lack of access ","2021","07","05","Transl Behav Med","Translational behavioral medicine","Cancer; Farm Bill; Health equity; Health policy; Healthy Food Financing Initiative; Supplemental Nutrition Assistance Program","Sanchez-Flack","Jennifer C","Institute for Health Research and Policy, University of Illinois at Chicago, Chicago, IL, USA",NA
"2335","34223908","10.1093/tbm/ibab081","Support policies that foster a healthy food environment and incentivize healthy food purchases to mitigate cancer inequities.","The COVID-19 pandemic has highlighted the inequitable access to resources, leading to a disproportionate burden of disease in vulnerable communities in the USA. However, these inequities in health outcomes are not limited to COVID-19. Approximately 18% of cancers are related to dietary behaviors and excess body weight. Underserved communities, such as minority racial/ethnic groups living in neighborhoods of low socioeconomic status, experience barriers to healthy eating including lack of access ","2021","07","05","Transl Behav Med","Translational behavioral medicine","Cancer; Farm Bill; Health equity; Health policy; Healthy Food Financing Initiative; Supplemental Nutrition Assistance Program","Buscemi","Joanna","Department of Psychology, DePaul University, Chicago, IL, USA",NA
"2336","34223908","10.1093/tbm/ibab081","Support policies that foster a healthy food environment and incentivize healthy food purchases to mitigate cancer inequities.","The COVID-19 pandemic has highlighted the inequitable access to resources, leading to a disproportionate burden of disease in vulnerable communities in the USA. However, these inequities in health outcomes are not limited to COVID-19. Approximately 18% of cancers are related to dietary behaviors and excess body weight. Underserved communities, such as minority racial/ethnic groups living in neighborhoods of low socioeconomic status, experience barriers to healthy eating including lack of access ","2021","07","05","Transl Behav Med","Translational behavioral medicine","Cancer; Farm Bill; Health equity; Health policy; Healthy Food Financing Initiative; Supplemental Nutrition Assistance Program","Fitzgibbon","Marian L","Institute for Health Research and Policy, University of Illinois at Chicago, Chicago, IL, USA",NA
"2337","34223908","10.1093/tbm/ibab081","Support policies that foster a healthy food environment and incentivize healthy food purchases to mitigate cancer inequities.","The COVID-19 pandemic has highlighted the inequitable access to resources, leading to a disproportionate burden of disease in vulnerable communities in the USA. However, these inequities in health outcomes are not limited to COVID-19. Approximately 18% of cancers are related to dietary behaviors and excess body weight. Underserved communities, such as minority racial/ethnic groups living in neighborhoods of low socioeconomic status, experience barriers to healthy eating including lack of access ","2021","07","05","Transl Behav Med","Translational behavioral medicine","Cancer; Farm Bill; Health equity; Health policy; Healthy Food Financing Initiative; Supplemental Nutrition Assistance Program","Gaskins","H Rex","Department of Animal Sciences, University of Illinois at Urbana-Champaign, Urbana, IL, USA",NA
"2338","34223908","10.1093/tbm/ibab081","Support policies that foster a healthy food environment and incentivize healthy food purchases to mitigate cancer inequities.","The COVID-19 pandemic has highlighted the inequitable access to resources, leading to a disproportionate burden of disease in vulnerable communities in the USA. However, these inequities in health outcomes are not limited to COVID-19. Approximately 18% of cancers are related to dietary behaviors and excess body weight. Underserved communities, such as minority racial/ethnic groups living in neighborhoods of low socioeconomic status, experience barriers to healthy eating including lack of access ","2021","07","05","Transl Behav Med","Translational behavioral medicine","Cancer; Farm Bill; Health equity; Health policy; Healthy Food Financing Initiative; Supplemental Nutrition Assistance Program","Ridlon","Jason M","Department of Animal Sciences, University of Illinois at Urbana-Champaign, Urbana, IL, USA",NA
"2339","34223908","10.1093/tbm/ibab081","Support policies that foster a healthy food environment and incentivize healthy food purchases to mitigate cancer inequities.","The COVID-19 pandemic has highlighted the inequitable access to resources, leading to a disproportionate burden of disease in vulnerable communities in the USA. However, these inequities in health outcomes are not limited to COVID-19. Approximately 18% of cancers are related to dietary behaviors and excess body weight. Underserved communities, such as minority racial/ethnic groups living in neighborhoods of low socioeconomic status, experience barriers to healthy eating including lack of access ","2021","07","05","Transl Behav Med","Translational behavioral medicine","Cancer; Farm Bill; Health equity; Health policy; Healthy Food Financing Initiative; Supplemental Nutrition Assistance Program","Kim","Sage","University of Illinois Cancer Center, University of Illinois at Chicago, Chicago, IL, USA",NA
"2340","34223908","10.1093/tbm/ibab081","Support policies that foster a healthy food environment and incentivize healthy food purchases to mitigate cancer inequities.","The COVID-19 pandemic has highlighted the inequitable access to resources, leading to a disproportionate burden of disease in vulnerable communities in the USA. However, these inequities in health outcomes are not limited to COVID-19. Approximately 18% of cancers are related to dietary behaviors and excess body weight. Underserved communities, such as minority racial/ethnic groups living in neighborhoods of low socioeconomic status, experience barriers to healthy eating including lack of access ","2021","07","05","Transl Behav Med","Translational behavioral medicine","Cancer; Farm Bill; Health equity; Health policy; Healthy Food Financing Initiative; Supplemental Nutrition Assistance Program","Tussing-Humphreys","Lisa","Institute for Health Research and Policy, University of Illinois at Chicago, Chicago, IL, USA",NA
"2341","34223896","10.1093/gerona/glab190","Long-term trajectories of C-reactive protein among men living with and without HIV infection in the Multicenter AIDS Cohort Study.","C-reactive protein (CRP) is an inflammatory biomarker associated with all-cause mortality and morbidities such as cardiovascular disease. CRP is increased with HIV infection and thought to increase with age, though trajectories of CRP with aging have not been well characterized. We investigated trajectories of CRP in men from the Multicenter AIDS Cohort Study, according to HIV infection and HIV viral load status. CRP measurements from 12,250 serum samples, provided by 2,132 men over a span of 30","2021","07","05","J Gerontol A Biol Sci Med Sci","The journals of gerontology. Series A, Biological sciences and medical sciences","CRP; aging; biomarkers; inflammation; longitudinal","Wada","Nikolas I","Novel Coronavirus Research Compendium, Johns Hopkins University, Baltimore, USA",NA
"2342","34223896","10.1093/gerona/glab190","Long-term trajectories of C-reactive protein among men living with and without HIV infection in the Multicenter AIDS Cohort Study.","C-reactive protein (CRP) is an inflammatory biomarker associated with all-cause mortality and morbidities such as cardiovascular disease. CRP is increased with HIV infection and thought to increase with age, though trajectories of CRP with aging have not been well characterized. We investigated trajectories of CRP in men from the Multicenter AIDS Cohort Study, according to HIV infection and HIV viral load status. CRP measurements from 12,250 serum samples, provided by 2,132 men over a span of 30","2021","07","05","J Gerontol A Biol Sci Med Sci","The journals of gerontology. Series A, Biological sciences and medical sciences","CRP; aging; biomarkers; inflammation; longitudinal","Breen","Elizabeth C","Department of Psychiatry &amp",NA
"2343","34223896","10.1093/gerona/glab190","Long-term trajectories of C-reactive protein among men living with and without HIV infection in the Multicenter AIDS Cohort Study.","C-reactive protein (CRP) is an inflammatory biomarker associated with all-cause mortality and morbidities such as cardiovascular disease. CRP is increased with HIV infection and thought to increase with age, though trajectories of CRP with aging have not been well characterized. We investigated trajectories of CRP in men from the Multicenter AIDS Cohort Study, according to HIV infection and HIV viral load status. CRP measurements from 12,250 serum samples, provided by 2,132 men over a span of 30","2021","07","05","J Gerontol A Biol Sci Med Sci","The journals of gerontology. Series A, Biological sciences and medical sciences","CRP; aging; biomarkers; inflammation; longitudinal","Post","Wendy S","Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, USA",NA
"2344","34223896","10.1093/gerona/glab190","Long-term trajectories of C-reactive protein among men living with and without HIV infection in the Multicenter AIDS Cohort Study.","C-reactive protein (CRP) is an inflammatory biomarker associated with all-cause mortality and morbidities such as cardiovascular disease. CRP is increased with HIV infection and thought to increase with age, though trajectories of CRP with aging have not been well characterized. We investigated trajectories of CRP in men from the Multicenter AIDS Cohort Study, according to HIV infection and HIV viral load status. CRP measurements from 12,250 serum samples, provided by 2,132 men over a span of 30","2021","07","05","J Gerontol A Biol Sci Med Sci","The journals of gerontology. Series A, Biological sciences and medical sciences","CRP; aging; biomarkers; inflammation; longitudinal","Stosor","Valentina","Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, USA",NA
"2345","34223896","10.1093/gerona/glab190","Long-term trajectories of C-reactive protein among men living with and without HIV infection in the Multicenter AIDS Cohort Study.","C-reactive protein (CRP) is an inflammatory biomarker associated with all-cause mortality and morbidities such as cardiovascular disease. CRP is increased with HIV infection and thought to increase with age, though trajectories of CRP with aging have not been well characterized. We investigated trajectories of CRP in men from the Multicenter AIDS Cohort Study, according to HIV infection and HIV viral load status. CRP measurements from 12,250 serum samples, provided by 2,132 men over a span of 30","2021","07","05","J Gerontol A Biol Sci Med Sci","The journals of gerontology. Series A, Biological sciences and medical sciences","CRP; aging; biomarkers; inflammation; longitudinal","Macatangay","Bernard J","University of Pittsburgh School of Medicine, Pittsburgh, USA",NA
"2346","34223896","10.1093/gerona/glab190","Long-term trajectories of C-reactive protein among men living with and without HIV infection in the Multicenter AIDS Cohort Study.","C-reactive protein (CRP) is an inflammatory biomarker associated with all-cause mortality and morbidities such as cardiovascular disease. CRP is increased with HIV infection and thought to increase with age, though trajectories of CRP with aging have not been well characterized. We investigated trajectories of CRP in men from the Multicenter AIDS Cohort Study, according to HIV infection and HIV viral load status. CRP measurements from 12,250 serum samples, provided by 2,132 men over a span of 30","2021","07","05","J Gerontol A Biol Sci Med Sci","The journals of gerontology. Series A, Biological sciences and medical sciences","CRP; aging; biomarkers; inflammation; longitudinal","Margolick","Joseph B","Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, USA",NA
"2347","34223886","10.1093/carcin/bgab061","COVID-19: a pandemic converged with global tobacco epidemic and widespread vaping - state of the evidence.","This review highlights the convergence of three global health challenges at a crossroad where the pandemic of COVID-19 meets the tobacco epidemic and vaping. It begins with an overview of the current knowledge on the biology, pathophysiology, and epidemiology of COVID-19. It then presents the state of smoking and vaping during the pandemic by summarizing the published data on prevalence, use patterns, product availability/accessibility, sales records, and motivation to quit before- and after the","2021","07","05","Carcinogenesis","Carcinogenesis","COVID-19; SARS-CoV-2; electronic cigarette; epidemic; nicotine; pandemic; public health; tobacco; vaping","Besaratinia","Ahmad","Department of Preventive Medicine, USC Keck School of Medicine, University of Southern California, M/C 9603, Los Angeles, CA 90033, USA",NA
"2348","34223884","10.1093/cid/ciab611","Persistent symptoms in adult patients one year after COVID-19: a prospective cohort study.","Long COVID is defined as the persistence of symptoms beyond 3 months after SARS-CoV-2 infection. To better understand the long-term course and etiology of symptoms we analyzed a cohort of COVID-19 patients prospectively. Patients were included at 5 months after acute COVID-19 in this prospective, non-interventional follow-up study. Patients followed until 12 months after COVID-19 symptom onset (n=96, 32.3% hospitalised, 55.2% females) were included in this analysis of symptoms, quality of life (","2021","07","05","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","ANA titers; Coronavirus disease of 2019 (COVID-19); life quality; long COVID; severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)","Seeßle","Jessica","Department of Internal Medicine IV, University Hospital Heidelberg, Heidelberg, Germany",NA
"2349","34223884","10.1093/cid/ciab611","Persistent symptoms in adult patients one year after COVID-19: a prospective cohort study.","Long COVID is defined as the persistence of symptoms beyond 3 months after SARS-CoV-2 infection. To better understand the long-term course and etiology of symptoms we analyzed a cohort of COVID-19 patients prospectively. Patients were included at 5 months after acute COVID-19 in this prospective, non-interventional follow-up study. Patients followed until 12 months after COVID-19 symptom onset (n=96, 32.3% hospitalised, 55.2% females) were included in this analysis of symptoms, quality of life (","2021","07","05","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","ANA titers; Coronavirus disease of 2019 (COVID-19); life quality; long COVID; severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)","Waterboer","Tim","Infections and Cancer Epidemiology, German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ), Heidelberg, Germany",NA
"2350","34223884","10.1093/cid/ciab611","Persistent symptoms in adult patients one year after COVID-19: a prospective cohort study.","Long COVID is defined as the persistence of symptoms beyond 3 months after SARS-CoV-2 infection. To better understand the long-term course and etiology of symptoms we analyzed a cohort of COVID-19 patients prospectively. Patients were included at 5 months after acute COVID-19 in this prospective, non-interventional follow-up study. Patients followed until 12 months after COVID-19 symptom onset (n=96, 32.3% hospitalised, 55.2% females) were included in this analysis of symptoms, quality of life (","2021","07","05","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","ANA titers; Coronavirus disease of 2019 (COVID-19); life quality; long COVID; severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)","Hippchen","Theresa","Department of Internal Medicine IV, University Hospital Heidelberg, Heidelberg, Germany",NA
"2351","34223884","10.1093/cid/ciab611","Persistent symptoms in adult patients one year after COVID-19: a prospective cohort study.","Long COVID is defined as the persistence of symptoms beyond 3 months after SARS-CoV-2 infection. To better understand the long-term course and etiology of symptoms we analyzed a cohort of COVID-19 patients prospectively. Patients were included at 5 months after acute COVID-19 in this prospective, non-interventional follow-up study. Patients followed until 12 months after COVID-19 symptom onset (n=96, 32.3% hospitalised, 55.2% females) were included in this analysis of symptoms, quality of life (","2021","07","05","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","ANA titers; Coronavirus disease of 2019 (COVID-19); life quality; long COVID; severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)","Simon","Julia","Infections and Cancer Epidemiology, German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ), Heidelberg, Germany, and Faculty of Biosciences, Heidelberg University, Heidelberg, Germany",NA
"2352","34223884","10.1093/cid/ciab611","Persistent symptoms in adult patients one year after COVID-19: a prospective cohort study.","Long COVID is defined as the persistence of symptoms beyond 3 months after SARS-CoV-2 infection. To better understand the long-term course and etiology of symptoms we analyzed a cohort of COVID-19 patients prospectively. Patients were included at 5 months after acute COVID-19 in this prospective, non-interventional follow-up study. Patients followed until 12 months after COVID-19 symptom onset (n=96, 32.3% hospitalised, 55.2% females) were included in this analysis of symptoms, quality of life (","2021","07","05","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","ANA titers; Coronavirus disease of 2019 (COVID-19); life quality; long COVID; severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)","Kirchner","Marietta","Institute of Medical Biometry and Informatics, University Hospital Heidelberg, Heidelberg, Germany",NA
"2353","34223884","10.1093/cid/ciab611","Persistent symptoms in adult patients one year after COVID-19: a prospective cohort study.","Long COVID is defined as the persistence of symptoms beyond 3 months after SARS-CoV-2 infection. To better understand the long-term course and etiology of symptoms we analyzed a cohort of COVID-19 patients prospectively. Patients were included at 5 months after acute COVID-19 in this prospective, non-interventional follow-up study. Patients followed until 12 months after COVID-19 symptom onset (n=96, 32.3% hospitalised, 55.2% females) were included in this analysis of symptoms, quality of life (","2021","07","05","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","ANA titers; Coronavirus disease of 2019 (COVID-19); life quality; long COVID; severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)","Lim","Adeline","Department of Internal Medicine IV, University Hospital Heidelberg, Heidelberg, Germany",NA
"2354","34223884","10.1093/cid/ciab611","Persistent symptoms in adult patients one year after COVID-19: a prospective cohort study.","Long COVID is defined as the persistence of symptoms beyond 3 months after SARS-CoV-2 infection. To better understand the long-term course and etiology of symptoms we analyzed a cohort of COVID-19 patients prospectively. Patients were included at 5 months after acute COVID-19 in this prospective, non-interventional follow-up study. Patients followed until 12 months after COVID-19 symptom onset (n=96, 32.3% hospitalised, 55.2% females) were included in this analysis of symptoms, quality of life (","2021","07","05","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","ANA titers; Coronavirus disease of 2019 (COVID-19); life quality; long COVID; severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)","Müller","Barbara","Department of Infectious Diseases, Virology, University Hospital Heidelberg, Heidelberg, Germany",NA
"2355","34223884","10.1093/cid/ciab611","Persistent symptoms in adult patients one year after COVID-19: a prospective cohort study.","Long COVID is defined as the persistence of symptoms beyond 3 months after SARS-CoV-2 infection. To better understand the long-term course and etiology of symptoms we analyzed a cohort of COVID-19 patients prospectively. Patients were included at 5 months after acute COVID-19 in this prospective, non-interventional follow-up study. Patients followed until 12 months after COVID-19 symptom onset (n=96, 32.3% hospitalised, 55.2% females) were included in this analysis of symptoms, quality of life (","2021","07","05","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","ANA titers; Coronavirus disease of 2019 (COVID-19); life quality; long COVID; severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)","Merle","Uta","Department of Internal Medicine IV, University Hospital Heidelberg, Heidelberg, Germany",NA
"2356","34223872","10.1093/ajhp/zxab270","Rapid implementation of pharmacy infusion services for emergency use authorization COVID-19 treatments at a field hospital.",NA,"2021","07","05","Am J Health Syst Pharm","American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists",NA,"Rivera","Glorimar","University of Maryland Medical Center, Baltimore, Maryland",NA
"2357","34223872","10.1093/ajhp/zxab270","Rapid implementation of pharmacy infusion services for emergency use authorization COVID-19 treatments at a field hospital.",NA,"2021","07","05","Am J Health Syst Pharm","American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists",NA,"De León","Marisol","University of Maryland Medical Center, Baltimore, Maryland",NA
"2358","34223872","10.1093/ajhp/zxab270","Rapid implementation of pharmacy infusion services for emergency use authorization COVID-19 treatments at a field hospital.",NA,"2021","07","05","Am J Health Syst Pharm","American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists",NA,"Bernardelli","Beril","University of Maryland Medical Center, Baltimore, Maryland",NA
"2359","34223872","10.1093/ajhp/zxab270","Rapid implementation of pharmacy infusion services for emergency use authorization COVID-19 treatments at a field hospital.",NA,"2021","07","05","Am J Health Syst Pharm","American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists",NA,"Brannan","Barbara","University of Maryland Medical Center, Baltimore, Maryland",NA
"2360","34223872","10.1093/ajhp/zxab270","Rapid implementation of pharmacy infusion services for emergency use authorization COVID-19 treatments at a field hospital.",NA,"2021","07","05","Am J Health Syst Pharm","American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists",NA,"Dicubellis","Joseph","University of Maryland Medical Center, Baltimore, Maryland",NA
"2361","34223872","10.1093/ajhp/zxab270","Rapid implementation of pharmacy infusion services for emergency use authorization COVID-19 treatments at a field hospital.",NA,"2021","07","05","Am J Health Syst Pharm","American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists",NA,"Williams","Carla","University of Maryland Medical Center, Baltimore, Maryland",NA
"2362","34223866","10.7416/ai.2021.2451","Mortality from COVID-19.","The differences of the epidemiology (incidence, case-to-death rate, mortality, etc) of COVID-19 between USA and Italy are analyzed taking into account the social, economic and sanitary characteristics of the two countries, both severely hit be the pandemic; and the causes of the so many different behaviors of the disease in each of them are discussed and explained.","2021","07","16","Ann Ig","Annali di igiene : medicina preventiva e di comunita","Covid-19 mortality; Italy; USA; COVID-19; Communicable Disease Control; Comorbidity; Europe; Health Policy; Health Resources; Humans; Immunization, Passive; Italy; Pandemics; SARS-CoV-2; Social Determinants of Health; United States","Franchini","M","Department of Hematology and Transfusion Medicine, Carlo Poma Hospital, Mantova, Italy",NA
"2363","34223866","10.7416/ai.2021.2451","Mortality from COVID-19.","The differences of the epidemiology (incidence, case-to-death rate, mortality, etc) of COVID-19 between USA and Italy are analyzed taking into account the social, economic and sanitary characteristics of the two countries, both severely hit be the pandemic; and the causes of the so many different behaviors of the disease in each of them are discussed and explained.","2021","07","16","Ann Ig","Annali di igiene : medicina preventiva e di comunita","Covid-19 mortality; Italy; USA; COVID-19; Communicable Disease Control; Comorbidity; Europe; Health Policy; Health Resources; Humans; Immunization, Passive; Italy; Pandemics; SARS-CoV-2; Social Determinants of Health; United States","Bongiovanni","G","Medical Direction, G. Fracastoro Hospital, AULSS 9 Scaligera, Italy",NA
"2364","34223866","10.7416/ai.2021.2451","Mortality from COVID-19.","The differences of the epidemiology (incidence, case-to-death rate, mortality, etc) of COVID-19 between USA and Italy are analyzed taking into account the social, economic and sanitary characteristics of the two countries, both severely hit be the pandemic; and the causes of the so many different behaviors of the disease in each of them are discussed and explained.","2021","07","16","Ann Ig","Annali di igiene : medicina preventiva e di comunita","Covid-19 mortality; Italy; USA; COVID-19; Communicable Disease Control; Comorbidity; Europe; Health Policy; Health Resources; Humans; Immunization, Passive; Italy; Pandemics; SARS-CoV-2; Social Determinants of Health; United States","Cruciani","M","AULSS9 Scaligera, Infection Control Committee and Antibiotic Stewardship Programme, Verona, Italy",NA
"2365","34223865","10.7416/ai.2021.2450","Prevention of the spread of SARS COV-2 by Rapid Antigenic Tests on the passengers entering an Italian seaport.","Out of 38,282 passengers entering Italy at a major seaport, submitted to SARS-CoV-2 rapid antigenic test, 272 (0.6%) resulted positive and 212 (93.4%) were confirmed positive by qRT-PCR, leaving a 0.6% of false positive. Those resident in the area under control of the same Local Health Authority of the seaport were immediately submitted to isolation and investigated for contact tracing, the others notified to their Local Health Authority which did the same in the following day. This procedure wa","2021","07","16","Ann Ig","Annali di igiene : medicina preventiva e di comunita","Covid-19 mortality; Italy; USA; Adult; Antigens, Viral; COVID-19; COVID-19 Nucleic Acid Testing; COVID-19 Testing; Contact Tracing; Female; Health Personnel; Humans; Italy; Male; Mass Screening; Middle Aged; Nasopharynx; Retrospective Studies; SARS-CoV-2; Ships; Socioeconomic Factors; Travel; Travel-Related Illness","Savini","S","PhD. Organisational Post at ASL Roma 4, Rome, Italy",NA
"2366","34223865","10.7416/ai.2021.2450","Prevention of the spread of SARS COV-2 by Rapid Antigenic Tests on the passengers entering an Italian seaport.","Out of 38,282 passengers entering Italy at a major seaport, submitted to SARS-CoV-2 rapid antigenic test, 272 (0.6%) resulted positive and 212 (93.4%) were confirmed positive by qRT-PCR, leaving a 0.6% of false positive. Those resident in the area under control of the same Local Health Authority of the seaport were immediately submitted to isolation and investigated for contact tracing, the others notified to their Local Health Authority which did the same in the following day. This procedure wa","2021","07","16","Ann Ig","Annali di igiene : medicina preventiva e di comunita","Covid-19 mortality; Italy; USA; Adult; Antigens, Viral; COVID-19; COVID-19 Nucleic Acid Testing; COVID-19 Testing; Contact Tracing; Female; Health Personnel; Humans; Italy; Male; Mass Screening; Middle Aged; Nasopharynx; Retrospective Studies; SARS-CoV-2; Ships; Socioeconomic Factors; Travel; Travel-Related Illness","Monaco","D","PhD Student, Department of Biomedicine and Prevention, Tor Vergata University of Rome, Italy",NA
"2367","34223865","10.7416/ai.2021.2450","Prevention of the spread of SARS COV-2 by Rapid Antigenic Tests on the passengers entering an Italian seaport.","Out of 38,282 passengers entering Italy at a major seaport, submitted to SARS-CoV-2 rapid antigenic test, 272 (0.6%) resulted positive and 212 (93.4%) were confirmed positive by qRT-PCR, leaving a 0.6% of false positive. Those resident in the area under control of the same Local Health Authority of the seaport were immediately submitted to isolation and investigated for contact tracing, the others notified to their Local Health Authority which did the same in the following day. This procedure wa","2021","07","16","Ann Ig","Annali di igiene : medicina preventiva e di comunita","Covid-19 mortality; Italy; USA; Adult; Antigens, Viral; COVID-19; COVID-19 Nucleic Acid Testing; COVID-19 Testing; Contact Tracing; Female; Health Personnel; Humans; Italy; Male; Mass Screening; Middle Aged; Nasopharynx; Retrospective Studies; SARS-CoV-2; Ships; Socioeconomic Factors; Travel; Travel-Related Illness","Turci","C","MSN. Director of the Nursing Department, ASL Roma 4, Rome Italy",NA
"2368","34223865","10.7416/ai.2021.2450","Prevention of the spread of SARS COV-2 by Rapid Antigenic Tests on the passengers entering an Italian seaport.","Out of 38,282 passengers entering Italy at a major seaport, submitted to SARS-CoV-2 rapid antigenic test, 272 (0.6%) resulted positive and 212 (93.4%) were confirmed positive by qRT-PCR, leaving a 0.6% of false positive. Those resident in the area under control of the same Local Health Authority of the seaport were immediately submitted to isolation and investigated for contact tracing, the others notified to their Local Health Authority which did the same in the following day. This procedure wa","2021","07","16","Ann Ig","Annali di igiene : medicina preventiva e di comunita","Covid-19 mortality; Italy; USA; Adult; Antigens, Viral; COVID-19; COVID-19 Nucleic Acid Testing; COVID-19 Testing; Contact Tracing; Female; Health Personnel; Humans; Italy; Male; Mass Screening; Middle Aged; Nasopharynx; Retrospective Studies; SARS-CoV-2; Ships; Socioeconomic Factors; Travel; Travel-Related Illness","Ursino","S","MD. Director of the Department of Prevention, Health Measures Office, ASL Roma 4, Rome Italy",NA
"2369","34223865","10.7416/ai.2021.2450","Prevention of the spread of SARS COV-2 by Rapid Antigenic Tests on the passengers entering an Italian seaport.","Out of 38,282 passengers entering Italy at a major seaport, submitted to SARS-CoV-2 rapid antigenic test, 272 (0.6%) resulted positive and 212 (93.4%) were confirmed positive by qRT-PCR, leaving a 0.6% of false positive. Those resident in the area under control of the same Local Health Authority of the seaport were immediately submitted to isolation and investigated for contact tracing, the others notified to their Local Health Authority which did the same in the following day. This procedure wa","2021","07","16","Ann Ig","Annali di igiene : medicina preventiva e di comunita","Covid-19 mortality; Italy; USA; Adult; Antigens, Viral; COVID-19; COVID-19 Nucleic Acid Testing; COVID-19 Testing; Contact Tracing; Female; Health Personnel; Humans; Italy; Male; Mass Screening; Middle Aged; Nasopharynx; Retrospective Studies; SARS-CoV-2; Ships; Socioeconomic Factors; Travel; Travel-Related Illness","Matera","C","MD. Medical Director, ASL Roma 4, Rome, Italy",NA
"2370","34223865","10.7416/ai.2021.2450","Prevention of the spread of SARS COV-2 by Rapid Antigenic Tests on the passengers entering an Italian seaport.","Out of 38,282 passengers entering Italy at a major seaport, submitted to SARS-CoV-2 rapid antigenic test, 272 (0.6%) resulted positive and 212 (93.4%) were confirmed positive by qRT-PCR, leaving a 0.6% of false positive. Those resident in the area under control of the same Local Health Authority of the seaport were immediately submitted to isolation and investigated for contact tracing, the others notified to their Local Health Authority which did the same in the following day. This procedure wa","2021","07","16","Ann Ig","Annali di igiene : medicina preventiva e di comunita","Covid-19 mortality; Italy; USA; Adult; Antigens, Viral; COVID-19; COVID-19 Nucleic Acid Testing; COVID-19 Testing; Contact Tracing; Female; Health Personnel; Humans; Italy; Male; Mass Screening; Middle Aged; Nasopharynx; Retrospective Studies; SARS-CoV-2; Ships; Socioeconomic Factors; Travel; Travel-Related Illness","Marchini","R","MSN. Organisational Post at ASL Roma 4, Rome, Italy",NA
"2371","34223865","10.7416/ai.2021.2450","Prevention of the spread of SARS COV-2 by Rapid Antigenic Tests on the passengers entering an Italian seaport.","Out of 38,282 passengers entering Italy at a major seaport, submitted to SARS-CoV-2 rapid antigenic test, 272 (0.6%) resulted positive and 212 (93.4%) were confirmed positive by qRT-PCR, leaving a 0.6% of false positive. Those resident in the area under control of the same Local Health Authority of the seaport were immediately submitted to isolation and investigated for contact tracing, the others notified to their Local Health Authority which did the same in the following day. This procedure wa","2021","07","16","Ann Ig","Annali di igiene : medicina preventiva e di comunita","Covid-19 mortality; Italy; USA; Adult; Antigens, Viral; COVID-19; COVID-19 Nucleic Acid Testing; COVID-19 Testing; Contact Tracing; Female; Health Personnel; Humans; Italy; Male; Mass Screening; Middle Aged; Nasopharynx; Retrospective Studies; SARS-CoV-2; Ships; Socioeconomic Factors; Travel; Travel-Related Illness","Di Giovanni","T","MSN. Organisational Post at ASL Roma 4, Rome, Italy",NA
"2372","34223865","10.7416/ai.2021.2450","Prevention of the spread of SARS COV-2 by Rapid Antigenic Tests on the passengers entering an Italian seaport.","Out of 38,282 passengers entering Italy at a major seaport, submitted to SARS-CoV-2 rapid antigenic test, 272 (0.6%) resulted positive and 212 (93.4%) were confirmed positive by qRT-PCR, leaving a 0.6% of false positive. Those resident in the area under control of the same Local Health Authority of the seaport were immediately submitted to isolation and investigated for contact tracing, the others notified to their Local Health Authority which did the same in the following day. This procedure wa","2021","07","16","Ann Ig","Annali di igiene : medicina preventiva e di comunita","Covid-19 mortality; Italy; USA; Adult; Antigens, Viral; COVID-19; COVID-19 Nucleic Acid Testing; COVID-19 Testing; Contact Tracing; Female; Health Personnel; Humans; Italy; Male; Mass Screening; Middle Aged; Nasopharynx; Retrospective Studies; SARS-CoV-2; Ships; Socioeconomic Factors; Travel; Travel-Related Illness","Ciambella","E","PT. Organisational Post at ASL Roma 4, Rome, Italy",NA
"2373","34223865","10.7416/ai.2021.2450","Prevention of the spread of SARS COV-2 by Rapid Antigenic Tests on the passengers entering an Italian seaport.","Out of 38,282 passengers entering Italy at a major seaport, submitted to SARS-CoV-2 rapid antigenic test, 272 (0.6%) resulted positive and 212 (93.4%) were confirmed positive by qRT-PCR, leaving a 0.6% of false positive. Those resident in the area under control of the same Local Health Authority of the seaport were immediately submitted to isolation and investigated for contact tracing, the others notified to their Local Health Authority which did the same in the following day. This procedure wa","2021","07","16","Ann Ig","Annali di igiene : medicina preventiva e di comunita","Covid-19 mortality; Italy; USA; Adult; Antigens, Viral; COVID-19; COVID-19 Nucleic Acid Testing; COVID-19 Testing; Contact Tracing; Female; Health Personnel; Humans; Italy; Male; Mass Screening; Middle Aged; Nasopharynx; Retrospective Studies; SARS-CoV-2; Ships; Socioeconomic Factors; Travel; Travel-Related Illness","Iannucci","V","MD. Department of Prevention, Health Measures Office, ASL Roma 4, Rome, Italy",NA
"2374","34223865","10.7416/ai.2021.2450","Prevention of the spread of SARS COV-2 by Rapid Antigenic Tests on the passengers entering an Italian seaport.","Out of 38,282 passengers entering Italy at a major seaport, submitted to SARS-CoV-2 rapid antigenic test, 272 (0.6%) resulted positive and 212 (93.4%) were confirmed positive by qRT-PCR, leaving a 0.6% of false positive. Those resident in the area under control of the same Local Health Authority of the seaport were immediately submitted to isolation and investigated for contact tracing, the others notified to their Local Health Authority which did the same in the following day. This procedure wa","2021","07","16","Ann Ig","Annali di igiene : medicina preventiva e di comunita","Covid-19 mortality; Italy; USA; Adult; Antigens, Viral; COVID-19; COVID-19 Nucleic Acid Testing; COVID-19 Testing; Contact Tracing; Female; Health Personnel; Humans; Italy; Male; Mass Screening; Middle Aged; Nasopharynx; Retrospective Studies; SARS-CoV-2; Ships; Socioeconomic Factors; Travel; Travel-Related Illness","Quintavalle","G","MD. General Director of ASL Roma 4, Rome, Italy",NA
"2375","34223812","10.1080/09273972.2021.1948072","Series of cases of acute acquired comitant esotropia in children associated with excessive online classes on smartphone during COVID-19 pandemic; digital eye strain among kids (DESK) study-3.","Extra time of sitting in front of a digital device is required for e-learning by children during Corona virus (COVID-19) pandemic which can lead to many ocular problems including digital eye strain (DES). In view of increased incidence of DES in children, multiple studies had been conducted in central India to assess the eye strain in children due to excessive online classes as a research project named ""Digital eye strain among kids (DESK) study."" This study DESK-3 aimed to report series of case","2021","07","05","Strabismus","Strabismus","Acute acquired comitant esotropia; COVID-19 pandemic; children; smartphone","Mohan","Amit","Children Eye Care Center, Department of Pediatric Ophthalmology and Strabismus, Sadguru Netra Chikitsalya and Postgraduate Institute of Ophthalmology, Chitrakoot, MP",NA
"2376","34223812","10.1080/09273972.2021.1948072","Series of cases of acute acquired comitant esotropia in children associated with excessive online classes on smartphone during COVID-19 pandemic; digital eye strain among kids (DESK) study-3.","Extra time of sitting in front of a digital device is required for e-learning by children during Corona virus (COVID-19) pandemic which can lead to many ocular problems including digital eye strain (DES). In view of increased incidence of DES in children, multiple studies had been conducted in central India to assess the eye strain in children due to excessive online classes as a research project named ""Digital eye strain among kids (DESK) study."" This study DESK-3 aimed to report series of case","2021","07","05","Strabismus","Strabismus","Acute acquired comitant esotropia; COVID-19 pandemic; children; smartphone","Sen","Pradhnya","Children Eye Care Center, Department of Pediatric Ophthalmology and Strabismus, Sadguru Netra Chikitsalya and Postgraduate Institute of Ophthalmology, Chitrakoot, MP",NA
"2377","34223812","10.1080/09273972.2021.1948072","Series of cases of acute acquired comitant esotropia in children associated with excessive online classes on smartphone during COVID-19 pandemic; digital eye strain among kids (DESK) study-3.","Extra time of sitting in front of a digital device is required for e-learning by children during Corona virus (COVID-19) pandemic which can lead to many ocular problems including digital eye strain (DES). In view of increased incidence of DES in children, multiple studies had been conducted in central India to assess the eye strain in children due to excessive online classes as a research project named ""Digital eye strain among kids (DESK) study."" This study DESK-3 aimed to report series of case","2021","07","05","Strabismus","Strabismus","Acute acquired comitant esotropia; COVID-19 pandemic; children; smartphone","Majmudar","Deepti","Children Eye Care Center, Department of Pediatric Ophthalmology and Strabismus, Sadguru Netra Chikitsalya and Postgraduate Institute of Ophthalmology, Chitrakoot, MP",NA
"2378","34223812","10.1080/09273972.2021.1948072","Series of cases of acute acquired comitant esotropia in children associated with excessive online classes on smartphone during COVID-19 pandemic; digital eye strain among kids (DESK) study-3.","Extra time of sitting in front of a digital device is required for e-learning by children during Corona virus (COVID-19) pandemic which can lead to many ocular problems including digital eye strain (DES). In view of increased incidence of DES in children, multiple studies had been conducted in central India to assess the eye strain in children due to excessive online classes as a research project named ""Digital eye strain among kids (DESK) study."" This study DESK-3 aimed to report series of case","2021","07","05","Strabismus","Strabismus","Acute acquired comitant esotropia; COVID-19 pandemic; children; smartphone","Shah","Chintan","Children Eye Care Center, Department of Pediatric Ophthalmology and Strabismus, Sadguru Netra Chikitsalya and Postgraduate Institute of Ophthalmology, Chitrakoot, MP",NA
"2379","34223812","10.1080/09273972.2021.1948072","Series of cases of acute acquired comitant esotropia in children associated with excessive online classes on smartphone during COVID-19 pandemic; digital eye strain among kids (DESK) study-3.","Extra time of sitting in front of a digital device is required for e-learning by children during Corona virus (COVID-19) pandemic which can lead to many ocular problems including digital eye strain (DES). In view of increased incidence of DES in children, multiple studies had been conducted in central India to assess the eye strain in children due to excessive online classes as a research project named ""Digital eye strain among kids (DESK) study."" This study DESK-3 aimed to report series of case","2021","07","05","Strabismus","Strabismus","Acute acquired comitant esotropia; COVID-19 pandemic; children; smartphone","Jain","Elesh","Children Eye Care Center, Department of Pediatric Ophthalmology and Strabismus, Sadguru Netra Chikitsalya and Postgraduate Institute of Ophthalmology, Chitrakoot, MP",NA
"2380","34223808","10.1080/20477724.2021.1947681","When and how: a plausible airborne transmission of SARS-CoV-2 - WHO needs to update its recommendations.",NA,"2021","07","05","Pathog Glob Health","Pathogens and global health","COVID-19; SARS-CoV-2; WHO; aerosol; air droplets; airborne","Sok","Phan","Institute of Medical Science, University of Toronto, Toronto, Canada",NA
"2381","34223786","10.2217/fmb-2020-0134","Prevalence of COVID-19 in 10,000 samples from 7853 patients in Eastern Turkey by positive real-time PCR.","Aim: COVID-19, caused by SARS-CoV-2, started in December 2019 and has spread across the world. Materials &amp; methods: We analyzed real-time PCR results of 10,000 samples from 2 April to 30 May 2020 in three neighbor cities located in the East of Turkey. The final study population was 7853 cases, after excluding screening tests. Results: Real-time PCR was performed to detect the SARS-CoV-2-specific RNA-dependent-RNA-polymerase gene fragment. The number of total positive sam","2021","07","20","Future Microbiol","Future microbiology","COVID-19; SARS-CoV-2; positivity rate; prevalence; real-time PCR; Adolescent; Adult; Aged; COVID-19; COVID-19 Testing; Child; Child, Preschool; Cough; Female; Fever; Humans; Infant; Infant, Newborn; Male; Middle Aged; Prevalence; Real-Time Polymerase Chain Reaction; SARS-CoV-2; Turkey; Young Adult","Karamese","Murat","Department of Medical Microbiology, Kafkas University, Faculty of Medicine, Kars, 36100, Turkey",NA
"2382","34223786","10.2217/fmb-2020-0134","Prevalence of COVID-19 in 10,000 samples from 7853 patients in Eastern Turkey by positive real-time PCR.","Aim: COVID-19, caused by SARS-CoV-2, started in December 2019 and has spread across the world. Materials &amp; methods: We analyzed real-time PCR results of 10,000 samples from 2 April to 30 May 2020 in three neighbor cities located in the East of Turkey. The final study population was 7853 cases, after excluding screening tests. Results: Real-time PCR was performed to detect the SARS-CoV-2-specific RNA-dependent-RNA-polymerase gene fragment. The number of total positive sam","2021","07","20","Future Microbiol","Future microbiology","COVID-19; SARS-CoV-2; positivity rate; prevalence; real-time PCR; Adolescent; Adult; Aged; COVID-19; COVID-19 Testing; Child; Child, Preschool; Cough; Female; Fever; Humans; Infant; Infant, Newborn; Male; Middle Aged; Prevalence; Real-Time Polymerase Chain Reaction; SARS-CoV-2; Turkey; Young Adult","Ozgur","Didem","Department of Medical Microbiology, Kafkas University, Faculty of Medicine, Kars, 36100, Turkey",NA
"2383","34223786","10.2217/fmb-2020-0134","Prevalence of COVID-19 in 10,000 samples from 7853 patients in Eastern Turkey by positive real-time PCR.","Aim: COVID-19, caused by SARS-CoV-2, started in December 2019 and has spread across the world. Materials &amp; methods: We analyzed real-time PCR results of 10,000 samples from 2 April to 30 May 2020 in three neighbor cities located in the East of Turkey. The final study population was 7853 cases, after excluding screening tests. Results: Real-time PCR was performed to detect the SARS-CoV-2-specific RNA-dependent-RNA-polymerase gene fragment. The number of total positive sam","2021","07","20","Future Microbiol","Future microbiology","COVID-19; SARS-CoV-2; positivity rate; prevalence; real-time PCR; Adolescent; Adult; Aged; COVID-19; COVID-19 Testing; Child; Child, Preschool; Cough; Female; Fever; Humans; Infant; Infant, Newborn; Male; Middle Aged; Prevalence; Real-Time Polymerase Chain Reaction; SARS-CoV-2; Turkey; Young Adult","Tarhan","Ceyda","Department of Otorhinolaryngology, Igdir State Hospital, Igdir, 76000, Turkey",NA
"2384","34223786","10.2217/fmb-2020-0134","Prevalence of COVID-19 in 10,000 samples from 7853 patients in Eastern Turkey by positive real-time PCR.","Aim: COVID-19, caused by SARS-CoV-2, started in December 2019 and has spread across the world. Materials &amp; methods: We analyzed real-time PCR results of 10,000 samples from 2 April to 30 May 2020 in three neighbor cities located in the East of Turkey. The final study population was 7853 cases, after excluding screening tests. Results: Real-time PCR was performed to detect the SARS-CoV-2-specific RNA-dependent-RNA-polymerase gene fragment. The number of total positive sam","2021","07","20","Future Microbiol","Future microbiology","COVID-19; SARS-CoV-2; positivity rate; prevalence; real-time PCR; Adolescent; Adult; Aged; COVID-19; COVID-19 Testing; Child; Child, Preschool; Cough; Female; Fever; Humans; Infant; Infant, Newborn; Male; Middle Aged; Prevalence; Real-Time Polymerase Chain Reaction; SARS-CoV-2; Turkey; Young Adult","Altintas","Susamber D","Department of Chest Diseases, Igdir State Hospital, Igdir, 76000, Turkey",NA
"2385","34223786","10.2217/fmb-2020-0134","Prevalence of COVID-19 in 10,000 samples from 7853 patients in Eastern Turkey by positive real-time PCR.","Aim: COVID-19, caused by SARS-CoV-2, started in December 2019 and has spread across the world. Materials &amp; methods: We analyzed real-time PCR results of 10,000 samples from 2 April to 30 May 2020 in three neighbor cities located in the East of Turkey. The final study population was 7853 cases, after excluding screening tests. Results: Real-time PCR was performed to detect the SARS-CoV-2-specific RNA-dependent-RNA-polymerase gene fragment. The number of total positive sam","2021","07","20","Future Microbiol","Future microbiology","COVID-19; SARS-CoV-2; positivity rate; prevalence; real-time PCR; Adolescent; Adult; Aged; COVID-19; COVID-19 Testing; Child; Child, Preschool; Cough; Female; Fever; Humans; Infant; Infant, Newborn; Male; Middle Aged; Prevalence; Real-Time Polymerase Chain Reaction; SARS-CoV-2; Turkey; Young Adult","Caliskan","Okan","Department of Infectious Disease &amp",NA
"2386","34223786","10.2217/fmb-2020-0134","Prevalence of COVID-19 in 10,000 samples from 7853 patients in Eastern Turkey by positive real-time PCR.","Aim: COVID-19, caused by SARS-CoV-2, started in December 2019 and has spread across the world. Materials &amp; methods: We analyzed real-time PCR results of 10,000 samples from 2 April to 30 May 2020 in three neighbor cities located in the East of Turkey. The final study population was 7853 cases, after excluding screening tests. Results: Real-time PCR was performed to detect the SARS-CoV-2-specific RNA-dependent-RNA-polymerase gene fragment. The number of total positive sam","2021","07","20","Future Microbiol","Future microbiology","COVID-19; SARS-CoV-2; positivity rate; prevalence; real-time PCR; Adolescent; Adult; Aged; COVID-19; COVID-19 Testing; Child; Child, Preschool; Cough; Female; Fever; Humans; Infant; Infant, Newborn; Male; Middle Aged; Prevalence; Real-Time Polymerase Chain Reaction; SARS-CoV-2; Turkey; Young Adult","Tuna","Aysegul","Department of Infectious Disease &amp",NA
"2387","34223786","10.2217/fmb-2020-0134","Prevalence of COVID-19 in 10,000 samples from 7853 patients in Eastern Turkey by positive real-time PCR.","Aim: COVID-19, caused by SARS-CoV-2, started in December 2019 and has spread across the world. Materials &amp; methods: We analyzed real-time PCR results of 10,000 samples from 2 April to 30 May 2020 in three neighbor cities located in the East of Turkey. The final study population was 7853 cases, after excluding screening tests. Results: Real-time PCR was performed to detect the SARS-CoV-2-specific RNA-dependent-RNA-polymerase gene fragment. The number of total positive sam","2021","07","20","Future Microbiol","Future microbiology","COVID-19; SARS-CoV-2; positivity rate; prevalence; real-time PCR; Adolescent; Adult; Aged; COVID-19; COVID-19 Testing; Child; Child, Preschool; Cough; Female; Fever; Humans; Infant; Infant, Newborn; Male; Middle Aged; Prevalence; Real-Time Polymerase Chain Reaction; SARS-CoV-2; Turkey; Young Adult","Kazci","Saliha","Department of Infectious Disease &amp",NA
"2388","34223786","10.2217/fmb-2020-0134","Prevalence of COVID-19 in 10,000 samples from 7853 patients in Eastern Turkey by positive real-time PCR.","Aim: COVID-19, caused by SARS-CoV-2, started in December 2019 and has spread across the world. Materials &amp; methods: We analyzed real-time PCR results of 10,000 samples from 2 April to 30 May 2020 in three neighbor cities located in the East of Turkey. The final study population was 7853 cases, after excluding screening tests. Results: Real-time PCR was performed to detect the SARS-CoV-2-specific RNA-dependent-RNA-polymerase gene fragment. The number of total positive sam","2021","07","20","Future Microbiol","Future microbiology","COVID-19; SARS-CoV-2; positivity rate; prevalence; real-time PCR; Adolescent; Adult; Aged; COVID-19; COVID-19 Testing; Child; Child, Preschool; Cough; Female; Fever; Humans; Infant; Infant, Newborn; Male; Middle Aged; Prevalence; Real-Time Polymerase Chain Reaction; SARS-CoV-2; Turkey; Young Adult","Karadavut","Mursel","Department of Internal Medicine, Ardahan State Hospital, Ardahan, 75100, Turkey",NA
"2389","34223786","10.2217/fmb-2020-0134","Prevalence of COVID-19 in 10,000 samples from 7853 patients in Eastern Turkey by positive real-time PCR.","Aim: COVID-19, caused by SARS-CoV-2, started in December 2019 and has spread across the world. Materials &amp; methods: We analyzed real-time PCR results of 10,000 samples from 2 April to 30 May 2020 in three neighbor cities located in the East of Turkey. The final study population was 7853 cases, after excluding screening tests. Results: Real-time PCR was performed to detect the SARS-CoV-2-specific RNA-dependent-RNA-polymerase gene fragment. The number of total positive sam","2021","07","20","Future Microbiol","Future microbiology","COVID-19; SARS-CoV-2; positivity rate; prevalence; real-time PCR; Adolescent; Adult; Aged; COVID-19; COVID-19 Testing; Child; Child, Preschool; Cough; Female; Fever; Humans; Infant; Infant, Newborn; Male; Middle Aged; Prevalence; Real-Time Polymerase Chain Reaction; SARS-CoV-2; Turkey; Young Adult","Gumus","Abdullah","Department of Medical Microbiology, Kafkas University, Faculty of Medicine, Kars, 36100, Turkey",NA
"2390","34223786","10.2217/fmb-2020-0134","Prevalence of COVID-19 in 10,000 samples from 7853 patients in Eastern Turkey by positive real-time PCR.","Aim: COVID-19, caused by SARS-CoV-2, started in December 2019 and has spread across the world. Materials &amp; methods: We analyzed real-time PCR results of 10,000 samples from 2 April to 30 May 2020 in three neighbor cities located in the East of Turkey. The final study population was 7853 cases, after excluding screening tests. Results: Real-time PCR was performed to detect the SARS-CoV-2-specific RNA-dependent-RNA-polymerase gene fragment. The number of total positive sam","2021","07","20","Future Microbiol","Future microbiology","COVID-19; SARS-CoV-2; positivity rate; prevalence; real-time PCR; Adolescent; Adult; Aged; COVID-19; COVID-19 Testing; Child; Child, Preschool; Cough; Female; Fever; Humans; Infant; Infant, Newborn; Male; Middle Aged; Prevalence; Real-Time Polymerase Chain Reaction; SARS-CoV-2; Turkey; Young Adult","Apaydin","Gozde","Department of Pediatric Health &amp",NA
"2391","34223786","10.2217/fmb-2020-0134","Prevalence of COVID-19 in 10,000 samples from 7853 patients in Eastern Turkey by positive real-time PCR.","Aim: COVID-19, caused by SARS-CoV-2, started in December 2019 and has spread across the world. Materials &amp; methods: We analyzed real-time PCR results of 10,000 samples from 2 April to 30 May 2020 in three neighbor cities located in the East of Turkey. The final study population was 7853 cases, after excluding screening tests. Results: Real-time PCR was performed to detect the SARS-CoV-2-specific RNA-dependent-RNA-polymerase gene fragment. The number of total positive sam","2021","07","20","Future Microbiol","Future microbiology","COVID-19; SARS-CoV-2; positivity rate; prevalence; real-time PCR; Adolescent; Adult; Aged; COVID-19; COVID-19 Testing; Child; Child, Preschool; Cough; Female; Fever; Humans; Infant; Infant, Newborn; Male; Middle Aged; Prevalence; Real-Time Polymerase Chain Reaction; SARS-CoV-2; Turkey; Young Adult","Mumcu","Necati","Department of Infectious Disease &amp",NA
"2392","34223786","10.2217/fmb-2020-0134","Prevalence of COVID-19 in 10,000 samples from 7853 patients in Eastern Turkey by positive real-time PCR.","Aim: COVID-19, caused by SARS-CoV-2, started in December 2019 and has spread across the world. Materials &amp; methods: We analyzed real-time PCR results of 10,000 samples from 2 April to 30 May 2020 in three neighbor cities located in the East of Turkey. The final study population was 7853 cases, after excluding screening tests. Results: Real-time PCR was performed to detect the SARS-CoV-2-specific RNA-dependent-RNA-polymerase gene fragment. The number of total positive sam","2021","07","20","Future Microbiol","Future microbiology","COVID-19; SARS-CoV-2; positivity rate; prevalence; real-time PCR; Adolescent; Adult; Aged; COVID-19; COVID-19 Testing; Child; Child, Preschool; Cough; Female; Fever; Humans; Infant; Infant, Newborn; Male; Middle Aged; Prevalence; Real-Time Polymerase Chain Reaction; SARS-CoV-2; Turkey; Young Adult","Coruh","Onur","Department of Anesthesiology &amp",NA
"2393","34223786","10.2217/fmb-2020-0134","Prevalence of COVID-19 in 10,000 samples from 7853 patients in Eastern Turkey by positive real-time PCR.","Aim: COVID-19, caused by SARS-CoV-2, started in December 2019 and has spread across the world. Materials &amp; methods: We analyzed real-time PCR results of 10,000 samples from 2 April to 30 May 2020 in three neighbor cities located in the East of Turkey. The final study population was 7853 cases, after excluding screening tests. Results: Real-time PCR was performed to detect the SARS-CoV-2-specific RNA-dependent-RNA-polymerase gene fragment. The number of total positive sam","2021","07","20","Future Microbiol","Future microbiology","COVID-19; SARS-CoV-2; positivity rate; prevalence; real-time PCR; Adolescent; Adult; Aged; COVID-19; COVID-19 Testing; Child; Child, Preschool; Cough; Female; Fever; Humans; Infant; Infant, Newborn; Male; Middle Aged; Prevalence; Real-Time Polymerase Chain Reaction; SARS-CoV-2; Turkey; Young Adult","Tutuncu","Emin E","Department of Infectious Disease &amp",NA
"2394","34223780","10.1080/15412555.2021.1945021","The Performance of Digital Monitoring Devices for Oxygen Saturation and Respiratory Rate in COPD: A Systematic Review.","Healthcare access and delivery for individuals with chronic obstructive pulmonary disease (COPD) who live in remote areas or who are susceptible to contracting communicable diseases, such as COVID-19, may be a challenge. Telehealth and remote monitoring devices can be used to overcome this issue. However, the accuracy of these devices must be ensured before forming healthcare decisions based on their outcomes. Therefore, a systematic review was performed to synthesize the evidence on the reliabi","2021","07","05","COPD","COPD","COPD; Digital devices; oxygen; reliability; respiratory rate; validity","Mehdipour","Ava","School of Rehabilitation Science, McMaster University, Hamilton, ON, Canada",NA
"2395","34223780","10.1080/15412555.2021.1945021","The Performance of Digital Monitoring Devices for Oxygen Saturation and Respiratory Rate in COPD: A Systematic Review.","Healthcare access and delivery for individuals with chronic obstructive pulmonary disease (COPD) who live in remote areas or who are susceptible to contracting communicable diseases, such as COVID-19, may be a challenge. Telehealth and remote monitoring devices can be used to overcome this issue. However, the accuracy of these devices must be ensured before forming healthcare decisions based on their outcomes. Therefore, a systematic review was performed to synthesize the evidence on the reliabi","2021","07","05","COPD","COPD","COPD; Digital devices; oxygen; reliability; respiratory rate; validity","Wiley","Elise","School of Rehabilitation Science, McMaster University, Hamilton, ON, Canada",NA
"2396","34223780","10.1080/15412555.2021.1945021","The Performance of Digital Monitoring Devices for Oxygen Saturation and Respiratory Rate in COPD: A Systematic Review.","Healthcare access and delivery for individuals with chronic obstructive pulmonary disease (COPD) who live in remote areas or who are susceptible to contracting communicable diseases, such as COVID-19, may be a challenge. Telehealth and remote monitoring devices can be used to overcome this issue. However, the accuracy of these devices must be ensured before forming healthcare decisions based on their outcomes. Therefore, a systematic review was performed to synthesize the evidence on the reliabi","2021","07","05","COPD","COPD","COPD; Digital devices; oxygen; reliability; respiratory rate; validity","Richardson","Julie","School of Rehabilitation Science, McMaster University, Hamilton, ON, Canada",NA
"2397","34223780","10.1080/15412555.2021.1945021","The Performance of Digital Monitoring Devices for Oxygen Saturation and Respiratory Rate in COPD: A Systematic Review.","Healthcare access and delivery for individuals with chronic obstructive pulmonary disease (COPD) who live in remote areas or who are susceptible to contracting communicable diseases, such as COVID-19, may be a challenge. Telehealth and remote monitoring devices can be used to overcome this issue. However, the accuracy of these devices must be ensured before forming healthcare decisions based on their outcomes. Therefore, a systematic review was performed to synthesize the evidence on the reliabi","2021","07","05","COPD","COPD","COPD; Digital devices; oxygen; reliability; respiratory rate; validity","Beauchamp","Marla","School of Rehabilitation Science, McMaster University, Hamilton, ON, Canada",NA
"2398","34223780","10.1080/15412555.2021.1945021","The Performance of Digital Monitoring Devices for Oxygen Saturation and Respiratory Rate in COPD: A Systematic Review.","Healthcare access and delivery for individuals with chronic obstructive pulmonary disease (COPD) who live in remote areas or who are susceptible to contracting communicable diseases, such as COVID-19, may be a challenge. Telehealth and remote monitoring devices can be used to overcome this issue. However, the accuracy of these devices must be ensured before forming healthcare decisions based on their outcomes. Therefore, a systematic review was performed to synthesize the evidence on the reliabi","2021","07","05","COPD","COPD","COPD; Digital devices; oxygen; reliability; respiratory rate; validity","Kuspinar","Ayse","School of Rehabilitation Science, McMaster University, Hamilton, ON, Canada",NA
"2399","34223748","10.20452/pamw.16059","The prevalence of invasive aspergillosis among COVID-19 intensive care unit patients: not so rare problem.",NA,"2021","07","05","Pol Arch Intern Med","Polish archives of internal medicine",NA,"Kluzik","Anna",NA,NA
"2400","34223748","10.20452/pamw.16059","The prevalence of invasive aspergillosis among COVID-19 intensive care unit patients: not so rare problem.",NA,"2021","07","05","Pol Arch Intern Med","Polish archives of internal medicine",NA,"Szrama","Jakub",NA,NA
"2401","34223748","10.20452/pamw.16059","The prevalence of invasive aspergillosis among COVID-19 intensive care unit patients: not so rare problem.",NA,"2021","07","05","Pol Arch Intern Med","Polish archives of internal medicine",NA,"Hampelska","Katarzyna",NA,NA
"2402","34223748","10.20452/pamw.16059","The prevalence of invasive aspergillosis among COVID-19 intensive care unit patients: not so rare problem.",NA,"2021","07","05","Pol Arch Intern Med","Polish archives of internal medicine",NA,"Kusza","Krzysztof",NA,NA
"2403","34223748","10.20452/pamw.16059","The prevalence of invasive aspergillosis among COVID-19 intensive care unit patients: not so rare problem.",NA,"2021","07","05","Pol Arch Intern Med","Polish archives of internal medicine",NA,"Tomczak","Hanna",NA,NA
"2404","34223651","10.1111/risa.13781","Effective Lockdown and Role of Hospital-Based COVID-19 Transmission in Some Indian States: An Outbreak Risk Analysis.","Several reports in India indicate hospitals and quarantined centers are COVID-19 hotspots. To study the transmission occurring from the hospitals and as well as from the community, we developed a mechanistic model with a lockdown effect. Using daily COVID-19 cases data from six states and overall India, we estimated several important parameters of our model. Moreover, we provided an estimation of the effective (RT ), the basic (R0 ), the community (RC ), and the ","2021","07","05","Risk Anal","Risk analysis : an official publication of the Society for Risk Analysis","COVID-19; effective lockdown policy; ensemble model forecast; hospital-based transmission; outbreak risk analysis","Sardar","Tridip","Department of Mathematics, Dinabandhu Andrews College, Kolkata, West Bengal, India",NA
"2405","34223651","10.1111/risa.13781","Effective Lockdown and Role of Hospital-Based COVID-19 Transmission in Some Indian States: An Outbreak Risk Analysis.","Several reports in India indicate hospitals and quarantined centers are COVID-19 hotspots. To study the transmission occurring from the hospitals and as well as from the community, we developed a mechanistic model with a lockdown effect. Using daily COVID-19 cases data from six states and overall India, we estimated several important parameters of our model. Moreover, we provided an estimation of the effective (RT ), the basic (R0 ), the community (RC ), and the ","2021","07","05","Risk Anal","Risk analysis : an official publication of the Society for Risk Analysis","COVID-19; effective lockdown policy; ensemble model forecast; hospital-based transmission; outbreak risk analysis","Rana","Sourav","Department of Statistics, Visva-Bharati University, Santiniketan, West Bengal, India",NA
"2406","34223610","10.1093/heapro/daab059","Predicting COVID-19 health behaviour initiation, consistency, interruptions and discontinuation among social media users in Nigeria.","Literature on the predictors of health behaviour initiation, interruption, consistency and discontinuation is scarce. This study sought to fill this gap by suggesting a model that takes into account these variables. Using the structural equation modelling, we surveyed 470 social media users in Nigeria and found that perceived vulnerability, perceived seriousness; benefits to action, self-efficacy and cues to action significantly predict health behaviour initiation. Also, the predictors of health","2021","07","05","Health Promot Int","Health promotion international","COVID-19; health behaviour; health belief model; modelling; social media Nigeria","Oyeoku","Eke Kalu","Department of Education Foundations, University of Nigeria, Nsukka, Nigeria",NA
"2407","34223610","10.1093/heapro/daab059","Predicting COVID-19 health behaviour initiation, consistency, interruptions and discontinuation among social media users in Nigeria.","Literature on the predictors of health behaviour initiation, interruption, consistency and discontinuation is scarce. This study sought to fill this gap by suggesting a model that takes into account these variables. Using the structural equation modelling, we surveyed 470 social media users in Nigeria and found that perceived vulnerability, perceived seriousness; benefits to action, self-efficacy and cues to action significantly predict health behaviour initiation. Also, the predictors of health","2021","07","05","Health Promot Int","Health promotion international","COVID-19; health behaviour; health belief model; modelling; social media Nigeria","Talabi","Felix Olajide","Department of Mass Communication, Redeemers' University, Osun State, Nigeria",NA
"2408","34223610","10.1093/heapro/daab059","Predicting COVID-19 health behaviour initiation, consistency, interruptions and discontinuation among social media users in Nigeria.","Literature on the predictors of health behaviour initiation, interruption, consistency and discontinuation is scarce. This study sought to fill this gap by suggesting a model that takes into account these variables. Using the structural equation modelling, we surveyed 470 social media users in Nigeria and found that perceived vulnerability, perceived seriousness; benefits to action, self-efficacy and cues to action significantly predict health behaviour initiation. Also, the predictors of health","2021","07","05","Health Promot Int","Health promotion international","COVID-19; health behaviour; health belief model; modelling; social media Nigeria","Oloyede","David","Department of Mass Communication, Adeleke University, Ede Osun State, Nigeria",NA
"2409","34223610","10.1093/heapro/daab059","Predicting COVID-19 health behaviour initiation, consistency, interruptions and discontinuation among social media users in Nigeria.","Literature on the predictors of health behaviour initiation, interruption, consistency and discontinuation is scarce. This study sought to fill this gap by suggesting a model that takes into account these variables. Using the structural equation modelling, we surveyed 470 social media users in Nigeria and found that perceived vulnerability, perceived seriousness; benefits to action, self-efficacy and cues to action significantly predict health behaviour initiation. Also, the predictors of health","2021","07","05","Health Promot Int","Health promotion international","COVID-19; health behaviour; health belief model; modelling; social media Nigeria","Boluwatife","Aiyesimoju Ayodeji","Department of Mass Communication, Joseph Ayo Babalola University, Ikeji-Arakeji, Osun State, Nigeria",NA
"2410","34223610","10.1093/heapro/daab059","Predicting COVID-19 health behaviour initiation, consistency, interruptions and discontinuation among social media users in Nigeria.","Literature on the predictors of health behaviour initiation, interruption, consistency and discontinuation is scarce. This study sought to fill this gap by suggesting a model that takes into account these variables. Using the structural equation modelling, we surveyed 470 social media users in Nigeria and found that perceived vulnerability, perceived seriousness; benefits to action, self-efficacy and cues to action significantly predict health behaviour initiation. Also, the predictors of health","2021","07","05","Health Promot Int","Health promotion international","COVID-19; health behaviour; health belief model; modelling; social media Nigeria","Gever","Verlumun Celestine","Department of Mass Communication, University of Nigeria, Nsukka, Nigeria",NA
"2411","34223610","10.1093/heapro/daab059","Predicting COVID-19 health behaviour initiation, consistency, interruptions and discontinuation among social media users in Nigeria.","Literature on the predictors of health behaviour initiation, interruption, consistency and discontinuation is scarce. This study sought to fill this gap by suggesting a model that takes into account these variables. Using the structural equation modelling, we surveyed 470 social media users in Nigeria and found that perceived vulnerability, perceived seriousness; benefits to action, self-efficacy and cues to action significantly predict health behaviour initiation. Also, the predictors of health","2021","07","05","Health Promot Int","Health promotion international","COVID-19; health behaviour; health belief model; modelling; social media Nigeria","Ebere","Ibe","Department of Science Education, University of Nigeria, Nsukka, Nigeria",NA
"2412","34223589","10.1039/d1cp01790j","Corilagin and 1,3,6-Tri-<i>O</i>-galloy-ß-D-glucose: potential inhibitors of SARS-CoV-2 variants.","The COVID-19 disease caused by the virus SARS-CoV-2, first detected in December 2019, is still emerging through virus mutations. Although almost under control in some countries due to effective vaccines that are mitigating the worldwide pandemic, the urgency to develop additional vaccines and therapeutic treatments is imperative. In this work, the natural polyphenols corilagin and 1,3,6-tri-O-galloy-ß-d-glucose (TGG) are investigated to determine the structural basis of inhibitor interactions as","2021","07","20","Phys Chem Chem Phys","Physical chemistry chemical physics : PCCP","Angiotensin-Converting Enzyme 2; Antiviral Agents; Binding Sites; Gallic Acid; Glucose; Glucosides; Humans; Hydrolyzable Tannins; Molecular Docking Simulation; Molecular Dynamics Simulation; Mutation; Protein Binding; Protein Interaction Domains and Motifs; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Virus Internalization","Binette","Vincent","Départment de physique, Université de Montréal, Case postale 6128, succursale Centre-ville, Montréal, QC, H3C 3J7 Canada. vincent.binette@umontreal.ca sebastien.cote.4@umontreal.ca roger.gaudreault@umontreal.ca normand.mousseau@umontreal","vincent.binette@umontreal.ca"
"2413","34223589","10.1039/d1cp01790j","Corilagin and 1,3,6-Tri-<i>O</i>-galloy-ß-D-glucose: potential inhibitors of SARS-CoV-2 variants.","The COVID-19 disease caused by the virus SARS-CoV-2, first detected in December 2019, is still emerging through virus mutations. Although almost under control in some countries due to effective vaccines that are mitigating the worldwide pandemic, the urgency to develop additional vaccines and therapeutic treatments is imperative. In this work, the natural polyphenols corilagin and 1,3,6-tri-O-galloy-ß-d-glucose (TGG) are investigated to determine the structural basis of inhibitor interactions as","2021","07","20","Phys Chem Chem Phys","Physical chemistry chemical physics : PCCP","Angiotensin-Converting Enzyme 2; Antiviral Agents; Binding Sites; Gallic Acid; Glucose; Glucosides; Humans; Hydrolyzable Tannins; Molecular Docking Simulation; Molecular Dynamics Simulation; Mutation; Protein Binding; Protein Interaction Domains and Motifs; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Virus Internalization","Côté","Sébastien","Départment de physique, Université de Montréal, Case postale 6128, succursale Centre-ville, Montréal, QC, H3C 3J7 Canada. vincent.binette@umontreal.ca sebastien.cote.4@umontreal.ca roger.gaudreault@umontreal.ca normand.mousseau@umontreal.ca and Cégep de Saint-Jérôme, 455 Rue Fournier, Saint-Jérôme, QC, J7Z 4V2 Canada","vincent.binette@umontreal.ca"
"2414","34223589","10.1039/d1cp01790j","Corilagin and 1,3,6-Tri-<i>O</i>-galloy-ß-D-glucose: potential inhibitors of SARS-CoV-2 variants.","The COVID-19 disease caused by the virus SARS-CoV-2, first detected in December 2019, is still emerging through virus mutations. Although almost under control in some countries due to effective vaccines that are mitigating the worldwide pandemic, the urgency to develop additional vaccines and therapeutic treatments is imperative. In this work, the natural polyphenols corilagin and 1,3,6-tri-O-galloy-ß-d-glucose (TGG) are investigated to determine the structural basis of inhibitor interactions as","2021","07","20","Phys Chem Chem Phys","Physical chemistry chemical physics : PCCP","Angiotensin-Converting Enzyme 2; Antiviral Agents; Binding Sites; Gallic Acid; Glucose; Glucosides; Humans; Hydrolyzable Tannins; Molecular Docking Simulation; Molecular Dynamics Simulation; Mutation; Protein Binding; Protein Interaction Domains and Motifs; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Virus Internalization","Haddad","Mohamed","Centre Armand-Frappier Santé Biotechnologie, 531 boulevard des Prairies, Laval, QC, H7V 1B7 Canada. Mohamed.Haddad@inrs.ca Charles.Ramassamy@inrs","Mohamed.Haddad@inrs.ca"
"2415","34223589","10.1039/d1cp01790j","Corilagin and 1,3,6-Tri-<i>O</i>-galloy-ß-D-glucose: potential inhibitors of SARS-CoV-2 variants.","The COVID-19 disease caused by the virus SARS-CoV-2, first detected in December 2019, is still emerging through virus mutations. Although almost under control in some countries due to effective vaccines that are mitigating the worldwide pandemic, the urgency to develop additional vaccines and therapeutic treatments is imperative. In this work, the natural polyphenols corilagin and 1,3,6-tri-O-galloy-ß-d-glucose (TGG) are investigated to determine the structural basis of inhibitor interactions as","2021","07","20","Phys Chem Chem Phys","Physical chemistry chemical physics : PCCP","Angiotensin-Converting Enzyme 2; Antiviral Agents; Binding Sites; Gallic Acid; Glucose; Glucosides; Humans; Hydrolyzable Tannins; Molecular Docking Simulation; Molecular Dynamics Simulation; Mutation; Protein Binding; Protein Interaction Domains and Motifs; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Virus Internalization","Nguyen","Phuong Trang","Département de Chimie, Université du Québec à Montréal, 2101 Rue Jeanne-Mance, Montreal, QC, H2X 2J6 Canada. bourgault.steve@uqam","bourgault.steve@uqam.ca"
"2416","34223589","10.1039/d1cp01790j","Corilagin and 1,3,6-Tri-<i>O</i>-galloy-ß-D-glucose: potential inhibitors of SARS-CoV-2 variants.","The COVID-19 disease caused by the virus SARS-CoV-2, first detected in December 2019, is still emerging through virus mutations. Although almost under control in some countries due to effective vaccines that are mitigating the worldwide pandemic, the urgency to develop additional vaccines and therapeutic treatments is imperative. In this work, the natural polyphenols corilagin and 1,3,6-tri-O-galloy-ß-d-glucose (TGG) are investigated to determine the structural basis of inhibitor interactions as","2021","07","20","Phys Chem Chem Phys","Physical chemistry chemical physics : PCCP","Angiotensin-Converting Enzyme 2; Antiviral Agents; Binding Sites; Gallic Acid; Glucose; Glucosides; Humans; Hydrolyzable Tannins; Molecular Docking Simulation; Molecular Dynamics Simulation; Mutation; Protein Binding; Protein Interaction Domains and Motifs; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Virus Internalization","Bélanger","Sébastien","Department of Physics, McGill University, 3600 University Street, Montreal, QC, H3A 2T8 Canada",NA
"2417","34223589","10.1039/d1cp01790j","Corilagin and 1,3,6-Tri-<i>O</i>-galloy-ß-D-glucose: potential inhibitors of SARS-CoV-2 variants.","The COVID-19 disease caused by the virus SARS-CoV-2, first detected in December 2019, is still emerging through virus mutations. Although almost under control in some countries due to effective vaccines that are mitigating the worldwide pandemic, the urgency to develop additional vaccines and therapeutic treatments is imperative. In this work, the natural polyphenols corilagin and 1,3,6-tri-O-galloy-ß-d-glucose (TGG) are investigated to determine the structural basis of inhibitor interactions as","2021","07","20","Phys Chem Chem Phys","Physical chemistry chemical physics : PCCP","Angiotensin-Converting Enzyme 2; Antiviral Agents; Binding Sites; Gallic Acid; Glucose; Glucosides; Humans; Hydrolyzable Tannins; Molecular Docking Simulation; Molecular Dynamics Simulation; Mutation; Protein Binding; Protein Interaction Domains and Motifs; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Virus Internalization","Bourgault","Steve","Département de Chimie, Université du Québec à Montréal, 2101 Rue Jeanne-Mance, Montreal, QC, H2X 2J6 Canada. bourgault.steve@uqam","bourgault.steve@uqam.ca"
"2418","34223589","10.1039/d1cp01790j","Corilagin and 1,3,6-Tri-<i>O</i>-galloy-ß-D-glucose: potential inhibitors of SARS-CoV-2 variants.","The COVID-19 disease caused by the virus SARS-CoV-2, first detected in December 2019, is still emerging through virus mutations. Although almost under control in some countries due to effective vaccines that are mitigating the worldwide pandemic, the urgency to develop additional vaccines and therapeutic treatments is imperative. In this work, the natural polyphenols corilagin and 1,3,6-tri-O-galloy-ß-d-glucose (TGG) are investigated to determine the structural basis of inhibitor interactions as","2021","07","20","Phys Chem Chem Phys","Physical chemistry chemical physics : PCCP","Angiotensin-Converting Enzyme 2; Antiviral Agents; Binding Sites; Gallic Acid; Glucose; Glucosides; Humans; Hydrolyzable Tannins; Molecular Docking Simulation; Molecular Dynamics Simulation; Mutation; Protein Binding; Protein Interaction Domains and Motifs; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Virus Internalization","Ramassamy","Charles","Centre Armand-Frappier Santé Biotechnologie, 531 boulevard des Prairies, Laval, QC, H7V 1B7 Canada. Mohamed.Haddad@inrs.ca Charles.Ramassamy@inrs","Mohamed.Haddad@inrs.ca"
"2419","34223589","10.1039/d1cp01790j","Corilagin and 1,3,6-Tri-<i>O</i>-galloy-ß-D-glucose: potential inhibitors of SARS-CoV-2 variants.","The COVID-19 disease caused by the virus SARS-CoV-2, first detected in December 2019, is still emerging through virus mutations. Although almost under control in some countries due to effective vaccines that are mitigating the worldwide pandemic, the urgency to develop additional vaccines and therapeutic treatments is imperative. In this work, the natural polyphenols corilagin and 1,3,6-tri-O-galloy-ß-d-glucose (TGG) are investigated to determine the structural basis of inhibitor interactions as","2021","07","20","Phys Chem Chem Phys","Physical chemistry chemical physics : PCCP","Angiotensin-Converting Enzyme 2; Antiviral Agents; Binding Sites; Gallic Acid; Glucose; Glucosides; Humans; Hydrolyzable Tannins; Molecular Docking Simulation; Molecular Dynamics Simulation; Mutation; Protein Binding; Protein Interaction Domains and Motifs; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Virus Internalization","Gaudreault","Roger","Départment de physique, Université de Montréal, Case postale 6128, succursale Centre-ville, Montréal, QC, H3C 3J7 Canada. vincent.binette@umontreal.ca sebastien.cote.4@umontreal.ca roger.gaudreault@umontreal.ca normand.mousseau@umontreal","vincent.binette@umontreal.ca"
"2420","34223589","10.1039/d1cp01790j","Corilagin and 1,3,6-Tri-<i>O</i>-galloy-ß-D-glucose: potential inhibitors of SARS-CoV-2 variants.","The COVID-19 disease caused by the virus SARS-CoV-2, first detected in December 2019, is still emerging through virus mutations. Although almost under control in some countries due to effective vaccines that are mitigating the worldwide pandemic, the urgency to develop additional vaccines and therapeutic treatments is imperative. In this work, the natural polyphenols corilagin and 1,3,6-tri-O-galloy-ß-d-glucose (TGG) are investigated to determine the structural basis of inhibitor interactions as","2021","07","20","Phys Chem Chem Phys","Physical chemistry chemical physics : PCCP","Angiotensin-Converting Enzyme 2; Antiviral Agents; Binding Sites; Gallic Acid; Glucose; Glucosides; Humans; Hydrolyzable Tannins; Molecular Docking Simulation; Molecular Dynamics Simulation; Mutation; Protein Binding; Protein Interaction Domains and Motifs; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Virus Internalization","Mousseau","Normand","Départment de physique, Université de Montréal, Case postale 6128, succursale Centre-ville, Montréal, QC, H3C 3J7 Canada. vincent.binette@umontreal.ca sebastien.cote.4@umontreal.ca roger.gaudreault@umontreal.ca normand.mousseau@umontreal","vincent.binette@umontreal.ca"
"2421","34223560","10.1007/s11528-021-00625-5","Technologies, Challenges and Needs of K-12 Teachers in the Transition to Distance Learning during the COVID-19 Pandemic.","In response to the COVID-19 pandemic, K-12 schools in the United States closed and teachers transitioned to distance learning. The purpose of this survey research study is to determine technology resources and strategies K-12 teachers have used in this transition. Additionally, this study examines the difficulties teachers experienced, along with support they wish they had during the transition. Findings indicate that a wide variety of websites and applications were used to provide academic cont","2021","07","06","TechTrends","TechTrends : for leaders in education &amp; training","COVID-19; Distance learning; Emergency; K-12; Online learning; Pandemic; Teachers","Francom","Gregory M","Mississippi State University, 2208 Plum Road, Starkville, MS 39759 USA",NA
"2422","34223560","10.1007/s11528-021-00625-5","Technologies, Challenges and Needs of K-12 Teachers in the Transition to Distance Learning during the COVID-19 Pandemic.","In response to the COVID-19 pandemic, K-12 schools in the United States closed and teachers transitioned to distance learning. The purpose of this survey research study is to determine technology resources and strategies K-12 teachers have used in this transition. Additionally, this study examines the difficulties teachers experienced, along with support they wish they had during the transition. Findings indicate that a wide variety of websites and applications were used to provide academic cont","2021","07","06","TechTrends","TechTrends : for leaders in education &amp; training","COVID-19; Distance learning; Emergency; K-12; Online learning; Pandemic; Teachers","Lee","Sang Joon","Mississippi State University, 2208 Plum Road, Starkville, MS 39759 USA",NA
"2423","34223560","10.1007/s11528-021-00625-5","Technologies, Challenges and Needs of K-12 Teachers in the Transition to Distance Learning during the COVID-19 Pandemic.","In response to the COVID-19 pandemic, K-12 schools in the United States closed and teachers transitioned to distance learning. The purpose of this survey research study is to determine technology resources and strategies K-12 teachers have used in this transition. Additionally, this study examines the difficulties teachers experienced, along with support they wish they had during the transition. Findings indicate that a wide variety of websites and applications were used to provide academic cont","2021","07","06","TechTrends","TechTrends : for leaders in education &amp; training","COVID-19; Distance learning; Emergency; K-12; Online learning; Pandemic; Teachers","Pinkney","Halle","Mississippi State University, 2208 Plum Road, Starkville, MS 39759 USA",NA
"2424","34223525","10.1089/neur.2020.0001","Traumatic Brain Injury during the SARS-CoV-2 Pandemic.","Emergency departments (EDs) are eerily quiet for illnesses apart from COVID-19. In this short communication, we assessed the effect of COVID-19 on ED attendance rates for traumatic brain injury (TBI). Data were collected from all consecutive patients with TBI attending our hospital (Haaglanden Medical Center, The Hague, The Netherlands) during the first 3 weeks of the Dutch lockdown (from March 18 to April 6) and for the same period last year. We observed a 36% decrease in ED attendance for TBI ","2021","07","06","Neurotrauma Rep","Neurotrauma reports","COVID-19; SARS-CoV-2; coronavirus; head trauma; traumatic brain injury","Santing","Juliette A L","Department of Neurology, Haaglanden Medical Center, The Hague, The Netherlands",NA
"2425","34223525","10.1089/neur.2020.0001","Traumatic Brain Injury during the SARS-CoV-2 Pandemic.","Emergency departments (EDs) are eerily quiet for illnesses apart from COVID-19. In this short communication, we assessed the effect of COVID-19 on ED attendance rates for traumatic brain injury (TBI). Data were collected from all consecutive patients with TBI attending our hospital (Haaglanden Medical Center, The Hague, The Netherlands) during the first 3 weeks of the Dutch lockdown (from March 18 to April 6) and for the same period last year. We observed a 36% decrease in ED attendance for TBI ","2021","07","06","Neurotrauma Rep","Neurotrauma reports","COVID-19; SARS-CoV-2; coronavirus; head trauma; traumatic brain injury","van den Brand","Crispijn L","Department of Emergency Medicine, Haaglanden Medical Center, The Hague, The Netherlands",NA
"2426","34223525","10.1089/neur.2020.0001","Traumatic Brain Injury during the SARS-CoV-2 Pandemic.","Emergency departments (EDs) are eerily quiet for illnesses apart from COVID-19. In this short communication, we assessed the effect of COVID-19 on ED attendance rates for traumatic brain injury (TBI). Data were collected from all consecutive patients with TBI attending our hospital (Haaglanden Medical Center, The Hague, The Netherlands) during the first 3 weeks of the Dutch lockdown (from March 18 to April 6) and for the same period last year. We observed a 36% decrease in ED attendance for TBI ","2021","07","06","Neurotrauma Rep","Neurotrauma reports","COVID-19; SARS-CoV-2; coronavirus; head trauma; traumatic brain injury","Jellema","Korné","Department of Neurology, Haaglanden Medical Center, The Hague, The Netherlands",NA
"2427","34223524","10.1089/neur.2020.0002","Perfect Storm: COVID-19 Associated Cardiac Injury and Implications for Neurological Disorders.","Coronavirus disease 2019 (COVID-19) can lead to considerable lung damage and even death. Less is known about the effects of COVID-19 on the cardiovascular system. In their recent JAMA Cardiology article, Shi and colleagues reported an association between cardiac injury and higher risk of in-hospital mortality in patients with COVID-19. Approximately 20% (82 patients) of the study cohort presented with a cardiac injury. The investigators identified cardiac injury as an independent risk fac","2021","07","06","Neurotrauma Rep","Neurotrauma reports","COVID-19; SARS-CoV-2; cardiac injury; injury-associated comorbidities; neurological disorders; risk factors","Jutzeler","Catherine Ruth","Department of Biosystems Science and Engineering, ETH Zurich, Basel, Switzerland",NA
"2428","34223524","10.1089/neur.2020.0002","Perfect Storm: COVID-19 Associated Cardiac Injury and Implications for Neurological Disorders.","Coronavirus disease 2019 (COVID-19) can lead to considerable lung damage and even death. Less is known about the effects of COVID-19 on the cardiovascular system. In their recent JAMA Cardiology article, Shi and colleagues reported an association between cardiac injury and higher risk of in-hospital mortality in patients with COVID-19. Approximately 20% (82 patients) of the study cohort presented with a cardiac injury. The investigators identified cardiac injury as an independent risk fac","2021","07","06","Neurotrauma Rep","Neurotrauma reports","COVID-19; SARS-CoV-2; cardiac injury; injury-associated comorbidities; neurological disorders; risk factors","Nightingale","Thomas Edward","School of Sport, Exercise, and Rehabilitation Sciences, University of Birmingham, Birmingham, United Kingdom",NA
"2429","34223524","10.1089/neur.2020.0002","Perfect Storm: COVID-19 Associated Cardiac Injury and Implications for Neurological Disorders.","Coronavirus disease 2019 (COVID-19) can lead to considerable lung damage and even death. Less is known about the effects of COVID-19 on the cardiovascular system. In their recent JAMA Cardiology article, Shi and colleagues reported an association between cardiac injury and higher risk of in-hospital mortality in patients with COVID-19. Approximately 20% (82 patients) of the study cohort presented with a cardiac injury. The investigators identified cardiac injury as an independent risk fac","2021","07","06","Neurotrauma Rep","Neurotrauma reports","COVID-19; SARS-CoV-2; cardiac injury; injury-associated comorbidities; neurological disorders; risk factors","Krassioukov","Andrei Vasilievich","International Collaboration on Repair Discoveries (ICORD), University of British Columbia, Vancouver, British Columbia, Canada",NA
"2430","34223524","10.1089/neur.2020.0002","Perfect Storm: COVID-19 Associated Cardiac Injury and Implications for Neurological Disorders.","Coronavirus disease 2019 (COVID-19) can lead to considerable lung damage and even death. Less is known about the effects of COVID-19 on the cardiovascular system. In their recent JAMA Cardiology article, Shi and colleagues reported an association between cardiac injury and higher risk of in-hospital mortality in patients with COVID-19. Approximately 20% (82 patients) of the study cohort presented with a cardiac injury. The investigators identified cardiac injury as an independent risk fac","2021","07","06","Neurotrauma Rep","Neurotrauma reports","COVID-19; SARS-CoV-2; cardiac injury; injury-associated comorbidities; neurological disorders; risk factors","Walter","Matthias","International Collaboration on Repair Discoveries (ICORD), University of British Columbia, Vancouver, British Columbia, Canada",NA
"2431","34223520","10.1089/pmr.2021.0013","A Limited Opportunity: COVID-19 and Promotion of Advance Care Planning.","Background: Little is known about how COVID-19 has influenced the role of family caregivers in advance care planning (ACP). Objectives: To explore the experiences of family caregivers and ACP in the United States during the COVID-19 pandemic. Design: Exploratory sequential mixed-methods design of caregiver characteristics and pandemic response to ACP. Settings/Subjects: Family caregivers of care recipients with varied caregiving needs (deme","2021","07","06","Palliat Med Rep","Palliative medicine reports","caregiving; end-of-life care; pandemic","Dassel","Kara B","College of Nursing, School of Medicine, University of Utah, Salt Lake City, Utah, USA",NA
"2432","34223520","10.1089/pmr.2021.0013","A Limited Opportunity: COVID-19 and Promotion of Advance Care Planning.","Background: Little is known about how COVID-19 has influenced the role of family caregivers in advance care planning (ACP). Objectives: To explore the experiences of family caregivers and ACP in the United States during the COVID-19 pandemic. Design: Exploratory sequential mixed-methods design of caregiver characteristics and pandemic response to ACP. Settings/Subjects: Family caregivers of care recipients with varied caregiving needs (deme","2021","07","06","Palliat Med Rep","Palliative medicine reports","caregiving; end-of-life care; pandemic","Towsley","Gail L","College of Nursing, School of Medicine, University of Utah, Salt Lake City, Utah, USA",NA
"2433","34223520","10.1089/pmr.2021.0013","A Limited Opportunity: COVID-19 and Promotion of Advance Care Planning.","Background: Little is known about how COVID-19 has influenced the role of family caregivers in advance care planning (ACP). Objectives: To explore the experiences of family caregivers and ACP in the United States during the COVID-19 pandemic. Design: Exploratory sequential mixed-methods design of caregiver characteristics and pandemic response to ACP. Settings/Subjects: Family caregivers of care recipients with varied caregiving needs (deme","2021","07","06","Palliat Med Rep","Palliative medicine reports","caregiving; end-of-life care; pandemic","Utz","Rebecca L","Department of Sociology, College of Social and Behavioral Sciences, School of Medicine, University of Utah, Salt Lake City, Utah, USA",NA
"2434","34223520","10.1089/pmr.2021.0013","A Limited Opportunity: COVID-19 and Promotion of Advance Care Planning.","Background: Little is known about how COVID-19 has influenced the role of family caregivers in advance care planning (ACP). Objectives: To explore the experiences of family caregivers and ACP in the United States during the COVID-19 pandemic. Design: Exploratory sequential mixed-methods design of caregiver characteristics and pandemic response to ACP. Settings/Subjects: Family caregivers of care recipients with varied caregiving needs (deme","2021","07","06","Palliat Med Rep","Palliative medicine reports","caregiving; end-of-life care; pandemic","Ellington","Lee","College of Nursing, School of Medicine, University of Utah, Salt Lake City, Utah, USA",NA
"2435","34223520","10.1089/pmr.2021.0013","A Limited Opportunity: COVID-19 and Promotion of Advance Care Planning.","Background: Little is known about how COVID-19 has influenced the role of family caregivers in advance care planning (ACP). Objectives: To explore the experiences of family caregivers and ACP in the United States during the COVID-19 pandemic. Design: Exploratory sequential mixed-methods design of caregiver characteristics and pandemic response to ACP. Settings/Subjects: Family caregivers of care recipients with varied caregiving needs (deme","2021","07","06","Palliat Med Rep","Palliative medicine reports","caregiving; end-of-life care; pandemic","Terrill","Alexandra","Department of Occupational and Recreational Therapies, College of Health, School of Medicine, University of Utah, Salt Lake City, Utah, USA",NA
"2436","34223520","10.1089/pmr.2021.0013","A Limited Opportunity: COVID-19 and Promotion of Advance Care Planning.","Background: Little is known about how COVID-19 has influenced the role of family caregivers in advance care planning (ACP). Objectives: To explore the experiences of family caregivers and ACP in the United States during the COVID-19 pandemic. Design: Exploratory sequential mixed-methods design of caregiver characteristics and pandemic response to ACP. Settings/Subjects: Family caregivers of care recipients with varied caregiving needs (deme","2021","07","06","Palliat Med Rep","Palliative medicine reports","caregiving; end-of-life care; pandemic","Scammon","Debra","Department of Marketing, David Eccles School of Business, School of Medicine, University of Utah, Salt Lake City, Utah, USA",NA
"2437","34223520","10.1089/pmr.2021.0013","A Limited Opportunity: COVID-19 and Promotion of Advance Care Planning.","Background: Little is known about how COVID-19 has influenced the role of family caregivers in advance care planning (ACP). Objectives: To explore the experiences of family caregivers and ACP in the United States during the COVID-19 pandemic. Design: Exploratory sequential mixed-methods design of caregiver characteristics and pandemic response to ACP. Settings/Subjects: Family caregivers of care recipients with varied caregiving needs (deme","2021","07","06","Palliat Med Rep","Palliative medicine reports","caregiving; end-of-life care; pandemic","Bristol","Alycia A","College of Nursing, School of Medicine, University of Utah, Salt Lake City, Utah, USA",NA
"2438","34223520","10.1089/pmr.2021.0013","A Limited Opportunity: COVID-19 and Promotion of Advance Care Planning.","Background: Little is known about how COVID-19 has influenced the role of family caregivers in advance care planning (ACP). Objectives: To explore the experiences of family caregivers and ACP in the United States during the COVID-19 pandemic. Design: Exploratory sequential mixed-methods design of caregiver characteristics and pandemic response to ACP. Settings/Subjects: Family caregivers of care recipients with varied caregiving needs (deme","2021","07","06","Palliat Med Rep","Palliative medicine reports","caregiving; end-of-life care; pandemic","Thompson","Amber","Department of Sociology, College of Social and Behavioral Sciences, School of Medicine, University of Utah, Salt Lake City, Utah, USA",NA
"2439","34223520","10.1089/pmr.2021.0013","A Limited Opportunity: COVID-19 and Promotion of Advance Care Planning.","Background: Little is known about how COVID-19 has influenced the role of family caregivers in advance care planning (ACP). Objectives: To explore the experiences of family caregivers and ACP in the United States during the COVID-19 pandemic. Design: Exploratory sequential mixed-methods design of caregiver characteristics and pandemic response to ACP. Settings/Subjects: Family caregivers of care recipients with varied caregiving needs (deme","2021","07","06","Palliat Med Rep","Palliative medicine reports","caregiving; end-of-life care; pandemic","Mickens","Melody","Division of Physical Medicine and Rehabilitation, School of Medicine, University of Utah, Salt Lake City, Utah, USA",NA
"2440","34223495","10.1089/pmr.2020.0075","Patient and Caregiver Experience with Outpatient Palliative Care Telemedicine Visits.","Background: Telemedicine visits reduce the physical and financial burdens associated with in-person appointments, especially for patients with serious illness. Little is known about patient and caregiver preferences regarding telemedicine visit timing and the discussion of sensitive topics by telemedicine. Objective: To characterize the experience of patients with serious illness and their caregivers receiving palliative care (PC) by telemedicine. Design:</b","2021","07","06","Palliat Med Rep","Palliative medicine reports","outpatient palliative care; patient satisfaction; telehealth; telemedicine","Calton","Brook","Division of Palliative Medicine, Department of Medicine, University of California, San Francisco, San Francisco, California, USA",NA
"2441","34223495","10.1089/pmr.2020.0075","Patient and Caregiver Experience with Outpatient Palliative Care Telemedicine Visits.","Background: Telemedicine visits reduce the physical and financial burdens associated with in-person appointments, especially for patients with serious illness. Little is known about patient and caregiver preferences regarding telemedicine visit timing and the discussion of sensitive topics by telemedicine. Objective: To characterize the experience of patients with serious illness and their caregivers receiving palliative care (PC) by telemedicine. Design:</b","2021","07","06","Palliat Med Rep","Palliative medicine reports","outpatient palliative care; patient satisfaction; telehealth; telemedicine","Shibley","William Patrick","School of Medicine, University of California, San Francisco, San Francisco, California, USA",NA
"2442","34223495","10.1089/pmr.2020.0075","Patient and Caregiver Experience with Outpatient Palliative Care Telemedicine Visits.","Background: Telemedicine visits reduce the physical and financial burdens associated with in-person appointments, especially for patients with serious illness. Little is known about patient and caregiver preferences regarding telemedicine visit timing and the discussion of sensitive topics by telemedicine. Objective: To characterize the experience of patients with serious illness and their caregivers receiving palliative care (PC) by telemedicine. Design:</b","2021","07","06","Palliat Med Rep","Palliative medicine reports","outpatient palliative care; patient satisfaction; telehealth; telemedicine","Cohen","Eve","Division of Palliative Medicine, Department of Medicine, University of California, San Francisco, San Francisco, California, USA",NA
"2443","34223495","10.1089/pmr.2020.0075","Patient and Caregiver Experience with Outpatient Palliative Care Telemedicine Visits.","Background: Telemedicine visits reduce the physical and financial burdens associated with in-person appointments, especially for patients with serious illness. Little is known about patient and caregiver preferences regarding telemedicine visit timing and the discussion of sensitive topics by telemedicine. Objective: To characterize the experience of patients with serious illness and their caregivers receiving palliative care (PC) by telemedicine. Design:</b","2021","07","06","Palliat Med Rep","Palliative medicine reports","outpatient palliative care; patient satisfaction; telehealth; telemedicine","Pantilat","Steven Z","Division of Palliative Medicine, Department of Medicine, University of California, San Francisco, San Francisco, California, USA",NA
"2444","34223495","10.1089/pmr.2020.0075","Patient and Caregiver Experience with Outpatient Palliative Care Telemedicine Visits.","Background: Telemedicine visits reduce the physical and financial burdens associated with in-person appointments, especially for patients with serious illness. Little is known about patient and caregiver preferences regarding telemedicine visit timing and the discussion of sensitive topics by telemedicine. Objective: To characterize the experience of patients with serious illness and their caregivers receiving palliative care (PC) by telemedicine. Design:</b","2021","07","06","Palliat Med Rep","Palliative medicine reports","outpatient palliative care; patient satisfaction; telehealth; telemedicine","Rabow","Michael W","Division of Palliative Medicine, Department of Medicine, University of California, San Francisco, San Francisco, California, USA",NA
"2445","34223495","10.1089/pmr.2020.0075","Patient and Caregiver Experience with Outpatient Palliative Care Telemedicine Visits.","Background: Telemedicine visits reduce the physical and financial burdens associated with in-person appointments, especially for patients with serious illness. Little is known about patient and caregiver preferences regarding telemedicine visit timing and the discussion of sensitive topics by telemedicine. Objective: To characterize the experience of patients with serious illness and their caregivers receiving palliative care (PC) by telemedicine. Design:</b","2021","07","06","Palliat Med Rep","Palliative medicine reports","outpatient palliative care; patient satisfaction; telehealth; telemedicine","O'Riordan","David L","Division of Palliative Medicine, Department of Medicine, University of California, San Francisco, San Francisco, California, USA",NA
"2446","34223495","10.1089/pmr.2020.0075","Patient and Caregiver Experience with Outpatient Palliative Care Telemedicine Visits.","Background: Telemedicine visits reduce the physical and financial burdens associated with in-person appointments, especially for patients with serious illness. Little is known about patient and caregiver preferences regarding telemedicine visit timing and the discussion of sensitive topics by telemedicine. Objective: To characterize the experience of patients with serious illness and their caregivers receiving palliative care (PC) by telemedicine. Design:</b","2021","07","06","Palliat Med Rep","Palliative medicine reports","outpatient palliative care; patient satisfaction; telehealth; telemedicine","Bischoff","Kara E","Division of Palliative Medicine, Department of Medicine, University of California, San Francisco, San Francisco, California, USA",NA
"2447","34223494","10.1089/pmr.2020.0115","Health Care Workers' Knowledge, Attitudes, and Beliefs Related to COVID-19 in Palliative Medicine and Hospice Care.","Background: Although coronavirus disease 2019 (COVID-19) has impacted on a global scale, the knowledge, attitudes, and beliefs of the health care workers who provide the care at the end of life have not been evaluated. Objectives: To assess and understand palliative medicine and hospice care health care workers' knowledge, attitudes, and beliefs related to COVID-19. Design: A web-based survey was created. Primary outcomes included attitudes, beliefs, and","2021","07","06","Palliat Med Rep","Palliative medicine reports","COVID-19; attitudes; beliefs; hospice; knowledge; palliative","Albarracin","Zaida","University of Miami/John F. Kennedy (JFK) Medical Center, Atlantis, Florida, USA",NA
"2448","34223494","10.1089/pmr.2020.0115","Health Care Workers' Knowledge, Attitudes, and Beliefs Related to COVID-19 in Palliative Medicine and Hospice Care.","Background: Although coronavirus disease 2019 (COVID-19) has impacted on a global scale, the knowledge, attitudes, and beliefs of the health care workers who provide the care at the end of life have not been evaluated. Objectives: To assess and understand palliative medicine and hospice care health care workers' knowledge, attitudes, and beliefs related to COVID-19. Design: A web-based survey was created. Primary outcomes included attitudes, beliefs, and","2021","07","06","Palliat Med Rep","Palliative medicine reports","COVID-19; attitudes; beliefs; hospice; knowledge; palliative","Silverman","Michael","Geriatrics/Palliative Medicine/Hospice, West Palm Beach VA Medical Center, West Palm Beach, Florida, USA",NA
"2449","34223494","10.1089/pmr.2020.0115","Health Care Workers' Knowledge, Attitudes, and Beliefs Related to COVID-19 in Palliative Medicine and Hospice Care.","Background: Although coronavirus disease 2019 (COVID-19) has impacted on a global scale, the knowledge, attitudes, and beliefs of the health care workers who provide the care at the end of life have not been evaluated. Objectives: To assess and understand palliative medicine and hospice care health care workers' knowledge, attitudes, and beliefs related to COVID-19. Design: A web-based survey was created. Primary outcomes included attitudes, beliefs, and","2021","07","06","Palliat Med Rep","Palliative medicine reports","COVID-19; attitudes; beliefs; hospice; knowledge; palliative","Mineo","Jocelyn","HCA Healthcare: East Florida Division GME, Ft. Lauderdale, Florida, USA",NA
"2450","34223494","10.1089/pmr.2020.0115","Health Care Workers' Knowledge, Attitudes, and Beliefs Related to COVID-19 in Palliative Medicine and Hospice Care.","Background: Although coronavirus disease 2019 (COVID-19) has impacted on a global scale, the knowledge, attitudes, and beliefs of the health care workers who provide the care at the end of life have not been evaluated. Objectives: To assess and understand palliative medicine and hospice care health care workers' knowledge, attitudes, and beliefs related to COVID-19. Design: A web-based survey was created. Primary outcomes included attitudes, beliefs, and","2021","07","06","Palliat Med Rep","Palliative medicine reports","COVID-19; attitudes; beliefs; hospice; knowledge; palliative","Al-Abbasi","Baher","University of Miami/John F. Kennedy (JFK) Medical Center, Atlantis, Florida, USA",NA
"2451","34223494","10.1089/pmr.2020.0115","Health Care Workers' Knowledge, Attitudes, and Beliefs Related to COVID-19 in Palliative Medicine and Hospice Care.","Background: Although coronavirus disease 2019 (COVID-19) has impacted on a global scale, the knowledge, attitudes, and beliefs of the health care workers who provide the care at the end of life have not been evaluated. Objectives: To assess and understand palliative medicine and hospice care health care workers' knowledge, attitudes, and beliefs related to COVID-19. Design: A web-based survey was created. Primary outcomes included attitudes, beliefs, and","2021","07","06","Palliat Med Rep","Palliative medicine reports","COVID-19; attitudes; beliefs; hospice; knowledge; palliative","Koff","Susan","Trustbridge Health, West Palm Beach, Florida, USA",NA
"2452","34223494","10.1089/pmr.2020.0115","Health Care Workers' Knowledge, Attitudes, and Beliefs Related to COVID-19 in Palliative Medicine and Hospice Care.","Background: Although coronavirus disease 2019 (COVID-19) has impacted on a global scale, the knowledge, attitudes, and beliefs of the health care workers who provide the care at the end of life have not been evaluated. Objectives: To assess and understand palliative medicine and hospice care health care workers' knowledge, attitudes, and beliefs related to COVID-19. Design: A web-based survey was created. Primary outcomes included attitudes, beliefs, and","2021","07","06","Palliat Med Rep","Palliative medicine reports","COVID-19; attitudes; beliefs; hospice; knowledge; palliative","Martell","Catherine","Trustbridge Health, West Palm Beach, Florida, USA",NA
"2453","34223494","10.1089/pmr.2020.0115","Health Care Workers' Knowledge, Attitudes, and Beliefs Related to COVID-19 in Palliative Medicine and Hospice Care.","Background: Although coronavirus disease 2019 (COVID-19) has impacted on a global scale, the knowledge, attitudes, and beliefs of the health care workers who provide the care at the end of life have not been evaluated. Objectives: To assess and understand palliative medicine and hospice care health care workers' knowledge, attitudes, and beliefs related to COVID-19. Design: A web-based survey was created. Primary outcomes included attitudes, beliefs, and","2021","07","06","Palliat Med Rep","Palliative medicine reports","COVID-19; attitudes; beliefs; hospice; knowledge; palliative","Levene","Richard S","University of Miami/John F. Kennedy (JFK) Medical Center, Atlantis, Florida, USA",NA
"2454","34223482","10.1089/pmr.2020.0102","Severe Chronic Pain Following Retroperitoneal Hemorrhage in a COVID-19 Patient: Amelioration with a Topical Pain Cream.",NA,"2021","07","06","Palliat Med Rep","Palliative medicine reports",NA,"Winegarden","Jennifer","Department of Hospice Medicine, The Medical Team Hospice, Livonia, Michigan, USA",NA
"2455","34223482","10.1089/pmr.2020.0102","Severe Chronic Pain Following Retroperitoneal Hemorrhage in a COVID-19 Patient: Amelioration with a Topical Pain Cream.",NA,"2021","07","06","Palliat Med Rep","Palliative medicine reports",NA,"Carr","Daniel B","Department of Public Health, Tufts University School of Medicine, Boston, Massachusetts, USA",NA
"2456","34223482","10.1089/pmr.2020.0102","Severe Chronic Pain Following Retroperitoneal Hemorrhage in a COVID-19 Patient: Amelioration with a Topical Pain Cream.",NA,"2021","07","06","Palliat Med Rep","Palliative medicine reports",NA,"Pike","Victoria","Department of Hospice Medicine, The Medical Team Hospice, Livonia, Michigan, USA",NA
"2457","34223481","10.1089/pmr.2020.0087","A Case Report of COVID-19 in New Orleans, Louisiana: Highlighting the Complexities of Prognostication in a Critically Ill Patient.","Palliative care teams and intensive care teams have experience providing goals-of-care guidance for critically ill patients and families. Critical coronavirus disease 2019 (COVID-19) infection is defined as infection requiring intensive care unit care, respiratory support, and often multiorgan involvement. This case presents a 53-year-old critically ill COVID-19 patient in multisystem organ failure who appeared hours from death despite best medical efforts. Comfort-focused care and compassionate","2021","07","06","Palliat Med Rep","Palliative medicine reports","COVID-19; intensive care; palliative care; prognostication","Lerner","Zachary I","Louisiana State University School of Medicine, New Orleans, Louisiana, USA",NA
"2458","34223481","10.1089/pmr.2020.0087","A Case Report of COVID-19 in New Orleans, Louisiana: Highlighting the Complexities of Prognostication in a Critically Ill Patient.","Palliative care teams and intensive care teams have experience providing goals-of-care guidance for critically ill patients and families. Critical coronavirus disease 2019 (COVID-19) infection is defined as infection requiring intensive care unit care, respiratory support, and often multiorgan involvement. This case presents a 53-year-old critically ill COVID-19 patient in multisystem organ failure who appeared hours from death despite best medical efforts. Comfort-focused care and compassionate","2021","07","06","Palliat Med Rep","Palliative medicine reports","COVID-19; intensive care; palliative care; prognostication","Burke","Rebecca V","Section of Geriatrics and Extended Care, Southeast Louisiana Veterans Health Care System (SLVHCS), New Orleans, Louisiana, USA",NA
"2459","34223481","10.1089/pmr.2020.0087","A Case Report of COVID-19 in New Orleans, Louisiana: Highlighting the Complexities of Prognostication in a Critically Ill Patient.","Palliative care teams and intensive care teams have experience providing goals-of-care guidance for critically ill patients and families. Critical coronavirus disease 2019 (COVID-19) infection is defined as infection requiring intensive care unit care, respiratory support, and often multiorgan involvement. This case presents a 53-year-old critically ill COVID-19 patient in multisystem organ failure who appeared hours from death despite best medical efforts. Comfort-focused care and compassionate","2021","07","06","Palliat Med Rep","Palliative medicine reports","COVID-19; intensive care; palliative care; prognostication","McCall","Jonathan","Section of Geriatrics and Extended Care, Southeast Louisiana Veterans Health Care System (SLVHCS), New Orleans, Louisiana, USA",NA
"2460","34223481","10.1089/pmr.2020.0087","A Case Report of COVID-19 in New Orleans, Louisiana: Highlighting the Complexities of Prognostication in a Critically Ill Patient.","Palliative care teams and intensive care teams have experience providing goals-of-care guidance for critically ill patients and families. Critical coronavirus disease 2019 (COVID-19) infection is defined as infection requiring intensive care unit care, respiratory support, and often multiorgan involvement. This case presents a 53-year-old critically ill COVID-19 patient in multisystem organ failure who appeared hours from death despite best medical efforts. Comfort-focused care and compassionate","2021","07","06","Palliat Med Rep","Palliative medicine reports","COVID-19; intensive care; palliative care; prognostication","Leigh","Alexandra","Section of Geriatrics and Extended Care, Southeast Louisiana Veterans Health Care System (SLVHCS), New Orleans, Louisiana, USA",NA
"2461","34223481","10.1089/pmr.2020.0087","A Case Report of COVID-19 in New Orleans, Louisiana: Highlighting the Complexities of Prognostication in a Critically Ill Patient.","Palliative care teams and intensive care teams have experience providing goals-of-care guidance for critically ill patients and families. Critical coronavirus disease 2019 (COVID-19) infection is defined as infection requiring intensive care unit care, respiratory support, and often multiorgan involvement. This case presents a 53-year-old critically ill COVID-19 patient in multisystem organ failure who appeared hours from death despite best medical efforts. Comfort-focused care and compassionate","2021","07","06","Palliat Med Rep","Palliative medicine reports","COVID-19; intensive care; palliative care; prognostication","Glass","Marcia","Section of Geriatrics and Extended Care, Southeast Louisiana Veterans Health Care System (SLVHCS), New Orleans, Louisiana, USA",NA
"2462","34223480","10.1089/pmr.2020.0074","Clinician Perspectives on Implementing Video Visits in Home-Based Palliative Care.","Background: Despite the increasing use and acceptance of technology in health care, there is limited evidence on the usefulness and appropriate use of telehealth in home-based palliative care (HBPC). As part of the process evaluation of a pragmatic trial of video visits in HBPC, we assessed clinician experience with video visit implementation. Methods: We assessed clinicians' experiences with and perception of the usefulness and appropriateness of video visits using a","2021","07","06","Palliat Med Rep","Palliative medicine reports","adoption; clinicians; implementation; palliative care; telehealth; video consultations","Osuji","Thearis A","Kaiser Permanente Southern California, Department of Research &amp",NA
"2463","34223480","10.1089/pmr.2020.0074","Clinician Perspectives on Implementing Video Visits in Home-Based Palliative Care.","Background: Despite the increasing use and acceptance of technology in health care, there is limited evidence on the usefulness and appropriate use of telehealth in home-based palliative care (HBPC). As part of the process evaluation of a pragmatic trial of video visits in HBPC, we assessed clinician experience with video visit implementation. Methods: We assessed clinicians' experiences with and perception of the usefulness and appropriateness of video visits using a","2021","07","06","Palliat Med Rep","Palliative medicine reports","adoption; clinicians; implementation; palliative care; telehealth; video consultations","Macias","Mayra","Kaiser Permanente Southern California, Department of Research &amp",NA
"2464","34223480","10.1089/pmr.2020.0074","Clinician Perspectives on Implementing Video Visits in Home-Based Palliative Care.","Background: Despite the increasing use and acceptance of technology in health care, there is limited evidence on the usefulness and appropriate use of telehealth in home-based palliative care (HBPC). As part of the process evaluation of a pragmatic trial of video visits in HBPC, we assessed clinician experience with video visit implementation. Methods: We assessed clinicians' experiences with and perception of the usefulness and appropriateness of video visits using a","2021","07","06","Palliat Med Rep","Palliative medicine reports","adoption; clinicians; implementation; palliative care; telehealth; video consultations","McMullen","Carmit","Kaiser Permanente Northwest, Center for Health Research, Portland, Oregon, USA",NA
"2465","34223480","10.1089/pmr.2020.0074","Clinician Perspectives on Implementing Video Visits in Home-Based Palliative Care.","Background: Despite the increasing use and acceptance of technology in health care, there is limited evidence on the usefulness and appropriate use of telehealth in home-based palliative care (HBPC). As part of the process evaluation of a pragmatic trial of video visits in HBPC, we assessed clinician experience with video visit implementation. Methods: We assessed clinicians' experiences with and perception of the usefulness and appropriateness of video visits using a","2021","07","06","Palliat Med Rep","Palliative medicine reports","adoption; clinicians; implementation; palliative care; telehealth; video consultations","Haupt","Eric","Kaiser Permanente Southern California, Department of Research &amp",NA
"2466","34223480","10.1089/pmr.2020.0074","Clinician Perspectives on Implementing Video Visits in Home-Based Palliative Care.","Background: Despite the increasing use and acceptance of technology in health care, there is limited evidence on the usefulness and appropriate use of telehealth in home-based palliative care (HBPC). As part of the process evaluation of a pragmatic trial of video visits in HBPC, we assessed clinician experience with video visit implementation. Methods: We assessed clinicians' experiences with and perception of the usefulness and appropriateness of video visits using a","2021","07","06","Palliat Med Rep","Palliative medicine reports","adoption; clinicians; implementation; palliative care; telehealth; video consultations","Mittman","Brian","Kaiser Permanente Southern California, Department of Research &amp",NA
"2467","34223480","10.1089/pmr.2020.0074","Clinician Perspectives on Implementing Video Visits in Home-Based Palliative Care.","Background: Despite the increasing use and acceptance of technology in health care, there is limited evidence on the usefulness and appropriate use of telehealth in home-based palliative care (HBPC). As part of the process evaluation of a pragmatic trial of video visits in HBPC, we assessed clinician experience with video visit implementation. Methods: We assessed clinicians' experiences with and perception of the usefulness and appropriateness of video visits using a","2021","07","06","Palliat Med Rep","Palliative medicine reports","adoption; clinicians; implementation; palliative care; telehealth; video consultations","Mularski","Richard A","Kaiser Permanente Northwest, Center for Health Research, Portland, Oregon, USA",NA
"2468","34223480","10.1089/pmr.2020.0074","Clinician Perspectives on Implementing Video Visits in Home-Based Palliative Care.","Background: Despite the increasing use and acceptance of technology in health care, there is limited evidence on the usefulness and appropriate use of telehealth in home-based palliative care (HBPC). As part of the process evaluation of a pragmatic trial of video visits in HBPC, we assessed clinician experience with video visit implementation. Methods: We assessed clinicians' experiences with and perception of the usefulness and appropriateness of video visits using a","2021","07","06","Palliat Med Rep","Palliative medicine reports","adoption; clinicians; implementation; palliative care; telehealth; video consultations","Wang","Susan E","Kaiser Permanente Southern California, West Los Angeles Medical Center, Los Angeles, California, USA",NA
"2469","34223480","10.1089/pmr.2020.0074","Clinician Perspectives on Implementing Video Visits in Home-Based Palliative Care.","Background: Despite the increasing use and acceptance of technology in health care, there is limited evidence on the usefulness and appropriate use of telehealth in home-based palliative care (HBPC). As part of the process evaluation of a pragmatic trial of video visits in HBPC, we assessed clinician experience with video visit implementation. Methods: We assessed clinicians' experiences with and perception of the usefulness and appropriateness of video visits using a","2021","07","06","Palliat Med Rep","Palliative medicine reports","adoption; clinicians; implementation; palliative care; telehealth; video consultations","Werch","Henry","Kaiser Permanente Northwest, Member-Caregiver, Stakeholder Advisory Committee, Portland, Oregon, USA",NA
"2470","34223480","10.1089/pmr.2020.0074","Clinician Perspectives on Implementing Video Visits in Home-Based Palliative Care.","Background: Despite the increasing use and acceptance of technology in health care, there is limited evidence on the usefulness and appropriate use of telehealth in home-based palliative care (HBPC). As part of the process evaluation of a pragmatic trial of video visits in HBPC, we assessed clinician experience with video visit implementation. Methods: We assessed clinicians' experiences with and perception of the usefulness and appropriateness of video visits using a","2021","07","06","Palliat Med Rep","Palliative medicine reports","adoption; clinicians; implementation; palliative care; telehealth; video consultations","Nguyen","Huong Q","Kaiser Permanente Southern California, Department of Research &amp",NA
"2471","34223473","10.1089/pmr.2020.0049","Cultural Responsiveness and Palliative Care during the COVID-19 Pandemic.","During the COVID-19 pandemic, much has changed in the delivery of palliative care (PC). However, cultural responsiveness remains critical to our mission. It is essential to our aims of identifying individual goals of care and providing relief of suffering for our patients. Cultural responsiveness may also enhance trust and could be a mitigating factor in the staggering health care disparities unmasked during this pandemic. In this study, the authors outline the rationale for renewed focus on thi","2021","07","06","Palliat Med Rep","Palliative medicine reports","COVID-19; cultural awareness; cultural competence; cultural humility; cultural responsiveness; palliative care","Patneaude","Arika","Division of Bioethics and Palliative Care, Treuman Katz Center for Pediatric Bioethics, Seattle Children's Hospital and Research Institute, Seattle, Washington, USA",NA
"2472","34223473","10.1089/pmr.2020.0049","Cultural Responsiveness and Palliative Care during the COVID-19 Pandemic.","During the COVID-19 pandemic, much has changed in the delivery of palliative care (PC). However, cultural responsiveness remains critical to our mission. It is essential to our aims of identifying individual goals of care and providing relief of suffering for our patients. Cultural responsiveness may also enhance trust and could be a mitigating factor in the staggering health care disparities unmasked during this pandemic. In this study, the authors outline the rationale for renewed focus on thi","2021","07","06","Palliat Med Rep","Palliative medicine reports","COVID-19; cultural awareness; cultural competence; cultural humility; cultural responsiveness; palliative care","Kett","Jennifer","Division of Bioethics and Palliative Care, Treuman Katz Center for Pediatric Bioethics, Seattle Children's Hospital and Research Institute, Seattle, Washington, USA",NA
"2473","34223444","10.1002/emp2.12483","Initial prehospital Rapid Emergency Medicine Score (REMS) to predict outcomes for COVID-19 patients.","The Rapid Emergency Medicine Score (REMS) has not been widely studied for use in predicting outcomes of COVID-19 patients encountered in the prehospital setting. This study aimed to determine whether the first prehospital REMS could predict emergency department and hospital dispositions for COVID-19 patients transported by emergency medical services. This retrospective study used linked prehospital and hospital records from the ESO Data Collaborative for all 911-initiated transports of patients ","2021","07","06","J Am Coll Emerg Physicians Open","Journal of the American College of Emergency Physicians open","COVID-19; Emergency Medical Services; Patient Outcomes; Prehospital; Retrospective Studies; Risk Stratification; Scoring System; Triage","Bourn","Scott S","ESO, Inc. Austin Texas USA",NA
"2474","34223444","10.1002/emp2.12483","Initial prehospital Rapid Emergency Medicine Score (REMS) to predict outcomes for COVID-19 patients.","The Rapid Emergency Medicine Score (REMS) has not been widely studied for use in predicting outcomes of COVID-19 patients encountered in the prehospital setting. This study aimed to determine whether the first prehospital REMS could predict emergency department and hospital dispositions for COVID-19 patients transported by emergency medical services. This retrospective study used linked prehospital and hospital records from the ESO Data Collaborative for all 911-initiated transports of patients ","2021","07","06","J Am Coll Emerg Physicians Open","Journal of the American College of Emergency Physicians open","COVID-19; Emergency Medical Services; Patient Outcomes; Prehospital; Retrospective Studies; Risk Stratification; Scoring System; Triage","Crowe","Remle P","ESO, Inc. Austin Texas USA",NA
"2475","34223444","10.1002/emp2.12483","Initial prehospital Rapid Emergency Medicine Score (REMS) to predict outcomes for COVID-19 patients.","The Rapid Emergency Medicine Score (REMS) has not been widely studied for use in predicting outcomes of COVID-19 patients encountered in the prehospital setting. This study aimed to determine whether the first prehospital REMS could predict emergency department and hospital dispositions for COVID-19 patients transported by emergency medical services. This retrospective study used linked prehospital and hospital records from the ESO Data Collaborative for all 911-initiated transports of patients ","2021","07","06","J Am Coll Emerg Physicians Open","Journal of the American College of Emergency Physicians open","COVID-19; Emergency Medical Services; Patient Outcomes; Prehospital; Retrospective Studies; Risk Stratification; Scoring System; Triage","Fernandez","Antonio R","ESO, Inc. Austin Texas USA",NA
"2476","34223444","10.1002/emp2.12483","Initial prehospital Rapid Emergency Medicine Score (REMS) to predict outcomes for COVID-19 patients.","The Rapid Emergency Medicine Score (REMS) has not been widely studied for use in predicting outcomes of COVID-19 patients encountered in the prehospital setting. This study aimed to determine whether the first prehospital REMS could predict emergency department and hospital dispositions for COVID-19 patients transported by emergency medical services. This retrospective study used linked prehospital and hospital records from the ESO Data Collaborative for all 911-initiated transports of patients ","2021","07","06","J Am Coll Emerg Physicians Open","Journal of the American College of Emergency Physicians open","COVID-19; Emergency Medical Services; Patient Outcomes; Prehospital; Retrospective Studies; Risk Stratification; Scoring System; Triage","Matt","Sarah E","ESO, Inc. Austin Texas USA",NA
"2477","34223444","10.1002/emp2.12483","Initial prehospital Rapid Emergency Medicine Score (REMS) to predict outcomes for COVID-19 patients.","The Rapid Emergency Medicine Score (REMS) has not been widely studied for use in predicting outcomes of COVID-19 patients encountered in the prehospital setting. This study aimed to determine whether the first prehospital REMS could predict emergency department and hospital dispositions for COVID-19 patients transported by emergency medical services. This retrospective study used linked prehospital and hospital records from the ESO Data Collaborative for all 911-initiated transports of patients ","2021","07","06","J Am Coll Emerg Physicians Open","Journal of the American College of Emergency Physicians open","COVID-19; Emergency Medical Services; Patient Outcomes; Prehospital; Retrospective Studies; Risk Stratification; Scoring System; Triage","Brown","Andrew L","ESO, Inc. Austin Texas USA",NA
"2478","34223444","10.1002/emp2.12483","Initial prehospital Rapid Emergency Medicine Score (REMS) to predict outcomes for COVID-19 patients.","The Rapid Emergency Medicine Score (REMS) has not been widely studied for use in predicting outcomes of COVID-19 patients encountered in the prehospital setting. This study aimed to determine whether the first prehospital REMS could predict emergency department and hospital dispositions for COVID-19 patients transported by emergency medical services. This retrospective study used linked prehospital and hospital records from the ESO Data Collaborative for all 911-initiated transports of patients ","2021","07","06","J Am Coll Emerg Physicians Open","Journal of the American College of Emergency Physicians open","COVID-19; Emergency Medical Services; Patient Outcomes; Prehospital; Retrospective Studies; Risk Stratification; Scoring System; Triage","Hawthorn","Andrew B","ESO, Inc. Austin Texas USA",NA
"2479","34223444","10.1002/emp2.12483","Initial prehospital Rapid Emergency Medicine Score (REMS) to predict outcomes for COVID-19 patients.","The Rapid Emergency Medicine Score (REMS) has not been widely studied for use in predicting outcomes of COVID-19 patients encountered in the prehospital setting. This study aimed to determine whether the first prehospital REMS could predict emergency department and hospital dispositions for COVID-19 patients transported by emergency medical services. This retrospective study used linked prehospital and hospital records from the ESO Data Collaborative for all 911-initiated transports of patients ","2021","07","06","J Am Coll Emerg Physicians Open","Journal of the American College of Emergency Physicians open","COVID-19; Emergency Medical Services; Patient Outcomes; Prehospital; Retrospective Studies; Risk Stratification; Scoring System; Triage","Myers","J Brent","ESO, Inc. Austin Texas USA",NA
"2480","34223443","10.1002/emp2.12453","Factors associated with clinical severity in emergency department patients presenting with symptomatic SARS-CoV-2 infection.","To measure the association of race, ethnicity, comorbidities, and insurance status with need for hospitalization of symptomatic emergency department patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. This study is a cohort study of symptomatic patients presenting to a single emergency department (ED) with laboratory-confirmed SARS-CoV-2 infection from March 7-August 9, 2020. We collected patient-level information regarding demographics, insurance status, comorb","2021","07","13","J Am Coll Emerg Physicians Open","Journal of the American College of Emergency Physicians open","COVID-19 disease; SARS-CoV-2 infection; emergency medicine; infectious diseases; socioeconomic factors","Newton","Sophia","School of Medicine and Health Sciences Department of Emergency Medicine, The George Washington University Washington District of Columbia USA",NA
"2481","34223443","10.1002/emp2.12453","Factors associated with clinical severity in emergency department patients presenting with symptomatic SARS-CoV-2 infection.","To measure the association of race, ethnicity, comorbidities, and insurance status with need for hospitalization of symptomatic emergency department patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. This study is a cohort study of symptomatic patients presenting to a single emergency department (ED) with laboratory-confirmed SARS-CoV-2 infection from March 7-August 9, 2020. We collected patient-level information regarding demographics, insurance status, comorb","2021","07","13","J Am Coll Emerg Physicians Open","Journal of the American College of Emergency Physicians open","COVID-19 disease; SARS-CoV-2 infection; emergency medicine; infectious diseases; socioeconomic factors","Zollinger","Benjamin","School of Medicine and Health Sciences Department of Emergency Medicine, The George Washington University Washington District of Columbia USA",NA
"2482","34223443","10.1002/emp2.12453","Factors associated with clinical severity in emergency department patients presenting with symptomatic SARS-CoV-2 infection.","To measure the association of race, ethnicity, comorbidities, and insurance status with need for hospitalization of symptomatic emergency department patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. This study is a cohort study of symptomatic patients presenting to a single emergency department (ED) with laboratory-confirmed SARS-CoV-2 infection from March 7-August 9, 2020. We collected patient-level information regarding demographics, insurance status, comorb","2021","07","13","J Am Coll Emerg Physicians Open","Journal of the American College of Emergency Physicians open","COVID-19 disease; SARS-CoV-2 infection; emergency medicine; infectious diseases; socioeconomic factors","Freeman","Jincong","Department of Biostatistics and Bioinformatics, George Washington University Milken Institute School of Public Health Washington District of Columbia USA",NA
"2483","34223443","10.1002/emp2.12453","Factors associated with clinical severity in emergency department patients presenting with symptomatic SARS-CoV-2 infection.","To measure the association of race, ethnicity, comorbidities, and insurance status with need for hospitalization of symptomatic emergency department patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. This study is a cohort study of symptomatic patients presenting to a single emergency department (ED) with laboratory-confirmed SARS-CoV-2 infection from March 7-August 9, 2020. We collected patient-level information regarding demographics, insurance status, comorb","2021","07","13","J Am Coll Emerg Physicians Open","Journal of the American College of Emergency Physicians open","COVID-19 disease; SARS-CoV-2 infection; emergency medicine; infectious diseases; socioeconomic factors","Moran","Seamus","School of Medicine and Health Sciences Department of Emergency Medicine, The George Washington University Washington District of Columbia USA",NA
"2484","34223443","10.1002/emp2.12453","Factors associated with clinical severity in emergency department patients presenting with symptomatic SARS-CoV-2 infection.","To measure the association of race, ethnicity, comorbidities, and insurance status with need for hospitalization of symptomatic emergency department patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. This study is a cohort study of symptomatic patients presenting to a single emergency department (ED) with laboratory-confirmed SARS-CoV-2 infection from March 7-August 9, 2020. We collected patient-level information regarding demographics, insurance status, comorb","2021","07","13","J Am Coll Emerg Physicians Open","Journal of the American College of Emergency Physicians open","COVID-19 disease; SARS-CoV-2 infection; emergency medicine; infectious diseases; socioeconomic factors","Helfand","Alexandra","School of Medicine and Health Sciences Department of Emergency Medicine, The George Washington University Washington District of Columbia USA",NA
"2485","34223443","10.1002/emp2.12453","Factors associated with clinical severity in emergency department patients presenting with symptomatic SARS-CoV-2 infection.","To measure the association of race, ethnicity, comorbidities, and insurance status with need for hospitalization of symptomatic emergency department patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. This study is a cohort study of symptomatic patients presenting to a single emergency department (ED) with laboratory-confirmed SARS-CoV-2 infection from March 7-August 9, 2020. We collected patient-level information regarding demographics, insurance status, comorb","2021","07","13","J Am Coll Emerg Physicians Open","Journal of the American College of Emergency Physicians open","COVID-19 disease; SARS-CoV-2 infection; emergency medicine; infectious diseases; socioeconomic factors","Authelet","Kayla","School of Medicine and Health Sciences Department of Emergency Medicine, The George Washington University Washington District of Columbia USA",NA
"2486","34223443","10.1002/emp2.12453","Factors associated with clinical severity in emergency department patients presenting with symptomatic SARS-CoV-2 infection.","To measure the association of race, ethnicity, comorbidities, and insurance status with need for hospitalization of symptomatic emergency department patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. This study is a cohort study of symptomatic patients presenting to a single emergency department (ED) with laboratory-confirmed SARS-CoV-2 infection from March 7-August 9, 2020. We collected patient-level information regarding demographics, insurance status, comorb","2021","07","13","J Am Coll Emerg Physicians Open","Journal of the American College of Emergency Physicians open","COVID-19 disease; SARS-CoV-2 infection; emergency medicine; infectious diseases; socioeconomic factors","McHarg","Matthew","School of Medicine and Health Sciences Department of Emergency Medicine, The George Washington University Washington District of Columbia USA",NA
"2487","34223443","10.1002/emp2.12453","Factors associated with clinical severity in emergency department patients presenting with symptomatic SARS-CoV-2 infection.","To measure the association of race, ethnicity, comorbidities, and insurance status with need for hospitalization of symptomatic emergency department patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. This study is a cohort study of symptomatic patients presenting to a single emergency department (ED) with laboratory-confirmed SARS-CoV-2 infection from March 7-August 9, 2020. We collected patient-level information regarding demographics, insurance status, comorb","2021","07","13","J Am Coll Emerg Physicians Open","Journal of the American College of Emergency Physicians open","COVID-19 disease; SARS-CoV-2 infection; emergency medicine; infectious diseases; socioeconomic factors","Montano Vargas","Nataly","School of Medicine and Health Sciences Department of Emergency Medicine, The George Washington University Washington District of Columbia USA",NA
"2488","34223443","10.1002/emp2.12453","Factors associated with clinical severity in emergency department patients presenting with symptomatic SARS-CoV-2 infection.","To measure the association of race, ethnicity, comorbidities, and insurance status with need for hospitalization of symptomatic emergency department patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. This study is a cohort study of symptomatic patients presenting to a single emergency department (ED) with laboratory-confirmed SARS-CoV-2 infection from March 7-August 9, 2020. We collected patient-level information regarding demographics, insurance status, comorb","2021","07","13","J Am Coll Emerg Physicians Open","Journal of the American College of Emergency Physicians open","COVID-19 disease; SARS-CoV-2 infection; emergency medicine; infectious diseases; socioeconomic factors","Shesser","Robert","School of Medicine and Health Sciences Department of Emergency Medicine, The George Washington University Washington District of Columbia USA",NA
"2489","34223443","10.1002/emp2.12453","Factors associated with clinical severity in emergency department patients presenting with symptomatic SARS-CoV-2 infection.","To measure the association of race, ethnicity, comorbidities, and insurance status with need for hospitalization of symptomatic emergency department patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. This study is a cohort study of symptomatic patients presenting to a single emergency department (ED) with laboratory-confirmed SARS-CoV-2 infection from March 7-August 9, 2020. We collected patient-level information regarding demographics, insurance status, comorb","2021","07","13","J Am Coll Emerg Physicians Open","Journal of the American College of Emergency Physicians open","COVID-19 disease; SARS-CoV-2 infection; emergency medicine; infectious diseases; socioeconomic factors","Cohen","Joanna S","Division of Emergency Medicine Children's National Medical Center Washington District of Columbia USA",NA
"2490","34223443","10.1002/emp2.12453","Factors associated with clinical severity in emergency department patients presenting with symptomatic SARS-CoV-2 infection.","To measure the association of race, ethnicity, comorbidities, and insurance status with need for hospitalization of symptomatic emergency department patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. This study is a cohort study of symptomatic patients presenting to a single emergency department (ED) with laboratory-confirmed SARS-CoV-2 infection from March 7-August 9, 2020. We collected patient-level information regarding demographics, insurance status, comorb","2021","07","13","J Am Coll Emerg Physicians Open","Journal of the American College of Emergency Physicians open","COVID-19 disease; SARS-CoV-2 infection; emergency medicine; infectious diseases; socioeconomic factors","Cummings","Derek A T","Department of Biology and Emerging Pathogens Institute, University of Florida Gainesville Florida USA",NA
"2491","34223443","10.1002/emp2.12453","Factors associated with clinical severity in emergency department patients presenting with symptomatic SARS-CoV-2 infection.","To measure the association of race, ethnicity, comorbidities, and insurance status with need for hospitalization of symptomatic emergency department patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. This study is a cohort study of symptomatic patients presenting to a single emergency department (ED) with laboratory-confirmed SARS-CoV-2 infection from March 7-August 9, 2020. We collected patient-level information regarding demographics, insurance status, comorb","2021","07","13","J Am Coll Emerg Physicians Open","Journal of the American College of Emergency Physicians open","COVID-19 disease; SARS-CoV-2 infection; emergency medicine; infectious diseases; socioeconomic factors","Ma","Yan","Department of Biostatistics and Bioinformatics, George Washington University Milken Institute School of Public Health Washington District of Columbia USA",NA
"2492","34223443","10.1002/emp2.12453","Factors associated with clinical severity in emergency department patients presenting with symptomatic SARS-CoV-2 infection.","To measure the association of race, ethnicity, comorbidities, and insurance status with need for hospitalization of symptomatic emergency department patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. This study is a cohort study of symptomatic patients presenting to a single emergency department (ED) with laboratory-confirmed SARS-CoV-2 infection from March 7-August 9, 2020. We collected patient-level information regarding demographics, insurance status, comorb","2021","07","13","J Am Coll Emerg Physicians Open","Journal of the American College of Emergency Physicians open","COVID-19 disease; SARS-CoV-2 infection; emergency medicine; infectious diseases; socioeconomic factors","Meltzer","Andrew C","School of Medicine and Health Sciences Department of Emergency Medicine, The George Washington University Washington District of Columbia USA",NA
"2493","34223441","10.1016/j.lanepe.2021.100139","Effects of non-pharmaceutical interventions against COVID-19 on the incidence of other diseases.",NA,"2021","07","20","Lancet Reg Health Eur","The Lancet regional health. Europe",NA,"Müller","Olaf","Institute of Global Health, Ruprecht-Karls-University Heidelberg, Germany",NA
"2494","34223441","10.1016/j.lanepe.2021.100139","Effects of non-pharmaceutical interventions against COVID-19 on the incidence of other diseases.",NA,"2021","07","20","Lancet Reg Health Eur","The Lancet regional health. Europe",NA,"Razum","Oliver","School of Public Health, Bielefeld University, Germany",NA
"2495","34223441","10.1016/j.lanepe.2021.100139","Effects of non-pharmaceutical interventions against COVID-19 on the incidence of other diseases.",NA,"2021","07","20","Lancet Reg Health Eur","The Lancet regional health. Europe",NA,"Jahn","Albrecht","Institute of Global Health, Ruprecht-Karls-University Heidelberg, Germany",NA
"2496","34223439","10.1016/j.ejvsvf.2021.06.009","Acute Mesenteric Arterial Thrombosis in COVID-19 Disease.",NA,"2021","07","05","EJVES Vasc Forum","EJVES vascular forum",NA,"Barberá-Carbonell","Beatriz","Department of Visceral Surgery, University Hospital CHUV and University of Lausanne (UNIL), Lausanne, Switzerland",NA
"2497","34223439","10.1016/j.ejvsvf.2021.06.009","Acute Mesenteric Arterial Thrombosis in COVID-19 Disease.",NA,"2021","07","05","EJVES Vasc Forum","EJVES vascular forum",NA,"Martin","David","Department of Visceral Surgery, University Hospital CHUV and University of Lausanne (UNIL), Lausanne, Switzerland",NA
"2498","34223401","10.1016/j.medj.2021.06.007","FDA-authorized mRNA COVID-19 vaccines are effective per real-world evidence synthesized across a multi-state health system.","Two FDA-authorized mRNA COVID-19 vaccines, BNT162b2 (Pfizer/BioNTech) and mRNA-1273 (Moderna), have demonstrated high efficacies in large Phase 3 randomized clinical trials. It is important to assess their effectiveness in a real-world setting. This is a retrospective analysis of 136,532 individuals in the Mayo Clinic health system (Arizona, Florida, Iowa, Minnesota, Wisconsin) with PCR testing data between December 1, 2020 and April 20, 2021. We compared clinical outcomes for a vaccinated cohor","2021","07","17","Med (N Y)","Med (New York, N.Y.)",NA,"Pawlowski","Colin","nference, Cambridge, MA 02142, USA",NA
"2499","34223401","10.1016/j.medj.2021.06.007","FDA-authorized mRNA COVID-19 vaccines are effective per real-world evidence synthesized across a multi-state health system.","Two FDA-authorized mRNA COVID-19 vaccines, BNT162b2 (Pfizer/BioNTech) and mRNA-1273 (Moderna), have demonstrated high efficacies in large Phase 3 randomized clinical trials. It is important to assess their effectiveness in a real-world setting. This is a retrospective analysis of 136,532 individuals in the Mayo Clinic health system (Arizona, Florida, Iowa, Minnesota, Wisconsin) with PCR testing data between December 1, 2020 and April 20, 2021. We compared clinical outcomes for a vaccinated cohor","2021","07","17","Med (N Y)","Med (New York, N.Y.)",NA,"Lenehan","Patrick","nference, Cambridge, MA 02142, USA",NA
"2500","34223401","10.1016/j.medj.2021.06.007","FDA-authorized mRNA COVID-19 vaccines are effective per real-world evidence synthesized across a multi-state health system.","Two FDA-authorized mRNA COVID-19 vaccines, BNT162b2 (Pfizer/BioNTech) and mRNA-1273 (Moderna), have demonstrated high efficacies in large Phase 3 randomized clinical trials. It is important to assess their effectiveness in a real-world setting. This is a retrospective analysis of 136,532 individuals in the Mayo Clinic health system (Arizona, Florida, Iowa, Minnesota, Wisconsin) with PCR testing data between December 1, 2020 and April 20, 2021. We compared clinical outcomes for a vaccinated cohor","2021","07","17","Med (N Y)","Med (New York, N.Y.)",NA,"Puranik","Arjun","nference, Cambridge, MA 02142, USA",NA
"2501","34223401","10.1016/j.medj.2021.06.007","FDA-authorized mRNA COVID-19 vaccines are effective per real-world evidence synthesized across a multi-state health system.","Two FDA-authorized mRNA COVID-19 vaccines, BNT162b2 (Pfizer/BioNTech) and mRNA-1273 (Moderna), have demonstrated high efficacies in large Phase 3 randomized clinical trials. It is important to assess their effectiveness in a real-world setting. This is a retrospective analysis of 136,532 individuals in the Mayo Clinic health system (Arizona, Florida, Iowa, Minnesota, Wisconsin) with PCR testing data between December 1, 2020 and April 20, 2021. We compared clinical outcomes for a vaccinated cohor","2021","07","17","Med (N Y)","Med (New York, N.Y.)",NA,"Agarwal","Vineet","nference, Cambridge, MA 02142, USA",NA
"2502","34223401","10.1016/j.medj.2021.06.007","FDA-authorized mRNA COVID-19 vaccines are effective per real-world evidence synthesized across a multi-state health system.","Two FDA-authorized mRNA COVID-19 vaccines, BNT162b2 (Pfizer/BioNTech) and mRNA-1273 (Moderna), have demonstrated high efficacies in large Phase 3 randomized clinical trials. It is important to assess their effectiveness in a real-world setting. This is a retrospective analysis of 136,532 individuals in the Mayo Clinic health system (Arizona, Florida, Iowa, Minnesota, Wisconsin) with PCR testing data between December 1, 2020 and April 20, 2021. We compared clinical outcomes for a vaccinated cohor","2021","07","17","Med (N Y)","Med (New York, N.Y.)",NA,"Venkatakrishnan","A J","nference, Cambridge, MA 02142, USA",NA
"2503","34223401","10.1016/j.medj.2021.06.007","FDA-authorized mRNA COVID-19 vaccines are effective per real-world evidence synthesized across a multi-state health system.","Two FDA-authorized mRNA COVID-19 vaccines, BNT162b2 (Pfizer/BioNTech) and mRNA-1273 (Moderna), have demonstrated high efficacies in large Phase 3 randomized clinical trials. It is important to assess their effectiveness in a real-world setting. This is a retrospective analysis of 136,532 individuals in the Mayo Clinic health system (Arizona, Florida, Iowa, Minnesota, Wisconsin) with PCR testing data between December 1, 2020 and April 20, 2021. We compared clinical outcomes for a vaccinated cohor","2021","07","17","Med (N Y)","Med (New York, N.Y.)",NA,"Niesen","Michiel J M","nference, Cambridge, MA 02142, USA",NA
"2504","34223401","10.1016/j.medj.2021.06.007","FDA-authorized mRNA COVID-19 vaccines are effective per real-world evidence synthesized across a multi-state health system.","Two FDA-authorized mRNA COVID-19 vaccines, BNT162b2 (Pfizer/BioNTech) and mRNA-1273 (Moderna), have demonstrated high efficacies in large Phase 3 randomized clinical trials. It is important to assess their effectiveness in a real-world setting. This is a retrospective analysis of 136,532 individuals in the Mayo Clinic health system (Arizona, Florida, Iowa, Minnesota, Wisconsin) with PCR testing data between December 1, 2020 and April 20, 2021. We compared clinical outcomes for a vaccinated cohor","2021","07","17","Med (N Y)","Med (New York, N.Y.)",NA,"O'Horo","John C","Mayo Clinic, Rochester, MN 55902, USA",NA
"2505","34223401","10.1016/j.medj.2021.06.007","FDA-authorized mRNA COVID-19 vaccines are effective per real-world evidence synthesized across a multi-state health system.","Two FDA-authorized mRNA COVID-19 vaccines, BNT162b2 (Pfizer/BioNTech) and mRNA-1273 (Moderna), have demonstrated high efficacies in large Phase 3 randomized clinical trials. It is important to assess their effectiveness in a real-world setting. This is a retrospective analysis of 136,532 individuals in the Mayo Clinic health system (Arizona, Florida, Iowa, Minnesota, Wisconsin) with PCR testing data between December 1, 2020 and April 20, 2021. We compared clinical outcomes for a vaccinated cohor","2021","07","17","Med (N Y)","Med (New York, N.Y.)",NA,"Virk","Abinash","Mayo Clinic, Rochester, MN 55902, USA",NA
"2506","34223401","10.1016/j.medj.2021.06.007","FDA-authorized mRNA COVID-19 vaccines are effective per real-world evidence synthesized across a multi-state health system.","Two FDA-authorized mRNA COVID-19 vaccines, BNT162b2 (Pfizer/BioNTech) and mRNA-1273 (Moderna), have demonstrated high efficacies in large Phase 3 randomized clinical trials. It is important to assess their effectiveness in a real-world setting. This is a retrospective analysis of 136,532 individuals in the Mayo Clinic health system (Arizona, Florida, Iowa, Minnesota, Wisconsin) with PCR testing data between December 1, 2020 and April 20, 2021. We compared clinical outcomes for a vaccinated cohor","2021","07","17","Med (N Y)","Med (New York, N.Y.)",NA,"Swift","Melanie D","Mayo Clinic, Rochester, MN 55902, USA",NA
"2507","34223401","10.1016/j.medj.2021.06.007","FDA-authorized mRNA COVID-19 vaccines are effective per real-world evidence synthesized across a multi-state health system.","Two FDA-authorized mRNA COVID-19 vaccines, BNT162b2 (Pfizer/BioNTech) and mRNA-1273 (Moderna), have demonstrated high efficacies in large Phase 3 randomized clinical trials. It is important to assess their effectiveness in a real-world setting. This is a retrospective analysis of 136,532 individuals in the Mayo Clinic health system (Arizona, Florida, Iowa, Minnesota, Wisconsin) with PCR testing data between December 1, 2020 and April 20, 2021. We compared clinical outcomes for a vaccinated cohor","2021","07","17","Med (N Y)","Med (New York, N.Y.)",NA,"Badley","Andrew D","Mayo Clinic, Rochester, MN 55902, USA",NA
"2508","34223401","10.1016/j.medj.2021.06.007","FDA-authorized mRNA COVID-19 vaccines are effective per real-world evidence synthesized across a multi-state health system.","Two FDA-authorized mRNA COVID-19 vaccines, BNT162b2 (Pfizer/BioNTech) and mRNA-1273 (Moderna), have demonstrated high efficacies in large Phase 3 randomized clinical trials. It is important to assess their effectiveness in a real-world setting. This is a retrospective analysis of 136,532 individuals in the Mayo Clinic health system (Arizona, Florida, Iowa, Minnesota, Wisconsin) with PCR testing data between December 1, 2020 and April 20, 2021. We compared clinical outcomes for a vaccinated cohor","2021","07","17","Med (N Y)","Med (New York, N.Y.)",NA,"Halamka","John","Mayo Clinic, Rochester, MN 55902, USA",NA
"2509","34223401","10.1016/j.medj.2021.06.007","FDA-authorized mRNA COVID-19 vaccines are effective per real-world evidence synthesized across a multi-state health system.","Two FDA-authorized mRNA COVID-19 vaccines, BNT162b2 (Pfizer/BioNTech) and mRNA-1273 (Moderna), have demonstrated high efficacies in large Phase 3 randomized clinical trials. It is important to assess their effectiveness in a real-world setting. This is a retrospective analysis of 136,532 individuals in the Mayo Clinic health system (Arizona, Florida, Iowa, Minnesota, Wisconsin) with PCR testing data between December 1, 2020 and April 20, 2021. We compared clinical outcomes for a vaccinated cohor","2021","07","17","Med (N Y)","Med (New York, N.Y.)",NA,"Soundararajan","Venky","nference, Cambridge, MA 02142, USA",NA
"2510","34223400","10.1016/S2666-5247(21)00147-6","SARS-CoV-2 rapid diagnostic tests for emerging variants.",NA,"2021","07","06","Lancet Microbe","The Lancet. Microbe",NA,"Bekliz","Meriem","Department of Microbiology and Molecular Medicine, University of Geneva, Geneva, Switzerland",NA
"2511","34223400","10.1016/S2666-5247(21)00147-6","SARS-CoV-2 rapid diagnostic tests for emerging variants.",NA,"2021","07","06","Lancet Microbe","The Lancet. Microbe",NA,"Adea","Kenneth","Department of Microbiology and Molecular Medicine, University of Geneva, Geneva, Switzerland",NA
"2512","34223400","10.1016/S2666-5247(21)00147-6","SARS-CoV-2 rapid diagnostic tests for emerging variants.",NA,"2021","07","06","Lancet Microbe","The Lancet. Microbe",NA,"Essaidi-Laziosi","Manel","Department of Microbiology and Molecular Medicine, University of Geneva, Geneva, Switzerland",NA
"2513","34223400","10.1016/S2666-5247(21)00147-6","SARS-CoV-2 rapid diagnostic tests for emerging variants.",NA,"2021","07","06","Lancet Microbe","The Lancet. Microbe",NA,"Sacks","Jilian A","Foundation for Innovative New Diagnostics, Geneva, Switzerland",NA
"2514","34223400","10.1016/S2666-5247(21)00147-6","SARS-CoV-2 rapid diagnostic tests for emerging variants.",NA,"2021","07","06","Lancet Microbe","The Lancet. Microbe",NA,"Escadafal","Camille","Foundation for Innovative New Diagnostics, Geneva, Switzerland",NA
"2515","34223400","10.1016/S2666-5247(21)00147-6","SARS-CoV-2 rapid diagnostic tests for emerging variants.",NA,"2021","07","06","Lancet Microbe","The Lancet. Microbe",NA,"Kaiser","Laurent","Division of Infectious Diseases, Geneva University Hospitals, 1205 Geneva, Switzerland",NA
"2516","34223400","10.1016/S2666-5247(21)00147-6","SARS-CoV-2 rapid diagnostic tests for emerging variants.",NA,"2021","07","06","Lancet Microbe","The Lancet. Microbe",NA,"Eckerle","Isabella","Department of Microbiology and Molecular Medicine, University of Geneva, Geneva, Switzerland",NA
"2517","34223399","10.1016/S2666-5247(21)00157-9","Paucity and discordance of neutralising antibody responses to SARS-CoV-2 VOCs in vaccinated immunodeficient patients and health-care workers in the UK.",NA,"2021","07","06","Lancet Microbe","The Lancet. Microbe",NA,"Nadesalingam","Angalee","Laboratory of Viral Zoonotics, University of Cambridge, Cambridge CB3 OES, UK",NA
"2518","34223399","10.1016/S2666-5247(21)00157-9","Paucity and discordance of neutralising antibody responses to SARS-CoV-2 VOCs in vaccinated immunodeficient patients and health-care workers in the UK.",NA,"2021","07","06","Lancet Microbe","The Lancet. Microbe",NA,"Cantoni","Diego","Viral Pseudotype Unit, Medway School of Pharmacy, University of Kent, Medway, UK",NA
"2519","34223399","10.1016/S2666-5247(21)00157-9","Paucity and discordance of neutralising antibody responses to SARS-CoV-2 VOCs in vaccinated immunodeficient patients and health-care workers in the UK.",NA,"2021","07","06","Lancet Microbe","The Lancet. Microbe",NA,"Wells","David A","Laboratory of Viral Zoonotics, University of Cambridge, Cambridge CB3 OES, UK",NA
"2520","34223399","10.1016/S2666-5247(21)00157-9","Paucity and discordance of neutralising antibody responses to SARS-CoV-2 VOCs in vaccinated immunodeficient patients and health-care workers in the UK.",NA,"2021","07","06","Lancet Microbe","The Lancet. Microbe",NA,"Aguinam","Ernest T","Laboratory of Viral Zoonotics, University of Cambridge, Cambridge CB3 OES, UK",NA
"2521","34223399","10.1016/S2666-5247(21)00157-9","Paucity and discordance of neutralising antibody responses to SARS-CoV-2 VOCs in vaccinated immunodeficient patients and health-care workers in the UK.",NA,"2021","07","06","Lancet Microbe","The Lancet. Microbe",NA,"Ferrari","Matteo","Laboratory of Viral Zoonotics, University of Cambridge, Cambridge CB3 OES, UK",NA
"2522","34223399","10.1016/S2666-5247(21)00157-9","Paucity and discordance of neutralising antibody responses to SARS-CoV-2 VOCs in vaccinated immunodeficient patients and health-care workers in the UK.",NA,"2021","07","06","Lancet Microbe","The Lancet. Microbe",NA,"Smith","Peter","Laboratory of Viral Zoonotics, University of Cambridge, Cambridge CB3 OES, UK",NA
"2523","34223399","10.1016/S2666-5247(21)00157-9","Paucity and discordance of neutralising antibody responses to SARS-CoV-2 VOCs in vaccinated immunodeficient patients and health-care workers in the UK.",NA,"2021","07","06","Lancet Microbe","The Lancet. Microbe",NA,"Chan","Andrew","Laboratory of Viral Zoonotics, University of Cambridge, Cambridge CB3 OES, UK",NA
"2524","34223399","10.1016/S2666-5247(21)00157-9","Paucity and discordance of neutralising antibody responses to SARS-CoV-2 VOCs in vaccinated immunodeficient patients and health-care workers in the UK.",NA,"2021","07","06","Lancet Microbe","The Lancet. Microbe",NA,"Carnell","George","Laboratory of Viral Zoonotics, University of Cambridge, Cambridge CB3 OES, UK",NA
"2525","34223399","10.1016/S2666-5247(21)00157-9","Paucity and discordance of neutralising antibody responses to SARS-CoV-2 VOCs in vaccinated immunodeficient patients and health-care workers in the UK.",NA,"2021","07","06","Lancet Microbe","The Lancet. Microbe",NA,"Ohlendorf","Luis","Laboratory of Viral Zoonotics, University of Cambridge, Cambridge CB3 OES, UK",NA
"2526","34223399","10.1016/S2666-5247(21)00157-9","Paucity and discordance of neutralising antibody responses to SARS-CoV-2 VOCs in vaccinated immunodeficient patients and health-care workers in the UK.",NA,"2021","07","06","Lancet Microbe","The Lancet. Microbe",NA,"Einhauser","Sebastian","Institute of Medical Microbiology and Hygiene, University of Regensburg, Regensburg, Germany",NA
"2527","34223399","10.1016/S2666-5247(21)00157-9","Paucity and discordance of neutralising antibody responses to SARS-CoV-2 VOCs in vaccinated immunodeficient patients and health-care workers in the UK.",NA,"2021","07","06","Lancet Microbe","The Lancet. Microbe",NA,"George","Charlotte","Laboratory of Viral Zoonotics, University of Cambridge, Cambridge CB3 OES, UK",NA
"2528","34223399","10.1016/S2666-5247(21)00157-9","Paucity and discordance of neutralising antibody responses to SARS-CoV-2 VOCs in vaccinated immunodeficient patients and health-care workers in the UK.",NA,"2021","07","06","Lancet Microbe","The Lancet. Microbe",NA,"Wagner","Ralf","Institute of Clinical Microbiology and Hygiene, University of Regensburg, Regensburg, Germany",NA
"2529","34223399","10.1016/S2666-5247(21)00157-9","Paucity and discordance of neutralising antibody responses to SARS-CoV-2 VOCs in vaccinated immunodeficient patients and health-care workers in the UK.",NA,"2021","07","06","Lancet Microbe","The Lancet. Microbe",NA,"Temperton","Nigel","Viral Pseudotype Unit, Medway School of Pharmacy, University of Kent, Medway, UK",NA
"2530","34223399","10.1016/S2666-5247(21)00157-9","Paucity and discordance of neutralising antibody responses to SARS-CoV-2 VOCs in vaccinated immunodeficient patients and health-care workers in the UK.",NA,"2021","07","06","Lancet Microbe","The Lancet. Microbe",NA,"Castillo-Olivares","Javier","Laboratory of Viral Zoonotics, University of Cambridge, Cambridge CB3 OES, UK",NA
"2531","34223399","10.1016/S2666-5247(21)00157-9","Paucity and discordance of neutralising antibody responses to SARS-CoV-2 VOCs in vaccinated immunodeficient patients and health-care workers in the UK.",NA,"2021","07","06","Lancet Microbe","The Lancet. Microbe",NA,"Baxendale","Helen","Clinical Immunology Department, Royal Papworth NHS Foundation Trust, Cambridge, UK",NA
"2532","34223399","10.1016/S2666-5247(21)00157-9","Paucity and discordance of neutralising antibody responses to SARS-CoV-2 VOCs in vaccinated immunodeficient patients and health-care workers in the UK.",NA,"2021","07","06","Lancet Microbe","The Lancet. Microbe",NA,"Heeney","Jonathan L","Laboratory of Viral Zoonotics, University of Cambridge, Cambridge CB3 OES, UK",NA
"2533","34223367","10.1016/j.resplu.2021.100105","Out-of-hospital cardiac arrests and mortality in Swiss Cantons with high and low COVID-19 incidence: A nationwide analysis.","Many countries reported an increase of out-of-hospital cardiac arrests (OHCAs) and mortality during the COVID-19 pandemic. However, all these data refer to regional settings and national data are still missing. We aimed to assess the OHCA incidence and population mortality during COVID-19 pandemic in whole Switzerland and in the different regions (Cantons) according to the infection rate. We considered OHCAs and deaths which occurred in Switzerland after the first diagnosed case of COVID-19 (Feb","2021","07","06","Resusc Plus","Resuscitation plus","COVID-19; Mortality; Out-of-hospital cardiac arrest; Switzerland","Baldi","Enrico","Fondazione Ticino Cuore, Breganzona, Switzerland",NA
"2534","34223367","10.1016/j.resplu.2021.100105","Out-of-hospital cardiac arrests and mortality in Swiss Cantons with high and low COVID-19 incidence: A nationwide analysis.","Many countries reported an increase of out-of-hospital cardiac arrests (OHCAs) and mortality during the COVID-19 pandemic. However, all these data refer to regional settings and national data are still missing. We aimed to assess the OHCA incidence and population mortality during COVID-19 pandemic in whole Switzerland and in the different regions (Cantons) according to the infection rate. We considered OHCAs and deaths which occurred in Switzerland after the first diagnosed case of COVID-19 (Feb","2021","07","06","Resusc Plus","Resuscitation plus","COVID-19; Mortality; Out-of-hospital cardiac arrest; Switzerland","Auricchio","Angelo","Fondazione Ticino Cuore, Breganzona, Switzerland",NA
"2535","34223367","10.1016/j.resplu.2021.100105","Out-of-hospital cardiac arrests and mortality in Swiss Cantons with high and low COVID-19 incidence: A nationwide analysis.","Many countries reported an increase of out-of-hospital cardiac arrests (OHCAs) and mortality during the COVID-19 pandemic. However, all these data refer to regional settings and national data are still missing. We aimed to assess the OHCA incidence and population mortality during COVID-19 pandemic in whole Switzerland and in the different regions (Cantons) according to the infection rate. We considered OHCAs and deaths which occurred in Switzerland after the first diagnosed case of COVID-19 (Feb","2021","07","06","Resusc Plus","Resuscitation plus","COVID-19; Mortality; Out-of-hospital cardiac arrest; Switzerland","Klersy","Catherine","Biometry and Clinical Epidemiology Service, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy",NA
"2536","34223367","10.1016/j.resplu.2021.100105","Out-of-hospital cardiac arrests and mortality in Swiss Cantons with high and low COVID-19 incidence: A nationwide analysis.","Many countries reported an increase of out-of-hospital cardiac arrests (OHCAs) and mortality during the COVID-19 pandemic. However, all these data refer to regional settings and national data are still missing. We aimed to assess the OHCA incidence and population mortality during COVID-19 pandemic in whole Switzerland and in the different regions (Cantons) according to the infection rate. We considered OHCAs and deaths which occurred in Switzerland after the first diagnosed case of COVID-19 (Feb","2021","07","06","Resusc Plus","Resuscitation plus","COVID-19; Mortality; Out-of-hospital cardiac arrest; Switzerland","Burkart","Roman","Interassociation for Rescue Services (IVR-IAS), Berne, Switzerland",NA
"2537","34223367","10.1016/j.resplu.2021.100105","Out-of-hospital cardiac arrests and mortality in Swiss Cantons with high and low COVID-19 incidence: A nationwide analysis.","Many countries reported an increase of out-of-hospital cardiac arrests (OHCAs) and mortality during the COVID-19 pandemic. However, all these data refer to regional settings and national data are still missing. We aimed to assess the OHCA incidence and population mortality during COVID-19 pandemic in whole Switzerland and in the different regions (Cantons) according to the infection rate. We considered OHCAs and deaths which occurred in Switzerland after the first diagnosed case of COVID-19 (Feb","2021","07","06","Resusc Plus","Resuscitation plus","COVID-19; Mortality; Out-of-hospital cardiac arrest; Switzerland","Benvenuti","Claudio","Fondazione Ticino Cuore, Breganzona, Switzerland",NA
"2538","34223367","10.1016/j.resplu.2021.100105","Out-of-hospital cardiac arrests and mortality in Swiss Cantons with high and low COVID-19 incidence: A nationwide analysis.","Many countries reported an increase of out-of-hospital cardiac arrests (OHCAs) and mortality during the COVID-19 pandemic. However, all these data refer to regional settings and national data are still missing. We aimed to assess the OHCA incidence and population mortality during COVID-19 pandemic in whole Switzerland and in the different regions (Cantons) according to the infection rate. We considered OHCAs and deaths which occurred in Switzerland after the first diagnosed case of COVID-19 (Feb","2021","07","06","Resusc Plus","Resuscitation plus","COVID-19; Mortality; Out-of-hospital cardiac arrest; Switzerland","Vanetta","Chiara","Fondazione Ticino Cuore, Breganzona, Switzerland",NA
"2539","34223367","10.1016/j.resplu.2021.100105","Out-of-hospital cardiac arrests and mortality in Swiss Cantons with high and low COVID-19 incidence: A nationwide analysis.","Many countries reported an increase of out-of-hospital cardiac arrests (OHCAs) and mortality during the COVID-19 pandemic. However, all these data refer to regional settings and national data are still missing. We aimed to assess the OHCA incidence and population mortality during COVID-19 pandemic in whole Switzerland and in the different regions (Cantons) according to the infection rate. We considered OHCAs and deaths which occurred in Switzerland after the first diagnosed case of COVID-19 (Feb","2021","07","06","Resusc Plus","Resuscitation plus","COVID-19; Mortality; Out-of-hospital cardiac arrest; Switzerland","Bärtschi","Jürg","Interassociation for Rescue Services (IVR-IAS), Berne, Switzerland",NA
"2540","34223349","10.1016/j.resplu.2021.100083","A review of ECMO for cardiac arrest.","Cardiac arrest is an important public health concern, affecting an estimated 356,500 people in the out-of-hospital setting and 209,000 people in the in-hospital setting each year. The causes of cardiac arrest include acute coronary syndromes, pulmonary embolism, dyskalemia, respiratory failure, hypovolemia, sepsis, and poisoning among many others. In order to tackle the enormous issue of high mortality among sufferers of cardiac arrest, ongoing research has been seeking improved treatment protoc","2021","07","06","Resusc Plus","Resuscitation plus","COVID-19; Cardiac arrest; ECMO; ECPR; Extracorporeal cardiopulmonary resuscitation; Extracorporeal membrane oxygenation","Klee","Tyler E","University of Arizona College of Medicine, Tucson, AZ, United States",NA
"2541","34223349","10.1016/j.resplu.2021.100083","A review of ECMO for cardiac arrest.","Cardiac arrest is an important public health concern, affecting an estimated 356,500 people in the out-of-hospital setting and 209,000 people in the in-hospital setting each year. The causes of cardiac arrest include acute coronary syndromes, pulmonary embolism, dyskalemia, respiratory failure, hypovolemia, sepsis, and poisoning among many others. In order to tackle the enormous issue of high mortality among sufferers of cardiac arrest, ongoing research has been seeking improved treatment protoc","2021","07","06","Resusc Plus","Resuscitation plus","COVID-19; Cardiac arrest; ECMO; ECPR; Extracorporeal cardiopulmonary resuscitation; Extracorporeal membrane oxygenation","Kern","Karl B","University of Arizona College of Medicine, Tucson, AZ, United States",NA
"2542","34223327","10.1016/j.resplu.2020.100053","Educational theory and its application to advanced life support courses: a narrative review.","The knowledge, skills and attitudes taught on Advanced Life Support (ALS) courses are an important learning requirement for healthcare professionals who are involved with the care of acutely unwell patients. It is essential that the course design and delivery is appropriately planned to ensure that it optimises the learning opportunities for all learners. This paper offers a narrative review of how the application of educational theory has positively influenced the evolution of ALS courses since","2021","07","06","Resusc Plus","Resuscitation plus","Advanced life support; Education; educational theory","Lockey","Andrew","Calderdale &amp",NA
"2543","34223327","10.1016/j.resplu.2020.100053","Educational theory and its application to advanced life support courses: a narrative review.","The knowledge, skills and attitudes taught on Advanced Life Support (ALS) courses are an important learning requirement for healthcare professionals who are involved with the care of acutely unwell patients. It is essential that the course design and delivery is appropriately planned to ensure that it optimises the learning opportunities for all learners. This paper offers a narrative review of how the application of educational theory has positively influenced the evolution of ALS courses since","2021","07","06","Resusc Plus","Resuscitation plus","Advanced life support; Education; educational theory","Conaghan","Patricia","University of Manchester, School of Health Sciences, UK",NA
"2544","34223327","10.1016/j.resplu.2020.100053","Educational theory and its application to advanced life support courses: a narrative review.","The knowledge, skills and attitudes taught on Advanced Life Support (ALS) courses are an important learning requirement for healthcare professionals who are involved with the care of acutely unwell patients. It is essential that the course design and delivery is appropriately planned to ensure that it optimises the learning opportunities for all learners. This paper offers a narrative review of how the application of educational theory has positively influenced the evolution of ALS courses since","2021","07","06","Resusc Plus","Resuscitation plus","Advanced life support; Education; educational theory","Bland","Andrew","University of Huddersfield, Centre for Applied Research in Health, UK",NA
"2545","34223327","10.1016/j.resplu.2020.100053","Educational theory and its application to advanced life support courses: a narrative review.","The knowledge, skills and attitudes taught on Advanced Life Support (ALS) courses are an important learning requirement for healthcare professionals who are involved with the care of acutely unwell patients. It is essential that the course design and delivery is appropriately planned to ensure that it optimises the learning opportunities for all learners. This paper offers a narrative review of how the application of educational theory has positively influenced the evolution of ALS courses since","2021","07","06","Resusc Plus","Resuscitation plus","Advanced life support; Education; educational theory","Astin","Felicity","Calderdale &amp",NA
"2546","34223287","10.1016/j.hroo.2021.06.005","PORTABLE SINGLE-LEAD ELECTROCARDIOGRAM DEVICE IS ACCURATE FOR QTc EVALUATION IN HOSPITALIZED PATIENTS.","Many commonly used drugs can prolong the QTc interval (QTc), which can lead to potentially life-threatening arrhythmias. In the current era of COVID-19 pandemic, it is worth mentioning that the disease itself and several drugs used for its treatment have been associated with QTc prolongation. To evaluate the agreement and clinical precision of a portable single-lead ECG device to measure the QTc interval compared to the standard 12-lead ECG. In sequential tests, QTc of ECG recordings obtained wi","2021","07","06","Heart Rhythm O2","Heart rhythm O2","COVID-19; Electrocardiography; KardiaMobile; Mobile Applications; QT/QTc interval; Smartphone; Ventricular Arrhythmias; single-lead ECG device","Marin O","María Mónica","Department of Cardiology, Pontificia Universidad Javeriana, Hospital Universitario San Ignacio, Bogotá D.C, Colombia",NA
"2547","34223287","10.1016/j.hroo.2021.06.005","PORTABLE SINGLE-LEAD ELECTROCARDIOGRAM DEVICE IS ACCURATE FOR QTc EVALUATION IN HOSPITALIZED PATIENTS.","Many commonly used drugs can prolong the QTc interval (QTc), which can lead to potentially life-threatening arrhythmias. In the current era of COVID-19 pandemic, it is worth mentioning that the disease itself and several drugs used for its treatment have been associated with QTc prolongation. To evaluate the agreement and clinical precision of a portable single-lead ECG device to measure the QTc interval compared to the standard 12-lead ECG. In sequential tests, QTc of ECG recordings obtained wi","2021","07","06","Heart Rhythm O2","Heart rhythm O2","COVID-19; Electrocardiography; KardiaMobile; Mobile Applications; QT/QTc interval; Smartphone; Ventricular Arrhythmias; single-lead ECG device","García P","Ángel Alberto","Department of Cardiology, Pontificia Universidad Javeriana, Hospital Universitario San Ignacio, Bogotá D.C, Colombia",NA
"2548","34223287","10.1016/j.hroo.2021.06.005","PORTABLE SINGLE-LEAD ELECTROCARDIOGRAM DEVICE IS ACCURATE FOR QTc EVALUATION IN HOSPITALIZED PATIENTS.","Many commonly used drugs can prolong the QTc interval (QTc), which can lead to potentially life-threatening arrhythmias. In the current era of COVID-19 pandemic, it is worth mentioning that the disease itself and several drugs used for its treatment have been associated with QTc prolongation. To evaluate the agreement and clinical precision of a portable single-lead ECG device to measure the QTc interval compared to the standard 12-lead ECG. In sequential tests, QTc of ECG recordings obtained wi","2021","07","06","Heart Rhythm O2","Heart rhythm O2","COVID-19; Electrocardiography; KardiaMobile; Mobile Applications; QT/QTc interval; Smartphone; Ventricular Arrhythmias; single-lead ECG device","Muñoz V","Oscar Mauricio","Department of Internal Medicine, Hospital Universitario San Ignacio, Pontificia Universidad Javeriana, Bogotá D.C, Colombia",NA
"2549","34223287","10.1016/j.hroo.2021.06.005","PORTABLE SINGLE-LEAD ELECTROCARDIOGRAM DEVICE IS ACCURATE FOR QTc EVALUATION IN HOSPITALIZED PATIENTS.","Many commonly used drugs can prolong the QTc interval (QTc), which can lead to potentially life-threatening arrhythmias. In the current era of COVID-19 pandemic, it is worth mentioning that the disease itself and several drugs used for its treatment have been associated with QTc prolongation. To evaluate the agreement and clinical precision of a portable single-lead ECG device to measure the QTc interval compared to the standard 12-lead ECG. In sequential tests, QTc of ECG recordings obtained wi","2021","07","06","Heart Rhythm O2","Heart rhythm O2","COVID-19; Electrocardiography; KardiaMobile; Mobile Applications; QT/QTc interval; Smartphone; Ventricular Arrhythmias; single-lead ECG device","Castellanos R","Julio César","Managing Director, Hospital Universitario San Ignacio, Bogotá D.C, Colombia",NA
"2550","34223287","10.1016/j.hroo.2021.06.005","PORTABLE SINGLE-LEAD ELECTROCARDIOGRAM DEVICE IS ACCURATE FOR QTc EVALUATION IN HOSPITALIZED PATIENTS.","Many commonly used drugs can prolong the QTc interval (QTc), which can lead to potentially life-threatening arrhythmias. In the current era of COVID-19 pandemic, it is worth mentioning that the disease itself and several drugs used for its treatment have been associated with QTc prolongation. To evaluate the agreement and clinical precision of a portable single-lead ECG device to measure the QTc interval compared to the standard 12-lead ECG. In sequential tests, QTc of ECG recordings obtained wi","2021","07","06","Heart Rhythm O2","Heart rhythm O2","COVID-19; Electrocardiography; KardiaMobile; Mobile Applications; QT/QTc interval; Smartphone; Ventricular Arrhythmias; single-lead ECG device","Cáceres M","Edward","Department of Cardiology, Pontificia Universidad Javeriana, Hospital Universitario San Ignacio, Bogotá D.C, Colombia",NA
"2551","34223287","10.1016/j.hroo.2021.06.005","PORTABLE SINGLE-LEAD ELECTROCARDIOGRAM DEVICE IS ACCURATE FOR QTc EVALUATION IN HOSPITALIZED PATIENTS.","Many commonly used drugs can prolong the QTc interval (QTc), which can lead to potentially life-threatening arrhythmias. In the current era of COVID-19 pandemic, it is worth mentioning that the disease itself and several drugs used for its treatment have been associated with QTc prolongation. To evaluate the agreement and clinical precision of a portable single-lead ECG device to measure the QTc interval compared to the standard 12-lead ECG. In sequential tests, QTc of ECG recordings obtained wi","2021","07","06","Heart Rhythm O2","Heart rhythm O2","COVID-19; Electrocardiography; KardiaMobile; Mobile Applications; QT/QTc interval; Smartphone; Ventricular Arrhythmias; single-lead ECG device","Pacheco","David Santacruz","Pontificia Universidad Javeriana. Professor of the training program in Cardiac Electrophysiology, Bogotá D.C, Colombia",NA
"2552","34223190","10.22037/aaem.v9i1.1250","Electrocardiographic Findings and In-Hospital Mortality of COVID-19 Patients; a Retrospective Cohort Study.","Although current evidence points to the possible prognostic value of electrocardiographic (ECG) findings for in-hospital mortality of COVID-19 patients, most of these studies have been performed on a small sample size. In this study, our aim was to investigate the ECG changes as prognostic indicators of in-hospital mortality. In a retrospective cohort study, the findings of the first and the second ECGs of COVID-19 patients were extracted and changes in the ECGs were examined. Any abnormal findi","2021","07","06","Arch Acad Emerg Med","Archives of academic emergency medicine","COVID-19; Electrocardiography; Hospital mortality; Prognosis","Haji Aghajani","Mohammad","Prevention of Cardiovascular Disease Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran",NA
"2553","34223190","10.22037/aaem.v9i1.1250","Electrocardiographic Findings and In-Hospital Mortality of COVID-19 Patients; a Retrospective Cohort Study.","Although current evidence points to the possible prognostic value of electrocardiographic (ECG) findings for in-hospital mortality of COVID-19 patients, most of these studies have been performed on a small sample size. In this study, our aim was to investigate the ECG changes as prognostic indicators of in-hospital mortality. In a retrospective cohort study, the findings of the first and the second ECGs of COVID-19 patients were extracted and changes in the ECGs were examined. Any abnormal findi","2021","07","06","Arch Acad Emerg Med","Archives of academic emergency medicine","COVID-19; Electrocardiography; Hospital mortality; Prognosis","Toloui","Amirmohammad","Physiology Research Center, Iran University of Medical Sciences, Tehran, Iran",NA
"2554","34223190","10.22037/aaem.v9i1.1250","Electrocardiographic Findings and In-Hospital Mortality of COVID-19 Patients; a Retrospective Cohort Study.","Although current evidence points to the possible prognostic value of electrocardiographic (ECG) findings for in-hospital mortality of COVID-19 patients, most of these studies have been performed on a small sample size. In this study, our aim was to investigate the ECG changes as prognostic indicators of in-hospital mortality. In a retrospective cohort study, the findings of the first and the second ECGs of COVID-19 patients were extracted and changes in the ECGs were examined. Any abnormal findi","2021","07","06","Arch Acad Emerg Med","Archives of academic emergency medicine","COVID-19; Electrocardiography; Hospital mortality; Prognosis","Aghamohammadi","Moazzameh","Prevention of Cardiovascular Disease Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran",NA
"2555","34223190","10.22037/aaem.v9i1.1250","Electrocardiographic Findings and In-Hospital Mortality of COVID-19 Patients; a Retrospective Cohort Study.","Although current evidence points to the possible prognostic value of electrocardiographic (ECG) findings for in-hospital mortality of COVID-19 patients, most of these studies have been performed on a small sample size. In this study, our aim was to investigate the ECG changes as prognostic indicators of in-hospital mortality. In a retrospective cohort study, the findings of the first and the second ECGs of COVID-19 patients were extracted and changes in the ECGs were examined. Any abnormal findi","2021","07","06","Arch Acad Emerg Med","Archives of academic emergency medicine","COVID-19; Electrocardiography; Hospital mortality; Prognosis","Pourhoseingholi","Asma","Prevention of Cardiovascular Disease Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran",NA
"2556","34223190","10.22037/aaem.v9i1.1250","Electrocardiographic Findings and In-Hospital Mortality of COVID-19 Patients; a Retrospective Cohort Study.","Although current evidence points to the possible prognostic value of electrocardiographic (ECG) findings for in-hospital mortality of COVID-19 patients, most of these studies have been performed on a small sample size. In this study, our aim was to investigate the ECG changes as prognostic indicators of in-hospital mortality. In a retrospective cohort study, the findings of the first and the second ECGs of COVID-19 patients were extracted and changes in the ECGs were examined. Any abnormal findi","2021","07","06","Arch Acad Emerg Med","Archives of academic emergency medicine","COVID-19; Electrocardiography; Hospital mortality; Prognosis","Taherpour","Niloufar","Prevention of Cardiovascular Disease Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran",NA
"2557","34223190","10.22037/aaem.v9i1.1250","Electrocardiographic Findings and In-Hospital Mortality of COVID-19 Patients; a Retrospective Cohort Study.","Although current evidence points to the possible prognostic value of electrocardiographic (ECG) findings for in-hospital mortality of COVID-19 patients, most of these studies have been performed on a small sample size. In this study, our aim was to investigate the ECG changes as prognostic indicators of in-hospital mortality. In a retrospective cohort study, the findings of the first and the second ECGs of COVID-19 patients were extracted and changes in the ECGs were examined. Any abnormal findi","2021","07","06","Arch Acad Emerg Med","Archives of academic emergency medicine","COVID-19; Electrocardiography; Hospital mortality; Prognosis","Sistanizad","Mohammad","Prevention of Cardiovascular Disease Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran",NA
"2558","34223190","10.22037/aaem.v9i1.1250","Electrocardiographic Findings and In-Hospital Mortality of COVID-19 Patients; a Retrospective Cohort Study.","Although current evidence points to the possible prognostic value of electrocardiographic (ECG) findings for in-hospital mortality of COVID-19 patients, most of these studies have been performed on a small sample size. In this study, our aim was to investigate the ECG changes as prognostic indicators of in-hospital mortality. In a retrospective cohort study, the findings of the first and the second ECGs of COVID-19 patients were extracted and changes in the ECGs were examined. Any abnormal findi","2021","07","06","Arch Acad Emerg Med","Archives of academic emergency medicine","COVID-19; Electrocardiography; Hospital mortality; Prognosis","Madani Neishaboori","Arian","Physiology Research Center, Iran University of Medical Sciences, Tehran, Iran",NA
"2559","34223190","10.22037/aaem.v9i1.1250","Electrocardiographic Findings and In-Hospital Mortality of COVID-19 Patients; a Retrospective Cohort Study.","Although current evidence points to the possible prognostic value of electrocardiographic (ECG) findings for in-hospital mortality of COVID-19 patients, most of these studies have been performed on a small sample size. In this study, our aim was to investigate the ECG changes as prognostic indicators of in-hospital mortality. In a retrospective cohort study, the findings of the first and the second ECGs of COVID-19 patients were extracted and changes in the ECGs were examined. Any abnormal findi","2021","07","06","Arch Acad Emerg Med","Archives of academic emergency medicine","COVID-19; Electrocardiography; Hospital mortality; Prognosis","Asadpoordezaki","Ziba","Human Health Institute, National University of Ireland, Mynooth, Mynooth, Ireland",NA
"2560","34223190","10.22037/aaem.v9i1.1250","Electrocardiographic Findings and In-Hospital Mortality of COVID-19 Patients; a Retrospective Cohort Study.","Although current evidence points to the possible prognostic value of electrocardiographic (ECG) findings for in-hospital mortality of COVID-19 patients, most of these studies have been performed on a small sample size. In this study, our aim was to investigate the ECG changes as prognostic indicators of in-hospital mortality. In a retrospective cohort study, the findings of the first and the second ECGs of COVID-19 patients were extracted and changes in the ECGs were examined. Any abnormal findi","2021","07","06","Arch Acad Emerg Med","Archives of academic emergency medicine","COVID-19; Electrocardiography; Hospital mortality; Prognosis","Miri","Reza","Prevention of Cardiovascular Disease Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran",NA
"2561","34223186","10.22037/aaem.v9i1.1201","Is Social Distancing Policy Effective in Controlling COVID-19? An Interrupted Time Series Analysis.","The social distancing plan is one of the ways that was implemented for management of COVID-19 pandemic. This study aimed to evaluate the effect of the social distancing on reducing the daily new cases and deaths from COVID-19. In this cross-sectional study, the data of daily new cases and daily deaths were collected from 15/02/2020 to 19/04/2020. Changes in the level and trend of daily new cases and daily deaths before and after the implementation of social distancing plan were evaluated using i","2021","07","06","Arch Acad Emerg Med","Archives of academic emergency medicine","COVID-19; Iran; Physical distancing; incidence; interrupted time series analysis","Yaseri","Mehdi","Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran. E-mail: m.yaseri@gmail","m.yaseri@gmail.com"
"2562","34223186","10.22037/aaem.v9i1.1201","Is Social Distancing Policy Effective in Controlling COVID-19? An Interrupted Time Series Analysis.","The social distancing plan is one of the ways that was implemented for management of COVID-19 pandemic. This study aimed to evaluate the effect of the social distancing on reducing the daily new cases and deaths from COVID-19. In this cross-sectional study, the data of daily new cases and daily deaths were collected from 15/02/2020 to 19/04/2020. Changes in the level and trend of daily new cases and daily deaths before and after the implementation of social distancing plan were evaluated using i","2021","07","06","Arch Acad Emerg Med","Archives of academic emergency medicine","COVID-19; Iran; Physical distancing; incidence; interrupted time series analysis","Soleimani-Jelodar","Rahim","Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran. E-mail: rahimsoleimani1361@yahoo","rahimsoleimani1361@yahoo.com"
"2563","34223186","10.22037/aaem.v9i1.1201","Is Social Distancing Policy Effective in Controlling COVID-19? An Interrupted Time Series Analysis.","The social distancing plan is one of the ways that was implemented for management of COVID-19 pandemic. This study aimed to evaluate the effect of the social distancing on reducing the daily new cases and deaths from COVID-19. In this cross-sectional study, the data of daily new cases and daily deaths were collected from 15/02/2020 to 19/04/2020. Changes in the level and trend of daily new cases and daily deaths before and after the implementation of social distancing plan were evaluated using i","2021","07","06","Arch Acad Emerg Med","Archives of academic emergency medicine","COVID-19; Iran; Physical distancing; incidence; interrupted time series analysis","Rostami","Zohreh","Department of Accounting, Qazvin Branch, Islamic Azad University, Qazvin, Iran. E-mail: rostamizohreh@yahoo","rostamizohreh@yahoo.com"
"2564","34223186","10.22037/aaem.v9i1.1201","Is Social Distancing Policy Effective in Controlling COVID-19? An Interrupted Time Series Analysis.","The social distancing plan is one of the ways that was implemented for management of COVID-19 pandemic. This study aimed to evaluate the effect of the social distancing on reducing the daily new cases and deaths from COVID-19. In this cross-sectional study, the data of daily new cases and daily deaths were collected from 15/02/2020 to 19/04/2020. Changes in the level and trend of daily new cases and daily deaths before and after the implementation of social distancing plan were evaluated using i","2021","07","06","Arch Acad Emerg Med","Archives of academic emergency medicine","COVID-19; Iran; Physical distancing; incidence; interrupted time series analysis","Shahsavari","Saeed","Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran. E-mail: m.yaseri@gmail","m.yaseri@gmail.com"
"2565","34223186","10.22037/aaem.v9i1.1201","Is Social Distancing Policy Effective in Controlling COVID-19? An Interrupted Time Series Analysis.","The social distancing plan is one of the ways that was implemented for management of COVID-19 pandemic. This study aimed to evaluate the effect of the social distancing on reducing the daily new cases and deaths from COVID-19. In this cross-sectional study, the data of daily new cases and daily deaths were collected from 15/02/2020 to 19/04/2020. Changes in the level and trend of daily new cases and daily deaths before and after the implementation of social distancing plan were evaluated using i","2021","07","06","Arch Acad Emerg Med","Archives of academic emergency medicine","COVID-19; Iran; Physical distancing; incidence; interrupted time series analysis","Hosseini","Mostafa","Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran. E-mail: m.yaseri@gmail","m.yaseri@gmail.com"
"2566","34223149","10.1093/jacamr/dlab052","Antibiotic resistance during and beyond COVID-19.","Antibiotics underpin the 'modern medicine' that has increased life expectancy, leading to societies with sizeable vulnerable elderly populations who have suffered disproportionately during the current COVID-19 pandemic. Governments have responded by shuttering economies, limiting social interactions and refocusing healthcare. There are implications for antibiotic resistance both during and after these events. During spring 2020, COVID-19-stressed ICUs relaxed stewardship, perhaps promoting resis","2021","07","06","JAC Antimicrob Resist","JAC-antimicrobial resistance",NA,"Livermore","David M","Norwich Medical School, University of East Anglia, Norwich, Norfolk NR4 7TJ, UK",NA
"2567","34223144","10.1093/jacamr/dlab085","Antibiotic prescribing patterns in patients hospitalized with COVID-19: lessons from the first wave.","A high proportion of hospitalized patients with COVID-19 receive antibiotics despite evidence to show low levels of true bacterial coinfection. A retrospective cohort study examining antibiotic prescribing patterns of 300 patients sequentially diagnosed with COVID-19. Patients were grouped into 3 sub-cohorts: Group 1 received no antibiotics, Group 2 received antibiotics for microbiologically confirmed infections and Group 3 was empirically treated with antibiotics for pneumonia. The primary aim ","2021","07","06","JAC Antimicrob Resist","JAC-antimicrobial resistance",NA,"O'Kelly","Brendan","Infectious Diseases Department, Mater Misericordiae University Hospital, Dublin 7, Ireland",NA
"2568","34223144","10.1093/jacamr/dlab085","Antibiotic prescribing patterns in patients hospitalized with COVID-19: lessons from the first wave.","A high proportion of hospitalized patients with COVID-19 receive antibiotics despite evidence to show low levels of true bacterial coinfection. A retrospective cohort study examining antibiotic prescribing patterns of 300 patients sequentially diagnosed with COVID-19. Patients were grouped into 3 sub-cohorts: Group 1 received no antibiotics, Group 2 received antibiotics for microbiologically confirmed infections and Group 3 was empirically treated with antibiotics for pneumonia. The primary aim ","2021","07","06","JAC Antimicrob Resist","JAC-antimicrobial resistance",NA,"Cronin","Colm","Infectious Diseases Department, Mater Misericordiae University Hospital, Dublin 7, Ireland",NA
"2569","34223144","10.1093/jacamr/dlab085","Antibiotic prescribing patterns in patients hospitalized with COVID-19: lessons from the first wave.","A high proportion of hospitalized patients with COVID-19 receive antibiotics despite evidence to show low levels of true bacterial coinfection. A retrospective cohort study examining antibiotic prescribing patterns of 300 patients sequentially diagnosed with COVID-19. Patients were grouped into 3 sub-cohorts: Group 1 received no antibiotics, Group 2 received antibiotics for microbiologically confirmed infections and Group 3 was empirically treated with antibiotics for pneumonia. The primary aim ","2021","07","06","JAC Antimicrob Resist","JAC-antimicrobial resistance",NA,"Connellan","David","Infectious Diseases Department, Mater Misericordiae University Hospital, Dublin 7, Ireland",NA
"2570","34223144","10.1093/jacamr/dlab085","Antibiotic prescribing patterns in patients hospitalized with COVID-19: lessons from the first wave.","A high proportion of hospitalized patients with COVID-19 receive antibiotics despite evidence to show low levels of true bacterial coinfection. A retrospective cohort study examining antibiotic prescribing patterns of 300 patients sequentially diagnosed with COVID-19. Patients were grouped into 3 sub-cohorts: Group 1 received no antibiotics, Group 2 received antibiotics for microbiologically confirmed infections and Group 3 was empirically treated with antibiotics for pneumonia. The primary aim ","2021","07","06","JAC Antimicrob Resist","JAC-antimicrobial resistance",NA,"Griffin","Sean","Infectious Diseases Department, Mater Misericordiae University Hospital, Dublin 7, Ireland",NA
"2571","34223144","10.1093/jacamr/dlab085","Antibiotic prescribing patterns in patients hospitalized with COVID-19: lessons from the first wave.","A high proportion of hospitalized patients with COVID-19 receive antibiotics despite evidence to show low levels of true bacterial coinfection. A retrospective cohort study examining antibiotic prescribing patterns of 300 patients sequentially diagnosed with COVID-19. Patients were grouped into 3 sub-cohorts: Group 1 received no antibiotics, Group 2 received antibiotics for microbiologically confirmed infections and Group 3 was empirically treated with antibiotics for pneumonia. The primary aim ","2021","07","06","JAC Antimicrob Resist","JAC-antimicrobial resistance",NA,"Connolly","Stephen Peter","Infectious Diseases Department, Mater Misericordiae University Hospital, Dublin 7, Ireland",NA
"2572","34223144","10.1093/jacamr/dlab085","Antibiotic prescribing patterns in patients hospitalized with COVID-19: lessons from the first wave.","A high proportion of hospitalized patients with COVID-19 receive antibiotics despite evidence to show low levels of true bacterial coinfection. A retrospective cohort study examining antibiotic prescribing patterns of 300 patients sequentially diagnosed with COVID-19. Patients were grouped into 3 sub-cohorts: Group 1 received no antibiotics, Group 2 received antibiotics for microbiologically confirmed infections and Group 3 was empirically treated with antibiotics for pneumonia. The primary aim ","2021","07","06","JAC Antimicrob Resist","JAC-antimicrobial resistance",NA,"McGrath","Jonathan","Infectious Diseases Department, Mater Misericordiae University Hospital, Dublin 7, Ireland",NA
"2573","34223144","10.1093/jacamr/dlab085","Antibiotic prescribing patterns in patients hospitalized with COVID-19: lessons from the first wave.","A high proportion of hospitalized patients with COVID-19 receive antibiotics despite evidence to show low levels of true bacterial coinfection. A retrospective cohort study examining antibiotic prescribing patterns of 300 patients sequentially diagnosed with COVID-19. Patients were grouped into 3 sub-cohorts: Group 1 received no antibiotics, Group 2 received antibiotics for microbiologically confirmed infections and Group 3 was empirically treated with antibiotics for pneumonia. The primary aim ","2021","07","06","JAC Antimicrob Resist","JAC-antimicrobial resistance",NA,"Cotter","Aoife G","Infectious Diseases Department, Mater Misericordiae University Hospital, Dublin 7, Ireland",NA
"2574","34223144","10.1093/jacamr/dlab085","Antibiotic prescribing patterns in patients hospitalized with COVID-19: lessons from the first wave.","A high proportion of hospitalized patients with COVID-19 receive antibiotics despite evidence to show low levels of true bacterial coinfection. A retrospective cohort study examining antibiotic prescribing patterns of 300 patients sequentially diagnosed with COVID-19. Patients were grouped into 3 sub-cohorts: Group 1 received no antibiotics, Group 2 received antibiotics for microbiologically confirmed infections and Group 3 was empirically treated with antibiotics for pneumonia. The primary aim ","2021","07","06","JAC Antimicrob Resist","JAC-antimicrobial resistance",NA,"McGinty","Tara","Infectious Diseases Department, Mater Misericordiae University Hospital, Dublin 7, Ireland",NA
"2575","34223144","10.1093/jacamr/dlab085","Antibiotic prescribing patterns in patients hospitalized with COVID-19: lessons from the first wave.","A high proportion of hospitalized patients with COVID-19 receive antibiotics despite evidence to show low levels of true bacterial coinfection. A retrospective cohort study examining antibiotic prescribing patterns of 300 patients sequentially diagnosed with COVID-19. Patients were grouped into 3 sub-cohorts: Group 1 received no antibiotics, Group 2 received antibiotics for microbiologically confirmed infections and Group 3 was empirically treated with antibiotics for pneumonia. The primary aim ","2021","07","06","JAC Antimicrob Resist","JAC-antimicrobial resistance",NA,"Muldoon","Eavan G","Infectious Diseases Department, Mater Misericordiae University Hospital, Dublin 7, Ireland",NA
"2576","34223144","10.1093/jacamr/dlab085","Antibiotic prescribing patterns in patients hospitalized with COVID-19: lessons from the first wave.","A high proportion of hospitalized patients with COVID-19 receive antibiotics despite evidence to show low levels of true bacterial coinfection. A retrospective cohort study examining antibiotic prescribing patterns of 300 patients sequentially diagnosed with COVID-19. Patients were grouped into 3 sub-cohorts: Group 1 received no antibiotics, Group 2 received antibiotics for microbiologically confirmed infections and Group 3 was empirically treated with antibiotics for pneumonia. The primary aim ","2021","07","06","JAC Antimicrob Resist","JAC-antimicrobial resistance",NA,"Sheehan","Gerard","Infectious Diseases Department, Mater Misericordiae University Hospital, Dublin 7, Ireland",NA
"2577","34223144","10.1093/jacamr/dlab085","Antibiotic prescribing patterns in patients hospitalized with COVID-19: lessons from the first wave.","A high proportion of hospitalized patients with COVID-19 receive antibiotics despite evidence to show low levels of true bacterial coinfection. A retrospective cohort study examining antibiotic prescribing patterns of 300 patients sequentially diagnosed with COVID-19. Patients were grouped into 3 sub-cohorts: Group 1 received no antibiotics, Group 2 received antibiotics for microbiologically confirmed infections and Group 3 was empirically treated with antibiotics for pneumonia. The primary aim ","2021","07","06","JAC Antimicrob Resist","JAC-antimicrobial resistance",NA,"Cullen","Walter","School of Medicine, University College Dublin, Dublin 4, Ireland",NA
"2578","34223144","10.1093/jacamr/dlab085","Antibiotic prescribing patterns in patients hospitalized with COVID-19: lessons from the first wave.","A high proportion of hospitalized patients with COVID-19 receive antibiotics despite evidence to show low levels of true bacterial coinfection. A retrospective cohort study examining antibiotic prescribing patterns of 300 patients sequentially diagnosed with COVID-19. Patients were grouped into 3 sub-cohorts: Group 1 received no antibiotics, Group 2 received antibiotics for microbiologically confirmed infections and Group 3 was empirically treated with antibiotics for pneumonia. The primary aim ","2021","07","06","JAC Antimicrob Resist","JAC-antimicrobial resistance",NA,"Doran","Peter","School of Medicine, University College Dublin, Dublin 4, Ireland",NA
"2579","34223144","10.1093/jacamr/dlab085","Antibiotic prescribing patterns in patients hospitalized with COVID-19: lessons from the first wave.","A high proportion of hospitalized patients with COVID-19 receive antibiotics despite evidence to show low levels of true bacterial coinfection. A retrospective cohort study examining antibiotic prescribing patterns of 300 patients sequentially diagnosed with COVID-19. Patients were grouped into 3 sub-cohorts: Group 1 received no antibiotics, Group 2 received antibiotics for microbiologically confirmed infections and Group 3 was empirically treated with antibiotics for pneumonia. The primary aim ","2021","07","06","JAC Antimicrob Resist","JAC-antimicrobial resistance",NA,"McHugh","Tina","School of Medicine, University College Dublin, Dublin 4, Ireland",NA
"2580","34223144","10.1093/jacamr/dlab085","Antibiotic prescribing patterns in patients hospitalized with COVID-19: lessons from the first wave.","A high proportion of hospitalized patients with COVID-19 receive antibiotics despite evidence to show low levels of true bacterial coinfection. A retrospective cohort study examining antibiotic prescribing patterns of 300 patients sequentially diagnosed with COVID-19. Patients were grouped into 3 sub-cohorts: Group 1 received no antibiotics, Group 2 received antibiotics for microbiologically confirmed infections and Group 3 was empirically treated with antibiotics for pneumonia. The primary aim ","2021","07","06","JAC Antimicrob Resist","JAC-antimicrobial resistance",NA,"Vidal","Louise","School of Medicine, University College Dublin, Dublin 4, Ireland",NA
"2581","34223144","10.1093/jacamr/dlab085","Antibiotic prescribing patterns in patients hospitalized with COVID-19: lessons from the first wave.","A high proportion of hospitalized patients with COVID-19 receive antibiotics despite evidence to show low levels of true bacterial coinfection. A retrospective cohort study examining antibiotic prescribing patterns of 300 patients sequentially diagnosed with COVID-19. Patients were grouped into 3 sub-cohorts: Group 1 received no antibiotics, Group 2 received antibiotics for microbiologically confirmed infections and Group 3 was empirically treated with antibiotics for pneumonia. The primary aim ","2021","07","06","JAC Antimicrob Resist","JAC-antimicrobial resistance",NA,"Avramovic","Gordana","School of Medicine, University College Dublin, Dublin 4, Ireland",NA
"2582","34223144","10.1093/jacamr/dlab085","Antibiotic prescribing patterns in patients hospitalized with COVID-19: lessons from the first wave.","A high proportion of hospitalized patients with COVID-19 receive antibiotics despite evidence to show low levels of true bacterial coinfection. A retrospective cohort study examining antibiotic prescribing patterns of 300 patients sequentially diagnosed with COVID-19. Patients were grouped into 3 sub-cohorts: Group 1 received no antibiotics, Group 2 received antibiotics for microbiologically confirmed infections and Group 3 was empirically treated with antibiotics for pneumonia. The primary aim ","2021","07","06","JAC Antimicrob Resist","JAC-antimicrobial resistance",NA,"Lambert","John S","Infectious Diseases Department, Mater Misericordiae University Hospital, Dublin 7, Ireland",NA
"2583","34223137","10.1093/jacamr/dlab078","Antibiotic prescribing for respiratory tract infection in patients with suspected and proven COVID-19: results from an antibiotic point prevalence survey in Scottish hospitals.","Bacterial co-infection is infrequently observed with SARS-CoV-2/COVID-19 infection outside of critical care, however, antibiotics are commonly prescribed. To examine factors associated with antibiotic prescribing for suspected respiratory tract infection (RTI) and evaluate the nature and dynamics of prescribing in hospitalized patients with suspected and proven COVID-19 infection. An antibiotic point prevalence survey in hospitalized adult patients was conducted in designated COVID-19 clinical a","2021","07","06","JAC Antimicrob Resist","JAC-antimicrobial resistance",NA,"Seaton","R Andrew","Infectious Diseases Unit, Queen Elizabeth University Hospital, 1345 Govan Road, Glasgow, G51 4TF, UK",NA
"2584","34223137","10.1093/jacamr/dlab078","Antibiotic prescribing for respiratory tract infection in patients with suspected and proven COVID-19: results from an antibiotic point prevalence survey in Scottish hospitals.","Bacterial co-infection is infrequently observed with SARS-CoV-2/COVID-19 infection outside of critical care, however, antibiotics are commonly prescribed. To examine factors associated with antibiotic prescribing for suspected respiratory tract infection (RTI) and evaluate the nature and dynamics of prescribing in hospitalized patients with suspected and proven COVID-19 infection. An antibiotic point prevalence survey in hospitalized adult patients was conducted in designated COVID-19 clinical a","2021","07","06","JAC Antimicrob Resist","JAC-antimicrobial resistance",NA,"Cooper","Lesley","Scottish Antimicrobial Prescribing Group, Healthcare Improvement Scotland, Delta House, 48 West Nile Street, Glasgow, G1 2NP, UK",NA
"2585","34223137","10.1093/jacamr/dlab078","Antibiotic prescribing for respiratory tract infection in patients with suspected and proven COVID-19: results from an antibiotic point prevalence survey in Scottish hospitals.","Bacterial co-infection is infrequently observed with SARS-CoV-2/COVID-19 infection outside of critical care, however, antibiotics are commonly prescribed. To examine factors associated with antibiotic prescribing for suspected respiratory tract infection (RTI) and evaluate the nature and dynamics of prescribing in hospitalized patients with suspected and proven COVID-19 infection. An antibiotic point prevalence survey in hospitalized adult patients was conducted in designated COVID-19 clinical a","2021","07","06","JAC Antimicrob Resist","JAC-antimicrobial resistance",NA,"Gibbons","Cheryl L","Public Health Scotland, NHS National Services Scotland, Meridian Court, 5 Cadogan Street, Glasgow, G2 6QE, UK",NA
"2586","34223137","10.1093/jacamr/dlab078","Antibiotic prescribing for respiratory tract infection in patients with suspected and proven COVID-19: results from an antibiotic point prevalence survey in Scottish hospitals.","Bacterial co-infection is infrequently observed with SARS-CoV-2/COVID-19 infection outside of critical care, however, antibiotics are commonly prescribed. To examine factors associated with antibiotic prescribing for suspected respiratory tract infection (RTI) and evaluate the nature and dynamics of prescribing in hospitalized patients with suspected and proven COVID-19 infection. An antibiotic point prevalence survey in hospitalized adult patients was conducted in designated COVID-19 clinical a","2021","07","06","JAC Antimicrob Resist","JAC-antimicrobial resistance",NA,"Malcolm","William","ARHAI Scotland, NHS National Services Scotland, Meridian Court, 5 Cadogan Street, Glasgow, G2 6QE, UK",NA
"2587","34223137","10.1093/jacamr/dlab078","Antibiotic prescribing for respiratory tract infection in patients with suspected and proven COVID-19: results from an antibiotic point prevalence survey in Scottish hospitals.","Bacterial co-infection is infrequently observed with SARS-CoV-2/COVID-19 infection outside of critical care, however, antibiotics are commonly prescribed. To examine factors associated with antibiotic prescribing for suspected respiratory tract infection (RTI) and evaluate the nature and dynamics of prescribing in hospitalized patients with suspected and proven COVID-19 infection. An antibiotic point prevalence survey in hospitalized adult patients was conducted in designated COVID-19 clinical a","2021","07","06","JAC Antimicrob Resist","JAC-antimicrobial resistance",NA,"Choo-Kang","Brian","Respiratory Medicine Unit, Glasgow Royal Infirmary, 84 Castle Street, Glasgow, G4 0SF, UK",NA
"2588","34223137","10.1093/jacamr/dlab078","Antibiotic prescribing for respiratory tract infection in patients with suspected and proven COVID-19: results from an antibiotic point prevalence survey in Scottish hospitals.","Bacterial co-infection is infrequently observed with SARS-CoV-2/COVID-19 infection outside of critical care, however, antibiotics are commonly prescribed. To examine factors associated with antibiotic prescribing for suspected respiratory tract infection (RTI) and evaluate the nature and dynamics of prescribing in hospitalized patients with suspected and proven COVID-19 infection. An antibiotic point prevalence survey in hospitalized adult patients was conducted in designated COVID-19 clinical a","2021","07","06","JAC Antimicrob Resist","JAC-antimicrobial resistance",NA,"Griffith","David","Department of Microbiology, Victoria Infirmary, Hayfield Road, Kirkcaldy, KY2 5AH, UK",NA
"2589","34223137","10.1093/jacamr/dlab078","Antibiotic prescribing for respiratory tract infection in patients with suspected and proven COVID-19: results from an antibiotic point prevalence survey in Scottish hospitals.","Bacterial co-infection is infrequently observed with SARS-CoV-2/COVID-19 infection outside of critical care, however, antibiotics are commonly prescribed. To examine factors associated with antibiotic prescribing for suspected respiratory tract infection (RTI) and evaluate the nature and dynamics of prescribing in hospitalized patients with suspected and proven COVID-19 infection. An antibiotic point prevalence survey in hospitalized adult patients was conducted in designated COVID-19 clinical a","2021","07","06","JAC Antimicrob Resist","JAC-antimicrobial resistance",NA,"Dundas","Stephanie","Infection Unit, University Hospital Monklands, Monkscourt Avenue, Airdrie, ML6 OJS, UK",NA
"2590","34223137","10.1093/jacamr/dlab078","Antibiotic prescribing for respiratory tract infection in patients with suspected and proven COVID-19: results from an antibiotic point prevalence survey in Scottish hospitals.","Bacterial co-infection is infrequently observed with SARS-CoV-2/COVID-19 infection outside of critical care, however, antibiotics are commonly prescribed. To examine factors associated with antibiotic prescribing for suspected respiratory tract infection (RTI) and evaluate the nature and dynamics of prescribing in hospitalized patients with suspected and proven COVID-19 infection. An antibiotic point prevalence survey in hospitalized adult patients was conducted in designated COVID-19 clinical a","2021","07","06","JAC Antimicrob Resist","JAC-antimicrobial resistance",NA,"Brittain","Suzanne","Antimicrobial Management Team, Aberdeen Royal Infirmary, Foresterhill Health Campus, Foresterhill Road, Aberdeen, AB25 2ZN, UK",NA
"2591","34223137","10.1093/jacamr/dlab078","Antibiotic prescribing for respiratory tract infection in patients with suspected and proven COVID-19: results from an antibiotic point prevalence survey in Scottish hospitals.","Bacterial co-infection is infrequently observed with SARS-CoV-2/COVID-19 infection outside of critical care, however, antibiotics are commonly prescribed. To examine factors associated with antibiotic prescribing for suspected respiratory tract infection (RTI) and evaluate the nature and dynamics of prescribing in hospitalized patients with suspected and proven COVID-19 infection. An antibiotic point prevalence survey in hospitalized adult patients was conducted in designated COVID-19 clinical a","2021","07","06","JAC Antimicrob Resist","JAC-antimicrobial resistance",NA,"Hamilton","Kayleigh","Antimicrobial Management Team, University Hospital Crosshouse, Kilmarnock Road, Crosshouse, Kilmarnock, KA2 0BE, UK",NA
"2592","34223137","10.1093/jacamr/dlab078","Antibiotic prescribing for respiratory tract infection in patients with suspected and proven COVID-19: results from an antibiotic point prevalence survey in Scottish hospitals.","Bacterial co-infection is infrequently observed with SARS-CoV-2/COVID-19 infection outside of critical care, however, antibiotics are commonly prescribed. To examine factors associated with antibiotic prescribing for suspected respiratory tract infection (RTI) and evaluate the nature and dynamics of prescribing in hospitalized patients with suspected and proven COVID-19 infection. An antibiotic point prevalence survey in hospitalized adult patients was conducted in designated COVID-19 clinical a","2021","07","06","JAC Antimicrob Resist","JAC-antimicrobial resistance",NA,"Jeffreys","Danielle","Respiratory Medicine Unit, Raigmore Hospital, Old Perth Road, Inverness, IV2 3UJ",NA
"2593","34223137","10.1093/jacamr/dlab078","Antibiotic prescribing for respiratory tract infection in patients with suspected and proven COVID-19: results from an antibiotic point prevalence survey in Scottish hospitals.","Bacterial co-infection is infrequently observed with SARS-CoV-2/COVID-19 infection outside of critical care, however, antibiotics are commonly prescribed. To examine factors associated with antibiotic prescribing for suspected respiratory tract infection (RTI) and evaluate the nature and dynamics of prescribing in hospitalized patients with suspected and proven COVID-19 infection. An antibiotic point prevalence survey in hospitalized adult patients was conducted in designated COVID-19 clinical a","2021","07","06","JAC Antimicrob Resist","JAC-antimicrobial resistance",NA,"McKinney","Rachel","Regional Infectious Diseases Unit, Western General Hospital, Crewe Road South, Edinburgh, EH4 2XU, UK",NA
"2594","34223137","10.1093/jacamr/dlab078","Antibiotic prescribing for respiratory tract infection in patients with suspected and proven COVID-19: results from an antibiotic point prevalence survey in Scottish hospitals.","Bacterial co-infection is infrequently observed with SARS-CoV-2/COVID-19 infection outside of critical care, however, antibiotics are commonly prescribed. To examine factors associated with antibiotic prescribing for suspected respiratory tract infection (RTI) and evaluate the nature and dynamics of prescribing in hospitalized patients with suspected and proven COVID-19 infection. An antibiotic point prevalence survey in hospitalized adult patients was conducted in designated COVID-19 clinical a","2021","07","06","JAC Antimicrob Resist","JAC-antimicrobial resistance",NA,"Guthrie","Debbie","Pharmacy Department, Ninewells Hospital, James Arrott Drive, Dundee, DD2 1SG, UK",NA
"2595","34223137","10.1093/jacamr/dlab078","Antibiotic prescribing for respiratory tract infection in patients with suspected and proven COVID-19: results from an antibiotic point prevalence survey in Scottish hospitals.","Bacterial co-infection is infrequently observed with SARS-CoV-2/COVID-19 infection outside of critical care, however, antibiotics are commonly prescribed. To examine factors associated with antibiotic prescribing for suspected respiratory tract infection (RTI) and evaluate the nature and dynamics of prescribing in hospitalized patients with suspected and proven COVID-19 infection. An antibiotic point prevalence survey in hospitalized adult patients was conducted in designated COVID-19 clinical a","2021","07","06","JAC Antimicrob Resist","JAC-antimicrobial resistance",NA,"Sneddon","Jacqueline","Scottish Antimicrobial Prescribing Group, Healthcare Improvement Scotland, Delta House, 48 West Nile Street, Glasgow, G1 2NP, UK",NA
"2596","34223134","10.1093/jacamr/dlab073","Antibacterial use in the age of SARS-CoV-2.","Balancing the use of antibacterial therapy against selection for resistance in this pandemic era has introduced both questions and guidelines. In this project, we explored how prescription of empirical antibacterial therapy differs between those with and without SARS-CoV-2 infection. Multivariable logistic regression was used to determine whether COVID-19 status and other factors play a role in the prescription of antibacterial therapy in an inpatient setting at a large referral academic medical","2021","07","06","JAC Antimicrob Resist","JAC-antimicrobial resistance",NA,"Angell","Kathleen E","Department of Epidemiology, College of Public Health, University of Nebraska Medical Center, Omaha, NE, USA",NA
"2597","34223134","10.1093/jacamr/dlab073","Antibacterial use in the age of SARS-CoV-2.","Balancing the use of antibacterial therapy against selection for resistance in this pandemic era has introduced both questions and guidelines. In this project, we explored how prescription of empirical antibacterial therapy differs between those with and without SARS-CoV-2 infection. Multivariable logistic regression was used to determine whether COVID-19 status and other factors play a role in the prescription of antibacterial therapy in an inpatient setting at a large referral academic medical","2021","07","06","JAC Antimicrob Resist","JAC-antimicrobial resistance",NA,"Lawler","James V","Global Center for Health Security, University of Nebraska Medical Center, Omaha, NE, USA",NA
"2598","34223134","10.1093/jacamr/dlab073","Antibacterial use in the age of SARS-CoV-2.","Balancing the use of antibacterial therapy against selection for resistance in this pandemic era has introduced both questions and guidelines. In this project, we explored how prescription of empirical antibacterial therapy differs between those with and without SARS-CoV-2 infection. Multivariable logistic regression was used to determine whether COVID-19 status and other factors play a role in the prescription of antibacterial therapy in an inpatient setting at a large referral academic medical","2021","07","06","JAC Antimicrob Resist","JAC-antimicrobial resistance",NA,"Hewlett","Angela L","Division of Infectious Diseases, Department of Internal Medicine, College of Medicine, University of Nebraska Medical Center, Omaha, NE, USA",NA
"2599","34223134","10.1093/jacamr/dlab073","Antibacterial use in the age of SARS-CoV-2.","Balancing the use of antibacterial therapy against selection for resistance in this pandemic era has introduced both questions and guidelines. In this project, we explored how prescription of empirical antibacterial therapy differs between those with and without SARS-CoV-2 infection. Multivariable logistic regression was used to determine whether COVID-19 status and other factors play a role in the prescription of antibacterial therapy in an inpatient setting at a large referral academic medical","2021","07","06","JAC Antimicrob Resist","JAC-antimicrobial resistance",NA,"Rupp","Mark E","Division of Infectious Diseases, Department of Internal Medicine, College of Medicine, University of Nebraska Medical Center, Omaha, NE, USA",NA
"2600","34223134","10.1093/jacamr/dlab073","Antibacterial use in the age of SARS-CoV-2.","Balancing the use of antibacterial therapy against selection for resistance in this pandemic era has introduced both questions and guidelines. In this project, we explored how prescription of empirical antibacterial therapy differs between those with and without SARS-CoV-2 infection. Multivariable logistic regression was used to determine whether COVID-19 status and other factors play a role in the prescription of antibacterial therapy in an inpatient setting at a large referral academic medical","2021","07","06","JAC Antimicrob Resist","JAC-antimicrobial resistance",NA,"Bergman","Scott J","Antimicrobial Stewardship Program, Nebraska Medicine, Omaha, NE, USA",NA
"2601","34223134","10.1093/jacamr/dlab073","Antibacterial use in the age of SARS-CoV-2.","Balancing the use of antibacterial therapy against selection for resistance in this pandemic era has introduced both questions and guidelines. In this project, we explored how prescription of empirical antibacterial therapy differs between those with and without SARS-CoV-2 infection. Multivariable logistic regression was used to determine whether COVID-19 status and other factors play a role in the prescription of antibacterial therapy in an inpatient setting at a large referral academic medical","2021","07","06","JAC Antimicrob Resist","JAC-antimicrobial resistance",NA,"Van Schooneveld","Trevor C","Division of Infectious Diseases, Department of Internal Medicine, College of Medicine, University of Nebraska Medical Center, Omaha, NE, USA",NA
"2602","34223134","10.1093/jacamr/dlab073","Antibacterial use in the age of SARS-CoV-2.","Balancing the use of antibacterial therapy against selection for resistance in this pandemic era has introduced both questions and guidelines. In this project, we explored how prescription of empirical antibacterial therapy differs between those with and without SARS-CoV-2 infection. Multivariable logistic regression was used to determine whether COVID-19 status and other factors play a role in the prescription of antibacterial therapy in an inpatient setting at a large referral academic medical","2021","07","06","JAC Antimicrob Resist","JAC-antimicrobial resistance",NA,"Broadhurst","M Jana","Global Center for Health Security, University of Nebraska Medical Center, Omaha, NE, USA",NA
"2603","34223134","10.1093/jacamr/dlab073","Antibacterial use in the age of SARS-CoV-2.","Balancing the use of antibacterial therapy against selection for resistance in this pandemic era has introduced both questions and guidelines. In this project, we explored how prescription of empirical antibacterial therapy differs between those with and without SARS-CoV-2 infection. Multivariable logistic regression was used to determine whether COVID-19 status and other factors play a role in the prescription of antibacterial therapy in an inpatient setting at a large referral academic medical","2021","07","06","JAC Antimicrob Resist","JAC-antimicrobial resistance",NA,"Brett-Major","David M","Department of Epidemiology, College of Public Health, University of Nebraska Medical Center, Omaha, NE, USA",NA
"2604","34222864","10.1093/braincomms/fcab012","Neurological and mental health consequences of COVID-19: potential implications for well-being and labour force.","Recent case studies show that the SARS-CoV-2 infectious disease, COVID-19, is associated with accelerated decline of mental health, in particular, cognition in elderly individuals, but also with neurological and neuropsychiatric illness in young people. Recent studies also show a bidirectional link between COVID-19 and mental health in that people with previous history of psychiatric illness have a higher risk for contracting COVID-19 and that COVID-19 patients display a variety of psychiatric i","2021","07","06","Brain Commun","Brain communications","Alzheimers disease; COVID-19; cognitive decline; post-operative cognitive dysfunction; production loss","Meier","Irene Beatrix","Chione GmbH, 8122 Binz, Switzerland",NA
"2605","34222864","10.1093/braincomms/fcab012","Neurological and mental health consequences of COVID-19: potential implications for well-being and labour force.","Recent case studies show that the SARS-CoV-2 infectious disease, COVID-19, is associated with accelerated decline of mental health, in particular, cognition in elderly individuals, but also with neurological and neuropsychiatric illness in young people. Recent studies also show a bidirectional link between COVID-19 and mental health in that people with previous history of psychiatric illness have a higher risk for contracting COVID-19 and that COVID-19 patients display a variety of psychiatric i","2021","07","06","Brain Commun","Brain communications","Alzheimers disease; COVID-19; cognitive decline; post-operative cognitive dysfunction; production loss","Vieira Ligo Teixeira","Camila","Brazilian Institute of Neuroscience and Neurotechnology, 3448433 São Paulo, Brazil",NA
"2606","34222864","10.1093/braincomms/fcab012","Neurological and mental health consequences of COVID-19: potential implications for well-being and labour force.","Recent case studies show that the SARS-CoV-2 infectious disease, COVID-19, is associated with accelerated decline of mental health, in particular, cognition in elderly individuals, but also with neurological and neuropsychiatric illness in young people. Recent studies also show a bidirectional link between COVID-19 and mental health in that people with previous history of psychiatric illness have a higher risk for contracting COVID-19 and that COVID-19 patients display a variety of psychiatric i","2021","07","06","Brain Commun","Brain communications","Alzheimers disease; COVID-19; cognitive decline; post-operative cognitive dysfunction; production loss","Tarnanas","Ioannis","Altoida, Inc, Houston, 77027 TX, USA",NA
"2607","34222864","10.1093/braincomms/fcab012","Neurological and mental health consequences of COVID-19: potential implications for well-being and labour force.","Recent case studies show that the SARS-CoV-2 infectious disease, COVID-19, is associated with accelerated decline of mental health, in particular, cognition in elderly individuals, but also with neurological and neuropsychiatric illness in young people. Recent studies also show a bidirectional link between COVID-19 and mental health in that people with previous history of psychiatric illness have a higher risk for contracting COVID-19 and that COVID-19 patients display a variety of psychiatric i","2021","07","06","Brain Commun","Brain communications","Alzheimers disease; COVID-19; cognitive decline; post-operative cognitive dysfunction; production loss","Mirza","Fareed","Center for Global and Digital Health (CGDH), W1J 5BF London, UK",NA
"2608","34222864","10.1093/braincomms/fcab012","Neurological and mental health consequences of COVID-19: potential implications for well-being and labour force.","Recent case studies show that the SARS-CoV-2 infectious disease, COVID-19, is associated with accelerated decline of mental health, in particular, cognition in elderly individuals, but also with neurological and neuropsychiatric illness in young people. Recent studies also show a bidirectional link between COVID-19 and mental health in that people with previous history of psychiatric illness have a higher risk for contracting COVID-19 and that COVID-19 patients display a variety of psychiatric i","2021","07","06","Brain Commun","Brain communications","Alzheimers disease; COVID-19; cognitive decline; post-operative cognitive dysfunction; production loss","Rajendran","Lawrence","UK Dementia Research Institute, King's College London, WC2R 2LS London, UK",NA
"2609","34222854","10.1016/j.jvacx.2021.100106","Intentions of public school teachers in British Columbia, Canada to receive a COVID-19 vaccine.","To control the COVID-19 pandemic high vaccine acceptability and uptake will be needed. Teachers represent a priority population to minimize social disruption and ensure continuity in education, which is vital for the well-being and healthy development of youth during the pandemic. The objective of this analysis was to measure public school teachers' intentions to receive a COVID-19 vaccine in British Columbia (BC), Canada. A population-wide cross-sectional online survey from August to November 2","2021","07","09","Vaccine X","Vaccine: X","COVID-19; Health policy; Infectious disease; Public health; Vaccines","Racey","C Sarai","School of Population and Public Health, University of British Columbia, Vancouver, BC, Canada",NA
"2610","34222854","10.1016/j.jvacx.2021.100106","Intentions of public school teachers in British Columbia, Canada to receive a COVID-19 vaccine.","To control the COVID-19 pandemic high vaccine acceptability and uptake will be needed. Teachers represent a priority population to minimize social disruption and ensure continuity in education, which is vital for the well-being and healthy development of youth during the pandemic. The objective of this analysis was to measure public school teachers' intentions to receive a COVID-19 vaccine in British Columbia (BC), Canada. A population-wide cross-sectional online survey from August to November 2","2021","07","09","Vaccine X","Vaccine: X","COVID-19; Health policy; Infectious disease; Public health; Vaccines","Donken","Robine","School of Population and Public Health, University of British Columbia, Vancouver, BC, Canada",NA
"2611","34222854","10.1016/j.jvacx.2021.100106","Intentions of public school teachers in British Columbia, Canada to receive a COVID-19 vaccine.","To control the COVID-19 pandemic high vaccine acceptability and uptake will be needed. Teachers represent a priority population to minimize social disruption and ensure continuity in education, which is vital for the well-being and healthy development of youth during the pandemic. The objective of this analysis was to measure public school teachers' intentions to receive a COVID-19 vaccine in British Columbia (BC), Canada. A population-wide cross-sectional online survey from August to November 2","2021","07","09","Vaccine X","Vaccine: X","COVID-19; Health policy; Infectious disease; Public health; Vaccines","Porter","Imogen","Vaccine Evaluation Center, BC Children's Hospital Research Institute, Vancouver, BC, Canada",NA
"2612","34222854","10.1016/j.jvacx.2021.100106","Intentions of public school teachers in British Columbia, Canada to receive a COVID-19 vaccine.","To control the COVID-19 pandemic high vaccine acceptability and uptake will be needed. Teachers represent a priority population to minimize social disruption and ensure continuity in education, which is vital for the well-being and healthy development of youth during the pandemic. The objective of this analysis was to measure public school teachers' intentions to receive a COVID-19 vaccine in British Columbia (BC), Canada. A population-wide cross-sectional online survey from August to November 2","2021","07","09","Vaccine X","Vaccine: X","COVID-19; Health policy; Infectious disease; Public health; Vaccines","Albert","Arianne","Women's Health Research Institute, British Columbia Women's Hospital and Health Centre, Vancouver, BC, Canada",NA
"2613","34222854","10.1016/j.jvacx.2021.100106","Intentions of public school teachers in British Columbia, Canada to receive a COVID-19 vaccine.","To control the COVID-19 pandemic high vaccine acceptability and uptake will be needed. Teachers represent a priority population to minimize social disruption and ensure continuity in education, which is vital for the well-being and healthy development of youth during the pandemic. The objective of this analysis was to measure public school teachers' intentions to receive a COVID-19 vaccine in British Columbia (BC), Canada. A population-wide cross-sectional online survey from August to November 2","2021","07","09","Vaccine X","Vaccine: X","COVID-19; Health policy; Infectious disease; Public health; Vaccines","Bettinger","Julie A","Vaccine Evaluation Center, BC Children's Hospital Research Institute, Vancouver, BC, Canada",NA
"2614","34222854","10.1016/j.jvacx.2021.100106","Intentions of public school teachers in British Columbia, Canada to receive a COVID-19 vaccine.","To control the COVID-19 pandemic high vaccine acceptability and uptake will be needed. Teachers represent a priority population to minimize social disruption and ensure continuity in education, which is vital for the well-being and healthy development of youth during the pandemic. The objective of this analysis was to measure public school teachers' intentions to receive a COVID-19 vaccine in British Columbia (BC), Canada. A population-wide cross-sectional online survey from August to November 2","2021","07","09","Vaccine X","Vaccine: X","COVID-19; Health policy; Infectious disease; Public health; Vaccines","Mark","Jennifer","Vaccine Evaluation Center, BC Children's Hospital Research Institute, Vancouver, BC, Canada",NA
"2615","34222854","10.1016/j.jvacx.2021.100106","Intentions of public school teachers in British Columbia, Canada to receive a COVID-19 vaccine.","To control the COVID-19 pandemic high vaccine acceptability and uptake will be needed. Teachers represent a priority population to minimize social disruption and ensure continuity in education, which is vital for the well-being and healthy development of youth during the pandemic. The objective of this analysis was to measure public school teachers' intentions to receive a COVID-19 vaccine in British Columbia (BC), Canada. A population-wide cross-sectional online survey from August to November 2","2021","07","09","Vaccine X","Vaccine: X","COVID-19; Health policy; Infectious disease; Public health; Vaccines","Bonifacio","Lizl","Vaccine Evaluation Center, BC Children's Hospital Research Institute, Vancouver, BC, Canada",NA
"2616","34222854","10.1016/j.jvacx.2021.100106","Intentions of public school teachers in British Columbia, Canada to receive a COVID-19 vaccine.","To control the COVID-19 pandemic high vaccine acceptability and uptake will be needed. Teachers represent a priority population to minimize social disruption and ensure continuity in education, which is vital for the well-being and healthy development of youth during the pandemic. The objective of this analysis was to measure public school teachers' intentions to receive a COVID-19 vaccine in British Columbia (BC), Canada. A population-wide cross-sectional online survey from August to November 2","2021","07","09","Vaccine X","Vaccine: X","COVID-19; Health policy; Infectious disease; Public health; Vaccines","Dawar","Meena","School of Population and Public Health, University of British Columbia, Vancouver, BC, Canada",NA
"2617","34222854","10.1016/j.jvacx.2021.100106","Intentions of public school teachers in British Columbia, Canada to receive a COVID-19 vaccine.","To control the COVID-19 pandemic high vaccine acceptability and uptake will be needed. Teachers represent a priority population to minimize social disruption and ensure continuity in education, which is vital for the well-being and healthy development of youth during the pandemic. The objective of this analysis was to measure public school teachers' intentions to receive a COVID-19 vaccine in British Columbia (BC), Canada. A population-wide cross-sectional online survey from August to November 2","2021","07","09","Vaccine X","Vaccine: X","COVID-19; Health policy; Infectious disease; Public health; Vaccines","Gagel","Mike","Northern Health Authority, Prince George, BC, Canada",NA
"2618","34222854","10.1016/j.jvacx.2021.100106","Intentions of public school teachers in British Columbia, Canada to receive a COVID-19 vaccine.","To control the COVID-19 pandemic high vaccine acceptability and uptake will be needed. Teachers represent a priority population to minimize social disruption and ensure continuity in education, which is vital for the well-being and healthy development of youth during the pandemic. The objective of this analysis was to measure public school teachers' intentions to receive a COVID-19 vaccine in British Columbia (BC), Canada. A population-wide cross-sectional online survey from August to November 2","2021","07","09","Vaccine X","Vaccine: X","COVID-19; Health policy; Infectious disease; Public health; Vaccines","Kling","Rakel","Northern Health Authority, Prince George, BC, Canada",NA
"2619","34222854","10.1016/j.jvacx.2021.100106","Intentions of public school teachers in British Columbia, Canada to receive a COVID-19 vaccine.","To control the COVID-19 pandemic high vaccine acceptability and uptake will be needed. Teachers represent a priority population to minimize social disruption and ensure continuity in education, which is vital for the well-being and healthy development of youth during the pandemic. The objective of this analysis was to measure public school teachers' intentions to receive a COVID-19 vaccine in British Columbia (BC), Canada. A population-wide cross-sectional online survey from August to November 2","2021","07","09","Vaccine X","Vaccine: X","COVID-19; Health policy; Infectious disease; Public health; Vaccines","Mema","Silvina","School of Population and Public Health, University of British Columbia, Vancouver, BC, Canada",NA
"2620","34222854","10.1016/j.jvacx.2021.100106","Intentions of public school teachers in British Columbia, Canada to receive a COVID-19 vaccine.","To control the COVID-19 pandemic high vaccine acceptability and uptake will be needed. Teachers represent a priority population to minimize social disruption and ensure continuity in education, which is vital for the well-being and healthy development of youth during the pandemic. The objective of this analysis was to measure public school teachers' intentions to receive a COVID-19 vaccine in British Columbia (BC), Canada. A population-wide cross-sectional online survey from August to November 2","2021","07","09","Vaccine X","Vaccine: X","COVID-19; Health policy; Infectious disease; Public health; Vaccines","Mitchell","Hana","Department of Pediatrics, University of British Columbia, Vancouver, BC, Canada",NA
"2621","34222854","10.1016/j.jvacx.2021.100106","Intentions of public school teachers in British Columbia, Canada to receive a COVID-19 vaccine.","To control the COVID-19 pandemic high vaccine acceptability and uptake will be needed. Teachers represent a priority population to minimize social disruption and ensure continuity in education, which is vital for the well-being and healthy development of youth during the pandemic. The objective of this analysis was to measure public school teachers' intentions to receive a COVID-19 vaccine in British Columbia (BC), Canada. A population-wide cross-sectional online survey from August to November 2","2021","07","09","Vaccine X","Vaccine: X","COVID-19; Health policy; Infectious disease; Public health; Vaccines","Roe","Ian","BC Centre for Disease Control, Vancouver, BC, Canada",NA
"2622","34222854","10.1016/j.jvacx.2021.100106","Intentions of public school teachers in British Columbia, Canada to receive a COVID-19 vaccine.","To control the COVID-19 pandemic high vaccine acceptability and uptake will be needed. Teachers represent a priority population to minimize social disruption and ensure continuity in education, which is vital for the well-being and healthy development of youth during the pandemic. The objective of this analysis was to measure public school teachers' intentions to receive a COVID-19 vaccine in British Columbia (BC), Canada. A population-wide cross-sectional online survey from August to November 2","2021","07","09","Vaccine X","Vaccine: X","COVID-19; Health policy; Infectious disease; Public health; Vaccines","Ogilvie","Gina","School of Population and Public Health, University of British Columbia, Vancouver, BC, Canada",NA
"2623","34222854","10.1016/j.jvacx.2021.100106","Intentions of public school teachers in British Columbia, Canada to receive a COVID-19 vaccine.","To control the COVID-19 pandemic high vaccine acceptability and uptake will be needed. Teachers represent a priority population to minimize social disruption and ensure continuity in education, which is vital for the well-being and healthy development of youth during the pandemic. The objective of this analysis was to measure public school teachers' intentions to receive a COVID-19 vaccine in British Columbia (BC), Canada. A population-wide cross-sectional online survey from August to November 2","2021","07","09","Vaccine X","Vaccine: X","COVID-19; Health policy; Infectious disease; Public health; Vaccines","Sadarangani","Manish","Vaccine Evaluation Center, BC Children's Hospital Research Institute, Vancouver, BC, Canada",NA
"2624","34222853","10.1016/j.medntd.2021.100084","A colloidal gold-based immunochromatographic strip for rapid detection of SARS-CoV-2 antibodies after vaccination.","Vaccination interventions is consideredan important preventive measure to block the transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and protect the organism from pathogen infection effectively. However, a quick and accurate technique to evaluate the immune efficacy of the SARS-CoV-2 inactivated vaccine remains scarce. In this paper, an IgM-IgG antibody combined detection colloidal gold immunochromatography assay kit was optimized and developed, which can assess the e","2021","07","19","Med Nov Technol Devices","Medicine in novel technology and devices","Colloidal gold immunization; IgM-IgG antibody; Inactivated SARS-CoV-2 vaccine","Liu","Jia","Interdisciplinary Institute of Cancer Diagnosis and Treatment, Beijing Advanced Innovation Center for Biomedical Engineering, Beihang University, Beijing, China",NA
"2625","34222853","10.1016/j.medntd.2021.100084","A colloidal gold-based immunochromatographic strip for rapid detection of SARS-CoV-2 antibodies after vaccination.","Vaccination interventions is consideredan important preventive measure to block the transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and protect the organism from pathogen infection effectively. However, a quick and accurate technique to evaluate the immune efficacy of the SARS-CoV-2 inactivated vaccine remains scarce. In this paper, an IgM-IgG antibody combined detection colloidal gold immunochromatography assay kit was optimized and developed, which can assess the e","2021","07","19","Med Nov Technol Devices","Medicine in novel technology and devices","Colloidal gold immunization; IgM-IgG antibody; Inactivated SARS-CoV-2 vaccine","Yan","Weiqi","Interdisciplinary Institute of Cancer Diagnosis and Treatment, Beijing Advanced Innovation Center for Biomedical Engineering, Beihang University, Beijing, China",NA
"2626","34222853","10.1016/j.medntd.2021.100084","A colloidal gold-based immunochromatographic strip for rapid detection of SARS-CoV-2 antibodies after vaccination.","Vaccination interventions is consideredan important preventive measure to block the transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and protect the organism from pathogen infection effectively. However, a quick and accurate technique to evaluate the immune efficacy of the SARS-CoV-2 inactivated vaccine remains scarce. In this paper, an IgM-IgG antibody combined detection colloidal gold immunochromatography assay kit was optimized and developed, which can assess the e","2021","07","19","Med Nov Technol Devices","Medicine in novel technology and devices","Colloidal gold immunization; IgM-IgG antibody; Inactivated SARS-CoV-2 vaccine","Liu","Zhuojun","Interdisciplinary Institute of Cancer Diagnosis and Treatment, Beijing Advanced Innovation Center for Biomedical Engineering, Beihang University, Beijing, China",NA
"2627","34222853","10.1016/j.medntd.2021.100084","A colloidal gold-based immunochromatographic strip for rapid detection of SARS-CoV-2 antibodies after vaccination.","Vaccination interventions is consideredan important preventive measure to block the transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and protect the organism from pathogen infection effectively. However, a quick and accurate technique to evaluate the immune efficacy of the SARS-CoV-2 inactivated vaccine remains scarce. In this paper, an IgM-IgG antibody combined detection colloidal gold immunochromatography assay kit was optimized and developed, which can assess the e","2021","07","19","Med Nov Technol Devices","Medicine in novel technology and devices","Colloidal gold immunization; IgM-IgG antibody; Inactivated SARS-CoV-2 vaccine","Han","Yizhao","Interdisciplinary Institute of Cancer Diagnosis and Treatment, Beijing Advanced Innovation Center for Biomedical Engineering, Beihang University, Beijing, China",NA
"2628","34222853","10.1016/j.medntd.2021.100084","A colloidal gold-based immunochromatographic strip for rapid detection of SARS-CoV-2 antibodies after vaccination.","Vaccination interventions is consideredan important preventive measure to block the transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and protect the organism from pathogen infection effectively. However, a quick and accurate technique to evaluate the immune efficacy of the SARS-CoV-2 inactivated vaccine remains scarce. In this paper, an IgM-IgG antibody combined detection colloidal gold immunochromatography assay kit was optimized and developed, which can assess the e","2021","07","19","Med Nov Technol Devices","Medicine in novel technology and devices","Colloidal gold immunization; IgM-IgG antibody; Inactivated SARS-CoV-2 vaccine","Xia","Yuanshi","Interdisciplinary Institute of Cancer Diagnosis and Treatment, Beijing Advanced Innovation Center for Biomedical Engineering, Beihang University, Beijing, China",NA
"2629","34222853","10.1016/j.medntd.2021.100084","A colloidal gold-based immunochromatographic strip for rapid detection of SARS-CoV-2 antibodies after vaccination.","Vaccination interventions is consideredan important preventive measure to block the transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and protect the organism from pathogen infection effectively. However, a quick and accurate technique to evaluate the immune efficacy of the SARS-CoV-2 inactivated vaccine remains scarce. In this paper, an IgM-IgG antibody combined detection colloidal gold immunochromatography assay kit was optimized and developed, which can assess the e","2021","07","19","Med Nov Technol Devices","Medicine in novel technology and devices","Colloidal gold immunization; IgM-IgG antibody; Inactivated SARS-CoV-2 vaccine","Yu","Jian","Interdisciplinary Institute of Cancer Diagnosis and Treatment, Beijing Advanced Innovation Center for Biomedical Engineering, Beihang University, Beijing, China",NA
"2630","34222852","10.1016/j.metop.2021.100103","Roles of existing drug and drug targets for COVID-19 management.","In December 2019, a highly transmissible, pneumonia epidemic caused by a novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), erupted in China and other countries, resulting in devastation and health crisis worldwide currently. The search and using existing drugs support to curb the current highly contagious viral infection is spirally increasing since the pandemic began. This is based on these drugs had against other related RNA-viruses such as MERS-Cov, and SARS-Cov","2021","07","06","Metabol Open","Metabolism open","3CLpro, 3-chymotrypsin-like protease; AAK1, adaptor-associated kinase 1; ACE-2, Angiotensin-Converting Enzyme-2; CEF, Cepharanthine; COVID-19; COVID-19, coronavirus disease-2019; Existing drug; GAK, cyclin G-associated kinase; MERS-CoV, Middle East respiratory syndrome coronavirus; Management; Nsp, non-structure protein; ORF, open reading frame; PLpro, papain-like protease; RdRp, RNA-dependence RNA-polymerase; SARS-COV-2, severe acute respiratory syndrome coronavirus-2; TMPRSS2, transmembrane Serine Protease 2; TPC2, two-pore channel 2; Therapeutic target","Ayele","Akeberegn Gorems","Department of Pharmacology and Clinical Pharmacy, School of Pharmacy, College of Health Science, Addis Ababa University, Addis Ababa, Ethiopia",NA
"2631","34222852","10.1016/j.metop.2021.100103","Roles of existing drug and drug targets for COVID-19 management.","In December 2019, a highly transmissible, pneumonia epidemic caused by a novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), erupted in China and other countries, resulting in devastation and health crisis worldwide currently. The search and using existing drugs support to curb the current highly contagious viral infection is spirally increasing since the pandemic began. This is based on these drugs had against other related RNA-viruses such as MERS-Cov, and SARS-Cov","2021","07","06","Metabol Open","Metabolism open","3CLpro, 3-chymotrypsin-like protease; AAK1, adaptor-associated kinase 1; ACE-2, Angiotensin-Converting Enzyme-2; CEF, Cepharanthine; COVID-19; COVID-19, coronavirus disease-2019; Existing drug; GAK, cyclin G-associated kinase; MERS-CoV, Middle East respiratory syndrome coronavirus; Management; Nsp, non-structure protein; ORF, open reading frame; PLpro, papain-like protease; RdRp, RNA-dependence RNA-polymerase; SARS-COV-2, severe acute respiratory syndrome coronavirus-2; TMPRSS2, transmembrane Serine Protease 2; TPC2, two-pore channel 2; Therapeutic target","Enyew","Engidaw Fentahun","Department of Human Anatomy, School of Medicine, College of Medicine and Health Sciences, Gondar, Ethiopia",NA
"2632","34222852","10.1016/j.metop.2021.100103","Roles of existing drug and drug targets for COVID-19 management.","In December 2019, a highly transmissible, pneumonia epidemic caused by a novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), erupted in China and other countries, resulting in devastation and health crisis worldwide currently. The search and using existing drugs support to curb the current highly contagious viral infection is spirally increasing since the pandemic began. This is based on these drugs had against other related RNA-viruses such as MERS-Cov, and SARS-Cov","2021","07","06","Metabol Open","Metabolism open","3CLpro, 3-chymotrypsin-like protease; AAK1, adaptor-associated kinase 1; ACE-2, Angiotensin-Converting Enzyme-2; CEF, Cepharanthine; COVID-19; COVID-19, coronavirus disease-2019; Existing drug; GAK, cyclin G-associated kinase; MERS-CoV, Middle East respiratory syndrome coronavirus; Management; Nsp, non-structure protein; ORF, open reading frame; PLpro, papain-like protease; RdRp, RNA-dependence RNA-polymerase; SARS-COV-2, severe acute respiratory syndrome coronavirus-2; TMPRSS2, transmembrane Serine Protease 2; TPC2, two-pore channel 2; Therapeutic target","Kifle","Zemene Demelash","Department of Pharmacology, School of Pharmacy, College of Medicine and Health Science, University of Gondar, Gondar, Ethiopia",NA
